data_7acs_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 7acs _Structure_validation_residue.Date_analyzed 2020-11-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.454 0 CA-C-O 120.832 0.349 . . . . 2.48 110.715 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -78.24 136.19 37.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 2.57 110.778 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -71.93 -15.5 62.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 2.4 111.634 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.69 172.27 8.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.952 -0.567 . . . . 2.02 109.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 p -75.55 -170.14 1.19 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.001 0.429 . . . . 2.65 110.709 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.58 -168.62 1.33 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.956 0.408 . . . . 2.4 110.885 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.578 HD21 HD23 ' A' ' 119' ' ' LEU . 77.3 mt -128.67 105.76 8.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.404 -0.591 . . . . 2.27 109.404 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -83.49 122.51 28.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.33 -0.396 . . . . 2.86 111.197 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.1 tp-100 -97.67 133.71 41.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.555 . . . . 2.89 111.182 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -128.22 76.32 1.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.237 -0.653 . . . . 4.07 109.237 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.41 -135.48 1.87 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.522 -0.847 . . . . 3.23 112.789 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -114.92 -38.88 3.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.092 0.472 . . . . 4.51 111.577 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -78.38 170.77 16.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.817 -0.629 . . . . 3.32 111.497 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.08 -92.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.17 -0.678 . . . . 2.41 109.17 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.414 HD12 ' CE1' ' A' ' 131' ' ' PHE . 39.8 tp -169.12 134.79 1.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.515 . . . . 2.18 109.975 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -153.37 113.4 3.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.199 -0.455 . . . . 2.46 110.166 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -100.86 145.68 30.79 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 1.78 110.066 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 51.1 Cg_endo -70.89 158.91 54.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.62 2.213 . . . . 2.15 111.608 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -62.77 113.98 3.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 2.84 110.923 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.12 -13.9 26.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.767 -0.73 . . . . 1.65 111.678 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.49 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 38.9 mt-30 -122.04 168.23 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 2.57 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.84 -10.19 29.79 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.335 -0.706 . . . . 1.42 111.335 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.58 115.01 64.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 1.09 109.629 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.12 -179.97 4.85 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.513 2.142 . . . . 1.27 112.159 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.25 83.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.197 -0.456 . . . . 1.7 110.364 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -83.33 83.73 7.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.955 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -7.77 54.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.866 -0.607 . . . . 1.96 111.264 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -90.08 -22.49 21.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.344 -0.389 . . . . 2.0 111.742 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.97 168.68 9.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.145 0.498 . . . . 1.44 112.187 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.05 167.15 22.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 2.06 110.089 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.4 -39.14 92.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 1.42 113.005 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -16.93 61.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.045 0.45 . . . . 1.78 110.815 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.643 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 41.8 m-20 -88.73 2.1 53.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 1.6 111.004 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -80.87 58.79 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.153 0.501 . . . . 1.19 111.674 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.9 tt -156.13 129.91 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.615 . . . . 1.17 109.991 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.91 -149.74 6.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.335 -0.936 . . . . 0.61 112.479 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.66 158.77 44.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.133 0.492 . . . . 1.13 111.019 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.624 ' HH ' HD11 ' A' ' 119' ' ' LEU . 14.8 m-85 -103.46 133.7 48.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.831 -0.622 . . . . 1.69 109.668 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.11 117.39 29.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 2.51 110.776 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -78.31 113.55 16.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.148 0.499 . . . . 2.62 110.978 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.74 159.55 24.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.082 -0.508 . . . . 2.21 110.793 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 148.93 45.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 2.68 110.137 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HB3' HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -121.86 93.41 3.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.075 0.464 . . . . 3.78 111.357 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 1.0 OUTLIER -121.43 104.03 9.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.223 -0.444 . . . . 3.58 110.662 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.33 125.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 4.26 110.791 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 5.46 110.076 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.4 mtt . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.515 0.198 . . . . 4.48 110.86 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -54.76 -44.78 73.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.785 -0.643 . . . . 4.47 110.358 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 36.1 t70 61.35 107.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.242 0.83 . . . . 4.09 113.242 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -123.89 143.32 50.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 3.36 110.3 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.441 ' HB2' HG23 ' A' ' 17' ' ' THR . 0.3 OUTLIER -61.04 143.66 91.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 3.47 111.391 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.27 126.27 19.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.955 2.437 . . . . 2.69 111.576 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 137.32 52.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.22 111.452 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -95.03 109.7 21.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.006 -0.543 . . . . 1.95 110.832 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -81.38 143.85 31.87 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.628 -0.508 . . . . 2.76 109.628 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -87.68 119.04 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.736 0.303 . . . . 1.4 111.032 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -120.61 139.35 53.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.735 -0.469 . . . . 2.07 109.735 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -79.69 159.06 26.82 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.312 -0.255 . . . . 1.28 110.312 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -61.15 123.24 17.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.666 0.27 . . . . 1.66 110.707 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.87 24.96 26.17 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.964 -0.636 . . . . 1.66 113.449 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.441 HG23 ' HA3' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -82.73 94.13 7.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.166 0.483 . . . . 1.62 110.811 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.22 122.02 2.08 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.954 -0.641 . . . . 1.96 111.696 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.87 -29.38 89.99 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.248 2.632 . . . . 2.62 112.756 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.14 46.55 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 3.09 110.358 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 -48.9 16.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 1.87 110.345 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 36.93 86.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.744 -0.662 . . . . 1.7 112.599 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.92 97.99 47.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 1.43 111.635 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 3.9 Cg_exo -81.74 155.38 18.07 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.769 2.313 . . . . 1.62 110.19 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.0 t80 -53.81 115.25 1.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.839 0.352 . . . . 1.75 110.866 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.44 -17.17 16.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.726 -0.749 . . . . 1.44 112.575 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.548 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -58.06 127.54 32.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 1.25 111.273 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -91.71 114.51 27.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.025 -0.534 . . . . 2.21 111.026 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -137.29 153.8 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.476 -0.329 . . . . 2.11 110.547 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.64 121.27 12.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.982 -0.554 . . . . 1.7 111.028 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.9 76.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.584 -0.817 . . . . 1.32 112.205 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.1 mm -130.54 109.94 17.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.758 0.313 . . . . 1.06 110.839 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -121.34 137.84 53.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 1.3 109.3 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -93.44 143.81 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.22 0.533 . . . . 1.08 112.346 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.77 129.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.438 -0.801 . . . . 1.04 110.211 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.75 154.45 44.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.195 -0.457 . . . . 1.27 110.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.1 t -132.02 176.12 8.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.336 -0.393 . . . . 1.58 110.091 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.3 125.06 24.9 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.809 0.338 . . . . 2.64 111.127 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.31 -8.26 28.72 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.806 -0.634 . . . . 1.63 111.967 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.03 138.2 31.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.946 0.403 . . . . 1.59 111.186 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.63 155.93 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 2.15 110.747 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.5 96.76 8.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.032 0.444 . . . . 2.3 111.488 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 t -170.25 140.71 1.61 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.866 -0.606 . . . . 2.69 109.673 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.36 136.98 53.57 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.728 2.285 . . . . 2.08 111.98 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -134.75 70.07 1.45 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.414 0.626 . . . . 1.99 110.842 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -71.22 -1.3 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 2.55 112.397 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -61.92 -27.56 68.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 2.28 111.756 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.45 10.15 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 2.0 110.886 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' A' ' 75' ' ' THR . . . -104.67 39.53 2.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 2.33 111.415 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -150.47 138.88 20.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.601 0.239 . . . . 3.21 110.658 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 179.59 147.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.688 -0.687 . . . . 3.03 109.25 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -82.02 109.74 16.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.24 -0.652 . . . . 3.75 109.24 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 -26.74 41.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.735 2.29 . . . . 3.39 113.004 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.89 23.0 6.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.971 0.415 . . . . 4.05 111.658 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -146.27 -36.22 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.457 . . . . 4.78 111.01 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -122.41 132.87 54.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.877 -0.786 . . . . 3.41 108.877 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.4 -175.06 5.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.464 -0.335 . . . . 3.21 111.551 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.83 155.63 29.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 3.0 110.602 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -90.84 147.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.86 -0.422 . . . . 2.42 109.86 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.84 121.98 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 2.74 110.25 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.624 HD11 ' HH ' ' A' ' 47' ' ' TYR . 4.6 tt -64.25 108.64 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.822 -0.626 . . . . 2.19 111.128 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -119.53 148.96 42.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.023 -0.535 . . . . 2.49 110.734 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.496 HD12 HG23 ' A' ' 125' ' ' THR . 16.0 mt -98.52 146.84 32.27 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.394 -0.367 . . . . 1.96 110.602 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.84 179.66 4.6 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.844 2.362 . . . . 1.84 112.581 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.67 138.96 58.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.739 -0.664 . . . . 2.77 111.002 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.02 80.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.956 -0.64 . . . . 2.2 112.108 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 121' ' ' LEU . 1.3 m -135.26 121.51 20.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.843 0.354 . . . . 2.1 110.366 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -121.15 152.38 38.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.285 -0.416 . . . . 2.87 110.513 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.43 146.34 80.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.376 -0.374 . . . . 2.62 110.051 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.51 143.9 77.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.739 2.293 . . . . 2.77 111.795 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -61.65 111.8 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 4.28 110.834 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 136.46 -21.84 3.4 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.783 -1.327 . . . . 3.18 109.783 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 21.0 m-85 -104.31 153.5 20.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.19 -0.505 . . . . 2.93 110.341 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -135.54 162.06 33.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.191 -0.459 . . . . 3.73 110.304 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.11 126.78 33.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 2.93 111.211 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.08 103.86 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.013 -0.539 . . . . 3.64 110.464 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.67 12.2 51.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.677 -0.773 . . . . 3.27 112.482 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 120.924 0.392 . . . . 3.59 111.304 179.745 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.238 0 CA-C-O 121.034 0.445 . . . . 2.48 111.962 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.75 155.52 39.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.51 -0.768 . . . . 2.57 111.373 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -91.69 -32.46 15.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.394 0.516 . . . . 2.4 112.394 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -109.38 -179.18 3.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 2.02 111.872 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.99 165.12 24.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.547 -0.751 . . . . 2.65 110.902 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -80.73 138.6 36.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.429 -0.35 . . . . 2.4 111.601 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 131' ' ' PHE . 75.9 mt -100.34 107.45 19.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 2.27 110.071 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -87.3 116.9 25.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.904 0.383 . . . . 2.86 111.692 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -91.36 140.33 29.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.469 . . . . 2.89 110.811 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -132.66 87.74 2.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 4.07 109.964 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.52 -166.01 34.55 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.696 -0.764 . . . . 3.23 111.732 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -93.33 -16.93 24.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 4.51 111.551 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.44 177.03 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.091 -0.504 . . . . 3.32 110.565 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 2.0 t0 -98.73 -89.91 0.3 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.164 -0.68 . . . . 2.41 109.164 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.41 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 26.9 tp -172.0 135.63 0.82 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 2.18 110.694 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -155.95 143.05 19.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.571 -0.529 . . . . 2.46 109.571 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.64 147.94 51.9 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.369 -0.378 . . . . 1.78 110.305 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.66 163.26 18.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.357 2.705 . . . . 2.15 112.297 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.0 117.88 8.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.837 -0.619 . . . . 2.84 110.954 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.95 6.96 63.0 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.761 -0.733 . . . . 1.65 112.673 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -134.53 159.19 41.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.914 -0.402 . . . . 2.57 109.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.9 -10.01 7.52 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.043 -0.598 . . . . 1.42 111.613 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.18 117.78 67.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 110.085 -0.339 . . . . 1.09 110.085 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.99 -176.47 2.89 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.585 2.19 . . . . 1.27 111.791 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.55 87.91 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.128 0.49 . . . . 1.7 110.305 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -80.33 80.07 6.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.23 110.747 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.84 57.12 2.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.079 -0.509 . . . . 1.96 110.736 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -161.66 -38.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 2.0 110.629 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.93 170.54 9.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.509 . . . . 1.44 111.306 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 m -86.61 162.1 46.06 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 2.06 110.135 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.83 -32.7 92.68 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.93 2.42 . . . . 1.42 112.679 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -71.38 -22.03 61.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.464 0.649 . . . . 1.78 110.396 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.64 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 52.1 m-20 -93.11 9.83 34.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.507 -0.769 . . . . 1.6 111.429 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -83.82 54.02 2.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 1.19 110.948 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 tt -150.9 138.28 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.002 -0.544 . . . . 1.17 109.949 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.38 -136.49 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.387 -0.911 . . . . 0.61 112.433 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -160.13 174.2 14.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.052 0.453 . . . . 1.13 110.968 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -114.93 139.31 49.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.242 -0.651 . . . . 1.69 109.242 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -112.41 127.69 56.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.247 -0.433 . . . . 2.51 111.072 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -88.5 112.27 22.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.014 -0.539 . . . . 2.62 110.09 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HB2' ' HE2' ' A' ' 69' ' ' TYR . . . -125.26 156.5 38.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.037 0.446 . . . . 2.21 111.543 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.91 142.43 49.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.69 -0.687 . . . . 2.68 110.813 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -111.54 119.33 38.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.905 0.384 . . . . 3.78 111.264 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt180 -137.16 169.47 17.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 3.58 109.942 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 pt -143.76 153.12 15.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.2 -0.296 . . . . 4.26 110.2 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 5.46 109.957 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 29.2 mtt . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 110.247 -0.279 . . . . 4.48 110.247 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -64.63 -54.49 31.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.944 -0.391 . . . . 4.47 109.944 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.9 t70 52.92 74.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.744 . . . . 4.09 112.047 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.07 149.7 29.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.781 -0.645 . . . . 3.36 110.443 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.99 154.63 92.06 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.837 -0.62 . . . . 3.47 110.908 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.34 122.31 10.99 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.919 2.413 . . . . 2.69 111.486 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 97.7 mtt180 -119.84 135.57 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.005 -0.543 . . . . 3.22 110.738 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.41 ' CZ3' HG12 ' A' ' 91' ' ' ILE . 73.8 m95 -97.57 135.43 39.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.751 -0.659 . . . . 1.95 110.463 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.589 ' HE2' ' HB2' ' A' ' 50' ' ' ALA . 73.0 m-85 -117.35 145.6 43.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 2.76 110.185 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -85.78 124.61 32.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.981 0.42 . . . . 1.4 111.449 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -126.19 138.97 53.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.71 -0.677 . . . . 2.07 110.117 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.88 161.33 29.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 1.28 111.679 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.9 tt -63.27 122.11 15.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 1.66 111.051 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.33 16.58 62.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.86 -0.686 . . . . 1.66 114.147 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.44 129.23 40.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.109 0.455 . . . . 1.62 110.416 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.5 110.29 3.32 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.928 -0.869 . . . . 1.96 110.928 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.14 -29.15 54.63 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.426 2.751 . . . . 2.62 113.62 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.91 25.73 9.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.987 0.366 . . . . 3.09 111.987 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.38 -53.78 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.515 -0.312 . . . . 1.87 111.156 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.0 44.07 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.843 -0.694 . . . . 1.7 111.629 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.2 mt -117.43 107.15 45.49 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.718 0.294 . . . . 1.43 111.441 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.6 159.4 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.971 2.447 . . . . 1.62 111.158 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.448 ' HB2' HD11 ' A' ' 73' ' ' LEU . 92.6 t80 -64.37 119.16 9.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 1.75 110.845 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.21 11.1 26.49 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.495 -0.86 . . . . 1.44 112.891 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.03 172.12 13.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.702 0.251 . . . . 1.25 110.407 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -124.62 111.28 15.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.784 0.326 . . . . 2.21 110.442 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -140.99 152.51 44.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.265 -0.425 . . . . 2.11 110.155 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.65 117.94 8.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.081 -0.509 . . . . 1.7 111.329 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.24 29.24 62.6 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.64 -0.709 . . . . 1.32 113.27 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 mm -131.77 108.5 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.734 0.267 . . . . 1.06 110.863 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.41 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 12.8 pt -113.77 125.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.77 -0.455 . . . . 1.3 109.77 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -87.51 139.12 30.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.446 0.535 . . . . 1.08 112.446 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.76 150.2 31.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.82 -0.627 . . . . 1.04 110.862 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.61 177.22 10.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.33 -0.248 . . . . 1.27 110.33 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.42 163.01 40.64 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.699 -0.482 . . . . 1.58 109.699 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.51 125.95 25.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 2.64 111.246 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.94 25.97 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.806 -0.711 . . . . 1.63 112.261 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -100.29 123.86 45.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.204 -0.295 . . . . 1.59 110.204 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.62 150.23 23.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.033 0.444 . . . . 2.15 111.459 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -75.12 102.77 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.745 -0.661 . . . . 2.3 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -170.89 148.19 2.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.85 -0.796 . . . . 2.69 108.85 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.43 131.5 15.08 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.296 1.998 . . . . 2.08 112.498 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.64 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.64 66.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.513 0.673 . . . . 1.99 110.99 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -1.75 25.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.661 -0.7 . . . . 2.55 111.776 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -52.34 -28.7 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.348 0.499 . . . . 2.28 112.348 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -25.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.248 -0.433 . . . . 2.0 112.009 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.81 63.51 4.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.069 -0.586 . . . . 2.33 112.167 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.2 t -138.51 23.09 2.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.208 0.528 . . . . 3.21 110.481 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.52 125.17 25.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.93 -0.577 . . . . 3.03 111.005 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.41 118.68 72.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.149 -0.686 . . . . 3.75 109.149 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.07 -33.68 91.23 Favored 'Trans proline' 0 CA--C 1.527 0.137 0 C-N-CA 123.001 2.467 . . . . 3.39 114.25 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.62 4.62 48.04 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.618 0.599 . . . . 4.05 112.618 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -125.1 -6.37 7.22 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 4.78 111.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -155.69 137.83 14.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.024 -0.535 . . . . 3.41 109.63 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 153.79 22.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.529 -0.305 . . . . 3.21 110.726 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.67 159.26 28.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 3.0 111.103 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.7 mt -88.38 132.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.263 -0.426 . . . . 2.42 110.146 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.26 121.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.852 -0.425 . . . . 2.74 109.852 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.77 121.45 14.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 2.19 111.108 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.0 157.16 46.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.525 -0.762 . . . . 2.49 109.687 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.7 mt -112.81 146.4 35.0 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.499 -0.319 . . . . 1.96 110.413 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.88 156.85 64.29 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.452 2.101 . . . . 1.84 111.758 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -52.38 125.07 14.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.74 -0.664 . . . . 2.77 111.137 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.77 -16.29 47.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.985 -0.626 . . . . 2.2 111.881 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.23 116.84 32.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.933 0.397 . . . . 2.1 110.565 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.68 158.31 16.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.082 -0.508 . . . . 2.87 110.511 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.0 mt -81.49 150.71 67.52 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.519 -0.31 . . . . 2.62 110.464 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.02 142.11 96.39 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.675 2.25 . . . . 2.77 111.515 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.44 112.33 2.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.102 -0.499 . . . . 4.28 110.95 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.88 -9.19 40.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.967 -0.635 . . . . 3.18 111.68 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 16' ' ' LEU . 47.6 t80 -118.18 103.47 9.89 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.486 -0.561 . . . . 2.93 109.486 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -112.34 162.62 15.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.18 -0.464 . . . . 3.73 111.06 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 136' ' ' SER . . . -97.92 147.35 24.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.133 -0.485 . . . . 2.93 110.306 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.68 111.7 2.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 3.64 110.73 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.75 10.31 70.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.988 -0.625 . . . . 3.27 112.77 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 133' ' ' ALA . 22.8 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.173 0.511 . . . . 3.59 111.019 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.298 0 N-CA-C 109.748 -0.464 . . . . 2.48 109.748 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -64.62 137.93 58.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.781 0.324 . . . . 2.57 111.431 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -73.36 -26.52 61.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 2.4 110.714 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 35' ' ' ASN . 74.3 m-85 -111.04 166.6 10.92 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.038 -0.528 . . . . 2.02 112.273 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -69.67 168.73 14.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.249 -0.887 . . . . 2.65 111.18 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.25 151.6 20.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.269 0.47 . . . . 2.4 112.269 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 133' ' ' ALA . 15.9 mt -99.88 125.17 45.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 2.27 109.031 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -95.87 121.92 38.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.195 0.521 . . . . 2.86 112.233 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -89.77 134.38 34.21 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.736 -0.666 . . . . 2.89 110.076 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -140.91 73.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 4.07 109.94 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -165.15 -140.83 2.97 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.781 -0.724 . . . . 3.23 112.438 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -110.81 -18.08 13.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.721 0.296 . . . . 4.51 111.342 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.12 -174.13 2.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.182 -0.463 . . . . 3.32 111.208 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -111.38 -77.46 0.59 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 2.41 110.208 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 31.6 tp 172.55 131.23 0.02 OUTLIER 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.863 0.727 . . . . 2.18 110.018 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -157.23 130.89 8.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 2.46 109.625 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -120.97 139.51 29.34 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.234 -0.439 . . . . 1.78 110.277 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.55 164.36 34.03 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.273 1.982 . . . . 2.15 110.696 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.91 131.79 51.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.602 0.239 . . . . 2.84 110.609 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.11 6.3 61.77 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 1.65 111.659 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -144.39 159.73 42.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.818 -0.438 . . . . 2.57 109.818 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.43 -11.48 36.23 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.906 -0.664 . . . . 1.42 111.481 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.76 114.58 61.84 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.809 -0.441 . . . . 1.09 109.809 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.28 -173.13 1.7 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.564 2.176 . . . . 1.27 111.102 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mt -79.97 91.92 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.751 -0.463 . . . . 1.7 109.751 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 13' ' ' PHE . 69.0 m-80 -87.44 77.38 8.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.97 -0.559 . . . . 1.23 110.694 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 39.65 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.016 -0.538 . . . . 1.96 111.68 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.49 -10.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.42 -0.355 . . . . 2.0 111.236 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.2 166.28 16.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.612 -0.267 . . . . 1.44 110.857 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -88.01 168.23 17.39 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.304 -0.407 . . . . 2.06 110.687 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.79 -45.01 33.92 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.247 2.631 . . . . 1.42 113.855 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -72.18 -22.74 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 1.78 111.522 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.801 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 14.8 m-20 -87.05 11.61 13.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.974 -0.557 . . . . 1.6 111.43 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -83.25 -6.46 59.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.761 0.282 . . . . 1.19 111.761 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.491 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -82.93 126.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.117 0.484 . . . . 1.17 111.33 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.44 -161.08 11.67 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.683 -0.77 . . . . 0.61 112.229 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 48.6 p90 -146.42 163.12 36.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.088 0.47 . . . . 1.13 110.717 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.56 ' HH ' HD11 ' A' ' 119' ' ' LEU . 5.9 m-85 -108.52 133.99 51.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.805 -0.634 . . . . 1.69 109.585 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -114.68 134.63 54.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.361 . . . . 2.51 111.234 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -85.38 123.73 31.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 2.62 110.245 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.605 0.24 . . . . 2.21 110.957 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.42 93.06 1.93 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.118 -0.492 . . . . 2.68 110.726 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -78.64 124.86 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.281 0.562 . . . . 3.78 111.826 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -141.71 117.65 10.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.901 -0.591 . . . . 3.58 109.991 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.3 pt -65.19 171.19 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.185 -0.461 . . . . 4.26 110.713 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.061 0.457 . . . . 5.46 112.149 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.781 -0.451 . . . . 4.48 109.781 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -57.13 -53.31 59.54 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.332 0.395 . . . . 4.47 110.906 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.9 t70 56.0 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.93 0.715 . . . . 4.09 112.93 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.9 mt -84.85 152.74 23.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 3.36 110.691 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -75.21 162.83 71.51 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.646 . . . . 3.47 109.989 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.95 111.06 0.66 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.64 2.227 . . . . 2.69 111.848 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.47 137.56 52.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.97 -0.559 . . . . 3.22 110.762 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -104.77 129.64 52.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.84 -0.618 . . . . 1.95 110.944 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -110.13 140.65 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 2.76 110.001 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -89.97 120.08 30.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 1.4 111.186 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.37 130.41 52.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 2.07 109.939 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -67.3 151.1 48.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.56 -0.291 . . . . 1.28 111.129 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.11 116.52 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 1.66 110.805 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.89 -4.29 24.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.474 -0.87 . . . . 1.66 112.901 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -63.74 123.54 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.64 0.257 . . . . 1.62 110.492 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.98 106.87 3.01 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.081 -0.807 . . . . 1.96 111.081 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -35.2 91.15 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.089 2.526 . . . . 2.62 113.062 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.72 21.98 13.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.473 -0.331 . . . . 3.09 111.619 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.33 -50.1 61.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 1.87 110.83 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.32 49.03 59.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.019 -0.61 . . . . 1.7 111.812 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 mt -118.44 91.68 41.85 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.692 0.282 . . . . 1.43 111.56 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.27 155.02 22.02 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.443 2.095 . . . . 1.62 110.301 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -60.54 110.46 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.772 0.32 . . . . 1.75 110.857 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.59 -14.49 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.869 -0.681 . . . . 1.44 112.393 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.62 147.21 49.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.809 0.338 . . . . 1.25 111.286 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -111.08 103.14 11.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.055 0.455 . . . . 2.21 111.424 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -125.77 149.43 48.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 2.11 109.712 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.75 118.62 5.91 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.455 0.472 . . . . 1.7 111.935 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.58 35.45 51.52 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.941 -0.572 . . . . 1.32 112.981 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.4 mm -134.87 113.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.544 0.212 . . . . 1.06 110.474 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.6 pt -119.9 134.67 62.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 110.444 -0.206 . . . . 1.3 110.444 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.408 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 70.2 m95 -95.34 140.98 29.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.403 -0.362 . . . . 1.08 111.907 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 m -134.22 125.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 1.04 110.394 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.9 158.7 40.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.013 0.435 . . . . 1.27 111.79 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 t -139.04 163.34 32.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.569 -0.9 . . . . 1.58 108.569 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.61 121.46 15.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 2.64 110.58 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.03 -17.91 12.61 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.992 -0.843 . . . . 1.63 110.992 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -81.97 121.08 26.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.857 0.36 . . . . 1.59 110.062 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -88.65 130.58 35.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.143 -0.481 . . . . 2.15 110.603 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -71.45 97.0 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.125 0.488 . . . . 2.3 110.9 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.494 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.6 t -168.41 143.44 2.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.863 -0.791 . . . . 2.69 108.863 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.89 128.7 25.05 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.605 2.204 . . . . 2.08 113.516 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.801 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -129.5 78.93 1.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.525 0.679 . . . . 1.99 110.244 178.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.6 -11.11 59.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 2.55 111.492 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -58.28 -22.86 54.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.73 0.641 . . . . 2.28 112.73 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.28 0.68 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.089 0.471 . . . . 2.0 110.97 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.94 -35.42 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.871 -0.681 . . . . 2.33 111.5 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 t -71.27 115.66 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.355 0.598 . . . . 3.21 110.623 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -154.22 138.66 16.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 3.03 110.159 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -94.75 108.04 34.77 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.863 -0.421 . . . . 3.75 109.863 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.79 -29.19 68.23 Favored 'Trans proline' 0 N--CA 1.47 0.124 0 C-N-CA 123.238 2.625 . . . . 3.39 113.451 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.99 12.71 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.113 0.412 . . . . 4.05 112.113 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -135.95 -43.0 0.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 4.78 110.777 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -103.33 134.58 46.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.555 -0.535 . . . . 3.41 109.555 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.92 150.67 25.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 3.21 111.24 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.05 158.93 19.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 3.0 111.258 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.33 145.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 2.42 109.712 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.01 118.66 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.63 0.252 . . . . 2.74 110.749 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.56 HD11 ' HH ' ' A' ' 47' ' ' TYR . 5.7 tt -65.45 117.72 8.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.782 -0.645 . . . . 2.19 111.175 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -130.33 150.45 51.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 2.49 110.747 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 26.1 mt -97.22 138.83 21.22 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.098 -0.501 . . . . 1.96 110.107 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.24 152.98 68.39 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.683 2.255 . . . . 1.84 111.775 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -50.5 124.12 10.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 2.77 111.277 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.91 -22.13 16.9 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.148 -0.781 . . . . 2.2 111.148 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -99.98 120.29 39.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.656 -0.498 . . . . 2.1 109.656 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.4 139.03 38.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.179 -0.464 . . . . 2.87 111.06 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.2 mt -72.61 146.39 88.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.81 149.23 26.2 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.646 2.23 . . . . 2.77 111.417 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.39 108.98 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.293 0.479 . . . . 4.28 112.293 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.12 6.03 54.13 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.735 -0.666 . . . . 3.18 112.998 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.02 141.87 28.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.958 0.379 . . . . 2.93 111.49 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -152.98 147.3 25.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.93 -0.577 . . . . 3.73 110.785 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.47 ' HB3' HD22 ' A' ' 16' ' ' LEU . . . -112.55 162.35 15.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.357 -0.383 . . . . 2.93 110.54 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.22 128.06 34.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.367 -0.378 . . . . 3.64 110.283 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.89 -12.35 62.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.725 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 120.839 0.352 . . . . 3.59 111.731 -179.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 0 N-CA-C 109.169 -0.678 . . . . 2.48 109.169 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 154.45 42.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.896 0.379 . . . . 2.57 111.332 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -31.45 53.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.464 0.65 . . . . 2.4 109.429 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.417 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 92.5 m-85 -114.9 176.57 5.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 2.02 109.878 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 p -69.95 167.52 17.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 2.65 110.747 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.11 18.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.472 . . . . 2.4 111.409 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.412 HD21 HD23 ' A' ' 119' ' ' LEU . 90.7 mt -107.95 115.8 30.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.144 -0.688 . . . . 2.27 109.144 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 4.6 m -93.12 132.71 37.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.155 0.502 . . . . 2.86 111.769 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -95.96 140.84 30.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.611 -0.722 . . . . 2.89 110.812 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -130.17 77.38 1.78 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.004 -0.544 . . . . 4.07 109.761 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -171.91 44.42 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.951 -0.642 . . . . 3.23 111.657 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -84.47 -23.69 29.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.027 0.441 . . . . 4.51 110.414 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.68 -179.9 6.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.626 -0.716 . . . . 3.32 110.802 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -117.96 -84.32 0.65 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.249 -0.432 . . . . 2.41 110.61 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.8 tp -175.72 129.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.18 111.072 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -152.27 88.95 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.218 -0.66 . . . . 2.46 109.218 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -72.68 142.06 83.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.277 -0.42 . . . . 1.78 111.877 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 56.2 Cg_endo -70.77 161.51 45.8 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.024 2.483 . . . . 2.15 112.426 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.59 119.58 8.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 2.84 111.784 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.63 -13.44 61.06 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.056 -0.593 . . . . 1.65 112.685 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.539 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 70.5 mt-30 -117.87 174.2 6.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.671 0.272 . . . . 2.57 110.753 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.78 -1.66 41.84 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.597 -0.811 . . . . 1.42 112.246 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 t -100.58 112.04 63.85 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.57 0.224 . . . . 1.09 110.482 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.2 174.86 9.26 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.676 2.251 . . . . 1.27 111.492 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.85 89.11 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.056 0.455 . . . . 1.7 110.642 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.88 84.8 7.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 1.23 109.63 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -66.66 -20.98 66.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.703 -0.68 . . . . 1.96 112.197 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -88.24 -11.86 45.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.319 0.488 . . . . 2.0 112.319 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.06 158.94 18.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.144 0.497 . . . . 1.44 111.993 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.06 163.02 36.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.644 -0.707 . . . . 2.06 109.34 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.17 -45.16 26.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.321 2.681 . . . . 1.42 113.315 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.25 -18.78 61.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.024 0.44 . . . . 1.78 111.411 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.12 -2.45 58.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.956 -0.566 . . . . 1.6 110.824 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -80.39 60.92 3.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.228 0.537 . . . . 1.19 110.686 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.9 tt -149.37 135.35 11.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 1.17 110.167 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.82 -146.85 6.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.129 -1.034 . . . . 0.61 112.98 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -152.76 168.46 25.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.134 0.492 . . . . 1.13 110.772 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.558 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -112.51 134.78 53.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.976 -0.557 . . . . 1.69 109.632 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -116.96 126.51 53.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.353 . . . . 2.51 111.113 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.69 132.45 34.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.085 -0.507 . . . . 2.62 110.774 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . . . -139.3 147.87 42.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.606 0.241 . . . . 2.21 110.792 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 101.05 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 2.68 110.564 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.464 ' HB3' HD13 ' A' ' 64' ' ' LEU . 6.4 tpt180 -77.53 129.24 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 3.78 111.315 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -144.58 93.35 2.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 3.58 110.884 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 62' ' ' LYS . 8.5 pt -77.51 154.01 5.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.601 -0.272 . . . . 4.26 110.382 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 5.46 110.664 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 CA--C 1.521 -0.164 0 N-CA-C 110.022 -0.362 . . . . 4.48 110.022 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.595 ' HB2' HG12 ' A' ' 54' ' ' ILE . 70.4 tttt -63.5 -43.8 96.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 4.47 111.157 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 62.77 101.01 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.511 -0.768 . . . . 4.09 112.847 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 52' ' ' ARG . 22.4 mt -117.53 150.46 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 3.36 110.5 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.93 147.61 97.83 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.215 -0.448 . . . . 3.47 110.449 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.32 120.42 8.33 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.869 2.379 . . . . 2.69 111.641 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -118.03 133.31 56.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.049 -0.523 . . . . 3.22 111.496 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.558 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 44.7 m95 -100.31 125.44 46.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.977 -0.556 . . . . 1.95 109.537 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 50' ' ' ALA . 24.7 m-85 -102.2 135.46 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.337 -0.392 . . . . 2.76 110.113 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -85.97 120.43 27.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.762 0.315 . . . . 1.4 110.65 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -118.78 144.66 46.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.996 -0.547 . . . . 2.07 109.723 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -79.45 164.49 23.92 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.136 -0.226 . . . . 1.28 110.7 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.52 117.57 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 1.66 112.073 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.15 38.89 17.34 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.749 -0.66 . . . . 1.66 113.043 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.31 70.08 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.62 111.234 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.64 121.56 0.58 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.531 -1.028 . . . . 1.96 110.531 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.03 -42.37 64.81 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.811 2.34 . . . . 2.62 112.801 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.64 29.19 8.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.428 -0.351 . . . . 3.09 111.339 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.72 -50.27 15.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 1.87 110.866 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.8 49.15 65.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.053 -0.594 . . . . 1.7 111.866 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.26 99.19 48.49 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.721 0.296 . . . . 1.43 111.638 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 94.6 Cg_endo -80.85 160.45 21.34 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.514 2.143 . . . . 1.62 110.595 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -59.06 112.46 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.016 0.436 . . . . 1.75 110.488 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.24 -3.89 23.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.902 -0.666 . . . . 1.44 112.34 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.483 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -64.52 116.66 6.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.808 0.337 . . . . 1.25 110.853 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.37 127.76 33.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.837 -0.62 . . . . 2.21 110.919 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HD2' HG13 ' A' ' 90' ' ' ILE . 12.1 ttmm -154.38 159.18 41.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.935 -0.765 . . . . 2.11 108.935 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 118.45 10.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.06 0.457 . . . . 1.7 111.481 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.94 60.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.654 -0.703 . . . . 1.32 112.741 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.534 HG13 ' HD2' ' A' ' 87' ' ' LYS . 28.3 mm -133.72 116.06 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.201 0.524 . . . . 1.06 111.256 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -124.16 139.87 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.868 -0.79 . . . . 1.3 108.868 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -100.26 141.87 32.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.272 0.471 . . . . 1.08 112.272 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.7 145.86 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.774 -0.648 . . . . 1.04 110.311 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.58 140.94 12.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.626 -0.261 . . . . 1.27 110.999 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 t -99.58 175.68 5.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.677 -0.49 . . . . 1.58 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -73.97 133.74 43.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.813 0.339 . . . . 2.64 110.674 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.62 -9.5 57.16 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.659 -0.781 . . . . 1.63 112.156 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.722 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.04 148.17 27.71 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.639 0.257 . . . . 1.59 110.421 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.69 134.79 49.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.797 0.332 . . . . 2.15 110.942 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -78.28 93.51 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.3 110.565 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.1 t -158.92 138.71 8.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.829 -0.623 . . . . 2.69 109.823 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.37 130.43 19.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.622 2.215 . . . . 2.08 112.238 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -151.9 92.08 1.7 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.268 0.556 . . . . 1.99 111.144 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.31 -4.03 36.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 2.55 111.883 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -55.01 -29.1 56.63 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.513 0.561 . . . . 2.28 112.513 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.35 4.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.785 0.326 . . . . 2.0 111.437 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -104.75 -21.74 8.93 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.368 -0.92 . . . . 2.33 113.301 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.1 t -80.24 111.58 16.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.309 0.576 . . . . 3.21 112.364 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -167.02 136.65 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.794 -0.639 . . . . 3.03 110.573 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -90.69 117.97 68.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 3.75 110.0 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -32.67 44.18 Favored 'Trans proline' 0 N--CA 1.473 0.298 0 C-N-CA 122.749 2.299 . . . . 3.39 113.179 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -17.12 61.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.783 0.29 . . . . 4.05 111.783 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -112.39 0.43 15.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.477 -0.329 . . . . 4.78 111.217 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -155.48 117.92 4.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.569 0.223 . . . . 3.41 110.728 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.42 154.16 42.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 3.21 111.411 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.79 151.08 19.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.089 0.471 . . . . 3.0 111.597 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.417 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 13.2 mt -91.93 149.0 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.26 -0.644 . . . . 2.42 109.26 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.99 116.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.609 0.242 . . . . 2.74 110.582 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.412 HD23 HD21 ' A' ' 16' ' ' LEU . 6.0 tt -64.1 111.81 2.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 2.19 110.999 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -131.88 150.75 52.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 2.49 110.545 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.59 154.52 41.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.955 -0.566 . . . . 1.96 109.521 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.63 166.81 12.78 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.487 2.124 . . . . 1.84 112.542 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -64.65 119.53 10.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 2.77 110.497 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.19 -19.33 22.68 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.046 -0.822 . . . . 2.2 111.046 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.36 118.75 37.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 2.1 110.148 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.42 155.83 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.419 . . . . 2.87 110.933 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -84.67 151.44 58.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.94 150.37 78.55 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.347 2.032 . . . . 2.77 111.213 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -59.13 125.45 23.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 4.28 110.735 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.0 51.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.014 -0.612 . . . . 3.18 111.688 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.84 124.26 40.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.114 -0.328 . . . . 2.93 110.114 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.426 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 55.3 p90 -127.62 148.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.909 0.385 . . . . 3.73 111.156 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.55 137.04 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 2.93 111.062 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' OE1' ' HA ' ' A' ' 134' ' ' GLU . 39.6 mm-40 -69.61 137.25 52.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.918 0.389 . . . . 3.64 110.801 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.18 -31.35 6.74 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.994 -1.242 . . . . 3.27 109.994 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.46 -0.57 . . . . 3.59 109.46 179.097 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.297 0 CA-C-O 120.567 0.222 . . . . 2.48 110.756 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -64.46 149.61 48.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.603 . . . . 2.57 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -86.37 -18.42 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 2.4 111.257 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -123.37 172.71 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.155 -0.475 . . . . 2.02 111.276 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.7 p -70.44 170.37 12.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 2.65 109.996 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB3' ' CD1' ' A' ' 69' ' ' TYR . . . -95.92 172.11 8.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.279 0.561 . . . . 2.4 111.211 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.6 mt -106.04 102.07 11.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.901 -0.778 . . . . 2.27 108.901 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.572 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.42 119.24 22.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.967 -0.56 . . . . 2.86 110.952 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 5.3 tp60 -100.36 132.73 45.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.886 -0.597 . . . . 2.89 110.801 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -126.29 57.16 1.41 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.692 -0.685 . . . . 4.07 109.436 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.61 -166.41 11.86 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.39 -0.823 . . . . 3.23 111.546 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -91.78 -37.97 12.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.887 0.343 . . . . 4.51 111.595 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -83.14 156.19 23.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.505 -0.316 . . . . 3.32 110.944 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -87.22 -154.37 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.278 -0.419 . . . . 2.41 110.556 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 tp -111.58 131.34 55.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.951 0.352 . . . . 2.18 111.951 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -154.65 105.44 2.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.782 -0.645 . . . . 2.46 109.371 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.54 150.59 51.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 1.78 110.952 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.74 -172.85 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.942 2.428 . . . . 2.15 112.707 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -69.6 130.04 41.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.625 -0.716 . . . . 2.84 111.447 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.98 87.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.24 -0.505 . . . . 1.65 112.575 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.455 HE22 HG22 ' A' ' 125' ' ' THR . 4.7 mm-40 -125.87 167.26 15.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.804 0.335 . . . . 2.57 111.018 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.0 -28.22 10.79 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.671 -0.695 . . . . 1.42 112.134 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.01 115.23 52.79 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.839 0.352 . . . . 1.09 110.254 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.38 -176.25 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.668 2.246 . . . . 1.27 111.095 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 mt -80.03 88.85 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.568 -0.53 . . . . 1.7 109.568 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.406 ' C ' ' H ' ' A' ' 37' ' ' ASN . 63.2 m-80 -86.08 82.61 8.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.465 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.74 37.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 1.96 111.486 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 35' ' ' ASN . 8.3 p30 -144.16 1.39 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.98 -0.555 . . . . 2.0 109.711 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.43 159.29 37.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.887 -0.597 . . . . 1.44 111.843 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.16 168.82 23.82 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.688 -0.687 . . . . 2.06 110.019 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.11 -37.96 93.77 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.648 2.232 . . . . 1.42 112.802 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.24 -15.76 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.631 0.234 . . . . 1.78 111.631 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.723 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 11.4 m-20 -88.75 -0.61 57.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 1.6 110.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -79.88 53.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.237 0.542 . . . . 1.19 111.074 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.727 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.4 tt -146.49 134.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.838 -0.619 . . . . 1.17 109.508 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.97 -146.67 5.41 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.412 -0.899 . . . . 0.61 112.498 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -156.41 165.78 35.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.611 0.243 . . . . 1.13 110.656 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.599 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 9.0 m-85 -106.15 141.91 36.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.483 -0.562 . . . . 1.69 109.483 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -121.77 127.75 50.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 2.51 110.912 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.4 ttt-85 -82.03 109.48 16.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 2.62 110.009 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.82 145.4 50.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.076 0.465 . . . . 2.21 112.114 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.9 m -140.44 119.58 12.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.68 109.765 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.511 ' HB3' HD13 ' A' ' 64' ' ' LEU . 25.0 tpt180 -84.58 125.35 32.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.075 0.464 . . . . 3.78 111.923 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -137.8 172.44 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 3.58 110.049 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.95 177.42 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.629 0.252 . . . . 4.26 110.857 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 116.408 -0.36 . . . . 5.46 110.086 178.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmt . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 110.048 -0.352 . . . . 4.48 110.048 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.54 -38.37 90.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.459 -0.571 . . . . 4.47 109.459 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 55.36 85.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.989 -1.005 . . . . 4.09 113.455 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 52' ' ' ARG . 81.3 mt -92.2 155.31 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 3.36 109.918 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -74.76 152.8 87.12 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.713 -0.222 . . . . 3.47 110.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.32 120.96 9.18 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 2.69 111.092 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HG2' HG22 ' A' ' 17' ' ' THR . 63.2 mtt180 -112.77 126.89 55.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 3.22 111.222 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.599 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.04 104.36 16.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.122 -0.49 . . . . 1.95 109.88 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 15' ' ' ALA . 89.0 m-85 -88.51 148.87 23.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.203 -0.453 . . . . 2.76 110.442 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.79 128.07 48.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.908 0.385 . . . . 1.4 111.294 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.67 157.82 31.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.157 -0.683 . . . . 2.07 109.157 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.69 159.0 16.6 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.633 -0.258 . . . . 1.28 110.999 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.1 120.45 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.183 -0.462 . . . . 1.66 112.111 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.67 36.08 8.12 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.939 -0.648 . . . . 1.66 112.728 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.44 104.46 15.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.966 0.412 . . . . 1.62 111.302 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.49 115.5 3.39 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.649 -0.786 . . . . 1.96 111.959 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.7 -24.03 55.49 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.642 2.228 . . . . 2.62 112.172 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 47.11 1.16 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.913 0.387 . . . . 3.09 110.531 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.69 -60.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.87 111.469 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.32 16.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.82 -0.705 . . . . 1.7 111.624 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' A' ' 87' ' ' LYS . 32.0 mt -120.77 94.19 48.82 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 1.43 111.581 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 83.4 Cg_endo -83.11 164.43 15.19 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.541 2.161 . . . . 1.62 111.009 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.57 110.28 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.75 111.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.15 9.19 24.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.796 -0.716 . . . . 1.44 113.055 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -77.73 134.95 37.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.864 0.364 . . . . 1.25 111.243 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -81.22 127.15 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.401 -0.363 . . . . 2.21 110.918 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' A' ' 81' ' ' LEU . 12.4 tttt -163.3 142.05 8.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 2.11 110.666 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.37 124.76 24.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 1.7 111.497 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.82 15.92 71.68 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.913 -0.585 . . . . 1.32 112.797 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.02 112.95 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.634 0.254 . . . . 1.06 110.709 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.5 pt -118.0 132.17 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.942 -0.392 . . . . 1.3 109.942 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -92.15 138.03 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.409 0.522 . . . . 1.08 112.409 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.75 146.4 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.407 -0.815 . . . . 1.04 109.706 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.19 174.71 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.831 0.348 . . . . 1.27 111.097 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -156.22 170.73 21.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 1.58 109.389 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.12 124.64 24.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 2.64 110.681 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.84 -21.58 18.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.829 -0.908 . . . . 1.63 110.829 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.727 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.09 126.81 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.097 -0.335 . . . . 1.59 110.097 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.18 143.68 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.857 0.36 . . . . 2.15 111.158 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.06 93.38 4.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.317 0.579 . . . . 2.3 110.722 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.4 t -161.71 149.49 12.11 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.454 -0.943 . . . . 2.69 108.454 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.99 129.73 17.85 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.259 1.973 . . . . 2.08 112.938 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.723 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -138.18 71.33 1.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.385 0.612 . . . . 1.99 111.203 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -76.96 -4.38 43.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.505 . . . . 2.55 111.918 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -57.82 -22.21 46.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.973 0.416 . . . . 2.28 111.878 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.72 8.86 9.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 2.0 110.973 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.69 -26.73 10.35 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 120.999 -0.619 . . . . 2.33 111.612 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.7 t -79.77 118.17 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 3.21 110.539 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -161.5 140.44 9.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 3.03 109.999 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.65 103.3 23.31 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.5 -0.318 . . . . 3.75 110.579 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.39 -17.09 39.43 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.761 2.308 . . . . 3.39 112.702 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.49 -11.42 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.054 0.454 . . . . 4.05 110.982 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -116.83 -53.62 2.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.031 -0.532 . . . . 4.78 110.14 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.79 139.58 38.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.682 -0.69 . . . . 3.41 109.944 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 148.13 22.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.735 0.302 . . . . 3.21 111.106 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.76 153.13 31.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.394 -0.366 . . . . 3.0 110.816 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.1 mt -88.1 149.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 2.42 110.116 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.88 125.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.36 . . . . 2.74 110.471 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.07 105.47 3.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 2.19 110.979 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -121.31 150.53 41.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.143 -0.48 . . . . 2.49 110.688 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.483 HD12 HG23 ' A' ' 125' ' ' THR . 96.0 mt -100.18 153.87 37.52 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.093 -0.503 . . . . 1.96 110.835 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.71 167.92 25.9 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.731 2.287 . . . . 1.84 111.912 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.07 122.54 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.493 . . . . 2.77 111.214 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.57 12.13 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.69 -0.686 . . . . 2.2 111.766 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.483 HG23 HD12 ' A' ' 121' ' ' LEU . 6.4 m -96.24 122.26 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.927 -0.397 . . . . 2.1 109.927 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 p -118.67 149.06 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.655 0.264 . . . . 2.87 110.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.2 mt -77.71 144.01 68.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.812 -0.44 . . . . 2.62 109.812 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.78 157.83 22.52 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.615 2.21 . . . . 2.77 111.701 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.7 118.34 7.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.136 -0.484 . . . . 4.28 110.733 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.21 -16.66 24.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 3.18 112.423 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.8 m-85 -99.63 124.92 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.71 0.291 . . . . 2.93 111.004 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -121.53 161.68 21.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 3.73 110.943 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 136' ' ' SER . . . -95.19 130.96 41.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.423 -0.353 . . . . 2.93 110.973 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -68.85 107.68 3.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 3.64 111.605 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.54 12.01 56.34 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.749 -0.66 . . . . 3.27 112.578 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . 4.7 t . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 110.128 -0.323 . . . . 3.59 110.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.42 0 N-CA-C 109.72 -0.474 . . . . 2.48 109.72 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 m -56.57 144.22 32.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.252 0.464 . . . . 2.57 112.252 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -69.58 -30.48 68.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.586 -0.734 . . . . 2.4 112.761 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 93.4 m-85 -108.92 167.26 10.21 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.783 0.29 . . . . 2.02 111.783 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -73.19 165.99 23.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.024 -0.535 . . . . 2.65 111.339 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -78.82 140.71 38.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.275 0.843 . . . . 2.4 113.275 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.6 mt -91.43 127.38 36.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.231 -1.026 . . . . 2.27 108.231 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -106.25 133.04 51.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.876 0.369 . . . . 2.86 111.692 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -96.18 144.08 26.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.716 -0.674 . . . . 2.89 109.292 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -125.69 47.27 2.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 4.07 110.693 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -162.8 -169.33 26.05 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.072 -0.585 . . . . 3.23 111.933 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -81.42 -28.96 34.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.753 0.311 . . . . 4.51 110.555 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -70.15 173.84 6.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.558 -0.746 . . . . 3.32 111.498 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.17 -156.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.375 -0.602 . . . . 2.41 109.375 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 35.8 tp -102.62 124.57 48.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.805 0.336 . . . . 2.18 111.408 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -151.5 116.88 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 2.46 110.064 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -105.33 149.62 37.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 1.78 110.557 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.45 173.31 13.4 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.066 2.51 . . . . 2.15 112.144 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -69.73 125.63 27.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.834 -0.621 . . . . 2.84 111.438 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 23.77 50.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.07 -0.586 . . . . 1.65 112.451 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.79 166.33 33.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.77 0.319 . . . . 2.57 110.188 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.36 2.86 50.83 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.895 -0.669 . . . . 1.42 113.156 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.16 121.04 63.2 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 110.203 -0.295 . . . . 1.09 110.203 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.03 178.88 5.41 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.707 2.271 . . . . 1.27 112.033 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.1 mt -76.06 86.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 1.7 110.607 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -88.94 79.91 7.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 1.23 110.523 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -17.06 56.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.96 110.82 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -74.79 -21.82 59.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 2.0 111.235 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.71 173.77 6.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.44 111.747 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.505 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 21.9 m -90.61 166.19 20.25 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 2.06 109.998 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.5 Cg_endo -51.92 -38.28 68.35 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.163 2.576 . . . . 1.42 113.763 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -19.14 61.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.711 0.263 . . . . 1.78 111.711 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.69 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.0 m-20 -88.17 4.1 46.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 1.6 110.969 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -80.38 51.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.176 0.512 . . . . 1.19 111.246 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.649 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -148.36 132.9 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.065 -0.516 . . . . 1.17 110.033 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.95 -146.34 5.27 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.192 -1.004 . . . . 0.61 112.632 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -156.15 162.23 40.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.587 0.232 . . . . 1.13 110.468 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -104.04 136.46 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.425 -0.583 . . . . 1.69 109.425 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -111.94 125.78 54.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 2.51 111.0 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -78.28 131.76 37.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.247 -0.433 . . . . 2.62 109.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.82 138.08 28.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 2.21 111.601 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.29 96.19 3.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.541 -0.754 . . . . 2.68 110.489 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HB3' HD13 ' A' ' 64' ' ' LEU . 22.6 tpt180 -68.5 120.92 15.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.212 0.529 . . . . 3.78 111.001 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -139.45 110.44 6.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.888 -0.596 . . . . 3.58 111.039 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.47 168.07 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 4.26 110.816 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 5.46 111.298 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.989 -0.375 . . . . 4.48 109.989 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -59.12 -48.87 80.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.3 -0.63 . . . . 4.47 109.3 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.9 t70 55.41 97.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.333 1.234 . . . . 4.09 114.333 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.433 HD13 ' HB3' ' A' ' 52' ' ' ARG . 38.5 mt -88.61 153.65 20.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 3.36 110.221 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -73.54 159.71 83.99 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 3.47 110.892 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.08 110.17 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.858 2.372 . . . . 2.69 112.134 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 28.7 mtt-85 -120.44 148.63 43.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.728 -0.669 . . . . 3.22 111.494 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -121.53 137.46 54.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.072 -0.513 . . . . 1.95 110.49 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.54 148.56 34.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.427 -0.583 . . . . 2.76 109.427 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.73 123.01 37.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.991 0.424 . . . . 1.4 111.642 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -119.13 162.78 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.759 -0.655 . . . . 2.07 109.791 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -102.21 155.77 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.596 -0.274 . . . . 1.28 110.644 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.4 tt -60.9 115.67 3.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.876 0.37 . . . . 1.66 111.322 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.26 38.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.841 -0.695 . . . . 1.66 114.53 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.6 p -56.48 119.9 6.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 117.599 0.699 . . . . 1.62 111.375 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.95 112.42 3.67 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.928 -0.654 . . . . 1.96 111.601 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.06 -36.05 98.28 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 122.738 2.292 . . . . 2.62 112.389 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.02 28.44 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 3.09 111.281 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -55.64 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.153 -0.476 . . . . 1.87 110.43 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.73 48.5 49.11 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.973 -0.851 . . . . 1.7 110.973 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.7 mt -116.5 94.46 43.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 112.192 0.441 . . . . 1.43 112.192 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 87.4 Cg_endo -87.01 158.7 8.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.689 2.259 . . . . 1.62 110.389 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HB2' HD11 ' A' ' 73' ' ' LEU . 48.4 t80 -58.86 115.17 2.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 1.75 111.112 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.76 -11.1 18.45 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.737 -0.744 . . . . 1.44 112.66 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.423 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -66.87 130.62 43.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 1.25 110.83 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -95.09 132.65 39.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.247 -0.433 . . . . 2.21 111.053 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -158.38 152.94 24.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.152 -0.685 . . . . 2.11 109.152 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.74 112.53 3.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.873 0.368 . . . . 1.7 111.606 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.97 28.71 27.86 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.32 112.602 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.6 mm -132.78 106.81 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 1.06 110.803 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.7 pt -118.7 127.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.995 -0.372 . . . . 1.3 109.995 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -85.53 139.52 31.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.966 0.728 . . . . 1.08 112.966 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 m -136.22 140.55 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.19 -0.914 . . . . 1.04 110.034 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.79 159.28 44.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.152 -0.476 . . . . 1.27 110.168 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 t -135.52 172.41 13.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 1.58 109.828 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.22 126.31 27.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.371 -0.377 . . . . 2.64 110.76 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.69 -10.5 38.32 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.649 . . . . 1.63 112.195 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.649 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.68 132.19 35.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.645 0.259 . . . . 1.59 111.342 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.0 mt -92.27 139.77 30.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.248 -0.433 . . . . 2.15 111.201 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -85.84 85.3 7.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 2.3 111.231 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.544 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 9.7 t -167.72 140.29 2.64 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.049 -0.723 . . . . 2.69 109.049 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.19 133.36 52.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.917 2.411 . . . . 2.08 113.038 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.69 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.33 67.53 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 1.99 110.968 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.3 6.97 7.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 2.55 112.48 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -59.78 -22.75 62.57 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.019 0.377 . . . . 2.28 112.019 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.92 -18.27 7.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.258 0.552 . . . . 2.0 109.905 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.88 70.56 3.16 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.308 -0.717 . . . . 2.33 111.308 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.9 t -149.33 19.67 0.95 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.677 0.751 . . . . 3.21 109.411 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -77.88 135.76 37.95 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.65 -0.704 . . . . 3.03 111.404 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -111.95 118.81 45.7 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.239 -0.652 . . . . 3.75 109.239 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.15 -23.69 74.53 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.061 2.508 . . . . 3.39 113.206 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.46 -1.66 57.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 4.05 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -132.08 14.62 4.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.397 -0.365 . . . . 4.78 110.951 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -177.97 135.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.898 -0.592 . . . . 3.41 110.398 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.1 144.15 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.507 -0.553 . . . . 3.21 109.507 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.74 144.74 52.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 3.0 111.205 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 21.5 mt -86.21 140.81 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.779 -0.646 . . . . 2.42 109.475 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.05 128.12 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.879 -0.415 . . . . 2.74 109.879 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.45 110.8 1.36 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 2.19 111.623 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -116.29 134.07 55.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.621 -0.718 . . . . 2.49 110.039 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 29.7 mt -98.9 145.48 30.04 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.424 -0.353 . . . . 1.96 110.556 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.9 155.29 71.4 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.441 2.094 . . . . 1.84 111.942 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -61.62 111.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.0 -0.545 . . . . 2.77 110.693 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.98 -17.42 8.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.126 -1.19 . . . . 2.2 110.126 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.7 m -108.86 112.81 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.102 -0.703 . . . . 2.1 109.102 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.23 150.09 31.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 2.87 111.358 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.5 mt -78.14 147.08 72.44 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 2.62 110.28 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.53 153.69 69.62 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.757 2.305 . . . . 2.77 110.862 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -59.44 122.21 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 4.28 111.295 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.77 -9.85 40.85 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.014 -0.613 . . . . 3.18 112.255 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -102.84 134.65 45.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.766 0.317 . . . . 2.93 111.751 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -146.26 143.41 29.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 3.73 110.49 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.95 134.87 34.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.781 0.325 . . . . 2.93 110.662 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.67 123.74 19.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.05 -0.523 . . . . 3.64 110.529 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.81 -12.77 46.07 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.012 -0.613 . . . . 3.27 112.234 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.639 0.257 . . . . 3.59 111.194 -179.42 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.312 0 CA-C-O 120.96 0.41 . . . . 2.48 111.374 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -79.26 167.41 20.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.879 -0.6 . . . . 2.57 110.821 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.464 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 31.3 m95 -92.91 -45.57 7.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 2.4 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -88.66 159.74 17.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.866 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 p -66.92 157.41 33.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 2.65 110.797 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -74.81 139.99 43.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.928 0.394 . . . . 2.4 111.321 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 95.6 mt -93.16 138.59 31.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.92 -0.582 . . . . 2.27 109.787 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -109.78 124.89 52.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.06 0.457 . . . . 2.86 111.897 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -97.39 124.3 41.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 2.89 110.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -116.82 92.61 3.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.115 -0.493 . . . . 4.07 110.104 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.77 -166.16 38.73 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.469 -0.872 . . . . 3.23 112.093 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -87.98 -22.2 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 4.51 111.211 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -87.79 171.25 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.137 -0.483 . . . . 3.32 110.652 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 13.3 t0 -102.63 -90.51 0.36 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 2.41 110.795 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.408 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 31.2 tp -169.27 129.64 1.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.766 0.317 . . . . 2.18 110.841 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -150.89 133.08 15.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 2.46 110.508 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -118.75 134.13 23.57 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.102 -0.499 . . . . 1.78 110.184 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.62 176.05 8.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.024 2.483 . . . . 2.15 112.56 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -58.92 126.87 29.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 2.84 112.102 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.17 20.63 75.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.182 -0.533 . . . . 1.65 113.339 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -141.52 153.32 44.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.065 -0.346 . . . . 2.57 110.065 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.5 -13.51 9.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.42 112.092 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.5 t -95.66 111.55 56.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.761 0.315 . . . . 1.09 110.37 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.25 -166.91 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.743 2.295 . . . . 1.27 111.648 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -79.66 88.4 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.166 0.508 . . . . 1.7 111.436 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -98.55 91.89 5.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.214 0.531 . . . . 1.23 109.655 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.15 2.67 55.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.84 0.682 . . . . 1.96 112.84 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -100.87 21.32 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.186 0.517 . . . . 2.0 111.274 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 m -148.84 174.77 11.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.841 -0.618 . . . . 1.44 110.075 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.445 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 17.6 m -84.36 166.09 34.77 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.885 -0.413 . . . . 2.06 109.885 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 18.8 Cg_endo -59.03 -22.54 64.25 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.663 2.242 . . . . 1.42 113.321 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.558 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 1.5 p-10 -89.53 -10.68 45.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.312 . . . . 1.78 111.709 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.561 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 23.6 m-20 -85.87 -0.93 56.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.6 110.144 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -79.09 59.2 2.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.987 -0.551 . . . . 1.19 111.419 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.744 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.7 tt -151.89 133.5 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.17 110.092 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.97 -142.45 4.41 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.03 -1.081 . . . . 0.61 112.637 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -160.17 159.24 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.006 0.432 . . . . 1.13 110.527 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.577 ' HH ' HD11 ' A' ' 119' ' ' LEU . 5.1 m-85 -99.8 135.7 40.83 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.434 -0.58 . . . . 1.69 109.434 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -111.73 128.22 56.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.323 -0.399 . . . . 2.51 111.061 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.5 128.41 34.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.949 -0.569 . . . . 2.62 109.726 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.79 157.86 44.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.02 0.438 . . . . 2.21 111.498 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -148.47 125.75 11.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.214 -0.661 . . . . 2.68 109.214 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -112.25 134.84 53.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.381 . . . . 3.78 111.154 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -149.32 121.36 8.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.501 -0.318 . . . . 3.58 110.833 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 pt -92.7 136.27 25.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.789 -0.449 . . . . 4.26 109.789 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.26 -0.427 . . . . 5.46 110.699 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.1 mmt . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 109.19 -0.671 . . . . 4.48 109.19 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -54.62 -51.69 64.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.078 -0.341 . . . . 4.47 110.078 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.9 t70 63.9 115.22 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.767 1.025 . . . . 4.09 113.767 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.1 mt -109.84 -179.13 3.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.855 -0.612 . . . . 3.36 110.639 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -102.83 155.44 36.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.079 -0.51 . . . . 3.47 110.224 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.3 109.91 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.518 2.145 . . . . 2.69 111.526 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.446 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 59.4 mtt180 -113.0 145.95 39.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.105 0.479 . . . . 3.22 112.055 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.547 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.2 m95 -113.36 132.72 55.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.64 -0.709 . . . . 1.95 110.508 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -110.4 141.57 43.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 2.76 109.929 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.77 116.01 28.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 1.4 111.49 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -115.6 156.6 25.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.034 -0.53 . . . . 2.07 110.162 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -96.52 162.55 13.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.459 -0.337 . . . . 1.28 110.635 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.9 OUTLIER -64.13 117.27 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.428 -0.351 . . . . 1.66 110.803 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.97 7.81 37.7 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.806 -0.712 . . . . 1.66 113.679 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -70.11 120.83 16.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 1.62 111.496 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.44 122.82 4.27 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.14 -0.784 . . . . 1.96 111.14 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.03 -56.64 2.6 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.07 2.514 . . . . 2.62 112.7 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.16 42.66 1.33 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 3.09 110.912 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.89 -54.1 14.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 1.87 110.014 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.62 38.51 96.53 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.649 -0.705 . . . . 1.7 112.223 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.48 101.93 48.36 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.751 0.31 . . . . 1.43 111.047 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.05 159.95 18.16 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.707 2.271 . . . . 1.62 111.258 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.457 ' HB2' HD11 ' A' ' 73' ' ' LEU . 51.2 t80 -56.74 113.46 1.65 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.421 -0.354 . . . . 1.75 110.688 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.67 -12.09 13.65 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.653 -0.784 . . . . 1.44 112.939 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.05 114.1 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 1.25 110.914 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -74.85 120.93 21.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.516 . . . . 2.21 111.396 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -143.84 151.71 40.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 2.11 110.041 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.37 115.52 4.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.89 0.376 . . . . 1.7 111.733 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.1 26.43 60.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.881 -0.676 . . . . 1.32 112.665 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -130.0 103.17 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.944 0.402 . . . . 1.06 110.6 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 pt -111.52 119.91 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.283 -0.417 . . . . 1.3 110.675 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -79.44 137.53 37.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.08 111.55 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.62 143.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.957 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.2 165.6 32.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.487 . . . . 1.27 110.003 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -134.82 -177.47 4.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.258 -0.428 . . . . 1.58 109.985 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.58 120.1 14.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.167 0.508 . . . . 2.64 110.938 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.02 -9.15 39.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.05 -0.595 . . . . 1.63 111.795 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.744 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.17 121.84 20.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.747 0.308 . . . . 1.59 110.387 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 53.8 mt -89.39 146.38 24.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 2.15 109.982 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -79.73 69.03 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.536 . . . . 2.3 109.874 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 m -135.34 136.28 24.06 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 2.69 109.792 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -81.2 119.21 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.926 2.417 . . . . 2.08 110.855 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.65 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -135.73 102.9 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.559 . . . . 1.99 111.143 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.13 4.1 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.968 -0.56 . . . . 2.55 111.924 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.65 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 12.3 p80 -57.75 -24.3 56.38 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.058 0.456 . . . . 2.28 112.102 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -105.36 5.33 10.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.178 -0.465 . . . . 2.0 111.129 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.61 46.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 2.33 111.64 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -146.56 28.62 1.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.315 0.579 . . . . 3.21 110.748 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.464 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 38.3 ttp85 -69.24 141.2 54.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 3.03 111.27 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -94.92 113.0 60.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.065 -0.516 . . . . 3.75 109.731 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.35 -12.99 23.06 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.045 2.497 . . . . 3.39 114.246 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.1 -15.22 44.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.102 0.477 . . . . 4.05 110.884 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -110.39 -9.32 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 4.78 111.546 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -153.01 138.67 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.718 0.294 . . . . 3.41 110.709 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.56 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 3.21 111.583 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.87 149.89 49.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 3.0 111.444 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.3 mt -91.02 138.62 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.807 -0.633 . . . . 2.42 110.258 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.23 119.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.377 -0.601 . . . . 2.74 109.377 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.577 HD11 ' HH ' ' A' ' 47' ' ' TYR . 1.4 tt -61.0 128.3 35.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 2.19 110.82 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -132.57 142.96 49.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.84 -0.618 . . . . 2.49 110.429 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 mt -105.62 145.69 31.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.075 -0.511 . . . . 1.96 110.19 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.78 167.27 10.48 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.991 2.461 . . . . 1.84 112.48 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.73 121.64 14.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 2.77 110.845 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.48 -18.91 34.79 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.762 . . . . 2.2 111.934 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.9 m -94.25 99.16 11.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.099 0.476 . . . . 2.1 110.234 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.11 156.22 16.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.997 -0.547 . . . . 2.87 111.24 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.84 146.17 31.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 2.62 109.755 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.0 152.67 73.86 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.608 2.206 . . . . 2.77 111.889 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.97 120.49 11.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 4.28 110.684 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 109.26 -8.15 32.86 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.724 -0.751 . . . . 3.18 111.55 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 2.7 t80 -94.15 132.08 39.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.189 -0.3 . . . . 2.93 110.189 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -134.65 146.84 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.865 0.365 . . . . 3.73 111.462 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.29 148.63 38.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.812 -0.631 . . . . 2.93 110.597 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.21 122.72 28.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 3.64 109.838 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.19 14.47 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.941 -0.647 . . . . 3.27 111.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 3.59 110.615 179.504 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.791 0.329 . . . . 2.48 111.403 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 m -71.33 152.76 42.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 2.57 110.653 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -86.58 -27.94 23.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.794 0.331 . . . . 2.4 111.199 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.92 164.04 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.327 -0.397 . . . . 2.02 111.945 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 p -63.22 166.01 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 2.65 111.779 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.0 150.4 22.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.226 -0.443 . . . . 2.4 111.408 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.21 136.42 41.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 2.27 110.305 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.423 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 13.4 m -106.65 132.77 52.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.756 0.312 . . . . 2.86 111.397 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -99.79 133.42 44.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 2.89 110.761 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -127.68 82.74 2.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.702 -0.481 . . . . 4.07 109.702 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.82 -160.9 26.34 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.444 -0.663 . . . . 3.23 111.444 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -99.34 9.51 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.0 0.429 . . . . 4.51 111.122 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -112.99 -173.88 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.816 -0.629 . . . . 3.32 110.297 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.25 -73.69 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.367 -0.379 . . . . 2.41 109.981 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.435 HD12 ' CE1' ' A' ' 131' ' ' PHE . 32.0 tp 178.32 125.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.587 0.554 . . . . 2.18 110.382 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -146.58 121.58 10.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 2.46 110.792 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -108.45 154.45 41.49 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.631 . . . . 1.78 109.896 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.629 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 58.4 Cg_endo -73.08 -163.16 0.15 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.761 2.307 . . . . 2.15 113.076 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -86.01 125.45 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 2.84 111.678 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.3 18.96 75.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.87 -0.604 . . . . 1.65 113.19 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.629 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.3 tm0? -142.16 132.98 25.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.766 -0.457 . . . . 2.57 109.766 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.04 -9.12 2.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.413 -0.899 . . . . 1.42 112.334 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.06 124.24 65.45 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.215 -0.291 . . . . 1.09 110.215 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.48 179.43 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.482 2.122 . . . . 1.27 112.204 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mt -75.51 88.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 1.7 110.602 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.34 80.18 9.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.119 0.485 . . . . 1.23 110.545 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -21.18 66.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 1.96 111.872 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -89.05 3.7 50.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.418 -0.355 . . . . 2.0 111.679 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 m -128.45 162.27 27.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.734 0.302 . . . . 1.44 111.417 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.59 165.71 38.45 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 2.06 109.963 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.44 -25.8 79.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.539 2.159 . . . . 1.42 111.958 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -89.16 -1.51 58.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 1.78 111.382 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -98.39 -1.38 41.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 1.6 110.243 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -77.49 60.5 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 1.19 111.552 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.71 121.11 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 1.17 109.953 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.1 -145.93 4.81 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.495 -0.86 . . . . 0.61 112.802 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -157.55 164.82 36.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.043 0.449 . . . . 1.13 111.106 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.545 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.9 m-85 -108.31 137.28 46.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.46 -0.791 . . . . 1.69 109.518 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -118.16 130.65 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.384 -0.371 . . . . 2.51 110.981 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -86.8 116.34 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.184 -0.462 . . . . 2.62 110.266 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.78 148.31 44.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.263 -0.426 . . . . 2.21 110.647 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -132.88 109.38 9.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.21 -0.45 . . . . 2.68 110.682 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB3' HD13 ' A' ' 64' ' ' LEU . 20.9 tpt180 -86.37 113.74 22.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 3.78 110.874 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -138.63 91.24 2.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 3.58 110.934 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.404 ' O ' ' HG2' ' A' ' 61' ' ' MET . 28.9 pt -70.46 146.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 4.26 111.01 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 5.46 110.492 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 76.5 mtm . . . . . 0 C--O 1.234 0.261 0 N-CA-C 110.251 -0.277 . . . . 4.48 110.251 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -67.8 -29.29 68.43 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.847 -0.797 . . . . 4.47 108.847 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t0 52.39 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.02 1.118 . . . . 4.09 114.02 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 52' ' ' ARG . 88.5 mt -106.07 140.25 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.015 -0.539 . . . . 3.36 110.064 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.92 150.61 96.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.526 . . . . 3.47 110.896 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.59 120.04 7.66 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.57 2.18 . . . . 2.69 111.438 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.75 144.85 39.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.691 -0.686 . . . . 3.22 111.198 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.545 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 65.9 m95 -104.67 124.87 50.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.804 -0.634 . . . . 1.95 110.895 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.41 143.49 35.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.682 . . . . 2.76 109.871 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -95.23 127.28 41.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.816 0.341 . . . . 1.4 110.917 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.31 153.52 47.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.08 -0.509 . . . . 2.07 110.128 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -84.46 163.14 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.9 tt -59.67 122.89 15.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.695 0.283 . . . . 1.66 111.759 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.6 20.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.003 -0.618 . . . . 1.66 112.634 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.66 70.85 7.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.914 0.388 . . . . 1.62 111.486 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.41 148.36 4.76 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.015 -0.612 . . . . 1.96 111.744 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.0 -47.2 11.06 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.79 2.326 . . . . 2.62 111.867 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.8 45.61 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.58 . . . . 3.09 111.257 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.0 -56.13 4.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 1.87 110.463 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.67 52.98 47.18 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.646 -0.582 . . . . 1.7 111.646 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.415 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 57.9 mt -132.72 100.0 15.06 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 111.579 0.215 . . . . 1.43 111.579 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 74.0 Cg_endo -78.93 162.79 26.29 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.16 1.907 . . . . 1.62 110.257 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.99 104.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 1.75 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.43 10.22 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.591 -0.814 . . . . 1.44 112.233 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.544 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -59.13 114.64 2.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.74 0.305 . . . . 1.25 110.891 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -78.9 104.56 9.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 2.21 112.023 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -126.15 150.88 47.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.692 -0.855 . . . . 2.11 108.692 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -63.44 118.33 7.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.939 0.399 . . . . 1.7 111.975 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.38 57.67 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.703 -0.68 . . . . 1.32 112.502 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.8 118.14 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.723 0.297 . . . . 1.06 110.383 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.4 pt -121.78 122.74 67.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.389 -0.369 . . . . 1.3 110.222 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.415 ' HZ2' ' HB3' ' A' ' 81' ' ' LEU . 87.7 m95 -86.55 138.24 31.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.014 0.376 . . . . 1.08 112.014 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.61 142.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 1.04 110.612 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.27 -177.78 6.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 1.27 109.605 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 t -148.74 169.7 19.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.32 -0.252 . . . . 1.58 110.32 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.6 128.16 34.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.385 -0.371 . . . . 2.64 111.076 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.98 -24.3 23.55 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.785 -0.721 . . . . 1.63 111.823 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.11 133.02 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 1.59 110.487 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 94.2 mt -94.45 133.77 37.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.314 -0.403 . . . . 2.15 110.849 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -75.98 96.57 3.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.3 110.337 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.21 150.03 6.89 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.734 -0.666 . . . . 2.69 109.416 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.54 125.21 18.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.816 2.344 . . . . 2.08 112.534 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -113.21 34.64 4.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 1.99 109.744 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.6 -30.58 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.548 0.573 . . . . 2.55 112.548 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -64.28 -8.94 14.51 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.81 0.671 . . . . 2.28 112.81 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.6 mt -109.11 0.58 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 2.0 109.822 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.05 -11.16 59.05 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.736 -0.745 . . . . 2.33 112.424 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 t -80.63 123.45 28.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.437 . . . . 3.21 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -164.37 146.15 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 3.03 109.806 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -107.42 106.93 59.62 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.84 0.352 . . . . 3.75 110.218 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.47 -21.4 26.13 Favored 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 122.862 2.375 . . . . 3.39 113.928 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.21 -14.04 59.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.104 0.409 . . . . 4.05 112.104 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -117.3 -18.51 9.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.201 -0.454 . . . . 4.78 111.408 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -140.72 131.2 25.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 3.41 111.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.26 163.99 20.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.193 -0.458 . . . . 3.21 110.332 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.74 165.65 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.037 0.446 . . . . 3.0 111.003 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -95.25 152.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.323 -0.621 . . . . 2.42 109.323 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.49 118.44 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.176 -0.305 . . . . 2.74 110.176 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.477 HD11 ' HH ' ' A' ' 47' ' ' TYR . 5.0 tt -63.13 114.31 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.278 0.561 . . . . 2.19 110.912 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.81 144.13 51.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.591 -0.731 . . . . 2.49 110.324 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 82.3 mt -95.02 148.17 34.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.088 -0.505 . . . . 1.96 110.216 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.23 159.74 45.59 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.576 2.184 . . . . 1.84 112.215 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -53.0 119.7 4.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 2.77 111.521 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.11 4.79 47.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.769 -0.729 . . . . 2.2 112.231 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.9 m -117.73 110.14 17.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.808 0.337 . . . . 2.1 110.227 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.34 137.7 40.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.159 -0.473 . . . . 2.87 111.42 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -70.61 140.92 87.22 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 116.199 -0.455 . . . . 2.62 109.825 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.74 148.97 62.49 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.963 2.442 . . . . 2.77 112.355 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.46 124.87 21.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 4.28 110.718 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.6 -12.55 39.11 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.315 -0.714 . . . . 3.18 111.315 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.435 ' CE1' HD12 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -105.42 152.09 23.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.816 0.341 . . . . 2.93 111.114 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 16.9 p90 -151.95 157.47 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 3.73 109.215 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.13 131.1 55.39 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.188 0.305 . . . . 2.93 111.158 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -66.97 125.49 26.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.443 -0.577 . . . . 3.64 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 108.8 -38.59 3.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.997 -0.841 . . . . 3.27 110.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.943 0.402 . . . . 3.59 110.596 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.847 0.356 . . . . 2.48 110.687 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.48 ' HG ' ' HD1' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -67.41 153.77 42.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.944 -0.571 . . . . 2.57 110.971 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -79.51 -18.82 51.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.053 0.454 . . . . 2.4 111.112 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -110.19 161.08 15.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.127 -0.488 . . . . 2.02 112.016 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 p -67.51 167.56 12.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.788 -0.642 . . . . 2.65 111.268 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -79.65 152.82 29.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.096 0.474 . . . . 2.4 111.408 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 76.8 mt -108.65 129.91 55.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 2.27 109.072 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.419 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -103.3 144.67 31.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.422 0.527 . . . . 2.86 112.422 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.503 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 5.0 tp-100 -112.21 134.72 53.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 2.89 110.158 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -125.85 69.36 1.19 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.057 -0.52 . . . . 4.07 109.826 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -172.76 -165.74 30.24 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.999 -0.62 . . . . 3.23 111.737 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -88.21 -30.02 20.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.914 0.388 . . . . 4.51 111.544 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.58 166.46 22.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 3.32 110.202 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -99.77 -90.05 0.32 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.014 -0.365 . . . . 2.41 110.014 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -159.26 134.97 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 2.18 111.018 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -151.51 134.58 15.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.733 -0.667 . . . . 2.46 109.457 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -130.73 134.54 26.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.447 -0.342 . . . . 1.78 110.405 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.46 156.53 55.92 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.985 2.457 . . . . 2.15 111.351 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.86 118.14 5.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.372 -0.377 . . . . 2.84 111.363 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.98 -9.07 57.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 1.65 111.982 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -120.71 152.25 38.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.752 0.31 . . . . 2.57 110.448 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.84 -6.07 22.26 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.698 -0.763 . . . . 1.42 112.77 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.38 116.52 66.57 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.592 0.234 . . . . 1.09 110.372 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.439 ' HA ' HD22 ' A' ' 121' ' ' LEU . 57.1 Cg_endo -71.23 177.16 6.9 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.633 2.222 . . . . 1.27 112.145 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.62 79.57 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.296 -0.411 . . . . 1.7 110.441 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -76.77 84.71 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 1.23 110.587 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -20.15 65.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 1.96 111.639 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -85.94 -11.92 51.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.199 -0.455 . . . . 2.0 111.553 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.1 150.23 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.158 0.504 . . . . 1.44 112.03 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.88 166.56 44.15 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.576 -0.738 . . . . 2.06 110.218 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.46 -40.06 79.89 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.947 2.431 . . . . 1.42 112.732 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.36 -24.84 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.977 0.418 . . . . 1.78 111.12 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.77 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 46.2 m-20 -84.82 1.53 46.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.802 -0.636 . . . . 1.6 111.829 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -80.27 57.43 2.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.89 0.376 . . . . 1.19 111.222 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 tt -153.02 134.84 5.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 116.175 -0.466 . . . . 1.17 110.394 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.83 -147.24 6.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.386 -0.911 . . . . 0.61 112.718 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -151.58 163.44 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.023 0.44 . . . . 1.13 110.698 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.572 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 37.6 m-85 -105.94 137.15 44.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.451 -0.574 . . . . 1.69 109.451 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -116.35 125.77 52.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.503 -0.317 . . . . 2.51 110.929 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -80.85 123.93 28.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.08 -0.509 . . . . 2.62 109.905 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.2 150.67 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.948 0.404 . . . . 2.21 111.841 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -149.86 96.58 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.863 -0.608 . . . . 2.68 110.469 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HB3' HD13 ' A' ' 64' ' ' LEU . 32.1 ttt85 -71.45 119.46 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 3.78 110.439 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 15.9 ttt-85 -135.72 106.31 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.127 -0.488 . . . . 3.58 110.591 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 pt -86.73 159.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.849 -0.614 . . . . 4.26 110.744 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.216 -0.447 . . . . 5.46 110.428 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 109.619 -0.512 . . . . 4.48 109.619 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -66.26 -51.41 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.234 -0.654 . . . . 4.47 109.234 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 20.8 t70 63.93 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.525 0.935 . . . . 4.09 113.525 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 52' ' ' ARG . 63.7 mt -114.9 156.99 23.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 3.36 110.562 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.25 153.53 92.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.842 -0.617 . . . . 3.47 110.962 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HA ' HG22 ' A' ' 51' ' ' THR . 19.7 Cg_endo -58.57 112.89 1.33 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.804 2.336 . . . . 2.69 111.625 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.515 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 93.8 mtt180 -114.47 125.38 53.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.249 0.547 . . . . 3.22 112.016 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.572 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 41.8 m95 -98.12 131.69 44.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.632 -0.713 . . . . 1.95 109.833 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.48 ' HD1' ' HG ' ' A' ' 11' ' ' SER . 64.2 m-85 -110.69 146.34 36.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.375 -0.375 . . . . 2.76 110.382 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.08 114.73 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.874 0.368 . . . . 1.4 110.927 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -113.63 143.65 44.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 2.07 110.085 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -81.83 154.01 26.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.2 tt -58.53 118.84 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.556 -0.293 . . . . 1.66 110.448 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.71 27.57 5.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.013 -0.613 . . . . 1.66 112.732 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.49 106.29 18.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.47 -0.429 . . . . 1.62 110.726 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.67 119.86 3.01 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.211 -0.756 . . . . 1.96 111.211 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.46 -51.99 8.69 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.797 2.331 . . . . 2.62 112.206 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.1 30.5 4.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 3.09 111.336 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.96 72.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 1.87 110.27 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.89 39.08 95.04 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.784 -0.644 . . . . 1.7 112.394 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.2 mt -118.75 93.71 46.64 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.255 . . . . 1.43 111.149 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 7.5 Cg_exo -75.93 157.17 38.97 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.966 2.444 . . . . 1.62 110.377 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.503 ' HB2' HD11 ' A' ' 73' ' ' LEU . 80.8 t80 -57.32 112.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 1.75 110.708 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.7 -6.62 26.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.603 -0.808 . . . . 1.44 112.42 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.567 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -66.69 145.78 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.872 0.368 . . . . 1.25 110.682 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -98.14 129.21 44.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.327 -0.397 . . . . 2.21 110.63 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -156.05 143.46 19.29 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.003 -0.74 . . . . 2.11 109.003 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.79 122.65 16.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.777 0.322 . . . . 1.7 111.589 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 21.76 70.84 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 1.32 112.575 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 mm -130.99 111.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.37 . . . . 1.06 110.87 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.5 pt -118.78 143.32 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.262 -0.644 . . . . 1.3 109.262 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -98.59 141.56 31.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.934 0.716 . . . . 1.08 112.934 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.81 138.5 38.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.329 -0.85 . . . . 1.04 110.387 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.61 168.94 20.72 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.378 -0.601 . . . . 1.27 109.378 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -140.74 157.93 44.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.23 -0.285 . . . . 1.58 110.23 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.06 118.69 8.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.394 . . . . 2.64 110.186 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.109 -0.567 . . . . 1.63 111.692 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -88.46 149.0 23.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.554 0.216 . . . . 1.59 110.54 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.9 mt -104.18 140.21 38.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 -0.285 . . . . 2.15 110.85 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -79.2 99.73 7.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 2.3 111.242 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -173.33 147.37 1.43 Allowed Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.642 . . . . 2.69 109.268 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.12 114.32 3.72 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.191 1.927 . . . . 2.08 112.366 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.77 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -114.59 78.96 1.2 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.442 0.639 . . . . 1.99 110.451 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.91 -6.66 48.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.481 -0.781 . . . . 2.55 112.041 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.466 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 4.7 p80 -60.79 -15.99 35.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.378 0.51 . . . . 2.28 112.378 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.02 15.03 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.947 0.403 . . . . 2.0 111.124 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.36 15.91 53.4 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.873 -0.68 . . . . 2.33 111.957 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 t -108.28 103.03 12.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.025 0.441 . . . . 3.21 111.414 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -159.97 111.81 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.576 . . . . 3.03 110.666 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.64 122.14 76.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.783 -0.451 . . . . 3.75 109.783 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.65 -21.04 59.54 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.202 2.601 . . . . 3.39 114.236 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.49 10.88 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.785 0.326 . . . . 4.05 111.578 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -142.06 14.95 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.082 0.468 . . . . 4.78 110.858 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -172.92 135.74 0.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 3.41 110.177 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.47 134.68 39.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.479 -0.328 . . . . 3.21 110.36 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 157.25 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.138 0.494 . . . . 3.0 111.968 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.4 mt -94.26 145.57 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.716 -0.675 . . . . 2.42 109.614 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.4 t -61.61 117.17 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.685 0.279 . . . . 2.74 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.51 121.08 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.898 -0.592 . . . . 2.19 111.24 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -137.98 150.95 47.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 2.49 110.413 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 33' ' ' PRO . 33.0 mt -103.74 150.3 38.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.242 -0.435 . . . . 1.96 110.071 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.6 150.65 80.75 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.451 2.101 . . . . 1.84 111.288 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -51.67 130.86 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.51 . . . . 2.77 111.378 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.79 -17.47 38.77 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.691 -0.766 . . . . 2.2 111.488 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.03 102.38 12.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 2.1 110.301 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 148.82 29.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.342 -0.39 . . . . 2.87 111.366 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.43 145.46 51.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.735 -0.469 . . . . 2.62 109.735 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.59 146.32 54.32 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.83 2.353 . . . . 2.77 111.918 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -60.91 112.32 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.84 -0.618 . . . . 4.28 111.93 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.88 -6.99 41.13 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.143 -0.551 . . . . 3.18 112.177 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -101.16 146.31 27.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.486 -0.191 . . . . 2.93 110.486 -179.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 11.6 p90 -155.93 165.13 37.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 3.73 110.093 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.64 136.92 38.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.814 0.34 . . . . 2.93 111.116 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -65.15 126.02 26.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 3.64 110.376 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.93 21.64 65.34 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.106 -0.569 . . . . 3.27 112.415 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.777 0.322 . . . . 3.59 110.168 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.875 0.369 . . . . 2.48 110.747 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.84 38.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 2.57 110.599 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -87.43 -22.76 24.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.996 0.369 . . . . 2.4 111.996 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.71 161.54 19.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 2.02 111.662 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 p -67.14 158.15 31.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 2.65 111.259 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.13 145.49 26.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 2.4 110.496 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.8 mp -99.85 152.49 20.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.456 -0.572 . . . . 2.27 109.456 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.563 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 2.0 m -109.09 128.29 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.858 0.361 . . . . 2.86 111.148 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -97.06 135.73 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 2.89 109.954 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -132.98 103.35 6.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.842 0.353 . . . . 4.07 110.375 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.07 -151.31 22.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.774 -0.726 . . . . 3.23 111.629 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -103.18 -19.25 14.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.91 0.386 . . . . 4.51 110.904 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -79.76 137.75 37.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.053 -0.721 . . . . 3.32 109.053 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 1.9 t0 -81.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.046 -0.724 . . . . 2.41 109.046 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 17.1 tp 173.07 122.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 2.18 110.98 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -144.39 123.19 12.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.104 -0.498 . . . . 2.46 109.768 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.55 142.14 25.96 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 1.78 110.636 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.75 164.93 27.4 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.238 2.625 . . . . 2.15 112.278 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -62.64 120.95 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 2.84 110.766 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.63 21.95 76.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.987 -0.625 . . . . 1.65 112.542 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -138.26 156.84 47.29 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.757 -0.261 . . . . 2.57 110.925 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.0 -3.92 48.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.817 -0.706 . . . . 1.42 112.719 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 120.94 79.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.602 0.239 . . . . 1.09 110.452 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.79 174.93 10.36 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.646 2.231 . . . . 1.27 111.577 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mt -81.83 83.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.857 0.36 . . . . 1.7 110.376 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -79.08 91.76 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 1.23 109.908 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -17.76 60.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 1.96 112.092 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -89.51 -18.72 26.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.042 0.386 . . . . 2.0 112.042 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.44 160.3 14.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.69 0.281 . . . . 1.44 111.673 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.4 m -80.94 168.52 24.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.09 -0.505 . . . . 2.06 110.02 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.19 -39.02 93.59 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.462 2.108 . . . . 1.42 112.09 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.9 p-10 -85.05 -1.53 56.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 1.78 111.105 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.3 0.12 44.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.805 -0.634 . . . . 1.6 110.212 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -79.43 57.52 2.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 1.19 110.814 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 tt -146.15 130.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 1.17 109.728 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.14 -148.03 5.88 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.297 -0.954 . . . . 0.61 112.404 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -153.84 152.96 31.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.802 0.334 . . . . 1.13 111.806 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -100.16 117.64 34.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.525 -0.917 . . . . 1.69 108.525 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -96.9 131.09 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.991 0.424 . . . . 2.51 111.802 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -79.63 107.23 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 2.62 109.715 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.37 156.13 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.13 0.49 . . . . 2.21 111.67 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.97 140.6 32.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 2.68 109.94 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -124.97 123.48 39.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.976 0.417 . . . . 3.78 111.615 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -139.8 165.34 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 3.58 109.452 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.636 HG12 ' H ' ' A' ' 62' ' ' LYS . 43.1 pt -133.97 173.61 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.367 -0.235 . . . . 4.26 110.367 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 116.525 -0.307 . . . . 5.46 110.766 179.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.929 0.395 . . . . 4.48 111.154 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.636 ' H ' HG12 ' A' ' 54' ' ' ILE . 66.6 tttt -72.67 -55.18 7.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.95 -0.759 . . . . 4.47 108.95 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.7 t70 56.78 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.162 -0.927 . . . . 4.09 113.042 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 157.07 16.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 3.36 110.304 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.24 158.24 82.42 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.491 . . . . 3.47 110.554 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 116.18 2.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.774 2.316 . . . . 2.69 111.898 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -117.14 125.97 52.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.746 -0.661 . . . . 3.22 110.692 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -99.77 126.18 45.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.976 -0.557 . . . . 1.95 111.128 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -103.51 139.42 38.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 2.76 109.604 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.97 123.12 33.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.077 0.465 . . . . 1.4 111.564 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -120.3 177.34 5.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.582 -0.735 . . . . 2.07 109.41 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.81 175.24 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.28 111.702 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.09 94.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.456 0.539 . . . . 1.66 112.456 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.69 45.62 3.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.95 -0.643 . . . . 1.66 114.04 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.85 84.65 4.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.173 0.487 . . . . 1.62 111.129 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.16 136.59 2.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.083 -0.579 . . . . 1.96 111.925 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.26 -35.3 74.78 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 2.62 112.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -129.08 40.36 3.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.3 0.571 . . . . 3.09 110.149 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.89 -60.78 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.727 -0.669 . . . . 1.87 110.069 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.13 51.91 16.07 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.886 -0.673 . . . . 1.7 111.487 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.3 mt -117.0 104.32 50.95 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.796 0.332 . . . . 1.43 111.537 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -88.1 151.25 6.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.651 2.234 . . . . 1.62 110.737 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -59.05 111.36 1.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 1.75 110.896 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.83 -3.01 14.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.645 -0.788 . . . . 1.44 112.805 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.73 131.23 42.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 1.25 110.724 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -97.18 114.9 26.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.064 0.459 . . . . 2.21 110.857 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HB3' HG13 ' A' ' 90' ' ' ILE . 22.3 ttmm -142.0 152.7 43.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.012 -0.736 . . . . 2.11 109.012 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.07 119.6 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 1.7 111.98 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.56 71.17 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.769 -0.651 . . . . 1.32 112.873 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.416 HG13 ' HB3' ' A' ' 87' ' ' LYS . 33.2 mm -125.25 96.09 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.877 0.37 . . . . 1.06 111.572 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.75 137.28 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.492 -0.559 . . . . 1.3 109.492 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -96.58 147.84 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.76 0.652 . . . . 1.08 112.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.27 137.05 33.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.67 -0.696 . . . . 1.04 110.246 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.36 166.44 28.05 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.655 -0.498 . . . . 1.27 109.655 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 t -139.76 168.4 19.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.745 -0.207 . . . . 1.58 110.689 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.2 124.39 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 2.64 111.254 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.9 -16.5 36.37 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.71 -0.677 . . . . 1.63 112.439 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -79.97 143.35 34.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.625 0.25 . . . . 1.59 110.656 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.76 148.62 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.417 -0.356 . . . . 2.15 110.526 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -84.54 64.43 8.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.465 0.65 . . . . 2.3 111.193 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.32 143.11 47.49 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.518 -0.765 . . . . 2.69 109.167 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.8 131.19 24.35 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.866 2.377 . . . . 2.08 112.988 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -119.93 44.26 2.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.944 -0.571 . . . . 1.99 110.302 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -13.04 62.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 2.55 112.155 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -21.63 65.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.283 0.475 . . . . 2.28 112.283 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.72 18.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.164 0.507 . . . . 2.0 110.963 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.33 12.19 69.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.862 -0.685 . . . . 2.33 111.659 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -114.44 128.16 56.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.859 0.362 . . . . 3.21 111.494 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -169.25 139.66 2.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.834 -0.621 . . . . 3.03 109.603 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -99.14 120.57 57.95 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.802 0.334 . . . . 3.75 110.648 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.91 -29.5 23.07 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.035 2.49 . . . . 3.39 114.975 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.02 -2.6 57.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.031 -0.418 . . . . 4.05 111.468 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -122.28 0.13 9.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.185 0.517 . . . . 4.78 111.223 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -160.21 142.66 13.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.137 -0.483 . . . . 3.41 109.77 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.33 145.93 24.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.75 0.31 . . . . 3.21 111.215 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.59 138.19 38.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.453 . . . . 3.0 109.778 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.79 141.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.27 -0.423 . . . . 2.42 110.337 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.92 122.37 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.858 -0.423 . . . . 2.74 109.858 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.433 HD12 HD11 ' A' ' 16' ' ' LEU . 2.3 tt -67.61 119.05 11.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.15 0.5 . . . . 2.19 111.436 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -131.01 143.62 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.574 -0.739 . . . . 2.49 110.452 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.3 mt -97.97 149.63 35.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.131 -0.486 . . . . 1.96 110.665 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.08 154.87 48.36 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.669 2.246 . . . . 1.84 111.875 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -58.76 119.2 6.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 2.77 110.515 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 117.81 -26.06 8.16 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.762 -0.732 . . . . 2.2 111.569 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 m -102.95 107.45 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 2.1 110.075 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 155.21 17.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.38 -0.373 . . . . 2.87 111.402 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.6 mt -74.57 142.51 77.71 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.505 -0.554 . . . . 2.62 109.505 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.1 150.01 59.41 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.649 2.233 . . . . 2.77 111.853 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -58.37 116.03 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 4.28 111.337 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 108.57 -20.19 30.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.076 -0.583 . . . . 3.18 111.762 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 16' ' ' LEU . 3.8 t80 -95.61 117.99 31.48 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.487 -0.56 . . . . 2.93 109.487 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.563 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 5.9 p90 -125.49 148.76 48.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.123 0.487 . . . . 3.73 111.535 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.49 142.17 28.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.854 -0.612 . . . . 2.93 110.018 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.85 140.14 33.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.958 0.408 . . . . 3.64 110.557 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.24 -19.57 52.33 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.287 -0.725 . . . . 3.27 111.287 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.734 0.302 . . . . 3.59 111.782 -179.648 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.919 0.39 . . . . 2.48 111.294 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.77 146.39 46.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 2.57 111.005 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.413 ' CE2' ' HD3' ' A' ' 109' ' ' ARG . 24.3 m95 -81.86 -34.93 29.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 2.4 111.234 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.07 164.97 11.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.834 -0.621 . . . . 2.02 111.355 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.766 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -62.8 164.65 7.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.068 -0.514 . . . . 2.65 111.663 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . . . -80.11 149.54 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 2.4 112.144 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.4 mt -105.41 119.15 38.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.325 -0.991 . . . . 2.27 108.325 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 m -100.32 129.42 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.64 0.607 . . . . 2.86 112.64 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -97.5 115.7 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 2.89 110.056 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -110.83 74.03 0.85 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.088 -0.506 . . . . 4.07 109.956 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.62 -162.24 22.61 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.861 -0.608 . . . . 3.23 111.649 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.56 -18.5 22.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.368 . . . . 4.51 110.82 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.18 170.08 12.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.039 -0.528 . . . . 3.32 111.103 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -101.59 -78.31 0.53 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.091 -0.707 . . . . 2.41 109.091 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -178.15 143.66 0.3 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.08 -0.509 . . . . 2.18 110.854 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -159.3 116.26 2.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.071 -0.513 . . . . 2.46 110.0 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.17 134.83 21.38 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 1.78 110.511 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.66 150.92 69.47 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.599 2.199 . . . . 2.15 112.267 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.1 121.53 10.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.799 -0.637 . . . . 2.84 110.15 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.46 -25.75 13.1 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.215 -0.754 . . . . 1.65 111.215 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -113.78 -172.47 2.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.22 -0.289 . . . . 2.57 110.22 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.63 -26.08 21.78 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.882 -0.675 . . . . 1.42 112.163 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.25 119.27 75.96 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.576 0.227 . . . . 1.09 110.615 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.88 177.23 8.19 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.197 . . . . 1.27 111.183 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mt -77.16 91.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 1.7 110.201 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -84.42 82.88 8.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 1.23 110.287 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.07 41.38 0.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.791 -0.64 . . . . 1.96 112.198 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -150.29 -2.6 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 2.0 111.352 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.32 170.34 14.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.497 -0.32 . . . . 1.44 111.503 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.36 165.67 32.2 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.594 -0.276 . . . . 2.06 110.271 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.43 -33.54 92.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.966 2.444 . . . . 1.42 112.225 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -71.74 -24.09 61.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 1.78 110.547 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.855 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 42.4 m-20 -83.53 -2.98 57.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.808 -0.633 . . . . 1.6 110.802 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -78.26 56.75 1.75 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.344 0.592 . . . . 1.19 111.354 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.4 tt -150.87 130.96 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.499 -0.773 . . . . 1.17 109.103 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.31 -146.45 5.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.113 -1.042 . . . . 0.61 112.979 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -155.41 161.35 41.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.003 0.43 . . . . 1.13 110.764 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.462 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 47.4 m-85 -104.56 134.66 47.36 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.187 -0.672 . . . . 1.69 109.187 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -114.65 122.47 46.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.027 -0.533 . . . . 2.51 110.834 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -87.6 123.42 32.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.33 . . . . 2.62 110.406 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.33 155.99 43.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.21 111.485 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.55 120.67 16.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.647 . . . . 2.68 109.95 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.442 ' HB3' HD13 ' A' ' 64' ' ' LEU . 25.9 tpt180 -96.56 122.18 39.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.101 0.477 . . . . 3.78 112.021 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -138.23 145.32 41.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.681 -0.69 . . . . 3.58 109.907 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.4 pt -121.72 -178.3 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.207 -0.452 . . . . 4.26 109.986 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 5.46 110.528 179.907 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.88 0.372 . . . . 4.48 110.944 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HE3' HD21 ' A' ' 64' ' ' LEU . 50.2 tttp -65.39 -54.37 29.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.556 . . . . 4.47 110.291 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.32 91.14 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.606 -0.724 . . . . 4.09 112.89 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 52' ' ' ARG . 63.6 mt -94.59 150.19 20.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 3.36 109.903 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -64.83 161.54 45.26 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.224 -0.444 . . . . 3.47 110.39 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.77 109.24 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.579 2.186 . . . . 2.69 111.244 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -103.51 123.38 46.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 3.22 111.422 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.462 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 79.9 m95 -96.2 120.64 36.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.976 -0.556 . . . . 1.95 110.056 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 15' ' ' ALA . 53.9 m-85 -106.7 133.31 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.727 -0.472 . . . . 2.76 109.727 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -85.95 121.19 28.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.802 0.334 . . . . 1.4 111.163 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -118.76 146.27 44.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.024 -0.534 . . . . 2.07 109.808 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -82.67 149.3 27.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.463 -0.335 . . . . 1.28 110.504 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 tp -59.44 113.5 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.474 -0.33 . . . . 1.66 110.652 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 122.38 -13.92 8.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.141 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.8 p -59.72 123.66 17.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.711 0.291 . . . . 1.62 110.787 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.1 99.64 2.6 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.789 -0.72 . . . . 1.96 111.573 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.9 -42.54 67.98 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 123.079 2.519 . . . . 2.62 112.334 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.47 28.13 8.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.034 0.445 . . . . 3.09 111.298 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.2 -43.22 53.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 1.87 110.484 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.33 51.82 56.35 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.923 -0.581 . . . . 1.7 111.973 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.22 95.66 35.8 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.735 0.302 . . . . 1.43 111.428 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 4.0 Cg_exo -76.04 159.61 37.42 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.836 2.357 . . . . 1.62 110.323 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -60.08 107.84 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 1.75 111.026 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.24 -13.91 8.35 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.706 -0.679 . . . . 1.44 112.19 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.492 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -60.02 116.64 4.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.054 0.454 . . . . 1.25 111.13 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -76.24 116.33 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 2.21 110.763 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -137.31 158.17 45.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.546 -0.539 . . . . 2.11 109.546 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.33 121.82 16.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.257 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 30.83 71.25 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.95 -0.568 . . . . 1.32 112.595 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.9 mm -131.74 113.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.621 0.248 . . . . 1.06 110.38 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 pt -121.36 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 1.3 109.71 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -91.72 139.61 30.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.347 0.499 . . . . 1.08 112.347 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.13 142.89 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.721 -0.672 . . . . 1.04 110.368 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.62 155.25 34.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.401 . . . . 1.27 110.588 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -121.83 170.11 10.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 1.58 109.73 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.73 114.33 11.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.934 0.397 . . . . 2.64 110.172 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.36 5.83 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.039 -0.824 . . . . 1.63 111.039 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.52 159.96 28.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 1.59 110.748 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.8 mt -118.49 140.56 49.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 2.15 111.263 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.67 80.58 7.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.399 0.619 . . . . 2.3 110.752 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.3 t -156.28 146.77 16.05 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.115 -0.698 . . . . 2.69 109.115 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.48 118.18 5.47 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.231 1.954 . . . . 2.08 112.401 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.855 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -118.31 67.42 0.77 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.728 . . . . 1.99 110.682 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.79 -4.24 36.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.897 . . . . 2.55 111.224 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -61.35 -14.19 25.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.005 -0.543 . . . . 2.28 112.392 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.5 mt -104.7 -26.22 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.804 0.335 . . . . 2.0 110.724 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.31 -33.23 83.7 Favored Glycine 0 C--N 1.328 0.138 0 CA-C-N 115.901 -0.59 . . . . 2.33 113.482 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -67.23 113.21 4.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.845 0.355 . . . . 3.21 111.387 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.413 ' HD3' ' CE2' ' A' ' 12' ' ' TRP . 10.7 ttp85 -162.95 128.83 3.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 3.03 111.1 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -91.59 116.92 67.39 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.722 -0.672 . . . . 3.75 109.882 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.81 -33.31 65.37 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.166 2.578 . . . . 3.39 113.044 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.21 14.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.976 0.417 . . . . 4.05 111.812 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -132.16 9.54 4.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.152 -0.476 . . . . 4.78 111.591 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -168.61 129.75 1.26 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.664 0.269 . . . . 3.41 111.653 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.46 168.19 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 3.21 110.519 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 156.98 16.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 3.0 111.627 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 30.3 mt -101.1 142.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.362 -0.977 . . . . 2.42 108.362 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.06 121.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.793 0.33 . . . . 2.74 110.286 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tt -58.92 112.2 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.706 . . . . 2.19 110.872 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -111.92 144.1 41.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.807 -0.633 . . . . 2.49 110.211 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.7 mt -107.5 143.46 27.28 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.301 -0.409 . . . . 1.96 110.766 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.92 156.67 63.16 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.653 2.235 . . . . 1.84 111.635 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -55.66 121.36 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 2.77 110.432 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.57 -21.0 19.9 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.885 -0.674 . . . . 2.2 111.442 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.5 m -99.24 104.17 16.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 2.1 110.116 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.97 140.86 35.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.723 -0.671 . . . . 2.87 110.952 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.54 HD23 ' HD2' ' A' ' 131' ' ' PHE . 21.3 mt -73.99 137.97 76.1 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 2.62 110.058 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.74 155.31 38.25 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.665 2.243 . . . . 2.77 112.055 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -58.22 127.87 34.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.734 -0.666 . . . . 4.28 111.306 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -17.21 59.76 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.091 -0.576 . . . . 3.18 112.652 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.54 ' HD2' HD23 ' A' ' 127' ' ' LEU . 2.6 t80 -94.53 120.22 34.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.562 0.22 . . . . 2.93 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -124.35 155.42 38.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.65 -0.25 . . . . 3.73 111.287 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 136.4 41.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.93 111.754 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.766 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.0 tp10 -61.44 123.58 18.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.592 -0.731 . . . . 3.64 110.742 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.84 66.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.9 -0.667 . . . . 3.27 113.631 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 121.037 0.446 . . . . 3.59 111.7 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 N-CA-C 110.005 -0.368 . . . . 2.48 110.005 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -73.16 155.61 39.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.197 0.522 . . . . 2.57 111.543 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -90.42 -24.24 20.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.609 . . . . 2.4 110.985 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -117.2 167.43 11.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 2.02 110.732 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -64.89 155.45 34.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.892 -0.595 . . . . 2.65 110.79 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 163.92 26.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.286 0.565 . . . . 2.4 111.261 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.708 ' HB3' ' HZ ' ' A' ' 131' ' ' PHE . 60.6 mt -111.3 111.55 22.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.675 -0.693 . . . . 2.27 109.854 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.44 119.63 22.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 2.86 111.61 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 23' ' ' ASP . 43.4 tp60 -90.49 124.99 35.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 2.89 110.673 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -132.24 91.29 2.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 4.07 110.424 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.13 38.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.298 -0.721 . . . . 3.23 111.298 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt -90.96 -7.76 51.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 4.51 111.176 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -114.73 -172.79 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.189 -0.671 . . . . 3.32 109.189 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -127.34 -149.99 0.43 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.178 -0.675 . . . . 2.41 109.178 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.62 133.38 39.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.751 0.31 . . . . 2.18 110.648 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.18 92.28 1.33 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.174 -0.466 . . . . 2.46 109.858 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -91.67 136.3 26.69 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 1.78 110.995 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -74.16 158.96 44.84 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.658 2.239 . . . . 2.15 111.187 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.5 125.26 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.007 0.432 . . . . 2.84 111.665 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.81 -15.66 52.01 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.637 -0.792 . . . . 1.65 112.62 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -129.98 153.49 48.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.651 0.262 . . . . 2.57 110.379 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.74 1.55 11.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.575 -0.821 . . . . 1.42 112.688 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.49 115.43 64.43 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.886 0.374 . . . . 1.09 110.852 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.45 178.64 5.93 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.761 2.308 . . . . 1.27 111.439 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.8 mt -77.06 92.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.996 0.427 . . . . 1.7 110.456 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -82.73 84.41 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 1.23 110.452 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 p -75.4 9.45 2.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.494 0.553 . . . . 1.96 112.494 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -118.08 -5.73 10.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.785 0.291 . . . . 2.0 111.785 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.52 168.11 13.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.89 0.376 . . . . 1.44 111.746 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.54 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.6 m -86.87 167.76 20.81 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 115.974 -0.557 . . . . 2.06 109.583 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.54 -36.86 72.39 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.344 2.696 . . . . 1.42 113.293 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.45 -14.76 59.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.057 0.391 . . . . 1.78 112.057 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -88.41 -0.04 56.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.624 0.25 . . . . 1.6 110.351 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -76.6 51.1 0.72 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.364 -0.38 . . . . 1.19 111.586 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.728 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.7 tt -146.39 130.46 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.17 -0.468 . . . . 1.17 110.233 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.63 -148.84 6.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.462 -0.875 . . . . 0.61 112.457 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -152.51 166.64 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 1.13 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.622 ' HH ' HD11 ' A' ' 119' ' ' LEU . 10.9 m-85 -111.72 134.53 53.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.944 -0.571 . . . . 1.69 109.955 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -112.94 133.98 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.195 -0.457 . . . . 2.51 111.211 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -87.25 121.77 30.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.1 -0.5 . . . . 2.62 109.876 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 156.85 47.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 2.21 111.531 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.21 154.5 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 2.68 110.288 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -130.14 118.65 21.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.973 -0.38 . . . . 3.78 109.973 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.88 107.52 5.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.634 -0.257 . . . . 3.58 110.409 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.766 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.8 pt -69.84 158.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 4.26 110.505 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.165 -0.47 . . . . 5.46 110.095 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.9 mmt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 110.106 -0.331 . . . . 4.48 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.766 ' HB2' HG12 ' A' ' 54' ' ' ILE . 43.7 tttt -71.07 -46.59 61.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.557 -0.534 . . . . 4.47 109.557 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 65.95 99.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.974 1.101 . . . . 4.09 113.974 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.8 mt -126.73 151.1 48.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.484 -0.78 . . . . 3.36 110.024 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.31 153.89 88.12 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.192 -0.458 . . . . 3.47 110.283 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.14 127.4 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.76 2.307 . . . . 2.69 111.756 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -115.22 124.64 51.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.486 . . . . 3.22 110.613 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.586 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 37.1 m95 -94.26 121.33 35.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 1.95 110.134 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -96.95 146.76 24.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 2.76 110.673 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -94.19 126.92 39.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.899 0.38 . . . . 1.4 110.33 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -126.99 165.77 18.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.955 -0.566 . . . . 2.07 109.867 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -100.62 169.21 9.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.773 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.92 103.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.088 0.773 . . . . 1.66 113.088 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.64 44.74 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.923 -0.58 . . . . 1.66 114.065 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.46 82.93 1.96 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.116 0.484 . . . . 1.62 111.321 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.71 131.18 1.21 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.596 -0.602 . . . . 1.96 111.596 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.23 -37.87 79.98 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.007 2.472 . . . . 2.62 112.322 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.03 31.77 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 3.09 111.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 -53.22 8.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.819 0.342 . . . . 1.87 110.626 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.3 48.49 83.32 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.933 -0.576 . . . . 1.7 112.025 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.1 mt -125.04 103.76 30.11 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.87 0.367 . . . . 1.43 111.592 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.11 162.44 17.9 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.633 2.222 . . . . 1.62 110.933 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -60.88 117.86 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 1.75 111.102 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.08 10.48 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 1.44 112.539 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.83 108.05 2.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 1.25 110.751 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -84.02 137.2 33.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.335 -0.393 . . . . 2.21 110.902 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -147.21 168.43 21.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.459 -0.941 . . . . 2.11 108.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.17 112.23 1.3 Allowed 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.285 0.366 . . . . 1.7 111.783 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.52 39.03 91.09 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.705 -0.68 . . . . 1.32 112.586 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 mm -132.9 102.98 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.825 0.345 . . . . 1.06 110.696 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.2 pt -113.73 133.86 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.812 -0.44 . . . . 1.3 109.812 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -90.38 140.03 30.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.035 0.445 . . . . 1.08 111.805 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.54 132.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.837 -0.62 . . . . 1.04 110.483 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.62 141.71 23.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 1.27 110.471 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 t -112.74 176.61 4.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.523 -0.547 . . . . 1.58 109.523 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -65.04 130.46 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 2.64 110.834 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.52 -15.36 49.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.003 -0.617 . . . . 1.63 112.148 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.728 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -74.56 130.26 39.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.59 110.742 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -103.14 139.51 38.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.136 -0.483 . . . . 2.15 110.873 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -74.15 88.84 1.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.215 0.531 . . . . 2.3 110.5 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.38 153.94 35.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 2.69 109.622 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.65 122.59 11.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.564 2.176 . . . . 2.08 111.468 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.8 mmtt -113.47 29.39 8.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.092 -0.503 . . . . 1.99 111.175 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -13.99 62.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 2.55 111.215 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -65.19 -17.65 64.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.08 -0.509 . . . . 2.28 112.105 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.55 -27.44 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 2.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.21 58.97 4.82 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.925 -0.579 . . . . 2.33 113.225 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 t -138.37 16.31 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 3.21 110.225 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -73.18 137.19 44.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.651 -0.704 . . . . 3.03 110.655 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -95.98 115.67 65.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.426 -0.352 . . . . 3.75 111.124 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.91 -27.97 11.71 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.721 2.281 . . . . 3.39 112.812 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.17 38.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.438 . . . . 4.05 110.847 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -170.1 -45.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 4.78 109.931 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -107.82 139.18 42.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.786 -0.643 . . . . 3.41 110.436 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.34 155.87 22.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.666 0.27 . . . . 3.21 110.876 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.04 162.11 14.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.22 0.533 . . . . 3.0 111.562 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.6 mt -98.48 150.55 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.082 -0.71 . . . . 2.42 109.082 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.1 t -69.43 126.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.301 -0.259 . . . . 2.74 110.301 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.622 HD11 ' HH ' ' A' ' 47' ' ' TYR . 4.4 tt -67.02 110.89 3.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.413 . . . . 2.19 109.911 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -118.11 146.13 44.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.004 -0.544 . . . . 2.49 110.978 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.9 mt -99.63 151.34 37.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.893 -0.594 . . . . 1.96 110.169 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.12 163.18 32.5 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.412 2.075 . . . . 1.84 112.48 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -60.69 115.33 3.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 2.77 110.783 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.49 -2.7 23.49 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.636 -0.792 . . . . 2.2 112.094 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.0 m -117.02 114.83 24.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 2.1 110.449 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.04 151.77 24.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.442 -0.345 . . . . 2.87 111.099 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.07 148.16 84.07 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.542 -0.54 . . . . 2.62 109.542 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.06 168.47 10.66 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.468 2.112 . . . . 2.77 112.059 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.38 130.93 45.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.076 -0.511 . . . . 4.28 111.891 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.32 65.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.103 -0.57 . . . . 3.18 112.347 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.708 ' HZ ' ' HB3' ' A' ' 16' ' ' LEU . 22.0 t80 -126.82 144.76 50.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.905 0.383 . . . . 2.93 111.384 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -146.65 157.87 43.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.932 -0.576 . . . . 3.73 109.801 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.07 134.12 45.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.012 -0.366 . . . . 2.93 110.012 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.51 150.25 47.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.846 0.355 . . . . 3.64 111.172 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.62 -91.7 0.49 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.873 -0.679 . . . . 3.27 111.779 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 120.64 0.257 . . . . 3.59 110.787 -179.703 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 0 N-CA-C 109.996 -0.372 . . . . 2.48 109.996 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.2 m -64.89 155.56 33.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.188 0.44 . . . . 2.57 112.188 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -84.53 -25.67 28.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.767 -0.652 . . . . 2.4 111.248 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -114.31 164.95 13.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.969 -0.56 . . . . 2.02 110.751 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 10.4 p -70.99 158.42 36.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.101 -0.5 . . . . 2.65 110.256 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 177.09 9.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.489 . . . . 2.4 110.768 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.67 129.25 48.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.411 -0.589 . . . . 2.27 109.411 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.54 115.87 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 2.86 111.268 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -83.13 143.97 30.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 2.89 110.685 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -140.36 79.93 1.73 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 4.07 110.164 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -170.47 41.36 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.728 -0.748 . . . . 3.23 111.975 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -88.09 -10.51 49.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 4.51 110.868 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.38 166.3 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 3.32 109.974 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -104.6 -82.28 0.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.77 -0.456 . . . . 2.41 109.77 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.3 tp -177.82 135.28 0.17 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.329 0.393 . . . . 2.18 110.803 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -162.84 124.09 2.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 2.46 109.576 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.3 138.9 23.9 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.578 -0.283 . . . . 1.78 110.709 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.23 175.25 6.96 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.074 2.516 . . . . 2.15 112.563 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.69 126.3 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 2.84 112.03 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.85 78.2 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.93 -0.652 . . . . 1.65 112.712 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.21 171.86 12.8 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.362 -0.236 . . . . 2.57 110.362 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.25 -8.14 69.49 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.661 -0.781 . . . . 1.42 112.783 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.15 114.73 63.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.673 0.273 . . . . 1.09 110.733 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.11 178.38 7.0 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.425 2.083 . . . . 1.27 111.472 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 mt -77.38 81.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.868 0.366 . . . . 1.7 110.608 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -81.73 81.55 7.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.23 109.942 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.07 3.98 9.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.1 -0.5 . . . . 1.96 112.156 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.9 -1.38 26.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 2.0 111.368 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.46 164.85 21.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.892 0.377 . . . . 1.44 111.59 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.88 168.08 27.73 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.013 -0.539 . . . . 2.06 110.275 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.85 -39.27 90.89 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.932 2.421 . . . . 1.42 113.039 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -73.16 -23.77 60.48 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.719 0.295 . . . . 1.78 110.772 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.849 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 34.4 m-20 -79.04 -2.12 38.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.6 111.256 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -81.86 55.71 2.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.245 0.545 . . . . 1.19 111.142 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.558 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.4 tt -152.14 131.96 3.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.17 109.961 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.79 -137.9 2.53 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.305 -0.95 . . . . 0.61 112.683 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -160.42 166.96 28.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.403 . . . . 1.13 110.645 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.492 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 3.0 m-85 -105.96 134.3 49.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.082 -0.71 . . . . 1.69 109.082 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -115.18 123.38 48.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.247 -0.433 . . . . 2.51 111.031 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -79.69 111.08 15.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 2.62 110.048 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.22 165.02 11.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 2.21 111.037 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -154.3 125.51 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 2.68 110.177 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 64' ' ' LEU . 17.4 tpt180 -115.37 120.62 40.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 3.78 110.656 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -132.03 162.88 29.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 3.58 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.433 HG12 ' HB2' ' A' ' 62' ' ' LYS . 38.1 pt -125.38 162.76 27.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 4.26 109.912 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.885 0.374 . . . . 5.46 110.631 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 mtm . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 120.743 0.306 . . . . 4.48 110.811 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.454 ' HE3' HD21 ' A' ' 64' ' ' LEU . 52.5 tttp -87.65 -40.19 14.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.19 -0.459 . . . . 4.47 110.451 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t70 40.96 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.247 1.202 . . . . 4.09 114.247 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.454 HD21 ' HE3' ' A' ' 62' ' ' LYS . 90.9 mt -95.78 157.32 15.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 3.36 110.365 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.72 153.06 95.92 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.73 -0.47 . . . . 3.47 109.73 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 113.85 1.49 Allowed 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.741 2.294 . . . . 2.69 112.057 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.1 mtt-85 -105.72 122.41 46.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 3.22 110.686 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.492 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 67.3 m95 -99.44 115.48 29.39 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.223 -0.444 . . . . 1.95 110.435 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -97.27 142.98 28.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.118 -0.492 . . . . 2.76 109.719 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.89 130.24 35.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 1.4 111.016 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -125.58 154.69 41.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.082 -0.508 . . . . 2.07 109.706 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.02 151.85 20.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.335 -0.393 . . . . 1.28 109.952 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.4 tt -60.38 112.23 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.262 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.49 -5.46 11.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.465 -0.874 . . . . 1.66 113.115 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 p -61.3 108.76 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 1.62 111.646 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 119.86 3.84 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.697 -0.763 . . . . 1.96 112.108 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.2 -37.33 51.95 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.662 2.242 . . . . 2.62 111.954 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -123.33 47.37 2.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.017 0.437 . . . . 3.09 111.013 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.43 -41.86 46.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.449 -0.574 . . . . 1.87 109.449 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 33.58 83.27 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.617 -0.719 . . . . 1.7 112.693 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.426 HD11 ' HD2' ' A' ' 87' ' ' LYS . 82.1 mt -131.05 99.12 18.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.778 0.323 . . . . 1.43 111.467 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 87.3 Cg_endo -82.87 170.38 12.57 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.488 2.125 . . . . 1.62 110.203 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.533 ' HB2' HD11 ' A' ' 73' ' ' LEU . 69.0 t80 -57.82 111.09 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.783 0.325 . . . . 1.75 110.886 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.06 -17.31 10.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.807 -0.711 . . . . 1.44 112.386 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -65.04 108.22 1.76 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 1.25 110.954 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -77.61 129.02 35.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.55 . . . . 2.21 110.936 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.426 ' HD2' HD11 ' A' ' 81' ' ' LEU . 75.0 tttt -143.14 162.64 35.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.458 -0.941 . . . . 2.11 108.458 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.81 110.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.881 0.372 . . . . 1.7 111.487 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 28.25 53.8 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.879 -0.677 . . . . 1.32 112.477 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.7 mm -128.68 105.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.972 0.415 . . . . 1.06 110.339 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.0 pt -117.7 127.0 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.198 -0.455 . . . . 1.3 110.135 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -87.25 138.25 31.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.141 0.423 . . . . 1.08 112.141 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.7 138.22 48.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.532 -0.758 . . . . 1.04 110.409 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.99 172.32 13.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.308 -0.406 . . . . 1.27 110.116 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 t -152.73 -176.37 5.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.403 -0.362 . . . . 1.58 110.791 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -65.71 134.82 54.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 2.64 111.118 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.4 -12.1 70.3 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.97 -0.633 . . . . 1.63 112.778 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.558 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.07 146.15 30.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.795 0.331 . . . . 1.59 110.727 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.55 149.14 43.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.165 -0.471 . . . . 2.15 110.704 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -82.15 82.75 7.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.259 0.552 . . . . 2.3 110.151 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.509 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 53.0 m -154.5 127.84 4.31 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.274 -0.876 . . . . 2.69 108.705 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.7 129.97 37.48 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.814 2.342 . . . . 2.08 112.783 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.849 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.12 67.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.707 0.765 . . . . 1.99 110.74 179.25 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.19 -7.94 51.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.291 -0.868 . . . . 2.55 111.7 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.14 -22.0 62.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.172 0.434 . . . . 2.28 112.172 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.2 mt -87.82 -35.64 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 2.0 110.563 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.83 66.42 3.75 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.931 -0.577 . . . . 2.33 112.436 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 t -148.35 16.68 1.04 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.533 0.682 . . . . 3.21 110.582 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -74.7 138.92 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.715 . . . . 3.03 110.855 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -85.68 123.16 72.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 3.75 110.605 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.62 -12.29 16.77 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.002 2.468 . . . . 3.39 114.293 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -111.3 9.67 21.65 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.995 -0.441 . . . . 4.05 111.544 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -136.85 12.16 3.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.215 -0.448 . . . . 4.78 111.226 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -169.38 142.12 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 3.41 111.033 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.37 141.73 28.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.388 -0.369 . . . . 3.21 110.624 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.49 146.89 38.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.323 -0.399 . . . . 3.0 110.755 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.5 mt -77.17 147.58 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.645 -0.707 . . . . 2.42 109.988 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.75 120.19 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.055 -0.35 . . . . 2.74 110.055 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.46 HD11 ' HH ' ' A' ' 47' ' ' TYR . 3.9 tt -62.31 121.67 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 2.19 111.536 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -132.11 142.56 49.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.702 -0.681 . . . . 2.49 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.407 HD12 HG23 ' A' ' 125' ' ' THR . 72.5 mt -94.16 148.39 35.06 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.184 -0.462 . . . . 1.96 110.296 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.21 167.25 16.78 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.894 2.396 . . . . 1.84 112.266 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -60.72 127.07 29.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 2.77 110.661 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.89 -19.66 46.15 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.548 -0.621 . . . . 2.2 111.548 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.407 HG23 HD12 ' A' ' 121' ' ' LEU . 6.4 m -102.42 109.21 20.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.748 0.308 . . . . 2.1 110.396 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 160.35 14.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.444 -0.344 . . . . 2.87 110.735 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -79.91 146.78 64.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.418 -0.355 . . . . 2.62 110.415 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.87 160.49 33.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.33 2.02 . . . . 2.77 111.778 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.6 113.63 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.578 -0.737 . . . . 4.28 112.142 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.11 0.2 61.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.144 -0.55 . . . . 3.18 113.611 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.15 129.99 47.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.828 0.314 . . . . 2.93 110.895 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -135.52 146.48 48.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 3.73 110.518 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.13 144.93 25.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 2.93 111.691 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 5.9 tt0 -67.81 128.45 36.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.946 -0.57 . . . . 3.64 110.175 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.23 -1.98 74.19 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 3.27 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 120.936 0.398 . . . . 3.59 111.181 179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.768 0.318 . . . . 2.48 110.719 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -55.64 139.42 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.671 -0.695 . . . . 2.57 112.195 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -73.26 -25.36 60.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 2.4 112.06 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.9 m-85 -109.92 172.97 6.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.496 0.554 . . . . 2.02 112.496 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 p -74.45 -172.94 1.6 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.244 -0.889 . . . . 2.65 111.032 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.65 136.81 35.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.838 0.681 . . . . 2.4 112.838 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 131' ' ' PHE . 17.6 mt -96.55 102.86 14.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.095 -1.076 . . . . 2.27 108.095 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.557 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -85.75 129.27 34.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.362 0.504 . . . . 2.86 112.362 -178.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -97.2 127.83 43.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 2.89 109.706 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.628 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 1.1 t60 -114.74 1.64 14.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.656 0.243 . . . . 4.07 111.656 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.39 -168.65 32.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.901 -0.666 . . . . 3.23 111.869 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -85.71 -33.41 21.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.864 0.364 . . . . 4.51 110.828 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.12 172.39 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 3.32 110.115 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.05 -76.01 0.57 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.952 -0.299 . . . . 2.41 110.64 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.6 tp -177.5 129.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.457 0.473 . . . . 2.18 111.16 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -156.34 119.23 4.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.291 -0.413 . . . . 2.46 110.212 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -110.3 151.09 42.41 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.147 -0.478 . . . . 1.78 110.562 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.65 164.34 34.81 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.92 2.413 . . . . 2.15 111.538 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -70.44 124.02 23.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 2.84 110.616 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.69 -10.49 52.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.793 -0.718 . . . . 1.65 111.578 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -122.35 -176.82 3.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.62 -0.511 . . . . 2.57 109.62 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.55 -31.63 8.12 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 1.42 112.542 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.95 120.14 78.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 110.336 -0.246 . . . . 1.09 110.336 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.74 -175.43 2.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.787 2.325 . . . . 1.27 112.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.1 mt -78.51 87.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 1.7 110.109 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.449 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 63.7 m-80 -82.38 73.04 9.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.325 -0.398 . . . . 1.23 110.557 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.1 68.52 1.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.036 -0.529 . . . . 1.96 111.047 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -176.7 -27.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.913 -0.585 . . . . 2.0 110.906 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 157.99 16.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.149 0.426 . . . . 1.44 112.149 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.06 164.14 61.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.767 -0.652 . . . . 2.06 111.105 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.11 -40.38 77.46 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.555 . . . . 1.42 113.389 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.53 -16.61 61.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.781 -0.367 . . . . 1.78 111.404 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.713 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 16.1 m-20 -87.42 -0.77 57.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.857 -0.611 . . . . 1.6 110.75 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 54.0 mm-40 -79.29 58.17 2.5 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.242 0.544 . . . . 1.19 110.714 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.452 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.4 tt -149.19 133.24 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.546 -0.752 . . . . 1.17 109.598 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.3 -144.5 5.38 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.342 -0.932 . . . . 0.61 112.633 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.65 162.1 41.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.871 0.367 . . . . 1.13 110.581 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.438 ' HB2' HG13 ' A' ' 91' ' ' ILE . 27.9 m-85 -102.22 123.97 46.98 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.838 -0.801 . . . . 1.69 108.838 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -101.72 133.61 46.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.009 -0.541 . . . . 2.51 111.231 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -82.17 129.26 34.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 2.62 110.099 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 130.17 43.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.099 0.476 . . . . 2.21 111.501 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 111.82 12.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 2.68 109.773 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HB3' HD13 ' A' ' 64' ' ' LEU . 12.1 tpt180 -91.68 111.02 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.293 0.568 . . . . 3.78 111.367 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -133.27 103.38 5.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 3.58 110.62 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 62' ' ' LYS . 44.2 pt -84.8 146.87 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 4.26 110.357 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.799 0.333 . . . . 5.46 110.487 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 38.1 mtt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.794 -0.447 . . . . 4.48 109.794 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HB2' HG12 ' A' ' 54' ' ' ILE . 48.8 tttp -58.19 -52.15 66.76 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.729 -0.214 . . . . 4.47 111.134 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t0 56.84 89.28 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.811 0.695 . . . . 4.09 112.51 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 52' ' ' ARG . 66.1 mt -101.08 170.15 8.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.112 0.482 . . . . 3.36 111.47 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.26 156.57 66.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 3.47 109.578 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.93 117.79 4.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 2.69 111.865 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -114.28 133.91 55.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.815 -0.63 . . . . 3.22 110.104 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -109.49 136.44 48.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 1.95 111.149 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -123.54 138.3 54.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.444 -0.576 . . . . 2.76 109.444 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -86.9 131.62 34.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.854 0.359 . . . . 1.4 111.611 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.23 144.9 51.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.942 -0.572 . . . . 2.07 110.115 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -77.69 151.81 34.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.247 -0.433 . . . . 1.28 110.083 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.39 120.28 11.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.582 -0.281 . . . . 1.66 110.669 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.38 -1.36 26.54 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.697 -0.763 . . . . 1.66 112.495 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 p -65.9 117.15 7.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.777 0.322 . . . . 1.62 110.866 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.22 112.38 3.21 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.946 -0.645 . . . . 1.96 111.731 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.42 -41.42 78.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.993 2.462 . . . . 2.62 111.908 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -110.52 39.74 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 3.09 111.034 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.01 -56.15 4.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.398 . . . . 1.87 110.677 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.67 45.88 95.38 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.1 -0.571 . . . . 1.7 112.184 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.74 108.03 17.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.655 0.264 . . . . 1.43 111.514 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 96.1 Cg_endo -86.92 173.77 5.8 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.811 2.34 . . . . 1.62 111.042 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -64.17 113.42 3.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.998 0.427 . . . . 1.75 110.737 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.02 -0.37 25.57 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.773 -0.727 . . . . 1.44 112.51 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.526 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -65.01 113.33 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 1.25 110.981 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -77.1 103.25 6.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 2.21 111.329 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -132.22 165.6 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.219 -0.446 . . . . 2.11 110.542 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.36 111.19 2.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.652 0.612 . . . . 1.7 112.652 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.21 41.77 85.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.735 -0.666 . . . . 1.32 112.948 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -131.27 104.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 1.06 110.799 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 47' ' ' TYR . 5.2 pt -110.12 123.59 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 1.3 109.875 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -89.76 135.88 33.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 1.08 112.082 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -137.24 145.63 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.032 -0.531 . . . . 1.04 110.612 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.29 149.69 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.491 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 169.29 8.63 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.07 -0.345 . . . . 1.58 110.07 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -70.11 111.34 5.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.799 -0.445 . . . . 2.64 109.799 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.49 -13.9 8.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 1.63 111.576 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.89 146.64 43.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.828 0.347 . . . . 1.59 110.547 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.1 mt -108.73 142.71 38.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.298 -0.41 . . . . 2.15 111.5 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -80.35 90.35 5.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 2.3 110.574 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 t -162.76 146.12 8.72 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.113 -0.699 . . . . 2.69 109.113 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.79 121.38 7.85 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.941 1.761 . . . . 2.08 111.246 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.713 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.83 76.9 1.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 1.99 112.343 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.56 5.91 29.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.34 -0.391 . . . . 2.55 111.394 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.474 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.9 p80 -57.84 -23.11 51.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.107 -0.497 . . . . 2.28 111.773 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.17 9.2 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.003 -0.544 . . . . 2.0 110.256 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.53 -35.65 13.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.652 -0.785 . . . . 2.33 111.973 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 t -68.65 125.59 27.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 3.21 110.863 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -162.59 125.72 2.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 3.03 109.873 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -86.42 116.39 65.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 123.276 0.36 . . . . 3.75 110.673 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.73 -32.51 46.82 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.879 2.386 . . . . 3.39 112.958 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.35 0.26 49.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.84 0.311 . . . . 4.05 111.84 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -128.39 -4.76 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.963 0.411 . . . . 4.78 111.167 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -149.88 128.25 12.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.766 0.317 . . . . 3.41 110.944 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.29 155.42 30.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.019 -0.537 . . . . 3.21 110.756 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.3 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 3.0 111.435 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 18.6 mt -101.5 146.54 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.711 -0.677 . . . . 2.42 109.621 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.23 120.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.61 0.243 . . . . 2.74 110.407 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.57 114.43 3.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.008 -0.542 . . . . 2.19 111.082 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -136.84 152.96 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 2.49 110.61 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.3 mt -100.94 147.7 34.05 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 1.96 110.114 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.56 160.86 30.27 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.756 2.304 . . . . 1.84 112.782 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.53 120.36 9.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.794 -0.639 . . . . 2.77 110.478 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.82 14.84 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.098 -1.201 . . . . 2.2 110.098 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.3 m -112.61 114.79 27.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 2.1 108.845 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 156.78 18.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.33 -0.396 . . . . 2.87 111.55 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.19 76.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 2.62 109.698 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.64 156.99 60.96 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.44 2.094 . . . . 2.77 111.448 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.46 120.95 14.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 4.28 111.644 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.17 -2.1 47.32 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.419 -0.672 . . . . 3.18 111.419 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 16' ' ' LEU . 1.6 t80 -110.3 129.38 55.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.29 . . . . 2.93 110.613 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.628 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 26.3 p90 -141.12 162.85 34.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 3.73 110.064 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.429 ' HB3' HD22 ' A' ' 16' ' ' LEU . . . -119.05 148.01 43.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.721 0.296 . . . . 2.93 111.029 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.0 131.05 43.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.591 -0.522 . . . . 3.64 109.591 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.78 -26.6 23.78 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 3.27 112.191 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.324 -0.521 0 O-C-N 122.593 -0.357 . . . . 3.59 110.701 179.847 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.647 0.261 . . . . 2.48 110.814 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.583 ' HG ' ' HD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.06 166.39 12.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.484 -0.326 . . . . 2.57 110.895 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.85 -38.64 7.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.313 0.577 . . . . 2.4 110.2 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -108.58 165.67 11.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.649 -0.705 . . . . 2.02 110.402 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.831 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 8.3 p -58.86 151.76 20.84 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.397 0.436 . . . . 2.65 111.366 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.98 137.31 40.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 2.4 112.015 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.4 mt -88.89 147.75 24.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.94 -0.763 . . . . 2.27 108.94 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -126.36 138.75 53.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.828 -0.349 . . . . 2.86 111.388 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -99.71 132.32 45.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 2.89 110.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.61 62.66 1.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.247 -0.649 . . . . 4.07 109.247 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.46 -159.68 9.58 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.686 -0.688 . . . . 3.23 111.907 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -91.05 -25.08 19.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.161 0.43 . . . . 4.51 112.161 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -90.6 176.02 6.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.671 0.272 . . . . 3.32 110.58 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.84 -71.38 0.68 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 2.41 109.961 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.9 tp 177.85 142.3 0.09 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.842 -0.617 . . . . 2.18 110.534 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -156.31 133.82 10.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.385 -0.37 . . . . 2.46 110.029 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -127.61 134.32 26.05 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.956 -0.387 . . . . 1.78 109.956 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.51 167.44 16.97 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.895 2.396 . . . . 2.15 112.411 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.54 127.06 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 2.84 110.518 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.09 6.88 78.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.826 -0.702 . . . . 1.65 112.466 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -138.75 147.27 42.45 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.232 -0.285 . . . . 2.57 110.232 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.63 -28.25 5.28 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.683 -0.77 . . . . 1.42 112.908 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.01 119.21 75.83 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.663 0.232 . . . . 1.09 110.725 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.94 168.71 18.07 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.556 2.17 . . . . 1.27 111.851 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 mt -74.62 81.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 1.7 111.604 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -83.97 86.61 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 1.23 110.118 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -21.66 65.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.96 111.597 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -75.85 -18.55 59.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 2.0 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -111.24 151.05 28.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.511 -0.313 . . . . 1.44 110.798 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.459 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 6.1 m -73.76 165.47 52.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 2.06 109.921 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.3 Cg_endo -52.77 -39.54 76.87 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.955 2.437 . . . . 1.42 113.342 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.509 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -76.51 -9.91 59.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.954 0.353 . . . . 1.78 111.954 -179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.6 m-20 -95.09 1.58 54.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.049 0.452 . . . . 1.6 109.946 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -83.9 61.64 6.52 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.058 -0.519 . . . . 1.19 111.108 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.644 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.2 tt -146.93 130.54 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.755 -0.657 . . . . 1.17 109.908 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.77 -141.32 3.51 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.237 -0.982 . . . . 0.61 113.111 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -163.69 170.18 17.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 1.13 110.345 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -109.94 130.31 55.55 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.507 -0.553 . . . . 1.69 109.507 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -103.41 132.38 49.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.895 0.379 . . . . 2.51 111.657 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -85.54 119.53 25.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.744 . . . . 2.62 110.216 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . . . -134.64 157.03 47.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 2.21 111.185 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.9 m -154.06 104.6 2.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.793 -0.639 . . . . 2.68 109.764 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -83.32 113.15 20.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.912 0.387 . . . . 3.78 111.459 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -121.72 87.47 2.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 3.58 109.438 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.5 pt -79.38 148.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 4.26 111.134 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 5.46 110.084 179.892 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.6 mtt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 110.01 -0.367 . . . . 4.48 110.01 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -60.95 -36.6 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.422 -0.584 . . . . 4.47 109.422 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t0 50.28 77.93 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.766 -1.106 . . . . 4.09 112.824 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.37 146.03 31.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.397 -0.594 . . . . 3.36 109.397 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.1 m -69.12 158.15 87.34 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.278 -0.268 . . . . 3.47 110.278 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.61 103.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.922 2.415 . . . . 2.69 112.644 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.491 HH22 ' CD ' ' A' ' 134' ' ' GLU . 3.4 mtt180 -101.42 138.8 37.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.836 -0.62 . . . . 3.22 110.296 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.8 124.55 49.75 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.728 -0.669 . . . . 1.95 110.72 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.583 ' HD1' ' HG ' ' A' ' 11' ' ' SER . 32.6 m-85 -109.42 127.32 54.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.683 -0.689 . . . . 2.76 109.525 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -78.07 126.47 30.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.905 0.383 . . . . 1.4 111.26 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.54 149.32 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.895 -0.78 . . . . 2.07 108.895 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -81.72 157.49 24.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.326 -0.25 . . . . 1.28 110.326 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.6 tp -58.45 115.34 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.524 -0.307 . . . . 1.66 111.045 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.57 52.19 4.03 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.606 -0.807 . . . . 1.66 111.852 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.94 78.55 5.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.921 0.391 . . . . 1.62 111.419 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.46 139.32 2.75 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.846 -0.692 . . . . 1.96 112.178 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.84 -26.27 32.3 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.587 2.191 . . . . 2.62 112.162 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.2 35.92 4.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 3.09 110.645 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.18 -55.59 5.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.999 -0.546 . . . . 1.87 110.95 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.13 36.57 92.05 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 1.7 112.019 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.67 103.55 53.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.026 0.441 . . . . 1.43 111.658 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 85.8 Cg_endo -84.8 165.46 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.388 2.059 . . . . 1.62 110.546 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -64.47 105.99 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.861 0.362 . . . . 1.75 110.274 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.13 -11.87 7.67 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.8 -0.714 . . . . 1.44 112.376 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -54.78 117.12 3.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.806 0.336 . . . . 1.25 111.389 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -76.48 99.76 5.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.539 . . . . 2.21 111.405 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -129.65 148.72 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 2.11 110.128 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.62 119.34 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.193 0.442 . . . . 1.7 112.193 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.02 53.31 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.848 -0.614 . . . . 1.32 112.624 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -129.54 111.09 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.88 0.371 . . . . 1.06 110.875 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.8 pt -115.91 118.71 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 1.3 110.08 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.72 136.95 35.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.634 0.605 . . . . 1.08 112.634 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 m -137.93 145.13 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.682 -0.69 . . . . 1.04 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.78 -177.58 6.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.274 -0.421 . . . . 1.27 109.972 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -153.64 172.8 16.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.629 -0.259 . . . . 1.58 110.581 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.62 115.91 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.275 0.559 . . . . 2.64 111.23 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.52 -19.63 16.47 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.82 -0.705 . . . . 1.63 112.001 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.644 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.85 126.98 31.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.382 -0.229 . . . . 1.59 110.382 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 66.9 mt -96.54 156.05 16.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.894 0.378 . . . . 2.15 111.295 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -84.4 83.82 7.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.145 0.498 . . . . 2.3 110.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.5 m -153.17 133.98 8.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.854 -0.612 . . . . 2.69 109.463 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.18 125.84 18.62 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.171 2.581 . . . . 2.08 112.086 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.3 mmtt -105.45 39.23 1.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.649 -0.705 . . . . 1.99 111.244 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -13.65 59.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.493 . . . . 2.55 111.551 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -70.38 -17.59 63.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 2.28 111.472 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.1 mt -96.02 -33.88 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.329 . . . . 2.0 110.768 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.58 57.22 4.17 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.914 -0.585 . . . . 2.33 112.389 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.7 t -134.1 20.23 3.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.421 0.629 . . . . 3.21 109.582 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 13.0 ttp180 -83.21 136.5 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.737 -0.665 . . . . 3.03 111.702 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -96.84 114.6 64.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 3.75 110.095 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.47 -28.3 83.42 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.912 2.408 . . . . 3.39 113.182 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 -10.84 59.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 4.05 111.364 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -116.31 -21.53 9.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.477 -0.328 . . . . 4.78 111.709 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.414 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 2.7 t-20 -137.14 120.0 16.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.689 0.28 . . . . 3.41 110.61 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 155.54 39.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.055 -0.52 . . . . 3.21 111.625 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.44 154.19 24.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 3.0 111.204 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.6 mt -102.74 150.34 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.777 -0.453 . . . . 2.42 109.777 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.7 120.19 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.586 0.231 . . . . 2.74 110.415 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.54 119.39 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 2.19 110.517 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -122.88 160.53 25.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.293 -0.412 . . . . 2.49 110.699 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.47 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 87.3 mt -110.08 150.4 41.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 1.96 111.297 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -65.05 170.88 9.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.986 2.457 . . . . 1.84 112.27 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.08 113.36 3.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 2.77 111.254 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.51 -14.0 30.2 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.993 -0.622 . . . . 2.2 112.723 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 4.7 m -88.47 140.95 28.94 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.707 -0.29 . . . . 2.1 110.393 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.39 144.82 50.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.818 0.342 . . . . 2.87 111.793 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.9 mt -87.28 144.38 35.91 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.08 -0.509 . . . . 2.62 109.738 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.34 156.18 26.89 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.913 2.408 . . . . 2.77 112.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -62.01 122.4 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.743 -0.662 . . . . 4.28 111.122 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.02 -8.53 61.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.917 -0.658 . . . . 3.18 111.873 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -97.1 144.16 27.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.916 -0.402 . . . . 2.93 109.916 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.592 ' CE1' ' HB ' ' A' ' 17' ' ' THR . 3.9 p90 -147.88 171.73 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 3.73 110.478 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -121.82 147.33 46.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 2.93 111.059 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.831 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.2 tp10 -68.47 122.5 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 3.64 110.67 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.86 66.65 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.013 -0.613 . . . . 3.27 112.98 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 3.59 111.779 -179.639 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.927 0.394 . . . . 2.48 111.906 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.52 164.91 26.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 2.57 111.016 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -90.65 -25.47 20.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 2.4 111.864 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 59.6 m-85 -115.75 171.61 7.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.27 0.47 . . . . 2.02 112.27 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -70.83 167.15 19.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 2.65 111.048 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.75 161.58 14.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.487 . . . . 2.4 111.058 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.98 127.24 56.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.505 -0.77 . . . . 2.27 109.758 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 65' ' ' SER . 80.7 m -90.93 126.86 36.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.301 -0.409 . . . . 2.86 111.058 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -97.08 134.01 40.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 2.89 110.199 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -130.82 90.26 2.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 4.07 109.308 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.36 -151.25 8.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.566 -0.826 . . . . 3.23 112.828 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -108.6 -2.21 18.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.801 0.334 . . . . 4.51 111.789 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -120.07 176.76 5.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.257 -0.275 . . . . 3.32 110.257 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.49 -87.62 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.283 -0.417 . . . . 2.41 110.76 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.436 HD12 ' CE1' ' A' ' 131' ' ' PHE . 55.4 tp -172.36 127.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.84 0.353 . . . . 2.18 110.869 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -148.93 105.11 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 2.46 109.949 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -89.24 146.97 37.26 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.074 -0.512 . . . . 1.78 110.541 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.0 163.34 39.12 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.569 2.18 . . . . 2.15 111.857 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -58.11 122.54 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.884 -0.598 . . . . 2.84 111.016 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.11 -12.32 66.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.612 -0.804 . . . . 1.65 113.172 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -118.06 157.73 26.29 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.632 -0.334 . . . . 2.57 110.969 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.16 -26.16 5.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.57 -0.612 . . . . 1.42 111.57 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.43 119.65 77.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.343 -0.243 . . . . 1.09 110.343 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.15 -170.44 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.488 2.125 . . . . 1.27 110.797 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.94 90.84 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.121 0.486 . . . . 1.7 110.816 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.403 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 70.2 m-20 -93.98 73.36 4.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.417 -0.586 . . . . 1.23 109.417 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -20.73 66.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.362 -0.835 . . . . 1.96 111.927 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -82.45 -3.48 55.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.33 -0.396 . . . . 2.0 111.84 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -126.69 159.58 33.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.921 0.391 . . . . 1.44 111.815 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.506 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 m -82.67 167.24 31.19 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.634 -0.712 . . . . 2.06 110.139 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 13.7 Cg_endo -55.88 -35.67 94.34 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.939 2.426 . . . . 1.42 112.878 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 p-10 -78.73 -11.22 59.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.267 -0.424 . . . . 1.78 111.605 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -97.46 -1.9 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 1.6 109.895 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 75.6 mm-40 -78.52 53.88 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 1.19 111.119 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.486 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 13.5 tt -144.09 125.57 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.794 -0.639 . . . . 1.17 109.856 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.44 -145.23 4.38 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.142 -1.028 . . . . 0.61 112.522 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -160.02 170.75 20.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.121 -0.326 . . . . 1.13 110.121 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.518 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 39.0 m-85 -112.51 136.95 51.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.503 -0.554 . . . . 1.69 109.503 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -115.27 132.07 56.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.569 0.224 . . . . 2.51 110.534 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -82.03 124.99 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.076 -0.511 . . . . 2.62 109.672 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' C ' ' HG1' ' A' ' 51' ' ' THR . . . -133.61 156.2 48.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 2.21 111.206 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 50' ' ' ALA . 20.7 m -158.53 134.65 9.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 2.68 109.935 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -107.07 122.17 45.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 3.78 110.461 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -138.96 82.38 1.9 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.716 0.293 . . . . 3.58 111.532 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.662 HG12 ' HB2' ' A' ' 62' ' ' LYS . 26.3 pt -72.13 154.73 7.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.448 -0.342 . . . . 4.26 110.539 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 5.46 110.091 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.873 -0.417 . . . . 4.48 109.873 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.662 ' HB2' HG12 ' A' ' 54' ' ' ILE . 39.6 tptt -55.44 -49.73 71.67 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.521 0.513 . . . . 4.47 110.421 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.0 t70 59.02 91.17 0.05 OUTLIER 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.561 -0.745 . . . . 4.09 112.691 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.78 148.63 36.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.735 -0.666 . . . . 3.36 110.161 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -70.32 146.44 94.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.16 -0.473 . . . . 3.47 110.557 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.5 118.45 5.33 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.858 2.372 . . . . 2.69 111.559 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -119.09 146.36 45.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 3.22 111.31 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.518 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.7 m95 -112.8 131.3 55.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.721 -0.672 . . . . 1.95 110.227 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -109.66 145.29 36.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.101 -0.499 . . . . 2.76 109.685 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -94.63 127.64 40.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 1.4 111.257 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -130.4 162.49 29.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.977 -0.556 . . . . 2.07 109.673 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -93.52 168.39 11.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.582 -0.281 . . . . 1.28 110.418 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.58 126.94 29.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.524 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.67 47.1 92.49 Favored Glycine 0 CA--C 1.516 0.105 0 N-CA-C 115.274 0.869 . . . . 1.66 115.274 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -74.92 101.97 4.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.246 0.523 . . . . 1.62 110.023 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.82 136.97 5.1 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.828 -0.701 . . . . 1.96 111.431 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.79 -28.4 68.02 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.678 2.252 . . . . 2.62 112.496 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.9 53.01 1.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 3.09 110.743 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.08 -46.97 5.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.879 -0.6 . . . . 1.87 110.515 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.64 24.84 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.882 -0.887 . . . . 1.7 110.882 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.626 ' HB3' ' HH2' ' A' ' 92' ' ' TRP . 65.2 mt -125.93 94.93 40.73 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 1.43 111.968 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -91.33 135.93 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 1.62 110.812 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -52.57 115.16 1.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.251 -0.431 . . . . 1.75 111.568 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.38 8.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.658 . . . . 1.44 112.778 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.83 163.49 21.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.993 0.425 . . . . 1.25 111.026 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.64 131.21 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.442 -0.345 . . . . 2.21 110.936 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -148.53 155.83 41.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.52 . . . . 2.11 110.109 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.35 117.57 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.257 -0.429 . . . . 1.7 111.919 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.6 34.62 67.34 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.75 -0.659 . . . . 1.32 112.635 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.3 mm -134.44 114.95 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.748 0.308 . . . . 1.06 110.687 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.5 pt -123.03 134.78 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.878 -0.416 . . . . 1.3 109.878 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.626 ' HH2' ' HB3' ' A' ' 81' ' ' LEU . 56.5 m95 -90.28 144.82 25.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.586 0.587 . . . . 1.08 112.586 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.0 m -142.07 134.6 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.521 -0.763 . . . . 1.04 109.993 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.62 147.46 26.78 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.818 0.342 . . . . 1.27 111.229 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.8 t -106.42 166.83 10.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.984 -0.553 . . . . 1.58 109.892 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.05 117.87 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.048 0.452 . . . . 2.64 110.319 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.7 -4.71 22.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.901 -0.666 . . . . 1.63 111.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -80.27 144.98 32.41 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.439 -0.208 . . . . 1.59 110.439 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.451 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 62.0 mt -90.38 139.61 30.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.728 0.299 . . . . 2.15 110.867 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -84.06 79.21 9.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.247 0.546 . . . . 2.3 110.111 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.44 154.22 13.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.788 -0.642 . . . . 2.69 110.034 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.67 129.02 27.63 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.678 2.252 . . . . 2.08 112.292 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -116.53 45.63 1.77 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.797 -0.638 . . . . 1.99 110.508 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -13.74 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.691 -0.686 . . . . 2.55 112.282 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -61.62 -12.97 18.25 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.375 0.509 . . . . 2.28 112.375 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.8 mt -104.0 -32.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 2.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.57 -9.0 42.29 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.845 -0.616 . . . . 2.33 114.558 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.0 t -79.72 63.0 4.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.332 0.586 . . . . 3.21 111.215 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.0 ttp85 -118.33 139.71 50.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 3.03 110.926 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -99.98 115.26 65.7 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.981 -0.554 . . . . 3.75 110.317 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.02 -24.47 39.17 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.979 2.453 . . . . 3.39 113.332 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.09 1.48 56.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 4.05 111.366 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -119.04 -48.61 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 4.78 110.158 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -106.93 137.13 45.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 3.41 110.52 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.44 139.5 45.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.103 -0.332 . . . . 3.21 110.103 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.8 158.1 28.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.057 0.456 . . . . 3.0 111.183 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 25.8 mt -104.99 141.92 19.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.974 -0.557 . . . . 2.42 109.796 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.62 127.08 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.883 -0.414 . . . . 2.74 109.883 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -66.7 116.73 7.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.485 . . . . 2.19 110.019 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.58 149.37 43.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.189 -0.46 . . . . 2.49 110.865 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.36 146.79 33.12 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.522 . . . . 1.96 109.957 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.64 157.18 62.18 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.603 2.202 . . . . 1.84 111.823 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.02 118.36 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 2.77 110.935 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.41 -15.18 17.85 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.744 -0.741 . . . . 2.2 111.349 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.2 m -104.99 119.42 38.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.965 0.412 . . . . 2.1 110.55 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.94 152.49 25.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.084 -0.507 . . . . 2.87 110.498 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.22 140.69 34.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.593 -0.276 . . . . 2.62 110.369 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.36 147.24 96.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.39 2.06 . . . . 2.77 110.902 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -51.3 123.15 9.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 4.28 112.042 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.24 4.74 56.31 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.059 -0.591 . . . . 3.18 112.586 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CE1' HD12 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -123.1 130.95 53.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.792 0.329 . . . . 2.93 111.182 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -153.45 149.56 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.085 -0.507 . . . . 3.73 110.248 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.4 146.32 27.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 2.93 110.886 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -70.59 150.31 46.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 3.64 110.891 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.14 64.97 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.756 -0.735 . . . . 3.27 112.255 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 120.614 0.245 . . . . 3.59 110.769 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.336 0 N-CA-C 109.49 -0.559 . . . . 2.48 109.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -53.23 146.17 12.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.348 0.87 . . . . 2.57 113.348 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -73.12 -35.0 66.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.793 -0.64 . . . . 2.4 110.759 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -108.36 170.92 7.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.822 -0.626 . . . . 2.02 111.245 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.743 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 11.2 p -69.15 168.48 13.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.646 -0.706 . . . . 2.65 111.142 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.99 159.76 15.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 2.4 110.989 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.613 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 35.9 mt -100.17 112.7 25.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.258 -0.428 . . . . 2.27 110.267 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 m -82.82 113.33 20.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.237 -0.438 . . . . 2.86 111.632 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.37 146.58 26.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 2.89 111.331 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -141.18 89.26 2.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.927 -0.579 . . . . 4.07 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.63 -168.33 41.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.893 -0.67 . . . . 3.23 112.22 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -81.93 -31.59 31.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.763 0.316 . . . . 4.51 111.267 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.61 -174.14 5.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.262 -0.426 . . . . 3.32 109.922 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -112.53 -88.12 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.608 -0.516 . . . . 2.41 109.608 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.5 tp -168.94 126.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 2.18 110.465 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -146.79 134.39 20.99 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.89 -0.411 . . . . 2.46 109.89 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.78 150.84 46.46 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 1.78 110.029 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 56.3 Cg_endo -73.06 -173.51 1.27 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.568 2.179 . . . . 2.15 112.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -79.97 126.39 30.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.234 -0.439 . . . . 2.84 110.891 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.9 -7.44 80.18 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 1.65 113.111 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.501 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 21.4 tt0 -122.55 154.28 38.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.184 -0.302 . . . . 2.57 110.184 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.3 -21.34 7.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.435 -0.888 . . . . 1.42 112.585 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 43' ' ' GLN . 43.1 t -80.06 119.53 76.89 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.661 0.267 . . . . 1.09 110.562 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.9 -176.59 2.68 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.947 2.431 . . . . 1.27 111.738 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.94 87.92 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.359 -0.382 . . . . 1.7 110.303 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -85.83 83.14 7.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 1.23 110.197 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.68 1.21 3.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.567 -0.742 . . . . 1.96 112.879 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -107.57 -6.39 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.28 . . . . 2.0 111.212 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.31 150.35 47.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.09 -0.244 . . . . 1.44 110.957 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -71.95 162.49 73.11 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.814 -0.439 . . . . 2.06 109.814 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -34.9 78.19 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 1.42 112.24 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -18.86 61.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.903 -0.59 . . . . 1.78 111.432 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.14 0.99 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 1.6 111.092 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.455 ' HB3' HG11 ' A' ' 32' ' ' VAL . 69.0 mm-40 -79.15 59.98 2.89 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.09 0.471 . . . . 1.19 110.957 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.523 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -146.66 130.68 10.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.919 -0.582 . . . . 1.17 110.252 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.72 -141.36 3.62 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.522 -0.847 . . . . 0.61 112.807 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -160.56 159.47 30.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 1.13 110.374 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.413 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 49.0 m-85 -100.09 133.14 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.621 -0.881 . . . . 1.69 108.621 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -117.86 122.41 43.28 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.229 0.331 . . . . 2.51 111.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.52 129.93 35.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.281 -0.418 . . . . 2.62 110.035 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.27 140.0 27.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.727 0.299 . . . . 2.21 110.814 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 133.81 38.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 2.68 111.074 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.536 ' HB3' HD13 ' A' ' 64' ' ' LEU . 28.0 tpt180 -101.87 129.27 48.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.006 -0.738 . . . . 3.78 109.006 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttt180 -138.86 78.05 1.65 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.668 -0.242 . . . . 3.58 110.851 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 153.3 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.965 -0.294 . . . . 4.26 110.592 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 5.46 110.489 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.555 0.217 . . . . 4.48 110.836 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -62.16 -47.31 85.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 4.47 110.988 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.471 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 25.0 t70 61.24 90.3 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.895 -0.593 . . . . 4.09 112.291 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 52' ' ' ARG . 15.4 mt -87.13 157.94 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.317 -0.401 . . . . 3.36 110.384 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -77.83 149.42 77.29 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.08 -0.509 . . . . 3.47 109.919 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.41 110.5 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.917 2.412 . . . . 2.69 111.648 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.525 HH21 ' CD ' ' A' ' 134' ' ' GLU . 5.5 mtp180 -121.42 138.81 54.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 3.22 111.51 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.445 ' CZ3' HG12 ' A' ' 91' ' ' ILE . 29.2 m95 -104.33 123.92 48.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.872 -0.604 . . . . 1.95 110.434 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.99 131.8 45.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.551 -0.537 . . . . 2.76 109.551 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -79.83 127.35 32.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.842 0.353 . . . . 1.4 111.099 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -124.84 148.25 48.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.988 -0.551 . . . . 2.07 109.587 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -84.87 159.27 20.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.939 -0.393 . . . . 1.28 109.939 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.534 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 1.9 tt -61.65 118.09 6.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.286 -0.265 . . . . 1.66 110.286 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.82 32.78 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 1.66 112.618 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.3 68.62 8.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 1.62 111.058 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.45 118.6 0.51 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.482 -1.047 . . . . 1.96 110.482 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.66 -43.68 44.54 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.101 2.534 . . . . 2.62 112.379 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.18 53.29 0.83 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.167 0.508 . . . . 3.09 111.153 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.19 -58.7 2.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.028 0.442 . . . . 1.87 109.808 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.72 65.02 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.7 112.706 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt -134.03 102.18 12.26 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.603 0.239 . . . . 1.43 110.509 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.05 176.61 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.933 2.422 . . . . 1.62 111.772 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -57.87 116.44 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 1.75 110.646 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.9 -17.51 9.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.685 -0.769 . . . . 1.44 111.987 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.16 110.35 3.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.408 . . . . 1.25 110.462 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -76.89 124.27 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 2.21 110.856 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.419 ' HB3' HG13 ' A' ' 90' ' ' ILE . 29.5 tttt -143.19 154.46 43.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.432 -0.581 . . . . 2.11 109.432 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.09 119.54 8.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.411 -0.358 . . . . 1.7 111.546 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.55 29.99 67.16 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.932 -0.577 . . . . 1.32 112.58 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.419 HG13 ' HB3' ' A' ' 87' ' ' LYS . 39.8 mm -127.77 111.82 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 1.06 110.933 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 26.7 pt -117.96 120.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.3 110.507 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.534 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 94.9 m95 -79.94 135.36 36.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.125 -0.488 . . . . 1.08 112.108 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.22 137.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.623 -0.717 . . . . 1.04 111.005 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.43 152.18 39.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.994 -0.548 . . . . 1.27 109.879 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.0 t -114.77 170.79 8.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.956 0.407 . . . . 1.58 110.694 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -67.27 113.23 5.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.081 -0.509 . . . . 2.64 110.67 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.39 -11.67 21.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.857 -0.687 . . . . 1.63 111.826 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -86.18 120.03 27.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.779 0.323 . . . . 1.59 110.512 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.77 142.72 27.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 2.15 111.397 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -71.5 96.66 1.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.894 -0.594 . . . . 2.3 110.237 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 72.7 m -156.19 138.62 10.35 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.561 -0.745 . . . . 2.69 109.176 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.13 107.33 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.383 2.056 . . . . 2.08 111.244 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -95.66 75.42 3.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.314 -0.403 . . . . 1.99 110.149 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -15.89 61.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.548 -0.296 . . . . 2.55 111.321 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -60.19 -25.02 65.25 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.196 -0.456 . . . . 2.28 111.958 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.87 2.15 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.46 0.648 . . . . 2.0 110.246 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.33 51.63 1.84 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.004 -0.617 . . . . 2.33 111.579 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t -160.93 125.88 3.67 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.99 -0.374 . . . . 3.21 109.99 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -166.1 134.66 3.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.871 -0.418 . . . . 3.03 109.871 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -83.33 112.0 35.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 3.75 110.169 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.02 -30.61 90.03 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.065 2.51 . . . . 3.39 113.864 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.91 -5.15 57.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.78 0.324 . . . . 4.05 111.797 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -116.42 1.27 12.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.495 -0.32 . . . . 4.78 111.664 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -154.39 133.64 12.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.673 0.273 . . . . 3.41 110.54 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.38 141.68 28.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.42 . . . . 3.21 110.209 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.59 140.77 49.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.992 0.425 . . . . 3.0 111.147 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 mt -92.21 150.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 2.42 109.885 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -62.54 120.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 2.74 110.683 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.52 124.27 22.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.736 -0.666 . . . . 2.19 110.333 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.66 151.83 48.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.17 -0.468 . . . . 2.49 110.704 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.4 mt -98.58 137.48 20.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.049 -0.523 . . . . 1.96 109.921 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.72 152.53 41.34 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.123 2.549 . . . . 1.84 112.939 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -52.3 123.62 11.23 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.476 -0.784 . . . . 2.77 110.915 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 109.08 -14.65 33.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.809 -0.71 . . . . 2.2 111.45 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.1 m -111.81 123.64 50.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.915 -0.402 . . . . 2.1 109.915 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 150.03 32.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.883 0.373 . . . . 2.87 111.246 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.54 143.15 58.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.588 . . . . 2.62 109.858 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.58 138.78 87.78 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.675 2.25 . . . . 2.77 111.13 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -55.21 118.38 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 4.28 111.263 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.15 -20.11 12.97 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.54 -0.624 . . . . 3.18 111.54 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.613 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -89.28 147.53 24.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.638 0.256 . . . . 2.93 110.794 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.12 145.87 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.141 -0.482 . . . . 3.73 110.931 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.48 152.03 23.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.924 -0.58 . . . . 2.93 111.317 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.743 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.1 tp10 -73.3 128.11 34.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 3.64 110.446 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.82 80.02 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.027 -0.606 . . . . 3.27 112.323 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 3.59 111.489 -179.453 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.952 0.406 . . . . 2.48 111.342 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.6 m -73.5 151.25 41.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 2.57 110.491 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -87.0 -13.72 43.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.424 . . . . 2.4 112.061 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -119.41 163.35 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.856 0.317 . . . . 2.02 111.856 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 p -71.03 168.36 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 2.65 111.034 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.65 156.75 27.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.266 0.555 . . . . 2.4 112.129 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.585 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -112.39 122.32 47.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.55 -0.75 . . . . 2.27 109.23 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.95 128.62 38.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.883 0.373 . . . . 2.86 111.951 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -105.26 128.89 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 2.89 110.25 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -119.7 89.36 3.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 4.07 110.504 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.53 -167.66 40.75 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.884 -0.886 . . . . 3.23 110.884 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -86.38 -34.87 20.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.146 0.473 . . . . 4.51 111.334 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -68.64 151.63 46.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.387 . . . . 3.32 110.105 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 -85.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.136 -0.32 . . . . 2.41 110.136 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 131' ' ' PHE . 34.4 tp -168.6 130.27 1.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.482 -0.326 . . . . 2.18 110.392 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -153.02 132.06 12.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 2.46 109.485 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -125.55 138.2 31.39 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.581 -0.281 . . . . 1.78 110.69 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.27 163.92 32.49 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.738 2.292 . . . . 2.15 112.235 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -60.99 117.43 5.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.356 -0.838 . . . . 2.84 111.023 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.32 0.2 56.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.788 . . . . 1.65 112.618 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -127.88 162.37 26.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.78 0.324 . . . . 2.57 110.139 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.73 5.75 44.48 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.869 -0.682 . . . . 1.42 111.821 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.4 t -100.03 114.81 65.84 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.931 -0.396 . . . . 1.09 109.931 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.1 -175.58 2.73 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.043 2.495 . . . . 1.27 111.73 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -83.1 85.33 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.146 0.498 . . . . 1.7 110.66 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -80.74 93.81 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.861 -0.609 . . . . 1.23 110.916 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.3 p -85.57 3.69 39.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 1.96 111.473 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -107.9 -4.12 18.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 2.0 111.075 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.75 152.12 51.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.899 0.38 . . . . 1.44 111.874 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -78.75 168.69 25.11 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 2.06 110.111 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 77.3 Cg_exo -53.2 -37.49 80.27 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.835 2.357 . . . . 1.42 112.904 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -72.37 -8.76 56.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 1.78 111.469 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.631 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 12.2 m-20 -104.41 4.35 33.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 1.6 110.508 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.401 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 36.8 mm-40 -79.26 58.55 2.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.993 0.425 . . . . 1.19 111.822 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -152.03 128.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 1.17 110.263 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.83 -157.51 10.09 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.31 -0.948 . . . . 0.61 112.971 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -149.72 147.92 28.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.918 0.389 . . . . 1.13 111.296 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 11.0 m-85 -90.38 137.0 32.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 1.69 109.552 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -114.13 130.29 56.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.453 -0.34 . . . . 2.51 111.259 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -71.29 125.17 26.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.002 -0.74 . . . . 2.62 109.002 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.31 127.55 55.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.035 0.445 . . . . 2.21 112.066 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.11 140.34 51.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.905 -0.776 . . . . 2.68 108.905 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.481 ' HB3' HD13 ' A' ' 64' ' ' LEU . 14.9 tpt180 -150.19 111.1 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.618 0.599 . . . . 3.78 112.618 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 94.0 mtt180 -135.72 107.06 6.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.797 -0.638 . . . . 3.58 110.223 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.0 pt -68.4 171.04 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 4.26 110.842 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.839 0.352 . . . . 5.46 110.85 -179.785 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 109.996 -0.372 . . . . 4.48 109.996 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HB2' HG12 ' A' ' 54' ' ' ILE . 68.9 tttt -75.7 -38.56 58.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 4.47 110.382 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 26.5 t70 52.4 81.45 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.547 -0.752 . . . . 4.09 112.429 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 52' ' ' ARG . 24.3 mt -81.7 151.51 27.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.222 -0.445 . . . . 3.36 110.439 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -67.85 148.14 98.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.902 -0.59 . . . . 3.47 110.011 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.39 108.12 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.849 2.366 . . . . 2.69 111.768 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 3.6 ptp180 -119.27 144.17 46.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 3.22 111.261 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.535 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 34.4 m95 -115.08 139.01 50.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.014 -0.539 . . . . 1.95 110.238 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -113.84 140.89 47.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 2.76 110.312 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.97 126.5 35.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 1.4 111.276 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -123.0 151.2 42.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 2.07 109.381 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.88 148.9 21.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.943 -0.392 . . . . 1.28 109.943 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.19 123.05 16.02 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.147 0.279 . . . . 1.66 110.563 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -9.16 19.01 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.631 -0.795 . . . . 1.66 112.22 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -65.24 131.7 47.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.607 0.242 . . . . 1.62 110.359 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.15 106.96 1.95 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.573 -0.822 . . . . 1.96 111.333 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.85 -44.43 47.59 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.654 2.236 . . . . 2.62 112.282 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.71 28.85 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.148 -0.478 . . . . 3.09 111.636 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.2 -61.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.821 0.343 . . . . 1.87 110.695 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.05 48.83 10.49 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.042 -0.823 . . . . 1.7 111.042 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.8 91.22 48.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 1.43 111.659 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.34 162.74 13.05 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.467 2.111 . . . . 1.62 110.929 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.17 104.88 0.35 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.123 0.487 . . . . 1.75 111.246 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.39 -26.97 3.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.665 -0.698 . . . . 1.44 112.006 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.79 123.5 19.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 1.25 110.872 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -95.76 136.11 36.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.227 -0.442 . . . . 2.21 111.602 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -143.22 155.17 44.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.873 -0.788 . . . . 2.11 108.873 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.74 115.28 6.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.184 0.516 . . . . 1.7 111.694 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.16 22.01 46.84 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.825 -0.625 . . . . 1.32 112.533 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.7 mm -136.7 133.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.163 -0.31 . . . . 1.06 110.163 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.4 pt -130.81 163.2 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.806 -0.442 . . . . 1.3 109.806 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -112.78 138.68 49.25 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.481 0.548 . . . . 1.08 112.481 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.62 133.29 32.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 1.04 110.233 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.74 132.97 14.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.354 -0.385 . . . . 1.27 110.214 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.4 t -102.47 170.57 7.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.818 0.342 . . . . 1.58 110.89 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -69.48 126.53 30.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.082 -0.508 . . . . 2.64 110.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.46 -11.61 25.96 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.307 -0.717 . . . . 1.63 111.307 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -89.75 149.22 22.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.647 -0.277 . . . . 1.59 110.539 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.61 141.71 41.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.352 -0.385 . . . . 2.15 110.951 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -80.27 97.78 7.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 2.3 110.555 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.484 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 5.0 t -170.29 145.54 2.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.044 -0.724 . . . . 2.69 109.044 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.34 128.7 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.542 2.161 . . . . 2.08 112.783 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.631 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.02 73.68 1.49 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 1.99 111.075 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.24 1.15 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.328 -0.396 . . . . 2.55 111.895 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -60.11 -16.61 33.6 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.077 0.399 . . . . 2.28 112.077 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.4 pt -121.95 27.36 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.104 0.478 . . . . 2.0 109.975 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.92 -24.68 7.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.731 -0.747 . . . . 2.33 113.807 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -96.35 131.23 43.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.217 0.532 . . . . 3.21 111.504 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.3 ttp85 -159.53 133.48 7.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.258 -0.428 . . . . 3.03 110.28 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -77.26 113.27 29.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 110.072 -0.344 . . . . 3.75 110.072 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -85.17 -12.06 7.11 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 3.39 112.897 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.06 -9.71 47.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 4.05 110.694 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -133.15 18.64 4.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.73 -0.668 . . . . 4.78 110.641 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -169.35 132.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 3.41 111.128 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.58 159.09 15.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.214 -0.448 . . . . 3.21 110.419 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.09 150.57 23.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.799 0.333 . . . . 3.0 111.351 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.3 mt -78.11 143.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 2.42 109.735 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.48 120.16 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.088 -0.245 . . . . 2.74 110.552 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.441 HD11 ' HH ' ' A' ' 47' ' ' TYR . 3.5 tt -62.85 118.72 8.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.081 0.467 . . . . 2.19 110.603 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.12 148.76 52.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 2.49 110.489 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 66.1 mt -98.59 147.34 33.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.318 -0.401 . . . . 1.96 110.247 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.63 166.16 10.34 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.833 2.356 . . . . 1.84 112.435 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -61.85 118.47 7.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.057 -0.52 . . . . 2.77 110.815 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.13 -24.98 14.87 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.403 -0.679 . . . . 2.2 111.403 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 m -88.46 103.75 16.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.926 0.393 . . . . 2.1 110.093 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -90.68 144.46 25.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.313 -0.403 . . . . 2.87 111.217 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.55 142.87 78.22 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 2.62 110.172 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -60.0 149.91 81.56 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 2.77 111.452 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -61.4 119.43 8.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 4.28 110.784 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.25 54.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.772 -0.728 . . . . 3.18 112.127 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.585 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -103.94 127.59 51.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 2.93 110.449 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -133.97 151.62 51.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.319 -0.401 . . . . 3.73 110.853 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.98 139.86 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 2.93 112.031 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.39 131.38 45.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.888 -0.596 . . . . 3.64 109.886 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.3 -37.07 3.14 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.328 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 120.64 0.257 . . . . 3.59 110.802 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.519 0.2 . . . . 2.48 110.851 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -55.08 143.47 26.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.052 -0.522 . . . . 2.57 112.019 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -67.89 -28.6 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 2.4 110.96 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.87 168.61 9.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.111 -0.495 . . . . 2.02 112.28 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -70.95 160.78 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.168 -0.923 . . . . 2.65 111.289 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.72 134.75 33.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.4 110.533 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.37 132.62 33.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.148 -0.478 . . . . 2.27 110.163 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 m -96.34 112.82 24.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.294 -0.412 . . . . 2.86 110.067 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -83.9 140.28 32.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 2.89 111.016 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -141.84 80.13 1.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.692 -0.485 . . . . 4.07 109.692 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.6 -166.45 29.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.987 -0.625 . . . . 3.23 112.199 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -91.68 -9.87 42.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 4.51 111.019 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -105.18 162.07 13.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.085 -0.507 . . . . 3.32 109.884 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -65.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.77 -0.826 . . . . 2.41 108.77 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.8 tp 175.31 133.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.395 -0.82 . . . . 2.18 110.533 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -150.64 117.57 5.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.068 -0.515 . . . . 2.46 110.304 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -108.12 139.63 20.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.55 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 49.8 Cg_endo -69.77 172.55 12.45 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.69 2.26 . . . . 2.15 112.421 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -69.45 127.62 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.878 -0.601 . . . . 2.84 110.848 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.68 25.06 63.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.942 -0.647 . . . . 1.65 112.622 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -151.38 158.78 44.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.547 -0.538 . . . . 2.57 109.547 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 21.63 9.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.744 -0.741 . . . . 1.42 111.418 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.84 110.35 63.6 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.183 -0.303 . . . . 1.09 110.183 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.65 175.15 7.5 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.723 2.282 . . . . 1.27 111.09 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.0 mt -72.93 87.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 1.7 110.686 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -82.76 74.96 9.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.808 -0.633 . . . . 1.23 109.775 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -31.5 72.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.34 0.496 . . . . 1.96 112.34 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.58 -7.19 59.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.596 -0.274 . . . . 2.0 111.68 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.92 150.15 32.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.098 0.475 . . . . 1.44 112.095 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.58 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 13.7 m -90.29 170.2 10.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.51 -0.768 . . . . 2.06 109.471 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 3.0 Cg_endo -46.79 -44.92 21.38 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.324 2.683 . . . . 1.42 114.094 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -70.52 -25.98 63.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.888 0.329 . . . . 1.78 111.888 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.805 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.3 m-20 -86.77 2.79 47.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.267 -0.424 . . . . 1.6 110.844 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -80.48 46.08 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.107 0.48 . . . . 1.19 111.119 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.784 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.7 tt -143.12 132.47 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.022 -0.535 . . . . 1.17 110.191 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.68 -145.55 4.8 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.414 -0.898 . . . . 0.61 112.158 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -155.6 159.91 40.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.122 0.487 . . . . 1.13 110.98 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -99.91 117.86 35.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.471 -0.786 . . . . 1.69 109.475 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -99.5 127.08 45.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.984 0.421 . . . . 2.51 111.321 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -85.24 135.25 34.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.839 -0.619 . . . . 2.62 110.432 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.7 42.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 2.21 111.37 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.7 m -152.98 127.32 9.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.062 -0.718 . . . . 2.68 109.062 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 -103.63 126.67 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.492 0.553 . . . . 3.78 112.492 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -142.92 107.56 4.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 3.58 109.472 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 169.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.63 0.252 . . . . 4.26 110.71 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.491 -0.322 . . . . 5.46 110.464 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.767 0.317 . . . . 4.48 110.906 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -97.89 -24.57 15.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 4.47 110.174 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 48.53 90.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.883 1.068 . . . . 4.09 113.883 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.53 147.75 33.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.257 -0.429 . . . . 3.36 110.178 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.4 m -78.4 162.12 67.43 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.492 -0.558 . . . . 3.47 109.492 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.0 108.08 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.768 2.312 . . . . 2.69 112.166 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -99.91 134.03 43.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.78 -0.646 . . . . 3.22 109.629 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -106.61 115.75 30.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.07 -0.514 . . . . 1.95 112.0 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -102.36 121.29 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.868 -0.79 . . . . 2.76 108.868 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.98 135.57 43.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 1.4 111.686 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -130.75 165.27 23.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 2.07 110.202 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -99.82 159.58 14.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.37 -0.377 . . . . 1.28 110.898 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.29 116.31 5.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.22 -0.445 . . . . 1.66 111.501 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.45 35.64 10.39 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.995 -0.621 . . . . 1.66 113.936 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.3 90.47 1.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 1.62 111.135 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.39 139.78 5.51 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.032 -0.604 . . . . 1.96 112.2 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -33.34 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.603 2.202 . . . . 2.62 112.053 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -103.67 36.45 2.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.026 -0.534 . . . . 3.09 111.093 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.03 -56.6 10.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 1.87 110.096 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.12 32.5 80.69 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.915 -0.584 . . . . 1.7 112.971 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 85' ' ' ALA . 3.0 tp -138.33 106.01 7.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.757 0.313 . . . . 1.43 110.688 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 92.2 Cg_endo -85.39 167.54 10.39 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.677 2.251 . . . . 1.62 111.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -60.95 106.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 1.75 110.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.54 -8.64 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.489 -0.862 . . . . 1.44 112.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.469 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . . . -69.24 137.99 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 1.25 110.967 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -88.44 128.18 35.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 2.21 111.839 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -155.24 144.01 20.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.781 -0.645 . . . . 2.11 109.283 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.73 113.34 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.196 0.443 . . . . 1.7 112.196 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.27 20.57 58.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.891 -0.671 . . . . 1.32 112.752 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.0 mm -127.72 102.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 1.06 110.51 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.8 pt -114.62 134.06 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.322 -0.399 . . . . 1.3 109.989 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -90.35 146.25 24.33 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.345 0.498 . . . . 1.08 112.345 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 m -140.47 144.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.518 -0.764 . . . . 1.04 110.311 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.95 169.59 23.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 1.27 110.869 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 t -146.17 179.04 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.969 -0.56 . . . . 1.58 109.5 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.7 123.37 19.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.399 . . . . 2.64 111.133 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 41' ' ' ASP . . . 107.35 -13.26 39.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.766 -0.73 . . . . 1.63 111.906 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.784 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.31 132.18 35.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.669 0.271 . . . . 1.59 110.785 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.9 mt -102.22 140.59 36.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.262 -0.426 . . . . 2.15 110.799 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -79.45 76.05 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.468 0.652 . . . . 2.3 110.09 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.54 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m -147.13 131.97 8.89 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.654 -0.869 . . . . 2.69 108.654 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.83 125.24 17.67 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.307 2.005 . . . . 2.08 112.251 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.805 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -126.85 75.87 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.585 0.707 . . . . 1.99 111.216 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.99 -4.53 44.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 2.55 112.058 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.445 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 4.1 p80 -59.18 -20.9 57.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.092 0.472 . . . . 2.28 111.864 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.3 pt -111.71 13.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.037 0.446 . . . . 2.0 110.616 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.22 -32.67 7.29 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.554 -0.831 . . . . 2.33 112.027 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.9 t -69.18 121.46 16.83 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.295 0.569 . . . . 3.21 110.978 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.0 ttp85 -164.57 131.18 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.781 . . . . 3.03 109.927 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -94.99 117.84 66.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 3.75 110.663 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 -34.97 92.94 Favored 'Trans proline' 0 N--CA 1.472 0.244 0 C-N-CA 123.123 2.549 . . . . 3.39 113.458 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.93 9.68 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.369 0.507 . . . . 4.05 112.369 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -139.52 9.1 2.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.871 0.367 . . . . 4.78 111.389 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -159.49 127.22 4.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 3.41 111.248 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.47 164.14 25.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 3.21 110.625 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.58 152.19 23.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.167 0.508 . . . . 3.0 111.466 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.76 145.86 7.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.746 -0.661 . . . . 2.42 109.417 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.497 ' HA ' ' OG1' ' A' ' 14' ' ' THR . 70.0 t -68.25 115.31 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.251 -0.277 . . . . 2.74 110.251 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.75 121.24 12.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.066 -0.515 . . . . 2.19 110.604 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -139.83 173.64 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.858 -0.61 . . . . 2.49 110.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.5 mt -123.14 152.48 63.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.558 -0.534 . . . . 1.96 109.558 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.42 154.65 34.39 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.003 2.469 . . . . 1.84 111.97 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -52.94 122.83 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 2.77 111.332 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.69 -11.34 49.88 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.632 -0.794 . . . . 2.2 112.321 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.3 m -109.11 113.89 27.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.486 -0.561 . . . . 2.1 109.486 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.2 159.63 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.358 -0.383 . . . . 2.87 110.892 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.4 mt -90.45 156.68 45.41 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.402 -0.363 . . . . 2.62 110.25 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.54 151.46 62.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.656 2.238 . . . . 2.77 111.912 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.36 119.2 8.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.185 0.517 . . . . 4.28 111.775 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.41 -8.88 44.8 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.723 -0.751 . . . . 3.18 112.346 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -101.51 112.91 25.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.788 -0.449 . . . . 2.93 109.788 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -133.1 149.88 52.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 3.73 111.663 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.45 147.35 27.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 2.93 110.073 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -73.67 121.61 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 3.64 111.237 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.85 -0.47 45.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.688 -0.767 . . . . 3.27 112.265 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 120.875 0.369 . . . . 3.59 110.733 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.992 0.425 . . . . 2.48 111.588 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -87.36 155.6 19.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.906 -0.588 . . . . 2.57 110.032 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -86.09 -29.4 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 2.4 110.146 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.52 -179.72 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.409 -0.814 . . . . 2.02 110.532 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.71 -172.35 4.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.458 . . . . 2.65 110.679 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -105.66 173.25 6.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 2.4 112.602 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.517 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 16.0 mt -112.1 122.85 48.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.931 -1.031 . . . . 2.27 109.312 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.1 m -92.52 116.39 28.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.99 0.424 . . . . 2.86 111.261 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -86.38 142.43 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 2.89 110.842 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -134.44 44.86 2.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.977 -0.556 . . . . 4.07 109.862 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.9 -167.24 12.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.832 -0.699 . . . . 3.23 112.442 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -86.74 -28.14 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 4.51 110.645 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.89 163.55 23.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 3.32 111.007 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.2 -85.5 0.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.825 -0.435 . . . . 2.41 109.825 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.517 HD12 ' CE1' ' A' ' 131' ' ' PHE . 36.5 tp -168.97 140.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 2.18 110.462 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -163.01 120.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.716 -0.675 . . . . 2.46 110.021 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -110.54 142.5 26.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.269 -0.423 . . . . 1.78 110.234 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.57 164.94 16.78 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.114 2.543 . . . . 2.15 111.965 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -69.61 128.47 36.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 2.84 110.426 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.83 29.92 49.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.287 -0.725 . . . . 1.65 111.287 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -157.84 171.52 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.46 -0.57 . . . . 2.57 109.46 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.31 17.32 64.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 1.42 112.511 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.78 111.15 65.0 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 1.09 109.826 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.51 168.57 11.2 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.783 2.322 . . . . 1.27 112.051 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.9 mt -74.69 87.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.16 -0.473 . . . . 1.7 110.497 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -84.11 77.69 9.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.039 0.447 . . . . 1.23 109.913 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -26.31 68.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 1.96 111.628 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -80.78 -3.78 52.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.127 -0.488 . . . . 2.0 111.653 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -120.52 157.52 29.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.351 . . . . 1.44 111.672 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.549 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 23.4 m -83.04 168.84 20.19 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.96 -0.564 . . . . 2.06 109.922 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.8 Cg_endo -52.9 -35.71 71.77 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.947 2.432 . . . . 1.42 113.913 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.2 p-10 -80.81 -16.01 54.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.652 0.242 . . . . 1.78 111.652 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.687 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 29.5 m-20 -84.37 -3.39 58.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 1.6 111.106 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -78.55 56.37 1.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 1.19 110.827 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 tt -149.97 127.38 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.673 . . . . 1.17 110.155 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.3 -139.83 3.0 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.515 -0.85 . . . . 0.61 112.214 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' CD2' HG22 ' A' ' 90' ' ' ILE . 53.7 p90 -162.09 158.65 25.12 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.08 0.467 . . . . 1.13 111.113 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.501 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -95.84 134.94 38.21 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.898 -0.778 . . . . 1.69 108.898 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -112.68 121.39 44.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.399 -0.364 . . . . 2.51 111.1 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -73.49 119.69 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.491 . . . . 2.62 109.787 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.31 148.29 43.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.173 0.511 . . . . 2.21 111.306 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.73 151.46 45.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.731 -0.84 . . . . 2.68 108.731 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.645 ' HB3' HD13 ' A' ' 64' ' ' LEU . 9.6 tpt180 -139.43 125.64 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.982 0.42 . . . . 3.78 111.604 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -140.73 98.58 3.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.905 -0.589 . . . . 3.58 110.789 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 61' ' ' MET . 33.8 pt -79.74 160.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.378 -0.601 . . . . 4.26 109.378 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 . . . . . 0 C--N 1.324 -0.533 0 C-N-CA 120.919 -0.312 . . . . 5.46 111.564 -179.216 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 mtt . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.943 0.401 . . . . 4.48 111.852 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.464 ' HE3' HD21 ' A' ' 64' ' ' LEU . 45.7 tttp -71.84 -33.72 68.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.517 -0.765 . . . . 4.47 110.288 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.1 t0 46.85 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.632 0.975 . . . . 4.09 113.632 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 52' ' ' ARG . 47.8 mt -89.22 137.3 32.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 3.36 110.46 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -64.04 144.73 98.17 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.099 -0.5 . . . . 3.47 110.271 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.81 119.32 5.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.915 2.41 . . . . 2.69 112.27 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.4 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 64.8 mtt85 -121.19 132.43 54.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 3.22 110.568 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.501 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.74 118.48 31.47 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.252 -0.431 . . . . 1.95 110.921 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.82 146.23 24.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.194 -0.669 . . . . 2.76 109.194 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.54 120.83 28.28 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.653 -0.419 . . . . 1.4 111.774 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -115.37 157.51 23.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.593 -0.521 . . . . 2.07 109.593 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -102.94 158.95 15.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.936 -0.394 . . . . 1.28 109.936 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.18 118.99 8.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.079 -0.341 . . . . 1.66 110.079 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.84 35.2 4.93 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.987 -0.625 . . . . 1.66 112.334 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.35 99.87 12.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.444 . . . . 1.62 110.796 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.85 123.94 3.38 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.181 -0.768 . . . . 1.96 111.181 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.3 -27.7 83.55 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.857 2.371 . . . . 2.62 113.181 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -127.59 35.35 4.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.737 0.303 . . . . 3.09 110.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.22 -50.65 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 1.87 111.023 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.62 51.27 26.38 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.308 -0.717 . . . . 1.7 111.308 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.7 mt -132.28 96.12 19.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.573 0.225 . . . . 1.43 111.596 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 92.9 Cg_endo -84.5 162.99 12.72 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.662 2.242 . . . . 1.62 110.661 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -58.8 113.26 1.97 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.013 0.435 . . . . 1.75 110.894 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.68 11.61 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.729 -0.748 . . . . 1.44 112.449 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.499 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -61.83 108.61 1.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.883 0.373 . . . . 1.25 110.486 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.0 107.45 8.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.153 -0.476 . . . . 2.21 110.543 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -125.62 149.83 48.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 2.11 109.968 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.15 110.49 1.62 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.236 -0.438 . . . . 1.7 111.683 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.17 21.48 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.794 -0.717 . . . . 1.32 112.284 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.403 HG22 ' CD2' ' A' ' 46' ' ' TYR . 48.1 mm -129.19 113.83 29.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.351 -0.24 . . . . 1.06 110.351 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.412 ' O ' HG13 ' A' ' 91' ' ' ILE . 7.8 pt -119.13 126.2 75.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.645 -0.502 . . . . 1.3 109.645 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -83.45 139.21 33.09 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.707 0.632 . . . . 1.08 112.707 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.45 139.44 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.538 -0.755 . . . . 1.04 110.411 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.5 172.33 18.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.082 -0.508 . . . . 1.27 109.745 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.2 t -142.9 170.84 14.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.748 0.309 . . . . 1.58 110.361 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.73 118.24 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.981 -0.554 . . . . 2.64 110.686 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.61 -15.22 8.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.967 -0.635 . . . . 1.63 111.647 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.669 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.25 159.26 22.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.671 0.272 . . . . 1.59 110.662 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.69 140.93 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 2.15 110.663 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -80.14 97.69 6.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.093 0.473 . . . . 2.3 111.179 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 t -171.2 148.93 2.51 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.968 -0.753 . . . . 2.69 108.968 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.54 111.75 3.39 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.045 1.83 . . . . 2.08 112.111 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -108.51 80.45 1.35 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.441 0.639 . . . . 1.99 110.264 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -72.64 -5.96 41.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.461 -0.79 . . . . 2.55 112.245 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -63.01 -15.61 56.99 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.519 0.562 . . . . 2.28 112.519 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.89 -24.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.463 . . . . 2.0 110.726 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.34 73.46 1.68 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.788 -0.72 . . . . 2.33 112.029 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.4 t -160.56 22.97 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.142 0.496 . . . . 3.21 110.979 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttp85 -84.29 136.85 33.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 3.03 110.824 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -83.85 119.64 73.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.42 -0.585 . . . . 3.75 109.42 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.52 -19.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.792 2.328 . . . . 3.39 113.769 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.43 -40.6 8.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.929 0.344 . . . . 4.05 111.929 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.88 7.72 26.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.41 -0.359 . . . . 4.78 111.394 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -160.23 139.92 11.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.333 . . . . 3.41 110.512 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.02 141.55 29.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.241 -0.436 . . . . 3.21 111.143 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.36 148.38 26.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 3.0 110.765 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.62 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 2.42 110.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.65 135.52 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.926 -0.398 . . . . 2.74 109.926 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.445 HD21 ' HH ' ' A' ' 47' ' ' TYR . 15.7 tp -63.3 119.66 10.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 2.19 110.691 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -124.33 135.24 53.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.49 110.915 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.0 mt -101.79 147.5 33.96 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 1.96 110.142 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.65 152.54 77.88 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.702 2.268 . . . . 1.84 111.807 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -54.86 129.49 37.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.858 -0.61 . . . . 2.77 111.258 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.64 14.17 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.419 -0.672 . . . . 2.2 111.419 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -99.81 98.26 9.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.718 0.294 . . . . 2.1 110.395 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.71 147.07 23.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 2.87 110.433 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.86 144.37 87.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.285 -0.416 . . . . 2.62 110.223 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.34 155.64 45.34 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.399 2.066 . . . . 2.77 111.505 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -60.89 127.41 31.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 4.28 111.105 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.95 63.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.908 -0.663 . . . . 3.18 112.648 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.51 116.56 30.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.917 0.389 . . . . 2.93 111.828 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -124.09 137.78 54.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 3.73 110.64 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 2.93 111.372 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.0 121.49 15.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 3.64 111.114 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 23.26 34.05 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.941 -0.572 . . . . 3.27 112.849 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 112.207 0.447 . . . . 3.59 112.207 -179.769 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.073 0.463 . . . . 2.48 112.236 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -73.1 139.21 46.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 2.57 110.306 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -98.06 -25.59 14.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.783 0.325 . . . . 2.4 111.788 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.66 176.98 5.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 2.02 110.571 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 p -69.89 175.62 4.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.983 0.421 . . . . 2.65 111.382 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -95.05 158.23 15.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.411 0.624 . . . . 2.4 111.527 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.662 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 88.7 mt -111.89 106.3 14.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.148 -0.933 . . . . 2.27 109.327 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.7 m -84.51 127.17 33.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 2.86 111.504 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.55 115.57 27.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.902 -0.59 . . . . 2.89 110.664 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -103.67 72.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.487 -0.56 . . . . 4.07 109.487 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.95 -161.85 26.86 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.842 -0.694 . . . . 3.23 112.156 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -94.28 -42.52 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.684 0.278 . . . . 4.51 111.115 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.69 153.32 36.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 3.32 110.064 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.9 -76.0 0.31 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.915 -0.314 . . . . 2.41 110.574 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.1 tp 179.8 130.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.897 -0.592 . . . . 2.18 110.264 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -145.18 123.97 12.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 2.46 110.32 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.406 ' CD1' ' HA2' ' A' ' 31' ' ' GLY . 46.6 m-85 -107.0 140.21 21.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.356 -0.384 . . . . 1.78 110.866 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 13.4 Cg_exo -71.58 168.96 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.839 2.359 . . . . 2.15 111.901 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -61.0 124.93 21.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 2.84 111.279 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.96 9.97 84.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.885 -0.674 . . . . 1.65 112.737 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 16.6 tt0 -129.5 160.7 32.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.814 -0.439 . . . . 2.57 109.814 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' A' ' 26' ' ' PHE . . . 118.36 -3.01 16.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.151 -0.547 . . . . 1.42 111.951 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.6 t -101.21 111.16 63.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.898 -0.408 . . . . 1.09 109.898 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.88 -170.7 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.001 2.467 . . . . 1.27 111.327 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -74.2 100.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.191 0.52 . . . . 1.7 111.268 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.499 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 71.2 m-80 -103.37 86.03 2.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.0 -0.741 . . . . 1.23 109.0 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -51.67 53.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.579 0.955 . . . . 1.96 113.579 -178.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -80.71 11.33 3.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.836 0.68 . . . . 2.0 112.836 -178.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -115.02 137.73 51.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.713 0.292 . . . . 1.44 110.802 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.98 164.05 50.99 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 2.06 111.006 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.17 -37.94 93.89 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.177 2.585 . . . . 1.42 113.312 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.4 p-10 -82.33 -5.97 58.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.548 0.213 . . . . 1.78 111.453 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.07 5.24 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 1.6 110.279 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.3 mm-40 -83.7 53.31 2.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 1.19 111.062 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.81 136.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.609 . . . . 1.17 110.142 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.19 -147.93 6.7 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.152 -1.023 . . . . 0.61 113.059 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -157.16 172.78 18.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.951 0.405 . . . . 1.13 110.699 -179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -117.34 134.76 54.44 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.478 -0.564 . . . . 1.69 109.478 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -107.53 136.17 47.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 2.51 111.141 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -81.37 98.12 8.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.607 -0.724 . . . . 2.62 110.282 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.8 148.35 30.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 2.21 111.803 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -155.64 121.5 5.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.68 109.464 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HB3' HD13 ' A' ' 64' ' ' LEU . 4.2 ttt85 -94.45 129.87 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.654 0.264 . . . . 3.78 111.038 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.17 94.95 2.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 3.58 110.457 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.17 141.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 4.26 111.359 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 5.46 112.237 -178.384 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.682 0.277 . . . . 4.48 110.969 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -62.35 -42.43 99.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 4.47 110.526 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 t70 58.85 77.53 0.3 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.353 -0.84 . . . . 4.09 112.069 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 52' ' ' ARG . 40.0 mt -87.45 164.09 16.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.024 -0.534 . . . . 3.36 111.062 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.65 152.74 54.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.131 -0.486 . . . . 3.47 110.634 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 115.17 2.48 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.479 2.119 . . . . 2.69 111.283 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 4.3 ptp180 -113.15 119.57 38.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 3.22 110.82 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -84.43 126.34 33.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.836 -0.62 . . . . 1.95 110.648 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 15' ' ' ALA . 51.1 m-85 -109.26 132.01 54.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.708 -0.479 . . . . 2.76 109.708 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.49 127.32 33.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.376 . . . . 1.4 111.179 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -130.24 157.66 41.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.51 -0.552 . . . . 2.07 109.51 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -86.28 156.31 20.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.984 0.421 . . . . 1.28 111.019 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.82 116.86 7.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.141 -0.481 . . . . 1.66 111.204 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.78 10.23 31.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.617 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -61.02 122.74 15.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.855 0.36 . . . . 1.62 110.976 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.63 123.87 4.76 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.87 -0.681 . . . . 1.96 112.005 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.35 -63.89 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.219 2.613 . . . . 2.62 112.434 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -91.95 72.7 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.309 0.576 . . . . 3.09 111.12 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.99 -61.17 1.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 1.87 109.936 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 39.46 57.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.797 -0.638 . . . . 1.7 112.316 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.89 95.17 44.72 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.217 -0.29 . . . . 1.43 110.217 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 84.2 Cg_endo -89.67 179.46 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.865 2.377 . . . . 1.62 112.206 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -61.42 107.48 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.935 -0.575 . . . . 1.75 111.247 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.17 -15.55 8.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.513 -0.851 . . . . 1.44 113.061 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.486 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -65.72 105.24 1.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.156 0.503 . . . . 1.25 111.033 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -79.06 122.47 26.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.036 -0.529 . . . . 2.21 111.214 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -141.11 173.74 11.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 2.11 109.732 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -73.96 114.87 12.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 1.7 111.492 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 31.64 59.91 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.83 -0.623 . . . . 1.32 113.01 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.7 mm -128.58 107.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 110.333 -0.247 . . . . 1.06 110.333 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 pt -115.14 124.92 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.543 0.211 . . . . 1.3 110.446 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -88.41 138.79 31.12 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.045 0.387 . . . . 1.08 112.045 -178.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.87 144.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 1.04 110.66 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.9 160.42 43.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.394 -0.366 . . . . 1.27 110.301 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -135.45 168.83 18.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.71 -0.478 . . . . 1.58 109.71 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.15 133.12 55.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 2.64 110.675 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.65 -16.97 55.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.969 -0.634 . . . . 1.63 112.349 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.41 143.05 29.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 1.59 110.577 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.6 mt -110.68 142.44 42.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.44 -0.345 . . . . 2.15 110.447 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.42 83.95 3.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.302 0.572 . . . . 2.3 110.902 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.1 t -151.65 139.09 12.47 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.459 -0.791 . . . . 2.69 109.416 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 126.55 22.39 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.013 2.476 . . . . 2.08 113.278 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -117.97 60.71 0.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.5 -0.773 . . . . 1.99 110.217 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.58 -0.87 21.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 2.55 112.101 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -74.76 -6.75 50.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 2.28 111.55 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.22 35.45 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 2.0 111.142 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 13.33 8.39 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.53 -0.843 . . . . 2.33 112.868 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -131.88 114.81 15.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.207 0.527 . . . . 3.21 110.898 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -151.05 160.57 43.83 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.604 -0.517 . . . . 3.03 109.604 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.14 105.83 50.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 3.75 110.715 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.47 -34.24 26.84 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.401 2.068 . . . . 3.39 113.087 -179.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.52 -8.07 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.972 0.36 . . . . 4.05 111.972 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -125.73 10.03 7.71 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.626 -0.261 . . . . 4.78 111.495 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -168.92 127.91 1.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 3.41 110.182 -179.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.33 164.5 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.703 0.287 . . . . 3.21 110.762 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.93 151.96 20.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.318 -0.401 . . . . 3.0 110.232 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.0 mt -83.97 143.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.589 -0.523 . . . . 2.42 109.589 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 136' ' ' SER . 85.7 t -65.92 119.85 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.796 0.331 . . . . 2.74 110.474 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.436 HD23 HD21 ' A' ' 16' ' ' LEU . 7.8 tt -63.28 118.65 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 2.19 109.718 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -133.53 165.64 24.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.28 -0.418 . . . . 2.49 110.898 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.33 157.67 43.31 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.646 -0.706 . . . . 1.96 110.042 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.39 172.82 15.33 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.62 2.213 . . . . 1.84 112.075 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.2 120.87 13.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.006 -0.543 . . . . 2.77 110.336 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.42 -25.8 8.98 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.551 -0.833 . . . . 2.2 112.099 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 m -98.13 112.93 24.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.805 -0.442 . . . . 2.1 109.805 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.9 m -104.7 145.34 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.727 -0.669 . . . . 2.87 111.257 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -76.92 149.38 80.13 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.09 -0.707 . . . . 2.62 109.09 178.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.42 146.23 97.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.529 2.153 . . . . 2.77 111.553 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.61 109.74 0.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 4.28 110.471 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.2 -12.42 9.73 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.371 -0.692 . . . . 3.18 111.371 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.662 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 1.4 t80 -103.24 134.34 46.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.125 -0.324 . . . . 2.93 110.125 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -128.78 164.95 21.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.349 -0.387 . . . . 3.73 110.53 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.34 139.54 38.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.511 -0.313 . . . . 2.93 110.479 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.82 123.11 28.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.921 0.391 . . . . 3.64 110.535 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.18 -1.39 82.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.297 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.447 ' HB2' HG11 ' A' ' 118' ' ' VAL . 4.7 t . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 3.59 110.566 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.286 0 CA-C-O 120.487 0.184 . . . . 2.48 111.012 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 m -57.86 153.02 14.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.082 -0.508 . . . . 2.57 112.35 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -74.92 -54.44 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.609 -0.723 . . . . 2.4 110.52 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.715 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 24.8 m-85 -74.75 159.65 31.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 2.02 112.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -68.92 158.58 34.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.543 -0.753 . . . . 2.65 111.017 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.08 144.99 38.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.911 0.386 . . . . 2.4 111.207 -179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.48 HD12 ' HE2' ' A' ' 131' ' ' PHE . 35.4 mt -89.53 119.9 30.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.988 -0.375 . . . . 2.27 109.988 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -90.97 126.44 36.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.279 0.561 . . . . 2.86 112.458 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -94.8 138.43 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.892 -0.594 . . . . 2.89 110.172 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -137.21 56.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.532 -0.544 . . . . 4.07 109.532 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -154.89 -169.34 19.39 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.58 -0.736 . . . . 3.23 111.685 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mmtt -92.84 -1.77 56.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.062 0.393 . . . . 4.51 112.062 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -104.53 171.92 7.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 3.32 110.308 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.74 -79.87 0.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.664 -0.243 . . . . 2.41 110.375 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.7 tp -179.57 132.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 2.18 110.421 179.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -154.07 117.31 4.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.333 -0.394 . . . . 2.46 110.628 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -109.74 141.29 23.37 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.191 -0.459 . . . . 1.78 110.155 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.72 165.01 29.12 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.564 2.176 . . . . 2.15 112.298 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -64.34 119.87 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.577 . . . . 2.84 111.085 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.36 0.52 56.88 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.798 -0.715 . . . . 1.65 112.567 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -130.0 165.76 21.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 2.57 110.62 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.38 -14.7 30.36 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.783 -0.722 . . . . 1.42 112.37 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -89.56 118.15 68.79 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.701 0.286 . . . . 1.09 110.999 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.19 -176.36 2.87 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.608 2.206 . . . . 1.27 111.345 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 mt -84.63 79.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 1.7 110.781 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -83.85 86.85 7.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.323 -0.399 . . . . 1.23 110.31 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.07 64.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.994 0.426 . . . . 1.96 110.832 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -76.42 0.67 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.959 -0.564 . . . . 2.0 111.394 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.402 ' HB3' ' CB ' ' A' ' 42' ' ' ASP . 4.3 m -128.36 152.19 48.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.855 0.36 . . . . 1.44 111.033 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 168.49 27.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.099 -0.501 . . . . 2.06 109.88 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.28 -36.61 93.91 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.585 2.19 . . . . 1.42 111.961 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -77.79 -19.94 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 1.78 111.054 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.806 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 31.7 m-20 -81.97 -5.8 58.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 1.6 111.275 -179.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -79.44 57.71 2.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.151 0.5 . . . . 1.19 111.379 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.422 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 10.9 tt -151.17 131.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.749 -0.659 . . . . 1.17 109.579 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.26 -146.15 6.07 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.368 -0.92 . . . . 0.61 112.661 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -153.03 165.01 36.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.914 0.387 . . . . 1.13 110.58 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -105.48 125.59 51.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 1.69 109.238 178.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -95.1 126.4 40.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.205 -0.452 . . . . 2.51 111.643 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -76.57 120.83 22.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.598 -0.728 . . . . 2.62 109.51 178.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.67 158.77 43.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 2.21 111.666 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.94 109.01 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.598 -0.728 . . . . 2.68 109.594 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HB3' HD13 ' A' ' 64' ' ' LEU . 11.3 tpt85 -81.26 103.84 11.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 3.78 111.531 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -114.5 110.34 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 3.58 111.179 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.72 131.9 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.822 -0.626 . . . . 4.26 109.397 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 123.331 0.395 . . . . 5.46 110.232 179.858 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.545 0.212 . . . . 4.48 110.575 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -68.24 -42.65 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 4.47 109.542 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t0 47.48 75.23 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.18 -0.918 . . . . 4.09 112.676 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' A' ' 52' ' ' ARG . 27.4 mt -94.46 158.92 15.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.912 -0.585 . . . . 3.36 111.195 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.11 149.51 89.58 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.777 -0.647 . . . . 3.47 111.289 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.66 116.25 3.12 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.844 2.363 . . . . 2.69 111.297 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -119.91 147.6 44.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.051 -0.522 . . . . 3.22 111.594 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -114.93 129.14 56.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 1.95 110.946 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -103.65 133.65 48.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.365 -0.606 . . . . 2.76 109.365 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -81.6 121.36 26.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 1.4 111.481 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -122.74 133.52 54.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 2.07 109.743 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.63 159.74 33.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.539 -0.3 . . . . 1.28 110.899 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.38 122.0 12.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 1.66 111.825 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.39 24.34 26.65 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.906 -0.664 . . . . 1.66 113.678 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.2 102.16 6.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 1.62 111.204 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.25 114.23 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.13 -0.788 . . . . 1.96 111.13 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.45 -26.51 82.22 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.91 2.407 . . . . 2.62 112.466 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.3 15.28 16.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.543 0.211 . . . . 3.09 111.526 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.66 -55.58 6.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.029 0.442 . . . . 1.87 110.223 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.64 36.35 89.29 Favored Glycine 0 C--N 1.329 0.157 0 CA-C-N 115.73 -0.668 . . . . 1.7 112.789 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 mt -107.85 105.9 57.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.565 0.221 . . . . 1.43 111.039 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.14 161.84 17.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.056 2.504 . . . . 1.62 111.511 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -57.91 111.07 1.04 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 1.75 110.51 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.76 -19.23 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.629 -0.796 . . . . 1.44 112.352 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.61 113.11 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 1.25 110.807 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -82.27 121.98 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.374 -0.376 . . . . 2.21 111.704 -179.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.94 171.46 14.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.295 -0.411 . . . . 2.11 110.269 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.35 110.29 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.878 -0.601 . . . . 1.7 111.195 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.37 97.06 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.95 -0.568 . . . . 1.32 112.823 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.5 mm -127.51 105.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.899 0.381 . . . . 1.06 110.611 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.8 pt -111.67 135.19 51.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.371 -0.603 . . . . 1.3 109.371 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -94.86 140.68 29.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.16 0.43 . . . . 1.08 112.16 -178.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.01 141.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.519 -0.764 . . . . 1.04 110.241 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.25 152.28 29.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.09 -0.337 . . . . 1.27 110.09 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -111.59 173.61 6.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.415 -0.357 . . . . 1.58 110.263 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.0 118.68 15.16 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.983 -0.377 . . . . 2.64 109.983 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.76 -3.8 24.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.84 -0.695 . . . . 1.63 111.881 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.21 131.4 34.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.46 -0.2 . . . . 1.59 110.46 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.14 148.52 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 2.15 111.188 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -87.1 72.27 10.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 2.3 110.557 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.426 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 8.5 m -148.68 125.93 5.58 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.466 -0.788 . . . . 2.69 109.498 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.18 133.75 53.69 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.983 2.455 . . . . 2.08 112.195 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.806 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.28 84.6 2.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.305 0.574 . . . . 1.99 111.346 -179.494 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -11.03 59.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.005 -0.543 . . . . 2.55 111.756 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -56.91 -22.24 35.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.797 0.665 . . . . 2.28 112.797 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.57 4.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.095 0.474 . . . . 2.0 110.753 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.27 -16.7 45.82 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.885 -0.674 . . . . 2.33 111.517 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -87.08 121.71 29.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.949 0.404 . . . . 3.21 110.519 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -164.91 131.04 2.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 3.03 110.614 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -95.12 122.64 59.45 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.553 -0.536 . . . . 3.75 109.553 178.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.6 -37.23 90.83 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 123.449 2.766 . . . . 3.39 114.086 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.67 -8.53 59.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.81 0.67 . . . . 4.05 112.81 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -115.5 7.18 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.463 0.542 . . . . 4.78 112.463 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.77 124.61 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.908 0.385 . . . . 3.41 110.998 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.31 158.59 28.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.26 -0.427 . . . . 3.21 110.871 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.24 151.98 41.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 3.0 111.487 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 44.3 mt -107.96 132.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 2.42 109.044 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.29 119.34 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.434 -0.348 . . . . 2.74 111.009 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.715 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 3.9 tt -66.82 122.49 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.208 0.528 . . . . 2.19 110.733 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -133.15 145.49 50.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.515 -0.766 . . . . 2.49 110.582 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.4 HD12 HG23 ' A' ' 125' ' ' THR . 34.3 mt -106.83 143.74 27.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 1.96 109.767 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.71 159.08 50.16 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.557 2.171 . . . . 1.84 111.847 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.87 126.36 27.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.106 -0.497 . . . . 2.77 111.041 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 -11.8 45.5 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.967 -0.853 . . . . 2.2 110.967 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.4 HG23 HD12 ' A' ' 121' ' ' LEU . 10.4 m -108.52 109.01 20.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.269 -0.641 . . . . 2.1 109.269 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.08 147.85 28.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.412 -0.358 . . . . 2.87 111.296 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.8 mt -83.46 145.95 49.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.89 -0.596 . . . . 2.62 109.96 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.28 154.57 45.7 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.72 2.28 . . . . 2.77 112.095 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.2 120.87 15.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.01 -0.541 . . . . 4.28 110.462 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.95 4.56 48.14 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.845 -0.693 . . . . 3.18 111.705 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.48 ' HE2' HD12 ' A' ' 16' ' ' LEU . 2.3 t80 -115.57 121.81 43.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.341 -0.614 . . . . 2.93 109.341 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -126.41 140.87 52.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.989 0.423 . . . . 3.73 111.37 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.94 154.43 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.744 -0.662 . . . . 2.93 111.521 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.4 tt0 -83.59 131.57 34.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.405 -0.816 . . . . 3.64 109.224 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.51 -52.0 2.38 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.964 -0.854 . . . . 3.27 110.964 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 3.59 110.066 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.906 0.384 . . . . 2.48 111.258 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -81.02 162.36 23.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.046 -0.525 . . . . 2.57 110.54 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -98.79 -11.4 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.978 0.362 . . . . 2.4 111.978 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -129.09 176.37 7.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.606 -0.27 . . . . 2.02 111.041 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 134' ' ' GLU . 1.9 p -71.69 174.19 7.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.075 -0.511 . . . . 2.65 110.077 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -97.41 167.36 11.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.189 0.519 . . . . 2.4 111.269 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.79 107.05 15.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.552 -0.749 . . . . 2.27 109.28 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.528 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -82.43 115.74 21.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.218 -0.446 . . . . 2.86 110.607 -179.943 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -85.33 128.49 34.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 2.89 110.371 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.61 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 42.9 t60 -112.98 -7.67 13.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.752 0.311 . . . . 4.07 111.247 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.76 -159.15 26.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.958 -0.639 . . . . 3.23 111.674 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.37 -32.07 12.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.83 0.315 . . . . 4.51 111.325 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.33 174.78 8.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.893 -0.594 . . . . 3.32 110.179 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -96.78 -82.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 2.41 109.403 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.513 HD12 ' CE1' ' A' ' 131' ' ' PHE . 31.6 tp -176.03 130.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 2.18 110.117 179.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -153.15 99.14 2.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.187 -0.46 . . . . 2.46 110.647 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -89.22 137.05 29.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 1.78 110.511 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.93 158.14 55.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.649 2.232 . . . . 2.15 111.852 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -56.93 118.14 4.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 2.84 111.355 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.35 -13.96 43.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 1.65 112.33 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -115.64 163.9 15.12 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.969 -0.382 . . . . 2.57 109.969 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.0 -19.05 13.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.839 -0.696 . . . . 1.42 112.808 179.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.77 113.76 54.71 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.726 0.298 . . . . 1.09 110.568 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HA ' HD22 ' A' ' 121' ' ' LEU . 2.9 Cg_exo -77.26 -174.89 2.39 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.265 2.643 . . . . 1.27 111.794 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.67 81.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 1.7 110.845 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.488 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 63.8 m-80 -81.79 84.18 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.424 . . . . 1.23 109.894 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -32.5 69.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.808 -0.633 . . . . 1.96 112.12 -178.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -76.95 -26.28 53.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 2.0 112.063 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -91.15 158.28 16.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.064 0.394 . . . . 1.44 112.064 -178.67 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.636 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 46.4 m -86.19 171.96 9.37 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.101 -0.499 . . . . 2.06 110.976 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.82 -43.53 55.46 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.037 2.491 . . . . 1.42 113.45 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.07 -16.05 60.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.78 111.53 179.966 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.689 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.0 m-20 -81.99 -3.62 54.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.6 111.237 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -77.2 51.8 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.3 0.572 . . . . 1.19 111.536 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' A' ' 94' ' ' ALA . 13.4 tt -150.98 128.03 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.654 -0.703 . . . . 1.17 109.468 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.28 -143.88 4.03 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.217 -0.992 . . . . 0.61 112.542 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -157.69 166.02 33.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.956 0.407 . . . . 1.13 111.001 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.618 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.5 m-85 -107.38 137.87 44.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 1.69 110.062 178.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -115.07 124.66 52.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.467 . . . . 2.51 110.82 -179.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -83.66 121.55 27.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 2.62 110.023 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.02 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 2.21 111.482 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -130.92 160.51 34.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.476 -0.784 . . . . 2.68 108.94 179.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -134.77 123.56 23.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.983 0.42 . . . . 3.78 111.769 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -138.92 115.21 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 3.58 110.942 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.09 149.42 4.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.185 -0.672 . . . . 4.26 109.185 178.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 120.843 0.354 . . . . 5.46 110.362 -179.787 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 20.8 mtt . . . . . 0 C--O 1.235 0.322 0 N-CA-C 110.337 -0.246 . . . . 4.48 110.337 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -54.37 -46.08 72.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 4.47 110.08 179.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t70 52.07 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.961 -1.018 . . . . 4.09 113.539 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.67 138.03 31.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.873 -0.603 . . . . 3.36 109.937 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.38 153.17 60.96 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 3.47 110.97 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 114.98 2.05 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.928 2.419 . . . . 2.69 111.89 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 56.7 mtp180 -110.03 113.18 25.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.776 -0.647 . . . . 3.22 110.046 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.618 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 47.3 m95 -84.91 120.3 26.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.241 -0.436 . . . . 1.95 111.117 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -98.96 150.94 21.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 2.76 110.567 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.32 122.31 43.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.4 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.91 164.53 17.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.839 -0.618 . . . . 2.07 109.745 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.49 155.68 17.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.64 -0.255 . . . . 1.28 110.334 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -60.7 111.88 1.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.224 -179.859 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.63 -8.27 26.07 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.308 -0.949 . . . . 1.66 113.993 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 p -62.89 103.68 0.47 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.66 0.73 . . . . 1.62 111.595 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.23 111.95 1.72 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.723 -0.951 . . . . 1.96 110.723 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.03 -26.07 78.12 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.762 2.308 . . . . 2.62 112.462 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -117.56 23.99 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 3.09 110.1 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.21 -53.98 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 1.87 111.122 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.2 49.29 80.14 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.877 -0.601 . . . . 1.7 112.146 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.6 mt -131.24 99.47 17.63 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.682 0.277 . . . . 1.43 111.548 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 7.7 Cg_exo -75.35 159.43 40.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.904 2.402 . . . . 1.62 110.974 178.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.598 ' HB2' HD11 ' A' ' 73' ' ' LEU . 79.5 t80 -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 1.75 111.021 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.12 -4.63 16.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.863 -0.684 . . . . 1.44 112.625 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.607 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -68.0 130.3 42.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 1.25 111.082 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -77.94 127.01 31.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.835 -0.62 . . . . 2.21 111.498 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -152.12 143.17 23.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.2 -0.667 . . . . 2.11 109.2 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.02 118.83 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 1.7 112.1 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.13 33.83 56.33 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.617 -0.72 . . . . 1.32 112.52 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.1 mm -136.3 112.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.157 -0.312 . . . . 1.06 110.157 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.6 pt -115.47 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.811 -0.44 . . . . 1.3 109.811 178.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -93.48 135.1 35.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 1.08 112.044 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.1 m -136.11 140.02 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.563 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 44' ' ' ILE . . . -157.89 144.11 17.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 1.27 110.121 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -110.47 -176.22 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.044 0.45 . . . . 1.58 111.022 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.06 133.28 44.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.677 -0.692 . . . . 2.64 110.725 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.89 -9.1 63.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.719 -0.753 . . . . 1.63 112.444 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -82.89 142.34 31.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.186 -0.301 . . . . 1.59 110.186 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.45 144.0 31.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.714 -0.221 . . . . 2.15 110.584 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -80.47 74.63 7.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 2.3 109.806 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.8 t -144.8 141.41 17.48 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.558 -0.747 . . . . 2.69 109.019 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.39 130.64 21.5 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.596 2.197 . . . . 2.08 113.351 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.689 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.43 71.41 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.53 -0.759 . . . . 1.99 110.874 179.438 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -16.84 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.76 -0.654 . . . . 2.55 111.548 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -61.0 -7.36 2.41 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.577 0.954 . . . . 2.28 113.577 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.39 -23.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.612 -0.514 . . . . 2.0 109.612 178.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.32 81.53 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.859 -0.61 . . . . 2.33 113.433 -178.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 t -79.08 94.41 5.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.673 0.749 . . . . 3.21 110.644 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -150.81 130.73 13.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.377 -0.829 . . . . 3.03 109.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.21 115.75 64.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.836 -0.431 . . . . 3.75 109.836 179.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.49 0.92 8.98 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.808 2.338 . . . . 3.39 114.198 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.21 -31.7 9.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 4.05 111.126 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.44 -16.85 21.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 4.78 110.596 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -143.19 143.87 31.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 3.41 110.23 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.59 148.44 25.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.525 -0.307 . . . . 3.21 110.45 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.48 160.28 31.72 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.105 -0.498 . . . . 3.0 111.771 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.3 mt -86.4 158.77 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.631 -0.713 . . . . 2.42 109.448 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.78 117.8 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.587 0.232 . . . . 2.74 110.462 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.536 HD11 ' HH ' ' A' ' 47' ' ' TYR . 6.5 tt -65.98 113.91 4.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 2.19 110.943 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -133.72 155.75 49.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 2.49 110.306 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 35.6 mt -105.79 146.35 32.68 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.194 -0.457 . . . . 1.96 110.59 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -64.66 161.7 34.57 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.861 2.374 . . . . 1.84 112.429 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -53.92 127.09 24.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.98 -0.554 . . . . 2.77 111.181 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.22 -7.7 58.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.765 -0.731 . . . . 2.2 111.697 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -112.79 100.01 8.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 2.1 110.095 179.997 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.01 156.14 18.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.209 -0.45 . . . . 2.87 110.663 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.4 mt -85.21 146.9 46.15 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.71 -0.478 . . . . 2.62 109.71 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.97 143.57 91.41 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.417 2.078 . . . . 2.77 111.56 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -59.54 124.25 19.48 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.89 -0.595 . . . . 4.28 111.245 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.21 45.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.955 -0.641 . . . . 3.18 111.869 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.513 ' CE1' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -109.51 139.13 44.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.695 0.283 . . . . 2.93 110.474 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.61 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 2.5 p90 -135.24 139.82 44.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.416 -0.356 . . . . 3.73 110.582 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.02 128.69 38.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.947 -0.569 . . . . 2.93 110.758 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 49.1 mt-10 -64.14 132.18 49.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.11 -0.495 . . . . 3.64 110.719 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.55 -37.32 3.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.909 -0.662 . . . . 3.27 112.9 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 3.59 111.265 -179.341 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.053 -0.351 . . . . 2.48 110.053 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -69.84 153.66 43.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.462 -0.336 . . . . 2.57 110.758 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -88.12 -9.15 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 2.4 111.109 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.0 m-85 -128.07 162.68 26.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.376 -0.374 . . . . 2.02 111.454 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 p -68.38 162.14 26.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 2.65 111.086 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.05 146.87 31.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 2.4 111.708 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.424 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 57.3 mt -97.48 123.87 41.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 2.27 108.935 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.474 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 6.0 m -105.11 128.12 53.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.831 0.348 . . . . 2.86 111.331 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -100.9 138.86 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.89 110.633 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -127.41 78.77 1.84 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.791 -0.448 . . . . 4.07 109.791 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.24 -158.91 16.13 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.97 -0.633 . . . . 3.23 111.892 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -94.56 -39.35 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.887 0.375 . . . . 4.51 110.238 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.72 155.74 21.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.985 -0.746 . . . . 3.32 108.985 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -96.87 -131.23 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.844 0.313 . . . . 2.41 111.844 -179.484 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 31.2 tp -114.77 135.95 53.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 2.18 112.253 -179.091 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -157.83 116.99 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.554 -0.748 . . . . 2.46 109.084 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -105.89 138.81 19.75 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.78 111.003 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.55 -178.94 2.9 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.847 2.365 . . . . 2.15 112.876 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -66.49 126.7 29.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.532 -0.758 . . . . 2.84 111.583 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 48.77 66.26 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.005 -0.543 . . . . 1.65 112.924 179.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -166.49 154.73 10.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.094 -0.336 . . . . 2.57 110.094 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.26 4.98 35.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.56 -0.829 . . . . 1.42 112.925 179.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.0 t -93.04 120.46 66.98 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.632 0.253 . . . . 1.09 110.506 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.97 178.75 5.53 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.069 2.512 . . . . 1.27 111.954 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.09 81.99 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 1.7 109.843 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.468 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 42.5 m-80 -83.3 75.18 9.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 1.23 110.946 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.93 3.62 6.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.395 0.617 . . . . 1.96 110.759 179.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -99.09 -8.5 25.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 2.0 110.667 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p -134.61 165.33 25.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 1.44 112.056 -178.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -78.92 163.97 57.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 2.06 110.493 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 51.5 Cg_exo -57.11 -31.56 90.7 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.806 2.337 . . . . 1.42 112.566 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.54 -24.29 61.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 1.78 110.472 179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.787 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 21.6 m-20 -84.59 -3.69 58.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.769 -0.651 . . . . 1.6 110.74 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.468 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 34.3 mm-40 -78.54 58.06 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 1.19 111.156 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -153.1 134.44 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.485 -0.561 . . . . 1.17 109.485 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.64 -141.93 4.57 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.322 -0.942 . . . . 0.61 112.663 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -155.1 164.02 39.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.141 0.496 . . . . 1.13 111.479 -178.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.474 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 46.1 m-85 -106.79 131.64 53.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.591 -0.731 . . . . 1.69 109.091 178.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -106.83 127.84 53.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 2.51 111.279 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 -83.34 109.11 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.797 -0.638 . . . . 2.62 109.771 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.95 170.58 9.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.83 0.347 . . . . 2.21 111.316 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 165.67 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.605 . . . . 2.68 110.304 179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -141.32 104.08 4.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 3.78 110.587 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -126.26 107.44 10.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.141 -0.482 . . . . 3.58 111.404 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -70.9 163.7 3.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.449 -0.341 . . . . 4.26 110.679 178.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.578 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 5.46 111.906 -179.005 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.9 ttm . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.501 -0.185 . . . . 4.48 110.501 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -67.69 -48.05 67.68 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.304 0.377 . . . . 4.47 110.854 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 65.79 99.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.719 -0.673 . . . . 4.09 112.385 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.31 157.51 30.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 3.36 111.062 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -78.73 158.51 75.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.697 -0.683 . . . . 3.47 110.284 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.22 123.94 14.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.949 2.433 . . . . 2.69 111.871 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -122.22 122.56 39.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 3.22 111.053 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.474 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 45.8 m95 -98.72 129.95 45.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.774 -0.648 . . . . 1.95 111.184 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -108.65 138.7 44.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.34 -0.615 . . . . 2.76 109.34 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.48 128.72 36.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 1.4 111.486 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.72 143.21 50.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 2.07 110.369 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -77.4 151.6 34.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.426 -0.352 . . . . 1.28 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -58.82 116.81 4.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 1.66 111.085 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.72 -3.37 23.06 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.555 -0.831 . . . . 1.66 113.735 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.41 114.18 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.994 0.397 . . . . 1.62 111.119 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.57 109.6 3.37 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.124 -0.791 . . . . 1.96 111.124 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.97 -39.61 90.15 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.098 2.532 . . . . 2.62 112.921 -179.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.71 31.17 6.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.377 . . . . 3.09 110.989 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.18 -42.94 59.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 1.87 111.137 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.39 51.65 41.49 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.971 -0.633 . . . . 1.7 111.546 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -120.41 97.33 48.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.614 0.245 . . . . 1.43 111.476 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.65 151.32 10.14 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.096 2.531 . . . . 1.62 110.914 178.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.55 ' HB2' HD11 ' A' ' 73' ' ' LEU . 68.9 t80 -62.77 111.32 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.368 . . . . 1.75 110.855 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.85 -27.09 5.23 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.456 -0.878 . . . . 1.44 112.201 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.53 122.37 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.683 0.277 . . . . 1.25 110.76 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -87.14 127.34 35.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.958 0.409 . . . . 2.21 111.524 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -139.97 157.89 44.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.728 -0.842 . . . . 2.11 108.728 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.54 115.87 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.229 0.455 . . . . 1.7 112.229 -179.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.55 30.36 62.29 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.32 112.756 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.51 95.19 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 1.06 110.476 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.2 pt -107.75 127.98 63.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.132 -0.486 . . . . 1.3 109.99 178.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.525 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 85.5 m95 -88.02 140.86 29.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.341 0.497 . . . . 1.08 112.341 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.73 146.78 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.446 -0.797 . . . . 1.04 109.781 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -140.9 173.6 11.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.013 0.435 . . . . 1.27 111.226 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 98' ' ' ALA . 1.4 t -133.49 168.11 19.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.972 -0.558 . . . . 1.58 110.079 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.41 105.35 5.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 2.64 109.829 179.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.25 26.39 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.657 -0.782 . . . . 1.63 111.95 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.534 ' HB3' HG23 ' A' ' 95' ' ' THR . . . -78.74 149.47 32.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.754 -0.462 . . . . 1.59 109.754 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.56 123.18 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.889 0.376 . . . . 2.15 110.721 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -76.63 72.3 3.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.584 0.707 . . . . 2.3 110.284 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.602 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 25.5 m -149.47 129.89 6.84 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.54 -0.911 . . . . 2.69 108.54 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.51 125.11 13.25 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.982 2.454 . . . . 2.08 112.418 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.787 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.3 69.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.344 0.593 . . . . 1.99 111.304 -179.488 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -77.42 4.36 11.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.186 -0.461 . . . . 2.55 112.003 -179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.447 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.5 p80 -57.81 -23.15 51.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.949 0.404 . . . . 2.28 111.743 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.84 16.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 2.0 111.147 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.19 -15.98 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.742 -0.742 . . . . 2.33 111.704 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -82.51 123.55 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 3.21 111.157 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -167.63 147.06 4.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 3.03 109.419 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.9 113.19 62.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.071 0.463 . . . . 3.75 110.872 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.78 -35.45 27.63 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.116 2.544 . . . . 3.39 113.875 -178.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.36 18.13 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 4.05 111.888 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -141.96 -39.08 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.195 -0.457 . . . . 4.78 110.707 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.271 -0.422 . . . . 3.41 110.911 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.87 146.9 23.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 3.21 110.585 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.17 165.36 21.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 3.0 110.957 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.6 mt -97.67 155.59 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.55 . . . . 2.42 110.077 -179.563 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -68.53 126.8 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.318 -0.253 . . . . 2.74 110.318 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -70.24 111.51 5.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.92 0.391 . . . . 2.19 110.407 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -128.38 153.57 46.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 2.49 109.952 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 93.3 mt -108.18 148.65 37.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.22 -0.445 . . . . 1.96 110.482 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.01 157.03 63.73 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.191 1.927 . . . . 1.84 111.383 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -53.68 124.4 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 2.77 110.877 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.07 -18.24 16.43 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.207 -0.757 . . . . 2.2 111.207 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -94.87 100.19 12.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.031 0.443 . . . . 2.1 110.196 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.5 m -80.0 129.64 34.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 2.87 111.071 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.7 mt -80.34 137.36 52.32 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 2.62 109.843 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.7 141.85 97.69 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.546 2.164 . . . . 2.77 111.654 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -60.49 128.03 34.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.039 -0.528 . . . . 4.28 111.033 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.94 -18.95 39.17 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.204 -0.758 . . . . 3.18 111.204 -179.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -95.73 138.21 33.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.647 0.26 . . . . 2.93 110.493 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 27.2 p90 -136.19 155.24 50.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.453 -0.34 . . . . 3.73 110.397 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.33 123.77 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 2.93 110.072 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.13 128.59 35.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.165 -0.47 . . . . 3.64 110.339 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 112.16 -20.45 21.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.795 -0.717 . . . . 3.27 111.355 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.166 0.508 . . . . 3.59 110.333 179.017 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 110.169 -0.308 . . . . 2.48 110.169 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 p -69.78 145.87 51.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.574 -0.285 . . . . 2.57 110.6 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -75.14 -20.22 59.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.44 -0.346 . . . . 2.4 111.377 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -108.16 166.27 10.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.02 112.098 -178.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.89 170.82 13.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.031 -0.986 . . . . 2.65 111.258 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.39 140.3 41.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.087 -0.506 . . . . 2.4 111.756 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.681 HD11 HD12 ' A' ' 119' ' ' LEU . 5.1 mp -107.61 115.75 30.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.294 -0.632 . . . . 2.27 109.294 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.9 m -96.34 129.33 43.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.657 0.614 . . . . 2.86 112.657 -178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -95.56 128.11 42.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.391 -0.822 . . . . 2.89 109.806 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.29 79.79 1.57 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.804 -0.443 . . . . 4.07 109.804 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.44 -167.54 39.13 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.652 -0.785 . . . . 3.23 111.991 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -81.58 -25.93 35.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.954 0.407 . . . . 4.51 111.681 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -81.35 173.1 12.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 3.32 109.771 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 -70.47 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.122 -0.696 . . . . 2.41 109.122 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp 178.61 127.91 0.06 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.603 -0.726 . . . . 2.18 111.133 179.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -159.59 107.43 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 2.46 110.24 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -98.11 148.32 34.32 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.049 -0.523 . . . . 1.78 109.737 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.98 162.09 41.88 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.337 2.024 . . . . 2.15 111.251 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -62.22 135.88 57.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 2.84 110.297 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 21.75 58.85 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.549 -0.834 . . . . 1.65 111.748 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -156.81 172.18 19.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.067 -0.345 . . . . 2.57 110.067 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.56 56.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.784 -0.722 . . . . 1.42 112.345 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.3 t -82.24 119.07 74.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 110.13 -0.322 . . . . 1.09 110.13 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.88 -179.14 5.16 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.299 . . . . 1.27 111.657 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -77.62 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 1.7 110.786 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.57 83.35 8.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.538 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.86 21.79 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.237 0.458 . . . . 1.96 112.237 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -124.44 -17.36 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.586 0.231 . . . . 2.0 111.457 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.6 168.6 10.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.84 0.352 . . . . 1.44 111.918 -178.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.8 m -86.86 166.3 27.56 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 2.06 110.687 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.4 Cg_endo -53.4 -39.84 80.34 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.268 2.645 . . . . 1.42 113.205 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.54 -13.93 61.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.077 0.465 . . . . 1.78 111.163 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -93.84 -1.63 54.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.614 . . . . 1.6 110.479 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -78.38 54.63 1.45 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.08 0.466 . . . . 1.19 111.108 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.65 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.8 tt -147.26 133.92 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.079 -0.51 . . . . 1.17 109.893 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.42 -144.4 4.99 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.432 -0.889 . . . . 0.61 112.477 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -156.15 164.43 38.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 1.13 110.935 -179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -107.67 130.79 54.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.055 -0.721 . . . . 1.69 109.055 178.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -110.09 135.39 50.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.089 0.243 . . . . 2.51 110.922 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -87.18 123.25 32.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.799 -0.445 . . . . 2.62 109.799 178.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.54 154.47 46.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.243 0.544 . . . . 2.21 111.399 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -154.26 111.4 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.483 -0.781 . . . . 2.68 109.828 179.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HB3' HD13 ' A' ' 64' ' ' LEU . 20.5 tpt180 -93.27 127.29 38.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.153 0.501 . . . . 3.78 110.917 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -128.59 141.13 51.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.478 -0.783 . . . . 3.58 109.922 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.633 HG12 ' H ' ' A' ' 62' ' ' LYS . 34.8 pt -92.83 175.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.203 -0.666 . . . . 4.26 109.203 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.673 0 N-CA-C 110.256 -0.275 . . . . 5.46 110.256 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 mmt . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.46 -0.941 . . . . 4.48 108.46 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.633 ' H ' HG12 ' A' ' 54' ' ' ILE . 53.5 tttt -49.94 -43.57 49.98 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.189 0.306 . . . . 4.47 110.615 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 43.95 71.56 0.24 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.432 -0.804 . . . . 4.09 112.748 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 52' ' ' ARG . 98.2 mt -67.04 145.35 55.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.002 -0.545 . . . . 3.36 110.363 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.52 162.58 61.21 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.747 -0.464 . . . . 3.47 109.747 179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.93 102.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.655 2.236 . . . . 2.69 111.858 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -108.74 122.69 47.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 3.22 110.893 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -98.27 145.17 26.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.95 110.042 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -128.01 137.98 52.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.762 -0.459 . . . . 2.76 109.762 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -88.49 128.98 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 1.4 111.444 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -128.13 150.57 49.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.806 -0.634 . . . . 2.07 109.686 178.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -84.53 156.78 21.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.941 0.401 . . . . 1.28 111.008 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.485 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 1.6 tt -64.0 115.01 4.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.408 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.46 1.17 24.76 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.731 -0.747 . . . . 1.66 113.769 179.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.8 p -58.47 110.18 0.93 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.192 0.496 . . . . 1.62 110.885 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.26 111.59 3.61 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.302 -0.719 . . . . 1.96 111.302 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.21 -18.11 63.31 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.707 2.271 . . . . 2.62 112.134 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -119.54 24.15 10.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.456 -0.338 . . . . 3.09 111.45 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.95 -48.84 15.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 1.87 110.51 179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.36 49.45 74.02 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.885 -0.598 . . . . 1.7 111.821 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.8 mt -119.72 100.06 49.17 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.866 0.365 . . . . 1.43 111.619 -179.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.22 153.28 14.16 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.464 2.11 . . . . 1.62 111.206 178.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.48 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.3 t80 -58.61 115.14 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 1.75 110.781 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.13 10.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.815 -0.707 . . . . 1.44 112.195 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.56 107.38 3.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 1.25 110.344 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.77 104.75 5.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.963 -0.562 . . . . 2.21 110.506 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.41 ' HB3' ' CG1' ' A' ' 90' ' ' ILE . 67.7 tttt -112.22 160.6 17.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.949 -0.569 . . . . 2.11 110.093 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.04 112.2 2.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.465 . . . . 1.7 111.298 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.33 32.17 65.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.923 -0.656 . . . . 1.32 112.327 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.41 ' CG1' ' HB3' ' A' ' 87' ' ' LYS . 36.6 mm -130.06 112.7 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.629 0.252 . . . . 1.06 110.601 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.0 pt -118.46 123.84 72.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.864 0.364 . . . . 1.3 110.428 178.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.485 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 89.7 m95 -82.61 137.95 34.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.069 -0.514 . . . . 1.08 111.769 -179.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.83 135.73 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 1.04 110.58 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.26 170.87 15.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 1.27 110.584 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -150.19 179.23 8.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.414 -0.587 . . . . 1.58 109.414 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -66.05 132.07 47.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.65 0.262 . . . . 2.64 110.382 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.66 32.88 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.854 -0.689 . . . . 1.63 111.53 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.65 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.18 134.3 36.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.117 -0.327 . . . . 1.59 110.117 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.92 149.05 26.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.387 -0.37 . . . . 2.15 110.634 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.73 74.03 5.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.521 0.677 . . . . 2.3 110.409 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -138.51 130.05 15.6 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.496 -0.774 . . . . 2.69 110.323 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.6 122.37 5.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.32 2.013 . . . . 2.08 111.466 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.594 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -146.07 106.29 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.103 -0.499 . . . . 1.99 111.402 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.18 8.06 32.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.56 . . . . 2.55 112.164 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.594 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 6.4 p80 -56.73 -28.66 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.212 0.529 . . . . 2.28 111.594 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.13 5.42 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 2.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.95 -21.62 22.75 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.778 -0.725 . . . . 2.33 112.248 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.6 t -74.97 105.62 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.492 0.663 . . . . 3.21 111.261 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -149.75 125.49 10.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.668 -0.696 . . . . 3.03 109.742 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -84.74 114.28 54.49 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.894 0.378 . . . . 3.75 110.341 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.67 -34.6 91.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.181 2.588 . . . . 3.39 113.449 -178.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.35 15.68 11.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.151 0.426 . . . . 4.05 112.151 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.48 -20.64 1.59 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.893 0.377 . . . . 4.78 111.664 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -131.78 137.4 48.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.694 0.283 . . . . 3.41 110.365 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.21 146.74 28.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.253 -0.431 . . . . 3.21 110.969 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.33 157.61 32.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.407 0.622 . . . . 3.0 111.904 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 62.4 mt -102.21 137.59 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.417 -0.81 . . . . 2.42 109.765 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.42 121.4 13.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.12 -0.696 . . . . 2.74 109.12 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.681 HD12 HD11 ' A' ' 16' ' ' LEU . 3.9 tt -63.44 117.9 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 2.19 111.549 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -126.75 141.58 51.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.443 -0.799 . . . . 2.49 109.816 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 79.9 mt -105.62 145.04 30.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.258 -0.428 . . . . 1.96 110.344 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.56 150.84 79.49 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.702 2.268 . . . . 1.84 111.557 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.67 98.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 2.77 110.888 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 143.94 -30.74 1.9 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.96 -0.638 . . . . 2.2 111.574 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -84.44 115.04 22.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.69 0.281 . . . . 2.1 110.369 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 137.17 37.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.272 -0.422 . . . . 2.87 110.904 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.2 mt -74.97 149.02 85.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 2.62 110.875 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.35 161.75 19.32 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.817 2.345 . . . . 2.77 112.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.85 119.26 10.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.836 -0.62 . . . . 4.28 111.597 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.55 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.137 -0.554 . . . . 3.18 112.923 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -106.25 126.98 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.728 0.299 . . . . 2.93 110.464 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.78 164.02 34.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.033 -0.53 . . . . 3.73 110.635 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.48 156.36 20.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.509 -0.314 . . . . 2.93 110.802 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.63 132.54 42.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.89 -0.595 . . . . 3.64 110.773 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.48 -45.15 1.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.097 -0.573 . . . . 3.27 112.936 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 3.59 110.588 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.891 0.377 . . . . 2.48 111.055 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -85.29 155.05 21.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.109 -0.496 . . . . 2.57 110.373 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 23.2 m95 -78.77 -28.29 44.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.442 . . . . 2.4 111.191 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.5 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 29.0 m-85 -99.33 173.81 6.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.737 -0.665 . . . . 2.02 110.957 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.434 ' HB ' ' H ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -78.8 -142.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.675 -0.693 . . . . 2.65 110.353 179.587 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' H ' ' HB ' ' A' ' 14' ' ' THR . . . -131.74 146.59 52.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.963 0.411 . . . . 2.4 111.566 -179.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.6 mt -96.99 120.02 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 2.27 109.112 178.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -92.97 122.99 35.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.433 -0.349 . . . . 2.86 111.249 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.3 tp-100 -101.22 145.02 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 2.89 110.067 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -140.58 89.47 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.384 -0.599 . . . . 4.07 109.384 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.38 -167.42 40.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.535 -0.84 . . . . 3.23 112.497 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -81.66 -36.47 28.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 4.51 110.605 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -75.59 154.68 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.47 -0.786 . . . . 3.32 110.671 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.02 -89.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.218 -0.446 . . . . 2.41 110.549 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.507 HD12 ' CE1' ' A' ' 131' ' ' PHE . 29.3 tp -168.71 134.61 1.76 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.985 0.421 . . . . 2.18 111.837 179.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -163.42 120.18 1.8 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.765 -0.652 . . . . 2.46 110.221 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -106.09 137.17 19.3 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.026 -0.534 . . . . 1.78 110.156 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.7 163.53 30.05 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.547 2.165 . . . . 2.15 111.908 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -63.64 103.19 0.52 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.159 0.504 . . . . 2.84 110.967 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.09 -9.19 8.46 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.794 -0.639 . . . . 1.65 111.873 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -120.43 163.07 18.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.765 0.317 . . . . 2.57 110.368 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -6.7 28.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.902 -0.666 . . . . 1.42 112.421 179.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 t -88.72 117.39 68.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.762 0.315 . . . . 1.09 110.307 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.04 -169.04 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.902 2.401 . . . . 1.27 111.718 -179.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 mt -82.58 77.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.08 0.467 . . . . 1.7 109.817 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.446 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 78.6 m-20 -78.4 78.06 4.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.58 . . . . 1.23 110.823 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.94 -1.55 26.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.113 -0.494 . . . . 1.96 111.238 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.21 2.67 22.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 2.0 110.652 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.89 155.16 46.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 1.44 111.284 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -86.61 169.08 15.98 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.929 -0.578 . . . . 2.06 110.318 179.432 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.62 -40.24 30.36 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.484 2.789 . . . . 1.42 114.252 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -17.44 44.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.732 0.301 . . . . 1.78 111.609 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.686 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -89.14 8.67 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 1.6 110.788 -179.628 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.446 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 85.1 mm-40 -80.76 0.57 34.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 1.19 112.104 -179.162 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.759 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.2 tt -89.51 126.62 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.975 0.417 . . . . 1.17 111.086 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.61 -152.2 6.28 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.345 -0.931 . . . . 0.61 112.919 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -163.19 170.9 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.917 0.389 . . . . 1.13 110.547 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.473 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 4.5 m-85 -111.46 138.22 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.213 -0.449 . . . . 1.69 110.422 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -117.94 127.44 53.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 2.51 110.819 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -79.01 126.92 31.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 2.62 109.95 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.01 151.82 42.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.005 0.431 . . . . 2.21 111.88 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 m -143.51 132.42 22.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 2.68 109.819 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -106.91 138.04 43.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.093 -0.336 . . . . 3.78 110.093 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -147.43 128.03 14.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.83 0.348 . . . . 3.58 111.851 -178.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 62' ' ' LYS . 41.3 pt -81.41 151.67 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.802 -0.814 . . . . 4.26 108.802 178.389 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--N 1.319 -0.734 0 C-N-CA 120.554 -0.458 . . . . 5.46 111.74 -179.412 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 mmt . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.615 0.245 . . . . 4.48 110.909 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.504 ' HB2' HG12 ' A' ' 54' ' ' ILE . 75.9 tttt -66.84 -35.71 80.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.028 -0.73 . . . . 4.47 109.028 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 50.12 82.86 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.748 -1.114 . . . . 4.09 113.047 179.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.0 mt -82.57 168.13 17.65 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.944 -0.571 . . . . 3.36 110.507 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -90.5 155.04 46.39 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.028 -0.533 . . . . 3.47 110.441 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.72 116.22 2.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.809 2.339 . . . . 2.69 111.757 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.3 mtt180 -115.79 119.03 34.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 3.22 111.265 -179.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.473 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 53.7 m95 -93.78 124.03 37.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 1.95 110.401 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -102.89 138.92 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.222 -0.444 . . . . 2.76 110.201 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -90.35 124.79 35.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.084 0.469 . . . . 1.4 111.344 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.0 167.75 12.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 2.07 109.894 179.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -108.02 151.58 25.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.688 -0.233 . . . . 1.28 110.43 -179.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.32 110.94 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.4 -0.364 . . . . 1.66 110.465 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.96 -15.55 6.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.763 -0.732 . . . . 1.66 112.357 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.548 HG23 ' HA3' ' A' ' 107' ' ' GLY . 9.5 p -59.13 125.77 24.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.571 0.224 . . . . 1.62 111.006 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.02 110.47 3.3 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.795 -0.717 . . . . 1.96 111.587 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.93 -37.0 97.8 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.006 2.47 . . . . 2.62 112.948 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -117.46 34.35 5.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 3.09 110.491 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.38 -52.23 29.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.87 110.379 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.34 46.47 93.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.977 -0.63 . . . . 1.7 111.693 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.1 mt -120.06 97.73 49.28 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.55 0.204 . . . . 1.43 111.55 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.22 147.43 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.896 2.398 . . . . 1.62 110.65 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 44.5 t80 -58.54 104.83 0.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 1.75 111.142 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.35 -16.69 5.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.852 -0.689 . . . . 1.44 111.878 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.48 20.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 1.25 110.753 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -80.93 119.34 23.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.007 -0.542 . . . . 2.21 110.75 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -135.25 149.69 49.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.069 -0.514 . . . . 2.11 109.832 179.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.96 110.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.326 0.584 . . . . 1.7 112.123 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.68 64.76 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.697 -0.683 . . . . 1.32 112.964 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 mm -128.05 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 1.06 110.641 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.2 pt -117.62 133.48 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.112 -0.494 . . . . 1.3 109.765 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.458 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 73.6 m95 -89.04 140.07 29.82 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.385 . . . . 1.08 112.038 -178.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 m -136.32 131.06 48.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.741 -0.663 . . . . 1.04 110.884 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.12 169.47 20.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.138 -0.483 . . . . 1.27 110.89 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -148.4 -169.99 3.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.535 -0.543 . . . . 1.58 109.535 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.91 136.84 57.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.875 0.369 . . . . 2.64 110.827 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.94 -25.15 27.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.148 -0.549 . . . . 1.63 112.404 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.759 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.45 136.24 45.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.813 0.339 . . . . 1.59 110.452 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.96 140.55 38.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.117 -0.492 . . . . 2.15 110.72 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -76.79 78.29 3.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.77 -0.455 . . . . 2.3 109.77 179.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.449 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 81.6 m -150.31 128.94 6.06 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.971 -0.752 . . . . 2.69 108.971 -179.394 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.71 124.54 12.49 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.602 2.201 . . . . 2.08 111.834 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.686 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.21 95.83 4.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 1.99 110.954 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.12 -5.91 58.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 2.55 112.427 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 14.8 p80 -61.44 -21.07 63.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.477 0.547 . . . . 2.28 112.477 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.497 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -102.02 12.26 7.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 2.0 111.363 -179.79 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.548 ' HA3' HG23 ' A' ' 75' ' ' THR . . . -124.89 38.29 2.37 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.653 -0.784 . . . . 2.33 111.4 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -131.74 33.46 3.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.597 0.713 . . . . 3.21 110.658 -179.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' ' HA ' ' A' ' 12' ' ' TRP . 54.0 ttp85 -72.99 137.63 45.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.895 -0.593 . . . . 3.03 111.258 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -98.43 107.68 43.48 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.17 -0.678 . . . . 3.75 109.17 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.64 -14.24 36.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.876 2.384 . . . . 3.39 113.652 -178.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.46 -25.03 27.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.663 0.268 . . . . 4.05 111.425 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -121.99 29.86 6.88 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.543 -0.299 . . . . 4.78 111.56 -179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -174.03 140.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 3.41 110.857 179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.28 142.82 26.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.207 -0.451 . . . . 3.21 110.1 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.83 145.83 50.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.259 -0.428 . . . . 3.0 111.23 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.0 mt -78.53 139.54 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.118 -0.492 . . . . 2.42 109.889 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.98 122.14 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 2.74 110.183 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.5 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 1.2 tt -59.75 109.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 2.19 111.231 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.64 152.07 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.759 -0.655 . . . . 2.49 110.182 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 mt -108.65 153.09 42.42 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.128 -0.487 . . . . 1.96 110.228 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.32 172.21 8.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.13 . . . . 1.84 112.337 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.16 131.97 50.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 2.77 111.203 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.89 36.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.91 -0.662 . . . . 2.2 112.704 179.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 m -85.64 107.79 17.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.913 0.387 . . . . 2.1 110.134 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.52 143.25 26.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 2.87 111.825 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.8 143.61 50.59 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 2.62 109.943 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.16 146.69 95.95 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.57 2.18 . . . . 2.77 111.663 179.244 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -61.15 119.27 8.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 4.28 111.398 -179.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.89 -13.49 29.34 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.923 -0.656 . . . . 3.18 111.991 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -97.16 133.58 41.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.596 0.236 . . . . 2.93 110.742 179.647 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -144.65 144.55 31.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 3.73 110.269 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.55 150.56 26.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.83 0.348 . . . . 2.93 111.358 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.09 135.74 39.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.565 -0.531 . . . . 3.64 109.565 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.43 69.5 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 3.27 112.399 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 3.59 110.141 -179.993 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.103 -0.332 . . . . 2.48 110.103 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -109.18 130.24 55.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.639 -0.255 . . . . 2.57 110.492 179.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.59 -25.75 62.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 2.4 110.753 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 95.6 m-85 -118.34 168.37 10.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.777 -0.647 . . . . 2.02 110.874 -179.543 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -68.47 170.16 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 2.65 110.221 178.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 149.73 27.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.363 0.602 . . . . 2.4 112.008 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.711 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 12.1 mt -94.77 116.58 28.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 2.27 109.54 178.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.1 112.12 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.31 -0.405 . . . . 2.86 111.763 -179.355 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -91.82 135.13 34.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 2.89 111.01 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -137.48 83.23 1.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 4.07 109.472 178.378 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.35 -166.46 30.18 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.859 -0.686 . . . . 3.23 111.968 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.18 -19.43 28.44 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.352 . . . . 4.51 111.949 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -100.98 170.43 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.66 0.267 . . . . 3.32 110.671 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 t0 -92.43 -61.49 1.59 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.074 -0.343 . . . . 2.41 110.074 179.454 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 131' ' ' PHE . 30.3 tp 169.76 137.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.742 0.651 . . . . 2.18 110.901 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -155.94 119.59 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 2.46 109.686 178.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -101.34 144.67 29.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.297 -0.41 . . . . 1.78 111.127 -179.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.34 177.67 6.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.274 2.649 . . . . 2.15 112.341 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -70.25 118.56 13.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 2.84 111.017 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.25 68.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.108 -0.568 . . . . 1.65 113.196 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.39 146.31 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.462 . . . . 2.57 109.754 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.68 -5.46 12.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.581 -0.818 . . . . 1.42 112.386 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.15 115.66 64.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.921 -0.399 . . . . 1.09 109.921 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HA ' HD22 ' A' ' 121' ' ' LEU . 58.2 Cg_endo -71.69 177.06 7.32 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.63 2.22 . . . . 1.27 112.383 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.2 mt -75.72 88.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 1.7 110.407 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -80.47 82.85 6.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.23 110.263 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.46 26.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.659 -0.7 . . . . 1.96 112.182 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -137.13 -4.04 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.047 0.451 . . . . 2.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.47 148.37 49.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.022 -0.536 . . . . 1.44 111.363 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.05 166.56 32.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.071 -0.513 . . . . 2.06 110.495 179.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.83 -35.25 78.71 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.861 2.374 . . . . 1.42 113.097 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -85.68 -7.07 59.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.718 0.294 . . . . 1.78 111.281 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.482 ' CG ' ' HZ1' ' A' ' 103' ' ' LYS . 2.8 m-20 -101.39 10.2 40.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.519 . . . . 1.6 110.014 179.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -84.68 3.42 37.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 1.19 111.447 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.433 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.2 tt -85.5 124.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.068 0.461 . . . . 1.17 111.068 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.77 -153.81 7.03 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.355 -0.926 . . . . 0.61 113.125 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -161.84 173.09 15.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.805 0.336 . . . . 1.13 110.694 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.57 ' HH ' HD11 ' A' ' 119' ' ' LEU . 10.2 m-85 -116.96 140.88 48.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.949 -0.569 . . . . 1.69 110.281 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -121.63 139.1 53.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.605 -0.517 . . . . 2.51 109.605 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -84.67 133.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.121 0.486 . . . . 2.62 111.009 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.24 147.97 51.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.239 0.542 . . . . 2.21 111.016 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -138.04 128.13 25.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.609 -0.515 . . . . 2.68 109.609 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -113.47 123.67 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.961 -0.296 . . . . 3.78 110.962 -179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -147.69 95.8 2.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.407 -0.36 . . . . 3.58 111.099 179.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.01 169.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.565 -0.532 . . . . 4.26 109.565 178.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 120.974 0.416 . . . . 5.46 111.366 179.922 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 C--O 1.233 0.185 0 N-CA-C 110.133 -0.321 . . . . 4.48 110.133 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -60.09 -51.48 69.44 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.181 -0.303 . . . . 4.47 110.181 178.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.42 105.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.289 0.848 . . . . 4.09 113.289 178.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -108.53 140.5 41.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.997 -0.547 . . . . 3.36 110.635 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.82 159.88 9.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 3.47 110.897 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.1 108.9 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.037 2.492 . . . . 2.69 111.768 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -95.8 103.73 15.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.577 -0.738 . . . . 3.22 110.731 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 47' ' ' TYR . 67.8 m95 -83.36 115.51 22.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 1.95 110.987 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -99.12 137.98 36.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.807 -0.633 . . . . 2.76 110.413 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -97.2 132.38 43.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 1.4 110.561 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.54 168.73 17.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 2.07 109.84 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -100.39 156.15 17.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 1.28 110.117 179.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 tp -63.36 103.68 0.53 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.519 -179.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.24 -2.38 22.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.282 -0.961 . . . . 1.66 113.787 178.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.42 HG23 ' HA3' ' A' ' 107' ' ' GLY . 5.8 p -59.04 114.0 2.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.118 0.459 . . . . 1.62 111.761 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.19 108.09 2.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.866 -0.683 . . . . 1.96 111.535 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -57.34 -30.09 86.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.077 2.518 . . . . 2.62 112.789 -179.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.77 42.74 2.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.145 0.498 . . . . 3.09 111.302 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.73 -55.08 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 1.87 110.568 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 42.89 79.11 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.937 -0.649 . . . . 1.7 112.373 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.9 mt -121.01 102.43 43.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.837 0.351 . . . . 1.43 111.701 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 1.3 Cg_endo -84.49 165.47 12.37 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.006 2.471 . . . . 1.62 110.635 178.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.73 112.96 2.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.933 0.397 . . . . 1.75 110.814 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.98 -12.88 14.45 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.979 -0.629 . . . . 1.44 112.608 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -56.23 116.53 3.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.049 0.452 . . . . 1.25 111.274 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -87.95 120.01 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 2.21 110.569 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -134.63 -148.48 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.273 -0.421 . . . . 2.11 110.384 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -108.05 103.29 12.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.004 0.431 . . . . 1.7 110.852 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.47 36.9 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.761 -0.733 . . . . 1.32 112.393 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mm -122.38 113.21 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.68 0.276 . . . . 1.06 110.319 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.0 122.58 67.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 1.3 110.176 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -88.01 145.83 25.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.133 -0.485 . . . . 1.08 111.87 -178.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.3 129.44 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 1.04 111.465 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.97 153.15 40.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.528 . . . . 1.27 110.403 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 t -132.13 -176.52 4.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.143 -0.48 . . . . 1.58 110.063 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.43 135.16 54.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.075 0.464 . . . . 2.64 110.67 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.95 58.58 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.906 -0.588 . . . . 1.63 112.165 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.433 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -78.86 144.36 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.847 0.356 . . . . 1.59 110.989 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -112.24 145.79 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.864 -0.607 . . . . 2.15 109.952 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -85.37 86.18 7.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.813 0.339 . . . . 2.3 110.826 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 m -157.24 137.29 8.77 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.67 -0.695 . . . . 2.69 109.215 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.92 111.28 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.107 2.538 . . . . 2.08 112.439 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HZ1' ' CG ' ' A' ' 42' ' ' ASP . 22.5 mmtt -101.83 47.04 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 1.99 109.802 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -70.25 -15.3 62.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.972 -0.558 . . . . 2.55 112.09 -179.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -57.44 -20.73 32.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.526 0.565 . . . . 2.28 112.526 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 pt -113.92 12.64 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.472 . . . . 2.0 110.85 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.42 ' HA3' HG23 ' A' ' 75' ' ' THR . . . -86.98 -39.59 7.42 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.868 -0.682 . . . . 2.33 112.162 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 t -65.69 124.69 23.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.195 0.521 . . . . 3.21 111.237 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -158.33 132.6 8.04 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.411 -0.588 . . . . 3.03 109.411 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -96.91 113.04 62.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.271 -0.27 . . . . 3.75 110.271 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.61 -18.9 64.23 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.96 2.44 . . . . 3.39 112.711 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.45 0.97 57.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.035 0.445 . . . . 4.05 110.839 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -136.51 13.01 3.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 4.78 110.723 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -171.85 132.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 3.41 109.828 -179.142 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.98 153.53 20.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.777 0.322 . . . . 3.21 110.54 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.5 153.98 25.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.094 0.473 . . . . 3.0 111.122 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 17.9 mt -92.85 145.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.882 -0.599 . . . . 2.42 109.717 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.82 125.79 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.908 -0.404 . . . . 2.74 109.908 179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.57 HD11 ' HH ' ' A' ' 47' ' ' TYR . 1.9 tt -58.46 113.87 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.264 0.554 . . . . 2.19 111.069 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -127.7 142.38 51.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.674 -0.693 . . . . 2.49 110.462 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.436 HD13 ' HG ' ' A' ' 127' ' ' LEU . 21.3 mt -103.63 148.37 35.67 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 1.96 110.013 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.98 155.94 57.55 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.535 2.157 . . . . 1.84 111.599 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -58.46 122.91 14.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 2.77 110.138 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.68 -11.28 42.12 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.212 -0.755 . . . . 2.2 111.212 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.7 m -104.18 105.89 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.638 -0.504 . . . . 2.1 109.638 179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.35 159.36 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.886 -0.597 . . . . 2.87 111.823 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.436 ' HG ' HD13 ' A' ' 121' ' ' LEU . 15.8 mt -99.87 147.87 34.02 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 2.62 109.796 179.002 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.85 159.23 34.28 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.502 2.135 . . . . 2.77 111.666 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -73.36 134.78 44.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.917 0.389 . . . . 4.28 110.235 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.8 13.29 67.26 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.145 -0.782 . . . . 3.18 111.145 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.711 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -127.84 122.02 31.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.001 -0.37 . . . . 2.93 110.001 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -129.01 146.78 50.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 3.73 110.891 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.18 127.53 35.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 2.93 110.806 -179.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -58.88 129.88 44.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.971 -0.559 . . . . 3.64 110.521 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.13 -4.37 67.53 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.961 -0.638 . . . . 3.27 112.053 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.325 -0.498 0 N-CA-C 110.275 -0.268 . . . . 3.59 110.275 179.951 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.644 0.259 . . . . 2.48 110.396 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 p -78.53 151.28 32.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.303 -0.408 . . . . 2.57 111.1 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.484 ' HA ' HH11 ' A' ' 109' ' ' ARG . 92.9 m95 -81.02 -28.56 35.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 2.4 110.622 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.54 159.21 15.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 2.02 111.403 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.26 166.3 18.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.822 -0.627 . . . . 2.65 110.767 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -82.19 142.59 32.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.416 . . . . 2.4 111.443 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.7 mt -97.31 145.99 25.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.1 -0.704 . . . . 2.27 109.1 179.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -120.26 140.41 51.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 2.86 111.908 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -109.1 120.94 44.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 2.89 111.06 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.72 71.12 0.75 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.336 0.588 . . . . 4.07 109.645 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.43 -163.01 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.695 -0.764 . . . . 3.23 111.815 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -88.8 -39.66 13.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 4.51 111.0 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.31 171.12 15.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.746 -0.464 . . . . 3.32 109.746 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -98.75 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.817 -0.353 . . . . 2.41 111.727 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -151.4 140.5 21.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 2.18 111.648 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -171.42 100.13 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.324 -0.853 . . . . 2.46 109.046 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -86.72 153.95 55.61 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.362 -0.381 . . . . 1.78 111.196 -179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.15 161.97 37.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.031 2.488 . . . . 2.15 111.717 179.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.22 131.72 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 2.84 110.543 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.5 74.68 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.218 -0.753 . . . . 1.65 111.218 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -138.65 172.22 13.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.284 -0.636 . . . . 2.57 109.284 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.99 -2.79 51.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.547 -0.835 . . . . 1.42 112.116 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.86 115.55 65.73 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.391 -0.596 . . . . 1.09 109.391 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.81 -173.39 1.8 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.0 2.467 . . . . 1.27 111.86 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.4 mt -74.64 93.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.339 0.59 . . . . 1.7 110.154 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -83.6 78.73 9.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.672 -0.694 . . . . 1.23 110.989 -179.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.11 37.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.105 -0.498 . . . . 1.96 112.147 -179.389 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.73 -2.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.061 0.457 . . . . 2.0 111.443 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.14 150.17 42.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.338 -0.392 . . . . 1.44 111.336 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.12 167.64 33.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 2.06 110.246 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -36.56 79.52 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.788 2.325 . . . . 1.42 113.011 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -78.56 -13.64 59.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.582 0.229 . . . . 1.78 111.396 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.753 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 25.5 m-20 -90.32 5.63 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 1.6 111.184 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -82.52 54.97 2.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.237 0.541 . . . . 1.19 111.232 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.8 tt -151.29 132.83 5.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.632 -0.713 . . . . 1.17 110.236 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.9 -144.75 4.74 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.249 -0.976 . . . . 0.61 112.879 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -158.5 170.59 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.158 0.504 . . . . 1.13 110.735 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.581 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 29.8 m-85 -115.98 136.53 52.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.827 -0.624 . . . . 1.69 109.323 178.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -115.64 131.18 57.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 2.51 111.163 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -85.04 120.82 26.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.659 -0.701 . . . . 2.62 109.515 179.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.29 157.54 45.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.316 0.579 . . . . 2.21 111.932 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -146.98 114.37 6.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.758 -0.655 . . . . 2.68 110.759 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -78.52 119.23 21.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.996 0.427 . . . . 3.78 110.574 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -144.59 123.7 12.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 3.58 110.772 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -106.96 169.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 4.26 109.872 179.159 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 120.959 0.409 . . . . 5.46 110.687 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.503 0.192 . . . . 4.48 110.966 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -53.44 -55.9 21.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 4.47 110.497 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.42 99.32 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.277 0.843 . . . . 4.09 113.277 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.1 mt -97.21 150.27 21.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 3.36 110.916 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.6 154.56 94.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.861 -0.609 . . . . 3.47 110.483 179.207 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.52 117.63 4.37 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.668 2.245 . . . . 2.69 111.017 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.533 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 48.0 mtt180 -119.35 140.01 51.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 3.22 111.402 -178.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.581 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 43.2 m95 -103.54 131.48 50.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 1.95 110.353 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -111.09 139.21 46.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.719 -0.474 . . . . 2.76 109.719 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.19 130.55 35.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.688 0.28 . . . . 1.4 111.041 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -133.88 158.31 43.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.96 -0.564 . . . . 2.07 110.33 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -92.97 165.34 12.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.632 -0.258 . . . . 1.28 110.865 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.78 118.99 5.88 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.309 0.381 . . . . 1.66 111.294 -179.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.44 53.98 8.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.062 -0.589 . . . . 1.66 112.966 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.55 48.11 1.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 1.62 111.11 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.44 137.02 4.23 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.093 -0.803 . . . . 1.96 111.093 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.39 -37.61 94.15 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.987 2.458 . . . . 2.62 112.482 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.09 35.95 4.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 3.09 110.574 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -49.78 49.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.87 110.823 -179.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.45 41.1 96.55 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.832 -0.622 . . . . 1.7 112.164 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.17 99.04 46.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.629 0.252 . . . . 1.43 111.426 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 89.2 Cg_endo -82.32 165.44 16.61 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 1.62 110.921 178.601 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -61.91 106.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 1.75 110.73 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.48 3.96 12.32 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.676 -0.773 . . . . 1.44 112.347 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.493 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -70.51 122.44 19.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 1.25 110.361 179.286 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -75.49 115.69 15.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.076 -0.511 . . . . 2.21 111.339 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -148.79 144.34 26.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 2.11 110.06 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.09 126.18 28.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.37 . . . . 1.7 111.055 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.58 77.25 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.032 -0.604 . . . . 1.32 112.219 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.5 mm -129.66 107.51 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.798 0.333 . . . . 1.06 110.216 179.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.7 pt -112.89 128.48 69.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.432 . . . . 1.3 110.362 179.108 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -88.55 137.7 32.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.45 0.537 . . . . 1.08 112.45 -178.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -136.63 141.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.75 -0.659 . . . . 1.04 110.416 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.86 156.35 31.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 1.27 110.634 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 t -126.55 170.3 12.18 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.128 -0.487 . . . . 1.58 110.167 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.59 130.59 42.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.431 -0.35 . . . . 2.64 110.166 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.22 -10.44 28.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.836 -0.697 . . . . 1.63 111.784 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -94.2 146.39 24.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.43 -0.211 . . . . 1.59 110.43 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.3 mt -91.97 149.17 21.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 2.15 111.146 -179.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -87.73 76.66 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.2 0.524 . . . . 2.3 110.089 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 t -158.24 147.43 14.73 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.776 -0.647 . . . . 2.69 109.506 -179.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.82 140.12 41.7 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.494 2.129 . . . . 2.08 111.738 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.753 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -137.66 86.88 2.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.093 0.473 . . . . 1.99 110.708 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -5.8 53.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 2.55 112.319 -178.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -58.15 -25.94 62.09 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.132 0.419 . . . . 2.28 112.132 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.91 9.92 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.135 0.493 . . . . 2.0 110.799 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.33 -25.25 11.23 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.779 -0.646 . . . . 2.33 111.946 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -78.83 99.99 6.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 3.21 111.103 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.484 HH11 ' HA ' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -144.41 145.66 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 3.03 110.067 179.709 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.89 130.73 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.301 -0.408 . . . . 3.75 110.153 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.91 -54.64 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.893 2.395 . . . . 3.39 112.905 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.27 27.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 4.05 112.691 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.8 19.67 2.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.232 0.539 . . . . 4.78 110.364 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -170.59 163.47 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 3.41 109.641 -179.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.66 173.86 6.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.818 0.342 . . . . 3.21 111.154 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 112.34 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.668 -0.493 . . . . 3.0 109.668 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 21.6 mt -77.18 129.74 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.245 -0.434 . . . . 2.42 110.252 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.03 120.94 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 2.74 110.372 179.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.39 105.4 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.916 -0.584 . . . . 2.19 109.996 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -112.17 146.3 38.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.997 -0.547 . . . . 2.49 110.413 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.1 mt -100.92 143.9 27.49 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.892 -0.594 . . . . 1.96 109.732 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.14 150.18 75.37 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.802 2.335 . . . . 1.84 111.91 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -51.05 119.91 4.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.684 -0.689 . . . . 2.77 111.58 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.7 -27.48 8.75 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.69 -0.964 . . . . 2.2 110.69 -179.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 m -102.13 116.58 32.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.723 -0.473 . . . . 2.1 109.723 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.49 163.08 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.419 -0.355 . . . . 2.87 110.763 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -85.41 144.88 41.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.343 -0.39 . . . . 2.62 110.137 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.46 151.75 66.51 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.816 2.344 . . . . 2.77 111.683 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.7 125.4 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.399 . . . . 4.28 111.121 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.42 -19.73 33.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.016 -0.612 . . . . 3.18 111.729 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -94.27 128.73 40.92 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.654 -0.498 . . . . 2.93 109.654 -179.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 47.6 p90 -133.21 171.09 14.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.697 0.284 . . . . 3.73 111.058 -179.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.81 144.4 45.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.483 -0.326 . . . . 2.93 111.208 -179.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -74.45 143.05 44.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.245 -0.434 . . . . 3.64 110.08 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.34 82.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.414 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 3.59 110.603 179.671 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 111' ' ' PRO . . . . . . . . 0 C--O 1.232 0.17 0 N-CA-C 110.018 -0.364 . . . . 2.48 110.018 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.436 ' HG ' ' HD1' ' A' ' 69' ' ' TYR . 1.1 m -62.25 143.6 56.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 2.57 110.642 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -68.92 -26.63 65.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 2.4 111.666 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -111.08 167.73 10.04 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.14 0.422 . . . . 2.02 112.14 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 p -69.08 170.32 10.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.647 -0.706 . . . . 2.65 111.332 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -90.14 133.27 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 2.4 111.291 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 mt -86.9 112.96 22.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.668 -0.493 . . . . 2.27 109.668 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 m -92.17 127.99 37.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.902 0.382 . . . . 2.86 111.203 -179.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -106.09 134.87 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 2.89 110.935 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -125.74 72.57 1.29 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.228 -0.656 . . . . 4.07 109.228 178.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.78 -169.23 26.99 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.964 -0.636 . . . . 3.23 112.067 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.68 -36.84 23.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.999 0.428 . . . . 4.51 110.844 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.09 172.2 13.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.796 -0.638 . . . . 3.32 110.712 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.84 -101.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.83 -0.433 . . . . 2.41 109.83 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.0 tp -156.74 133.6 10.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.798 0.332 . . . . 2.18 110.527 179.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.29 111.92 2.97 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.966 -0.561 . . . . 2.46 109.748 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.14 135.48 19.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.409 . . . . 1.78 110.563 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.6 155.54 69.74 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.536 2.157 . . . . 2.15 111.963 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -57.88 125.85 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 2.84 110.769 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.53 -1.51 62.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.904 -0.665 . . . . 1.65 112.033 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -137.09 155.15 49.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.204 -0.295 . . . . 2.57 110.204 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.05 -13.94 19.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.329 -0.938 . . . . 1.42 113.127 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.99 122.04 84.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.069 -0.345 . . . . 1.09 110.069 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.31 -179.13 5.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 1.27 111.661 -179.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.36 81.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.099 0.476 . . . . 1.7 110.821 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.86 97.87 4.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.382 -0.599 . . . . 1.23 109.382 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.33 -20.11 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.792 0.664 . . . . 1.96 112.792 -178.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -99.76 -29.54 12.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.422 0.527 . . . . 2.0 112.422 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.09 150.62 35.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.518 0.562 . . . . 1.44 112.518 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 2.0 m -74.42 166.92 40.77 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.681 -0.691 . . . . 2.06 110.895 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 17.5 Cg_endo -58.77 -39.75 79.0 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.814 2.343 . . . . 1.42 112.53 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -85.21 3.15 40.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 1.78 110.626 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.64 7.03 37.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.662 -0.699 . . . . 1.6 110.617 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -81.27 52.1 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 1.19 110.784 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.65 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.5 tt -144.87 134.91 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.92 -0.582 . . . . 1.17 110.17 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.14 -155.63 11.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.414 -0.898 . . . . 0.61 112.135 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -148.67 158.68 44.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.964 0.412 . . . . 1.13 111.151 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.608 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 13.2 m-85 -103.12 140.46 37.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.839 -0.8 . . . . 1.69 108.839 178.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -127.84 122.71 33.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.795 0.331 . . . . 2.51 110.965 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 128.37 33.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.858 -0.423 . . . . 2.62 109.858 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.04 156.21 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.108 0.48 . . . . 2.21 111.514 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.0 m -135.55 127.83 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.679 -0.691 . . . . 2.68 109.734 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.594 ' HB3' HD13 ' A' ' 64' ' ' LEU . 8.9 tpt180 -126.01 130.05 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.119 0.485 . . . . 3.78 111.702 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -143.87 -175.67 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.537 -0.756 . . . . 3.58 109.38 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.1 pt -126.72 161.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.544 -0.539 . . . . 4.26 109.544 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.319 -0.754 0 CA-C-O 121.334 0.588 . . . . 5.46 110.733 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.498 0.189 . . . . 4.48 111.127 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -69.98 -42.98 72.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.078 -0.712 . . . . 4.47 109.078 178.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.72 82.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.939 -1.028 . . . . 4.09 113.451 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.594 HD13 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -74.6 160.55 30.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.872 0.368 . . . . 3.36 110.559 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -74.13 156.03 87.9 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.293 -0.412 . . . . 3.47 110.127 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.47 111.15 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.542 2.161 . . . . 2.69 111.357 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.45 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 10.1 mtp180 -116.7 131.63 56.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 3.22 111.579 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.608 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 35.8 m95 -105.67 124.32 49.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.684 -0.689 . . . . 1.95 109.99 179.053 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.436 ' HD1' ' HG ' ' A' ' 11' ' ' SER . 49.5 m-85 -102.81 151.22 22.67 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 2.76 109.71 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -102.98 126.45 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.913 0.387 . . . . 1.4 111.486 -179.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.655 ' HB3' ' HG1' ' A' ' 75' ' ' THR . 96.8 m-85 -126.46 150.21 48.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 2.07 110.067 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.87 165.39 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.506 -0.315 . . . . 1.28 111.463 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 tt -54.48 113.48 1.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.445 0.905 . . . . 1.66 113.445 -178.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 63.4 47.9 83.39 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.508 -0.769 . . . . 1.66 114.065 178.331 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.655 ' HG1' ' HB3' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -72.98 86.36 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 1.62 111.444 179.58 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.63 131.0 2.53 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.019 -0.61 . . . . 1.96 111.68 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.23 -31.81 89.99 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.984 2.456 . . . . 2.62 112.558 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.93 30.69 4.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.849 0.357 . . . . 3.09 111.782 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.0 -70.57 0.41 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 1.87 110.582 179.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.97 34.38 55.84 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.829 -0.7 . . . . 1.7 111.546 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.496 HD21 ' HD2' ' A' ' 87' ' ' LYS . 3.2 mt -123.4 95.17 45.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.727 0.298 . . . . 1.43 110.831 -179.649 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.77 158.13 43.26 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.591 2.194 . . . . 1.62 112.095 179.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -59.26 106.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 1.75 110.322 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.38 -17.8 5.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.819 -0.705 . . . . 1.44 112.408 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.3 138.3 51.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 1.25 110.492 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -100.04 144.86 28.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.458 -0.337 . . . . 2.21 111.026 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.496 ' HD2' HD21 ' A' ' 81' ' ' LEU . 26.6 tttt -158.47 169.48 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 2.11 109.982 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.04 112.52 2.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.313 0.486 . . . . 1.7 112.313 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.3 39.62 91.94 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.841 -0.618 . . . . 1.32 112.389 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -128.88 113.71 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.073 0.464 . . . . 1.06 111.295 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.412 ' CG1' ' HB2' ' A' ' 47' ' ' TYR . 24.3 pt -122.54 139.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.369 -0.604 . . . . 1.3 109.369 178.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -96.44 137.88 34.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.877 0.37 . . . . 1.08 111.686 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -133.15 131.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.621 -0.718 . . . . 1.04 110.617 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.41 162.87 40.92 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.27 110.363 -179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -139.09 172.85 12.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 1.58 109.907 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.69 127.56 32.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.333 -0.394 . . . . 2.64 110.626 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.14 -20.5 26.01 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.908 -0.663 . . . . 1.63 111.618 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.65 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -82.68 135.27 35.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.894 0.378 . . . . 1.59 110.362 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.07 139.66 43.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 2.15 110.858 -179.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -72.6 107.02 4.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.489 . . . . 2.3 110.526 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 t -174.57 150.22 1.41 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.959 -0.756 . . . . 2.69 108.959 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.1 116.88 3.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.82 2.347 . . . . 2.08 112.231 179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -114.76 34.29 4.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.852 -0.613 . . . . 1.99 110.383 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 8.7 p-10 -71.05 -3.68 20.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 2.55 112.175 -179.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -61.18 -21.16 63.55 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.437 0.532 . . . . 2.28 112.437 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.99 -16.54 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.265 0.555 . . . . 2.0 110.441 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.84 72.2 2.61 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.933 -0.576 . . . . 2.33 112.693 -179.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 t -160.65 36.07 0.16 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.787 0.803 . . . . 3.21 110.453 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -76.49 138.03 40.01 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.694 -0.684 . . . . 3.03 111.153 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -80.92 117.79 69.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 3.75 110.519 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.644 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 51.8 Cg_endo -70.88 -47.33 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.871 2.381 . . . . 3.39 114.219 -178.695 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.77 18.91 2.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.035 0.754 . . . . 4.05 113.035 -177.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -150.22 23.33 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.936 0.398 . . . . 4.78 111.589 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -174.51 136.02 0.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 3.41 109.986 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.2 154.66 19.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.662 0.268 . . . . 3.21 111.095 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.75 154.31 26.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.164 0.506 . . . . 3.0 111.234 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.2 mt -89.04 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.654 -0.703 . . . . 2.42 109.598 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.05 113.33 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.665 -0.495 . . . . 2.74 109.665 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.84 115.52 5.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 2.19 111.593 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.0 148.71 50.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.652 -0.704 . . . . 2.49 109.399 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.12 157.37 34.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.343 -0.39 . . . . 1.96 110.695 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.32 148.49 92.83 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.538 2.158 . . . . 1.84 111.85 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -57.62 113.08 1.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.131 -0.486 . . . . 2.77 110.274 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 127.42 -24.15 5.32 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.194 -1.162 . . . . 2.2 110.194 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.7 m -91.94 109.75 21.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.127 0.489 . . . . 2.1 109.712 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 131.97 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 2.87 111.198 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.62 134.79 86.21 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.132 -0.485 . . . . 2.62 109.731 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.57 142.18 95.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.612 2.208 . . . . 2.77 111.468 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.83 124.25 21.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 4.28 110.621 -179.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.12 41.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.768 -0.73 . . . . 3.18 111.9 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -99.47 128.92 45.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.066 0.46 . . . . 2.93 111.416 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -145.98 139.13 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.627 -0.715 . . . . 3.73 109.738 179.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.45 148.15 29.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.631 0.253 . . . . 2.93 110.452 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.77 125.9 27.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.384 -0.371 . . . . 3.64 110.232 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.2 -18.18 57.93 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.712 -0.756 . . . . 3.27 112.615 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 3.59 110.806 179.621 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.881 0.372 . . . . 2.48 111.066 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.71 149.28 41.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.996 -0.547 . . . . 2.57 111.038 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -78.62 -30.63 46.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 2.4 111.254 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.453 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 76.7 m-85 -112.19 168.23 9.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.926 -0.579 . . . . 2.02 111.84 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.1 175.02 4.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.817 -0.629 . . . . 2.65 111.362 179.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.87 148.33 22.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 2.4 111.058 -179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.486 HD21 HD23 ' A' ' 119' ' ' LEU . 95.9 mt -84.22 119.21 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.847 -0.615 . . . . 2.27 109.653 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 107.28 14.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 2.86 110.523 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 66' ' ' PRO . 5.8 tp-100 -85.9 133.93 33.92 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 2.89 111.286 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -129.96 10.05 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.951 -0.568 . . . . 4.07 110.428 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.4 -178.17 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.735 -0.745 . . . . 3.23 112.846 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -74.03 -38.08 64.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 4.51 111.468 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.94 166.78 23.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 3.32 111.412 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.78 -70.34 0.68 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.249 -0.648 . . . . 2.41 109.249 178.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.572 HD12 ' CE1' ' A' ' 131' ' ' PHE . 16.9 tp -177.58 134.28 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.747 -0.66 . . . . 2.18 110.614 178.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -154.46 128.69 9.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 2.46 109.495 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -123.56 144.78 45.16 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.466 . . . . 1.78 110.284 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.58 161.77 44.59 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.814 2.343 . . . . 2.15 112.386 -179.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.41 130.35 42.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.84 110.454 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.92 59.46 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.901 -0.666 . . . . 1.65 111.937 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -159.66 159.27 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.644 0.259 . . . . 2.57 110.328 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.67 -17.78 10.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.715 -0.755 . . . . 1.42 112.797 179.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.41 122.27 80.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.154 -0.313 . . . . 1.09 110.154 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.71 -177.92 4.13 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.68 2.253 . . . . 1.27 112.047 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.21 98.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.594 -0.521 . . . . 1.7 109.594 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -89.48 83.41 6.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.087 0.47 . . . . 1.23 111.018 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.79 65.78 2.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.682 -0.69 . . . . 1.96 111.055 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -173.19 -28.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.258 -0.428 . . . . 2.0 111.255 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.59 167.16 9.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.31 -0.405 . . . . 1.44 111.827 -178.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.94 166.0 38.16 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 2.06 110.095 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.19 -37.47 94.24 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.894 2.396 . . . . 1.42 112.505 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -20.36 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 1.78 110.75 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.799 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 27.1 m-20 -85.58 -0.72 55.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 1.6 110.777 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -78.62 55.47 1.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 1.19 111.637 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.542 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -149.72 130.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 1.17 109.82 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -144.45 4.33 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.311 -0.947 . . . . 0.61 112.631 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -157.2 161.89 39.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.853 0.359 . . . . 1.13 110.685 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -103.27 131.82 50.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.054 -0.721 . . . . 1.69 109.054 178.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -110.75 125.35 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 2.51 110.965 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -72.15 130.85 41.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 2.62 109.775 178.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.14 155.14 51.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 2.21 110.753 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.69 160.08 42.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.046 -0.525 . . . . 2.68 110.538 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -136.32 115.27 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 3.78 111.081 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -139.15 103.12 4.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.416 -0.356 . . . . 3.58 111.639 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.2 pt -72.09 160.99 5.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.645 -0.502 . . . . 4.26 109.645 178.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 5.46 111.075 -179.478 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.286 -0.264 . . . . 4.48 110.286 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -64.64 -57.88 7.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 4.47 109.586 179.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.64 83.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.507 -0.769 . . . . 4.09 112.354 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.2 mt -93.6 170.96 9.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.854 -0.612 . . . . 3.36 110.786 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.37 154.71 94.3 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 3.47 109.829 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.656 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 51.4 Cg_exo -55.28 123.62 14.26 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.559 2.173 . . . . 2.69 110.616 178.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -120.27 144.16 47.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.563 0.579 . . . . 3.22 112.563 -178.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -128.11 124.71 37.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.68 -0.691 . . . . 1.95 109.699 178.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -103.6 145.95 29.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.047 -0.353 . . . . 2.76 110.047 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -96.48 129.43 43.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.812 0.339 . . . . 1.4 111.1 179.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -128.12 153.42 46.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 2.07 110.106 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -86.85 163.4 17.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.522 -0.308 . . . . 1.28 110.309 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.551 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 2.3 tt -62.69 121.93 14.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.297 -0.41 . . . . 1.66 110.513 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.82 29.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.918 -0.658 . . . . 1.66 113.762 178.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.21 90.11 4.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.338 0.569 . . . . 1.62 111.109 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.52 124.34 2.29 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.638 -0.791 . . . . 1.96 111.878 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.51 -21.61 39.83 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.701 2.267 . . . . 2.62 112.324 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -115.88 17.94 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.009 0.433 . . . . 3.09 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.65 -61.94 1.58 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 1.87 110.842 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.33 94.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.213 -0.518 . . . . 1.7 112.572 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.1 mt -118.13 104.76 47.95 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 120.676 0.274 . . . . 1.43 110.478 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.16 161.43 29.29 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.655 2.237 . . . . 1.62 111.344 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -54.21 119.34 4.99 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.488 -0.324 . . . . 1.75 110.464 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 111.38 -14.73 27.78 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.838 -0.696 . . . . 1.44 112.335 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.4 123.28 16.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.833 0.349 . . . . 1.25 110.845 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -90.74 131.45 36.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 2.21 111.278 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -150.93 154.99 38.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.992 -1.114 . . . . 2.11 107.992 179.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.5 115.41 3.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.04 0.448 . . . . 1.7 111.685 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.74 32.7 49.32 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.682 -0.69 . . . . 1.32 112.586 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.63 105.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.912 0.387 . . . . 1.06 110.995 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 pt -117.31 130.23 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 1.3 109.72 178.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.551 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 86.3 m95 -86.23 145.42 26.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.714 0.635 . . . . 1.08 112.714 -178.508 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.47 133.84 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.218 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.6 166.53 24.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.365 -0.38 . . . . 1.27 111.102 -179.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -137.99 164.08 29.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.217 -0.66 . . . . 1.58 109.217 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.68 114.0 8.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.74 -0.467 . . . . 2.64 109.74 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.12 -18.15 6.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.538 -1.025 . . . . 1.63 110.538 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.542 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.25 142.45 34.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.516 -0.342 . . . . 1.59 110.084 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.79 133.65 44.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.499 -0.319 . . . . 2.15 111.135 -179.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -76.07 86.97 2.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.223 0.535 . . . . 2.3 109.873 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 6.3 t -161.98 144.34 8.73 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.609 -0.723 . . . . 2.69 109.125 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.93 126.94 17.48 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.159 1.906 . . . . 2.08 112.137 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.799 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -133.22 77.78 1.75 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.463 0.649 . . . . 1.99 111.22 179.584 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.15 -0.34 35.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.744 -0.662 . . . . 2.55 111.618 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.411 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.4 p80 -60.48 -19.85 58.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.075 0.464 . . . . 2.28 111.894 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.3 pt -114.12 14.21 8.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 2.0 110.296 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.74 69.28 0.29 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.71 -0.757 . . . . 2.33 112.067 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -165.04 27.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.33 0.586 . . . . 3.21 110.821 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -65.33 128.05 34.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.057 -0.52 . . . . 3.03 110.291 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -75.87 117.58 64.85 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.311 -0.404 . . . . 3.75 110.213 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.88 -21.55 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.691 2.261 . . . . 3.39 113.815 -178.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.14 -21.43 17.93 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.311 0.485 . . . . 4.05 112.311 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -113.7 19.32 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.032 0.382 . . . . 4.78 112.032 -178.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -163.68 139.52 6.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.421 -0.354 . . . . 3.41 110.412 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.96 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.051 -0.351 . . . . 3.21 110.051 179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.14 161.19 31.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.209 0.528 . . . . 3.0 111.456 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.453 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 6.5 mt -100.04 155.15 4.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.099 -0.704 . . . . 2.42 109.099 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -74.69 127.36 36.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.182 -0.207 . . . . 2.74 110.445 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.486 HD23 HD21 ' A' ' 16' ' ' LEU . 4.6 tt -64.53 116.96 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 2.19 110.553 179.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -130.17 130.41 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.227 -0.442 . . . . 2.49 110.402 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.508 HD12 HG23 ' A' ' 125' ' ' THR . 72.9 mt -79.64 149.17 70.91 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.476 -0.329 . . . . 1.96 110.5 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.08 177.94 4.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.836 2.357 . . . . 1.84 112.974 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -64.52 126.03 26.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.46 -0.791 . . . . 2.77 110.319 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.09 65.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.599 -0.81 . . . . 2.2 112.347 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.508 HG23 HD12 ' A' ' 121' ' ' LEU . 7.2 m -124.85 116.13 21.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.942 -0.392 . . . . 2.1 109.942 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.03 151.88 35.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 2.87 111.853 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.93 147.52 77.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 2.62 110.829 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.06 164.7 26.59 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.823 2.349 . . . . 2.77 112.359 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.39 120.5 12.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 4.28 111.728 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.41 55.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.975 -0.631 . . . . 3.18 112.913 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.572 ' CE1' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -114.2 130.95 56.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.761 0.315 . . . . 2.93 111.243 -179.294 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -142.17 152.63 43.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.439 . . . . 3.73 111.053 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.23 134.67 33.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.0 0.371 . . . . 2.93 112.0 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -64.06 124.23 21.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.809 -0.632 . . . . 3.64 110.176 178.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.58 -9.46 64.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.995 -0.621 . . . . 3.27 112.651 -179.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.502 0.191 . . . . 3.59 110.548 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.493 -0.643 . . . . 9.22 111.493 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.03 143.53 26.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.962 0.411 . . . . 8.25 111.34 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.49 176.77 8.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.928 -0.578 . . . . 8.02 110.031 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.78 89.6 0.76 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.827 -0.701 . . . . 5.79 111.39 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.79 113.67 65.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.585 0.231 . . . . 4.72 110.654 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.9 64.44 8.78 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.54 2.16 . . . . 4.45 111.816 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -101.72 124.14 46.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 4.89 111.215 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -92.77 -69.14 0.76 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.987 -0.551 . . . . 4.35 111.065 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p 48.83 83.81 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.082 0.771 . . . . 2.87 113.082 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.07 140.16 30.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 2.48 110.715 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -78.24 136.19 37.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 2.57 110.778 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -71.93 -15.5 62.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 2.4 111.634 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.69 172.27 8.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.952 -0.567 . . . . 2.02 109.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 p -75.55 -170.14 1.19 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.001 0.429 . . . . 2.65 110.709 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.58 -168.62 1.33 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.956 0.408 . . . . 2.4 110.885 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.578 HD21 HD23 ' A' ' 119' ' ' LEU . 77.3 mt -128.67 105.76 8.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.404 -0.591 . . . . 2.27 109.404 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -83.49 122.51 28.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.33 -0.396 . . . . 2.86 111.197 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.1 tp-100 -97.67 133.71 41.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.555 . . . . 2.89 111.182 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -128.22 76.32 1.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.237 -0.653 . . . . 4.07 109.237 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.41 -135.48 1.87 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.522 -0.847 . . . . 3.23 112.789 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -114.92 -38.88 3.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.092 0.472 . . . . 4.51 111.577 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -78.38 170.77 16.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.817 -0.629 . . . . 3.32 111.497 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.08 -92.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.17 -0.678 . . . . 2.41 109.17 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.414 HD12 ' CE1' ' A' ' 131' ' ' PHE . 39.8 tp -169.12 134.79 1.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.515 . . . . 2.18 109.975 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -153.37 113.4 3.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.199 -0.455 . . . . 2.46 110.166 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -100.86 145.68 30.79 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 1.78 110.066 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 51.1 Cg_endo -70.89 158.91 54.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.62 2.213 . . . . 2.15 111.608 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -62.77 113.98 3.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 2.84 110.923 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.12 -13.9 26.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.767 -0.73 . . . . 1.65 111.678 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.49 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 38.9 mt-30 -122.04 168.23 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 2.57 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.84 -10.19 29.79 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.335 -0.706 . . . . 1.42 111.335 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.58 115.01 64.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 1.09 109.629 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.12 -179.97 4.85 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.513 2.142 . . . . 1.27 112.159 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.25 83.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.197 -0.456 . . . . 1.7 110.364 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -83.33 83.73 7.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.955 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -7.77 54.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.866 -0.607 . . . . 1.96 111.264 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -90.08 -22.49 21.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.344 -0.389 . . . . 2.0 111.742 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.97 168.68 9.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.145 0.498 . . . . 1.44 112.187 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.05 167.15 22.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 2.06 110.089 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.4 -39.14 92.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 1.42 113.005 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -16.93 61.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.045 0.45 . . . . 1.78 110.815 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.643 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 41.8 m-20 -88.73 2.1 53.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 1.6 111.004 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -80.87 58.79 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.153 0.501 . . . . 1.19 111.674 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.9 tt -156.13 129.91 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.615 . . . . 1.17 109.991 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.91 -149.74 6.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.335 -0.936 . . . . 0.61 112.479 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.66 158.77 44.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.133 0.492 . . . . 1.13 111.019 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.624 ' HH ' HD11 ' A' ' 119' ' ' LEU . 14.8 m-85 -103.46 133.7 48.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.831 -0.622 . . . . 1.69 109.668 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.11 117.39 29.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 2.51 110.776 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -78.31 113.55 16.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.148 0.499 . . . . 2.62 110.978 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.74 159.55 24.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.082 -0.508 . . . . 2.21 110.793 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 148.93 45.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 2.68 110.137 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HB3' HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -121.86 93.41 3.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.075 0.464 . . . . 3.78 111.357 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 1.0 OUTLIER -121.43 104.03 9.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.223 -0.444 . . . . 3.58 110.662 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.33 125.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 4.26 110.791 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.43 98.48 11.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 5.46 110.076 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.66 167.56 32.38 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.771 -0.728 . . . . 4.66 112.7 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.12 -40.27 25.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.922 -0.656 . . . . 5.04 112.178 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.04 -31.41 61.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 5.51 110.036 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.3 10.32 5.63 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.889 -0.672 . . . . 4.73 111.912 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -76.54 113.25 13.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 5.75 110.624 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.4 mtt -118.02 126.47 52.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.218 -0.446 . . . . 4.48 110.86 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -54.76 -44.78 73.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.785 -0.643 . . . . 4.47 110.358 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 36.1 t70 61.35 107.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.242 0.83 . . . . 4.09 113.242 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -123.89 143.32 50.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 3.36 110.3 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.441 ' HB2' HG23 ' A' ' 17' ' ' THR . 0.3 OUTLIER -61.04 143.66 91.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 3.47 111.391 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.27 126.27 19.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.955 2.437 . . . . 2.69 111.576 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 137.32 52.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.22 111.452 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -95.03 109.7 21.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.006 -0.543 . . . . 1.95 110.832 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -81.38 143.85 31.87 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.628 -0.508 . . . . 2.76 109.628 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -87.68 119.04 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.736 0.303 . . . . 1.4 111.032 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -120.61 139.35 53.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.735 -0.469 . . . . 2.07 109.735 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -79.69 159.06 26.82 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.312 -0.255 . . . . 1.28 110.312 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -61.15 123.24 17.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.666 0.27 . . . . 1.66 110.707 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.87 24.96 26.17 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.964 -0.636 . . . . 1.66 113.449 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.441 HG23 ' HA3' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -82.73 94.13 7.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.166 0.483 . . . . 1.62 110.811 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.22 122.02 2.08 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.954 -0.641 . . . . 1.96 111.696 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.87 -29.38 89.99 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.248 2.632 . . . . 2.62 112.756 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.14 46.55 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 3.09 110.358 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 -48.9 16.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 1.87 110.345 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 36.93 86.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.744 -0.662 . . . . 1.7 112.599 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.92 97.99 47.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 1.43 111.635 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 3.9 Cg_exo -81.74 155.38 18.07 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.769 2.313 . . . . 1.62 110.19 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.454 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.0 t80 -53.81 115.25 1.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.839 0.352 . . . . 1.75 110.866 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.44 -17.17 16.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.726 -0.749 . . . . 1.44 112.575 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.548 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -58.06 127.54 32.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 1.25 111.273 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -91.71 114.51 27.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.025 -0.534 . . . . 2.21 111.026 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -137.29 153.8 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.476 -0.329 . . . . 2.11 110.547 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.64 121.27 12.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.982 -0.554 . . . . 1.7 111.028 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.9 76.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.584 -0.817 . . . . 1.32 112.205 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.1 mm -130.54 109.94 17.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.758 0.313 . . . . 1.06 110.839 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -121.34 137.84 53.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 1.3 109.3 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -93.44 143.81 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.22 0.533 . . . . 1.08 112.346 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.77 129.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.438 -0.801 . . . . 1.04 110.211 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.75 154.45 44.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.195 -0.457 . . . . 1.27 110.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.1 t -132.02 176.12 8.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.336 -0.393 . . . . 1.58 110.091 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.3 125.06 24.9 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.809 0.338 . . . . 2.64 111.127 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.31 -8.26 28.72 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.806 -0.634 . . . . 1.63 111.967 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.03 138.2 31.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.946 0.403 . . . . 1.59 111.186 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.63 155.93 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 2.15 110.747 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.5 96.76 8.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.032 0.444 . . . . 2.3 111.488 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 t -170.25 140.71 1.61 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.866 -0.606 . . . . 2.69 109.673 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.36 136.98 53.57 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.728 2.285 . . . . 2.08 111.98 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.643 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -134.75 70.07 1.45 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.414 0.626 . . . . 1.99 110.842 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -71.22 -1.3 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 2.55 112.397 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -61.92 -27.56 68.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 2.28 111.756 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.45 10.15 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 2.0 110.886 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' A' ' 75' ' ' THR . . . -104.67 39.53 2.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 2.33 111.415 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -150.47 138.88 20.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.601 0.239 . . . . 3.21 110.658 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 179.59 147.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.688 -0.687 . . . . 3.03 109.25 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -82.02 109.74 16.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.24 -0.652 . . . . 3.75 109.24 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 -26.74 41.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.735 2.29 . . . . 3.39 113.004 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.89 23.0 6.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.971 0.415 . . . . 4.05 111.658 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -146.27 -36.22 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.457 . . . . 4.78 111.01 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -122.41 132.87 54.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.877 -0.786 . . . . 3.41 108.877 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.4 -175.06 5.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.464 -0.335 . . . . 3.21 111.551 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.83 155.63 29.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 3.0 110.602 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -90.84 147.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.86 -0.422 . . . . 2.42 109.86 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.84 121.98 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 2.74 110.25 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.624 HD11 ' HH ' ' A' ' 47' ' ' TYR . 4.6 tt -64.25 108.64 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.822 -0.626 . . . . 2.19 111.128 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -119.53 148.96 42.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.023 -0.535 . . . . 2.49 110.734 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.496 HD12 HG23 ' A' ' 125' ' ' THR . 16.0 mt -98.52 146.84 32.27 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.394 -0.367 . . . . 1.96 110.602 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.84 179.66 4.6 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.844 2.362 . . . . 1.84 112.581 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.67 138.96 58.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.739 -0.664 . . . . 2.77 111.002 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.02 80.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.956 -0.64 . . . . 2.2 112.108 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.496 HG23 HD12 ' A' ' 121' ' ' LEU . 1.3 m -135.26 121.51 20.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.843 0.354 . . . . 2.1 110.366 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -121.15 152.38 38.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.285 -0.416 . . . . 2.87 110.513 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.43 146.34 80.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.376 -0.374 . . . . 2.62 110.051 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.51 143.9 77.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.739 2.293 . . . . 2.77 111.795 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -61.65 111.8 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 4.28 110.834 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 136.46 -21.84 3.4 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.783 -1.327 . . . . 3.18 109.783 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 21.0 m-85 -104.31 153.5 20.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.19 -0.505 . . . . 2.93 110.341 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -135.54 162.06 33.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.191 -0.459 . . . . 3.73 110.304 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.11 126.78 33.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 2.93 111.211 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.08 103.86 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.013 -0.539 . . . . 3.64 110.464 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.67 12.2 51.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.677 -0.773 . . . . 3.27 112.482 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.1 m -148.24 131.22 16.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.924 0.392 . . . . 3.59 111.304 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.85 151.3 34.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.992 -0.549 . . . . 6.05 110.026 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.0 69.72 3.04 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.883 -0.675 . . . . 5.22 111.719 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 138.78 -46.97 0.94 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.425 -0.67 . . . . 5.91 111.425 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.973 -0.536 . . . . 7.27 111.772 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.493 -3.487 1 C4'-C3'-C2' 97.01 -5.69 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.506 2 N19-C1'-C2' 103.497 -6.19 . 0.231 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.716 3 O4'-C1'-N19 115.758 7.558 . 0.527 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.595 6.336 4 O4'-C1'-N19 116.707 8.507 . 0.509 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.15 2 C4'-C3'-C2' 97.58 -5.12 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.671 4 C1'-O4'-C4' 105.629 -4.412 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.321 3 P-O3'-C3' 127.096 6.163 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.581 5.337 3 O4'-C4'-C3' 114.977 6.769 . 0.0 '__' . 15.4 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.054 2 O4'-C1'-N19 118.623 10.423 . 0.414 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.636 3 O3'-P-O5' 116.372 6.512 . 0.461 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.17 1 C4'-C3'-C2' 98.263 -4.437 . 0.311 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.435 1 C4'-C3'-C2' 94.318 -8.382 . 0.454 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.797 1 O3'-P-O5' 111.757 4.083 . 0.107 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.932 2 C3'-C2'-C1' 105.719 4.688 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 111.529 -0.628 . . . . 9.22 111.529 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.53 87.8 5.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.05 0.453 . . . . 8.25 110.688 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -133.61 174.17 10.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.962 -0.563 . . . . 8.02 110.495 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.57 -127.33 5.68 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.063 -0.815 . . . . 5.79 111.063 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.2 mt -132.1 82.01 60.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.589 0.233 . . . . 4.72 111.33 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -95.65 22.06 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.097 2.531 . . . . 4.45 111.477 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -104.61 134.5 47.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.802 -0.635 . . . . 4.89 110.315 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -107.59 -78.69 0.58 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.82 -0.173 . . . . 4.35 111.293 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.7 p 48.43 75.54 0.14 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.051 0.76 . . . . 2.87 113.051 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.72 162.9 20.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.034 0.445 . . . . 2.48 111.962 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.75 155.52 39.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.51 -0.768 . . . . 2.57 111.373 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -91.69 -32.46 15.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.394 0.516 . . . . 2.4 112.394 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -109.38 -179.18 3.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 2.02 111.872 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.99 165.12 24.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.547 -0.751 . . . . 2.65 110.902 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -80.73 138.6 36.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.429 -0.35 . . . . 2.4 111.601 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 131' ' ' PHE . 75.9 mt -100.34 107.45 19.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 2.27 110.071 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -87.3 116.9 25.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.904 0.383 . . . . 2.86 111.692 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -91.36 140.33 29.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.469 . . . . 2.89 110.811 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -132.66 87.74 2.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 4.07 109.964 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.52 -166.01 34.55 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.696 -0.764 . . . . 3.23 111.732 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -93.33 -16.93 24.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 4.51 111.551 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.44 177.03 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.091 -0.504 . . . . 3.32 110.565 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 2.0 t0 -98.73 -89.91 0.3 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.164 -0.68 . . . . 2.41 109.164 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.41 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 26.9 tp -172.0 135.63 0.82 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 2.18 110.694 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -155.95 143.05 19.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.571 -0.529 . . . . 2.46 109.571 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.64 147.94 51.9 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.369 -0.378 . . . . 1.78 110.305 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.66 163.26 18.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.357 2.705 . . . . 2.15 112.297 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.0 117.88 8.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.837 -0.619 . . . . 2.84 110.954 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.95 6.96 63.0 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.761 -0.733 . . . . 1.65 112.673 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -134.53 159.19 41.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.914 -0.402 . . . . 2.57 109.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.9 -10.01 7.52 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.043 -0.598 . . . . 1.42 111.613 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.18 117.78 67.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 110.085 -0.339 . . . . 1.09 110.085 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.99 -176.47 2.89 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.585 2.19 . . . . 1.27 111.791 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.55 87.91 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.128 0.49 . . . . 1.7 110.305 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -80.33 80.07 6.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.23 110.747 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.84 57.12 2.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.079 -0.509 . . . . 1.96 110.736 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -161.66 -38.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 2.0 110.629 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.93 170.54 9.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.509 . . . . 1.44 111.306 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.1 m -86.61 162.1 46.06 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 2.06 110.135 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.83 -32.7 92.68 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.93 2.42 . . . . 1.42 112.679 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -71.38 -22.03 61.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.464 0.649 . . . . 1.78 110.396 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.64 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 52.1 m-20 -93.11 9.83 34.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.507 -0.769 . . . . 1.6 111.429 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -83.82 54.02 2.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 1.19 110.948 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 tt -150.9 138.28 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.002 -0.544 . . . . 1.17 109.949 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.38 -136.49 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.387 -0.911 . . . . 0.61 112.433 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -160.13 174.2 14.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.052 0.453 . . . . 1.13 110.968 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -114.93 139.31 49.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.242 -0.651 . . . . 1.69 109.242 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -112.41 127.69 56.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.247 -0.433 . . . . 2.51 111.072 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -88.5 112.27 22.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.014 -0.539 . . . . 2.62 110.09 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HB2' ' HE2' ' A' ' 69' ' ' TYR . . . -125.26 156.5 38.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.037 0.446 . . . . 2.21 111.543 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.91 142.43 49.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.69 -0.687 . . . . 2.68 110.813 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -111.54 119.33 38.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.905 0.384 . . . . 3.78 111.264 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt180 -137.16 169.47 17.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 3.58 109.942 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 pt -143.76 153.12 15.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.2 -0.296 . . . . 4.26 110.2 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.03 85.87 7.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 5.46 109.957 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.586 ' HA2' ' OP2' ' C' ' 13' ' ' ' U' . . . -64.8 133.55 37.59 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.632 -0.713 . . . . 4.66 113.277 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.5 -49.44 76.99 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.488 -0.387 . . . . 5.04 112.137 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.37 -23.24 35.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.387 0.613 . . . . 5.51 110.185 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.14 -16.56 6.77 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.838 -0.696 . . . . 4.73 111.597 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -73.12 122.7 22.25 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.495 -0.558 . . . . 5.75 109.495 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 29.2 mtt -130.0 159.29 37.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.316 -0.402 . . . . 4.48 110.247 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -64.63 -54.49 31.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.944 -0.391 . . . . 4.47 109.944 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.9 t70 52.92 74.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.744 . . . . 4.09 112.047 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.07 149.7 29.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.781 -0.645 . . . . 3.36 110.443 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.99 154.63 92.06 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.837 -0.62 . . . . 3.47 110.908 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.34 122.31 10.99 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.919 2.413 . . . . 2.69 111.486 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 97.7 mtt180 -119.84 135.57 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.005 -0.543 . . . . 3.22 110.738 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.41 ' CZ3' HG12 ' A' ' 91' ' ' ILE . 73.8 m95 -97.57 135.43 39.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.751 -0.659 . . . . 1.95 110.463 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.589 ' HE2' ' HB2' ' A' ' 50' ' ' ALA . 73.0 m-85 -117.35 145.6 43.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 2.76 110.185 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -85.78 124.61 32.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.981 0.42 . . . . 1.4 111.449 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -126.19 138.97 53.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.71 -0.677 . . . . 2.07 110.117 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.88 161.33 29.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 1.28 111.679 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.9 tt -63.27 122.11 15.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 1.66 111.051 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.33 16.58 62.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.86 -0.686 . . . . 1.66 114.147 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.44 129.23 40.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.109 0.455 . . . . 1.62 110.416 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.5 110.29 3.32 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.928 -0.869 . . . . 1.96 110.928 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.14 -29.15 54.63 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.426 2.751 . . . . 2.62 113.62 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.91 25.73 9.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.987 0.366 . . . . 3.09 111.987 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.38 -53.78 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.515 -0.312 . . . . 1.87 111.156 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.0 44.07 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.843 -0.694 . . . . 1.7 111.629 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.2 mt -117.43 107.15 45.49 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.718 0.294 . . . . 1.43 111.441 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.6 159.4 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.971 2.447 . . . . 1.62 111.158 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.448 ' HB2' HD11 ' A' ' 73' ' ' LEU . 92.6 t80 -64.37 119.16 9.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 1.75 110.845 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.21 11.1 26.49 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.495 -0.86 . . . . 1.44 112.891 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.03 172.12 13.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.702 0.251 . . . . 1.25 110.407 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -124.62 111.28 15.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.784 0.326 . . . . 2.21 110.442 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -140.99 152.51 44.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.265 -0.425 . . . . 2.11 110.155 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.65 117.94 8.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.081 -0.509 . . . . 1.7 111.329 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.24 29.24 62.6 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.64 -0.709 . . . . 1.32 113.27 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 mm -131.77 108.5 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.734 0.267 . . . . 1.06 110.863 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.41 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 12.8 pt -113.77 125.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.77 -0.455 . . . . 1.3 109.77 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -87.51 139.12 30.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.446 0.535 . . . . 1.08 112.446 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.76 150.2 31.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.82 -0.627 . . . . 1.04 110.862 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.61 177.22 10.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.33 -0.248 . . . . 1.27 110.33 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.42 163.01 40.64 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.699 -0.482 . . . . 1.58 109.699 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.51 125.95 25.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 2.64 111.246 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.94 25.97 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.806 -0.711 . . . . 1.63 112.261 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -100.29 123.86 45.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.204 -0.295 . . . . 1.59 110.204 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.62 150.23 23.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.033 0.444 . . . . 2.15 111.459 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -75.12 102.77 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.745 -0.661 . . . . 2.3 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -170.89 148.19 2.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.85 -0.796 . . . . 2.69 108.85 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.43 131.5 15.08 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.296 1.998 . . . . 2.08 112.498 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.64 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.64 66.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.513 0.673 . . . . 1.99 110.99 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -1.75 25.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.661 -0.7 . . . . 2.55 111.776 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -52.34 -28.7 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.348 0.499 . . . . 2.28 112.348 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -25.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.248 -0.433 . . . . 2.0 112.009 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.81 63.51 4.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.069 -0.586 . . . . 2.33 112.167 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.2 t -138.51 23.09 2.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.208 0.528 . . . . 3.21 110.481 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.52 125.17 25.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.93 -0.577 . . . . 3.03 111.005 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.41 118.68 72.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.149 -0.686 . . . . 3.75 109.149 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.07 -33.68 91.23 Favored 'Trans proline' 0 CA--C 1.527 0.137 0 C-N-CA 123.001 2.467 . . . . 3.39 114.25 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.62 4.62 48.04 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.618 0.599 . . . . 4.05 112.618 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -125.1 -6.37 7.22 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 4.78 111.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -155.69 137.83 14.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.024 -0.535 . . . . 3.41 109.63 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 153.79 22.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.529 -0.305 . . . . 3.21 110.726 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.67 159.26 28.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 3.0 111.103 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.7 mt -88.38 132.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.263 -0.426 . . . . 2.42 110.146 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.26 121.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.852 -0.425 . . . . 2.74 109.852 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.77 121.45 14.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 2.19 111.108 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.0 157.16 46.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.525 -0.762 . . . . 2.49 109.687 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.7 mt -112.81 146.4 35.0 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.499 -0.319 . . . . 1.96 110.413 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.88 156.85 64.29 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.452 2.101 . . . . 1.84 111.758 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -52.38 125.07 14.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.74 -0.664 . . . . 2.77 111.137 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.77 -16.29 47.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.985 -0.626 . . . . 2.2 111.881 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.23 116.84 32.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.933 0.397 . . . . 2.1 110.565 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.68 158.31 16.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.082 -0.508 . . . . 2.87 110.511 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.0 mt -81.49 150.71 67.52 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.519 -0.31 . . . . 2.62 110.464 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.02 142.11 96.39 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.675 2.25 . . . . 2.77 111.515 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.44 112.33 2.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.102 -0.499 . . . . 4.28 110.95 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.88 -9.19 40.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.967 -0.635 . . . . 3.18 111.68 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 16' ' ' LEU . 47.6 t80 -118.18 103.47 9.89 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.486 -0.561 . . . . 2.93 109.486 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -112.34 162.62 15.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.18 -0.464 . . . . 3.73 111.06 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 136' ' ' SER . . . -97.92 147.35 24.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.133 -0.485 . . . . 2.93 110.306 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.68 111.7 2.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 3.64 110.73 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.75 10.31 70.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.988 -0.625 . . . . 3.27 112.77 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.535 ' HB2' ' HB2' ' A' ' 133' ' ' ALA . 22.8 t -78.62 96.3 5.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.173 0.511 . . . . 3.59 111.019 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -98.6 78.48 2.38 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.559 -0.534 . . . . 6.05 109.559 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.01 100.66 2.68 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.582 -0.736 . . . . 5.22 112.263 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.79 -90.47 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.512 -0.635 . . . . 5.91 111.512 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.999 -0.524 . . . . 7.27 110.834 179.75 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.604 1 C4'-C3'-C2' 97.053 -5.647 . 0.0 '__' . 12.52 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.527 2 N19-C1'-C2' 103.559 -6.151 . 0.227 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.784 3 O4'-C1'-N19 115.757 7.557 . 0.526 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.228 4 O4'-C1'-N19 116.705 8.505 . 0.51 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.131 2 C4'-C3'-C2' 97.569 -5.131 . 0.647 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.564 5 C4'-C3'-C2' 98.302 -4.398 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 O3'--C3' 1.498 5.324 3 P-O3'-C3' 127.077 6.147 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.449 3 O4'-C4'-C3' 114.938 6.741 . 0.0 '__' . 15.4 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -4.977 2 O4'-C1'-N19 118.615 10.415 . 0.415 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.546 -4.667 3 O3'-P-O5' 116.391 6.521 . 0.461 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.079 1 C4'-C3'-C2' 98.318 -4.382 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.61 1 C4'-C3'-C2' 94.335 -8.365 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.586 ' OP2' ' HA2' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.588 5.864 1 O3'-P-O5' 111.749 4.078 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.035 2 C3'-C2'-C1' 105.638 4.598 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.627 -0.589 . . . . 9.22 111.627 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.42 133.11 55.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 8.25 111.265 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -81.23 123.34 28.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 8.02 110.648 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.08 67.29 3.63 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.793 -0.718 . . . . 5.79 111.42 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.45 111.28 61.03 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.626 0.25 . . . . 4.72 111.022 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.28 0.11 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.622 2.215 . . . . 4.45 112.28 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -91.89 147.07 23.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.94 0.4 . . . . 4.89 111.275 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -101.03 -82.93 0.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.521 -0.548 . . . . 4.35 109.521 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.4 m 65.65 117.66 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.338 0.866 . . . . 2.87 113.338 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.492 ' HB1' " O2'" ' C' ' 8' ' ' ' G' . . . -147.84 141.8 25.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.403 -0.817 . . . . 2.48 109.748 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -64.62 137.93 58.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.781 0.324 . . . . 2.57 111.431 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -73.36 -26.52 61.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 2.4 110.714 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 35' ' ' ASN . 74.3 m-85 -111.04 166.6 10.92 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.038 -0.528 . . . . 2.02 112.273 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -69.67 168.73 14.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.249 -0.887 . . . . 2.65 111.18 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.25 151.6 20.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.269 0.47 . . . . 2.4 112.269 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 133' ' ' ALA . 15.9 mt -99.88 125.17 45.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 2.27 109.031 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -95.87 121.92 38.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.195 0.521 . . . . 2.86 112.233 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -89.77 134.38 34.21 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.736 -0.666 . . . . 2.89 110.076 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -140.91 73.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 4.07 109.94 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -165.15 -140.83 2.97 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.781 -0.724 . . . . 3.23 112.438 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -110.81 -18.08 13.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.721 0.296 . . . . 4.51 111.342 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.12 -174.13 2.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.182 -0.463 . . . . 3.32 111.208 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -111.38 -77.46 0.59 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 2.41 110.208 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 31.6 tp 172.55 131.23 0.02 OUTLIER 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.863 0.727 . . . . 2.18 110.018 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -157.23 130.89 8.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 2.46 109.625 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -120.97 139.51 29.34 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.234 -0.439 . . . . 1.78 110.277 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.55 164.36 34.03 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.273 1.982 . . . . 2.15 110.696 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.91 131.79 51.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.602 0.239 . . . . 2.84 110.609 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.11 6.3 61.77 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 1.65 111.659 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -144.39 159.73 42.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.818 -0.438 . . . . 2.57 109.818 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.43 -11.48 36.23 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.906 -0.664 . . . . 1.42 111.481 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.76 114.58 61.84 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.809 -0.441 . . . . 1.09 109.809 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.28 -173.13 1.7 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.564 2.176 . . . . 1.27 111.102 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mt -79.97 91.92 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.751 -0.463 . . . . 1.7 109.751 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 13' ' ' PHE . 69.0 m-80 -87.44 77.38 8.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.97 -0.559 . . . . 1.23 110.694 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 39.65 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.016 -0.538 . . . . 1.96 111.68 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.49 -10.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.42 -0.355 . . . . 2.0 111.236 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.2 166.28 16.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.612 -0.267 . . . . 1.44 110.857 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.5 m -88.01 168.23 17.39 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.304 -0.407 . . . . 2.06 110.687 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.79 -45.01 33.92 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.247 2.631 . . . . 1.42 113.855 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -72.18 -22.74 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 1.78 111.522 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.801 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 14.8 m-20 -87.05 11.61 13.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.974 -0.557 . . . . 1.6 111.43 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -83.25 -6.46 59.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.761 0.282 . . . . 1.19 111.761 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.491 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -82.93 126.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.117 0.484 . . . . 1.17 111.33 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.44 -161.08 11.67 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.683 -0.77 . . . . 0.61 112.229 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 48.6 p90 -146.42 163.12 36.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.088 0.47 . . . . 1.13 110.717 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.56 ' HH ' HD11 ' A' ' 119' ' ' LEU . 5.9 m-85 -108.52 133.99 51.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.805 -0.634 . . . . 1.69 109.585 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -114.68 134.63 54.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.361 . . . . 2.51 111.234 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -85.38 123.73 31.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 2.62 110.245 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.605 0.24 . . . . 2.21 110.957 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.42 93.06 1.93 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.118 -0.492 . . . . 2.68 110.726 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -78.64 124.86 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.281 0.562 . . . . 3.78 111.826 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -141.71 117.65 10.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.901 -0.591 . . . . 3.58 109.991 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.3 pt -65.19 171.19 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.185 -0.461 . . . . 4.26 110.713 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.5 106.26 9.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.061 0.457 . . . . 5.46 112.149 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.62 169.12 22.07 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.083 -0.807 . . . . 4.66 111.083 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.51 -15.58 52.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.63 -0.795 . . . . 5.04 112.647 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -86.31 -38.17 17.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.907 0.384 . . . . 5.51 111.374 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.99 -10.13 6.66 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.755 -0.736 . . . . 4.73 111.805 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -90.83 122.88 33.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.619 -0.512 . . . . 5.75 109.619 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.19 155.2 50.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.781 -0.451 . . . . 4.48 109.781 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -57.13 -53.31 59.54 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.332 0.395 . . . . 4.47 110.906 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.9 t70 56.0 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.93 0.715 . . . . 4.09 112.93 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.9 mt -84.85 152.74 23.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 3.36 110.691 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 m -75.21 162.83 71.51 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.646 . . . . 3.47 109.989 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.95 111.06 0.66 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.64 2.227 . . . . 2.69 111.848 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.47 137.56 52.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.97 -0.559 . . . . 3.22 110.762 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -104.77 129.64 52.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.84 -0.618 . . . . 1.95 110.944 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -110.13 140.65 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 2.76 110.001 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -89.97 120.08 30.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 1.4 111.186 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.37 130.41 52.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 2.07 109.939 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -67.3 151.1 48.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.56 -0.291 . . . . 1.28 111.129 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.11 116.52 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 1.66 110.805 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.89 -4.29 24.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.474 -0.87 . . . . 1.66 112.901 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -63.74 123.54 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.64 0.257 . . . . 1.62 110.492 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.98 106.87 3.01 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.081 -0.807 . . . . 1.96 111.081 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -35.2 91.15 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.089 2.526 . . . . 2.62 113.062 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.72 21.98 13.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.473 -0.331 . . . . 3.09 111.619 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.33 -50.1 61.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 1.87 110.83 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.32 49.03 59.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.019 -0.61 . . . . 1.7 111.812 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 mt -118.44 91.68 41.85 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.692 0.282 . . . . 1.43 111.56 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.27 155.02 22.02 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.443 2.095 . . . . 1.62 110.301 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -60.54 110.46 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.772 0.32 . . . . 1.75 110.857 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.59 -14.49 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.869 -0.681 . . . . 1.44 112.393 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.62 147.21 49.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.809 0.338 . . . . 1.25 111.286 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -111.08 103.14 11.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.055 0.455 . . . . 2.21 111.424 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -125.77 149.43 48.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 2.11 109.712 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.75 118.62 5.91 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.455 0.472 . . . . 1.7 111.935 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.58 35.45 51.52 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.941 -0.572 . . . . 1.32 112.981 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.4 mm -134.87 113.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.544 0.212 . . . . 1.06 110.474 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 23.6 pt -119.9 134.67 62.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 110.444 -0.206 . . . . 1.3 110.444 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.408 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 70.2 m95 -95.34 140.98 29.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.403 -0.362 . . . . 1.08 111.907 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 m -134.22 125.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 1.04 110.394 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.9 158.7 40.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.013 0.435 . . . . 1.27 111.79 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 t -139.04 163.34 32.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.569 -0.9 . . . . 1.58 108.569 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.61 121.46 15.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 2.64 110.58 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.03 -17.91 12.61 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.992 -0.843 . . . . 1.63 110.992 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -81.97 121.08 26.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.857 0.36 . . . . 1.59 110.062 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -88.65 130.58 35.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.143 -0.481 . . . . 2.15 110.603 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -71.45 97.0 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.125 0.488 . . . . 2.3 110.9 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.494 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.6 t -168.41 143.44 2.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.863 -0.791 . . . . 2.69 108.863 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.89 128.7 25.05 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.605 2.204 . . . . 2.08 113.516 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.801 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -129.5 78.93 1.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.525 0.679 . . . . 1.99 110.244 178.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.6 -11.11 59.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 2.55 111.492 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -58.28 -22.86 54.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.73 0.641 . . . . 2.28 112.73 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.28 0.68 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.089 0.471 . . . . 2.0 110.97 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.94 -35.42 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.871 -0.681 . . . . 2.33 111.5 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 t -71.27 115.66 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.355 0.598 . . . . 3.21 110.623 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.548 HH22 " H1'" ' C' ' 8' ' ' ' G' . 35.2 ttp85 -154.22 138.66 16.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 3.03 110.159 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -94.75 108.04 34.77 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.863 -0.421 . . . . 3.75 109.863 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.455 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 37.4 Cg_endo -63.79 -29.19 68.23 Favored 'Trans proline' 0 N--CA 1.47 0.124 0 C-N-CA 123.238 2.625 . . . . 3.39 113.451 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.416 ' HB1' HO2' ' B' ' 7' ' ' ' C' . . . -87.99 12.71 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.113 0.412 . . . . 4.05 112.113 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -135.95 -43.0 0.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 4.78 110.777 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -103.33 134.58 46.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.555 -0.535 . . . . 3.41 109.555 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.92 150.67 25.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 3.21 111.24 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.05 158.93 19.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 3.0 111.258 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.33 145.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 2.42 109.712 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.01 118.66 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.63 0.252 . . . . 2.74 110.749 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.56 HD11 ' HH ' ' A' ' 47' ' ' TYR . 5.7 tt -65.45 117.72 8.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.782 -0.645 . . . . 2.19 111.175 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -130.33 150.45 51.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 2.49 110.747 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 26.1 mt -97.22 138.83 21.22 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.098 -0.501 . . . . 1.96 110.107 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.24 152.98 68.39 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.683 2.255 . . . . 1.84 111.775 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -50.5 124.12 10.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 2.77 111.277 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.91 -22.13 16.9 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.148 -0.781 . . . . 2.2 111.148 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -99.98 120.29 39.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.656 -0.498 . . . . 2.1 109.656 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.4 139.03 38.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.179 -0.464 . . . . 2.87 111.06 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.2 mt -72.61 146.39 88.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.81 149.23 26.2 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.646 2.23 . . . . 2.77 111.417 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.39 108.98 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.293 0.479 . . . . 4.28 112.293 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.12 6.03 54.13 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.735 -0.666 . . . . 3.18 112.998 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.02 141.87 28.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.958 0.379 . . . . 2.93 111.49 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.801 ' HE1' " H5'" ' B' ' 1' ' ' ' C' . 37.1 p90 -152.98 147.3 25.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.93 -0.577 . . . . 3.73 110.785 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.47 ' HB3' HD22 ' A' ' 16' ' ' LEU . . . -112.55 162.35 15.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.357 -0.383 . . . . 2.93 110.54 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.22 128.06 34.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.367 -0.378 . . . . 3.64 110.283 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.89 -12.35 62.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.725 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.0 m -79.58 -18.56 51.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.839 0.352 . . . . 3.59 111.731 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -133.86 35.71 3.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.098 -0.501 . . . . 6.05 110.347 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 110.68 -131.83 10.61 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.582 -0.818 . . . . 5.22 112.252 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.39 -131.46 10.77 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 5.91 112.098 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.563 -0.732 . . . . 7.27 110.992 -179.83 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.801 " H5'" ' HE1' ' A' ' 132' ' ' TYR . . . . . . . . 0 C2'--C1' 1.492 -3.6 1 C4'-C3'-C2' 97.067 -5.633 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.473 4.634 2 N19-C1'-C2' 103.444 -6.222 . 0.228 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.773 3 O4'-C1'-N19 115.719 7.519 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.223 4 O4'-C1'-N19 116.681 8.481 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.374 -4.141 2 C4'-C3'-C2' 97.579 -5.121 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.524 -6.897 4 N19-C1'-C2' 106.354 -4.404 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . 0.416 HO2' ' HB1' ' A' ' 112' ' ' ALA . . . . . . . . 2 O3'--C3' 1.497 5.289 3 P-O3'-C3' 127.079 6.149 . 0.01 1a . 18.49 . . . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.548 " H1'" HH22 ' A' ' 109' ' ' ARG . . . . . . . . 2 C2'--C1' 1.582 5.374 3 O4'-C4'-C3' 115.046 6.818 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.049 2 O4'-C1'-N19 118.63 10.43 . 0.418 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.587 3 O4'-C1'-N19 114.681 6.481 . 0.462 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.218 1 C4'-C3'-C2' 98.31 -4.39 . 0.311 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.598 1 C4'-C3'-C2' 94.261 -8.439 . 0.449 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.589 5.877 1 O3'-P-O5' 111.725 4.066 . 0.103 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.576 4.846 2 C3'-C2'-C1' 105.739 4.71 . 0.335 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.66 -0.576 . . . . 9.22 111.66 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.62 147.92 23.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.745 0.307 . . . . 8.25 110.717 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -125.79 27.1 6.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.15 -0.477 . . . . 8.02 110.738 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.73 133.62 12.91 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.721 -0.752 . . . . 5.79 111.615 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.5 mt -129.49 134.51 26.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.553 0.216 . . . . 4.72 110.843 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.23 33.51 0.51 Allowed 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.915 2.41 . . . . 4.45 111.962 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.11 152.22 23.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 4.89 110.333 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.65 -77.28 0.55 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.197 -0.668 . . . . 4.35 109.197 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 108' ' ' THR . 6.8 p 45.37 78.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.019 1.118 . . . . 2.87 114.019 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.06 168.5 19.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.169 -0.678 . . . . 2.48 109.169 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 154.45 42.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.896 0.379 . . . . 2.57 111.332 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -31.45 53.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.464 0.65 . . . . 2.4 109.429 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.417 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 92.5 m-85 -114.9 176.57 5.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 2.02 109.878 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 p -69.95 167.52 17.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 2.65 110.747 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.11 18.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.472 . . . . 2.4 111.409 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.412 HD21 HD23 ' A' ' 119' ' ' LEU . 90.7 mt -107.95 115.8 30.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.144 -0.688 . . . . 2.27 109.144 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.426 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 4.6 m -93.12 132.71 37.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.155 0.502 . . . . 2.86 111.769 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -95.96 140.84 30.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.611 -0.722 . . . . 2.89 110.812 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -130.17 77.38 1.78 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.004 -0.544 . . . . 4.07 109.761 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -171.91 44.42 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.951 -0.642 . . . . 3.23 111.657 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -84.47 -23.69 29.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.027 0.441 . . . . 4.51 110.414 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.68 -179.9 6.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.626 -0.716 . . . . 3.32 110.802 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -117.96 -84.32 0.65 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.249 -0.432 . . . . 2.41 110.61 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 30.8 tp -175.72 129.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.18 111.072 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -152.27 88.95 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.218 -0.66 . . . . 2.46 109.218 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -72.68 142.06 83.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.277 -0.42 . . . . 1.78 111.877 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.539 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 56.2 Cg_endo -70.77 161.51 45.8 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.024 2.483 . . . . 2.15 112.426 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.59 119.58 8.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 2.84 111.784 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.63 -13.44 61.06 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.056 -0.593 . . . . 1.65 112.685 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.539 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 70.5 mt-30 -117.87 174.2 6.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.671 0.272 . . . . 2.57 110.753 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.78 -1.66 41.84 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.597 -0.811 . . . . 1.42 112.246 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 t -100.58 112.04 63.85 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.57 0.224 . . . . 1.09 110.482 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.2 174.86 9.26 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.676 2.251 . . . . 1.27 111.492 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.85 89.11 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.056 0.455 . . . . 1.7 110.642 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.88 84.8 7.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 1.23 109.63 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -66.66 -20.98 66.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.703 -0.68 . . . . 1.96 112.197 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -88.24 -11.86 45.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.319 0.488 . . . . 2.0 112.319 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.06 158.94 18.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.144 0.497 . . . . 1.44 111.993 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.06 163.02 36.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.644 -0.707 . . . . 2.06 109.34 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.17 -45.16 26.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.321 2.681 . . . . 1.42 113.315 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.25 -18.78 61.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.024 0.44 . . . . 1.78 111.411 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.12 -2.45 58.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.956 -0.566 . . . . 1.6 110.824 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -80.39 60.92 3.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.228 0.537 . . . . 1.19 110.686 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.9 tt -149.37 135.35 11.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 1.17 110.167 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.82 -146.85 6.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.129 -1.034 . . . . 0.61 112.98 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -152.76 168.46 25.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.134 0.492 . . . . 1.13 110.772 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.558 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -112.51 134.78 53.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.976 -0.557 . . . . 1.69 109.632 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -116.96 126.51 53.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.353 . . . . 2.51 111.113 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.69 132.45 34.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.085 -0.507 . . . . 2.62 110.774 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . . . -139.3 147.87 42.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.606 0.241 . . . . 2.21 110.792 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 101.05 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 2.68 110.564 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.464 ' HB3' HD13 ' A' ' 64' ' ' LEU . 6.4 tpt180 -77.53 129.24 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 3.78 111.315 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -144.58 93.35 2.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 3.58 110.884 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 62' ' ' LYS . 8.5 pt -77.51 154.01 5.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.601 -0.272 . . . . 4.26 110.382 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.09 119.34 39.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 5.46 110.664 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.22 162.14 40.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.783 -0.723 . . . . 4.66 111.758 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.6 -21.96 67.46 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.908 -0.477 . . . . 5.04 111.908 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -76.48 -12.8 60.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.311 0.576 . . . . 5.51 110.432 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.69 0.28 59.21 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.867 -0.682 . . . . 4.73 112.26 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -91.33 159.84 15.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.829 0.347 . . . . 5.75 110.588 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.8 mmt -108.82 150.5 27.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.228 -0.442 . . . . 4.48 110.022 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.595 ' HB2' HG12 ' A' ' 54' ' ' ILE . 70.4 tttt -63.5 -43.8 96.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 4.47 111.157 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 62.77 101.01 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.511 -0.768 . . . . 4.09 112.847 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 52' ' ' ARG . 22.4 mt -117.53 150.46 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 3.36 110.5 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.93 147.61 97.83 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.215 -0.448 . . . . 3.47 110.449 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.32 120.42 8.33 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.869 2.379 . . . . 2.69 111.641 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.464 ' NH2' HOP3 ' B' ' 1' ' ' ' C' . 71.7 mtt180 -118.03 133.31 56.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.049 -0.523 . . . . 3.22 111.496 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.558 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 44.7 m95 -100.31 125.44 46.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.977 -0.556 . . . . 1.95 109.537 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 50' ' ' ALA . 24.7 m-85 -102.2 135.46 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.337 -0.392 . . . . 2.76 110.113 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -85.97 120.43 27.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.762 0.315 . . . . 1.4 110.65 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -118.78 144.66 46.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.996 -0.547 . . . . 2.07 109.723 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -79.45 164.49 23.92 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.136 -0.226 . . . . 1.28 110.7 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.52 117.57 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 1.66 112.073 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.15 38.89 17.34 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.749 -0.66 . . . . 1.66 113.043 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.31 70.08 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.62 111.234 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.64 121.56 0.58 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.531 -1.028 . . . . 1.96 110.531 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.03 -42.37 64.81 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.811 2.34 . . . . 2.62 112.801 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.64 29.19 8.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.428 -0.351 . . . . 3.09 111.339 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.72 -50.27 15.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 1.87 110.866 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.8 49.15 65.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.053 -0.594 . . . . 1.7 111.866 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.26 99.19 48.49 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.721 0.296 . . . . 1.43 111.638 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 94.6 Cg_endo -80.85 160.45 21.34 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.514 2.143 . . . . 1.62 110.595 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -59.06 112.46 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.016 0.436 . . . . 1.75 110.488 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.24 -3.89 23.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.902 -0.666 . . . . 1.44 112.34 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.483 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -64.52 116.66 6.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.808 0.337 . . . . 1.25 110.853 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.37 127.76 33.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.837 -0.62 . . . . 2.21 110.919 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HD2' HG13 ' A' ' 90' ' ' ILE . 12.1 ttmm -154.38 159.18 41.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.935 -0.765 . . . . 2.11 108.935 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 118.45 10.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.06 0.457 . . . . 1.7 111.481 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.94 60.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.654 -0.703 . . . . 1.32 112.741 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.534 HG13 ' HD2' ' A' ' 87' ' ' LYS . 28.3 mm -133.72 116.06 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.201 0.524 . . . . 1.06 111.256 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -124.16 139.87 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.868 -0.79 . . . . 1.3 108.868 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -100.26 141.87 32.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.272 0.471 . . . . 1.08 112.272 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.7 145.86 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.774 -0.648 . . . . 1.04 110.311 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.58 140.94 12.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.626 -0.261 . . . . 1.27 110.999 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 t -99.58 175.68 5.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.677 -0.49 . . . . 1.58 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -73.97 133.74 43.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.813 0.339 . . . . 2.64 110.674 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.62 -9.5 57.16 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.659 -0.781 . . . . 1.63 112.156 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.722 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.04 148.17 27.71 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.639 0.257 . . . . 1.59 110.421 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.69 134.79 49.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.797 0.332 . . . . 2.15 110.942 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -78.28 93.51 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.3 110.565 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.1 t -158.92 138.71 8.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.829 -0.623 . . . . 2.69 109.823 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.37 130.43 19.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.622 2.215 . . . . 2.08 112.238 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -151.9 92.08 1.7 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.268 0.556 . . . . 1.99 111.144 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.31 -4.03 36.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 2.55 111.883 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -55.01 -29.1 56.63 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.513 0.561 . . . . 2.28 112.513 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.35 4.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.785 0.326 . . . . 2.0 111.437 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -104.75 -21.74 8.93 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.368 -0.92 . . . . 2.33 113.301 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.417 ' HA ' HG23 ' A' ' 9' ' ' THR . 3.1 t -80.24 111.58 16.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.309 0.576 . . . . 3.21 112.364 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -167.02 136.65 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.794 -0.639 . . . . 3.03 110.573 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -90.69 117.97 68.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 3.75 110.0 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -32.67 44.18 Favored 'Trans proline' 0 N--CA 1.473 0.298 0 C-N-CA 122.749 2.299 . . . . 3.39 113.179 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -17.12 61.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.783 0.29 . . . . 4.05 111.783 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -112.39 0.43 15.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.477 -0.329 . . . . 4.78 111.217 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -155.48 117.92 4.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.569 0.223 . . . . 3.41 110.728 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.42 154.16 42.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 3.21 111.411 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.79 151.08 19.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.089 0.471 . . . . 3.0 111.597 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.417 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 13.2 mt -91.93 149.0 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.26 -0.644 . . . . 2.42 109.26 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.99 116.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.609 0.242 . . . . 2.74 110.582 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.412 HD23 HD21 ' A' ' 16' ' ' LEU . 6.0 tt -64.1 111.81 2.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 2.19 110.999 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -131.88 150.75 52.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 2.49 110.545 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.59 154.52 41.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.955 -0.566 . . . . 1.96 109.521 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.63 166.81 12.78 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.487 2.124 . . . . 1.84 112.542 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -64.65 119.53 10.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 2.77 110.497 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.19 -19.33 22.68 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.046 -0.822 . . . . 2.2 111.046 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.36 118.75 37.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 2.1 110.148 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.42 155.83 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.419 . . . . 2.87 110.933 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -84.67 151.44 58.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.94 150.37 78.55 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.347 2.032 . . . . 2.77 111.213 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -59.13 125.45 23.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 4.28 110.735 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.0 51.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.014 -0.612 . . . . 3.18 111.688 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.84 124.26 40.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.114 -0.328 . . . . 2.93 110.114 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.426 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 55.3 p90 -127.62 148.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.909 0.385 . . . . 3.73 111.156 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.55 137.04 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 2.93 111.062 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' OE1' ' HA ' ' A' ' 134' ' ' GLU . 39.6 mm-40 -69.61 137.25 52.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.918 0.389 . . . . 3.64 110.801 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.18 -31.35 6.74 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.994 -1.242 . . . . 3.27 109.994 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 t -93.96 125.71 38.74 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.46 -0.57 . . . . 3.59 109.46 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -114.72 94.51 4.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.094 0.473 . . . . 6.05 110.158 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.18 160.18 18.57 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.734 -0.746 . . . . 5.22 112.233 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 69.01 -119.35 9.57 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.867 -0.683 . . . . 5.91 112.082 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 119.047 -0.501 . . . . 7.27 110.549 -179.543 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.464 HOP3 ' NH2' ' A' ' 67' ' ' ARG . . . . . . . . 0 C2'--C1' 1.492 -3.63 1 C4'-C3'-C2' 97.141 -5.559 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.555 2 N19-C1'-C2' 103.499 -6.188 . 0.23 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.463 -5.676 3 O4'-C1'-N19 115.673 7.473 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.267 4 O4'-C1'-N19 116.583 8.383 . 0.51 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.044 2 C4'-C3'-C2' 97.626 -5.074 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.711 4 C4'-C3'-C2' 98.274 -4.426 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.498 5.358 3 P-O3'-C3' 127.08 6.15 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.422 3 O4'-C4'-C3' 114.961 6.758 . 0.0 '__' . 15.4 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.028 2 O4'-C1'-N19 118.654 10.454 . 0.414 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.462 3 O3'-P-O5' 116.366 6.509 . 0.459 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.133 1 C4'-C3'-C2' 98.349 -4.351 . 0.308 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.611 1 C4'-C3'-C2' 94.38 -8.32 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.819 1 O3'-P-O5' 111.654 4.028 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . 0.501 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.579 5.148 2 C3'-C2'-C1' 105.681 4.645 . 0.338 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 111.729 -0.548 . . . . 9.22 111.729 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.15 128.03 34.48 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.935 0.398 . . . . 8.25 111.274 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.434 ' HA ' ' HE2' ' A' ' 3' ' ' MET . 5.0 tpt -114.03 106.96 15.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.372 -0.377 . . . . 8.02 111.059 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 179.68 40.46 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.878 -0.677 . . . . 5.79 111.746 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.6 mt -137.78 109.49 8.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.694 0.283 . . . . 4.72 110.687 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.33 29.49 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.787 2.325 . . . . 4.45 111.816 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -66.19 116.48 7.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.476 . . . . 4.89 110.893 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.91 -163.83 0.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.238 -0.437 . . . . 4.35 110.337 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 m 63.68 93.33 0.06 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.588 0.555 . . . . 2.87 111.155 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.45 139.68 51.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.072 -0.513 . . . . 2.48 110.756 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -64.46 149.61 48.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.603 . . . . 2.57 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -86.37 -18.42 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 2.4 111.257 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -123.37 172.71 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.155 -0.475 . . . . 2.02 111.276 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.843 HG23 " H5'" ' C' ' 8' ' ' ' G' . 17.7 p -70.44 170.37 12.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 2.65 109.996 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB3' ' CD1' ' A' ' 69' ' ' TYR . . . -95.92 172.11 8.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.279 0.561 . . . . 2.4 111.211 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 43.6 mt -106.04 102.07 11.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.901 -0.778 . . . . 2.27 108.901 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.572 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.42 119.24 22.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.967 -0.56 . . . . 2.86 110.952 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 5.3 tp60 -100.36 132.73 45.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.886 -0.597 . . . . 2.89 110.801 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -126.29 57.16 1.41 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.692 -0.685 . . . . 4.07 109.436 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.61 -166.41 11.86 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.39 -0.823 . . . . 3.23 111.546 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -91.78 -37.97 12.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.887 0.343 . . . . 4.51 111.595 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -83.14 156.19 23.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.505 -0.316 . . . . 3.32 110.944 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -87.22 -154.37 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.278 -0.419 . . . . 2.41 110.556 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 tp -111.58 131.34 55.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.951 0.352 . . . . 2.18 111.951 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -154.65 105.44 2.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.782 -0.645 . . . . 2.46 109.371 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.54 150.59 51.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 1.78 110.952 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.74 -172.85 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.942 2.428 . . . . 2.15 112.707 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -69.6 130.04 41.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.625 -0.716 . . . . 2.84 111.447 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.98 87.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.24 -0.505 . . . . 1.65 112.575 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.455 HE22 HG22 ' A' ' 125' ' ' THR . 4.7 mm-40 -125.87 167.26 15.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.804 0.335 . . . . 2.57 111.018 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.0 -28.22 10.79 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.671 -0.695 . . . . 1.42 112.134 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.01 115.23 52.79 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.839 0.352 . . . . 1.09 110.254 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.38 -176.25 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.668 2.246 . . . . 1.27 111.095 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 mt -80.03 88.85 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.568 -0.53 . . . . 1.7 109.568 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.406 ' C ' ' H ' ' A' ' 37' ' ' ASN . 63.2 m-80 -86.08 82.61 8.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.465 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.74 37.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 1.96 111.486 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 35' ' ' ASN . 8.3 p30 -144.16 1.39 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.98 -0.555 . . . . 2.0 109.711 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.43 159.29 37.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.887 -0.597 . . . . 1.44 111.843 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.16 168.82 23.82 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.688 -0.687 . . . . 2.06 110.019 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.11 -37.96 93.77 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.648 2.232 . . . . 1.42 112.802 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.24 -15.76 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.631 0.234 . . . . 1.78 111.631 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.723 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 11.4 m-20 -88.75 -0.61 57.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 1.6 110.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -79.88 53.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.237 0.542 . . . . 1.19 111.074 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.727 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.4 tt -146.49 134.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.838 -0.619 . . . . 1.17 109.508 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.97 -146.67 5.41 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.412 -0.899 . . . . 0.61 112.498 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -156.41 165.78 35.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.611 0.243 . . . . 1.13 110.656 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.599 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 9.0 m-85 -106.15 141.91 36.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.483 -0.562 . . . . 1.69 109.483 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -121.77 127.75 50.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 2.51 110.912 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.4 ttt-85 -82.03 109.48 16.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 2.62 110.009 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.82 145.4 50.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.076 0.465 . . . . 2.21 112.114 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.9 m -140.44 119.58 12.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.68 109.765 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.511 ' HB3' HD13 ' A' ' 64' ' ' LEU . 25.0 tpt180 -84.58 125.35 32.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.075 0.464 . . . . 3.78 111.923 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -137.8 172.44 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 3.58 110.049 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.95 177.42 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.629 0.252 . . . . 4.26 110.857 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -112.7 113.18 25.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.408 -0.36 . . . . 5.46 110.086 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.63 144.67 15.51 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.97 -0.633 . . . . 4.66 111.573 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.95 -38.94 21.78 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.043 -0.599 . . . . 5.04 112.371 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -72.33 -45.76 58.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 5.51 110.949 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.21 3.0 5.39 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.329 -0.938 . . . . 4.73 113.305 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -79.22 118.86 21.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.912 -0.403 . . . . 5.75 109.912 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmt -131.15 152.4 50.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.264 -0.425 . . . . 4.48 110.048 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.54 -38.37 90.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.459 -0.571 . . . . 4.47 109.459 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 55.36 85.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.989 -1.005 . . . . 4.09 113.455 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 52' ' ' ARG . 81.3 mt -92.2 155.31 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 3.36 109.918 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -74.76 152.8 87.12 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.713 -0.222 . . . . 3.47 110.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.32 120.96 9.18 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 2.69 111.092 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HG2' HG22 ' A' ' 17' ' ' THR . 63.2 mtt180 -112.77 126.89 55.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 3.22 111.222 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.599 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.04 104.36 16.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.122 -0.49 . . . . 1.95 109.88 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 15' ' ' ALA . 89.0 m-85 -88.51 148.87 23.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.203 -0.453 . . . . 2.76 110.442 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.79 128.07 48.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.908 0.385 . . . . 1.4 111.294 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.67 157.82 31.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.157 -0.683 . . . . 2.07 109.157 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.69 159.0 16.6 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.633 -0.258 . . . . 1.28 110.999 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.1 120.45 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.183 -0.462 . . . . 1.66 112.111 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.67 36.08 8.12 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.939 -0.648 . . . . 1.66 112.728 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.44 104.46 15.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.966 0.412 . . . . 1.62 111.302 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.49 115.5 3.39 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.649 -0.786 . . . . 1.96 111.959 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.7 -24.03 55.49 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.642 2.228 . . . . 2.62 112.172 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 47.11 1.16 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.913 0.387 . . . . 3.09 110.531 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.69 -60.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.87 111.469 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.32 16.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.82 -0.705 . . . . 1.7 111.624 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' A' ' 87' ' ' LYS . 32.0 mt -120.77 94.19 48.82 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 1.43 111.581 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 83.4 Cg_endo -83.11 164.43 15.19 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.541 2.161 . . . . 1.62 111.009 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.57 110.28 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.75 111.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.15 9.19 24.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.796 -0.716 . . . . 1.44 113.055 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.457 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -77.73 134.95 37.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.864 0.364 . . . . 1.25 111.243 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -81.22 127.15 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.401 -0.363 . . . . 2.21 110.918 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' A' ' 81' ' ' LEU . 12.4 tttt -163.3 142.05 8.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 2.11 110.666 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.37 124.76 24.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 1.7 111.497 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.82 15.92 71.68 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.913 -0.585 . . . . 1.32 112.797 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.02 112.95 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.634 0.254 . . . . 1.06 110.709 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.5 pt -118.0 132.17 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.942 -0.392 . . . . 1.3 109.942 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -92.15 138.03 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.409 0.522 . . . . 1.08 112.409 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.75 146.4 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.407 -0.815 . . . . 1.04 109.706 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.19 174.71 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.831 0.348 . . . . 1.27 111.097 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -156.22 170.73 21.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 1.58 109.389 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.12 124.64 24.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 2.64 110.681 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.84 -21.58 18.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.829 -0.908 . . . . 1.63 110.829 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.727 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.09 126.81 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.097 -0.335 . . . . 1.59 110.097 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.18 143.68 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.857 0.36 . . . . 2.15 111.158 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.06 93.38 4.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.317 0.579 . . . . 2.3 110.722 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.4 t -161.71 149.49 12.11 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.454 -0.943 . . . . 2.69 108.454 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.99 129.73 17.85 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.259 1.973 . . . . 2.08 112.938 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.723 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -138.18 71.33 1.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.385 0.612 . . . . 1.99 111.203 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -76.96 -4.38 43.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.505 . . . . 2.55 111.918 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -57.82 -22.21 46.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.973 0.416 . . . . 2.28 111.878 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.72 8.86 9.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 2.0 110.973 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.69 -26.73 10.35 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 120.999 -0.619 . . . . 2.33 111.612 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.7 t -79.77 118.17 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 3.21 110.539 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -161.5 140.44 9.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 3.03 109.999 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.65 103.3 23.31 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.5 -0.318 . . . . 3.75 110.579 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.39 -17.09 39.43 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.761 2.308 . . . . 3.39 112.702 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.49 -11.42 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.054 0.454 . . . . 4.05 110.982 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -116.83 -53.62 2.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.031 -0.532 . . . . 4.78 110.14 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.79 139.58 38.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.682 -0.69 . . . . 3.41 109.944 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 148.13 22.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.735 0.302 . . . . 3.21 111.106 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.542 ' H ' " H1'" ' C' ' 8' ' ' ' G' . . . -78.76 153.13 31.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.394 -0.366 . . . . 3.0 110.816 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.1 mt -88.1 149.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 2.42 110.116 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.88 125.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.36 . . . . 2.74 110.471 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.07 105.47 3.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 2.19 110.979 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -121.31 150.53 41.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.143 -0.48 . . . . 2.49 110.688 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.483 HD12 HG23 ' A' ' 125' ' ' THR . 96.0 mt -100.18 153.87 37.52 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.093 -0.503 . . . . 1.96 110.835 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.71 167.92 25.9 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.731 2.287 . . . . 1.84 111.912 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.07 122.54 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.493 . . . . 2.77 111.214 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.57 12.13 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.69 -0.686 . . . . 2.2 111.766 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.483 HG23 HD12 ' A' ' 121' ' ' LEU . 6.4 m -96.24 122.26 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.927 -0.397 . . . . 2.1 109.927 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 p -118.67 149.06 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.655 0.264 . . . . 2.87 110.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.2 mt -77.71 144.01 68.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.812 -0.44 . . . . 2.62 109.812 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.78 157.83 22.52 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.615 2.21 . . . . 2.77 111.701 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.7 118.34 7.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.136 -0.484 . . . . 4.28 110.733 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.21 -16.66 24.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 3.18 112.423 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.478 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.8 m-85 -99.63 124.92 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.71 0.291 . . . . 2.93 111.004 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -121.53 161.68 21.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 3.73 110.943 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 136' ' ' SER . . . -95.19 130.96 41.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.423 -0.353 . . . . 2.93 110.973 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -68.85 107.68 3.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 3.64 111.605 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.54 12.01 56.34 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.749 -0.66 . . . . 3.27 112.578 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 133' ' ' ALA . 4.7 t -130.14 145.6 51.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.128 -0.323 . . . . 3.59 110.128 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -128.55 166.97 17.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.329 -0.396 . . . . 6.05 110.334 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.95 120.74 6.95 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.756 -0.735 . . . . 5.22 111.567 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 146.66 -122.67 1.65 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.664 -0.779 . . . . 5.91 111.963 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 119.02 -0.514 . . . . 7.27 111.163 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.649 1 C4'-C3'-C2' 97.108 -5.592 . 0.0 '__' . 12.52 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.548 2 N19-C1'-C2' 103.556 -6.153 . 0.232 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.725 3 O4'-C1'-N19 115.758 7.558 . 0.526 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.265 4 O4'-C1'-N19 116.758 8.558 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.117 2 C4'-C3'-C2' 97.509 -5.191 . 0.655 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.711 4 C4'-C3'-C2' 98.261 -4.439 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.316 3 P-O3'-C3' 127.061 6.134 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.843 " H5'" HG23 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.581 5.308 3 O4'-C4'-C3' 114.89 6.707 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.106 2 O4'-C1'-N19 118.645 10.445 . 0.416 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.555 3 O3'-P-O5' 116.363 6.507 . 0.459 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.07 1 C4'-C3'-C2' 98.309 -4.391 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.536 1 C4'-C3'-C2' 94.402 -8.298 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.78 1 O3'-P-O5' 111.775 4.092 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.134 2 C3'-C2'-C1' 105.641 4.601 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 112.174 -0.37 . . . . 9.22 112.174 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.97 110.84 5.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.724 0.297 . . . . 8.25 110.306 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.9 mtm -94.05 84.47 4.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.153 0.502 . . . . 8.02 110.986 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.99 78.7 1.52 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.769 -0.651 . . . . 5.79 111.953 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.6 mt -77.36 138.94 63.74 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.764 0.316 . . . . 4.72 110.866 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.7 -12.25 20.18 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.656 2.237 . . . . 4.45 111.386 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -77.89 109.06 11.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.585 . . . . 4.89 110.777 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -98.43 -61.03 1.43 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.358 -0.608 . . . . 4.35 109.358 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p 49.82 65.28 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.788 1.032 . . . . 2.87 113.788 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.99 134.78 41.4 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.72 -0.474 . . . . 2.48 109.72 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 m -56.57 144.22 32.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.252 0.464 . . . . 2.57 112.252 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -69.58 -30.48 68.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.586 -0.734 . . . . 2.4 112.761 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 93.4 m-85 -108.92 167.26 10.21 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.783 0.29 . . . . 2.02 111.783 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -73.19 165.99 23.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.024 -0.535 . . . . 2.65 111.339 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -78.82 140.71 38.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.275 0.843 . . . . 2.4 113.275 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 40.6 mt -91.43 127.38 36.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.231 -1.026 . . . . 2.27 108.231 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -106.25 133.04 51.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.876 0.369 . . . . 2.86 111.692 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -96.18 144.08 26.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.716 -0.674 . . . . 2.89 109.292 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -125.69 47.27 2.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 4.07 110.693 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -162.8 -169.33 26.05 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.072 -0.585 . . . . 3.23 111.933 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -81.42 -28.96 34.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.753 0.311 . . . . 4.51 110.555 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -70.15 173.84 6.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.558 -0.746 . . . . 3.32 111.498 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.17 -156.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.375 -0.602 . . . . 2.41 109.375 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 35.8 tp -102.62 124.57 48.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.805 0.336 . . . . 2.18 111.408 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -151.5 116.88 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 2.46 110.064 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -105.33 149.62 37.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 1.78 110.557 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.45 173.31 13.4 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.066 2.51 . . . . 2.15 112.144 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -69.73 125.63 27.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.834 -0.621 . . . . 2.84 111.438 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 23.77 50.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.07 -0.586 . . . . 1.65 112.451 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.79 166.33 33.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.77 0.319 . . . . 2.57 110.188 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.36 2.86 50.83 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.895 -0.669 . . . . 1.42 113.156 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.16 121.04 63.2 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 110.203 -0.295 . . . . 1.09 110.203 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.03 178.88 5.41 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.707 2.271 . . . . 1.27 112.033 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.1 mt -76.06 86.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 1.7 110.607 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -88.94 79.91 7.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 1.23 110.523 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -17.06 56.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.96 110.82 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -74.79 -21.82 59.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 2.0 111.235 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.71 173.77 6.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.44 111.747 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.505 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 21.9 m -90.61 166.19 20.25 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 2.06 109.998 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.5 Cg_endo -51.92 -38.28 68.35 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.163 2.576 . . . . 1.42 113.763 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.71 -19.14 61.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.711 0.263 . . . . 1.78 111.711 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.69 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.0 m-20 -88.17 4.1 46.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 1.6 110.969 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -80.38 51.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.176 0.512 . . . . 1.19 111.246 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.649 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -148.36 132.9 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.065 -0.516 . . . . 1.17 110.033 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.95 -146.34 5.27 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.192 -1.004 . . . . 0.61 112.632 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -156.15 162.23 40.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.587 0.232 . . . . 1.13 110.468 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -104.04 136.46 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.425 -0.583 . . . . 1.69 109.425 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -111.94 125.78 54.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 2.51 111.0 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -78.28 131.76 37.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.247 -0.433 . . . . 2.62 109.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.82 138.08 28.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 2.21 111.601 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.29 96.19 3.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.541 -0.754 . . . . 2.68 110.489 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HB3' HD13 ' A' ' 64' ' ' LEU . 22.6 tpt180 -68.5 120.92 15.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.212 0.529 . . . . 3.78 111.001 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -139.45 110.44 6.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.888 -0.596 . . . . 3.58 111.039 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.47 168.07 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 4.26 110.816 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.57 118.42 32.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 5.46 111.298 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.19 156.99 20.93 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.922 -0.656 . . . . 4.66 112.086 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.1 -31.8 72.43 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.399 -0.429 . . . . 5.04 112.608 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.32 -10.39 59.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.261 0.553 . . . . 5.51 110.248 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.61 -4.08 46.63 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.593 -1.003 . . . . 4.73 110.593 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -70.34 148.25 48.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.128 -0.536 . . . . 5.75 110.304 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.4 mtt -143.12 136.98 28.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.031 -0.531 . . . . 4.48 109.989 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -59.12 -48.87 80.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.3 -0.63 . . . . 4.47 109.3 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.9 t70 55.41 97.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.333 1.234 . . . . 4.09 114.333 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.433 HD13 ' HB3' ' A' ' 52' ' ' ARG . 38.5 mt -88.61 153.65 20.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 3.36 110.221 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -73.54 159.71 83.99 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 3.47 110.892 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.08 110.17 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.858 2.372 . . . . 2.69 112.134 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 28.7 mtt-85 -120.44 148.63 43.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.728 -0.669 . . . . 3.22 111.494 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -121.53 137.46 54.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.072 -0.513 . . . . 1.95 110.49 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.54 148.56 34.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.427 -0.583 . . . . 2.76 109.427 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.73 123.01 37.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.991 0.424 . . . . 1.4 111.642 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -119.13 162.78 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.759 -0.655 . . . . 2.07 109.791 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -102.21 155.77 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.596 -0.274 . . . . 1.28 110.644 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.4 tt -60.9 115.67 3.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.876 0.37 . . . . 1.66 111.322 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.26 38.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.841 -0.695 . . . . 1.66 114.53 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.6 p -56.48 119.9 6.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 117.599 0.699 . . . . 1.62 111.375 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.95 112.42 3.67 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.928 -0.654 . . . . 1.96 111.601 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.06 -36.05 98.28 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 122.738 2.292 . . . . 2.62 112.389 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.02 28.44 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 3.09 111.281 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -55.64 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.153 -0.476 . . . . 1.87 110.43 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.73 48.5 49.11 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.973 -0.851 . . . . 1.7 110.973 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.7 mt -116.5 94.46 43.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 112.192 0.441 . . . . 1.43 112.192 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 87.4 Cg_endo -87.01 158.7 8.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.689 2.259 . . . . 1.62 110.389 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.452 ' HB2' HD11 ' A' ' 73' ' ' LEU . 48.4 t80 -58.86 115.17 2.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 1.75 111.112 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.76 -11.1 18.45 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.737 -0.744 . . . . 1.44 112.66 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.423 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -66.87 130.62 43.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 1.25 110.83 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -95.09 132.65 39.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.247 -0.433 . . . . 2.21 111.053 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -158.38 152.94 24.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.152 -0.685 . . . . 2.11 109.152 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.74 112.53 3.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.873 0.368 . . . . 1.7 111.606 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.97 28.71 27.86 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.32 112.602 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.6 mm -132.78 106.81 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 1.06 110.803 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.7 pt -118.7 127.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.995 -0.372 . . . . 1.3 109.995 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -85.53 139.52 31.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.966 0.728 . . . . 1.08 112.966 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 m -136.22 140.55 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.19 -0.914 . . . . 1.04 110.034 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.79 159.28 44.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.152 -0.476 . . . . 1.27 110.168 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 t -135.52 172.41 13.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 1.58 109.828 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.22 126.31 27.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.371 -0.377 . . . . 2.64 110.76 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.69 -10.5 38.32 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.649 . . . . 1.63 112.195 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.649 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.68 132.19 35.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.645 0.259 . . . . 1.59 111.342 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.0 mt -92.27 139.77 30.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.248 -0.433 . . . . 2.15 111.201 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -85.84 85.3 7.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 2.3 111.231 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.544 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 9.7 t -167.72 140.29 2.64 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.049 -0.723 . . . . 2.69 109.049 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.19 133.36 52.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.917 2.411 . . . . 2.08 113.038 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.69 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.33 67.53 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 1.99 110.968 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.3 6.97 7.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 2.55 112.48 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -59.78 -22.75 62.57 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.019 0.377 . . . . 2.28 112.019 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.92 -18.27 7.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.258 0.552 . . . . 2.0 109.905 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.88 70.56 3.16 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.308 -0.717 . . . . 2.33 111.308 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.9 t -149.33 19.67 0.95 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.677 0.751 . . . . 3.21 109.411 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -77.88 135.76 37.95 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.65 -0.704 . . . . 3.03 111.404 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -111.95 118.81 45.7 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.239 -0.652 . . . . 3.75 109.239 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.15 -23.69 74.53 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.061 2.508 . . . . 3.39 113.206 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.46 -1.66 57.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 4.05 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -132.08 14.62 4.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.397 -0.365 . . . . 4.78 110.951 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -177.97 135.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.898 -0.592 . . . . 3.41 110.398 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.1 144.15 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.507 -0.553 . . . . 3.21 109.507 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.434 ' HB2' " H4'" ' C' ' 8' ' ' ' G' . . . -69.74 144.74 52.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 3.0 111.205 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 21.5 mt -86.21 140.81 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.779 -0.646 . . . . 2.42 109.475 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.05 128.12 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.879 -0.415 . . . . 2.74 109.879 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.45 110.8 1.36 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 2.19 111.623 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -116.29 134.07 55.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.621 -0.718 . . . . 2.49 110.039 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 29.7 mt -98.9 145.48 30.04 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.424 -0.353 . . . . 1.96 110.556 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.9 155.29 71.4 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.441 2.094 . . . . 1.84 111.942 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -61.62 111.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.0 -0.545 . . . . 2.77 110.693 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.98 -17.42 8.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.126 -1.19 . . . . 2.2 110.126 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 89.7 m -108.86 112.81 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.102 -0.703 . . . . 2.1 109.102 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.23 150.09 31.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 2.87 111.358 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.5 mt -78.14 147.08 72.44 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 2.62 110.28 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.53 153.69 69.62 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.757 2.305 . . . . 2.77 110.862 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -59.44 122.21 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 4.28 111.295 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.77 -9.85 40.85 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.014 -0.613 . . . . 3.18 112.255 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -102.84 134.65 45.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.766 0.317 . . . . 2.93 111.751 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -146.26 143.41 29.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 3.73 110.49 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.95 134.87 34.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.781 0.325 . . . . 2.93 110.662 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.67 123.74 19.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.05 -0.523 . . . . 3.64 110.529 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.81 -12.77 46.07 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.012 -0.613 . . . . 3.27 112.234 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.3 m -85.62 111.17 19.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.639 0.257 . . . . 3.59 111.194 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -100.69 111.4 23.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.344 -0.389 . . . . 6.05 109.984 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.66 150.05 51.7 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.806 -0.634 . . . . 5.22 112.761 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.92 -122.81 7.73 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.873 -0.68 . . . . 5.91 111.771 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 119.04 -0.505 . . . . 7.27 111.24 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.401 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.491 -3.677 1 C4'-C3'-C2' 97.077 -5.623 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.401 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.539 2 N19-C1'-C2' 103.497 -6.189 . 0.23 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.777 3 O4'-C1'-N19 115.778 7.578 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.144 4 O4'-C1'-N19 116.713 8.513 . 0.508 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.376 -4.013 2 C4'-C3'-C2' 97.596 -5.104 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.799 4 C4'-C3'-C2' 98.255 -4.445 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.499 5.435 3 P-O3'-C3' 127.106 6.172 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.434 " H4'" ' HB2' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.345 3 O4'-C4'-C3' 114.957 6.755 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -4.995 2 O4'-C1'-N19 118.626 10.426 . 0.417 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.589 3 O3'-P-O5' 116.345 6.498 . 0.459 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.14 1 C4'-C3'-C2' 98.257 -4.443 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.556 1 C4'-C3'-C2' 94.305 -8.395 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.719 1 O3'-P-O5' 111.761 4.085 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.963 2 C3'-C2'-C1' 105.649 4.61 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 112.303 -0.319 . . . . 9.22 112.303 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.14 136.84 34.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.163 -0.31 . . . . 8.25 110.163 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.2 tpt -120.99 131.7 54.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.18 0.514 . . . . 8.02 111.226 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.82 145.4 13.71 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.841 -0.695 . . . . 5.79 111.764 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.91 105.78 46.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.048 -0.352 . . . . 4.72 110.048 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.91 36.66 0.62 Allowed 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.213 2.609 . . . . 4.45 111.983 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -86.86 135.63 33.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.585 . . . . 4.89 110.464 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -111.57 -82.7 0.58 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.349 -0.387 . . . . 4.35 110.579 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p 51.39 76.46 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.241 0.543 . . . . 2.87 112.403 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.89 150.84 21.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.879 -0.6 . . . . 2.48 111.374 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -79.26 167.41 20.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.879 -0.6 . . . . 2.57 110.821 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.464 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 31.3 m95 -92.91 -45.57 7.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 2.4 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -88.66 159.74 17.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.866 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 p -66.92 157.41 33.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 2.65 110.797 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -74.81 139.99 43.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.928 0.394 . . . . 2.4 111.321 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 95.6 mt -93.16 138.59 31.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.92 -0.582 . . . . 2.27 109.787 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -109.78 124.89 52.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.06 0.457 . . . . 2.86 111.897 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -97.39 124.3 41.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 2.89 110.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -116.82 92.61 3.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.115 -0.493 . . . . 4.07 110.104 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.77 -166.16 38.73 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.469 -0.872 . . . . 3.23 112.093 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -87.98 -22.2 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 4.51 111.211 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -87.79 171.25 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.137 -0.483 . . . . 3.32 110.652 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 13.3 t0 -102.63 -90.51 0.36 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 2.41 110.795 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 31.2 tp -169.27 129.64 1.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.766 0.317 . . . . 2.18 110.841 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -150.89 133.08 15.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 2.46 110.508 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -118.75 134.13 23.57 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.102 -0.499 . . . . 1.78 110.184 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.62 176.05 8.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.024 2.483 . . . . 2.15 112.56 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -58.92 126.87 29.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 2.84 112.102 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.17 20.63 75.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.182 -0.533 . . . . 1.65 113.339 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -141.52 153.32 44.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.065 -0.346 . . . . 2.57 110.065 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.5 -13.51 9.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.42 112.092 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.5 t -95.66 111.55 56.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.761 0.315 . . . . 1.09 110.37 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.25 -166.91 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.743 2.295 . . . . 1.27 111.648 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -79.66 88.4 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.166 0.508 . . . . 1.7 111.436 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -98.55 91.89 5.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.214 0.531 . . . . 1.23 109.655 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.15 2.67 55.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.84 0.682 . . . . 1.96 112.84 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -100.87 21.32 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.186 0.517 . . . . 2.0 111.274 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.7 m -148.84 174.77 11.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.841 -0.618 . . . . 1.44 110.075 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.445 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 17.6 m -84.36 166.09 34.77 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.885 -0.413 . . . . 2.06 109.885 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 18.8 Cg_endo -59.03 -22.54 64.25 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.663 2.242 . . . . 1.42 113.321 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.558 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 1.5 p-10 -89.53 -10.68 45.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.312 . . . . 1.78 111.709 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.561 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 23.6 m-20 -85.87 -0.93 56.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.6 110.144 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -79.09 59.2 2.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.987 -0.551 . . . . 1.19 111.419 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.744 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.7 tt -151.89 133.5 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.17 110.092 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.97 -142.45 4.41 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.03 -1.081 . . . . 0.61 112.637 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -160.17 159.24 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.006 0.432 . . . . 1.13 110.527 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.577 ' HH ' HD11 ' A' ' 119' ' ' LEU . 5.1 m-85 -99.8 135.7 40.83 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.434 -0.58 . . . . 1.69 109.434 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -111.73 128.22 56.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.323 -0.399 . . . . 2.51 111.061 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.5 128.41 34.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.949 -0.569 . . . . 2.62 109.726 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.79 157.86 44.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.02 0.438 . . . . 2.21 111.498 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -148.47 125.75 11.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.214 -0.661 . . . . 2.68 109.214 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -112.25 134.84 53.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.381 . . . . 3.78 111.154 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -149.32 121.36 8.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.501 -0.318 . . . . 3.58 110.833 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 pt -92.7 136.27 25.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.789 -0.449 . . . . 4.26 109.789 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.72 113.61 27.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.26 -0.427 . . . . 5.46 110.699 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.0 151.03 40.07 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.541 -0.838 . . . . 4.66 111.326 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.47 -28.34 69.38 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 121.253 -0.498 . . . . 5.04 112.003 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.09 -31.55 69.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.159 0.505 . . . . 5.51 110.556 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.05 10.51 6.77 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.633 -0.794 . . . . 4.73 111.899 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -86.47 135.67 33.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.887 0.375 . . . . 5.75 110.834 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.1 mmt -114.76 115.31 26.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.19 -0.671 . . . . 4.48 109.19 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HG2' ' H42' ' B' ' 1' ' ' ' C' . 77.2 tttt -54.62 -51.69 64.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.078 -0.341 . . . . 4.47 110.078 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.9 t70 63.9 115.22 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.767 1.025 . . . . 4.09 113.767 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD22 ' H5 ' ' B' ' 1' ' ' ' C' . 27.1 mt -109.84 -179.13 3.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.855 -0.612 . . . . 3.36 110.639 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -102.83 155.44 36.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.079 -0.51 . . . . 3.47 110.224 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.3 109.91 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.518 2.145 . . . . 2.69 111.526 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.446 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 59.4 mtt180 -113.0 145.95 39.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.105 0.479 . . . . 3.22 112.055 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.547 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.2 m95 -113.36 132.72 55.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.64 -0.709 . . . . 1.95 110.508 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.559 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 44.8 m-85 -110.4 141.57 43.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 2.76 109.929 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.77 116.01 28.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 1.4 111.49 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -115.6 156.6 25.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.034 -0.53 . . . . 2.07 110.162 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -96.52 162.55 13.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.459 -0.337 . . . . 1.28 110.635 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.9 OUTLIER -64.13 117.27 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.428 -0.351 . . . . 1.66 110.803 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.97 7.81 37.7 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.806 -0.712 . . . . 1.66 113.679 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -70.11 120.83 16.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 1.62 111.496 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.44 122.82 4.27 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.14 -0.784 . . . . 1.96 111.14 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.03 -56.64 2.6 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.07 2.514 . . . . 2.62 112.7 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.16 42.66 1.33 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 3.09 110.912 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.89 -54.1 14.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 1.87 110.014 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.62 38.51 96.53 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.649 -0.705 . . . . 1.7 112.223 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.48 101.93 48.36 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.751 0.31 . . . . 1.43 111.047 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.05 159.95 18.16 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.707 2.271 . . . . 1.62 111.258 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.457 ' HB2' HD11 ' A' ' 73' ' ' LEU . 51.2 t80 -56.74 113.46 1.65 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.421 -0.354 . . . . 1.75 110.688 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.67 -12.09 13.65 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.653 -0.784 . . . . 1.44 112.939 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.05 114.1 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 1.25 110.914 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -74.85 120.93 21.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.516 . . . . 2.21 111.396 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -143.84 151.71 40.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 2.11 110.041 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.37 115.52 4.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.89 0.376 . . . . 1.7 111.733 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.1 26.43 60.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.881 -0.676 . . . . 1.32 112.665 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -130.0 103.17 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.944 0.402 . . . . 1.06 110.6 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.0 pt -111.52 119.91 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.283 -0.417 . . . . 1.3 110.675 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -79.44 137.53 37.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.08 111.55 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.62 143.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.957 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.2 165.6 32.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.487 . . . . 1.27 110.003 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -134.82 -177.47 4.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.258 -0.428 . . . . 1.58 109.985 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.58 120.1 14.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.167 0.508 . . . . 2.64 110.938 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.02 -9.15 39.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.05 -0.595 . . . . 1.63 111.795 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.744 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.17 121.84 20.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.747 0.308 . . . . 1.59 110.387 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 53.8 mt -89.39 146.38 24.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 2.15 109.982 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -79.73 69.03 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.536 . . . . 2.3 109.874 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 m -135.34 136.28 24.06 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 2.69 109.792 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -81.2 119.21 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.926 2.417 . . . . 2.08 110.855 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.65 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -135.73 102.9 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.559 . . . . 1.99 111.143 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.13 4.1 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.968 -0.56 . . . . 2.55 111.924 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.65 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 12.3 p80 -57.75 -24.3 56.38 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.058 0.456 . . . . 2.28 112.102 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -105.36 5.33 10.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.178 -0.465 . . . . 2.0 111.129 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.61 46.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 2.33 111.64 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -146.56 28.62 1.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.315 0.579 . . . . 3.21 110.748 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.464 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 38.3 ttp85 -69.24 141.2 54.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 3.03 111.27 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -94.92 113.0 60.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.065 -0.516 . . . . 3.75 109.731 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.453 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 73.6 Cg_endo -74.35 -12.99 23.06 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.045 2.497 . . . . 3.39 114.246 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.1 -15.22 44.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.102 0.477 . . . . 4.05 110.884 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -110.39 -9.32 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 4.78 111.546 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -153.01 138.67 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.718 0.294 . . . . 3.41 110.709 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.56 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 3.21 111.583 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.87 149.89 49.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 3.0 111.444 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.3 mt -91.02 138.62 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.807 -0.633 . . . . 2.42 110.258 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.23 119.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.377 -0.601 . . . . 2.74 109.377 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.577 HD11 ' HH ' ' A' ' 47' ' ' TYR . 1.4 tt -61.0 128.3 35.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 2.19 110.82 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -132.57 142.96 49.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.84 -0.618 . . . . 2.49 110.429 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 mt -105.62 145.69 31.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.075 -0.511 . . . . 1.96 110.19 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.78 167.27 10.48 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.991 2.461 . . . . 1.84 112.48 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.73 121.64 14.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 2.77 110.845 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.48 -18.91 34.79 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.762 . . . . 2.2 111.934 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.9 m -94.25 99.16 11.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.099 0.476 . . . . 2.1 110.234 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.11 156.22 16.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.997 -0.547 . . . . 2.87 111.24 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.84 146.17 31.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 2.62 109.755 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.0 152.67 73.86 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.608 2.206 . . . . 2.77 111.889 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.97 120.49 11.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 4.28 110.684 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 109.26 -8.15 32.86 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.724 -0.751 . . . . 3.18 111.55 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 2.7 t80 -94.15 132.08 39.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.189 -0.3 . . . . 2.93 110.189 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -134.65 146.84 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.865 0.365 . . . . 3.73 111.462 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.29 148.63 38.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.812 -0.631 . . . . 2.93 110.597 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.21 122.72 28.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 3.64 109.838 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.19 14.47 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.941 -0.647 . . . . 3.27 111.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m -75.22 89.26 2.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 3.59 110.615 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -118.62 81.5 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 6.05 110.146 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.53 144.84 18.58 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.903 -0.665 . . . . 5.22 111.828 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.6 -80.07 1.83 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.855 -0.688 . . . . 5.91 112.306 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.969 -0.539 . . . . 7.27 111.295 -179.878 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.479 ' H5 ' HD22 ' A' ' 64' ' ' LEU . . . . . . . . 0 C2'--C1' 1.492 -3.605 1 C4'-C3'-C2' 97.044 -5.656 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.4 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.548 2 N19-C1'-C2' 103.537 -6.165 . 0.23 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.81 3 O4'-C1'-N19 115.647 7.447 . 0.527 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.268 4 O4'-C1'-N19 116.661 8.461 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.144 2 C4'-C3'-C2' 97.575 -5.125 . 0.652 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.699 4 N19-C1'-C2' 106.33 -4.419 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.314 3 P-O3'-C3' 127.063 6.136 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.559 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.582 5.353 3 O4'-C4'-C3' 114.962 6.759 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.541 -5.161 2 O4'-C1'-N19 118.644 10.444 . 0.418 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.523 3 O3'-P-O5' 116.341 6.495 . 0.46 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.237 1 C4'-C3'-C2' 98.248 -4.452 . 0.311 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.533 1 C4'-C3'-C2' 94.373 -8.327 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.77 1 O3'-P-O5' 111.738 4.073 . 0.104 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.017 2 C3'-C2'-C1' 105.716 4.685 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.509 -0.636 . . . . 9.22 111.509 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.63 153.67 26.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.623 0.249 . . . . 8.25 110.832 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.4 ttm -148.47 129.96 14.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.14 -0.482 . . . . 8.02 110.208 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.85 160.89 27.64 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.619 -0.592 . . . . 5.79 111.619 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.5 mt -104.88 147.38 34.37 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.778 -0.453 . . . . 4.72 109.778 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.64 31.28 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.285 2.657 . . . . 4.45 111.843 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -109.72 176.86 4.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.144 -0.48 . . . . 4.89 109.927 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -80.06 -80.74 0.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.713 -0.221 . . . . 4.35 110.936 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.4 p 48.66 79.76 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.712 0.634 . . . . 2.87 112.712 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.38 145.62 29.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 2.48 111.403 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 m -71.33 152.76 42.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 2.57 110.653 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -86.58 -27.94 23.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.794 0.331 . . . . 2.4 111.199 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.92 164.04 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.327 -0.397 . . . . 2.02 111.945 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.567 HG23 " H5'" ' C' ' 8' ' ' ' G' . 1.5 p -63.22 166.01 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 2.65 111.779 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.0 150.4 22.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.226 -0.443 . . . . 2.4 111.408 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.21 136.42 41.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 2.27 110.305 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.423 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 13.4 m -106.65 132.77 52.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.756 0.312 . . . . 2.86 111.397 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -99.79 133.42 44.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 2.89 110.761 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -127.68 82.74 2.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.702 -0.481 . . . . 4.07 109.702 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.82 -160.9 26.34 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.444 -0.663 . . . . 3.23 111.444 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -99.34 9.51 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.0 0.429 . . . . 4.51 111.122 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -112.99 -173.88 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.816 -0.629 . . . . 3.32 110.297 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.25 -73.69 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.367 -0.379 . . . . 2.41 109.981 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.435 HD12 ' CE1' ' A' ' 131' ' ' PHE . 32.0 tp 178.32 125.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.587 0.554 . . . . 2.18 110.382 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -146.58 121.58 10.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 2.46 110.792 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -108.45 154.45 41.49 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.631 . . . . 1.78 109.896 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.629 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 58.4 Cg_endo -73.08 -163.16 0.15 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.761 2.307 . . . . 2.15 113.076 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -86.01 125.45 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 2.84 111.678 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.3 18.96 75.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.87 -0.604 . . . . 1.65 113.19 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.629 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.3 tm0? -142.16 132.98 25.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.766 -0.457 . . . . 2.57 109.766 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.04 -9.12 2.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.413 -0.899 . . . . 1.42 112.334 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.06 124.24 65.45 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.215 -0.291 . . . . 1.09 110.215 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.48 179.43 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.482 2.122 . . . . 1.27 112.204 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mt -75.51 88.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 1.7 110.602 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.34 80.18 9.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.119 0.485 . . . . 1.23 110.545 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -21.18 66.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 1.96 111.872 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -89.05 3.7 50.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.418 -0.355 . . . . 2.0 111.679 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 m -128.45 162.27 27.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.734 0.302 . . . . 1.44 111.417 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.59 165.71 38.45 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 2.06 109.963 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.44 -25.8 79.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.539 2.159 . . . . 1.42 111.958 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.685 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -89.16 -1.51 58.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 1.78 111.382 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -98.39 -1.38 41.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 1.6 110.243 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -77.49 60.5 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 1.19 111.552 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.71 121.11 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 1.17 109.953 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.1 -145.93 4.81 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.495 -0.86 . . . . 0.61 112.802 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -157.55 164.82 36.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.043 0.449 . . . . 1.13 111.106 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.545 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.9 m-85 -108.31 137.28 46.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.46 -0.791 . . . . 1.69 109.518 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -118.16 130.65 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.384 -0.371 . . . . 2.51 110.981 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -86.8 116.34 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.184 -0.462 . . . . 2.62 110.266 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.78 148.31 44.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.263 -0.426 . . . . 2.21 110.647 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -132.88 109.38 9.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.21 -0.45 . . . . 2.68 110.682 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HB3' HD13 ' A' ' 64' ' ' LEU . 20.9 tpt180 -86.37 113.74 22.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 3.78 110.874 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -138.63 91.24 2.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 3.58 110.934 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.404 ' O ' ' HG2' ' A' ' 61' ' ' MET . 28.9 pt -70.46 146.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 4.26 111.01 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -106.7 103.37 12.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 5.46 110.492 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.561 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -75.33 160.43 52.28 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.125 -0.56 . . . . 4.66 112.907 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.37 -23.19 71.67 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.58 -0.343 . . . . 5.04 113.489 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -92.77 14.29 17.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.177 0.513 . . . . 5.51 110.868 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.36 35.55 63.45 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.96 -0.638 . . . . 4.73 111.562 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -113.67 158.88 20.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.022 -0.362 . . . . 5.75 110.022 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 76.5 mtm -139.77 143.41 36.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.259 -0.428 . . . . 4.48 110.251 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -67.8 -29.29 68.43 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.847 -0.797 . . . . 4.47 108.847 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t0 52.39 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.02 1.118 . . . . 4.09 114.02 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 52' ' ' ARG . 88.5 mt -106.07 140.25 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.015 -0.539 . . . . 3.36 110.064 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.92 150.61 96.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.526 . . . . 3.47 110.896 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.59 120.04 7.66 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.57 2.18 . . . . 2.69 111.438 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.75 144.85 39.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.691 -0.686 . . . . 3.22 111.198 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.545 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 65.9 m95 -104.67 124.87 50.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.804 -0.634 . . . . 1.95 110.895 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.41 143.49 35.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.682 . . . . 2.76 109.871 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -95.23 127.28 41.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.816 0.341 . . . . 1.4 110.917 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.31 153.52 47.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.08 -0.509 . . . . 2.07 110.128 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -84.46 163.14 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.9 tt -59.67 122.89 15.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.695 0.283 . . . . 1.66 111.759 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.6 20.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.003 -0.618 . . . . 1.66 112.634 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.66 70.85 7.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.914 0.388 . . . . 1.62 111.486 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.41 148.36 4.76 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.015 -0.612 . . . . 1.96 111.744 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.0 -47.2 11.06 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.79 2.326 . . . . 2.62 111.867 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.8 45.61 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.58 . . . . 3.09 111.257 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.0 -56.13 4.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 1.87 110.463 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.67 52.98 47.18 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.646 -0.582 . . . . 1.7 111.646 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.415 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 57.9 mt -132.72 100.0 15.06 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 111.579 0.215 . . . . 1.43 111.579 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 74.0 Cg_endo -78.93 162.79 26.29 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.16 1.907 . . . . 1.62 110.257 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.99 104.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 1.75 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.43 10.22 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.591 -0.814 . . . . 1.44 112.233 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.544 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -59.13 114.64 2.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.74 0.305 . . . . 1.25 110.891 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -78.9 104.56 9.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 2.21 112.023 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -126.15 150.88 47.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.692 -0.855 . . . . 2.11 108.692 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -63.44 118.33 7.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.939 0.399 . . . . 1.7 111.975 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.38 57.67 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.703 -0.68 . . . . 1.32 112.502 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.8 118.14 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.723 0.297 . . . . 1.06 110.383 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.4 pt -121.78 122.74 67.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.389 -0.369 . . . . 1.3 110.222 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.415 ' HZ2' ' HB3' ' A' ' 81' ' ' LEU . 87.7 m95 -86.55 138.24 31.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.014 0.376 . . . . 1.08 112.014 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.61 142.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 1.04 110.612 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.27 -177.78 6.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 1.27 109.605 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 t -148.74 169.7 19.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.32 -0.252 . . . . 1.58 110.32 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.6 128.16 34.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.385 -0.371 . . . . 2.64 111.076 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.98 -24.3 23.55 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.785 -0.721 . . . . 1.63 111.823 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.11 133.02 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 1.59 110.487 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 94.2 mt -94.45 133.77 37.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.314 -0.403 . . . . 2.15 110.849 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -75.98 96.57 3.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.3 110.337 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.21 150.03 6.89 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.734 -0.666 . . . . 2.69 109.416 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.54 125.21 18.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.816 2.344 . . . . 2.08 112.534 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -113.21 34.64 4.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 1.99 109.744 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.6 -30.58 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.548 0.573 . . . . 2.55 112.548 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -64.28 -8.94 14.51 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.81 0.671 . . . . 2.28 112.81 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.6 mt -109.11 0.58 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 2.0 109.822 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.05 -11.16 59.05 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.736 -0.745 . . . . 2.33 112.424 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 t -80.63 123.45 28.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.437 . . . . 3.21 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -164.37 146.15 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 3.03 109.806 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -107.42 106.93 59.62 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.84 0.352 . . . . 3.75 110.218 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.47 -21.4 26.13 Favored 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 122.862 2.375 . . . . 3.39 113.928 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.21 -14.04 59.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.104 0.409 . . . . 4.05 112.104 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -117.3 -18.51 9.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.201 -0.454 . . . . 4.78 111.408 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -140.72 131.2 25.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 3.41 111.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.472 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -83.26 163.99 20.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.193 -0.458 . . . . 3.21 110.332 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.74 165.65 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.037 0.446 . . . . 3.0 111.003 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -95.25 152.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.323 -0.621 . . . . 2.42 109.323 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.49 118.44 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.176 -0.305 . . . . 2.74 110.176 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.477 HD11 ' HH ' ' A' ' 47' ' ' TYR . 5.0 tt -63.13 114.31 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.278 0.561 . . . . 2.19 110.912 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.81 144.13 51.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.591 -0.731 . . . . 2.49 110.324 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 82.3 mt -95.02 148.17 34.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.088 -0.505 . . . . 1.96 110.216 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.23 159.74 45.59 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.576 2.184 . . . . 1.84 112.215 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -53.0 119.7 4.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 2.77 111.521 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.11 4.79 47.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.769 -0.729 . . . . 2.2 112.231 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.9 m -117.73 110.14 17.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.808 0.337 . . . . 2.1 110.227 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.34 137.7 40.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.159 -0.473 . . . . 2.87 111.42 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -70.61 140.92 87.22 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 116.199 -0.455 . . . . 2.62 109.825 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.74 148.97 62.49 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.963 2.442 . . . . 2.77 112.355 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.46 124.87 21.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 4.28 110.718 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.6 -12.55 39.11 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.315 -0.714 . . . . 3.18 111.315 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.435 ' CE1' HD12 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -105.42 152.09 23.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.816 0.341 . . . . 2.93 111.114 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 16.9 p90 -151.95 157.47 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 3.73 109.215 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.13 131.1 55.39 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.188 0.305 . . . . 2.93 111.158 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -66.97 125.49 26.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.443 -0.577 . . . . 3.64 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 108.8 -38.59 3.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.997 -0.841 . . . . 3.27 110.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.8 68.33 8.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.943 0.402 . . . . 3.59 110.596 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -106.75 -5.17 18.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.291 -0.413 . . . . 6.05 110.721 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.19 146.17 4.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.876 -0.678 . . . . 5.22 111.573 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.28 36.9 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.877 -0.678 . . . . 5.91 111.841 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.772 -0.632 . . . . 7.27 111.551 -179.736 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.491 -3.714 1 C4'-C3'-C2' 97.0 -5.7 . 0.0 '__' . 12.52 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.473 4.608 2 N19-C1'-C2' 103.488 -6.195 . 0.235 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.809 3 O4'-C1'-N19 115.769 7.569 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.201 4 O4'-C1'-N19 116.692 8.492 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.156 2 C4'-C3'-C2' 97.542 -5.158 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.607 4 C1'-O4'-C4' 105.619 -4.424 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.499 5.396 3 P-O3'-C3' 127.073 6.144 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.567 " H5'" HG23 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.582 5.435 3 O4'-C4'-C3' 114.938 6.742 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.934 2 O4'-C1'-N19 118.65 10.45 . 0.415 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.576 3 O3'-P-O5' 116.388 6.52 . 0.46 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.125 1 C4'-C3'-C2' 98.29 -4.41 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.583 1 C4'-C3'-C2' 94.294 -8.406 . 0.451 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.561 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.588 5.809 1 O3'-P-O5' 111.76 4.084 . 0.106 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.926 2 C3'-C2'-C1' 105.772 4.747 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.976 0 N-CA-C 111.853 -0.499 . . . . 9.22 111.853 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.04 122.2 46.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.237 -0.283 . . . . 8.25 110.237 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 ttt -136.52 126.76 26.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.067 0.461 . . . . 8.02 111.715 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.18 158.08 16.88 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.233 -0.747 . . . . 5.79 111.233 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.06 133.38 23.42 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.755 0.312 . . . . 4.72 110.711 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.48 28.13 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.791 2.994 . . . . 4.45 113.641 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -108.11 133.96 51.66 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.52 -0.548 . . . . 4.89 109.52 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -79.87 -88.59 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.292 -0.413 . . . . 4.35 111.355 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m 65.15 75.13 0.37 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.969 0.414 . . . . 2.87 111.341 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.01 140.57 43.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 2.48 110.687 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.48 ' HG ' ' HD1' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -67.41 153.77 42.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.944 -0.571 . . . . 2.57 110.971 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -79.51 -18.82 51.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.053 0.454 . . . . 2.4 111.112 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -110.19 161.08 15.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.127 -0.488 . . . . 2.02 112.016 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 p -67.51 167.56 12.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.788 -0.642 . . . . 2.65 111.268 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -79.65 152.82 29.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.096 0.474 . . . . 2.4 111.408 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.431 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 76.8 mt -108.65 129.91 55.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 2.27 109.072 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.419 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -103.3 144.67 31.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.422 0.527 . . . . 2.86 112.422 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.503 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 5.0 tp-100 -112.21 134.72 53.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 2.89 110.158 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -125.85 69.36 1.19 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.057 -0.52 . . . . 4.07 109.826 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -172.76 -165.74 30.24 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.999 -0.62 . . . . 3.23 111.737 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -88.21 -30.02 20.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.914 0.388 . . . . 4.51 111.544 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.58 166.46 22.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 3.32 110.202 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -99.77 -90.05 0.32 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.014 -0.365 . . . . 2.41 110.014 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -159.26 134.97 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 2.18 111.018 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -151.51 134.58 15.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.733 -0.667 . . . . 2.46 109.457 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -130.73 134.54 26.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.447 -0.342 . . . . 1.78 110.405 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.46 156.53 55.92 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.985 2.457 . . . . 2.15 111.351 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.86 118.14 5.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.372 -0.377 . . . . 2.84 111.363 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.98 -9.07 57.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 1.65 111.982 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -120.71 152.25 38.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.752 0.31 . . . . 2.57 110.448 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.84 -6.07 22.26 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.698 -0.763 . . . . 1.42 112.77 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.38 116.52 66.57 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.592 0.234 . . . . 1.09 110.372 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.439 ' HA ' HD22 ' A' ' 121' ' ' LEU . 57.1 Cg_endo -71.23 177.16 6.9 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.633 2.222 . . . . 1.27 112.145 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.62 79.57 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.296 -0.411 . . . . 1.7 110.441 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -76.77 84.71 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 1.23 110.587 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -20.15 65.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 1.96 111.639 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -85.94 -11.92 51.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.199 -0.455 . . . . 2.0 111.553 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.1 150.23 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.158 0.504 . . . . 1.44 112.03 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.88 166.56 44.15 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.576 -0.738 . . . . 2.06 110.218 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.46 -40.06 79.89 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.947 2.431 . . . . 1.42 112.732 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.36 -24.84 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.977 0.418 . . . . 1.78 111.12 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.77 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 46.2 m-20 -84.82 1.53 46.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.802 -0.636 . . . . 1.6 111.829 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -80.27 57.43 2.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.89 0.376 . . . . 1.19 111.222 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 tt -153.02 134.84 5.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 116.175 -0.466 . . . . 1.17 110.394 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.83 -147.24 6.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.386 -0.911 . . . . 0.61 112.718 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -151.58 163.44 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.023 0.44 . . . . 1.13 110.698 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.572 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 37.6 m-85 -105.94 137.15 44.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.451 -0.574 . . . . 1.69 109.451 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -116.35 125.77 52.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.503 -0.317 . . . . 2.51 110.929 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -80.85 123.93 28.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.08 -0.509 . . . . 2.62 109.905 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.2 150.67 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.948 0.404 . . . . 2.21 111.841 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -149.86 96.58 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.863 -0.608 . . . . 2.68 110.469 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HB3' HD13 ' A' ' 64' ' ' LEU . 32.1 ttt85 -71.45 119.46 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 3.78 110.439 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 15.9 ttt-85 -135.72 106.31 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.127 -0.488 . . . . 3.58 110.591 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 pt -86.73 159.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.849 -0.614 . . . . 4.26 110.744 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.37 114.14 21.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.216 -0.447 . . . . 5.46 110.428 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.65 158.3 41.01 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.668 -0.777 . . . . 4.66 112.146 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.63 -22.59 69.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.344 -0.455 . . . . 5.04 112.793 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.54 -4.5 59.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.255 0.55 . . . . 5.51 110.414 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.7 2.45 67.24 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.087 -0.805 . . . . 4.73 111.087 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -79.29 141.92 36.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.934 0.397 . . . . 5.75 110.513 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 mmt -118.98 132.31 56.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.619 -0.512 . . . . 4.48 109.619 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HE3' ' O4 ' ' C' ' 13' ' ' ' U' . 75.3 tttt -66.26 -51.41 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.234 -0.654 . . . . 4.47 109.234 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 20.8 t70 63.93 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.525 0.935 . . . . 4.09 113.525 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 52' ' ' ARG . 63.7 mt -114.9 156.99 23.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 3.36 110.562 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.25 153.53 92.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.842 -0.617 . . . . 3.47 110.962 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HA ' HG22 ' A' ' 51' ' ' THR . 19.7 Cg_endo -58.57 112.89 1.33 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.804 2.336 . . . . 2.69 111.625 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 93.8 mtt180 -114.47 125.38 53.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.249 0.547 . . . . 3.22 112.016 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.572 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 41.8 m95 -98.12 131.69 44.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.632 -0.713 . . . . 1.95 109.833 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.48 ' HD1' ' HG ' ' A' ' 11' ' ' SER . 64.2 m-85 -110.69 146.34 36.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.375 -0.375 . . . . 2.76 110.382 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.08 114.73 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.874 0.368 . . . . 1.4 110.927 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -113.63 143.65 44.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 2.07 110.085 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -81.83 154.01 26.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.2 tt -58.53 118.84 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.556 -0.293 . . . . 1.66 110.448 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.71 27.57 5.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.013 -0.613 . . . . 1.66 112.732 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.49 106.29 18.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.47 -0.429 . . . . 1.62 110.726 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.67 119.86 3.01 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.211 -0.756 . . . . 1.96 111.211 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.46 -51.99 8.69 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.797 2.331 . . . . 2.62 112.206 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.1 30.5 4.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 3.09 111.336 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.96 72.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 1.87 110.27 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.89 39.08 95.04 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.784 -0.644 . . . . 1.7 112.394 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.2 mt -118.75 93.71 46.64 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.255 . . . . 1.43 111.149 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 7.5 Cg_exo -75.93 157.17 38.97 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.966 2.444 . . . . 1.62 110.377 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.503 ' HB2' HD11 ' A' ' 73' ' ' LEU . 80.8 t80 -57.32 112.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 1.75 110.708 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.7 -6.62 26.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.603 -0.808 . . . . 1.44 112.42 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.567 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -66.69 145.78 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.872 0.368 . . . . 1.25 110.682 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -98.14 129.21 44.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.327 -0.397 . . . . 2.21 110.63 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -156.05 143.46 19.29 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.003 -0.74 . . . . 2.11 109.003 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.79 122.65 16.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.777 0.322 . . . . 1.7 111.589 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 21.76 70.84 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 1.32 112.575 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.7 mm -130.99 111.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.37 . . . . 1.06 110.87 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.5 pt -118.78 143.32 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.262 -0.644 . . . . 1.3 109.262 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -98.59 141.56 31.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.934 0.716 . . . . 1.08 112.934 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.81 138.5 38.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.329 -0.85 . . . . 1.04 110.387 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.61 168.94 20.72 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.378 -0.601 . . . . 1.27 109.378 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -140.74 157.93 44.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.23 -0.285 . . . . 1.58 110.23 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.06 118.69 8.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.394 . . . . 2.64 110.186 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.109 -0.567 . . . . 1.63 111.692 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -88.46 149.0 23.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.554 0.216 . . . . 1.59 110.54 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.9 mt -104.18 140.21 38.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 -0.285 . . . . 2.15 110.85 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -79.2 99.73 7.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 2.3 111.242 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -173.33 147.37 1.43 Allowed Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.642 . . . . 2.69 109.268 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.12 114.32 3.72 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.191 1.927 . . . . 2.08 112.366 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.77 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -114.59 78.96 1.2 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.442 0.639 . . . . 1.99 110.451 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.91 -6.66 48.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.481 -0.781 . . . . 2.55 112.041 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.466 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 4.7 p80 -60.79 -15.99 35.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.378 0.51 . . . . 2.28 112.378 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.02 15.03 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.947 0.403 . . . . 2.0 111.124 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.36 15.91 53.4 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.873 -0.68 . . . . 2.33 111.957 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 t -108.28 103.03 12.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.025 0.441 . . . . 3.21 111.414 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -159.97 111.81 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.576 . . . . 3.03 110.666 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.64 122.14 76.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.783 -0.451 . . . . 3.75 109.783 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.415 ' CB ' " H4'" ' C' ' 9' ' ' ' U' . 41.1 Cg_endo -65.65 -21.04 59.54 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.202 2.601 . . . . 3.39 114.236 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.49 10.88 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.785 0.326 . . . . 4.05 111.578 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -142.06 14.95 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.082 0.468 . . . . 4.78 110.858 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -172.92 135.74 0.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 3.41 110.177 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.47 134.68 39.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.479 -0.328 . . . . 3.21 110.36 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 157.25 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.138 0.494 . . . . 3.0 111.968 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.4 mt -94.26 145.57 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.716 -0.675 . . . . 2.42 109.614 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.4 t -61.61 117.17 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.685 0.279 . . . . 2.74 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.51 121.08 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.898 -0.592 . . . . 2.19 111.24 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -137.98 150.95 47.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 2.49 110.413 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 33' ' ' PRO . 33.0 mt -103.74 150.3 38.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.242 -0.435 . . . . 1.96 110.071 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.6 150.65 80.75 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.451 2.101 . . . . 1.84 111.288 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -51.67 130.86 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.51 . . . . 2.77 111.378 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.79 -17.47 38.77 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.691 -0.766 . . . . 2.2 111.488 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.03 102.38 12.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 2.1 110.301 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 148.82 29.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.342 -0.39 . . . . 2.87 111.366 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.43 145.46 51.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.735 -0.469 . . . . 2.62 109.735 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.59 146.32 54.32 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.83 2.353 . . . . 2.77 111.918 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -60.91 112.32 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.84 -0.618 . . . . 4.28 111.93 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.88 -6.99 41.13 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.143 -0.551 . . . . 3.18 112.177 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -101.16 146.31 27.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.486 -0.191 . . . . 2.93 110.486 -179.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.419 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 11.6 p90 -155.93 165.13 37.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 3.73 110.093 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.64 136.92 38.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.814 0.34 . . . . 2.93 111.116 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -65.15 126.02 26.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 3.64 110.376 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.93 21.64 65.34 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.106 -0.569 . . . . 3.27 112.415 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.96 135.35 47.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.777 0.322 . . . . 3.59 110.168 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -110.68 101.28 9.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.185 -0.461 . . . . 6.05 110.619 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.65 121.94 7.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.782 -0.723 . . . . 5.22 111.865 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.41 -61.23 4.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.431 -0.414 . . . . 5.91 112.719 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.856 -0.593 . . . . 7.27 110.795 -179.214 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.402 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.492 -3.625 1 C4'-C3'-C2' 97.036 -5.664 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.402 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.523 2 N19-C1'-C2' 103.499 -6.188 . 0.235 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.808 3 O4'-C1'-N19 115.681 7.481 . 0.533 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.17 4 O4'-C1'-N19 116.604 8.404 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.063 2 C4'-C3'-C2' 97.543 -5.157 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.753 4 N19-C1'-C2' 106.319 -4.426 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.322 3 P-O3'-C3' 126.978 6.065 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.411 3 O4'-C4'-C3' 114.895 6.71 . 0.0 '__' . 15.4 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . 0.415 " H4'" ' CB ' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.542 -5.125 2 O4'-C1'-N19 118.686 10.486 . 0.418 1a . 14.62 . . . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.547 4 O3'-P-O5' 116.285 6.466 . 0.46 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.139 1 C4'-C3'-C2' 98.236 -4.464 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . 0.404 " H4'" HO2' ' C' ' 12' ' ' ' G' . . . . . . . . 1 C4'--C3' 1.586 5.604 1 C4'-C3'-C2' 94.341 -8.359 . 0.452 1a . 14.32 . . . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.447 ' O4 ' ' HE3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.588 5.848 1 O3'-P-O5' 111.83 4.121 . 0.105 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.079 2 C3'-C2'-C1' 105.728 4.697 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.907 -0.477 . . . . 9.22 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.36 121.09 33.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.78 0.324 . . . . 8.25 110.457 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.9 tpt -81.01 116.64 21.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.266 -0.425 . . . . 8.02 110.538 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.29 170.6 42.67 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.994 -0.622 . . . . 5.79 111.724 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.7 mt -136.94 111.7 9.48 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.327 -0.249 . . . . 4.72 110.327 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.92 56.62 5.42 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.953 2.435 . . . . 4.45 111.638 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -128.14 164.04 23.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.988 -0.551 . . . . 4.89 109.751 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -77.27 -69.94 0.5 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.411 -0.359 . . . . 4.35 110.219 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m 58.74 82.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.819 -0.628 . . . . 2.87 112.083 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.25 145.54 41.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.554 -0.748 . . . . 2.48 110.747 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.84 38.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 2.57 110.599 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -87.43 -22.76 24.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.996 0.369 . . . . 2.4 111.996 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.71 161.54 19.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 2.02 111.662 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 p -67.14 158.15 31.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 2.65 111.259 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.13 145.49 26.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 2.4 110.496 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.8 mp -99.85 152.49 20.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.456 -0.572 . . . . 2.27 109.456 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.563 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 2.0 m -109.09 128.29 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.858 0.361 . . . . 2.86 111.148 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -97.06 135.73 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 2.89 109.954 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -132.98 103.35 6.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.842 0.353 . . . . 4.07 110.375 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.07 -151.31 22.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.774 -0.726 . . . . 3.23 111.629 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -103.18 -19.25 14.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.91 0.386 . . . . 4.51 110.904 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -79.76 137.75 37.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.053 -0.721 . . . . 3.32 109.053 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 1.9 t0 -81.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.046 -0.724 . . . . 2.41 109.046 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 17.1 tp 173.07 122.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 2.18 110.98 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -144.39 123.19 12.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.104 -0.498 . . . . 2.46 109.768 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -111.55 142.14 25.96 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 1.78 110.636 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.75 164.93 27.4 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.238 2.625 . . . . 2.15 112.278 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -62.64 120.95 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 2.84 110.766 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.63 21.95 76.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.987 -0.625 . . . . 1.65 112.542 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -138.26 156.84 47.29 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.757 -0.261 . . . . 2.57 110.925 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.0 -3.92 48.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.817 -0.706 . . . . 1.42 112.719 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 120.94 79.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.602 0.239 . . . . 1.09 110.452 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.79 174.93 10.36 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.646 2.231 . . . . 1.27 111.577 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mt -81.83 83.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.857 0.36 . . . . 1.7 110.376 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -79.08 91.76 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 1.23 109.908 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -17.76 60.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 1.96 112.092 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -89.51 -18.72 26.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.042 0.386 . . . . 2.0 112.042 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.44 160.3 14.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.69 0.281 . . . . 1.44 111.673 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.4 m -80.94 168.52 24.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.09 -0.505 . . . . 2.06 110.02 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.19 -39.02 93.59 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.462 2.108 . . . . 1.42 112.09 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.9 p-10 -85.05 -1.53 56.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 1.78 111.105 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.3 0.12 44.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.805 -0.634 . . . . 1.6 110.212 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -79.43 57.52 2.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 1.19 110.814 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 tt -146.15 130.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 1.17 109.728 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.14 -148.03 5.88 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.297 -0.954 . . . . 0.61 112.404 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -153.84 152.96 31.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.802 0.334 . . . . 1.13 111.806 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -100.16 117.64 34.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.525 -0.917 . . . . 1.69 108.525 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -96.9 131.09 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.991 0.424 . . . . 2.51 111.802 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -79.63 107.23 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 2.62 109.715 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.37 156.13 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.13 0.49 . . . . 2.21 111.67 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.97 140.6 32.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 2.68 109.94 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -124.97 123.48 39.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.976 0.417 . . . . 3.78 111.615 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -139.8 165.34 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 3.58 109.452 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.636 HG12 ' H ' ' A' ' 62' ' ' LYS . 43.1 pt -133.97 173.61 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.367 -0.235 . . . . 4.26 110.367 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -128.91 100.91 5.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.525 -0.307 . . . . 5.46 110.766 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.96 168.39 35.55 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.909 -0.662 . . . . 4.66 111.813 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.79 -37.34 93.3 Favored Glycine 0 C--N 1.329 0.191 0 C-N-CA 121.022 -0.608 . . . . 5.04 112.272 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.73 -17.22 61.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.154 0.502 . . . . 5.51 110.325 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.95 9.01 43.79 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.958 -0.639 . . . . 4.73 111.574 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -86.32 169.32 13.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.747 0.308 . . . . 5.75 110.762 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.77 161.54 42.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.131 -0.486 . . . . 4.48 111.154 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.636 ' H ' HG12 ' A' ' 54' ' ' ILE . 66.6 tttt -72.67 -55.18 7.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.95 -0.759 . . . . 4.47 108.95 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.7 t70 56.78 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.162 -0.927 . . . . 4.09 113.042 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 157.07 16.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 3.36 110.304 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.24 158.24 82.42 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.491 . . . . 3.47 110.554 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 116.18 2.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.774 2.316 . . . . 2.69 111.898 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -117.14 125.97 52.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.746 -0.661 . . . . 3.22 110.692 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -99.77 126.18 45.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.976 -0.557 . . . . 1.95 111.128 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -103.51 139.42 38.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 2.76 109.604 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.97 123.12 33.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.077 0.465 . . . . 1.4 111.564 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -120.3 177.34 5.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.582 -0.735 . . . . 2.07 109.41 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.81 175.24 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.28 111.702 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.09 94.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.456 0.539 . . . . 1.66 112.456 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.69 45.62 3.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.95 -0.643 . . . . 1.66 114.04 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.85 84.65 4.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.173 0.487 . . . . 1.62 111.129 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.16 136.59 2.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.083 -0.579 . . . . 1.96 111.925 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.26 -35.3 74.78 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 2.62 112.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -129.08 40.36 3.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.3 0.571 . . . . 3.09 110.149 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.89 -60.78 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.727 -0.669 . . . . 1.87 110.069 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.13 51.91 16.07 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.886 -0.673 . . . . 1.7 111.487 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.3 mt -117.0 104.32 50.95 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.796 0.332 . . . . 1.43 111.537 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -88.1 151.25 6.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.651 2.234 . . . . 1.62 110.737 178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -59.05 111.36 1.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 1.75 110.896 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.83 -3.01 14.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.645 -0.788 . . . . 1.44 112.805 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.73 131.23 42.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 1.25 110.724 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -97.18 114.9 26.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.064 0.459 . . . . 2.21 110.857 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HB3' HG13 ' A' ' 90' ' ' ILE . 22.3 ttmm -142.0 152.7 43.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.012 -0.736 . . . . 2.11 109.012 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.07 119.6 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 1.7 111.98 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.56 71.17 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.769 -0.651 . . . . 1.32 112.873 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.416 HG13 ' HB3' ' A' ' 87' ' ' LYS . 33.2 mm -125.25 96.09 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.877 0.37 . . . . 1.06 111.572 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.75 137.28 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.492 -0.559 . . . . 1.3 109.492 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -96.58 147.84 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.76 0.652 . . . . 1.08 112.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.27 137.05 33.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.67 -0.696 . . . . 1.04 110.246 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.36 166.44 28.05 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.655 -0.498 . . . . 1.27 109.655 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 t -139.76 168.4 19.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.745 -0.207 . . . . 1.58 110.689 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.2 124.39 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 2.64 111.254 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.9 -16.5 36.37 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.71 -0.677 . . . . 1.63 112.439 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -79.97 143.35 34.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.625 0.25 . . . . 1.59 110.656 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.76 148.62 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.417 -0.356 . . . . 2.15 110.526 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -84.54 64.43 8.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.465 0.65 . . . . 2.3 111.193 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.32 143.11 47.49 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.518 -0.765 . . . . 2.69 109.167 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.8 131.19 24.35 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.866 2.377 . . . . 2.08 112.988 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -119.93 44.26 2.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.944 -0.571 . . . . 1.99 110.302 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -13.04 62.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 2.55 112.155 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -21.63 65.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.283 0.475 . . . . 2.28 112.283 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.72 18.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.164 0.507 . . . . 2.0 110.963 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.33 12.19 69.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.862 -0.685 . . . . 2.33 111.659 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -114.44 128.16 56.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.859 0.362 . . . . 3.21 111.494 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -169.25 139.66 2.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.834 -0.621 . . . . 3.03 109.603 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -99.14 120.57 57.95 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.802 0.334 . . . . 3.75 110.648 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.91 -29.5 23.07 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.035 2.49 . . . . 3.39 114.975 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.02 -2.6 57.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.031 -0.418 . . . . 4.05 111.468 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -122.28 0.13 9.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.185 0.517 . . . . 4.78 111.223 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -160.21 142.66 13.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.137 -0.483 . . . . 3.41 109.77 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.33 145.93 24.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.75 0.31 . . . . 3.21 111.215 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.549 ' HB2' " H4'" ' C' ' 8' ' ' ' G' . . . -78.59 138.19 38.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.453 . . . . 3.0 109.778 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.79 141.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.27 -0.423 . . . . 2.42 110.337 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.92 122.37 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.858 -0.423 . . . . 2.74 109.858 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.433 HD12 HD11 ' A' ' 16' ' ' LEU . 2.3 tt -67.61 119.05 11.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.15 0.5 . . . . 2.19 111.436 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -131.01 143.62 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.574 -0.739 . . . . 2.49 110.452 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.3 mt -97.97 149.63 35.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.131 -0.486 . . . . 1.96 110.665 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.08 154.87 48.36 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.669 2.246 . . . . 1.84 111.875 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -58.76 119.2 6.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 2.77 110.515 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 117.81 -26.06 8.16 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.762 -0.732 . . . . 2.2 111.569 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 m -102.95 107.45 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 2.1 110.075 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 155.21 17.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.38 -0.373 . . . . 2.87 111.402 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.6 mt -74.57 142.51 77.71 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.505 -0.554 . . . . 2.62 109.505 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.1 150.01 59.41 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.649 2.233 . . . . 2.77 111.853 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -58.37 116.03 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 4.28 111.337 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 108.57 -20.19 30.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.076 -0.583 . . . . 3.18 111.762 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 16' ' ' LEU . 3.8 t80 -95.61 117.99 31.48 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.487 -0.56 . . . . 2.93 109.487 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.563 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 5.9 p90 -125.49 148.76 48.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.123 0.487 . . . . 3.73 111.535 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.49 142.17 28.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.854 -0.612 . . . . 2.93 110.018 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.85 140.14 33.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.958 0.408 . . . . 3.64 110.557 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.24 -19.57 52.33 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.287 -0.725 . . . . 3.27 111.287 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.3 m -81.36 -9.26 59.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.734 0.302 . . . . 3.59 111.782 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -101.75 16.81 24.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.696 0.284 . . . . 6.05 111.33 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.51 39.85 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.358 -0.925 . . . . 5.22 113.134 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.48 61.36 3.2 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.782 -0.723 . . . . 5.91 111.816 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.993 -0.527 . . . . 7.27 110.999 -179.639 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.49 -3.759 1 C4'-C3'-C2' 97.054 -5.646 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.473 4.644 2 N19-C1'-C2' 103.458 -6.214 . 0.228 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.747 3 O4'-C1'-N19 115.69 7.49 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.182 3 O4'-C1'-N19 116.671 8.471 . 0.515 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.088 2 C4'-C3'-C2' 97.528 -5.172 . 0.656 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.688 5 N19-C1'-C2' 106.387 -4.383 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.367 3 P-O3'-C3' 127.021 6.101 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.549 " H4'" ' HB2' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.368 3 O4'-C4'-C3' 115.01 6.793 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.132 2 O4'-C1'-N19 118.612 10.412 . 0.415 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.55 3 O3'-P-O5' 116.369 6.51 . 0.459 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.119 1 C4'-C3'-C2' 98.274 -4.426 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.533 1 C4'-C3'-C2' 94.334 -8.366 . 0.458 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.795 1 O3'-P-O5' 111.683 4.044 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.063 2 C3'-C2'-C1' 105.653 4.614 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.583 -0.607 . . . . 9.22 111.583 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.02 128.54 51.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.745 0.307 . . . . 8.25 110.473 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.2 mtt -100.61 127.56 46.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.389 -0.369 . . . . 8.02 110.142 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.18 107.01 0.25 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.482 -0.866 . . . . 5.79 112.148 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.36 120.42 70.44 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-O 120.638 0.256 . . . . 4.72 110.435 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.06 -14.36 29.02 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.633 2.222 . . . . 4.45 111.63 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -71.53 150.23 44.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.473 -0.785 . . . . 4.89 110.343 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -81.2 -64.82 1.11 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.547 -0.297 . . . . 4.35 111.16 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 p 49.2 75.53 0.15 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.829 0.678 . . . . 2.87 112.829 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB1' " O2'" ' C' ' 8' ' ' ' G' . . . -77.51 142.04 39.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 2.48 111.294 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.77 146.39 46.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 2.57 111.005 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.413 ' CE2' ' HD3' ' A' ' 109' ' ' ARG . 24.3 m95 -81.86 -34.93 29.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 2.4 111.234 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.07 164.97 11.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.834 -0.621 . . . . 2.02 111.355 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.766 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -62.8 164.65 7.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.068 -0.514 . . . . 2.65 111.663 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . . . -80.11 149.54 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 2.4 112.144 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.4 mt -105.41 119.15 38.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.325 -0.991 . . . . 2.27 108.325 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 m -100.32 129.42 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.64 0.607 . . . . 2.86 112.64 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -97.5 115.7 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 2.89 110.056 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -110.83 74.03 0.85 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.088 -0.506 . . . . 4.07 109.956 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.62 -162.24 22.61 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.861 -0.608 . . . . 3.23 111.649 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.56 -18.5 22.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.368 . . . . 4.51 110.82 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.18 170.08 12.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.039 -0.528 . . . . 3.32 111.103 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -101.59 -78.31 0.53 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.091 -0.707 . . . . 2.41 109.091 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -178.15 143.66 0.3 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.08 -0.509 . . . . 2.18 110.854 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -159.3 116.26 2.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.071 -0.513 . . . . 2.46 110.0 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.17 134.83 21.38 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 1.78 110.511 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.66 150.92 69.47 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.599 2.199 . . . . 2.15 112.267 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.1 121.53 10.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.799 -0.637 . . . . 2.84 110.15 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.46 -25.75 13.1 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.215 -0.754 . . . . 1.65 111.215 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -113.78 -172.47 2.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.22 -0.289 . . . . 2.57 110.22 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.63 -26.08 21.78 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.882 -0.675 . . . . 1.42 112.163 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.25 119.27 75.96 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.576 0.227 . . . . 1.09 110.615 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.88 177.23 8.19 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.197 . . . . 1.27 111.183 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mt -77.16 91.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 1.7 110.201 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -84.42 82.88 8.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 1.23 110.287 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.07 41.38 0.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.791 -0.64 . . . . 1.96 112.198 -178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -150.29 -2.6 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 2.0 111.352 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.32 170.34 14.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.497 -0.32 . . . . 1.44 111.503 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.36 165.67 32.2 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.594 -0.276 . . . . 2.06 110.271 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.43 -33.54 92.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.966 2.444 . . . . 1.42 112.225 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -71.74 -24.09 61.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 1.78 110.547 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.855 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 42.4 m-20 -83.53 -2.98 57.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.808 -0.633 . . . . 1.6 110.802 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -78.26 56.75 1.75 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.344 0.592 . . . . 1.19 111.354 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.4 tt -150.87 130.96 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.499 -0.773 . . . . 1.17 109.103 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.31 -146.45 5.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.113 -1.042 . . . . 0.61 112.979 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -155.41 161.35 41.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.003 0.43 . . . . 1.13 110.764 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.462 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 47.4 m-85 -104.56 134.66 47.36 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.187 -0.672 . . . . 1.69 109.187 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -114.65 122.47 46.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.027 -0.533 . . . . 2.51 110.834 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -87.6 123.42 32.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.33 . . . . 2.62 110.406 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.33 155.99 43.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.21 111.485 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.55 120.67 16.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.647 . . . . 2.68 109.95 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.442 ' HB3' HD13 ' A' ' 64' ' ' LEU . 25.9 tpt180 -96.56 122.18 39.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.101 0.477 . . . . 3.78 112.021 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -138.23 145.32 41.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.681 -0.69 . . . . 3.58 109.907 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.4 pt -121.72 -178.3 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.207 -0.452 . . . . 4.26 109.986 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -145.98 96.01 2.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 5.46 110.528 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.77 179.28 41.39 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.755 -0.736 . . . . 4.66 112.121 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.3 -47.51 89.15 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.919 -0.658 . . . . 5.04 112.012 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.69 -38.09 89.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 5.51 111.151 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.88 1.41 6.91 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.989 -0.624 . . . . 4.73 112.227 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -71.81 160.27 32.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.734 0.302 . . . . 5.75 111.124 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.25 150.62 38.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 4.48 110.944 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HE3' HD21 ' A' ' 64' ' ' LEU . 50.2 tttp -65.39 -54.37 29.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.556 . . . . 4.47 110.291 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.32 91.14 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.606 -0.724 . . . . 4.09 112.89 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 52' ' ' ARG . 63.6 mt -94.59 150.19 20.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 3.36 109.903 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -64.83 161.54 45.26 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.224 -0.444 . . . . 3.47 110.39 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.77 109.24 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.579 2.186 . . . . 2.69 111.244 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -103.51 123.38 46.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 3.22 111.422 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.462 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 79.9 m95 -96.2 120.64 36.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.976 -0.556 . . . . 1.95 110.056 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.419 ' CE1' ' HB3' ' A' ' 15' ' ' ALA . 53.9 m-85 -106.7 133.31 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.727 -0.472 . . . . 2.76 109.727 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -85.95 121.19 28.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.802 0.334 . . . . 1.4 111.163 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -118.76 146.27 44.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.024 -0.534 . . . . 2.07 109.808 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -82.67 149.3 27.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.463 -0.335 . . . . 1.28 110.504 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 tp -59.44 113.5 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.474 -0.33 . . . . 1.66 110.652 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 122.38 -13.92 8.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.141 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.8 p -59.72 123.66 17.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.711 0.291 . . . . 1.62 110.787 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.1 99.64 2.6 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.789 -0.72 . . . . 1.96 111.573 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.9 -42.54 67.98 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 123.079 2.519 . . . . 2.62 112.334 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.47 28.13 8.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.034 0.445 . . . . 3.09 111.298 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.2 -43.22 53.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 1.87 110.484 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.33 51.82 56.35 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.923 -0.581 . . . . 1.7 111.973 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.22 95.66 35.8 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.735 0.302 . . . . 1.43 111.428 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 4.0 Cg_exo -76.04 159.61 37.42 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.836 2.357 . . . . 1.62 110.323 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -60.08 107.84 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 1.75 111.026 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.24 -13.91 8.35 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.706 -0.679 . . . . 1.44 112.19 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.492 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -60.02 116.64 4.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.054 0.454 . . . . 1.25 111.13 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -76.24 116.33 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 2.21 110.763 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -137.31 158.17 45.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.546 -0.539 . . . . 2.11 109.546 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.33 121.82 16.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.257 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 30.83 71.25 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.95 -0.568 . . . . 1.32 112.595 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.9 mm -131.74 113.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.621 0.248 . . . . 1.06 110.38 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.8 pt -121.36 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 1.3 109.71 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -91.72 139.61 30.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.347 0.499 . . . . 1.08 112.347 -178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.13 142.89 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.721 -0.672 . . . . 1.04 110.368 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.62 155.25 34.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.401 . . . . 1.27 110.588 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -121.83 170.11 10.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 1.58 109.73 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.73 114.33 11.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.934 0.397 . . . . 2.64 110.172 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.36 5.83 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.039 -0.824 . . . . 1.63 111.039 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.52 159.96 28.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 1.59 110.748 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.8 mt -118.49 140.56 49.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 2.15 111.263 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.67 80.58 7.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.399 0.619 . . . . 2.3 110.752 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.3 t -156.28 146.77 16.05 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.115 -0.698 . . . . 2.69 109.115 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.48 118.18 5.47 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.231 1.954 . . . . 2.08 112.401 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.855 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -118.31 67.42 0.77 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.728 . . . . 1.99 110.682 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.79 -4.24 36.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.897 . . . . 2.55 111.224 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -61.35 -14.19 25.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.005 -0.543 . . . . 2.28 112.392 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.5 mt -104.7 -26.22 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.804 0.335 . . . . 2.0 110.724 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -61.31 -33.23 83.7 Favored Glycine 0 C--N 1.328 0.138 0 CA-C-N 115.901 -0.59 . . . . 2.33 113.482 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -67.23 113.21 4.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.845 0.355 . . . . 3.21 111.387 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.413 ' HD3' ' CE2' ' A' ' 12' ' ' TRP . 10.7 ttp85 -162.95 128.83 3.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 3.03 111.1 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -91.59 116.92 67.39 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.722 -0.672 . . . . 3.75 109.882 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.81 -33.31 65.37 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.166 2.578 . . . . 3.39 113.044 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.21 14.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.976 0.417 . . . . 4.05 111.812 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -132.16 9.54 4.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.152 -0.476 . . . . 4.78 111.591 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -168.61 129.75 1.26 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.664 0.269 . . . . 3.41 111.653 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.46 168.19 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 3.21 110.519 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 156.98 16.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 3.0 111.627 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 30.3 mt -101.1 142.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.362 -0.977 . . . . 2.42 108.362 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.06 121.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.793 0.33 . . . . 2.74 110.286 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tt -58.92 112.2 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.706 . . . . 2.19 110.872 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -111.92 144.1 41.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.807 -0.633 . . . . 2.49 110.211 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.7 mt -107.5 143.46 27.28 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.301 -0.409 . . . . 1.96 110.766 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.92 156.67 63.16 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.653 2.235 . . . . 1.84 111.635 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -55.66 121.36 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 2.77 110.432 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.57 -21.0 19.9 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.885 -0.674 . . . . 2.2 111.442 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.5 m -99.24 104.17 16.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 2.1 110.116 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.97 140.86 35.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.723 -0.671 . . . . 2.87 110.952 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.54 HD23 ' HD2' ' A' ' 131' ' ' PHE . 21.3 mt -73.99 137.97 76.1 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 2.62 110.058 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.74 155.31 38.25 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.665 2.243 . . . . 2.77 112.055 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -58.22 127.87 34.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.734 -0.666 . . . . 4.28 111.306 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -17.21 59.76 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.091 -0.576 . . . . 3.18 112.652 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.54 ' HD2' HD23 ' A' ' 127' ' ' LEU . 2.6 t80 -94.53 120.22 34.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.562 0.22 . . . . 2.93 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' OH ' " H5'" ' B' ' 1' ' ' ' C' . 36.7 p90 -124.35 155.42 38.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.65 -0.25 . . . . 3.73 111.287 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 136.4 41.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.93 111.754 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.766 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.0 tp10 -61.44 123.58 18.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.592 -0.731 . . . . 3.64 110.742 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.84 66.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.9 -0.667 . . . . 3.27 113.631 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.6 m -77.11 112.71 14.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.037 0.446 . . . . 3.59 111.7 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -160.24 155.47 24.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.834 -0.621 . . . . 6.05 110.563 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -119.39 80.66 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.861 -0.685 . . . . 5.22 112.226 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -105.79 111.0 3.54 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.884 -0.674 . . . . 5.91 111.52 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.861 -0.59 . . . . 7.27 111.206 -179.416 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.402 " H5'" ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . 0 C2'--C1' 1.491 -3.663 1 C4'-C3'-C2' 97.058 -5.642 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.56 2 N19-C1'-C2' 103.521 -6.174 . 0.23 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.763 3 O4'-C1'-N19 115.743 7.543 . 0.53 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.167 4 O4'-C1'-N19 116.649 8.449 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O4'--C4' 1.403 -4.152 2 C4'-C3'-C2' 97.563 -5.137 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.733 4 N19-C1'-C2' 106.37 -4.394 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.496 5.223 3 P-O3'-C3' 127.002 6.085 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.428 " O2'" ' HB1' ' A' ' 10' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.325 3 O4'-C4'-C3' 114.961 6.758 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.107 2 O4'-C1'-N19 118.591 10.391 . 0.411 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.506 3 O3'-P-O5' 116.389 6.52 . 0.457 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.165 1 C4'-C3'-C2' 98.226 -4.474 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.432 1 C4'-C3'-C2' 94.336 -8.364 . 0.459 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.781 1 O3'-P-O5' 111.754 4.081 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.961 2 C3'-C2'-C1' 105.64 4.6 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.684 -0.566 . . . . 9.22 111.684 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.76 125.93 30.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.903 0.382 . . . . 8.25 110.791 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.9 mtt -119.52 107.94 13.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 8.02 110.088 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.57 150.57 22.6 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.838 -0.696 . . . . 5.79 112.65 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.69 136.82 21.06 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.947 -0.39 . . . . 4.72 109.947 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.92 48.06 2.37 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.001 2.468 . . . . 4.45 112.179 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -99.54 27.04 5.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.04 -0.527 . . . . 4.89 110.409 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -111.29 -160.33 0.71 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.798 -0.637 . . . . 4.35 109.526 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.435 HG23 ' HE2' ' A' ' 71' ' ' TYR . 28.7 m 68.45 83.35 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.429 0.633 . . . . 2.87 112.107 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.63 163.1 13.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.783 -0.644 . . . . 2.48 110.005 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -73.16 155.61 39.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.197 0.522 . . . . 2.57 111.543 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -90.42 -24.24 20.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.609 . . . . 2.4 110.985 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -117.2 167.43 11.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 2.02 110.732 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -64.89 155.45 34.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.892 -0.595 . . . . 2.65 110.79 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 163.92 26.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.286 0.565 . . . . 2.4 111.261 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.708 ' HB3' ' HZ ' ' A' ' 131' ' ' PHE . 60.6 mt -111.3 111.55 22.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.675 -0.693 . . . . 2.27 109.854 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.44 119.63 22.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 2.86 111.61 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 23' ' ' ASP . 43.4 tp60 -90.49 124.99 35.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 2.89 110.673 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -132.24 91.29 2.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 4.07 110.424 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.13 38.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.298 -0.721 . . . . 3.23 111.298 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.6 mmtt -90.96 -7.76 51.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 4.51 111.176 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -114.73 -172.79 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.189 -0.671 . . . . 3.32 109.189 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -127.34 -149.99 0.43 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.178 -0.675 . . . . 2.41 109.178 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 mp -95.62 133.38 39.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.751 0.31 . . . . 2.18 110.648 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.18 92.28 1.33 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.174 -0.466 . . . . 2.46 109.858 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -91.67 136.3 26.69 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 1.78 110.995 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -74.16 158.96 44.84 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.658 2.239 . . . . 2.15 111.187 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.5 125.26 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.007 0.432 . . . . 2.84 111.665 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.81 -15.66 52.01 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.637 -0.792 . . . . 1.65 112.62 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -129.98 153.49 48.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.651 0.262 . . . . 2.57 110.379 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.74 1.55 11.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.575 -0.821 . . . . 1.42 112.688 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.49 115.43 64.43 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.886 0.374 . . . . 1.09 110.852 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.45 178.64 5.93 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.761 2.308 . . . . 1.27 111.439 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.8 mt -77.06 92.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.996 0.427 . . . . 1.7 110.456 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -82.73 84.41 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 1.23 110.452 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 p -75.4 9.45 2.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.494 0.553 . . . . 1.96 112.494 -179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -118.08 -5.73 10.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.785 0.291 . . . . 2.0 111.785 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.52 168.11 13.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.89 0.376 . . . . 1.44 111.746 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.54 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.6 m -86.87 167.76 20.81 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 115.974 -0.557 . . . . 2.06 109.583 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.54 -36.86 72.39 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.344 2.696 . . . . 1.42 113.293 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.45 -14.76 59.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.057 0.391 . . . . 1.78 112.057 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -88.41 -0.04 56.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.624 0.25 . . . . 1.6 110.351 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -76.6 51.1 0.72 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.364 -0.38 . . . . 1.19 111.586 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.728 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.7 tt -146.39 130.46 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.17 -0.468 . . . . 1.17 110.233 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.63 -148.84 6.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.462 -0.875 . . . . 0.61 112.457 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -152.51 166.64 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 1.13 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.622 ' HH ' HD11 ' A' ' 119' ' ' LEU . 10.9 m-85 -111.72 134.53 53.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.944 -0.571 . . . . 1.69 109.955 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -112.94 133.98 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.195 -0.457 . . . . 2.51 111.211 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -87.25 121.77 30.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.1 -0.5 . . . . 2.62 109.876 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 156.85 47.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 2.21 111.531 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.21 154.5 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 2.68 110.288 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -130.14 118.65 21.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.973 -0.38 . . . . 3.78 109.973 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.88 107.52 5.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.634 -0.257 . . . . 3.58 110.409 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.766 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.8 pt -69.84 158.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 4.26 110.505 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.15 98.98 4.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.165 -0.47 . . . . 5.46 110.095 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.2 157.55 51.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.842 -0.694 . . . . 4.66 111.81 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.33 -35.95 89.7 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.197 -0.525 . . . . 5.04 112.744 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -78.02 -0.36 27.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.061 0.458 . . . . 5.51 111.042 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.94 44.3 5.15 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.851 -0.69 . . . . 4.73 112.081 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -100.25 144.71 28.94 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.787 -0.449 . . . . 5.75 109.787 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.9 mmt -128.38 136.13 50.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.261 -0.427 . . . . 4.48 110.106 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.766 ' HB2' HG12 ' A' ' 54' ' ' ILE . 43.7 tttt -71.07 -46.59 61.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.557 -0.534 . . . . 4.47 109.557 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 65.95 99.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.974 1.101 . . . . 4.09 113.974 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.8 mt -126.73 151.1 48.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.484 -0.78 . . . . 3.36 110.024 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.31 153.89 88.12 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.192 -0.458 . . . . 3.47 110.283 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -58.14 127.4 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.76 2.307 . . . . 2.69 111.756 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -115.22 124.64 51.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.486 . . . . 3.22 110.613 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.586 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 37.1 m95 -94.26 121.33 35.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 1.95 110.134 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -96.95 146.76 24.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 2.76 110.673 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -94.19 126.92 39.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.899 0.38 . . . . 1.4 110.33 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' HE2' HG23 ' A' ' 9' ' ' THR . 23.7 m-85 -126.99 165.77 18.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.955 -0.566 . . . . 2.07 109.867 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -100.62 169.21 9.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.773 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.92 103.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.088 0.773 . . . . 1.66 113.088 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.64 44.74 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.923 -0.58 . . . . 1.66 114.065 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.46 82.93 1.96 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.116 0.484 . . . . 1.62 111.321 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.71 131.18 1.21 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.596 -0.602 . . . . 1.96 111.596 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.23 -37.87 79.98 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.007 2.472 . . . . 2.62 112.322 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.03 31.77 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 3.09 111.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 -53.22 8.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.819 0.342 . . . . 1.87 110.626 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.3 48.49 83.32 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.933 -0.576 . . . . 1.7 112.025 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.1 mt -125.04 103.76 30.11 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.87 0.367 . . . . 1.43 111.592 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.11 162.44 17.9 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.633 2.222 . . . . 1.62 110.933 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -60.88 117.86 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 1.75 111.102 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.08 10.48 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 1.44 112.539 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.83 108.05 2.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 1.25 110.751 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -84.02 137.2 33.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.335 -0.393 . . . . 2.21 110.902 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -147.21 168.43 21.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.459 -0.941 . . . . 2.11 108.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.17 112.23 1.3 Allowed 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.285 0.366 . . . . 1.7 111.783 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.52 39.03 91.09 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.705 -0.68 . . . . 1.32 112.586 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 mm -132.9 102.98 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.825 0.345 . . . . 1.06 110.696 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.2 pt -113.73 133.86 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.812 -0.44 . . . . 1.3 109.812 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -90.38 140.03 30.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.035 0.445 . . . . 1.08 111.805 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.54 132.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.837 -0.62 . . . . 1.04 110.483 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.62 141.71 23.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 1.27 110.471 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 t -112.74 176.61 4.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.523 -0.547 . . . . 1.58 109.523 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -65.04 130.46 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 2.64 110.834 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.52 -15.36 49.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.003 -0.617 . . . . 1.63 112.148 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.728 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -74.56 130.26 39.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.59 110.742 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -103.14 139.51 38.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.136 -0.483 . . . . 2.15 110.873 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -74.15 88.84 1.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.215 0.531 . . . . 2.3 110.5 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.38 153.94 35.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 2.69 109.622 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.65 122.59 11.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.564 2.176 . . . . 2.08 111.468 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.8 mmtt -113.47 29.39 8.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.092 -0.503 . . . . 1.99 111.175 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -13.99 62.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 2.55 111.215 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -65.19 -17.65 64.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.08 -0.509 . . . . 2.28 112.105 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.55 -27.44 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 2.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.21 58.97 4.82 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.925 -0.579 . . . . 2.33 113.225 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 t -138.37 16.31 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 3.21 110.225 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -73.18 137.19 44.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.651 -0.704 . . . . 3.03 110.655 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -95.98 115.67 65.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.426 -0.352 . . . . 3.75 111.124 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.91 -27.97 11.71 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.721 2.281 . . . . 3.39 112.812 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.17 38.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.438 . . . . 4.05 110.847 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -170.1 -45.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 4.78 109.931 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -107.82 139.18 42.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.786 -0.643 . . . . 3.41 110.436 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.34 155.87 22.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.666 0.27 . . . . 3.21 110.876 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.04 162.11 14.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.22 0.533 . . . . 3.0 111.562 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.6 mt -98.48 150.55 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.082 -0.71 . . . . 2.42 109.082 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.1 t -69.43 126.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.301 -0.259 . . . . 2.74 110.301 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.622 HD11 ' HH ' ' A' ' 47' ' ' TYR . 4.4 tt -67.02 110.89 3.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.413 . . . . 2.19 109.911 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -118.11 146.13 44.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.004 -0.544 . . . . 2.49 110.978 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.9 mt -99.63 151.34 37.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.893 -0.594 . . . . 1.96 110.169 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.12 163.18 32.5 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.412 2.075 . . . . 1.84 112.48 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -60.69 115.33 3.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 2.77 110.783 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.49 -2.7 23.49 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.636 -0.792 . . . . 2.2 112.094 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.0 m -117.02 114.83 24.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 2.1 110.449 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.04 151.77 24.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.442 -0.345 . . . . 2.87 111.099 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.07 148.16 84.07 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.542 -0.54 . . . . 2.62 109.542 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.06 168.47 10.66 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.468 2.112 . . . . 2.77 112.059 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.38 130.93 45.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.076 -0.511 . . . . 4.28 111.891 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.32 65.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.103 -0.57 . . . . 3.18 112.347 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.708 ' HZ ' ' HB3' ' A' ' 16' ' ' LEU . 22.0 t80 -126.82 144.76 50.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.905 0.383 . . . . 2.93 111.384 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -146.65 157.87 43.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.932 -0.576 . . . . 3.73 109.801 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.07 134.12 45.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.012 -0.366 . . . . 2.93 110.012 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.51 150.25 47.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.846 0.355 . . . . 3.64 111.172 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.62 -91.7 0.49 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.873 -0.679 . . . . 3.27 111.779 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 m -89.39 150.0 22.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.64 0.257 . . . . 3.59 110.787 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -92.65 169.02 10.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.535 -0.302 . . . . 6.05 110.367 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.43 142.9 20.63 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.668 -0.777 . . . . 5.22 111.382 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.35 -108.74 3.24 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.774 -0.727 . . . . 5.91 111.68 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.4 m . . . . . 0 C--O 1.251 1.165 0 CA-C-O 119.228 -0.415 . . . . 7.27 111.439 179.841 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.421 " H4'" HO2' ' B' ' 1' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.492 -3.59 1 C4'-C3'-C2' 97.037 -5.663 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.467 2 N19-C1'-C2' 103.547 -6.158 . 0.235 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.709 3 O4'-C1'-N19 115.718 7.518 . 0.531 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.256 4 O4'-C1'-N19 116.633 8.433 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.092 2 C4'-C3'-C2' 97.556 -5.144 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.811 4 N19-C1'-C2' 106.361 -4.399 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.314 3 P-O3'-C3' 127.026 6.105 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.581 5.293 3 O4'-C4'-C3' 114.991 6.779 . 0.0 '__' . 15.4 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.021 2 O4'-C1'-N19 118.705 10.505 . 0.416 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.603 3 O3'-P-O5' 116.374 6.513 . 0.46 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.113 1 C4'-C3'-C2' 98.302 -4.398 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.634 1 C4'-C3'-C2' 94.374 -8.326 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.738 1 O3'-P-O5' 111.72 4.063 . 0.107 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.01 2 C3'-C2'-C1' 105.723 4.692 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.606 -0.598 . . . . 9.22 111.606 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.47 163.72 25.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.918 -0.401 . . . . 8.25 109.918 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.0 tpt -93.41 103.7 15.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.454 -0.339 . . . . 8.02 110.203 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.49 79.43 0.34 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.619 -0.8 . . . . 5.79 112.616 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.9 mt -114.7 119.68 39.05 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.54 0.209 . . . . 4.72 110.644 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.32 63.94 7.13 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.218 2.612 . . . . 4.45 112.173 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -79.75 124.57 28.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 4.89 110.323 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -136.97 -102.58 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.337 -0.392 . . . . 4.35 110.437 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.3 m 59.66 84.99 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.826 0.676 . . . . 2.87 112.826 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.37 143.32 26.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.806 -0.634 . . . . 2.48 109.996 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.2 m -64.89 155.56 33.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.188 0.44 . . . . 2.57 112.188 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -84.53 -25.67 28.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.767 -0.652 . . . . 2.4 111.248 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -114.31 164.95 13.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.969 -0.56 . . . . 2.02 110.751 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 10.4 p -70.99 158.42 36.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.101 -0.5 . . . . 2.65 110.256 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 177.09 9.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.489 . . . . 2.4 110.768 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.67 129.25 48.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.411 -0.589 . . . . 2.27 109.411 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.54 115.87 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 2.86 111.268 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -83.13 143.97 30.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 2.89 110.685 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -140.36 79.93 1.73 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 4.07 110.164 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -170.47 41.36 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.728 -0.748 . . . . 3.23 111.975 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -88.09 -10.51 49.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 4.51 110.868 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.38 166.3 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 3.32 109.974 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -104.6 -82.28 0.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.77 -0.456 . . . . 2.41 109.77 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.3 tp -177.82 135.28 0.17 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.329 0.393 . . . . 2.18 110.803 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -162.84 124.09 2.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 2.46 109.576 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.3 138.9 23.9 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.578 -0.283 . . . . 1.78 110.709 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.23 175.25 6.96 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.074 2.516 . . . . 2.15 112.563 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.69 126.3 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 2.84 112.03 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.85 78.2 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.93 -0.652 . . . . 1.65 112.712 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.21 171.86 12.8 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.362 -0.236 . . . . 2.57 110.362 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.25 -8.14 69.49 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.661 -0.781 . . . . 1.42 112.783 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.15 114.73 63.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.673 0.273 . . . . 1.09 110.733 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.11 178.38 7.0 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.425 2.083 . . . . 1.27 111.472 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 mt -77.38 81.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.868 0.366 . . . . 1.7 110.608 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -81.73 81.55 7.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.23 109.942 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.07 3.98 9.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.1 -0.5 . . . . 1.96 112.156 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.9 -1.38 26.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 2.0 111.368 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.46 164.85 21.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.892 0.377 . . . . 1.44 111.59 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.88 168.08 27.73 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.013 -0.539 . . . . 2.06 110.275 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.85 -39.27 90.89 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.932 2.421 . . . . 1.42 113.039 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -73.16 -23.77 60.48 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.719 0.295 . . . . 1.78 110.772 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.849 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 34.4 m-20 -79.04 -2.12 38.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.6 111.256 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -81.86 55.71 2.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.245 0.545 . . . . 1.19 111.142 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.558 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.4 tt -152.14 131.96 3.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.17 109.961 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.79 -137.9 2.53 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.305 -0.95 . . . . 0.61 112.683 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -160.42 166.96 28.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.403 . . . . 1.13 110.645 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.492 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 3.0 m-85 -105.96 134.3 49.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.082 -0.71 . . . . 1.69 109.082 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -115.18 123.38 48.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.247 -0.433 . . . . 2.51 111.031 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -79.69 111.08 15.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 2.62 110.048 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.22 165.02 11.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 2.21 111.037 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -154.3 125.51 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 2.68 110.177 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 64' ' ' LEU . 17.4 tpt180 -115.37 120.62 40.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 3.78 110.656 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -132.03 162.88 29.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 3.58 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.433 HG12 ' HB2' ' A' ' 62' ' ' LYS . 38.1 pt -125.38 162.76 27.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 4.26 109.912 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.71 99.29 6.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.885 0.374 . . . . 5.46 110.631 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.16 152.84 33.23 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.828 -0.701 . . . . 4.66 111.872 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.16 -37.57 94.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.032 -0.604 . . . . 5.04 112.382 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -85.0 11.18 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.174 0.511 . . . . 5.51 111.143 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.9 22.32 55.61 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.928 -0.653 . . . . 4.73 112.266 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -79.54 156.56 27.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.246 -0.279 . . . . 5.75 110.246 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 mtm -140.1 158.89 43.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.743 0.306 . . . . 4.48 110.811 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.454 ' HE3' HD21 ' A' ' 64' ' ' LEU . 52.5 tttp -87.65 -40.19 14.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.19 -0.459 . . . . 4.47 110.451 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t70 40.96 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.247 1.202 . . . . 4.09 114.247 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.454 HD21 ' HE3' ' A' ' 62' ' ' LYS . 90.9 mt -95.78 157.32 15.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 3.36 110.365 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.72 153.06 95.92 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.73 -0.47 . . . . 3.47 109.73 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 113.85 1.49 Allowed 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.741 2.294 . . . . 2.69 112.057 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.1 mtt-85 -105.72 122.41 46.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 3.22 110.686 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.492 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 67.3 m95 -99.44 115.48 29.39 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.223 -0.444 . . . . 1.95 110.435 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -97.27 142.98 28.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.118 -0.492 . . . . 2.76 109.719 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.89 130.24 35.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 1.4 111.016 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -125.58 154.69 41.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.082 -0.508 . . . . 2.07 109.706 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.02 151.85 20.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.335 -0.393 . . . . 1.28 109.952 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.4 tt -60.38 112.23 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.262 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.49 -5.46 11.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.465 -0.874 . . . . 1.66 113.115 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 p -61.3 108.76 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 1.62 111.646 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 119.86 3.84 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.697 -0.763 . . . . 1.96 112.108 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.2 -37.33 51.95 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.662 2.242 . . . . 2.62 111.954 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -123.33 47.37 2.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.017 0.437 . . . . 3.09 111.013 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.43 -41.86 46.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.449 -0.574 . . . . 1.87 109.449 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 33.58 83.27 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.617 -0.719 . . . . 1.7 112.693 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.426 HD11 ' HD2' ' A' ' 87' ' ' LYS . 82.1 mt -131.05 99.12 18.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.778 0.323 . . . . 1.43 111.467 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 87.3 Cg_endo -82.87 170.38 12.57 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.488 2.125 . . . . 1.62 110.203 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.533 ' HB2' HD11 ' A' ' 73' ' ' LEU . 69.0 t80 -57.82 111.09 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.783 0.325 . . . . 1.75 110.886 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.06 -17.31 10.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.807 -0.711 . . . . 1.44 112.386 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -65.04 108.22 1.76 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 1.25 110.954 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -77.61 129.02 35.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.55 . . . . 2.21 110.936 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.426 ' HD2' HD11 ' A' ' 81' ' ' LEU . 75.0 tttt -143.14 162.64 35.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.458 -0.941 . . . . 2.11 108.458 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.81 110.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.881 0.372 . . . . 1.7 111.487 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 28.25 53.8 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.879 -0.677 . . . . 1.32 112.477 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.7 mm -128.68 105.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.972 0.415 . . . . 1.06 110.339 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.0 pt -117.7 127.0 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.198 -0.455 . . . . 1.3 110.135 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -87.25 138.25 31.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.141 0.423 . . . . 1.08 112.141 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.7 138.22 48.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.532 -0.758 . . . . 1.04 110.409 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.99 172.32 13.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.308 -0.406 . . . . 1.27 110.116 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 t -152.73 -176.37 5.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.403 -0.362 . . . . 1.58 110.791 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -65.71 134.82 54.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 2.64 111.118 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.4 -12.1 70.3 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.97 -0.633 . . . . 1.63 112.778 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.558 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.07 146.15 30.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.795 0.331 . . . . 1.59 110.727 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.55 149.14 43.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.165 -0.471 . . . . 2.15 110.704 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -82.15 82.75 7.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.259 0.552 . . . . 2.3 110.151 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.509 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 53.0 m -154.5 127.84 4.31 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.274 -0.876 . . . . 2.69 108.705 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.7 129.97 37.48 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.814 2.342 . . . . 2.08 112.783 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.849 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.12 67.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.707 0.765 . . . . 1.99 110.74 179.25 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.19 -7.94 51.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.291 -0.868 . . . . 2.55 111.7 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -60.14 -22.0 62.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.172 0.434 . . . . 2.28 112.172 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.2 mt -87.82 -35.64 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 2.0 110.563 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.83 66.42 3.75 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.931 -0.577 . . . . 2.33 112.436 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 t -148.35 16.68 1.04 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.533 0.682 . . . . 3.21 110.582 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -74.7 138.92 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.715 . . . . 3.03 110.855 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -85.68 123.16 72.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 3.75 110.605 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.62 -12.29 16.77 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.002 2.468 . . . . 3.39 114.293 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -111.3 9.67 21.65 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.995 -0.441 . . . . 4.05 111.544 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -136.85 12.16 3.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.215 -0.448 . . . . 4.78 111.226 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -169.38 142.12 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 3.41 111.033 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.454 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -92.37 141.73 28.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.388 -0.369 . . . . 3.21 110.624 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.49 146.89 38.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.323 -0.399 . . . . 3.0 110.755 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.5 mt -77.17 147.58 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.645 -0.707 . . . . 2.42 109.988 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.75 120.19 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.055 -0.35 . . . . 2.74 110.055 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.46 HD11 ' HH ' ' A' ' 47' ' ' TYR . 3.9 tt -62.31 121.67 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 2.19 111.536 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -132.11 142.56 49.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.702 -0.681 . . . . 2.49 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.407 HD12 HG23 ' A' ' 125' ' ' THR . 72.5 mt -94.16 148.39 35.06 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.184 -0.462 . . . . 1.96 110.296 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.21 167.25 16.78 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.894 2.396 . . . . 1.84 112.266 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -60.72 127.07 29.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 2.77 110.661 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.89 -19.66 46.15 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.548 -0.621 . . . . 2.2 111.548 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.407 HG23 HD12 ' A' ' 121' ' ' LEU . 6.4 m -102.42 109.21 20.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.748 0.308 . . . . 2.1 110.396 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 160.35 14.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.444 -0.344 . . . . 2.87 110.735 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -79.91 146.78 64.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.418 -0.355 . . . . 2.62 110.415 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.87 160.49 33.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.33 2.02 . . . . 2.77 111.778 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.6 113.63 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.578 -0.737 . . . . 4.28 112.142 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.11 0.2 61.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.144 -0.55 . . . . 3.18 113.611 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.15 129.99 47.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.828 0.314 . . . . 2.93 110.895 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -135.52 146.48 48.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 3.73 110.518 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.13 144.93 25.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 2.93 111.691 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 5.9 tt0 -67.81 128.45 36.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.946 -0.57 . . . . 3.64 110.175 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.23 -1.98 74.19 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 3.27 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.7 m -102.14 91.0 4.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.936 0.398 . . . . 3.59 111.181 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.477 ' NH2' H5'' ' B' ' 1' ' ' ' C' . 19.0 mmt180 -117.5 50.27 1.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.198 0.523 . . . . 6.05 109.918 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.76 153.97 35.31 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.743 -0.662 . . . . 5.22 112.768 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 138.32 -75.12 0.39 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.846 -0.902 . . . . 5.91 110.846 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 119.006 -0.521 . . . . 7.27 112.001 179.635 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.477 H5'' ' NH2' ' A' ' 137' ' ' ARG . . . . . . . . 0 C2'--C1' 1.491 -3.727 1 C4'-C3'-C2' 97.042 -5.658 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.507 2 N19-C1'-C2' 103.523 -6.173 . 0.235 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.699 3 O4'-C1'-N19 115.699 7.499 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.215 4 O4'-C1'-N19 116.718 8.518 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.115 2 C4'-C3'-C2' 97.565 -5.135 . 0.65 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.731 4 N19-C1'-C2' 106.338 -4.414 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.312 3 P-O3'-C3' 127.051 6.126 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.454 " H1'" ' HA ' ' A' ' 115' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.31 3 O4'-C4'-C3' 114.903 6.716 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -4.976 2 O4'-C1'-N19 118.697 10.497 . 0.415 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.587 3 O3'-P-O5' 116.355 6.503 . 0.459 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . 0.502 HO2' " H5'" ' C' ' 12' ' ' ' G' . . . . . . . . 1 P--O3' 1.557 -4.142 1 C4'-C3'-C2' 98.299 -4.401 . 0.308 1a . 13.73 . . . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . 0.502 " H5'" HO2' ' C' ' 11' ' ' ' A' . . . . . . . . 1 C4'--C3' 1.586 5.606 1 C4'-C3'-C2' 94.356 -8.344 . 0.453 1a . 14.32 . . . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.796 1 O3'-P-O5' 111.694 4.05 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.905 2 C3'-C2'-C1' 105.742 4.714 . 0.333 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.469 -0.652 . . . . 9.22 111.469 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.89 118.26 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.706 0.288 . . . . 8.25 110.225 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 mmt -75.21 -37.71 61.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.999 0.428 . . . . 8.02 111.314 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.95 34.55 55.62 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.958 -0.639 . . . . 5.79 111.558 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -109.09 116.85 54.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.829 0.347 . . . . 4.72 111.188 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.57 51.41 3.76 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.974 2.449 . . . . 4.45 111.899 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -122.78 148.63 45.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.834 -0.621 . . . . 4.89 110.0 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -150.63 -61.53 0.19 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.471 -0.332 . . . . 4.35 110.94 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 p 53.01 78.17 0.15 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.362 0.875 . . . . 2.87 113.362 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB1' " O2'" ' C' ' 8' ' ' ' G' . . . -93.29 140.24 29.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 2.48 110.719 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -55.64 139.42 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.671 -0.695 . . . . 2.57 112.195 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -73.26 -25.36 60.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 2.4 112.06 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.9 m-85 -109.92 172.97 6.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.496 0.554 . . . . 2.02 112.496 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 p -74.45 -172.94 1.6 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.244 -0.889 . . . . 2.65 111.032 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.65 136.81 35.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.838 0.681 . . . . 2.4 112.838 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 131' ' ' PHE . 17.6 mt -96.55 102.86 14.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.095 -1.076 . . . . 2.27 108.095 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.557 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -85.75 129.27 34.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.362 0.504 . . . . 2.86 112.362 -178.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -97.2 127.83 43.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 2.89 109.706 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.628 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 1.1 t60 -114.74 1.64 14.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.656 0.243 . . . . 4.07 111.656 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.39 -168.65 32.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.901 -0.666 . . . . 3.23 111.869 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -85.71 -33.41 21.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.864 0.364 . . . . 4.51 110.828 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.12 172.39 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 3.32 110.115 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.05 -76.01 0.57 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.952 -0.299 . . . . 2.41 110.64 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.6 tp -177.5 129.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.457 0.473 . . . . 2.18 111.16 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -156.34 119.23 4.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.291 -0.413 . . . . 2.46 110.212 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -110.3 151.09 42.41 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.147 -0.478 . . . . 1.78 110.562 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.65 164.34 34.81 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.92 2.413 . . . . 2.15 111.538 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -70.44 124.02 23.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 2.84 110.616 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.69 -10.49 52.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.793 -0.718 . . . . 1.65 111.578 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -122.35 -176.82 3.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.62 -0.511 . . . . 2.57 109.62 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.55 -31.63 8.12 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 1.42 112.542 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.95 120.14 78.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 110.336 -0.246 . . . . 1.09 110.336 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.74 -175.43 2.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.787 2.325 . . . . 1.27 112.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.1 mt -78.51 87.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 1.7 110.109 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.449 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 63.7 m-80 -82.38 73.04 9.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.325 -0.398 . . . . 1.23 110.557 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.1 68.52 1.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.036 -0.529 . . . . 1.96 111.047 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -176.7 -27.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.913 -0.585 . . . . 2.0 110.906 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 157.99 16.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.149 0.426 . . . . 1.44 112.149 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.06 164.14 61.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.767 -0.652 . . . . 2.06 111.105 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.11 -40.38 77.46 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.555 . . . . 1.42 113.389 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.53 -16.61 61.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.781 -0.367 . . . . 1.78 111.404 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.713 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 16.1 m-20 -87.42 -0.77 57.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.857 -0.611 . . . . 1.6 110.75 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 54.0 mm-40 -79.29 58.17 2.5 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.242 0.544 . . . . 1.19 110.714 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.452 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.4 tt -149.19 133.24 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.546 -0.752 . . . . 1.17 109.598 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.3 -144.5 5.38 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.342 -0.932 . . . . 0.61 112.633 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.65 162.1 41.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.871 0.367 . . . . 1.13 110.581 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' HB2' HG13 ' A' ' 91' ' ' ILE . 27.9 m-85 -102.22 123.97 46.98 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.838 -0.801 . . . . 1.69 108.838 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -101.72 133.61 46.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.009 -0.541 . . . . 2.51 111.231 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -82.17 129.26 34.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 2.62 110.099 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 130.17 43.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.099 0.476 . . . . 2.21 111.501 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 111.82 12.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 2.68 109.773 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HB3' HD13 ' A' ' 64' ' ' LEU . 12.1 tpt180 -91.68 111.02 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.293 0.568 . . . . 3.78 111.367 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -133.27 103.38 5.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 3.58 110.62 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 62' ' ' LYS . 44.2 pt -84.8 146.87 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 4.26 110.357 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 -120.69 111.44 17.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.799 0.333 . . . . 5.46 110.487 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.13 160.5 32.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.801 -0.714 . . . . 4.66 112.268 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.48 -24.82 75.61 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.154 -0.546 . . . . 5.04 112.14 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.81 -34.4 71.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.089 0.471 . . . . 5.51 110.1 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.11 29.13 1.26 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.772 -0.728 . . . . 4.73 113.103 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -112.25 154.34 25.77 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.646 -0.326 . . . . 5.75 111.017 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 38.1 mtt -141.61 132.27 25.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.98 -0.554 . . . . 4.48 109.794 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HB2' HG12 ' A' ' 54' ' ' ILE . 48.8 tttp -58.19 -52.15 66.76 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.729 -0.214 . . . . 4.47 111.134 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t0 56.84 89.28 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.811 0.695 . . . . 4.09 112.51 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD13 ' HB3' ' A' ' 52' ' ' ARG . 66.1 mt -101.08 170.15 8.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.112 0.482 . . . . 3.36 111.47 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.26 156.57 66.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 3.47 109.578 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.93 117.79 4.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 2.69 111.865 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -114.28 133.91 55.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.815 -0.63 . . . . 3.22 110.104 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -109.49 136.44 48.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 1.95 111.149 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.478 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 55.6 m-85 -123.54 138.3 54.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.444 -0.576 . . . . 2.76 109.444 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -86.9 131.62 34.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.854 0.359 . . . . 1.4 111.611 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.23 144.9 51.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.942 -0.572 . . . . 2.07 110.115 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -77.69 151.81 34.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.247 -0.433 . . . . 1.28 110.083 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.39 120.28 11.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.582 -0.281 . . . . 1.66 110.669 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.38 -1.36 26.54 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.697 -0.763 . . . . 1.66 112.495 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 p -65.9 117.15 7.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.777 0.322 . . . . 1.62 110.866 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.22 112.38 3.21 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.946 -0.645 . . . . 1.96 111.731 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.42 -41.42 78.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.993 2.462 . . . . 2.62 111.908 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -110.52 39.74 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 3.09 111.034 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.01 -56.15 4.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.398 . . . . 1.87 110.677 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.67 45.88 95.38 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.1 -0.571 . . . . 1.7 112.184 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.74 108.03 17.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.655 0.264 . . . . 1.43 111.514 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 96.1 Cg_endo -86.92 173.77 5.8 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.811 2.34 . . . . 1.62 111.042 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -64.17 113.42 3.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.998 0.427 . . . . 1.75 110.737 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.02 -0.37 25.57 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.773 -0.727 . . . . 1.44 112.51 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.526 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -65.01 113.33 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 1.25 110.981 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -77.1 103.25 6.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 2.21 111.329 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -132.22 165.6 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.219 -0.446 . . . . 2.11 110.542 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.36 111.19 2.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.652 0.612 . . . . 1.7 112.652 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.21 41.77 85.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.735 -0.666 . . . . 1.32 112.948 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -131.27 104.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 1.06 110.799 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 47' ' ' TYR . 5.2 pt -110.12 123.59 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 1.3 109.875 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -89.76 135.88 33.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 1.08 112.082 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -137.24 145.63 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.032 -0.531 . . . . 1.04 110.612 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.29 149.69 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.491 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 169.29 8.63 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.07 -0.345 . . . . 1.58 110.07 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -70.11 111.34 5.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.799 -0.445 . . . . 2.64 109.799 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.49 -13.9 8.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 1.63 111.576 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.89 146.64 43.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.828 0.347 . . . . 1.59 110.547 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.1 mt -108.73 142.71 38.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.298 -0.41 . . . . 2.15 111.5 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -80.35 90.35 5.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 2.3 110.574 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 t -162.76 146.12 8.72 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.113 -0.699 . . . . 2.69 109.113 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.79 121.38 7.85 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.941 1.761 . . . . 2.08 111.246 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.713 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.83 76.9 1.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 1.99 112.343 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -85.56 5.91 29.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.34 -0.391 . . . . 2.55 111.394 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.474 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.9 p80 -57.84 -23.11 51.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.107 -0.497 . . . . 2.28 111.773 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.17 9.2 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.003 -0.544 . . . . 2.0 110.256 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.53 -35.65 13.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.652 -0.785 . . . . 2.33 111.973 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 t -68.65 125.59 27.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 3.21 110.863 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -162.59 125.72 2.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 3.03 109.873 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -86.42 116.39 65.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 123.276 0.36 . . . . 3.75 110.673 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.73 -32.51 46.82 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.879 2.386 . . . . 3.39 112.958 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.35 0.26 49.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.84 0.311 . . . . 4.05 111.84 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -128.39 -4.76 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.963 0.411 . . . . 4.78 111.167 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -149.88 128.25 12.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.766 0.317 . . . . 3.41 110.944 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.29 155.42 30.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.019 -0.537 . . . . 3.21 110.756 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.3 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 3.0 111.435 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 18.6 mt -101.5 146.54 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.711 -0.677 . . . . 2.42 109.621 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.23 120.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.61 0.243 . . . . 2.74 110.407 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.57 114.43 3.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.008 -0.542 . . . . 2.19 111.082 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -136.84 152.96 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 2.49 110.61 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.3 mt -100.94 147.7 34.05 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 1.96 110.114 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.56 160.86 30.27 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.756 2.304 . . . . 1.84 112.782 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.53 120.36 9.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.794 -0.639 . . . . 2.77 110.478 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.82 14.84 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.098 -1.201 . . . . 2.2 110.098 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.3 m -112.61 114.79 27.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 2.1 108.845 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 156.78 18.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.33 -0.396 . . . . 2.87 111.55 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.19 76.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 2.62 109.698 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.64 156.99 60.96 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.44 2.094 . . . . 2.77 111.448 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.46 120.95 14.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 4.28 111.644 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.17 -2.1 47.32 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.419 -0.672 . . . . 3.18 111.419 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 16' ' ' LEU . 1.6 t80 -110.3 129.38 55.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.29 . . . . 2.93 110.613 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.628 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 26.3 p90 -141.12 162.85 34.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 3.73 110.064 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.429 ' HB3' HD22 ' A' ' 16' ' ' LEU . . . -119.05 148.01 43.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.721 0.296 . . . . 2.93 111.029 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.0 131.05 43.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.591 -0.522 . . . . 3.64 109.591 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.78 -26.6 23.78 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 3.27 112.191 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m -77.39 141.87 39.57 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.593 -0.357 . . . . 3.59 110.701 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -133.85 87.0 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 6.05 110.424 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.67 105.43 1.24 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.81 -0.632 . . . . 5.22 112.408 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 126.72 -92.86 0.39 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.361 -0.696 . . . . 5.91 111.361 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.881 -0.58 . . . . 7.27 111.562 -179.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.4 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.492 -3.602 1 C4'-C3'-C2' 97.053 -5.647 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.4 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.504 2 N19-C1'-C2' 103.548 -6.158 . 0.229 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.697 3 O4'-C1'-N19 115.727 7.527 . 0.527 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.162 4 O4'-C1'-N19 116.668 8.468 . 0.509 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.374 -4.133 2 C4'-C3'-C2' 97.573 -5.127 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.653 4 N19-C1'-C2' 106.394 -4.379 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.319 3 P-O3'-C3' 127.006 6.088 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.488 " O2'" ' HB1' ' A' ' 10' ' ' ALA . . . . . . . . 2 C2'--C1' 1.583 5.518 3 O4'-C4'-C3' 114.971 6.765 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.029 2 O4'-C1'-N19 118.646 10.446 . 0.414 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.539 3 O3'-P-O5' 116.354 6.502 . 0.458 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.247 1 C4'-C3'-C2' 98.248 -4.452 . 0.308 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.645 1 C4'-C3'-C2' 94.303 -8.397 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.772 1 O3'-P-O5' 111.688 4.046 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.858 2 C3'-C2'-C1' 105.684 4.649 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.895 -0.482 . . . . 9.22 111.895 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.31 111.19 22.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.749 0.309 . . . . 8.25 110.376 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -91.86 -160.56 0.74 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.099 0.476 . . . . 8.02 111.192 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.52 -176.77 14.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.467 -0.653 . . . . 5.79 111.467 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.5 tp -113.75 103.19 55.35 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.744 0.307 . . . . 4.72 111.366 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -95.04 59.85 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.375 2.717 . . . . 4.45 111.539 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -95.53 104.85 16.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.958 -0.564 . . . . 4.89 111.34 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -133.77 -171.02 2.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.854 -0.612 . . . . 4.35 110.442 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 m 73.12 94.51 0.08 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.429 0.633 . . . . 2.87 112.345 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -115.21 -162.36 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.959 -0.564 . . . . 2.48 110.814 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.583 ' HG ' ' HD1' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -94.06 166.39 12.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.484 -0.326 . . . . 2.57 110.895 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.85 -38.64 7.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.313 0.577 . . . . 2.4 110.2 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -108.58 165.67 11.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.649 -0.705 . . . . 2.02 110.402 179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.831 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 8.3 p -58.86 151.76 20.84 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.397 0.436 . . . . 2.65 111.366 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.98 137.31 40.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 2.4 112.015 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.4 mt -88.89 147.75 24.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.94 -0.763 . . . . 2.27 108.94 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.592 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -126.36 138.75 53.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.828 -0.349 . . . . 2.86 111.388 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -99.71 132.32 45.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 2.89 110.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.61 62.66 1.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.247 -0.649 . . . . 4.07 109.247 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.46 -159.68 9.58 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.686 -0.688 . . . . 3.23 111.907 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -91.05 -25.08 19.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.161 0.43 . . . . 4.51 112.161 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -90.6 176.02 6.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.671 0.272 . . . . 3.32 110.58 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.84 -71.38 0.68 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 2.41 109.961 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.9 tp 177.85 142.3 0.09 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.842 -0.617 . . . . 2.18 110.534 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -156.31 133.82 10.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.385 -0.37 . . . . 2.46 110.029 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -127.61 134.32 26.05 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.956 -0.387 . . . . 1.78 109.956 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.51 167.44 16.97 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.895 2.396 . . . . 2.15 112.411 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.54 127.06 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 2.84 110.518 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.09 6.88 78.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.826 -0.702 . . . . 1.65 112.466 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -138.75 147.27 42.45 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.232 -0.285 . . . . 2.57 110.232 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.63 -28.25 5.28 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.683 -0.77 . . . . 1.42 112.908 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.01 119.21 75.83 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.663 0.232 . . . . 1.09 110.725 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.94 168.71 18.07 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.556 2.17 . . . . 1.27 111.851 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 mt -74.62 81.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 1.7 111.604 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -83.97 86.61 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 1.23 110.118 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -21.66 65.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.96 111.597 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -75.85 -18.55 59.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 2.0 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -111.24 151.05 28.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.511 -0.313 . . . . 1.44 110.798 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.459 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 6.1 m -73.76 165.47 52.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 2.06 109.921 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.3 Cg_endo -52.77 -39.54 76.87 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.955 2.437 . . . . 1.42 113.342 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.509 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -76.51 -9.91 59.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.954 0.353 . . . . 1.78 111.954 -179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.6 m-20 -95.09 1.58 54.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.049 0.452 . . . . 1.6 109.946 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -83.9 61.64 6.52 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.058 -0.519 . . . . 1.19 111.108 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.644 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.2 tt -146.93 130.54 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.755 -0.657 . . . . 1.17 109.908 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.77 -141.32 3.51 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.237 -0.982 . . . . 0.61 113.111 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -163.69 170.18 17.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 1.13 110.345 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -109.94 130.31 55.55 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.507 -0.553 . . . . 1.69 109.507 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -103.41 132.38 49.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.895 0.379 . . . . 2.51 111.657 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -85.54 119.53 25.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.744 . . . . 2.62 110.216 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . . . -134.64 157.03 47.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 2.21 111.185 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 93.9 m -154.06 104.6 2.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.793 -0.639 . . . . 2.68 109.764 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -83.32 113.15 20.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.912 0.387 . . . . 3.78 111.459 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -121.72 87.47 2.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 3.58 109.438 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.5 pt -79.38 148.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 4.26 111.134 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -107.0 111.5 24.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 5.46 110.084 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.49 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -73.02 -167.03 10.74 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.933 -0.651 . . . . 4.66 113.606 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.56 -45.53 66.77 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.314 -0.47 . . . . 5.04 113.293 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -77.9 -10.86 59.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.342 0.591 . . . . 5.51 110.804 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.76 22.82 10.57 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.186 -0.765 . . . . 4.73 111.186 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HE3' ' OP2' ' C' ' 14' ' ' ' G' . 72.0 mmtt -84.24 159.34 21.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.044 -0.354 . . . . 5.75 110.044 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 35.6 mtt -133.4 131.82 40.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.371 -0.377 . . . . 4.48 110.01 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -60.95 -36.6 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.422 -0.584 . . . . 4.47 109.422 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t0 50.28 77.93 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.766 -1.106 . . . . 4.09 112.824 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 89.3 mt -80.37 146.03 31.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.397 -0.594 . . . . 3.36 109.397 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.1 m -69.12 158.15 87.34 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.278 -0.268 . . . . 3.47 110.278 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.61 103.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.922 2.415 . . . . 2.69 112.644 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' NH2' HOP3 ' B' ' 1' ' ' ' C' . 3.4 mtt180 -101.42 138.8 37.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.836 -0.62 . . . . 3.22 110.296 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.8 124.55 49.75 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.728 -0.669 . . . . 1.95 110.72 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.668 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 32.6 m-85 -109.42 127.32 54.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.683 -0.689 . . . . 2.76 109.525 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -78.07 126.47 30.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.905 0.383 . . . . 1.4 111.26 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.54 149.32 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.895 -0.78 . . . . 2.07 108.895 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -81.72 157.49 24.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.326 -0.25 . . . . 1.28 110.326 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.6 tp -58.45 115.34 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.524 -0.307 . . . . 1.66 111.045 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.57 52.19 4.03 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.606 -0.807 . . . . 1.66 111.852 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.94 78.55 5.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.921 0.391 . . . . 1.62 111.419 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.46 139.32 2.75 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.846 -0.692 . . . . 1.96 112.178 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.84 -26.27 32.3 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.587 2.191 . . . . 2.62 112.162 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.2 35.92 4.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 3.09 110.645 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.18 -55.59 5.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.999 -0.546 . . . . 1.87 110.95 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.13 36.57 92.05 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 1.7 112.019 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.67 103.55 53.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.026 0.441 . . . . 1.43 111.658 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 85.8 Cg_endo -84.8 165.46 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.388 2.059 . . . . 1.62 110.546 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -64.47 105.99 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.861 0.362 . . . . 1.75 110.274 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.13 -11.87 7.67 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.8 -0.714 . . . . 1.44 112.376 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -54.78 117.12 3.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.806 0.336 . . . . 1.25 111.389 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -76.48 99.76 5.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.539 . . . . 2.21 111.405 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -129.65 148.72 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 2.11 110.128 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.62 119.34 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.193 0.442 . . . . 1.7 112.193 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.02 53.31 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.848 -0.614 . . . . 1.32 112.624 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -129.54 111.09 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.88 0.371 . . . . 1.06 110.875 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.8 pt -115.91 118.71 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 1.3 110.08 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.72 136.95 35.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.634 0.605 . . . . 1.08 112.634 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 m -137.93 145.13 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.682 -0.69 . . . . 1.04 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.78 -177.58 6.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.274 -0.421 . . . . 1.27 109.972 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -153.64 172.8 16.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.629 -0.259 . . . . 1.58 110.581 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.62 115.91 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.275 0.559 . . . . 2.64 111.23 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.52 -19.63 16.47 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.82 -0.705 . . . . 1.63 112.001 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.644 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.85 126.98 31.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.382 -0.229 . . . . 1.59 110.382 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 66.9 mt -96.54 156.05 16.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.894 0.378 . . . . 2.15 111.295 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -84.4 83.82 7.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.145 0.498 . . . . 2.3 110.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.5 m -153.17 133.98 8.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.854 -0.612 . . . . 2.69 109.463 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.18 125.84 18.62 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.171 2.581 . . . . 2.08 112.086 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.3 mmtt -105.45 39.23 1.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.649 -0.705 . . . . 1.99 111.244 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -13.65 59.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.493 . . . . 2.55 111.551 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -70.38 -17.59 63.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 2.28 111.472 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.1 mt -96.02 -33.88 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.329 . . . . 2.0 110.768 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.58 57.22 4.17 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.914 -0.585 . . . . 2.33 112.389 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.7 t -134.1 20.23 3.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.421 0.629 . . . . 3.21 109.582 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 13.0 ttp180 -83.21 136.5 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.737 -0.665 . . . . 3.03 111.702 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -96.84 114.6 64.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 3.75 110.095 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 26.6 Cg_endo -61.47 -28.3 83.42 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.912 2.408 . . . . 3.39 113.182 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 -10.84 59.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 4.05 111.364 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -116.31 -21.53 9.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.477 -0.328 . . . . 4.78 111.709 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.414 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 2.7 t-20 -137.14 120.0 16.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.689 0.28 . . . . 3.41 110.61 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 155.54 39.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.055 -0.52 . . . . 3.21 111.625 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.44 154.19 24.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 3.0 111.204 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.6 mt -102.74 150.34 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.777 -0.453 . . . . 2.42 109.777 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.7 120.19 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.586 0.231 . . . . 2.74 110.415 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.54 119.39 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 2.19 110.517 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -122.88 160.53 25.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.293 -0.412 . . . . 2.49 110.699 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.47 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 87.3 mt -110.08 150.4 41.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 1.96 111.297 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -65.05 170.88 9.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.986 2.457 . . . . 1.84 112.27 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.08 113.36 3.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 2.77 111.254 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.51 -14.0 30.2 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.993 -0.622 . . . . 2.2 112.723 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 4.7 m -88.47 140.95 28.94 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.707 -0.29 . . . . 2.1 110.393 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.39 144.82 50.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.818 0.342 . . . . 2.87 111.793 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.9 mt -87.28 144.38 35.91 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.08 -0.509 . . . . 2.62 109.738 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.34 156.18 26.89 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.913 2.408 . . . . 2.77 112.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -62.01 122.4 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.743 -0.662 . . . . 4.28 111.122 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.02 -8.53 61.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.917 -0.658 . . . . 3.18 111.873 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -97.1 144.16 27.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.916 -0.402 . . . . 2.93 109.916 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.594 ' HH ' " H5'" ' B' ' 1' ' ' ' C' . 3.9 p90 -147.88 171.73 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 3.73 110.478 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -121.82 147.33 46.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 2.93 111.059 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.831 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.2 tp10 -68.47 122.5 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 3.64 110.67 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.86 66.65 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.013 -0.613 . . . . 3.27 112.98 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.7 m -76.54 106.28 8.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 3.59 111.779 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -119.69 91.53 3.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.789 -0.819 . . . . 6.05 108.789 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.87 160.34 50.22 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.056 -0.592 . . . . 5.22 112.51 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.64 -94.83 0.77 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.923 -0.656 . . . . 5.91 112.087 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.415 -0.802 . . . . 7.27 111.662 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.594 " H5'" ' HH ' ' A' ' 132' ' ' TYR . . . . . . . . 0 C2'--C1' 1.492 -3.572 1 C4'-C3'-C2' 97.023 -5.677 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.53 2 N19-C1'-C2' 103.505 -6.185 . 0.23 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.82 3 O4'-C1'-N19 115.743 7.543 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.188 4 O4'-C1'-N19 116.692 8.492 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.373 -4.159 2 C4'-C3'-C2' 97.541 -5.159 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.784 4 C1'-O4'-C4' 105.611 -4.432 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.252 3 P-O3'-C3' 127.053 6.128 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.668 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.581 5.31 3 O4'-C4'-C3' 114.96 6.757 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.101 2 O4'-C1'-N19 118.595 10.395 . 0.416 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.528 3 O3'-P-O5' 116.374 6.513 . 0.46 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.06 1 C4'-C3'-C2' 98.336 -4.364 . 0.313 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.533 1 C4'-C3'-C2' 94.393 -8.307 . 0.458 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.49 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.74 1 O3'-P-O5' 111.75 4.079 . 0.104 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . 0.479 ' OP2' ' HE3' ' A' ' 60' ' ' LYS . . . . . . . . 2 C2'--C1' 1.577 4.913 2 C3'-C2'-C1' 105.695 4.661 . 0.337 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.526 -0.63 . . . . 9.22 111.526 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.76 114.31 16.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.792 0.33 . . . . 8.25 110.176 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.75 110.62 12.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.275 -0.42 . . . . 8.02 111.339 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.76 141.66 7.66 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.365 -0.694 . . . . 5.79 111.365 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 mp -110.45 138.82 21.05 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.577 0.188 . . . . 4.72 110.738 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.93 -1.98 11.54 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.837 2.358 . . . . 4.45 112.46 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -73.12 142.74 47.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.209 -0.451 . . . . 4.89 110.521 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -92.79 -82.5 0.33 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.613 -0.267 . . . . 4.35 110.774 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 54.56 56.38 6.88 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.375 0.422 . . . . 2.87 111.564 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.53 160.49 29.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 2.48 111.906 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.52 164.91 26.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 2.57 111.016 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -90.65 -25.47 20.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 2.4 111.864 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 59.6 m-85 -115.75 171.61 7.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.27 0.47 . . . . 2.02 112.27 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.759 HG23 " H5'" ' C' ' 8' ' ' ' G' . 1.9 p -70.83 167.15 19.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 2.65 111.048 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.75 161.58 14.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.487 . . . . 2.4 111.058 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.98 127.24 56.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.505 -0.77 . . . . 2.27 109.758 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.439 HG22 ' HB2' ' A' ' 65' ' ' SER . 80.7 m -90.93 126.86 36.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.301 -0.409 . . . . 2.86 111.058 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -97.08 134.01 40.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 2.89 110.199 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -130.82 90.26 2.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 4.07 109.308 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.36 -151.25 8.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.566 -0.826 . . . . 3.23 112.828 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -108.6 -2.21 18.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.801 0.334 . . . . 4.51 111.789 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -120.07 176.76 5.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.257 -0.275 . . . . 3.32 110.257 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.49 -87.62 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.283 -0.417 . . . . 2.41 110.76 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.436 HD12 ' CE1' ' A' ' 131' ' ' PHE . 55.4 tp -172.36 127.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.84 0.353 . . . . 2.18 110.869 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -148.93 105.11 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 2.46 109.949 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -89.24 146.97 37.26 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.074 -0.512 . . . . 1.78 110.541 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.0 163.34 39.12 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.569 2.18 . . . . 2.15 111.857 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -58.11 122.54 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.884 -0.598 . . . . 2.84 111.016 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.11 -12.32 66.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.612 -0.804 . . . . 1.65 113.172 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -118.06 157.73 26.29 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.632 -0.334 . . . . 2.57 110.969 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.16 -26.16 5.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.57 -0.612 . . . . 1.42 111.57 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.43 119.65 77.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.343 -0.243 . . . . 1.09 110.343 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.15 -170.44 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.488 2.125 . . . . 1.27 110.797 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.94 90.84 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.121 0.486 . . . . 1.7 110.816 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.403 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 70.2 m-20 -93.98 73.36 4.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.417 -0.586 . . . . 1.23 109.417 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -20.73 66.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.362 -0.835 . . . . 1.96 111.927 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -82.45 -3.48 55.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.33 -0.396 . . . . 2.0 111.84 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -126.69 159.58 33.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.921 0.391 . . . . 1.44 111.815 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.506 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 m -82.67 167.24 31.19 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.634 -0.712 . . . . 2.06 110.139 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 13.7 Cg_endo -55.88 -35.67 94.34 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.939 2.426 . . . . 1.42 112.878 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 p-10 -78.73 -11.22 59.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.267 -0.424 . . . . 1.78 111.605 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -97.46 -1.9 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 1.6 109.895 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 75.6 mm-40 -78.52 53.88 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 1.19 111.119 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.486 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 13.5 tt -144.09 125.57 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.794 -0.639 . . . . 1.17 109.856 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.44 -145.23 4.38 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.142 -1.028 . . . . 0.61 112.522 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -160.02 170.75 20.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.121 -0.326 . . . . 1.13 110.121 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.518 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 39.0 m-85 -112.51 136.95 51.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.503 -0.554 . . . . 1.69 109.503 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -115.27 132.07 56.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.569 0.224 . . . . 2.51 110.534 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -82.03 124.99 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.076 -0.511 . . . . 2.62 109.672 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' C ' ' HG1' ' A' ' 51' ' ' THR . . . -133.61 156.2 48.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 2.21 111.206 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 50' ' ' ALA . 20.7 m -158.53 134.65 9.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 2.68 109.935 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -107.07 122.17 45.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 3.78 110.461 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -138.96 82.38 1.9 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.716 0.293 . . . . 3.58 111.532 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.662 HG12 ' HB2' ' A' ' 62' ' ' LYS . 26.3 pt -72.13 154.73 7.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.448 -0.342 . . . . 4.26 110.539 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -106.51 113.44 26.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 5.46 110.091 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.433 ' HA2' ' OP2' ' C' ' 13' ' ' ' U' . . . -72.51 161.52 54.39 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.161 -0.542 . . . . 4.66 112.449 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.94 -38.53 94.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.539 -0.362 . . . . 5.04 113.068 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.24 -35.98 76.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.161 0.505 . . . . 5.51 110.768 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.47 2.34 4.51 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.009 -0.836 . . . . 4.73 111.009 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -76.34 158.54 31.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.044 -0.354 . . . . 5.75 110.044 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.1 mmt -122.64 147.35 46.54 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.873 -0.417 . . . . 4.48 109.873 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.662 ' HB2' HG12 ' A' ' 54' ' ' ILE . 39.6 tptt -55.44 -49.73 71.67 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.521 0.513 . . . . 4.47 110.421 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.0 t70 59.02 91.17 0.05 OUTLIER 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.561 -0.745 . . . . 4.09 112.691 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.78 148.63 36.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.735 -0.666 . . . . 3.36 110.161 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -70.32 146.44 94.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.16 -0.473 . . . . 3.47 110.557 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.5 118.45 5.33 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.858 2.372 . . . . 2.69 111.559 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -119.09 146.36 45.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 3.22 111.31 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.518 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.7 m95 -112.8 131.3 55.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.721 -0.672 . . . . 1.95 110.227 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -109.66 145.29 36.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.101 -0.499 . . . . 2.76 109.685 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -94.63 127.64 40.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 1.4 111.257 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -130.4 162.49 29.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.977 -0.556 . . . . 2.07 109.673 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -93.52 168.39 11.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.582 -0.281 . . . . 1.28 110.418 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.58 126.94 29.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.524 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.67 47.1 92.49 Favored Glycine 0 CA--C 1.516 0.105 0 N-CA-C 115.274 0.869 . . . . 1.66 115.274 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -74.92 101.97 4.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.246 0.523 . . . . 1.62 110.023 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.82 136.97 5.1 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.828 -0.701 . . . . 1.96 111.431 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.79 -28.4 68.02 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.678 2.252 . . . . 2.62 112.496 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.9 53.01 1.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 3.09 110.743 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.08 -46.97 5.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.879 -0.6 . . . . 1.87 110.515 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.64 24.84 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.882 -0.887 . . . . 1.7 110.882 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.626 ' HB3' ' HH2' ' A' ' 92' ' ' TRP . 65.2 mt -125.93 94.93 40.73 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 1.43 111.968 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -91.33 135.93 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 1.62 110.812 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -52.57 115.16 1.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.251 -0.431 . . . . 1.75 111.568 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.38 8.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.658 . . . . 1.44 112.778 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.83 163.49 21.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.993 0.425 . . . . 1.25 111.026 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.64 131.21 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.442 -0.345 . . . . 2.21 110.936 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -148.53 155.83 41.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.52 . . . . 2.11 110.109 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.35 117.57 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.257 -0.429 . . . . 1.7 111.919 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.6 34.62 67.34 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.75 -0.659 . . . . 1.32 112.635 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.3 mm -134.44 114.95 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.748 0.308 . . . . 1.06 110.687 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.5 pt -123.03 134.78 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.878 -0.416 . . . . 1.3 109.878 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.626 ' HH2' ' HB3' ' A' ' 81' ' ' LEU . 56.5 m95 -90.28 144.82 25.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.586 0.587 . . . . 1.08 112.586 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.0 m -142.07 134.6 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.521 -0.763 . . . . 1.04 109.993 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.62 147.46 26.78 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.818 0.342 . . . . 1.27 111.229 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.8 t -106.42 166.83 10.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.984 -0.553 . . . . 1.58 109.892 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.05 117.87 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.048 0.452 . . . . 2.64 110.319 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.7 -4.71 22.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.901 -0.666 . . . . 1.63 111.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -80.27 144.98 32.41 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.439 -0.208 . . . . 1.59 110.439 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.451 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 62.0 mt -90.38 139.61 30.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.728 0.299 . . . . 2.15 110.867 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -84.06 79.21 9.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.247 0.546 . . . . 2.3 110.111 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.44 154.22 13.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.788 -0.642 . . . . 2.69 110.034 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.67 129.02 27.63 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.678 2.252 . . . . 2.08 112.292 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -116.53 45.63 1.77 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.797 -0.638 . . . . 1.99 110.508 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -13.74 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.691 -0.686 . . . . 2.55 112.282 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -61.62 -12.97 18.25 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.375 0.509 . . . . 2.28 112.375 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.8 mt -104.0 -32.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 2.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.57 -9.0 42.29 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.845 -0.616 . . . . 2.33 114.558 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.0 t -79.72 63.0 4.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.332 0.586 . . . . 3.21 111.215 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.0 ttp85 -118.33 139.71 50.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 3.03 110.926 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -99.98 115.26 65.7 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.981 -0.554 . . . . 3.75 110.317 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.02 -24.47 39.17 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.979 2.453 . . . . 3.39 113.332 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.09 1.48 56.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 4.05 111.366 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -119.04 -48.61 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 4.78 110.158 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -106.93 137.13 45.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 3.41 110.52 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.44 139.5 45.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.103 -0.332 . . . . 3.21 110.103 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.8 158.1 28.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.057 0.456 . . . . 3.0 111.183 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 25.8 mt -104.99 141.92 19.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.974 -0.557 . . . . 2.42 109.796 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.62 127.08 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.883 -0.414 . . . . 2.74 109.883 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -66.7 116.73 7.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.485 . . . . 2.19 110.019 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.58 149.37 43.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.189 -0.46 . . . . 2.49 110.865 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.36 146.79 33.12 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.522 . . . . 1.96 109.957 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.64 157.18 62.18 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.603 2.202 . . . . 1.84 111.823 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.02 118.36 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 2.77 110.935 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.41 -15.18 17.85 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.744 -0.741 . . . . 2.2 111.349 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.2 m -104.99 119.42 38.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.965 0.412 . . . . 2.1 110.55 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.94 152.49 25.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.084 -0.507 . . . . 2.87 110.498 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.22 140.69 34.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.593 -0.276 . . . . 2.62 110.369 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.36 147.24 96.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.39 2.06 . . . . 2.77 110.902 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -51.3 123.15 9.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 4.28 112.042 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.24 4.74 56.31 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.059 -0.591 . . . . 3.18 112.586 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CE1' HD12 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -123.1 130.95 53.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.792 0.329 . . . . 2.93 111.182 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -153.45 149.56 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.085 -0.507 . . . . 3.73 110.248 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.4 146.32 27.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 2.93 110.886 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -70.59 150.31 46.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 3.64 110.891 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.14 64.97 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.756 -0.735 . . . . 3.27 112.255 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 116.93 22.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.614 0.245 . . . . 3.59 110.769 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? -128.4 -178.88 4.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.507 -0.553 . . . . 6.05 109.507 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.54 70.65 2.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.661 -0.781 . . . . 5.22 111.862 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -110.69 93.72 0.74 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.905 -0.664 . . . . 5.91 112.245 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.879 -0.581 . . . . 7.27 111.195 179.78 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.421 ' H42' ' HE3' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.575 1 C4'-C3'-C2' 97.108 -5.592 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.473 4.594 2 N19-C1'-C2' 103.532 -6.167 . 0.229 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.463 -5.66 3 O4'-C1'-N19 115.798 7.598 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.592 6.112 4 O4'-C1'-N19 116.711 8.511 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.09 2 C4'-C3'-C2' 97.593 -5.107 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.734 4 N19-C1'-C2' 106.338 -4.413 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.381 3 P-O3'-C3' 127.03 6.109 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.759 " H5'" HG23 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.582 5.356 3 O4'-C4'-C3' 114.952 6.751 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.912 2 O4'-C1'-N19 118.616 10.416 . 0.415 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.483 3 O3'-P-O5' 116.334 6.492 . 0.461 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.211 1 C4'-C3'-C2' 98.274 -4.426 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.581 1 C4'-C3'-C2' 94.346 -8.354 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.433 ' OP2' ' HA2' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.723 1 O3'-P-O5' 111.747 4.077 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.958 2 C3'-C2'-C1' 105.749 4.721 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 111.827 -0.509 . . . . 9.22 111.827 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.71 109.56 20.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.856 0.36 . . . . 8.25 110.779 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -98.45 116.61 31.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 8.02 110.231 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.09 -149.66 6.01 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.558 -0.829 . . . . 5.79 112.125 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.0 mt -140.97 121.68 8.84 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 110.488 -0.19 . . . . 4.72 110.488 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.97 41.06 1.06 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.959 2.439 . . . . 4.45 111.261 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -134.23 -173.7 3.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.692 -0.686 . . . . 4.89 109.849 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -105.48 -68.91 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.459 -0.337 . . . . 4.35 110.276 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 57.69 75.21 0.39 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.412 0.893 . . . . 2.87 113.412 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.85 128.74 37.81 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.49 -0.559 . . . . 2.48 109.49 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -53.23 146.17 12.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.348 0.87 . . . . 2.57 113.348 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -73.12 -35.0 66.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.793 -0.64 . . . . 2.4 110.759 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -108.36 170.92 7.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.822 -0.626 . . . . 2.02 111.245 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.743 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 11.2 p -69.15 168.48 13.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.646 -0.706 . . . . 2.65 111.142 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.99 159.76 15.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 2.4 110.989 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.613 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 35.9 mt -100.17 112.7 25.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.258 -0.428 . . . . 2.27 110.267 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 m -82.82 113.33 20.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.237 -0.438 . . . . 2.86 111.632 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.37 146.58 26.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 2.89 111.331 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -141.18 89.26 2.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.927 -0.579 . . . . 4.07 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.63 -168.33 41.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.893 -0.67 . . . . 3.23 112.22 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -81.93 -31.59 31.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.763 0.316 . . . . 4.51 111.267 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.61 -174.14 5.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.262 -0.426 . . . . 3.32 109.922 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -112.53 -88.12 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.608 -0.516 . . . . 2.41 109.608 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.5 tp -168.94 126.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 2.18 110.465 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -146.79 134.39 20.99 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.89 -0.411 . . . . 2.46 109.89 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.78 150.84 46.46 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 1.78 110.029 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 56.3 Cg_endo -73.06 -173.51 1.27 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.568 2.179 . . . . 2.15 112.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -79.97 126.39 30.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.234 -0.439 . . . . 2.84 110.891 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.9 -7.44 80.18 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 1.65 113.111 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.501 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 21.4 tt0 -122.55 154.28 38.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.184 -0.302 . . . . 2.57 110.184 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.3 -21.34 7.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.435 -0.888 . . . . 1.42 112.585 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 43' ' ' GLN . 43.1 t -80.06 119.53 76.89 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.661 0.267 . . . . 1.09 110.562 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.9 -176.59 2.68 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.947 2.431 . . . . 1.27 111.738 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.94 87.92 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.359 -0.382 . . . . 1.7 110.303 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -85.83 83.14 7.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 1.23 110.197 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.68 1.21 3.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.567 -0.742 . . . . 1.96 112.879 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -107.57 -6.39 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.28 . . . . 2.0 111.212 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.31 150.35 47.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.09 -0.244 . . . . 1.44 110.957 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -71.95 162.49 73.11 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.814 -0.439 . . . . 2.06 109.814 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -34.9 78.19 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 1.42 112.24 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -18.86 61.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.903 -0.59 . . . . 1.78 111.432 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.14 0.99 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 1.6 111.092 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.455 ' HB3' HG11 ' A' ' 32' ' ' VAL . 69.0 mm-40 -79.15 59.98 2.89 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.09 0.471 . . . . 1.19 110.957 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.523 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -146.66 130.68 10.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.919 -0.582 . . . . 1.17 110.252 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.72 -141.36 3.62 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.522 -0.847 . . . . 0.61 112.807 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -160.56 159.47 30.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 1.13 110.374 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.413 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 49.0 m-85 -100.09 133.14 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.621 -0.881 . . . . 1.69 108.621 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -117.86 122.41 43.28 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.229 0.331 . . . . 2.51 111.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.52 129.93 35.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.281 -0.418 . . . . 2.62 110.035 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.27 140.0 27.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.727 0.299 . . . . 2.21 110.814 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 133.81 38.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 2.68 111.074 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.536 ' HB3' HD13 ' A' ' 64' ' ' LEU . 28.0 tpt180 -101.87 129.27 48.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.006 -0.738 . . . . 3.78 109.006 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttt180 -138.86 78.05 1.65 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.668 -0.242 . . . . 3.58 110.851 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 153.3 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.965 -0.294 . . . . 4.26 110.592 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -134.75 120.92 20.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 5.46 110.489 -178.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.77 179.86 40.41 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.869 -0.682 . . . . 4.66 112.306 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.65 -39.27 96.6 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.127 -0.559 . . . . 5.04 112.975 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.83 -35.5 78.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.852 0.358 . . . . 5.51 111.157 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.05 27.3 1.55 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.448 -0.882 . . . . 4.73 112.731 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 55' ' ' ARG . 21.8 mmtt -91.36 141.17 29.05 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.225 -0.657 . . . . 5.75 109.225 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.9 mtt -125.78 131.3 52.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.555 0.217 . . . . 4.48 110.836 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -62.16 -47.31 85.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 4.47 110.988 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.471 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 25.0 t70 61.24 90.3 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.895 -0.593 . . . . 4.09 112.291 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 52' ' ' ARG . 15.4 mt -87.13 157.94 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.317 -0.401 . . . . 3.36 110.384 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -77.83 149.42 77.29 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.08 -0.509 . . . . 3.47 109.919 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.41 110.5 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.917 2.412 . . . . 2.69 111.648 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.525 HH21 ' CD ' ' A' ' 134' ' ' GLU . 5.5 mtp180 -121.42 138.81 54.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 3.22 111.51 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.445 ' CZ3' HG12 ' A' ' 91' ' ' ILE . 29.2 m95 -104.33 123.92 48.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.872 -0.604 . . . . 1.95 110.434 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.99 131.8 45.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.551 -0.537 . . . . 2.76 109.551 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -79.83 127.35 32.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.842 0.353 . . . . 1.4 111.099 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -124.84 148.25 48.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.988 -0.551 . . . . 2.07 109.587 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -84.87 159.27 20.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.939 -0.393 . . . . 1.28 109.939 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 1.9 tt -61.65 118.09 6.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.286 -0.265 . . . . 1.66 110.286 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.82 32.78 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 1.66 112.618 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.3 68.62 8.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 1.62 111.058 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.45 118.6 0.51 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.482 -1.047 . . . . 1.96 110.482 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.66 -43.68 44.54 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.101 2.534 . . . . 2.62 112.379 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.18 53.29 0.83 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.167 0.508 . . . . 3.09 111.153 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.19 -58.7 2.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.028 0.442 . . . . 1.87 109.808 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.72 65.02 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.7 112.706 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt -134.03 102.18 12.26 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.603 0.239 . . . . 1.43 110.509 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.05 176.61 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.933 2.422 . . . . 1.62 111.772 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -57.87 116.44 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 1.75 110.646 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.9 -17.51 9.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.685 -0.769 . . . . 1.44 111.987 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.16 110.35 3.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.408 . . . . 1.25 110.462 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -76.89 124.27 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 2.21 110.856 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' HB3' HG13 ' A' ' 90' ' ' ILE . 29.5 tttt -143.19 154.46 43.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.432 -0.581 . . . . 2.11 109.432 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.09 119.54 8.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.411 -0.358 . . . . 1.7 111.546 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.55 29.99 67.16 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.932 -0.577 . . . . 1.32 112.58 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.419 HG13 ' HB3' ' A' ' 87' ' ' LYS . 39.8 mm -127.77 111.82 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 1.06 110.933 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 26.7 pt -117.96 120.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.3 110.507 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.534 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 94.9 m95 -79.94 135.36 36.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.125 -0.488 . . . . 1.08 112.108 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.22 137.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.623 -0.717 . . . . 1.04 111.005 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.43 152.18 39.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.994 -0.548 . . . . 1.27 109.879 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.0 t -114.77 170.79 8.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.956 0.407 . . . . 1.58 110.694 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -67.27 113.23 5.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.081 -0.509 . . . . 2.64 110.67 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.39 -11.67 21.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.857 -0.687 . . . . 1.63 111.826 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -86.18 120.03 27.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.779 0.323 . . . . 1.59 110.512 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.77 142.72 27.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 2.15 111.397 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -71.5 96.66 1.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.894 -0.594 . . . . 2.3 110.237 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 72.7 m -156.19 138.62 10.35 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.561 -0.745 . . . . 2.69 109.176 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -67.13 107.33 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.383 2.056 . . . . 2.08 111.244 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -95.66 75.42 3.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.314 -0.403 . . . . 1.99 110.149 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -15.89 61.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.548 -0.296 . . . . 2.55 111.321 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -60.19 -25.02 65.25 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.196 -0.456 . . . . 2.28 111.958 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.87 2.15 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.46 0.648 . . . . 2.0 110.246 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.33 51.63 1.84 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.004 -0.617 . . . . 2.33 111.579 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t -160.93 125.88 3.67 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.99 -0.374 . . . . 3.21 109.99 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -166.1 134.66 3.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.871 -0.418 . . . . 3.03 109.871 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -83.33 112.0 35.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 3.75 110.169 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.02 -30.61 90.03 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.065 2.51 . . . . 3.39 113.864 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.91 -5.15 57.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.78 0.324 . . . . 4.05 111.797 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -116.42 1.27 12.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.495 -0.32 . . . . 4.78 111.664 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -154.39 133.64 12.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.673 0.273 . . . . 3.41 110.54 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.38 141.68 28.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.42 . . . . 3.21 110.209 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.59 140.77 49.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.992 0.425 . . . . 3.0 111.147 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 mt -92.21 150.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 2.42 109.885 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -62.54 120.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 2.74 110.683 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.52 124.27 22.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.736 -0.666 . . . . 2.19 110.333 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.66 151.83 48.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.17 -0.468 . . . . 2.49 110.704 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.4 mt -98.58 137.48 20.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.049 -0.523 . . . . 1.96 109.921 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.72 152.53 41.34 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.123 2.549 . . . . 1.84 112.939 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -52.3 123.62 11.23 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.476 -0.784 . . . . 2.77 110.915 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 109.08 -14.65 33.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.809 -0.71 . . . . 2.2 111.45 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.1 m -111.81 123.64 50.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.915 -0.402 . . . . 2.1 109.915 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 150.03 32.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.883 0.373 . . . . 2.87 111.246 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.54 143.15 58.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.588 . . . . 2.62 109.858 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.58 138.78 87.78 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.675 2.25 . . . . 2.77 111.13 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -55.21 118.38 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 4.28 111.263 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.15 -20.11 12.97 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.54 -0.624 . . . . 3.18 111.54 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.613 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -89.28 147.53 24.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.638 0.256 . . . . 2.93 110.794 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.12 145.87 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.141 -0.482 . . . . 3.73 110.931 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.48 152.03 23.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.924 -0.58 . . . . 2.93 111.317 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.743 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.1 tp10 -73.3 128.11 34.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 3.64 110.446 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.82 80.02 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.027 -0.606 . . . . 3.27 112.323 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 t -101.4 134.44 44.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 3.59 111.489 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -167.81 176.61 6.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.381 -0.827 . . . . 6.05 108.829 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.43 133.72 33.09 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.429 -0.891 . . . . 5.22 111.254 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.33 -127.21 7.9 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.847 -0.692 . . . . 5.91 112.017 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 119.021 -0.514 . . . . 7.27 111.971 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.61 1 C4'-C3'-C2' 97.045 -5.655 . 0.0 '__' . 12.52 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.471 4.49 2 N19-C1'-C2' 103.557 -6.152 . 0.232 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.7 3 O4'-C1'-N19 115.773 7.573 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.272 4 O4'-C1'-N19 116.651 8.451 . 0.509 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.087 2 C4'-C3'-C2' 97.508 -5.192 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.778 4 N19-C1'-C2' 106.364 -4.398 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.33 3 P-O3'-C3' 126.972 6.06 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.581 5.324 3 O4'-C4'-C3' 114.855 6.682 . 0.0 '__' . 15.4 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.946 2 O4'-C1'-N19 118.548 10.348 . 0.416 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.469 3 O3'-P-O5' 116.284 6.465 . 0.462 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.159 1 C4'-C3'-C2' 98.309 -4.391 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.521 1 C4'-C3'-C2' 94.401 -8.299 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.705 1 O3'-P-O5' 111.731 4.069 . 0.104 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.986 2 C3'-C2'-C1' 105.753 4.726 . 0.333 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 111.612 -0.595 . . . . 9.22 111.612 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.05 121.23 14.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.689 0.28 . . . . 8.25 110.611 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.0 ttt -105.86 140.39 38.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 8.02 110.724 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.9 143.1 11.5 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.957 -0.639 . . . . 5.79 111.646 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.8 134.01 23.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 O-C-N 122.603 -0.351 . . . . 4.72 111.204 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -90.48 26.14 0.51 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.143 2.562 . . . . 4.45 111.272 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -91.66 156.01 17.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.851 -0.613 . . . . 4.89 110.692 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -71.1 -74.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.618 0.574 . . . . 4.35 110.781 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p 44.88 77.1 0.08 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.706 0.632 . . . . 2.87 112.706 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.29 135.62 50.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.952 0.406 . . . . 2.48 111.342 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.6 m -73.5 151.25 41.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 2.57 110.491 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -87.0 -13.72 43.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.424 . . . . 2.4 112.061 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -119.41 163.35 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.856 0.317 . . . . 2.02 111.856 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 p -71.03 168.36 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 2.65 111.034 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.65 156.75 27.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.266 0.555 . . . . 2.4 112.129 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.585 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -112.39 122.32 47.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.55 -0.75 . . . . 2.27 109.23 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.95 128.62 38.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.883 0.373 . . . . 2.86 111.951 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -105.26 128.89 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 2.89 110.25 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -119.7 89.36 3.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 4.07 110.504 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.53 -167.66 40.75 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.884 -0.886 . . . . 3.23 110.884 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -86.38 -34.87 20.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.146 0.473 . . . . 4.51 111.334 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -68.64 151.63 46.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.387 . . . . 3.32 110.105 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 -85.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.136 -0.32 . . . . 2.41 110.136 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 131' ' ' PHE . 34.4 tp -168.6 130.27 1.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.482 -0.326 . . . . 2.18 110.392 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -153.02 132.06 12.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 2.46 109.485 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -125.55 138.2 31.39 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.581 -0.281 . . . . 1.78 110.69 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.27 163.92 32.49 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.738 2.292 . . . . 2.15 112.235 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -60.99 117.43 5.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.356 -0.838 . . . . 2.84 111.023 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.32 0.2 56.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.788 . . . . 1.65 112.618 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -127.88 162.37 26.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.78 0.324 . . . . 2.57 110.139 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.73 5.75 44.48 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.869 -0.682 . . . . 1.42 111.821 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.4 t -100.03 114.81 65.84 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.931 -0.396 . . . . 1.09 109.931 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.1 -175.58 2.73 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.043 2.495 . . . . 1.27 111.73 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -83.1 85.33 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.146 0.498 . . . . 1.7 110.66 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -80.74 93.81 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.861 -0.609 . . . . 1.23 110.916 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.3 p -85.57 3.69 39.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 1.96 111.473 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -107.9 -4.12 18.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 2.0 111.075 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.75 152.12 51.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.899 0.38 . . . . 1.44 111.874 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.4 m -78.75 168.69 25.11 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 2.06 110.111 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 77.3 Cg_exo -53.2 -37.49 80.27 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.835 2.357 . . . . 1.42 112.904 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -72.37 -8.76 56.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 1.78 111.469 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.631 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 12.2 m-20 -104.41 4.35 33.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 1.6 110.508 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.401 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 36.8 mm-40 -79.26 58.55 2.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.993 0.425 . . . . 1.19 111.822 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -152.03 128.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 1.17 110.263 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.83 -157.51 10.09 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.31 -0.948 . . . . 0.61 112.971 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -149.72 147.92 28.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.918 0.389 . . . . 1.13 111.296 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 11.0 m-85 -90.38 137.0 32.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 1.69 109.552 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -114.13 130.29 56.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.453 -0.34 . . . . 2.51 111.259 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -71.29 125.17 26.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.002 -0.74 . . . . 2.62 109.002 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.31 127.55 55.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.035 0.445 . . . . 2.21 112.066 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.11 140.34 51.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.905 -0.776 . . . . 2.68 108.905 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.481 ' HB3' HD13 ' A' ' 64' ' ' LEU . 14.9 tpt180 -150.19 111.1 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.618 0.599 . . . . 3.78 112.618 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 94.0 mtt180 -135.72 107.06 6.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.797 -0.638 . . . . 3.58 110.223 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.0 pt -68.4 171.04 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 4.26 110.842 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -128.18 107.8 10.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.839 0.352 . . . . 5.46 110.85 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.43 164.59 36.5 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.648 -0.787 . . . . 4.66 111.408 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.32 -33.06 85.67 Favored Glycine 0 C--N 1.328 0.138 0 C-N-CA 120.931 -0.652 . . . . 5.04 112.137 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -79.27 -2.9 43.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.647 0.737 . . . . 5.51 110.421 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.37 29.38 22.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.595 -0.73 . . . . 4.73 111.399 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -90.08 164.21 14.58 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.342 -0.244 . . . . 5.75 110.342 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -139.37 148.13 42.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.047 -0.524 . . . . 4.48 109.996 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HB2' HG12 ' A' ' 54' ' ' ILE . 68.9 tttt -75.7 -38.56 58.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 4.47 110.382 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 26.5 t70 52.4 81.45 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.547 -0.752 . . . . 4.09 112.429 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 52' ' ' ARG . 24.3 mt -81.7 151.51 27.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.222 -0.445 . . . . 3.36 110.439 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -67.85 148.14 98.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.902 -0.59 . . . . 3.47 110.011 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.39 108.12 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.849 2.366 . . . . 2.69 111.768 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.477 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 3.6 ptp180 -119.27 144.17 46.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 3.22 111.261 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.535 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 34.4 m95 -115.08 139.01 50.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.014 -0.539 . . . . 1.95 110.238 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.549 ' OH ' H5'' ' C' ' 8' ' ' ' G' . 6.1 m-85 -113.84 140.89 47.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 2.76 110.312 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.97 126.5 35.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 1.4 111.276 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -123.0 151.2 42.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 2.07 109.381 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.88 148.9 21.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.943 -0.392 . . . . 1.28 109.943 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.19 123.05 16.02 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.147 0.279 . . . . 1.66 110.563 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -9.16 19.01 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.631 -0.795 . . . . 1.66 112.22 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -65.24 131.7 47.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.607 0.242 . . . . 1.62 110.359 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.15 106.96 1.95 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.573 -0.822 . . . . 1.96 111.333 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.85 -44.43 47.59 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.654 2.236 . . . . 2.62 112.282 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.71 28.85 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.148 -0.478 . . . . 3.09 111.636 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.2 -61.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.821 0.343 . . . . 1.87 110.695 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.05 48.83 10.49 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.042 -0.823 . . . . 1.7 111.042 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.8 91.22 48.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 1.43 111.659 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.34 162.74 13.05 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.467 2.111 . . . . 1.62 110.929 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.17 104.88 0.35 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.123 0.487 . . . . 1.75 111.246 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.39 -26.97 3.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.665 -0.698 . . . . 1.44 112.006 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.79 123.5 19.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 1.25 110.872 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -95.76 136.11 36.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.227 -0.442 . . . . 2.21 111.602 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -143.22 155.17 44.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.873 -0.788 . . . . 2.11 108.873 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.74 115.28 6.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.184 0.516 . . . . 1.7 111.694 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.16 22.01 46.84 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.825 -0.625 . . . . 1.32 112.533 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.7 mm -136.7 133.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.163 -0.31 . . . . 1.06 110.163 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.4 pt -130.81 163.2 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.806 -0.442 . . . . 1.3 109.806 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -112.78 138.68 49.25 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.481 0.548 . . . . 1.08 112.481 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.62 133.29 32.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 1.04 110.233 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.74 132.97 14.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.354 -0.385 . . . . 1.27 110.214 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.4 t -102.47 170.57 7.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.818 0.342 . . . . 1.58 110.89 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -69.48 126.53 30.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.082 -0.508 . . . . 2.64 110.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.46 -11.61 25.96 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.307 -0.717 . . . . 1.63 111.307 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -89.75 149.22 22.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.647 -0.277 . . . . 1.59 110.539 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.61 141.71 41.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.352 -0.385 . . . . 2.15 110.951 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -80.27 97.78 7.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 2.3 110.555 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.484 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 5.0 t -170.29 145.54 2.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.044 -0.724 . . . . 2.69 109.044 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.34 128.7 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.542 2.161 . . . . 2.08 112.783 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.631 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.02 73.68 1.49 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 1.99 111.075 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.24 1.15 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.328 -0.396 . . . . 2.55 111.895 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -60.11 -16.61 33.6 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.077 0.399 . . . . 2.28 112.077 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.4 pt -121.95 27.36 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.104 0.478 . . . . 2.0 109.975 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -102.92 -24.68 7.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.731 -0.747 . . . . 2.33 113.807 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -96.35 131.23 43.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.217 0.532 . . . . 3.21 111.504 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.3 ttp85 -159.53 133.48 7.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.258 -0.428 . . . . 3.03 110.28 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -77.26 113.27 29.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 110.072 -0.344 . . . . 3.75 110.072 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -85.17 -12.06 7.11 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 3.39 112.897 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.06 -9.71 47.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 4.05 110.694 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -133.15 18.64 4.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.73 -0.668 . . . . 4.78 110.641 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -169.35 132.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 3.41 111.128 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.566 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -94.58 159.09 15.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.214 -0.448 . . . . 3.21 110.419 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.09 150.57 23.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.799 0.333 . . . . 3.0 111.351 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.3 mt -78.11 143.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 2.42 109.735 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.8 t -61.48 120.16 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.088 -0.245 . . . . 2.74 110.552 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.441 HD11 ' HH ' ' A' ' 47' ' ' TYR . 3.5 tt -62.85 118.72 8.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.081 0.467 . . . . 2.19 110.603 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.12 148.76 52.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 2.49 110.489 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 66.1 mt -98.59 147.34 33.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.318 -0.401 . . . . 1.96 110.247 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.63 166.16 10.34 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.833 2.356 . . . . 1.84 112.435 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -61.85 118.47 7.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.057 -0.52 . . . . 2.77 110.815 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.13 -24.98 14.87 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.403 -0.679 . . . . 2.2 111.403 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 m -88.46 103.75 16.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.926 0.393 . . . . 2.1 110.093 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -90.68 144.46 25.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.313 -0.403 . . . . 2.87 111.217 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.55 142.87 78.22 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 2.62 110.172 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -60.0 149.91 81.56 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 2.77 111.452 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -61.4 119.43 8.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 4.28 110.784 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.25 54.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.772 -0.728 . . . . 3.18 112.127 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.585 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -103.94 127.59 51.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 2.93 110.449 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -133.97 151.62 51.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.319 -0.401 . . . . 3.73 110.853 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.98 139.86 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 2.93 112.031 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.434 ' HG2' ' OP1' ' C' ' 8' ' ' ' G' . 10.6 tp10 -66.39 131.38 45.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.888 -0.596 . . . . 3.64 109.886 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.3 -37.07 3.14 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.328 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.76 119.22 18.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.64 0.257 . . . . 3.59 110.802 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -118.3 113.96 22.25 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.576 -0.527 . . . . 6.05 109.576 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.09 134.54 12.63 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.847 -0.692 . . . . 5.22 112.648 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.32 -74.42 0.32 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.999 -0.619 . . . . 5.91 111.707 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 119.034 -0.508 . . . . 7.27 111.686 179.752 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.402 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.493 -3.533 1 C4'-C3'-C2' 97.068 -5.632 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.402 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.464 2 N19-C1'-C2' 103.569 -6.145 . 0.234 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.797 3 O4'-C1'-N19 115.687 7.487 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.268 4 O4'-C1'-N19 116.703 8.503 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.373 -4.206 2 C4'-C3'-C2' 97.525 -5.175 . 0.655 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.597 4 C4'-C3'-C2' 98.274 -4.426 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.496 5.228 3 P-O3'-C3' 126.991 6.076 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.566 " H1'" ' HA ' ' A' ' 115' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.357 3 O4'-C4'-C3' 114.909 6.721 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.019 2 O4'-C1'-N19 118.643 10.443 . 0.413 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.485 3 O3'-P-O5' 116.338 6.494 . 0.462 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.073 1 C4'-C3'-C2' 98.271 -4.429 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.658 1 C4'-C3'-C2' 94.298 -8.402 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.586 5.658 1 O3'-P-O5' 111.66 4.031 . 0.107 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.886 2 C3'-C2'-C1' 105.758 4.731 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.615 -0.594 . . . . 9.22 111.615 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 115.92 23.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.702 0.287 . . . . 8.25 110.734 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -83.15 132.56 35.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.194 -0.457 . . . . 8.02 110.838 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.54 -172.27 40.25 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.512 -0.635 . . . . 5.79 111.512 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.7 tp -106.09 115.07 61.8 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.64 0.257 . . . . 4.72 110.461 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.59 40.68 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.107 2.538 . . . . 4.45 111.885 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -115.07 66.88 0.69 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.33 -0.396 . . . . 4.89 110.704 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -170.24 174.75 5.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 4.35 110.185 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p 52.49 81.6 0.08 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.396 0.887 . . . . 2.87 113.396 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.24 138.33 31.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 2.48 110.851 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -55.08 143.47 26.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.052 -0.522 . . . . 2.57 112.019 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -67.89 -28.6 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 2.4 110.96 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.87 168.61 9.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.111 -0.495 . . . . 2.02 112.28 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -70.95 160.78 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.168 -0.923 . . . . 2.65 111.289 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.72 134.75 33.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.4 110.533 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.37 132.62 33.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.148 -0.478 . . . . 2.27 110.163 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 m -96.34 112.82 24.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.294 -0.412 . . . . 2.86 110.067 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -83.9 140.28 32.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 2.89 111.016 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -141.84 80.13 1.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.692 -0.485 . . . . 4.07 109.692 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.6 -166.45 29.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.987 -0.625 . . . . 3.23 112.199 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -91.68 -9.87 42.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 4.51 111.019 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -105.18 162.07 13.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.085 -0.507 . . . . 3.32 109.884 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.0 -65.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.77 -0.826 . . . . 2.41 108.77 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.8 tp 175.31 133.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.395 -0.82 . . . . 2.18 110.533 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -150.64 117.57 5.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.068 -0.515 . . . . 2.46 110.304 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -108.12 139.63 20.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.55 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 49.8 Cg_endo -69.77 172.55 12.45 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.69 2.26 . . . . 2.15 112.421 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -69.45 127.62 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.878 -0.601 . . . . 2.84 110.848 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.68 25.06 63.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.942 -0.647 . . . . 1.65 112.622 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -151.38 158.78 44.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.547 -0.538 . . . . 2.57 109.547 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 21.63 9.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.744 -0.741 . . . . 1.42 111.418 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.84 110.35 63.6 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.183 -0.303 . . . . 1.09 110.183 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.65 175.15 7.5 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.723 2.282 . . . . 1.27 111.09 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.0 mt -72.93 87.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 1.7 110.686 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -82.76 74.96 9.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.808 -0.633 . . . . 1.23 109.775 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -31.5 72.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.34 0.496 . . . . 1.96 112.34 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.58 -7.19 59.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.596 -0.274 . . . . 2.0 111.68 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.92 150.15 32.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.098 0.475 . . . . 1.44 112.095 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.58 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 13.7 m -90.29 170.2 10.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.51 -0.768 . . . . 2.06 109.471 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 3.0 Cg_endo -46.79 -44.92 21.38 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.324 2.683 . . . . 1.42 114.094 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -70.52 -25.98 63.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.888 0.329 . . . . 1.78 111.888 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.805 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.3 m-20 -86.77 2.79 47.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.267 -0.424 . . . . 1.6 110.844 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -80.48 46.08 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.107 0.48 . . . . 1.19 111.119 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.784 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.7 tt -143.12 132.47 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.022 -0.535 . . . . 1.17 110.191 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.68 -145.55 4.8 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.414 -0.898 . . . . 0.61 112.158 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -155.6 159.91 40.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.122 0.487 . . . . 1.13 110.98 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -99.91 117.86 35.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.471 -0.786 . . . . 1.69 109.475 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -99.5 127.08 45.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.984 0.421 . . . . 2.51 111.321 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -85.24 135.25 34.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.839 -0.619 . . . . 2.62 110.432 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.7 42.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 2.21 111.37 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.7 m -152.98 127.32 9.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.062 -0.718 . . . . 2.68 109.062 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 tpt85 -103.63 126.67 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.492 0.553 . . . . 3.78 112.492 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -142.92 107.56 4.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 3.58 109.472 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 169.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.63 0.252 . . . . 4.26 110.71 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.4 110.6 22.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.491 -0.322 . . . . 5.46 110.464 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.07 168.53 50.82 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.529 -0.843 . . . . 4.66 112.714 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.35 -38.61 70.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.984 -0.627 . . . . 5.04 112.154 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -95.13 11.46 32.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.386 0.612 . . . . 5.51 110.351 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.09 18.93 54.91 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.812 -0.709 . . . . 4.73 111.76 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -76.45 155.4 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.175 -0.305 . . . . 5.75 110.175 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.32 174.3 10.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 4.48 110.906 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -97.89 -24.57 15.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 4.47 110.174 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 48.53 90.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.883 1.068 . . . . 4.09 113.883 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.53 147.75 33.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.257 -0.429 . . . . 3.36 110.178 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.4 m -78.4 162.12 67.43 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.492 -0.558 . . . . 3.47 109.492 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.0 108.08 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.768 2.312 . . . . 2.69 112.166 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -99.91 134.03 43.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.78 -0.646 . . . . 3.22 109.629 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -106.61 115.75 30.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.07 -0.514 . . . . 1.95 112.0 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -102.36 121.29 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.868 -0.79 . . . . 2.76 108.868 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.98 135.57 43.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 1.4 111.686 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -130.75 165.27 23.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 2.07 110.202 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -99.82 159.58 14.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.37 -0.377 . . . . 1.28 110.898 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.29 116.31 5.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.22 -0.445 . . . . 1.66 111.501 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.45 35.64 10.39 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.995 -0.621 . . . . 1.66 113.936 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.3 90.47 1.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 1.62 111.135 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.39 139.78 5.51 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.032 -0.604 . . . . 1.96 112.2 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -33.34 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.603 2.202 . . . . 2.62 112.053 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -103.67 36.45 2.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.026 -0.534 . . . . 3.09 111.093 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.03 -56.6 10.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 1.87 110.096 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.12 32.5 80.69 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.915 -0.584 . . . . 1.7 112.971 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' A' ' 85' ' ' ALA . 3.0 tp -138.33 106.01 7.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.757 0.313 . . . . 1.43 110.688 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 92.2 Cg_endo -85.39 167.54 10.39 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.677 2.251 . . . . 1.62 111.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -60.95 106.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 1.75 110.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.54 -8.64 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.489 -0.862 . . . . 1.44 112.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.469 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . . . -69.24 137.99 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 1.25 110.967 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -88.44 128.18 35.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 2.21 111.839 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -155.24 144.01 20.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.781 -0.645 . . . . 2.11 109.283 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.73 113.34 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.196 0.443 . . . . 1.7 112.196 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.27 20.57 58.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.891 -0.671 . . . . 1.32 112.752 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.0 mm -127.72 102.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 1.06 110.51 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 24.8 pt -114.62 134.06 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.322 -0.399 . . . . 1.3 109.989 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -90.35 146.25 24.33 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.345 0.498 . . . . 1.08 112.345 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 m -140.47 144.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.518 -0.764 . . . . 1.04 110.311 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.95 169.59 23.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 1.27 110.869 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 t -146.17 179.04 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.969 -0.56 . . . . 1.58 109.5 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.7 123.37 19.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.399 . . . . 2.64 111.133 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 41' ' ' ASP . . . 107.35 -13.26 39.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.766 -0.73 . . . . 1.63 111.906 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.784 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.31 132.18 35.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.669 0.271 . . . . 1.59 110.785 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.9 mt -102.22 140.59 36.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.262 -0.426 . . . . 2.15 110.799 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -79.45 76.05 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.468 0.652 . . . . 2.3 110.09 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.54 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m -147.13 131.97 8.89 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.654 -0.869 . . . . 2.69 108.654 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.83 125.24 17.67 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.307 2.005 . . . . 2.08 112.251 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.805 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -126.85 75.87 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.585 0.707 . . . . 1.99 111.216 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.99 -4.53 44.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 2.55 112.058 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.445 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 4.1 p80 -59.18 -20.9 57.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.092 0.472 . . . . 2.28 111.864 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.3 pt -111.71 13.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.037 0.446 . . . . 2.0 110.616 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.22 -32.67 7.29 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.554 -0.831 . . . . 2.33 112.027 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.9 t -69.18 121.46 16.83 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.295 0.569 . . . . 3.21 110.978 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.0 ttp85 -164.57 131.18 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.781 . . . . 3.03 109.927 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -94.99 117.84 66.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 3.75 110.663 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 -34.97 92.94 Favored 'Trans proline' 0 N--CA 1.472 0.244 0 C-N-CA 123.123 2.549 . . . . 3.39 113.458 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.93 9.68 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.369 0.507 . . . . 4.05 112.369 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -139.52 9.1 2.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.871 0.367 . . . . 4.78 111.389 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -159.49 127.22 4.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 3.41 111.248 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.47 164.14 25.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 3.21 110.625 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.58 152.19 23.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.167 0.508 . . . . 3.0 111.466 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.76 145.86 7.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.746 -0.661 . . . . 2.42 109.417 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.497 ' HA ' ' OG1' ' A' ' 14' ' ' THR . 70.0 t -68.25 115.31 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.251 -0.277 . . . . 2.74 110.251 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.75 121.24 12.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.066 -0.515 . . . . 2.19 110.604 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -139.83 173.64 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.858 -0.61 . . . . 2.49 110.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.5 mt -123.14 152.48 63.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.558 -0.534 . . . . 1.96 109.558 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.42 154.65 34.39 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.003 2.469 . . . . 1.84 111.97 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -52.94 122.83 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 2.77 111.332 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.69 -11.34 49.88 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.632 -0.794 . . . . 2.2 112.321 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.3 m -109.11 113.89 27.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.486 -0.561 . . . . 2.1 109.486 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.2 159.63 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.358 -0.383 . . . . 2.87 110.892 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.4 mt -90.45 156.68 45.41 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.402 -0.363 . . . . 2.62 110.25 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.54 151.46 62.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.656 2.238 . . . . 2.77 111.912 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.36 119.2 8.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.185 0.517 . . . . 4.28 111.775 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.41 -8.88 44.8 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.723 -0.751 . . . . 3.18 112.346 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -101.51 112.91 25.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.788 -0.449 . . . . 2.93 109.788 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -133.1 149.88 52.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 3.73 111.663 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.45 147.35 27.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 2.93 110.073 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -73.67 121.61 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 3.64 111.237 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.85 -0.47 45.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.688 -0.767 . . . . 3.27 112.265 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -86.87 135.36 33.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.875 0.369 . . . . 3.59 110.733 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -121.58 4.32 10.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.191 0.519 . . . . 6.05 110.197 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.08 -138.71 6.61 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.656 -0.702 . . . . 5.22 111.402 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 109.57 -131.56 10.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.657 -0.782 . . . . 5.91 112.99 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.065 -0.969 . . . . 7.27 110.691 -179.594 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.4 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.491 -3.722 1 C4'-C3'-C2' 97.005 -5.695 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.4 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.554 2 N19-C1'-C2' 103.574 -6.141 . 0.23 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.709 2 O4'-C1'-N19 115.723 7.523 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.21 4 O4'-C1'-N19 116.651 8.451 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.375 -4.063 2 C4'-C3'-C2' 97.576 -5.124 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.759 4 C4'-C3'-C2' 98.298 -4.402 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.275 3 P-O3'-C3' 127.008 6.09 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.58 5.249 3 O4'-C4'-C3' 114.875 6.696 . 0.0 '__' . 15.4 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.541 -5.154 2 O4'-C1'-N19 118.641 10.441 . 0.417 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.589 3 O3'-P-O5' 116.394 6.523 . 0.459 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.217 1 C4'-C3'-C2' 98.249 -4.451 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.482 1 C4'-C3'-C2' 94.401 -8.299 . 0.459 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.767 1 O3'-P-O5' 111.7 4.053 . 0.107 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.077 2 C3'-C2'-C1' 105.708 4.675 . 0.34 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.785 -0.526 . . . . 9.22 111.785 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.8 103.02 10.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.889 0.376 . . . . 8.25 111.207 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 46.4 mtt -127.17 84.07 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.901 0.381 . . . . 8.02 110.913 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.74 144.52 12.31 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.006 -0.616 . . . . 5.79 112.146 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.05 103.35 8.95 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.721 0.296 . . . . 4.72 110.483 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.59 35.2 0.55 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.008 2.472 . . . . 4.45 112.618 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -103.85 164.84 11.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.84 -0.43 . . . . 4.89 109.84 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' C ' ' HG1' ' A' ' 9' ' ' THR . 22.5 t-20 -68.34 -74.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.141 -0.318 . . . . 4.35 110.141 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.433 ' HG1' ' C ' ' A' ' 8' ' ' ASN . 2.1 p 43.6 56.93 4.21 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 112.68 0.622 . . . . 2.87 112.68 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.91 154.5 26.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.211 -0.449 . . . . 2.48 111.588 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -87.36 155.6 19.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.906 -0.588 . . . . 2.57 110.032 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -86.09 -29.4 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 2.4 110.146 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.52 -179.72 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.409 -0.814 . . . . 2.02 110.532 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.71 -172.35 4.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.458 . . . . 2.65 110.679 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -105.66 173.25 6.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 2.4 112.602 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.517 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 16.0 mt -112.1 122.85 48.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.931 -1.031 . . . . 2.27 109.312 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.1 m -92.52 116.39 28.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.99 0.424 . . . . 2.86 111.261 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -86.38 142.43 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 2.89 110.842 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -134.44 44.86 2.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.977 -0.556 . . . . 4.07 109.862 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.9 -167.24 12.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.832 -0.699 . . . . 3.23 112.442 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -86.74 -28.14 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 4.51 110.645 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.89 163.55 23.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 3.32 111.007 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.2 -85.5 0.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.825 -0.435 . . . . 2.41 109.825 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.517 HD12 ' CE1' ' A' ' 131' ' ' PHE . 36.5 tp -168.97 140.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 2.18 110.462 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -163.01 120.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.716 -0.675 . . . . 2.46 110.021 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -110.54 142.5 26.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.269 -0.423 . . . . 1.78 110.234 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.57 164.94 16.78 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.114 2.543 . . . . 2.15 111.965 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -69.61 128.47 36.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 2.84 110.426 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.83 29.92 49.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.287 -0.725 . . . . 1.65 111.287 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -157.84 171.52 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.46 -0.57 . . . . 2.57 109.46 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.31 17.32 64.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 1.42 112.511 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.78 111.15 65.0 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 1.09 109.826 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.51 168.57 11.2 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.783 2.322 . . . . 1.27 112.051 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.9 mt -74.69 87.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.16 -0.473 . . . . 1.7 110.497 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -84.11 77.69 9.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.039 0.447 . . . . 1.23 109.913 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -26.31 68.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 1.96 111.628 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -80.78 -3.78 52.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.127 -0.488 . . . . 2.0 111.653 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -120.52 157.52 29.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.351 . . . . 1.44 111.672 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.549 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 23.4 m -83.04 168.84 20.19 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.96 -0.564 . . . . 2.06 109.922 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.8 Cg_endo -52.9 -35.71 71.77 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.947 2.432 . . . . 1.42 113.913 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.2 p-10 -80.81 -16.01 54.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.652 0.242 . . . . 1.78 111.652 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.687 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 29.5 m-20 -84.37 -3.39 58.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 1.6 111.106 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -78.55 56.37 1.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 1.19 110.827 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 tt -149.97 127.38 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.673 . . . . 1.17 110.155 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.3 -139.83 3.0 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.515 -0.85 . . . . 0.61 112.214 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' CD2' HG22 ' A' ' 90' ' ' ILE . 53.7 p90 -162.09 158.65 25.12 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.08 0.467 . . . . 1.13 111.113 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.501 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -95.84 134.94 38.21 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.898 -0.778 . . . . 1.69 108.898 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -112.68 121.39 44.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.399 -0.364 . . . . 2.51 111.1 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -73.49 119.69 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.491 . . . . 2.62 109.787 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.31 148.29 43.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.173 0.511 . . . . 2.21 111.306 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.73 151.46 45.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.731 -0.84 . . . . 2.68 108.731 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.645 ' HB3' HD13 ' A' ' 64' ' ' LEU . 9.6 tpt180 -139.43 125.64 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.982 0.42 . . . . 3.78 111.604 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -140.73 98.58 3.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.905 -0.589 . . . . 3.58 110.789 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.45 ' O ' ' HG2' ' A' ' 61' ' ' MET . 33.8 pt -79.74 160.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.378 -0.601 . . . . 4.26 109.378 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -131.23 120.27 23.0 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.919 -0.312 . . . . 5.46 111.564 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.64 -174.97 50.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.938 -0.648 . . . . 4.66 112.538 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.36 -51.52 54.0 Favored Glycine 0 CA--C 1.516 0.113 0 C-N-CA 121.416 -0.421 . . . . 5.04 113.249 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.3 -32.68 72.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.983 0.421 . . . . 5.51 110.054 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.5 36.16 0.75 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.908 -0.663 . . . . 4.73 112.125 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -86.99 154.74 20.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.15 -0.685 . . . . 5.75 109.15 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 mtt -137.77 138.04 38.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.943 0.401 . . . . 4.48 111.852 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.464 ' HE3' HD21 ' A' ' 64' ' ' LEU . 45.7 tttp -71.84 -33.72 68.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.517 -0.765 . . . . 4.47 110.288 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.1 t0 46.85 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.632 0.975 . . . . 4.09 113.632 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 52' ' ' ARG . 47.8 mt -89.22 137.3 32.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 3.36 110.46 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -64.04 144.73 98.17 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.099 -0.5 . . . . 3.47 110.271 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.81 119.32 5.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.915 2.41 . . . . 2.69 112.27 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.4 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 64.8 mtt85 -121.19 132.43 54.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 3.22 110.568 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.501 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.74 118.48 31.47 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.252 -0.431 . . . . 1.95 110.921 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.82 146.23 24.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.194 -0.669 . . . . 2.76 109.194 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.54 120.83 28.28 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.653 -0.419 . . . . 1.4 111.774 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -115.37 157.51 23.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.593 -0.521 . . . . 2.07 109.593 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -102.94 158.95 15.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.936 -0.394 . . . . 1.28 109.936 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.18 118.99 8.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.079 -0.341 . . . . 1.66 110.079 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.84 35.2 4.93 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.987 -0.625 . . . . 1.66 112.334 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.35 99.87 12.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.444 . . . . 1.62 110.796 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.85 123.94 3.38 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.181 -0.768 . . . . 1.96 111.181 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.3 -27.7 83.55 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.857 2.371 . . . . 2.62 113.181 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -127.59 35.35 4.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.737 0.303 . . . . 3.09 110.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.22 -50.65 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 1.87 111.023 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.62 51.27 26.38 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.308 -0.717 . . . . 1.7 111.308 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.7 mt -132.28 96.12 19.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.573 0.225 . . . . 1.43 111.596 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 92.9 Cg_endo -84.5 162.99 12.72 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.662 2.242 . . . . 1.62 110.661 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -58.8 113.26 1.97 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.013 0.435 . . . . 1.75 110.894 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.68 11.61 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.729 -0.748 . . . . 1.44 112.449 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.499 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -61.83 108.61 1.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.883 0.373 . . . . 1.25 110.486 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.0 107.45 8.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.153 -0.476 . . . . 2.21 110.543 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -125.62 149.83 48.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 2.11 109.968 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.15 110.49 1.62 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.236 -0.438 . . . . 1.7 111.683 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.17 21.48 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.794 -0.717 . . . . 1.32 112.284 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.403 HG22 ' CD2' ' A' ' 46' ' ' TYR . 48.1 mm -129.19 113.83 29.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.351 -0.24 . . . . 1.06 110.351 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.412 ' O ' HG13 ' A' ' 91' ' ' ILE . 7.8 pt -119.13 126.2 75.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.645 -0.502 . . . . 1.3 109.645 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -83.45 139.21 33.09 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.707 0.632 . . . . 1.08 112.707 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.45 139.44 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.538 -0.755 . . . . 1.04 110.411 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.5 172.33 18.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.082 -0.508 . . . . 1.27 109.745 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.2 t -142.9 170.84 14.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.748 0.309 . . . . 1.58 110.361 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.73 118.24 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.981 -0.554 . . . . 2.64 110.686 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.61 -15.22 8.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.967 -0.635 . . . . 1.63 111.647 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.669 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.25 159.26 22.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.671 0.272 . . . . 1.59 110.662 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.69 140.93 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 2.15 110.663 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -80.14 97.69 6.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.093 0.473 . . . . 2.3 111.179 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 t -171.2 148.93 2.51 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.968 -0.753 . . . . 2.69 108.968 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.54 111.75 3.39 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.045 1.83 . . . . 2.08 112.111 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -108.51 80.45 1.35 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.441 0.639 . . . . 1.99 110.264 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -72.64 -5.96 41.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.461 -0.79 . . . . 2.55 112.245 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -63.01 -15.61 56.99 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.519 0.562 . . . . 2.28 112.519 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.89 -24.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.463 . . . . 2.0 110.726 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.34 73.46 1.68 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.788 -0.72 . . . . 2.33 112.029 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.4 t -160.56 22.97 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.142 0.496 . . . . 3.21 110.979 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttp85 -84.29 136.85 33.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 3.03 110.824 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -83.85 119.64 73.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.42 -0.585 . . . . 3.75 109.42 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.699 ' HB2' " H5'" ' C' ' 9' ' ' ' U' . 71.9 Cg_endo -75.52 -19.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.792 2.328 . . . . 3.39 113.769 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.43 -40.6 8.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.929 0.344 . . . . 4.05 111.929 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.88 7.72 26.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.41 -0.359 . . . . 4.78 111.394 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -160.23 139.92 11.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.333 . . . . 3.41 110.512 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.495 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -86.02 141.55 29.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.241 -0.436 . . . . 3.21 111.143 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.583 ' HB2' " H4'" ' C' ' 8' ' ' ' G' . . . -85.36 148.38 26.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 3.0 110.765 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.62 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 2.42 110.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.65 135.52 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.926 -0.398 . . . . 2.74 109.926 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.445 HD21 ' HH ' ' A' ' 47' ' ' TYR . 15.7 tp -63.3 119.66 10.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 2.19 110.691 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -124.33 135.24 53.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.49 110.915 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.0 mt -101.79 147.5 33.96 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 1.96 110.142 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.65 152.54 77.88 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.702 2.268 . . . . 1.84 111.807 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -54.86 129.49 37.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.858 -0.61 . . . . 2.77 111.258 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.64 14.17 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.419 -0.672 . . . . 2.2 111.419 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -99.81 98.26 9.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.718 0.294 . . . . 2.1 110.395 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.71 147.07 23.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 2.87 110.433 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.86 144.37 87.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.285 -0.416 . . . . 2.62 110.223 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.34 155.64 45.34 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.399 2.066 . . . . 2.77 111.505 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -60.89 127.41 31.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 4.28 111.105 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.95 63.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.908 -0.663 . . . . 3.18 112.648 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.51 116.56 30.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.917 0.389 . . . . 2.93 111.828 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -124.09 137.78 54.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 3.73 110.64 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 2.93 111.372 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.0 121.49 15.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 3.64 111.114 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 23.26 34.05 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.941 -0.572 . . . . 3.27 112.849 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.9 m -107.29 -23.37 12.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.207 0.447 . . . . 3.59 112.207 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -139.45 127.98 23.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.089 0.471 . . . . 6.05 111.783 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 134.6 -169.15 23.26 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.971 -0.851 . . . . 5.22 110.971 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -91.88 43.66 2.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.786 -0.721 . . . . 5.91 111.815 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 119.005 -0.522 . . . . 7.27 111.219 -179.868 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.491 -3.655 1 C4'-C3'-C2' 97.124 -5.576 . 0.0 '__' . 12.52 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.503 2 N19-C1'-C2' 103.478 -6.201 . 0.232 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.863 3 O4'-C1'-N19 115.748 7.548 . 0.531 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.168 4 O4'-C1'-N19 116.661 8.461 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.119 2 C4'-C3'-C2' 97.573 -5.127 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.769 4 C1'-O4'-C4' 105.612 -4.431 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.496 5.235 3 P-O3'-C3' 127.041 6.117 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.583 " H4'" ' HB2' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.262 3 O4'-C4'-C3' 114.884 6.703 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . 0.699 " H5'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.543 -5.014 2 O4'-C1'-N19 118.634 10.434 . 0.416 1a . 14.62 . . . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.549 -4.404 3 O3'-P-O5' 116.382 6.517 . 0.457 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.148 1 C4'-C3'-C2' 98.237 -4.463 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.587 5.701 1 C4'-C3'-C2' 94.307 -8.393 . 0.461 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.457 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.587 5.693 1 O3'-P-O5' 111.706 4.056 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.042 2 C3'-C2'-C1' 105.754 4.727 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.755 -0.538 . . . . 9.22 111.755 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.69 93.97 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.018 0.437 . . . . 8.25 110.483 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -100.78 105.63 16.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.031 -0.532 . . . . 8.02 110.447 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.79 141.14 19.28 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.792 -0.718 . . . . 5.79 111.801 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.58 HD23 ' HB2' ' A' ' 7' ' ' ASN . 0.7 OUTLIER -110.37 112.8 56.75 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.557 0.218 . . . . 4.72 110.513 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.86 56.19 5.57 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.794 2.329 . . . . 4.45 111.249 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.58 ' HB2' HD23 ' A' ' 5' ' ' LEU . 17.5 t-20 -98.33 112.67 24.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.718 -0.674 . . . . 4.89 110.762 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -110.65 -58.02 2.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.56 -0.291 . . . . 4.35 110.918 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m 69.54 104.73 0.06 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.606 0.566 . . . . 2.87 111.127 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.22 127.84 53.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.073 0.463 . . . . 2.48 112.236 -178.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -73.1 139.21 46.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 2.57 110.306 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -98.06 -25.59 14.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.783 0.325 . . . . 2.4 111.788 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.66 176.98 5.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 2.02 110.571 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.438 HG23 " H5'" ' C' ' 8' ' ' ' G' . 14.7 p -69.89 175.62 4.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.983 0.421 . . . . 2.65 111.382 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -95.05 158.23 15.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.411 0.624 . . . . 2.4 111.527 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.662 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 88.7 mt -111.89 106.3 14.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.148 -0.933 . . . . 2.27 109.327 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.7 m -84.51 127.17 33.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 2.86 111.504 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.55 115.57 27.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.902 -0.59 . . . . 2.89 110.664 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -103.67 72.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.487 -0.56 . . . . 4.07 109.487 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.95 -161.85 26.86 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.842 -0.694 . . . . 3.23 112.156 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -94.28 -42.52 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.684 0.278 . . . . 4.51 111.115 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.69 153.32 36.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 3.32 110.064 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.9 -76.0 0.31 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.915 -0.314 . . . . 2.41 110.574 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.1 tp 179.8 130.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.897 -0.592 . . . . 2.18 110.264 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -145.18 123.97 12.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 2.46 110.32 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.406 ' CD1' ' HA2' ' A' ' 31' ' ' GLY . 46.6 m-85 -107.0 140.21 21.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.356 -0.384 . . . . 1.78 110.866 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 13.4 Cg_exo -71.58 168.96 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.839 2.359 . . . . 2.15 111.901 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -61.0 124.93 21.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 2.84 111.279 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.96 9.97 84.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.885 -0.674 . . . . 1.65 112.737 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 16.6 tt0 -129.5 160.7 32.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.814 -0.439 . . . . 2.57 109.814 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' HA2' ' CD1' ' A' ' 26' ' ' PHE . . . 118.36 -3.01 16.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.151 -0.547 . . . . 1.42 111.951 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.6 t -101.21 111.16 63.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.898 -0.408 . . . . 1.09 109.898 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.88 -170.7 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.001 2.467 . . . . 1.27 111.327 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -74.2 100.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.191 0.52 . . . . 1.7 111.268 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.499 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 71.2 m-80 -103.37 86.03 2.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.0 -0.741 . . . . 1.23 109.0 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -51.67 53.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.579 0.955 . . . . 1.96 113.579 -178.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -80.71 11.33 3.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.836 0.68 . . . . 2.0 112.836 -178.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -115.02 137.73 51.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.713 0.292 . . . . 1.44 110.802 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.98 164.05 50.99 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 2.06 111.006 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.17 -37.94 93.89 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.177 2.585 . . . . 1.42 113.312 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.4 p-10 -82.33 -5.97 58.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.548 0.213 . . . . 1.78 111.453 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.07 5.24 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 1.6 110.279 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.3 mm-40 -83.7 53.31 2.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 1.19 111.062 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.7 tt -144.81 136.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.609 . . . . 1.17 110.142 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.19 -147.93 6.7 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.152 -1.023 . . . . 0.61 113.059 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -157.16 172.78 18.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.951 0.405 . . . . 1.13 110.699 -179.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -117.34 134.76 54.44 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.478 -0.564 . . . . 1.69 109.478 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -107.53 136.17 47.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 2.51 111.141 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -81.37 98.12 8.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.607 -0.724 . . . . 2.62 110.282 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.8 148.35 30.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 2.21 111.803 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -155.64 121.5 5.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.68 109.464 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.628 ' HB3' HD13 ' A' ' 64' ' ' LEU . 4.2 ttt85 -94.45 129.87 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.654 0.264 . . . . 3.78 111.038 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.17 94.95 2.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 3.58 110.457 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.17 141.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 4.26 111.359 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -97.75 115.39 27.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 5.46 112.237 -178.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 157.97 52.02 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.845 -0.693 . . . . 4.66 111.47 178.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.15 -51.04 61.25 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.397 -0.43 . . . . 5.04 112.622 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.56 -25.27 63.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.187 0.517 . . . . 5.51 110.998 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.72 36.18 0.65 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.519 -0.848 . . . . 4.73 111.589 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -91.31 155.77 18.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.182 -0.303 . . . . 5.75 110.182 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 mmt -148.83 125.79 11.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.445 -0.343 . . . . 4.48 110.969 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HG3' ' O4 ' ' C' ' 13' ' ' ' U' . 58.6 tttt -62.35 -42.43 99.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 4.47 110.526 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 t70 58.85 77.53 0.3 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.353 -0.84 . . . . 4.09 112.069 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 52' ' ' ARG . 40.0 mt -87.45 164.09 16.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.024 -0.534 . . . . 3.36 111.062 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.65 152.74 54.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.131 -0.486 . . . . 3.47 110.634 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 115.17 2.48 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.479 2.119 . . . . 2.69 111.283 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 4.3 ptp180 -113.15 119.57 38.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 3.22 110.82 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -84.43 126.34 33.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.836 -0.62 . . . . 1.95 110.648 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 15' ' ' ALA . 51.1 m-85 -109.26 132.01 54.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.708 -0.479 . . . . 2.76 109.708 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.49 127.32 33.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.376 . . . . 1.4 111.179 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -130.24 157.66 41.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.51 -0.552 . . . . 2.07 109.51 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -86.28 156.31 20.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.984 0.421 . . . . 1.28 111.019 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.82 116.86 7.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.141 -0.481 . . . . 1.66 111.204 -179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.78 10.23 31.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.617 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -61.02 122.74 15.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.855 0.36 . . . . 1.62 110.976 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.63 123.87 4.76 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.87 -0.681 . . . . 1.96 112.005 -179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.35 -63.89 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.219 2.613 . . . . 2.62 112.434 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HB2' HD21 ' A' ' 5' ' ' LEU . 42.7 mt-10 -91.95 72.7 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.309 0.576 . . . . 3.09 111.12 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.99 -61.17 1.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 1.87 109.936 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 39.46 57.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.797 -0.638 . . . . 1.7 112.316 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.89 95.17 44.72 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.217 -0.29 . . . . 1.43 110.217 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 84.2 Cg_endo -89.67 179.46 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.865 2.377 . . . . 1.62 112.206 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -61.42 107.48 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.935 -0.575 . . . . 1.75 111.247 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.17 -15.55 8.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.513 -0.851 . . . . 1.44 113.061 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.486 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -65.72 105.24 1.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.156 0.503 . . . . 1.25 111.033 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -79.06 122.47 26.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.036 -0.529 . . . . 2.21 111.214 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -141.11 173.74 11.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 2.11 109.732 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -73.96 114.87 12.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 1.7 111.492 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 31.64 59.91 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.83 -0.623 . . . . 1.32 113.01 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.7 mm -128.58 107.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 110.333 -0.247 . . . . 1.06 110.333 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 pt -115.14 124.92 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.543 0.211 . . . . 1.3 110.446 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -88.41 138.79 31.12 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.045 0.387 . . . . 1.08 112.045 -178.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.87 144.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 1.04 110.66 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.9 160.42 43.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.394 -0.366 . . . . 1.27 110.301 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -135.45 168.83 18.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.71 -0.478 . . . . 1.58 109.71 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.15 133.12 55.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 2.64 110.675 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.65 -16.97 55.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.969 -0.634 . . . . 1.63 112.349 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.41 143.05 29.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 1.59 110.577 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.6 mt -110.68 142.44 42.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.44 -0.345 . . . . 2.15 110.447 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.42 83.95 3.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.302 0.572 . . . . 2.3 110.902 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.1 t -151.65 139.09 12.47 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.459 -0.791 . . . . 2.69 109.416 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 126.55 22.39 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.013 2.476 . . . . 2.08 113.278 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -117.97 60.71 0.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.5 -0.773 . . . . 1.99 110.217 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.58 -0.87 21.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 2.55 112.101 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -74.76 -6.75 50.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 2.28 111.55 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.22 35.45 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 2.0 111.142 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 13.33 8.39 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.53 -0.843 . . . . 2.33 112.868 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -131.88 114.81 15.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.207 0.527 . . . . 3.21 110.898 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -151.05 160.57 43.83 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.604 -0.517 . . . . 3.03 109.604 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.14 105.83 50.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 3.75 110.715 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.47 -34.24 26.84 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.401 2.068 . . . . 3.39 113.087 -179.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.525 ' HA ' ' H22' ' C' ' 8' ' ' ' G' . . . -74.52 -8.07 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.972 0.36 . . . . 4.05 111.972 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -125.73 10.03 7.71 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.626 -0.261 . . . . 4.78 111.495 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -168.92 127.91 1.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 3.41 110.182 -179.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.581 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -80.33 164.5 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.703 0.287 . . . . 3.21 110.762 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.473 ' HB2' " H4'" ' C' ' 8' ' ' ' G' . . . -99.93 151.96 20.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.318 -0.401 . . . . 3.0 110.232 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.0 mt -83.97 143.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.589 -0.523 . . . . 2.42 109.589 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' A' ' 136' ' ' SER . 85.7 t -65.92 119.85 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.796 0.331 . . . . 2.74 110.474 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.436 HD23 HD21 ' A' ' 16' ' ' LEU . 7.8 tt -63.28 118.65 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 2.19 109.718 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -133.53 165.64 24.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.28 -0.418 . . . . 2.49 110.898 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.33 157.67 43.31 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.646 -0.706 . . . . 1.96 110.042 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.39 172.82 15.33 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.62 2.213 . . . . 1.84 112.075 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.2 120.87 13.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.006 -0.543 . . . . 2.77 110.336 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.42 -25.8 8.98 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.551 -0.833 . . . . 2.2 112.099 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 m -98.13 112.93 24.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.805 -0.442 . . . . 2.1 109.805 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.9 m -104.7 145.34 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.727 -0.669 . . . . 2.87 111.257 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -76.92 149.38 80.13 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.09 -0.707 . . . . 2.62 109.09 178.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.42 146.23 97.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.529 2.153 . . . . 2.77 111.553 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.61 109.74 0.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 4.28 110.471 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.2 -12.42 9.73 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.371 -0.692 . . . . 3.18 111.371 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.662 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 1.4 t80 -103.24 134.34 46.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.125 -0.324 . . . . 2.93 110.125 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -128.78 164.95 21.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.349 -0.387 . . . . 3.73 110.53 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.34 139.54 38.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.511 -0.313 . . . . 2.93 110.479 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.82 123.11 28.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.921 0.391 . . . . 3.64 110.535 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.18 -1.39 82.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.297 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.447 ' HB2' HG11 ' A' ' 118' ' ' VAL . 4.7 t -118.19 110.69 17.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 3.59 110.566 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.86 101.5 10.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.024 -0.535 . . . . 6.05 110.848 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.86 -134.04 9.7 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.266 -0.733 . . . . 5.22 111.266 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.43 79.29 0.51 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.914 -0.66 . . . . 5.91 112.786 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.253 1.262 0 CA-C-O 119.056 -0.497 . . . . 7.27 111.528 179.669 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.401 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.492 -3.615 1 C4'-C3'-C2' 97.04 -5.66 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.401 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.506 2 N19-C1'-C2' 103.494 -6.191 . 0.232 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.705 3 O4'-C1'-N19 115.722 7.522 . 0.531 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.195 4 O4'-C1'-N19 116.707 8.507 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.375 -4.086 2 C4'-C3'-C2' 97.608 -5.092 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.765 4 N19-C1'-C2' 106.385 -4.384 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.498 5.357 3 P-O3'-C3' 127.02 6.1 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 021 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.581 " H1'" ' HA ' ' A' ' 115' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.353 3 O4'-C4'-C3' 114.915 6.725 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 021 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.86 2 O4'-C1'-N19 118.668 10.468 . 0.416 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 021 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.532 3 O3'-P-O5' 116.424 6.539 . 0.463 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 021 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.142 1 C4'-C3'-C2' 98.325 -4.375 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 021 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.464 1 C4'-C3'-C2' 94.338 -8.362 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 021 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.452 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.588 5.856 1 O3'-P-O5' 111.688 4.046 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 021 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.065 2 C3'-C2'-C1' 105.657 4.619 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.597 -0.601 . . . . 9.22 111.597 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.53 119.96 18.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.817 0.341 . . . . 8.25 111.073 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.7 mmt -80.89 88.28 5.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.193 -0.458 . . . . 8.02 109.812 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.86 140.15 4.12 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.435 -0.802 . . . . 5.79 111.142 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -107.84 110.98 62.56 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.818 0.342 . . . . 4.72 110.51 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -93.47 18.82 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.064 2.51 . . . . 4.45 111.862 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -94.07 142.54 27.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.202 -0.454 . . . . 4.89 110.517 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -116.19 -77.33 0.57 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.506 -0.316 . . . . 4.35 110.29 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p 51.35 83.63 0.05 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.66 0.985 . . . . 2.87 113.66 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.05 40.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 2.48 111.012 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 m -57.86 153.02 14.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.082 -0.508 . . . . 2.57 112.35 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -74.92 -54.44 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.609 -0.723 . . . . 2.4 110.52 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.715 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 24.8 m-85 -74.75 159.65 31.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 2.02 112.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -68.92 158.58 34.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.543 -0.753 . . . . 2.65 111.017 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.08 144.99 38.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.911 0.386 . . . . 2.4 111.207 -179.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.48 HD12 ' HE2' ' A' ' 131' ' ' PHE . 35.4 mt -89.53 119.9 30.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.988 -0.375 . . . . 2.27 109.988 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -90.97 126.44 36.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.279 0.561 . . . . 2.86 112.458 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -94.8 138.43 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.892 -0.594 . . . . 2.89 110.172 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -137.21 56.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.532 -0.544 . . . . 4.07 109.532 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -154.89 -169.34 19.39 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.58 -0.736 . . . . 3.23 111.685 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mmtt -92.84 -1.77 56.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.062 0.393 . . . . 4.51 112.062 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -104.53 171.92 7.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 3.32 110.308 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.74 -79.87 0.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.664 -0.243 . . . . 2.41 110.375 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.7 tp -179.57 132.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 2.18 110.421 179.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -154.07 117.31 4.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.333 -0.394 . . . . 2.46 110.628 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -109.74 141.29 23.37 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.191 -0.459 . . . . 1.78 110.155 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.72 165.01 29.12 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.564 2.176 . . . . 2.15 112.298 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -64.34 119.87 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.577 . . . . 2.84 111.085 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.36 0.52 56.88 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.798 -0.715 . . . . 1.65 112.567 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -130.0 165.76 21.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 2.57 110.62 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.38 -14.7 30.36 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.783 -0.722 . . . . 1.42 112.37 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -89.56 118.15 68.79 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.701 0.286 . . . . 1.09 110.999 -179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.19 -176.36 2.87 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.608 2.206 . . . . 1.27 111.345 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 mt -84.63 79.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 1.7 110.781 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -83.85 86.85 7.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.323 -0.399 . . . . 1.23 110.31 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.07 64.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.994 0.426 . . . . 1.96 110.832 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -76.42 0.67 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.959 -0.564 . . . . 2.0 111.394 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.402 ' HB3' ' CB ' ' A' ' 42' ' ' ASP . 4.3 m -128.36 152.19 48.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.855 0.36 . . . . 1.44 111.033 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 168.49 27.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.099 -0.501 . . . . 2.06 109.88 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.28 -36.61 93.91 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.585 2.19 . . . . 1.42 111.961 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -77.79 -19.94 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 1.78 111.054 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.806 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 31.7 m-20 -81.97 -5.8 58.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 1.6 111.275 -179.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -79.44 57.71 2.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.151 0.5 . . . . 1.19 111.379 -179.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.422 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 10.9 tt -151.17 131.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.749 -0.659 . . . . 1.17 109.579 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.26 -146.15 6.07 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.368 -0.92 . . . . 0.61 112.661 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -153.03 165.01 36.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.914 0.387 . . . . 1.13 110.58 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -105.48 125.59 51.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 1.69 109.238 178.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -95.1 126.4 40.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.205 -0.452 . . . . 2.51 111.643 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -76.57 120.83 22.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.598 -0.728 . . . . 2.62 109.51 178.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.67 158.77 43.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 2.21 111.666 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.94 109.01 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.598 -0.728 . . . . 2.68 109.594 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HB3' HD13 ' A' ' 64' ' ' LEU . 11.3 tpt85 -81.26 103.84 11.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 3.78 111.531 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -114.5 110.34 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 3.58 111.179 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.72 131.9 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.822 -0.626 . . . . 4.26 109.397 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -105.74 124.76 50.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.331 0.395 . . . . 5.46 110.232 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.44 165.8 28.96 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.862 -0.685 . . . . 4.66 111.697 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.8 -26.95 74.24 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.128 -0.558 . . . . 5.04 112.129 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.83 3.86 31.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.46 0.648 . . . . 5.51 110.602 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.06 10.62 68.73 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.805 -0.712 . . . . 4.73 111.57 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -73.47 144.35 46.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.712 0.291 . . . . 5.75 110.265 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt -121.9 141.36 51.36 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.104 -0.498 . . . . 4.48 110.575 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -68.24 -42.65 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 4.47 109.542 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t0 47.48 75.23 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.18 -0.918 . . . . 4.09 112.676 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' A' ' 52' ' ' ARG . 27.4 mt -94.46 158.92 15.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.912 -0.585 . . . . 3.36 111.195 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.11 149.51 89.58 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.777 -0.647 . . . . 3.47 111.289 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.66 116.25 3.12 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.844 2.363 . . . . 2.69 111.297 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -119.91 147.6 44.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.051 -0.522 . . . . 3.22 111.594 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -114.93 129.14 56.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 1.95 110.946 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -103.65 133.65 48.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.365 -0.606 . . . . 2.76 109.365 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -81.6 121.36 26.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 1.4 111.481 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -122.74 133.52 54.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 2.07 109.743 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.63 159.74 33.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.539 -0.3 . . . . 1.28 110.899 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.38 122.0 12.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 1.66 111.825 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.39 24.34 26.65 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.906 -0.664 . . . . 1.66 113.678 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.2 102.16 6.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 1.62 111.204 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.25 114.23 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.13 -0.788 . . . . 1.96 111.13 -179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.45 -26.51 82.22 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.91 2.407 . . . . 2.62 112.466 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.3 15.28 16.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.543 0.211 . . . . 3.09 111.526 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.66 -55.58 6.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.029 0.442 . . . . 1.87 110.223 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.64 36.35 89.29 Favored Glycine 0 C--N 1.329 0.157 0 CA-C-N 115.73 -0.668 . . . . 1.7 112.789 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 mt -107.85 105.9 57.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.565 0.221 . . . . 1.43 111.039 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.14 161.84 17.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.056 2.504 . . . . 1.62 111.511 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -57.91 111.07 1.04 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 1.75 110.51 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.76 -19.23 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.629 -0.796 . . . . 1.44 112.352 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.61 113.11 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 1.25 110.807 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -82.27 121.98 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.374 -0.376 . . . . 2.21 111.704 -179.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.94 171.46 14.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.295 -0.411 . . . . 2.11 110.269 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.35 110.29 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.878 -0.601 . . . . 1.7 111.195 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.37 97.06 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.95 -0.568 . . . . 1.32 112.823 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.5 mm -127.51 105.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.899 0.381 . . . . 1.06 110.611 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.8 pt -111.67 135.19 51.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.371 -0.603 . . . . 1.3 109.371 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -94.86 140.68 29.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.16 0.43 . . . . 1.08 112.16 -178.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.01 141.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.519 -0.764 . . . . 1.04 110.241 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.25 152.28 29.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.09 -0.337 . . . . 1.27 110.09 -179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -111.59 173.61 6.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.415 -0.357 . . . . 1.58 110.263 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.0 118.68 15.16 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.983 -0.377 . . . . 2.64 109.983 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.76 -3.8 24.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.84 -0.695 . . . . 1.63 111.881 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.21 131.4 34.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.46 -0.2 . . . . 1.59 110.46 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.14 148.52 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 2.15 111.188 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -87.1 72.27 10.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 2.3 110.557 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.426 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 8.5 m -148.68 125.93 5.58 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.466 -0.788 . . . . 2.69 109.498 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.18 133.75 53.69 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.983 2.455 . . . . 2.08 112.195 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.806 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.28 84.6 2.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.305 0.574 . . . . 1.99 111.346 -179.494 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -11.03 59.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.005 -0.543 . . . . 2.55 111.756 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -56.91 -22.24 35.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.797 0.665 . . . . 2.28 112.797 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.57 4.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.095 0.474 . . . . 2.0 110.753 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.27 -16.7 45.82 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.885 -0.674 . . . . 2.33 111.517 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -87.08 121.71 29.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.949 0.404 . . . . 3.21 110.519 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.3 ttp85 -164.91 131.04 2.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 3.03 110.614 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -95.12 122.64 59.45 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.553 -0.536 . . . . 3.75 109.553 178.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.6 -37.23 90.83 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 123.449 2.766 . . . . 3.39 114.086 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.67 -8.53 59.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.81 0.67 . . . . 4.05 112.81 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -115.5 7.18 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.463 0.542 . . . . 4.78 112.463 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.77 124.61 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.908 0.385 . . . . 3.41 110.998 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.31 158.59 28.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.26 -0.427 . . . . 3.21 110.871 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.24 151.98 41.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 3.0 111.487 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 44.3 mt -107.96 132.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 2.42 109.044 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.29 119.34 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.434 -0.348 . . . . 2.74 111.009 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.715 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 3.9 tt -66.82 122.49 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.208 0.528 . . . . 2.19 110.733 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -133.15 145.49 50.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.515 -0.766 . . . . 2.49 110.582 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.4 HD12 HG23 ' A' ' 125' ' ' THR . 34.3 mt -106.83 143.74 27.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 1.96 109.767 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.71 159.08 50.16 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.557 2.171 . . . . 1.84 111.847 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.87 126.36 27.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.106 -0.497 . . . . 2.77 111.041 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 -11.8 45.5 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.967 -0.853 . . . . 2.2 110.967 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.4 HG23 HD12 ' A' ' 121' ' ' LEU . 10.4 m -108.52 109.01 20.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.269 -0.641 . . . . 2.1 109.269 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.08 147.85 28.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.412 -0.358 . . . . 2.87 111.296 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.8 mt -83.46 145.95 49.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.89 -0.596 . . . . 2.62 109.96 179.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.28 154.57 45.7 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.72 2.28 . . . . 2.77 112.095 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.2 120.87 15.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.01 -0.541 . . . . 4.28 110.462 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.95 4.56 48.14 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.845 -0.693 . . . . 3.18 111.705 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.48 ' HE2' HD12 ' A' ' 16' ' ' LEU . 2.3 t80 -115.57 121.81 43.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.341 -0.614 . . . . 2.93 109.341 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -126.41 140.87 52.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.989 0.423 . . . . 3.73 111.37 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.94 154.43 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.744 -0.662 . . . . 2.93 111.521 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.514 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.4 tt0 -83.59 131.57 34.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.405 -0.816 . . . . 3.64 109.224 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.51 -52.0 2.38 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.964 -0.854 . . . . 3.27 110.964 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.29 106.12 3.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 3.59 110.066 178.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -115.1 156.72 24.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.368 -0.378 . . . . 6.05 110.481 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.85 118.86 16.43 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.238 -0.506 . . . . 5.22 113.234 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 113.93 -92.02 0.59 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.109 -0.567 . . . . 5.91 111.763 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.248 0.996 0 CA-C-O 119.011 -0.519 . . . . 7.27 111.191 -179.979 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.566 1 C4'-C3'-C2' 97.065 -5.635 . 0.0 '__' . 12.52 . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.505 2 N19-C1'-C2' 103.543 -6.161 . 0.23 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.755 3 O4'-C1'-N19 115.717 7.517 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.231 4 O4'-C1'-N19 116.65 8.45 . 0.514 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.373 -4.171 2 C4'-C3'-C2' 97.583 -5.117 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.656 4 C4'-C3'-C2' 98.264 -4.436 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.498 5.344 3 P-O3'-C3' 127.002 6.085 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.366 3 O4'-C4'-C3' 114.977 6.769 . 0.0 '__' . 15.4 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.083 2 O4'-C1'-N19 118.609 10.409 . 0.417 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.49 3 O3'-P-O5' 116.308 6.478 . 0.46 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.136 1 C4'-C3'-C2' 98.305 -4.395 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.568 1 C4'-C3'-C2' 94.371 -8.329 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.844 1 O3'-P-O5' 111.696 4.051 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 022 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.964 2 C3'-C2'-C1' 105.718 4.686 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.974 0 N-CA-C 111.841 -0.504 . . . . 9.22 111.841 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.37 116.47 23.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.932 0.396 . . . . 8.25 110.624 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.5 mmm -120.69 131.14 54.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.019 -0.537 . . . . 8.02 110.672 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.58 126.41 7.39 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.631 -0.795 . . . . 5.79 111.966 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.33 121.47 71.27 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.882 -0.414 . . . . 4.72 109.882 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.84 63.99 7.56 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 123.201 2.601 . . . . 4.45 111.874 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -106.25 115.82 30.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.02 -0.536 . . . . 4.89 110.604 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -89.37 -85.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.228 -0.442 . . . . 4.35 110.827 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m 61.92 90.89 0.07 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.187 0.518 . . . . 2.87 111.67 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.51 161.74 13.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 2.48 111.258 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -81.02 162.36 23.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.046 -0.525 . . . . 2.57 110.54 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -98.79 -11.4 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.978 0.362 . . . . 2.4 111.978 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -129.09 176.37 7.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.606 -0.27 . . . . 2.02 111.041 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.982 HG23 " H5'" ' C' ' 8' ' ' ' G' . 1.9 p -71.69 174.19 7.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.075 -0.511 . . . . 2.65 110.077 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -97.41 167.36 11.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.189 0.519 . . . . 2.4 111.269 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.79 107.05 15.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.552 -0.749 . . . . 2.27 109.28 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.528 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -82.43 115.74 21.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.218 -0.446 . . . . 2.86 110.607 -179.943 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -85.33 128.49 34.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 2.89 110.371 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.61 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 42.9 t60 -112.98 -7.67 13.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.752 0.311 . . . . 4.07 111.247 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.76 -159.15 26.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.958 -0.639 . . . . 3.23 111.674 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.37 -32.07 12.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.83 0.315 . . . . 4.51 111.325 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.33 174.78 8.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.893 -0.594 . . . . 3.32 110.179 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -96.78 -82.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 2.41 109.403 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.513 HD12 ' CE1' ' A' ' 131' ' ' PHE . 31.6 tp -176.03 130.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 2.18 110.117 179.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -153.15 99.14 2.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.187 -0.46 . . . . 2.46 110.647 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -89.22 137.05 29.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 1.78 110.511 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.93 158.14 55.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.649 2.232 . . . . 2.15 111.852 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -56.93 118.14 4.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 2.84 111.355 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.35 -13.96 43.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 1.65 112.33 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -115.64 163.9 15.12 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.969 -0.382 . . . . 2.57 109.969 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.0 -19.05 13.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.839 -0.696 . . . . 1.42 112.808 179.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.77 113.76 54.71 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.726 0.298 . . . . 1.09 110.568 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HA ' HD22 ' A' ' 121' ' ' LEU . 2.9 Cg_exo -77.26 -174.89 2.39 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.265 2.643 . . . . 1.27 111.794 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.67 81.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 1.7 110.845 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.488 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 63.8 m-80 -81.79 84.18 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.424 . . . . 1.23 109.894 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -32.5 69.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.808 -0.633 . . . . 1.96 112.12 -178.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -76.95 -26.28 53.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 2.0 112.063 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -91.15 158.28 16.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.064 0.394 . . . . 1.44 112.064 -178.67 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.636 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 46.4 m -86.19 171.96 9.37 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.101 -0.499 . . . . 2.06 110.976 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.82 -43.53 55.46 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.037 2.491 . . . . 1.42 113.45 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.07 -16.05 60.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.78 111.53 179.966 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.689 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.0 m-20 -81.99 -3.62 54.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.6 111.237 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -77.2 51.8 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.3 0.572 . . . . 1.19 111.536 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.437 HG13 ' HB3' ' A' ' 94' ' ' ALA . 13.4 tt -150.98 128.03 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.654 -0.703 . . . . 1.17 109.468 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.28 -143.88 4.03 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.217 -0.992 . . . . 0.61 112.542 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -157.69 166.02 33.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.956 0.407 . . . . 1.13 111.001 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.618 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.5 m-85 -107.38 137.87 44.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 1.69 110.062 178.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -115.07 124.66 52.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.467 . . . . 2.51 110.82 -179.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -83.66 121.55 27.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 2.62 110.023 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.02 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 2.21 111.482 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -130.92 160.51 34.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.476 -0.784 . . . . 2.68 108.94 179.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -134.77 123.56 23.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.983 0.42 . . . . 3.78 111.769 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -138.92 115.21 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 3.58 110.942 179.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.609 HD11 ' H5 ' ' C' ' 13' ' ' ' U' . 28.5 pt -90.09 149.42 4.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.185 -0.672 . . . . 4.26 109.185 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -90.57 97.12 10.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.843 0.354 . . . . 5.46 110.362 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.588 ' HA2' ' OP2' ' C' ' 13' ' ' ' U' . . . -73.78 134.71 19.31 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.936 -0.65 . . . . 4.66 111.882 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 -23.32 69.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.888 -0.672 . . . . 5.04 112.007 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.81 3.55 41.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.999 0.428 . . . . 5.51 110.994 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.91 13.53 66.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.849 -0.691 . . . . 4.73 111.719 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -99.55 166.78 10.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.558 -0.321 . . . . 5.75 110.478 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 20.8 mtt -146.6 132.31 18.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.264 -0.426 . . . . 4.48 110.337 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HG3' ' N4 ' ' B' ' 1' ' ' ' C' . 73.2 tttt -54.37 -46.08 72.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 4.47 110.08 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t70 52.07 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.961 -1.018 . . . . 4.09 113.539 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.67 138.03 31.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.873 -0.603 . . . . 3.36 109.937 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.38 153.17 60.96 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 3.47 110.97 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 114.98 2.05 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.928 2.419 . . . . 2.69 111.89 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 56.7 mtp180 -110.03 113.18 25.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.776 -0.647 . . . . 3.22 110.046 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.618 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 47.3 m95 -84.91 120.3 26.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.241 -0.436 . . . . 1.95 111.117 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -98.96 150.94 21.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 2.76 110.567 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.32 122.31 43.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.4 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.91 164.53 17.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.839 -0.618 . . . . 2.07 109.745 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.49 155.68 17.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.64 -0.255 . . . . 1.28 110.334 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -60.7 111.88 1.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.224 -179.859 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.63 -8.27 26.07 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.308 -0.949 . . . . 1.66 113.993 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 p -62.89 103.68 0.47 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.66 0.73 . . . . 1.62 111.595 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.23 111.95 1.72 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.723 -0.951 . . . . 1.96 110.723 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.03 -26.07 78.12 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.762 2.308 . . . . 2.62 112.462 -179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -117.56 23.99 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 3.09 110.1 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.21 -53.98 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 1.87 111.122 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.2 49.29 80.14 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.877 -0.601 . . . . 1.7 112.146 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.6 mt -131.24 99.47 17.63 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.682 0.277 . . . . 1.43 111.548 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 7.7 Cg_exo -75.35 159.43 40.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.904 2.402 . . . . 1.62 110.974 178.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.598 ' HB2' HD11 ' A' ' 73' ' ' LEU . 79.5 t80 -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 1.75 111.021 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.12 -4.63 16.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.863 -0.684 . . . . 1.44 112.625 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.607 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -68.0 130.3 42.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 1.25 111.082 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -77.94 127.01 31.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.835 -0.62 . . . . 2.21 111.498 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -152.12 143.17 23.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.2 -0.667 . . . . 2.11 109.2 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.02 118.83 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 1.7 112.1 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.13 33.83 56.33 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.617 -0.72 . . . . 1.32 112.52 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.1 mm -136.3 112.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.157 -0.312 . . . . 1.06 110.157 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.6 pt -115.47 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.811 -0.44 . . . . 1.3 109.811 178.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -93.48 135.1 35.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 1.08 112.044 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.1 m -136.11 140.02 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.563 -179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB3' HG13 ' A' ' 44' ' ' ILE . . . -157.89 144.11 17.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 1.27 110.121 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -110.47 -176.22 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.044 0.45 . . . . 1.58 111.022 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.06 133.28 44.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.677 -0.692 . . . . 2.64 110.725 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.89 -9.1 63.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.719 -0.753 . . . . 1.63 112.444 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -82.89 142.34 31.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.186 -0.301 . . . . 1.59 110.186 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.45 144.0 31.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.714 -0.221 . . . . 2.15 110.584 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -80.47 74.63 7.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 2.3 109.806 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.8 t -144.8 141.41 17.48 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.558 -0.747 . . . . 2.69 109.019 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.39 130.64 21.5 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.596 2.197 . . . . 2.08 113.351 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.689 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.43 71.41 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.53 -0.759 . . . . 1.99 110.874 179.438 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -16.84 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.76 -0.654 . . . . 2.55 111.548 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -61.0 -7.36 2.41 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.577 0.954 . . . . 2.28 113.577 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.39 -23.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.612 -0.514 . . . . 2.0 109.612 178.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.32 81.53 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.859 -0.61 . . . . 2.33 113.433 -178.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 t -79.08 94.41 5.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.673 0.749 . . . . 3.21 110.644 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -150.81 130.73 13.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.377 -0.829 . . . . 3.03 109.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.21 115.75 64.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.836 -0.431 . . . . 3.75 109.836 179.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.49 0.92 8.98 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.808 2.338 . . . . 3.39 114.198 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.21 -31.7 9.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 4.05 111.126 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.44 -16.85 21.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 4.78 110.596 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -143.19 143.87 31.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 3.41 110.23 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.59 148.44 25.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.525 -0.307 . . . . 3.21 110.45 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.546 ' H ' " H1'" ' C' ' 8' ' ' ' G' . . . -69.48 160.28 31.72 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.105 -0.498 . . . . 3.0 111.771 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.3 mt -86.4 158.77 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.631 -0.713 . . . . 2.42 109.448 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.78 117.8 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.587 0.232 . . . . 2.74 110.462 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.536 HD11 ' HH ' ' A' ' 47' ' ' TYR . 6.5 tt -65.98 113.91 4.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 2.19 110.943 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -133.72 155.75 49.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 2.49 110.306 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 35.6 mt -105.79 146.35 32.68 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.194 -0.457 . . . . 1.96 110.59 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -64.66 161.7 34.57 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.861 2.374 . . . . 1.84 112.429 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -53.92 127.09 24.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.98 -0.554 . . . . 2.77 111.181 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.22 -7.7 58.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.765 -0.731 . . . . 2.2 111.697 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -112.79 100.01 8.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 2.1 110.095 179.997 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.01 156.14 18.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.209 -0.45 . . . . 2.87 110.663 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.4 mt -85.21 146.9 46.15 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.71 -0.478 . . . . 2.62 109.71 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.97 143.57 91.41 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.417 2.078 . . . . 2.77 111.56 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -59.54 124.25 19.48 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.89 -0.595 . . . . 4.28 111.245 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.21 45.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.955 -0.641 . . . . 3.18 111.869 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.513 ' CE1' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -109.51 139.13 44.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.695 0.283 . . . . 2.93 110.474 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.61 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 2.5 p90 -135.24 139.82 44.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.416 -0.356 . . . . 3.73 110.582 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.02 128.69 38.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.947 -0.569 . . . . 2.93 110.758 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 49.1 mt-10 -64.14 132.18 49.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.11 -0.495 . . . . 3.64 110.719 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.55 -37.32 3.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.909 -0.662 . . . . 3.27 112.9 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 m -75.2 142.98 43.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 3.59 111.265 -179.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -117.94 142.85 46.9 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.425 -0.583 . . . . 6.05 109.425 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.15 71.02 2.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 5.22 112.225 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.47 -114.67 5.0 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 111.424 -0.67 . . . . 5.91 111.424 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 119.167 -0.444 . . . . 7.27 111.504 -179.935 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.536 ' N4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.604 1 C4'-C3'-C2' 97.031 -5.669 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.405 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.474 4.69 2 N19-C1'-C2' 103.506 -6.184 . 0.233 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.757 3 O4'-C1'-N19 115.733 7.533 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.235 4 O4'-C1'-N19 116.694 8.494 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.374 -4.133 2 C4'-C3'-C2' 97.603 -5.097 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.659 4 C4'-C3'-C2' 98.267 -4.433 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.499 5.412 3 P-O3'-C3' 127.027 6.106 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 023 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.982 " H5'" HG23 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.582 5.446 3 O4'-C4'-C3' 114.861 6.686 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 023 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.541 -5.163 2 O4'-C1'-N19 118.618 10.418 . 0.416 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 023 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.473 3 O4'-C1'-N19 114.73 6.53 . 0.458 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 023 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.136 1 C4'-C3'-C2' 98.271 -4.429 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 023 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.606 1 C4'-C3'-C2' 94.39 -8.31 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 023 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.609 ' H5 ' HD11 ' A' ' 54' ' ' ILE . . . . . . . . 3 C4'--C3' 1.587 5.766 1 O3'-P-O5' 111.663 4.033 . 0.106 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 023 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.002 2 C3'-C2'-C1' 105.679 4.643 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.622 -0.591 . . . . 9.22 111.622 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.28 86.49 5.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.097 0.475 . . . . 8.25 109.797 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -92.94 127.65 38.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.753 -0.658 . . . . 8.02 111.174 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.18 174.86 34.03 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.459 -0.657 . . . . 5.79 111.459 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.9 mt -107.3 121.99 42.76 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 110.511 -0.181 . . . . 4.72 110.511 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -75.3 51.28 2.84 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.293 2.662 . . . . 4.45 111.615 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -135.33 162.7 31.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.571 -0.9 . . . . 4.89 108.571 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -96.6 -60.1 1.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.824 0.345 . . . . 4.35 110.48 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 p 49.21 61.71 2.99 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.888 1.07 . . . . 2.87 113.888 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.01 147.39 45.17 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.053 -0.351 . . . . 2.48 110.053 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -69.84 153.66 43.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.462 -0.336 . . . . 2.57 110.758 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -88.12 -9.15 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 2.4 111.109 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.0 m-85 -128.07 162.68 26.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.376 -0.374 . . . . 2.02 111.454 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.456 HG23 " H5'" ' C' ' 8' ' ' ' G' . 10.8 p -68.38 162.14 26.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 2.65 111.086 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.05 146.87 31.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 2.4 111.708 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.424 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 57.3 mt -97.48 123.87 41.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 2.27 108.935 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.474 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 6.0 m -105.11 128.12 53.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.831 0.348 . . . . 2.86 111.331 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -100.9 138.86 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.89 110.633 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -127.41 78.77 1.84 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.791 -0.448 . . . . 4.07 109.791 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.24 -158.91 16.13 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.97 -0.633 . . . . 3.23 111.892 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -94.56 -39.35 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.887 0.375 . . . . 4.51 110.238 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.72 155.74 21.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.985 -0.746 . . . . 3.32 108.985 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -96.87 -131.23 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.844 0.313 . . . . 2.41 111.844 -179.484 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 31.2 tp -114.77 135.95 53.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 2.18 112.253 -179.091 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -157.83 116.99 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.554 -0.748 . . . . 2.46 109.084 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -105.89 138.81 19.75 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.78 111.003 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.55 -178.94 2.9 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.847 2.365 . . . . 2.15 112.876 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -66.49 126.7 29.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.532 -0.758 . . . . 2.84 111.583 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 48.77 66.26 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.005 -0.543 . . . . 1.65 112.924 179.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -166.49 154.73 10.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.094 -0.336 . . . . 2.57 110.094 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.26 4.98 35.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.56 -0.829 . . . . 1.42 112.925 179.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.0 t -93.04 120.46 66.98 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.632 0.253 . . . . 1.09 110.506 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.97 178.75 5.53 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.069 2.512 . . . . 1.27 111.954 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.09 81.99 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 1.7 109.843 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.468 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 42.5 m-80 -83.3 75.18 9.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 1.23 110.946 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.93 3.62 6.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.395 0.617 . . . . 1.96 110.759 179.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -99.09 -8.5 25.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 2.0 110.667 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 p -134.61 165.33 25.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 1.44 112.056 -178.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -78.92 163.97 57.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 2.06 110.493 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 51.5 Cg_exo -57.11 -31.56 90.7 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.806 2.337 . . . . 1.42 112.566 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.54 -24.29 61.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 1.78 110.472 179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.787 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 21.6 m-20 -84.59 -3.69 58.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.769 -0.651 . . . . 1.6 110.74 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.468 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 34.3 mm-40 -78.54 58.06 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 1.19 111.156 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -153.1 134.44 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.485 -0.561 . . . . 1.17 109.485 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.64 -141.93 4.57 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.322 -0.942 . . . . 0.61 112.663 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -155.1 164.02 39.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.141 0.496 . . . . 1.13 111.479 -178.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.474 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 46.1 m-85 -106.79 131.64 53.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.591 -0.731 . . . . 1.69 109.091 178.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -106.83 127.84 53.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 2.51 111.279 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.4 ttt-85 -83.34 109.11 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.797 -0.638 . . . . 2.62 109.771 179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.95 170.58 9.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.83 0.347 . . . . 2.21 111.316 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 165.67 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.605 . . . . 2.68 110.304 179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -141.32 104.08 4.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 3.78 110.587 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -126.26 107.44 10.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.141 -0.482 . . . . 3.58 111.404 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -70.9 163.7 3.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.449 -0.341 . . . . 4.26 110.679 178.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.578 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -130.17 94.92 3.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 5.46 111.906 -179.005 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.64 158.75 52.65 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.924 -0.655 . . . . 4.66 112.094 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.18 83.03 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.905 -0.665 . . . . 5.04 112.053 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -88.63 28.85 1.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.185 0.517 . . . . 5.51 110.943 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.87 38.03 88.78 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.945 -0.57 . . . . 4.73 112.309 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -91.53 157.37 17.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.814 0.34 . . . . 5.75 111.15 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.9 ttm -158.74 139.14 12.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.28 -0.418 . . . . 4.48 110.501 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HG3' ' O4 ' ' C' ' 13' ' ' ' U' . 48.6 tttp -67.69 -48.05 67.68 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.304 0.377 . . . . 4.47 110.854 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 65.79 99.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.719 -0.673 . . . . 4.09 112.385 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.31 157.51 30.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 3.36 111.062 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -78.73 158.51 75.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.697 -0.683 . . . . 3.47 110.284 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.22 123.94 14.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.949 2.433 . . . . 2.69 111.871 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -122.22 122.56 39.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 3.22 111.053 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.474 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 45.8 m95 -98.72 129.95 45.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.774 -0.648 . . . . 1.95 111.184 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -108.65 138.7 44.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.34 -0.615 . . . . 2.76 109.34 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.48 128.72 36.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 1.4 111.486 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.72 143.21 50.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 2.07 110.369 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -77.4 151.6 34.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.426 -0.352 . . . . 1.28 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -58.82 116.81 4.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 1.66 111.085 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.72 -3.37 23.06 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.555 -0.831 . . . . 1.66 113.735 178.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.41 114.18 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.994 0.397 . . . . 1.62 111.119 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.57 109.6 3.37 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.124 -0.791 . . . . 1.96 111.124 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.97 -39.61 90.15 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.098 2.532 . . . . 2.62 112.921 -179.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.71 31.17 6.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.377 . . . . 3.09 110.989 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.18 -42.94 59.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 1.87 111.137 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.39 51.65 41.49 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.971 -0.633 . . . . 1.7 111.546 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -120.41 97.33 48.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.614 0.245 . . . . 1.43 111.476 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.65 151.32 10.14 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.096 2.531 . . . . 1.62 110.914 178.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.55 ' HB2' HD11 ' A' ' 73' ' ' LEU . 68.9 t80 -62.77 111.32 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.368 . . . . 1.75 110.855 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.85 -27.09 5.23 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.456 -0.878 . . . . 1.44 112.201 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.53 122.37 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.683 0.277 . . . . 1.25 110.76 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -87.14 127.34 35.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.958 0.409 . . . . 2.21 111.524 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -139.97 157.89 44.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.728 -0.842 . . . . 2.11 108.728 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.54 115.87 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.229 0.455 . . . . 1.7 112.229 -179.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.55 30.36 62.29 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.32 112.756 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.51 95.19 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 1.06 110.476 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.2 pt -107.75 127.98 63.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.132 -0.486 . . . . 1.3 109.99 178.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.525 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 85.5 m95 -88.02 140.86 29.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.341 0.497 . . . . 1.08 112.341 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.73 146.78 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.446 -0.797 . . . . 1.04 109.781 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -140.9 173.6 11.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.013 0.435 . . . . 1.27 111.226 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 98' ' ' ALA . 1.4 t -133.49 168.11 19.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.972 -0.558 . . . . 1.58 110.079 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.41 105.35 5.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 2.64 109.829 179.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.25 26.39 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.657 -0.782 . . . . 1.63 111.95 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.534 ' HB3' HG23 ' A' ' 95' ' ' THR . . . -78.74 149.47 32.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.754 -0.462 . . . . 1.59 109.754 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.56 123.18 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.889 0.376 . . . . 2.15 110.721 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -76.63 72.3 3.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.584 0.707 . . . . 2.3 110.284 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.602 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 25.5 m -149.47 129.89 6.84 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.54 -0.911 . . . . 2.69 108.54 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.51 125.11 13.25 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.982 2.454 . . . . 2.08 112.418 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.787 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.3 69.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.344 0.593 . . . . 1.99 111.304 -179.488 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -77.42 4.36 11.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.186 -0.461 . . . . 2.55 112.003 -179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.447 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.5 p80 -57.81 -23.15 51.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.949 0.404 . . . . 2.28 111.743 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.84 16.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 2.0 111.147 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.19 -15.98 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.742 -0.742 . . . . 2.33 111.704 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -82.51 123.55 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 3.21 111.157 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -167.63 147.06 4.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 3.03 109.419 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.9 113.19 62.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.071 0.463 . . . . 3.75 110.872 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.78 -35.45 27.63 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.116 2.544 . . . . 3.39 113.875 -178.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.36 18.13 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 4.05 111.888 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -141.96 -39.08 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.195 -0.457 . . . . 4.78 110.707 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.271 -0.422 . . . . 3.41 110.911 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.615 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -92.87 146.9 23.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 3.21 110.585 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.471 ' HB2' " H4'" ' C' ' 8' ' ' ' G' . . . -81.17 165.36 21.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 3.0 110.957 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.6 mt -97.67 155.59 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.55 . . . . 2.42 110.077 -179.563 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -68.53 126.8 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.318 -0.253 . . . . 2.74 110.318 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -70.24 111.51 5.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.92 0.391 . . . . 2.19 110.407 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -128.38 153.57 46.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 2.49 109.952 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 93.3 mt -108.18 148.65 37.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.22 -0.445 . . . . 1.96 110.482 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.01 157.03 63.73 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.191 1.927 . . . . 1.84 111.383 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -53.68 124.4 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 2.77 110.877 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.07 -18.24 16.43 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.207 -0.757 . . . . 2.2 111.207 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -94.87 100.19 12.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.031 0.443 . . . . 2.1 110.196 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.5 m -80.0 129.64 34.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 2.87 111.071 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.7 mt -80.34 137.36 52.32 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 2.62 109.843 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.7 141.85 97.69 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.546 2.164 . . . . 2.77 111.654 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -60.49 128.03 34.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.039 -0.528 . . . . 4.28 111.033 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.94 -18.95 39.17 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.204 -0.758 . . . . 3.18 111.204 -179.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -95.73 138.21 33.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.647 0.26 . . . . 2.93 110.493 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.474 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 27.2 p90 -136.19 155.24 50.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.453 -0.34 . . . . 3.73 110.397 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.33 123.77 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 2.93 110.072 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.13 128.59 35.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.165 -0.47 . . . . 3.64 110.339 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 112.16 -20.45 21.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.795 -0.717 . . . . 3.27 111.355 -179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.7 m -80.28 77.39 7.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.166 0.508 . . . . 3.59 110.333 179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -144.1 39.14 1.32 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.599 -0.728 . . . . 6.05 109.86 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.76 47.45 4.8 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.858 -0.897 . . . . 5.22 110.858 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -99.87 69.54 0.52 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.047 -0.597 . . . . 5.91 112.969 -178.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.247 0.937 0 CA-C-O 119.071 -0.49 . . . . 7.27 111.727 179.569 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.404 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.491 -3.703 1 C4'-C3'-C2' 96.995 -5.705 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.478 2 N19-C1'-C2' 103.452 -6.217 . 0.231 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 024 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.85 3 O4'-C1'-N19 115.734 7.534 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 024 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.179 4 O4'-C1'-N19 116.635 8.435 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 024 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.081 2 C4'-C3'-C2' 97.584 -5.116 . 0.656 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 024 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.674 4 C4'-C3'-C2' 98.265 -4.435 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 024 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.499 5.429 3 P-O3'-C3' 127.098 6.165 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 024 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.615 " H1'" ' HA ' ' A' ' 115' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.368 3 O4'-C4'-C3' 114.917 6.726 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 024 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.127 2 O4'-C1'-N19 118.589 10.389 . 0.412 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 024 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.474 3 O3'-P-O5' 116.371 6.511 . 0.46 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 024 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.108 1 C4'-C3'-C2' 98.286 -4.414 . 0.307 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 024 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.595 1 C4'-C3'-C2' 94.327 -8.373 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 024 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.441 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.588 5.837 1 O3'-P-O5' 111.776 4.093 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 024 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.966 2 C3'-C2'-C1' 105.647 4.608 . 0.341 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.902 -0.479 . . . . 9.22 111.902 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.95 96.09 8.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.93 0.395 . . . . 8.25 110.947 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.51 118.45 30.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.152 -0.476 . . . . 8.02 110.879 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.66 146.21 9.58 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.619 -0.801 . . . . 5.79 111.986 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.1 tp -113.95 107.36 52.38 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.763 0.316 . . . . 4.72 110.532 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -93.46 23.9 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.122 2.548 . . . . 4.45 113.213 -179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -102.32 117.92 35.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.873 0.368 . . . . 4.89 110.838 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -76.15 105.06 6.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.885 -0.598 . . . . 4.35 110.734 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -129.95 118.88 22.33 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.977 -0.556 . . . . 2.87 110.222 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.88 129.2 27.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.891 -0.595 . . . . 2.48 110.169 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 p -69.78 145.87 51.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.574 -0.285 . . . . 2.57 110.6 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -75.14 -20.22 59.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.44 -0.346 . . . . 2.4 111.377 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -108.16 166.27 10.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.02 112.098 -178.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.89 170.82 13.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.031 -0.986 . . . . 2.65 111.258 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.39 140.3 41.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.087 -0.506 . . . . 2.4 111.756 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.681 HD11 HD12 ' A' ' 119' ' ' LEU . 5.1 mp -107.61 115.75 30.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.294 -0.632 . . . . 2.27 109.294 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.9 m -96.34 129.33 43.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.657 0.614 . . . . 2.86 112.657 -178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -95.56 128.11 42.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.391 -0.822 . . . . 2.89 109.806 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.29 79.79 1.57 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.804 -0.443 . . . . 4.07 109.804 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.44 -167.54 39.13 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.652 -0.785 . . . . 3.23 111.991 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -81.58 -25.93 35.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.954 0.407 . . . . 4.51 111.681 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -81.35 173.1 12.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 3.32 109.771 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 -70.47 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.122 -0.696 . . . . 2.41 109.122 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp 178.61 127.91 0.06 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.603 -0.726 . . . . 2.18 111.133 179.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -159.59 107.43 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 2.46 110.24 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -98.11 148.32 34.32 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.049 -0.523 . . . . 1.78 109.737 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.98 162.09 41.88 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.337 2.024 . . . . 2.15 111.251 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -62.22 135.88 57.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 2.84 110.297 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 21.75 58.85 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.549 -0.834 . . . . 1.65 111.748 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -156.81 172.18 19.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.067 -0.345 . . . . 2.57 110.067 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.56 56.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.784 -0.722 . . . . 1.42 112.345 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.3 t -82.24 119.07 74.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 110.13 -0.322 . . . . 1.09 110.13 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.88 -179.14 5.16 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.299 . . . . 1.27 111.657 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -77.62 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 1.7 110.786 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.57 83.35 8.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.538 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.86 21.79 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.237 0.458 . . . . 1.96 112.237 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -124.44 -17.36 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.586 0.231 . . . . 2.0 111.457 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.6 168.6 10.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.84 0.352 . . . . 1.44 111.918 -178.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.8 m -86.86 166.3 27.56 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 2.06 110.687 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.4 Cg_endo -53.4 -39.84 80.34 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.268 2.645 . . . . 1.42 113.205 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.54 -13.93 61.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.077 0.465 . . . . 1.78 111.163 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -93.84 -1.63 54.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.614 . . . . 1.6 110.479 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -78.38 54.63 1.45 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.08 0.466 . . . . 1.19 111.108 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.65 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.8 tt -147.26 133.92 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.079 -0.51 . . . . 1.17 109.893 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.42 -144.4 4.99 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.432 -0.889 . . . . 0.61 112.477 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -156.15 164.43 38.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 1.13 110.935 -179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -107.67 130.79 54.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.055 -0.721 . . . . 1.69 109.055 178.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -110.09 135.39 50.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.089 0.243 . . . . 2.51 110.922 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -87.18 123.25 32.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.799 -0.445 . . . . 2.62 109.799 178.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.54 154.47 46.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.243 0.544 . . . . 2.21 111.399 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -154.26 111.4 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.483 -0.781 . . . . 2.68 109.828 179.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HB3' HD13 ' A' ' 64' ' ' LEU . 20.5 tpt180 -93.27 127.29 38.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.153 0.501 . . . . 3.78 110.917 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -128.59 141.13 51.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.478 -0.783 . . . . 3.58 109.922 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.633 HG12 ' H ' ' A' ' 62' ' ' LYS . 34.8 pt -92.83 175.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.203 -0.666 . . . . 4.26 109.203 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.4 92.57 3.75 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.256 -0.275 . . . . 5.46 110.256 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.434 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -140.11 113.11 0.86 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.924 -0.655 . . . . 4.66 111.682 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.02 5.91 78.9 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.966 -0.635 . . . . 5.04 112.485 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.79 -3.82 54.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.859 0.361 . . . . 5.51 110.452 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.453 ' HA3' ' OP2' ' C' ' 14' ' ' ' G' . . . -167.63 -134.79 1.76 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.81 -0.709 . . . . 4.73 112.277 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -108.29 143.85 36.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.83 0.347 . . . . 5.75 110.607 -179.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 mmt -77.71 151.26 34.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.46 -0.941 . . . . 4.48 108.46 178.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.633 ' H ' HG12 ' A' ' 54' ' ' ILE . 53.5 tttt -49.94 -43.57 49.98 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.189 0.306 . . . . 4.47 110.615 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 43.95 71.56 0.24 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.432 -0.804 . . . . 4.09 112.748 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 52' ' ' ARG . 98.2 mt -67.04 145.35 55.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.002 -0.545 . . . . 3.36 110.363 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.52 162.58 61.21 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.747 -0.464 . . . . 3.47 109.747 179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.93 102.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.655 2.236 . . . . 2.69 111.858 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -108.74 122.69 47.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 3.22 110.893 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 51.0 m95 -98.27 145.17 26.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.95 110.042 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.612 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 81.1 m-85 -128.01 137.98 52.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.762 -0.459 . . . . 2.76 109.762 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -88.49 128.98 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 1.4 111.444 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -128.13 150.57 49.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.806 -0.634 . . . . 2.07 109.686 178.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -84.53 156.78 21.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.941 0.401 . . . . 1.28 111.008 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 1.6 tt -64.0 115.01 4.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.408 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.46 1.17 24.76 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.731 -0.747 . . . . 1.66 113.769 179.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.8 p -58.47 110.18 0.93 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.192 0.496 . . . . 1.62 110.885 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.26 111.59 3.61 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.302 -0.719 . . . . 1.96 111.302 -179.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.21 -18.11 63.31 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.707 2.271 . . . . 2.62 112.134 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -119.54 24.15 10.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.456 -0.338 . . . . 3.09 111.45 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.95 -48.84 15.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 1.87 110.51 179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.36 49.45 74.02 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.885 -0.598 . . . . 1.7 111.821 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.8 mt -119.72 100.06 49.17 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.866 0.365 . . . . 1.43 111.619 -179.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.22 153.28 14.16 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.464 2.11 . . . . 1.62 111.206 178.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.48 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.3 t80 -58.61 115.14 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 1.75 110.781 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.13 10.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.815 -0.707 . . . . 1.44 112.195 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.56 107.38 3.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 1.25 110.344 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.77 104.75 5.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.963 -0.562 . . . . 2.21 110.506 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.41 ' HB3' ' CG1' ' A' ' 90' ' ' ILE . 67.7 tttt -112.22 160.6 17.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.949 -0.569 . . . . 2.11 110.093 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.04 112.2 2.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.465 . . . . 1.7 111.298 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.33 32.17 65.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.923 -0.656 . . . . 1.32 112.327 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.41 ' CG1' ' HB3' ' A' ' 87' ' ' LYS . 36.6 mm -130.06 112.7 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.629 0.252 . . . . 1.06 110.601 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.0 pt -118.46 123.84 72.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.864 0.364 . . . . 1.3 110.428 178.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.485 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 89.7 m95 -82.61 137.95 34.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.069 -0.514 . . . . 1.08 111.769 -179.106 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.83 135.73 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 1.04 110.58 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.26 170.87 15.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 1.27 110.584 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -150.19 179.23 8.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.414 -0.587 . . . . 1.58 109.414 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -66.05 132.07 47.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.65 0.262 . . . . 2.64 110.382 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.66 32.88 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.854 -0.689 . . . . 1.63 111.53 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.65 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.18 134.3 36.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.117 -0.327 . . . . 1.59 110.117 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.92 149.05 26.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.387 -0.37 . . . . 2.15 110.634 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.73 74.03 5.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.521 0.677 . . . . 2.3 110.409 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -138.51 130.05 15.6 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.496 -0.774 . . . . 2.69 110.323 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.6 122.37 5.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.32 2.013 . . . . 2.08 111.466 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.594 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -146.07 106.29 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.103 -0.499 . . . . 1.99 111.402 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.18 8.06 32.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.56 . . . . 2.55 112.164 -178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.594 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 6.4 p80 -56.73 -28.66 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.212 0.529 . . . . 2.28 111.594 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.13 5.42 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 2.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.95 -21.62 22.75 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.778 -0.725 . . . . 2.33 112.248 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.6 t -74.97 105.62 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.492 0.663 . . . . 3.21 111.261 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -149.75 125.49 10.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.668 -0.696 . . . . 3.03 109.742 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -84.74 114.28 54.49 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.894 0.378 . . . . 3.75 110.341 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 28.4 Cg_endo -60.67 -34.6 91.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.181 2.588 . . . . 3.39 113.449 -178.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.35 15.68 11.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.151 0.426 . . . . 4.05 112.151 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.48 -20.64 1.59 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.893 0.377 . . . . 4.78 111.664 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -131.78 137.4 48.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.694 0.283 . . . . 3.41 110.365 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.21 146.74 28.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.253 -0.431 . . . . 3.21 110.969 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.33 157.61 32.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.407 0.622 . . . . 3.0 111.904 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 62.4 mt -102.21 137.59 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.417 -0.81 . . . . 2.42 109.765 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.42 121.4 13.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.12 -0.696 . . . . 2.74 109.12 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.681 HD12 HD11 ' A' ' 16' ' ' LEU . 3.9 tt -63.44 117.9 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 2.19 111.549 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -126.75 141.58 51.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.443 -0.799 . . . . 2.49 109.816 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 79.9 mt -105.62 145.04 30.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.258 -0.428 . . . . 1.96 110.344 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.56 150.84 79.49 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.702 2.268 . . . . 1.84 111.557 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.67 98.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 2.77 110.888 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 143.94 -30.74 1.9 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.96 -0.638 . . . . 2.2 111.574 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.1 m -84.44 115.04 22.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.69 0.281 . . . . 2.1 110.369 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 137.17 37.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.272 -0.422 . . . . 2.87 110.904 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.2 mt -74.97 149.02 85.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 2.62 110.875 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.35 161.75 19.32 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.817 2.345 . . . . 2.77 112.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.85 119.26 10.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.836 -0.62 . . . . 4.28 111.597 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.55 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.137 -0.554 . . . . 3.18 112.923 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -106.25 126.98 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.728 0.299 . . . . 2.93 110.464 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.78 164.02 34.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.033 -0.53 . . . . 3.73 110.635 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -110.48 156.36 20.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.509 -0.314 . . . . 2.93 110.802 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.63 132.54 42.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.89 -0.595 . . . . 3.64 110.773 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.48 -45.15 1.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.097 -0.573 . . . . 3.27 112.936 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.97 132.52 45.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 3.59 110.588 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -110.3 -164.9 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.642 -0.253 . . . . 6.05 110.831 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.72 110.61 3.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.962 -0.637 . . . . 5.22 112.397 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.86 -67.91 3.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.126 -0.559 . . . . 5.91 112.61 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.76 -0.638 . . . . 7.27 111.281 -179.954 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.469 ' H5 ' HD22 ' A' ' 64' ' ' LEU . . . . . . . . 0 C2'--C1' 1.493 -3.503 1 C4'-C3'-C2' 97.092 -5.608 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.529 2 N19-C1'-C2' 103.502 -6.187 . 0.23 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.743 3 O4'-C1'-N19 115.73 7.53 . 0.526 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.217 4 O4'-C1'-N19 116.658 8.458 . 0.507 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.056 2 C4'-C3'-C2' 97.535 -5.165 . 0.652 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.604 4 C4'-C3'-C2' 98.271 -4.429 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.298 3 P-O3'-C3' 127.041 6.117 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.612 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.581 5.289 3 O4'-C4'-C3' 114.931 6.736 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 025 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.122 2 O4'-C1'-N19 118.707 10.507 . 0.416 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.486 3 O3'-P-O5' 116.326 6.487 . 0.458 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.171 1 C4'-C3'-C2' 98.252 -4.448 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.57 1 C4'-C3'-C2' 94.388 -8.312 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 025 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.434 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.588 5.803 1 O3'-P-O5' 111.743 4.075 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 025 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . 0.453 ' OP2' ' HA3' ' A' ' 59' ' ' GLY . . . . . . . . 2 C2'--C1' 1.578 4.95 2 C3'-C2'-C1' 105.655 4.617 . 0.337 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.882 -0.487 . . . . 9.22 111.882 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.51 107.9 17.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.937 0.399 . . . . 8.25 110.35 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.2 tpt -84.45 111.29 19.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.852 -0.613 . . . . 8.02 111.158 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.69 107.7 3.44 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.262 -0.735 . . . . 5.79 111.262 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.6 tp -147.43 112.27 4.02 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.207 -0.294 . . . . 4.72 110.207 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.63 69.33 7.8 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.614 2.209 . . . . 4.45 112.179 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -155.1 154.63 32.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 4.89 110.897 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -122.11 -47.31 2.16 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.299 -0.41 . . . . 4.35 110.668 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.92 76.62 0.33 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.601 -0.727 . . . . 2.87 111.148 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.39 138.59 39.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.115 -0.493 . . . . 2.48 111.055 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -85.29 155.05 21.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.109 -0.496 . . . . 2.57 110.373 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 23.2 m95 -78.77 -28.29 44.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.442 . . . . 2.4 111.191 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.5 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 29.0 m-85 -99.33 173.81 6.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.737 -0.665 . . . . 2.02 110.957 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.434 ' HB ' ' H ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -78.8 -142.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.675 -0.693 . . . . 2.65 110.353 179.587 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' H ' ' HB ' ' A' ' 14' ' ' THR . . . -131.74 146.59 52.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.963 0.411 . . . . 2.4 111.566 -179.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.6 mt -96.99 120.02 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 2.27 109.112 178.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -92.97 122.99 35.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.433 -0.349 . . . . 2.86 111.249 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.3 tp-100 -101.22 145.02 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 2.89 110.067 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -140.58 89.47 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.384 -0.599 . . . . 4.07 109.384 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.38 -167.42 40.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.535 -0.84 . . . . 3.23 112.497 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -81.66 -36.47 28.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 4.51 110.605 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -75.59 154.68 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.47 -0.786 . . . . 3.32 110.671 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.02 -89.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.218 -0.446 . . . . 2.41 110.549 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.507 HD12 ' CE1' ' A' ' 131' ' ' PHE . 29.3 tp -168.71 134.61 1.76 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.985 0.421 . . . . 2.18 111.837 179.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -163.42 120.18 1.8 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.765 -0.652 . . . . 2.46 110.221 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -106.09 137.17 19.3 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.026 -0.534 . . . . 1.78 110.156 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.7 163.53 30.05 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.547 2.165 . . . . 2.15 111.908 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -63.64 103.19 0.52 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.159 0.504 . . . . 2.84 110.967 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.09 -9.19 8.46 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.794 -0.639 . . . . 1.65 111.873 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -120.43 163.07 18.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.765 0.317 . . . . 2.57 110.368 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -6.7 28.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.902 -0.666 . . . . 1.42 112.421 179.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 t -88.72 117.39 68.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.762 0.315 . . . . 1.09 110.307 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.04 -169.04 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.902 2.401 . . . . 1.27 111.718 -179.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 mt -82.58 77.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.08 0.467 . . . . 1.7 109.817 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.446 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 78.6 m-20 -78.4 78.06 4.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.58 . . . . 1.23 110.823 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.94 -1.55 26.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.113 -0.494 . . . . 1.96 111.238 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.21 2.67 22.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 2.0 110.652 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.89 155.16 46.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 1.44 111.284 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.8 m -86.61 169.08 15.98 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.929 -0.578 . . . . 2.06 110.318 179.432 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.62 -40.24 30.36 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.484 2.789 . . . . 1.42 114.252 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -17.44 44.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.732 0.301 . . . . 1.78 111.609 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.686 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -89.14 8.67 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 1.6 110.788 -179.628 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.446 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 85.1 mm-40 -80.76 0.57 34.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 1.19 112.104 -179.162 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.759 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.2 tt -89.51 126.62 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.975 0.417 . . . . 1.17 111.086 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.61 -152.2 6.28 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.345 -0.931 . . . . 0.61 112.919 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -163.19 170.9 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.917 0.389 . . . . 1.13 110.547 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.473 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 4.5 m-85 -111.46 138.22 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.213 -0.449 . . . . 1.69 110.422 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -117.94 127.44 53.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 2.51 110.819 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -79.01 126.92 31.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 2.62 109.95 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.01 151.82 42.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.005 0.431 . . . . 2.21 111.88 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 m -143.51 132.42 22.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 2.68 109.819 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 HH21 ' P ' ' C' ' 10' ' ' ' C' . 2.2 tpt180 -106.91 138.04 43.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.093 -0.336 . . . . 3.78 110.093 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -147.43 128.03 14.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.83 0.348 . . . . 3.58 111.851 -178.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 62' ' ' LYS . 41.3 pt -81.41 151.67 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.802 -0.814 . . . . 4.26 108.802 178.389 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -118.92 93.04 3.96 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.554 -0.458 . . . . 5.46 111.74 -179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.91 148.7 26.02 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.506 -0.854 . . . . 4.66 111.519 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.64 -29.88 76.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.087 -0.578 . . . . 5.04 112.482 -179.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.88 -0.86 36.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.28 0.562 . . . . 5.51 111.001 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.93 11.26 63.67 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.661 -0.78 . . . . 4.73 111.416 -179.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -70.14 129.16 38.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.59 -0.305 . . . . 5.75 110.499 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 mmt -124.25 127.18 47.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.066 -0.516 . . . . 4.48 110.909 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.504 ' HB2' HG12 ' A' ' 54' ' ' ILE . 75.9 tttt -66.84 -35.71 80.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.028 -0.73 . . . . 4.47 109.028 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 50.12 82.86 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.748 -1.114 . . . . 4.09 113.047 179.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.0 mt -82.57 168.13 17.65 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.944 -0.571 . . . . 3.36 110.507 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -90.5 155.04 46.39 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.028 -0.533 . . . . 3.47 110.441 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.72 116.22 2.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.809 2.339 . . . . 2.69 111.757 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.414 HH21 ' P ' ' B' ' 1' ' ' ' C' . 29.3 mtt180 -115.79 119.03 34.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 3.22 111.265 -179.2 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.473 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 53.7 m95 -93.78 124.03 37.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 1.95 110.401 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -102.89 138.92 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.222 -0.444 . . . . 2.76 110.201 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -90.35 124.79 35.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.084 0.469 . . . . 1.4 111.344 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.0 167.75 12.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 2.07 109.894 179.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -108.02 151.58 25.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.688 -0.233 . . . . 1.28 110.43 -179.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.32 110.94 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.4 -0.364 . . . . 1.66 110.465 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.96 -15.55 6.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.763 -0.732 . . . . 1.66 112.357 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.548 HG23 ' HA3' ' A' ' 107' ' ' GLY . 9.5 p -59.13 125.77 24.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.571 0.224 . . . . 1.62 111.006 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.02 110.47 3.3 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.795 -0.717 . . . . 1.96 111.587 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.93 -37.0 97.8 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.006 2.47 . . . . 2.62 112.948 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -117.46 34.35 5.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 3.09 110.491 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.38 -52.23 29.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.87 110.379 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.34 46.47 93.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.977 -0.63 . . . . 1.7 111.693 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.1 mt -120.06 97.73 49.28 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.55 0.204 . . . . 1.43 111.55 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.22 147.43 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.896 2.398 . . . . 1.62 110.65 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.458 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 44.5 t80 -58.54 104.83 0.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 1.75 111.142 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.35 -16.69 5.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.852 -0.689 . . . . 1.44 111.878 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.48 20.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 1.25 110.753 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -80.93 119.34 23.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.007 -0.542 . . . . 2.21 110.75 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -135.25 149.69 49.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.069 -0.514 . . . . 2.11 109.832 179.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.96 110.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.326 0.584 . . . . 1.7 112.123 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.68 64.76 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.697 -0.683 . . . . 1.32 112.964 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 mm -128.05 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 1.06 110.641 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 13.2 pt -117.62 133.48 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.112 -0.494 . . . . 1.3 109.765 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.458 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 73.6 m95 -89.04 140.07 29.82 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.385 . . . . 1.08 112.038 -178.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 m -136.32 131.06 48.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.741 -0.663 . . . . 1.04 110.884 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.12 169.47 20.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.138 -0.483 . . . . 1.27 110.89 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -148.4 -169.99 3.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.535 -0.543 . . . . 1.58 109.535 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.91 136.84 57.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.875 0.369 . . . . 2.64 110.827 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.94 -25.15 27.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.148 -0.549 . . . . 1.63 112.404 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.759 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.45 136.24 45.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.813 0.339 . . . . 1.59 110.452 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.96 140.55 38.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.117 -0.492 . . . . 2.15 110.72 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -76.79 78.29 3.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.77 -0.455 . . . . 2.3 109.77 179.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.449 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 81.6 m -150.31 128.94 6.06 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.971 -0.752 . . . . 2.69 108.971 -179.394 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.71 124.54 12.49 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.602 2.201 . . . . 2.08 111.834 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.686 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.21 95.83 4.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 1.99 110.954 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.12 -5.91 58.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 2.55 112.427 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.434 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 14.8 p80 -61.44 -21.07 63.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.477 0.547 . . . . 2.28 112.477 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.497 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -102.02 12.26 7.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 2.0 111.363 -179.79 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.548 ' HA3' HG23 ' A' ' 75' ' ' THR . . . -124.89 38.29 2.37 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.653 -0.784 . . . . 2.33 111.4 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -131.74 33.46 3.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.597 0.713 . . . . 3.21 110.658 -179.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HD3' ' HA ' ' A' ' 12' ' ' TRP . 54.0 ttp85 -72.99 137.63 45.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.895 -0.593 . . . . 3.03 111.258 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -98.43 107.68 43.48 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.17 -0.678 . . . . 3.75 109.17 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.443 ' CB ' " H1'" ' C' ' 8' ' ' ' G' . 57.4 Cg_endo -69.64 -14.24 36.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.876 2.384 . . . . 3.39 113.652 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.46 -25.03 27.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.663 0.268 . . . . 4.05 111.425 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -121.99 29.86 6.88 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.543 -0.299 . . . . 4.78 111.56 -179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -174.03 140.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 3.41 110.857 179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.28 142.82 26.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.207 -0.451 . . . . 3.21 110.1 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.83 145.83 50.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.259 -0.428 . . . . 3.0 111.23 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.0 mt -78.53 139.54 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.118 -0.492 . . . . 2.42 109.889 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.98 122.14 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 2.74 110.183 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.5 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 1.2 tt -59.75 109.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 2.19 111.231 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.64 152.07 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.759 -0.655 . . . . 2.49 110.182 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 mt -108.65 153.09 42.42 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.128 -0.487 . . . . 1.96 110.228 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.32 172.21 8.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.13 . . . . 1.84 112.337 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.16 131.97 50.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 2.77 111.203 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.89 36.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.91 -0.662 . . . . 2.2 112.704 179.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 m -85.64 107.79 17.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.913 0.387 . . . . 2.1 110.134 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.52 143.25 26.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 2.87 111.825 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.8 143.61 50.59 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 2.62 109.943 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.16 146.69 95.95 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.57 2.18 . . . . 2.77 111.663 179.244 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -61.15 119.27 8.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 4.28 111.398 -179.331 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.89 -13.49 29.34 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.923 -0.656 . . . . 3.18 111.991 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -97.16 133.58 41.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.596 0.236 . . . . 2.93 110.742 179.647 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -144.65 144.55 31.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 3.73 110.269 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.55 150.56 26.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.83 0.348 . . . . 2.93 111.358 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.09 135.74 39.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.565 -0.531 . . . . 3.64 109.565 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.43 69.5 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 3.27 112.399 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t -69.1 115.62 8.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 3.59 110.141 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -96.03 119.1 33.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.865 -0.607 . . . . 6.05 111.481 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.3 66.23 3.02 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.284 -0.726 . . . . 5.22 111.284 179.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.25 -71.63 0.39 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.728 -0.949 . . . . 5.91 110.728 -179.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.865 -0.588 . . . . 7.27 112.438 179.269 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.414 ' P ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 C2'--C1' 1.492 -3.607 1 C4'-C3'-C2' 97.038 -5.662 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.481 2 N19-C1'-C2' 103.578 -6.139 . 0.233 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 026 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.742 3 O4'-C1'-N19 115.83 7.63 . 0.53 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 026 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.233 4 O4'-C1'-N19 116.661 8.461 . 0.508 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 026 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.056 2 C4'-C3'-C2' 97.557 -5.143 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 026 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.732 5 C4'-C3'-C2' 98.246 -4.454 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 026 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 O3'--C3' 1.498 5.345 3 P-O3'-C3' 126.998 6.082 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 026 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.443 " H1'" ' CB ' ' A' ' 111' ' ' PRO . . . . . . . . 2 C2'--C1' 1.582 5.382 3 O4'-C4'-C3' 114.958 6.756 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 026 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.057 2 O4'-C1'-N19 118.652 10.452 . 0.415 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 026 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . 0.404 ' P ' HH21 ' A' ' 52' ' ' ARG . . . . . . . . 2 P--O5' 1.547 -4.578 3 O3'-P-O5' 116.301 6.474 . 0.459 1a . 13.87 . . . . . . . . . . 3 2 . 1 . 026 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.153 1 C4'-C3'-C2' 98.259 -4.441 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 026 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.534 1 C4'-C3'-C2' 94.366 -8.334 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 026 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.853 1 O3'-P-O5' 111.744 4.076 . 0.104 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 026 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . 0.41 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.578 4.967 2 C3'-C2'-C1' 105.749 4.721 . 0.335 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 111.743 -0.543 . . . . 9.22 111.743 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.81 143.14 57.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.977 0.418 . . . . 8.25 111.487 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.2 tpp -84.21 124.36 31.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.828 -0.624 . . . . 8.02 110.184 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.73 107.46 1.52 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.855 -0.688 . . . . 5.79 111.621 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.3 mt -100.77 117.76 62.0 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.804 0.335 . . . . 4.72 110.952 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -93.62 65.82 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.207 2.605 . . . . 4.45 111.925 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -112.8 -78.41 0.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.456 -0.338 . . . . 4.89 111.332 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 t30 64.41 27.82 13.6 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.521 0.677 . . . . 4.35 110.665 -179.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.47 137.83 35.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.506 -0.77 . . . . 2.87 110.594 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.96 -178.59 5.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.103 -0.332 . . . . 2.48 110.103 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -109.18 130.24 55.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.639 -0.255 . . . . 2.57 110.492 179.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.59 -25.75 62.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 2.4 110.753 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 95.6 m-85 -118.34 168.37 10.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.777 -0.647 . . . . 2.02 110.874 -179.543 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -68.47 170.16 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 2.65 110.221 178.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 149.73 27.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.363 0.602 . . . . 2.4 112.008 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.711 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 12.1 mt -94.77 116.58 28.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 2.27 109.54 178.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.1 112.12 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.31 -0.405 . . . . 2.86 111.763 -179.355 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -91.82 135.13 34.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 2.89 111.01 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -137.48 83.23 1.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 4.07 109.472 178.378 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.35 -166.46 30.18 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.859 -0.686 . . . . 3.23 111.968 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.18 -19.43 28.44 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.352 . . . . 4.51 111.949 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -100.98 170.43 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.66 0.267 . . . . 3.32 110.671 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 t0 -92.43 -61.49 1.59 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.074 -0.343 . . . . 2.41 110.074 179.454 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 131' ' ' PHE . 30.3 tp 169.76 137.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.742 0.651 . . . . 2.18 110.901 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -155.94 119.59 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 2.46 109.686 178.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -101.34 144.67 29.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.297 -0.41 . . . . 1.78 111.127 -179.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.34 177.67 6.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.274 2.649 . . . . 2.15 112.341 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -70.25 118.56 13.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 2.84 111.017 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.25 68.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.108 -0.568 . . . . 1.65 113.196 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.39 146.31 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.462 . . . . 2.57 109.754 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.68 -5.46 12.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.581 -0.818 . . . . 1.42 112.386 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.15 115.66 64.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.921 -0.399 . . . . 1.09 109.921 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HA ' HD22 ' A' ' 121' ' ' LEU . 58.2 Cg_endo -71.69 177.06 7.32 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.63 2.22 . . . . 1.27 112.383 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.2 mt -75.72 88.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 1.7 110.407 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -80.47 82.85 6.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.23 110.263 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.46 26.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.659 -0.7 . . . . 1.96 112.182 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -137.13 -4.04 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.047 0.451 . . . . 2.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.47 148.37 49.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.022 -0.536 . . . . 1.44 111.363 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.05 166.56 32.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.071 -0.513 . . . . 2.06 110.495 179.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.83 -35.25 78.71 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.861 2.374 . . . . 1.42 113.097 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -85.68 -7.07 59.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.718 0.294 . . . . 1.78 111.281 179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.482 ' CG ' ' HZ1' ' A' ' 103' ' ' LYS . 2.8 m-20 -101.39 10.2 40.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.519 . . . . 1.6 110.014 179.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -84.68 3.42 37.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 1.19 111.447 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.433 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.2 tt -85.5 124.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.068 0.461 . . . . 1.17 111.068 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.77 -153.81 7.03 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.355 -0.926 . . . . 0.61 113.125 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -161.84 173.09 15.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.805 0.336 . . . . 1.13 110.694 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.57 ' HH ' HD11 ' A' ' 119' ' ' LEU . 10.2 m-85 -116.96 140.88 48.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.949 -0.569 . . . . 1.69 110.281 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -121.63 139.1 53.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.605 -0.517 . . . . 2.51 109.605 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -84.67 133.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.121 0.486 . . . . 2.62 111.009 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.24 147.97 51.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.239 0.542 . . . . 2.21 111.016 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -138.04 128.13 25.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.609 -0.515 . . . . 2.68 109.609 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -113.47 123.67 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.961 -0.296 . . . . 3.78 110.962 -179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -147.69 95.8 2.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.407 -0.36 . . . . 3.58 111.099 179.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.01 169.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.565 -0.532 . . . . 4.26 109.565 178.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -141.23 106.23 4.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.974 0.416 . . . . 5.46 111.366 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.424 ' HA3' ' P ' ' C' ' 13' ' ' ' U' . . . -73.6 -30.19 62.44 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.895 -0.669 . . . . 4.66 111.838 179.221 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.24 -67.16 0.48 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.439 -0.886 . . . . 5.04 113.151 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.02 57.71 2.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.161 0.505 . . . . 5.51 112.298 -178.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.38 14.58 49.17 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.906 -0.588 . . . . 4.73 113.751 179.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -86.06 120.33 27.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.755 -0.461 . . . . 5.75 109.755 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 59.2 mtt -139.29 132.09 29.15 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.133 -0.321 . . . . 4.48 110.133 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -60.09 -51.48 69.44 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.181 -0.303 . . . . 4.47 110.181 178.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.42 105.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.289 0.848 . . . . 4.09 113.289 178.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -108.53 140.5 41.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.997 -0.547 . . . . 3.36 110.635 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.82 159.88 9.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 3.47 110.897 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.1 108.9 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.037 2.492 . . . . 2.69 111.768 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -95.8 103.73 15.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.577 -0.738 . . . . 3.22 110.731 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 47' ' ' TYR . 67.8 m95 -83.36 115.51 22.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 1.95 110.987 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -99.12 137.98 36.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.807 -0.633 . . . . 2.76 110.413 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -97.2 132.38 43.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 1.4 110.561 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.54 168.73 17.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 2.07 109.84 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -100.39 156.15 17.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 1.28 110.117 179.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.5 tp -63.36 103.68 0.53 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.519 -179.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.24 -2.38 22.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.282 -0.961 . . . . 1.66 113.787 178.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.42 HG23 ' HA3' ' A' ' 107' ' ' GLY . 5.8 p -59.04 114.0 2.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.118 0.459 . . . . 1.62 111.761 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.19 108.09 2.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.866 -0.683 . . . . 1.96 111.535 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -57.34 -30.09 86.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.077 2.518 . . . . 2.62 112.789 -179.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.77 42.74 2.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.145 0.498 . . . . 3.09 111.302 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.73 -55.08 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 1.87 110.568 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 42.89 79.11 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.937 -0.649 . . . . 1.7 112.373 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.9 mt -121.01 102.43 43.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.837 0.351 . . . . 1.43 111.701 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 1.3 Cg_endo -84.49 165.47 12.37 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.006 2.471 . . . . 1.62 110.635 178.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.73 112.96 2.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.933 0.397 . . . . 1.75 110.814 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.98 -12.88 14.45 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.979 -0.629 . . . . 1.44 112.608 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -56.23 116.53 3.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.049 0.452 . . . . 1.25 111.274 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -87.95 120.01 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 2.21 110.569 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -134.63 -148.48 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.273 -0.421 . . . . 2.11 110.384 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -108.05 103.29 12.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.004 0.431 . . . . 1.7 110.852 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.47 36.9 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.761 -0.733 . . . . 1.32 112.393 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mm -122.38 113.21 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.68 0.276 . . . . 1.06 110.319 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.0 122.58 67.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 1.3 110.176 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -88.01 145.83 25.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.133 -0.485 . . . . 1.08 111.87 -178.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.3 129.44 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 1.04 111.465 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.97 153.15 40.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.528 . . . . 1.27 110.403 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 t -132.13 -176.52 4.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.143 -0.48 . . . . 1.58 110.063 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.43 135.16 54.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.075 0.464 . . . . 2.64 110.67 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.95 58.58 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.906 -0.588 . . . . 1.63 112.165 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.433 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -78.86 144.36 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.847 0.356 . . . . 1.59 110.989 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -112.24 145.79 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.864 -0.607 . . . . 2.15 109.952 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -85.37 86.18 7.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.813 0.339 . . . . 2.3 110.826 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 m -157.24 137.29 8.77 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.67 -0.695 . . . . 2.69 109.215 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.92 111.28 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.107 2.538 . . . . 2.08 112.439 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HZ1' ' CG ' ' A' ' 42' ' ' ASP . 22.5 mmtt -101.83 47.04 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 1.99 109.802 179.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -70.25 -15.3 62.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.972 -0.558 . . . . 2.55 112.09 -179.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -57.44 -20.73 32.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.526 0.565 . . . . 2.28 112.526 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 pt -113.92 12.64 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.472 . . . . 2.0 110.85 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.42 ' HA3' HG23 ' A' ' 75' ' ' THR . . . -86.98 -39.59 7.42 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.868 -0.682 . . . . 2.33 112.162 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 t -65.69 124.69 23.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.195 0.521 . . . . 3.21 111.237 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -158.33 132.6 8.04 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.411 -0.588 . . . . 3.03 109.411 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -96.91 113.04 62.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.271 -0.27 . . . . 3.75 110.271 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.61 -18.9 64.23 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.96 2.44 . . . . 3.39 112.711 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.45 0.97 57.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.035 0.445 . . . . 4.05 110.839 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -136.51 13.01 3.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 4.78 110.723 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -171.85 132.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 3.41 109.828 -179.142 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.98 153.53 20.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.777 0.322 . . . . 3.21 110.54 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' HB2' " H4'" ' C' ' 8' ' ' ' G' . . . -82.5 153.98 25.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.094 0.473 . . . . 3.0 111.122 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 17.9 mt -92.85 145.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.882 -0.599 . . . . 2.42 109.717 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.82 125.79 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.908 -0.404 . . . . 2.74 109.908 179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.57 HD11 ' HH ' ' A' ' 47' ' ' TYR . 1.9 tt -58.46 113.87 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.264 0.554 . . . . 2.19 111.069 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -127.7 142.38 51.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.674 -0.693 . . . . 2.49 110.462 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.436 HD13 ' HG ' ' A' ' 127' ' ' LEU . 21.3 mt -103.63 148.37 35.67 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 1.96 110.013 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.98 155.94 57.55 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.535 2.157 . . . . 1.84 111.599 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -58.46 122.91 14.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 2.77 110.138 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.68 -11.28 42.12 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.212 -0.755 . . . . 2.2 111.212 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.7 m -104.18 105.89 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.638 -0.504 . . . . 2.1 109.638 179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.35 159.36 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.886 -0.597 . . . . 2.87 111.823 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.436 ' HG ' HD13 ' A' ' 121' ' ' LEU . 15.8 mt -99.87 147.87 34.02 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 2.62 109.796 179.002 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.85 159.23 34.28 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.502 2.135 . . . . 2.77 111.666 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -73.36 134.78 44.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.917 0.389 . . . . 4.28 110.235 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.8 13.29 67.26 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.145 -0.782 . . . . 3.18 111.145 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.711 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -127.84 122.02 31.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.001 -0.37 . . . . 2.93 110.001 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -129.01 146.78 50.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 3.73 110.891 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.18 127.53 35.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 2.93 110.806 -179.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -58.88 129.88 44.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.971 -0.559 . . . . 3.64 110.521 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.13 -4.37 67.53 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.961 -0.638 . . . . 3.27 112.053 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m -108.97 159.02 17.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.275 -0.268 . . . . 3.59 110.275 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -126.38 -174.59 3.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.304 -0.407 . . . . 6.05 110.275 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -95.67 46.59 1.93 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.847 -0.692 . . . . 5.22 112.689 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 138.75 -47.88 0.9 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.726 -0.749 . . . . 5.91 112.336 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.981 -0.533 . . . . 7.27 111.243 -179.485 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.49 -3.75 1 C4'-C3'-C2' 96.968 -5.732 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.514 2 N19-C1'-C2' 103.517 -6.177 . 0.232 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.758 3 O4'-C1'-N19 115.703 7.503 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 027 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.144 4 O4'-C1'-N19 116.659 8.459 . 0.514 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 027 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.126 2 C4'-C3'-C2' 97.607 -5.093 . 0.651 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 027 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.759 4 C4'-C3'-C2' 98.289 -4.411 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 027 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.389 3 P-O3'-C3' 127.035 6.112 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 027 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.453 " H4'" ' HB2' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.404 3 O4'-C4'-C3' 114.937 6.741 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -4.973 2 O4'-C1'-N19 118.599 10.399 . 0.417 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 027 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.502 3 O3'-P-O5' 116.381 6.516 . 0.455 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 027 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . 0.589 HO2' " H5'" ' C' ' 12' ' ' ' G' . . . . . . . . 1 P--O3' 1.558 -4.056 1 C4'-C3'-C2' 98.243 -4.457 . 0.307 1a . 13.73 . . . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . 0.589 " H5'" HO2' ' C' ' 11' ' ' ' A' . . . . . . . . 1 C4'--C3' 1.585 5.545 1 C4'-C3'-C2' 94.321 -8.379 . 0.457 1a . 14.32 . . . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . 0.424 ' P ' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.738 1 O3'-P-O5' 111.697 4.051 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.026 2 C3'-C2'-C1' 105.702 4.669 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 111.807 -0.517 . . . . 9.22 111.807 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.25 102.5 13.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.691 0.281 . . . . 8.25 110.578 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -87.81 101.06 13.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.328 -0.396 . . . . 8.02 110.915 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.15 131.91 1.85 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.944 -0.646 . . . . 5.79 111.982 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.3 mt -109.28 131.61 21.74 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.642 0.258 . . . . 4.72 110.742 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.11 44.49 1.56 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.919 2.413 . . . . 4.45 111.57 179.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -131.34 159.13 38.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.558 . . . . 4.89 109.868 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -85.01 -76.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.525 -0.307 . . . . 4.35 110.362 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 p 48.5 70.82 0.41 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.755 0.65 . . . . 2.87 112.755 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.71 143.77 28.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 2.48 110.396 179.576 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 p -78.53 151.28 32.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.303 -0.408 . . . . 2.57 111.1 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.484 ' HA ' HH11 ' A' ' 109' ' ' ARG . 92.9 m95 -81.02 -28.56 35.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 2.4 110.622 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.54 159.21 15.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 2.02 111.403 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.26 166.3 18.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.822 -0.627 . . . . 2.65 110.767 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -82.19 142.59 32.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.416 . . . . 2.4 111.443 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.7 mt -97.31 145.99 25.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.1 -0.704 . . . . 2.27 109.1 179.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -120.26 140.41 51.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 2.86 111.908 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -109.1 120.94 44.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 2.89 111.06 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.72 71.12 0.75 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.336 0.588 . . . . 4.07 109.645 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.43 -163.01 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.695 -0.764 . . . . 3.23 111.815 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -88.8 -39.66 13.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 4.51 111.0 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.31 171.12 15.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.746 -0.464 . . . . 3.32 109.746 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -98.75 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.817 -0.353 . . . . 2.41 111.727 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -151.4 140.5 21.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 2.18 111.648 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -171.42 100.13 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.324 -0.853 . . . . 2.46 109.046 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -86.72 153.95 55.61 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.362 -0.381 . . . . 1.78 111.196 -179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.15 161.97 37.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.031 2.488 . . . . 2.15 111.717 179.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.22 131.72 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 2.84 110.543 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.5 74.68 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.218 -0.753 . . . . 1.65 111.218 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -138.65 172.22 13.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.284 -0.636 . . . . 2.57 109.284 -179.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.99 -2.79 51.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.547 -0.835 . . . . 1.42 112.116 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.86 115.55 65.73 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.391 -0.596 . . . . 1.09 109.391 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.81 -173.39 1.8 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.0 2.467 . . . . 1.27 111.86 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 63.4 mt -74.64 93.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.339 0.59 . . . . 1.7 110.154 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -83.6 78.73 9.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.672 -0.694 . . . . 1.23 110.989 -179.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.11 37.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.105 -0.498 . . . . 1.96 112.147 -179.389 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.73 -2.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.061 0.457 . . . . 2.0 111.443 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.14 150.17 42.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.338 -0.392 . . . . 1.44 111.336 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.12 167.64 33.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 2.06 110.246 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -36.56 79.52 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.788 2.325 . . . . 1.42 113.011 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.56 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -78.56 -13.64 59.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.582 0.229 . . . . 1.78 111.396 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.753 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 25.5 m-20 -90.32 5.63 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 1.6 111.184 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -82.52 54.97 2.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.237 0.541 . . . . 1.19 111.232 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.8 tt -151.29 132.83 5.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.632 -0.713 . . . . 1.17 110.236 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.9 -144.75 4.74 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.249 -0.976 . . . . 0.61 112.879 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -158.5 170.59 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.158 0.504 . . . . 1.13 110.735 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.581 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 29.8 m-85 -115.98 136.53 52.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.827 -0.624 . . . . 1.69 109.323 178.726 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -115.64 131.18 57.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 2.51 111.163 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -85.04 120.82 26.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.659 -0.701 . . . . 2.62 109.515 179.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.29 157.54 45.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.316 0.579 . . . . 2.21 111.932 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -146.98 114.37 6.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.758 -0.655 . . . . 2.68 110.759 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -78.52 119.23 21.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.996 0.427 . . . . 3.78 110.574 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -144.59 123.7 12.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 3.58 110.772 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -106.96 169.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 4.26 109.872 179.159 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.5 119.51 39.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.959 0.409 . . . . 5.46 110.687 179.759 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.19 155.24 19.53 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.961 -0.638 . . . . 4.66 111.884 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.0 -30.82 69.74 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.065 -0.588 . . . . 5.04 112.184 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -71.24 -55.89 7.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.429 0.633 . . . . 5.51 109.972 179.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.39 -40.76 1.2 Allowed Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 109.611 -1.396 . . . . 4.73 109.611 -178.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -86.2 116.37 24.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.415 -0.587 . . . . 5.75 109.415 178.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.19 179.05 4.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 4.48 110.966 -179.402 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.622 ' HA ' ' O6 ' ' C' ' 14' ' ' ' G' . 64.5 tttt -53.44 -55.9 21.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 4.47 110.497 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.42 99.32 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.277 0.843 . . . . 4.09 113.277 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.1 mt -97.21 150.27 21.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 3.36 110.916 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.6 154.56 94.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.861 -0.609 . . . . 3.47 110.483 179.207 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.52 117.63 4.37 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.668 2.245 . . . . 2.69 111.017 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.533 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 48.0 mtt180 -119.35 140.01 51.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 3.22 111.402 -178.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.581 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 43.2 m95 -103.54 131.48 50.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 1.95 110.353 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.586 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 39.4 m-85 -111.09 139.21 46.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.719 -0.474 . . . . 2.76 109.719 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.19 130.55 35.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.688 0.28 . . . . 1.4 111.041 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -133.88 158.31 43.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.96 -0.564 . . . . 2.07 110.33 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -92.97 165.34 12.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.632 -0.258 . . . . 1.28 110.865 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.78 118.99 5.88 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.309 0.381 . . . . 1.66 111.294 -179.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.44 53.98 8.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.062 -0.589 . . . . 1.66 112.966 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.55 48.11 1.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 1.62 111.11 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.44 137.02 4.23 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.093 -0.803 . . . . 1.96 111.093 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.39 -37.61 94.15 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.987 2.458 . . . . 2.62 112.482 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.09 35.95 4.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 3.09 110.574 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -49.78 49.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.87 110.823 -179.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.45 41.1 96.55 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.832 -0.622 . . . . 1.7 112.164 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.17 99.04 46.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.629 0.252 . . . . 1.43 111.426 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 85' ' ' ALA . 89.2 Cg_endo -82.32 165.44 16.61 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 1.62 110.921 178.601 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -61.91 106.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 1.75 110.73 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.48 3.96 12.32 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.676 -0.773 . . . . 1.44 112.347 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.493 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . . . -70.51 122.44 19.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 1.25 110.361 179.286 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -75.49 115.69 15.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.076 -0.511 . . . . 2.21 111.339 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -148.79 144.34 26.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 2.11 110.06 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.09 126.18 28.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.37 . . . . 1.7 111.055 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.58 77.25 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.032 -0.604 . . . . 1.32 112.219 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.5 mm -129.66 107.51 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.798 0.333 . . . . 1.06 110.216 179.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.7 pt -112.89 128.48 69.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.432 . . . . 1.3 110.362 179.108 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -88.55 137.7 32.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.45 0.537 . . . . 1.08 112.45 -178.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -136.63 141.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.75 -0.659 . . . . 1.04 110.416 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.86 156.35 31.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 1.27 110.634 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 t -126.55 170.3 12.18 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.128 -0.487 . . . . 1.58 110.167 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.59 130.59 42.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.431 -0.35 . . . . 2.64 110.166 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.22 -10.44 28.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.836 -0.697 . . . . 1.63 111.784 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -94.2 146.39 24.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.43 -0.211 . . . . 1.59 110.43 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.3 mt -91.97 149.17 21.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 2.15 111.146 -179.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -87.73 76.66 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.2 0.524 . . . . 2.3 110.089 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 t -158.24 147.43 14.73 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.776 -0.647 . . . . 2.69 109.506 -179.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.82 140.12 41.7 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.494 2.129 . . . . 2.08 111.738 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.753 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -137.66 86.88 2.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.093 0.473 . . . . 1.99 110.708 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -5.8 53.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 2.55 112.319 -178.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -58.15 -25.94 62.09 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.132 0.419 . . . . 2.28 112.132 -179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.91 9.92 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.135 0.493 . . . . 2.0 110.799 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.33 -25.25 11.23 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.779 -0.646 . . . . 2.33 111.946 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -78.83 99.99 6.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 3.21 111.103 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.484 HH11 ' HA ' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -144.41 145.66 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 3.03 110.067 179.709 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.89 130.73 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.301 -0.408 . . . . 3.75 110.153 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.91 -54.64 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.893 2.395 . . . . 3.39 112.905 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.27 27.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 4.05 112.691 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.8 19.67 2.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.232 0.539 . . . . 4.78 110.364 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -170.59 163.47 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 3.41 109.641 -179.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.66 173.86 6.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.818 0.342 . . . . 3.21 111.154 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 112.34 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.668 -0.493 . . . . 3.0 109.668 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 21.6 mt -77.18 129.74 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.245 -0.434 . . . . 2.42 110.252 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.03 120.94 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 2.74 110.372 179.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.4 tt -68.39 105.4 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.916 -0.584 . . . . 2.19 109.996 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -112.17 146.3 38.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.997 -0.547 . . . . 2.49 110.413 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.1 mt -100.92 143.9 27.49 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.892 -0.594 . . . . 1.96 109.732 179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.14 150.18 75.37 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.802 2.335 . . . . 1.84 111.91 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -51.05 119.91 4.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.684 -0.689 . . . . 2.77 111.58 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.7 -27.48 8.75 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.69 -0.964 . . . . 2.2 110.69 -179.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.9 m -102.13 116.58 32.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.723 -0.473 . . . . 2.1 109.723 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.49 163.08 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.419 -0.355 . . . . 2.87 110.763 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -85.41 144.88 41.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.343 -0.39 . . . . 2.62 110.137 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.46 151.75 66.51 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.816 2.344 . . . . 2.77 111.683 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.7 125.4 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.399 . . . . 4.28 111.121 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.42 -19.73 33.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.016 -0.612 . . . . 3.18 111.729 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -94.27 128.73 40.92 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.654 -0.498 . . . . 2.93 109.654 -179.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.475 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 47.6 p90 -133.21 171.09 14.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.697 0.284 . . . . 3.73 111.058 -179.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.81 144.4 45.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.483 -0.326 . . . . 2.93 111.208 -179.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -74.45 143.05 44.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.245 -0.434 . . . . 3.64 110.08 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.34 82.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.414 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 m -70.6 122.31 19.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 3.59 110.603 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -110.61 131.95 54.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.149 -0.478 . . . . 6.05 110.006 179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.14 59.28 3.88 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.923 -0.656 . . . . 5.22 112.425 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.63 -159.16 32.2 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.432 -0.667 . . . . 5.91 111.432 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.912 -0.566 . . . . 7.27 111.602 -179.871 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.471 ' H42' ' HG2' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.632 1 C4'-C3'-C2' 97.124 -5.576 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.513 2 N19-C1'-C2' 103.509 -6.182 . 0.227 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.766 3 O4'-C1'-N19 115.758 7.558 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.185 4 O4'-C1'-N19 116.662 8.462 . 0.51 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.373 -4.205 2 C4'-C3'-C2' 97.612 -5.088 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.659 4 C4'-C3'-C2' 98.248 -4.452 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 O3'--C3' 1.497 5.268 3 P-O3'-C3' 127.066 6.138 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . 0.586 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.582 5.351 3 O4'-C4'-C3' 114.911 6.722 . 0.0 '__' . 15.4 . . . . . . . . . . 3 2 . 1 . 028 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.065 2 O4'-C1'-N19 118.656 10.456 . 0.414 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.549 -4.439 3 O4'-C1'-N19 114.758 6.558 . 0.466 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.105 1 C4'-C3'-C2' 98.248 -4.452 . 0.313 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.566 1 C4'-C3'-C2' 94.324 -8.376 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.861 1 O3'-P-O5' 111.743 4.075 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 028 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . 0.622 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.578 4.952 2 C3'-C2'-C1' 105.738 4.709 . 0.336 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.632 -0.587 . . . . 9.22 111.632 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.74 109.04 6.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 8.25 110.565 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.7 ptp -120.62 -5.55 9.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.259 -0.428 . . . . 8.02 111.231 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.2 116.15 0.67 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.904 -0.665 . . . . 5.79 112.084 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.57 137.83 22.87 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.91 -0.404 . . . . 4.72 109.91 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.83 31.43 0.38 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.884 2.389 . . . . 4.45 112.818 -179.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -98.7 159.01 15.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.507 -0.315 . . . . 4.89 110.621 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.43 -141.76 0.38 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.694 -0.484 . . . . 4.35 109.694 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.637 HG23 ' HA ' ' A' ' 108' ' ' THR . 76.1 p 53.81 81.28 0.1 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.029 0.752 . . . . 2.87 113.029 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 111' ' ' PRO . . . -74.94 146.71 41.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.386 -0.37 . . . . 2.48 110.018 179.568 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.436 ' HG ' ' HD1' ' A' ' 69' ' ' TYR . 1.1 m -62.25 143.6 56.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 2.57 110.642 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -68.92 -26.63 65.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 2.4 111.666 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -111.08 167.73 10.04 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.14 0.422 . . . . 2.02 112.14 -179.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 p -69.08 170.32 10.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.647 -0.706 . . . . 2.65 111.332 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -90.14 133.27 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 2.4 111.291 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 mt -86.9 112.96 22.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.668 -0.493 . . . . 2.27 109.668 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 m -92.17 127.99 37.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.902 0.382 . . . . 2.86 111.203 -179.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -106.09 134.87 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 2.89 110.935 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -125.74 72.57 1.29 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.228 -0.656 . . . . 4.07 109.228 178.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.78 -169.23 26.99 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.964 -0.636 . . . . 3.23 112.067 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.68 -36.84 23.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.999 0.428 . . . . 4.51 110.844 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.09 172.2 13.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.796 -0.638 . . . . 3.32 110.712 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -103.84 -101.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.83 -0.433 . . . . 2.41 109.83 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.0 tp -156.74 133.6 10.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.798 0.332 . . . . 2.18 110.527 179.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.29 111.92 2.97 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.966 -0.561 . . . . 2.46 109.748 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.14 135.48 19.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.409 . . . . 1.78 110.563 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.6 155.54 69.74 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.536 2.157 . . . . 2.15 111.963 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -57.88 125.85 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 2.84 110.769 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.53 -1.51 62.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.904 -0.665 . . . . 1.65 112.033 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -137.09 155.15 49.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.204 -0.295 . . . . 2.57 110.204 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.05 -13.94 19.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.329 -0.938 . . . . 1.42 113.127 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.99 122.04 84.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.069 -0.345 . . . . 1.09 110.069 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.31 -179.13 5.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 1.27 111.661 -179.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.36 81.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.099 0.476 . . . . 1.7 110.821 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.86 97.87 4.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.382 -0.599 . . . . 1.23 109.382 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.33 -20.11 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.792 0.664 . . . . 1.96 112.792 -178.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -99.76 -29.54 12.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.422 0.527 . . . . 2.0 112.422 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.09 150.62 35.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.518 0.562 . . . . 1.44 112.518 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 2.0 m -74.42 166.92 40.77 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.681 -0.691 . . . . 2.06 110.895 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 17.5 Cg_endo -58.77 -39.75 79.0 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.814 2.343 . . . . 1.42 112.53 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -85.21 3.15 40.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 1.78 110.626 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.64 7.03 37.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.662 -0.699 . . . . 1.6 110.617 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -81.27 52.1 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 1.19 110.784 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.65 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.5 tt -144.87 134.91 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.92 -0.582 . . . . 1.17 110.17 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.14 -155.63 11.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.414 -0.898 . . . . 0.61 112.135 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -148.67 158.68 44.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.964 0.412 . . . . 1.13 111.151 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.608 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 13.2 m-85 -103.12 140.46 37.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.839 -0.8 . . . . 1.69 108.839 178.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -127.84 122.71 33.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.795 0.331 . . . . 2.51 110.965 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 128.37 33.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.858 -0.423 . . . . 2.62 109.858 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.04 156.21 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.108 0.48 . . . . 2.21 111.514 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.0 m -135.55 127.83 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.679 -0.691 . . . . 2.68 109.734 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.594 ' HB3' HD13 ' A' ' 64' ' ' LEU . 8.9 tpt180 -126.01 130.05 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.119 0.485 . . . . 3.78 111.702 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -143.87 -175.67 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.537 -0.756 . . . . 3.58 109.38 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.1 pt -126.72 161.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.544 -0.539 . . . . 4.26 109.544 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.03 69.15 0.8 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.334 0.588 . . . . 5.46 110.733 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.38 117.87 4.5 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.672 -0.775 . . . . 4.66 111.852 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.66 -25.3 63.24 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 121.374 -0.441 . . . . 5.04 112.531 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -82.74 -1.49 51.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.143 0.497 . . . . 5.51 110.511 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.91 26.6 12.42 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.062 -0.815 . . . . 4.73 111.062 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -77.66 122.77 25.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.791 0.329 . . . . 5.75 111.005 -179.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt -127.12 113.58 16.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.053 -0.521 . . . . 4.48 111.127 -179.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -69.98 -42.98 72.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.078 -0.712 . . . . 4.47 109.078 178.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.72 82.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.939 -1.028 . . . . 4.09 113.451 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.594 HD13 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -74.6 160.55 30.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.872 0.368 . . . . 3.36 110.559 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -74.13 156.03 87.9 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.293 -0.412 . . . . 3.47 110.127 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.47 111.15 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.542 2.161 . . . . 2.69 111.357 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.45 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 10.1 mtp180 -116.7 131.63 56.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 3.22 111.579 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.608 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 35.8 m95 -105.67 124.32 49.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.684 -0.689 . . . . 1.95 109.99 179.053 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.436 ' HD1' ' HG ' ' A' ' 11' ' ' SER . 49.5 m-85 -102.81 151.22 22.67 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 2.76 109.71 179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -102.98 126.45 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.913 0.387 . . . . 1.4 111.486 -179.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.655 ' HB3' ' HG1' ' A' ' 75' ' ' THR . 96.8 m-85 -126.46 150.21 48.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 2.07 110.067 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.87 165.39 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.506 -0.315 . . . . 1.28 111.463 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 tt -54.48 113.48 1.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.445 0.905 . . . . 1.66 113.445 -178.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 63.4 47.9 83.39 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.508 -0.769 . . . . 1.66 114.065 178.331 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.655 ' HG1' ' HB3' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -72.98 86.36 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 1.62 111.444 179.58 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.63 131.0 2.53 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.019 -0.61 . . . . 1.96 111.68 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.23 -31.81 89.99 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.984 2.456 . . . . 2.62 112.558 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.93 30.69 4.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.849 0.357 . . . . 3.09 111.782 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.0 -70.57 0.41 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 1.87 110.582 179.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.97 34.38 55.84 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.829 -0.7 . . . . 1.7 111.546 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.496 HD21 ' HD2' ' A' ' 87' ' ' LYS . 3.2 mt -123.4 95.17 45.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.727 0.298 . . . . 1.43 110.831 -179.649 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.77 158.13 43.26 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.591 2.194 . . . . 1.62 112.095 179.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -59.26 106.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 1.75 110.322 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.38 -17.8 5.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.819 -0.705 . . . . 1.44 112.408 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.3 138.3 51.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 1.25 110.492 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -100.04 144.86 28.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.458 -0.337 . . . . 2.21 111.026 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.496 ' HD2' HD21 ' A' ' 81' ' ' LEU . 26.6 tttt -158.47 169.48 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 2.11 109.982 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.04 112.52 2.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.313 0.486 . . . . 1.7 112.313 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.3 39.62 91.94 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.841 -0.618 . . . . 1.32 112.389 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -128.88 113.71 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.073 0.464 . . . . 1.06 111.295 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.412 ' CG1' ' HB2' ' A' ' 47' ' ' TYR . 24.3 pt -122.54 139.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.369 -0.604 . . . . 1.3 109.369 178.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -96.44 137.88 34.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.877 0.37 . . . . 1.08 111.686 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -133.15 131.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.621 -0.718 . . . . 1.04 110.617 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.41 162.87 40.92 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.27 110.363 -179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -139.09 172.85 12.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 1.58 109.907 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.69 127.56 32.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.333 -0.394 . . . . 2.64 110.626 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.14 -20.5 26.01 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.908 -0.663 . . . . 1.63 111.618 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.65 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -82.68 135.27 35.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.894 0.378 . . . . 1.59 110.362 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.07 139.66 43.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 2.15 110.858 -179.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -72.6 107.02 4.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.489 . . . . 2.3 110.526 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 t -174.57 150.22 1.41 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.959 -0.756 . . . . 2.69 108.959 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.1 116.88 3.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.82 2.347 . . . . 2.08 112.231 179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -114.76 34.29 4.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.852 -0.613 . . . . 1.99 110.383 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 8.7 p-10 -71.05 -3.68 20.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 2.55 112.175 -179.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -61.18 -21.16 63.55 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.437 0.532 . . . . 2.28 112.437 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.99 -16.54 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.265 0.555 . . . . 2.0 110.441 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.84 72.2 2.61 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.933 -0.576 . . . . 2.33 112.693 -179.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.637 ' HA ' HG23 ' A' ' 9' ' ' THR . 14.9 t -160.65 36.07 0.16 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.787 0.803 . . . . 3.21 110.453 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -76.49 138.03 40.01 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.694 -0.684 . . . . 3.03 111.153 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -80.92 117.79 69.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 3.75 110.519 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.644 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 51.8 Cg_endo -70.88 -47.33 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.871 2.381 . . . . 3.39 114.219 -178.695 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.77 18.91 2.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.035 0.754 . . . . 4.05 113.035 -177.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -150.22 23.33 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.936 0.398 . . . . 4.78 111.589 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -174.51 136.02 0.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 3.41 109.986 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.2 154.66 19.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.662 0.268 . . . . 3.21 111.095 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.75 154.31 26.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.164 0.506 . . . . 3.0 111.234 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.2 mt -89.04 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.654 -0.703 . . . . 2.42 109.598 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.05 113.33 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.665 -0.495 . . . . 2.74 109.665 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.84 115.52 5.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 2.19 111.593 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.0 148.71 50.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.652 -0.704 . . . . 2.49 109.399 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.12 157.37 34.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.343 -0.39 . . . . 1.96 110.695 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.32 148.49 92.83 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.538 2.158 . . . . 1.84 111.85 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -57.62 113.08 1.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.131 -0.486 . . . . 2.77 110.274 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 127.42 -24.15 5.32 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.194 -1.162 . . . . 2.2 110.194 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.7 m -91.94 109.75 21.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.127 0.489 . . . . 2.1 109.712 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 131.97 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 2.87 111.198 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.62 134.79 86.21 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.132 -0.485 . . . . 2.62 109.731 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.57 142.18 95.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.612 2.208 . . . . 2.77 111.468 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.83 124.25 21.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 4.28 110.621 -179.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.12 41.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.768 -0.73 . . . . 3.18 111.9 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -99.47 128.92 45.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.066 0.46 . . . . 2.93 111.416 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -145.98 139.13 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.627 -0.715 . . . . 3.73 109.738 179.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.45 148.15 29.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.631 0.253 . . . . 2.93 110.452 179.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.77 125.9 27.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.384 -0.371 . . . . 3.64 110.232 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.2 -18.18 57.93 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.712 -0.756 . . . . 3.27 112.615 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.7 m -75.13 95.26 3.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 3.59 110.806 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -93.13 123.84 36.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.074 -0.512 . . . . 6.05 110.141 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -94.84 100.35 2.56 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.831 -0.7 . . . . 5.22 111.892 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 99.31 -96.88 1.74 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.766 -0.731 . . . . 5.91 112.041 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.248 0.996 0 CA-C-O 119.108 -0.472 . . . . 7.27 111.331 -179.727 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.574 1 C4'-C3'-C2' 97.091 -5.609 . 0.0 '__' . 12.52 . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.473 4.607 2 N19-C1'-C2' 103.459 -6.213 . 0.233 1a . 11.67 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.726 3 O4'-C1'-N19 115.746 7.546 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.592 6.122 4 O4'-C1'-N19 116.641 8.441 . 0.514 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.141 2 C4'-C3'-C2' 97.567 -5.133 . 0.651 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.672 4 N19-C1'-C2' 106.341 -4.412 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.496 5.214 3 P-O3'-C3' 127.004 6.087 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.581 5.315 3 O4'-C4'-C3' 114.958 6.756 . 0.0 '__' . 15.4 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.935 2 O4'-C1'-N19 118.571 10.371 . 0.414 1a . 14.62 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.549 -4.443 3 O3'-P-O5' 116.298 6.473 . 0.458 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.191 1 C4'-C3'-C2' 98.267 -4.433 . 0.307 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.552 1 C4'-C3'-C2' 94.371 -8.329 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.731 1 O3'-P-O5' 111.75 4.079 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 029 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.934 2 C3'-C2'-C1' 105.7 4.666 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.491 -0.644 . . . . 9.22 111.491 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.42 133.98 45.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.768 0.318 . . . . 8.25 110.569 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.9 mtm -113.78 86.43 2.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.269 -0.423 . . . . 8.02 111.048 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.35 83.94 1.39 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.986 -0.626 . . . . 5.79 111.746 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.8 mt -77.99 139.52 61.49 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.535 0.207 . . . . 4.72 110.749 -179.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.28 -18.85 26.34 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.493 2.129 . . . . 4.45 111.72 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -82.21 125.53 31.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.834 -0.621 . . . . 4.89 110.478 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -99.75 -57.02 2.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.45 -0.341 . . . . 4.35 111.608 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.7 p 51.72 74.06 0.28 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.917 0.71 . . . . 2.87 112.917 -179.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.47 153.09 17.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.314 -0.403 . . . . 2.48 111.066 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.71 149.28 41.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.996 -0.547 . . . . 2.57 111.038 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -78.62 -30.63 46.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 2.4 111.254 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.453 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 76.7 m-85 -112.19 168.23 9.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.926 -0.579 . . . . 2.02 111.84 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.1 175.02 4.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.817 -0.629 . . . . 2.65 111.362 179.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.87 148.33 22.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 2.4 111.058 -179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.486 HD21 HD23 ' A' ' 119' ' ' LEU . 95.9 mt -84.22 119.21 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.847 -0.615 . . . . 2.27 109.653 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 107.28 14.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 2.86 110.523 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 66' ' ' PRO . 5.8 tp-100 -85.9 133.93 33.92 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 2.89 111.286 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -129.96 10.05 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.951 -0.568 . . . . 4.07 110.428 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.4 -178.17 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.735 -0.745 . . . . 3.23 112.846 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -74.03 -38.08 64.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 4.51 111.468 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.94 166.78 23.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 3.32 111.412 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.78 -70.34 0.68 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.249 -0.648 . . . . 2.41 109.249 178.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.572 HD12 ' CE1' ' A' ' 131' ' ' PHE . 16.9 tp -177.58 134.28 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.747 -0.66 . . . . 2.18 110.614 178.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -154.46 128.69 9.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 2.46 109.495 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -123.56 144.78 45.16 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.466 . . . . 1.78 110.284 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.58 161.77 44.59 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.814 2.343 . . . . 2.15 112.386 -179.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.41 130.35 42.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.84 110.454 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.92 59.46 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.901 -0.666 . . . . 1.65 111.937 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -159.66 159.27 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.644 0.259 . . . . 2.57 110.328 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.67 -17.78 10.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.715 -0.755 . . . . 1.42 112.797 179.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.41 122.27 80.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.154 -0.313 . . . . 1.09 110.154 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.71 -177.92 4.13 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.68 2.253 . . . . 1.27 112.047 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.21 98.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.594 -0.521 . . . . 1.7 109.594 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -89.48 83.41 6.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.087 0.47 . . . . 1.23 111.018 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.79 65.78 2.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.682 -0.69 . . . . 1.96 111.055 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -173.19 -28.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.258 -0.428 . . . . 2.0 111.255 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.59 167.16 9.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.31 -0.405 . . . . 1.44 111.827 -178.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.94 166.0 38.16 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 2.06 110.095 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.19 -37.47 94.24 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.894 2.396 . . . . 1.42 112.505 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -20.36 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 1.78 110.75 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.799 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 27.1 m-20 -85.58 -0.72 55.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 1.6 110.777 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -78.62 55.47 1.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 1.19 111.637 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.542 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -149.72 130.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 1.17 109.82 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -144.45 4.33 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.311 -0.947 . . . . 0.61 112.631 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -157.2 161.89 39.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.853 0.359 . . . . 1.13 110.685 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -103.27 131.82 50.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.054 -0.721 . . . . 1.69 109.054 178.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -110.75 125.35 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 2.51 110.965 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -72.15 130.85 41.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 2.62 109.775 178.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.14 155.14 51.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 2.21 110.753 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.69 160.08 42.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.046 -0.525 . . . . 2.68 110.538 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -136.32 115.27 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 3.78 111.081 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -139.15 103.12 4.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.416 -0.356 . . . . 3.58 111.639 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.2 pt -72.09 160.99 5.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.645 -0.502 . . . . 4.26 109.645 178.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -121.12 92.95 3.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 5.46 111.075 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.75 155.23 40.83 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 4.66 111.594 179.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.51 -38.56 96.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.249 -0.5 . . . . 5.04 112.288 -179.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.52 32.17 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.395 0.617 . . . . 5.51 110.834 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.76 21.71 71.34 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.935 -0.575 . . . . 4.73 112.267 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -76.62 145.75 38.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.675 0.274 . . . . 5.75 110.333 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt -141.88 139.24 32.55 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.204 -0.453 . . . . 4.48 110.286 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -64.64 -57.88 7.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 4.47 109.586 179.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.64 83.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.507 -0.769 . . . . 4.09 112.354 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.2 mt -93.6 170.96 9.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.854 -0.612 . . . . 3.36 110.786 -179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.37 154.71 94.3 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 3.47 109.829 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.656 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 51.4 Cg_exo -55.28 123.62 14.26 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.559 2.173 . . . . 2.69 110.616 178.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -120.27 144.16 47.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.563 0.579 . . . . 3.22 112.563 -178.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -128.11 124.71 37.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.68 -0.691 . . . . 1.95 109.699 178.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -103.6 145.95 29.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.047 -0.353 . . . . 2.76 110.047 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -96.48 129.43 43.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.812 0.339 . . . . 1.4 111.1 179.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -128.12 153.42 46.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 2.07 110.106 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -86.85 163.4 17.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.522 -0.308 . . . . 1.28 110.309 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.551 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 2.3 tt -62.69 121.93 14.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.297 -0.41 . . . . 1.66 110.513 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.82 29.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.918 -0.658 . . . . 1.66 113.762 178.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.21 90.11 4.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.338 0.569 . . . . 1.62 111.109 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.52 124.34 2.29 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.638 -0.791 . . . . 1.96 111.878 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.51 -21.61 39.83 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.701 2.267 . . . . 2.62 112.324 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -115.88 17.94 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.009 0.433 . . . . 3.09 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.65 -61.94 1.58 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 1.87 110.842 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.33 94.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.213 -0.518 . . . . 1.7 112.572 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.1 mt -118.13 104.76 47.95 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 120.676 0.274 . . . . 1.43 110.478 -179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.16 161.43 29.29 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.655 2.237 . . . . 1.62 111.344 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -54.21 119.34 4.99 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.488 -0.324 . . . . 1.75 110.464 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 111.38 -14.73 27.78 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.838 -0.696 . . . . 1.44 112.335 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.4 123.28 16.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.833 0.349 . . . . 1.25 110.845 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -90.74 131.45 36.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 2.21 111.278 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -150.93 154.99 38.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.992 -1.114 . . . . 2.11 107.992 179.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.5 115.41 3.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.04 0.448 . . . . 1.7 111.685 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.74 32.7 49.32 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.682 -0.69 . . . . 1.32 112.586 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.63 105.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.912 0.387 . . . . 1.06 110.995 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 pt -117.31 130.23 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 1.3 109.72 178.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.551 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 86.3 m95 -86.23 145.42 26.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.714 0.635 . . . . 1.08 112.714 -178.508 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.47 133.84 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.218 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.6 166.53 24.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.365 -0.38 . . . . 1.27 111.102 -179.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -137.99 164.08 29.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.217 -0.66 . . . . 1.58 109.217 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.68 114.0 8.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.74 -0.467 . . . . 2.64 109.74 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.12 -18.15 6.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.538 -1.025 . . . . 1.63 110.538 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.542 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.25 142.45 34.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.516 -0.342 . . . . 1.59 110.084 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.79 133.65 44.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.499 -0.319 . . . . 2.15 111.135 -179.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -76.07 86.97 2.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.223 0.535 . . . . 2.3 109.873 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 6.3 t -161.98 144.34 8.73 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.609 -0.723 . . . . 2.69 109.125 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.93 126.94 17.48 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.159 1.906 . . . . 2.08 112.137 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.799 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -133.22 77.78 1.75 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.463 0.649 . . . . 1.99 111.22 179.584 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.15 -0.34 35.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.744 -0.662 . . . . 2.55 111.618 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.411 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.4 p80 -60.48 -19.85 58.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.075 0.464 . . . . 2.28 111.894 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.3 pt -114.12 14.21 8.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 2.0 110.296 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.74 69.28 0.29 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.71 -0.757 . . . . 2.33 112.067 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -165.04 27.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.33 0.586 . . . . 3.21 110.821 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -65.33 128.05 34.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.057 -0.52 . . . . 3.03 110.291 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -75.87 117.58 64.85 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.311 -0.404 . . . . 3.75 110.213 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.497 ' HB2' " H5'" ' C' ' 9' ' ' ' U' . 73.4 Cg_endo -74.88 -21.55 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.691 2.261 . . . . 3.39 113.815 -178.367 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.14 -21.43 17.93 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.311 0.485 . . . . 4.05 112.311 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -113.7 19.32 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.032 0.382 . . . . 4.78 112.032 -178.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -163.68 139.52 6.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.421 -0.354 . . . . 3.41 110.412 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.96 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.051 -0.351 . . . . 3.21 110.051 179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.14 161.19 31.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.209 0.528 . . . . 3.0 111.456 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.453 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 6.5 mt -100.04 155.15 4.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.099 -0.704 . . . . 2.42 109.099 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -74.69 127.36 36.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.182 -0.207 . . . . 2.74 110.445 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.486 HD23 HD21 ' A' ' 16' ' ' LEU . 4.6 tt -64.53 116.96 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 2.19 110.553 179.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -130.17 130.41 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.227 -0.442 . . . . 2.49 110.402 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.508 HD12 HG23 ' A' ' 125' ' ' THR . 72.9 mt -79.64 149.17 70.91 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.476 -0.329 . . . . 1.96 110.5 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.08 177.94 4.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.836 2.357 . . . . 1.84 112.974 -179.333 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -64.52 126.03 26.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.46 -0.791 . . . . 2.77 110.319 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.09 65.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.599 -0.81 . . . . 2.2 112.347 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.508 HG23 HD12 ' A' ' 121' ' ' LEU . 7.2 m -124.85 116.13 21.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.942 -0.392 . . . . 2.1 109.942 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.03 151.88 35.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 2.87 111.853 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.93 147.52 77.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 2.62 110.829 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.06 164.7 26.59 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.823 2.349 . . . . 2.77 112.359 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.39 120.5 12.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 4.28 111.728 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.41 55.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.975 -0.631 . . . . 3.18 112.913 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.572 ' CE1' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -114.2 130.95 56.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.761 0.315 . . . . 2.93 111.243 -179.294 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -142.17 152.63 43.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.439 . . . . 3.73 111.053 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.23 134.67 33.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.0 0.371 . . . . 2.93 112.0 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -64.06 124.23 21.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.809 -0.632 . . . . 3.64 110.176 178.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.58 -9.46 64.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.995 -0.621 . . . . 3.27 112.651 -179.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.21 128.92 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.502 0.191 . . . . 3.59 110.548 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -126.27 110.79 13.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.266 -0.425 . . . . 6.05 110.618 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.29 126.67 13.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.811 -0.709 . . . . 5.22 112.182 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 134.69 -172.7 21.82 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.587 -0.605 . . . . 5.91 111.587 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 119.072 -0.49 . . . . 7.27 111.61 179.837 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.489 -3.853 1 C4'-C3'-C2' 97.018 -5.682 . 0.0 '__' . 12.52 . . . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.514 2 N19-C1'-C2' 103.471 -6.206 . 0.229 1a . 11.67 . . . . . . . . . . 3 2 . 1 . 030 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.464 -5.581 2 O4'-C1'-N19 115.683 7.483 . 0.524 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.171 4 O4'-C1'-N19 116.685 8.485 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.062 2 C4'-C3'-C2' 97.652 -5.048 . 0.65 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.676 4 C4'-C3'-C2' 98.3 -4.4 . 0.946 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.267 3 P-O3'-C3' 127.067 6.139 . 0.01 1a . 18.49 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.448 3 O4'-C4'-C3' 114.916 6.726 . 0.0 '__' . 15.4 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' C' C ' 9' ' ' ' U' . . . . . 0.497 " H5'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.543 -5.002 2 O4'-C1'-N19 118.619 10.419 . 0.419 1a . 14.62 . . . . . . . . . . 3 2 . 1 . 030 nuclear orig full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.596 3 O3'-P-O5' 116.383 6.517 . 0.459 1a . 13.87 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.13 1 C4'-C3'-C2' 98.199 -4.501 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.638 1 C4'-C3'-C2' 94.325 -8.375 . 0.453 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.587 5.704 1 O3'-P-O5' 111.734 4.071 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 030 nuclear orig full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.979 2 C3'-C2'-C1' 105.657 4.619 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.454 0 CA-C-O 120.832 0.349 . . . . 2.48 110.715 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -78.24 136.19 37.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 2.13 110.778 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -71.93 -15.5 62.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 2.4 111.634 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.69 172.27 8.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.952 -0.567 . . . . 2.02 109.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 p -75.55 -170.14 1.19 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.001 0.429 . . . . 2.65 110.709 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.58 -168.62 1.33 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.956 0.408 . . . . 2.4 110.885 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.731 HD21 HD22 ' A' ' 119' ' ' LEU . 77.3 mt -128.67 105.76 8.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.404 -0.591 . . . . 2.27 109.404 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.577 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -83.49 122.51 28.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.33 -0.396 . . . . 2.84 111.197 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.1 tp-100 -97.67 133.71 41.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.555 . . . . 2.89 111.182 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -128.22 76.32 1.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.237 -0.653 . . . . 3.82 109.237 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.41 -135.48 1.87 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.522 -0.847 . . . . 3.23 112.789 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -114.92 -38.88 3.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.092 0.472 . . . . 4.27 111.577 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -78.38 170.77 16.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.817 -0.629 . . . . 3.32 111.497 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.08 -92.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.17 -0.678 . . . . 2.39 109.17 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.499 HD13 ' CE1' ' A' ' 131' ' ' PHE . 39.8 tp -169.12 134.79 1.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.515 . . . . 2.06 109.975 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -153.37 113.4 3.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.199 -0.455 . . . . 2.22 110.166 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -100.86 145.68 30.79 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 1.78 110.066 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.65 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 51.1 Cg_endo -70.89 158.91 54.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.62 2.213 . . . . 2.15 111.608 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -62.77 113.98 3.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 2.6 110.923 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.12 -13.9 26.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.767 -0.73 . . . . 1.65 111.678 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.65 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 38.9 mt-30 -122.04 168.23 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 2.31 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.84 -10.19 29.79 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.335 -0.706 . . . . 1.33 111.335 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.403 HG11 ' HB3' ' A' ' 43' ' ' GLN . 22.2 t -94.58 115.01 64.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 1.06 109.629 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.12 -179.97 4.85 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.513 2.142 . . . . 1.27 112.159 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.25 83.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.197 -0.456 . . . . 1.7 110.364 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.425 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 63.0 m-80 -83.33 83.73 7.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.955 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -7.77 54.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.866 -0.607 . . . . 1.94 111.264 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -90.08 -22.49 21.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.344 -0.389 . . . . 1.96 111.742 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -110.97 168.68 9.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.145 0.498 . . . . 1.42 112.187 -178.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.05 167.15 22.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 1.73 110.089 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.4 -39.14 92.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 1.42 113.005 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -16.93 61.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.045 0.45 . . . . 1.78 110.815 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.773 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 41.8 m-20 -88.73 2.1 53.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 1.6 111.004 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.403 ' HB3' HG11 ' A' ' 32' ' ' VAL . 37.5 mm-40 -80.87 58.79 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.153 0.501 . . . . 1.05 111.674 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.9 tt -156.13 129.91 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.615 . . . . 1.17 109.991 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.91 -149.74 6.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.335 -0.936 . . . . 0.6 112.479 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.66 158.77 44.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.133 0.492 . . . . 0.99 111.019 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 14.8 m-85 -103.46 133.7 48.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.831 -0.622 . . . . 1.26 109.668 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.11 117.39 29.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 2.15 110.776 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -78.31 113.55 16.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.148 0.499 . . . . 2.4 110.978 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.74 159.55 24.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.082 -0.508 . . . . 2.21 110.793 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 148.93 45.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 2.68 110.137 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB3' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -121.86 93.41 3.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.075 0.464 . . . . 3.59 111.357 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.623 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 1.0 OUTLIER -121.43 104.03 9.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.223 -0.444 . . . . 3.43 110.662 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.33 125.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 4.26 110.791 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 5.17 110.076 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.4 mtt . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.515 0.198 . . . . 4.48 110.86 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -54.76 -44.78 73.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.785 -0.643 . . . . 4.16 110.358 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 36.1 t70 61.35 107.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.242 0.83 . . . . 4.09 113.242 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.597 HD12 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -123.89 143.32 50.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 3.36 110.3 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.577 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -61.04 143.66 91.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 3.36 111.391 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.27 126.27 19.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.955 2.437 . . . . 2.69 111.576 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -127.86 137.32 52.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.03 111.452 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.493 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 36.8 m95 -95.03 109.7 21.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.006 -0.543 . . . . 1.84 110.832 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -81.38 143.85 31.87 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.628 -0.508 . . . . 2.76 109.628 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -87.68 119.04 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.736 0.303 . . . . 1.27 111.032 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -120.61 139.35 53.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.735 -0.469 . . . . 1.84 109.735 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -79.69 159.06 26.82 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.312 -0.255 . . . . 1.28 110.312 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -61.15 123.24 17.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.666 0.27 . . . . 1.66 110.707 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 90.87 24.96 26.17 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.964 -0.636 . . . . 1.66 113.449 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.589 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -82.73 94.13 7.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.166 0.483 . . . . 1.58 110.811 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 137.22 122.02 2.08 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.954 -0.641 . . . . 1.96 111.696 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 18.9 Cg_endo -58.87 -29.38 89.99 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.248 2.632 . . . . 2.62 112.756 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.14 46.55 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 3.09 110.358 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 -48.9 16.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 1.79 110.345 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 36.93 86.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.744 -0.662 . . . . 1.65 112.599 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.92 97.99 47.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 1.38 111.635 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.688 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 3.9 Cg_exo -81.74 155.38 18.07 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.769 2.313 . . . . 1.62 110.19 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.622 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.0 t80 -53.81 115.25 1.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.839 0.352 . . . . 1.58 110.866 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.44 -17.17 16.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.726 -0.749 . . . . 1.44 112.575 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.688 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -58.06 127.54 32.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 1.25 111.273 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -91.71 114.51 27.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.025 -0.534 . . . . 1.86 111.026 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -137.29 153.8 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.476 -0.329 . . . . 1.68 110.547 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.64 121.27 12.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.982 -0.554 . . . . 1.7 111.028 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.9 76.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.584 -0.817 . . . . 1.27 112.205 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 26.1 mm -130.54 109.94 17.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.758 0.313 . . . . 1.01 110.839 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -121.34 137.84 53.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 1.3 109.3 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.538 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 85.7 m95 -93.44 143.81 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.22 0.533 . . . . 1.08 112.346 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.77 129.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.438 -0.801 . . . . 1.04 110.211 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.75 154.45 44.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.195 -0.457 . . . . 1.27 110.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.1 t -132.02 176.12 8.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.336 -0.393 . . . . 1.36 110.091 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.3 125.06 24.9 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.809 0.338 . . . . 2.64 111.127 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.31 -8.26 28.72 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.806 -0.634 . . . . 1.52 111.967 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.426 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -93.03 138.2 31.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.946 0.403 . . . . 1.59 111.186 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.63 155.93 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 2.15 110.747 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.5 96.76 8.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.032 0.444 . . . . 2.07 111.488 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 1.9 t -170.25 140.71 1.61 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.866 -0.606 . . . . 2.36 109.673 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 27.8 Cg_exo -64.36 136.98 53.57 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.728 2.285 . . . . 2.08 111.98 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.773 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -134.75 70.07 1.45 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.414 0.626 . . . . 1.78 110.842 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 7.5 p-10 -71.22 -1.3 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 2.55 112.397 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 9.8 p80 -61.92 -27.56 68.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 2.24 111.756 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.45 10.15 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 2.0 110.886 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -104.67 39.53 2.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 2.33 111.415 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -150.47 138.88 20.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.601 0.239 . . . . 2.99 110.658 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 109' ' ' ARG . 22.6 ttp180 179.59 147.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.688 -0.687 . . . . 2.83 109.25 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -82.02 109.74 16.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.24 -0.652 . . . . 3.56 109.24 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 -26.74 41.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.735 2.29 . . . . 3.39 113.004 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.89 23.0 6.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.971 0.415 . . . . 4.05 111.658 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -146.27 -36.22 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.457 . . . . 4.48 111.01 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -122.41 132.87 54.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.877 -0.786 . . . . 3.39 108.877 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.4 -175.06 5.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.464 -0.335 . . . . 3.21 111.551 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.83 155.63 29.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 2.85 110.602 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -90.84 147.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.86 -0.422 . . . . 2.42 109.86 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.84 121.98 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 2.74 110.25 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.731 HD22 HD21 ' A' ' 16' ' ' LEU . 4.6 tt -64.25 108.64 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.822 -0.626 . . . . 2.11 111.128 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -119.53 148.96 42.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.023 -0.535 . . . . 2.49 110.734 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.641 HD13 HG22 ' A' ' 125' ' ' THR . 16.0 mt -98.52 146.84 32.27 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.394 -0.367 . . . . 1.91 110.602 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.84 179.66 4.6 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.844 2.362 . . . . 1.84 112.581 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.67 138.96 58.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.739 -0.664 . . . . 2.53 111.002 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.02 80.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.956 -0.64 . . . . 2.2 112.108 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.641 HG22 HD13 ' A' ' 121' ' ' LEU . 1.3 m -135.26 121.51 20.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.843 0.354 . . . . 2.1 110.366 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -121.15 152.38 38.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.285 -0.416 . . . . 2.78 110.513 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.43 146.34 80.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.376 -0.374 . . . . 2.62 110.051 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.51 143.9 77.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.739 2.293 . . . . 2.77 111.795 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -61.65 111.8 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 4.11 110.834 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 136.46 -21.84 3.4 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.783 -1.327 . . . . 3.18 109.783 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 21.0 m-85 -104.31 153.5 20.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.19 -0.505 . . . . 2.91 110.341 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 32.3 p90 -135.54 162.06 33.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.191 -0.459 . . . . 3.54 110.304 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.11 126.78 33.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 2.93 111.211 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.08 103.86 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.013 -0.539 . . . . 3.64 110.464 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.67 12.2 51.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.677 -0.773 . . . . 3.27 112.482 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 120.924 0.392 . . . . 3.59 111.304 179.745 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.238 0 CA-C-O 121.034 0.445 . . . . 2.48 111.962 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.75 155.52 39.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.51 -0.768 . . . . 2.13 111.373 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -91.69 -32.46 15.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.394 0.516 . . . . 2.4 112.394 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.418 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 35.3 m-85 -109.38 -179.18 3.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 2.02 111.872 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.99 165.12 24.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.547 -0.751 . . . . 2.65 110.902 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -80.73 138.6 36.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.429 -0.35 . . . . 2.4 111.601 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 131' ' ' PHE . 75.9 mt -100.34 107.45 19.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 2.27 110.071 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -87.3 116.9 25.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.904 0.383 . . . . 2.84 111.692 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -91.36 140.33 29.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.469 . . . . 2.89 110.811 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -132.66 87.74 2.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 3.82 109.964 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.52 -166.01 34.55 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.696 -0.764 . . . . 3.23 111.732 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 46.2 mmtt -93.33 -16.93 24.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 4.27 111.551 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.44 177.03 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.091 -0.504 . . . . 3.32 110.565 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.487 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 2.0 t0 -98.73 -89.91 0.3 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.164 -0.68 . . . . 2.39 109.164 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 26.9 tp -172.0 135.63 0.82 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 2.06 110.694 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -155.95 143.05 19.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.571 -0.529 . . . . 2.22 109.571 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.64 147.94 51.9 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.369 -0.378 . . . . 1.78 110.305 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.66 163.26 18.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.357 2.705 . . . . 2.15 112.297 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.0 117.88 8.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.837 -0.619 . . . . 2.6 110.954 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.95 6.96 63.0 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.761 -0.733 . . . . 1.65 112.673 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -134.53 159.19 41.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.914 -0.402 . . . . 2.31 109.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.9 -10.01 7.52 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.043 -0.598 . . . . 1.33 111.613 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.18 117.78 67.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 110.085 -0.339 . . . . 1.06 110.085 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.99 -176.47 2.89 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.585 2.19 . . . . 1.27 111.791 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.55 87.91 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.128 0.49 . . . . 1.7 110.305 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.438 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 49.0 m-80 -80.33 80.07 6.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.23 110.747 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.84 57.12 2.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.079 -0.509 . . . . 1.94 110.736 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -161.66 -38.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 1.96 110.629 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.93 170.54 9.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.509 . . . . 1.42 111.306 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 5.1 m -86.61 162.1 46.06 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 1.73 110.135 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.52 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 12.4 Cg_endo -56.83 -32.7 92.68 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.93 2.42 . . . . 1.42 112.679 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 18.5 t70 -71.38 -22.03 61.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.464 0.649 . . . . 1.78 110.396 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.803 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 52.1 m-20 -93.11 9.83 34.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.507 -0.769 . . . . 1.6 111.429 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.52 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 39.0 mm-40 -83.82 54.02 2.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 1.05 110.948 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.48 HG12 HD12 ' A' ' 73' ' ' LEU . 18.7 tt -150.9 138.28 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.002 -0.544 . . . . 1.17 109.949 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.38 -136.49 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.387 -0.911 . . . . 0.6 112.433 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.427 ' CD2' HG23 ' A' ' 90' ' ' ILE . 50.4 p90 -160.13 174.2 14.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.052 0.453 . . . . 0.99 110.968 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 49.8 m-85 -114.93 139.31 49.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.242 -0.651 . . . . 1.26 109.242 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -112.41 127.69 56.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.247 -0.433 . . . . 2.15 111.072 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 49' ' ' ARG . 2.2 ttt-85 -88.5 112.27 22.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.014 -0.539 . . . . 2.4 110.09 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB3' ' HE2' ' A' ' 69' ' ' TYR . . . -125.26 156.5 38.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.037 0.446 . . . . 2.21 111.543 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.91 142.43 49.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.69 -0.687 . . . . 2.68 110.813 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.477 ' HB3' HD12 ' A' ' 64' ' ' LEU . 6.5 tpt180 -111.54 119.33 38.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.905 0.384 . . . . 3.59 111.264 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt180 -137.16 169.47 17.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 3.43 109.942 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 pt -143.76 153.12 15.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.2 -0.296 . . . . 4.26 110.2 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 5.17 109.957 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 29.2 mtt . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 110.247 -0.279 . . . . 4.48 110.247 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -64.63 -54.49 31.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.944 -0.391 . . . . 4.16 109.944 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.9 t70 52.92 74.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.744 . . . . 4.09 112.047 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 52' ' ' ARG . 89.0 mt -81.07 149.7 29.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.781 -0.645 . . . . 3.36 110.443 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.99 154.63 92.06 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.837 -0.62 . . . . 3.36 110.908 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.34 122.31 10.99 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.919 2.413 . . . . 2.69 111.486 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.603 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 97.7 mtt180 -119.84 135.57 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.005 -0.543 . . . . 3.03 110.738 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.522 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 73.8 m95 -97.57 135.43 39.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.751 -0.659 . . . . 1.84 110.463 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.742 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 73.0 m-85 -117.35 145.6 43.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 2.76 110.185 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -85.78 124.61 32.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.981 0.42 . . . . 1.27 111.449 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -126.19 138.97 53.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.71 -0.677 . . . . 1.84 110.117 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.88 161.33 29.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 1.28 111.679 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.9 tt -63.27 122.11 15.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 1.66 111.051 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.33 16.58 62.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.86 -0.686 . . . . 1.66 114.147 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.44 129.23 40.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.109 0.455 . . . . 1.58 110.416 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.5 110.29 3.32 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.928 -0.869 . . . . 1.96 110.928 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.14 -29.15 54.63 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.426 2.751 . . . . 2.62 113.62 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.91 25.73 9.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.987 0.366 . . . . 3.09 111.987 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.38 -53.78 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.515 -0.312 . . . . 1.79 111.156 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.0 44.07 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.843 -0.694 . . . . 1.65 111.629 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 78.2 mt -117.43 107.15 45.49 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.718 0.294 . . . . 1.38 111.441 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.6 159.4 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.971 2.447 . . . . 1.62 111.158 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.614 ' HB2' HD11 ' A' ' 73' ' ' LEU . 92.6 t80 -64.37 119.16 9.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 1.58 110.845 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.21 11.1 26.49 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.495 -0.86 . . . . 1.44 112.891 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.03 172.12 13.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.702 0.251 . . . . 1.25 110.407 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -124.62 111.28 15.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.784 0.326 . . . . 1.86 110.442 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -140.99 152.51 44.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.265 -0.425 . . . . 1.68 110.155 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.65 117.94 8.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.081 -0.509 . . . . 1.7 111.329 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.24 29.24 62.6 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.64 -0.709 . . . . 1.27 113.27 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.427 HG23 ' CD2' ' A' ' 46' ' ' TYR . 38.4 mm -131.77 108.5 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.734 0.267 . . . . 1.01 110.863 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.5 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 12.8 pt -113.77 125.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.77 -0.455 . . . . 1.3 109.77 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.421 ' HZ2' ' HB3' ' A' ' 81' ' ' LEU . 79.3 m95 -87.51 139.12 30.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.446 0.535 . . . . 1.08 112.446 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.76 150.2 31.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.82 -0.627 . . . . 1.04 110.862 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.61 177.22 10.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.33 -0.248 . . . . 1.27 110.33 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.42 163.01 40.64 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.699 -0.482 . . . . 1.36 109.699 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.51 125.95 25.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 2.64 111.246 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.94 25.97 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.806 -0.711 . . . . 1.52 112.261 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -100.29 123.86 45.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.204 -0.295 . . . . 1.59 110.204 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 99' ' ' LEU . 26.3 mt -88.62 150.23 23.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.033 0.444 . . . . 2.15 111.459 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -75.12 102.77 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.745 -0.661 . . . . 2.07 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -170.89 148.19 2.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.85 -0.796 . . . . 2.36 108.85 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.43 131.5 15.08 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.296 1.998 . . . . 2.08 112.498 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.64 66.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.513 0.673 . . . . 1.78 110.99 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -1.75 25.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.661 -0.7 . . . . 2.55 111.776 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.44 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 8.6 p80 -52.34 -28.7 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.348 0.499 . . . . 2.24 112.348 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -25.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.248 -0.433 . . . . 2.0 112.009 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.81 63.51 4.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.069 -0.586 . . . . 2.33 112.167 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.2 t -138.51 23.09 2.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.208 0.528 . . . . 2.99 110.481 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.52 125.17 25.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.93 -0.577 . . . . 2.83 111.005 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.41 118.68 72.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.149 -0.686 . . . . 3.56 109.149 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.07 -33.68 91.23 Favored 'Trans proline' 0 CA--C 1.527 0.137 0 C-N-CA 123.001 2.467 . . . . 3.39 114.25 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.62 4.62 48.04 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.618 0.599 . . . . 4.05 112.618 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -125.1 -6.37 7.22 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 4.48 111.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -155.69 137.83 14.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.024 -0.535 . . . . 3.39 109.63 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 153.79 22.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.529 -0.305 . . . . 3.21 110.726 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.67 159.26 28.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 2.85 111.103 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.7 mt -88.38 132.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.263 -0.426 . . . . 2.42 110.146 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.26 121.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.852 -0.425 . . . . 2.74 109.852 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.77 121.45 14.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 2.11 111.108 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.0 157.16 46.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.525 -0.762 . . . . 2.49 109.687 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.7 mt -112.81 146.4 35.0 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.499 -0.319 . . . . 1.91 110.413 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.88 156.85 64.29 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.452 2.101 . . . . 1.84 111.758 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -52.38 125.07 14.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.74 -0.664 . . . . 2.53 111.137 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.77 -16.29 47.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.985 -0.626 . . . . 2.2 111.881 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.23 116.84 32.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.933 0.397 . . . . 2.1 110.565 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.68 158.31 16.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.082 -0.508 . . . . 2.78 110.511 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 27.0 mt -81.49 150.71 67.52 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.519 -0.31 . . . . 2.62 110.464 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 127' ' ' LEU . 32.0 Cg_exo -61.02 142.11 96.39 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.675 2.25 . . . . 2.77 111.515 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.44 112.33 2.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.102 -0.499 . . . . 4.11 110.95 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.88 -9.19 40.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.967 -0.635 . . . . 3.18 111.68 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 16' ' ' LEU . 47.6 t80 -118.18 103.47 9.89 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.486 -0.561 . . . . 2.91 109.486 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -112.34 162.62 15.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.18 -0.464 . . . . 3.54 111.06 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 136' ' ' SER . . . -97.92 147.35 24.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.133 -0.485 . . . . 2.93 110.306 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.68 111.7 2.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 3.64 110.73 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.75 10.31 70.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.988 -0.625 . . . . 3.27 112.77 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.693 ' HB2' ' HB3' ' A' ' 133' ' ' ALA . 22.8 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.173 0.511 . . . . 3.59 111.019 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.298 0 N-CA-C 109.748 -0.464 . . . . 2.48 109.748 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -64.62 137.93 58.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.781 0.324 . . . . 2.13 111.431 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -73.36 -26.52 61.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 2.4 110.714 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.496 ' CZ ' ' HA ' ' A' ' 35' ' ' ASN . 74.3 m-85 -111.04 166.6 10.92 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.038 -0.528 . . . . 2.02 112.273 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -69.67 168.73 14.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.249 -0.887 . . . . 2.65 111.18 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -92.25 151.6 20.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.269 0.47 . . . . 2.4 112.269 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 133' ' ' ALA . 15.9 mt -99.88 125.17 45.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 2.27 109.031 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -95.87 121.92 38.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.195 0.521 . . . . 2.84 112.233 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -89.77 134.38 34.21 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.736 -0.666 . . . . 2.89 110.076 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -140.91 73.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 3.82 109.94 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -165.15 -140.83 2.97 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.781 -0.724 . . . . 3.23 112.438 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -110.81 -18.08 13.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.721 0.296 . . . . 4.27 111.342 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.12 -174.13 2.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.182 -0.463 . . . . 3.32 111.208 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -111.38 -77.46 0.59 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 2.39 110.208 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 31.6 tp 172.55 131.23 0.02 OUTLIER 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.863 0.727 . . . . 2.06 110.018 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -157.23 130.89 8.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 2.22 109.625 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -120.97 139.51 29.34 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.234 -0.439 . . . . 1.78 110.277 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.55 164.36 34.03 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.273 1.982 . . . . 2.15 110.696 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.91 131.79 51.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.602 0.239 . . . . 2.6 110.609 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.11 6.3 61.77 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 1.65 111.659 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -144.39 159.73 42.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.818 -0.438 . . . . 2.31 109.818 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 108.43 -11.48 36.23 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.906 -0.664 . . . . 1.33 111.481 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.76 114.58 61.84 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.809 -0.441 . . . . 1.06 109.809 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.28 -173.13 1.7 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.564 2.176 . . . . 1.27 111.102 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mt -79.97 91.92 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.751 -0.463 . . . . 1.7 109.751 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 13' ' ' PHE . 69.0 m-80 -87.44 77.38 8.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.97 -0.559 . . . . 1.23 110.694 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 39.65 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.016 -0.538 . . . . 1.94 111.68 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.49 -10.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.42 -0.355 . . . . 1.96 111.236 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.2 166.28 16.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.612 -0.267 . . . . 1.42 110.857 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 19.5 m -88.01 168.23 17.39 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.304 -0.407 . . . . 1.73 110.687 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 86.3 Cg_exo -49.79 -45.01 33.92 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.247 2.631 . . . . 1.42 113.855 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -72.18 -22.74 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 1.78 111.522 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.958 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 14.8 m-20 -87.05 11.61 13.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.974 -0.557 . . . . 1.6 111.43 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 39.3 mm-40 -83.25 -6.46 59.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.761 0.282 . . . . 1.05 111.761 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.593 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -82.93 126.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.117 0.484 . . . . 1.17 111.33 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.44 -161.08 11.67 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.683 -0.77 . . . . 0.6 112.229 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.495 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 48.6 p90 -146.42 163.12 36.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.088 0.47 . . . . 0.99 110.717 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.534 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 5.9 m-85 -108.52 133.99 51.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.805 -0.634 . . . . 1.26 109.585 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 48' ' ' ARG . 30.8 ttt180 -114.68 134.63 54.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.361 . . . . 2.15 111.234 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -85.38 123.73 31.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 2.4 110.245 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.605 0.24 . . . . 2.21 110.957 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -150.42 93.06 1.93 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.118 -0.492 . . . . 2.68 110.726 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.528 ' HB3' HD12 ' A' ' 64' ' ' LEU . 28.5 tpt180 -78.64 124.86 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.281 0.562 . . . . 3.59 111.826 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -141.71 117.65 10.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.901 -0.591 . . . . 3.43 109.991 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.3 pt -65.19 171.19 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.185 -0.461 . . . . 4.26 110.713 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.061 0.457 . . . . 5.17 112.149 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.781 -0.451 . . . . 4.48 109.781 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.423 ' HE2' HD21 ' A' ' 64' ' ' LEU . 79.0 tttt -57.13 -53.31 59.54 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.332 0.395 . . . . 4.16 110.906 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.9 t70 56.0 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.93 0.715 . . . . 4.09 112.93 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 52' ' ' ARG . 68.9 mt -84.85 152.74 23.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 3.36 110.691 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.3 m -75.21 162.83 71.51 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.646 . . . . 3.36 109.989 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 11.9 Cg_endo -55.95 111.06 0.66 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.64 2.227 . . . . 2.69 111.848 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -116.47 137.56 52.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.97 -0.559 . . . . 3.03 110.762 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.534 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 69.1 m95 -104.77 129.64 52.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.84 -0.618 . . . . 1.84 110.944 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -110.13 140.65 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 2.76 110.001 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -89.97 120.08 30.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 1.27 111.186 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.37 130.41 52.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 1.84 109.939 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -67.3 151.1 48.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.56 -0.291 . . . . 1.28 111.129 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.11 116.52 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 1.66 110.805 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.89 -4.29 24.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.474 -0.87 . . . . 1.66 112.901 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.532 HG22 ' HA3' ' A' ' 107' ' ' GLY . 1.2 p -63.74 123.54 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.64 0.257 . . . . 1.58 110.492 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.98 106.87 3.01 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.081 -0.807 . . . . 1.96 111.081 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -35.2 91.15 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.089 2.526 . . . . 2.62 113.062 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.72 21.98 13.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.473 -0.331 . . . . 3.09 111.619 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.33 -50.1 61.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 1.79 110.83 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.32 49.03 59.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.019 -0.61 . . . . 1.65 111.812 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 mt -118.44 91.68 41.85 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.692 0.282 . . . . 1.38 111.56 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.27 155.02 22.02 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.443 2.095 . . . . 1.62 110.301 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 76.7 t80 -60.54 110.46 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.772 0.32 . . . . 1.58 110.857 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.59 -14.49 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.869 -0.681 . . . . 1.44 112.393 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.62 147.21 49.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.809 0.338 . . . . 1.25 111.286 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -111.08 103.14 11.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.055 0.455 . . . . 1.86 111.424 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 90' ' ' ILE . 12.8 ttmt -125.77 149.43 48.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 1.68 109.712 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.75 118.62 5.91 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.455 0.472 . . . . 1.7 111.935 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.58 35.45 51.52 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.941 -0.572 . . . . 1.27 112.981 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.413 HG13 ' HB3' ' A' ' 87' ' ' LYS . 27.4 mm -134.87 113.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.544 0.212 . . . . 1.01 110.474 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.5 HG13 ' HB2' ' A' ' 47' ' ' TYR . 23.6 pt -119.9 134.67 62.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 110.444 -0.206 . . . . 1.3 110.444 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.495 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 70.2 m95 -95.34 140.98 29.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.403 -0.362 . . . . 1.08 111.907 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.49 HG11 ' HA3' ' A' ' 31' ' ' GLY . 9.2 m -134.22 125.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 1.04 110.394 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.9 158.7 40.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.013 0.435 . . . . 1.27 111.79 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 t -139.04 163.34 32.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.569 -0.9 . . . . 1.36 108.569 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.61 121.46 15.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 2.64 110.58 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.03 -17.91 12.61 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.992 -0.843 . . . . 1.52 110.992 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.674 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -81.97 121.08 26.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.857 0.36 . . . . 1.59 110.062 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -88.65 130.58 35.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.143 -0.481 . . . . 2.15 110.603 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -71.45 97.0 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.125 0.488 . . . . 2.07 110.9 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.579 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.6 t -168.41 143.44 2.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.863 -0.791 . . . . 2.36 108.863 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.89 128.7 25.05 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.605 2.204 . . . . 2.08 113.516 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.958 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -129.5 78.93 1.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.525 0.679 . . . . 1.78 110.244 178.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.6 -11.11 59.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 2.55 111.492 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -58.28 -22.86 54.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.73 0.641 . . . . 2.24 112.73 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.28 0.68 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.089 0.471 . . . . 2.0 110.97 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -86.94 -35.42 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.871 -0.681 . . . . 2.33 111.5 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 t -71.27 115.66 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.355 0.598 . . . . 2.99 110.623 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -154.22 138.66 16.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 2.83 110.159 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 97.4 m-20 -94.75 108.04 34.77 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.863 -0.421 . . . . 3.56 109.863 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 37.4 Cg_endo -63.79 -29.19 68.23 Favored 'Trans proline' 0 N--CA 1.47 0.124 0 C-N-CA 123.238 2.625 . . . . 3.39 113.451 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.99 12.71 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.113 0.412 . . . . 4.05 112.113 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -135.95 -43.0 0.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 4.48 110.777 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -103.33 134.58 46.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.555 -0.535 . . . . 3.39 109.555 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.92 150.67 25.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 3.21 111.24 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.05 158.93 19.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 2.85 111.258 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 15.7 mt -113.33 145.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 2.42 109.712 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.01 118.66 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.63 0.252 . . . . 2.74 110.749 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.45 117.72 8.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.782 -0.645 . . . . 2.11 111.175 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -130.33 150.45 51.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 2.49 110.747 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.599 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 26.1 mt -97.22 138.83 21.22 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.098 -0.501 . . . . 1.91 110.107 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.24 152.98 68.39 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.683 2.255 . . . . 1.84 111.775 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -50.5 124.12 10.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 2.53 111.277 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.91 -22.13 16.9 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.148 -0.781 . . . . 2.2 111.148 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -99.98 120.29 39.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.656 -0.498 . . . . 2.1 109.656 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.4 139.03 38.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.179 -0.464 . . . . 2.78 111.06 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.2 mt -72.61 146.39 88.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.81 149.23 26.2 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.646 2.23 . . . . 2.77 111.417 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.39 108.98 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.293 0.479 . . . . 4.11 112.293 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.12 6.03 54.13 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.735 -0.666 . . . . 3.18 112.998 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -94.02 141.87 28.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.958 0.379 . . . . 2.91 111.49 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -152.98 147.3 25.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.93 -0.577 . . . . 3.54 110.785 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.63 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -112.55 162.35 15.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.357 -0.383 . . . . 2.93 110.54 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.22 128.06 34.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.367 -0.378 . . . . 3.64 110.283 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.89 -12.35 62.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.725 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 120.839 0.352 . . . . 3.59 111.731 -179.775 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 0 N-CA-C 109.169 -0.678 . . . . 2.48 109.169 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 154.45 42.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.896 0.379 . . . . 2.13 111.332 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -31.45 53.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.464 0.65 . . . . 2.4 109.429 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.505 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 92.5 m-85 -114.9 176.57 5.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 2.02 109.878 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 134' ' ' GLU . 2.3 p -69.95 167.52 17.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 2.65 110.747 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.11 18.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.472 . . . . 2.4 111.409 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.564 HD21 HD22 ' A' ' 119' ' ' LEU . 90.7 mt -107.95 115.8 30.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.144 -0.688 . . . . 2.27 109.144 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 4.6 m -93.12 132.71 37.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.155 0.502 . . . . 2.84 111.769 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HA ' ' HD1' ' A' ' 131' ' ' PHE . 6.4 tp-100 -95.96 140.84 30.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.611 -0.722 . . . . 2.89 110.812 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -130.17 77.38 1.78 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.004 -0.544 . . . . 3.82 109.761 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -171.91 44.42 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.951 -0.642 . . . . 3.23 111.657 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -84.47 -23.69 29.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.027 0.441 . . . . 4.27 110.414 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.68 -179.9 6.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.626 -0.716 . . . . 3.32 110.802 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 1.4 t0 -117.96 -84.32 0.65 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.249 -0.432 . . . . 2.39 110.61 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 30.8 tp -175.72 129.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.06 111.072 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -152.27 88.95 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.218 -0.66 . . . . 2.22 109.218 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -72.68 142.06 83.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.277 -0.42 . . . . 1.78 111.877 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 56.2 Cg_endo -70.77 161.51 45.8 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.024 2.483 . . . . 2.15 112.426 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.59 119.58 8.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 2.6 111.784 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.63 -13.44 61.06 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.056 -0.593 . . . . 1.65 112.685 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.692 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 70.5 mt-30 -117.87 174.2 6.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.671 0.272 . . . . 2.31 110.753 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.78 -1.66 41.84 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.597 -0.811 . . . . 1.33 112.246 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 t -100.58 112.04 63.85 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.57 0.224 . . . . 1.06 110.482 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HA ' HD23 ' A' ' 121' ' ' LEU . 53.7 Cg_endo -70.2 174.86 9.26 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.676 2.251 . . . . 1.27 111.492 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.85 89.11 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.056 0.455 . . . . 1.7 110.642 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 13' ' ' PHE . 62.0 m-80 -85.88 84.8 7.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 1.23 109.63 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -66.66 -20.98 66.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.703 -0.68 . . . . 1.94 112.197 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -88.24 -11.86 45.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.319 0.488 . . . . 1.96 112.319 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.06 158.94 18.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.144 0.497 . . . . 1.42 111.993 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 0.7 OUTLIER -89.06 163.02 36.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.644 -0.707 . . . . 1.73 109.34 179.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.17 -45.16 26.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.321 2.681 . . . . 1.42 113.315 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.906 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.25 -18.78 61.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.024 0.44 . . . . 1.78 111.411 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.12 -2.45 58.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.956 -0.566 . . . . 1.6 110.824 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 39' ' ' SER . 73.2 mm-40 -80.39 60.92 3.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.228 0.537 . . . . 1.05 110.686 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.501 HG12 HD12 ' A' ' 73' ' ' LEU . 15.9 tt -149.37 135.35 11.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 1.17 110.167 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.82 -146.85 6.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.129 -1.034 . . . . 0.6 112.98 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -152.76 168.46 25.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.134 0.492 . . . . 0.99 110.772 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.714 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -112.51 134.78 53.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.976 -0.557 . . . . 1.26 109.632 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 48' ' ' ARG . 27.7 ttt180 -116.96 126.51 53.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.353 . . . . 2.15 111.113 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.69 132.45 34.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.085 -0.507 . . . . 2.4 110.774 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.591 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -139.3 147.87 42.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.606 0.241 . . . . 2.21 110.792 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 101.05 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 2.68 110.564 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HB3' HD12 ' A' ' 64' ' ' LEU . 6.4 tpt180 -77.53 129.24 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 3.59 111.315 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -144.58 93.35 2.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 3.43 110.884 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.77 HG12 ' HB2' ' A' ' 62' ' ' LYS . 8.5 pt -77.51 154.01 5.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.601 -0.272 . . . . 4.26 110.382 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 5.17 110.664 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 CA--C 1.521 -0.164 0 N-CA-C 110.022 -0.362 . . . . 4.48 110.022 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.77 ' HB2' HG12 ' A' ' 54' ' ' ILE . 70.4 tttt -63.5 -43.8 96.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 4.16 111.157 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 62.77 101.01 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.511 -0.768 . . . . 4.09 112.847 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 52' ' ' ARG . 22.4 mt -117.53 150.46 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 3.36 110.5 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.445 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 0.2 OUTLIER -68.93 147.61 97.83 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.215 -0.448 . . . . 3.36 110.449 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.32 120.42 8.33 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.869 2.379 . . . . 2.69 111.641 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -118.03 133.31 56.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.049 -0.523 . . . . 3.03 111.496 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.714 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 44.7 m95 -100.31 125.44 46.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.977 -0.556 . . . . 1.84 109.537 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 24.7 m-85 -102.2 135.46 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.337 -0.392 . . . . 2.76 110.113 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -85.97 120.43 27.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.762 0.315 . . . . 1.27 110.65 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -118.78 144.66 46.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.996 -0.547 . . . . 1.84 109.723 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.448 ' CD2' HD12 ' A' ' 106' ' ' ILE . 99.2 m-85 -79.45 164.49 23.92 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.136 -0.226 . . . . 1.28 110.7 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.501 HD12 HG12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -60.52 117.57 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 1.66 112.073 -179.153 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.15 38.89 17.34 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.749 -0.66 . . . . 1.66 113.043 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.496 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -78.31 70.08 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.58 111.234 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.64 121.56 0.58 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.531 -1.028 . . . . 1.96 110.531 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.03 -42.37 64.81 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.811 2.34 . . . . 2.62 112.801 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.64 29.19 8.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.428 -0.351 . . . . 3.09 111.339 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.72 -50.27 15.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 1.79 110.866 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.8 49.15 65.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.053 -0.594 . . . . 1.65 111.866 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.26 99.19 48.49 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.721 0.296 . . . . 1.38 111.638 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 94.6 Cg_endo -80.85 160.45 21.34 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.514 2.143 . . . . 1.62 110.595 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -59.06 112.46 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.016 0.436 . . . . 1.58 110.488 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.24 -3.89 23.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.902 -0.666 . . . . 1.44 112.34 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.569 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -64.52 116.66 6.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.808 0.337 . . . . 1.25 110.853 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.37 127.76 33.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.837 -0.62 . . . . 1.86 110.919 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.69 ' HD2' HG13 ' A' ' 90' ' ' ILE . 12.1 ttmm -154.38 159.18 41.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.935 -0.765 . . . . 1.68 108.935 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 118.45 10.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.06 0.457 . . . . 1.7 111.481 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.94 60.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.654 -0.703 . . . . 1.27 112.741 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.69 HG13 ' HD2' ' A' ' 87' ' ' LYS . 28.3 mm -133.72 116.06 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.201 0.524 . . . . 1.01 111.256 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -124.16 139.87 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.868 -0.79 . . . . 1.3 108.868 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -100.26 141.87 32.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.272 0.471 . . . . 1.08 112.272 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.7 145.86 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.774 -0.648 . . . . 1.04 110.311 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -159.58 140.94 12.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.626 -0.261 . . . . 1.27 110.999 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 t -99.58 175.68 5.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.677 -0.49 . . . . 1.36 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -73.97 133.74 43.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.813 0.339 . . . . 2.64 110.674 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.62 -9.5 57.16 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.659 -0.781 . . . . 1.52 112.156 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.906 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.04 148.17 27.71 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.639 0.257 . . . . 1.59 110.421 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.69 134.79 49.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.797 0.332 . . . . 2.15 110.942 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -78.28 93.51 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.07 110.565 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.1 t -158.92 138.71 8.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.829 -0.623 . . . . 2.36 109.823 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.37 130.43 19.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.622 2.215 . . . . 2.08 112.238 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.56 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 14.5 pttt -151.9 92.08 1.7 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.268 0.556 . . . . 1.78 111.144 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.31 -4.03 36.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 2.55 111.883 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.56 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 1.7 p80 -55.01 -29.1 56.63 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.513 0.561 . . . . 2.24 112.513 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -96.35 4.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.785 0.326 . . . . 2.0 111.437 -179.306 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.496 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -104.75 -21.74 8.93 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.368 -0.92 . . . . 2.33 113.301 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.1 t -80.24 111.58 16.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.309 0.576 . . . . 2.99 112.364 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 109' ' ' ARG . 12.4 ttp180 -167.02 136.65 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.794 -0.639 . . . . 2.83 110.573 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -90.69 117.97 68.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 3.56 110.0 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -32.67 44.18 Favored 'Trans proline' 0 N--CA 1.473 0.298 0 C-N-CA 122.749 2.299 . . . . 3.39 113.179 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -17.12 61.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.783 0.29 . . . . 4.05 111.783 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -112.39 0.43 15.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.477 -0.329 . . . . 4.48 111.217 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -155.48 117.92 4.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.569 0.223 . . . . 3.39 110.728 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.42 154.16 42.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 3.21 111.411 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.79 151.08 19.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.089 0.471 . . . . 2.85 111.597 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.505 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 13.2 mt -91.93 149.0 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.26 -0.644 . . . . 2.42 109.26 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.99 116.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.609 0.242 . . . . 2.74 110.582 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.564 HD22 HD21 ' A' ' 16' ' ' LEU . 6.0 tt -64.1 111.81 2.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 2.11 110.999 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -131.88 150.75 52.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 2.49 110.545 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 33' ' ' PRO . 60.3 mt -93.59 154.52 41.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.955 -0.566 . . . . 1.91 109.521 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.63 166.81 12.78 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.487 2.124 . . . . 1.84 112.542 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -64.65 119.53 10.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 2.53 110.497 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.19 -19.33 22.68 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.046 -0.822 . . . . 2.2 111.046 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -105.36 118.75 37.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 2.1 110.148 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.42 155.83 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.419 . . . . 2.78 110.933 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -84.67 151.44 58.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.94 150.37 78.55 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.347 2.032 . . . . 2.77 111.213 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -59.13 125.45 23.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 4.11 110.735 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.0 51.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.014 -0.612 . . . . 3.18 111.688 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -96.84 124.26 40.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.114 -0.328 . . . . 2.91 110.114 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.485 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 55.3 p90 -127.62 148.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.909 0.385 . . . . 3.54 111.156 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.506 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -91.55 137.04 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 2.93 111.062 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.49 ' HA ' ' OE1' ' A' ' 134' ' ' GLU . 39.6 mm-40 -69.61 137.25 52.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.918 0.389 . . . . 3.64 110.801 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.18 -31.35 6.74 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.994 -1.242 . . . . 3.27 109.994 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.46 -0.57 . . . . 3.59 109.46 179.097 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.297 0 CA-C-O 120.567 0.222 . . . . 2.48 110.756 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -64.46 149.61 48.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.603 . . . . 2.13 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -86.37 -18.42 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 2.4 111.257 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 96.8 m-85 -123.37 172.71 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.155 -0.475 . . . . 2.02 111.276 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 134' ' ' GLU . 17.7 p -70.44 170.37 12.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 2.65 109.996 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . . . -95.92 172.11 8.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.279 0.561 . . . . 2.4 111.211 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 131' ' ' PHE . 43.6 mt -106.04 102.07 11.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.901 -0.778 . . . . 2.27 108.901 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.738 HG23 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.42 119.24 22.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.967 -0.56 . . . . 2.84 110.952 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 5.3 tp60 -100.36 132.73 45.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.886 -0.597 . . . . 2.89 110.801 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -126.29 57.16 1.41 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.692 -0.685 . . . . 3.82 109.436 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.61 -166.41 11.86 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.39 -0.823 . . . . 3.23 111.546 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -91.78 -37.97 12.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.887 0.343 . . . . 4.27 111.595 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -83.14 156.19 23.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.505 -0.316 . . . . 3.32 110.944 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' OD2' ' HZ2' ' A' ' 68' ' ' TRP . 1.4 t0 -87.22 -154.37 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.278 -0.419 . . . . 2.39 110.556 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 tp -111.58 131.34 55.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.951 0.352 . . . . 2.06 111.951 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -154.65 105.44 2.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.782 -0.645 . . . . 2.22 109.371 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.54 150.59 51.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 1.78 110.952 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 72.8 Cg_endo -75.74 -172.85 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.942 2.428 . . . . 2.15 112.707 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 28' ' ' ARG . 7.2 tpt180 -69.6 130.04 41.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.625 -0.716 . . . . 2.6 111.447 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.98 87.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.24 -0.505 . . . . 1.65 112.575 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.525 HE22 HG23 ' A' ' 125' ' ' THR . 4.7 mm-40 -125.87 167.26 15.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.804 0.335 . . . . 2.31 111.018 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.508 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 110.0 -28.22 10.79 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.671 -0.695 . . . . 1.33 112.134 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 43' ' ' GLN . 45.4 t -80.01 115.23 52.79 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.839 0.352 . . . . 1.06 110.254 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 6.2 Cg_exo -78.38 -176.25 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.668 2.246 . . . . 1.27 111.095 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 36' ' ' THR . 32.9 mt -80.03 88.85 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.568 -0.53 . . . . 1.7 109.568 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -86.08 82.61 8.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.465 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.429 HG23 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -77.74 37.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 1.94 111.486 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.16 1.39 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.98 -0.555 . . . . 1.96 109.711 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.43 159.29 37.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.887 -0.597 . . . . 1.42 111.843 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.16 168.82 23.82 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.688 -0.687 . . . . 1.73 110.019 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.11 -37.96 93.77 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.648 2.232 . . . . 1.42 112.802 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 1.3 p30 -78.24 -15.76 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.631 0.234 . . . . 1.78 111.631 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.894 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 11.4 m-20 -88.75 -0.61 57.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 1.6 110.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.456 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.1 mm-40 -79.88 53.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.237 0.542 . . . . 1.05 111.074 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.868 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.4 tt -146.49 134.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.838 -0.619 . . . . 1.17 109.508 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.97 -146.67 5.41 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.412 -0.899 . . . . 0.6 112.498 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 51.2 p90 -156.41 165.78 35.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.611 0.243 . . . . 0.99 110.656 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.732 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 9.0 m-85 -106.15 141.91 36.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.483 -0.562 . . . . 1.26 109.483 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -121.77 127.75 50.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 2.15 110.912 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.4 ttt-85 -82.03 109.48 16.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 2.4 110.009 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.82 145.4 50.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.076 0.465 . . . . 2.21 112.114 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.9 m -140.44 119.58 12.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.68 109.765 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' A' ' 64' ' ' LEU . 25.0 tpt180 -84.58 125.35 32.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.075 0.464 . . . . 3.59 111.923 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -137.8 172.44 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 3.43 110.049 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.95 177.42 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.629 0.252 . . . . 4.26 110.857 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 116.408 -0.36 . . . . 5.17 110.086 178.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmt . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 110.048 -0.352 . . . . 4.48 110.048 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.54 -38.37 90.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.459 -0.571 . . . . 4.16 109.459 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 55.36 85.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.989 -1.005 . . . . 4.09 113.455 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 52' ' ' ARG . 81.3 mt -92.2 155.31 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 3.36 109.918 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -74.76 152.8 87.12 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.713 -0.222 . . . . 3.36 110.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.32 120.96 9.18 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 2.69 111.092 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.738 ' HG2' HG23 ' A' ' 17' ' ' THR . 63.2 mtt180 -112.77 126.89 55.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 3.03 111.222 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.732 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.04 104.36 16.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.122 -0.49 . . . . 1.84 109.88 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 89.0 m-85 -88.51 148.87 23.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.203 -0.453 . . . . 2.76 110.442 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.79 128.07 48.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.908 0.385 . . . . 1.27 111.294 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.67 157.82 31.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.157 -0.683 . . . . 1.84 109.157 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.69 159.0 16.6 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.633 -0.258 . . . . 1.28 110.999 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.1 120.45 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.183 -0.462 . . . . 1.66 112.111 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 88.67 36.08 8.12 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.939 -0.648 . . . . 1.66 112.728 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.44 104.46 15.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.966 0.412 . . . . 1.58 111.302 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.49 115.5 3.39 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.649 -0.786 . . . . 1.96 111.959 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.7 -24.03 55.49 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.642 2.228 . . . . 2.62 112.172 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 47.11 1.16 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.913 0.387 . . . . 3.09 110.531 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.69 -60.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.79 111.469 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.32 16.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.82 -0.705 . . . . 1.65 111.624 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HD2' ' A' ' 87' ' ' LYS . 32.0 mt -120.77 94.19 48.82 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 1.38 111.581 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 83.4 Cg_endo -83.11 164.43 15.19 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.541 2.161 . . . . 1.62 111.009 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.57 110.28 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.58 111.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.15 9.19 24.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.796 -0.716 . . . . 1.44 113.055 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.561 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -77.73 134.95 37.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.864 0.364 . . . . 1.25 111.243 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -81.22 127.15 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.401 -0.363 . . . . 1.86 110.918 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HD2' HD21 ' A' ' 81' ' ' LEU . 12.4 tttt -163.3 142.05 8.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 1.68 110.666 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.37 124.76 24.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 1.7 111.497 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.82 15.92 71.68 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.913 -0.585 . . . . 1.27 112.797 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.02 112.95 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.634 0.254 . . . . 1.01 110.709 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.457 HG13 ' HB2' ' A' ' 47' ' ' TYR . 17.5 pt -118.0 132.17 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.942 -0.392 . . . . 1.3 109.942 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 71.7 m95 -92.15 138.03 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.409 0.522 . . . . 1.08 112.409 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.508 HG11 ' HA3' ' A' ' 31' ' ' GLY . 17.4 m -132.75 146.4 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.407 -0.815 . . . . 1.04 109.706 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.19 174.71 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.831 0.348 . . . . 1.27 111.097 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -156.22 170.73 21.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 1.36 109.389 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.12 124.64 24.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 2.64 110.681 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' ASP . . . 112.84 -21.58 18.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.829 -0.908 . . . . 1.52 110.829 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.868 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.09 126.81 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.097 -0.335 . . . . 1.59 110.097 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.18 143.68 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.857 0.36 . . . . 2.15 111.158 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.06 93.38 4.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.317 0.579 . . . . 2.07 110.722 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.417 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 8.4 t -161.71 149.49 12.11 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.454 -0.943 . . . . 2.36 108.454 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 50.7 Cg_endo -69.99 129.73 17.85 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.259 1.973 . . . . 2.08 112.938 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.894 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -138.18 71.33 1.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.385 0.612 . . . . 1.78 111.203 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 1.2 p-10 -76.96 -4.38 43.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.505 . . . . 2.55 111.918 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.413 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.5 p80 -57.82 -22.21 46.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.973 0.416 . . . . 2.24 111.878 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.72 8.86 9.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 2.0 110.973 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.69 -26.73 10.35 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 120.999 -0.619 . . . . 2.33 111.612 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.7 t -79.77 118.17 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 2.99 110.539 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -161.5 140.44 9.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 2.83 109.999 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.65 103.3 23.31 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.5 -0.318 . . . . 3.56 110.579 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.39 -17.09 39.43 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.761 2.308 . . . . 3.39 112.702 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.49 -11.42 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.054 0.454 . . . . 4.05 110.982 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -116.83 -53.62 2.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.031 -0.532 . . . . 4.48 110.14 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.79 139.58 38.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.682 -0.69 . . . . 3.39 109.944 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 148.13 22.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.735 0.302 . . . . 3.21 111.106 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.76 153.13 31.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.394 -0.366 . . . . 2.85 110.816 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 9.1 mt -88.1 149.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 2.42 110.116 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 136' ' ' SER . 40.3 t -67.88 125.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.36 . . . . 2.74 110.471 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.07 105.47 3.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 2.11 110.979 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -121.31 150.53 41.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.143 -0.48 . . . . 2.49 110.688 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.633 HD13 HG22 ' A' ' 125' ' ' THR . 96.0 mt -100.18 153.87 37.52 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.093 -0.503 . . . . 1.91 110.835 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.71 167.92 25.9 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.731 2.287 . . . . 1.84 111.912 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.07 122.54 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.493 . . . . 2.53 111.214 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.57 12.13 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.69 -0.686 . . . . 2.2 111.766 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.633 HG22 HD13 ' A' ' 121' ' ' LEU . 6.4 m -96.24 122.26 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.927 -0.397 . . . . 2.1 109.927 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 p -118.67 149.06 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.655 0.264 . . . . 2.78 110.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.2 mt -77.71 144.01 68.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.812 -0.44 . . . . 2.62 109.812 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.439 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 12.4 Cg_endo -57.78 157.83 22.52 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.615 2.21 . . . . 2.77 111.701 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.7 118.34 7.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.136 -0.484 . . . . 4.11 110.733 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.21 -16.66 24.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 3.18 112.423 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.8 m-85 -99.63 124.92 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.71 0.291 . . . . 2.91 111.004 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -121.53 161.68 21.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 3.54 110.943 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 136' ' ' SER . . . -95.19 130.96 41.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.423 -0.353 . . . . 2.93 110.973 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 55.5 mt-10 -68.85 107.68 3.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 3.64 111.605 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.54 12.01 56.34 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.749 -0.66 . . . . 3.27 112.578 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' A' ' 133' ' ' ALA . 4.7 t . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 110.128 -0.323 . . . . 3.59 110.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.42 0 N-CA-C 109.72 -0.474 . . . . 2.48 109.72 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 m -56.57 144.22 32.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.252 0.464 . . . . 2.13 112.252 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.424 ' NE1' HG22 ' A' ' 106' ' ' ILE . 26.5 m95 -69.58 -30.48 68.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.586 -0.734 . . . . 2.4 112.761 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 93.4 m-85 -108.92 167.26 10.21 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.783 0.29 . . . . 2.02 111.783 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -73.19 165.99 23.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.024 -0.535 . . . . 2.65 111.339 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.59 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -78.82 140.71 38.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.275 0.843 . . . . 2.4 113.275 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 67' ' ' ARG . 40.6 mt -91.43 127.38 36.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.231 -1.026 . . . . 2.27 108.231 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -106.25 133.04 51.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.876 0.369 . . . . 2.84 111.692 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 20' ' ' GLY . 3.6 tp-100 -96.18 144.08 26.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.716 -0.674 . . . . 2.89 109.292 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -125.69 47.27 2.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 3.82 110.693 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' H ' ' HG3' ' A' ' 18' ' ' GLN . . . -162.8 -169.33 26.05 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.072 -0.585 . . . . 3.23 111.933 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -81.42 -28.96 34.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.753 0.311 . . . . 4.27 110.555 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -70.15 173.84 6.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.558 -0.746 . . . . 3.32 111.498 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.17 -156.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.375 -0.602 . . . . 2.39 109.375 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 35.8 tp -102.62 124.57 48.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.805 0.336 . . . . 2.06 111.408 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 40.8 tptt -151.5 116.88 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 2.22 110.064 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 47.7 m-85 -105.33 149.62 37.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 1.78 110.557 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 11.4 Cg_exo -72.45 173.31 13.4 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.066 2.51 . . . . 2.15 112.144 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -69.73 125.63 27.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.834 -0.621 . . . . 2.6 111.438 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 23.77 50.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.07 -0.586 . . . . 1.65 112.451 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.79 166.33 33.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.77 0.319 . . . . 2.31 110.188 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.36 2.86 50.83 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.895 -0.669 . . . . 1.33 113.156 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.16 121.04 63.2 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 110.203 -0.295 . . . . 1.06 110.203 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.03 178.88 5.41 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.707 2.271 . . . . 1.27 112.033 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.1 mt -76.06 86.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 1.7 110.607 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -88.94 79.91 7.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 1.23 110.523 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -17.06 56.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.94 110.82 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -74.79 -21.82 59.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 1.96 111.235 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.71 173.77 6.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.42 111.747 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.618 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 21.9 m -90.61 166.19 20.25 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 1.73 109.998 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.5 Cg_endo -51.92 -38.28 68.35 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.163 2.576 . . . . 1.42 113.763 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -72.71 -19.14 61.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.711 0.263 . . . . 1.78 111.711 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.86 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.0 m-20 -88.17 4.1 46.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 1.6 110.969 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -80.38 51.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.176 0.512 . . . . 1.05 111.246 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.763 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -148.36 132.9 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.065 -0.516 . . . . 1.17 110.033 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.95 -146.34 5.27 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.192 -1.004 . . . . 0.6 112.632 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -156.15 162.23 40.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.587 0.232 . . . . 0.99 110.468 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.452 ' HB2' HG13 ' A' ' 91' ' ' ILE . 61.8 m-85 -104.04 136.46 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.425 -0.583 . . . . 1.26 109.425 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -111.94 125.78 54.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 2.15 111.0 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -78.28 131.76 37.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.247 -0.433 . . . . 2.4 109.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.82 138.08 28.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 2.21 111.601 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.29 96.19 3.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.541 -0.754 . . . . 2.68 110.489 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HB3' HD12 ' A' ' 64' ' ' LEU . 22.6 tpt180 -68.5 120.92 15.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.212 0.529 . . . . 3.59 111.001 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.448 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 7.2 ttm180 -139.45 110.44 6.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.888 -0.596 . . . . 3.43 111.039 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.47 168.07 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 4.26 110.816 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 5.17 111.298 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.448 ' SD ' ' HD3' ' A' ' 53' ' ' ARG . 64.4 mtt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.989 -0.375 . . . . 4.48 109.989 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -59.12 -48.87 80.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.3 -0.63 . . . . 4.16 109.3 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.9 t70 55.41 97.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.333 1.234 . . . . 4.09 114.333 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' A' ' 52' ' ' ARG . 38.5 mt -88.61 153.65 20.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 3.36 110.221 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -73.54 159.71 83.99 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 3.36 110.892 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.08 110.17 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.858 2.372 . . . . 2.69 112.134 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 28.7 mtt-85 -120.44 148.63 43.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.728 -0.669 . . . . 3.03 111.494 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.426 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 56.4 m95 -121.53 137.46 54.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.072 -0.513 . . . . 1.84 110.49 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.8 m-85 -112.54 148.56 34.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.427 -0.583 . . . . 2.76 109.427 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.73 123.01 37.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.991 0.424 . . . . 1.27 111.642 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.446 ' HD2' HG21 ' A' ' 75' ' ' THR . 9.3 m-85 -119.13 162.78 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.759 -0.655 . . . . 1.84 109.791 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -102.21 155.77 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.596 -0.274 . . . . 1.28 110.644 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.4 tt -60.9 115.67 3.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.876 0.37 . . . . 1.66 111.322 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.26 38.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.841 -0.695 . . . . 1.66 114.53 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.446 HG21 ' HD2' ' A' ' 71' ' ' TYR . 5.6 p -56.48 119.9 6.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 117.599 0.699 . . . . 1.58 111.375 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 102.95 112.42 3.67 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.928 -0.654 . . . . 1.96 111.601 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 13.7 Cg_endo -58.06 -36.05 98.28 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 122.738 2.292 . . . . 2.62 112.389 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.02 28.44 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 3.09 111.281 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -55.64 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.153 -0.476 . . . . 1.79 110.43 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.73 48.5 49.11 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.973 -0.851 . . . . 1.65 110.973 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.532 HD21 ' HE3' ' A' ' 87' ' ' LYS . 32.7 mt -116.5 94.46 43.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 112.192 0.441 . . . . 1.38 112.192 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 87.4 Cg_endo -87.01 158.7 8.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.689 2.259 . . . . 1.62 110.389 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.599 ' HB2' HD11 ' A' ' 73' ' ' LEU . 48.4 t80 -58.86 115.17 2.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 1.58 111.112 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.76 -11.1 18.45 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.737 -0.744 . . . . 1.44 112.66 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.529 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -66.87 130.62 43.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 1.25 110.83 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -95.09 132.65 39.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.247 -0.433 . . . . 1.86 111.053 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.532 ' HE3' HD21 ' A' ' 81' ' ' LEU . 13.1 ttmm -158.38 152.94 24.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.152 -0.685 . . . . 1.68 109.152 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.74 112.53 3.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.873 0.368 . . . . 1.7 111.606 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.97 28.71 27.86 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.27 112.602 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 87' ' ' LYS . 29.6 mm -132.78 106.81 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 1.01 110.803 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 47' ' ' TYR . 3.7 pt -118.7 127.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.995 -0.372 . . . . 1.3 109.995 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.412 ' CZ3' ' HG ' ' A' ' 73' ' ' LEU . 92.1 m95 -85.53 139.52 31.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.966 0.728 . . . . 1.08 112.966 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 m -136.22 140.55 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.19 -0.914 . . . . 1.04 110.034 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.79 159.28 44.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.152 -0.476 . . . . 1.27 110.168 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 t -135.52 172.41 13.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 1.36 109.828 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.22 126.31 27.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.371 -0.377 . . . . 2.64 110.76 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.69 -10.5 38.32 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.649 . . . . 1.52 112.195 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.763 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.68 132.19 35.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.645 0.259 . . . . 1.59 111.342 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 59.0 mt -92.27 139.77 30.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.248 -0.433 . . . . 2.15 111.201 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -85.84 85.3 7.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 2.07 111.231 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.631 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 9.7 t -167.72 140.29 2.64 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.049 -0.723 . . . . 2.36 109.049 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.19 133.36 52.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.917 2.411 . . . . 2.08 113.038 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.33 67.53 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 1.78 110.968 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.3 6.97 7.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 2.55 112.48 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -59.78 -22.75 62.57 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.019 0.377 . . . . 2.24 112.019 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.424 HG22 ' NE1' ' A' ' 12' ' ' TRP . 3.5 mt -88.92 -18.27 7.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.258 0.552 . . . . 2.0 109.905 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.88 70.56 3.16 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.308 -0.717 . . . . 2.33 111.308 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.9 t -149.33 19.67 0.95 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.677 0.751 . . . . 2.99 109.411 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -77.88 135.76 37.95 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.65 -0.704 . . . . 2.83 111.404 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 113' ' ' ASN . 45.4 t-20 -111.95 118.81 45.7 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.239 -0.652 . . . . 3.56 109.239 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.15 -23.69 74.53 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.061 2.508 . . . . 3.39 113.206 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.46 -1.66 57.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 4.05 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 110' ' ' ASN . 40.6 m-20 -132.08 14.62 4.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.397 -0.365 . . . . 4.48 110.951 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -177.97 135.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.898 -0.592 . . . . 3.39 110.398 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.1 144.15 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.507 -0.553 . . . . 3.21 109.507 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.74 144.74 52.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 2.85 111.205 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 21.5 mt -86.21 140.81 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.779 -0.646 . . . . 2.42 109.475 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.05 128.12 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.879 -0.415 . . . . 2.74 109.879 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.457 HD13 ' HG ' ' A' ' 16' ' ' LEU . 2.0 tt -60.45 110.8 1.36 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 2.11 111.623 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -116.29 134.07 55.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.621 -0.718 . . . . 2.49 110.039 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.522 HD13 HG22 ' A' ' 125' ' ' THR . 29.7 mt -98.9 145.48 30.04 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.424 -0.353 . . . . 1.91 110.556 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.9 155.29 71.4 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.441 2.094 . . . . 1.84 111.942 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -61.62 111.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.0 -0.545 . . . . 2.53 110.693 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.98 -17.42 8.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.126 -1.19 . . . . 2.2 110.126 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.522 HG22 HD13 ' A' ' 121' ' ' LEU . 89.7 m -108.86 112.81 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.102 -0.703 . . . . 2.1 109.102 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.23 150.09 31.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 2.78 111.358 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.464 ' HG ' ' CD1' ' A' ' 121' ' ' LEU . 18.5 mt -78.14 147.08 72.44 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 2.62 110.28 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.53 153.69 69.62 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.757 2.305 . . . . 2.77 110.862 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -59.44 122.21 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 4.11 111.295 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.77 -9.85 40.85 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.014 -0.613 . . . . 3.18 112.255 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -102.84 134.65 45.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.766 0.317 . . . . 2.91 111.751 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -146.26 143.41 29.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 3.54 110.49 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.95 134.87 34.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.781 0.325 . . . . 2.93 110.662 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.67 123.74 19.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.05 -0.523 . . . . 3.64 110.529 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.81 -12.77 46.07 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.012 -0.613 . . . . 3.27 112.234 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.639 0.257 . . . . 3.59 111.194 -179.42 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.312 0 CA-C-O 120.96 0.41 . . . . 2.48 111.374 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -79.26 167.41 20.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.879 -0.6 . . . . 2.13 110.821 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.556 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 31.3 m95 -92.91 -45.57 7.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 2.4 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 29.9 m-85 -88.66 159.74 17.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.866 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 p -66.92 157.41 33.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 2.65 110.797 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -74.81 139.99 43.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.928 0.394 . . . . 2.4 111.321 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 95.6 mt -93.16 138.59 31.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.92 -0.582 . . . . 2.27 109.787 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -109.78 124.89 52.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.06 0.457 . . . . 2.84 111.897 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -97.39 124.3 41.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 2.89 110.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 35.5 t60 -116.82 92.61 3.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.115 -0.493 . . . . 3.82 110.104 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.77 -166.16 38.73 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.469 -0.872 . . . . 3.23 112.093 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 45.1 mmtt -87.98 -22.2 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 4.27 111.211 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -87.79 171.25 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.137 -0.483 . . . . 3.32 110.652 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.418 ' OD2' ' HZ2' ' A' ' 68' ' ' TRP . 13.3 t0 -102.63 -90.51 0.36 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 2.39 110.795 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 31.2 tp -169.27 129.64 1.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.766 0.317 . . . . 2.06 110.841 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -150.89 133.08 15.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 2.22 110.508 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -118.75 134.13 23.57 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.102 -0.499 . . . . 1.78 110.184 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.62 176.05 8.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.024 2.483 . . . . 2.15 112.56 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -58.92 126.87 29.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 2.6 112.102 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.17 20.63 75.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.182 -0.533 . . . . 1.65 113.339 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -141.52 153.32 44.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.065 -0.346 . . . . 2.31 110.065 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.5 -13.51 9.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.33 112.092 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.5 t -95.66 111.55 56.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.761 0.315 . . . . 1.06 110.37 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.25 -166.91 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.743 2.295 . . . . 1.27 111.648 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -79.66 88.4 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.166 0.508 . . . . 1.7 111.436 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.483 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . 31.3 t30 -98.55 91.89 5.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.214 0.531 . . . . 1.23 109.655 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.15 2.67 55.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.84 0.682 . . . . 1.94 112.84 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -100.87 21.32 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.186 0.517 . . . . 1.96 111.274 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.418 ' OG ' HG21 ' A' ' 106' ' ' ILE . 3.7 m -148.84 174.77 11.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.841 -0.618 . . . . 1.42 110.075 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.578 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 17.6 m -84.36 166.09 34.77 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.885 -0.413 . . . . 1.73 109.885 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 18.8 Cg_endo -59.03 -22.54 64.25 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.663 2.242 . . . . 1.42 113.321 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.712 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 1.5 p-10 -89.53 -10.68 45.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.312 . . . . 1.78 111.709 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.727 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 23.6 m-20 -85.87 -0.93 56.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.6 110.144 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.54 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.7 mm-40 -79.09 59.2 2.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.987 -0.551 . . . . 1.05 111.419 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.865 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.7 tt -151.89 133.5 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.17 110.092 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.97 -142.45 4.41 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.03 -1.081 . . . . 0.6 112.637 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -160.17 159.24 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.006 0.432 . . . . 0.99 110.527 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.692 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 5.1 m-85 -99.8 135.7 40.83 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.434 -0.58 . . . . 1.26 109.434 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -111.73 128.22 56.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.323 -0.399 . . . . 2.15 111.061 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -84.5 128.41 34.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.949 -0.569 . . . . 2.4 109.726 179.222 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.79 157.86 44.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.02 0.438 . . . . 2.21 111.498 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -148.47 125.75 11.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.214 -0.661 . . . . 2.68 109.214 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -112.25 134.84 53.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.381 . . . . 3.59 111.154 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 28.4 ttm180 -149.32 121.36 8.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.501 -0.318 . . . . 3.43 110.833 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 pt -92.7 136.27 25.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.789 -0.449 . . . . 4.26 109.789 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.26 -0.427 . . . . 5.17 110.699 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.402 ' SD ' ' HD3' ' A' ' 53' ' ' ARG . 17.1 mmt . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 109.19 -0.671 . . . . 4.48 109.19 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -54.62 -51.69 64.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.078 -0.341 . . . . 4.16 110.078 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.9 t70 63.9 115.22 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.767 1.025 . . . . 4.09 113.767 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.1 mt -109.84 -179.13 3.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.855 -0.612 . . . . 3.36 110.639 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -102.83 155.44 36.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.079 -0.51 . . . . 3.36 110.224 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.3 109.91 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.518 2.145 . . . . 2.69 111.526 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.597 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 59.4 mtt180 -113.0 145.95 39.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.105 0.479 . . . . 3.03 112.055 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.692 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.2 m95 -113.36 132.72 55.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.64 -0.709 . . . . 1.84 110.508 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -110.4 141.57 43.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 2.76 109.929 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.77 116.01 28.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 1.27 111.49 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -115.6 156.6 25.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.034 -0.53 . . . . 1.84 110.162 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -96.52 162.55 13.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.459 -0.337 . . . . 1.28 110.635 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.9 OUTLIER -64.13 117.27 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.428 -0.351 . . . . 1.66 110.803 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.97 7.81 37.7 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.806 -0.712 . . . . 1.66 113.679 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -70.11 120.83 16.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 1.58 111.496 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 111.44 122.82 4.27 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.14 -0.784 . . . . 1.96 111.14 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 9.7 Cg_endo -53.03 -56.64 2.6 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.07 2.514 . . . . 2.62 112.7 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.16 42.66 1.33 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 3.09 110.912 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.89 -54.1 14.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.014 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.62 38.51 96.53 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.649 -0.705 . . . . 1.65 112.223 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.48 101.93 48.36 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.751 0.31 . . . . 1.38 111.047 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.05 159.95 18.16 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.707 2.271 . . . . 1.62 111.258 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.623 ' HB2' HD11 ' A' ' 73' ' ' LEU . 51.2 t80 -56.74 113.46 1.65 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.421 -0.354 . . . . 1.58 110.688 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.67 -12.09 13.65 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.653 -0.784 . . . . 1.44 112.939 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.05 114.1 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 1.25 110.914 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -74.85 120.93 21.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.516 . . . . 1.86 111.396 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -143.84 151.71 40.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 1.68 110.041 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.37 115.52 4.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.89 0.376 . . . . 1.7 111.733 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.1 26.43 60.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.881 -0.676 . . . . 1.27 112.665 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -130.0 103.17 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.944 0.402 . . . . 1.01 110.6 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 47' ' ' TYR . 21.0 pt -111.52 119.91 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.283 -0.417 . . . . 1.3 110.675 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -79.44 137.53 37.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.08 111.55 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.62 143.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.957 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.2 165.6 32.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.487 . . . . 1.27 110.003 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -134.82 -177.47 4.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.258 -0.428 . . . . 1.36 109.985 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.58 120.1 14.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.167 0.508 . . . . 2.64 110.938 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.02 -9.15 39.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.05 -0.595 . . . . 1.52 111.795 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.865 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.17 121.84 20.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.747 0.308 . . . . 1.59 110.387 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.712 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 53.8 mt -89.39 146.38 24.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 2.15 109.982 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -79.73 69.03 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.536 . . . . 2.07 109.874 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 1.4 m -135.34 136.28 24.06 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 2.36 109.792 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 5.2 Cg_exo -81.2 119.21 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.926 2.417 . . . . 2.08 110.855 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.81 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -135.73 102.9 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.559 . . . . 1.78 111.143 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.13 4.1 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.968 -0.56 . . . . 2.55 111.924 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.81 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 12.3 p80 -57.75 -24.3 56.38 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.058 0.456 . . . . 2.24 112.102 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.418 HG21 ' OG ' ' A' ' 38' ' ' SER . 1.2 pt -105.36 5.33 10.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.178 -0.465 . . . . 2.0 111.129 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.61 46.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 2.33 111.64 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -146.56 28.62 1.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.315 0.579 . . . . 2.99 110.748 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 38.3 ttp85 -69.24 141.2 54.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 2.83 111.27 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -94.92 113.0 60.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.065 -0.516 . . . . 3.56 109.731 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.35 -12.99 23.06 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.045 2.497 . . . . 3.39 114.246 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.1 -15.22 44.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.102 0.477 . . . . 4.05 110.884 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -110.39 -9.32 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 4.48 111.546 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -153.01 138.67 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.718 0.294 . . . . 3.39 110.709 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.56 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 3.21 111.583 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.87 149.89 49.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 2.85 111.444 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.3 mt -91.02 138.62 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.807 -0.633 . . . . 2.42 110.258 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.23 119.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.377 -0.601 . . . . 2.74 109.377 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.436 HD22 HD21 ' A' ' 16' ' ' LEU . 1.4 tt -61.0 128.3 35.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 2.11 110.82 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -132.57 142.96 49.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.84 -0.618 . . . . 2.49 110.429 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 26.3 mt -105.62 145.69 31.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.075 -0.511 . . . . 1.91 110.19 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 36.9 Cg_exo -61.78 167.27 10.48 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.991 2.461 . . . . 1.84 112.48 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.73 121.64 14.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 2.53 110.845 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.48 -18.91 34.79 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.762 . . . . 2.2 111.934 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 1.9 m -94.25 99.16 11.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.099 0.476 . . . . 2.1 110.234 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.11 156.22 16.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.997 -0.547 . . . . 2.78 111.24 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.84 146.17 31.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 2.62 109.755 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.0 152.67 73.86 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.608 2.206 . . . . 2.77 111.889 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.97 120.49 11.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 4.11 110.684 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 19' ' ' HIS . . . 109.26 -8.15 32.86 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.724 -0.751 . . . . 3.18 111.55 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 2.7 t80 -94.15 132.08 39.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.189 -0.3 . . . . 2.91 110.189 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.472 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 41.3 p90 -134.65 146.84 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.865 0.365 . . . . 3.54 111.462 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.29 148.63 38.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.812 -0.631 . . . . 2.93 110.597 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.21 122.72 28.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 3.64 109.838 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.19 14.47 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.941 -0.647 . . . . 3.27 111.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 3.59 110.615 179.504 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.791 0.329 . . . . 2.48 111.403 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 m -71.33 152.76 42.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 2.13 110.653 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -86.58 -27.94 23.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.794 0.331 . . . . 2.4 111.199 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.92 164.04 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.327 -0.397 . . . . 2.02 111.945 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 p -63.22 166.01 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 2.65 111.779 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -89.0 150.4 22.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.226 -0.443 . . . . 2.4 111.408 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.561 HD21 HD22 ' A' ' 119' ' ' LEU . 96.9 mt -101.21 136.42 41.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 2.27 110.305 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.496 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 13.4 m -106.65 132.77 52.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.756 0.312 . . . . 2.84 111.397 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -99.79 133.42 44.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 2.89 110.761 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -127.68 82.74 2.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.702 -0.481 . . . . 3.82 109.702 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.82 -160.9 26.34 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.444 -0.663 . . . . 3.23 111.444 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -99.34 9.51 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.0 0.429 . . . . 4.27 111.122 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -112.99 -173.88 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.816 -0.629 . . . . 3.32 110.297 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -118.25 -73.69 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.367 -0.379 . . . . 2.39 109.981 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' CE1' ' A' ' 131' ' ' PHE . 32.0 tp 178.32 125.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.587 0.554 . . . . 2.06 110.382 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -146.58 121.58 10.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 2.22 110.792 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.447 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 26.2 m-85 -108.45 154.45 41.49 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.631 . . . . 1.78 109.896 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.796 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 58.4 Cg_endo -73.08 -163.16 0.15 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.761 2.307 . . . . 2.15 113.076 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -86.01 125.45 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 2.6 111.678 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 94' ' ' ALA . . . 70.3 18.96 75.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.87 -0.604 . . . . 1.65 113.19 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.796 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.3 tm0? -142.16 132.98 25.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.766 -0.457 . . . . 2.31 109.766 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.04 -9.12 2.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.413 -0.899 . . . . 1.33 112.334 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.06 124.24 65.45 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.215 -0.291 . . . . 1.06 110.215 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.48 179.43 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.482 2.122 . . . . 1.27 112.204 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mt -75.51 88.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 1.7 110.602 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.34 80.18 9.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.119 0.485 . . . . 1.23 110.545 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -21.18 66.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 1.94 111.872 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -89.05 3.7 50.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.418 -0.355 . . . . 1.96 111.679 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 m -128.45 162.27 27.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.734 0.302 . . . . 1.42 111.417 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -83.59 165.71 38.45 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 1.73 109.963 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 19.8 Cg_endo -59.44 -25.8 79.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.539 2.159 . . . . 1.42 111.958 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -89.16 -1.51 58.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 1.78 111.382 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -98.39 -1.38 41.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 1.6 110.243 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -77.49 60.5 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 1.05 111.552 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.71 121.11 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 1.17 109.953 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.1 -145.93 4.81 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.495 -0.86 . . . . 0.6 112.802 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -157.55 164.82 36.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.043 0.449 . . . . 0.99 111.106 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.702 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.9 m-85 -108.31 137.28 46.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.46 -0.791 . . . . 1.26 109.518 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -118.16 130.65 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.384 -0.371 . . . . 2.15 110.981 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -86.8 116.34 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.184 -0.462 . . . . 2.4 110.266 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.78 148.31 44.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.263 -0.426 . . . . 2.21 110.647 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -132.88 109.38 9.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.21 -0.45 . . . . 2.68 110.682 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.604 ' HB3' HD12 ' A' ' 64' ' ' LEU . 20.9 tpt180 -86.37 113.74 22.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 3.59 110.874 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -138.63 91.24 2.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 3.43 110.934 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 61' ' ' MET . 28.9 pt -70.46 146.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 4.26 111.01 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 5.17 110.492 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 76.5 mtm . . . . . 0 C--O 1.234 0.261 0 N-CA-C 110.251 -0.277 . . . . 4.48 110.251 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -67.8 -29.29 68.43 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.847 -0.797 . . . . 4.16 108.847 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t0 52.39 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.02 1.118 . . . . 4.09 114.02 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 52' ' ' ARG . 88.5 mt -106.07 140.25 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.015 -0.539 . . . . 3.36 110.064 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.46 ' O ' ' HD2' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -65.92 150.61 96.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.526 . . . . 3.36 110.896 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.59 120.04 7.66 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.57 2.18 . . . . 2.69 111.438 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -110.75 144.85 39.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.691 -0.686 . . . . 3.03 111.198 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.702 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 65.9 m95 -104.67 124.87 50.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.804 -0.634 . . . . 1.84 110.895 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.41 143.49 35.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.682 . . . . 2.76 109.871 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -95.23 127.28 41.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.816 0.341 . . . . 1.27 110.917 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.31 153.52 47.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.08 -0.509 . . . . 1.84 110.128 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.478 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 86.9 m-85 -84.46 163.14 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.9 tt -59.67 122.89 15.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.695 0.283 . . . . 1.66 111.759 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.6 20.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.003 -0.618 . . . . 1.66 112.634 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.66 70.85 7.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.914 0.388 . . . . 1.58 111.486 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 77' ' ' PRO . . . 150.41 148.36 4.76 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.015 -0.612 . . . . 1.96 111.744 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 76' ' ' GLY . 29.3 Cg_exo -62.0 -47.2 11.06 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.79 2.326 . . . . 2.62 111.867 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.8 45.61 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.58 . . . . 3.09 111.257 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.0 -56.13 4.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 1.79 110.463 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.67 52.98 47.18 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.646 -0.582 . . . . 1.65 111.646 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.565 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 57.9 mt -132.72 100.0 15.06 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 111.579 0.215 . . . . 1.38 111.579 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 74.0 Cg_endo -78.93 162.79 26.29 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.16 1.907 . . . . 1.62 110.257 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.99 104.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 1.58 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.43 10.22 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.591 -0.814 . . . . 1.44 112.233 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -59.13 114.64 2.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.74 0.305 . . . . 1.25 110.891 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -78.9 104.56 9.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 1.86 112.023 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HE3' HD21 ' A' ' 81' ' ' LEU . 26.4 ttmt -126.15 150.88 47.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.692 -0.855 . . . . 1.68 108.692 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -63.44 118.33 7.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.939 0.399 . . . . 1.7 111.975 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.38 57.67 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.703 -0.68 . . . . 1.27 112.502 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.8 118.14 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.723 0.297 . . . . 1.01 110.383 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 47' ' ' TYR . 10.4 pt -121.78 122.74 67.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.389 -0.369 . . . . 1.3 110.222 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.565 ' HZ2' ' HB3' ' A' ' 81' ' ' LEU . 87.7 m95 -86.55 138.24 31.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.014 0.376 . . . . 1.08 112.014 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.61 142.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 1.04 110.612 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' O ' ' HA2' ' A' ' 29' ' ' GLY . . . -152.27 -177.78 6.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 1.27 109.605 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 t -148.74 169.7 19.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.32 -0.252 . . . . 1.36 110.32 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.6 128.16 34.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.385 -0.371 . . . . 2.64 111.076 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.98 -24.3 23.55 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.785 -0.721 . . . . 1.52 111.823 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.827 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.11 133.02 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 1.59 110.487 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 94.2 mt -94.45 133.77 37.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.314 -0.403 . . . . 2.15 110.849 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -75.98 96.57 3.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.07 110.337 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.21 150.03 6.89 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.734 -0.666 . . . . 2.36 109.416 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.54 125.21 18.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.816 2.344 . . . . 2.08 112.534 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 72' ' ' TYR . 67.3 mmtt -113.21 34.64 4.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 1.78 109.744 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.6 -30.58 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.548 0.573 . . . . 2.55 112.548 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -64.28 -8.94 14.51 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.81 0.671 . . . . 2.24 112.81 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 103' ' ' LYS . 1.6 mt -109.11 0.58 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 2.0 109.822 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.05 -11.16 59.05 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.736 -0.745 . . . . 2.33 112.424 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 t -80.63 123.45 28.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.437 . . . . 2.99 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -164.37 146.15 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 2.83 109.806 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -107.42 106.93 59.62 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.84 0.352 . . . . 3.56 110.218 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.47 -21.4 26.13 Favored 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 122.862 2.375 . . . . 3.39 113.928 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.21 -14.04 59.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.104 0.409 . . . . 4.05 112.104 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -117.3 -18.51 9.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.201 -0.454 . . . . 4.48 111.408 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -140.72 131.2 25.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 3.39 111.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.26 163.99 20.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.193 -0.458 . . . . 3.21 110.332 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.74 165.65 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.037 0.446 . . . . 2.85 111.003 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -95.25 152.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.323 -0.621 . . . . 2.42 109.323 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.49 118.44 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.176 -0.305 . . . . 2.74 110.176 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.561 HD22 HD21 ' A' ' 16' ' ' LEU . 5.0 tt -63.13 114.31 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.278 0.561 . . . . 2.11 110.912 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.81 144.13 51.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.591 -0.731 . . . . 2.49 110.324 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 82.3 mt -95.02 148.17 34.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.088 -0.505 . . . . 1.91 110.216 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.23 159.74 45.59 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.576 2.184 . . . . 1.84 112.215 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -53.0 119.7 4.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 2.53 111.521 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.11 4.79 47.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.769 -0.729 . . . . 2.2 112.231 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.9 m -117.73 110.14 17.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.808 0.337 . . . . 2.1 110.227 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.34 137.7 40.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.159 -0.473 . . . . 2.78 111.42 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -70.61 140.92 87.22 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 116.199 -0.455 . . . . 2.62 109.825 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.74 148.97 62.49 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.963 2.442 . . . . 2.77 112.355 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.46 124.87 21.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 4.11 110.718 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.6 -12.55 39.11 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.315 -0.714 . . . . 3.18 111.315 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -105.42 152.09 23.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.816 0.341 . . . . 2.91 111.114 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.496 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 16.9 p90 -151.95 157.47 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 3.54 109.215 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.13 131.1 55.39 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.188 0.305 . . . . 2.93 111.158 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -66.97 125.49 26.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.443 -0.577 . . . . 3.64 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 108.8 -38.59 3.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.997 -0.841 . . . . 3.27 110.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.943 0.402 . . . . 3.59 110.596 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.847 0.356 . . . . 2.48 110.687 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.41 153.77 42.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.944 -0.571 . . . . 2.13 110.971 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.443 ' HD1' ' HE1' ' A' ' 72' ' ' TYR . 76.6 m95 -79.51 -18.82 51.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.053 0.454 . . . . 2.4 111.112 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 119' ' ' LEU . 80.2 m-85 -110.19 161.08 15.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.127 -0.488 . . . . 2.02 112.016 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 p -67.51 167.56 12.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.788 -0.642 . . . . 2.65 111.268 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -79.65 152.82 29.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.096 0.474 . . . . 2.4 111.408 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 76.8 mt -108.65 129.91 55.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 2.27 109.072 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.442 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -103.3 144.67 31.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.422 0.527 . . . . 2.84 112.422 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 5.0 tp-100 -112.21 134.72 53.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 2.89 110.158 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -125.85 69.36 1.19 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.057 -0.52 . . . . 3.82 109.826 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -172.76 -165.74 30.24 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.999 -0.62 . . . . 3.23 111.737 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 65.3 mmtt -88.21 -30.02 20.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.914 0.388 . . . . 4.27 111.544 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.58 166.46 22.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 3.32 110.202 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 4.6 t0 -99.77 -90.05 0.32 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.014 -0.365 . . . . 2.39 110.014 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.475 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 34.2 tp -159.26 134.97 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 2.06 111.018 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -151.51 134.58 15.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.733 -0.667 . . . . 2.22 109.457 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -130.73 134.54 26.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.447 -0.342 . . . . 1.78 110.405 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.46 156.53 55.92 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.985 2.457 . . . . 2.15 111.351 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.86 118.14 5.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.372 -0.377 . . . . 2.6 111.363 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.98 -9.07 57.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 1.65 111.982 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -120.71 152.25 38.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.752 0.31 . . . . 2.31 110.448 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.84 -6.07 22.26 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.698 -0.763 . . . . 1.33 112.77 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 43' ' ' GLN . 38.7 t -90.38 116.52 66.57 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.592 0.234 . . . . 1.06 110.372 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.547 ' HA ' HD23 ' A' ' 121' ' ' LEU . 57.1 Cg_endo -71.23 177.16 6.9 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.633 2.222 . . . . 1.27 112.145 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.62 79.57 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.296 -0.411 . . . . 1.7 110.441 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB2' HE22 ' A' ' 43' ' ' GLN . 46.9 m-80 -76.77 84.71 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 1.23 110.587 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -20.15 65.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 1.94 111.639 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -85.94 -11.92 51.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.199 -0.455 . . . . 1.96 111.553 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.48 ' HB2' HE22 ' A' ' 43' ' ' GLN . 0.7 OUTLIER -118.1 150.23 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.158 0.504 . . . . 1.42 112.03 -178.563 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.88 166.56 44.15 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.576 -0.738 . . . . 1.73 110.218 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.46 -40.06 79.89 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.947 2.431 . . . . 1.42 112.732 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.36 -24.84 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.977 0.418 . . . . 1.78 111.12 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.934 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 46.2 m-20 -84.82 1.53 46.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.802 -0.636 . . . . 1.6 111.829 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.48 HE22 ' HB2' ' A' ' 38' ' ' SER . 42.0 mm-40 -80.27 57.43 2.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.89 0.376 . . . . 1.05 111.222 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 tt -153.02 134.84 5.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 116.175 -0.466 . . . . 1.17 110.394 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.83 -147.24 6.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.386 -0.911 . . . . 0.6 112.718 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 52.5 p90 -151.58 163.44 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.023 0.44 . . . . 0.99 110.698 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.726 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 37.6 m-85 -105.94 137.15 44.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.451 -0.574 . . . . 1.26 109.451 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -116.35 125.77 52.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.503 -0.317 . . . . 2.15 110.929 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -80.85 123.93 28.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.08 -0.509 . . . . 2.4 109.905 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.2 150.67 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.948 0.404 . . . . 2.21 111.841 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -149.86 96.58 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.863 -0.608 . . . . 2.68 110.469 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HB3' HD12 ' A' ' 64' ' ' LEU . 32.1 ttt85 -71.45 119.46 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 3.59 110.439 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 15.9 ttt-85 -135.72 106.31 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.127 -0.488 . . . . 3.43 110.591 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 pt -86.73 159.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.849 -0.614 . . . . 4.26 110.744 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.216 -0.447 . . . . 5.17 110.428 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 109.619 -0.512 . . . . 4.48 109.619 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -66.26 -51.41 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.234 -0.654 . . . . 4.16 109.234 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 20.8 t70 63.93 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.525 0.935 . . . . 4.09 113.525 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' A' ' 52' ' ' ARG . 63.7 mt -114.9 156.99 23.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 3.36 110.562 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.25 153.53 92.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.842 -0.617 . . . . 3.36 110.962 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HA ' HG23 ' A' ' 51' ' ' THR . 19.7 Cg_endo -58.57 112.89 1.33 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.804 2.336 . . . . 2.69 111.625 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 93.8 mtt180 -114.47 125.38 53.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.249 0.547 . . . . 3.03 112.016 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.726 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 41.8 m95 -98.12 131.69 44.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.632 -0.713 . . . . 1.84 109.833 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -110.69 146.34 36.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.375 -0.375 . . . . 2.76 110.382 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.08 114.73 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.874 0.368 . . . . 1.27 110.927 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.41 ' HD2' HG21 ' A' ' 75' ' ' THR . 31.5 m-85 -113.63 143.65 44.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 1.84 110.085 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.443 ' HE1' ' HD1' ' A' ' 12' ' ' TRP . 76.6 m-85 -81.83 154.01 26.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.2 tt -58.53 118.84 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.556 -0.293 . . . . 1.66 110.448 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.71 27.57 5.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.013 -0.613 . . . . 1.66 112.732 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.41 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -92.49 106.29 18.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.47 -0.429 . . . . 1.58 110.726 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.67 119.86 3.01 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.211 -0.756 . . . . 1.96 111.211 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.46 -51.99 8.69 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.797 2.331 . . . . 2.62 112.206 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.1 30.5 4.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 3.09 111.336 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.96 72.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 1.79 110.27 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.89 39.08 95.04 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.784 -0.644 . . . . 1.65 112.394 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.523 HD21 ' HD2' ' A' ' 87' ' ' LYS . 83.2 mt -118.75 93.71 46.64 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.255 . . . . 1.38 111.149 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.699 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 7.5 Cg_exo -75.93 157.17 38.97 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.966 2.444 . . . . 1.62 110.377 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.671 ' HB2' HD11 ' A' ' 73' ' ' LEU . 80.8 t80 -57.32 112.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 1.58 110.708 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.7 -6.62 26.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.603 -0.808 . . . . 1.44 112.42 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.699 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -66.69 145.78 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.872 0.368 . . . . 1.25 110.682 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -98.14 129.21 44.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.327 -0.397 . . . . 1.86 110.63 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.523 ' HD2' HD21 ' A' ' 81' ' ' LEU . 1.9 ttmt -156.05 143.46 19.29 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.003 -0.74 . . . . 1.68 109.003 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.79 122.65 16.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.777 0.322 . . . . 1.7 111.589 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 21.76 70.84 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 1.27 112.575 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 31.7 mm -130.99 111.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.37 . . . . 1.01 110.87 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.5 pt -118.78 143.32 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.262 -0.644 . . . . 1.3 109.262 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.52 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 91.2 m95 -98.59 141.56 31.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.934 0.716 . . . . 1.08 112.934 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.81 138.5 38.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.329 -0.85 . . . . 1.04 110.387 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.61 168.94 20.72 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.378 -0.601 . . . . 1.27 109.378 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -140.74 157.93 44.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.23 -0.285 . . . . 1.36 110.23 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.06 118.69 8.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.394 . . . . 2.64 110.186 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.109 -0.567 . . . . 1.52 111.692 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.703 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -88.46 149.0 23.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.554 0.216 . . . . 1.59 110.54 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 48.9 mt -104.18 140.21 38.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 -0.285 . . . . 2.15 110.85 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -79.2 99.73 7.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 2.07 111.242 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.428 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 0.4 OUTLIER -173.33 147.37 1.43 Allowed Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.642 . . . . 2.36 109.268 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.12 114.32 3.72 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.191 1.927 . . . . 2.08 112.366 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.934 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -114.59 78.96 1.2 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.442 0.639 . . . . 1.78 110.451 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.91 -6.66 48.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.481 -0.781 . . . . 2.55 112.041 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.566 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 4.7 p80 -60.79 -15.99 35.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.378 0.51 . . . . 2.24 112.378 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.02 15.03 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.947 0.403 . . . . 2.0 111.124 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.36 15.91 53.4 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.873 -0.68 . . . . 2.33 111.957 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 t -108.28 103.03 12.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.025 0.441 . . . . 2.99 111.414 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -159.97 111.81 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.576 . . . . 2.83 110.666 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.64 122.14 76.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.783 -0.451 . . . . 3.56 109.783 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.65 -21.04 59.54 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.202 2.601 . . . . 3.39 114.236 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.49 10.88 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.785 0.326 . . . . 4.05 111.578 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -142.06 14.95 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.082 0.468 . . . . 4.48 110.858 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -172.92 135.74 0.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 3.39 110.177 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.47 134.68 39.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.479 -0.328 . . . . 3.21 110.36 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 157.25 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.138 0.494 . . . . 2.85 111.968 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 5.4 mt -94.26 145.57 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.716 -0.675 . . . . 2.42 109.614 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.4 t -61.61 117.17 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.685 0.279 . . . . 2.74 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.442 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . 2.8 tt -61.51 121.08 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.898 -0.592 . . . . 2.11 111.24 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -137.98 150.95 47.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 2.49 110.413 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 33' ' ' PRO . 33.0 mt -103.74 150.3 38.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.242 -0.435 . . . . 1.91 110.071 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.6 150.65 80.75 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.451 2.101 . . . . 1.84 111.288 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -51.67 130.86 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.51 . . . . 2.53 111.378 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.79 -17.47 38.77 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.691 -0.766 . . . . 2.2 111.488 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.03 102.38 12.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 2.1 110.301 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 148.82 29.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.342 -0.39 . . . . 2.78 111.366 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.454 HD23 HD12 ' A' ' 121' ' ' LEU . 70.7 mt -82.43 145.46 51.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.735 -0.469 . . . . 2.62 109.735 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.463 ' HG2' ' CB ' ' A' ' 131' ' ' PHE . 9.9 Cg_endo -54.59 146.32 54.32 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.83 2.353 . . . . 2.77 111.918 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -60.91 112.32 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.84 -0.618 . . . . 4.11 111.93 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.88 -6.99 41.13 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.143 -0.551 . . . . 3.18 112.177 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -101.16 146.31 27.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.486 -0.191 . . . . 2.91 110.486 -179.208 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.442 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 11.6 p90 -155.93 165.13 37.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 3.54 110.093 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.64 136.92 38.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.814 0.34 . . . . 2.93 111.116 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -65.15 126.02 26.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 3.64 110.376 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.93 21.64 65.34 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.106 -0.569 . . . . 3.27 112.415 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.777 0.322 . . . . 3.59 110.168 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.875 0.369 . . . . 2.48 110.747 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.84 38.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 2.13 110.599 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -87.43 -22.76 24.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.996 0.369 . . . . 2.4 111.996 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.71 161.54 19.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 2.02 111.662 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 p -67.14 158.15 31.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 2.65 111.259 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -87.13 145.49 26.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 2.4 110.496 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.57 HD11 HD13 ' A' ' 119' ' ' LEU . 2.8 mp -99.85 152.49 20.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.456 -0.572 . . . . 2.27 109.456 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.622 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 2.0 m -109.09 128.29 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.858 0.361 . . . . 2.84 111.148 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -97.06 135.73 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 2.89 109.954 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -132.98 103.35 6.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.842 0.353 . . . . 3.82 110.375 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.07 -151.31 22.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.774 -0.726 . . . . 3.23 111.629 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 25.7 mmtp -103.18 -19.25 14.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.91 0.386 . . . . 4.27 110.904 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -79.76 137.75 37.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.053 -0.721 . . . . 3.32 109.053 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 1.9 t0 -81.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.046 -0.724 . . . . 2.39 109.046 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 17.1 tp 173.07 122.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 2.06 110.98 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -144.39 123.19 12.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.104 -0.498 . . . . 2.22 109.768 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 29.4 m-85 -111.55 142.14 25.96 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 1.78 110.636 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 21.6 Cg_exo -66.75 164.93 27.4 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.238 2.625 . . . . 2.15 112.278 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -62.64 120.95 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 2.6 110.766 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 94' ' ' ALA . . . 75.63 21.95 76.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.987 -0.625 . . . . 1.65 112.542 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 1.7 tt0 -138.26 156.84 47.29 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.757 -0.261 . . . . 2.31 110.925 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.0 -3.92 48.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.817 -0.706 . . . . 1.33 112.719 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 120.94 79.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.602 0.239 . . . . 1.06 110.452 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.424 ' HD3' ' OH ' ' A' ' 47' ' ' TYR . 58.7 Cg_endo -71.79 174.93 10.36 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.646 2.231 . . . . 1.27 111.577 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mt -81.83 83.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.857 0.36 . . . . 1.7 110.376 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -79.08 91.76 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 1.23 109.908 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -17.76 60.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 1.94 112.092 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -89.51 -18.72 26.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.042 0.386 . . . . 1.96 112.042 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -99.44 160.3 14.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.69 0.281 . . . . 1.42 111.673 -179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.4 m -80.94 168.52 24.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.09 -0.505 . . . . 1.73 110.02 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.19 -39.02 93.59 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.462 2.108 . . . . 1.42 112.09 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.9 p-10 -85.05 -1.53 56.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 1.78 111.105 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 0.4 OUTLIER -98.3 0.12 44.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.805 -0.634 . . . . 1.6 110.212 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -79.43 57.52 2.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 1.05 110.814 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 tt -146.15 130.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 1.17 109.728 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.14 -148.03 5.88 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.297 -0.954 . . . . 0.6 112.404 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -153.84 152.96 31.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.802 0.334 . . . . 0.99 111.806 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.424 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 49.3 m-85 -100.16 117.64 34.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.525 -0.917 . . . . 1.26 108.525 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -96.9 131.09 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.991 0.424 . . . . 2.15 111.802 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -79.63 107.23 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 2.4 109.715 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.37 156.13 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.13 0.49 . . . . 2.21 111.67 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.97 140.6 32.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 2.68 109.94 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -124.97 123.48 39.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.976 0.417 . . . . 3.59 111.615 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -139.8 165.34 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 3.43 109.452 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.73 HG12 ' H ' ' A' ' 62' ' ' LYS . 43.1 pt -133.97 173.61 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.367 -0.235 . . . . 4.26 110.367 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.469 HH21 ' HB3' ' A' ' 61' ' ' MET . 3.7 mmp_? . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 116.525 -0.307 . . . . 5.17 110.766 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.469 ' HB3' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.929 0.395 . . . . 4.48 111.154 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.73 ' H ' HG12 ' A' ' 54' ' ' ILE . 66.6 tttt -72.67 -55.18 7.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.95 -0.759 . . . . 4.16 108.95 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.7 t70 56.78 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.162 -0.927 . . . . 4.09 113.042 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 157.07 16.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 3.36 110.304 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.24 158.24 82.42 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.491 . . . . 3.36 110.554 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 116.18 2.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.774 2.316 . . . . 2.69 111.898 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -117.14 125.97 52.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.746 -0.661 . . . . 3.03 110.692 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -99.77 126.18 45.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.976 -0.557 . . . . 1.84 111.128 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 42.5 m-85 -103.51 139.42 38.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 2.76 109.604 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.97 123.12 33.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.077 0.465 . . . . 1.27 111.564 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.448 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 57.5 m-85 -120.3 177.34 5.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.582 -0.735 . . . . 1.84 109.41 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.81 175.24 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.28 111.702 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.09 94.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.456 0.539 . . . . 1.66 112.456 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.69 45.62 3.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.95 -0.643 . . . . 1.66 114.04 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -78.85 84.65 4.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.173 0.487 . . . . 1.58 111.129 179.095 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.16 136.59 2.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.083 -0.579 . . . . 1.96 111.925 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.26 -35.3 74.78 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 2.62 112.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -129.08 40.36 3.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.3 0.571 . . . . 3.09 110.149 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.89 -60.78 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.727 -0.669 . . . . 1.79 110.069 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.13 51.91 16.07 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.886 -0.673 . . . . 1.65 111.487 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.3 mt -117.0 104.32 50.95 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.796 0.332 . . . . 1.38 111.537 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 91.5 Cg_endo -88.1 151.25 6.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.651 2.234 . . . . 1.62 110.737 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -59.05 111.36 1.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 1.58 110.896 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.83 -3.01 14.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.645 -0.788 . . . . 1.44 112.805 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.454 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -71.73 131.23 42.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 1.25 110.724 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -97.18 114.9 26.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.064 0.459 . . . . 1.86 110.857 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 90' ' ' ILE . 22.3 ttmm -142.0 152.7 43.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.012 -0.736 . . . . 1.68 109.012 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.07 119.6 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 1.7 111.98 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.56 71.17 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.769 -0.651 . . . . 1.27 112.873 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.544 HG13 ' HB3' ' A' ' 87' ' ' LYS . 33.2 mm -125.25 96.09 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.877 0.37 . . . . 1.01 111.572 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.75 137.28 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.492 -0.559 . . . . 1.3 109.492 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -96.58 147.84 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.76 0.652 . . . . 1.08 112.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.27 137.05 33.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.67 -0.696 . . . . 1.04 110.246 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' O ' ' HA2' ' A' ' 29' ' ' GLY . . . -148.36 166.44 28.05 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.655 -0.498 . . . . 1.27 109.655 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 t -139.76 168.4 19.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.745 -0.207 . . . . 1.36 110.689 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.2 124.39 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 2.64 111.254 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.9 -16.5 36.37 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.71 -0.677 . . . . 1.52 112.439 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.783 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -79.97 143.35 34.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.625 0.25 . . . . 1.59 110.656 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.76 148.62 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.417 -0.356 . . . . 2.15 110.526 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -84.54 64.43 8.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.465 0.65 . . . . 2.07 111.193 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.32 143.11 47.49 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.518 -0.765 . . . . 2.36 109.167 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.8 131.19 24.35 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.866 2.377 . . . . 2.08 112.988 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -119.93 44.26 2.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.944 -0.571 . . . . 1.78 110.302 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -13.04 62.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 2.55 112.155 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -21.63 65.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.283 0.475 . . . . 2.24 112.283 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.72 18.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.164 0.507 . . . . 2.0 110.963 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.33 12.19 69.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.862 -0.685 . . . . 2.33 111.659 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -114.44 128.16 56.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.859 0.362 . . . . 2.99 111.494 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -169.25 139.66 2.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.834 -0.621 . . . . 2.83 109.603 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -99.14 120.57 57.95 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.802 0.334 . . . . 3.56 110.648 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.91 -29.5 23.07 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.035 2.49 . . . . 3.39 114.975 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.02 -2.6 57.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.031 -0.418 . . . . 4.05 111.468 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -122.28 0.13 9.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.185 0.517 . . . . 4.48 111.223 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -160.21 142.66 13.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.137 -0.483 . . . . 3.39 109.77 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.33 145.93 24.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.75 0.31 . . . . 3.21 111.215 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.59 138.19 38.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.453 . . . . 2.85 109.778 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.79 141.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.27 -0.423 . . . . 2.42 110.337 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.92 122.37 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.858 -0.423 . . . . 2.74 109.858 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.57 HD13 HD11 ' A' ' 16' ' ' LEU . 2.3 tt -67.61 119.05 11.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.15 0.5 . . . . 2.11 111.436 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -131.01 143.62 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.574 -0.739 . . . . 2.49 110.452 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.3 mt -97.97 149.63 35.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.131 -0.486 . . . . 1.91 110.665 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.08 154.87 48.36 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.669 2.246 . . . . 1.84 111.875 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -58.76 119.2 6.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 2.53 110.515 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 117.81 -26.06 8.16 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.762 -0.732 . . . . 2.2 111.569 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 m -102.95 107.45 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 2.1 110.075 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 155.21 17.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.38 -0.373 . . . . 2.78 111.402 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.6 mt -74.57 142.51 77.71 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.505 -0.554 . . . . 2.62 109.505 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.1 150.01 59.41 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.649 2.233 . . . . 2.77 111.853 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -58.37 116.03 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 4.11 111.337 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 108.57 -20.19 30.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.076 -0.583 . . . . 3.18 111.762 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 16' ' ' LEU . 3.8 t80 -95.61 117.99 31.48 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.487 -0.56 . . . . 2.91 109.487 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.622 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 5.9 p90 -125.49 148.76 48.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.123 0.487 . . . . 3.54 111.535 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.49 142.17 28.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.854 -0.612 . . . . 2.93 110.018 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.85 140.14 33.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.958 0.408 . . . . 3.64 110.557 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.24 -19.57 52.33 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.287 -0.725 . . . . 3.27 111.287 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.734 0.302 . . . . 3.59 111.782 -179.648 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.919 0.39 . . . . 2.48 111.294 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.77 146.39 46.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 2.13 111.005 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.499 ' CE2' ' HD3' ' A' ' 109' ' ' ARG . 24.3 m95 -81.86 -34.93 29.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 2.4 111.234 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.07 164.97 11.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.834 -0.621 . . . . 2.02 111.355 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.903 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -62.8 164.65 7.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.068 -0.514 . . . . 2.65 111.663 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -80.11 149.54 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 2.4 112.144 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 119' ' ' LEU . 95.4 mt -105.41 119.15 38.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.325 -0.991 . . . . 2.27 108.325 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 m -100.32 129.42 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.64 0.607 . . . . 2.84 112.64 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -97.5 115.7 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 2.89 110.056 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -110.83 74.03 0.85 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.088 -0.506 . . . . 3.82 109.956 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.62 -162.24 22.61 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.861 -0.608 . . . . 3.23 111.649 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.56 -18.5 22.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.368 . . . . 4.27 110.82 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.18 170.08 12.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.039 -0.528 . . . . 3.32 111.103 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -101.59 -78.31 0.53 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.091 -0.707 . . . . 2.39 109.091 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -178.15 143.66 0.3 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.08 -0.509 . . . . 2.06 110.854 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -159.3 116.26 2.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.071 -0.513 . . . . 2.22 110.0 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.17 134.83 21.38 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 1.78 110.511 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 55.2 Cg_endo -69.66 150.92 69.47 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.599 2.199 . . . . 2.15 112.267 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.1 121.53 10.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.799 -0.637 . . . . 2.6 110.15 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.46 -25.75 13.1 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.215 -0.754 . . . . 1.65 111.215 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 50.5 mt-30 -113.78 -172.47 2.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.22 -0.289 . . . . 2.31 110.22 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.63 -26.08 21.78 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.882 -0.675 . . . . 1.33 112.163 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.25 119.27 75.96 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.576 0.227 . . . . 1.06 110.615 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.88 177.23 8.19 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.197 . . . . 1.27 111.183 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.453 HG22 HG23 ' A' ' 36' ' ' THR . 44.9 mt -77.16 91.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 1.7 110.201 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -84.42 82.88 8.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 1.23 110.287 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.453 HG23 HG22 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -78.07 41.38 0.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.791 -0.64 . . . . 1.94 112.198 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -150.29 -2.6 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 1.96 111.352 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -130.32 170.34 14.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.497 -0.32 . . . . 1.42 111.503 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.36 165.67 32.2 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.594 -0.276 . . . . 1.73 110.271 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 11.8 Cg_endo -56.43 -33.54 92.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.966 2.444 . . . . 1.42 112.225 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -71.74 -24.09 61.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 1.78 110.547 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.99 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 42.4 m-20 -83.53 -2.98 57.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.808 -0.633 . . . . 1.6 110.802 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 32.3 mm-40 -78.26 56.75 1.75 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.344 0.592 . . . . 1.05 111.354 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.418 HG13 ' HB2' ' A' ' 94' ' ' ALA . 14.4 tt -150.87 130.96 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.499 -0.773 . . . . 1.17 109.103 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.31 -146.45 5.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.113 -1.042 . . . . 0.6 112.979 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.453 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 34.2 p90 -155.41 161.35 41.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.003 0.43 . . . . 0.99 110.764 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.599 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 47.4 m-85 -104.56 134.66 47.36 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.187 -0.672 . . . . 1.26 109.187 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -114.65 122.47 46.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.027 -0.533 . . . . 2.15 110.834 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -87.6 123.42 32.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.33 . . . . 2.4 110.406 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.33 155.99 43.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.21 111.485 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.55 120.67 16.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.647 . . . . 2.68 109.95 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.61 ' HB3' HD12 ' A' ' 64' ' ' LEU . 25.9 tpt180 -96.56 122.18 39.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.101 0.477 . . . . 3.59 112.021 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -138.23 145.32 41.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.681 -0.69 . . . . 3.43 109.907 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.479 HG12 ' H ' ' A' ' 62' ' ' LYS . 33.4 pt -121.72 -178.3 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.207 -0.452 . . . . 4.26 109.986 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 5.17 110.528 179.907 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.88 0.372 . . . . 4.48 110.944 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.608 ' HE3' HD21 ' A' ' 64' ' ' LEU . 50.2 tttp -65.39 -54.37 29.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.556 . . . . 4.16 110.291 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.32 91.14 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.606 -0.724 . . . . 4.09 112.89 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 52' ' ' ARG . 63.6 mt -94.59 150.19 20.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 3.36 109.903 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.434 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m -64.83 161.54 45.26 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.224 -0.444 . . . . 3.36 110.39 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 12.2 Cg_endo -56.77 109.24 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.579 2.186 . . . . 2.69 111.244 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -103.51 123.38 46.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 3.03 111.422 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.599 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 79.9 m95 -96.2 120.64 36.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.976 -0.556 . . . . 1.84 110.056 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 53.9 m-85 -106.7 133.31 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.727 -0.472 . . . . 2.76 109.727 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -85.95 121.19 28.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.802 0.334 . . . . 1.27 111.163 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -118.76 146.27 44.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.024 -0.534 . . . . 1.84 109.808 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -82.67 149.3 27.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.463 -0.335 . . . . 1.28 110.504 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 tp -59.44 113.5 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.474 -0.33 . . . . 1.66 110.652 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 122.38 -13.92 8.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.141 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.471 HG22 ' HA3' ' A' ' 107' ' ' GLY . 9.8 p -59.72 123.66 17.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.711 0.291 . . . . 1.58 110.787 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.471 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 105.1 99.64 2.6 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.789 -0.72 . . . . 1.96 111.573 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 10.9 Cg_endo -54.9 -42.54 67.98 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 123.079 2.519 . . . . 2.62 112.334 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.47 28.13 8.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.034 0.445 . . . . 3.09 111.298 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.2 -43.22 53.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 1.79 110.484 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.33 51.82 56.35 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.923 -0.581 . . . . 1.65 111.973 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.22 95.66 35.8 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.735 0.302 . . . . 1.38 111.428 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 4.0 Cg_exo -76.04 159.61 37.42 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.836 2.357 . . . . 1.62 110.323 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -60.08 107.84 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 1.58 111.026 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.24 -13.91 8.35 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.706 -0.679 . . . . 1.44 112.19 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.626 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -60.02 116.64 4.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.054 0.454 . . . . 1.25 111.13 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -76.24 116.33 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 1.86 110.763 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -137.31 158.17 45.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.546 -0.539 . . . . 1.68 109.546 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.33 121.82 16.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.257 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 30.83 71.25 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.95 -0.568 . . . . 1.27 112.595 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.9 mm -131.74 113.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.621 0.248 . . . . 1.01 110.38 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 91' ' ' ILE . 11.8 pt -121.36 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 1.3 109.71 178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 76.4 m95 -91.72 139.61 30.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.347 0.499 . . . . 1.08 112.347 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.13 142.89 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.721 -0.672 . . . . 1.04 110.368 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -154.62 155.25 34.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.401 . . . . 1.27 110.588 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -121.83 170.11 10.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 1.36 109.73 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.73 114.33 11.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.934 0.397 . . . . 2.64 110.172 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.36 5.83 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.039 -0.824 . . . . 1.52 111.039 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.732 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.52 159.96 28.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 1.59 110.748 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.442 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 94.8 mt -118.49 140.56 49.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 2.15 111.263 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.67 80.58 7.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.399 0.619 . . . . 2.07 110.752 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.533 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.3 t -156.28 146.77 16.05 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.115 -0.698 . . . . 2.36 109.115 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.48 118.18 5.47 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.231 1.954 . . . . 2.08 112.401 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.99 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -118.31 67.42 0.77 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.728 . . . . 1.78 110.682 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.79 -4.24 36.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.897 . . . . 2.55 111.224 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -61.35 -14.19 25.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.005 -0.543 . . . . 2.24 112.392 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.42 HD13 ' HB3' ' A' ' 38' ' ' SER . 2.5 mt -104.7 -26.22 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.804 0.335 . . . . 2.0 110.724 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -61.31 -33.23 83.7 Favored Glycine 0 C--N 1.328 0.138 0 CA-C-N 115.901 -0.59 . . . . 2.33 113.482 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -67.23 113.21 4.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.845 0.355 . . . . 2.99 111.387 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HD3' ' CE2' ' A' ' 12' ' ' TRP . 10.7 ttp85 -162.95 128.83 3.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 2.83 111.1 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -91.59 116.92 67.39 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.722 -0.672 . . . . 3.56 109.882 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.81 -33.31 65.37 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.166 2.578 . . . . 3.39 113.044 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.21 14.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.976 0.417 . . . . 4.05 111.812 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -132.16 9.54 4.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.152 -0.476 . . . . 4.48 111.591 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.424 HD22 ' HA ' ' A' ' 114' ' ' ASN . 1.4 t-20 -168.61 129.75 1.26 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.664 0.269 . . . . 3.39 111.653 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.46 168.19 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 3.21 110.519 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 156.98 16.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 2.85 111.627 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 30.3 mt -101.1 142.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.362 -0.977 . . . . 2.42 108.362 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.06 121.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.793 0.33 . . . . 2.74 110.286 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 16' ' ' LEU . 4.2 tt -58.92 112.2 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.706 . . . . 2.11 110.872 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -111.92 144.1 41.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.807 -0.633 . . . . 2.49 110.211 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 65.7 mt -107.5 143.46 27.28 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.301 -0.409 . . . . 1.91 110.766 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.92 156.67 63.16 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.653 2.235 . . . . 1.84 111.635 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -55.66 121.36 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 2.53 110.432 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.57 -21.0 19.9 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.885 -0.674 . . . . 2.2 111.442 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 6.5 m -99.24 104.17 16.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 2.1 110.116 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.97 140.86 35.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.723 -0.671 . . . . 2.78 110.952 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.692 HD22 ' HD2' ' A' ' 131' ' ' PHE . 21.3 mt -73.99 137.97 76.1 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 2.62 110.058 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.74 155.31 38.25 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.665 2.243 . . . . 2.77 112.055 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -58.22 127.87 34.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.734 -0.666 . . . . 4.11 111.306 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -17.21 59.76 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.091 -0.576 . . . . 3.18 112.652 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.692 ' HD2' HD22 ' A' ' 127' ' ' LEU . 2.6 t80 -94.53 120.22 34.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.562 0.22 . . . . 2.91 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -124.35 155.42 38.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.65 -0.25 . . . . 3.54 111.287 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 136.4 41.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.93 111.754 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.903 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.0 tp10 -61.44 123.58 18.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.592 -0.731 . . . . 3.64 110.742 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.84 66.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.9 -0.667 . . . . 3.27 113.631 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 121.037 0.446 . . . . 3.59 111.7 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 N-CA-C 110.005 -0.368 . . . . 2.48 110.005 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -73.16 155.61 39.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.197 0.522 . . . . 2.13 111.543 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -90.42 -24.24 20.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.609 . . . . 2.4 110.985 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 89.2 m-85 -117.2 167.43 11.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 2.02 110.732 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -64.89 155.45 34.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.892 -0.595 . . . . 2.65 110.79 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 163.92 26.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.286 0.565 . . . . 2.4 111.261 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.849 ' HB3' ' HZ ' ' A' ' 131' ' ' PHE . 60.6 mt -111.3 111.55 22.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.675 -0.693 . . . . 2.27 109.854 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.2 OUTLIER -79.44 119.63 22.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 2.84 111.61 -179.159 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 23' ' ' ASP . 43.4 tp60 -90.49 124.99 35.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 2.89 110.673 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -132.24 91.29 2.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 3.82 110.424 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.13 38.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.298 -0.721 . . . . 3.23 111.298 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 52.6 mmtt -90.96 -7.76 51.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 4.27 111.176 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -114.73 -172.79 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.189 -0.671 . . . . 3.32 109.189 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.572 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -127.34 -149.99 0.43 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.178 -0.675 . . . . 2.39 109.178 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 5.3 mp -95.62 133.38 39.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.751 0.31 . . . . 2.06 110.648 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.18 92.28 1.33 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.174 -0.466 . . . . 2.22 109.858 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -91.67 136.3 26.69 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 1.78 110.995 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -74.16 158.96 44.84 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.658 2.239 . . . . 2.15 111.187 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.5 125.26 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.007 0.432 . . . . 2.6 111.665 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.81 -15.66 52.01 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.637 -0.792 . . . . 1.65 112.62 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -129.98 153.49 48.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.651 0.262 . . . . 2.31 110.379 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.74 1.55 11.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.575 -0.821 . . . . 1.33 112.688 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 43' ' ' GLN . 47.0 t -102.49 115.43 64.43 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.886 0.374 . . . . 1.06 110.852 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.45 178.64 5.93 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.761 2.308 . . . . 1.27 111.439 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.409 HG22 HG23 ' A' ' 36' ' ' THR . 28.8 mt -77.06 92.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.996 0.427 . . . . 1.7 110.456 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.467 ' HB2' HE22 ' A' ' 43' ' ' GLN . 56.0 m-80 -82.73 84.41 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 1.23 110.452 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.409 HG23 HG22 ' A' ' 34' ' ' ILE . 4.4 p -75.4 9.45 2.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.494 0.553 . . . . 1.94 112.494 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -118.08 -5.73 10.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.785 0.291 . . . . 1.96 111.785 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -124.52 168.11 13.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.89 0.376 . . . . 1.42 111.746 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.665 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.6 m -86.87 167.76 20.81 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 115.974 -0.557 . . . . 1.73 109.583 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.54 -36.86 72.39 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.344 2.696 . . . . 1.42 113.293 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.45 -14.76 59.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.057 0.391 . . . . 1.78 112.057 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -88.41 -0.04 56.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.624 0.25 . . . . 1.6 110.351 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.467 HE22 ' HB2' ' A' ' 35' ' ' ASN . 41.0 mm-40 -76.6 51.1 0.72 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.364 -0.38 . . . . 1.05 111.586 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.866 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.7 tt -146.39 130.46 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.17 -0.468 . . . . 1.17 110.233 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.63 -148.84 6.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.462 -0.875 . . . . 0.6 112.457 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -152.51 166.64 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 0.99 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.746 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.9 m-85 -111.72 134.53 53.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.944 -0.571 . . . . 1.26 109.955 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -112.94 133.98 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.195 -0.457 . . . . 2.15 111.211 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 49' ' ' ARG . 12.2 ttt-85 -87.25 121.77 30.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.1 -0.5 . . . . 2.4 109.876 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 156.85 47.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 2.21 111.531 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.409 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -145.21 154.5 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 2.68 110.288 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' HD12 ' A' ' 64' ' ' LEU . 12.8 tpt180 -130.14 118.65 21.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.973 -0.38 . . . . 3.59 109.973 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.88 107.52 5.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.634 -0.257 . . . . 3.43 110.409 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.933 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.8 pt -69.84 158.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 4.26 110.505 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.165 -0.47 . . . . 5.17 110.095 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.9 mmt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 110.106 -0.331 . . . . 4.48 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.933 ' HB2' HG12 ' A' ' 54' ' ' ILE . 43.7 tttt -71.07 -46.59 61.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.557 -0.534 . . . . 4.16 109.557 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 65.95 99.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.974 1.101 . . . . 4.09 113.974 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 52' ' ' ARG . 93.8 mt -126.73 151.1 48.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.484 -0.78 . . . . 3.36 110.024 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.46 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.4 OUTLIER -74.31 153.89 88.12 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.192 -0.458 . . . . 3.36 110.283 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HA ' HG23 ' A' ' 51' ' ' THR . 15.0 Cg_endo -58.14 127.4 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.76 2.307 . . . . 2.69 111.756 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -115.22 124.64 51.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.486 . . . . 3.03 110.613 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.746 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 37.1 m95 -94.26 121.33 35.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 1.84 110.134 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -96.95 146.76 24.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 2.76 110.673 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -94.19 126.92 39.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.899 0.38 . . . . 1.27 110.33 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -126.99 165.77 18.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.955 -0.566 . . . . 1.84 109.867 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -100.62 169.21 9.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.773 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.92 103.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.088 0.773 . . . . 1.66 113.088 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.64 44.74 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.923 -0.58 . . . . 1.66 114.065 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.527 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -74.46 82.93 1.96 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.116 0.484 . . . . 1.58 111.321 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 77' ' ' PRO . . . 159.71 131.18 1.21 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.596 -0.602 . . . . 1.96 111.596 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' ' 76' ' ' GLY . 31.9 Cg_exo -60.23 -37.87 79.98 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.007 2.472 . . . . 2.62 112.322 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.03 31.77 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 3.09 111.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 -53.22 8.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.819 0.342 . . . . 1.79 110.626 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.3 48.49 83.32 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.933 -0.576 . . . . 1.65 112.025 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.1 mt -125.04 103.76 30.11 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.87 0.367 . . . . 1.38 111.592 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.11 162.44 17.9 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.633 2.222 . . . . 1.62 110.933 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -60.88 117.86 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 1.58 111.102 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.08 10.48 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 1.44 112.539 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.83 108.05 2.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 1.25 110.751 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -84.02 137.2 33.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.335 -0.393 . . . . 1.86 110.902 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -147.21 168.43 21.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.459 -0.941 . . . . 1.68 108.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.17 112.23 1.3 Allowed 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.285 0.366 . . . . 1.7 111.783 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.52 39.03 91.09 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.705 -0.68 . . . . 1.27 112.586 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 mm -132.9 102.98 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.825 0.345 . . . . 1.01 110.696 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 47' ' ' TYR . 17.2 pt -113.73 133.86 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.812 -0.44 . . . . 1.3 109.812 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -90.38 140.03 30.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.035 0.445 . . . . 1.08 111.805 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.54 132.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.837 -0.62 . . . . 1.04 110.483 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -150.62 141.71 23.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 1.27 110.471 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 t -112.74 176.61 4.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.523 -0.547 . . . . 1.36 109.523 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -65.04 130.46 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 2.64 110.834 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.52 -15.36 49.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.003 -0.617 . . . . 1.52 112.148 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.866 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -74.56 130.26 39.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.59 110.742 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -103.14 139.51 38.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.136 -0.483 . . . . 2.15 110.873 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -74.15 88.84 1.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.215 0.531 . . . . 2.07 110.5 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.414 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -150.38 153.94 35.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 2.36 109.622 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.414 ' HD2' HG22 ' A' ' 101' ' ' THR . 17.6 Cg_endo -58.65 122.59 11.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.564 2.176 . . . . 2.08 111.468 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.8 mmtt -113.47 29.39 8.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.092 -0.503 . . . . 1.78 111.175 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -13.99 62.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 2.55 111.215 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -65.19 -17.65 64.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.08 -0.509 . . . . 2.24 112.105 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.55 -27.44 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 2.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.527 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -81.21 58.97 4.82 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.925 -0.579 . . . . 2.33 113.225 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 t -138.37 16.31 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 2.99 110.225 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -73.18 137.19 44.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.651 -0.704 . . . . 2.83 110.655 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -95.98 115.67 65.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.426 -0.352 . . . . 3.56 111.124 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.91 -27.97 11.71 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.721 2.281 . . . . 3.39 112.812 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.17 38.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.438 . . . . 4.05 110.847 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -170.1 -45.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 4.48 109.931 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -107.82 139.18 42.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.786 -0.643 . . . . 3.39 110.436 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.34 155.87 22.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.666 0.27 . . . . 3.21 110.876 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.04 162.11 14.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.22 0.533 . . . . 2.85 111.562 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 9.6 mt -98.48 150.55 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.082 -0.71 . . . . 2.42 109.082 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.1 t -69.43 126.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.301 -0.259 . . . . 2.74 110.301 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.476 HD22 HD21 ' A' ' 16' ' ' LEU . 4.4 tt -67.02 110.89 3.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.413 . . . . 2.11 109.911 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -118.11 146.13 44.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.004 -0.544 . . . . 2.49 110.978 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 64.9 mt -99.63 151.34 37.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.893 -0.594 . . . . 1.91 110.169 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.12 163.18 32.5 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.412 2.075 . . . . 1.84 112.48 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -60.69 115.33 3.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 2.53 110.783 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.49 -2.7 23.49 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.636 -0.792 . . . . 2.2 112.094 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 4.0 m -117.02 114.83 24.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 2.1 110.449 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.04 151.77 24.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.442 -0.345 . . . . 2.78 111.099 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.07 148.16 84.07 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.542 -0.54 . . . . 2.62 109.542 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.06 168.47 10.66 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.468 2.112 . . . . 2.77 112.059 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.38 130.93 45.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.076 -0.511 . . . . 4.11 111.891 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.32 65.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.103 -0.57 . . . . 3.18 112.347 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.849 ' HZ ' ' HB3' ' A' ' 16' ' ' LEU . 22.0 t80 -126.82 144.76 50.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.905 0.383 . . . . 2.91 111.384 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -146.65 157.87 43.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.932 -0.576 . . . . 3.54 109.801 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.07 134.12 45.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.012 -0.366 . . . . 2.93 110.012 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.51 150.25 47.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.846 0.355 . . . . 3.64 111.172 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.62 -91.7 0.49 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.873 -0.679 . . . . 3.27 111.779 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 120.64 0.257 . . . . 3.59 110.787 -179.703 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 0 N-CA-C 109.996 -0.372 . . . . 2.48 109.996 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.2 m -64.89 155.56 33.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.188 0.44 . . . . 2.13 112.188 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -84.53 -25.67 28.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.767 -0.652 . . . . 2.4 111.248 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 81.0 m-85 -114.31 164.95 13.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.969 -0.56 . . . . 2.02 110.751 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 10.4 p -70.99 158.42 36.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.101 -0.5 . . . . 2.65 110.256 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 177.09 9.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.489 . . . . 2.4 110.768 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.67 129.25 48.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.411 -0.589 . . . . 2.27 109.411 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -90.54 115.87 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 2.84 111.268 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -83.13 143.97 30.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 2.89 110.685 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -140.36 79.93 1.73 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 3.82 110.164 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -170.47 41.36 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.728 -0.748 . . . . 3.23 111.975 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 61.8 mmtt -88.09 -10.51 49.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 4.27 110.868 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.38 166.3 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 3.32 109.974 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -104.6 -82.28 0.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.77 -0.456 . . . . 2.39 109.77 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.3 tp -177.82 135.28 0.17 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.329 0.393 . . . . 2.06 110.803 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -162.84 124.09 2.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 2.22 109.576 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.3 138.9 23.9 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.578 -0.283 . . . . 1.78 110.709 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.23 175.25 6.96 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.074 2.516 . . . . 2.15 112.563 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.69 126.3 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 2.6 112.03 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.85 78.2 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.93 -0.652 . . . . 1.65 112.712 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.21 171.86 12.8 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.362 -0.236 . . . . 2.31 110.362 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.25 -8.14 69.49 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.661 -0.781 . . . . 1.33 112.783 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.15 114.73 63.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.673 0.273 . . . . 1.06 110.733 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.11 178.38 7.0 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.425 2.083 . . . . 1.27 111.472 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.449 HG22 HG23 ' A' ' 36' ' ' THR . 11.8 mt -77.38 81.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.868 0.366 . . . . 1.7 110.608 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 56.0 m-80 -81.73 81.55 7.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.23 109.942 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.449 HG23 HG22 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -76.07 3.98 9.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.1 -0.5 . . . . 1.94 112.156 -179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.9 -1.38 26.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 1.96 111.368 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.46 164.85 21.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.892 0.377 . . . . 1.42 111.59 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.432 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -80.88 168.08 27.73 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.013 -0.539 . . . . 1.73 110.275 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 10.3 Cg_endo -54.85 -39.27 90.89 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.932 2.421 . . . . 1.42 113.039 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 2.4 p-10 -73.16 -23.77 60.48 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.719 0.295 . . . . 1.78 110.772 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.977 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 34.4 m-20 -79.04 -2.12 38.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.6 111.256 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.462 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 39.9 mm-40 -81.86 55.71 2.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.245 0.545 . . . . 1.05 111.142 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.68 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.4 tt -152.14 131.96 3.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.17 109.961 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.79 -137.9 2.53 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.305 -0.95 . . . . 0.6 112.683 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -160.42 166.96 28.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.403 . . . . 0.99 110.645 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.631 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 3.0 m-85 -105.96 134.3 49.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.082 -0.71 . . . . 1.26 109.082 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -115.18 123.38 48.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.247 -0.433 . . . . 2.15 111.031 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -79.69 111.08 15.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 2.4 110.048 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.22 165.02 11.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 2.21 111.037 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -154.3 125.51 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 2.68 110.177 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HB3' HD12 ' A' ' 64' ' ' LEU . 17.4 tpt180 -115.37 120.62 40.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 3.59 110.656 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -132.03 162.88 29.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 3.43 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.58 HG12 ' HB2' ' A' ' 62' ' ' LYS . 38.1 pt -125.38 162.76 27.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 4.26 109.912 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.885 0.374 . . . . 5.17 110.631 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 mtm . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 120.743 0.306 . . . . 4.48 110.811 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.631 ' HE3' HD21 ' A' ' 64' ' ' LEU . 52.5 tttp -87.65 -40.19 14.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.19 -0.459 . . . . 4.16 110.451 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t70 40.96 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.247 1.202 . . . . 4.09 114.247 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.631 HD21 ' HE3' ' A' ' 62' ' ' LYS . 90.9 mt -95.78 157.32 15.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 3.36 110.365 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.507 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.7 OUTLIER -69.72 153.06 95.92 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.73 -0.47 . . . . 3.36 109.73 179.145 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 113.85 1.49 Allowed 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.741 2.294 . . . . 2.69 112.057 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.413 HH21 HD13 ' A' ' 64' ' ' LEU . 48.1 mtt-85 -105.72 122.41 46.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 3.03 110.686 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.631 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 67.3 m95 -99.44 115.48 29.39 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.223 -0.444 . . . . 1.84 110.435 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -97.27 142.98 28.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.118 -0.492 . . . . 2.76 109.719 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.89 130.24 35.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 1.27 111.016 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -125.58 154.69 41.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.082 -0.508 . . . . 1.84 109.706 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.02 151.85 20.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.335 -0.393 . . . . 1.28 109.952 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.4 tt -60.38 112.23 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.262 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.49 -5.46 11.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.465 -0.874 . . . . 1.66 113.115 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 p -61.3 108.76 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 1.58 111.646 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 119.86 3.84 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.697 -0.763 . . . . 1.96 112.108 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.2 -37.33 51.95 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.662 2.242 . . . . 2.62 111.954 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -123.33 47.37 2.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.017 0.437 . . . . 3.09 111.013 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.43 -41.86 46.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.449 -0.574 . . . . 1.79 109.449 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 33.58 83.27 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.617 -0.719 . . . . 1.65 112.693 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.583 HD11 ' HD2' ' A' ' 87' ' ' LYS . 82.1 mt -131.05 99.12 18.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.778 0.323 . . . . 1.38 111.467 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.64 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 87.3 Cg_endo -82.87 170.38 12.57 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.488 2.125 . . . . 1.62 110.203 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.695 ' HB2' HD11 ' A' ' 73' ' ' LEU . 69.0 t80 -57.82 111.09 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.783 0.325 . . . . 1.58 110.886 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.06 -17.31 10.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.807 -0.711 . . . . 1.44 112.386 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.04 108.22 1.76 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 1.25 110.954 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -77.61 129.02 35.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.55 . . . . 1.86 110.936 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.583 ' HD2' HD11 ' A' ' 81' ' ' LEU . 75.0 tttt -143.14 162.64 35.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.458 -0.941 . . . . 1.68 108.458 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.81 110.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.881 0.372 . . . . 1.7 111.487 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 28.25 53.8 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.879 -0.677 . . . . 1.27 112.477 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.472 HG13 ' HB3' ' A' ' 87' ' ' LYS . 35.7 mm -128.68 105.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.972 0.415 . . . . 1.01 110.339 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 47' ' ' TYR . 16.0 pt -117.7 127.0 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.198 -0.455 . . . . 1.3 110.135 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.527 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 80.3 m95 -87.25 138.25 31.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.141 0.423 . . . . 1.08 112.141 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.7 138.22 48.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.532 -0.758 . . . . 1.04 110.409 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.99 172.32 13.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.308 -0.406 . . . . 1.27 110.116 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 t -152.73 -176.37 5.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.403 -0.362 . . . . 1.36 110.791 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -65.71 134.82 54.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 2.64 111.118 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.4 -12.1 70.3 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.97 -0.633 . . . . 1.52 112.778 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.07 146.15 30.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.795 0.331 . . . . 1.59 110.727 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.55 149.14 43.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.165 -0.471 . . . . 2.15 110.704 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -82.15 82.75 7.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.259 0.552 . . . . 2.07 110.151 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.588 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 53.0 m -154.5 127.84 4.31 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.274 -0.876 . . . . 2.36 108.705 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.7 129.97 37.48 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.814 2.342 . . . . 2.08 112.783 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.977 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.12 67.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.707 0.765 . . . . 1.78 110.74 179.25 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.19 -7.94 51.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.291 -0.868 . . . . 2.55 111.7 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.405 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.0 p80 -60.14 -22.0 62.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.172 0.434 . . . . 2.24 112.172 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.2 mt -87.82 -35.64 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 2.0 110.563 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.83 66.42 3.75 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.931 -0.577 . . . . 2.33 112.436 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 t -148.35 16.68 1.04 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.533 0.682 . . . . 2.99 110.582 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -74.7 138.92 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.715 . . . . 2.83 110.855 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -85.68 123.16 72.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 3.56 110.605 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.62 -12.29 16.77 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.002 2.468 . . . . 3.39 114.293 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -111.3 9.67 21.65 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.995 -0.441 . . . . 4.05 111.544 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -136.85 12.16 3.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.215 -0.448 . . . . 4.48 111.226 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -169.38 142.12 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 3.39 111.033 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.37 141.73 28.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.388 -0.369 . . . . 3.21 110.624 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.49 146.89 38.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.323 -0.399 . . . . 2.85 110.755 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.419 ' H ' HG13 ' A' ' 117' ' ' ILE . 3.5 mt -77.17 147.58 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.645 -0.707 . . . . 2.42 109.988 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.75 120.19 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.055 -0.35 . . . . 2.74 110.055 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.31 121.67 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 2.11 111.536 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -132.11 142.56 49.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.702 -0.681 . . . . 2.49 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.561 HD13 HG22 ' A' ' 125' ' ' THR . 72.5 mt -94.16 148.39 35.06 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.184 -0.462 . . . . 1.91 110.296 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.21 167.25 16.78 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.894 2.396 . . . . 1.84 112.266 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -60.72 127.07 29.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 2.53 110.661 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.89 -19.66 46.15 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.548 -0.621 . . . . 2.2 111.548 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.561 HG22 HD13 ' A' ' 121' ' ' LEU . 6.4 m -102.42 109.21 20.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.748 0.308 . . . . 2.1 110.396 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 160.35 14.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.444 -0.344 . . . . 2.78 110.735 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -79.91 146.78 64.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.418 -0.355 . . . . 2.62 110.415 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 18.2 Cg_endo -62.87 160.49 33.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.33 2.02 . . . . 2.77 111.778 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.6 113.63 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.578 -0.737 . . . . 4.11 112.142 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.11 0.2 61.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.144 -0.55 . . . . 3.18 113.611 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.486 ' HB2' ' HG2' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -101.15 129.99 47.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.828 0.314 . . . . 2.91 110.895 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -135.52 146.48 48.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 3.54 110.518 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.13 144.93 25.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 2.93 111.691 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 5.9 tt0 -67.81 128.45 36.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.946 -0.57 . . . . 3.64 110.175 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.23 -1.98 74.19 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 3.27 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 120.936 0.398 . . . . 3.59 111.181 179.99 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.768 0.318 . . . . 2.48 110.719 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -55.64 139.42 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.671 -0.695 . . . . 2.13 112.195 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -73.26 -25.36 60.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 2.4 112.06 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.9 m-85 -109.92 172.97 6.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.496 0.554 . . . . 2.02 112.496 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 p -74.45 -172.94 1.6 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.244 -0.889 . . . . 2.65 111.032 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -95.65 136.81 35.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.838 0.681 . . . . 2.4 112.838 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.598 HD13 ' HE2' ' A' ' 131' ' ' PHE . 17.6 mt -96.55 102.86 14.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.095 -1.076 . . . . 2.27 108.095 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.603 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -85.75 129.27 34.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.362 0.504 . . . . 2.84 112.362 -178.19 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.468 ' HB2' ' HE1' ' A' ' 131' ' ' PHE . 6.1 tp-100 -97.2 127.83 43.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 2.89 109.706 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.782 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 1.1 t60 -114.74 1.64 14.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.656 0.243 . . . . 3.82 111.656 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.39 -168.65 32.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.901 -0.666 . . . . 3.23 111.869 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -85.71 -33.41 21.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.864 0.364 . . . . 4.27 110.828 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.12 172.39 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 3.32 110.115 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.422 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -101.05 -76.01 0.57 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.952 -0.299 . . . . 2.39 110.64 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 26' ' ' PHE . 23.6 tp -177.5 129.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.457 0.473 . . . . 2.06 111.16 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -156.34 119.23 4.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.291 -0.413 . . . . 2.22 110.212 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 62.2 m-85 -110.3 151.09 42.41 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.147 -0.478 . . . . 1.78 110.562 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.65 164.34 34.81 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.92 2.413 . . . . 2.15 111.538 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -70.44 124.02 23.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 2.6 110.616 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.69 -10.49 52.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.793 -0.718 . . . . 1.65 111.578 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -122.35 -176.82 3.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.62 -0.511 . . . . 2.31 109.62 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.55 -31.63 8.12 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 1.33 112.542 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.95 120.14 78.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 110.336 -0.246 . . . . 1.06 110.336 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.74 -175.43 2.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.787 2.325 . . . . 1.27 112.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.1 mt -78.51 87.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 1.7 110.109 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 63.7 m-80 -82.38 73.04 9.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.325 -0.398 . . . . 1.23 110.557 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.1 68.52 1.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.036 -0.529 . . . . 1.94 111.047 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -176.7 -27.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.913 -0.585 . . . . 1.96 110.906 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 157.99 16.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.149 0.426 . . . . 1.42 112.149 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.06 164.14 61.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.767 -0.652 . . . . 1.73 111.105 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.11 -40.38 77.46 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.555 . . . . 1.42 113.389 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.53 -16.61 61.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.781 -0.367 . . . . 1.78 111.404 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.86 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 16.1 m-20 -87.42 -0.77 57.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.857 -0.611 . . . . 1.6 110.75 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.531 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 54.0 mm-40 -79.29 58.17 2.5 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.242 0.544 . . . . 1.05 110.714 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.538 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.4 tt -149.19 133.24 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.546 -0.752 . . . . 1.17 109.598 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.3 -144.5 5.38 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.342 -0.932 . . . . 0.6 112.633 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.65 162.1 41.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.871 0.367 . . . . 0.99 110.581 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.561 ' HB2' HG13 ' A' ' 91' ' ' ILE . 27.9 m-85 -102.22 123.97 46.98 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.838 -0.801 . . . . 1.26 108.838 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -101.72 133.61 46.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.009 -0.541 . . . . 2.15 111.231 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -82.17 129.26 34.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 2.4 110.099 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 130.17 43.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.099 0.476 . . . . 2.21 111.501 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 111.82 12.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 2.68 109.773 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.637 ' HB3' HD12 ' A' ' 64' ' ' LEU . 12.1 tpt180 -91.68 111.02 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.293 0.568 . . . . 3.59 111.367 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -133.27 103.38 5.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 3.43 110.62 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.629 HG12 ' HB2' ' A' ' 62' ' ' LYS . 44.2 pt -84.8 146.87 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 4.26 110.357 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.799 0.333 . . . . 5.17 110.487 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 38.1 mtt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.794 -0.447 . . . . 4.48 109.794 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.629 ' HB2' HG12 ' A' ' 54' ' ' ILE . 48.8 tttp -58.19 -52.15 66.76 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.729 -0.214 . . . . 4.16 111.134 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t0 56.84 89.28 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.811 0.695 . . . . 4.09 112.51 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.637 HD12 ' HB3' ' A' ' 52' ' ' ARG . 66.1 mt -101.08 170.15 8.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.112 0.482 . . . . 3.36 111.47 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.26 156.57 66.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 3.36 109.578 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.93 117.79 4.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 2.69 111.865 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 67' ' ' ARG . 15.0 mtt-85 -114.28 133.91 55.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.815 -0.63 . . . . 3.03 110.104 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.422 ' HZ2' ' HB3' ' A' ' 23' ' ' ASP . 80.7 m95 -109.49 136.44 48.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 1.84 111.149 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 55.6 m-85 -123.54 138.3 54.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.444 -0.576 . . . . 2.76 109.444 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -86.9 131.62 34.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.854 0.359 . . . . 1.27 111.611 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.23 144.9 51.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.942 -0.572 . . . . 1.84 110.115 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -77.69 151.81 34.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.247 -0.433 . . . . 1.28 110.083 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 6.1 tt -64.39 120.28 11.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.582 -0.281 . . . . 1.66 110.669 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 112.38 -1.36 26.54 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.697 -0.763 . . . . 1.66 112.495 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 p -65.9 117.15 7.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.777 0.322 . . . . 1.58 110.866 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.22 112.38 3.21 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.946 -0.645 . . . . 1.96 111.731 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.42 -41.42 78.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.993 2.462 . . . . 2.62 111.908 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -110.52 39.74 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 3.09 111.034 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.01 -56.15 4.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.398 . . . . 1.79 110.677 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.67 45.88 95.38 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.1 -0.571 . . . . 1.65 112.184 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.74 108.03 17.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.655 0.264 . . . . 1.38 111.514 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 96.1 Cg_endo -86.92 173.77 5.8 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.811 2.34 . . . . 1.62 111.042 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.422 ' HB2' HD11 ' A' ' 73' ' ' LEU . 54.9 t80 -64.17 113.42 3.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.998 0.427 . . . . 1.58 110.737 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.02 -0.37 25.57 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.773 -0.727 . . . . 1.44 112.51 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.01 113.33 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 1.25 110.981 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -77.1 103.25 6.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 1.86 111.329 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -132.22 165.6 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.219 -0.446 . . . . 1.68 110.542 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.36 111.19 2.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.652 0.612 . . . . 1.7 112.652 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.21 41.77 85.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.735 -0.666 . . . . 1.27 112.948 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -131.27 104.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 1.01 110.799 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.561 HG13 ' HB2' ' A' ' 47' ' ' TYR . 5.2 pt -110.12 123.59 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 1.3 109.875 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 80.5 m95 -89.76 135.88 33.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 1.08 112.082 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -137.24 145.63 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.032 -0.531 . . . . 1.04 110.612 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.29 149.69 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.491 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 169.29 8.63 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.07 -0.345 . . . . 1.36 110.07 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -70.11 111.34 5.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.799 -0.445 . . . . 2.64 109.799 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.49 -13.9 8.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 1.52 111.576 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.89 146.64 43.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.828 0.347 . . . . 1.59 110.547 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.1 mt -108.73 142.71 38.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.298 -0.41 . . . . 2.15 111.5 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -80.35 90.35 5.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 2.07 110.574 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.428 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 5.2 t -162.76 146.12 8.72 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.113 -0.699 . . . . 2.36 109.113 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.79 121.38 7.85 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.941 1.761 . . . . 2.08 111.246 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.83 76.9 1.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 1.78 112.343 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 2.7 p-10 -85.56 5.91 29.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.34 -0.391 . . . . 2.55 111.394 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.9 p80 -57.84 -23.11 51.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.773 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.17 9.2 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.003 -0.544 . . . . 2.0 110.256 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.53 -35.65 13.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.652 -0.785 . . . . 2.33 111.973 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 t -68.65 125.59 27.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 2.99 110.863 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -162.59 125.72 2.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 2.83 109.873 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -86.42 116.39 65.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 123.276 0.36 . . . . 3.56 110.673 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.73 -32.51 46.82 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.879 2.386 . . . . 3.39 112.958 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.35 0.26 49.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.84 0.311 . . . . 4.05 111.84 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -128.39 -4.76 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.963 0.411 . . . . 4.48 111.167 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -149.88 128.25 12.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.766 0.317 . . . . 3.39 110.944 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.29 155.42 30.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.019 -0.537 . . . . 3.21 110.756 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.3 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 2.85 111.435 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 18.6 mt -101.5 146.54 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.711 -0.677 . . . . 2.42 109.621 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.23 120.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.61 0.243 . . . . 2.74 110.407 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.57 114.43 3.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.008 -0.542 . . . . 2.11 111.082 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -136.84 152.96 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 2.49 110.61 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.51 HD13 HG22 ' A' ' 125' ' ' THR . 72.3 mt -100.94 147.7 34.05 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 1.91 110.114 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.56 160.86 30.27 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.756 2.304 . . . . 1.84 112.782 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.53 120.36 9.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.794 -0.639 . . . . 2.53 110.478 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.82 14.84 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.098 -1.201 . . . . 2.2 110.098 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.51 HG22 HD13 ' A' ' 121' ' ' LEU . 6.3 m -112.61 114.79 27.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 2.1 108.845 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 156.78 18.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.33 -0.396 . . . . 2.78 111.55 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.19 76.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 2.62 109.698 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 28.4 Cg_endo -65.64 156.99 60.96 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.44 2.094 . . . . 2.77 111.448 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.46 120.95 14.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 4.11 111.644 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.17 -2.1 47.32 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.419 -0.672 . . . . 3.18 111.419 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.598 ' HE2' HD13 ' A' ' 16' ' ' LEU . 1.6 t80 -110.3 129.38 55.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.29 . . . . 2.91 110.613 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.782 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 26.3 p90 -141.12 162.85 34.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 3.54 110.064 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -119.05 148.01 43.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.721 0.296 . . . . 2.93 111.029 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.0 131.05 43.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.591 -0.522 . . . . 3.64 109.591 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.78 -26.6 23.78 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 3.27 112.191 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.324 -0.521 0 O-C-N 122.593 -0.357 . . . . 3.59 110.701 179.847 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.647 0.261 . . . . 2.48 110.814 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.06 166.39 12.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.484 -0.326 . . . . 2.13 110.895 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.85 -38.64 7.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.313 0.577 . . . . 2.4 110.2 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.4 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 86.1 m-85 -108.58 165.67 11.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.649 -0.705 . . . . 2.02 110.402 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.939 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 8.3 p -58.86 151.76 20.84 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.397 0.436 . . . . 2.65 111.366 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HB3' ' HD3' ' A' ' 67' ' ' ARG . . . -75.98 137.31 40.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 2.4 112.015 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 55.4 mt -88.89 147.75 24.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.94 -0.763 . . . . 2.27 108.94 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.658 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -126.36 138.75 53.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.828 -0.349 . . . . 2.84 111.388 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -99.71 132.32 45.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 2.89 110.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.61 62.66 1.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.247 -0.649 . . . . 3.82 109.247 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.46 -159.68 9.58 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.686 -0.688 . . . . 3.23 111.907 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -91.05 -25.08 19.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.161 0.43 . . . . 4.27 112.161 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -90.6 176.02 6.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.671 0.272 . . . . 3.32 110.58 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.84 -71.38 0.68 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 2.39 109.961 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.9 tp 177.85 142.3 0.09 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.842 -0.617 . . . . 2.06 110.534 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -156.31 133.82 10.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.385 -0.37 . . . . 2.22 110.029 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 43.1 m-85 -127.61 134.32 26.05 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.956 -0.387 . . . . 1.78 109.956 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 22.3 Cg_exo -65.51 167.44 16.97 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.895 2.396 . . . . 2.15 112.411 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.54 127.06 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 2.6 110.518 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.09 6.88 78.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.826 -0.702 . . . . 1.65 112.466 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -138.75 147.27 42.45 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.232 -0.285 . . . . 2.31 110.232 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.63 -28.25 5.28 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.683 -0.77 . . . . 1.33 112.908 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.01 119.21 75.83 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.663 0.232 . . . . 1.06 110.725 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.478 ' HG2' HD21 ' A' ' 35' ' ' ASN . 41.8 Cg_endo -67.94 168.71 18.07 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.556 2.17 . . . . 1.27 111.851 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 mt -74.62 81.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 1.7 111.604 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.478 HD21 ' HG2' ' A' ' 33' ' ' PRO . 40.5 m-80 -83.97 86.61 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 1.23 110.118 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -21.66 65.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.94 111.597 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -75.85 -18.55 59.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 1.96 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -111.24 151.05 28.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.511 -0.313 . . . . 1.42 110.798 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.588 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 6.1 m -73.76 165.47 52.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 1.73 109.921 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.3 Cg_endo -52.77 -39.54 76.87 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.955 2.437 . . . . 1.42 113.342 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.682 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -76.51 -9.91 59.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.954 0.353 . . . . 1.78 111.954 -179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.65 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.6 m-20 -95.09 1.58 54.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.049 0.452 . . . . 1.6 109.946 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -83.9 61.64 6.52 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.058 -0.519 . . . . 1.05 111.108 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.761 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.2 tt -146.93 130.54 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.755 -0.657 . . . . 1.17 109.908 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.77 -141.32 3.51 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.237 -0.982 . . . . 0.6 113.111 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -163.69 170.18 17.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 0.99 110.345 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.466 ' HB2' HG13 ' A' ' 91' ' ' ILE . 42.9 m-85 -109.94 130.31 55.55 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.507 -0.553 . . . . 1.26 109.507 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -103.41 132.38 49.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.895 0.379 . . . . 2.15 111.657 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -85.54 119.53 25.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.744 . . . . 2.4 110.216 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -134.64 157.03 47.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 2.21 111.185 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 64' ' ' LEU . 93.9 m -154.06 104.6 2.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.793 -0.639 . . . . 2.68 109.764 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.482 ' HB3' HD12 ' A' ' 64' ' ' LEU . 10.1 tpt180 -83.32 113.15 20.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.912 0.387 . . . . 3.59 111.459 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 5.6 mtp180 -121.72 87.47 2.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 3.43 109.438 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 61' ' ' MET . 38.5 pt -79.38 148.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 4.26 111.134 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 5.17 110.084 179.892 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 35.6 mtt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 110.01 -0.367 . . . . 4.48 110.01 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -60.95 -36.6 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.422 -0.584 . . . . 4.16 109.422 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 29.3 t0 50.28 77.93 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.766 -1.106 . . . . 4.09 112.824 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 52' ' ' ARG . 89.3 mt -80.37 146.03 31.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.397 -0.594 . . . . 3.36 109.397 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 45.1 m -69.12 158.15 87.34 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.278 -0.268 . . . . 3.36 110.278 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 9.7 Cg_endo -51.61 103.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.922 2.415 . . . . 2.69 112.644 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.501 HH22 ' CD ' ' A' ' 134' ' ' GLU . 3.4 mtt180 -101.42 138.8 37.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.836 -0.62 . . . . 3.03 110.296 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.8 124.55 49.75 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.728 -0.669 . . . . 1.84 110.72 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 32.6 m-85 -109.42 127.32 54.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.683 -0.689 . . . . 2.76 109.525 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -78.07 126.47 30.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.905 0.383 . . . . 1.27 111.26 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.54 149.32 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.895 -0.78 . . . . 1.84 108.895 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -81.72 157.49 24.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.326 -0.25 . . . . 1.28 110.326 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.6 tp -58.45 115.34 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.524 -0.307 . . . . 1.66 111.045 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.57 52.19 4.03 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.606 -0.807 . . . . 1.66 111.852 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.94 78.55 5.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.921 0.391 . . . . 1.58 111.419 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.46 139.32 2.75 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.846 -0.692 . . . . 1.96 112.178 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.84 -26.27 32.3 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.587 2.191 . . . . 2.62 112.162 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.2 35.92 4.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 3.09 110.645 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.18 -55.59 5.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.999 -0.546 . . . . 1.79 110.95 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.13 36.57 92.05 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 1.65 112.019 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.67 103.55 53.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.026 0.441 . . . . 1.38 111.658 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.755 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 85.8 Cg_endo -84.8 165.46 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.388 2.059 . . . . 1.62 110.546 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -64.47 105.99 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.861 0.362 . . . . 1.58 110.274 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.13 -11.87 7.67 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.8 -0.714 . . . . 1.44 112.376 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -54.78 117.12 3.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.806 0.336 . . . . 1.25 111.389 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -76.48 99.76 5.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.539 . . . . 1.86 111.405 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -129.65 148.72 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 1.68 110.128 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.62 119.34 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.193 0.442 . . . . 1.7 112.193 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.02 53.31 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.848 -0.614 . . . . 1.27 112.624 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -129.54 111.09 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.88 0.371 . . . . 1.01 110.875 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 47' ' ' TYR . 5.8 pt -115.91 118.71 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 1.3 110.08 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.72 136.95 35.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.634 0.605 . . . . 1.08 112.634 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 m -137.93 145.13 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.682 -0.69 . . . . 1.04 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.78 -177.58 6.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.274 -0.421 . . . . 1.27 109.972 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -153.64 172.8 16.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.629 -0.259 . . . . 1.36 110.581 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.62 115.91 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.275 0.559 . . . . 2.64 111.23 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.52 -19.63 16.47 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.82 -0.705 . . . . 1.52 112.001 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.761 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.85 126.98 31.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.382 -0.229 . . . . 1.59 110.382 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.682 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 66.9 mt -96.54 156.05 16.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.894 0.378 . . . . 2.15 111.295 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -84.4 83.82 7.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.145 0.498 . . . . 2.07 110.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.5 m -153.17 133.98 8.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.854 -0.612 . . . . 2.36 109.463 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.18 125.84 18.62 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.171 2.581 . . . . 2.08 112.086 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.65 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.3 mmtt -105.45 39.23 1.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.649 -0.705 . . . . 1.78 111.244 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -13.65 59.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.493 . . . . 2.55 111.551 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -70.38 -17.59 63.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.472 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.1 mt -96.02 -33.88 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.329 . . . . 2.0 110.768 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.58 57.22 4.17 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.914 -0.585 . . . . 2.33 112.389 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.7 t -134.1 20.23 3.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.421 0.629 . . . . 2.99 109.582 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 13.0 ttp180 -83.21 136.5 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.737 -0.665 . . . . 2.83 111.702 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.443 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 4.1 m-20 -96.84 114.6 64.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 3.56 110.095 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 26.6 Cg_endo -61.47 -28.3 83.42 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.912 2.408 . . . . 3.39 113.182 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 -10.84 59.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 4.05 111.364 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -116.31 -21.53 9.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.477 -0.328 . . . . 4.48 111.709 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.5 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 2.7 t-20 -137.14 120.0 16.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.689 0.28 . . . . 3.39 110.61 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 155.54 39.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.055 -0.52 . . . . 3.21 111.625 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.44 154.19 24.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 2.85 111.204 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 18.6 mt -102.74 150.34 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.777 -0.453 . . . . 2.42 109.777 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.7 120.19 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.586 0.231 . . . . 2.74 110.415 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.54 119.39 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 2.11 110.517 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -122.88 160.53 25.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.293 -0.412 . . . . 2.49 110.699 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.627 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 87.3 mt -110.08 150.4 41.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 1.91 111.297 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -65.05 170.88 9.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.986 2.457 . . . . 1.84 112.27 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.08 113.36 3.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 2.53 111.254 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.51 -14.0 30.2 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.993 -0.622 . . . . 2.2 112.723 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 4.7 m -88.47 140.95 28.94 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.707 -0.29 . . . . 2.1 110.393 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.39 144.82 50.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.818 0.342 . . . . 2.78 111.793 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.47 ' HG ' HD11 ' A' ' 121' ' ' LEU . 21.9 mt -87.28 144.38 35.91 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.08 -0.509 . . . . 2.62 109.738 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.34 156.18 26.89 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.913 2.408 . . . . 2.77 112.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -62.01 122.4 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.743 -0.662 . . . . 4.11 111.122 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.02 -8.53 61.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.917 -0.658 . . . . 3.18 111.873 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 3.7 t80 -97.1 144.16 27.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.916 -0.402 . . . . 2.91 109.916 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.658 ' CE1' ' HB ' ' A' ' 17' ' ' THR . 3.9 p90 -147.88 171.73 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 3.54 110.478 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -121.82 147.33 46.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 2.93 111.059 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.939 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.2 tp10 -68.47 122.5 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 3.64 110.67 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.86 66.65 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.013 -0.613 . . . . 3.27 112.98 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 3.59 111.779 -179.639 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.927 0.394 . . . . 2.48 111.906 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.52 164.91 26.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 2.13 111.016 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -90.65 -25.47 20.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 2.4 111.864 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 59.6 m-85 -115.75 171.61 7.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.27 0.47 . . . . 2.02 112.27 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -70.83 167.15 19.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 2.65 111.048 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -91.75 161.58 14.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.487 . . . . 2.4 111.058 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.98 127.24 56.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.505 -0.77 . . . . 2.27 109.758 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 65' ' ' SER . 80.7 m -90.93 126.86 36.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.301 -0.409 . . . . 2.84 111.058 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -97.08 134.01 40.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 2.89 110.199 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -130.82 90.26 2.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 3.82 109.308 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.36 -151.25 8.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.566 -0.826 . . . . 3.23 112.828 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 71.2 mmtt -108.6 -2.21 18.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.801 0.334 . . . . 4.27 111.789 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -120.07 176.76 5.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.257 -0.275 . . . . 3.32 110.257 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.49 -87.62 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.283 -0.417 . . . . 2.39 110.76 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 131' ' ' PHE . 55.4 tp -172.36 127.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.84 0.353 . . . . 2.06 110.869 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -148.93 105.11 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 2.22 109.949 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -89.24 146.97 37.26 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.074 -0.512 . . . . 1.78 110.541 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 57.6 Cg_endo -72.0 163.34 39.12 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.569 2.18 . . . . 2.15 111.857 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -58.11 122.54 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.884 -0.598 . . . . 2.6 111.016 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.11 -12.32 66.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.612 -0.804 . . . . 1.65 113.172 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.502 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 37.0 tt0 -118.06 157.73 26.29 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.632 -0.334 . . . . 2.31 110.969 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 126.16 -26.16 5.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.57 -0.612 . . . . 1.33 111.57 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.43 119.65 77.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.343 -0.243 . . . . 1.06 110.343 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.15 -170.44 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.488 2.125 . . . . 1.27 110.797 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.94 90.84 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.121 0.486 . . . . 1.7 110.816 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 70.2 m-20 -93.98 73.36 4.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.417 -0.586 . . . . 1.23 109.417 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -20.73 66.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.362 -0.835 . . . . 1.94 111.927 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -82.45 -3.48 55.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.33 -0.396 . . . . 1.96 111.84 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -126.69 159.58 33.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.921 0.391 . . . . 1.42 111.815 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.624 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 m -82.67 167.24 31.19 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.634 -0.712 . . . . 1.73 110.139 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.624 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 13.7 Cg_endo -55.88 -35.67 94.34 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.939 2.426 . . . . 1.42 112.878 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.667 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 p-10 -78.73 -11.22 59.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.267 -0.424 . . . . 1.78 111.605 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -97.46 -1.9 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 1.6 109.895 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 75.6 mm-40 -78.52 53.88 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 1.05 111.119 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.58 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 13.5 tt -144.09 125.57 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.794 -0.639 . . . . 1.17 109.856 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.44 -145.23 4.38 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.142 -1.028 . . . . 0.6 112.522 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.454 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 48.8 p90 -160.02 170.75 20.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.121 -0.326 . . . . 0.99 110.121 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.676 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 39.0 m-85 -112.51 136.95 51.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.503 -0.554 . . . . 1.26 109.503 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -115.27 132.07 56.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.569 0.224 . . . . 2.15 110.534 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -82.03 124.99 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.076 -0.511 . . . . 2.4 109.672 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -133.61 156.2 48.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 2.21 111.206 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 m -158.53 134.65 9.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 2.68 109.935 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 52' ' ' ARG . 4.1 tpt180 -107.07 122.17 45.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 3.59 110.461 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 4.3 ttt180 -138.96 82.38 1.9 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.716 0.293 . . . . 3.43 111.532 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.825 HG12 ' HB2' ' A' ' 62' ' ' LYS . 26.3 pt -72.13 154.73 7.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.448 -0.342 . . . . 4.26 110.539 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 5.17 110.091 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.873 -0.417 . . . . 4.48 109.873 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.825 ' HB2' HG12 ' A' ' 54' ' ' ILE . 39.6 tptt -55.44 -49.73 71.67 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.521 0.513 . . . . 4.16 110.421 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 15.0 t70 59.02 91.17 0.05 OUTLIER 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.561 -0.745 . . . . 4.09 112.691 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.78 148.63 36.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.735 -0.666 . . . . 3.36 110.161 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.562 ' HB2' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -70.32 146.44 94.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.16 -0.473 . . . . 3.36 110.557 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.5 118.45 5.33 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.858 2.372 . . . . 2.69 111.559 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -119.09 146.36 45.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 3.03 111.31 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.676 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.7 m95 -112.8 131.3 55.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.721 -0.672 . . . . 1.84 110.227 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 58.6 m-85 -109.66 145.29 36.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.101 -0.499 . . . . 2.76 109.685 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -94.63 127.64 40.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 1.27 111.257 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -130.4 162.49 29.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.977 -0.556 . . . . 1.84 109.673 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -93.52 168.39 11.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.582 -0.281 . . . . 1.28 110.418 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.58 126.94 29.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.524 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.67 47.1 92.49 Favored Glycine 0 CA--C 1.516 0.105 0 N-CA-C 115.274 0.869 . . . . 1.66 115.274 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -74.92 101.97 4.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.246 0.523 . . . . 1.58 110.023 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.82 136.97 5.1 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.828 -0.701 . . . . 1.96 111.431 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.79 -28.4 68.02 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.678 2.252 . . . . 2.62 112.496 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.9 53.01 1.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 3.09 110.743 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.08 -46.97 5.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.879 -0.6 . . . . 1.79 110.515 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.64 24.84 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.882 -0.887 . . . . 1.65 110.882 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.779 ' HB3' ' HH2' ' A' ' 92' ' ' TRP . 65.2 mt -125.93 94.93 40.73 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 1.38 111.968 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -91.33 135.93 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 1.62 110.812 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -52.57 115.16 1.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.251 -0.431 . . . . 1.58 111.568 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.38 8.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.658 . . . . 1.44 112.778 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.83 163.49 21.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.993 0.425 . . . . 1.25 111.026 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.64 131.21 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.442 -0.345 . . . . 1.86 110.936 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -148.53 155.83 41.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.52 . . . . 1.68 110.109 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.35 117.57 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.257 -0.429 . . . . 1.7 111.919 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.6 34.62 67.34 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.75 -0.659 . . . . 1.27 112.635 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.3 mm -134.44 114.95 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.748 0.308 . . . . 1.01 110.687 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 91' ' ' ILE . 8.5 pt -123.03 134.78 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.878 -0.416 . . . . 1.3 109.878 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.779 ' HH2' ' HB3' ' A' ' 81' ' ' LEU . 56.5 m95 -90.28 144.82 25.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.586 0.587 . . . . 1.08 112.586 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.466 HG11 ' HA3' ' A' ' 31' ' ' GLY . 11.0 m -142.07 134.6 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.521 -0.763 . . . . 1.04 109.993 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.62 147.46 26.78 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.818 0.342 . . . . 1.27 111.229 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 43' ' ' GLN . 2.8 t -106.42 166.83 10.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.984 -0.553 . . . . 1.36 109.892 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.05 117.87 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.048 0.452 . . . . 2.64 110.319 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.7 -4.71 22.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.901 -0.666 . . . . 1.52 111.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.667 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -80.27 144.98 32.41 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.439 -0.208 . . . . 1.59 110.439 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 62.0 mt -90.38 139.61 30.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.728 0.299 . . . . 2.15 110.867 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -84.06 79.21 9.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.247 0.546 . . . . 2.07 110.111 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.44 154.22 13.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.788 -0.642 . . . . 2.36 110.034 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.67 129.02 27.63 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.678 2.252 . . . . 2.08 112.292 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -116.53 45.63 1.77 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.797 -0.638 . . . . 1.78 110.508 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -13.74 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.691 -0.686 . . . . 2.55 112.282 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -61.62 -12.97 18.25 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.375 0.509 . . . . 2.24 112.375 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.8 mt -104.0 -32.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 2.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.57 -9.0 42.29 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.845 -0.616 . . . . 2.33 114.558 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.0 t -79.72 63.0 4.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.332 0.586 . . . . 2.99 111.215 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.402 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 47.0 ttp85 -118.33 139.71 50.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 2.83 110.926 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -99.98 115.26 65.7 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.981 -0.554 . . . . 3.56 110.317 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.02 -24.47 39.17 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.979 2.453 . . . . 3.39 113.332 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.09 1.48 56.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 4.05 111.366 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -119.04 -48.61 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 4.48 110.158 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 12.9 t-20 -106.93 137.13 45.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 3.39 110.52 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.44 139.5 45.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.103 -0.332 . . . . 3.21 110.103 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.8 158.1 28.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.057 0.456 . . . . 2.85 111.183 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 25.8 mt -104.99 141.92 19.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.974 -0.557 . . . . 2.42 109.796 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.62 127.08 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.883 -0.414 . . . . 2.74 109.883 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -66.7 116.73 7.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.485 . . . . 2.11 110.019 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.58 149.37 43.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.189 -0.46 . . . . 2.49 110.865 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.36 146.79 33.12 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.522 . . . . 1.91 109.957 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.64 157.18 62.18 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.603 2.202 . . . . 1.84 111.823 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.02 118.36 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 2.53 110.935 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.41 -15.18 17.85 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.744 -0.741 . . . . 2.2 111.349 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.2 m -104.99 119.42 38.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.965 0.412 . . . . 2.1 110.55 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.94 152.49 25.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.084 -0.507 . . . . 2.78 110.498 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.22 140.69 34.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.593 -0.276 . . . . 2.62 110.369 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.36 147.24 96.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.39 2.06 . . . . 2.77 110.902 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -51.3 123.15 9.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 4.11 112.042 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.24 4.74 56.31 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.059 -0.591 . . . . 3.18 112.586 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -123.1 130.95 53.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.792 0.329 . . . . 2.91 111.182 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -153.45 149.56 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.085 -0.507 . . . . 3.54 110.248 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.4 146.32 27.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 2.93 110.886 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -70.59 150.31 46.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 3.64 110.891 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.14 64.97 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.756 -0.735 . . . . 3.27 112.255 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 120.614 0.245 . . . . 3.59 110.769 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.336 0 N-CA-C 109.49 -0.559 . . . . 2.48 109.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -53.23 146.17 12.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.348 0.87 . . . . 2.13 113.348 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -73.12 -35.0 66.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.793 -0.64 . . . . 2.4 110.759 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -108.36 170.92 7.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.822 -0.626 . . . . 2.02 111.245 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.866 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 11.2 p -69.15 168.48 13.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.646 -0.706 . . . . 2.65 111.142 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -92.99 159.76 15.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 2.4 110.989 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 35.9 mt -100.17 112.7 25.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.258 -0.428 . . . . 2.27 110.267 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 m -82.82 113.33 20.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.237 -0.438 . . . . 2.84 111.632 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.37 146.58 26.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 2.89 111.331 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -141.18 89.26 2.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.927 -0.579 . . . . 3.82 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.63 -168.33 41.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.893 -0.67 . . . . 3.23 112.22 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 48.5 mmtt -81.93 -31.59 31.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.763 0.316 . . . . 4.27 111.267 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.61 -174.14 5.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.262 -0.426 . . . . 3.32 109.922 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.54 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -112.53 -88.12 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.608 -0.516 . . . . 2.39 109.608 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.405 HD13 ' CE1' ' A' ' 131' ' ' PHE . 52.5 tp -168.94 126.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 2.06 110.465 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -146.79 134.39 20.99 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.89 -0.411 . . . . 2.22 109.89 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.78 150.84 46.46 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 1.78 110.029 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.667 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 56.3 Cg_endo -73.06 -173.51 1.27 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.568 2.179 . . . . 2.15 112.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -79.97 126.39 30.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.234 -0.439 . . . . 2.6 110.891 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.9 -7.44 80.18 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 1.65 113.111 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.667 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 21.4 tt0 -122.55 154.28 38.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.184 -0.302 . . . . 2.31 110.184 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.3 -21.34 7.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.435 -0.888 . . . . 1.33 112.585 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 43' ' ' GLN . 43.1 t -80.06 119.53 76.89 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.661 0.267 . . . . 1.06 110.562 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.9 -176.59 2.68 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.947 2.431 . . . . 1.27 111.738 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.94 87.92 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.359 -0.382 . . . . 1.7 110.303 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.433 ' HB2' HE22 ' A' ' 43' ' ' GLN . 63.6 m-80 -85.83 83.14 7.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 1.23 110.197 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.68 1.21 3.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.567 -0.742 . . . . 1.94 112.879 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -107.57 -6.39 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.28 . . . . 1.96 111.212 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.31 150.35 47.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.09 -0.244 . . . . 1.42 110.957 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -71.95 162.49 73.11 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.814 -0.439 . . . . 1.73 109.814 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -34.9 78.19 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 1.42 112.24 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -18.86 61.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.903 -0.59 . . . . 1.78 111.432 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.14 0.99 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 1.6 111.092 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.61 ' HB3' HG11 ' A' ' 32' ' ' VAL . 69.0 mm-40 -79.15 59.98 2.89 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.09 0.471 . . . . 1.05 110.957 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.621 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -146.66 130.68 10.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.919 -0.582 . . . . 1.17 110.252 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.72 -141.36 3.62 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.522 -0.847 . . . . 0.6 112.807 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -160.56 159.47 30.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 0.99 110.374 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.564 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 49.0 m-85 -100.09 133.14 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.621 -0.881 . . . . 1.26 108.621 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -117.86 122.41 43.28 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.229 0.331 . . . . 2.15 111.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.52 129.93 35.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.281 -0.418 . . . . 2.4 110.035 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.27 140.0 27.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.727 0.299 . . . . 2.21 110.814 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 133.81 38.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 2.68 111.074 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.693 ' HB3' HD12 ' A' ' 64' ' ' LEU . 28.0 tpt180 -101.87 129.27 48.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.006 -0.738 . . . . 3.59 109.006 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttt180 -138.86 78.05 1.65 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.668 -0.242 . . . . 3.43 110.851 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 153.3 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.965 -0.294 . . . . 4.26 110.592 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 5.17 110.489 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.555 0.217 . . . . 4.48 110.836 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -62.16 -47.31 85.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 4.16 110.988 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.615 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 25.0 t70 61.24 90.3 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.895 -0.593 . . . . 4.09 112.291 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 52' ' ' ARG . 15.4 mt -87.13 157.94 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.317 -0.401 . . . . 3.36 110.384 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -77.83 149.42 77.29 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.08 -0.509 . . . . 3.36 109.919 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.41 110.5 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.917 2.412 . . . . 2.69 111.648 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.533 HH21 ' CD ' ' A' ' 134' ' ' GLU . 5.5 mtp180 -121.42 138.81 54.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 3.03 111.51 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.564 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 29.2 m95 -104.33 123.92 48.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.872 -0.604 . . . . 1.84 110.434 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.99 131.8 45.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.551 -0.537 . . . . 2.76 109.551 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -79.83 127.35 32.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.842 0.353 . . . . 1.27 111.099 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -124.84 148.25 48.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.988 -0.551 . . . . 1.84 109.587 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -84.87 159.27 20.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.939 -0.393 . . . . 1.28 109.939 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.685 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 1.9 tt -61.65 118.09 6.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.286 -0.265 . . . . 1.66 110.286 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.82 32.78 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 1.66 112.618 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.3 68.62 8.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 1.58 111.058 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.45 118.6 0.51 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.482 -1.047 . . . . 1.96 110.482 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.66 -43.68 44.54 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.101 2.534 . . . . 2.62 112.379 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.18 53.29 0.83 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.167 0.508 . . . . 3.09 111.153 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.19 -58.7 2.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.028 0.442 . . . . 1.79 109.808 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.72 65.02 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.65 112.706 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt -134.03 102.18 12.26 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.603 0.239 . . . . 1.38 110.509 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.05 176.61 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.933 2.422 . . . . 1.62 111.772 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.522 ' HB2' HD11 ' A' ' 73' ' ' LEU . 13.0 t80 -57.87 116.44 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 1.58 110.646 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.9 -17.51 9.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.685 -0.769 . . . . 1.44 111.987 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.16 110.35 3.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.408 . . . . 1.25 110.462 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -76.89 124.27 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 1.86 110.856 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB3' HG13 ' A' ' 90' ' ' ILE . 29.5 tttt -143.19 154.46 43.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.432 -0.581 . . . . 1.68 109.432 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.09 119.54 8.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.411 -0.358 . . . . 1.7 111.546 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.55 29.99 67.16 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.932 -0.577 . . . . 1.27 112.58 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.541 HG13 ' HB3' ' A' ' 87' ' ' LYS . 39.8 mm -127.77 111.82 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 1.01 110.933 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.525 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 26.7 pt -117.96 120.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.3 110.507 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.685 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 94.9 m95 -79.94 135.36 36.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.125 -0.488 . . . . 1.08 112.108 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.22 137.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.623 -0.717 . . . . 1.04 111.005 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.43 152.18 39.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.994 -0.548 . . . . 1.27 109.879 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.0 t -114.77 170.79 8.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.956 0.407 . . . . 1.36 110.694 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -67.27 113.23 5.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.081 -0.509 . . . . 2.64 110.67 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.39 -11.67 21.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.857 -0.687 . . . . 1.52 111.826 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -86.18 120.03 27.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.779 0.323 . . . . 1.59 110.512 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.77 142.72 27.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 2.15 111.397 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -71.5 96.66 1.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.894 -0.594 . . . . 2.07 110.237 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 72.7 m -156.19 138.62 10.35 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.561 -0.745 . . . . 2.36 109.176 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 21.8 Cg_exo -67.13 107.33 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.383 2.056 . . . . 2.08 111.244 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -95.66 75.42 3.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.314 -0.403 . . . . 1.78 110.149 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -15.89 61.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.548 -0.296 . . . . 2.55 111.321 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -60.19 -25.02 65.25 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.196 -0.456 . . . . 2.24 111.958 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.87 2.15 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.46 0.648 . . . . 2.0 110.246 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.33 51.63 1.84 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.004 -0.617 . . . . 2.33 111.579 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t -160.93 125.88 3.67 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.99 -0.374 . . . . 2.99 109.99 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 40.7 ttp85 -166.1 134.66 3.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.871 -0.418 . . . . 2.83 109.871 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -83.33 112.0 35.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 3.56 110.169 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.02 -30.61 90.03 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.065 2.51 . . . . 3.39 113.864 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.91 -5.15 57.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.78 0.324 . . . . 4.05 111.797 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -116.42 1.27 12.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.495 -0.32 . . . . 4.48 111.664 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 27.6 t-20 -154.39 133.64 12.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.673 0.273 . . . . 3.39 110.54 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.38 141.68 28.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.42 . . . . 3.21 110.209 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.59 140.77 49.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.992 0.425 . . . . 2.85 111.147 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 mt -92.21 150.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 2.42 109.885 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -62.54 120.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 2.74 110.683 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.52 124.27 22.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.736 -0.666 . . . . 2.11 110.333 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.66 151.83 48.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.17 -0.468 . . . . 2.49 110.704 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.496 HD13 HG22 ' A' ' 125' ' ' THR . 26.4 mt -98.58 137.48 20.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.049 -0.523 . . . . 1.91 109.921 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.72 152.53 41.34 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.123 2.549 . . . . 1.84 112.939 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -52.3 123.62 11.23 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.476 -0.784 . . . . 2.53 110.915 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 109.08 -14.65 33.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.809 -0.71 . . . . 2.2 111.45 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 HD13 ' A' ' 121' ' ' LEU . 15.1 m -111.81 123.64 50.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.915 -0.402 . . . . 2.1 109.915 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 150.03 32.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.883 0.373 . . . . 2.78 111.246 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.54 143.15 58.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.588 . . . . 2.62 109.858 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.58 138.78 87.78 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.675 2.25 . . . . 2.77 111.13 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -55.21 118.38 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 4.11 111.263 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.15 -20.11 12.97 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.54 -0.624 . . . . 3.18 111.54 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.749 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -89.28 147.53 24.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.638 0.256 . . . . 2.91 110.794 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.12 145.87 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.141 -0.482 . . . . 3.54 110.931 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.48 152.03 23.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.924 -0.58 . . . . 2.93 111.317 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.866 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.1 tp10 -73.3 128.11 34.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 3.64 110.446 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.82 80.02 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.027 -0.606 . . . . 3.27 112.323 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 3.59 111.489 -179.453 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.952 0.406 . . . . 2.48 111.342 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.6 m -73.5 151.25 41.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 2.13 110.491 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -87.0 -13.72 43.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.424 . . . . 2.4 112.061 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.491 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 85.8 m-85 -119.41 163.35 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.856 0.317 . . . . 2.02 111.856 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 118' ' ' VAL . 10.7 p -71.03 168.36 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 2.65 111.034 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.65 156.75 27.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.266 0.555 . . . . 2.4 112.129 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -112.39 122.32 47.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.55 -0.75 . . . . 2.27 109.23 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.43 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -92.95 128.62 38.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.883 0.373 . . . . 2.84 111.951 -178.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -105.26 128.89 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 2.89 110.25 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -119.7 89.36 3.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 3.82 110.504 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.53 -167.66 40.75 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.884 -0.886 . . . . 3.23 110.884 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -86.38 -34.87 20.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.146 0.473 . . . . 4.27 111.334 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -68.64 151.63 46.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.387 . . . . 3.32 110.105 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 -85.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.136 -0.32 . . . . 2.39 110.136 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 131' ' ' PHE . 34.4 tp -168.6 130.27 1.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.482 -0.326 . . . . 2.06 110.392 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -153.02 132.06 12.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 2.22 109.485 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.47 ' HD1' ' HD2' ' A' ' 27' ' ' PRO . 5.1 m-85 -125.55 138.2 31.39 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.581 -0.281 . . . . 1.78 110.69 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD2' ' HD1' ' A' ' 26' ' ' PHE . 38.1 Cg_endo -67.27 163.92 32.49 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.738 2.292 . . . . 2.15 112.235 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 28' ' ' ARG . 20.5 ttt180 -60.99 117.43 5.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.356 -0.838 . . . . 2.6 111.023 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.32 0.2 56.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.788 . . . . 1.65 112.618 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -127.88 162.37 26.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.78 0.324 . . . . 2.31 110.139 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.73 5.75 44.48 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.869 -0.682 . . . . 1.33 111.821 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 95' ' ' THR . 40.4 t -100.03 114.81 65.84 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.931 -0.396 . . . . 1.06 109.931 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.1 -175.58 2.73 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.043 2.495 . . . . 1.27 111.73 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -83.1 85.33 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.146 0.498 . . . . 1.7 110.66 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.491 ' HA ' ' HZ ' ' A' ' 13' ' ' PHE . 44.8 m-80 -80.74 93.81 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.861 -0.609 . . . . 1.23 110.916 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.3 p -85.57 3.69 39.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 1.94 111.473 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -107.9 -4.12 18.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 1.96 111.075 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.75 152.12 51.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.899 0.38 . . . . 1.42 111.874 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.4 m -78.75 168.69 25.11 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 1.73 110.111 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.512 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 77.3 Cg_exo -53.2 -37.49 80.27 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.835 2.357 . . . . 1.42 112.904 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -72.37 -8.76 56.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 1.78 111.469 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.795 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 12.2 m-20 -104.41 4.35 33.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 1.6 110.508 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 36.8 mm-40 -79.26 58.55 2.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.993 0.425 . . . . 1.05 111.822 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -152.03 128.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 1.17 110.263 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.83 -157.51 10.09 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.31 -0.948 . . . . 0.6 112.971 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -149.72 147.92 28.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.918 0.389 . . . . 0.99 111.296 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.689 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 11.0 m-85 -90.38 137.0 32.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 1.26 109.552 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 48' ' ' ARG . 33.2 ttt-85 -114.13 130.29 56.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.453 -0.34 . . . . 2.15 111.259 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -71.29 125.17 26.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.002 -0.74 . . . . 2.4 109.002 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.31 127.55 55.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.035 0.445 . . . . 2.21 112.066 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.11 140.34 51.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.905 -0.776 . . . . 2.68 108.905 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.645 ' HB3' HD12 ' A' ' 64' ' ' LEU . 14.9 tpt180 -150.19 111.1 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.618 0.599 . . . . 3.59 112.618 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.574 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 94.0 mtt180 -135.72 107.06 6.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.797 -0.638 . . . . 3.43 110.223 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.744 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.0 pt -68.4 171.04 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 4.26 110.842 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 55' ' ' ARG . 30.2 ttt180 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.839 0.352 . . . . 5.17 110.85 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 109.996 -0.372 . . . . 4.48 109.996 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.744 ' HB2' HG12 ' A' ' 54' ' ' ILE . 68.9 tttt -75.7 -38.56 58.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 4.16 110.382 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 26.5 t70 52.4 81.45 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.547 -0.752 . . . . 4.09 112.429 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 52' ' ' ARG . 24.3 mt -81.7 151.51 27.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.222 -0.445 . . . . 3.36 110.439 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -67.85 148.14 98.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.902 -0.59 . . . . 3.36 110.011 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.39 108.12 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.849 2.366 . . . . 2.69 111.768 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.624 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 3.6 ptp180 -119.27 144.17 46.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 3.03 111.261 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.689 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 34.4 m95 -115.08 139.01 50.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.014 -0.539 . . . . 1.84 110.238 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -113.84 140.89 47.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 2.76 110.312 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.97 126.5 35.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 1.27 111.276 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -123.0 151.2 42.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 1.84 109.381 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.88 148.9 21.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.943 -0.392 . . . . 1.28 109.943 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.19 123.05 16.02 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.147 0.279 . . . . 1.66 110.563 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -9.16 19.01 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.631 -0.795 . . . . 1.66 112.22 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.413 HG22 ' HA3' ' A' ' 107' ' ' GLY . 1.2 p -65.24 131.7 47.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.607 0.242 . . . . 1.58 110.359 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 94.15 106.96 1.95 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.573 -0.822 . . . . 1.96 111.333 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 10.8 Cg_endo -55.85 -44.43 47.59 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.654 2.236 . . . . 2.62 112.282 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.71 28.85 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.148 -0.478 . . . . 3.09 111.636 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.2 -61.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.821 0.343 . . . . 1.79 110.695 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.05 48.83 10.49 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.042 -0.823 . . . . 1.65 111.042 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.8 91.22 48.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 1.38 111.659 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.34 162.74 13.05 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.467 2.111 . . . . 1.62 110.929 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.17 104.88 0.35 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.123 0.487 . . . . 1.58 111.246 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.39 -26.97 3.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.665 -0.698 . . . . 1.44 112.006 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.79 123.5 19.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 1.25 110.872 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -95.76 136.11 36.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.227 -0.442 . . . . 1.86 111.602 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -143.22 155.17 44.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.873 -0.788 . . . . 1.68 108.873 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.74 115.28 6.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.184 0.516 . . . . 1.7 111.694 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.16 22.01 46.84 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.825 -0.625 . . . . 1.27 112.533 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 48' ' ' ARG . 7.7 mm -136.7 133.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.163 -0.31 . . . . 1.01 110.163 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.4 pt -130.81 163.2 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.806 -0.442 . . . . 1.3 109.806 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -112.78 138.68 49.25 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.481 0.548 . . . . 1.08 112.481 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.62 133.29 32.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 1.04 110.233 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.74 132.97 14.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.354 -0.385 . . . . 1.27 110.214 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 32' ' ' VAL . 3.4 t -102.47 170.57 7.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.818 0.342 . . . . 1.36 110.89 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -69.48 126.53 30.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.082 -0.508 . . . . 2.64 110.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.46 -11.61 25.96 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.307 -0.717 . . . . 1.52 111.307 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -89.75 149.22 22.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.647 -0.277 . . . . 1.59 110.539 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.61 141.71 41.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.352 -0.385 . . . . 2.15 110.951 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -80.27 97.78 7.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 2.07 110.555 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.57 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 5.0 t -170.29 145.54 2.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.044 -0.724 . . . . 2.36 109.044 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.34 128.7 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.542 2.161 . . . . 2.08 112.783 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.02 73.68 1.49 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 1.78 111.075 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.24 1.15 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.328 -0.396 . . . . 2.55 111.895 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.456 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.0 p80 -60.11 -16.61 33.6 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.077 0.399 . . . . 2.24 112.077 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.4 pt -121.95 27.36 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.104 0.478 . . . . 2.0 109.975 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.413 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -102.92 -24.68 7.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.731 -0.747 . . . . 2.33 113.807 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -96.35 131.23 43.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.217 0.532 . . . . 2.99 111.504 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.3 ttp85 -159.53 133.48 7.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.258 -0.428 . . . . 2.83 110.28 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -77.26 113.27 29.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 110.072 -0.344 . . . . 3.56 110.072 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -85.17 -12.06 7.11 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 3.39 112.897 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.06 -9.71 47.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 4.05 110.694 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -133.15 18.64 4.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.73 -0.668 . . . . 4.48 110.641 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -169.35 132.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 3.39 111.128 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.58 159.09 15.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.214 -0.448 . . . . 3.21 110.419 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.09 150.57 23.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.799 0.333 . . . . 2.85 111.351 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 27.3 mt -78.11 143.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 2.42 109.735 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.4 ' HA ' ' OG1' ' A' ' 14' ' ' THR . 96.8 t -61.48 120.16 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.088 -0.245 . . . . 2.74 110.552 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.85 118.72 8.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.081 0.467 . . . . 2.11 110.603 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.12 148.76 52.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 2.49 110.489 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.657 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 66.1 mt -98.59 147.34 33.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.318 -0.401 . . . . 1.91 110.247 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.63 166.16 10.34 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.833 2.356 . . . . 1.84 112.435 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -61.85 118.47 7.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.057 -0.52 . . . . 2.53 110.815 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.13 -24.98 14.87 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.403 -0.679 . . . . 2.2 111.403 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 m -88.46 103.75 16.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.926 0.393 . . . . 2.1 110.093 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -90.68 144.46 25.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.313 -0.403 . . . . 2.78 111.217 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 15.7 mt -74.55 142.87 78.22 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 2.62 110.172 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 127' ' ' LEU . 42.2 Cg_exo -60.0 149.91 81.56 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 2.77 111.452 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -61.4 119.43 8.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 4.11 110.784 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.25 54.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.772 -0.728 . . . . 3.18 112.127 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -103.94 127.59 51.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 2.91 110.449 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 37.4 p90 -133.97 151.62 51.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.319 -0.401 . . . . 3.54 110.853 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.98 139.86 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 2.93 112.031 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.39 131.38 45.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.888 -0.596 . . . . 3.64 109.886 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.3 -37.07 3.14 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.328 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 120.64 0.257 . . . . 3.59 110.802 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.519 0.2 . . . . 2.48 110.851 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -55.08 143.47 26.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.052 -0.522 . . . . 2.13 112.019 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -67.89 -28.6 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 2.4 110.96 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 62.9 m-85 -107.87 168.61 9.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.111 -0.495 . . . . 2.02 112.28 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -70.95 160.78 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.168 -0.923 . . . . 2.65 111.289 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.72 134.75 33.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.4 110.533 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 133' ' ' ALA . 1.2 mt -87.37 132.62 33.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.148 -0.478 . . . . 2.27 110.163 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 m -96.34 112.82 24.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.294 -0.412 . . . . 2.84 110.067 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -83.9 140.28 32.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 2.89 111.016 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -141.84 80.13 1.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.692 -0.485 . . . . 3.82 109.692 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.6 -166.45 29.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.987 -0.625 . . . . 3.23 112.199 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -91.68 -9.87 42.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 4.27 111.019 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -105.18 162.07 13.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.085 -0.507 . . . . 3.32 109.884 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -90.0 -65.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.77 -0.826 . . . . 2.39 108.77 178.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 21.8 tp 175.31 133.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.395 -0.82 . . . . 2.06 110.533 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -150.64 117.57 5.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.068 -0.515 . . . . 2.22 110.304 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -108.12 139.63 20.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.55 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 49.8 Cg_endo -69.77 172.55 12.45 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.69 2.26 . . . . 2.15 112.421 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -69.45 127.62 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.878 -0.601 . . . . 2.6 110.848 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.68 25.06 63.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.942 -0.647 . . . . 1.65 112.622 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -151.38 158.78 44.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.547 -0.538 . . . . 2.31 109.547 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 21.63 9.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.744 -0.741 . . . . 1.33 111.418 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' A' ' 95' ' ' THR . 21.6 t -106.84 110.35 63.6 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.183 -0.303 . . . . 1.06 110.183 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' A' ' 121' ' ' LEU . 39.8 Cg_endo -68.65 175.15 7.5 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.723 2.282 . . . . 1.27 111.09 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.0 mt -72.93 87.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 1.7 110.686 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 71.3 m-20 -82.76 74.96 9.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.808 -0.633 . . . . 1.23 109.775 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -31.5 72.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.34 0.496 . . . . 1.94 112.34 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.58 -7.19 59.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.596 -0.274 . . . . 1.96 111.68 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.92 150.15 32.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.098 0.475 . . . . 1.42 112.095 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.712 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 13.7 m -90.29 170.2 10.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.51 -0.768 . . . . 1.73 109.471 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.712 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 3.0 Cg_endo -46.79 -44.92 21.38 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.324 2.683 . . . . 1.42 114.094 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -70.52 -25.98 63.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.888 0.329 . . . . 1.78 111.888 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.947 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.3 m-20 -86.77 2.79 47.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.267 -0.424 . . . . 1.6 110.844 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 83.4 mm-40 -80.48 46.08 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.107 0.48 . . . . 1.05 111.119 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.879 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.7 tt -143.12 132.47 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.022 -0.535 . . . . 1.17 110.191 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' ' N ' ' A' ' 73' ' ' LEU . . . -170.68 -145.55 4.8 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.414 -0.898 . . . . 0.6 112.158 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.479 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 45.7 p90 -155.6 159.91 40.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.122 0.487 . . . . 0.99 110.98 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.494 ' HB2' HG13 ' A' ' 91' ' ' ILE . 12.0 m-85 -99.91 117.86 35.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.471 -0.786 . . . . 1.26 109.475 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 48' ' ' ARG . 32.7 ttt180 -99.5 127.08 45.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.984 0.421 . . . . 2.15 111.321 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -85.24 135.25 34.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.839 -0.619 . . . . 2.4 110.432 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.7 42.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 2.21 111.37 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.7 m -152.98 127.32 9.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.062 -0.718 . . . . 2.68 109.062 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 3.8 tpt85 -103.63 126.67 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.492 0.553 . . . . 3.59 112.492 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 53' ' ' ARG . 17.5 mtt180 -142.92 107.56 4.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 3.43 109.472 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 169.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.63 0.252 . . . . 4.26 110.71 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.491 -0.322 . . . . 5.17 110.464 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.767 0.317 . . . . 4.48 110.906 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -97.89 -24.57 15.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 4.16 110.174 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 48.53 90.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.883 1.068 . . . . 4.09 113.883 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.53 147.75 33.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.257 -0.429 . . . . 3.36 110.178 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 24.4 m -78.4 162.12 67.43 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.492 -0.558 . . . . 3.36 109.492 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 9.2 Cg_endo -53.0 108.08 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.768 2.312 . . . . 2.69 112.166 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.454 HH22 ' HB2' ' A' ' 134' ' ' GLU . 19.4 mtp180 -99.91 134.03 43.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.78 -0.646 . . . . 3.03 109.629 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -106.61 115.75 30.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.07 -0.514 . . . . 1.84 112.0 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -102.36 121.29 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.868 -0.79 . . . . 2.76 108.868 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.98 135.57 43.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 1.27 111.686 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HD2' HG21 ' A' ' 75' ' ' THR . 14.3 m-85 -130.75 165.27 23.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 1.84 110.202 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -99.82 159.58 14.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.37 -0.377 . . . . 1.28 110.898 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.419 ' N ' ' HA2' ' A' ' 45' ' ' GLY . 54.8 tp -63.29 116.31 5.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.22 -0.445 . . . . 1.66 111.501 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.45 35.64 10.39 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.995 -0.621 . . . . 1.66 113.936 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.565 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.8 OUTLIER -73.3 90.47 1.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 1.58 111.135 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.39 139.78 5.51 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.032 -0.604 . . . . 1.96 112.2 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -33.34 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.603 2.202 . . . . 2.62 112.053 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -103.67 36.45 2.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.026 -0.534 . . . . 3.09 111.093 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.03 -56.6 10.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 1.79 110.096 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.12 32.5 80.69 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.915 -0.584 . . . . 1.65 112.971 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' ' HB3' ' A' ' 85' ' ' ALA . 3.0 tp -138.33 106.01 7.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.757 0.313 . . . . 1.38 110.688 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 92.2 Cg_endo -85.39 167.54 10.39 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.677 2.251 . . . . 1.62 111.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -60.95 106.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 1.58 110.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.54 -8.64 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.489 -0.862 . . . . 1.44 112.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.577 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . . . -69.24 137.99 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 1.25 110.967 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -88.44 128.18 35.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 1.86 111.839 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 6.5 ttmm -155.24 144.01 20.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.781 -0.645 . . . . 1.68 109.283 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.73 113.34 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.196 0.443 . . . . 1.7 112.196 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.27 20.57 58.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.891 -0.671 . . . . 1.27 112.752 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 35.0 mm -127.72 102.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 1.01 110.51 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 47' ' ' TYR . 24.8 pt -114.62 134.06 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.322 -0.399 . . . . 1.3 109.989 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.479 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 49.3 m95 -90.35 146.25 24.33 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.345 0.498 . . . . 1.08 112.345 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 m -140.47 144.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.518 -0.764 . . . . 1.04 110.311 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.95 169.59 23.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 1.27 110.869 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.445 ' HB ' HG21 ' A' ' 32' ' ' VAL . 13.4 t -146.17 179.04 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.969 -0.56 . . . . 1.36 109.5 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.7 123.37 19.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.399 . . . . 2.64 111.133 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 41' ' ' ASP . . . 107.35 -13.26 39.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.766 -0.73 . . . . 1.52 111.906 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.879 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.31 132.18 35.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.669 0.271 . . . . 1.59 110.785 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.9 mt -102.22 140.59 36.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.262 -0.426 . . . . 2.15 110.799 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -79.45 76.05 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.468 0.652 . . . . 2.07 110.09 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.632 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m -147.13 131.97 8.89 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.654 -0.869 . . . . 2.36 108.654 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.83 125.24 17.67 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.307 2.005 . . . . 2.08 112.251 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.947 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -126.85 75.87 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.585 0.707 . . . . 1.78 111.216 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.99 -4.53 44.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 2.55 112.058 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 4.1 p80 -59.18 -20.9 57.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.092 0.472 . . . . 2.24 111.864 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.3 pt -111.71 13.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.037 0.446 . . . . 2.0 110.616 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.22 -32.67 7.29 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.554 -0.831 . . . . 2.33 112.027 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.9 t -69.18 121.46 16.83 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.295 0.569 . . . . 2.99 110.978 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.0 ttp85 -164.57 131.18 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.781 . . . . 2.83 109.927 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 59.5 m-80 -94.99 117.84 66.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 3.56 110.663 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 18.3 Cg_endo -60.35 -34.97 92.94 Favored 'Trans proline' 0 N--CA 1.472 0.244 0 C-N-CA 123.123 2.549 . . . . 3.39 113.458 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.93 9.68 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.369 0.507 . . . . 4.05 112.369 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -139.52 9.1 2.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.871 0.367 . . . . 4.48 111.389 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -159.49 127.22 4.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 3.39 111.248 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.47 164.14 25.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 3.21 110.625 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.58 152.19 23.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.167 0.508 . . . . 2.85 111.466 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 3.4 mp -95.76 145.86 7.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.746 -0.661 . . . . 2.42 109.417 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.578 ' HA ' ' OG1' ' A' ' 14' ' ' THR . 70.0 t -68.25 115.31 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.251 -0.277 . . . . 2.74 110.251 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.75 121.24 12.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.066 -0.515 . . . . 2.11 110.604 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -139.83 173.64 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.858 -0.61 . . . . 2.49 110.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 33' ' ' PRO . 91.5 mt -123.14 152.48 63.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.558 -0.534 . . . . 1.91 109.558 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.42 154.65 34.39 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.003 2.469 . . . . 1.84 111.97 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -52.94 122.83 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 2.53 111.332 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.69 -11.34 49.88 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.632 -0.794 . . . . 2.2 112.321 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 HD13 ' A' ' 121' ' ' LEU . 5.3 m -109.11 113.89 27.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.486 -0.561 . . . . 2.1 109.486 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.2 159.63 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.358 -0.383 . . . . 2.78 110.892 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.416 HD22 ' HD2' ' A' ' 131' ' ' PHE . 28.4 mt -90.45 156.68 45.41 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.402 -0.363 . . . . 2.62 110.25 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.54 151.46 62.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.656 2.238 . . . . 2.77 111.912 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.36 119.2 8.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.185 0.517 . . . . 4.11 111.775 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.41 -8.88 44.8 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.723 -0.751 . . . . 3.18 112.346 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.416 ' HD2' HD22 ' A' ' 127' ' ' LEU . 2.1 t80 -101.51 112.91 25.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.788 -0.449 . . . . 2.91 109.788 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -133.1 149.88 52.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 3.54 111.663 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.422 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -103.45 147.35 27.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 2.93 110.073 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.454 ' HB2' HH22 ' A' ' 67' ' ' ARG . 25.5 tt0 -73.67 121.61 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 3.64 111.237 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.85 -0.47 45.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.688 -0.767 . . . . 3.27 112.265 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 120.875 0.369 . . . . 3.59 110.733 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.992 0.425 . . . . 2.48 111.588 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -87.36 155.6 19.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.906 -0.588 . . . . 2.13 110.032 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -86.09 -29.4 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 2.4 110.146 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.52 -179.72 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.409 -0.814 . . . . 2.02 110.532 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.71 -172.35 4.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.458 . . . . 2.65 110.679 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -105.66 173.25 6.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 2.4 112.602 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.607 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 16.0 mt -112.1 122.85 48.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.931 -1.031 . . . . 2.27 109.312 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.1 m -92.52 116.39 28.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.99 0.424 . . . . 2.84 111.261 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -86.38 142.43 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 2.89 110.842 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -134.44 44.86 2.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.977 -0.556 . . . . 3.82 109.862 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.9 -167.24 12.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.832 -0.699 . . . . 3.23 112.442 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -86.74 -28.14 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 4.27 110.645 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.89 163.55 23.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 3.32 111.007 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.2 -85.5 0.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.825 -0.435 . . . . 2.39 109.825 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.597 HD13 ' CE1' ' A' ' 131' ' ' PHE . 36.5 tp -168.97 140.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 2.06 110.462 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -163.01 120.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.716 -0.675 . . . . 2.22 110.021 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -110.54 142.5 26.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.269 -0.423 . . . . 1.78 110.234 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.57 164.94 16.78 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.114 2.543 . . . . 2.15 111.965 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -69.61 128.47 36.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 2.6 110.426 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.83 29.92 49.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.287 -0.725 . . . . 1.65 111.287 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -157.84 171.52 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.46 -0.57 . . . . 2.31 109.46 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.31 17.32 64.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 1.33 112.511 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.78 111.15 65.0 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 1.06 109.826 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.51 168.57 11.2 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.783 2.322 . . . . 1.27 112.051 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.9 mt -74.69 87.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.16 -0.473 . . . . 1.7 110.497 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -84.11 77.69 9.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.039 0.447 . . . . 1.23 109.913 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -26.31 68.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 1.94 111.628 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -80.78 -3.78 52.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.127 -0.488 . . . . 1.96 111.653 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.478 ' HB3' ' CB ' ' A' ' 42' ' ' ASP . 1.4 m -120.52 157.52 29.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.351 . . . . 1.42 111.672 -178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.672 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 23.4 m -83.04 168.84 20.19 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.96 -0.564 . . . . 1.73 109.922 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.8 Cg_endo -52.9 -35.71 71.77 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.947 2.432 . . . . 1.42 113.913 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.839 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.2 p-10 -80.81 -16.01 54.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.652 0.242 . . . . 1.78 111.652 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.827 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 29.5 m-20 -84.37 -3.39 58.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 1.6 111.106 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -78.55 56.37 1.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 1.05 110.827 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 94' ' ' ALA . 16.6 tt -149.97 127.38 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.673 . . . . 1.17 110.155 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.3 -139.83 3.0 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.515 -0.85 . . . . 0.6 112.214 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.483 ' CD2' HG23 ' A' ' 90' ' ' ILE . 53.7 p90 -162.09 158.65 25.12 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.08 0.467 . . . . 0.99 111.113 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.641 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -95.84 134.94 38.21 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.898 -0.778 . . . . 1.26 108.898 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -112.68 121.39 44.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.399 -0.364 . . . . 2.15 111.1 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -73.49 119.69 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.491 . . . . 2.4 109.787 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.31 148.29 43.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.173 0.511 . . . . 2.21 111.306 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.73 151.46 45.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.731 -0.84 . . . . 2.68 108.731 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.784 ' HB3' HD12 ' A' ' 64' ' ' LEU . 9.6 tpt180 -139.43 125.64 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.982 0.42 . . . . 3.59 111.604 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 25.7 mtt180 -140.73 98.58 3.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.905 -0.589 . . . . 3.43 110.789 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 61' ' ' MET . 33.8 pt -79.74 160.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.378 -0.601 . . . . 4.26 109.378 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 55' ' ' ARG . 3.8 ttt180 . . . . . 0 C--N 1.324 -0.533 0 C-N-CA 120.919 -0.312 . . . . 5.17 111.564 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 mtt . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.943 0.401 . . . . 4.48 111.852 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HE3' HD21 ' A' ' 64' ' ' LEU . 45.7 tttp -71.84 -33.72 68.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.517 -0.765 . . . . 4.16 110.288 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 26.1 t0 46.85 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.632 0.975 . . . . 4.09 113.632 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 52' ' ' ARG . 47.8 mt -89.22 137.3 32.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 3.36 110.46 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -64.04 144.73 98.17 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.099 -0.5 . . . . 3.36 110.271 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.81 119.32 5.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.915 2.41 . . . . 2.69 112.27 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.528 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 64.8 mtt85 -121.19 132.43 54.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 3.03 110.568 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.641 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.74 118.48 31.47 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.252 -0.431 . . . . 1.84 110.921 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.82 146.23 24.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.194 -0.669 . . . . 2.76 109.194 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.54 120.83 28.28 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.653 -0.419 . . . . 1.27 111.774 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -115.37 157.51 23.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.593 -0.521 . . . . 1.84 109.593 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -102.94 158.95 15.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.936 -0.394 . . . . 1.28 109.936 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -63.18 118.99 8.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.079 -0.341 . . . . 1.66 110.079 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.84 35.2 4.93 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.987 -0.625 . . . . 1.66 112.334 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.35 99.87 12.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.444 . . . . 1.58 110.796 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.85 123.94 3.38 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.181 -0.768 . . . . 1.96 111.181 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.3 -27.7 83.55 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.857 2.371 . . . . 2.62 113.181 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -127.59 35.35 4.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.737 0.303 . . . . 3.09 110.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.22 -50.65 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 1.79 111.023 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.62 51.27 26.38 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.308 -0.717 . . . . 1.65 111.308 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.7 mt -132.28 96.12 19.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.573 0.225 . . . . 1.38 111.596 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 92.9 Cg_endo -84.5 162.99 12.72 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.662 2.242 . . . . 1.62 110.661 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.538 ' HB2' HD11 ' A' ' 73' ' ' LEU . 34.7 t80 -58.8 113.26 1.97 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.013 0.435 . . . . 1.58 110.894 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.68 11.61 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.729 -0.748 . . . . 1.44 112.449 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -61.83 108.61 1.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.883 0.373 . . . . 1.25 110.486 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.0 107.45 8.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.153 -0.476 . . . . 1.86 110.543 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -125.62 149.83 48.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 1.68 109.968 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.15 110.49 1.62 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.236 -0.438 . . . . 1.7 111.683 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.17 21.48 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.794 -0.717 . . . . 1.27 112.284 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.483 HG23 ' CD2' ' A' ' 46' ' ' TYR . 48.1 mm -129.19 113.83 29.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.351 -0.24 . . . . 1.01 110.351 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 91' ' ' ILE . 7.8 pt -119.13 126.2 75.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.645 -0.502 . . . . 1.3 109.645 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.436 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 82.9 m95 -83.45 139.21 33.09 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.707 0.632 . . . . 1.08 112.707 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.45 139.44 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.538 -0.755 . . . . 1.04 110.411 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -155.5 172.33 18.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.082 -0.508 . . . . 1.27 109.745 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.2 t -142.9 170.84 14.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.748 0.309 . . . . 1.36 110.361 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.73 118.24 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.981 -0.554 . . . . 2.64 110.686 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.61 -15.22 8.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.967 -0.635 . . . . 1.52 111.647 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.839 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.25 159.26 22.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.671 0.272 . . . . 1.59 110.662 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.69 140.93 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 2.15 110.663 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -80.14 97.69 6.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.093 0.473 . . . . 2.07 111.179 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 t -171.2 148.93 2.51 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.968 -0.753 . . . . 2.36 108.968 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.54 111.75 3.39 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.045 1.83 . . . . 2.08 112.111 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.827 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -108.51 80.45 1.35 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.441 0.639 . . . . 1.78 110.264 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -72.64 -5.96 41.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.461 -0.79 . . . . 2.55 112.245 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -63.01 -15.61 56.99 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.519 0.562 . . . . 2.24 112.519 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.89 -24.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.463 . . . . 2.0 110.726 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.34 73.46 1.68 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.788 -0.72 . . . . 2.33 112.029 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.4 t -160.56 22.97 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.142 0.496 . . . . 2.99 110.979 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttp85 -84.29 136.85 33.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 2.83 110.824 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -83.85 119.64 73.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.42 -0.585 . . . . 3.56 109.42 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.52 -19.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.792 2.328 . . . . 3.39 113.769 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.43 -40.6 8.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.929 0.344 . . . . 4.05 111.929 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.88 7.72 26.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.41 -0.359 . . . . 4.48 111.394 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -160.23 139.92 11.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.333 . . . . 3.39 110.512 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.02 141.55 29.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.241 -0.436 . . . . 3.21 111.143 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.36 148.38 26.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 2.85 110.765 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.62 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 2.42 110.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.65 135.52 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.926 -0.398 . . . . 2.74 109.926 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.48 HD23 ' HG ' ' A' ' 16' ' ' LEU . 15.7 tp -63.3 119.66 10.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 2.11 110.691 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -124.33 135.24 53.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.49 110.915 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.0 mt -101.79 147.5 33.96 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 1.91 110.142 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.65 152.54 77.88 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.702 2.268 . . . . 1.84 111.807 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -54.86 129.49 37.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.858 -0.61 . . . . 2.53 111.258 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.64 14.17 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.419 -0.672 . . . . 2.2 111.419 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -99.81 98.26 9.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.718 0.294 . . . . 2.1 110.395 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.71 147.07 23.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 2.78 110.433 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.86 144.37 87.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.285 -0.416 . . . . 2.62 110.223 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.521 ' HG2' ' HD1' ' A' ' 131' ' ' PHE . 17.6 Cg_endo -60.34 155.64 45.34 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.399 2.066 . . . . 2.77 111.505 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -60.89 127.41 31.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 4.11 111.105 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.95 63.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.908 -0.663 . . . . 3.18 112.648 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.51 116.56 30.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.917 0.389 . . . . 2.91 111.828 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -124.09 137.78 54.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 3.54 110.64 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.473 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 2.93 111.372 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.0 121.49 15.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 3.64 111.114 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 23.26 34.05 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.941 -0.572 . . . . 3.27 112.849 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 112.207 0.447 . . . . 3.59 112.207 -179.769 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.073 0.463 . . . . 2.48 112.236 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -73.1 139.21 46.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 2.13 110.306 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -98.06 -25.59 14.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.783 0.325 . . . . 2.4 111.788 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.66 176.98 5.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 2.02 110.571 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 p -69.89 175.62 4.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.983 0.421 . . . . 2.65 111.382 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -95.05 158.23 15.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.411 0.624 . . . . 2.4 111.527 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.743 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 88.7 mt -111.89 106.3 14.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.148 -0.933 . . . . 2.27 109.327 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.7 m -84.51 127.17 33.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 2.84 111.504 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.55 115.57 27.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.902 -0.59 . . . . 2.89 110.664 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -103.67 72.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.487 -0.56 . . . . 3.82 109.487 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.95 -161.85 26.86 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.842 -0.694 . . . . 3.23 112.156 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 70.3 mmtt -94.28 -42.52 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.684 0.278 . . . . 4.27 111.115 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.69 153.32 36.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 3.32 110.064 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.9 -76.0 0.31 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.915 -0.314 . . . . 2.39 110.574 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.1 tp 179.8 130.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.897 -0.592 . . . . 2.06 110.264 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -145.18 123.97 12.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 2.22 110.32 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.47 ' CD1' ' HA2' ' A' ' 31' ' ' GLY . 46.6 m-85 -107.0 140.21 21.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.356 -0.384 . . . . 1.78 110.866 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 13.4 Cg_exo -71.58 168.96 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.839 2.359 . . . . 2.15 111.901 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -61.0 124.93 21.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 2.6 111.279 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.96 9.97 84.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.885 -0.674 . . . . 1.65 112.737 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.584 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 16.6 tt0 -129.5 160.7 32.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.814 -0.439 . . . . 2.31 109.814 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 26' ' ' PHE . . . 118.36 -3.01 16.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.151 -0.547 . . . . 1.33 111.951 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.6 t -101.21 111.16 63.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.898 -0.408 . . . . 1.06 109.898 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 4.0 Cg_exo -76.88 -170.7 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.001 2.467 . . . . 1.27 111.327 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -74.2 100.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.191 0.52 . . . . 1.7 111.268 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.587 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 71.2 m-80 -103.37 86.03 2.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.0 -0.741 . . . . 1.23 109.0 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -51.67 53.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.579 0.955 . . . . 1.94 113.579 -178.045 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -80.71 11.33 3.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.836 0.68 . . . . 1.96 112.836 -178.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.587 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -115.02 137.73 51.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.713 0.292 . . . . 1.42 110.802 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.98 164.05 50.99 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 1.73 111.006 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.17 -37.94 93.89 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.177 2.585 . . . . 1.42 113.312 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.4 p-10 -82.33 -5.97 58.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.548 0.213 . . . . 1.78 111.453 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.07 5.24 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 1.6 110.279 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.483 ' HB3' HG11 ' A' ' 32' ' ' VAL . 63.3 mm-40 -83.7 53.31 2.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 1.05 111.062 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.448 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.7 tt -144.81 136.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.609 . . . . 1.17 110.142 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.19 -147.93 6.7 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.152 -1.023 . . . . 0.6 113.059 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.428 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 44.2 p90 -157.16 172.78 18.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.951 0.405 . . . . 0.99 110.699 -179.077 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -117.34 134.76 54.44 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.478 -0.564 . . . . 1.26 109.478 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -107.53 136.17 47.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 2.15 111.141 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -81.37 98.12 8.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.607 -0.724 . . . . 2.4 110.282 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.8 148.35 30.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 2.21 111.803 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -155.64 121.5 5.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.68 109.464 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.804 ' HB3' HD12 ' A' ' 64' ' ' LEU . 4.2 ttt85 -94.45 129.87 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.654 0.264 . . . . 3.59 111.038 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.17 94.95 2.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 3.43 110.457 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.529 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -83.17 141.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 4.26 111.359 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 5.17 112.237 -178.384 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.682 0.277 . . . . 4.48 110.969 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -62.35 -42.43 99.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 4.16 110.526 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 t70 58.85 77.53 0.3 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.353 -0.84 . . . . 4.09 112.069 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.804 HD12 ' HB3' ' A' ' 52' ' ' ARG . 40.0 mt -87.45 164.09 16.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.024 -0.534 . . . . 3.36 111.062 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.65 152.74 54.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.131 -0.486 . . . . 3.36 110.634 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 115.17 2.48 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.479 2.119 . . . . 2.69 111.283 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.663 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 4.3 ptp180 -113.15 119.57 38.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 3.03 110.82 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -84.43 126.34 33.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.836 -0.62 . . . . 1.84 110.648 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 51.1 m-85 -109.26 132.01 54.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.708 -0.479 . . . . 2.76 109.708 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.49 127.32 33.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.376 . . . . 1.27 111.179 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -130.24 157.66 41.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.51 -0.552 . . . . 1.84 109.51 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -86.28 156.31 20.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.984 0.421 . . . . 1.28 111.019 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 83' ' ' TYR . 4.2 tt -65.82 116.86 7.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.141 -0.481 . . . . 1.66 111.204 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.78 10.23 31.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.617 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -61.02 122.74 15.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.855 0.36 . . . . 1.58 110.976 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.419 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 97.63 123.87 4.76 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.87 -0.681 . . . . 1.96 112.005 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 9.9 Cg_endo -53.35 -63.89 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.219 2.613 . . . . 2.62 112.434 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -91.95 72.7 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.309 0.576 . . . . 3.09 111.12 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.99 -61.17 1.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 1.79 109.936 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 39.46 57.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.797 -0.638 . . . . 1.65 112.316 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.89 95.17 44.72 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.217 -0.29 . . . . 1.38 110.217 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 84.2 Cg_endo -89.67 179.46 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.865 2.377 . . . . 1.62 112.206 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.447 ' HB2' HD11 ' A' ' 73' ' ' LEU . 43.2 t80 -61.42 107.48 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.935 -0.575 . . . . 1.58 111.247 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.17 -15.55 8.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.513 -0.851 . . . . 1.44 113.061 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.634 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.72 105.24 1.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.156 0.503 . . . . 1.25 111.033 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -79.06 122.47 26.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.036 -0.529 . . . . 1.86 111.214 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -141.11 173.74 11.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 1.68 109.732 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -73.96 114.87 12.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 1.7 111.492 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 31.64 59.91 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.83 -0.623 . . . . 1.27 113.01 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.7 mm -128.58 107.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 110.333 -0.247 . . . . 1.01 110.333 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 pt -115.14 124.92 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.543 0.211 . . . . 1.3 110.446 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 76.3 m95 -88.41 138.79 31.12 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.045 0.387 . . . . 1.08 112.045 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.87 144.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 1.04 110.66 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.9 160.42 43.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.394 -0.366 . . . . 1.27 110.301 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -135.45 168.83 18.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.71 -0.478 . . . . 1.36 109.71 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.15 133.12 55.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 2.64 110.675 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.65 -16.97 55.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.969 -0.634 . . . . 1.52 112.349 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.41 143.05 29.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 1.59 110.577 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.6 mt -110.68 142.44 42.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.44 -0.345 . . . . 2.15 110.447 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.42 83.95 3.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.302 0.572 . . . . 2.07 110.902 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.1 t -151.65 139.09 12.47 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.459 -0.791 . . . . 2.36 109.416 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 126.55 22.39 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.013 2.476 . . . . 2.08 113.278 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -117.97 60.71 0.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.5 -0.773 . . . . 1.78 110.217 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.58 -0.87 21.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 2.55 112.101 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -74.76 -6.75 50.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 2.24 111.55 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.22 35.45 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 2.0 111.142 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 13.33 8.39 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.53 -0.843 . . . . 2.33 112.868 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -131.88 114.81 15.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.207 0.527 . . . . 2.99 110.898 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -151.05 160.57 43.83 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.604 -0.517 . . . . 2.83 109.604 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.14 105.83 50.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 3.56 110.715 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.47 -34.24 26.84 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.401 2.068 . . . . 3.39 113.087 -179.113 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.52 -8.07 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.972 0.36 . . . . 4.05 111.972 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -125.73 10.03 7.71 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.626 -0.261 . . . . 4.48 111.495 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -168.92 127.91 1.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 3.39 110.182 -179.068 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.33 164.5 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.703 0.287 . . . . 3.21 110.762 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.93 151.96 20.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.318 -0.401 . . . . 2.85 110.232 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.0 mt -83.97 143.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.589 -0.523 . . . . 2.42 109.589 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.546 HG11 ' HB2' ' A' ' 136' ' ' SER . 85.7 t -65.92 119.85 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.796 0.331 . . . . 2.74 110.474 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.612 HD22 HD21 ' A' ' 16' ' ' LEU . 7.8 tt -63.28 118.65 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 2.11 109.718 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -133.53 165.64 24.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.28 -0.418 . . . . 2.49 110.898 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.33 157.67 43.31 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.646 -0.706 . . . . 1.91 110.042 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.39 172.82 15.33 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.62 2.213 . . . . 1.84 112.075 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.2 120.87 13.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.006 -0.543 . . . . 2.53 110.336 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.42 -25.8 8.98 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.551 -0.833 . . . . 2.2 112.099 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 m -98.13 112.93 24.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.805 -0.442 . . . . 2.1 109.805 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.9 m -104.7 145.34 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.727 -0.669 . . . . 2.78 111.257 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -76.92 149.38 80.13 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.09 -0.707 . . . . 2.62 109.09 178.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 18.4 Cg_endo -60.42 146.23 97.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.529 2.153 . . . . 2.77 111.553 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.61 109.74 0.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 4.11 110.471 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.2 -12.42 9.73 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.371 -0.692 . . . . 3.18 111.371 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.743 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 1.4 t80 -103.24 134.34 46.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.125 -0.324 . . . . 2.91 110.125 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -128.78 164.95 21.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.349 -0.387 . . . . 3.54 110.53 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 136' ' ' SER . . . -103.34 139.54 38.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.511 -0.313 . . . . 2.93 110.479 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.82 123.11 28.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.921 0.391 . . . . 3.64 110.535 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.18 -1.39 82.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.297 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.546 ' HB2' HG11 ' A' ' 118' ' ' VAL . 4.7 t . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 3.59 110.566 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.286 0 CA-C-O 120.487 0.184 . . . . 2.48 111.012 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 m -57.86 153.02 14.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.082 -0.508 . . . . 2.13 112.35 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 109' ' ' ARG . 32.2 m95 -74.92 -54.44 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.609 -0.723 . . . . 2.4 110.52 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.82 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 24.8 m-85 -74.75 159.65 31.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 2.02 112.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -68.92 158.58 34.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.543 -0.753 . . . . 2.65 111.017 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -77.08 144.99 38.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.911 0.386 . . . . 2.4 111.207 -179.576 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.637 HD13 ' HE2' ' A' ' 131' ' ' PHE . 35.4 mt -89.53 119.9 30.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.988 -0.375 . . . . 2.27 109.988 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -90.97 126.44 36.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.279 0.561 . . . . 2.84 112.458 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.423 ' HB2' ' HE1' ' A' ' 131' ' ' PHE . 6.2 tp-100 -94.8 138.43 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.892 -0.594 . . . . 2.89 110.172 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 14.6 t60 -137.21 56.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.532 -0.544 . . . . 3.82 109.532 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -154.89 -169.34 19.39 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.58 -0.736 . . . . 3.23 111.685 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mmtt -92.84 -1.77 56.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.062 0.393 . . . . 4.27 112.062 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -104.53 171.92 7.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 3.32 110.308 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.74 -79.87 0.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.664 -0.243 . . . . 2.39 110.375 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.7 tp -179.57 132.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 2.06 110.421 179.082 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -154.07 117.31 4.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.333 -0.394 . . . . 2.22 110.628 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -109.74 141.29 23.37 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.191 -0.459 . . . . 1.78 110.155 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.72 165.01 29.12 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.564 2.176 . . . . 2.15 112.298 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -64.34 119.87 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.577 . . . . 2.6 111.085 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.36 0.52 56.88 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.798 -0.715 . . . . 1.65 112.567 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -130.0 165.76 21.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 2.31 110.62 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.38 -14.7 30.36 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.783 -0.722 . . . . 1.33 112.37 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.555 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.8 t -89.56 118.15 68.79 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.701 0.286 . . . . 1.06 110.999 -179.239 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.19 -176.36 2.87 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.608 2.206 . . . . 1.27 111.345 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 mt -84.63 79.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 1.7 110.781 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -83.85 86.85 7.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.323 -0.399 . . . . 1.23 110.31 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.07 64.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.994 0.426 . . . . 1.94 110.832 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -76.42 0.67 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.959 -0.564 . . . . 1.96 111.394 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.499 ' HB3' ' CB ' ' A' ' 42' ' ' ASP . 4.3 m -128.36 152.19 48.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.855 0.36 . . . . 1.42 111.033 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 168.49 27.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.099 -0.501 . . . . 1.73 109.88 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.28 -36.61 93.91 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.585 2.19 . . . . 1.42 111.961 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -77.79 -19.94 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 1.78 111.054 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.934 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 31.7 m-20 -81.97 -5.8 58.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 1.6 111.275 -179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.555 ' HB3' HG11 ' A' ' 32' ' ' VAL . 76.8 mm-40 -79.44 57.71 2.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.151 0.5 . . . . 1.05 111.379 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.493 HG13 ' HB2' ' A' ' 94' ' ' ALA . 10.9 tt -151.17 131.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.749 -0.659 . . . . 1.17 109.579 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.26 -146.15 6.07 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.368 -0.92 . . . . 0.6 112.661 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -153.03 165.01 36.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.914 0.387 . . . . 0.99 110.58 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -105.48 125.59 51.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 1.26 109.238 178.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -95.1 126.4 40.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.205 -0.452 . . . . 2.15 111.643 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -76.57 120.83 22.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.598 -0.728 . . . . 2.4 109.51 178.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.67 158.77 43.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 2.21 111.666 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.94 109.01 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.598 -0.728 . . . . 2.68 109.594 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.648 ' HB3' HD12 ' A' ' 64' ' ' LEU . 11.3 tpt85 -81.26 103.84 11.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 3.59 111.531 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -114.5 110.34 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 3.43 111.179 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.72 131.9 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.822 -0.626 . . . . 4.26 109.397 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 55' ' ' ARG . 1.4 ttp180 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 123.331 0.395 . . . . 5.17 110.232 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.545 0.212 . . . . 4.48 110.575 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -68.24 -42.65 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 4.16 109.542 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t0 47.48 75.23 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.18 -0.918 . . . . 4.09 112.676 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 52' ' ' ARG . 27.4 mt -94.46 158.92 15.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.912 -0.585 . . . . 3.36 111.195 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.11 149.51 89.58 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.777 -0.647 . . . . 3.36 111.289 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.66 116.25 3.12 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.844 2.363 . . . . 2.69 111.297 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 10.8 mtt-85 -119.91 147.6 44.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.051 -0.522 . . . . 3.03 111.594 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -114.93 129.14 56.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 1.84 110.946 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -103.65 133.65 48.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.365 -0.606 . . . . 2.76 109.365 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -81.6 121.36 26.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 1.27 111.481 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.44 ' HD2' HG21 ' A' ' 75' ' ' THR . 20.2 m-85 -122.74 133.52 54.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 1.84 109.743 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.63 159.74 33.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.539 -0.3 . . . . 1.28 110.899 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.38 122.0 12.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 1.66 111.825 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.39 24.34 26.65 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.906 -0.664 . . . . 1.66 113.678 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.44 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -77.2 102.16 6.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 1.58 111.204 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.403 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 127.25 114.23 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.13 -0.788 . . . . 1.96 111.13 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 18.0 Cg_endo -59.45 -26.51 82.22 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.91 2.407 . . . . 2.62 112.466 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.3 15.28 16.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.543 0.211 . . . . 3.09 111.526 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.66 -55.58 6.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.029 0.442 . . . . 1.79 110.223 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.64 36.35 89.29 Favored Glycine 0 C--N 1.329 0.157 0 CA-C-N 115.73 -0.668 . . . . 1.65 112.789 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 mt -107.85 105.9 57.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.565 0.221 . . . . 1.38 111.039 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.14 161.84 17.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.056 2.504 . . . . 1.62 111.511 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -57.91 111.07 1.04 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 1.58 110.51 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.76 -19.23 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.629 -0.796 . . . . 1.44 112.352 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.61 113.11 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 1.25 110.807 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -82.27 121.98 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.374 -0.376 . . . . 1.86 111.704 -179.27 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.94 171.46 14.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.295 -0.411 . . . . 1.68 110.269 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.35 110.29 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.878 -0.601 . . . . 1.7 111.195 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.37 97.06 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.95 -0.568 . . . . 1.27 112.823 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.5 mm -127.51 105.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.899 0.381 . . . . 1.01 110.611 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.8 pt -111.67 135.19 51.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.371 -0.603 . . . . 1.3 109.371 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -94.86 140.68 29.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.16 0.43 . . . . 1.08 112.16 -178.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.01 141.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.519 -0.764 . . . . 1.04 110.241 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -155.25 152.28 29.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.09 -0.337 . . . . 1.27 110.09 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -111.59 173.61 6.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.415 -0.357 . . . . 1.36 110.263 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.0 118.68 15.16 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.983 -0.377 . . . . 2.64 109.983 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.76 -3.8 24.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.84 -0.695 . . . . 1.52 111.881 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.21 131.4 34.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.46 -0.2 . . . . 1.59 110.46 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.14 148.52 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 2.15 111.188 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -87.1 72.27 10.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 2.07 110.557 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.504 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 8.5 m -148.68 125.93 5.58 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.466 -0.788 . . . . 2.36 109.498 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.18 133.75 53.69 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.983 2.455 . . . . 2.08 112.195 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.934 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.28 84.6 2.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.305 0.574 . . . . 1.78 111.346 -179.494 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -11.03 59.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.005 -0.543 . . . . 2.55 111.756 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.444 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.4 p80 -56.91 -22.24 35.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.797 0.665 . . . . 2.24 112.797 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.57 4.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.095 0.474 . . . . 2.0 110.753 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.27 -16.7 45.82 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.885 -0.674 . . . . 2.33 111.517 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -87.08 121.71 29.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.949 0.404 . . . . 2.99 110.519 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 12' ' ' TRP . 10.3 ttp85 -164.91 131.04 2.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 2.83 110.614 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 28.3 t-20 -95.12 122.64 59.45 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.553 -0.536 . . . . 3.56 109.553 178.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 11.7 Cg_endo -54.6 -37.23 90.83 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 123.449 2.766 . . . . 3.39 114.086 -178.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.67 -8.53 59.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.81 0.67 . . . . 4.05 112.81 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -115.5 7.18 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.463 0.542 . . . . 4.48 112.463 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.77 124.61 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.908 0.385 . . . . 3.39 110.998 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.31 158.59 28.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.26 -0.427 . . . . 3.21 110.871 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.24 151.98 41.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 2.85 111.487 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 44.3 mt -107.96 132.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 2.42 109.044 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.29 119.34 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.434 -0.348 . . . . 2.74 111.009 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.82 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 3.9 tt -66.82 122.49 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.208 0.528 . . . . 2.11 110.733 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -133.15 145.49 50.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.515 -0.766 . . . . 2.49 110.582 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.553 HD13 HG22 ' A' ' 125' ' ' THR . 34.3 mt -106.83 143.74 27.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 1.91 109.767 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.71 159.08 50.16 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.557 2.171 . . . . 1.84 111.847 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.87 126.36 27.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.106 -0.497 . . . . 2.53 111.041 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 -11.8 45.5 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.967 -0.853 . . . . 2.2 110.967 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.553 HG22 HD13 ' A' ' 121' ' ' LEU . 10.4 m -108.52 109.01 20.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.269 -0.641 . . . . 2.1 109.269 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.08 147.85 28.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.412 -0.358 . . . . 2.78 111.296 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.494 HD22 ' HD2' ' A' ' 131' ' ' PHE . 27.8 mt -83.46 145.95 49.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.89 -0.596 . . . . 2.62 109.96 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.28 154.57 45.7 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.72 2.28 . . . . 2.77 112.095 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.2 120.87 15.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.01 -0.541 . . . . 4.11 110.462 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.95 4.56 48.14 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.845 -0.693 . . . . 3.18 111.705 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.637 ' HE2' HD13 ' A' ' 16' ' ' LEU . 2.3 t80 -115.57 121.81 43.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.341 -0.614 . . . . 2.91 109.341 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.408 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 29.8 p90 -126.41 140.87 52.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.989 0.423 . . . . 3.54 111.37 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.94 154.43 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.744 -0.662 . . . . 2.93 111.521 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.664 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.4 tt0 -83.59 131.57 34.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.405 -0.816 . . . . 3.64 109.224 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.51 -52.0 2.38 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.964 -0.854 . . . . 3.27 110.964 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 3.59 110.066 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.906 0.384 . . . . 2.48 111.258 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -81.02 162.36 23.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.046 -0.525 . . . . 2.13 110.54 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -98.79 -11.4 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.978 0.362 . . . . 2.4 111.978 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 92.6 m-85 -129.09 176.37 7.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.606 -0.27 . . . . 2.02 111.041 -179.02 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 134' ' ' GLU . 1.9 p -71.69 174.19 7.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.075 -0.511 . . . . 2.65 110.077 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -97.41 167.36 11.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.189 0.519 . . . . 2.4 111.269 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.79 107.05 15.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.552 -0.749 . . . . 2.27 109.28 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -82.43 115.74 21.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.218 -0.446 . . . . 2.84 110.607 -179.943 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -85.33 128.49 34.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 2.89 110.371 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.735 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 42.9 t60 -112.98 -7.67 13.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.752 0.311 . . . . 3.82 111.247 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.76 -159.15 26.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.958 -0.639 . . . . 3.23 111.674 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.37 -32.07 12.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.83 0.315 . . . . 4.27 111.325 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.33 174.78 8.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.893 -0.594 . . . . 3.32 110.179 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -96.78 -82.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 2.39 109.403 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 131' ' ' PHE . 31.6 tp -176.03 130.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 2.06 110.117 179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -153.15 99.14 2.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.187 -0.46 . . . . 2.22 110.647 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 24' ' ' LEU . 16.6 m-85 -89.22 137.05 29.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 1.78 110.511 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.93 158.14 55.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.649 2.232 . . . . 2.15 111.852 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -56.93 118.14 4.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 2.6 111.355 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.35 -13.96 43.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 1.65 112.33 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -115.64 163.9 15.12 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.969 -0.382 . . . . 2.31 109.969 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.448 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 116.0 -19.05 13.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.839 -0.696 . . . . 1.33 112.808 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 49.1 t -86.77 113.76 54.71 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.726 0.298 . . . . 1.06 110.568 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.536 ' HA ' HD23 ' A' ' 121' ' ' LEU . 2.9 Cg_exo -77.26 -174.89 2.39 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.265 2.643 . . . . 1.27 111.794 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.67 81.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 1.7 110.845 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.576 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 63.8 m-80 -81.79 84.18 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.424 . . . . 1.23 109.894 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -32.5 69.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.808 -0.633 . . . . 1.94 112.12 -178.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -76.95 -26.28 53.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 1.96 112.063 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.576 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -91.15 158.28 16.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.064 0.394 . . . . 1.42 112.064 -178.67 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.737 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 46.4 m -86.19 171.96 9.37 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.101 -0.499 . . . . 1.73 110.976 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.737 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.82 -43.53 55.46 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.037 2.491 . . . . 1.42 113.45 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.07 -16.05 60.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.78 111.53 179.966 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.834 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.0 m-20 -81.99 -3.62 54.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.6 111.237 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.478 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 41.0 mm-40 -77.2 51.8 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.3 0.572 . . . . 1.05 111.536 -179.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 94' ' ' ALA . 13.4 tt -150.98 128.03 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.654 -0.703 . . . . 1.17 109.468 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.28 -143.88 4.03 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.217 -0.992 . . . . 0.6 112.542 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -157.69 166.02 33.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.956 0.407 . . . . 0.99 111.001 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.782 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.5 m-85 -107.38 137.87 44.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 1.26 110.062 178.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.456 ' HA ' HD13 ' A' ' 90' ' ' ILE . 19.7 ttt180 -115.07 124.66 52.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.467 . . . . 2.15 110.82 -179.278 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -83.66 121.55 27.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.023 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.02 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 2.21 111.482 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -130.92 160.51 34.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.476 -0.784 . . . . 2.68 108.94 179.084 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 52' ' ' ARG . 5.0 tpt180 -134.77 123.56 23.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.983 0.42 . . . . 3.59 111.769 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 74.9 mtt180 -138.92 115.21 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 3.43 110.942 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.455 ' O ' ' HG2' ' A' ' 61' ' ' MET . 28.5 pt -90.09 149.42 4.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.185 -0.672 . . . . 4.26 109.185 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 120.843 0.354 . . . . 5.17 110.362 -179.787 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 20.8 mtt . . . . . 0 C--O 1.235 0.322 0 N-CA-C 110.337 -0.246 . . . . 4.48 110.337 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -54.37 -46.08 72.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 4.16 110.08 179.013 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 30.2 t70 52.07 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.961 -1.018 . . . . 4.09 113.539 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.67 138.03 31.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.873 -0.603 . . . . 3.36 109.937 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.481 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.7 OUTLIER -60.38 153.17 60.96 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 3.36 110.97 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 114.98 2.05 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.928 2.419 . . . . 2.69 111.89 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.465 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 56.7 mtp180 -110.03 113.18 25.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.776 -0.647 . . . . 3.03 110.046 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.782 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 47.3 m95 -84.91 120.3 26.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.241 -0.436 . . . . 1.84 111.117 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 79.5 m-85 -98.96 150.94 21.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 2.76 110.567 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.32 122.31 43.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.27 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.91 164.53 17.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.839 -0.618 . . . . 1.84 109.745 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.49 155.68 17.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.64 -0.255 . . . . 1.28 110.334 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -60.7 111.88 1.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.224 -179.859 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.63 -8.27 26.07 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.308 -0.949 . . . . 1.66 113.993 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 p -62.89 103.68 0.47 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.66 0.73 . . . . 1.58 111.595 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 127.23 111.95 1.72 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.723 -0.951 . . . . 1.96 110.723 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.423 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 26.2 Cg_endo -62.03 -26.07 78.12 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.762 2.308 . . . . 2.62 112.462 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -117.56 23.99 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 3.09 110.1 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.21 -53.98 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 1.79 111.122 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.2 49.29 80.14 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.877 -0.601 . . . . 1.65 112.146 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.6 mt -131.24 99.47 17.63 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.682 0.277 . . . . 1.38 111.548 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 7.7 Cg_exo -75.35 159.43 40.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.904 2.402 . . . . 1.62 110.974 178.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.768 ' HB2' HD11 ' A' ' 73' ' ' LEU . 79.5 t80 -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 1.58 111.021 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.12 -4.63 16.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.863 -0.684 . . . . 1.44 112.625 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -68.0 130.3 42.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 1.25 111.082 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -77.94 127.01 31.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.835 -0.62 . . . . 1.86 111.498 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.436 ' HG2' HG13 ' A' ' 90' ' ' ILE . 3.8 ttmt -152.12 143.17 23.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.2 -0.667 . . . . 1.68 109.2 178.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.02 118.83 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 1.7 112.1 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.13 33.83 56.33 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.617 -0.72 . . . . 1.27 112.52 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 48' ' ' ARG . 25.1 mm -136.3 112.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.157 -0.312 . . . . 1.01 110.157 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.494 HD13 ' HG ' ' A' ' 24' ' ' LEU . 19.6 pt -115.47 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.811 -0.44 . . . . 1.3 109.811 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -93.48 135.1 35.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 1.08 112.044 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.448 HG11 ' HA3' ' A' ' 31' ' ' GLY . 18.1 m -136.11 140.02 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.563 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.562 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -157.89 144.11 17.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 1.27 110.121 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -110.47 -176.22 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.044 0.45 . . . . 1.36 111.022 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.06 133.28 44.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.677 -0.692 . . . . 2.64 110.725 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.89 -9.1 63.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.719 -0.753 . . . . 1.52 112.444 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -82.89 142.34 31.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.186 -0.301 . . . . 1.59 110.186 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.45 144.0 31.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.714 -0.221 . . . . 2.15 110.584 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -80.47 74.63 7.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 2.07 109.806 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.445 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.8 t -144.8 141.41 17.48 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.558 -0.747 . . . . 2.36 109.019 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.39 130.64 21.5 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.596 2.197 . . . . 2.08 113.351 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.834 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.43 71.41 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.53 -0.759 . . . . 1.78 110.874 179.438 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -16.84 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.76 -0.654 . . . . 2.55 111.548 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -61.0 -7.36 2.41 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.577 0.954 . . . . 2.24 113.577 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.39 -23.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.612 -0.514 . . . . 2.0 109.612 178.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.32 81.53 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.859 -0.61 . . . . 2.33 113.433 -178.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 t -79.08 94.41 5.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.673 0.749 . . . . 2.99 110.644 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -150.81 130.73 13.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.377 -0.829 . . . . 2.83 109.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.21 115.75 64.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.836 -0.431 . . . . 3.56 109.836 179.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.49 0.92 8.98 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.808 2.338 . . . . 3.39 114.198 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.21 -31.7 9.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 4.05 111.126 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.44 -16.85 21.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 4.48 110.596 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -143.19 143.87 31.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 3.39 110.23 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.59 148.44 25.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.525 -0.307 . . . . 3.21 110.45 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.48 160.28 31.72 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.105 -0.498 . . . . 2.85 111.771 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 18.3 mt -86.4 158.77 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.631 -0.713 . . . . 2.42 109.448 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.78 117.8 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.587 0.232 . . . . 2.74 110.462 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.98 113.91 4.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 2.11 110.943 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -133.72 155.75 49.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 2.49 110.306 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 35.6 mt -105.79 146.35 32.68 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.194 -0.457 . . . . 1.91 110.59 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 25.7 Cg_exo -64.66 161.7 34.57 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.861 2.374 . . . . 1.84 112.429 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -53.92 127.09 24.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.98 -0.554 . . . . 2.53 111.181 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.22 -7.7 58.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.765 -0.731 . . . . 2.2 111.697 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -112.79 100.01 8.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 2.1 110.095 179.997 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.01 156.14 18.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.209 -0.45 . . . . 2.78 110.663 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.4 mt -85.21 146.9 46.15 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.71 -0.478 . . . . 2.62 109.71 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.97 143.57 91.41 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.417 2.078 . . . . 2.77 111.56 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -59.54 124.25 19.48 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.89 -0.595 . . . . 4.11 111.245 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.21 45.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.955 -0.641 . . . . 3.18 111.869 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.6 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -109.51 139.13 44.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.695 0.283 . . . . 2.91 110.474 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.735 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 2.5 p90 -135.24 139.82 44.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.416 -0.356 . . . . 3.54 110.582 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.02 128.69 38.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.947 -0.569 . . . . 2.93 110.758 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 49.1 mt-10 -64.14 132.18 49.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.11 -0.495 . . . . 3.64 110.719 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.55 -37.32 3.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.909 -0.662 . . . . 3.27 112.9 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 3.59 111.265 -179.341 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.053 -0.351 . . . . 2.48 110.053 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -69.84 153.66 43.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.462 -0.336 . . . . 2.13 110.758 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -88.12 -9.15 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 2.4 111.109 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.0 m-85 -128.07 162.68 26.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.376 -0.374 . . . . 2.02 111.454 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 p -68.38 162.14 26.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 2.65 111.086 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.05 146.87 31.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 2.4 111.708 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 57.3 mt -97.48 123.87 41.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 2.27 108.935 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.561 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 6.0 m -105.11 128.12 53.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.831 0.348 . . . . 2.84 111.331 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.6 tp-100 -100.9 138.86 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.89 110.633 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -127.41 78.77 1.84 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.791 -0.448 . . . . 3.82 109.791 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.24 -158.91 16.13 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.97 -0.633 . . . . 3.23 111.892 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -94.56 -39.35 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.887 0.375 . . . . 4.27 110.238 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.72 155.74 21.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.985 -0.746 . . . . 3.32 108.985 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.462 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -96.87 -131.23 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.844 0.313 . . . . 2.39 111.844 -179.484 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' CE1' ' A' ' 131' ' ' PHE . 31.2 tp -114.77 135.95 53.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 2.06 112.253 -179.091 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -157.83 116.99 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.554 -0.748 . . . . 2.22 109.084 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 28.6 m-85 -105.89 138.81 19.75 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.78 111.003 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.55 -178.94 2.9 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.847 2.365 . . . . 2.15 112.876 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -66.49 126.7 29.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.532 -0.758 . . . . 2.6 111.583 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 48.77 66.26 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.005 -0.543 . . . . 1.65 112.924 179.364 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -166.49 154.73 10.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.094 -0.336 . . . . 2.31 110.094 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.26 4.98 35.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.56 -0.829 . . . . 1.33 112.925 179.192 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 43' ' ' GLN . 45.0 t -93.04 120.46 66.98 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.632 0.253 . . . . 1.06 110.506 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 121' ' ' LEU . 11.3 Cg_exo -71.97 178.75 5.53 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.069 2.512 . . . . 1.27 111.954 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.09 81.99 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 1.7 109.843 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.538 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 42.5 m-80 -83.3 75.18 9.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 1.23 110.946 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.93 3.62 6.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.395 0.617 . . . . 1.94 110.759 179.529 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -99.09 -8.5 25.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 1.96 110.667 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 1.4 p -134.61 165.33 25.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 1.42 112.056 -178.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -78.92 163.97 57.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 1.73 110.493 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 51.5 Cg_exo -57.11 -31.56 90.7 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.806 2.337 . . . . 1.42 112.566 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.54 -24.29 61.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 1.78 110.472 179.363 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.954 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 21.6 m-20 -84.59 -3.69 58.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.769 -0.651 . . . . 1.6 110.74 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 34.3 mm-40 -78.54 58.06 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 1.05 111.156 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.507 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -153.1 134.44 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.485 -0.561 . . . . 1.17 109.485 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.64 -141.93 4.57 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.322 -0.942 . . . . 0.6 112.663 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -155.1 164.02 39.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.141 0.496 . . . . 0.99 111.479 -178.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.623 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 46.1 m-85 -106.79 131.64 53.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.591 -0.731 . . . . 1.26 109.091 178.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -106.83 127.84 53.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 2.15 111.279 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 49' ' ' ARG . 29.4 ttt-85 -83.34 109.11 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.797 -0.638 . . . . 2.4 109.771 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.95 170.58 9.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.83 0.347 . . . . 2.21 111.316 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 165.67 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.605 . . . . 2.68 110.304 179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -141.32 104.08 4.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 3.59 110.587 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -126.26 107.44 10.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.141 -0.482 . . . . 3.43 111.404 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 62' ' ' LYS . 49.8 pt -70.9 163.7 3.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.449 -0.341 . . . . 4.26 110.679 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.673 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 5.17 111.906 -179.005 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.9 ttm . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.501 -0.185 . . . . 4.48 110.501 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HB2' HG12 ' A' ' 54' ' ' ILE . 48.6 tttp -67.69 -48.05 67.68 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.304 0.377 . . . . 4.16 110.854 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 65.79 99.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.719 -0.673 . . . . 4.09 112.385 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.31 157.51 30.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 3.36 111.062 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -78.73 158.51 75.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.697 -0.683 . . . . 3.36 110.284 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.22 123.94 14.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.949 2.433 . . . . 2.69 111.871 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -122.22 122.56 39.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 3.03 111.053 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.623 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 45.8 m95 -98.72 129.95 45.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.774 -0.648 . . . . 1.84 111.184 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 47.9 m-85 -108.65 138.7 44.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.34 -0.615 . . . . 2.76 109.34 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.48 128.72 36.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 1.27 111.486 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.72 143.21 50.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 1.84 110.369 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -77.4 151.6 34.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.426 -0.352 . . . . 1.28 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -58.82 116.81 4.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 1.66 111.085 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 114.72 -3.37 23.06 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.555 -0.831 . . . . 1.66 113.735 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.41 114.18 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.994 0.397 . . . . 1.58 111.119 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.427 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 107.57 109.6 3.37 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.124 -0.791 . . . . 1.96 111.124 -179.117 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.427 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 14.2 Cg_endo -56.97 -39.61 90.15 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.098 2.532 . . . . 2.62 112.921 -179.013 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.71 31.17 6.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.377 . . . . 3.09 110.989 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.18 -42.94 59.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 1.79 111.137 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.39 51.65 41.49 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.971 -0.633 . . . . 1.65 111.546 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -120.41 97.33 48.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.614 0.245 . . . . 1.38 111.476 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.65 151.32 10.14 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.096 2.531 . . . . 1.62 110.914 178.615 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.71 ' HB2' HD11 ' A' ' 73' ' ' LEU . 68.9 t80 -62.77 111.32 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.368 . . . . 1.58 110.855 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.85 -27.09 5.23 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.456 -0.878 . . . . 1.44 112.201 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.53 122.37 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.683 0.277 . . . . 1.25 110.76 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -87.14 127.34 35.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.958 0.409 . . . . 1.86 111.524 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -139.97 157.89 44.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.728 -0.842 . . . . 1.68 108.728 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.54 115.87 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.229 0.455 . . . . 1.7 112.229 -179.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.55 30.36 62.29 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.27 112.756 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.51 95.19 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 1.01 110.476 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.44 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 27.2 pt -107.75 127.98 63.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.132 -0.486 . . . . 1.3 109.99 178.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.658 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 85.5 m95 -88.02 140.86 29.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.341 0.497 . . . . 1.08 112.341 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.73 146.78 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.446 -0.797 . . . . 1.04 109.781 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -140.9 173.6 11.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.013 0.435 . . . . 1.27 111.226 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.713 HG22 ' HB2' ' A' ' 98' ' ' ALA . 1.4 t -133.49 168.11 19.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.972 -0.558 . . . . 1.36 110.079 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.41 105.35 5.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 2.64 109.829 179.325 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.25 26.39 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.657 -0.782 . . . . 1.52 111.95 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.713 ' HB2' HG22 ' A' ' 95' ' ' THR . . . -78.74 149.47 32.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.754 -0.462 . . . . 1.59 109.754 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 45.3 mt -102.56 123.18 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.889 0.376 . . . . 2.15 110.721 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -76.63 72.3 3.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.584 0.707 . . . . 2.07 110.284 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.693 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 25.5 m -149.47 129.89 6.84 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.54 -0.911 . . . . 2.36 108.54 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.51 125.11 13.25 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.982 2.454 . . . . 2.08 112.418 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.954 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.3 69.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.344 0.593 . . . . 1.78 111.304 -179.488 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 1.2 p-10 -77.42 4.36 11.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.186 -0.461 . . . . 2.55 112.003 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.5 p80 -57.81 -23.15 51.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.949 0.404 . . . . 2.24 111.743 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.84 16.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 2.0 111.147 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.19 -15.98 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.742 -0.742 . . . . 2.33 111.704 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -82.51 123.55 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 2.99 111.157 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -167.63 147.06 4.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 2.83 109.419 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.9 113.19 62.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.071 0.463 . . . . 3.56 110.872 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.78 -35.45 27.63 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.116 2.544 . . . . 3.39 113.875 -178.465 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.36 18.13 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 4.05 111.888 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -141.96 -39.08 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.195 -0.457 . . . . 4.48 110.707 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.271 -0.422 . . . . 3.39 110.911 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.87 146.9 23.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 3.21 110.585 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.17 165.36 21.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 2.85 110.957 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.6 mt -97.67 155.59 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.55 . . . . 2.42 110.077 -179.563 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.415 HG22 ' HA3' ' A' ' 135' ' ' GLY . 65.1 t -68.53 126.8 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.318 -0.253 . . . . 2.74 110.318 179.417 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -70.24 111.51 5.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.92 0.391 . . . . 2.11 110.407 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -128.38 153.57 46.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 2.49 109.952 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 33' ' ' PRO . 93.3 mt -108.18 148.65 37.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.22 -0.445 . . . . 1.91 110.482 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.01 157.03 63.73 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.191 1.927 . . . . 1.84 111.383 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -53.68 124.4 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 2.53 110.877 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.07 -18.24 16.43 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.207 -0.757 . . . . 2.2 111.207 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -94.87 100.19 12.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.031 0.443 . . . . 2.1 110.196 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.5 m -80.0 129.64 34.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 2.78 111.071 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 121' ' ' LEU . 12.7 mt -80.34 137.36 52.32 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 2.62 109.843 179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.7 141.85 97.69 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.546 2.164 . . . . 2.77 111.654 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -60.49 128.03 34.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.039 -0.528 . . . . 4.11 111.033 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.94 -18.95 39.17 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.204 -0.758 . . . . 3.18 111.204 -179.525 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.511 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -95.73 138.21 33.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.647 0.26 . . . . 2.91 110.493 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.561 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 27.2 p90 -136.19 155.24 50.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.453 -0.34 . . . . 3.54 110.397 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.33 123.77 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 2.93 110.072 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.13 128.59 35.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.165 -0.47 . . . . 3.64 110.339 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.415 ' HA3' HG22 ' A' ' 118' ' ' VAL . . . 112.16 -20.45 21.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.795 -0.717 . . . . 3.27 111.355 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.166 0.508 . . . . 3.59 110.333 179.017 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 110.169 -0.308 . . . . 2.48 110.169 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 p -69.78 145.87 51.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.574 -0.285 . . . . 2.13 110.6 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -75.14 -20.22 59.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.44 -0.346 . . . . 2.4 111.377 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 99.5 m-85 -108.16 166.27 10.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.02 112.098 -178.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.89 170.82 13.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.031 -0.986 . . . . 2.65 111.258 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -76.39 140.3 41.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.087 -0.506 . . . . 2.4 111.756 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.827 HD11 HD13 ' A' ' 119' ' ' LEU . 5.1 mp -107.61 115.75 30.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.294 -0.632 . . . . 2.27 109.294 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.437 HG23 ' HB2' ' A' ' 65' ' ' SER . 54.9 m -96.34 129.33 43.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.657 0.614 . . . . 2.84 112.657 -178.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -95.56 128.11 42.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.391 -0.822 . . . . 2.89 109.806 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.29 79.79 1.57 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.804 -0.443 . . . . 3.82 109.804 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.44 -167.54 39.13 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.652 -0.785 . . . . 3.23 111.991 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -81.58 -25.93 35.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.954 0.407 . . . . 4.27 111.681 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -81.35 173.1 12.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 3.32 109.771 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 -70.47 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.122 -0.696 . . . . 2.39 109.122 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.405 HD11 ' CE2' ' A' ' 26' ' ' PHE . 25.5 tp 178.61 127.91 0.06 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.603 -0.726 . . . . 2.06 111.133 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -159.59 107.43 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 2.22 110.24 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.405 ' CE2' HD11 ' A' ' 24' ' ' LEU . 27.3 m-85 -98.11 148.32 34.32 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.049 -0.523 . . . . 1.78 109.737 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.98 162.09 41.88 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.337 2.024 . . . . 2.15 111.251 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -62.22 135.88 57.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 2.6 110.297 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 21.75 58.85 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.549 -0.834 . . . . 1.65 111.748 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -156.81 172.18 19.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.067 -0.345 . . . . 2.31 110.067 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.56 56.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.784 -0.722 . . . . 1.33 112.345 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 43' ' ' GLN . 20.3 t -82.24 119.07 74.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 110.13 -0.322 . . . . 1.06 110.13 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.88 -179.14 5.16 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.299 . . . . 1.27 111.657 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -77.62 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 1.7 110.786 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.57 83.35 8.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.538 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.86 21.79 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.237 0.458 . . . . 1.94 112.237 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -124.44 -17.36 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.586 0.231 . . . . 1.96 111.457 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.523 ' HB3' HG21 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -118.6 168.6 10.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.84 0.352 . . . . 1.42 111.918 -178.382 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.626 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.8 m -86.86 166.3 27.56 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 1.73 110.687 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.4 Cg_endo -53.4 -39.84 80.34 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.268 2.645 . . . . 1.42 113.205 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.54 -13.93 61.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.077 0.465 . . . . 1.78 111.163 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -93.84 -1.63 54.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.614 . . . . 1.6 110.479 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.448 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 37.5 mm-40 -78.38 54.63 1.45 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.08 0.466 . . . . 1.05 111.108 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.754 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.8 tt -147.26 133.92 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.079 -0.51 . . . . 1.17 109.893 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.42 -144.4 4.99 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.432 -0.889 . . . . 0.6 112.477 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -156.15 164.43 38.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 0.99 110.935 -179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.49 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 34.7 m-85 -107.67 130.79 54.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.055 -0.721 . . . . 1.26 109.055 178.393 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HG3' HD11 ' A' ' 90' ' ' ILE . 22.3 ttt180 -110.09 135.39 50.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.089 0.243 . . . . 2.15 110.922 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -87.18 123.25 32.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.799 -0.445 . . . . 2.4 109.799 178.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.448 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -128.54 154.47 46.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.243 0.544 . . . . 2.21 111.399 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -154.26 111.4 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.483 -0.781 . . . . 2.68 109.828 179.241 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HB3' HD12 ' A' ' 64' ' ' LEU . 20.5 tpt180 -93.27 127.29 38.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.153 0.501 . . . . 3.59 110.917 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -128.59 141.13 51.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.478 -0.783 . . . . 3.43 109.922 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.755 HG12 ' H ' ' A' ' 62' ' ' LYS . 34.8 pt -92.83 175.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.203 -0.666 . . . . 4.26 109.203 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.673 0 N-CA-C 110.256 -0.275 . . . . 5.17 110.256 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 mmt . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.46 -0.941 . . . . 4.48 108.46 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.755 ' H ' HG12 ' A' ' 54' ' ' ILE . 53.5 tttt -49.94 -43.57 49.98 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.189 0.306 . . . . 4.16 110.615 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 43.95 71.56 0.24 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.432 -0.804 . . . . 4.09 112.748 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.613 HD12 ' HB3' ' A' ' 52' ' ' ARG . 98.2 mt -67.04 145.35 55.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.002 -0.545 . . . . 3.36 110.363 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.437 ' HB2' HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -68.52 162.58 61.21 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.747 -0.464 . . . . 3.36 109.747 179.517 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.93 102.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.655 2.236 . . . . 2.69 111.858 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.418 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 3.1 mtp180 -108.74 122.69 47.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 3.03 110.893 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.49 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.0 m95 -98.27 145.17 26.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.84 110.042 179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 81.1 m-85 -128.01 137.98 52.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.762 -0.459 . . . . 2.76 109.762 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -88.49 128.98 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 1.27 111.444 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -128.13 150.57 49.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.806 -0.634 . . . . 1.84 109.686 178.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -84.53 156.78 21.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.941 0.401 . . . . 1.28 111.008 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.642 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.6 tt -64.0 115.01 4.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.408 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 113.46 1.17 24.76 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.731 -0.747 . . . . 1.66 113.769 179.033 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.8 p -58.47 110.18 0.93 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.192 0.496 . . . . 1.58 110.885 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 104.26 111.59 3.61 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.302 -0.719 . . . . 1.96 111.302 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.438 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 31.0 Cg_endo -63.21 -18.11 63.31 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.707 2.271 . . . . 2.62 112.134 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -119.54 24.15 10.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.456 -0.338 . . . . 3.09 111.45 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.95 -48.84 15.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 1.79 110.51 179.572 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.36 49.45 74.02 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.885 -0.598 . . . . 1.65 111.821 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.422 HD21 ' HD2' ' A' ' 87' ' ' LYS . 87.8 mt -119.72 100.06 49.17 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.866 0.365 . . . . 1.38 111.619 -179.314 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.22 153.28 14.16 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.464 2.11 . . . . 1.62 111.206 178.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.3 t80 -58.61 115.14 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 1.58 110.781 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.13 10.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.815 -0.707 . . . . 1.44 112.195 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.56 107.38 3.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 1.25 110.344 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.77 104.75 5.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.963 -0.562 . . . . 1.86 110.506 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.512 ' HB3' HG13 ' A' ' 90' ' ' ILE . 67.7 tttt -112.22 160.6 17.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.949 -0.569 . . . . 1.68 110.093 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.04 112.2 2.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.465 . . . . 1.7 111.298 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.33 32.17 65.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.923 -0.656 . . . . 1.27 112.327 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.512 HG13 ' HB3' ' A' ' 87' ' ' LYS . 36.6 mm -130.06 112.7 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.629 0.252 . . . . 1.01 110.601 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.434 HG13 ' HB2' ' A' ' 47' ' ' TYR . 7.0 pt -118.46 123.84 72.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.864 0.364 . . . . 1.3 110.428 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.637 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 89.7 m95 -82.61 137.95 34.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.069 -0.514 . . . . 1.08 111.769 -179.106 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.83 135.73 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 1.04 110.58 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.26 170.87 15.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 1.27 110.584 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -150.19 179.23 8.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.414 -0.587 . . . . 1.36 109.414 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -66.05 132.07 47.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.65 0.262 . . . . 2.64 110.382 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.66 32.88 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.854 -0.689 . . . . 1.52 111.53 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.754 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.18 134.3 36.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.117 -0.327 . . . . 1.59 110.117 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.92 149.05 26.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.387 -0.37 . . . . 2.15 110.634 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.73 74.03 5.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.521 0.677 . . . . 2.07 110.409 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -138.51 130.05 15.6 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.496 -0.774 . . . . 2.36 110.323 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.6 122.37 5.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.32 2.013 . . . . 2.08 111.466 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.745 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -146.07 106.29 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.103 -0.499 . . . . 1.78 111.402 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 5.0 p-10 -89.18 8.06 32.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.56 . . . . 2.55 112.164 -178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.745 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 6.4 p80 -56.73 -28.66 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.212 0.529 . . . . 2.24 111.594 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.523 HG21 ' HB3' ' A' ' 38' ' ' SER . 1.0 OUTLIER -99.13 5.42 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 2.0 110.913 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.95 -21.62 22.75 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.778 -0.725 . . . . 2.33 112.248 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.6 t -74.97 105.62 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.492 0.663 . . . . 2.99 111.261 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -149.75 125.49 10.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.668 -0.696 . . . . 2.83 109.742 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.7 m-80 -84.74 114.28 54.49 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.894 0.378 . . . . 3.56 110.341 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 28.4 Cg_endo -60.67 -34.6 91.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.181 2.588 . . . . 3.39 113.449 -178.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.35 15.68 11.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.151 0.426 . . . . 4.05 112.151 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.48 -20.64 1.59 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.893 0.377 . . . . 4.48 111.664 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -131.78 137.4 48.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.694 0.283 . . . . 3.39 110.365 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.21 146.74 28.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.253 -0.431 . . . . 3.21 110.969 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.33 157.61 32.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.407 0.622 . . . . 2.85 111.904 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 62.4 mt -102.21 137.59 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.417 -0.81 . . . . 2.42 109.765 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.42 121.4 13.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.12 -0.696 . . . . 2.74 109.12 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 16' ' ' LEU . 3.9 tt -63.44 117.9 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 2.11 111.549 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -126.75 141.58 51.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.443 -0.799 . . . . 2.49 109.816 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 79.9 mt -105.62 145.04 30.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.258 -0.428 . . . . 1.91 110.344 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.56 150.84 79.49 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.702 2.268 . . . . 1.84 111.557 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.67 98.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 2.53 110.888 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 143.94 -30.74 1.9 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.96 -0.638 . . . . 2.2 111.574 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 24.1 m -84.44 115.04 22.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.69 0.281 . . . . 2.1 110.369 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 137.17 37.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.272 -0.422 . . . . 2.78 110.904 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.496 HD22 ' HD2' ' A' ' 131' ' ' PHE . 20.2 mt -74.97 149.02 85.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 2.62 110.875 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.35 161.75 19.32 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.817 2.345 . . . . 2.77 112.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.85 119.26 10.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.836 -0.62 . . . . 4.11 111.597 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.55 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.137 -0.554 . . . . 3.18 112.923 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.496 ' HD2' HD22 ' A' ' 127' ' ' LEU . 18.4 t80 -106.25 126.98 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.728 0.299 . . . . 2.91 110.464 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.78 164.02 34.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.033 -0.53 . . . . 3.54 110.635 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' LEU . . . -110.48 156.36 20.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.509 -0.314 . . . . 2.93 110.802 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.63 132.54 42.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.89 -0.595 . . . . 3.64 110.773 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.48 -45.15 1.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.097 -0.573 . . . . 3.27 112.936 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 3.59 110.588 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.891 0.377 . . . . 2.48 111.055 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -85.29 155.05 21.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.109 -0.496 . . . . 2.13 110.373 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.63 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 23.2 m95 -78.77 -28.29 44.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.442 . . . . 2.4 111.191 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.586 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 29.0 m-85 -99.33 173.81 6.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.737 -0.665 . . . . 2.02 110.957 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -78.8 -142.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.675 -0.693 . . . . 2.65 110.353 179.587 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' H ' ' HB ' ' A' ' 14' ' ' THR . . . -131.74 146.59 52.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.963 0.411 . . . . 2.4 111.566 -179.489 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.669 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.6 mt -96.99 120.02 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 2.27 109.112 178.722 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -92.97 122.99 35.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.433 -0.349 . . . . 2.84 111.249 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.3 tp-100 -101.22 145.02 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 2.89 110.067 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -140.58 89.47 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.384 -0.599 . . . . 3.82 109.384 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.38 -167.42 40.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.535 -0.84 . . . . 3.23 112.497 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -81.66 -36.47 28.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 4.27 110.605 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -75.59 154.68 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.47 -0.786 . . . . 3.32 110.671 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.02 -89.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.218 -0.446 . . . . 2.39 110.549 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.599 HD13 ' CE1' ' A' ' 131' ' ' PHE . 29.3 tp -168.71 134.61 1.76 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.985 0.421 . . . . 2.06 111.837 179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -163.42 120.18 1.8 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.765 -0.652 . . . . 2.22 110.221 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -106.09 137.17 19.3 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.026 -0.534 . . . . 1.78 110.156 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.7 163.53 30.05 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.547 2.165 . . . . 2.15 111.908 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -63.64 103.19 0.52 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.159 0.504 . . . . 2.6 110.967 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.09 -9.19 8.46 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.794 -0.639 . . . . 1.65 111.873 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -120.43 163.07 18.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.765 0.317 . . . . 2.31 110.368 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -6.7 28.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.902 -0.666 . . . . 1.33 112.421 179.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 t -88.72 117.39 68.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.762 0.315 . . . . 1.06 110.307 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.04 -169.04 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.902 2.401 . . . . 1.27 111.718 -179.75 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.437 ' O ' ' HZ ' ' A' ' 13' ' ' PHE . 18.1 mt -82.58 77.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.08 0.467 . . . . 1.7 109.817 179.319 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.524 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 78.6 m-20 -78.4 78.06 4.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.58 . . . . 1.23 110.823 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.94 -1.55 26.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.113 -0.494 . . . . 1.94 111.238 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.21 2.67 22.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.96 110.652 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.89 155.16 46.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 1.42 111.284 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 19.8 m -86.61 169.08 15.98 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.929 -0.578 . . . . 1.73 110.318 179.432 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 88.0 Cg_exo -47.62 -40.24 30.36 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.484 2.789 . . . . 1.42 114.252 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -17.44 44.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.732 0.301 . . . . 1.78 111.609 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.856 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -89.14 8.67 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 1.6 110.788 -179.628 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.524 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 85.1 mm-40 -80.76 0.57 34.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 1.05 112.104 -179.162 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.902 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.2 tt -89.51 126.62 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.975 0.417 . . . . 1.17 111.086 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.61 -152.2 6.28 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.345 -0.931 . . . . 0.6 112.919 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.444 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 44.0 p90 -163.19 170.9 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.917 0.389 . . . . 0.99 110.547 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.608 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 4.5 m-85 -111.46 138.22 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.213 -0.449 . . . . 1.26 110.422 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -117.94 127.44 53.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 2.15 110.819 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -79.01 126.92 31.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 2.4 109.95 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.01 151.82 42.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.005 0.431 . . . . 2.21 111.88 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 m -143.51 132.42 22.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 2.68 109.819 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HB3' HD12 ' A' ' 64' ' ' LEU . 2.2 tpt180 -106.91 138.04 43.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.093 -0.336 . . . . 3.59 110.093 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -147.43 128.03 14.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.83 0.348 . . . . 3.43 111.851 -178.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.63 HG12 ' HB2' ' A' ' 62' ' ' LYS . 41.3 pt -81.41 151.67 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.802 -0.814 . . . . 4.26 108.802 178.389 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--N 1.319 -0.734 0 C-N-CA 120.554 -0.458 . . . . 5.17 111.74 -179.412 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 mmt . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.615 0.245 . . . . 4.48 110.909 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.63 ' HB2' HG12 ' A' ' 54' ' ' ILE . 75.9 tttt -66.84 -35.71 80.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.028 -0.73 . . . . 4.16 109.028 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 50.12 82.86 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.748 -1.114 . . . . 4.09 113.047 179.071 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 52' ' ' ARG . 9.0 mt -82.57 168.13 17.65 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.944 -0.571 . . . . 3.36 110.507 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -90.5 155.04 46.39 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.028 -0.533 . . . . 3.36 110.441 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.72 116.22 2.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.809 2.339 . . . . 2.69 111.757 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 29.3 mtt180 -115.79 119.03 34.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 3.03 111.265 -179.2 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.608 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 53.7 m95 -93.78 124.03 37.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 1.84 110.401 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -102.89 138.92 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.222 -0.444 . . . . 2.76 110.201 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -90.35 124.79 35.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.084 0.469 . . . . 1.27 111.344 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.0 167.75 12.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 1.84 109.894 179.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -108.02 151.58 25.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.688 -0.233 . . . . 1.28 110.43 -179.253 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.32 110.94 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.4 -0.364 . . . . 1.66 110.465 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.96 -15.55 6.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.763 -0.732 . . . . 1.66 112.357 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.71 HG22 ' HA3' ' A' ' 107' ' ' GLY . 9.5 p -59.13 125.77 24.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.571 0.224 . . . . 1.58 111.006 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.02 110.47 3.3 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.795 -0.717 . . . . 1.96 111.587 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.93 -37.0 97.8 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.006 2.47 . . . . 2.62 112.948 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -117.46 34.35 5.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 3.09 110.491 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.38 -52.23 29.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.79 110.379 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.34 46.47 93.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.977 -0.63 . . . . 1.65 111.693 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.1 mt -120.06 97.73 49.28 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.55 0.204 . . . . 1.38 111.55 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.22 147.43 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.896 2.398 . . . . 1.62 110.65 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 44.5 t80 -58.54 104.83 0.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 1.58 111.142 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.35 -16.69 5.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.852 -0.689 . . . . 1.44 111.878 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.48 20.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 1.25 110.753 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -80.93 119.34 23.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.007 -0.542 . . . . 1.86 110.75 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.531 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 9.1 ttmt -135.25 149.69 49.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.069 -0.514 . . . . 1.68 109.832 179.196 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.96 110.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.326 0.584 . . . . 1.7 112.123 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.68 64.76 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.697 -0.683 . . . . 1.27 112.964 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 38.1 mm -128.05 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 1.01 110.641 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 47' ' ' TYR . 13.2 pt -117.62 133.48 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.112 -0.494 . . . . 1.3 109.765 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.55 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 73.6 m95 -89.04 140.07 29.82 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.385 . . . . 1.08 112.038 -178.373 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 m -136.32 131.06 48.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.741 -0.663 . . . . 1.04 110.884 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.12 169.47 20.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.138 -0.483 . . . . 1.27 110.89 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -148.4 -169.99 3.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.535 -0.543 . . . . 1.36 109.535 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.91 136.84 57.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.875 0.369 . . . . 2.64 110.827 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.94 -25.15 27.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.148 -0.549 . . . . 1.52 112.404 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.902 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.45 136.24 45.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.813 0.339 . . . . 1.59 110.452 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.96 140.55 38.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.117 -0.492 . . . . 2.15 110.72 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -76.79 78.29 3.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.77 -0.455 . . . . 2.07 109.77 179.278 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.524 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 81.6 m -150.31 128.94 6.06 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.971 -0.752 . . . . 2.36 108.971 -179.394 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.71 124.54 12.49 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.602 2.201 . . . . 2.08 111.834 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.856 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.21 95.83 4.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 1.78 110.954 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.12 -5.91 58.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 2.55 112.427 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 14.8 p80 -61.44 -21.07 63.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.477 0.547 . . . . 2.24 112.477 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.666 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -102.02 12.26 7.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 2.0 111.363 -179.79 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.71 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -124.89 38.29 2.37 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.653 -0.784 . . . . 2.33 111.4 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -131.74 33.46 3.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.597 0.713 . . . . 2.99 110.658 -179.152 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HD3' ' HA ' ' A' ' 12' ' ' TRP . 54.0 ttp85 -72.99 137.63 45.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.895 -0.593 . . . . 2.83 111.258 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -98.43 107.68 43.48 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.17 -0.678 . . . . 3.56 109.17 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.64 -14.24 36.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.876 2.384 . . . . 3.39 113.652 -178.51 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.46 -25.03 27.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.663 0.268 . . . . 4.05 111.425 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -121.99 29.86 6.88 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.543 -0.299 . . . . 4.48 111.56 -179.484 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.433 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 9.7 t-20 -174.03 140.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 3.39 110.857 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.28 142.82 26.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.207 -0.451 . . . . 3.21 110.1 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.83 145.83 50.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.259 -0.428 . . . . 2.85 111.23 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.0 mt -78.53 139.54 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.118 -0.492 . . . . 2.42 109.889 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.98 122.14 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 2.74 110.183 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.586 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 1.2 tt -59.75 109.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 2.11 111.231 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.64 152.07 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.759 -0.655 . . . . 2.49 110.182 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 67.3 mt -108.65 153.09 42.42 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.128 -0.487 . . . . 1.91 110.228 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.32 172.21 8.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.13 . . . . 1.84 112.337 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.16 131.97 50.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 2.53 111.203 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.89 36.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.91 -0.662 . . . . 2.2 112.704 179.348 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 3.1 m -85.64 107.79 17.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.913 0.387 . . . . 2.1 110.134 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.52 143.25 26.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 2.78 111.825 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.8 143.61 50.59 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 2.62 109.943 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.16 146.69 95.95 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.57 2.18 . . . . 2.77 111.663 179.244 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -61.15 119.27 8.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 4.11 111.398 -179.331 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.89 -13.49 29.34 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.923 -0.656 . . . . 3.18 111.991 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.669 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -97.16 133.58 41.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.596 0.236 . . . . 2.91 110.742 179.647 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -144.65 144.55 31.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 3.54 110.269 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.55 150.56 26.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.83 0.348 . . . . 2.93 111.358 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.09 135.74 39.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.565 -0.531 . . . . 3.64 109.565 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.43 69.5 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 3.27 112.399 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 3.59 110.141 -179.993 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.103 -0.332 . . . . 2.48 110.103 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -109.18 130.24 55.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.639 -0.255 . . . . 2.13 110.492 179.586 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.59 -25.75 62.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 2.4 110.753 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 95.6 m-85 -118.34 168.37 10.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.777 -0.647 . . . . 2.02 110.874 -179.543 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 2.5 p -68.47 170.16 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 2.65 110.221 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 149.73 27.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.363 0.602 . . . . 2.4 112.008 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.817 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 12.1 mt -94.77 116.58 28.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 2.27 109.54 178.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.1 112.12 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.31 -0.405 . . . . 2.84 111.763 -179.355 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -91.82 135.13 34.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 2.89 111.01 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -137.48 83.23 1.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 3.82 109.472 178.378 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.35 -166.46 30.18 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.859 -0.686 . . . . 3.23 111.968 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.18 -19.43 28.44 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.352 . . . . 4.27 111.949 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -100.98 170.43 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.66 0.267 . . . . 3.32 110.671 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 t0 -92.43 -61.49 1.59 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.074 -0.343 . . . . 2.39 110.074 179.454 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD13 ' CE1' ' A' ' 131' ' ' PHE . 30.3 tp 169.76 137.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.742 0.651 . . . . 2.06 110.901 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -155.94 119.59 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 2.22 109.686 178.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 36.5 m-85 -101.34 144.67 29.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.297 -0.41 . . . . 1.78 111.127 -179.473 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 13.5 Cg_exo -71.34 177.67 6.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.274 2.649 . . . . 2.15 112.341 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -70.25 118.56 13.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 2.6 111.017 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.25 68.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.108 -0.568 . . . . 1.65 113.196 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.511 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -141.39 146.31 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.462 . . . . 2.31 109.754 179.92 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.68 -5.46 12.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.581 -0.818 . . . . 1.33 112.386 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.15 115.66 64.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.921 -0.399 . . . . 1.06 109.921 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HA ' HD23 ' A' ' 121' ' ' LEU . 58.2 Cg_endo -71.69 177.06 7.32 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.63 2.22 . . . . 1.27 112.383 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.2 mt -75.72 88.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 1.7 110.407 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.467 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 69.1 m-80 -80.47 82.85 6.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.23 110.263 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.46 26.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.659 -0.7 . . . . 1.94 112.182 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -137.13 -4.04 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.047 0.451 . . . . 1.96 110.328 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -126.47 148.37 49.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.022 -0.536 . . . . 1.42 111.363 -178.751 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.05 166.56 32.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.071 -0.513 . . . . 1.73 110.495 179.345 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.83 -35.25 78.71 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.861 2.374 . . . . 1.42 113.097 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 11.9 p-10 -85.68 -7.07 59.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.718 0.294 . . . . 1.78 111.281 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.39 10.2 40.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.519 . . . . 1.6 110.014 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -84.68 3.42 37.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 1.05 111.447 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.574 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.2 tt -85.5 124.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.068 0.461 . . . . 1.17 111.068 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 73' ' ' LEU . . . -159.77 -153.81 7.03 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.355 -0.926 . . . . 0.6 113.125 -179.458 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -161.84 173.09 15.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.805 0.336 . . . . 0.99 110.694 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.513 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 10.2 m-85 -116.96 140.88 48.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.949 -0.569 . . . . 1.26 110.281 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -121.63 139.1 53.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.605 -0.517 . . . . 2.15 109.605 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -84.67 133.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.121 0.486 . . . . 2.4 111.009 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.24 147.97 51.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.239 0.542 . . . . 2.21 111.016 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -138.04 128.13 25.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.609 -0.515 . . . . 2.68 109.609 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -113.47 123.67 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.961 -0.296 . . . . 3.59 110.962 -179.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -147.69 95.8 2.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.407 -0.36 . . . . 3.43 111.099 179.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.01 169.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.565 -0.532 . . . . 4.26 109.565 178.745 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 120.974 0.416 . . . . 5.17 111.366 179.922 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 C--O 1.233 0.185 0 N-CA-C 110.133 -0.321 . . . . 4.48 110.133 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -60.09 -51.48 69.44 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.181 -0.303 . . . . 4.16 110.181 178.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.42 105.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.289 0.848 . . . . 4.09 113.289 178.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -108.53 140.5 41.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.997 -0.547 . . . . 3.36 110.635 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.82 159.88 9.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 3.36 110.897 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.1 108.9 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.037 2.492 . . . . 2.69 111.768 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -95.8 103.73 15.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.577 -0.738 . . . . 3.03 110.731 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.513 ' CE3' ' HB3' ' A' ' 47' ' ' TYR . 67.8 m95 -83.36 115.51 22.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 1.84 110.987 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -99.12 137.98 36.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.807 -0.633 . . . . 2.76 110.413 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -97.2 132.38 43.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 1.27 110.561 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.54 168.73 17.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 1.84 109.84 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -100.39 156.15 17.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 1.28 110.117 179.551 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 102' ' ' PRO . 14.5 tp -63.36 103.68 0.53 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.519 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 115.24 -2.38 22.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.282 -0.961 . . . . 1.66 113.787 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.567 HG22 ' HA3' ' A' ' 107' ' ' GLY . 5.8 p -59.04 114.0 2.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.118 0.459 . . . . 1.58 111.761 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 117.19 108.09 2.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.866 -0.683 . . . . 1.96 111.535 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 12.8 Cg_endo -57.34 -30.09 86.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.077 2.518 . . . . 2.62 112.789 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.77 42.74 2.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.145 0.498 . . . . 3.09 111.302 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.73 -55.08 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 1.79 110.568 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 42.89 79.11 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.937 -0.649 . . . . 1.65 112.373 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.9 mt -121.01 102.43 43.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.837 0.351 . . . . 1.38 111.701 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.711 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 1.3 Cg_endo -84.49 165.47 12.37 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.006 2.471 . . . . 1.62 110.635 178.639 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.73 112.96 2.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.933 0.397 . . . . 1.58 110.814 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.98 -12.88 14.45 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.979 -0.629 . . . . 1.44 112.608 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.711 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -56.23 116.53 3.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.049 0.452 . . . . 1.25 111.274 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -87.95 120.01 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 1.86 110.569 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 88' ' ' ASP . 29.5 mttt -134.63 -148.48 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.273 -0.421 . . . . 1.68 110.384 179.523 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 87' ' ' LYS . 16.3 t70 -108.05 103.29 12.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.004 0.431 . . . . 1.7 110.852 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.47 36.9 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.761 -0.733 . . . . 1.27 112.393 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mm -122.38 113.21 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.68 0.276 . . . . 1.01 110.319 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.0 122.58 67.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 1.3 110.176 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -88.01 145.83 25.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.133 -0.485 . . . . 1.08 111.87 -178.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.3 129.44 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 1.04 111.465 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.97 153.15 40.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.528 . . . . 1.27 110.403 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 t -132.13 -176.52 4.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.143 -0.48 . . . . 1.36 110.063 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.43 135.16 54.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.075 0.464 . . . . 2.64 110.67 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.95 58.58 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.906 -0.588 . . . . 1.52 112.165 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -78.86 144.36 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.847 0.356 . . . . 1.59 110.989 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -112.24 145.79 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.864 -0.607 . . . . 2.15 109.952 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -85.37 86.18 7.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.813 0.339 . . . . 2.07 110.826 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 m -157.24 137.29 8.77 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.67 -0.695 . . . . 2.36 109.215 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.7 Cg_endo -52.92 111.28 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.107 2.538 . . . . 2.08 112.439 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -101.83 47.04 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 1.78 109.802 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 3.9 p30 -70.25 -15.3 62.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.972 -0.558 . . . . 2.55 112.09 -179.016 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -57.44 -20.73 32.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.526 0.565 . . . . 2.24 112.526 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 pt -113.92 12.64 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.472 . . . . 2.0 110.85 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -86.98 -39.59 7.42 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.868 -0.682 . . . . 2.33 112.162 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 t -65.69 124.69 23.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.195 0.521 . . . . 2.99 111.237 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -158.33 132.6 8.04 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.411 -0.588 . . . . 2.83 109.411 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 38.3 t-20 -96.91 113.04 62.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.271 -0.27 . . . . 3.56 110.271 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 33.9 Cg_endo -64.61 -18.9 64.23 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.96 2.44 . . . . 3.39 112.711 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.45 0.97 57.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.035 0.445 . . . . 4.05 110.839 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -136.51 13.01 3.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 4.48 110.723 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -171.85 132.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 3.39 109.828 -179.142 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.98 153.53 20.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.777 0.322 . . . . 3.21 110.54 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.5 153.98 25.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.094 0.473 . . . . 2.85 111.122 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 17.9 mt -92.85 145.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.882 -0.599 . . . . 2.42 109.717 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.82 125.79 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.908 -0.404 . . . . 2.74 109.908 179.169 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.617 HD13 ' HG ' ' A' ' 16' ' ' LEU . 1.9 tt -58.46 113.87 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.264 0.554 . . . . 2.11 111.069 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -127.7 142.38 51.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.674 -0.693 . . . . 2.49 110.462 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' A' ' 127' ' ' LEU . 21.3 mt -103.63 148.37 35.67 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 1.91 110.013 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.98 155.94 57.55 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.535 2.157 . . . . 1.84 111.599 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -58.46 122.91 14.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 2.53 110.138 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.68 -11.28 42.12 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.212 -0.755 . . . . 2.2 111.212 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.437 HG22 HD13 ' A' ' 121' ' ' LEU . 4.7 m -104.18 105.89 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.638 -0.504 . . . . 2.1 109.638 179.432 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.35 159.36 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.886 -0.597 . . . . 2.78 111.823 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' A' ' 121' ' ' LEU . 15.8 mt -99.87 147.87 34.02 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 2.62 109.796 179.002 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.85 159.23 34.28 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.502 2.135 . . . . 2.77 111.666 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -73.36 134.78 44.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.917 0.389 . . . . 4.11 110.235 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.8 13.29 67.26 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.145 -0.782 . . . . 3.18 111.145 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.817 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -127.84 122.02 31.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.001 -0.37 . . . . 2.91 110.001 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -129.01 146.78 50.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 3.54 110.891 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -88.18 127.53 35.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 2.93 110.806 -179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 26.3 tt0 -58.88 129.88 44.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.971 -0.559 . . . . 3.64 110.521 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.13 -4.37 67.53 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.961 -0.638 . . . . 3.27 112.053 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.325 -0.498 0 N-CA-C 110.275 -0.268 . . . . 3.59 110.275 179.951 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB2' ' HG3' ' A' ' 111' ' ' PRO . . . . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.644 0.259 . . . . 2.48 110.396 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 p -78.53 151.28 32.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.303 -0.408 . . . . 2.13 111.1 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.583 ' HA ' HH11 ' A' ' 109' ' ' ARG . 92.9 m95 -81.02 -28.56 35.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 2.4 110.622 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 53.7 m-85 -103.54 159.21 15.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 2.02 111.403 -179.125 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.26 166.3 18.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.822 -0.627 . . . . 2.65 110.767 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.69 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -82.19 142.59 32.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.416 . . . . 2.4 111.443 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.522 HD13 ' HE2' ' A' ' 131' ' ' PHE . 28.7 mt -97.31 145.99 25.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.1 -0.704 . . . . 2.27 109.1 179.213 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.52 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -120.26 140.41 51.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 2.84 111.908 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -109.1 120.94 44.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 2.89 111.06 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.72 71.12 0.75 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.336 0.588 . . . . 3.82 109.645 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.43 -163.01 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.695 -0.764 . . . . 3.23 111.815 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -88.8 -39.66 13.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 4.27 111.0 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.31 171.12 15.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.746 -0.464 . . . . 3.32 109.746 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -98.75 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.817 -0.353 . . . . 2.39 111.727 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -151.4 140.5 21.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 2.06 111.648 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -171.42 100.13 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.324 -0.853 . . . . 2.22 109.046 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 59.9 m-85 -86.72 153.95 55.61 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.362 -0.381 . . . . 1.78 111.196 -179.597 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 3.0 Cg_exo -75.15 161.97 37.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.031 2.488 . . . . 2.15 111.717 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.22 131.72 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 2.6 110.543 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.5 74.68 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.218 -0.753 . . . . 1.65 111.218 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 11.5 tt0 -138.65 172.22 13.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.284 -0.636 . . . . 2.31 109.284 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' H ' ' HG2' ' A' ' 30' ' ' GLN . . . 101.99 -2.79 51.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.547 -0.835 . . . . 1.33 112.116 179.612 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.86 115.55 65.73 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.391 -0.596 . . . . 1.06 109.391 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.81 -173.39 1.8 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.0 2.467 . . . . 1.27 111.86 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.459 HG22 HG23 ' A' ' 36' ' ' THR . 63.4 mt -74.64 93.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.339 0.59 . . . . 1.7 110.154 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.439 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 51.9 m-20 -83.6 78.73 9.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.672 -0.694 . . . . 1.23 110.989 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -79.11 37.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.105 -0.498 . . . . 1.94 112.147 -179.389 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.73 -2.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.061 0.457 . . . . 1.96 111.443 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -122.14 150.17 42.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.338 -0.392 . . . . 1.42 111.336 -178.83 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.12 167.64 33.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 1.73 110.246 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -36.56 79.52 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.788 2.325 . . . . 1.42 113.011 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.731 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -78.56 -13.64 59.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.582 0.229 . . . . 1.78 111.396 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.903 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 25.5 m-20 -90.32 5.63 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 1.6 111.184 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -82.52 54.97 2.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.237 0.541 . . . . 1.05 111.232 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 94' ' ' ALA . 14.8 tt -151.29 132.83 5.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.632 -0.713 . . . . 1.17 110.236 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.9 -144.75 4.74 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.249 -0.976 . . . . 0.6 112.879 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -158.5 170.59 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.158 0.504 . . . . 0.99 110.735 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.735 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 29.8 m-85 -115.98 136.53 52.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.827 -0.624 . . . . 1.26 109.323 178.726 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -115.64 131.18 57.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 2.15 111.163 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -85.04 120.82 26.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.659 -0.701 . . . . 2.4 109.515 179.008 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.466 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -133.29 157.54 45.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.316 0.579 . . . . 2.21 111.932 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -146.98 114.37 6.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.758 -0.655 . . . . 2.68 110.759 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -78.52 119.23 21.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.996 0.427 . . . . 3.59 110.574 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -144.59 123.7 12.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 3.43 110.772 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.604 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -106.96 169.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 4.26 109.872 179.159 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 120.959 0.409 . . . . 5.17 110.687 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.503 0.192 . . . . 4.48 110.966 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -53.44 -55.9 21.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 4.16 110.497 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.42 99.32 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.277 0.843 . . . . 4.09 113.277 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 64' ' ' LEU . 11.1 mt -97.21 150.27 21.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 3.36 110.916 179.899 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.6 154.56 94.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.861 -0.609 . . . . 3.36 110.483 179.207 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.52 117.63 4.37 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.668 2.245 . . . . 2.69 111.017 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.69 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 48.0 mtt180 -119.35 140.01 51.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 3.03 111.402 -178.732 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.735 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 43.2 m95 -103.54 131.48 50.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 1.84 110.353 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 39.4 m-85 -111.09 139.21 46.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.719 -0.474 . . . . 2.76 109.719 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.19 130.55 35.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.688 0.28 . . . . 1.27 111.041 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.445 ' HD2' HG21 ' A' ' 75' ' ' THR . 41.5 m-85 -133.88 158.31 43.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.96 -0.564 . . . . 1.84 110.33 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -92.97 165.34 12.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.632 -0.258 . . . . 1.28 110.865 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.1 tt -57.78 118.99 5.88 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.309 0.381 . . . . 1.66 111.294 -179.513 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.44 53.98 8.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.062 -0.589 . . . . 1.66 112.966 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.445 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -86.55 48.11 1.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 1.58 111.11 -179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.44 137.02 4.23 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.093 -0.803 . . . . 1.96 111.093 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.39 -37.61 94.15 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.987 2.458 . . . . 2.62 112.482 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.09 35.95 4.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 3.09 110.574 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -49.78 49.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.79 110.823 -179.626 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.45 41.1 96.55 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.832 -0.622 . . . . 1.65 112.164 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.17 99.04 46.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.629 0.252 . . . . 1.38 111.426 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 89.2 Cg_endo -82.32 165.44 16.61 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 1.62 110.921 178.601 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.51 ' HB2' HD11 ' A' ' 73' ' ' LEU . 74.4 t80 -61.91 106.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 1.58 110.73 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.48 3.96 12.32 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.676 -0.773 . . . . 1.44 112.347 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.627 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -70.51 122.44 19.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 1.25 110.361 179.286 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -75.49 115.69 15.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.076 -0.511 . . . . 1.86 111.339 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 12.3 tttt -148.79 144.34 26.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 1.68 110.06 179.525 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.09 126.18 28.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.37 . . . . 1.7 111.055 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.58 77.25 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.032 -0.604 . . . . 1.27 112.219 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 29.5 mm -129.66 107.51 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.798 0.333 . . . . 1.01 110.216 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 91' ' ' ILE . 14.7 pt -112.89 128.48 69.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.432 . . . . 1.3 110.362 179.108 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -88.55 137.7 32.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.45 0.537 . . . . 1.08 112.45 -178.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -136.63 141.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.75 -0.659 . . . . 1.04 110.416 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -157.86 156.35 31.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 1.27 110.634 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 t -126.55 170.3 12.18 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.128 -0.487 . . . . 1.36 110.167 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.59 130.59 42.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.431 -0.35 . . . . 2.64 110.166 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.22 -10.44 28.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.836 -0.697 . . . . 1.52 111.784 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.731 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -94.2 146.39 24.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.43 -0.211 . . . . 1.59 110.43 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.3 mt -91.97 149.17 21.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 2.15 111.146 -179.228 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -87.73 76.66 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.2 0.524 . . . . 2.07 110.089 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 3.7 t -158.24 147.43 14.73 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.776 -0.647 . . . . 2.36 109.506 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 16.6 Cg_exo -69.82 140.12 41.7 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.494 2.129 . . . . 2.08 111.738 179.444 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.903 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -137.66 86.88 2.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.093 0.473 . . . . 1.78 110.708 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -5.8 53.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 2.55 112.319 -178.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.43 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 11.9 p80 -58.15 -25.94 62.09 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.132 0.419 . . . . 2.24 112.132 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.91 9.92 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.135 0.493 . . . . 2.0 110.799 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.33 -25.25 11.23 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.779 -0.646 . . . . 2.33 111.946 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -78.83 99.99 6.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 2.99 111.103 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.583 HH11 ' HA ' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -144.41 145.66 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 2.83 110.067 179.709 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 85.8 m-20 -100.89 130.73 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.301 -0.408 . . . . 3.56 110.153 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 110' ' ' ASN . 34.2 Cg_exo -61.91 -54.64 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.893 2.395 . . . . 3.39 112.905 -179.461 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.27 27.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 4.05 112.691 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.8 19.67 2.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.232 0.539 . . . . 4.48 110.364 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 109' ' ' ARG . 4.2 t-20 -170.59 163.47 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 3.39 109.641 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.66 173.86 6.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.818 0.342 . . . . 3.21 111.154 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 112.34 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.668 -0.493 . . . . 2.85 109.668 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 21.6 mt -77.18 129.74 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.245 -0.434 . . . . 2.42 110.252 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.03 120.94 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 2.74 110.372 179.303 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HB3' HD21 ' A' ' 16' ' ' LEU . 5.4 tt -68.39 105.4 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.916 -0.584 . . . . 2.11 109.996 -179.739 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -112.17 146.3 38.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.997 -0.547 . . . . 2.49 110.413 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.466 HD13 HG22 ' A' ' 125' ' ' THR . 51.1 mt -100.92 143.9 27.49 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.892 -0.594 . . . . 1.91 109.732 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.14 150.18 75.37 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.802 2.335 . . . . 1.84 111.91 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -51.05 119.91 4.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.684 -0.689 . . . . 2.53 111.58 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.7 -27.48 8.75 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.69 -0.964 . . . . 2.2 110.69 -179.344 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.466 HG22 HD13 ' A' ' 121' ' ' LEU . 9.9 m -102.13 116.58 32.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.723 -0.473 . . . . 2.1 109.723 179.666 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.49 163.08 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.419 -0.355 . . . . 2.78 110.763 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -85.41 144.88 41.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.343 -0.39 . . . . 2.62 110.137 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.46 151.75 66.51 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.816 2.344 . . . . 2.77 111.683 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.7 125.4 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.399 . . . . 4.11 111.121 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.42 -19.73 33.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.016 -0.612 . . . . 3.18 111.729 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.522 ' HE2' HD13 ' A' ' 16' ' ' LEU . 8.7 t80 -94.27 128.73 40.92 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.654 -0.498 . . . . 2.91 109.654 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.52 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 47.6 p90 -133.21 171.09 14.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.697 0.284 . . . . 3.54 111.058 -179.84 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.81 144.4 45.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.483 -0.326 . . . . 2.93 111.208 -179.476 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -74.45 143.05 44.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.245 -0.434 . . . . 3.64 110.08 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.34 82.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.414 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 3.59 110.603 179.671 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . . . . . . . . 0 C--O 1.232 0.17 0 N-CA-C 110.018 -0.364 . . . . 2.48 110.018 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -62.25 143.6 56.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 2.13 110.642 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -68.92 -26.63 65.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 2.4 111.666 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.535 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 96.5 m-85 -111.08 167.73 10.04 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.14 0.422 . . . . 2.02 112.14 -179.233 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 p -69.08 170.32 10.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.647 -0.706 . . . . 2.65 111.332 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -90.14 133.27 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 2.4 111.291 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.565 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 mt -86.9 112.96 22.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.668 -0.493 . . . . 2.27 109.668 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 m -92.17 127.99 37.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.902 0.382 . . . . 2.84 111.203 -179.299 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.1 tp-100 -106.09 134.87 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 2.89 110.935 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.409 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 79.3 t60 -125.74 72.57 1.29 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.228 -0.656 . . . . 3.82 109.228 178.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.78 -169.23 26.99 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.964 -0.636 . . . . 3.23 112.067 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.68 -36.84 23.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.999 0.428 . . . . 4.27 110.844 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.09 172.2 13.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.796 -0.638 . . . . 3.32 110.712 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.477 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 1.2 t0 -103.84 -101.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.83 -0.433 . . . . 2.39 109.83 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.477 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 54.0 tp -156.74 133.6 10.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.798 0.332 . . . . 2.06 110.527 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.29 111.92 2.97 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.966 -0.561 . . . . 2.22 109.748 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.14 135.48 19.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.409 . . . . 1.78 110.563 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.423 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 39.3 Cg_endo -67.6 155.54 69.74 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.536 2.157 . . . . 2.15 111.963 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -57.88 125.85 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 2.6 110.769 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.53 -1.51 62.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.904 -0.665 . . . . 1.65 112.033 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 32.0 tt0 -137.09 155.15 49.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.204 -0.295 . . . . 2.31 110.204 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.05 -13.94 19.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.329 -0.938 . . . . 1.33 113.127 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.99 122.04 84.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.069 -0.345 . . . . 1.06 110.069 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.31 -179.13 5.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 1.27 111.661 -179.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.36 81.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.099 0.476 . . . . 1.7 110.821 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.86 97.87 4.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.382 -0.599 . . . . 1.23 109.382 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.33 -20.11 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.792 0.664 . . . . 1.94 112.792 -178.699 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -99.76 -29.54 12.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.422 0.527 . . . . 1.96 112.422 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.09 150.62 35.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.518 0.562 . . . . 1.42 112.518 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.58 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 2.0 m -74.42 166.92 40.77 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.681 -0.691 . . . . 1.73 110.895 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 17.5 Cg_endo -58.77 -39.75 79.0 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.814 2.343 . . . . 1.42 112.53 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -85.21 3.15 40.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 1.78 110.626 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.64 7.03 37.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.662 -0.699 . . . . 1.6 110.617 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -81.27 52.1 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 1.05 110.784 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.5 tt -144.87 134.91 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.92 -0.582 . . . . 1.17 110.17 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.14 -155.63 11.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.414 -0.898 . . . . 0.6 112.135 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -148.67 158.68 44.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.964 0.412 . . . . 0.99 111.151 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.755 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 13.2 m-85 -103.12 140.46 37.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.839 -0.8 . . . . 1.26 108.839 178.623 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -127.84 122.71 33.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.795 0.331 . . . . 2.15 110.965 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -77.81 128.37 33.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.858 -0.423 . . . . 2.4 109.858 179.373 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.04 156.21 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.108 0.48 . . . . 2.21 111.514 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.0 m -135.55 127.83 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.679 -0.691 . . . . 2.68 109.734 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.749 ' HB3' HD12 ' A' ' 64' ' ' LEU . 8.9 tpt180 -126.01 130.05 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.119 0.485 . . . . 3.59 111.702 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -143.87 -175.67 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.537 -0.756 . . . . 3.43 109.38 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.1 pt -126.72 161.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.544 -0.539 . . . . 4.26 109.544 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.319 -0.754 0 CA-C-O 121.334 0.588 . . . . 5.17 110.733 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.498 0.189 . . . . 4.48 111.127 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -69.98 -42.98 72.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.078 -0.712 . . . . 4.16 109.078 178.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.72 82.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.939 -1.028 . . . . 4.09 113.451 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -74.6 160.55 30.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.872 0.368 . . . . 3.36 110.559 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 1.5 m -74.13 156.03 87.9 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.293 -0.412 . . . . 3.36 110.127 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.47 111.15 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.542 2.161 . . . . 2.69 111.357 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.609 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 10.1 mtp180 -116.7 131.63 56.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 3.03 111.579 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.755 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 35.8 m95 -105.67 124.32 49.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.684 -0.689 . . . . 1.84 109.99 179.053 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -102.81 151.22 22.67 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 2.76 109.71 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -102.98 126.45 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.913 0.387 . . . . 1.27 111.486 -179.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.46 150.21 48.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 1.84 110.067 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.87 165.39 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.506 -0.315 . . . . 1.28 111.463 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 44' ' ' ILE . 2.3 tt -54.48 113.48 1.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.445 0.905 . . . . 1.66 113.445 -178.21 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 63.4 47.9 83.39 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.508 -0.769 . . . . 1.66 114.065 178.331 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.455 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -72.98 86.36 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 1.58 111.444 179.58 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.63 131.0 2.53 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.019 -0.61 . . . . 1.96 111.68 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.23 -31.81 89.99 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.984 2.456 . . . . 2.62 112.558 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.93 30.69 4.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.849 0.357 . . . . 3.09 111.782 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.0 -70.57 0.41 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 1.79 110.582 179.482 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.97 34.38 55.84 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.829 -0.7 . . . . 1.65 111.546 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HD2' ' A' ' 87' ' ' LYS . 3.2 mt -123.4 95.17 45.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.727 0.298 . . . . 1.38 110.831 -179.649 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.77 158.13 43.26 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.591 2.194 . . . . 1.62 112.095 179.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -59.26 106.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 1.58 110.322 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.38 -17.8 5.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.819 -0.705 . . . . 1.44 112.408 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.3 138.3 51.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 1.25 110.492 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -100.04 144.86 28.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.458 -0.337 . . . . 1.86 111.026 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HD2' HD21 ' A' ' 81' ' ' LEU . 26.6 tttt -158.47 169.48 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 1.68 109.982 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.04 112.52 2.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.313 0.486 . . . . 1.7 112.313 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.3 39.62 91.94 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.841 -0.618 . . . . 1.27 112.389 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -128.88 113.71 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.073 0.464 . . . . 1.01 111.295 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.503 ' CG1' ' HB2' ' A' ' 47' ' ' TYR . 24.3 pt -122.54 139.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.369 -0.604 . . . . 1.3 109.369 178.423 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -96.44 137.88 34.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.877 0.37 . . . . 1.08 111.686 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -133.15 131.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.621 -0.718 . . . . 1.04 110.617 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -154.41 162.87 40.92 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.27 110.363 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -139.09 172.85 12.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 1.36 109.907 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.69 127.56 32.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.333 -0.394 . . . . 2.64 110.626 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.14 -20.5 26.01 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.908 -0.663 . . . . 1.52 111.618 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.771 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -82.68 135.27 35.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.894 0.378 . . . . 1.59 110.362 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.07 139.66 43.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 2.15 110.858 -179.806 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -72.6 107.02 4.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.489 . . . . 2.07 110.526 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.469 ' H ' HD13 ' A' ' 73' ' ' LEU . 1.9 t -174.57 150.22 1.41 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.959 -0.756 . . . . 2.36 108.959 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.452 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 10.5 Cg_endo -55.1 116.88 3.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.82 2.347 . . . . 2.08 112.231 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -114.76 34.29 4.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.852 -0.613 . . . . 1.78 110.383 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 8.7 p-10 -71.05 -3.68 20.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 2.55 112.175 -179.39 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -61.18 -21.16 63.55 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.437 0.532 . . . . 2.24 112.437 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.99 -16.54 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.265 0.555 . . . . 2.0 110.441 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.455 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -79.84 72.2 2.61 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.933 -0.576 . . . . 2.33 112.693 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 t -160.65 36.07 0.16 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.787 0.803 . . . . 2.99 110.453 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -76.49 138.03 40.01 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.694 -0.684 . . . . 2.83 111.153 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -80.92 117.79 69.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 3.56 110.519 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.772 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 51.8 Cg_endo -70.88 -47.33 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.871 2.381 . . . . 3.39 114.219 -178.695 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.77 18.91 2.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.035 0.754 . . . . 4.05 113.035 -177.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -150.22 23.33 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.936 0.398 . . . . 4.48 111.589 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -174.51 136.02 0.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 3.39 109.986 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.2 154.66 19.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.662 0.268 . . . . 3.21 111.095 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.75 154.31 26.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.164 0.506 . . . . 2.85 111.234 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.2 mt -89.04 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.654 -0.703 . . . . 2.42 109.598 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.05 113.33 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.665 -0.495 . . . . 2.74 109.665 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 13' ' ' PHE . 7.5 tt -64.84 115.52 5.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 2.11 111.593 -178.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.0 148.71 50.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.652 -0.704 . . . . 2.49 109.399 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.12 157.37 34.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.343 -0.39 . . . . 1.91 110.695 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.32 148.49 92.83 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.538 2.158 . . . . 1.84 111.85 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -57.62 113.08 1.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.131 -0.486 . . . . 2.53 110.274 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 127.42 -24.15 5.32 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.194 -1.162 . . . . 2.2 110.194 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.7 m -91.94 109.75 21.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.127 0.489 . . . . 2.1 109.712 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 131.97 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 2.78 111.198 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.62 134.79 86.21 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.132 -0.485 . . . . 2.62 109.731 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.57 142.18 95.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.612 2.208 . . . . 2.77 111.468 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.83 124.25 21.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 4.11 110.621 -179.723 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.12 41.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.768 -0.73 . . . . 3.18 111.9 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -99.47 128.92 45.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.066 0.46 . . . . 2.91 111.416 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 33.1 p90 -145.98 139.13 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.627 -0.715 . . . . 3.54 109.738 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -107.45 148.15 29.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.631 0.253 . . . . 2.93 110.452 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.417 ' HB2' ' NH2' ' A' ' 67' ' ' ARG . 37.3 tt0 -67.77 125.9 27.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.384 -0.371 . . . . 3.64 110.232 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.2 -18.18 57.93 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.712 -0.756 . . . . 3.27 112.615 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 133' ' ' ALA . 14.7 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 3.59 110.806 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.881 0.372 . . . . 2.48 111.066 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.71 149.28 41.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.996 -0.547 . . . . 2.13 111.038 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 31.5 m95 -78.62 -30.63 46.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 2.4 111.254 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 76.7 m-85 -112.19 168.23 9.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.926 -0.579 . . . . 2.02 111.84 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 1.0 OUTLIER -70.1 175.02 4.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.817 -0.629 . . . . 2.65 111.362 179.644 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -91.87 148.33 22.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 2.4 111.058 -179.475 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD21 HD22 ' A' ' 119' ' ' LEU . 95.9 mt -84.22 119.21 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.847 -0.615 . . . . 2.27 109.653 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 107.28 14.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 2.84 110.523 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.829 ' HB3' ' HB2' ' A' ' 66' ' ' PRO . 5.8 tp-100 -85.9 133.93 33.92 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 2.89 111.286 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -129.96 10.05 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.951 -0.568 . . . . 3.82 110.428 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.4 -178.17 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.735 -0.745 . . . . 3.23 112.846 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -74.03 -38.08 64.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 4.27 111.468 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.94 166.78 23.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 3.32 111.412 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.78 -70.34 0.68 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.249 -0.648 . . . . 2.39 109.249 178.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.666 HD13 ' CE1' ' A' ' 131' ' ' PHE . 16.9 tp -177.58 134.28 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.747 -0.66 . . . . 2.06 110.614 178.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' H ' HD12 ' A' ' 24' ' ' LEU . 45.8 tptt -154.46 128.69 9.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 2.22 109.495 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 11.7 m-85 -123.56 144.78 45.16 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.466 . . . . 1.78 110.284 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 13.6 Cg_exo -69.58 161.77 44.59 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.814 2.343 . . . . 2.15 112.386 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.41 130.35 42.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.6 110.454 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.92 59.46 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.901 -0.666 . . . . 1.65 111.937 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -159.66 159.27 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.644 0.259 . . . . 2.31 110.328 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.67 -17.78 10.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.715 -0.755 . . . . 1.33 112.797 179.085 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.41 122.27 80.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.154 -0.313 . . . . 1.06 110.154 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 74.2 Cg_endo -76.71 -177.92 4.13 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.68 2.253 . . . . 1.27 112.047 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.21 98.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.594 -0.521 . . . . 1.7 109.594 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.446 ' HA ' ' HZ ' ' A' ' 13' ' ' PHE . 60.9 m-80 -89.48 83.41 6.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.087 0.47 . . . . 1.23 111.018 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.79 65.78 2.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.682 -0.69 . . . . 1.94 111.055 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -173.19 -28.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.258 -0.428 . . . . 1.96 111.255 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -105.59 167.16 9.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.31 -0.405 . . . . 1.42 111.827 -178.796 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.94 166.0 38.16 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 1.73 110.095 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.19 -37.47 94.24 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.894 2.396 . . . . 1.42 112.505 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.532 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.77 -20.36 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 1.78 110.75 179.804 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.946 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 27.1 m-20 -85.58 -0.72 55.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 1.6 110.777 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -78.62 55.47 1.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 1.05 111.637 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.614 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -149.72 130.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 1.17 109.82 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -144.45 4.33 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.311 -0.947 . . . . 0.6 112.631 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -157.2 161.89 39.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.853 0.359 . . . . 0.99 110.685 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.428 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 53.1 m-85 -103.27 131.82 50.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.054 -0.721 . . . . 1.26 109.054 178.367 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -110.75 125.35 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 2.15 110.965 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -72.15 130.85 41.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 2.4 109.775 178.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.14 155.14 51.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 2.21 110.753 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.69 160.08 42.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.046 -0.525 . . . . 2.68 110.538 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HB3' HD12 ' A' ' 64' ' ' LEU . 21.5 tpt180 -136.32 115.27 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 3.59 111.081 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -139.15 103.12 4.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.416 -0.356 . . . . 3.43 111.639 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 62' ' ' LYS . 22.2 pt -72.09 160.99 5.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.645 -0.502 . . . . 4.26 109.645 178.675 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 5.17 111.075 -179.478 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.286 -0.264 . . . . 4.48 110.286 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HB2' HG12 ' A' ' 54' ' ' ILE . 43.8 tptt -64.64 -57.88 7.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 4.16 109.586 179.356 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.64 83.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.507 -0.769 . . . . 4.09 112.354 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.42 HD21 ' HE3' ' A' ' 62' ' ' LYS . 37.2 mt -93.6 170.96 9.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.854 -0.612 . . . . 3.36 110.786 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -70.37 154.71 94.3 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 3.36 109.829 179.201 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.829 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 51.4 Cg_exo -55.28 123.62 14.26 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.559 2.173 . . . . 2.69 110.616 178.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 56.5 mtt-85 -120.27 144.16 47.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.563 0.579 . . . . 3.03 112.563 -178.052 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.428 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 53.4 m95 -128.11 124.71 37.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.68 -0.691 . . . . 1.84 109.699 178.717 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -103.6 145.95 29.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.047 -0.353 . . . . 2.76 110.047 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -96.48 129.43 43.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.812 0.339 . . . . 1.27 111.1 179.754 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -128.12 153.42 46.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 1.84 110.106 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -86.85 163.4 17.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.522 -0.308 . . . . 1.28 110.309 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.684 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 2.3 tt -62.69 121.93 14.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.297 -0.41 . . . . 1.66 110.513 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.82 29.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.918 -0.658 . . . . 1.66 113.762 178.833 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.21 90.11 4.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.338 0.569 . . . . 1.58 111.109 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.52 124.34 2.29 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.638 -0.791 . . . . 1.96 111.878 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.51 -21.61 39.83 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.701 2.267 . . . . 2.62 112.324 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -115.88 17.94 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.009 0.433 . . . . 3.09 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.65 -61.94 1.58 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 1.79 110.842 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.33 94.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.213 -0.518 . . . . 1.65 112.572 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.466 HD11 ' HE3' ' A' ' 87' ' ' LYS . 86.1 mt -118.13 104.76 47.95 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 120.676 0.274 . . . . 1.38 110.478 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.16 161.43 29.29 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.655 2.237 . . . . 1.62 111.344 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.515 ' HB2' HD11 ' A' ' 73' ' ' LEU . 92.2 t80 -54.21 119.34 4.99 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.488 -0.324 . . . . 1.58 110.464 179.598 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 111.38 -14.73 27.78 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.838 -0.696 . . . . 1.44 112.335 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.4 123.28 16.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.833 0.349 . . . . 1.25 110.845 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -90.74 131.45 36.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 1.86 111.278 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HE3' HD11 ' A' ' 81' ' ' LEU . 15.0 ttmm -150.93 154.99 38.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.992 -1.114 . . . . 1.68 107.992 179.075 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.5 115.41 3.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.04 0.448 . . . . 1.7 111.685 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.74 32.7 49.32 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.682 -0.69 . . . . 1.27 112.586 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.63 105.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.912 0.387 . . . . 1.01 110.995 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 91' ' ' ILE . 4.1 pt -117.31 130.23 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 1.3 109.72 178.66 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.684 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 86.3 m95 -86.23 145.42 26.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.714 0.635 . . . . 1.08 112.714 -178.508 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.47 133.84 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.218 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.6 166.53 24.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.365 -0.38 . . . . 1.27 111.102 -179.523 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -137.99 164.08 29.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.217 -0.66 . . . . 1.36 109.217 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.68 114.0 8.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.74 -0.467 . . . . 2.64 109.74 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.12 -18.15 6.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.538 -1.025 . . . . 1.52 110.538 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.25 142.45 34.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.516 -0.342 . . . . 1.59 110.084 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.532 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 97.0 mt -100.79 133.65 44.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.499 -0.319 . . . . 2.15 111.135 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -76.07 86.97 2.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.223 0.535 . . . . 2.07 109.873 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.554 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 6.3 t -161.98 144.34 8.73 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.609 -0.723 . . . . 2.36 109.125 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.93 126.94 17.48 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.159 1.906 . . . . 2.08 112.137 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.946 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -133.22 77.78 1.75 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.463 0.649 . . . . 1.78 111.22 179.584 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.15 -0.34 35.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.744 -0.662 . . . . 2.55 111.618 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.501 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.4 p80 -60.48 -19.85 58.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.075 0.464 . . . . 2.24 111.894 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.3 pt -114.12 14.21 8.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 2.0 110.296 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.74 69.28 0.29 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.71 -0.757 . . . . 2.33 112.067 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -165.04 27.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.33 0.586 . . . . 2.99 110.821 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 12' ' ' TRP . 59.5 ttp85 -65.33 128.05 34.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.057 -0.52 . . . . 2.83 110.291 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -75.87 117.58 64.85 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.311 -0.404 . . . . 3.56 110.213 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.88 -21.55 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.691 2.261 . . . . 3.39 113.815 -178.367 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.14 -21.43 17.93 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.311 0.485 . . . . 4.05 112.311 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -113.7 19.32 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.032 0.382 . . . . 4.48 112.032 -178.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -163.68 139.52 6.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.421 -0.354 . . . . 3.39 110.412 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.96 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.051 -0.351 . . . . 3.21 110.051 179.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.14 161.19 31.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.209 0.528 . . . . 2.85 111.456 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.542 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 6.5 mt -100.04 155.15 4.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.099 -0.704 . . . . 2.42 109.099 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -74.69 127.36 36.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.182 -0.207 . . . . 2.74 110.445 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.673 HD22 HD21 ' A' ' 16' ' ' LEU . 4.6 tt -64.53 116.96 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 2.11 110.553 179.72 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -130.17 130.41 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.227 -0.442 . . . . 2.49 110.402 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.684 HD13 HG22 ' A' ' 125' ' ' THR . 72.9 mt -79.64 149.17 70.91 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.476 -0.329 . . . . 1.91 110.5 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 33' ' ' PRO . 54.4 Cg_endo -69.08 177.94 4.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.836 2.357 . . . . 1.84 112.974 -179.333 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -64.52 126.03 26.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.46 -0.791 . . . . 2.53 110.319 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.09 65.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.599 -0.81 . . . . 2.2 112.347 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.684 HG22 HD13 ' A' ' 121' ' ' LEU . 7.2 m -124.85 116.13 21.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.942 -0.392 . . . . 2.1 109.942 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.03 151.88 35.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 2.78 111.853 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.93 147.52 77.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 2.62 110.829 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.06 164.7 26.59 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.823 2.349 . . . . 2.77 112.359 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.39 120.5 12.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 4.11 111.728 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.41 55.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.975 -0.631 . . . . 3.18 112.913 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.666 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -114.2 130.95 56.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.761 0.315 . . . . 2.91 111.243 -179.294 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -142.17 152.63 43.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.439 . . . . 3.54 111.053 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.23 134.67 33.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.0 0.371 . . . . 2.93 112.0 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 25.7 tt0 -64.06 124.23 21.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.809 -0.632 . . . . 3.64 110.176 178.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.58 -9.46 64.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.995 -0.621 . . . . 3.27 112.651 -179.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.502 0.191 . . . . 3.59 110.548 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.493 -0.643 . . . . 9.05 111.493 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.03 143.53 26.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.962 0.411 . . . . 8.09 111.34 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.49 176.77 8.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.928 -0.578 . . . . 8.02 110.031 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.78 89.6 0.76 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.827 -0.701 . . . . 5.76 111.39 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.79 113.67 65.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.585 0.231 . . . . 4.72 110.654 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.9 64.44 8.78 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.54 2.16 . . . . 4.45 111.816 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -101.72 124.14 46.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 4.41 111.215 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -92.77 -69.14 0.76 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.987 -0.551 . . . . 3.92 111.065 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p 48.83 83.81 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.082 0.771 . . . . 2.53 113.082 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.07 140.16 30.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 2.48 110.715 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -78.24 136.19 37.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 2.13 110.778 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -71.93 -15.5 62.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 2.4 111.634 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.69 172.27 8.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.952 -0.567 . . . . 2.02 109.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 p -75.55 -170.14 1.19 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.001 0.429 . . . . 2.65 110.709 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.58 -168.62 1.33 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.956 0.408 . . . . 2.4 110.885 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.731 HD21 HD22 ' A' ' 119' ' ' LEU . 77.3 mt -128.67 105.76 8.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.404 -0.591 . . . . 2.27 109.404 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.577 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -83.49 122.51 28.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.33 -0.396 . . . . 2.84 111.197 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.1 tp-100 -97.67 133.71 41.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.555 . . . . 2.89 111.182 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -128.22 76.32 1.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.237 -0.653 . . . . 3.82 109.237 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.41 -135.48 1.87 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.522 -0.847 . . . . 3.23 112.789 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -114.92 -38.88 3.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.092 0.472 . . . . 4.27 111.577 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -78.38 170.77 16.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.817 -0.629 . . . . 3.32 111.497 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.08 -92.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.17 -0.678 . . . . 2.39 109.17 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.499 HD13 ' CE1' ' A' ' 131' ' ' PHE . 39.8 tp -169.12 134.79 1.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.515 . . . . 2.06 109.975 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -153.37 113.4 3.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.199 -0.455 . . . . 2.22 110.166 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -100.86 145.68 30.79 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 1.78 110.066 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.65 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 51.1 Cg_endo -70.89 158.91 54.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.62 2.213 . . . . 2.15 111.608 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -62.77 113.98 3.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 2.6 110.923 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.12 -13.9 26.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.767 -0.73 . . . . 1.65 111.678 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.65 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 38.9 mt-30 -122.04 168.23 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 2.31 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.84 -10.19 29.79 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.335 -0.706 . . . . 1.33 111.335 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.403 HG11 ' HB3' ' A' ' 43' ' ' GLN . 22.2 t -94.58 115.01 64.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 1.06 109.629 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.12 -179.97 4.85 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.513 2.142 . . . . 1.27 112.159 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.25 83.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.197 -0.456 . . . . 1.7 110.364 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.425 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 63.0 m-80 -83.33 83.73 7.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.955 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -7.77 54.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.866 -0.607 . . . . 1.94 111.264 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -90.08 -22.49 21.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.344 -0.389 . . . . 1.96 111.742 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -110.97 168.68 9.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.145 0.498 . . . . 1.42 112.187 -178.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.05 167.15 22.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 1.73 110.089 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.4 -39.14 92.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 1.42 113.005 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -16.93 61.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.045 0.45 . . . . 1.78 110.815 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.773 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 41.8 m-20 -88.73 2.1 53.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 1.6 111.004 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.403 ' HB3' HG11 ' A' ' 32' ' ' VAL . 37.5 mm-40 -80.87 58.79 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.153 0.501 . . . . 1.05 111.674 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.9 tt -156.13 129.91 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.615 . . . . 1.17 109.991 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.91 -149.74 6.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.335 -0.936 . . . . 0.6 112.479 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.66 158.77 44.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.133 0.492 . . . . 0.99 111.019 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 14.8 m-85 -103.46 133.7 48.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.831 -0.622 . . . . 1.26 109.668 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.11 117.39 29.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 2.15 110.776 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -78.31 113.55 16.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.148 0.499 . . . . 2.4 110.978 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.74 159.55 24.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.082 -0.508 . . . . 2.21 110.793 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 148.93 45.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 2.68 110.137 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB3' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -121.86 93.41 3.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.075 0.464 . . . . 3.59 111.357 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.623 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 1.0 OUTLIER -121.43 104.03 9.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.223 -0.444 . . . . 3.43 110.662 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.33 125.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 4.26 110.791 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.43 98.48 11.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 5.17 110.076 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.66 167.56 32.38 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.771 -0.728 . . . . 4.66 112.7 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.12 -40.27 25.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.922 -0.656 . . . . 5.04 112.178 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.04 -31.41 61.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 5.51 110.036 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.3 10.32 5.63 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.889 -0.672 . . . . 4.73 111.912 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -76.54 113.25 13.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 5.52 110.624 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.4 mtt -118.02 126.47 52.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.218 -0.446 . . . . 4.48 110.86 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -54.76 -44.78 73.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.785 -0.643 . . . . 4.16 110.358 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 36.1 t70 61.35 107.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.242 0.83 . . . . 4.09 113.242 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.597 HD12 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -123.89 143.32 50.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 3.36 110.3 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.577 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -61.04 143.66 91.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 3.36 111.391 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.27 126.27 19.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.955 2.437 . . . . 2.69 111.576 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -127.86 137.32 52.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.03 111.452 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.493 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 36.8 m95 -95.03 109.7 21.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.006 -0.543 . . . . 1.84 110.832 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -81.38 143.85 31.87 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.628 -0.508 . . . . 2.76 109.628 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -87.68 119.04 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.736 0.303 . . . . 1.27 111.032 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -120.61 139.35 53.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.735 -0.469 . . . . 1.84 109.735 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -79.69 159.06 26.82 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.312 -0.255 . . . . 1.28 110.312 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -61.15 123.24 17.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.666 0.27 . . . . 1.66 110.707 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 90.87 24.96 26.17 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.964 -0.636 . . . . 1.66 113.449 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.589 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -82.73 94.13 7.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.166 0.483 . . . . 1.58 110.811 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 137.22 122.02 2.08 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.954 -0.641 . . . . 1.96 111.696 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 18.9 Cg_endo -58.87 -29.38 89.99 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.248 2.632 . . . . 2.62 112.756 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.14 46.55 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 3.09 110.358 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 -48.9 16.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 1.79 110.345 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 36.93 86.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.744 -0.662 . . . . 1.65 112.599 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.92 97.99 47.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 1.38 111.635 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.688 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 3.9 Cg_exo -81.74 155.38 18.07 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.769 2.313 . . . . 1.62 110.19 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.622 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.0 t80 -53.81 115.25 1.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.839 0.352 . . . . 1.58 110.866 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.44 -17.17 16.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.726 -0.749 . . . . 1.44 112.575 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.688 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -58.06 127.54 32.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 1.25 111.273 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -91.71 114.51 27.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.025 -0.534 . . . . 1.86 111.026 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -137.29 153.8 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.476 -0.329 . . . . 1.68 110.547 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.64 121.27 12.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.982 -0.554 . . . . 1.7 111.028 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.9 76.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.584 -0.817 . . . . 1.27 112.205 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 26.1 mm -130.54 109.94 17.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.758 0.313 . . . . 1.01 110.839 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -121.34 137.84 53.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 1.3 109.3 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.538 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 85.7 m95 -93.44 143.81 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.22 0.533 . . . . 1.08 112.346 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.77 129.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.438 -0.801 . . . . 1.04 110.211 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.75 154.45 44.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.195 -0.457 . . . . 1.27 110.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.1 t -132.02 176.12 8.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.336 -0.393 . . . . 1.36 110.091 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.3 125.06 24.9 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.809 0.338 . . . . 2.64 111.127 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.31 -8.26 28.72 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.806 -0.634 . . . . 1.52 111.967 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.426 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -93.03 138.2 31.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.946 0.403 . . . . 1.59 111.186 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.63 155.93 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 2.15 110.747 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.5 96.76 8.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.032 0.444 . . . . 2.07 111.488 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 1.9 t -170.25 140.71 1.61 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.866 -0.606 . . . . 2.36 109.673 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 27.8 Cg_exo -64.36 136.98 53.57 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.728 2.285 . . . . 2.08 111.98 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.773 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -134.75 70.07 1.45 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.414 0.626 . . . . 1.78 110.842 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 7.5 p-10 -71.22 -1.3 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 2.55 112.397 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 9.8 p80 -61.92 -27.56 68.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 2.24 111.756 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.45 10.15 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 2.0 110.886 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -104.67 39.53 2.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 2.33 111.415 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -150.47 138.88 20.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.601 0.239 . . . . 2.99 110.658 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 109' ' ' ARG . 22.6 ttp180 179.59 147.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.688 -0.687 . . . . 2.83 109.25 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -82.02 109.74 16.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.24 -0.652 . . . . 3.56 109.24 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 -26.74 41.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.735 2.29 . . . . 3.39 113.004 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.89 23.0 6.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.971 0.415 . . . . 4.05 111.658 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -146.27 -36.22 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.457 . . . . 4.48 111.01 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -122.41 132.87 54.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.877 -0.786 . . . . 3.39 108.877 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.4 -175.06 5.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.464 -0.335 . . . . 3.21 111.551 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.83 155.63 29.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 2.85 110.602 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -90.84 147.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.86 -0.422 . . . . 2.42 109.86 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.84 121.98 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 2.74 110.25 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.731 HD22 HD21 ' A' ' 16' ' ' LEU . 4.6 tt -64.25 108.64 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.822 -0.626 . . . . 2.11 111.128 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -119.53 148.96 42.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.023 -0.535 . . . . 2.49 110.734 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.641 HD13 HG22 ' A' ' 125' ' ' THR . 16.0 mt -98.52 146.84 32.27 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.394 -0.367 . . . . 1.91 110.602 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.84 179.66 4.6 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.844 2.362 . . . . 1.84 112.581 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.67 138.96 58.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.739 -0.664 . . . . 2.53 111.002 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.02 80.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.956 -0.64 . . . . 2.2 112.108 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.641 HG22 HD13 ' A' ' 121' ' ' LEU . 1.3 m -135.26 121.51 20.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.843 0.354 . . . . 2.1 110.366 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -121.15 152.38 38.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.285 -0.416 . . . . 2.78 110.513 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.43 146.34 80.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.376 -0.374 . . . . 2.62 110.051 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.51 143.9 77.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.739 2.293 . . . . 2.77 111.795 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -61.65 111.8 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 4.11 110.834 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 136.46 -21.84 3.4 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.783 -1.327 . . . . 3.18 109.783 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 21.0 m-85 -104.31 153.5 20.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.19 -0.505 . . . . 2.91 110.341 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 32.3 p90 -135.54 162.06 33.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.191 -0.459 . . . . 3.54 110.304 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.11 126.78 33.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 2.93 111.211 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.08 103.86 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.013 -0.539 . . . . 3.64 110.464 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.67 12.2 51.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.677 -0.773 . . . . 3.27 112.482 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.1 m -148.24 131.22 16.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.924 0.392 . . . . 3.59 111.304 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.85 151.3 34.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.992 -0.549 . . . . 5.55 110.026 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.0 69.72 3.04 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.883 -0.675 . . . . 5.22 111.719 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 138.78 -46.97 0.94 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.425 -0.67 . . . . 5.91 111.425 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.973 -0.536 . . . . 7.27 111.772 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.493 -3.487 1 C4'-C3'-C2' 97.01 -5.69 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.506 2 N19-C1'-C2' 103.497 -6.19 . 0.231 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.716 3 O4'-C1'-N19 115.758 7.558 . 0.527 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.595 6.336 4 O4'-C1'-N19 116.707 8.507 . 0.509 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.15 2 C4'-C3'-C2' 97.58 -5.12 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.671 4 C1'-O4'-C4' 105.629 -4.412 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.321 3 P-O3'-C3' 127.096 6.163 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.581 5.337 3 O4'-C4'-C3' 114.977 6.769 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.054 2 O4'-C1'-N19 118.623 10.423 . 0.414 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.636 3 O3'-P-O5' 116.372 6.512 . 0.461 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.17 1 C4'-C3'-C2' 98.263 -4.437 . 0.311 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.435 1 C4'-C3'-C2' 94.318 -8.382 . 0.454 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.797 1 O3'-P-O5' 111.757 4.083 . 0.107 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.932 2 C3'-C2'-C1' 105.719 4.688 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 111.529 -0.628 . . . . 9.05 111.529 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.53 87.8 5.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.05 0.453 . . . . 8.09 110.688 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -133.61 174.17 10.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.962 -0.563 . . . . 8.02 110.495 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.57 -127.33 5.68 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.063 -0.815 . . . . 5.76 111.063 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.2 mt -132.1 82.01 60.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.589 0.233 . . . . 4.72 111.33 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -95.65 22.06 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.097 2.531 . . . . 4.45 111.477 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -104.61 134.5 47.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.802 -0.635 . . . . 4.41 110.315 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -107.59 -78.69 0.58 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.82 -0.173 . . . . 3.92 111.293 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.7 p 48.43 75.54 0.14 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.051 0.76 . . . . 2.53 113.051 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.72 162.9 20.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.034 0.445 . . . . 2.48 111.962 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.75 155.52 39.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.51 -0.768 . . . . 2.13 111.373 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -91.69 -32.46 15.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.394 0.516 . . . . 2.4 112.394 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.418 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 35.3 m-85 -109.38 -179.18 3.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 2.02 111.872 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.99 165.12 24.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.547 -0.751 . . . . 2.65 110.902 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -80.73 138.6 36.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.429 -0.35 . . . . 2.4 111.601 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 131' ' ' PHE . 75.9 mt -100.34 107.45 19.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 2.27 110.071 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -87.3 116.9 25.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.904 0.383 . . . . 2.84 111.692 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -91.36 140.33 29.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.469 . . . . 2.89 110.811 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -132.66 87.74 2.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 3.82 109.964 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.52 -166.01 34.55 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.696 -0.764 . . . . 3.23 111.732 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 46.2 mmtt -93.33 -16.93 24.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 4.27 111.551 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.44 177.03 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.091 -0.504 . . . . 3.32 110.565 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 2.0 t0 -98.73 -89.91 0.3 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.164 -0.68 . . . . 2.39 109.164 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 26.9 tp -172.0 135.63 0.82 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 2.06 110.694 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -155.95 143.05 19.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.571 -0.529 . . . . 2.22 109.571 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.64 147.94 51.9 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.369 -0.378 . . . . 1.78 110.305 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.66 163.26 18.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.357 2.705 . . . . 2.15 112.297 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.0 117.88 8.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.837 -0.619 . . . . 2.6 110.954 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.95 6.96 63.0 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.761 -0.733 . . . . 1.65 112.673 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -134.53 159.19 41.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.914 -0.402 . . . . 2.31 109.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.9 -10.01 7.52 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.043 -0.598 . . . . 1.33 111.613 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.18 117.78 67.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 110.085 -0.339 . . . . 1.06 110.085 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.99 -176.47 2.89 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.585 2.19 . . . . 1.27 111.791 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.55 87.91 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.128 0.49 . . . . 1.7 110.305 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.438 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 49.0 m-80 -80.33 80.07 6.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.23 110.747 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.84 57.12 2.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.079 -0.509 . . . . 1.94 110.736 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -161.66 -38.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 1.96 110.629 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.93 170.54 9.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.509 . . . . 1.42 111.306 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 5.1 m -86.61 162.1 46.06 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 1.73 110.135 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.52 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 12.4 Cg_endo -56.83 -32.7 92.68 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.93 2.42 . . . . 1.42 112.679 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 18.5 t70 -71.38 -22.03 61.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.464 0.649 . . . . 1.78 110.396 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.803 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 52.1 m-20 -93.11 9.83 34.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.507 -0.769 . . . . 1.6 111.429 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.52 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 39.0 mm-40 -83.82 54.02 2.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 1.05 110.948 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.48 HG12 HD12 ' A' ' 73' ' ' LEU . 18.7 tt -150.9 138.28 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.002 -0.544 . . . . 1.17 109.949 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.38 -136.49 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.387 -0.911 . . . . 0.6 112.433 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.427 ' CD2' HG23 ' A' ' 90' ' ' ILE . 50.4 p90 -160.13 174.2 14.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.052 0.453 . . . . 0.99 110.968 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 49.8 m-85 -114.93 139.31 49.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.242 -0.651 . . . . 1.26 109.242 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -112.41 127.69 56.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.247 -0.433 . . . . 2.15 111.072 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 49' ' ' ARG . 2.2 ttt-85 -88.5 112.27 22.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.014 -0.539 . . . . 2.4 110.09 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB3' ' HE2' ' A' ' 69' ' ' TYR . . . -125.26 156.5 38.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.037 0.446 . . . . 2.21 111.543 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.91 142.43 49.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.69 -0.687 . . . . 2.68 110.813 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.477 ' HB3' HD12 ' A' ' 64' ' ' LEU . 6.5 tpt180 -111.54 119.33 38.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.905 0.384 . . . . 3.59 111.264 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt180 -137.16 169.47 17.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 3.43 109.942 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 pt -143.76 153.12 15.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.2 -0.296 . . . . 4.26 110.2 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.03 85.87 7.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 5.17 109.957 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.668 ' HA2' ' OP2' ' C' ' 13' ' ' ' U' . . . -64.8 133.55 37.59 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.632 -0.713 . . . . 4.66 113.277 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.5 -49.44 76.99 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.488 -0.387 . . . . 5.04 112.137 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.37 -23.24 35.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.387 0.613 . . . . 5.51 110.185 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.14 -16.56 6.77 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.838 -0.696 . . . . 4.73 111.597 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -73.12 122.7 22.25 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.495 -0.558 . . . . 5.52 109.495 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 29.2 mtt -130.0 159.29 37.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.316 -0.402 . . . . 4.48 110.247 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HE2' ' H62' ' B' ' 2' ' ' ' A' . 30.8 mttt -64.63 -54.49 31.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.944 -0.391 . . . . 4.16 109.944 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.9 t70 52.92 74.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.744 . . . . 4.09 112.047 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 52' ' ' ARG . 89.0 mt -81.07 149.7 29.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.781 -0.645 . . . . 3.36 110.443 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.99 154.63 92.06 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.837 -0.62 . . . . 3.36 110.908 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.34 122.31 10.99 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.919 2.413 . . . . 2.69 111.486 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.603 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 97.7 mtt180 -119.84 135.57 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.005 -0.543 . . . . 3.03 110.738 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.522 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 73.8 m95 -97.57 135.43 39.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.751 -0.659 . . . . 1.84 110.463 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.742 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 73.0 m-85 -117.35 145.6 43.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 2.76 110.185 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -85.78 124.61 32.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.981 0.42 . . . . 1.27 111.449 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -126.19 138.97 53.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.71 -0.677 . . . . 1.84 110.117 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.88 161.33 29.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 1.28 111.679 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.9 tt -63.27 122.11 15.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 1.66 111.051 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.33 16.58 62.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.86 -0.686 . . . . 1.66 114.147 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.44 129.23 40.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.109 0.455 . . . . 1.58 110.416 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.5 110.29 3.32 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.928 -0.869 . . . . 1.96 110.928 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.14 -29.15 54.63 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.426 2.751 . . . . 2.62 113.62 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.91 25.73 9.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.987 0.366 . . . . 3.09 111.987 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.38 -53.78 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.515 -0.312 . . . . 1.79 111.156 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.0 44.07 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.843 -0.694 . . . . 1.65 111.629 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 78.2 mt -117.43 107.15 45.49 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.718 0.294 . . . . 1.38 111.441 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.6 159.4 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.971 2.447 . . . . 1.62 111.158 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.614 ' HB2' HD11 ' A' ' 73' ' ' LEU . 92.6 t80 -64.37 119.16 9.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 1.58 110.845 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.21 11.1 26.49 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.495 -0.86 . . . . 1.44 112.891 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.03 172.12 13.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.702 0.251 . . . . 1.25 110.407 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -124.62 111.28 15.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.784 0.326 . . . . 1.86 110.442 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -140.99 152.51 44.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.265 -0.425 . . . . 1.68 110.155 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.65 117.94 8.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.081 -0.509 . . . . 1.7 111.329 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.24 29.24 62.6 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.64 -0.709 . . . . 1.27 113.27 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.427 HG23 ' CD2' ' A' ' 46' ' ' TYR . 38.4 mm -131.77 108.5 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.734 0.267 . . . . 1.01 110.863 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.5 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 12.8 pt -113.77 125.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.77 -0.455 . . . . 1.3 109.77 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.421 ' HZ2' ' HB3' ' A' ' 81' ' ' LEU . 79.3 m95 -87.51 139.12 30.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.446 0.535 . . . . 1.08 112.446 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.76 150.2 31.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.82 -0.627 . . . . 1.04 110.862 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.61 177.22 10.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.33 -0.248 . . . . 1.27 110.33 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.42 163.01 40.64 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.699 -0.482 . . . . 1.36 109.699 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.51 125.95 25.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 2.64 111.246 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.94 25.97 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.806 -0.711 . . . . 1.52 112.261 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -100.29 123.86 45.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.204 -0.295 . . . . 1.59 110.204 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 99' ' ' LEU . 26.3 mt -88.62 150.23 23.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.033 0.444 . . . . 2.15 111.459 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -75.12 102.77 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.745 -0.661 . . . . 2.07 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -170.89 148.19 2.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.85 -0.796 . . . . 2.36 108.85 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.43 131.5 15.08 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.296 1.998 . . . . 2.08 112.498 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.64 66.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.513 0.673 . . . . 1.78 110.99 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -1.75 25.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.661 -0.7 . . . . 2.55 111.776 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.44 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 8.6 p80 -52.34 -28.7 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.348 0.499 . . . . 2.24 112.348 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -25.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.248 -0.433 . . . . 2.0 112.009 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.81 63.51 4.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.069 -0.586 . . . . 2.33 112.167 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.2 t -138.51 23.09 2.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.208 0.528 . . . . 2.99 110.481 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.52 125.17 25.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.93 -0.577 . . . . 2.83 111.005 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.41 118.68 72.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.149 -0.686 . . . . 3.56 109.149 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.07 -33.68 91.23 Favored 'Trans proline' 0 CA--C 1.527 0.137 0 C-N-CA 123.001 2.467 . . . . 3.39 114.25 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.407 ' HB1' " O2'" ' B' ' 7' ' ' ' C' . . . -98.62 4.62 48.04 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.618 0.599 . . . . 4.05 112.618 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -125.1 -6.37 7.22 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 4.48 111.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -155.69 137.83 14.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.024 -0.535 . . . . 3.39 109.63 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 153.79 22.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.529 -0.305 . . . . 3.21 110.726 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.67 159.26 28.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 2.85 111.103 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.7 mt -88.38 132.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.263 -0.426 . . . . 2.42 110.146 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.26 121.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.852 -0.425 . . . . 2.74 109.852 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.77 121.45 14.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 2.11 111.108 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.0 157.16 46.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.525 -0.762 . . . . 2.49 109.687 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.7 mt -112.81 146.4 35.0 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.499 -0.319 . . . . 1.91 110.413 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.88 156.85 64.29 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.452 2.101 . . . . 1.84 111.758 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -52.38 125.07 14.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.74 -0.664 . . . . 2.53 111.137 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.77 -16.29 47.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.985 -0.626 . . . . 2.2 111.881 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.23 116.84 32.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.933 0.397 . . . . 2.1 110.565 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.68 158.31 16.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.082 -0.508 . . . . 2.78 110.511 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 27.0 mt -81.49 150.71 67.52 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.519 -0.31 . . . . 2.62 110.464 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 127' ' ' LEU . 32.0 Cg_exo -61.02 142.11 96.39 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.675 2.25 . . . . 2.77 111.515 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.44 112.33 2.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.102 -0.499 . . . . 4.11 110.95 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.88 -9.19 40.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.967 -0.635 . . . . 3.18 111.68 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 16' ' ' LEU . 47.6 t80 -118.18 103.47 9.89 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.486 -0.561 . . . . 2.91 109.486 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -112.34 162.62 15.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.18 -0.464 . . . . 3.54 111.06 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 136' ' ' SER . . . -97.92 147.35 24.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.133 -0.485 . . . . 2.93 110.306 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.68 111.7 2.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 3.64 110.73 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.75 10.31 70.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.988 -0.625 . . . . 3.27 112.77 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.693 ' HB2' ' HB3' ' A' ' 133' ' ' ALA . 22.8 t -78.62 96.3 5.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.173 0.511 . . . . 3.59 111.019 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -98.6 78.48 2.38 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.559 -0.534 . . . . 5.55 109.559 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.01 100.66 2.68 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.582 -0.736 . . . . 5.22 112.263 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.79 -90.47 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.512 -0.635 . . . . 5.91 111.512 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.999 -0.524 . . . . 7.27 110.834 179.75 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.604 1 C4'-C3'-C2' 97.053 -5.647 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.407 ' H62' ' HE2' ' A' ' 62' ' ' LYS . . . . . . . . 1 C2'--O2' 1.472 4.527 2 N19-C1'-C2' 103.559 -6.151 . 0.227 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.784 3 O4'-C1'-N19 115.757 7.557 . 0.526 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.228 4 O4'-C1'-N19 116.705 8.505 . 0.51 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.131 2 C4'-C3'-C2' 97.569 -5.131 . 0.647 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.564 5 C4'-C3'-C2' 98.302 -4.398 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.407 " O2'" ' HB1' ' A' ' 112' ' ' ALA . . . . . . . . 3 O3'--C3' 1.498 5.324 3 P-O3'-C3' 127.077 6.147 . 0.01 1a . 18.24 . . . . . . . . . . 3 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.449 3 O4'-C4'-C3' 114.938 6.741 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -4.977 2 O4'-C1'-N19 118.615 10.415 . 0.415 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.546 -4.667 3 O3'-P-O5' 116.391 6.521 . 0.461 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.079 1 C4'-C3'-C2' 98.318 -4.382 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.61 1 C4'-C3'-C2' 94.335 -8.365 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.668 ' OP2' ' HA2' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.588 5.864 1 O3'-P-O5' 111.749 4.078 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.035 2 C3'-C2'-C1' 105.638 4.598 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.627 -0.589 . . . . 9.05 111.627 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.42 133.11 55.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 8.09 111.265 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -81.23 123.34 28.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 8.02 110.648 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.08 67.29 3.63 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.793 -0.718 . . . . 5.76 111.42 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.45 111.28 61.03 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.626 0.25 . . . . 4.72 111.022 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.28 0.11 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.622 2.215 . . . . 4.45 112.28 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -91.89 147.07 23.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.94 0.4 . . . . 4.41 111.275 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.414 ' HB3' ' H ' ' A' ' 9' ' ' THR . 14.0 t-20 -101.03 -82.93 0.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.521 -0.548 . . . . 3.92 109.521 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 8' ' ' ASN . 40.4 m 65.65 117.66 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.338 0.866 . . . . 2.53 113.338 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' HB1' " O2'" ' C' ' 8' ' ' ' G' . . . -147.84 141.8 25.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.403 -0.817 . . . . 2.48 109.748 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -64.62 137.93 58.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.781 0.324 . . . . 2.13 111.431 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -73.36 -26.52 61.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 2.4 110.714 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.496 ' CZ ' ' HA ' ' A' ' 35' ' ' ASN . 74.3 m-85 -111.04 166.6 10.92 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.038 -0.528 . . . . 2.02 112.273 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -69.67 168.73 14.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.249 -0.887 . . . . 2.65 111.18 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -92.25 151.6 20.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.269 0.47 . . . . 2.4 112.269 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 133' ' ' ALA . 15.9 mt -99.88 125.17 45.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 2.27 109.031 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -95.87 121.92 38.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.195 0.521 . . . . 2.84 112.233 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -89.77 134.38 34.21 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.736 -0.666 . . . . 2.89 110.076 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -140.91 73.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 3.82 109.94 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -165.15 -140.83 2.97 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.781 -0.724 . . . . 3.23 112.438 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -110.81 -18.08 13.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.721 0.296 . . . . 4.27 111.342 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.12 -174.13 2.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.182 -0.463 . . . . 3.32 111.208 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -111.38 -77.46 0.59 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 2.39 110.208 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 31.6 tp 172.55 131.23 0.02 OUTLIER 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.863 0.727 . . . . 2.06 110.018 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -157.23 130.89 8.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 2.22 109.625 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -120.97 139.51 29.34 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.234 -0.439 . . . . 1.78 110.277 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.55 164.36 34.03 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.273 1.982 . . . . 2.15 110.696 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.91 131.79 51.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.602 0.239 . . . . 2.6 110.609 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.11 6.3 61.77 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 1.65 111.659 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -144.39 159.73 42.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.818 -0.438 . . . . 2.31 109.818 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 108.43 -11.48 36.23 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.906 -0.664 . . . . 1.33 111.481 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.76 114.58 61.84 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.809 -0.441 . . . . 1.06 109.809 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.28 -173.13 1.7 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.564 2.176 . . . . 1.27 111.102 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mt -79.97 91.92 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.751 -0.463 . . . . 1.7 109.751 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 13' ' ' PHE . 69.0 m-80 -87.44 77.38 8.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.97 -0.559 . . . . 1.23 110.694 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 39.65 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.016 -0.538 . . . . 1.94 111.68 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.49 -10.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.42 -0.355 . . . . 1.96 111.236 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.2 166.28 16.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.612 -0.267 . . . . 1.42 110.857 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 19.5 m -88.01 168.23 17.39 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.304 -0.407 . . . . 1.73 110.687 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 86.3 Cg_exo -49.79 -45.01 33.92 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.247 2.631 . . . . 1.42 113.855 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -72.18 -22.74 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 1.78 111.522 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.958 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 14.8 m-20 -87.05 11.61 13.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.974 -0.557 . . . . 1.6 111.43 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 39.3 mm-40 -83.25 -6.46 59.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.761 0.282 . . . . 1.05 111.761 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.593 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -82.93 126.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.117 0.484 . . . . 1.17 111.33 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.44 -161.08 11.67 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.683 -0.77 . . . . 0.6 112.229 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.495 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 48.6 p90 -146.42 163.12 36.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.088 0.47 . . . . 0.99 110.717 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.534 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 5.9 m-85 -108.52 133.99 51.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.805 -0.634 . . . . 1.26 109.585 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 48' ' ' ARG . 30.8 ttt180 -114.68 134.63 54.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.361 . . . . 2.15 111.234 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -85.38 123.73 31.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 2.4 110.245 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.605 0.24 . . . . 2.21 110.957 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -150.42 93.06 1.93 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.118 -0.492 . . . . 2.68 110.726 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.528 ' HB3' HD12 ' A' ' 64' ' ' LEU . 28.5 tpt180 -78.64 124.86 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.281 0.562 . . . . 3.59 111.826 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -141.71 117.65 10.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.901 -0.591 . . . . 3.43 109.991 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.3 pt -65.19 171.19 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.185 -0.461 . . . . 4.26 110.713 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.5 106.26 9.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.061 0.457 . . . . 5.17 112.149 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.62 169.12 22.07 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.083 -0.807 . . . . 4.66 111.083 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.51 -15.58 52.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.63 -0.795 . . . . 5.04 112.647 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -86.31 -38.17 17.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.907 0.384 . . . . 5.51 111.374 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.99 -10.13 6.66 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.755 -0.736 . . . . 4.73 111.805 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -90.83 122.88 33.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.619 -0.512 . . . . 5.52 109.619 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.19 155.2 50.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.781 -0.451 . . . . 4.48 109.781 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.423 ' HE2' HD21 ' A' ' 64' ' ' LEU . 79.0 tttt -57.13 -53.31 59.54 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.332 0.395 . . . . 4.16 110.906 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.9 t70 56.0 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.93 0.715 . . . . 4.09 112.93 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 52' ' ' ARG . 68.9 mt -84.85 152.74 23.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 3.36 110.691 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.3 m -75.21 162.83 71.51 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.646 . . . . 3.36 109.989 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 11.9 Cg_endo -55.95 111.06 0.66 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.64 2.227 . . . . 2.69 111.848 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -116.47 137.56 52.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.97 -0.559 . . . . 3.03 110.762 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.534 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 69.1 m95 -104.77 129.64 52.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.84 -0.618 . . . . 1.84 110.944 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.423 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 54.3 m-85 -110.13 140.65 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 2.76 110.001 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -89.97 120.08 30.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 1.27 111.186 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.37 130.41 52.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 1.84 109.939 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -67.3 151.1 48.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.56 -0.291 . . . . 1.28 111.129 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.11 116.52 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 1.66 110.805 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.89 -4.29 24.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.474 -0.87 . . . . 1.66 112.901 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.532 HG22 ' HA3' ' A' ' 107' ' ' GLY . 1.2 p -63.74 123.54 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.64 0.257 . . . . 1.58 110.492 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.98 106.87 3.01 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.081 -0.807 . . . . 1.96 111.081 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -35.2 91.15 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.089 2.526 . . . . 2.62 113.062 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.72 21.98 13.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.473 -0.331 . . . . 3.09 111.619 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.33 -50.1 61.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 1.79 110.83 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.32 49.03 59.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.019 -0.61 . . . . 1.65 111.812 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 mt -118.44 91.68 41.85 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.692 0.282 . . . . 1.38 111.56 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.27 155.02 22.02 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.443 2.095 . . . . 1.62 110.301 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 76.7 t80 -60.54 110.46 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.772 0.32 . . . . 1.58 110.857 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.59 -14.49 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.869 -0.681 . . . . 1.44 112.393 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.62 147.21 49.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.809 0.338 . . . . 1.25 111.286 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -111.08 103.14 11.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.055 0.455 . . . . 1.86 111.424 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 90' ' ' ILE . 12.8 ttmt -125.77 149.43 48.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 1.68 109.712 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.75 118.62 5.91 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.455 0.472 . . . . 1.7 111.935 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.58 35.45 51.52 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.941 -0.572 . . . . 1.27 112.981 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.413 HG13 ' HB3' ' A' ' 87' ' ' LYS . 27.4 mm -134.87 113.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.544 0.212 . . . . 1.01 110.474 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.5 HG13 ' HB2' ' A' ' 47' ' ' TYR . 23.6 pt -119.9 134.67 62.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 110.444 -0.206 . . . . 1.3 110.444 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.495 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 70.2 m95 -95.34 140.98 29.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.403 -0.362 . . . . 1.08 111.907 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.49 HG11 ' HA3' ' A' ' 31' ' ' GLY . 9.2 m -134.22 125.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 1.04 110.394 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.9 158.7 40.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.013 0.435 . . . . 1.27 111.79 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 t -139.04 163.34 32.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.569 -0.9 . . . . 1.36 108.569 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.61 121.46 15.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 2.64 110.58 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.03 -17.91 12.61 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.992 -0.843 . . . . 1.52 110.992 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.674 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -81.97 121.08 26.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.857 0.36 . . . . 1.59 110.062 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -88.65 130.58 35.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.143 -0.481 . . . . 2.15 110.603 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -71.45 97.0 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.125 0.488 . . . . 2.07 110.9 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.579 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.6 t -168.41 143.44 2.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.863 -0.791 . . . . 2.36 108.863 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.89 128.7 25.05 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.605 2.204 . . . . 2.08 113.516 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.958 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -129.5 78.93 1.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.525 0.679 . . . . 1.78 110.244 178.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.6 -11.11 59.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 2.55 111.492 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -58.28 -22.86 54.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.73 0.641 . . . . 2.24 112.73 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.28 0.68 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.089 0.471 . . . . 2.0 110.97 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -86.94 -35.42 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.871 -0.681 . . . . 2.33 111.5 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 t -71.27 115.66 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.355 0.598 . . . . 2.99 110.623 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.466 HH22 " H1'" ' C' ' 8' ' ' ' G' . 35.2 ttp85 -154.22 138.66 16.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 2.83 110.159 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 97.4 m-20 -94.75 108.04 34.77 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.863 -0.421 . . . . 3.56 109.863 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 37.4 Cg_endo -63.79 -29.19 68.23 Favored 'Trans proline' 0 N--CA 1.47 0.124 0 C-N-CA 123.238 2.625 . . . . 3.39 113.451 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.99 12.71 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.113 0.412 . . . . 4.05 112.113 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -135.95 -43.0 0.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 4.48 110.777 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -103.33 134.58 46.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.555 -0.535 . . . . 3.39 109.555 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.92 150.67 25.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 3.21 111.24 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.05 158.93 19.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 2.85 111.258 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 15.7 mt -113.33 145.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 2.42 109.712 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.01 118.66 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.63 0.252 . . . . 2.74 110.749 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.45 117.72 8.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.782 -0.645 . . . . 2.11 111.175 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -130.33 150.45 51.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 2.49 110.747 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.599 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 26.1 mt -97.22 138.83 21.22 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.098 -0.501 . . . . 1.91 110.107 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.24 152.98 68.39 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.683 2.255 . . . . 1.84 111.775 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -50.5 124.12 10.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 2.53 111.277 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.91 -22.13 16.9 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.148 -0.781 . . . . 2.2 111.148 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -99.98 120.29 39.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.656 -0.498 . . . . 2.1 109.656 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.4 139.03 38.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.179 -0.464 . . . . 2.78 111.06 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.2 mt -72.61 146.39 88.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.81 149.23 26.2 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.646 2.23 . . . . 2.77 111.417 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.39 108.98 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.293 0.479 . . . . 4.11 112.293 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.12 6.03 54.13 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.735 -0.666 . . . . 3.18 112.998 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -94.02 141.87 28.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.958 0.379 . . . . 2.91 111.49 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.867 ' HE1' " H5'" ' B' ' 1' ' ' ' C' . 37.1 p90 -152.98 147.3 25.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.93 -0.577 . . . . 3.54 110.785 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.63 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -112.55 162.35 15.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.357 -0.383 . . . . 2.93 110.54 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.22 128.06 34.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.367 -0.378 . . . . 3.64 110.283 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 138' ' ' GLY . . . 98.89 -12.35 62.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.725 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.0 m -79.58 -18.56 51.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.839 0.352 . . . . 3.59 111.731 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -133.86 35.71 3.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.098 -0.501 . . . . 5.55 110.347 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.435 ' O ' ' HA2' ' A' ' 135' ' ' GLY . . . 110.68 -131.83 10.61 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.582 -0.818 . . . . 5.22 112.252 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.39 -131.46 10.77 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 5.91 112.098 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.563 -0.732 . . . . 7.27 110.992 -179.83 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.867 " H5'" ' HE1' ' A' ' 132' ' ' TYR . . . . . . . . 0 C2'--C1' 1.492 -3.6 1 C4'-C3'-C2' 97.067 -5.633 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.473 4.634 2 N19-C1'-C2' 103.444 -6.222 . 0.228 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.773 3 O4'-C1'-N19 115.719 7.519 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.223 4 O4'-C1'-N19 116.681 8.481 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.374 -4.141 2 C4'-C3'-C2' 97.579 -5.121 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.524 -6.897 4 N19-C1'-C2' 106.354 -4.404 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.289 3 P-O3'-C3' 127.079 6.149 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.557 " O2'" ' HB1' ' A' ' 10' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.374 3 O4'-C4'-C3' 115.046 6.818 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.049 2 O4'-C1'-N19 118.63 10.43 . 0.418 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.587 3 O4'-C1'-N19 114.681 6.481 . 0.462 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.218 1 C4'-C3'-C2' 98.31 -4.39 . 0.311 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.598 1 C4'-C3'-C2' 94.261 -8.439 . 0.449 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.589 5.877 1 O3'-P-O5' 111.725 4.066 . 0.103 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.576 4.846 2 C3'-C2'-C1' 105.739 4.71 . 0.335 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.66 -0.576 . . . . 9.05 111.66 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.62 147.92 23.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.745 0.307 . . . . 8.09 110.717 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -125.79 27.1 6.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.15 -0.477 . . . . 8.02 110.738 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.73 133.62 12.91 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.721 -0.752 . . . . 5.76 111.615 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.5 mt -129.49 134.51 26.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.553 0.216 . . . . 4.72 110.843 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.23 33.51 0.51 Allowed 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.915 2.41 . . . . 4.45 111.962 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.11 152.22 23.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 4.41 110.333 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.65 -77.28 0.55 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.197 -0.668 . . . . 3.92 109.197 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 108' ' ' THR . 6.8 p 45.37 78.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.019 1.118 . . . . 2.53 114.019 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.06 168.5 19.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.169 -0.678 . . . . 2.48 109.169 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 154.45 42.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.896 0.379 . . . . 2.13 111.332 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -31.45 53.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.464 0.65 . . . . 2.4 109.429 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.505 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 92.5 m-85 -114.9 176.57 5.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 2.02 109.878 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 134' ' ' GLU . 2.3 p -69.95 167.52 17.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 2.65 110.747 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.11 18.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.472 . . . . 2.4 111.409 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.564 HD21 HD22 ' A' ' 119' ' ' LEU . 90.7 mt -107.95 115.8 30.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.144 -0.688 . . . . 2.27 109.144 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 4.6 m -93.12 132.71 37.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.155 0.502 . . . . 2.84 111.769 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HA ' ' HD1' ' A' ' 131' ' ' PHE . 6.4 tp-100 -95.96 140.84 30.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.611 -0.722 . . . . 2.89 110.812 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -130.17 77.38 1.78 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.004 -0.544 . . . . 3.82 109.761 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -171.91 44.42 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.951 -0.642 . . . . 3.23 111.657 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -84.47 -23.69 29.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.027 0.441 . . . . 4.27 110.414 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.68 -179.9 6.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.626 -0.716 . . . . 3.32 110.802 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 1.4 t0 -117.96 -84.32 0.65 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.249 -0.432 . . . . 2.39 110.61 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 30.8 tp -175.72 129.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.06 111.072 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -152.27 88.95 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.218 -0.66 . . . . 2.22 109.218 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -72.68 142.06 83.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.277 -0.42 . . . . 1.78 111.877 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 56.2 Cg_endo -70.77 161.51 45.8 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.024 2.483 . . . . 2.15 112.426 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.59 119.58 8.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 2.6 111.784 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.63 -13.44 61.06 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.056 -0.593 . . . . 1.65 112.685 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.692 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 70.5 mt-30 -117.87 174.2 6.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.671 0.272 . . . . 2.31 110.753 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.78 -1.66 41.84 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.597 -0.811 . . . . 1.33 112.246 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 t -100.58 112.04 63.85 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.57 0.224 . . . . 1.06 110.482 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HA ' HD23 ' A' ' 121' ' ' LEU . 53.7 Cg_endo -70.2 174.86 9.26 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.676 2.251 . . . . 1.27 111.492 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.85 89.11 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.056 0.455 . . . . 1.7 110.642 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 13' ' ' PHE . 62.0 m-80 -85.88 84.8 7.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 1.23 109.63 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -66.66 -20.98 66.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.703 -0.68 . . . . 1.94 112.197 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -88.24 -11.86 45.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.319 0.488 . . . . 1.96 112.319 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.06 158.94 18.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.144 0.497 . . . . 1.42 111.993 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 0.7 OUTLIER -89.06 163.02 36.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.644 -0.707 . . . . 1.73 109.34 179.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.17 -45.16 26.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.321 2.681 . . . . 1.42 113.315 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.906 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.25 -18.78 61.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.024 0.44 . . . . 1.78 111.411 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.12 -2.45 58.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.956 -0.566 . . . . 1.6 110.824 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 39' ' ' SER . 73.2 mm-40 -80.39 60.92 3.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.228 0.537 . . . . 1.05 110.686 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.501 HG12 HD12 ' A' ' 73' ' ' LEU . 15.9 tt -149.37 135.35 11.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 1.17 110.167 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.82 -146.85 6.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.129 -1.034 . . . . 0.6 112.98 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -152.76 168.46 25.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.134 0.492 . . . . 0.99 110.772 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.714 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -112.51 134.78 53.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.976 -0.557 . . . . 1.26 109.632 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 48' ' ' ARG . 27.7 ttt180 -116.96 126.51 53.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.353 . . . . 2.15 111.113 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.69 132.45 34.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.085 -0.507 . . . . 2.4 110.774 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.591 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -139.3 147.87 42.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.606 0.241 . . . . 2.21 110.792 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 101.05 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 2.68 110.564 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HB3' HD12 ' A' ' 64' ' ' LEU . 6.4 tpt180 -77.53 129.24 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 3.59 111.315 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -144.58 93.35 2.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 3.43 110.884 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.77 HG12 ' HB2' ' A' ' 62' ' ' LYS . 8.5 pt -77.51 154.01 5.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.601 -0.272 . . . . 4.26 110.382 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.09 119.34 39.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 5.17 110.664 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.22 162.14 40.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.783 -0.723 . . . . 4.66 111.758 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.6 -21.96 67.46 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.908 -0.477 . . . . 5.04 111.908 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -76.48 -12.8 60.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.311 0.576 . . . . 5.51 110.432 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.69 0.28 59.21 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.867 -0.682 . . . . 4.73 112.26 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -91.33 159.84 15.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.829 0.347 . . . . 5.52 110.588 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.8 mmt -108.82 150.5 27.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.228 -0.442 . . . . 4.48 110.022 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.77 ' HB2' HG12 ' A' ' 54' ' ' ILE . 70.4 tttt -63.5 -43.8 96.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 4.16 111.157 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 62.77 101.01 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.511 -0.768 . . . . 4.09 112.847 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 52' ' ' ARG . 22.4 mt -117.53 150.46 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 3.36 110.5 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.445 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 0.2 OUTLIER -68.93 147.61 97.83 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.215 -0.448 . . . . 3.36 110.449 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.32 120.42 8.33 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.869 2.379 . . . . 2.69 111.641 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -118.03 133.31 56.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.049 -0.523 . . . . 3.03 111.496 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.714 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 44.7 m95 -100.31 125.44 46.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.977 -0.556 . . . . 1.84 109.537 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 24.7 m-85 -102.2 135.46 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.337 -0.392 . . . . 2.76 110.113 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -85.97 120.43 27.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.762 0.315 . . . . 1.27 110.65 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -118.78 144.66 46.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.996 -0.547 . . . . 1.84 109.723 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.448 ' CD2' HD12 ' A' ' 106' ' ' ILE . 99.2 m-85 -79.45 164.49 23.92 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.136 -0.226 . . . . 1.28 110.7 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.501 HD12 HG12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -60.52 117.57 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 1.66 112.073 -179.153 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.15 38.89 17.34 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.749 -0.66 . . . . 1.66 113.043 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.496 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -78.31 70.08 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.58 111.234 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.64 121.56 0.58 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.531 -1.028 . . . . 1.96 110.531 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.03 -42.37 64.81 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.811 2.34 . . . . 2.62 112.801 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.64 29.19 8.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.428 -0.351 . . . . 3.09 111.339 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.72 -50.27 15.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 1.79 110.866 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.8 49.15 65.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.053 -0.594 . . . . 1.65 111.866 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.26 99.19 48.49 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.721 0.296 . . . . 1.38 111.638 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 94.6 Cg_endo -80.85 160.45 21.34 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.514 2.143 . . . . 1.62 110.595 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -59.06 112.46 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.016 0.436 . . . . 1.58 110.488 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.24 -3.89 23.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.902 -0.666 . . . . 1.44 112.34 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.569 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -64.52 116.66 6.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.808 0.337 . . . . 1.25 110.853 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.37 127.76 33.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.837 -0.62 . . . . 1.86 110.919 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.69 ' HD2' HG13 ' A' ' 90' ' ' ILE . 12.1 ttmm -154.38 159.18 41.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.935 -0.765 . . . . 1.68 108.935 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 118.45 10.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.06 0.457 . . . . 1.7 111.481 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.94 60.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.654 -0.703 . . . . 1.27 112.741 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.69 HG13 ' HD2' ' A' ' 87' ' ' LYS . 28.3 mm -133.72 116.06 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.201 0.524 . . . . 1.01 111.256 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -124.16 139.87 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.868 -0.79 . . . . 1.3 108.868 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -100.26 141.87 32.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.272 0.471 . . . . 1.08 112.272 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.7 145.86 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.774 -0.648 . . . . 1.04 110.311 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -159.58 140.94 12.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.626 -0.261 . . . . 1.27 110.999 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 t -99.58 175.68 5.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.677 -0.49 . . . . 1.36 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -73.97 133.74 43.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.813 0.339 . . . . 2.64 110.674 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.62 -9.5 57.16 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.659 -0.781 . . . . 1.52 112.156 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.906 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.04 148.17 27.71 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.639 0.257 . . . . 1.59 110.421 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.69 134.79 49.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.797 0.332 . . . . 2.15 110.942 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -78.28 93.51 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.07 110.565 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.1 t -158.92 138.71 8.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.829 -0.623 . . . . 2.36 109.823 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.37 130.43 19.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.622 2.215 . . . . 2.08 112.238 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.56 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 14.5 pttt -151.9 92.08 1.7 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.268 0.556 . . . . 1.78 111.144 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.31 -4.03 36.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 2.55 111.883 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.56 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 1.7 p80 -55.01 -29.1 56.63 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.513 0.561 . . . . 2.24 112.513 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -96.35 4.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.785 0.326 . . . . 2.0 111.437 -179.306 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.496 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -104.75 -21.74 8.93 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.368 -0.92 . . . . 2.33 113.301 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.558 ' HA ' HG22 ' A' ' 9' ' ' THR . 3.1 t -80.24 111.58 16.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.309 0.576 . . . . 2.99 112.364 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 109' ' ' ARG . 12.4 ttp180 -167.02 136.65 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.794 -0.639 . . . . 2.83 110.573 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -90.69 117.97 68.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 3.56 110.0 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -32.67 44.18 Favored 'Trans proline' 0 N--CA 1.473 0.298 0 C-N-CA 122.749 2.299 . . . . 3.39 113.179 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -17.12 61.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.783 0.29 . . . . 4.05 111.783 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -112.39 0.43 15.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.477 -0.329 . . . . 4.48 111.217 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -155.48 117.92 4.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.569 0.223 . . . . 3.39 110.728 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.42 154.16 42.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 3.21 111.411 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.79 151.08 19.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.089 0.471 . . . . 2.85 111.597 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.505 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 13.2 mt -91.93 149.0 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.26 -0.644 . . . . 2.42 109.26 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.99 116.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.609 0.242 . . . . 2.74 110.582 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.564 HD22 HD21 ' A' ' 16' ' ' LEU . 6.0 tt -64.1 111.81 2.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 2.11 110.999 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -131.88 150.75 52.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 2.49 110.545 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 33' ' ' PRO . 60.3 mt -93.59 154.52 41.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.955 -0.566 . . . . 1.91 109.521 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.63 166.81 12.78 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.487 2.124 . . . . 1.84 112.542 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -64.65 119.53 10.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 2.53 110.497 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.19 -19.33 22.68 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.046 -0.822 . . . . 2.2 111.046 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -105.36 118.75 37.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 2.1 110.148 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.42 155.83 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.419 . . . . 2.78 110.933 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -84.67 151.44 58.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.94 150.37 78.55 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.347 2.032 . . . . 2.77 111.213 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -59.13 125.45 23.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 4.11 110.735 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.0 51.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.014 -0.612 . . . . 3.18 111.688 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -96.84 124.26 40.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.114 -0.328 . . . . 2.91 110.114 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.485 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 55.3 p90 -127.62 148.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.909 0.385 . . . . 3.54 111.156 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.506 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -91.55 137.04 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 2.93 111.062 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.49 ' HA ' ' OE1' ' A' ' 134' ' ' GLU . 39.6 mm-40 -69.61 137.25 52.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.918 0.389 . . . . 3.64 110.801 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.18 -31.35 6.74 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.994 -1.242 . . . . 3.27 109.994 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 t -93.96 125.71 38.74 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.46 -0.57 . . . . 3.59 109.46 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -114.72 94.51 4.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.094 0.473 . . . . 5.55 110.158 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.18 160.18 18.57 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.734 -0.746 . . . . 5.22 112.233 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 69.01 -119.35 9.57 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.867 -0.683 . . . . 5.91 112.082 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 119.047 -0.501 . . . . 7.27 110.549 -179.543 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.63 1 C4'-C3'-C2' 97.141 -5.559 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.555 2 N19-C1'-C2' 103.499 -6.188 . 0.23 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.463 -5.676 3 O4'-C1'-N19 115.673 7.473 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.267 4 O4'-C1'-N19 116.583 8.383 . 0.51 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.044 2 C4'-C3'-C2' 97.626 -5.074 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.711 4 C4'-C3'-C2' 98.274 -4.426 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.498 5.358 3 P-O3'-C3' 127.08 6.15 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.422 3 O4'-C4'-C3' 114.961 6.758 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.028 2 O4'-C1'-N19 118.654 10.454 . 0.414 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.462 3 O3'-P-O5' 116.366 6.509 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.133 1 C4'-C3'-C2' 98.349 -4.351 . 0.308 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.611 1 C4'-C3'-C2' 94.38 -8.32 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.819 1 O3'-P-O5' 111.654 4.028 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . 0.599 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.579 5.148 2 C3'-C2'-C1' 105.681 4.645 . 0.338 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 111.729 -0.548 . . . . 9.05 111.729 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.15 128.03 34.48 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.935 0.398 . . . . 8.09 111.274 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 tpt -114.03 106.96 15.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.372 -0.377 . . . . 8.02 111.059 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 179.68 40.46 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.878 -0.677 . . . . 5.76 111.746 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.6 mt -137.78 109.49 8.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.694 0.283 . . . . 4.72 110.687 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.33 29.49 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.787 2.325 . . . . 4.45 111.816 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -66.19 116.48 7.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.476 . . . . 4.41 110.893 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.91 -163.83 0.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.238 -0.437 . . . . 3.92 110.337 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 m 63.68 93.33 0.06 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.588 0.555 . . . . 2.53 111.155 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.45 139.68 51.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.072 -0.513 . . . . 2.48 110.756 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -64.46 149.61 48.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.603 . . . . 2.13 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -86.37 -18.42 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 2.4 111.257 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 96.8 m-85 -123.37 172.71 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.155 -0.475 . . . . 2.02 111.276 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.914 HG22 " H5'" ' C' ' 8' ' ' ' G' . 17.7 p -70.44 170.37 12.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 2.65 109.996 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . . . -95.92 172.11 8.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.279 0.561 . . . . 2.4 111.211 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 131' ' ' PHE . 43.6 mt -106.04 102.07 11.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.901 -0.778 . . . . 2.27 108.901 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.738 HG23 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.42 119.24 22.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.967 -0.56 . . . . 2.84 110.952 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 5.3 tp60 -100.36 132.73 45.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.886 -0.597 . . . . 2.89 110.801 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -126.29 57.16 1.41 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.692 -0.685 . . . . 3.82 109.436 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.61 -166.41 11.86 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.39 -0.823 . . . . 3.23 111.546 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -91.78 -37.97 12.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.887 0.343 . . . . 4.27 111.595 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -83.14 156.19 23.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.505 -0.316 . . . . 3.32 110.944 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' OD2' ' HZ2' ' A' ' 68' ' ' TRP . 1.4 t0 -87.22 -154.37 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.278 -0.419 . . . . 2.39 110.556 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 tp -111.58 131.34 55.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.951 0.352 . . . . 2.06 111.951 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -154.65 105.44 2.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.782 -0.645 . . . . 2.22 109.371 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.54 150.59 51.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 1.78 110.952 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 72.8 Cg_endo -75.74 -172.85 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.942 2.428 . . . . 2.15 112.707 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 28' ' ' ARG . 7.2 tpt180 -69.6 130.04 41.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.625 -0.716 . . . . 2.6 111.447 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.98 87.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.24 -0.505 . . . . 1.65 112.575 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.525 HE22 HG23 ' A' ' 125' ' ' THR . 4.7 mm-40 -125.87 167.26 15.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.804 0.335 . . . . 2.31 111.018 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.508 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 110.0 -28.22 10.79 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.671 -0.695 . . . . 1.33 112.134 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 43' ' ' GLN . 45.4 t -80.01 115.23 52.79 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.839 0.352 . . . . 1.06 110.254 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 6.2 Cg_exo -78.38 -176.25 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.668 2.246 . . . . 1.27 111.095 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 36' ' ' THR . 32.9 mt -80.03 88.85 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.568 -0.53 . . . . 1.7 109.568 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -86.08 82.61 8.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.465 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.429 HG23 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -77.74 37.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 1.94 111.486 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.16 1.39 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.98 -0.555 . . . . 1.96 109.711 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.43 159.29 37.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.887 -0.597 . . . . 1.42 111.843 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.16 168.82 23.82 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.688 -0.687 . . . . 1.73 110.019 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.11 -37.96 93.77 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.648 2.232 . . . . 1.42 112.802 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 1.3 p30 -78.24 -15.76 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.631 0.234 . . . . 1.78 111.631 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.894 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 11.4 m-20 -88.75 -0.61 57.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 1.6 110.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.456 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.1 mm-40 -79.88 53.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.237 0.542 . . . . 1.05 111.074 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.868 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.4 tt -146.49 134.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.838 -0.619 . . . . 1.17 109.508 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.97 -146.67 5.41 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.412 -0.899 . . . . 0.6 112.498 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 51.2 p90 -156.41 165.78 35.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.611 0.243 . . . . 0.99 110.656 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.732 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 9.0 m-85 -106.15 141.91 36.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.483 -0.562 . . . . 1.26 109.483 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -121.77 127.75 50.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 2.15 110.912 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.4 ttt-85 -82.03 109.48 16.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 2.4 110.009 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.82 145.4 50.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.076 0.465 . . . . 2.21 112.114 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.9 m -140.44 119.58 12.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.68 109.765 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' A' ' 64' ' ' LEU . 25.0 tpt180 -84.58 125.35 32.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.075 0.464 . . . . 3.59 111.923 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -137.8 172.44 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 3.43 110.049 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.95 177.42 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.629 0.252 . . . . 4.26 110.857 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -112.7 113.18 25.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.408 -0.36 . . . . 5.17 110.086 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.63 144.67 15.51 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.97 -0.633 . . . . 4.66 111.573 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.95 -38.94 21.78 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.043 -0.599 . . . . 5.04 112.371 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -72.33 -45.76 58.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 5.51 110.949 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.21 3.0 5.39 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.329 -0.938 . . . . 4.73 113.305 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -79.22 118.86 21.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.912 -0.403 . . . . 5.52 109.912 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmt -131.15 152.4 50.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.264 -0.425 . . . . 4.48 110.048 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.54 -38.37 90.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.459 -0.571 . . . . 4.16 109.459 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 55.36 85.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.989 -1.005 . . . . 4.09 113.455 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 52' ' ' ARG . 81.3 mt -92.2 155.31 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 3.36 109.918 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -74.76 152.8 87.12 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.713 -0.222 . . . . 3.36 110.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.32 120.96 9.18 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 2.69 111.092 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.738 ' HG2' HG23 ' A' ' 17' ' ' THR . 63.2 mtt180 -112.77 126.89 55.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 3.03 111.222 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.732 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.04 104.36 16.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.122 -0.49 . . . . 1.84 109.88 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 89.0 m-85 -88.51 148.87 23.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.203 -0.453 . . . . 2.76 110.442 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.79 128.07 48.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.908 0.385 . . . . 1.27 111.294 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.67 157.82 31.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.157 -0.683 . . . . 1.84 109.157 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.69 159.0 16.6 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.633 -0.258 . . . . 1.28 110.999 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.1 120.45 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.183 -0.462 . . . . 1.66 112.111 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 88.67 36.08 8.12 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.939 -0.648 . . . . 1.66 112.728 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.44 104.46 15.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.966 0.412 . . . . 1.58 111.302 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.49 115.5 3.39 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.649 -0.786 . . . . 1.96 111.959 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.7 -24.03 55.49 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.642 2.228 . . . . 2.62 112.172 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 47.11 1.16 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.913 0.387 . . . . 3.09 110.531 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.69 -60.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.79 111.469 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.32 16.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.82 -0.705 . . . . 1.65 111.624 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HD2' ' A' ' 87' ' ' LYS . 32.0 mt -120.77 94.19 48.82 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 1.38 111.581 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 83.4 Cg_endo -83.11 164.43 15.19 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.541 2.161 . . . . 1.62 111.009 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.57 110.28 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.58 111.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.15 9.19 24.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.796 -0.716 . . . . 1.44 113.055 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.561 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -77.73 134.95 37.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.864 0.364 . . . . 1.25 111.243 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -81.22 127.15 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.401 -0.363 . . . . 1.86 110.918 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HD2' HD21 ' A' ' 81' ' ' LEU . 12.4 tttt -163.3 142.05 8.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 1.68 110.666 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.37 124.76 24.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 1.7 111.497 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.82 15.92 71.68 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.913 -0.585 . . . . 1.27 112.797 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.02 112.95 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.634 0.254 . . . . 1.01 110.709 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.457 HG13 ' HB2' ' A' ' 47' ' ' TYR . 17.5 pt -118.0 132.17 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.942 -0.392 . . . . 1.3 109.942 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 71.7 m95 -92.15 138.03 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.409 0.522 . . . . 1.08 112.409 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.508 HG11 ' HA3' ' A' ' 31' ' ' GLY . 17.4 m -132.75 146.4 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.407 -0.815 . . . . 1.04 109.706 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.19 174.71 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.831 0.348 . . . . 1.27 111.097 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -156.22 170.73 21.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 1.36 109.389 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.12 124.64 24.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 2.64 110.681 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' ASP . . . 112.84 -21.58 18.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.829 -0.908 . . . . 1.52 110.829 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.868 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.09 126.81 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.097 -0.335 . . . . 1.59 110.097 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.18 143.68 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.857 0.36 . . . . 2.15 111.158 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.06 93.38 4.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.317 0.579 . . . . 2.07 110.722 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.417 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 8.4 t -161.71 149.49 12.11 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.454 -0.943 . . . . 2.36 108.454 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 50.7 Cg_endo -69.99 129.73 17.85 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.259 1.973 . . . . 2.08 112.938 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.894 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -138.18 71.33 1.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.385 0.612 . . . . 1.78 111.203 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 1.2 p-10 -76.96 -4.38 43.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.505 . . . . 2.55 111.918 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.413 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.5 p80 -57.82 -22.21 46.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.973 0.416 . . . . 2.24 111.878 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.72 8.86 9.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 2.0 110.973 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.69 -26.73 10.35 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 120.999 -0.619 . . . . 2.33 111.612 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.7 t -79.77 118.17 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 2.99 110.539 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -161.5 140.44 9.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 2.83 109.999 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.65 103.3 23.31 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.5 -0.318 . . . . 3.56 110.579 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.39 -17.09 39.43 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.761 2.308 . . . . 3.39 112.702 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.49 -11.42 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.054 0.454 . . . . 4.05 110.982 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -116.83 -53.62 2.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.031 -0.532 . . . . 4.48 110.14 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.79 139.58 38.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.682 -0.69 . . . . 3.39 109.944 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 148.13 22.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.735 0.302 . . . . 3.21 111.106 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.542 ' H ' " H1'" ' C' ' 8' ' ' ' G' . . . -78.76 153.13 31.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.394 -0.366 . . . . 2.85 110.816 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 9.1 mt -88.1 149.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 2.42 110.116 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 136' ' ' SER . 40.3 t -67.88 125.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.36 . . . . 2.74 110.471 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.07 105.47 3.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 2.11 110.979 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -121.31 150.53 41.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.143 -0.48 . . . . 2.49 110.688 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.633 HD13 HG22 ' A' ' 125' ' ' THR . 96.0 mt -100.18 153.87 37.52 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.093 -0.503 . . . . 1.91 110.835 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.71 167.92 25.9 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.731 2.287 . . . . 1.84 111.912 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.07 122.54 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.493 . . . . 2.53 111.214 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.57 12.13 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.69 -0.686 . . . . 2.2 111.766 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.633 HG22 HD13 ' A' ' 121' ' ' LEU . 6.4 m -96.24 122.26 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.927 -0.397 . . . . 2.1 109.927 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 p -118.67 149.06 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.655 0.264 . . . . 2.78 110.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.2 mt -77.71 144.01 68.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.812 -0.44 . . . . 2.62 109.812 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.439 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 12.4 Cg_endo -57.78 157.83 22.52 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.615 2.21 . . . . 2.77 111.701 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.7 118.34 7.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.136 -0.484 . . . . 4.11 110.733 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.21 -16.66 24.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 3.18 112.423 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.8 m-85 -99.63 124.92 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.71 0.291 . . . . 2.91 111.004 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -121.53 161.68 21.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 3.54 110.943 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 136' ' ' SER . . . -95.19 130.96 41.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.423 -0.353 . . . . 2.93 110.973 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 55.5 mt-10 -68.85 107.68 3.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 3.64 111.605 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.54 12.01 56.34 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.749 -0.66 . . . . 3.27 112.578 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' A' ' 133' ' ' ALA . 4.7 t -130.14 145.6 51.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.128 -0.323 . . . . 3.59 110.128 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -128.55 166.97 17.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.329 -0.396 . . . . 5.55 110.334 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.95 120.74 6.95 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.756 -0.735 . . . . 5.22 111.567 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 146.66 -122.67 1.65 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.664 -0.779 . . . . 5.91 111.963 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 119.02 -0.514 . . . . 7.27 111.163 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.649 1 C4'-C3'-C2' 97.108 -5.592 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.548 2 N19-C1'-C2' 103.556 -6.153 . 0.232 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.725 3 O4'-C1'-N19 115.758 7.558 . 0.526 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.265 4 O4'-C1'-N19 116.758 8.558 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.117 2 C4'-C3'-C2' 97.509 -5.191 . 0.655 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.711 4 C4'-C3'-C2' 98.261 -4.439 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.316 3 P-O3'-C3' 127.061 6.134 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.914 " H5'" HG22 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.581 5.308 3 O4'-C4'-C3' 114.89 6.707 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.106 2 O4'-C1'-N19 118.645 10.445 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.555 3 O3'-P-O5' 116.363 6.507 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.07 1 C4'-C3'-C2' 98.309 -4.391 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.536 1 C4'-C3'-C2' 94.402 -8.298 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.78 1 O3'-P-O5' 111.775 4.092 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.134 2 C3'-C2'-C1' 105.641 4.601 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 112.174 -0.37 . . . . 9.05 112.174 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.97 110.84 5.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.724 0.297 . . . . 8.09 110.306 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.9 mtm -94.05 84.47 4.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.153 0.502 . . . . 8.02 110.986 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.99 78.7 1.52 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.769 -0.651 . . . . 5.76 111.953 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.6 mt -77.36 138.94 63.74 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.764 0.316 . . . . 4.72 110.866 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.7 -12.25 20.18 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.656 2.237 . . . . 4.45 111.386 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -77.89 109.06 11.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.585 . . . . 4.41 110.777 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -98.43 -61.03 1.43 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.358 -0.608 . . . . 3.92 109.358 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p 49.82 65.28 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.788 1.032 . . . . 2.53 113.788 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.99 134.78 41.4 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.72 -0.474 . . . . 2.48 109.72 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 m -56.57 144.22 32.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.252 0.464 . . . . 2.13 112.252 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.424 ' NE1' HG22 ' A' ' 106' ' ' ILE . 26.5 m95 -69.58 -30.48 68.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.586 -0.734 . . . . 2.4 112.761 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 93.4 m-85 -108.92 167.26 10.21 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.783 0.29 . . . . 2.02 111.783 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -73.19 165.99 23.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.024 -0.535 . . . . 2.65 111.339 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.59 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -78.82 140.71 38.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.275 0.843 . . . . 2.4 113.275 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 67' ' ' ARG . 40.6 mt -91.43 127.38 36.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.231 -1.026 . . . . 2.27 108.231 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -106.25 133.04 51.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.876 0.369 . . . . 2.84 111.692 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 20' ' ' GLY . 3.6 tp-100 -96.18 144.08 26.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.716 -0.674 . . . . 2.89 109.292 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -125.69 47.27 2.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 3.82 110.693 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' H ' ' HG3' ' A' ' 18' ' ' GLN . . . -162.8 -169.33 26.05 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.072 -0.585 . . . . 3.23 111.933 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -81.42 -28.96 34.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.753 0.311 . . . . 4.27 110.555 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -70.15 173.84 6.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.558 -0.746 . . . . 3.32 111.498 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.17 -156.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.375 -0.602 . . . . 2.39 109.375 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 35.8 tp -102.62 124.57 48.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.805 0.336 . . . . 2.06 111.408 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 40.8 tptt -151.5 116.88 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 2.22 110.064 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 47.7 m-85 -105.33 149.62 37.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 1.78 110.557 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 11.4 Cg_exo -72.45 173.31 13.4 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.066 2.51 . . . . 2.15 112.144 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -69.73 125.63 27.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.834 -0.621 . . . . 2.6 111.438 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 23.77 50.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.07 -0.586 . . . . 1.65 112.451 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.79 166.33 33.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.77 0.319 . . . . 2.31 110.188 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.36 2.86 50.83 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.895 -0.669 . . . . 1.33 113.156 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.16 121.04 63.2 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 110.203 -0.295 . . . . 1.06 110.203 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.03 178.88 5.41 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.707 2.271 . . . . 1.27 112.033 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.1 mt -76.06 86.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 1.7 110.607 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -88.94 79.91 7.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 1.23 110.523 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -17.06 56.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.94 110.82 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -74.79 -21.82 59.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 1.96 111.235 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.71 173.77 6.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.42 111.747 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.618 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 21.9 m -90.61 166.19 20.25 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 1.73 109.998 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.5 Cg_endo -51.92 -38.28 68.35 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.163 2.576 . . . . 1.42 113.763 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -72.71 -19.14 61.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.711 0.263 . . . . 1.78 111.711 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.86 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.0 m-20 -88.17 4.1 46.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 1.6 110.969 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -80.38 51.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.176 0.512 . . . . 1.05 111.246 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.763 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -148.36 132.9 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.065 -0.516 . . . . 1.17 110.033 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.95 -146.34 5.27 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.192 -1.004 . . . . 0.6 112.632 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -156.15 162.23 40.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.587 0.232 . . . . 0.99 110.468 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.452 ' HB2' HG13 ' A' ' 91' ' ' ILE . 61.8 m-85 -104.04 136.46 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.425 -0.583 . . . . 1.26 109.425 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -111.94 125.78 54.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 2.15 111.0 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -78.28 131.76 37.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.247 -0.433 . . . . 2.4 109.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.82 138.08 28.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 2.21 111.601 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.29 96.19 3.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.541 -0.754 . . . . 2.68 110.489 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HB3' HD12 ' A' ' 64' ' ' LEU . 22.6 tpt180 -68.5 120.92 15.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.212 0.529 . . . . 3.59 111.001 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.448 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 7.2 ttm180 -139.45 110.44 6.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.888 -0.596 . . . . 3.43 111.039 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.47 168.07 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 4.26 110.816 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.57 118.42 32.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 5.17 111.298 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.19 156.99 20.93 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.922 -0.656 . . . . 4.66 112.086 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.1 -31.8 72.43 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.399 -0.429 . . . . 5.04 112.608 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.32 -10.39 59.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.261 0.553 . . . . 5.51 110.248 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.61 -4.08 46.63 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.593 -1.003 . . . . 4.73 110.593 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -70.34 148.25 48.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.128 -0.536 . . . . 5.52 110.304 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.448 ' SD ' ' HD3' ' A' ' 53' ' ' ARG . 64.4 mtt -143.12 136.98 28.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.031 -0.531 . . . . 4.48 109.989 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -59.12 -48.87 80.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.3 -0.63 . . . . 4.16 109.3 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.9 t70 55.41 97.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.333 1.234 . . . . 4.09 114.333 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' A' ' 52' ' ' ARG . 38.5 mt -88.61 153.65 20.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 3.36 110.221 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -73.54 159.71 83.99 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 3.36 110.892 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.08 110.17 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.858 2.372 . . . . 2.69 112.134 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 28.7 mtt-85 -120.44 148.63 43.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.728 -0.669 . . . . 3.03 111.494 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.426 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 56.4 m95 -121.53 137.46 54.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.072 -0.513 . . . . 1.84 110.49 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.8 m-85 -112.54 148.56 34.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.427 -0.583 . . . . 2.76 109.427 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.73 123.01 37.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.991 0.424 . . . . 1.27 111.642 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.446 ' HD2' HG21 ' A' ' 75' ' ' THR . 9.3 m-85 -119.13 162.78 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.759 -0.655 . . . . 1.84 109.791 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -102.21 155.77 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.596 -0.274 . . . . 1.28 110.644 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.4 tt -60.9 115.67 3.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.876 0.37 . . . . 1.66 111.322 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.26 38.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.841 -0.695 . . . . 1.66 114.53 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.446 HG21 ' HD2' ' A' ' 71' ' ' TYR . 5.6 p -56.48 119.9 6.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 117.599 0.699 . . . . 1.58 111.375 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 102.95 112.42 3.67 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.928 -0.654 . . . . 1.96 111.601 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 13.7 Cg_endo -58.06 -36.05 98.28 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 122.738 2.292 . . . . 2.62 112.389 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.02 28.44 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 3.09 111.281 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -55.64 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.153 -0.476 . . . . 1.79 110.43 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.73 48.5 49.11 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.973 -0.851 . . . . 1.65 110.973 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.532 HD21 ' HE3' ' A' ' 87' ' ' LYS . 32.7 mt -116.5 94.46 43.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 112.192 0.441 . . . . 1.38 112.192 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 87.4 Cg_endo -87.01 158.7 8.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.689 2.259 . . . . 1.62 110.389 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.599 ' HB2' HD11 ' A' ' 73' ' ' LEU . 48.4 t80 -58.86 115.17 2.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 1.58 111.112 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.76 -11.1 18.45 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.737 -0.744 . . . . 1.44 112.66 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.529 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -66.87 130.62 43.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 1.25 110.83 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -95.09 132.65 39.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.247 -0.433 . . . . 1.86 111.053 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.532 ' HE3' HD21 ' A' ' 81' ' ' LEU . 13.1 ttmm -158.38 152.94 24.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.152 -0.685 . . . . 1.68 109.152 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.74 112.53 3.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.873 0.368 . . . . 1.7 111.606 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.97 28.71 27.86 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.27 112.602 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 87' ' ' LYS . 29.6 mm -132.78 106.81 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 1.01 110.803 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 47' ' ' TYR . 3.7 pt -118.7 127.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.995 -0.372 . . . . 1.3 109.995 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.412 ' CZ3' ' HG ' ' A' ' 73' ' ' LEU . 92.1 m95 -85.53 139.52 31.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.966 0.728 . . . . 1.08 112.966 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 m -136.22 140.55 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.19 -0.914 . . . . 1.04 110.034 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.79 159.28 44.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.152 -0.476 . . . . 1.27 110.168 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 t -135.52 172.41 13.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 1.36 109.828 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.22 126.31 27.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.371 -0.377 . . . . 2.64 110.76 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.69 -10.5 38.32 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.649 . . . . 1.52 112.195 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.763 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.68 132.19 35.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.645 0.259 . . . . 1.59 111.342 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 59.0 mt -92.27 139.77 30.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.248 -0.433 . . . . 2.15 111.201 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -85.84 85.3 7.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 2.07 111.231 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.631 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 9.7 t -167.72 140.29 2.64 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.049 -0.723 . . . . 2.36 109.049 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.19 133.36 52.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.917 2.411 . . . . 2.08 113.038 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.33 67.53 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 1.78 110.968 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.3 6.97 7.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 2.55 112.48 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -59.78 -22.75 62.57 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.019 0.377 . . . . 2.24 112.019 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.424 HG22 ' NE1' ' A' ' 12' ' ' TRP . 3.5 mt -88.92 -18.27 7.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.258 0.552 . . . . 2.0 109.905 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.88 70.56 3.16 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.308 -0.717 . . . . 2.33 111.308 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.9 t -149.33 19.67 0.95 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.677 0.751 . . . . 2.99 109.411 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -77.88 135.76 37.95 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.65 -0.704 . . . . 2.83 111.404 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 113' ' ' ASN . 45.4 t-20 -111.95 118.81 45.7 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.239 -0.652 . . . . 3.56 109.239 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.15 -23.69 74.53 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.061 2.508 . . . . 3.39 113.206 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.46 -1.66 57.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 4.05 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 110' ' ' ASN . 40.6 m-20 -132.08 14.62 4.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.397 -0.365 . . . . 4.48 110.951 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -177.97 135.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.898 -0.592 . . . . 3.39 110.398 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.1 144.15 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.507 -0.553 . . . . 3.21 109.507 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.421 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -69.74 144.74 52.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 2.85 111.205 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 21.5 mt -86.21 140.81 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.779 -0.646 . . . . 2.42 109.475 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.05 128.12 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.879 -0.415 . . . . 2.74 109.879 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.457 HD13 ' HG ' ' A' ' 16' ' ' LEU . 2.0 tt -60.45 110.8 1.36 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 2.11 111.623 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -116.29 134.07 55.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.621 -0.718 . . . . 2.49 110.039 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.522 HD13 HG22 ' A' ' 125' ' ' THR . 29.7 mt -98.9 145.48 30.04 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.424 -0.353 . . . . 1.91 110.556 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.9 155.29 71.4 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.441 2.094 . . . . 1.84 111.942 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -61.62 111.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.0 -0.545 . . . . 2.53 110.693 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.98 -17.42 8.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.126 -1.19 . . . . 2.2 110.126 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.522 HG22 HD13 ' A' ' 121' ' ' LEU . 89.7 m -108.86 112.81 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.102 -0.703 . . . . 2.1 109.102 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.23 150.09 31.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 2.78 111.358 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.464 ' HG ' ' CD1' ' A' ' 121' ' ' LEU . 18.5 mt -78.14 147.08 72.44 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 2.62 110.28 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.53 153.69 69.62 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.757 2.305 . . . . 2.77 110.862 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -59.44 122.21 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 4.11 111.295 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.77 -9.85 40.85 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.014 -0.613 . . . . 3.18 112.255 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -102.84 134.65 45.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.766 0.317 . . . . 2.91 111.751 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -146.26 143.41 29.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 3.54 110.49 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.95 134.87 34.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.781 0.325 . . . . 2.93 110.662 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.67 123.74 19.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.05 -0.523 . . . . 3.64 110.529 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.81 -12.77 46.07 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.012 -0.613 . . . . 3.27 112.234 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.3 m -85.62 111.17 19.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.639 0.257 . . . . 3.59 111.194 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -100.69 111.4 23.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.344 -0.389 . . . . 5.55 109.984 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.66 150.05 51.7 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.806 -0.634 . . . . 5.22 112.761 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.92 -122.81 7.73 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.873 -0.68 . . . . 5.91 111.771 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 119.04 -0.505 . . . . 7.27 111.24 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.401 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.491 -3.677 1 C4'-C3'-C2' 97.077 -5.623 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.401 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.539 2 N19-C1'-C2' 103.497 -6.189 . 0.23 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.777 3 O4'-C1'-N19 115.778 7.578 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.144 4 O4'-C1'-N19 116.713 8.513 . 0.508 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.376 -4.013 2 C4'-C3'-C2' 97.596 -5.104 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.799 4 C4'-C3'-C2' 98.255 -4.445 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.499 5.435 3 P-O3'-C3' 127.106 6.172 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.421 " H4'" ' HB3' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.345 3 O4'-C4'-C3' 114.957 6.755 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -4.995 2 O4'-C1'-N19 118.626 10.426 . 0.417 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.589 3 O3'-P-O5' 116.345 6.498 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.14 1 C4'-C3'-C2' 98.257 -4.443 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.556 1 C4'-C3'-C2' 94.305 -8.395 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.719 1 O3'-P-O5' 111.761 4.085 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.963 2 C3'-C2'-C1' 105.649 4.61 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 112.303 -0.319 . . . . 9.05 112.303 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.14 136.84 34.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.163 -0.31 . . . . 8.09 110.163 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.2 tpt -120.99 131.7 54.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.18 0.514 . . . . 8.02 111.226 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.82 145.4 13.71 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.841 -0.695 . . . . 5.76 111.764 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.91 105.78 46.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.048 -0.352 . . . . 4.72 110.048 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.91 36.66 0.62 Allowed 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.213 2.609 . . . . 4.45 111.983 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -86.86 135.63 33.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.585 . . . . 4.41 110.464 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -111.57 -82.7 0.58 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.349 -0.387 . . . . 3.92 110.579 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p 51.39 76.46 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.241 0.543 . . . . 2.53 112.403 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.89 150.84 21.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.879 -0.6 . . . . 2.48 111.374 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -79.26 167.41 20.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.879 -0.6 . . . . 2.13 110.821 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.556 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 31.3 m95 -92.91 -45.57 7.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 2.4 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 29.9 m-85 -88.66 159.74 17.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.866 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 p -66.92 157.41 33.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 2.65 110.797 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -74.81 139.99 43.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.928 0.394 . . . . 2.4 111.321 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 95.6 mt -93.16 138.59 31.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.92 -0.582 . . . . 2.27 109.787 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -109.78 124.89 52.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.06 0.457 . . . . 2.84 111.897 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -97.39 124.3 41.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 2.89 110.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 35.5 t60 -116.82 92.61 3.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.115 -0.493 . . . . 3.82 110.104 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.77 -166.16 38.73 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.469 -0.872 . . . . 3.23 112.093 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 45.1 mmtt -87.98 -22.2 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 4.27 111.211 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -87.79 171.25 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.137 -0.483 . . . . 3.32 110.652 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' OD2' ' HZ2' ' A' ' 68' ' ' TRP . 13.3 t0 -102.63 -90.51 0.36 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 2.39 110.795 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 31.2 tp -169.27 129.64 1.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.766 0.317 . . . . 2.06 110.841 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -150.89 133.08 15.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 2.22 110.508 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -118.75 134.13 23.57 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.102 -0.499 . . . . 1.78 110.184 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.62 176.05 8.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.024 2.483 . . . . 2.15 112.56 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -58.92 126.87 29.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 2.6 112.102 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.17 20.63 75.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.182 -0.533 . . . . 1.65 113.339 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -141.52 153.32 44.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.065 -0.346 . . . . 2.31 110.065 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.5 -13.51 9.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.33 112.092 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.5 t -95.66 111.55 56.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.761 0.315 . . . . 1.06 110.37 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.25 -166.91 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.743 2.295 . . . . 1.27 111.648 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -79.66 88.4 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.166 0.508 . . . . 1.7 111.436 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.483 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . 31.3 t30 -98.55 91.89 5.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.214 0.531 . . . . 1.23 109.655 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.15 2.67 55.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.84 0.682 . . . . 1.94 112.84 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -100.87 21.32 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.186 0.517 . . . . 1.96 111.274 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.418 ' OG ' HG21 ' A' ' 106' ' ' ILE . 3.7 m -148.84 174.77 11.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.841 -0.618 . . . . 1.42 110.075 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.578 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 17.6 m -84.36 166.09 34.77 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.885 -0.413 . . . . 1.73 109.885 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 18.8 Cg_endo -59.03 -22.54 64.25 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.663 2.242 . . . . 1.42 113.321 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.712 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 1.5 p-10 -89.53 -10.68 45.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.312 . . . . 1.78 111.709 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.727 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 23.6 m-20 -85.87 -0.93 56.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.6 110.144 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.54 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.7 mm-40 -79.09 59.2 2.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.987 -0.551 . . . . 1.05 111.419 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.865 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.7 tt -151.89 133.5 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.17 110.092 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.97 -142.45 4.41 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.03 -1.081 . . . . 0.6 112.637 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -160.17 159.24 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.006 0.432 . . . . 0.99 110.527 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.692 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 5.1 m-85 -99.8 135.7 40.83 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.434 -0.58 . . . . 1.26 109.434 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -111.73 128.22 56.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.323 -0.399 . . . . 2.15 111.061 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -84.5 128.41 34.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.949 -0.569 . . . . 2.4 109.726 179.222 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.79 157.86 44.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.02 0.438 . . . . 2.21 111.498 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -148.47 125.75 11.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.214 -0.661 . . . . 2.68 109.214 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -112.25 134.84 53.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.381 . . . . 3.59 111.154 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 28.4 ttm180 -149.32 121.36 8.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.501 -0.318 . . . . 3.43 110.833 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 pt -92.7 136.27 25.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.789 -0.449 . . . . 4.26 109.789 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.72 113.61 27.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.26 -0.427 . . . . 5.17 110.699 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.0 151.03 40.07 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.541 -0.838 . . . . 4.66 111.326 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.47 -28.34 69.38 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 121.253 -0.498 . . . . 5.04 112.003 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.09 -31.55 69.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.159 0.505 . . . . 5.51 110.556 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.05 10.51 6.77 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.633 -0.794 . . . . 4.73 111.899 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -86.47 135.67 33.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.887 0.375 . . . . 5.52 110.834 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.402 ' SD ' ' HD3' ' A' ' 53' ' ' ARG . 17.1 mmt -114.76 115.31 26.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.19 -0.671 . . . . 4.48 109.19 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HG2' ' H41' ' B' ' 1' ' ' ' C' . 77.2 tttt -54.62 -51.69 64.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.078 -0.341 . . . . 4.16 110.078 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.9 t70 63.9 115.22 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.767 1.025 . . . . 4.09 113.767 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.497 HD23 ' H5 ' ' B' ' 1' ' ' ' C' . 27.1 mt -109.84 -179.13 3.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.855 -0.612 . . . . 3.36 110.639 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -102.83 155.44 36.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.079 -0.51 . . . . 3.36 110.224 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.3 109.91 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.518 2.145 . . . . 2.69 111.526 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.597 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 59.4 mtt180 -113.0 145.95 39.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.105 0.479 . . . . 3.03 112.055 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.692 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.2 m95 -113.36 132.72 55.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.64 -0.709 . . . . 1.84 110.508 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.623 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 44.8 m-85 -110.4 141.57 43.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 2.76 109.929 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.77 116.01 28.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 1.27 111.49 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -115.6 156.6 25.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.034 -0.53 . . . . 1.84 110.162 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -96.52 162.55 13.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.459 -0.337 . . . . 1.28 110.635 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.9 OUTLIER -64.13 117.27 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.428 -0.351 . . . . 1.66 110.803 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.97 7.81 37.7 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.806 -0.712 . . . . 1.66 113.679 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -70.11 120.83 16.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 1.58 111.496 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 111.44 122.82 4.27 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.14 -0.784 . . . . 1.96 111.14 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 9.7 Cg_endo -53.03 -56.64 2.6 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.07 2.514 . . . . 2.62 112.7 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.16 42.66 1.33 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 3.09 110.912 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.89 -54.1 14.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.014 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.62 38.51 96.53 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.649 -0.705 . . . . 1.65 112.223 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.48 101.93 48.36 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.751 0.31 . . . . 1.38 111.047 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.05 159.95 18.16 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.707 2.271 . . . . 1.62 111.258 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.623 ' HB2' HD11 ' A' ' 73' ' ' LEU . 51.2 t80 -56.74 113.46 1.65 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.421 -0.354 . . . . 1.58 110.688 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.67 -12.09 13.65 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.653 -0.784 . . . . 1.44 112.939 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.05 114.1 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 1.25 110.914 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -74.85 120.93 21.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.516 . . . . 1.86 111.396 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -143.84 151.71 40.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 1.68 110.041 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.37 115.52 4.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.89 0.376 . . . . 1.7 111.733 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.1 26.43 60.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.881 -0.676 . . . . 1.27 112.665 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -130.0 103.17 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.944 0.402 . . . . 1.01 110.6 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 47' ' ' TYR . 21.0 pt -111.52 119.91 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.283 -0.417 . . . . 1.3 110.675 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -79.44 137.53 37.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.08 111.55 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.62 143.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.957 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.2 165.6 32.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.487 . . . . 1.27 110.003 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -134.82 -177.47 4.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.258 -0.428 . . . . 1.36 109.985 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.58 120.1 14.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.167 0.508 . . . . 2.64 110.938 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.02 -9.15 39.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.05 -0.595 . . . . 1.52 111.795 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.865 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.17 121.84 20.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.747 0.308 . . . . 1.59 110.387 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.712 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 53.8 mt -89.39 146.38 24.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 2.15 109.982 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -79.73 69.03 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.536 . . . . 2.07 109.874 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 1.4 m -135.34 136.28 24.06 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 2.36 109.792 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 5.2 Cg_exo -81.2 119.21 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.926 2.417 . . . . 2.08 110.855 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.81 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -135.73 102.9 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.559 . . . . 1.78 111.143 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.13 4.1 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.968 -0.56 . . . . 2.55 111.924 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.81 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 12.3 p80 -57.75 -24.3 56.38 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.058 0.456 . . . . 2.24 112.102 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.418 HG21 ' OG ' ' A' ' 38' ' ' SER . 1.2 pt -105.36 5.33 10.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.178 -0.465 . . . . 2.0 111.129 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.61 46.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 2.33 111.64 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -146.56 28.62 1.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.315 0.579 . . . . 2.99 110.748 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 38.3 ttp85 -69.24 141.2 54.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 2.83 111.27 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -94.92 113.0 60.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.065 -0.516 . . . . 3.56 109.731 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 73.6 Cg_endo -74.35 -12.99 23.06 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.045 2.497 . . . . 3.39 114.246 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.1 -15.22 44.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.102 0.477 . . . . 4.05 110.884 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -110.39 -9.32 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 4.48 111.546 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -153.01 138.67 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.718 0.294 . . . . 3.39 110.709 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.56 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 3.21 111.583 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.87 149.89 49.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 2.85 111.444 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.3 mt -91.02 138.62 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.807 -0.633 . . . . 2.42 110.258 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.23 119.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.377 -0.601 . . . . 2.74 109.377 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.436 HD22 HD21 ' A' ' 16' ' ' LEU . 1.4 tt -61.0 128.3 35.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 2.11 110.82 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -132.57 142.96 49.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.84 -0.618 . . . . 2.49 110.429 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 26.3 mt -105.62 145.69 31.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.075 -0.511 . . . . 1.91 110.19 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 36.9 Cg_exo -61.78 167.27 10.48 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.991 2.461 . . . . 1.84 112.48 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.73 121.64 14.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 2.53 110.845 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.48 -18.91 34.79 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.762 . . . . 2.2 111.934 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 1.9 m -94.25 99.16 11.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.099 0.476 . . . . 2.1 110.234 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.11 156.22 16.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.997 -0.547 . . . . 2.78 111.24 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.84 146.17 31.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 2.62 109.755 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.0 152.67 73.86 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.608 2.206 . . . . 2.77 111.889 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.97 120.49 11.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 4.11 110.684 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 19' ' ' HIS . . . 109.26 -8.15 32.86 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.724 -0.751 . . . . 3.18 111.55 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 2.7 t80 -94.15 132.08 39.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.189 -0.3 . . . . 2.91 110.189 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.472 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 41.3 p90 -134.65 146.84 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.865 0.365 . . . . 3.54 111.462 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.29 148.63 38.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.812 -0.631 . . . . 2.93 110.597 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.21 122.72 28.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 3.64 109.838 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.19 14.47 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.941 -0.647 . . . . 3.27 111.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m -75.22 89.26 2.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 3.59 110.615 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -118.62 81.5 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 5.55 110.146 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.53 144.84 18.58 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.903 -0.665 . . . . 5.22 111.828 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.6 -80.07 1.83 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.855 -0.688 . . . . 5.91 112.306 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.969 -0.539 . . . . 7.27 111.295 -179.878 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.611 ' H41' ' HG2' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.605 1 C4'-C3'-C2' 97.044 -5.656 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.4 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.548 2 N19-C1'-C2' 103.537 -6.165 . 0.23 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.81 3 O4'-C1'-N19 115.647 7.447 . 0.527 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.268 4 O4'-C1'-N19 116.661 8.461 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.144 2 C4'-C3'-C2' 97.575 -5.125 . 0.652 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.699 4 N19-C1'-C2' 106.33 -4.419 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.314 3 P-O3'-C3' 127.063 6.136 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.623 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.582 5.353 3 O4'-C4'-C3' 114.962 6.759 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.541 -5.161 2 O4'-C1'-N19 118.644 10.444 . 0.418 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.523 3 O3'-P-O5' 116.341 6.495 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.237 1 C4'-C3'-C2' 98.248 -4.452 . 0.311 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.533 1 C4'-C3'-C2' 94.373 -8.327 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.466 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.587 5.77 1 O3'-P-O5' 111.738 4.073 . 0.104 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . 0.451 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.578 5.017 2 C3'-C2'-C1' 105.716 4.685 . 0.338 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.509 -0.636 . . . . 9.05 111.509 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.63 153.67 26.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.623 0.249 . . . . 8.09 110.832 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.4 ttm -148.47 129.96 14.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.14 -0.482 . . . . 8.02 110.208 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.85 160.89 27.64 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.619 -0.592 . . . . 5.76 111.619 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 64.5 mt -104.88 147.38 34.37 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.778 -0.453 . . . . 4.72 109.778 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 3.1 Cg_exo -78.64 31.28 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.285 2.657 . . . . 4.45 111.843 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -109.72 176.86 4.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.144 -0.48 . . . . 4.41 109.927 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -80.06 -80.74 0.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.713 -0.221 . . . . 3.92 110.936 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 21.4 p 48.66 79.76 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.712 0.634 . . . . 2.53 112.712 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.38 145.62 29.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 2.48 111.403 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 m -71.33 152.76 42.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 2.13 110.653 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -86.58 -27.94 23.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.794 0.331 . . . . 2.4 111.199 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.92 164.04 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.327 -0.397 . . . . 2.02 111.945 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.627 HG22 " H5'" ' C' ' 8' ' ' ' G' . 1.5 p -63.22 166.01 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 2.65 111.779 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -89.0 150.4 22.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.226 -0.443 . . . . 2.4 111.408 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.561 HD21 HD22 ' A' ' 119' ' ' LEU . 96.9 mt -101.21 136.42 41.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 2.27 110.305 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.496 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 13.4 m -106.65 132.77 52.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.756 0.312 . . . . 2.84 111.397 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -99.79 133.42 44.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 2.89 110.761 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -127.68 82.74 2.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.702 -0.481 . . . . 3.82 109.702 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.82 -160.9 26.34 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.444 -0.663 . . . . 3.23 111.444 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -99.34 9.51 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.0 0.429 . . . . 4.27 111.122 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -112.99 -173.88 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.816 -0.629 . . . . 3.32 110.297 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -118.25 -73.69 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.367 -0.379 . . . . 2.39 109.981 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' CE1' ' A' ' 131' ' ' PHE . 32.0 tp 178.32 125.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.587 0.554 . . . . 2.06 110.382 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -146.58 121.58 10.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 2.22 110.792 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.447 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 26.2 m-85 -108.45 154.45 41.49 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.631 . . . . 1.78 109.896 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.796 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 58.4 Cg_endo -73.08 -163.16 0.15 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.761 2.307 . . . . 2.15 113.076 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -86.01 125.45 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 2.6 111.678 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 94' ' ' ALA . . . 70.3 18.96 75.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.87 -0.604 . . . . 1.65 113.19 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.796 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.3 tm0? -142.16 132.98 25.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.766 -0.457 . . . . 2.31 109.766 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.04 -9.12 2.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.413 -0.899 . . . . 1.33 112.334 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.06 124.24 65.45 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.215 -0.291 . . . . 1.06 110.215 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.48 179.43 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.482 2.122 . . . . 1.27 112.204 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mt -75.51 88.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 1.7 110.602 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.34 80.18 9.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.119 0.485 . . . . 1.23 110.545 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -21.18 66.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 1.94 111.872 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -89.05 3.7 50.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.418 -0.355 . . . . 1.96 111.679 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 m -128.45 162.27 27.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.734 0.302 . . . . 1.42 111.417 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -83.59 165.71 38.45 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 1.73 109.963 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 19.8 Cg_endo -59.44 -25.8 79.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.539 2.159 . . . . 1.42 111.958 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -89.16 -1.51 58.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 1.78 111.382 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -98.39 -1.38 41.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 1.6 110.243 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -77.49 60.5 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 1.05 111.552 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.71 121.11 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 1.17 109.953 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.1 -145.93 4.81 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.495 -0.86 . . . . 0.6 112.802 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -157.55 164.82 36.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.043 0.449 . . . . 0.99 111.106 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.702 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.9 m-85 -108.31 137.28 46.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.46 -0.791 . . . . 1.26 109.518 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -118.16 130.65 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.384 -0.371 . . . . 2.15 110.981 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -86.8 116.34 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.184 -0.462 . . . . 2.4 110.266 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.78 148.31 44.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.263 -0.426 . . . . 2.21 110.647 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -132.88 109.38 9.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.21 -0.45 . . . . 2.68 110.682 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.604 ' HB3' HD12 ' A' ' 64' ' ' LEU . 20.9 tpt180 -86.37 113.74 22.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 3.59 110.874 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -138.63 91.24 2.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 3.43 110.934 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 61' ' ' MET . 28.9 pt -70.46 146.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 4.26 111.01 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -106.7 103.37 12.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 5.17 110.492 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.651 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -75.33 160.43 52.28 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.125 -0.56 . . . . 4.66 112.907 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.37 -23.19 71.67 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.58 -0.343 . . . . 5.04 113.489 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -92.77 14.29 17.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.177 0.513 . . . . 5.51 110.868 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.36 35.55 63.45 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.96 -0.638 . . . . 4.73 111.562 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -113.67 158.88 20.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.022 -0.362 . . . . 5.52 110.022 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 76.5 mtm -139.77 143.41 36.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.259 -0.428 . . . . 4.48 110.251 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -67.8 -29.29 68.43 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.847 -0.797 . . . . 4.16 108.847 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t0 52.39 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.02 1.118 . . . . 4.09 114.02 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 52' ' ' ARG . 88.5 mt -106.07 140.25 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.015 -0.539 . . . . 3.36 110.064 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.46 ' O ' ' HD2' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -65.92 150.61 96.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.526 . . . . 3.36 110.896 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.59 120.04 7.66 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.57 2.18 . . . . 2.69 111.438 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -110.75 144.85 39.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.691 -0.686 . . . . 3.03 111.198 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.702 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 65.9 m95 -104.67 124.87 50.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.804 -0.634 . . . . 1.84 110.895 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.41 143.49 35.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.682 . . . . 2.76 109.871 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -95.23 127.28 41.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.816 0.341 . . . . 1.27 110.917 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.31 153.52 47.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.08 -0.509 . . . . 1.84 110.128 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.478 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 86.9 m-85 -84.46 163.14 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.9 tt -59.67 122.89 15.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.695 0.283 . . . . 1.66 111.759 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.6 20.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.003 -0.618 . . . . 1.66 112.634 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.66 70.85 7.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.914 0.388 . . . . 1.58 111.486 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 77' ' ' PRO . . . 150.41 148.36 4.76 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.015 -0.612 . . . . 1.96 111.744 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 76' ' ' GLY . 29.3 Cg_exo -62.0 -47.2 11.06 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.79 2.326 . . . . 2.62 111.867 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.8 45.61 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.58 . . . . 3.09 111.257 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.0 -56.13 4.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 1.79 110.463 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.67 52.98 47.18 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.646 -0.582 . . . . 1.65 111.646 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 57.9 mt -132.72 100.0 15.06 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 111.579 0.215 . . . . 1.38 111.579 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 74.0 Cg_endo -78.93 162.79 26.29 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.16 1.907 . . . . 1.62 110.257 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.99 104.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 1.58 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.43 10.22 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.591 -0.814 . . . . 1.44 112.233 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -59.13 114.64 2.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.74 0.305 . . . . 1.25 110.891 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -78.9 104.56 9.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 1.86 112.023 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HE3' HD21 ' A' ' 81' ' ' LEU . 26.4 ttmt -126.15 150.88 47.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.692 -0.855 . . . . 1.68 108.692 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -63.44 118.33 7.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.939 0.399 . . . . 1.7 111.975 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.38 57.67 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.703 -0.68 . . . . 1.27 112.502 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.8 118.14 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.723 0.297 . . . . 1.01 110.383 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 47' ' ' TYR . 10.4 pt -121.78 122.74 67.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.389 -0.369 . . . . 1.3 110.222 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.565 ' HZ2' ' HB3' ' A' ' 81' ' ' LEU . 87.7 m95 -86.55 138.24 31.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.014 0.376 . . . . 1.08 112.014 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.61 142.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 1.04 110.612 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' O ' ' HA2' ' A' ' 29' ' ' GLY . . . -152.27 -177.78 6.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 1.27 109.605 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 t -148.74 169.7 19.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.32 -0.252 . . . . 1.36 110.32 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.6 128.16 34.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.385 -0.371 . . . . 2.64 111.076 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.98 -24.3 23.55 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.785 -0.721 . . . . 1.52 111.823 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.827 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.11 133.02 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 1.59 110.487 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 94.2 mt -94.45 133.77 37.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.314 -0.403 . . . . 2.15 110.849 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -75.98 96.57 3.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.07 110.337 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.21 150.03 6.89 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.734 -0.666 . . . . 2.36 109.416 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.54 125.21 18.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.816 2.344 . . . . 2.08 112.534 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 72' ' ' TYR . 67.3 mmtt -113.21 34.64 4.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 1.78 109.744 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.6 -30.58 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.548 0.573 . . . . 2.55 112.548 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -64.28 -8.94 14.51 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.81 0.671 . . . . 2.24 112.81 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 103' ' ' LYS . 1.6 mt -109.11 0.58 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 2.0 109.822 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' THR . . . -93.05 -11.16 59.05 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.736 -0.745 . . . . 2.33 112.424 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 t -80.63 123.45 28.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.437 . . . . 2.99 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -164.37 146.15 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 2.83 109.806 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -107.42 106.93 59.62 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.84 0.352 . . . . 3.56 110.218 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.47 -21.4 26.13 Favored 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 122.862 2.375 . . . . 3.39 113.928 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.21 -14.04 59.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.104 0.409 . . . . 4.05 112.104 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -117.3 -18.51 9.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.201 -0.454 . . . . 4.48 111.408 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -140.72 131.2 25.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 3.39 111.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -83.26 163.99 20.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.193 -0.458 . . . . 3.21 110.332 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.74 165.65 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.037 0.446 . . . . 2.85 111.003 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -95.25 152.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.323 -0.621 . . . . 2.42 109.323 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.49 118.44 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.176 -0.305 . . . . 2.74 110.176 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.561 HD22 HD21 ' A' ' 16' ' ' LEU . 5.0 tt -63.13 114.31 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.278 0.561 . . . . 2.11 110.912 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.81 144.13 51.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.591 -0.731 . . . . 2.49 110.324 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 82.3 mt -95.02 148.17 34.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.088 -0.505 . . . . 1.91 110.216 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.23 159.74 45.59 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.576 2.184 . . . . 1.84 112.215 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -53.0 119.7 4.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 2.53 111.521 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.11 4.79 47.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.769 -0.729 . . . . 2.2 112.231 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.9 m -117.73 110.14 17.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.808 0.337 . . . . 2.1 110.227 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.34 137.7 40.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.159 -0.473 . . . . 2.78 111.42 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -70.61 140.92 87.22 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 116.199 -0.455 . . . . 2.62 109.825 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.74 148.97 62.49 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.963 2.442 . . . . 2.77 112.355 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.46 124.87 21.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 4.11 110.718 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.6 -12.55 39.11 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.315 -0.714 . . . . 3.18 111.315 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -105.42 152.09 23.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.816 0.341 . . . . 2.91 111.114 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.496 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 16.9 p90 -151.95 157.47 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 3.54 109.215 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.13 131.1 55.39 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.188 0.305 . . . . 2.93 111.158 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -66.97 125.49 26.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.443 -0.577 . . . . 3.64 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 108.8 -38.59 3.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.997 -0.841 . . . . 3.27 110.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.8 68.33 8.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.943 0.402 . . . . 3.59 110.596 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -106.75 -5.17 18.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.291 -0.413 . . . . 5.55 110.721 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.19 146.17 4.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.876 -0.678 . . . . 5.22 111.573 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.28 36.9 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.877 -0.678 . . . . 5.91 111.841 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.772 -0.632 . . . . 7.27 111.551 -179.736 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.491 -3.714 1 C4'-C3'-C2' 97.0 -5.7 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.473 4.608 2 N19-C1'-C2' 103.488 -6.195 . 0.235 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.809 3 O4'-C1'-N19 115.769 7.569 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.201 4 O4'-C1'-N19 116.692 8.492 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.156 2 C4'-C3'-C2' 97.542 -5.158 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.607 4 C1'-O4'-C4' 105.619 -4.424 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.499 5.396 3 P-O3'-C3' 127.073 6.144 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.627 " H5'" HG22 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.582 5.435 3 O4'-C4'-C3' 114.938 6.742 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.934 2 O4'-C1'-N19 118.65 10.45 . 0.415 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.576 3 O3'-P-O5' 116.388 6.52 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.125 1 C4'-C3'-C2' 98.29 -4.41 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.583 1 C4'-C3'-C2' 94.294 -8.406 . 0.451 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.651 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.588 5.809 1 O3'-P-O5' 111.76 4.084 . 0.106 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.926 2 C3'-C2'-C1' 105.772 4.747 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.976 0 N-CA-C 111.853 -0.499 . . . . 9.05 111.853 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.04 122.2 46.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.237 -0.283 . . . . 8.09 110.237 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 ttt -136.52 126.76 26.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.067 0.461 . . . . 8.02 111.715 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.18 158.08 16.88 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.233 -0.747 . . . . 5.76 111.233 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -118.06 133.38 23.42 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.755 0.312 . . . . 4.72 110.711 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 2.7 Cg_exo -77.48 28.13 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.791 2.994 . . . . 4.45 113.641 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -108.11 133.96 51.66 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.52 -0.548 . . . . 4.41 109.52 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -79.87 -88.59 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.292 -0.413 . . . . 3.92 111.355 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m 65.15 75.13 0.37 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.969 0.414 . . . . 2.53 111.341 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.01 140.57 43.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 2.48 110.687 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.41 153.77 42.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.944 -0.571 . . . . 2.13 110.971 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.443 ' HD1' ' HE1' ' A' ' 72' ' ' TYR . 76.6 m95 -79.51 -18.82 51.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.053 0.454 . . . . 2.4 111.112 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 119' ' ' LEU . 80.2 m-85 -110.19 161.08 15.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.127 -0.488 . . . . 2.02 112.016 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 p -67.51 167.56 12.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.788 -0.642 . . . . 2.65 111.268 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -79.65 152.82 29.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.096 0.474 . . . . 2.4 111.408 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 76.8 mt -108.65 129.91 55.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 2.27 109.072 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.442 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -103.3 144.67 31.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.422 0.527 . . . . 2.84 112.422 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 5.0 tp-100 -112.21 134.72 53.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 2.89 110.158 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -125.85 69.36 1.19 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.057 -0.52 . . . . 3.82 109.826 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -172.76 -165.74 30.24 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.999 -0.62 . . . . 3.23 111.737 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 65.3 mmtt -88.21 -30.02 20.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.914 0.388 . . . . 4.27 111.544 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.58 166.46 22.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 3.32 110.202 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 4.6 t0 -99.77 -90.05 0.32 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.014 -0.365 . . . . 2.39 110.014 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.475 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 34.2 tp -159.26 134.97 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 2.06 111.018 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -151.51 134.58 15.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.733 -0.667 . . . . 2.22 109.457 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -130.73 134.54 26.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.447 -0.342 . . . . 1.78 110.405 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.46 156.53 55.92 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.985 2.457 . . . . 2.15 111.351 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.86 118.14 5.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.372 -0.377 . . . . 2.6 111.363 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.98 -9.07 57.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 1.65 111.982 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -120.71 152.25 38.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.752 0.31 . . . . 2.31 110.448 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.84 -6.07 22.26 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.698 -0.763 . . . . 1.33 112.77 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 43' ' ' GLN . 38.7 t -90.38 116.52 66.57 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.592 0.234 . . . . 1.06 110.372 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.547 ' HA ' HD23 ' A' ' 121' ' ' LEU . 57.1 Cg_endo -71.23 177.16 6.9 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.633 2.222 . . . . 1.27 112.145 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.62 79.57 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.296 -0.411 . . . . 1.7 110.441 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB2' HE22 ' A' ' 43' ' ' GLN . 46.9 m-80 -76.77 84.71 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 1.23 110.587 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -20.15 65.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 1.94 111.639 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -85.94 -11.92 51.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.199 -0.455 . . . . 1.96 111.553 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.48 ' HB2' HE22 ' A' ' 43' ' ' GLN . 0.7 OUTLIER -118.1 150.23 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.158 0.504 . . . . 1.42 112.03 -178.563 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.88 166.56 44.15 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.576 -0.738 . . . . 1.73 110.218 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.46 -40.06 79.89 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.947 2.431 . . . . 1.42 112.732 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.36 -24.84 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.977 0.418 . . . . 1.78 111.12 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.934 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 46.2 m-20 -84.82 1.53 46.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.802 -0.636 . . . . 1.6 111.829 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.48 HE22 ' HB2' ' A' ' 38' ' ' SER . 42.0 mm-40 -80.27 57.43 2.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.89 0.376 . . . . 1.05 111.222 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 tt -153.02 134.84 5.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 116.175 -0.466 . . . . 1.17 110.394 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.83 -147.24 6.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.386 -0.911 . . . . 0.6 112.718 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 52.5 p90 -151.58 163.44 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.023 0.44 . . . . 0.99 110.698 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.726 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 37.6 m-85 -105.94 137.15 44.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.451 -0.574 . . . . 1.26 109.451 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -116.35 125.77 52.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.503 -0.317 . . . . 2.15 110.929 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -80.85 123.93 28.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.08 -0.509 . . . . 2.4 109.905 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.2 150.67 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.948 0.404 . . . . 2.21 111.841 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -149.86 96.58 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.863 -0.608 . . . . 2.68 110.469 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HB3' HD12 ' A' ' 64' ' ' LEU . 32.1 ttt85 -71.45 119.46 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 3.59 110.439 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 15.9 ttt-85 -135.72 106.31 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.127 -0.488 . . . . 3.43 110.591 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 pt -86.73 159.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.849 -0.614 . . . . 4.26 110.744 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.37 114.14 21.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.216 -0.447 . . . . 5.17 110.428 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.65 158.3 41.01 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.668 -0.777 . . . . 4.66 112.146 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.63 -22.59 69.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.344 -0.455 . . . . 5.04 112.793 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.54 -4.5 59.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.255 0.55 . . . . 5.51 110.414 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.7 2.45 67.24 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.087 -0.805 . . . . 4.73 111.087 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -79.29 141.92 36.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.934 0.397 . . . . 5.52 110.513 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 mmt -118.98 132.31 56.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.619 -0.512 . . . . 4.48 109.619 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HE3' ' O4 ' ' C' ' 13' ' ' ' U' . 75.3 tttt -66.26 -51.41 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.234 -0.654 . . . . 4.16 109.234 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 20.8 t70 63.93 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.525 0.935 . . . . 4.09 113.525 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' A' ' 52' ' ' ARG . 63.7 mt -114.9 156.99 23.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 3.36 110.562 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.25 153.53 92.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.842 -0.617 . . . . 3.36 110.962 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HA ' HG23 ' A' ' 51' ' ' THR . 19.7 Cg_endo -58.57 112.89 1.33 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.804 2.336 . . . . 2.69 111.625 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 93.8 mtt180 -114.47 125.38 53.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.249 0.547 . . . . 3.03 112.016 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.726 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 41.8 m95 -98.12 131.69 44.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.632 -0.713 . . . . 1.84 109.833 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -110.69 146.34 36.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.375 -0.375 . . . . 2.76 110.382 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.08 114.73 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.874 0.368 . . . . 1.27 110.927 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.41 ' HD2' HG21 ' A' ' 75' ' ' THR . 31.5 m-85 -113.63 143.65 44.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 1.84 110.085 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.443 ' HE1' ' HD1' ' A' ' 12' ' ' TRP . 76.6 m-85 -81.83 154.01 26.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.2 tt -58.53 118.84 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.556 -0.293 . . . . 1.66 110.448 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.71 27.57 5.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.013 -0.613 . . . . 1.66 112.732 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.41 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -92.49 106.29 18.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.47 -0.429 . . . . 1.58 110.726 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.67 119.86 3.01 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.211 -0.756 . . . . 1.96 111.211 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.46 -51.99 8.69 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.797 2.331 . . . . 2.62 112.206 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.1 30.5 4.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 3.09 111.336 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.96 72.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 1.79 110.27 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.89 39.08 95.04 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.784 -0.644 . . . . 1.65 112.394 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.523 HD21 ' HD2' ' A' ' 87' ' ' LYS . 83.2 mt -118.75 93.71 46.64 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.255 . . . . 1.38 111.149 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.699 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 7.5 Cg_exo -75.93 157.17 38.97 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.966 2.444 . . . . 1.62 110.377 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.671 ' HB2' HD11 ' A' ' 73' ' ' LEU . 80.8 t80 -57.32 112.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 1.58 110.708 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.7 -6.62 26.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.603 -0.808 . . . . 1.44 112.42 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.699 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -66.69 145.78 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.872 0.368 . . . . 1.25 110.682 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -98.14 129.21 44.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.327 -0.397 . . . . 1.86 110.63 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.523 ' HD2' HD21 ' A' ' 81' ' ' LEU . 1.9 ttmt -156.05 143.46 19.29 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.003 -0.74 . . . . 1.68 109.003 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.79 122.65 16.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.777 0.322 . . . . 1.7 111.589 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 21.76 70.84 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 1.27 112.575 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 31.7 mm -130.99 111.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.37 . . . . 1.01 110.87 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.5 pt -118.78 143.32 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.262 -0.644 . . . . 1.3 109.262 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.52 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 91.2 m95 -98.59 141.56 31.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.934 0.716 . . . . 1.08 112.934 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.81 138.5 38.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.329 -0.85 . . . . 1.04 110.387 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.61 168.94 20.72 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.378 -0.601 . . . . 1.27 109.378 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -140.74 157.93 44.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.23 -0.285 . . . . 1.36 110.23 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.06 118.69 8.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.394 . . . . 2.64 110.186 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.109 -0.567 . . . . 1.52 111.692 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.703 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -88.46 149.0 23.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.554 0.216 . . . . 1.59 110.54 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 48.9 mt -104.18 140.21 38.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 -0.285 . . . . 2.15 110.85 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -79.2 99.73 7.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 2.07 111.242 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.428 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 0.4 OUTLIER -173.33 147.37 1.43 Allowed Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.642 . . . . 2.36 109.268 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.12 114.32 3.72 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.191 1.927 . . . . 2.08 112.366 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.934 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -114.59 78.96 1.2 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.442 0.639 . . . . 1.78 110.451 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.91 -6.66 48.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.481 -0.781 . . . . 2.55 112.041 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.566 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 4.7 p80 -60.79 -15.99 35.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.378 0.51 . . . . 2.24 112.378 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.02 15.03 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.947 0.403 . . . . 2.0 111.124 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.36 15.91 53.4 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.873 -0.68 . . . . 2.33 111.957 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 t -108.28 103.03 12.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.025 0.441 . . . . 2.99 111.414 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -159.97 111.81 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.576 . . . . 2.83 110.666 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.64 122.14 76.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.783 -0.451 . . . . 3.56 109.783 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.464 ' HB2' " H4'" ' C' ' 9' ' ' ' U' . 41.1 Cg_endo -65.65 -21.04 59.54 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.202 2.601 . . . . 3.39 114.236 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.49 10.88 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.785 0.326 . . . . 4.05 111.578 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -142.06 14.95 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.082 0.468 . . . . 4.48 110.858 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -172.92 135.74 0.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 3.39 110.177 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.47 134.68 39.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.479 -0.328 . . . . 3.21 110.36 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 157.25 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.138 0.494 . . . . 2.85 111.968 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 5.4 mt -94.26 145.57 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.716 -0.675 . . . . 2.42 109.614 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.4 t -61.61 117.17 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.685 0.279 . . . . 2.74 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.442 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . 2.8 tt -61.51 121.08 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.898 -0.592 . . . . 2.11 111.24 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -137.98 150.95 47.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 2.49 110.413 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 33' ' ' PRO . 33.0 mt -103.74 150.3 38.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.242 -0.435 . . . . 1.91 110.071 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.6 150.65 80.75 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.451 2.101 . . . . 1.84 111.288 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -51.67 130.86 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.51 . . . . 2.53 111.378 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.79 -17.47 38.77 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.691 -0.766 . . . . 2.2 111.488 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.03 102.38 12.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 2.1 110.301 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 148.82 29.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.342 -0.39 . . . . 2.78 111.366 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.454 HD23 HD12 ' A' ' 121' ' ' LEU . 70.7 mt -82.43 145.46 51.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.735 -0.469 . . . . 2.62 109.735 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.463 ' HG2' ' CB ' ' A' ' 131' ' ' PHE . 9.9 Cg_endo -54.59 146.32 54.32 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.83 2.353 . . . . 2.77 111.918 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -60.91 112.32 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.84 -0.618 . . . . 4.11 111.93 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.88 -6.99 41.13 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.143 -0.551 . . . . 3.18 112.177 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -101.16 146.31 27.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.486 -0.191 . . . . 2.91 110.486 -179.208 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.442 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 11.6 p90 -155.93 165.13 37.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 3.54 110.093 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.64 136.92 38.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.814 0.34 . . . . 2.93 111.116 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -65.15 126.02 26.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 3.64 110.376 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.93 21.64 65.34 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.106 -0.569 . . . . 3.27 112.415 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.96 135.35 47.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.777 0.322 . . . . 3.59 110.168 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -110.68 101.28 9.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.185 -0.461 . . . . 5.55 110.619 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.65 121.94 7.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.782 -0.723 . . . . 5.22 111.865 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.41 -61.23 4.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.431 -0.414 . . . . 5.91 112.719 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.856 -0.593 . . . . 7.27 110.795 -179.214 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.411 ' H41' ' HE2' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.625 1 C4'-C3'-C2' 97.036 -5.664 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.402 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.523 2 N19-C1'-C2' 103.499 -6.188 . 0.235 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.808 3 O4'-C1'-N19 115.681 7.481 . 0.533 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.17 4 O4'-C1'-N19 116.604 8.404 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.063 2 C4'-C3'-C2' 97.543 -5.157 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.753 4 N19-C1'-C2' 106.319 -4.426 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.322 3 P-O3'-C3' 126.978 6.065 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.411 3 O4'-C4'-C3' 114.895 6.71 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . 0.464 " H4'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.542 -5.125 2 O4'-C1'-N19 118.686 10.486 . 0.418 1a . 14.39 . . . . . . . . . . 3 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.547 4 O3'-P-O5' 116.285 6.466 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.139 1 C4'-C3'-C2' 98.236 -4.464 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.604 1 C4'-C3'-C2' 94.341 -8.359 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.528 ' O4 ' ' HE3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.588 5.848 1 O3'-P-O5' 111.83 4.121 . 0.105 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.079 2 C3'-C2'-C1' 105.728 4.697 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.907 -0.477 . . . . 9.05 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.36 121.09 33.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.78 0.324 . . . . 8.09 110.457 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.9 tpt -81.01 116.64 21.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.266 -0.425 . . . . 8.02 110.538 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.29 170.6 42.67 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.994 -0.622 . . . . 5.76 111.724 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 78' ' ' GLU . 80.7 mt -136.94 111.7 9.48 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.327 -0.249 . . . . 4.72 110.327 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.92 56.62 5.42 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.953 2.435 . . . . 4.45 111.638 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -128.14 164.04 23.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.988 -0.551 . . . . 4.41 109.751 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -77.27 -69.94 0.5 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.411 -0.359 . . . . 3.92 110.219 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m 58.74 82.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.819 -0.628 . . . . 2.53 112.083 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.25 145.54 41.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.554 -0.748 . . . . 2.48 110.747 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.84 38.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 2.13 110.599 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -87.43 -22.76 24.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.996 0.369 . . . . 2.4 111.996 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.71 161.54 19.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 2.02 111.662 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 p -67.14 158.15 31.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 2.65 111.259 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -87.13 145.49 26.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 2.4 110.496 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.57 HD11 HD13 ' A' ' 119' ' ' LEU . 2.8 mp -99.85 152.49 20.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.456 -0.572 . . . . 2.27 109.456 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.622 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 2.0 m -109.09 128.29 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.858 0.361 . . . . 2.84 111.148 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -97.06 135.73 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 2.89 109.954 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -132.98 103.35 6.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.842 0.353 . . . . 3.82 110.375 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.07 -151.31 22.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.774 -0.726 . . . . 3.23 111.629 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 25.7 mmtp -103.18 -19.25 14.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.91 0.386 . . . . 4.27 110.904 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -79.76 137.75 37.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.053 -0.721 . . . . 3.32 109.053 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 1.9 t0 -81.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.046 -0.724 . . . . 2.39 109.046 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 17.1 tp 173.07 122.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 2.06 110.98 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -144.39 123.19 12.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.104 -0.498 . . . . 2.22 109.768 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 29.4 m-85 -111.55 142.14 25.96 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 1.78 110.636 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 21.6 Cg_exo -66.75 164.93 27.4 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.238 2.625 . . . . 2.15 112.278 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -62.64 120.95 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 2.6 110.766 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 94' ' ' ALA . . . 75.63 21.95 76.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.987 -0.625 . . . . 1.65 112.542 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 1.7 tt0 -138.26 156.84 47.29 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.757 -0.261 . . . . 2.31 110.925 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.0 -3.92 48.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.817 -0.706 . . . . 1.33 112.719 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 120.94 79.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.602 0.239 . . . . 1.06 110.452 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.424 ' HD3' ' OH ' ' A' ' 47' ' ' TYR . 58.7 Cg_endo -71.79 174.93 10.36 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.646 2.231 . . . . 1.27 111.577 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mt -81.83 83.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.857 0.36 . . . . 1.7 110.376 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -79.08 91.76 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 1.23 109.908 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -17.76 60.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 1.94 112.092 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -89.51 -18.72 26.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.042 0.386 . . . . 1.96 112.042 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -99.44 160.3 14.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.69 0.281 . . . . 1.42 111.673 -179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.4 m -80.94 168.52 24.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.09 -0.505 . . . . 1.73 110.02 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.19 -39.02 93.59 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.462 2.108 . . . . 1.42 112.09 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.9 p-10 -85.05 -1.53 56.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 1.78 111.105 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 0.4 OUTLIER -98.3 0.12 44.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.805 -0.634 . . . . 1.6 110.212 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -79.43 57.52 2.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 1.05 110.814 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 tt -146.15 130.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 1.17 109.728 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.14 -148.03 5.88 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.297 -0.954 . . . . 0.6 112.404 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -153.84 152.96 31.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.802 0.334 . . . . 0.99 111.806 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.424 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 49.3 m-85 -100.16 117.64 34.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.525 -0.917 . . . . 1.26 108.525 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -96.9 131.09 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.991 0.424 . . . . 2.15 111.802 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -79.63 107.23 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 2.4 109.715 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.37 156.13 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.13 0.49 . . . . 2.21 111.67 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.97 140.6 32.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 2.68 109.94 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -124.97 123.48 39.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.976 0.417 . . . . 3.59 111.615 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -139.8 165.34 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 3.43 109.452 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.73 HG12 ' H ' ' A' ' 62' ' ' LYS . 43.1 pt -133.97 173.61 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.367 -0.235 . . . . 4.26 110.367 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.469 HH21 ' HB3' ' A' ' 61' ' ' MET . 3.7 mmp_? -128.91 100.91 5.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.525 -0.307 . . . . 5.17 110.766 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.96 168.39 35.55 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.909 -0.662 . . . . 4.66 111.813 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.79 -37.34 93.3 Favored Glycine 0 C--N 1.329 0.191 0 C-N-CA 121.022 -0.608 . . . . 5.04 112.272 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.73 -17.22 61.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.154 0.502 . . . . 5.51 110.325 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.95 9.01 43.79 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.958 -0.639 . . . . 4.73 111.574 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -86.32 169.32 13.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.747 0.308 . . . . 5.52 110.762 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.469 ' HB3' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -152.77 161.54 42.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.131 -0.486 . . . . 4.48 111.154 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.73 ' H ' HG12 ' A' ' 54' ' ' ILE . 66.6 tttt -72.67 -55.18 7.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.95 -0.759 . . . . 4.16 108.95 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.7 t70 56.78 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.162 -0.927 . . . . 4.09 113.042 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 157.07 16.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 3.36 110.304 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.24 158.24 82.42 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.491 . . . . 3.36 110.554 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 116.18 2.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.774 2.316 . . . . 2.69 111.898 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -117.14 125.97 52.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.746 -0.661 . . . . 3.03 110.692 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -99.77 126.18 45.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.976 -0.557 . . . . 1.84 111.128 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 42.5 m-85 -103.51 139.42 38.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 2.76 109.604 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.97 123.12 33.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.077 0.465 . . . . 1.27 111.564 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.448 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 57.5 m-85 -120.3 177.34 5.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.582 -0.735 . . . . 1.84 109.41 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.81 175.24 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.28 111.702 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.09 94.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.456 0.539 . . . . 1.66 112.456 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.69 45.62 3.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.95 -0.643 . . . . 1.66 114.04 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -78.85 84.65 4.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.173 0.487 . . . . 1.58 111.129 179.095 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.16 136.59 2.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.083 -0.579 . . . . 1.96 111.925 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.26 -35.3 74.78 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 2.62 112.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' HB2' HD21 ' A' ' 5' ' ' LEU . 36.5 mt-10 -129.08 40.36 3.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.3 0.571 . . . . 3.09 110.149 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.89 -60.78 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.727 -0.669 . . . . 1.79 110.069 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.13 51.91 16.07 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.886 -0.673 . . . . 1.65 111.487 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.3 mt -117.0 104.32 50.95 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.796 0.332 . . . . 1.38 111.537 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 91.5 Cg_endo -88.1 151.25 6.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.651 2.234 . . . . 1.62 110.737 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -59.05 111.36 1.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 1.58 110.896 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.83 -3.01 14.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.645 -0.788 . . . . 1.44 112.805 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.454 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -71.73 131.23 42.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 1.25 110.724 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -97.18 114.9 26.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.064 0.459 . . . . 1.86 110.857 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 90' ' ' ILE . 22.3 ttmm -142.0 152.7 43.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.012 -0.736 . . . . 1.68 109.012 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.07 119.6 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 1.7 111.98 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.56 71.17 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.769 -0.651 . . . . 1.27 112.873 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.544 HG13 ' HB3' ' A' ' 87' ' ' LYS . 33.2 mm -125.25 96.09 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.877 0.37 . . . . 1.01 111.572 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.75 137.28 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.492 -0.559 . . . . 1.3 109.492 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -96.58 147.84 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.76 0.652 . . . . 1.08 112.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.27 137.05 33.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.67 -0.696 . . . . 1.04 110.246 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' O ' ' HA2' ' A' ' 29' ' ' GLY . . . -148.36 166.44 28.05 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.655 -0.498 . . . . 1.27 109.655 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 t -139.76 168.4 19.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.745 -0.207 . . . . 1.36 110.689 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.2 124.39 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 2.64 111.254 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.9 -16.5 36.37 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.71 -0.677 . . . . 1.52 112.439 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.783 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -79.97 143.35 34.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.625 0.25 . . . . 1.59 110.656 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.76 148.62 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.417 -0.356 . . . . 2.15 110.526 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -84.54 64.43 8.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.465 0.65 . . . . 2.07 111.193 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.32 143.11 47.49 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.518 -0.765 . . . . 2.36 109.167 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.8 131.19 24.35 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.866 2.377 . . . . 2.08 112.988 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -119.93 44.26 2.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.944 -0.571 . . . . 1.78 110.302 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -13.04 62.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 2.55 112.155 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -21.63 65.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.283 0.475 . . . . 2.24 112.283 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.72 18.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.164 0.507 . . . . 2.0 110.963 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.33 12.19 69.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.862 -0.685 . . . . 2.33 111.659 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -114.44 128.16 56.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.859 0.362 . . . . 2.99 111.494 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -169.25 139.66 2.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.834 -0.621 . . . . 2.83 109.603 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -99.14 120.57 57.95 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.802 0.334 . . . . 3.56 110.648 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.91 -29.5 23.07 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.035 2.49 . . . . 3.39 114.975 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.02 -2.6 57.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.031 -0.418 . . . . 4.05 111.468 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -122.28 0.13 9.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.185 0.517 . . . . 4.48 111.223 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -160.21 142.66 13.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.137 -0.483 . . . . 3.39 109.77 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.33 145.93 24.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.75 0.31 . . . . 3.21 111.215 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.597 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -78.59 138.19 38.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.453 . . . . 2.85 109.778 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.79 141.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.27 -0.423 . . . . 2.42 110.337 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.92 122.37 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.858 -0.423 . . . . 2.74 109.858 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.57 HD13 HD11 ' A' ' 16' ' ' LEU . 2.3 tt -67.61 119.05 11.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.15 0.5 . . . . 2.11 111.436 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -131.01 143.62 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.574 -0.739 . . . . 2.49 110.452 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.3 mt -97.97 149.63 35.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.131 -0.486 . . . . 1.91 110.665 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.08 154.87 48.36 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.669 2.246 . . . . 1.84 111.875 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -58.76 119.2 6.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 2.53 110.515 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 117.81 -26.06 8.16 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.762 -0.732 . . . . 2.2 111.569 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 m -102.95 107.45 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 2.1 110.075 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 155.21 17.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.38 -0.373 . . . . 2.78 111.402 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.6 mt -74.57 142.51 77.71 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.505 -0.554 . . . . 2.62 109.505 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.1 150.01 59.41 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.649 2.233 . . . . 2.77 111.853 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -58.37 116.03 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 4.11 111.337 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 108.57 -20.19 30.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.076 -0.583 . . . . 3.18 111.762 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 16' ' ' LEU . 3.8 t80 -95.61 117.99 31.48 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.487 -0.56 . . . . 2.91 109.487 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.622 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 5.9 p90 -125.49 148.76 48.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.123 0.487 . . . . 3.54 111.535 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.49 142.17 28.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.854 -0.612 . . . . 2.93 110.018 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.85 140.14 33.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.958 0.408 . . . . 3.64 110.557 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.24 -19.57 52.33 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.287 -0.725 . . . . 3.27 111.287 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.3 m -81.36 -9.26 59.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.734 0.302 . . . . 3.59 111.782 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -101.75 16.81 24.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.696 0.284 . . . . 5.55 111.33 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.51 39.85 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.358 -0.925 . . . . 5.22 113.134 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.48 61.36 3.2 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.782 -0.723 . . . . 5.91 111.816 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.993 -0.527 . . . . 7.27 110.999 -179.639 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.49 -3.759 1 C4'-C3'-C2' 97.054 -5.646 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.473 4.644 2 N19-C1'-C2' 103.458 -6.214 . 0.228 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.747 3 O4'-C1'-N19 115.69 7.49 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.182 3 O4'-C1'-N19 116.671 8.471 . 0.515 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.088 2 C4'-C3'-C2' 97.528 -5.172 . 0.656 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.688 5 N19-C1'-C2' 106.387 -4.383 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.367 3 P-O3'-C3' 127.021 6.101 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.597 " H4'" ' HB3' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.368 3 O4'-C4'-C3' 115.01 6.793 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.132 2 O4'-C1'-N19 118.612 10.412 . 0.415 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.55 3 O3'-P-O5' 116.369 6.51 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.119 1 C4'-C3'-C2' 98.274 -4.426 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.533 1 C4'-C3'-C2' 94.334 -8.366 . 0.458 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.795 1 O3'-P-O5' 111.683 4.044 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.063 2 C3'-C2'-C1' 105.653 4.614 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.583 -0.607 . . . . 9.05 111.583 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.02 128.54 51.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.745 0.307 . . . . 8.09 110.473 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.2 mtt -100.61 127.56 46.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.389 -0.369 . . . . 8.02 110.142 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.18 107.01 0.25 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.482 -0.866 . . . . 5.76 112.148 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.36 120.42 70.44 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-O 120.638 0.256 . . . . 4.72 110.435 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.06 -14.36 29.02 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.633 2.222 . . . . 4.45 111.63 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -71.53 150.23 44.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.473 -0.785 . . . . 4.41 110.343 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -81.2 -64.82 1.11 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.547 -0.297 . . . . 3.92 111.16 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 p 49.2 75.53 0.15 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.829 0.678 . . . . 2.53 112.829 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.491 ' HB1' " O2'" ' C' ' 8' ' ' ' G' . . . -77.51 142.04 39.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 2.48 111.294 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.77 146.39 46.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 2.13 111.005 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.499 ' CE2' ' HD3' ' A' ' 109' ' ' ARG . 24.3 m95 -81.86 -34.93 29.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 2.4 111.234 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.07 164.97 11.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.834 -0.621 . . . . 2.02 111.355 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.903 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -62.8 164.65 7.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.068 -0.514 . . . . 2.65 111.663 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -80.11 149.54 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 2.4 112.144 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 119' ' ' LEU . 95.4 mt -105.41 119.15 38.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.325 -0.991 . . . . 2.27 108.325 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 m -100.32 129.42 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.64 0.607 . . . . 2.84 112.64 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -97.5 115.7 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 2.89 110.056 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -110.83 74.03 0.85 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.088 -0.506 . . . . 3.82 109.956 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.62 -162.24 22.61 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.861 -0.608 . . . . 3.23 111.649 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.56 -18.5 22.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.368 . . . . 4.27 110.82 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.18 170.08 12.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.039 -0.528 . . . . 3.32 111.103 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -101.59 -78.31 0.53 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.091 -0.707 . . . . 2.39 109.091 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -178.15 143.66 0.3 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.08 -0.509 . . . . 2.06 110.854 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -159.3 116.26 2.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.071 -0.513 . . . . 2.22 110.0 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.17 134.83 21.38 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 1.78 110.511 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 55.2 Cg_endo -69.66 150.92 69.47 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.599 2.199 . . . . 2.15 112.267 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.1 121.53 10.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.799 -0.637 . . . . 2.6 110.15 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.46 -25.75 13.1 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.215 -0.754 . . . . 1.65 111.215 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 50.5 mt-30 -113.78 -172.47 2.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.22 -0.289 . . . . 2.31 110.22 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.63 -26.08 21.78 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.882 -0.675 . . . . 1.33 112.163 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.25 119.27 75.96 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.576 0.227 . . . . 1.06 110.615 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.88 177.23 8.19 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.197 . . . . 1.27 111.183 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.453 HG22 HG23 ' A' ' 36' ' ' THR . 44.9 mt -77.16 91.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 1.7 110.201 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -84.42 82.88 8.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 1.23 110.287 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.453 HG23 HG22 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -78.07 41.38 0.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.791 -0.64 . . . . 1.94 112.198 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -150.29 -2.6 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 1.96 111.352 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -130.32 170.34 14.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.497 -0.32 . . . . 1.42 111.503 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.36 165.67 32.2 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.594 -0.276 . . . . 1.73 110.271 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 11.8 Cg_endo -56.43 -33.54 92.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.966 2.444 . . . . 1.42 112.225 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -71.74 -24.09 61.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 1.78 110.547 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.99 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 42.4 m-20 -83.53 -2.98 57.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.808 -0.633 . . . . 1.6 110.802 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 32.3 mm-40 -78.26 56.75 1.75 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.344 0.592 . . . . 1.05 111.354 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.418 HG13 ' HB2' ' A' ' 94' ' ' ALA . 14.4 tt -150.87 130.96 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.499 -0.773 . . . . 1.17 109.103 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.31 -146.45 5.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.113 -1.042 . . . . 0.6 112.979 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.453 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 34.2 p90 -155.41 161.35 41.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.003 0.43 . . . . 0.99 110.764 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.599 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 47.4 m-85 -104.56 134.66 47.36 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.187 -0.672 . . . . 1.26 109.187 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -114.65 122.47 46.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.027 -0.533 . . . . 2.15 110.834 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -87.6 123.42 32.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.33 . . . . 2.4 110.406 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.33 155.99 43.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.21 111.485 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.55 120.67 16.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.647 . . . . 2.68 109.95 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.61 ' HB3' HD12 ' A' ' 64' ' ' LEU . 25.9 tpt180 -96.56 122.18 39.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.101 0.477 . . . . 3.59 112.021 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -138.23 145.32 41.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.681 -0.69 . . . . 3.43 109.907 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.479 HG12 ' H ' ' A' ' 62' ' ' LYS . 33.4 pt -121.72 -178.3 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.207 -0.452 . . . . 4.26 109.986 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -145.98 96.01 2.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 5.17 110.528 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.77 179.28 41.39 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.755 -0.736 . . . . 4.66 112.121 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.3 -47.51 89.15 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.919 -0.658 . . . . 5.04 112.012 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.69 -38.09 89.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 5.51 111.151 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.88 1.41 6.91 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.989 -0.624 . . . . 4.73 112.227 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -71.81 160.27 32.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.734 0.302 . . . . 5.52 111.124 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.25 150.62 38.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 4.48 110.944 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.608 ' HE3' HD21 ' A' ' 64' ' ' LEU . 50.2 tttp -65.39 -54.37 29.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.556 . . . . 4.16 110.291 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.32 91.14 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.606 -0.724 . . . . 4.09 112.89 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 52' ' ' ARG . 63.6 mt -94.59 150.19 20.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 3.36 109.903 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.434 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m -64.83 161.54 45.26 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.224 -0.444 . . . . 3.36 110.39 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 12.2 Cg_endo -56.77 109.24 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.579 2.186 . . . . 2.69 111.244 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -103.51 123.38 46.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 3.03 111.422 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.599 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 79.9 m95 -96.2 120.64 36.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.976 -0.556 . . . . 1.84 110.056 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 53.9 m-85 -106.7 133.31 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.727 -0.472 . . . . 2.76 109.727 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -85.95 121.19 28.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.802 0.334 . . . . 1.27 111.163 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -118.76 146.27 44.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.024 -0.534 . . . . 1.84 109.808 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -82.67 149.3 27.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.463 -0.335 . . . . 1.28 110.504 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 tp -59.44 113.5 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.474 -0.33 . . . . 1.66 110.652 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 122.38 -13.92 8.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.141 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.471 HG22 ' HA3' ' A' ' 107' ' ' GLY . 9.8 p -59.72 123.66 17.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.711 0.291 . . . . 1.58 110.787 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.471 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 105.1 99.64 2.6 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.789 -0.72 . . . . 1.96 111.573 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 10.9 Cg_endo -54.9 -42.54 67.98 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 123.079 2.519 . . . . 2.62 112.334 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.47 28.13 8.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.034 0.445 . . . . 3.09 111.298 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.2 -43.22 53.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 1.79 110.484 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.33 51.82 56.35 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.923 -0.581 . . . . 1.65 111.973 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.22 95.66 35.8 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.735 0.302 . . . . 1.38 111.428 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 4.0 Cg_exo -76.04 159.61 37.42 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.836 2.357 . . . . 1.62 110.323 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -60.08 107.84 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 1.58 111.026 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.24 -13.91 8.35 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.706 -0.679 . . . . 1.44 112.19 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.626 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -60.02 116.64 4.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.054 0.454 . . . . 1.25 111.13 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -76.24 116.33 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 1.86 110.763 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -137.31 158.17 45.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.546 -0.539 . . . . 1.68 109.546 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.33 121.82 16.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.257 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 30.83 71.25 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.95 -0.568 . . . . 1.27 112.595 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.9 mm -131.74 113.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.621 0.248 . . . . 1.01 110.38 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 91' ' ' ILE . 11.8 pt -121.36 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 1.3 109.71 178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 76.4 m95 -91.72 139.61 30.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.347 0.499 . . . . 1.08 112.347 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.13 142.89 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.721 -0.672 . . . . 1.04 110.368 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -154.62 155.25 34.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.401 . . . . 1.27 110.588 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -121.83 170.11 10.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 1.36 109.73 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.73 114.33 11.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.934 0.397 . . . . 2.64 110.172 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.36 5.83 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.039 -0.824 . . . . 1.52 111.039 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.732 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.52 159.96 28.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 1.59 110.748 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.442 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 94.8 mt -118.49 140.56 49.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 2.15 111.263 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.67 80.58 7.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.399 0.619 . . . . 2.07 110.752 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.533 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.3 t -156.28 146.77 16.05 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.115 -0.698 . . . . 2.36 109.115 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.48 118.18 5.47 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.231 1.954 . . . . 2.08 112.401 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.99 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -118.31 67.42 0.77 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.728 . . . . 1.78 110.682 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.79 -4.24 36.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.897 . . . . 2.55 111.224 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -61.35 -14.19 25.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.005 -0.543 . . . . 2.24 112.392 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.42 HD13 ' HB3' ' A' ' 38' ' ' SER . 2.5 mt -104.7 -26.22 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.804 0.335 . . . . 2.0 110.724 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -61.31 -33.23 83.7 Favored Glycine 0 C--N 1.328 0.138 0 CA-C-N 115.901 -0.59 . . . . 2.33 113.482 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -67.23 113.21 4.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.845 0.355 . . . . 2.99 111.387 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HD3' ' CE2' ' A' ' 12' ' ' TRP . 10.7 ttp85 -162.95 128.83 3.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 2.83 111.1 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -91.59 116.92 67.39 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.722 -0.672 . . . . 3.56 109.882 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.422 ' HB3' " O2'" ' C' ' 8' ' ' ' G' . 34.7 Cg_endo -63.81 -33.31 65.37 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.166 2.578 . . . . 3.39 113.044 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.21 14.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.976 0.417 . . . . 4.05 111.812 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -132.16 9.54 4.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.152 -0.476 . . . . 4.48 111.591 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.424 HD22 ' HA ' ' A' ' 114' ' ' ASN . 1.4 t-20 -168.61 129.75 1.26 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.664 0.269 . . . . 3.39 111.653 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.46 168.19 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 3.21 110.519 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 156.98 16.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 2.85 111.627 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 30.3 mt -101.1 142.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.362 -0.977 . . . . 2.42 108.362 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.06 121.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.793 0.33 . . . . 2.74 110.286 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 16' ' ' LEU . 4.2 tt -58.92 112.2 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.706 . . . . 2.11 110.872 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -111.92 144.1 41.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.807 -0.633 . . . . 2.49 110.211 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 65.7 mt -107.5 143.46 27.28 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.301 -0.409 . . . . 1.91 110.766 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.92 156.67 63.16 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.653 2.235 . . . . 1.84 111.635 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -55.66 121.36 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 2.53 110.432 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.57 -21.0 19.9 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.885 -0.674 . . . . 2.2 111.442 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 6.5 m -99.24 104.17 16.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 2.1 110.116 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.97 140.86 35.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.723 -0.671 . . . . 2.78 110.952 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.692 HD22 ' HD2' ' A' ' 131' ' ' PHE . 21.3 mt -73.99 137.97 76.1 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 2.62 110.058 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.74 155.31 38.25 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.665 2.243 . . . . 2.77 112.055 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -58.22 127.87 34.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.734 -0.666 . . . . 4.11 111.306 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -17.21 59.76 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.091 -0.576 . . . . 3.18 112.652 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.692 ' HD2' HD22 ' A' ' 127' ' ' LEU . 2.6 t80 -94.53 120.22 34.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.562 0.22 . . . . 2.91 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' OH ' " H5'" ' B' ' 1' ' ' ' C' . 36.7 p90 -124.35 155.42 38.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.65 -0.25 . . . . 3.54 111.287 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 136.4 41.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.93 111.754 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.903 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.0 tp10 -61.44 123.58 18.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.592 -0.731 . . . . 3.64 110.742 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.84 66.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.9 -0.667 . . . . 3.27 113.631 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.6 m -77.11 112.71 14.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.037 0.446 . . . . 3.59 111.7 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -160.24 155.47 24.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.834 -0.621 . . . . 5.55 110.563 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -119.39 80.66 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.861 -0.685 . . . . 5.22 112.226 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -105.79 111.0 3.54 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.884 -0.674 . . . . 5.91 111.52 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.861 -0.59 . . . . 7.27 111.206 -179.416 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.405 " H5'" ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . 0 C2'--C1' 1.491 -3.663 1 C4'-C3'-C2' 97.058 -5.642 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.56 2 N19-C1'-C2' 103.521 -6.174 . 0.23 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.763 3 O4'-C1'-N19 115.743 7.543 . 0.53 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.167 4 O4'-C1'-N19 116.649 8.449 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O4'--C4' 1.403 -4.152 2 C4'-C3'-C2' 97.563 -5.137 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.733 4 N19-C1'-C2' 106.37 -4.394 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.496 5.223 3 P-O3'-C3' 127.002 6.085 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.491 " O2'" ' HB1' ' A' ' 10' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.325 3 O4'-C4'-C3' 114.961 6.758 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 011 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.107 2 O4'-C1'-N19 118.591 10.391 . 0.411 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.506 3 O3'-P-O5' 116.389 6.52 . 0.457 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.165 1 C4'-C3'-C2' 98.226 -4.474 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.432 1 C4'-C3'-C2' 94.336 -8.364 . 0.459 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.781 1 O3'-P-O5' 111.754 4.081 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.961 2 C3'-C2'-C1' 105.64 4.6 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.684 -0.566 . . . . 9.05 111.684 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.76 125.93 30.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.903 0.382 . . . . 8.09 110.791 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.9 mtt -119.52 107.94 13.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 8.02 110.088 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.57 150.57 22.6 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.838 -0.696 . . . . 5.76 112.65 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.69 136.82 21.06 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.947 -0.39 . . . . 4.72 109.947 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.92 48.06 2.37 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.001 2.468 . . . . 4.45 112.179 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -99.54 27.04 5.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.04 -0.527 . . . . 4.41 110.409 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -111.29 -160.33 0.71 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.798 -0.637 . . . . 3.92 109.526 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.585 HG22 ' HE2' ' A' ' 71' ' ' TYR . 28.7 m 68.45 83.35 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.429 0.633 . . . . 2.53 112.107 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.63 163.1 13.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.783 -0.644 . . . . 2.48 110.005 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -73.16 155.61 39.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.197 0.522 . . . . 2.13 111.543 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -90.42 -24.24 20.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.609 . . . . 2.4 110.985 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 89.2 m-85 -117.2 167.43 11.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 2.02 110.732 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -64.89 155.45 34.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.892 -0.595 . . . . 2.65 110.79 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 163.92 26.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.286 0.565 . . . . 2.4 111.261 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.849 ' HB3' ' HZ ' ' A' ' 131' ' ' PHE . 60.6 mt -111.3 111.55 22.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.675 -0.693 . . . . 2.27 109.854 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.2 OUTLIER -79.44 119.63 22.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 2.84 111.61 -179.159 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 23' ' ' ASP . 43.4 tp60 -90.49 124.99 35.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 2.89 110.673 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -132.24 91.29 2.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 3.82 110.424 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.13 38.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.298 -0.721 . . . . 3.23 111.298 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 52.6 mmtt -90.96 -7.76 51.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 4.27 111.176 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -114.73 -172.79 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.189 -0.671 . . . . 3.32 109.189 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.572 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -127.34 -149.99 0.43 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.178 -0.675 . . . . 2.39 109.178 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 5.3 mp -95.62 133.38 39.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.751 0.31 . . . . 2.06 110.648 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.18 92.28 1.33 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.174 -0.466 . . . . 2.22 109.858 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -91.67 136.3 26.69 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 1.78 110.995 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -74.16 158.96 44.84 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.658 2.239 . . . . 2.15 111.187 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.5 125.26 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.007 0.432 . . . . 2.6 111.665 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.81 -15.66 52.01 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.637 -0.792 . . . . 1.65 112.62 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -129.98 153.49 48.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.651 0.262 . . . . 2.31 110.379 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.74 1.55 11.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.575 -0.821 . . . . 1.33 112.688 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 43' ' ' GLN . 47.0 t -102.49 115.43 64.43 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.886 0.374 . . . . 1.06 110.852 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.45 178.64 5.93 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.761 2.308 . . . . 1.27 111.439 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.409 HG22 HG23 ' A' ' 36' ' ' THR . 28.8 mt -77.06 92.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.996 0.427 . . . . 1.7 110.456 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.467 ' HB2' HE22 ' A' ' 43' ' ' GLN . 56.0 m-80 -82.73 84.41 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 1.23 110.452 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.409 HG23 HG22 ' A' ' 34' ' ' ILE . 4.4 p -75.4 9.45 2.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.494 0.553 . . . . 1.94 112.494 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -118.08 -5.73 10.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.785 0.291 . . . . 1.96 111.785 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -124.52 168.11 13.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.89 0.376 . . . . 1.42 111.746 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.665 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.6 m -86.87 167.76 20.81 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 115.974 -0.557 . . . . 1.73 109.583 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.54 -36.86 72.39 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.344 2.696 . . . . 1.42 113.293 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.45 -14.76 59.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.057 0.391 . . . . 1.78 112.057 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -88.41 -0.04 56.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.624 0.25 . . . . 1.6 110.351 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.467 HE22 ' HB2' ' A' ' 35' ' ' ASN . 41.0 mm-40 -76.6 51.1 0.72 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.364 -0.38 . . . . 1.05 111.586 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.866 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.7 tt -146.39 130.46 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.17 -0.468 . . . . 1.17 110.233 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.63 -148.84 6.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.462 -0.875 . . . . 0.6 112.457 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -152.51 166.64 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 0.99 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.746 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.9 m-85 -111.72 134.53 53.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.944 -0.571 . . . . 1.26 109.955 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -112.94 133.98 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.195 -0.457 . . . . 2.15 111.211 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 49' ' ' ARG . 12.2 ttt-85 -87.25 121.77 30.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.1 -0.5 . . . . 2.4 109.876 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 156.85 47.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 2.21 111.531 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.409 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -145.21 154.5 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 2.68 110.288 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' HD12 ' A' ' 64' ' ' LEU . 12.8 tpt180 -130.14 118.65 21.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.973 -0.38 . . . . 3.59 109.973 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.88 107.52 5.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.634 -0.257 . . . . 3.43 110.409 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.933 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.8 pt -69.84 158.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 4.26 110.505 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.15 98.98 4.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.165 -0.47 . . . . 5.17 110.095 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.2 157.55 51.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.842 -0.694 . . . . 4.66 111.81 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.33 -35.95 89.7 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.197 -0.525 . . . . 5.04 112.744 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -78.02 -0.36 27.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.061 0.458 . . . . 5.51 111.042 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.94 44.3 5.15 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.851 -0.69 . . . . 4.73 112.081 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -100.25 144.71 28.94 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.787 -0.449 . . . . 5.52 109.787 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.9 mmt -128.38 136.13 50.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.261 -0.427 . . . . 4.48 110.106 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.933 ' HB2' HG12 ' A' ' 54' ' ' ILE . 43.7 tttt -71.07 -46.59 61.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.557 -0.534 . . . . 4.16 109.557 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 65.95 99.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.974 1.101 . . . . 4.09 113.974 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 52' ' ' ARG . 93.8 mt -126.73 151.1 48.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.484 -0.78 . . . . 3.36 110.024 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.46 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.4 OUTLIER -74.31 153.89 88.12 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.192 -0.458 . . . . 3.36 110.283 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HA ' HG23 ' A' ' 51' ' ' THR . 15.0 Cg_endo -58.14 127.4 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.76 2.307 . . . . 2.69 111.756 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -115.22 124.64 51.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.486 . . . . 3.03 110.613 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.746 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 37.1 m95 -94.26 121.33 35.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 1.84 110.134 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -96.95 146.76 24.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 2.76 110.673 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -94.19 126.92 39.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.899 0.38 . . . . 1.27 110.33 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.585 ' HE2' HG22 ' A' ' 9' ' ' THR . 23.7 m-85 -126.99 165.77 18.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.955 -0.566 . . . . 1.84 109.867 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -100.62 169.21 9.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.773 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.92 103.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.088 0.773 . . . . 1.66 113.088 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.64 44.74 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.923 -0.58 . . . . 1.66 114.065 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.527 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -74.46 82.93 1.96 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.116 0.484 . . . . 1.58 111.321 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 77' ' ' PRO . . . 159.71 131.18 1.21 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.596 -0.602 . . . . 1.96 111.596 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' ' 76' ' ' GLY . 31.9 Cg_exo -60.23 -37.87 79.98 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.007 2.472 . . . . 2.62 112.322 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.03 31.77 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 3.09 111.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 -53.22 8.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.819 0.342 . . . . 1.79 110.626 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.3 48.49 83.32 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.933 -0.576 . . . . 1.65 112.025 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.1 mt -125.04 103.76 30.11 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.87 0.367 . . . . 1.38 111.592 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.11 162.44 17.9 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.633 2.222 . . . . 1.62 110.933 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -60.88 117.86 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 1.58 111.102 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.08 10.48 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 1.44 112.539 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.83 108.05 2.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 1.25 110.751 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -84.02 137.2 33.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.335 -0.393 . . . . 1.86 110.902 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -147.21 168.43 21.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.459 -0.941 . . . . 1.68 108.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.17 112.23 1.3 Allowed 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.285 0.366 . . . . 1.7 111.783 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.52 39.03 91.09 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.705 -0.68 . . . . 1.27 112.586 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 mm -132.9 102.98 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.825 0.345 . . . . 1.01 110.696 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 47' ' ' TYR . 17.2 pt -113.73 133.86 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.812 -0.44 . . . . 1.3 109.812 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -90.38 140.03 30.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.035 0.445 . . . . 1.08 111.805 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.54 132.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.837 -0.62 . . . . 1.04 110.483 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -150.62 141.71 23.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 1.27 110.471 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 t -112.74 176.61 4.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.523 -0.547 . . . . 1.36 109.523 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -65.04 130.46 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 2.64 110.834 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.52 -15.36 49.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.003 -0.617 . . . . 1.52 112.148 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.866 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -74.56 130.26 39.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.59 110.742 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -103.14 139.51 38.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.136 -0.483 . . . . 2.15 110.873 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -74.15 88.84 1.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.215 0.531 . . . . 2.07 110.5 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.414 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -150.38 153.94 35.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 2.36 109.622 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.414 ' HD2' HG22 ' A' ' 101' ' ' THR . 17.6 Cg_endo -58.65 122.59 11.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.564 2.176 . . . . 2.08 111.468 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.8 mmtt -113.47 29.39 8.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.092 -0.503 . . . . 1.78 111.175 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -13.99 62.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 2.55 111.215 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -65.19 -17.65 64.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.08 -0.509 . . . . 2.24 112.105 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.55 -27.44 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 2.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.527 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -81.21 58.97 4.82 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.925 -0.579 . . . . 2.33 113.225 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 t -138.37 16.31 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 2.99 110.225 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -73.18 137.19 44.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.651 -0.704 . . . . 2.83 110.655 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -95.98 115.67 65.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.426 -0.352 . . . . 3.56 111.124 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.91 -27.97 11.71 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.721 2.281 . . . . 3.39 112.812 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.17 38.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.438 . . . . 4.05 110.847 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -170.1 -45.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 4.48 109.931 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -107.82 139.18 42.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.786 -0.643 . . . . 3.39 110.436 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.34 155.87 22.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.666 0.27 . . . . 3.21 110.876 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.04 162.11 14.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.22 0.533 . . . . 2.85 111.562 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 9.6 mt -98.48 150.55 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.082 -0.71 . . . . 2.42 109.082 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.1 t -69.43 126.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.301 -0.259 . . . . 2.74 110.301 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.476 HD22 HD21 ' A' ' 16' ' ' LEU . 4.4 tt -67.02 110.89 3.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.413 . . . . 2.11 109.911 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -118.11 146.13 44.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.004 -0.544 . . . . 2.49 110.978 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 64.9 mt -99.63 151.34 37.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.893 -0.594 . . . . 1.91 110.169 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.12 163.18 32.5 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.412 2.075 . . . . 1.84 112.48 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -60.69 115.33 3.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 2.53 110.783 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.49 -2.7 23.49 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.636 -0.792 . . . . 2.2 112.094 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 4.0 m -117.02 114.83 24.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 2.1 110.449 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.04 151.77 24.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.442 -0.345 . . . . 2.78 111.099 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.07 148.16 84.07 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.542 -0.54 . . . . 2.62 109.542 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.06 168.47 10.66 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.468 2.112 . . . . 2.77 112.059 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.38 130.93 45.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.076 -0.511 . . . . 4.11 111.891 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.32 65.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.103 -0.57 . . . . 3.18 112.347 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.849 ' HZ ' ' HB3' ' A' ' 16' ' ' LEU . 22.0 t80 -126.82 144.76 50.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.905 0.383 . . . . 2.91 111.384 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -146.65 157.87 43.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.932 -0.576 . . . . 3.54 109.801 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.07 134.12 45.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.012 -0.366 . . . . 2.93 110.012 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.51 150.25 47.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.846 0.355 . . . . 3.64 111.172 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.62 -91.7 0.49 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.873 -0.679 . . . . 3.27 111.779 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 m -89.39 150.0 22.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.64 0.257 . . . . 3.59 110.787 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 137' ' ' ARG . 2.3 mmp_? -92.65 169.02 10.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.535 -0.302 . . . . 5.55 110.367 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.43 142.9 20.63 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.668 -0.777 . . . . 5.22 111.382 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.35 -108.74 3.24 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.774 -0.727 . . . . 5.91 111.68 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.4 m . . . . . 0 C--O 1.251 1.165 0 CA-C-O 119.228 -0.415 . . . . 7.27 111.439 179.841 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.492 -3.59 1 C4'-C3'-C2' 97.037 -5.663 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.467 2 N19-C1'-C2' 103.547 -6.158 . 0.235 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.709 3 O4'-C1'-N19 115.718 7.518 . 0.531 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.256 4 O4'-C1'-N19 116.633 8.433 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.092 2 C4'-C3'-C2' 97.556 -5.144 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.811 4 N19-C1'-C2' 106.361 -4.399 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.314 3 P-O3'-C3' 127.026 6.105 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.581 5.293 3 O4'-C4'-C3' 114.991 6.779 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.021 2 O4'-C1'-N19 118.705 10.505 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.603 3 O3'-P-O5' 116.374 6.513 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.113 1 C4'-C3'-C2' 98.302 -4.398 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.634 1 C4'-C3'-C2' 94.374 -8.326 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.738 1 O3'-P-O5' 111.72 4.063 . 0.107 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.01 2 C3'-C2'-C1' 105.723 4.692 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.606 -0.598 . . . . 9.05 111.606 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.47 163.72 25.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.918 -0.401 . . . . 8.09 109.918 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.0 tpt -93.41 103.7 15.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.454 -0.339 . . . . 8.02 110.203 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.49 79.43 0.34 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.619 -0.8 . . . . 5.76 112.616 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.9 mt -114.7 119.68 39.05 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.54 0.209 . . . . 4.72 110.644 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.32 63.94 7.13 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.218 2.612 . . . . 4.45 112.173 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -79.75 124.57 28.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 4.41 110.323 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -136.97 -102.58 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.337 -0.392 . . . . 3.92 110.437 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.3 m 59.66 84.99 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.826 0.676 . . . . 2.53 112.826 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.37 143.32 26.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.806 -0.634 . . . . 2.48 109.996 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.2 m -64.89 155.56 33.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.188 0.44 . . . . 2.13 112.188 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -84.53 -25.67 28.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.767 -0.652 . . . . 2.4 111.248 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 81.0 m-85 -114.31 164.95 13.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.969 -0.56 . . . . 2.02 110.751 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 10.4 p -70.99 158.42 36.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.101 -0.5 . . . . 2.65 110.256 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 177.09 9.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.489 . . . . 2.4 110.768 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.67 129.25 48.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.411 -0.589 . . . . 2.27 109.411 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -90.54 115.87 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 2.84 111.268 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -83.13 143.97 30.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 2.89 110.685 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -140.36 79.93 1.73 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 3.82 110.164 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -170.47 41.36 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.728 -0.748 . . . . 3.23 111.975 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 61.8 mmtt -88.09 -10.51 49.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 4.27 110.868 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.38 166.3 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 3.32 109.974 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -104.6 -82.28 0.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.77 -0.456 . . . . 2.39 109.77 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.3 tp -177.82 135.28 0.17 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.329 0.393 . . . . 2.06 110.803 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -162.84 124.09 2.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 2.22 109.576 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.3 138.9 23.9 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.578 -0.283 . . . . 1.78 110.709 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.23 175.25 6.96 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.074 2.516 . . . . 2.15 112.563 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.69 126.3 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 2.6 112.03 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.85 78.2 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.93 -0.652 . . . . 1.65 112.712 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.21 171.86 12.8 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.362 -0.236 . . . . 2.31 110.362 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.25 -8.14 69.49 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.661 -0.781 . . . . 1.33 112.783 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.15 114.73 63.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.673 0.273 . . . . 1.06 110.733 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.11 178.38 7.0 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.425 2.083 . . . . 1.27 111.472 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.449 HG22 HG23 ' A' ' 36' ' ' THR . 11.8 mt -77.38 81.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.868 0.366 . . . . 1.7 110.608 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 56.0 m-80 -81.73 81.55 7.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.23 109.942 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.449 HG23 HG22 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -76.07 3.98 9.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.1 -0.5 . . . . 1.94 112.156 -179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.9 -1.38 26.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 1.96 111.368 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.46 164.85 21.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.892 0.377 . . . . 1.42 111.59 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.432 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -80.88 168.08 27.73 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.013 -0.539 . . . . 1.73 110.275 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 10.3 Cg_endo -54.85 -39.27 90.89 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.932 2.421 . . . . 1.42 113.039 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 2.4 p-10 -73.16 -23.77 60.48 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.719 0.295 . . . . 1.78 110.772 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.977 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 34.4 m-20 -79.04 -2.12 38.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.6 111.256 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.462 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 39.9 mm-40 -81.86 55.71 2.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.245 0.545 . . . . 1.05 111.142 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.68 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.4 tt -152.14 131.96 3.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.17 109.961 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.79 -137.9 2.53 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.305 -0.95 . . . . 0.6 112.683 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -160.42 166.96 28.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.403 . . . . 0.99 110.645 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.631 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 3.0 m-85 -105.96 134.3 49.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.082 -0.71 . . . . 1.26 109.082 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -115.18 123.38 48.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.247 -0.433 . . . . 2.15 111.031 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -79.69 111.08 15.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 2.4 110.048 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.22 165.02 11.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 2.21 111.037 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -154.3 125.51 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 2.68 110.177 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HB3' HD12 ' A' ' 64' ' ' LEU . 17.4 tpt180 -115.37 120.62 40.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 3.59 110.656 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -132.03 162.88 29.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 3.43 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.58 HG12 ' HB2' ' A' ' 62' ' ' LYS . 38.1 pt -125.38 162.76 27.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 4.26 109.912 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.71 99.29 6.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.885 0.374 . . . . 5.17 110.631 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.16 152.84 33.23 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.828 -0.701 . . . . 4.66 111.872 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.16 -37.57 94.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.032 -0.604 . . . . 5.04 112.382 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -85.0 11.18 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.174 0.511 . . . . 5.51 111.143 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.9 22.32 55.61 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.928 -0.653 . . . . 4.73 112.266 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -79.54 156.56 27.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.246 -0.279 . . . . 5.52 110.246 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 mtm -140.1 158.89 43.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.743 0.306 . . . . 4.48 110.811 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.631 ' HE3' HD21 ' A' ' 64' ' ' LEU . 52.5 tttp -87.65 -40.19 14.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.19 -0.459 . . . . 4.16 110.451 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t70 40.96 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.247 1.202 . . . . 4.09 114.247 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.631 HD21 ' HE3' ' A' ' 62' ' ' LYS . 90.9 mt -95.78 157.32 15.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 3.36 110.365 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.507 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.7 OUTLIER -69.72 153.06 95.92 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.73 -0.47 . . . . 3.36 109.73 179.145 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 113.85 1.49 Allowed 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.741 2.294 . . . . 2.69 112.057 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.413 HH21 HD13 ' A' ' 64' ' ' LEU . 48.1 mtt-85 -105.72 122.41 46.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 3.03 110.686 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.631 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 67.3 m95 -99.44 115.48 29.39 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.223 -0.444 . . . . 1.84 110.435 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -97.27 142.98 28.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.118 -0.492 . . . . 2.76 109.719 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.89 130.24 35.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 1.27 111.016 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -125.58 154.69 41.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.082 -0.508 . . . . 1.84 109.706 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.02 151.85 20.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.335 -0.393 . . . . 1.28 109.952 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.4 tt -60.38 112.23 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.262 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.49 -5.46 11.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.465 -0.874 . . . . 1.66 113.115 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 p -61.3 108.76 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 1.58 111.646 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 119.86 3.84 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.697 -0.763 . . . . 1.96 112.108 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.2 -37.33 51.95 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.662 2.242 . . . . 2.62 111.954 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -123.33 47.37 2.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.017 0.437 . . . . 3.09 111.013 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.43 -41.86 46.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.449 -0.574 . . . . 1.79 109.449 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 33.58 83.27 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.617 -0.719 . . . . 1.65 112.693 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.583 HD11 ' HD2' ' A' ' 87' ' ' LYS . 82.1 mt -131.05 99.12 18.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.778 0.323 . . . . 1.38 111.467 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.64 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 87.3 Cg_endo -82.87 170.38 12.57 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.488 2.125 . . . . 1.62 110.203 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.695 ' HB2' HD11 ' A' ' 73' ' ' LEU . 69.0 t80 -57.82 111.09 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.783 0.325 . . . . 1.58 110.886 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.06 -17.31 10.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.807 -0.711 . . . . 1.44 112.386 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.04 108.22 1.76 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 1.25 110.954 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -77.61 129.02 35.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.55 . . . . 1.86 110.936 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.583 ' HD2' HD11 ' A' ' 81' ' ' LEU . 75.0 tttt -143.14 162.64 35.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.458 -0.941 . . . . 1.68 108.458 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.81 110.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.881 0.372 . . . . 1.7 111.487 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 28.25 53.8 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.879 -0.677 . . . . 1.27 112.477 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.472 HG13 ' HB3' ' A' ' 87' ' ' LYS . 35.7 mm -128.68 105.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.972 0.415 . . . . 1.01 110.339 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 47' ' ' TYR . 16.0 pt -117.7 127.0 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.198 -0.455 . . . . 1.3 110.135 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.527 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 80.3 m95 -87.25 138.25 31.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.141 0.423 . . . . 1.08 112.141 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.7 138.22 48.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.532 -0.758 . . . . 1.04 110.409 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.99 172.32 13.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.308 -0.406 . . . . 1.27 110.116 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 t -152.73 -176.37 5.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.403 -0.362 . . . . 1.36 110.791 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -65.71 134.82 54.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 2.64 111.118 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.4 -12.1 70.3 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.97 -0.633 . . . . 1.52 112.778 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.07 146.15 30.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.795 0.331 . . . . 1.59 110.727 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.55 149.14 43.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.165 -0.471 . . . . 2.15 110.704 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -82.15 82.75 7.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.259 0.552 . . . . 2.07 110.151 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.588 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 53.0 m -154.5 127.84 4.31 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.274 -0.876 . . . . 2.36 108.705 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.7 129.97 37.48 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.814 2.342 . . . . 2.08 112.783 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.977 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.12 67.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.707 0.765 . . . . 1.78 110.74 179.25 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.19 -7.94 51.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.291 -0.868 . . . . 2.55 111.7 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.405 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.0 p80 -60.14 -22.0 62.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.172 0.434 . . . . 2.24 112.172 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.2 mt -87.82 -35.64 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 2.0 110.563 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.83 66.42 3.75 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.931 -0.577 . . . . 2.33 112.436 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 t -148.35 16.68 1.04 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.533 0.682 . . . . 2.99 110.582 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -74.7 138.92 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.715 . . . . 2.83 110.855 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -85.68 123.16 72.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 3.56 110.605 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HB2' " H5'" ' C' ' 9' ' ' ' U' . 97.7 Cg_endo -77.62 -12.29 16.77 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.002 2.468 . . . . 3.39 114.293 -178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.487 ' HA ' ' H21' ' C' ' 8' ' ' ' G' . . . -111.3 9.67 21.65 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.995 -0.441 . . . . 4.05 111.544 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -136.85 12.16 3.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.215 -0.448 . . . . 4.48 111.226 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -169.38 142.12 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 3.39 111.033 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.447 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -92.37 141.73 28.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.388 -0.369 . . . . 3.21 110.624 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.49 146.89 38.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.323 -0.399 . . . . 2.85 110.755 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.419 ' H ' HG13 ' A' ' 117' ' ' ILE . 3.5 mt -77.17 147.58 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.645 -0.707 . . . . 2.42 109.988 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.75 120.19 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.055 -0.35 . . . . 2.74 110.055 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.31 121.67 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 2.11 111.536 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -132.11 142.56 49.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.702 -0.681 . . . . 2.49 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.561 HD13 HG22 ' A' ' 125' ' ' THR . 72.5 mt -94.16 148.39 35.06 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.184 -0.462 . . . . 1.91 110.296 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.21 167.25 16.78 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.894 2.396 . . . . 1.84 112.266 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -60.72 127.07 29.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 2.53 110.661 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.89 -19.66 46.15 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.548 -0.621 . . . . 2.2 111.548 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.561 HG22 HD13 ' A' ' 121' ' ' LEU . 6.4 m -102.42 109.21 20.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.748 0.308 . . . . 2.1 110.396 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 160.35 14.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.444 -0.344 . . . . 2.78 110.735 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -79.91 146.78 64.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.418 -0.355 . . . . 2.62 110.415 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 18.2 Cg_endo -62.87 160.49 33.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.33 2.02 . . . . 2.77 111.778 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.6 113.63 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.578 -0.737 . . . . 4.11 112.142 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.11 0.2 61.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.144 -0.55 . . . . 3.18 113.611 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.486 ' HB2' ' HG2' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -101.15 129.99 47.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.828 0.314 . . . . 2.91 110.895 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -135.52 146.48 48.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 3.54 110.518 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.13 144.93 25.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 2.93 111.691 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 5.9 tt0 -67.81 128.45 36.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.946 -0.57 . . . . 3.64 110.175 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.23 -1.98 74.19 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 3.27 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.7 m -102.14 91.0 4.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.936 0.398 . . . . 3.59 111.181 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.476 ' NH2' H5'' ' B' ' 1' ' ' ' C' . 19.0 mmt180 -117.5 50.27 1.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.198 0.523 . . . . 5.55 109.918 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.76 153.97 35.31 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.743 -0.662 . . . . 5.22 112.768 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 138.32 -75.12 0.39 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.846 -0.902 . . . . 5.91 110.846 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 119.006 -0.521 . . . . 7.27 112.001 179.635 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.476 H5'' ' NH2' ' A' ' 137' ' ' ARG . . . . . . . . 0 C2'--C1' 1.491 -3.727 1 C4'-C3'-C2' 97.042 -5.658 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.507 2 N19-C1'-C2' 103.523 -6.173 . 0.235 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.699 3 O4'-C1'-N19 115.699 7.499 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.215 4 O4'-C1'-N19 116.718 8.518 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.115 2 C4'-C3'-C2' 97.565 -5.135 . 0.65 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.731 4 N19-C1'-C2' 106.338 -4.414 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.312 3 P-O3'-C3' 127.051 6.126 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.487 ' H21' ' HA ' ' A' ' 112' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.31 3 O4'-C4'-C3' 114.903 6.716 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 013 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . 0.444 " H5'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.543 -4.976 2 O4'-C1'-N19 118.697 10.497 . 0.415 1a . 14.39 . . . . . . . . . . 3 2 . 1 . 013 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.587 3 O3'-P-O5' 116.355 6.503 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.142 1 C4'-C3'-C2' 98.299 -4.401 . 0.308 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.606 1 C4'-C3'-C2' 94.356 -8.344 . 0.453 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.796 1 O3'-P-O5' 111.694 4.05 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.905 2 C3'-C2'-C1' 105.742 4.714 . 0.333 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.469 -0.652 . . . . 9.05 111.469 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.89 118.26 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.706 0.288 . . . . 8.09 110.225 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 mmt -75.21 -37.71 61.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.999 0.428 . . . . 8.02 111.314 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.95 34.55 55.62 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.958 -0.639 . . . . 5.76 111.558 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -109.09 116.85 54.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.829 0.347 . . . . 4.72 111.188 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.57 51.41 3.76 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.974 2.449 . . . . 4.45 111.899 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -122.78 148.63 45.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.834 -0.621 . . . . 4.41 110.0 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -150.63 -61.53 0.19 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.471 -0.332 . . . . 3.92 110.94 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 p 53.01 78.17 0.15 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.362 0.875 . . . . 2.53 113.362 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB1' " O2'" ' C' ' 8' ' ' ' G' . . . -93.29 140.24 29.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 2.48 110.719 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -55.64 139.42 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.671 -0.695 . . . . 2.13 112.195 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -73.26 -25.36 60.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 2.4 112.06 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.9 m-85 -109.92 172.97 6.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.496 0.554 . . . . 2.02 112.496 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 p -74.45 -172.94 1.6 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.244 -0.889 . . . . 2.65 111.032 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -95.65 136.81 35.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.838 0.681 . . . . 2.4 112.838 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.598 HD13 ' HE2' ' A' ' 131' ' ' PHE . 17.6 mt -96.55 102.86 14.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.095 -1.076 . . . . 2.27 108.095 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.603 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -85.75 129.27 34.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.362 0.504 . . . . 2.84 112.362 -178.19 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.468 ' HB2' ' HE1' ' A' ' 131' ' ' PHE . 6.1 tp-100 -97.2 127.83 43.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 2.89 109.706 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.782 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 1.1 t60 -114.74 1.64 14.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.656 0.243 . . . . 3.82 111.656 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.39 -168.65 32.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.901 -0.666 . . . . 3.23 111.869 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -85.71 -33.41 21.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.864 0.364 . . . . 4.27 110.828 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.12 172.39 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 3.32 110.115 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -101.05 -76.01 0.57 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.952 -0.299 . . . . 2.39 110.64 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 26' ' ' PHE . 23.6 tp -177.5 129.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.457 0.473 . . . . 2.06 111.16 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -156.34 119.23 4.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.291 -0.413 . . . . 2.22 110.212 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 62.2 m-85 -110.3 151.09 42.41 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.147 -0.478 . . . . 1.78 110.562 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.65 164.34 34.81 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.92 2.413 . . . . 2.15 111.538 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -70.44 124.02 23.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 2.6 110.616 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.69 -10.49 52.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.793 -0.718 . . . . 1.65 111.578 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -122.35 -176.82 3.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.62 -0.511 . . . . 2.31 109.62 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.55 -31.63 8.12 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 1.33 112.542 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.95 120.14 78.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 110.336 -0.246 . . . . 1.06 110.336 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.74 -175.43 2.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.787 2.325 . . . . 1.27 112.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.1 mt -78.51 87.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 1.7 110.109 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 63.7 m-80 -82.38 73.04 9.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.325 -0.398 . . . . 1.23 110.557 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.1 68.52 1.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.036 -0.529 . . . . 1.94 111.047 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -176.7 -27.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.913 -0.585 . . . . 1.96 110.906 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 157.99 16.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.149 0.426 . . . . 1.42 112.149 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.06 164.14 61.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.767 -0.652 . . . . 1.73 111.105 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.11 -40.38 77.46 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.555 . . . . 1.42 113.389 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.53 -16.61 61.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.781 -0.367 . . . . 1.78 111.404 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.86 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 16.1 m-20 -87.42 -0.77 57.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.857 -0.611 . . . . 1.6 110.75 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.531 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 54.0 mm-40 -79.29 58.17 2.5 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.242 0.544 . . . . 1.05 110.714 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.538 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.4 tt -149.19 133.24 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.546 -0.752 . . . . 1.17 109.598 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.3 -144.5 5.38 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.342 -0.932 . . . . 0.6 112.633 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.65 162.1 41.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.871 0.367 . . . . 0.99 110.581 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.561 ' HB2' HG13 ' A' ' 91' ' ' ILE . 27.9 m-85 -102.22 123.97 46.98 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.838 -0.801 . . . . 1.26 108.838 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -101.72 133.61 46.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.009 -0.541 . . . . 2.15 111.231 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -82.17 129.26 34.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 2.4 110.099 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 130.17 43.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.099 0.476 . . . . 2.21 111.501 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 111.82 12.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 2.68 109.773 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.637 ' HB3' HD12 ' A' ' 64' ' ' LEU . 12.1 tpt180 -91.68 111.02 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.293 0.568 . . . . 3.59 111.367 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -133.27 103.38 5.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 3.43 110.62 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.629 HG12 ' HB2' ' A' ' 62' ' ' LYS . 44.2 pt -84.8 146.87 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 4.26 110.357 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 -120.69 111.44 17.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.799 0.333 . . . . 5.17 110.487 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.13 160.5 32.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.801 -0.714 . . . . 4.66 112.268 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.48 -24.82 75.61 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.154 -0.546 . . . . 5.04 112.14 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.81 -34.4 71.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.089 0.471 . . . . 5.51 110.1 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.11 29.13 1.26 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.772 -0.728 . . . . 4.73 113.103 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -112.25 154.34 25.77 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.646 -0.326 . . . . 5.52 111.017 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 38.1 mtt -141.61 132.27 25.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.98 -0.554 . . . . 4.48 109.794 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.629 ' HB2' HG12 ' A' ' 54' ' ' ILE . 48.8 tttp -58.19 -52.15 66.76 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.729 -0.214 . . . . 4.16 111.134 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t0 56.84 89.28 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.811 0.695 . . . . 4.09 112.51 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.637 HD12 ' HB3' ' A' ' 52' ' ' ARG . 66.1 mt -101.08 170.15 8.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.112 0.482 . . . . 3.36 111.47 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.26 156.57 66.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 3.36 109.578 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.93 117.79 4.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 2.69 111.865 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 67' ' ' ARG . 15.0 mtt-85 -114.28 133.91 55.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.815 -0.63 . . . . 3.03 110.104 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.422 ' HZ2' ' HB3' ' A' ' 23' ' ' ASP . 80.7 m95 -109.49 136.44 48.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 1.84 111.149 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.558 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 55.6 m-85 -123.54 138.3 54.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.444 -0.576 . . . . 2.76 109.444 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -86.9 131.62 34.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.854 0.359 . . . . 1.27 111.611 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.23 144.9 51.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.942 -0.572 . . . . 1.84 110.115 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -77.69 151.81 34.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.247 -0.433 . . . . 1.28 110.083 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 6.1 tt -64.39 120.28 11.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.582 -0.281 . . . . 1.66 110.669 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 112.38 -1.36 26.54 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.697 -0.763 . . . . 1.66 112.495 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 p -65.9 117.15 7.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.777 0.322 . . . . 1.58 110.866 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.22 112.38 3.21 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.946 -0.645 . . . . 1.96 111.731 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.42 -41.42 78.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.993 2.462 . . . . 2.62 111.908 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -110.52 39.74 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 3.09 111.034 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.01 -56.15 4.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.398 . . . . 1.79 110.677 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.67 45.88 95.38 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.1 -0.571 . . . . 1.65 112.184 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.74 108.03 17.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.655 0.264 . . . . 1.38 111.514 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 96.1 Cg_endo -86.92 173.77 5.8 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.811 2.34 . . . . 1.62 111.042 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.422 ' HB2' HD11 ' A' ' 73' ' ' LEU . 54.9 t80 -64.17 113.42 3.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.998 0.427 . . . . 1.58 110.737 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.02 -0.37 25.57 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.773 -0.727 . . . . 1.44 112.51 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.01 113.33 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 1.25 110.981 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -77.1 103.25 6.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 1.86 111.329 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -132.22 165.6 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.219 -0.446 . . . . 1.68 110.542 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.36 111.19 2.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.652 0.612 . . . . 1.7 112.652 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.21 41.77 85.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.735 -0.666 . . . . 1.27 112.948 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -131.27 104.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 1.01 110.799 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.561 HG13 ' HB2' ' A' ' 47' ' ' TYR . 5.2 pt -110.12 123.59 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 1.3 109.875 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 80.5 m95 -89.76 135.88 33.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 1.08 112.082 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -137.24 145.63 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.032 -0.531 . . . . 1.04 110.612 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.29 149.69 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.491 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 169.29 8.63 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.07 -0.345 . . . . 1.36 110.07 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -70.11 111.34 5.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.799 -0.445 . . . . 2.64 109.799 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.49 -13.9 8.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 1.52 111.576 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.89 146.64 43.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.828 0.347 . . . . 1.59 110.547 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.1 mt -108.73 142.71 38.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.298 -0.41 . . . . 2.15 111.5 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -80.35 90.35 5.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 2.07 110.574 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.428 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 5.2 t -162.76 146.12 8.72 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.113 -0.699 . . . . 2.36 109.113 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.79 121.38 7.85 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.941 1.761 . . . . 2.08 111.246 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.83 76.9 1.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 1.78 112.343 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 2.7 p-10 -85.56 5.91 29.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.34 -0.391 . . . . 2.55 111.394 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.9 p80 -57.84 -23.11 51.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.773 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.17 9.2 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.003 -0.544 . . . . 2.0 110.256 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.53 -35.65 13.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.652 -0.785 . . . . 2.33 111.973 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 t -68.65 125.59 27.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 2.99 110.863 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -162.59 125.72 2.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 2.83 109.873 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -86.42 116.39 65.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 123.276 0.36 . . . . 3.56 110.673 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.73 -32.51 46.82 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.879 2.386 . . . . 3.39 112.958 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.35 0.26 49.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.84 0.311 . . . . 4.05 111.84 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -128.39 -4.76 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.963 0.411 . . . . 4.48 111.167 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -149.88 128.25 12.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.766 0.317 . . . . 3.39 110.944 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.29 155.42 30.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.019 -0.537 . . . . 3.21 110.756 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.3 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 2.85 111.435 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 18.6 mt -101.5 146.54 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.711 -0.677 . . . . 2.42 109.621 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.23 120.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.61 0.243 . . . . 2.74 110.407 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.57 114.43 3.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.008 -0.542 . . . . 2.11 111.082 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -136.84 152.96 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 2.49 110.61 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.51 HD13 HG22 ' A' ' 125' ' ' THR . 72.3 mt -100.94 147.7 34.05 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 1.91 110.114 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.56 160.86 30.27 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.756 2.304 . . . . 1.84 112.782 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.53 120.36 9.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.794 -0.639 . . . . 2.53 110.478 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.82 14.84 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.098 -1.201 . . . . 2.2 110.098 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.51 HG22 HD13 ' A' ' 121' ' ' LEU . 6.3 m -112.61 114.79 27.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 2.1 108.845 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 156.78 18.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.33 -0.396 . . . . 2.78 111.55 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.19 76.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 2.62 109.698 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 28.4 Cg_endo -65.64 156.99 60.96 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.44 2.094 . . . . 2.77 111.448 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.46 120.95 14.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 4.11 111.644 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.17 -2.1 47.32 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.419 -0.672 . . . . 3.18 111.419 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.598 ' HE2' HD13 ' A' ' 16' ' ' LEU . 1.6 t80 -110.3 129.38 55.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.29 . . . . 2.91 110.613 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.782 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 26.3 p90 -141.12 162.85 34.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 3.54 110.064 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -119.05 148.01 43.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.721 0.296 . . . . 2.93 111.029 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.0 131.05 43.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.591 -0.522 . . . . 3.64 109.591 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.78 -26.6 23.78 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 3.27 112.191 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m -77.39 141.87 39.57 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.593 -0.357 . . . . 3.59 110.701 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.458 ' NE ' ' HA ' ' A' ' 137' ' ' ARG . 3.5 mmp_? -133.85 87.0 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 5.55 110.424 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.67 105.43 1.24 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.81 -0.632 . . . . 5.22 112.408 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 126.72 -92.86 0.39 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.361 -0.696 . . . . 5.91 111.361 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.881 -0.58 . . . . 7.27 111.562 -179.875 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.4 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.492 -3.602 1 C4'-C3'-C2' 97.053 -5.647 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.4 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.504 2 N19-C1'-C2' 103.548 -6.158 . 0.229 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.697 3 O4'-C1'-N19 115.727 7.527 . 0.527 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.162 4 O4'-C1'-N19 116.668 8.468 . 0.509 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.374 -4.133 2 C4'-C3'-C2' 97.573 -5.127 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.653 4 N19-C1'-C2' 106.394 -4.379 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.319 3 P-O3'-C3' 127.006 6.088 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.558 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.583 5.518 3 O4'-C4'-C3' 114.971 6.765 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 014 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.029 2 O4'-C1'-N19 118.646 10.446 . 0.414 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.539 3 O3'-P-O5' 116.354 6.502 . 0.458 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.247 1 C4'-C3'-C2' 98.248 -4.452 . 0.308 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.645 1 C4'-C3'-C2' 94.303 -8.397 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.772 1 O3'-P-O5' 111.688 4.046 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 014 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.858 2 C3'-C2'-C1' 105.684 4.649 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.895 -0.482 . . . . 9.05 111.895 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.31 111.19 22.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.749 0.309 . . . . 8.09 110.376 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.442 ' HB3' ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER -91.86 -160.56 0.74 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.099 0.476 . . . . 8.02 111.192 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' H ' ' HB3' ' A' ' 3' ' ' MET . . . -134.52 -176.77 14.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.467 -0.653 . . . . 5.76 111.467 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.5 tp -113.75 103.19 55.35 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.744 0.307 . . . . 4.72 111.366 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -95.04 59.85 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.375 2.717 . . . . 4.45 111.539 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -95.53 104.85 16.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.958 -0.564 . . . . 4.41 111.34 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -133.77 -171.02 2.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.854 -0.612 . . . . 3.92 110.442 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 m 73.12 94.51 0.08 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.429 0.633 . . . . 2.53 112.345 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -115.21 -162.36 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.959 -0.564 . . . . 2.48 110.814 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.06 166.39 12.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.484 -0.326 . . . . 2.13 110.895 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.85 -38.64 7.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.313 0.577 . . . . 2.4 110.2 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.4 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 86.1 m-85 -108.58 165.67 11.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.649 -0.705 . . . . 2.02 110.402 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.939 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 8.3 p -58.86 151.76 20.84 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.397 0.436 . . . . 2.65 111.366 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HB3' ' HD3' ' A' ' 67' ' ' ARG . . . -75.98 137.31 40.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 2.4 112.015 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 55.4 mt -88.89 147.75 24.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.94 -0.763 . . . . 2.27 108.94 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.658 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -126.36 138.75 53.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.828 -0.349 . . . . 2.84 111.388 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -99.71 132.32 45.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 2.89 110.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.61 62.66 1.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.247 -0.649 . . . . 3.82 109.247 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.46 -159.68 9.58 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.686 -0.688 . . . . 3.23 111.907 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -91.05 -25.08 19.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.161 0.43 . . . . 4.27 112.161 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -90.6 176.02 6.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.671 0.272 . . . . 3.32 110.58 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.84 -71.38 0.68 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 2.39 109.961 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.9 tp 177.85 142.3 0.09 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.842 -0.617 . . . . 2.06 110.534 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -156.31 133.82 10.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.385 -0.37 . . . . 2.22 110.029 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 43.1 m-85 -127.61 134.32 26.05 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.956 -0.387 . . . . 1.78 109.956 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 22.3 Cg_exo -65.51 167.44 16.97 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.895 2.396 . . . . 2.15 112.411 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.54 127.06 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 2.6 110.518 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.09 6.88 78.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.826 -0.702 . . . . 1.65 112.466 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -138.75 147.27 42.45 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.232 -0.285 . . . . 2.31 110.232 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.63 -28.25 5.28 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.683 -0.77 . . . . 1.33 112.908 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.01 119.21 75.83 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.663 0.232 . . . . 1.06 110.725 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.478 ' HG2' HD21 ' A' ' 35' ' ' ASN . 41.8 Cg_endo -67.94 168.71 18.07 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.556 2.17 . . . . 1.27 111.851 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 mt -74.62 81.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 1.7 111.604 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.478 HD21 ' HG2' ' A' ' 33' ' ' PRO . 40.5 m-80 -83.97 86.61 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 1.23 110.118 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -21.66 65.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.94 111.597 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -75.85 -18.55 59.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 1.96 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -111.24 151.05 28.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.511 -0.313 . . . . 1.42 110.798 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.588 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 6.1 m -73.76 165.47 52.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 1.73 109.921 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.3 Cg_endo -52.77 -39.54 76.87 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.955 2.437 . . . . 1.42 113.342 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.682 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -76.51 -9.91 59.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.954 0.353 . . . . 1.78 111.954 -179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.65 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.6 m-20 -95.09 1.58 54.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.049 0.452 . . . . 1.6 109.946 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -83.9 61.64 6.52 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.058 -0.519 . . . . 1.05 111.108 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.761 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.2 tt -146.93 130.54 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.755 -0.657 . . . . 1.17 109.908 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.77 -141.32 3.51 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.237 -0.982 . . . . 0.6 113.111 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -163.69 170.18 17.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 0.99 110.345 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.466 ' HB2' HG13 ' A' ' 91' ' ' ILE . 42.9 m-85 -109.94 130.31 55.55 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.507 -0.553 . . . . 1.26 109.507 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -103.41 132.38 49.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.895 0.379 . . . . 2.15 111.657 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -85.54 119.53 25.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.744 . . . . 2.4 110.216 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -134.64 157.03 47.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 2.21 111.185 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 64' ' ' LEU . 93.9 m -154.06 104.6 2.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.793 -0.639 . . . . 2.68 109.764 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' HB3' HD12 ' A' ' 64' ' ' LEU . 10.1 tpt180 -83.32 113.15 20.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.912 0.387 . . . . 3.59 111.459 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 5.6 mtp180 -121.72 87.47 2.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 3.43 109.438 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 61' ' ' MET . 38.5 pt -79.38 148.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 4.26 111.134 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -107.0 111.5 24.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 5.17 110.084 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.565 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -73.02 -167.03 10.74 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.933 -0.651 . . . . 4.66 113.606 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.56 -45.53 66.77 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.314 -0.47 . . . . 5.04 113.293 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' OD2' ' HE2' ' A' ' 60' ' ' LYS . 13.4 t70 -77.9 -10.86 59.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.342 0.591 . . . . 5.51 110.804 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.76 22.82 10.57 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.186 -0.765 . . . . 4.73 111.186 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.548 ' HE3' ' OP2' ' C' ' 14' ' ' ' G' . 72.0 mmtt -84.24 159.34 21.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.044 -0.354 . . . . 5.52 110.044 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 35.6 mtt -133.4 131.82 40.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.371 -0.377 . . . . 4.48 110.01 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.462 ' HA ' ' O4 ' ' C' ' 13' ' ' ' U' . 54.2 tttt -60.95 -36.6 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.422 -0.584 . . . . 4.16 109.422 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 29.3 t0 50.28 77.93 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.766 -1.106 . . . . 4.09 112.824 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 52' ' ' ARG . 89.3 mt -80.37 146.03 31.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.397 -0.594 . . . . 3.36 109.397 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 45.1 m -69.12 158.15 87.34 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.278 -0.268 . . . . 3.36 110.278 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 9.7 Cg_endo -51.61 103.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.922 2.415 . . . . 2.69 112.644 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.501 HH22 ' CD ' ' A' ' 134' ' ' GLU . 3.4 mtt180 -101.42 138.8 37.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.836 -0.62 . . . . 3.03 110.296 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.8 124.55 49.75 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.728 -0.669 . . . . 1.84 110.72 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.741 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 32.6 m-85 -109.42 127.32 54.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.683 -0.689 . . . . 2.76 109.525 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -78.07 126.47 30.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.905 0.383 . . . . 1.27 111.26 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.54 149.32 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.895 -0.78 . . . . 1.84 108.895 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -81.72 157.49 24.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.326 -0.25 . . . . 1.28 110.326 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.6 tp -58.45 115.34 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.524 -0.307 . . . . 1.66 111.045 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.57 52.19 4.03 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.606 -0.807 . . . . 1.66 111.852 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.94 78.55 5.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.921 0.391 . . . . 1.58 111.419 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.46 139.32 2.75 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.846 -0.692 . . . . 1.96 112.178 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.84 -26.27 32.3 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.587 2.191 . . . . 2.62 112.162 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.2 35.92 4.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 3.09 110.645 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.18 -55.59 5.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.999 -0.546 . . . . 1.79 110.95 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.13 36.57 92.05 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 1.65 112.019 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.67 103.55 53.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.026 0.441 . . . . 1.38 111.658 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.755 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 85.8 Cg_endo -84.8 165.46 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.388 2.059 . . . . 1.62 110.546 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -64.47 105.99 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.861 0.362 . . . . 1.58 110.274 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.13 -11.87 7.67 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.8 -0.714 . . . . 1.44 112.376 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -54.78 117.12 3.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.806 0.336 . . . . 1.25 111.389 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -76.48 99.76 5.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.539 . . . . 1.86 111.405 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -129.65 148.72 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 1.68 110.128 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.62 119.34 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.193 0.442 . . . . 1.7 112.193 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.02 53.31 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.848 -0.614 . . . . 1.27 112.624 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -129.54 111.09 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.88 0.371 . . . . 1.01 110.875 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 47' ' ' TYR . 5.8 pt -115.91 118.71 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 1.3 110.08 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.72 136.95 35.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.634 0.605 . . . . 1.08 112.634 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 m -137.93 145.13 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.682 -0.69 . . . . 1.04 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.78 -177.58 6.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.274 -0.421 . . . . 1.27 109.972 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -153.64 172.8 16.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.629 -0.259 . . . . 1.36 110.581 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.62 115.91 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.275 0.559 . . . . 2.64 111.23 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.52 -19.63 16.47 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.82 -0.705 . . . . 1.52 112.001 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.761 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.85 126.98 31.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.382 -0.229 . . . . 1.59 110.382 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.682 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 66.9 mt -96.54 156.05 16.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.894 0.378 . . . . 2.15 111.295 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -84.4 83.82 7.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.145 0.498 . . . . 2.07 110.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.5 m -153.17 133.98 8.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.854 -0.612 . . . . 2.36 109.463 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.18 125.84 18.62 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.171 2.581 . . . . 2.08 112.086 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.65 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.3 mmtt -105.45 39.23 1.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.649 -0.705 . . . . 1.78 111.244 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -13.65 59.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.493 . . . . 2.55 111.551 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -70.38 -17.59 63.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.472 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.1 mt -96.02 -33.88 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.329 . . . . 2.0 110.768 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.58 57.22 4.17 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.914 -0.585 . . . . 2.33 112.389 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.7 t -134.1 20.23 3.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.421 0.629 . . . . 2.99 109.582 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 13.0 ttp180 -83.21 136.5 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.737 -0.665 . . . . 2.83 111.702 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.443 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 4.1 m-20 -96.84 114.6 64.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 3.56 110.095 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.53 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 26.6 Cg_endo -61.47 -28.3 83.42 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.912 2.408 . . . . 3.39 113.182 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 -10.84 59.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 4.05 111.364 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -116.31 -21.53 9.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.477 -0.328 . . . . 4.48 111.709 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.5 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 2.7 t-20 -137.14 120.0 16.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.689 0.28 . . . . 3.39 110.61 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 155.54 39.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.055 -0.52 . . . . 3.21 111.625 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.44 154.19 24.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 2.85 111.204 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 18.6 mt -102.74 150.34 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.777 -0.453 . . . . 2.42 109.777 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.7 120.19 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.586 0.231 . . . . 2.74 110.415 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.54 119.39 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 2.11 110.517 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -122.88 160.53 25.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.293 -0.412 . . . . 2.49 110.699 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.627 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 87.3 mt -110.08 150.4 41.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 1.91 111.297 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -65.05 170.88 9.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.986 2.457 . . . . 1.84 112.27 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.08 113.36 3.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 2.53 111.254 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.51 -14.0 30.2 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.993 -0.622 . . . . 2.2 112.723 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 4.7 m -88.47 140.95 28.94 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.707 -0.29 . . . . 2.1 110.393 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.39 144.82 50.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.818 0.342 . . . . 2.78 111.793 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.47 ' HG ' HD11 ' A' ' 121' ' ' LEU . 21.9 mt -87.28 144.38 35.91 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.08 -0.509 . . . . 2.62 109.738 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.34 156.18 26.89 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.913 2.408 . . . . 2.77 112.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -62.01 122.4 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.743 -0.662 . . . . 4.11 111.122 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.02 -8.53 61.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.917 -0.658 . . . . 3.18 111.873 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 3.7 t80 -97.1 144.16 27.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.916 -0.402 . . . . 2.91 109.916 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.658 ' CE1' ' HB ' ' A' ' 17' ' ' THR . 3.9 p90 -147.88 171.73 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 3.54 110.478 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -121.82 147.33 46.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 2.93 111.059 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.939 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.2 tp10 -68.47 122.5 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 3.64 110.67 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.86 66.65 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.013 -0.613 . . . . 3.27 112.98 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.7 m -76.54 106.28 8.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 3.59 111.779 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -119.69 91.53 3.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.789 -0.819 . . . . 5.55 108.789 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.87 160.34 50.22 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.056 -0.592 . . . . 5.22 112.51 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.64 -94.83 0.77 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.923 -0.656 . . . . 5.91 112.087 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.415 -0.802 . . . . 7.27 111.662 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.572 1 C4'-C3'-C2' 97.023 -5.677 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.53 2 N19-C1'-C2' 103.505 -6.185 . 0.23 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.82 3 O4'-C1'-N19 115.743 7.543 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.188 4 O4'-C1'-N19 116.692 8.492 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.373 -4.159 2 C4'-C3'-C2' 97.541 -5.159 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.784 4 C1'-O4'-C4' 105.611 -4.432 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.252 3 P-O3'-C3' 127.053 6.128 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.741 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.581 5.31 3 O4'-C4'-C3' 114.96 6.757 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 015 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.101 2 O4'-C1'-N19 118.595 10.395 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.528 3 O3'-P-O5' 116.374 6.513 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.06 1 C4'-C3'-C2' 98.336 -4.364 . 0.313 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.533 1 C4'-C3'-C2' 94.393 -8.307 . 0.458 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.565 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.74 1 O3'-P-O5' 111.75 4.079 . 0.104 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 015 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . 0.548 ' OP2' ' HE3' ' A' ' 60' ' ' LYS . . . . . . . . 2 C2'--C1' 1.577 4.913 2 C3'-C2'-C1' 105.695 4.661 . 0.337 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.526 -0.63 . . . . 9.05 111.526 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.76 114.31 16.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.792 0.33 . . . . 8.09 110.176 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.75 110.62 12.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.275 -0.42 . . . . 8.02 111.339 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.76 141.66 7.66 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.365 -0.694 . . . . 5.76 111.365 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 mp -110.45 138.82 21.05 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.577 0.188 . . . . 4.72 110.738 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.93 -1.98 11.54 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.837 2.358 . . . . 4.45 112.46 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -73.12 142.74 47.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.209 -0.451 . . . . 4.41 110.521 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -92.79 -82.5 0.33 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.613 -0.267 . . . . 3.92 110.774 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 54.56 56.38 6.88 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.375 0.422 . . . . 2.53 111.564 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.53 160.49 29.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 2.48 111.906 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.52 164.91 26.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 2.13 111.016 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -90.65 -25.47 20.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 2.4 111.864 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 59.6 m-85 -115.75 171.61 7.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.27 0.47 . . . . 2.02 112.27 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.844 HG22 " H5'" ' C' ' 8' ' ' ' G' . 1.9 p -70.83 167.15 19.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 2.65 111.048 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -91.75 161.58 14.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.487 . . . . 2.4 111.058 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.98 127.24 56.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.505 -0.77 . . . . 2.27 109.758 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 65' ' ' SER . 80.7 m -90.93 126.86 36.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.301 -0.409 . . . . 2.84 111.058 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -97.08 134.01 40.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 2.89 110.199 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -130.82 90.26 2.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 3.82 109.308 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.36 -151.25 8.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.566 -0.826 . . . . 3.23 112.828 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 71.2 mmtt -108.6 -2.21 18.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.801 0.334 . . . . 4.27 111.789 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -120.07 176.76 5.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.257 -0.275 . . . . 3.32 110.257 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.49 -87.62 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.283 -0.417 . . . . 2.39 110.76 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 131' ' ' PHE . 55.4 tp -172.36 127.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.84 0.353 . . . . 2.06 110.869 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -148.93 105.11 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 2.22 109.949 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -89.24 146.97 37.26 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.074 -0.512 . . . . 1.78 110.541 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 57.6 Cg_endo -72.0 163.34 39.12 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.569 2.18 . . . . 2.15 111.857 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -58.11 122.54 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.884 -0.598 . . . . 2.6 111.016 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.11 -12.32 66.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.612 -0.804 . . . . 1.65 113.172 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.502 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 37.0 tt0 -118.06 157.73 26.29 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.632 -0.334 . . . . 2.31 110.969 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 126.16 -26.16 5.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.57 -0.612 . . . . 1.33 111.57 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.43 119.65 77.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.343 -0.243 . . . . 1.06 110.343 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.15 -170.44 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.488 2.125 . . . . 1.27 110.797 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.94 90.84 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.121 0.486 . . . . 1.7 110.816 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 70.2 m-20 -93.98 73.36 4.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.417 -0.586 . . . . 1.23 109.417 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -20.73 66.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.362 -0.835 . . . . 1.94 111.927 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -82.45 -3.48 55.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.33 -0.396 . . . . 1.96 111.84 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -126.69 159.58 33.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.921 0.391 . . . . 1.42 111.815 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.624 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 m -82.67 167.24 31.19 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.634 -0.712 . . . . 1.73 110.139 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.624 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 13.7 Cg_endo -55.88 -35.67 94.34 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.939 2.426 . . . . 1.42 112.878 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.667 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 p-10 -78.73 -11.22 59.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.267 -0.424 . . . . 1.78 111.605 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -97.46 -1.9 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 1.6 109.895 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 75.6 mm-40 -78.52 53.88 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 1.05 111.119 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.58 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 13.5 tt -144.09 125.57 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.794 -0.639 . . . . 1.17 109.856 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.44 -145.23 4.38 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.142 -1.028 . . . . 0.6 112.522 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.454 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 48.8 p90 -160.02 170.75 20.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.121 -0.326 . . . . 0.99 110.121 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.676 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 39.0 m-85 -112.51 136.95 51.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.503 -0.554 . . . . 1.26 109.503 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -115.27 132.07 56.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.569 0.224 . . . . 2.15 110.534 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -82.03 124.99 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.076 -0.511 . . . . 2.4 109.672 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -133.61 156.2 48.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 2.21 111.206 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 m -158.53 134.65 9.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 2.68 109.935 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 52' ' ' ARG . 4.1 tpt180 -107.07 122.17 45.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 3.59 110.461 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 4.3 ttt180 -138.96 82.38 1.9 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.716 0.293 . . . . 3.43 111.532 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.825 HG12 ' HB2' ' A' ' 62' ' ' LYS . 26.3 pt -72.13 154.73 7.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.448 -0.342 . . . . 4.26 110.539 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -106.51 113.44 26.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 5.17 110.091 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.522 ' HA2' ' OP2' ' C' ' 13' ' ' ' U' . . . -72.51 161.52 54.39 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.161 -0.542 . . . . 4.66 112.449 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.94 -38.53 94.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.539 -0.362 . . . . 5.04 113.068 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.24 -35.98 76.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.161 0.505 . . . . 5.51 110.768 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.47 2.34 4.51 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.009 -0.836 . . . . 4.73 111.009 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -76.34 158.54 31.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.044 -0.354 . . . . 5.52 110.044 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.1 mmt -122.64 147.35 46.54 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.873 -0.417 . . . . 4.48 109.873 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.825 ' HB2' HG12 ' A' ' 54' ' ' ILE . 39.6 tptt -55.44 -49.73 71.67 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.521 0.513 . . . . 4.16 110.421 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 15.0 t70 59.02 91.17 0.05 OUTLIER 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.561 -0.745 . . . . 4.09 112.691 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.78 148.63 36.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.735 -0.666 . . . . 3.36 110.161 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.562 ' HB2' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -70.32 146.44 94.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.16 -0.473 . . . . 3.36 110.557 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.5 118.45 5.33 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.858 2.372 . . . . 2.69 111.559 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -119.09 146.36 45.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 3.03 111.31 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.676 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.7 m95 -112.8 131.3 55.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.721 -0.672 . . . . 1.84 110.227 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 58.6 m-85 -109.66 145.29 36.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.101 -0.499 . . . . 2.76 109.685 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -94.63 127.64 40.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 1.27 111.257 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -130.4 162.49 29.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.977 -0.556 . . . . 1.84 109.673 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -93.52 168.39 11.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.582 -0.281 . . . . 1.28 110.418 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.58 126.94 29.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.524 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.67 47.1 92.49 Favored Glycine 0 CA--C 1.516 0.105 0 N-CA-C 115.274 0.869 . . . . 1.66 115.274 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -74.92 101.97 4.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.246 0.523 . . . . 1.58 110.023 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.82 136.97 5.1 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.828 -0.701 . . . . 1.96 111.431 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.79 -28.4 68.02 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.678 2.252 . . . . 2.62 112.496 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.9 53.01 1.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 3.09 110.743 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.08 -46.97 5.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.879 -0.6 . . . . 1.79 110.515 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.64 24.84 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.882 -0.887 . . . . 1.65 110.882 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.779 ' HB3' ' HH2' ' A' ' 92' ' ' TRP . 65.2 mt -125.93 94.93 40.73 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 1.38 111.968 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -91.33 135.93 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 1.62 110.812 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -52.57 115.16 1.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.251 -0.431 . . . . 1.58 111.568 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.38 8.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.658 . . . . 1.44 112.778 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.83 163.49 21.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.993 0.425 . . . . 1.25 111.026 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.64 131.21 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.442 -0.345 . . . . 1.86 110.936 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -148.53 155.83 41.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.52 . . . . 1.68 110.109 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.35 117.57 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.257 -0.429 . . . . 1.7 111.919 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.6 34.62 67.34 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.75 -0.659 . . . . 1.27 112.635 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.3 mm -134.44 114.95 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.748 0.308 . . . . 1.01 110.687 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 91' ' ' ILE . 8.5 pt -123.03 134.78 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.878 -0.416 . . . . 1.3 109.878 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.779 ' HH2' ' HB3' ' A' ' 81' ' ' LEU . 56.5 m95 -90.28 144.82 25.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.586 0.587 . . . . 1.08 112.586 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.466 HG11 ' HA3' ' A' ' 31' ' ' GLY . 11.0 m -142.07 134.6 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.521 -0.763 . . . . 1.04 109.993 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.62 147.46 26.78 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.818 0.342 . . . . 1.27 111.229 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 43' ' ' GLN . 2.8 t -106.42 166.83 10.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.984 -0.553 . . . . 1.36 109.892 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.05 117.87 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.048 0.452 . . . . 2.64 110.319 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.7 -4.71 22.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.901 -0.666 . . . . 1.52 111.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.667 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -80.27 144.98 32.41 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.439 -0.208 . . . . 1.59 110.439 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 62.0 mt -90.38 139.61 30.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.728 0.299 . . . . 2.15 110.867 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -84.06 79.21 9.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.247 0.546 . . . . 2.07 110.111 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.44 154.22 13.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.788 -0.642 . . . . 2.36 110.034 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.67 129.02 27.63 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.678 2.252 . . . . 2.08 112.292 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -116.53 45.63 1.77 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.797 -0.638 . . . . 1.78 110.508 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -13.74 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.691 -0.686 . . . . 2.55 112.282 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -61.62 -12.97 18.25 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.375 0.509 . . . . 2.24 112.375 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.8 mt -104.0 -32.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 2.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.57 -9.0 42.29 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.845 -0.616 . . . . 2.33 114.558 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.0 t -79.72 63.0 4.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.332 0.586 . . . . 2.99 111.215 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.402 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 47.0 ttp85 -118.33 139.71 50.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 2.83 110.926 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -99.98 115.26 65.7 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.981 -0.554 . . . . 3.56 110.317 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.02 -24.47 39.17 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.979 2.453 . . . . 3.39 113.332 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.09 1.48 56.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 4.05 111.366 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -119.04 -48.61 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 4.48 110.158 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 12.9 t-20 -106.93 137.13 45.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 3.39 110.52 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.44 139.5 45.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.103 -0.332 . . . . 3.21 110.103 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.8 158.1 28.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.057 0.456 . . . . 2.85 111.183 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 25.8 mt -104.99 141.92 19.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.974 -0.557 . . . . 2.42 109.796 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.62 127.08 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.883 -0.414 . . . . 2.74 109.883 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -66.7 116.73 7.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.485 . . . . 2.11 110.019 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.58 149.37 43.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.189 -0.46 . . . . 2.49 110.865 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.36 146.79 33.12 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.522 . . . . 1.91 109.957 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.64 157.18 62.18 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.603 2.202 . . . . 1.84 111.823 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.02 118.36 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 2.53 110.935 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.41 -15.18 17.85 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.744 -0.741 . . . . 2.2 111.349 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.2 m -104.99 119.42 38.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.965 0.412 . . . . 2.1 110.55 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.94 152.49 25.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.084 -0.507 . . . . 2.78 110.498 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.22 140.69 34.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.593 -0.276 . . . . 2.62 110.369 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.36 147.24 96.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.39 2.06 . . . . 2.77 110.902 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -51.3 123.15 9.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 4.11 112.042 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.24 4.74 56.31 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.059 -0.591 . . . . 3.18 112.586 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -123.1 130.95 53.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.792 0.329 . . . . 2.91 111.182 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -153.45 149.56 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.085 -0.507 . . . . 3.54 110.248 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.4 146.32 27.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 2.93 110.886 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -70.59 150.31 46.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 3.64 110.891 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.14 64.97 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.756 -0.735 . . . . 3.27 112.255 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 116.93 22.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.614 0.245 . . . . 3.59 110.769 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? -128.4 -178.88 4.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.507 -0.553 . . . . 5.55 109.507 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.54 70.65 2.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.661 -0.781 . . . . 5.22 111.862 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -110.69 93.72 0.74 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.905 -0.664 . . . . 5.91 112.245 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.879 -0.581 . . . . 7.27 111.195 179.78 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.407 ' H41' ' HE3' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.575 1 C4'-C3'-C2' 97.108 -5.592 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.473 4.594 2 N19-C1'-C2' 103.532 -6.167 . 0.229 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.463 -5.66 3 O4'-C1'-N19 115.798 7.598 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.592 6.112 4 O4'-C1'-N19 116.711 8.511 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.09 2 C4'-C3'-C2' 97.593 -5.107 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.734 4 N19-C1'-C2' 106.338 -4.413 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.381 3 P-O3'-C3' 127.03 6.109 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.844 " H5'" HG22 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.582 5.356 3 O4'-C4'-C3' 114.952 6.751 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 016 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.912 2 O4'-C1'-N19 118.616 10.416 . 0.415 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.483 3 O3'-P-O5' 116.334 6.492 . 0.461 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.211 1 C4'-C3'-C2' 98.274 -4.426 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.581 1 C4'-C3'-C2' 94.346 -8.354 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.522 ' OP2' ' HA2' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.723 1 O3'-P-O5' 111.747 4.077 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 016 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.958 2 C3'-C2'-C1' 105.749 4.721 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 111.827 -0.509 . . . . 9.05 111.827 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.71 109.56 20.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.856 0.36 . . . . 8.09 110.779 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -98.45 116.61 31.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 8.02 110.231 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.09 -149.66 6.01 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.558 -0.829 . . . . 5.76 112.125 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.0 mt -140.97 121.68 8.84 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 110.488 -0.19 . . . . 4.72 110.488 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.97 41.06 1.06 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.959 2.439 . . . . 4.45 111.261 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -134.23 -173.7 3.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.692 -0.686 . . . . 4.41 109.849 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -105.48 -68.91 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.459 -0.337 . . . . 3.92 110.276 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 57.69 75.21 0.39 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.412 0.893 . . . . 2.53 113.412 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.85 128.74 37.81 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.49 -0.559 . . . . 2.48 109.49 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -53.23 146.17 12.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.348 0.87 . . . . 2.13 113.348 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -73.12 -35.0 66.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.793 -0.64 . . . . 2.4 110.759 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -108.36 170.92 7.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.822 -0.626 . . . . 2.02 111.245 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.866 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 11.2 p -69.15 168.48 13.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.646 -0.706 . . . . 2.65 111.142 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -92.99 159.76 15.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 2.4 110.989 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 35.9 mt -100.17 112.7 25.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.258 -0.428 . . . . 2.27 110.267 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 m -82.82 113.33 20.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.237 -0.438 . . . . 2.84 111.632 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.37 146.58 26.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 2.89 111.331 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -141.18 89.26 2.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.927 -0.579 . . . . 3.82 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.63 -168.33 41.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.893 -0.67 . . . . 3.23 112.22 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 48.5 mmtt -81.93 -31.59 31.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.763 0.316 . . . . 4.27 111.267 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.61 -174.14 5.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.262 -0.426 . . . . 3.32 109.922 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.54 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -112.53 -88.12 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.608 -0.516 . . . . 2.39 109.608 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD13 ' CE1' ' A' ' 131' ' ' PHE . 52.5 tp -168.94 126.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 2.06 110.465 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -146.79 134.39 20.99 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.89 -0.411 . . . . 2.22 109.89 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.78 150.84 46.46 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 1.78 110.029 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.667 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 56.3 Cg_endo -73.06 -173.51 1.27 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.568 2.179 . . . . 2.15 112.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -79.97 126.39 30.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.234 -0.439 . . . . 2.6 110.891 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.9 -7.44 80.18 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 1.65 113.111 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.667 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 21.4 tt0 -122.55 154.28 38.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.184 -0.302 . . . . 2.31 110.184 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.3 -21.34 7.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.435 -0.888 . . . . 1.33 112.585 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 43' ' ' GLN . 43.1 t -80.06 119.53 76.89 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.661 0.267 . . . . 1.06 110.562 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.9 -176.59 2.68 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.947 2.431 . . . . 1.27 111.738 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.94 87.92 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.359 -0.382 . . . . 1.7 110.303 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' HB2' HE22 ' A' ' 43' ' ' GLN . 63.6 m-80 -85.83 83.14 7.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 1.23 110.197 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.68 1.21 3.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.567 -0.742 . . . . 1.94 112.879 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -107.57 -6.39 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.28 . . . . 1.96 111.212 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.31 150.35 47.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.09 -0.244 . . . . 1.42 110.957 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -71.95 162.49 73.11 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.814 -0.439 . . . . 1.73 109.814 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -34.9 78.19 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 1.42 112.24 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -18.86 61.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.903 -0.59 . . . . 1.78 111.432 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.14 0.99 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 1.6 111.092 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.61 ' HB3' HG11 ' A' ' 32' ' ' VAL . 69.0 mm-40 -79.15 59.98 2.89 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.09 0.471 . . . . 1.05 110.957 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.621 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -146.66 130.68 10.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.919 -0.582 . . . . 1.17 110.252 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.72 -141.36 3.62 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.522 -0.847 . . . . 0.6 112.807 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -160.56 159.47 30.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 0.99 110.374 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.564 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 49.0 m-85 -100.09 133.14 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.621 -0.881 . . . . 1.26 108.621 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -117.86 122.41 43.28 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.229 0.331 . . . . 2.15 111.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.52 129.93 35.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.281 -0.418 . . . . 2.4 110.035 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.27 140.0 27.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.727 0.299 . . . . 2.21 110.814 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 133.81 38.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 2.68 111.074 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.693 ' HB3' HD12 ' A' ' 64' ' ' LEU . 28.0 tpt180 -101.87 129.27 48.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.006 -0.738 . . . . 3.59 109.006 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttt180 -138.86 78.05 1.65 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.668 -0.242 . . . . 3.43 110.851 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 153.3 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.965 -0.294 . . . . 4.26 110.592 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -134.75 120.92 20.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 5.17 110.489 -178.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.77 179.86 40.41 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.869 -0.682 . . . . 4.66 112.306 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.65 -39.27 96.6 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.127 -0.559 . . . . 5.04 112.975 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.83 -35.5 78.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.852 0.358 . . . . 5.51 111.157 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.05 27.3 1.55 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.448 -0.882 . . . . 4.73 112.731 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 55' ' ' ARG . 21.8 mmtt -91.36 141.17 29.05 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.225 -0.657 . . . . 5.52 109.225 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.9 mtt -125.78 131.3 52.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.555 0.217 . . . . 4.48 110.836 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HG3' ' O4 ' ' C' ' 13' ' ' ' U' . 39.6 tttp -62.16 -47.31 85.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 4.16 110.988 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.615 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 25.0 t70 61.24 90.3 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.895 -0.593 . . . . 4.09 112.291 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 52' ' ' ARG . 15.4 mt -87.13 157.94 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.317 -0.401 . . . . 3.36 110.384 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -77.83 149.42 77.29 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.08 -0.509 . . . . 3.36 109.919 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.41 110.5 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.917 2.412 . . . . 2.69 111.648 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.533 HH21 ' CD ' ' A' ' 134' ' ' GLU . 5.5 mtp180 -121.42 138.81 54.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 3.03 111.51 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.564 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 29.2 m95 -104.33 123.92 48.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.872 -0.604 . . . . 1.84 110.434 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.99 131.8 45.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.551 -0.537 . . . . 2.76 109.551 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -79.83 127.35 32.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.842 0.353 . . . . 1.27 111.099 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -124.84 148.25 48.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.988 -0.551 . . . . 1.84 109.587 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -84.87 159.27 20.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.939 -0.393 . . . . 1.28 109.939 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.685 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 1.9 tt -61.65 118.09 6.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.286 -0.265 . . . . 1.66 110.286 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.82 32.78 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 1.66 112.618 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.3 68.62 8.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 1.58 111.058 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.45 118.6 0.51 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.482 -1.047 . . . . 1.96 110.482 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.66 -43.68 44.54 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.101 2.534 . . . . 2.62 112.379 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.18 53.29 0.83 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.167 0.508 . . . . 3.09 111.153 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.19 -58.7 2.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.028 0.442 . . . . 1.79 109.808 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.72 65.02 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.65 112.706 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt -134.03 102.18 12.26 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.603 0.239 . . . . 1.38 110.509 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.05 176.61 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.933 2.422 . . . . 1.62 111.772 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.522 ' HB2' HD11 ' A' ' 73' ' ' LEU . 13.0 t80 -57.87 116.44 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 1.58 110.646 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.9 -17.51 9.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.685 -0.769 . . . . 1.44 111.987 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.16 110.35 3.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.408 . . . . 1.25 110.462 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -76.89 124.27 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 1.86 110.856 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB3' HG13 ' A' ' 90' ' ' ILE . 29.5 tttt -143.19 154.46 43.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.432 -0.581 . . . . 1.68 109.432 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.09 119.54 8.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.411 -0.358 . . . . 1.7 111.546 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.55 29.99 67.16 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.932 -0.577 . . . . 1.27 112.58 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.541 HG13 ' HB3' ' A' ' 87' ' ' LYS . 39.8 mm -127.77 111.82 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 1.01 110.933 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.525 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 26.7 pt -117.96 120.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.3 110.507 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.685 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 94.9 m95 -79.94 135.36 36.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.125 -0.488 . . . . 1.08 112.108 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.22 137.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.623 -0.717 . . . . 1.04 111.005 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.43 152.18 39.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.994 -0.548 . . . . 1.27 109.879 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.0 t -114.77 170.79 8.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.956 0.407 . . . . 1.36 110.694 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -67.27 113.23 5.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.081 -0.509 . . . . 2.64 110.67 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.39 -11.67 21.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.857 -0.687 . . . . 1.52 111.826 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -86.18 120.03 27.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.779 0.323 . . . . 1.59 110.512 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.77 142.72 27.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 2.15 111.397 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -71.5 96.66 1.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.894 -0.594 . . . . 2.07 110.237 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 72.7 m -156.19 138.62 10.35 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.561 -0.745 . . . . 2.36 109.176 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 21.8 Cg_exo -67.13 107.33 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.383 2.056 . . . . 2.08 111.244 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -95.66 75.42 3.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.314 -0.403 . . . . 1.78 110.149 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -15.89 61.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.548 -0.296 . . . . 2.55 111.321 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -60.19 -25.02 65.25 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.196 -0.456 . . . . 2.24 111.958 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.87 2.15 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.46 0.648 . . . . 2.0 110.246 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.33 51.63 1.84 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.004 -0.617 . . . . 2.33 111.579 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t -160.93 125.88 3.67 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.99 -0.374 . . . . 2.99 109.99 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 40.7 ttp85 -166.1 134.66 3.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.871 -0.418 . . . . 2.83 109.871 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -83.33 112.0 35.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 3.56 110.169 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.02 -30.61 90.03 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.065 2.51 . . . . 3.39 113.864 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.91 -5.15 57.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.78 0.324 . . . . 4.05 111.797 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -116.42 1.27 12.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.495 -0.32 . . . . 4.48 111.664 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 27.6 t-20 -154.39 133.64 12.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.673 0.273 . . . . 3.39 110.54 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.38 141.68 28.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.42 . . . . 3.21 110.209 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.59 140.77 49.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.992 0.425 . . . . 2.85 111.147 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 mt -92.21 150.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 2.42 109.885 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -62.54 120.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 2.74 110.683 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.52 124.27 22.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.736 -0.666 . . . . 2.11 110.333 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.66 151.83 48.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.17 -0.468 . . . . 2.49 110.704 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.496 HD13 HG22 ' A' ' 125' ' ' THR . 26.4 mt -98.58 137.48 20.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.049 -0.523 . . . . 1.91 109.921 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.72 152.53 41.34 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.123 2.549 . . . . 1.84 112.939 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -52.3 123.62 11.23 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.476 -0.784 . . . . 2.53 110.915 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 109.08 -14.65 33.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.809 -0.71 . . . . 2.2 111.45 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 HD13 ' A' ' 121' ' ' LEU . 15.1 m -111.81 123.64 50.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.915 -0.402 . . . . 2.1 109.915 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 150.03 32.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.883 0.373 . . . . 2.78 111.246 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.54 143.15 58.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.588 . . . . 2.62 109.858 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.58 138.78 87.78 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.675 2.25 . . . . 2.77 111.13 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -55.21 118.38 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 4.11 111.263 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.15 -20.11 12.97 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.54 -0.624 . . . . 3.18 111.54 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.749 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -89.28 147.53 24.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.638 0.256 . . . . 2.91 110.794 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.12 145.87 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.141 -0.482 . . . . 3.54 110.931 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.48 152.03 23.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.924 -0.58 . . . . 2.93 111.317 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.866 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.1 tp10 -73.3 128.11 34.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 3.64 110.446 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.82 80.02 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.027 -0.606 . . . . 3.27 112.323 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 t -101.4 134.44 44.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 3.59 111.489 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -167.81 176.61 6.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.381 -0.827 . . . . 5.55 108.829 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.43 133.72 33.09 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.429 -0.891 . . . . 5.22 111.254 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.33 -127.21 7.9 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.847 -0.692 . . . . 5.91 112.017 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 119.021 -0.514 . . . . 7.27 111.971 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.61 1 C4'-C3'-C2' 97.045 -5.655 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.471 4.49 2 N19-C1'-C2' 103.557 -6.152 . 0.232 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.7 3 O4'-C1'-N19 115.773 7.573 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.272 4 O4'-C1'-N19 116.651 8.451 . 0.509 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.087 2 C4'-C3'-C2' 97.508 -5.192 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.778 4 N19-C1'-C2' 106.364 -4.398 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.33 3 P-O3'-C3' 126.972 6.06 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.581 5.324 3 O4'-C4'-C3' 114.855 6.682 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.946 2 O4'-C1'-N19 118.548 10.348 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.469 3 O3'-P-O5' 116.284 6.465 . 0.462 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.159 1 C4'-C3'-C2' 98.309 -4.391 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.521 1 C4'-C3'-C2' 94.401 -8.299 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.413 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.587 5.705 1 O3'-P-O5' 111.731 4.069 . 0.104 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 017 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.986 2 C3'-C2'-C1' 105.753 4.726 . 0.333 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 111.612 -0.595 . . . . 9.05 111.612 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.05 121.23 14.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.689 0.28 . . . . 8.09 110.611 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.0 ttt -105.86 140.39 38.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 8.02 110.724 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.9 143.1 11.5 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.957 -0.639 . . . . 5.76 111.646 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.8 134.01 23.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 O-C-N 122.603 -0.351 . . . . 4.72 111.204 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -90.48 26.14 0.51 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.143 2.562 . . . . 4.45 111.272 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -91.66 156.01 17.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.851 -0.613 . . . . 4.41 110.692 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.475 HD21 ' HD3' ' A' ' 111' ' ' PRO . 12.9 t-20 -71.1 -74.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.618 0.574 . . . . 3.92 110.781 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p 44.88 77.1 0.08 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.706 0.632 . . . . 2.53 112.706 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.29 135.62 50.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.952 0.406 . . . . 2.48 111.342 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.6 m -73.5 151.25 41.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 2.13 110.491 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -87.0 -13.72 43.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.424 . . . . 2.4 112.061 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.491 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 85.8 m-85 -119.41 163.35 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.856 0.317 . . . . 2.02 111.856 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 118' ' ' VAL . 10.7 p -71.03 168.36 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 2.65 111.034 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.65 156.75 27.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.266 0.555 . . . . 2.4 112.129 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -112.39 122.32 47.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.55 -0.75 . . . . 2.27 109.23 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.43 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -92.95 128.62 38.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.883 0.373 . . . . 2.84 111.951 -178.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -105.26 128.89 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 2.89 110.25 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -119.7 89.36 3.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 3.82 110.504 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.53 -167.66 40.75 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.884 -0.886 . . . . 3.23 110.884 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -86.38 -34.87 20.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.146 0.473 . . . . 4.27 111.334 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -68.64 151.63 46.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.387 . . . . 3.32 110.105 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 -85.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.136 -0.32 . . . . 2.39 110.136 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 131' ' ' PHE . 34.4 tp -168.6 130.27 1.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.482 -0.326 . . . . 2.06 110.392 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -153.02 132.06 12.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 2.22 109.485 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.47 ' HD1' ' HD2' ' A' ' 27' ' ' PRO . 5.1 m-85 -125.55 138.2 31.39 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.581 -0.281 . . . . 1.78 110.69 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD2' ' HD1' ' A' ' 26' ' ' PHE . 38.1 Cg_endo -67.27 163.92 32.49 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.738 2.292 . . . . 2.15 112.235 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 28' ' ' ARG . 20.5 ttt180 -60.99 117.43 5.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.356 -0.838 . . . . 2.6 111.023 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.32 0.2 56.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.788 . . . . 1.65 112.618 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -127.88 162.37 26.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.78 0.324 . . . . 2.31 110.139 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.73 5.75 44.48 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.869 -0.682 . . . . 1.33 111.821 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 95' ' ' THR . 40.4 t -100.03 114.81 65.84 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.931 -0.396 . . . . 1.06 109.931 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.1 -175.58 2.73 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.043 2.495 . . . . 1.27 111.73 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -83.1 85.33 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.146 0.498 . . . . 1.7 110.66 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.491 ' HA ' ' HZ ' ' A' ' 13' ' ' PHE . 44.8 m-80 -80.74 93.81 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.861 -0.609 . . . . 1.23 110.916 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.3 p -85.57 3.69 39.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 1.94 111.473 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -107.9 -4.12 18.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 1.96 111.075 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.75 152.12 51.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.899 0.38 . . . . 1.42 111.874 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.4 m -78.75 168.69 25.11 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 1.73 110.111 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.512 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 77.3 Cg_exo -53.2 -37.49 80.27 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.835 2.357 . . . . 1.42 112.904 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -72.37 -8.76 56.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 1.78 111.469 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.795 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 12.2 m-20 -104.41 4.35 33.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 1.6 110.508 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 36.8 mm-40 -79.26 58.55 2.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.993 0.425 . . . . 1.05 111.822 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -152.03 128.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 1.17 110.263 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.83 -157.51 10.09 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.31 -0.948 . . . . 0.6 112.971 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -149.72 147.92 28.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.918 0.389 . . . . 0.99 111.296 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.689 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 11.0 m-85 -90.38 137.0 32.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 1.26 109.552 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 48' ' ' ARG . 33.2 ttt-85 -114.13 130.29 56.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.453 -0.34 . . . . 2.15 111.259 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -71.29 125.17 26.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.002 -0.74 . . . . 2.4 109.002 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.31 127.55 55.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.035 0.445 . . . . 2.21 112.066 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.11 140.34 51.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.905 -0.776 . . . . 2.68 108.905 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.645 ' HB3' HD12 ' A' ' 64' ' ' LEU . 14.9 tpt180 -150.19 111.1 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.618 0.599 . . . . 3.59 112.618 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.574 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 94.0 mtt180 -135.72 107.06 6.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.797 -0.638 . . . . 3.43 110.223 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.744 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.0 pt -68.4 171.04 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 4.26 110.842 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 55' ' ' ARG . 30.2 ttt180 -128.18 107.8 10.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.839 0.352 . . . . 5.17 110.85 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.43 164.59 36.5 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.648 -0.787 . . . . 4.66 111.408 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.32 -33.06 85.67 Favored Glycine 0 C--N 1.328 0.138 0 C-N-CA 120.931 -0.652 . . . . 5.04 112.137 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -79.27 -2.9 43.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.647 0.737 . . . . 5.51 110.421 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.37 29.38 22.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.595 -0.73 . . . . 4.73 111.399 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -90.08 164.21 14.58 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.342 -0.244 . . . . 5.52 110.342 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -139.37 148.13 42.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.047 -0.524 . . . . 4.48 109.996 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.744 ' HB2' HG12 ' A' ' 54' ' ' ILE . 68.9 tttt -75.7 -38.56 58.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 4.16 110.382 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 26.5 t70 52.4 81.45 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.547 -0.752 . . . . 4.09 112.429 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 52' ' ' ARG . 24.3 mt -81.7 151.51 27.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.222 -0.445 . . . . 3.36 110.439 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -67.85 148.14 98.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.902 -0.59 . . . . 3.36 110.011 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.39 108.12 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.849 2.366 . . . . 2.69 111.768 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.624 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 3.6 ptp180 -119.27 144.17 46.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 3.03 111.261 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.689 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 34.4 m95 -115.08 139.01 50.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.014 -0.539 . . . . 1.84 110.238 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.549 ' OH ' H5'' ' C' ' 8' ' ' ' G' . 6.1 m-85 -113.84 140.89 47.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 2.76 110.312 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.97 126.5 35.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 1.27 111.276 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -123.0 151.2 42.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 1.84 109.381 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.88 148.9 21.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.943 -0.392 . . . . 1.28 109.943 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.19 123.05 16.02 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.147 0.279 . . . . 1.66 110.563 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -9.16 19.01 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.631 -0.795 . . . . 1.66 112.22 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.413 HG22 ' HA3' ' A' ' 107' ' ' GLY . 1.2 p -65.24 131.7 47.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.607 0.242 . . . . 1.58 110.359 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 94.15 106.96 1.95 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.573 -0.822 . . . . 1.96 111.333 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 10.8 Cg_endo -55.85 -44.43 47.59 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.654 2.236 . . . . 2.62 112.282 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.71 28.85 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.148 -0.478 . . . . 3.09 111.636 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.2 -61.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.821 0.343 . . . . 1.79 110.695 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.05 48.83 10.49 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.042 -0.823 . . . . 1.65 111.042 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.8 91.22 48.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 1.38 111.659 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.34 162.74 13.05 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.467 2.111 . . . . 1.62 110.929 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.17 104.88 0.35 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.123 0.487 . . . . 1.58 111.246 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.39 -26.97 3.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.665 -0.698 . . . . 1.44 112.006 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.79 123.5 19.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 1.25 110.872 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -95.76 136.11 36.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.227 -0.442 . . . . 1.86 111.602 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -143.22 155.17 44.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.873 -0.788 . . . . 1.68 108.873 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.74 115.28 6.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.184 0.516 . . . . 1.7 111.694 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.16 22.01 46.84 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.825 -0.625 . . . . 1.27 112.533 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 48' ' ' ARG . 7.7 mm -136.7 133.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.163 -0.31 . . . . 1.01 110.163 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.4 pt -130.81 163.2 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.806 -0.442 . . . . 1.3 109.806 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -112.78 138.68 49.25 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.481 0.548 . . . . 1.08 112.481 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.62 133.29 32.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 1.04 110.233 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.74 132.97 14.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.354 -0.385 . . . . 1.27 110.214 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 32' ' ' VAL . 3.4 t -102.47 170.57 7.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.818 0.342 . . . . 1.36 110.89 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -69.48 126.53 30.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.082 -0.508 . . . . 2.64 110.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.46 -11.61 25.96 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.307 -0.717 . . . . 1.52 111.307 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -89.75 149.22 22.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.647 -0.277 . . . . 1.59 110.539 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.61 141.71 41.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.352 -0.385 . . . . 2.15 110.951 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -80.27 97.78 7.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 2.07 110.555 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.57 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 5.0 t -170.29 145.54 2.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.044 -0.724 . . . . 2.36 109.044 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.34 128.7 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.542 2.161 . . . . 2.08 112.783 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.02 73.68 1.49 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 1.78 111.075 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.24 1.15 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.328 -0.396 . . . . 2.55 111.895 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.456 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.0 p80 -60.11 -16.61 33.6 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.077 0.399 . . . . 2.24 112.077 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.4 pt -121.95 27.36 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.104 0.478 . . . . 2.0 109.975 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.413 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -102.92 -24.68 7.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.731 -0.747 . . . . 2.33 113.807 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -96.35 131.23 43.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.217 0.532 . . . . 2.99 111.504 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.3 ttp85 -159.53 133.48 7.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.258 -0.428 . . . . 2.83 110.28 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -77.26 113.27 29.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 110.072 -0.344 . . . . 3.56 110.072 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.475 ' HD3' HD21 ' A' ' 8' ' ' ASN . 94.0 Cg_endo -85.17 -12.06 7.11 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 3.39 112.897 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.06 -9.71 47.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 4.05 110.694 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -133.15 18.64 4.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.73 -0.668 . . . . 4.48 110.641 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -169.35 132.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 3.39 111.128 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.647 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -94.58 159.09 15.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.214 -0.448 . . . . 3.21 110.419 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.09 150.57 23.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.799 0.333 . . . . 2.85 111.351 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 27.3 mt -78.11 143.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 2.42 109.735 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.4 ' HA ' ' OG1' ' A' ' 14' ' ' THR . 96.8 t -61.48 120.16 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.088 -0.245 . . . . 2.74 110.552 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.85 118.72 8.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.081 0.467 . . . . 2.11 110.603 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.12 148.76 52.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 2.49 110.489 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.657 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 66.1 mt -98.59 147.34 33.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.318 -0.401 . . . . 1.91 110.247 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.63 166.16 10.34 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.833 2.356 . . . . 1.84 112.435 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -61.85 118.47 7.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.057 -0.52 . . . . 2.53 110.815 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.13 -24.98 14.87 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.403 -0.679 . . . . 2.2 111.403 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 m -88.46 103.75 16.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.926 0.393 . . . . 2.1 110.093 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -90.68 144.46 25.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.313 -0.403 . . . . 2.78 111.217 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 15.7 mt -74.55 142.87 78.22 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 2.62 110.172 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 127' ' ' LEU . 42.2 Cg_exo -60.0 149.91 81.56 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 2.77 111.452 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -61.4 119.43 8.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 4.11 110.784 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.25 54.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.772 -0.728 . . . . 3.18 112.127 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -103.94 127.59 51.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 2.91 110.449 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 37.4 p90 -133.97 151.62 51.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.319 -0.401 . . . . 3.54 110.853 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.98 139.86 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 2.93 112.031 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.525 ' HG2' ' OP1' ' C' ' 8' ' ' ' G' . 10.6 tp10 -66.39 131.38 45.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.888 -0.596 . . . . 3.64 109.886 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.3 -37.07 3.14 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.328 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.76 119.22 18.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.64 0.257 . . . . 3.59 110.802 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -118.3 113.96 22.25 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.576 -0.527 . . . . 5.55 109.576 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.09 134.54 12.63 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.847 -0.692 . . . . 5.22 112.648 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.32 -74.42 0.32 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.999 -0.619 . . . . 5.91 111.707 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 119.034 -0.508 . . . . 7.27 111.686 179.752 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.402 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.493 -3.533 1 C4'-C3'-C2' 97.068 -5.632 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.402 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.464 2 N19-C1'-C2' 103.569 -6.145 . 0.234 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.797 3 O4'-C1'-N19 115.687 7.487 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.268 4 O4'-C1'-N19 116.703 8.503 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.373 -4.206 2 C4'-C3'-C2' 97.525 -5.175 . 0.655 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.597 4 C4'-C3'-C2' 98.274 -4.426 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.496 5.228 3 P-O3'-C3' 126.991 6.076 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.647 " H1'" ' HA ' ' A' ' 115' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.357 3 O4'-C4'-C3' 114.909 6.721 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 018 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.019 2 O4'-C1'-N19 118.643 10.443 . 0.413 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.485 3 O3'-P-O5' 116.338 6.494 . 0.462 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.073 1 C4'-C3'-C2' 98.271 -4.429 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.658 1 C4'-C3'-C2' 94.298 -8.402 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.586 5.658 1 O3'-P-O5' 111.66 4.031 . 0.107 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.886 2 C3'-C2'-C1' 105.758 4.731 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.615 -0.594 . . . . 9.05 111.615 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 115.92 23.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.702 0.287 . . . . 8.09 110.734 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -83.15 132.56 35.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.194 -0.457 . . . . 8.02 110.838 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.54 -172.27 40.25 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.512 -0.635 . . . . 5.76 111.512 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.7 tp -106.09 115.07 61.8 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.64 0.257 . . . . 4.72 110.461 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.59 40.68 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.107 2.538 . . . . 4.45 111.885 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -115.07 66.88 0.69 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.33 -0.396 . . . . 4.41 110.704 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -170.24 174.75 5.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 3.92 110.185 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 108' ' ' THR . 34.0 p 52.49 81.6 0.08 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.396 0.887 . . . . 2.53 113.396 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.24 138.33 31.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 2.48 110.851 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -55.08 143.47 26.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.052 -0.522 . . . . 2.13 112.019 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -67.89 -28.6 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 2.4 110.96 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 62.9 m-85 -107.87 168.61 9.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.111 -0.495 . . . . 2.02 112.28 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -70.95 160.78 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.168 -0.923 . . . . 2.65 111.289 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.72 134.75 33.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.4 110.533 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 133' ' ' ALA . 1.2 mt -87.37 132.62 33.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.148 -0.478 . . . . 2.27 110.163 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 m -96.34 112.82 24.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.294 -0.412 . . . . 2.84 110.067 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -83.9 140.28 32.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 2.89 111.016 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -141.84 80.13 1.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.692 -0.485 . . . . 3.82 109.692 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.6 -166.45 29.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.987 -0.625 . . . . 3.23 112.199 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -91.68 -9.87 42.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 4.27 111.019 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -105.18 162.07 13.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.085 -0.507 . . . . 3.32 109.884 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -90.0 -65.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.77 -0.826 . . . . 2.39 108.77 178.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 21.8 tp 175.31 133.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.395 -0.82 . . . . 2.06 110.533 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -150.64 117.57 5.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.068 -0.515 . . . . 2.22 110.304 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -108.12 139.63 20.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.55 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 49.8 Cg_endo -69.77 172.55 12.45 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.69 2.26 . . . . 2.15 112.421 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -69.45 127.62 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.878 -0.601 . . . . 2.6 110.848 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.68 25.06 63.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.942 -0.647 . . . . 1.65 112.622 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -151.38 158.78 44.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.547 -0.538 . . . . 2.31 109.547 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 21.63 9.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.744 -0.741 . . . . 1.33 111.418 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' A' ' 95' ' ' THR . 21.6 t -106.84 110.35 63.6 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.183 -0.303 . . . . 1.06 110.183 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' A' ' 121' ' ' LEU . 39.8 Cg_endo -68.65 175.15 7.5 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.723 2.282 . . . . 1.27 111.09 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.0 mt -72.93 87.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 1.7 110.686 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 71.3 m-20 -82.76 74.96 9.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.808 -0.633 . . . . 1.23 109.775 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -31.5 72.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.34 0.496 . . . . 1.94 112.34 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.58 -7.19 59.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.596 -0.274 . . . . 1.96 111.68 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.92 150.15 32.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.098 0.475 . . . . 1.42 112.095 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.712 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 13.7 m -90.29 170.2 10.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.51 -0.768 . . . . 1.73 109.471 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.712 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 3.0 Cg_endo -46.79 -44.92 21.38 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.324 2.683 . . . . 1.42 114.094 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -70.52 -25.98 63.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.888 0.329 . . . . 1.78 111.888 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.947 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.3 m-20 -86.77 2.79 47.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.267 -0.424 . . . . 1.6 110.844 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 83.4 mm-40 -80.48 46.08 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.107 0.48 . . . . 1.05 111.119 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.879 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.7 tt -143.12 132.47 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.022 -0.535 . . . . 1.17 110.191 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' ' N ' ' A' ' 73' ' ' LEU . . . -170.68 -145.55 4.8 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.414 -0.898 . . . . 0.6 112.158 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.479 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 45.7 p90 -155.6 159.91 40.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.122 0.487 . . . . 0.99 110.98 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.494 ' HB2' HG13 ' A' ' 91' ' ' ILE . 12.0 m-85 -99.91 117.86 35.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.471 -0.786 . . . . 1.26 109.475 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 48' ' ' ARG . 32.7 ttt180 -99.5 127.08 45.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.984 0.421 . . . . 2.15 111.321 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -85.24 135.25 34.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.839 -0.619 . . . . 2.4 110.432 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.7 42.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 2.21 111.37 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.7 m -152.98 127.32 9.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.062 -0.718 . . . . 2.68 109.062 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 3.8 tpt85 -103.63 126.67 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.492 0.553 . . . . 3.59 112.492 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 53' ' ' ARG . 17.5 mtt180 -142.92 107.56 4.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 3.43 109.472 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 169.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.63 0.252 . . . . 4.26 110.71 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.4 110.6 22.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.491 -0.322 . . . . 5.17 110.464 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.426 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -81.07 168.53 50.82 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.529 -0.843 . . . . 4.66 112.714 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.35 -38.61 70.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.984 -0.627 . . . . 5.04 112.154 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -95.13 11.46 32.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.386 0.612 . . . . 5.51 110.351 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.09 18.93 54.91 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.812 -0.709 . . . . 4.73 111.76 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -76.45 155.4 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.175 -0.305 . . . . 5.52 110.175 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.32 174.3 10.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 4.48 110.906 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -97.89 -24.57 15.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 4.16 110.174 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 48.53 90.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.883 1.068 . . . . 4.09 113.883 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.53 147.75 33.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.257 -0.429 . . . . 3.36 110.178 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 24.4 m -78.4 162.12 67.43 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.492 -0.558 . . . . 3.36 109.492 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 9.2 Cg_endo -53.0 108.08 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.768 2.312 . . . . 2.69 112.166 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.454 HH22 ' HB2' ' A' ' 134' ' ' GLU . 19.4 mtp180 -99.91 134.03 43.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.78 -0.646 . . . . 3.03 109.629 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -106.61 115.75 30.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.07 -0.514 . . . . 1.84 112.0 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -102.36 121.29 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.868 -0.79 . . . . 2.76 108.868 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.98 135.57 43.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 1.27 111.686 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HD2' HG21 ' A' ' 75' ' ' THR . 14.3 m-85 -130.75 165.27 23.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 1.84 110.202 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -99.82 159.58 14.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.37 -0.377 . . . . 1.28 110.898 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.419 ' N ' ' HA2' ' A' ' 45' ' ' GLY . 54.8 tp -63.29 116.31 5.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.22 -0.445 . . . . 1.66 111.501 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.45 35.64 10.39 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.995 -0.621 . . . . 1.66 113.936 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.565 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.8 OUTLIER -73.3 90.47 1.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 1.58 111.135 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.39 139.78 5.51 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.032 -0.604 . . . . 1.96 112.2 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -33.34 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.603 2.202 . . . . 2.62 112.053 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -103.67 36.45 2.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.026 -0.534 . . . . 3.09 111.093 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.03 -56.6 10.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 1.79 110.096 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.12 32.5 80.69 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.915 -0.584 . . . . 1.65 112.971 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' ' HB3' ' A' ' 85' ' ' ALA . 3.0 tp -138.33 106.01 7.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.757 0.313 . . . . 1.38 110.688 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 92.2 Cg_endo -85.39 167.54 10.39 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.677 2.251 . . . . 1.62 111.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -60.95 106.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 1.58 110.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.54 -8.64 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.489 -0.862 . . . . 1.44 112.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.577 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . . . -69.24 137.99 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 1.25 110.967 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -88.44 128.18 35.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 1.86 111.839 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 6.5 ttmm -155.24 144.01 20.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.781 -0.645 . . . . 1.68 109.283 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.73 113.34 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.196 0.443 . . . . 1.7 112.196 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.27 20.57 58.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.891 -0.671 . . . . 1.27 112.752 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 35.0 mm -127.72 102.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 1.01 110.51 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 47' ' ' TYR . 24.8 pt -114.62 134.06 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.322 -0.399 . . . . 1.3 109.989 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.479 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 49.3 m95 -90.35 146.25 24.33 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.345 0.498 . . . . 1.08 112.345 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 m -140.47 144.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.518 -0.764 . . . . 1.04 110.311 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.95 169.59 23.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 1.27 110.869 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.445 ' HB ' HG21 ' A' ' 32' ' ' VAL . 13.4 t -146.17 179.04 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.969 -0.56 . . . . 1.36 109.5 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.7 123.37 19.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.399 . . . . 2.64 111.133 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 41' ' ' ASP . . . 107.35 -13.26 39.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.766 -0.73 . . . . 1.52 111.906 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.879 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.31 132.18 35.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.669 0.271 . . . . 1.59 110.785 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.9 mt -102.22 140.59 36.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.262 -0.426 . . . . 2.15 110.799 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -79.45 76.05 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.468 0.652 . . . . 2.07 110.09 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.632 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m -147.13 131.97 8.89 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.654 -0.869 . . . . 2.36 108.654 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.83 125.24 17.67 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.307 2.005 . . . . 2.08 112.251 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.947 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -126.85 75.87 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.585 0.707 . . . . 1.78 111.216 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.99 -4.53 44.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 2.55 112.058 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 4.1 p80 -59.18 -20.9 57.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.092 0.472 . . . . 2.24 111.864 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.3 pt -111.71 13.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.037 0.446 . . . . 2.0 110.616 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.22 -32.67 7.29 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.554 -0.831 . . . . 2.33 112.027 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.467 ' HA ' HG22 ' A' ' 9' ' ' THR . 1.9 t -69.18 121.46 16.83 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.295 0.569 . . . . 2.99 110.978 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.0 ttp85 -164.57 131.18 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.781 . . . . 2.83 109.927 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 59.5 m-80 -94.99 117.84 66.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 3.56 110.663 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 18.3 Cg_endo -60.35 -34.97 92.94 Favored 'Trans proline' 0 N--CA 1.472 0.244 0 C-N-CA 123.123 2.549 . . . . 3.39 113.458 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.93 9.68 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.369 0.507 . . . . 4.05 112.369 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -139.52 9.1 2.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.871 0.367 . . . . 4.48 111.389 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -159.49 127.22 4.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 3.39 111.248 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.47 164.14 25.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 3.21 110.625 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.58 152.19 23.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.167 0.508 . . . . 2.85 111.466 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 3.4 mp -95.76 145.86 7.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.746 -0.661 . . . . 2.42 109.417 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.578 ' HA ' ' OG1' ' A' ' 14' ' ' THR . 70.0 t -68.25 115.31 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.251 -0.277 . . . . 2.74 110.251 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.75 121.24 12.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.066 -0.515 . . . . 2.11 110.604 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -139.83 173.64 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.858 -0.61 . . . . 2.49 110.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 33' ' ' PRO . 91.5 mt -123.14 152.48 63.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.558 -0.534 . . . . 1.91 109.558 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.42 154.65 34.39 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.003 2.469 . . . . 1.84 111.97 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 140' ' ' SER . 24.2 tt0 -52.94 122.83 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 2.53 111.332 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.69 -11.34 49.88 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.632 -0.794 . . . . 2.2 112.321 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 HD13 ' A' ' 121' ' ' LEU . 5.3 m -109.11 113.89 27.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.486 -0.561 . . . . 2.1 109.486 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.2 159.63 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.358 -0.383 . . . . 2.78 110.892 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.416 HD22 ' HD2' ' A' ' 131' ' ' PHE . 28.4 mt -90.45 156.68 45.41 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.402 -0.363 . . . . 2.62 110.25 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.54 151.46 62.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.656 2.238 . . . . 2.77 111.912 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.36 119.2 8.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.185 0.517 . . . . 4.11 111.775 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.41 -8.88 44.8 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.723 -0.751 . . . . 3.18 112.346 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.416 ' HD2' HD22 ' A' ' 127' ' ' LEU . 2.1 t80 -101.51 112.91 25.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.788 -0.449 . . . . 2.91 109.788 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -133.1 149.88 52.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 3.54 111.663 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.422 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -103.45 147.35 27.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 2.93 110.073 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.454 ' HB2' HH22 ' A' ' 67' ' ' ARG . 25.5 tt0 -73.67 121.61 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 3.64 111.237 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.85 -0.47 45.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.688 -0.767 . . . . 3.27 112.265 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -86.87 135.36 33.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.875 0.369 . . . . 3.59 110.733 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -121.58 4.32 10.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.191 0.519 . . . . 5.55 110.197 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.08 -138.71 6.61 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.656 -0.702 . . . . 5.22 111.402 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 109.57 -131.56 10.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.657 -0.782 . . . . 5.91 112.99 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 9.7 m . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.065 -0.969 . . . . 7.27 110.691 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.4 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.491 -3.722 1 C4'-C3'-C2' 97.005 -5.695 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.4 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.554 2 N19-C1'-C2' 103.574 -6.141 . 0.23 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.709 2 O4'-C1'-N19 115.723 7.523 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.21 4 O4'-C1'-N19 116.651 8.451 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.375 -4.063 2 C4'-C3'-C2' 97.576 -5.124 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.759 4 C4'-C3'-C2' 98.298 -4.402 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.275 3 P-O3'-C3' 127.008 6.09 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.58 5.249 3 O4'-C4'-C3' 114.875 6.696 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.541 -5.154 2 O4'-C1'-N19 118.641 10.441 . 0.417 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.589 3 O3'-P-O5' 116.394 6.523 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.217 1 C4'-C3'-C2' 98.249 -4.451 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.482 1 C4'-C3'-C2' 94.401 -8.299 . 0.459 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.426 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.767 1 O3'-P-O5' 111.7 4.053 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.077 2 C3'-C2'-C1' 105.708 4.675 . 0.34 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.785 -0.526 . . . . 9.05 111.785 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.8 103.02 10.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.889 0.376 . . . . 8.09 111.207 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 46.4 mtt -127.17 84.07 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.901 0.381 . . . . 8.02 110.913 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.74 144.52 12.31 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.006 -0.616 . . . . 5.76 112.146 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.05 103.35 8.95 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.721 0.296 . . . . 4.72 110.483 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.59 35.2 0.55 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.008 2.472 . . . . 4.45 112.618 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -103.85 164.84 11.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.84 -0.43 . . . . 4.41 109.84 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -68.34 -74.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.141 -0.318 . . . . 3.92 110.141 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p 43.6 56.93 4.21 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 112.68 0.622 . . . . 2.53 112.68 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.91 154.5 26.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.211 -0.449 . . . . 2.48 111.588 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -87.36 155.6 19.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.906 -0.588 . . . . 2.13 110.032 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -86.09 -29.4 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 2.4 110.146 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.52 -179.72 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.409 -0.814 . . . . 2.02 110.532 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.71 -172.35 4.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.458 . . . . 2.65 110.679 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -105.66 173.25 6.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 2.4 112.602 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.607 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 16.0 mt -112.1 122.85 48.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.931 -1.031 . . . . 2.27 109.312 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.1 m -92.52 116.39 28.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.99 0.424 . . . . 2.84 111.261 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -86.38 142.43 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 2.89 110.842 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -134.44 44.86 2.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.977 -0.556 . . . . 3.82 109.862 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.9 -167.24 12.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.832 -0.699 . . . . 3.23 112.442 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -86.74 -28.14 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 4.27 110.645 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.89 163.55 23.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 3.32 111.007 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.2 -85.5 0.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.825 -0.435 . . . . 2.39 109.825 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.597 HD13 ' CE1' ' A' ' 131' ' ' PHE . 36.5 tp -168.97 140.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 2.06 110.462 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -163.01 120.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.716 -0.675 . . . . 2.22 110.021 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -110.54 142.5 26.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.269 -0.423 . . . . 1.78 110.234 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.57 164.94 16.78 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.114 2.543 . . . . 2.15 111.965 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -69.61 128.47 36.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 2.6 110.426 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.83 29.92 49.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.287 -0.725 . . . . 1.65 111.287 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -157.84 171.52 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.46 -0.57 . . . . 2.31 109.46 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.31 17.32 64.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 1.33 112.511 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.78 111.15 65.0 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 1.06 109.826 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.51 168.57 11.2 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.783 2.322 . . . . 1.27 112.051 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.9 mt -74.69 87.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.16 -0.473 . . . . 1.7 110.497 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -84.11 77.69 9.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.039 0.447 . . . . 1.23 109.913 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -26.31 68.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 1.94 111.628 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -80.78 -3.78 52.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.127 -0.488 . . . . 1.96 111.653 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.478 ' HB3' ' CB ' ' A' ' 42' ' ' ASP . 1.4 m -120.52 157.52 29.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.351 . . . . 1.42 111.672 -178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.672 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 23.4 m -83.04 168.84 20.19 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.96 -0.564 . . . . 1.73 109.922 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.8 Cg_endo -52.9 -35.71 71.77 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.947 2.432 . . . . 1.42 113.913 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.839 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.2 p-10 -80.81 -16.01 54.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.652 0.242 . . . . 1.78 111.652 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.827 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 29.5 m-20 -84.37 -3.39 58.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 1.6 111.106 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -78.55 56.37 1.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 1.05 110.827 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 94' ' ' ALA . 16.6 tt -149.97 127.38 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.673 . . . . 1.17 110.155 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.3 -139.83 3.0 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.515 -0.85 . . . . 0.6 112.214 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.483 ' CD2' HG23 ' A' ' 90' ' ' ILE . 53.7 p90 -162.09 158.65 25.12 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.08 0.467 . . . . 0.99 111.113 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.641 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -95.84 134.94 38.21 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.898 -0.778 . . . . 1.26 108.898 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -112.68 121.39 44.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.399 -0.364 . . . . 2.15 111.1 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -73.49 119.69 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.491 . . . . 2.4 109.787 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.31 148.29 43.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.173 0.511 . . . . 2.21 111.306 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.73 151.46 45.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.731 -0.84 . . . . 2.68 108.731 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.784 ' HB3' HD12 ' A' ' 64' ' ' LEU . 9.6 tpt180 -139.43 125.64 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.982 0.42 . . . . 3.59 111.604 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 25.7 mtt180 -140.73 98.58 3.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.905 -0.589 . . . . 3.43 110.789 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 61' ' ' MET . 33.8 pt -79.74 160.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.378 -0.601 . . . . 4.26 109.378 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 55' ' ' ARG . 3.8 ttt180 -131.23 120.27 23.0 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.919 -0.312 . . . . 5.17 111.564 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -83.64 -174.97 50.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.938 -0.648 . . . . 4.66 112.538 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.36 -51.52 54.0 Favored Glycine 0 CA--C 1.516 0.113 0 C-N-CA 121.416 -0.421 . . . . 5.04 113.249 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.3 -32.68 72.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.983 0.421 . . . . 5.51 110.054 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.5 36.16 0.75 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.908 -0.663 . . . . 4.73 112.125 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -86.99 154.74 20.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.15 -0.685 . . . . 5.52 109.15 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 mtt -137.77 138.04 38.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.943 0.401 . . . . 4.48 111.852 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HE3' HD21 ' A' ' 64' ' ' LEU . 45.7 tttp -71.84 -33.72 68.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.517 -0.765 . . . . 4.16 110.288 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 26.1 t0 46.85 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.632 0.975 . . . . 4.09 113.632 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 52' ' ' ARG . 47.8 mt -89.22 137.3 32.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 3.36 110.46 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -64.04 144.73 98.17 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.099 -0.5 . . . . 3.36 110.271 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.81 119.32 5.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.915 2.41 . . . . 2.69 112.27 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.528 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 64.8 mtt85 -121.19 132.43 54.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 3.03 110.568 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.641 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.74 118.48 31.47 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.252 -0.431 . . . . 1.84 110.921 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.82 146.23 24.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.194 -0.669 . . . . 2.76 109.194 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.54 120.83 28.28 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.653 -0.419 . . . . 1.27 111.774 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -115.37 157.51 23.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.593 -0.521 . . . . 1.84 109.593 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -102.94 158.95 15.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.936 -0.394 . . . . 1.28 109.936 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -63.18 118.99 8.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.079 -0.341 . . . . 1.66 110.079 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.84 35.2 4.93 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.987 -0.625 . . . . 1.66 112.334 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.35 99.87 12.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.444 . . . . 1.58 110.796 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.85 123.94 3.38 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.181 -0.768 . . . . 1.96 111.181 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.3 -27.7 83.55 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.857 2.371 . . . . 2.62 113.181 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -127.59 35.35 4.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.737 0.303 . . . . 3.09 110.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.22 -50.65 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 1.79 111.023 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.62 51.27 26.38 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.308 -0.717 . . . . 1.65 111.308 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.7 mt -132.28 96.12 19.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.573 0.225 . . . . 1.38 111.596 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 92.9 Cg_endo -84.5 162.99 12.72 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.662 2.242 . . . . 1.62 110.661 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.538 ' HB2' HD11 ' A' ' 73' ' ' LEU . 34.7 t80 -58.8 113.26 1.97 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.013 0.435 . . . . 1.58 110.894 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.68 11.61 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.729 -0.748 . . . . 1.44 112.449 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -61.83 108.61 1.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.883 0.373 . . . . 1.25 110.486 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.0 107.45 8.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.153 -0.476 . . . . 1.86 110.543 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -125.62 149.83 48.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 1.68 109.968 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.15 110.49 1.62 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.236 -0.438 . . . . 1.7 111.683 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.17 21.48 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.794 -0.717 . . . . 1.27 112.284 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.483 HG23 ' CD2' ' A' ' 46' ' ' TYR . 48.1 mm -129.19 113.83 29.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.351 -0.24 . . . . 1.01 110.351 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 91' ' ' ILE . 7.8 pt -119.13 126.2 75.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.645 -0.502 . . . . 1.3 109.645 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.436 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 82.9 m95 -83.45 139.21 33.09 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.707 0.632 . . . . 1.08 112.707 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.45 139.44 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.538 -0.755 . . . . 1.04 110.411 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -155.5 172.33 18.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.082 -0.508 . . . . 1.27 109.745 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.2 t -142.9 170.84 14.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.748 0.309 . . . . 1.36 110.361 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.73 118.24 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.981 -0.554 . . . . 2.64 110.686 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.61 -15.22 8.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.967 -0.635 . . . . 1.52 111.647 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.839 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.25 159.26 22.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.671 0.272 . . . . 1.59 110.662 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.69 140.93 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 2.15 110.663 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -80.14 97.69 6.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.093 0.473 . . . . 2.07 111.179 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 t -171.2 148.93 2.51 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.968 -0.753 . . . . 2.36 108.968 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.54 111.75 3.39 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.045 1.83 . . . . 2.08 112.111 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.827 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -108.51 80.45 1.35 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.441 0.639 . . . . 1.78 110.264 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -72.64 -5.96 41.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.461 -0.79 . . . . 2.55 112.245 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -63.01 -15.61 56.99 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.519 0.562 . . . . 2.24 112.519 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.89 -24.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.463 . . . . 2.0 110.726 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.34 73.46 1.68 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.788 -0.72 . . . . 2.33 112.029 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.4 t -160.56 22.97 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.142 0.496 . . . . 2.99 110.979 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttp85 -84.29 136.85 33.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 2.83 110.824 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -83.85 119.64 73.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.42 -0.585 . . . . 3.56 109.42 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.795 ' HB2' " H5'" ' C' ' 9' ' ' ' U' . 71.9 Cg_endo -75.52 -19.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.792 2.328 . . . . 3.39 113.769 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.43 -40.6 8.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.929 0.344 . . . . 4.05 111.929 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.88 7.72 26.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.41 -0.359 . . . . 4.48 111.394 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -160.23 139.92 11.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.333 . . . . 3.39 110.512 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.597 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -86.02 141.55 29.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.241 -0.436 . . . . 3.21 111.143 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.64 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -85.36 148.38 26.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 2.85 110.765 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.62 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 2.42 110.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.65 135.52 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.926 -0.398 . . . . 2.74 109.926 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.48 HD23 ' HG ' ' A' ' 16' ' ' LEU . 15.7 tp -63.3 119.66 10.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 2.11 110.691 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -124.33 135.24 53.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.49 110.915 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.0 mt -101.79 147.5 33.96 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 1.91 110.142 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.65 152.54 77.88 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.702 2.268 . . . . 1.84 111.807 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -54.86 129.49 37.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.858 -0.61 . . . . 2.53 111.258 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.64 14.17 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.419 -0.672 . . . . 2.2 111.419 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -99.81 98.26 9.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.718 0.294 . . . . 2.1 110.395 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.71 147.07 23.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 2.78 110.433 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.86 144.37 87.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.285 -0.416 . . . . 2.62 110.223 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.521 ' HG2' ' HD1' ' A' ' 131' ' ' PHE . 17.6 Cg_endo -60.34 155.64 45.34 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.399 2.066 . . . . 2.77 111.505 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -60.89 127.41 31.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 4.11 111.105 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.95 63.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.908 -0.663 . . . . 3.18 112.648 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.51 116.56 30.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.917 0.389 . . . . 2.91 111.828 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -124.09 137.78 54.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 3.54 110.64 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.473 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 2.93 111.372 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.0 121.49 15.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 3.64 111.114 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 23.26 34.05 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.941 -0.572 . . . . 3.27 112.849 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.9 m -107.29 -23.37 12.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.207 0.447 . . . . 3.59 112.207 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -139.45 127.98 23.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.089 0.471 . . . . 5.55 111.783 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 134.6 -169.15 23.26 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.971 -0.851 . . . . 5.22 110.971 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -91.88 43.66 2.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.786 -0.721 . . . . 5.91 111.815 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 119.005 -0.522 . . . . 7.27 111.219 -179.868 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.491 -3.655 1 C4'-C3'-C2' 97.124 -5.576 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.503 2 N19-C1'-C2' 103.478 -6.201 . 0.232 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.863 3 O4'-C1'-N19 115.748 7.548 . 0.531 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.168 4 O4'-C1'-N19 116.661 8.461 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.119 2 C4'-C3'-C2' 97.573 -5.127 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.769 4 C1'-O4'-C4' 105.612 -4.431 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.496 5.235 3 P-O3'-C3' 127.041 6.117 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.64 " H4'" ' HB3' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.262 3 O4'-C4'-C3' 114.884 6.703 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 020 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . 0.795 " H5'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.543 -5.014 2 O4'-C1'-N19 118.634 10.434 . 0.416 1a . 14.39 . . . . . . . . . . 3 2 . 1 . 020 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.549 -4.404 3 O3'-P-O5' 116.382 6.517 . 0.457 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.148 1 C4'-C3'-C2' 98.237 -4.463 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 020 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.587 5.701 1 C4'-C3'-C2' 94.307 -8.393 . 0.461 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.529 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.587 5.693 1 O3'-P-O5' 111.706 4.056 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 020 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.042 2 C3'-C2'-C1' 105.754 4.727 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.755 -0.538 . . . . 9.05 111.755 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.69 93.97 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.018 0.437 . . . . 8.09 110.483 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -100.78 105.63 16.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.031 -0.532 . . . . 8.02 110.447 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.79 141.14 19.28 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.792 -0.718 . . . . 5.76 111.801 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.746 HD22 ' HB2' ' A' ' 7' ' ' ASN . 0.7 OUTLIER -110.37 112.8 56.75 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.557 0.218 . . . . 4.72 110.513 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HD2' HD23 ' A' ' 5' ' ' LEU . 79.9 Cg_endo -77.86 56.19 5.57 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.794 2.329 . . . . 4.45 111.249 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.746 ' HB2' HD22 ' A' ' 5' ' ' LEU . 17.5 t-20 -98.33 112.67 24.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.718 -0.674 . . . . 4.41 110.762 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -110.65 -58.02 2.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.56 -0.291 . . . . 3.92 110.918 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m 69.54 104.73 0.06 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.606 0.566 . . . . 2.53 111.127 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.22 127.84 53.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.073 0.463 . . . . 2.48 112.236 -178.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -73.1 139.21 46.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 2.13 110.306 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -98.06 -25.59 14.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.783 0.325 . . . . 2.4 111.788 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.66 176.98 5.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 2.02 110.571 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.526 HG22 " H5'" ' C' ' 8' ' ' ' G' . 14.7 p -69.89 175.62 4.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.983 0.421 . . . . 2.65 111.382 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -95.05 158.23 15.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.411 0.624 . . . . 2.4 111.527 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.743 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 88.7 mt -111.89 106.3 14.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.148 -0.933 . . . . 2.27 109.327 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.7 m -84.51 127.17 33.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 2.84 111.504 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.55 115.57 27.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.902 -0.59 . . . . 2.89 110.664 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -103.67 72.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.487 -0.56 . . . . 3.82 109.487 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.95 -161.85 26.86 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.842 -0.694 . . . . 3.23 112.156 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 70.3 mmtt -94.28 -42.52 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.684 0.278 . . . . 4.27 111.115 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.69 153.32 36.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 3.32 110.064 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.9 -76.0 0.31 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.915 -0.314 . . . . 2.39 110.574 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.1 tp 179.8 130.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.897 -0.592 . . . . 2.06 110.264 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -145.18 123.97 12.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 2.22 110.32 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.47 ' CD1' ' HA2' ' A' ' 31' ' ' GLY . 46.6 m-85 -107.0 140.21 21.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.356 -0.384 . . . . 1.78 110.866 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 13.4 Cg_exo -71.58 168.96 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.839 2.359 . . . . 2.15 111.901 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -61.0 124.93 21.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 2.6 111.279 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.96 9.97 84.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.885 -0.674 . . . . 1.65 112.737 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.584 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 16.6 tt0 -129.5 160.7 32.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.814 -0.439 . . . . 2.31 109.814 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 26' ' ' PHE . . . 118.36 -3.01 16.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.151 -0.547 . . . . 1.33 111.951 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.6 t -101.21 111.16 63.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.898 -0.408 . . . . 1.06 109.898 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 4.0 Cg_exo -76.88 -170.7 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.001 2.467 . . . . 1.27 111.327 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -74.2 100.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.191 0.52 . . . . 1.7 111.268 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.587 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 71.2 m-80 -103.37 86.03 2.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.0 -0.741 . . . . 1.23 109.0 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -51.67 53.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.579 0.955 . . . . 1.94 113.579 -178.045 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -80.71 11.33 3.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.836 0.68 . . . . 1.96 112.836 -178.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.587 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -115.02 137.73 51.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.713 0.292 . . . . 1.42 110.802 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.98 164.05 50.99 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 1.73 111.006 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.17 -37.94 93.89 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.177 2.585 . . . . 1.42 113.312 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.4 p-10 -82.33 -5.97 58.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.548 0.213 . . . . 1.78 111.453 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.07 5.24 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 1.6 110.279 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.483 ' HB3' HG11 ' A' ' 32' ' ' VAL . 63.3 mm-40 -83.7 53.31 2.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 1.05 111.062 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.448 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.7 tt -144.81 136.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.609 . . . . 1.17 110.142 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.19 -147.93 6.7 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.152 -1.023 . . . . 0.6 113.059 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.428 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 44.2 p90 -157.16 172.78 18.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.951 0.405 . . . . 0.99 110.699 -179.077 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -117.34 134.76 54.44 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.478 -0.564 . . . . 1.26 109.478 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -107.53 136.17 47.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 2.15 111.141 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -81.37 98.12 8.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.607 -0.724 . . . . 2.4 110.282 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.8 148.35 30.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 2.21 111.803 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -155.64 121.5 5.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.68 109.464 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.804 ' HB3' HD12 ' A' ' 64' ' ' LEU . 4.2 ttt85 -94.45 129.87 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.654 0.264 . . . . 3.59 111.038 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.17 94.95 2.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 3.43 110.457 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.529 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -83.17 141.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 4.26 111.359 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -97.75 115.39 27.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 5.17 112.237 -178.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 157.97 52.02 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.845 -0.693 . . . . 4.66 111.47 178.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.15 -51.04 61.25 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.397 -0.43 . . . . 5.04 112.622 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.56 -25.27 63.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.187 0.517 . . . . 5.51 110.998 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.72 36.18 0.65 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.519 -0.848 . . . . 4.73 111.589 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -91.31 155.77 18.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.182 -0.303 . . . . 5.52 110.182 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 mmt -148.83 125.79 11.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.445 -0.343 . . . . 4.48 110.969 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HG3' ' O4 ' ' C' ' 13' ' ' ' U' . 58.6 tttt -62.35 -42.43 99.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 4.16 110.526 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 t70 58.85 77.53 0.3 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.353 -0.84 . . . . 4.09 112.069 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.804 HD12 ' HB3' ' A' ' 52' ' ' ARG . 40.0 mt -87.45 164.09 16.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.024 -0.534 . . . . 3.36 111.062 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.65 152.74 54.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.131 -0.486 . . . . 3.36 110.634 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 115.17 2.48 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.479 2.119 . . . . 2.69 111.283 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.663 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 4.3 ptp180 -113.15 119.57 38.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 3.03 110.82 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -84.43 126.34 33.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.836 -0.62 . . . . 1.84 110.648 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 51.1 m-85 -109.26 132.01 54.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.708 -0.479 . . . . 2.76 109.708 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.49 127.32 33.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.376 . . . . 1.27 111.179 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -130.24 157.66 41.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.51 -0.552 . . . . 1.84 109.51 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -86.28 156.31 20.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.984 0.421 . . . . 1.28 111.019 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 83' ' ' TYR . 4.2 tt -65.82 116.86 7.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.141 -0.481 . . . . 1.66 111.204 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.78 10.23 31.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.617 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -61.02 122.74 15.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.855 0.36 . . . . 1.58 110.976 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.419 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 97.63 123.87 4.76 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.87 -0.681 . . . . 1.96 112.005 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 9.9 Cg_endo -53.35 -63.89 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.219 2.613 . . . . 2.62 112.434 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.69 ' HB2' HD21 ' A' ' 5' ' ' LEU . 42.7 mt-10 -91.95 72.7 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.309 0.576 . . . . 3.09 111.12 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.99 -61.17 1.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 1.79 109.936 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 39.46 57.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.797 -0.638 . . . . 1.65 112.316 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.89 95.17 44.72 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.217 -0.29 . . . . 1.38 110.217 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 84.2 Cg_endo -89.67 179.46 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.865 2.377 . . . . 1.62 112.206 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.447 ' HB2' HD11 ' A' ' 73' ' ' LEU . 43.2 t80 -61.42 107.48 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.935 -0.575 . . . . 1.58 111.247 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.17 -15.55 8.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.513 -0.851 . . . . 1.44 113.061 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.634 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.72 105.24 1.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.156 0.503 . . . . 1.25 111.033 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -79.06 122.47 26.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.036 -0.529 . . . . 1.86 111.214 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -141.11 173.74 11.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 1.68 109.732 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -73.96 114.87 12.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 1.7 111.492 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 31.64 59.91 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.83 -0.623 . . . . 1.27 113.01 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.7 mm -128.58 107.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 110.333 -0.247 . . . . 1.01 110.333 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 pt -115.14 124.92 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.543 0.211 . . . . 1.3 110.446 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 76.3 m95 -88.41 138.79 31.12 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.045 0.387 . . . . 1.08 112.045 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.87 144.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 1.04 110.66 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.9 160.42 43.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.394 -0.366 . . . . 1.27 110.301 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -135.45 168.83 18.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.71 -0.478 . . . . 1.36 109.71 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.15 133.12 55.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 2.64 110.675 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.65 -16.97 55.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.969 -0.634 . . . . 1.52 112.349 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.41 143.05 29.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 1.59 110.577 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.6 mt -110.68 142.44 42.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.44 -0.345 . . . . 2.15 110.447 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.42 83.95 3.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.302 0.572 . . . . 2.07 110.902 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.1 t -151.65 139.09 12.47 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.459 -0.791 . . . . 2.36 109.416 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 126.55 22.39 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.013 2.476 . . . . 2.08 113.278 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -117.97 60.71 0.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.5 -0.773 . . . . 1.78 110.217 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.58 -0.87 21.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 2.55 112.101 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -74.76 -6.75 50.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 2.24 111.55 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.22 35.45 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 2.0 111.142 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 13.33 8.39 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.53 -0.843 . . . . 2.33 112.868 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -131.88 114.81 15.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.207 0.527 . . . . 2.99 110.898 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -151.05 160.57 43.83 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.604 -0.517 . . . . 2.83 109.604 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.14 105.83 50.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 3.56 110.715 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.47 -34.24 26.84 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.401 2.068 . . . . 3.39 113.087 -179.113 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.592 ' HA ' ' N2 ' ' C' ' 8' ' ' ' G' . . . -74.52 -8.07 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.972 0.36 . . . . 4.05 111.972 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -125.73 10.03 7.71 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.626 -0.261 . . . . 4.48 111.495 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -168.92 127.91 1.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 3.39 110.182 -179.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.658 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -80.33 164.5 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.703 0.287 . . . . 3.21 110.762 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.521 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -99.93 151.96 20.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.318 -0.401 . . . . 2.85 110.232 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.0 mt -83.97 143.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.589 -0.523 . . . . 2.42 109.589 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.546 HG11 ' HB2' ' A' ' 136' ' ' SER . 85.7 t -65.92 119.85 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.796 0.331 . . . . 2.74 110.474 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.612 HD22 HD21 ' A' ' 16' ' ' LEU . 7.8 tt -63.28 118.65 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 2.11 109.718 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -133.53 165.64 24.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.28 -0.418 . . . . 2.49 110.898 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.33 157.67 43.31 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.646 -0.706 . . . . 1.91 110.042 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.39 172.82 15.33 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.62 2.213 . . . . 1.84 112.075 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.2 120.87 13.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.006 -0.543 . . . . 2.53 110.336 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.42 -25.8 8.98 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.551 -0.833 . . . . 2.2 112.099 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 m -98.13 112.93 24.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.805 -0.442 . . . . 2.1 109.805 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.9 m -104.7 145.34 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.727 -0.669 . . . . 2.78 111.257 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -76.92 149.38 80.13 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.09 -0.707 . . . . 2.62 109.09 178.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 18.4 Cg_endo -60.42 146.23 97.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.529 2.153 . . . . 2.77 111.553 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.61 109.74 0.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 4.11 110.471 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.2 -12.42 9.73 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.371 -0.692 . . . . 3.18 111.371 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.743 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 1.4 t80 -103.24 134.34 46.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.125 -0.324 . . . . 2.91 110.125 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -128.78 164.95 21.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.349 -0.387 . . . . 3.54 110.53 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 136' ' ' SER . . . -103.34 139.54 38.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.511 -0.313 . . . . 2.93 110.479 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.82 123.11 28.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.921 0.391 . . . . 3.64 110.535 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.18 -1.39 82.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.297 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.546 ' HB2' HG11 ' A' ' 118' ' ' VAL . 4.7 t -118.19 110.69 17.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 3.59 110.566 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.86 101.5 10.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.024 -0.535 . . . . 5.55 110.848 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.86 -134.04 9.7 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.266 -0.733 . . . . 5.22 111.266 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.43 79.29 0.51 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.914 -0.66 . . . . 5.91 112.786 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.253 1.262 0 CA-C-O 119.056 -0.497 . . . . 7.27 111.528 179.669 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.401 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.492 -3.615 1 C4'-C3'-C2' 97.04 -5.66 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.401 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.506 2 N19-C1'-C2' 103.494 -6.191 . 0.232 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 021 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.705 3 O4'-C1'-N19 115.722 7.522 . 0.531 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 021 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.195 4 O4'-C1'-N19 116.707 8.507 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 021 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.375 -4.086 2 C4'-C3'-C2' 97.608 -5.092 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 021 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.765 4 N19-C1'-C2' 106.385 -4.384 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 021 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.498 5.357 3 P-O3'-C3' 127.02 6.1 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 021 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.658 " H1'" ' HA ' ' A' ' 115' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.353 3 O4'-C4'-C3' 114.915 6.725 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 021 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.86 2 O4'-C1'-N19 118.668 10.468 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 021 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.532 3 O3'-P-O5' 116.424 6.539 . 0.463 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 021 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.142 1 C4'-C3'-C2' 98.325 -4.375 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 021 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.464 1 C4'-C3'-C2' 94.338 -8.362 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 021 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.512 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.588 5.856 1 O3'-P-O5' 111.688 4.046 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 021 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.065 2 C3'-C2'-C1' 105.657 4.619 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.597 -0.601 . . . . 9.05 111.597 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.53 119.96 18.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.817 0.341 . . . . 8.09 111.073 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.7 mmt -80.89 88.28 5.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.193 -0.458 . . . . 8.02 109.812 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.86 140.15 4.12 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.435 -0.802 . . . . 5.76 111.142 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -107.84 110.98 62.56 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.818 0.342 . . . . 4.72 110.51 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -93.47 18.82 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.064 2.51 . . . . 4.45 111.862 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -94.07 142.54 27.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.202 -0.454 . . . . 4.41 110.517 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -116.19 -77.33 0.57 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.506 -0.316 . . . . 3.92 110.29 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p 51.35 83.63 0.05 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.66 0.985 . . . . 2.53 113.66 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.05 40.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 2.48 111.012 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 m -57.86 153.02 14.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.082 -0.508 . . . . 2.13 112.35 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 109' ' ' ARG . 32.2 m95 -74.92 -54.44 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.609 -0.723 . . . . 2.4 110.52 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.82 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 24.8 m-85 -74.75 159.65 31.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 2.02 112.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -68.92 158.58 34.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.543 -0.753 . . . . 2.65 111.017 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -77.08 144.99 38.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.911 0.386 . . . . 2.4 111.207 -179.576 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.637 HD13 ' HE2' ' A' ' 131' ' ' PHE . 35.4 mt -89.53 119.9 30.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.988 -0.375 . . . . 2.27 109.988 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -90.97 126.44 36.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.279 0.561 . . . . 2.84 112.458 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.423 ' HB2' ' HE1' ' A' ' 131' ' ' PHE . 6.2 tp-100 -94.8 138.43 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.892 -0.594 . . . . 2.89 110.172 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 14.6 t60 -137.21 56.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.532 -0.544 . . . . 3.82 109.532 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -154.89 -169.34 19.39 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.58 -0.736 . . . . 3.23 111.685 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mmtt -92.84 -1.77 56.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.062 0.393 . . . . 4.27 112.062 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -104.53 171.92 7.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 3.32 110.308 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.74 -79.87 0.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.664 -0.243 . . . . 2.39 110.375 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.7 tp -179.57 132.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 2.06 110.421 179.082 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -154.07 117.31 4.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.333 -0.394 . . . . 2.22 110.628 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -109.74 141.29 23.37 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.191 -0.459 . . . . 1.78 110.155 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.72 165.01 29.12 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.564 2.176 . . . . 2.15 112.298 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -64.34 119.87 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.577 . . . . 2.6 111.085 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.36 0.52 56.88 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.798 -0.715 . . . . 1.65 112.567 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -130.0 165.76 21.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 2.31 110.62 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.38 -14.7 30.36 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.783 -0.722 . . . . 1.33 112.37 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.555 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.8 t -89.56 118.15 68.79 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.701 0.286 . . . . 1.06 110.999 -179.239 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.19 -176.36 2.87 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.608 2.206 . . . . 1.27 111.345 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 mt -84.63 79.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 1.7 110.781 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -83.85 86.85 7.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.323 -0.399 . . . . 1.23 110.31 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.07 64.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.994 0.426 . . . . 1.94 110.832 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -76.42 0.67 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.959 -0.564 . . . . 1.96 111.394 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.499 ' HB3' ' CB ' ' A' ' 42' ' ' ASP . 4.3 m -128.36 152.19 48.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.855 0.36 . . . . 1.42 111.033 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 168.49 27.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.099 -0.501 . . . . 1.73 109.88 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.28 -36.61 93.91 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.585 2.19 . . . . 1.42 111.961 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -77.79 -19.94 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 1.78 111.054 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.934 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 31.7 m-20 -81.97 -5.8 58.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 1.6 111.275 -179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.555 ' HB3' HG11 ' A' ' 32' ' ' VAL . 76.8 mm-40 -79.44 57.71 2.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.151 0.5 . . . . 1.05 111.379 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.493 HG13 ' HB2' ' A' ' 94' ' ' ALA . 10.9 tt -151.17 131.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.749 -0.659 . . . . 1.17 109.579 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.26 -146.15 6.07 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.368 -0.92 . . . . 0.6 112.661 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -153.03 165.01 36.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.914 0.387 . . . . 0.99 110.58 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -105.48 125.59 51.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 1.26 109.238 178.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -95.1 126.4 40.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.205 -0.452 . . . . 2.15 111.643 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -76.57 120.83 22.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.598 -0.728 . . . . 2.4 109.51 178.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.67 158.77 43.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 2.21 111.666 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.94 109.01 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.598 -0.728 . . . . 2.68 109.594 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.648 ' HB3' HD12 ' A' ' 64' ' ' LEU . 11.3 tpt85 -81.26 103.84 11.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 3.59 111.531 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -114.5 110.34 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 3.43 111.179 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.72 131.9 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.822 -0.626 . . . . 4.26 109.397 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 55' ' ' ARG . 1.4 ttp180 -105.74 124.76 50.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.331 0.395 . . . . 5.17 110.232 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.44 165.8 28.96 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.862 -0.685 . . . . 4.66 111.697 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.8 -26.95 74.24 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.128 -0.558 . . . . 5.04 112.129 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.83 3.86 31.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.46 0.648 . . . . 5.51 110.602 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.06 10.62 68.73 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.805 -0.712 . . . . 4.73 111.57 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -73.47 144.35 46.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.712 0.291 . . . . 5.52 110.265 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt -121.9 141.36 51.36 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.104 -0.498 . . . . 4.48 110.575 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -68.24 -42.65 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 4.16 109.542 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t0 47.48 75.23 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.18 -0.918 . . . . 4.09 112.676 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 52' ' ' ARG . 27.4 mt -94.46 158.92 15.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.912 -0.585 . . . . 3.36 111.195 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.11 149.51 89.58 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.777 -0.647 . . . . 3.36 111.289 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.66 116.25 3.12 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.844 2.363 . . . . 2.69 111.297 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 10.8 mtt-85 -119.91 147.6 44.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.051 -0.522 . . . . 3.03 111.594 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -114.93 129.14 56.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 1.84 110.946 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -103.65 133.65 48.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.365 -0.606 . . . . 2.76 109.365 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -81.6 121.36 26.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 1.27 111.481 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.44 ' HD2' HG21 ' A' ' 75' ' ' THR . 20.2 m-85 -122.74 133.52 54.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 1.84 109.743 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.63 159.74 33.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.539 -0.3 . . . . 1.28 110.899 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.38 122.0 12.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 1.66 111.825 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.39 24.34 26.65 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.906 -0.664 . . . . 1.66 113.678 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.44 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -77.2 102.16 6.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 1.58 111.204 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.403 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 127.25 114.23 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.13 -0.788 . . . . 1.96 111.13 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 18.0 Cg_endo -59.45 -26.51 82.22 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.91 2.407 . . . . 2.62 112.466 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.3 15.28 16.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.543 0.211 . . . . 3.09 111.526 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.66 -55.58 6.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.029 0.442 . . . . 1.79 110.223 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.64 36.35 89.29 Favored Glycine 0 C--N 1.329 0.157 0 CA-C-N 115.73 -0.668 . . . . 1.65 112.789 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 mt -107.85 105.9 57.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.565 0.221 . . . . 1.38 111.039 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.14 161.84 17.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.056 2.504 . . . . 1.62 111.511 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -57.91 111.07 1.04 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 1.58 110.51 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.76 -19.23 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.629 -0.796 . . . . 1.44 112.352 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.61 113.11 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 1.25 110.807 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -82.27 121.98 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.374 -0.376 . . . . 1.86 111.704 -179.27 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.94 171.46 14.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.295 -0.411 . . . . 1.68 110.269 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.35 110.29 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.878 -0.601 . . . . 1.7 111.195 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.37 97.06 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.95 -0.568 . . . . 1.27 112.823 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.5 mm -127.51 105.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.899 0.381 . . . . 1.01 110.611 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.8 pt -111.67 135.19 51.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.371 -0.603 . . . . 1.3 109.371 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -94.86 140.68 29.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.16 0.43 . . . . 1.08 112.16 -178.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.01 141.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.519 -0.764 . . . . 1.04 110.241 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -155.25 152.28 29.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.09 -0.337 . . . . 1.27 110.09 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -111.59 173.61 6.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.415 -0.357 . . . . 1.36 110.263 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.0 118.68 15.16 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.983 -0.377 . . . . 2.64 109.983 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.76 -3.8 24.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.84 -0.695 . . . . 1.52 111.881 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.21 131.4 34.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.46 -0.2 . . . . 1.59 110.46 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.14 148.52 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 2.15 111.188 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -87.1 72.27 10.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 2.07 110.557 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.504 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 8.5 m -148.68 125.93 5.58 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.466 -0.788 . . . . 2.36 109.498 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.18 133.75 53.69 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.983 2.455 . . . . 2.08 112.195 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.934 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.28 84.6 2.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.305 0.574 . . . . 1.78 111.346 -179.494 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -11.03 59.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.005 -0.543 . . . . 2.55 111.756 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.444 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.4 p80 -56.91 -22.24 35.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.797 0.665 . . . . 2.24 112.797 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.57 4.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.095 0.474 . . . . 2.0 110.753 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.27 -16.7 45.82 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.885 -0.674 . . . . 2.33 111.517 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -87.08 121.71 29.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.949 0.404 . . . . 2.99 110.519 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 12' ' ' TRP . 10.3 ttp85 -164.91 131.04 2.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 2.83 110.614 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 28.3 t-20 -95.12 122.64 59.45 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.553 -0.536 . . . . 3.56 109.553 178.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 11.7 Cg_endo -54.6 -37.23 90.83 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 123.449 2.766 . . . . 3.39 114.086 -178.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.67 -8.53 59.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.81 0.67 . . . . 4.05 112.81 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -115.5 7.18 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.463 0.542 . . . . 4.48 112.463 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.77 124.61 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.908 0.385 . . . . 3.39 110.998 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.31 158.59 28.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.26 -0.427 . . . . 3.21 110.871 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.433 ' HB2' " O4'" ' C' ' 8' ' ' ' G' . . . -73.24 151.98 41.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 2.85 111.487 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 44.3 mt -107.96 132.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 2.42 109.044 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.29 119.34 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.434 -0.348 . . . . 2.74 111.009 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.82 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 3.9 tt -66.82 122.49 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.208 0.528 . . . . 2.11 110.733 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -133.15 145.49 50.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.515 -0.766 . . . . 2.49 110.582 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.553 HD13 HG22 ' A' ' 125' ' ' THR . 34.3 mt -106.83 143.74 27.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 1.91 109.767 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.71 159.08 50.16 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.557 2.171 . . . . 1.84 111.847 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.87 126.36 27.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.106 -0.497 . . . . 2.53 111.041 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 -11.8 45.5 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.967 -0.853 . . . . 2.2 110.967 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.553 HG22 HD13 ' A' ' 121' ' ' LEU . 10.4 m -108.52 109.01 20.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.269 -0.641 . . . . 2.1 109.269 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.08 147.85 28.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.412 -0.358 . . . . 2.78 111.296 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.494 HD22 ' HD2' ' A' ' 131' ' ' PHE . 27.8 mt -83.46 145.95 49.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.89 -0.596 . . . . 2.62 109.96 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.28 154.57 45.7 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.72 2.28 . . . . 2.77 112.095 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.2 120.87 15.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.01 -0.541 . . . . 4.11 110.462 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.95 4.56 48.14 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.845 -0.693 . . . . 3.18 111.705 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.637 ' HE2' HD13 ' A' ' 16' ' ' LEU . 2.3 t80 -115.57 121.81 43.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.341 -0.614 . . . . 2.91 109.341 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.408 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 29.8 p90 -126.41 140.87 52.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.989 0.423 . . . . 3.54 111.37 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.94 154.43 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.744 -0.662 . . . . 2.93 111.521 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.664 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.4 tt0 -83.59 131.57 34.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.405 -0.816 . . . . 3.64 109.224 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.51 -52.0 2.38 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.964 -0.854 . . . . 3.27 110.964 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.29 106.12 3.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 3.59 110.066 178.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -115.1 156.72 24.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.368 -0.378 . . . . 5.55 110.481 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.85 118.86 16.43 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.238 -0.506 . . . . 5.22 113.234 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 113.93 -92.02 0.59 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.109 -0.567 . . . . 5.91 111.763 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.248 0.996 0 CA-C-O 119.011 -0.519 . . . . 7.27 111.191 -179.979 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.566 1 C4'-C3'-C2' 97.065 -5.635 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.505 2 N19-C1'-C2' 103.543 -6.161 . 0.23 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.755 3 O4'-C1'-N19 115.717 7.517 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.231 4 O4'-C1'-N19 116.65 8.45 . 0.514 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.373 -4.171 2 C4'-C3'-C2' 97.583 -5.117 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.656 4 C4'-C3'-C2' 98.264 -4.436 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.498 5.344 3 P-O3'-C3' 127.002 6.085 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.433 " O4'" ' HB2' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.366 3 O4'-C4'-C3' 114.977 6.769 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 022 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.083 2 O4'-C1'-N19 118.609 10.409 . 0.417 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.49 3 O3'-P-O5' 116.308 6.478 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.136 1 C4'-C3'-C2' 98.305 -4.395 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.568 1 C4'-C3'-C2' 94.371 -8.329 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.844 1 O3'-P-O5' 111.696 4.051 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 022 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.964 2 C3'-C2'-C1' 105.718 4.686 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.974 0 N-CA-C 111.841 -0.504 . . . . 9.05 111.841 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.37 116.47 23.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.932 0.396 . . . . 8.09 110.624 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.5 mmm -120.69 131.14 54.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.019 -0.537 . . . . 8.02 110.672 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.58 126.41 7.39 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.631 -0.795 . . . . 5.76 111.966 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 85.8 mt -87.33 121.47 71.27 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.882 -0.414 . . . . 4.72 109.882 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 2.6 Cg_exo -76.84 63.99 7.56 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 123.201 2.601 . . . . 4.45 111.874 -179.542 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -106.25 115.82 30.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.02 -0.536 . . . . 4.41 110.604 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -89.37 -85.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.228 -0.442 . . . . 3.92 110.827 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m 61.92 90.89 0.07 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.187 0.518 . . . . 2.53 111.67 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.51 161.74 13.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 2.48 111.258 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -81.02 162.36 23.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.046 -0.525 . . . . 2.13 110.54 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -98.79 -11.4 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.978 0.362 . . . . 2.4 111.978 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 92.6 m-85 -129.09 176.37 7.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.606 -0.27 . . . . 2.02 111.041 -179.02 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.07 HG22 " H5'" ' C' ' 8' ' ' ' G' . 1.9 p -71.69 174.19 7.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.075 -0.511 . . . . 2.65 110.077 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -97.41 167.36 11.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.189 0.519 . . . . 2.4 111.269 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.79 107.05 15.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.552 -0.749 . . . . 2.27 109.28 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -82.43 115.74 21.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.218 -0.446 . . . . 2.84 110.607 -179.943 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -85.33 128.49 34.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 2.89 110.371 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.735 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 42.9 t60 -112.98 -7.67 13.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.752 0.311 . . . . 3.82 111.247 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.76 -159.15 26.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.958 -0.639 . . . . 3.23 111.674 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.37 -32.07 12.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.83 0.315 . . . . 4.27 111.325 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.33 174.78 8.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.893 -0.594 . . . . 3.32 110.179 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -96.78 -82.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 2.39 109.403 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 131' ' ' PHE . 31.6 tp -176.03 130.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 2.06 110.117 179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -153.15 99.14 2.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.187 -0.46 . . . . 2.22 110.647 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 24' ' ' LEU . 16.6 m-85 -89.22 137.05 29.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 1.78 110.511 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.93 158.14 55.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.649 2.232 . . . . 2.15 111.852 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -56.93 118.14 4.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 2.6 111.355 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.35 -13.96 43.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 1.65 112.33 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -115.64 163.9 15.12 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.969 -0.382 . . . . 2.31 109.969 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 116.0 -19.05 13.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.839 -0.696 . . . . 1.33 112.808 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 49.1 t -86.77 113.76 54.71 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.726 0.298 . . . . 1.06 110.568 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.536 ' HA ' HD23 ' A' ' 121' ' ' LEU . 2.9 Cg_exo -77.26 -174.89 2.39 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.265 2.643 . . . . 1.27 111.794 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.67 81.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 1.7 110.845 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.576 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 63.8 m-80 -81.79 84.18 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.424 . . . . 1.23 109.894 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -32.5 69.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.808 -0.633 . . . . 1.94 112.12 -178.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -76.95 -26.28 53.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 1.96 112.063 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.576 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -91.15 158.28 16.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.064 0.394 . . . . 1.42 112.064 -178.67 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.737 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 46.4 m -86.19 171.96 9.37 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.101 -0.499 . . . . 1.73 110.976 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.737 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.82 -43.53 55.46 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.037 2.491 . . . . 1.42 113.45 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.07 -16.05 60.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.78 111.53 179.966 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.834 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.0 m-20 -81.99 -3.62 54.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.6 111.237 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.478 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 41.0 mm-40 -77.2 51.8 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.3 0.572 . . . . 1.05 111.536 -179.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 94' ' ' ALA . 13.4 tt -150.98 128.03 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.654 -0.703 . . . . 1.17 109.468 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.28 -143.88 4.03 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.217 -0.992 . . . . 0.6 112.542 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -157.69 166.02 33.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.956 0.407 . . . . 0.99 111.001 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.782 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.5 m-85 -107.38 137.87 44.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 1.26 110.062 178.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.456 ' HA ' HD13 ' A' ' 90' ' ' ILE . 19.7 ttt180 -115.07 124.66 52.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.467 . . . . 2.15 110.82 -179.278 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -83.66 121.55 27.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.023 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.02 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 2.21 111.482 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -130.92 160.51 34.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.476 -0.784 . . . . 2.68 108.94 179.084 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 52' ' ' ARG . 5.0 tpt180 -134.77 123.56 23.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.983 0.42 . . . . 3.59 111.769 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 74.9 mtt180 -138.92 115.21 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 3.43 110.942 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.659 HD11 ' H5 ' ' C' ' 13' ' ' ' U' . 28.5 pt -90.09 149.42 4.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.185 -0.672 . . . . 4.26 109.185 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -90.57 97.12 10.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.843 0.354 . . . . 5.17 110.362 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.683 ' HA2' ' OP2' ' C' ' 13' ' ' ' U' . . . -73.78 134.71 19.31 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.936 -0.65 . . . . 4.66 111.882 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 -23.32 69.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.888 -0.672 . . . . 5.04 112.007 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.81 3.55 41.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.999 0.428 . . . . 5.51 110.994 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.91 13.53 66.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.849 -0.691 . . . . 4.73 111.719 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -99.55 166.78 10.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.558 -0.321 . . . . 5.52 110.478 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 20.8 mtt -146.6 132.31 18.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.264 -0.426 . . . . 4.48 110.337 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.621 ' HG3' ' N4 ' ' B' ' 1' ' ' ' C' . 73.2 tttt -54.37 -46.08 72.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 4.16 110.08 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 30.2 t70 52.07 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.961 -1.018 . . . . 4.09 113.539 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.67 138.03 31.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.873 -0.603 . . . . 3.36 109.937 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.481 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.7 OUTLIER -60.38 153.17 60.96 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 3.36 110.97 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 114.98 2.05 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.928 2.419 . . . . 2.69 111.89 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.465 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 56.7 mtp180 -110.03 113.18 25.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.776 -0.647 . . . . 3.03 110.046 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.782 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 47.3 m95 -84.91 120.3 26.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.241 -0.436 . . . . 1.84 111.117 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 79.5 m-85 -98.96 150.94 21.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 2.76 110.567 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.32 122.31 43.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.27 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.91 164.53 17.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.839 -0.618 . . . . 1.84 109.745 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.49 155.68 17.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.64 -0.255 . . . . 1.28 110.334 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -60.7 111.88 1.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.224 -179.859 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.63 -8.27 26.07 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.308 -0.949 . . . . 1.66 113.993 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 p -62.89 103.68 0.47 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.66 0.73 . . . . 1.58 111.595 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 127.23 111.95 1.72 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.723 -0.951 . . . . 1.96 110.723 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.423 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 26.2 Cg_endo -62.03 -26.07 78.12 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.762 2.308 . . . . 2.62 112.462 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -117.56 23.99 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 3.09 110.1 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.21 -53.98 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 1.79 111.122 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.2 49.29 80.14 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.877 -0.601 . . . . 1.65 112.146 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.6 mt -131.24 99.47 17.63 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.682 0.277 . . . . 1.38 111.548 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 7.7 Cg_exo -75.35 159.43 40.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.904 2.402 . . . . 1.62 110.974 178.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.768 ' HB2' HD11 ' A' ' 73' ' ' LEU . 79.5 t80 -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 1.58 111.021 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.12 -4.63 16.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.863 -0.684 . . . . 1.44 112.625 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -68.0 130.3 42.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 1.25 111.082 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -77.94 127.01 31.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.835 -0.62 . . . . 1.86 111.498 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.436 ' HG2' HG13 ' A' ' 90' ' ' ILE . 3.8 ttmt -152.12 143.17 23.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.2 -0.667 . . . . 1.68 109.2 178.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.02 118.83 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 1.7 112.1 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.13 33.83 56.33 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.617 -0.72 . . . . 1.27 112.52 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 48' ' ' ARG . 25.1 mm -136.3 112.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.157 -0.312 . . . . 1.01 110.157 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.494 HD13 ' HG ' ' A' ' 24' ' ' LEU . 19.6 pt -115.47 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.811 -0.44 . . . . 1.3 109.811 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -93.48 135.1 35.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 1.08 112.044 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.448 HG11 ' HA3' ' A' ' 31' ' ' GLY . 18.1 m -136.11 140.02 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.563 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.562 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -157.89 144.11 17.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 1.27 110.121 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -110.47 -176.22 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.044 0.45 . . . . 1.36 111.022 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.06 133.28 44.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.677 -0.692 . . . . 2.64 110.725 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.89 -9.1 63.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.719 -0.753 . . . . 1.52 112.444 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -82.89 142.34 31.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.186 -0.301 . . . . 1.59 110.186 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.45 144.0 31.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.714 -0.221 . . . . 2.15 110.584 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -80.47 74.63 7.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 2.07 109.806 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.445 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.8 t -144.8 141.41 17.48 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.558 -0.747 . . . . 2.36 109.019 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.39 130.64 21.5 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.596 2.197 . . . . 2.08 113.351 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.834 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.43 71.41 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.53 -0.759 . . . . 1.78 110.874 179.438 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -16.84 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.76 -0.654 . . . . 2.55 111.548 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -61.0 -7.36 2.41 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.577 0.954 . . . . 2.24 113.577 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.39 -23.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.612 -0.514 . . . . 2.0 109.612 178.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.32 81.53 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.859 -0.61 . . . . 2.33 113.433 -178.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 t -79.08 94.41 5.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.673 0.749 . . . . 2.99 110.644 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -150.81 130.73 13.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.377 -0.829 . . . . 2.83 109.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.21 115.75 64.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.836 -0.431 . . . . 3.56 109.836 179.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.49 0.92 8.98 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.808 2.338 . . . . 3.39 114.198 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.21 -31.7 9.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 4.05 111.126 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.44 -16.85 21.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 4.48 110.596 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -143.19 143.87 31.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 3.39 110.23 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.59 148.44 25.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.525 -0.307 . . . . 3.21 110.45 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' H ' " H1'" ' C' ' 8' ' ' ' G' . . . -69.48 160.28 31.72 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.105 -0.498 . . . . 2.85 111.771 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 18.3 mt -86.4 158.77 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.631 -0.713 . . . . 2.42 109.448 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.78 117.8 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.587 0.232 . . . . 2.74 110.462 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.98 113.91 4.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 2.11 110.943 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -133.72 155.75 49.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 2.49 110.306 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 35.6 mt -105.79 146.35 32.68 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.194 -0.457 . . . . 1.91 110.59 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 25.7 Cg_exo -64.66 161.7 34.57 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.861 2.374 . . . . 1.84 112.429 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -53.92 127.09 24.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.98 -0.554 . . . . 2.53 111.181 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.22 -7.7 58.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.765 -0.731 . . . . 2.2 111.697 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -112.79 100.01 8.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 2.1 110.095 179.997 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.01 156.14 18.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.209 -0.45 . . . . 2.78 110.663 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.4 mt -85.21 146.9 46.15 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.71 -0.478 . . . . 2.62 109.71 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.97 143.57 91.41 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.417 2.078 . . . . 2.77 111.56 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -59.54 124.25 19.48 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.89 -0.595 . . . . 4.11 111.245 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.21 45.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.955 -0.641 . . . . 3.18 111.869 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.6 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -109.51 139.13 44.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.695 0.283 . . . . 2.91 110.474 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.735 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 2.5 p90 -135.24 139.82 44.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.416 -0.356 . . . . 3.54 110.582 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.02 128.69 38.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.947 -0.569 . . . . 2.93 110.758 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 49.1 mt-10 -64.14 132.18 49.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.11 -0.495 . . . . 3.64 110.719 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.55 -37.32 3.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.909 -0.662 . . . . 3.27 112.9 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 m -75.2 142.98 43.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 3.59 111.265 -179.341 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -117.94 142.85 46.9 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.425 -0.583 . . . . 5.55 109.425 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.15 71.02 2.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 5.22 112.225 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.47 -114.67 5.0 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 111.424 -0.67 . . . . 5.91 111.424 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 119.167 -0.444 . . . . 7.27 111.504 -179.935 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.621 ' N4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.604 1 C4'-C3'-C2' 97.031 -5.669 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.405 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.474 4.69 2 N19-C1'-C2' 103.506 -6.184 . 0.233 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 023 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.757 3 O4'-C1'-N19 115.733 7.533 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 023 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.235 4 O4'-C1'-N19 116.694 8.494 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 023 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.374 -4.133 2 C4'-C3'-C2' 97.603 -5.097 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 023 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.659 4 C4'-C3'-C2' 98.267 -4.433 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 023 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.499 5.412 3 P-O3'-C3' 127.027 6.106 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 023 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 1.07 " H5'" HG22 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.582 5.446 3 O4'-C4'-C3' 114.861 6.686 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 023 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.541 -5.163 2 O4'-C1'-N19 118.618 10.418 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 023 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.473 3 O4'-C1'-N19 114.73 6.53 . 0.458 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 023 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.136 1 C4'-C3'-C2' 98.271 -4.429 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 023 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.606 1 C4'-C3'-C2' 94.39 -8.31 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 023 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.683 ' OP2' ' HA2' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.766 1 O3'-P-O5' 111.663 4.033 . 0.106 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 023 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . 0.452 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.578 5.002 2 C3'-C2'-C1' 105.679 4.643 . 0.338 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.622 -0.591 . . . . 9.05 111.622 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.28 86.49 5.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.097 0.475 . . . . 8.09 109.797 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -92.94 127.65 38.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.753 -0.658 . . . . 8.02 111.174 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.18 174.86 34.03 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.459 -0.657 . . . . 5.76 111.459 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 96.9 mt -107.3 121.99 42.76 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 110.511 -0.181 . . . . 4.72 110.511 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 7.1 Cg_exo -75.3 51.28 2.84 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.293 2.662 . . . . 4.45 111.615 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -135.33 162.7 31.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.571 -0.9 . . . . 4.41 108.571 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -96.6 -60.1 1.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.824 0.345 . . . . 3.92 110.48 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 p 49.21 61.71 2.99 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.888 1.07 . . . . 2.53 113.888 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.01 147.39 45.17 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.053 -0.351 . . . . 2.48 110.053 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -69.84 153.66 43.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.462 -0.336 . . . . 2.13 110.758 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -88.12 -9.15 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 2.4 111.109 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.0 m-85 -128.07 162.68 26.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.376 -0.374 . . . . 2.02 111.454 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.515 HG22 " H5'" ' C' ' 8' ' ' ' G' . 10.8 p -68.38 162.14 26.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 2.65 111.086 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.05 146.87 31.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 2.4 111.708 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 57.3 mt -97.48 123.87 41.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 2.27 108.935 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.561 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 6.0 m -105.11 128.12 53.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.831 0.348 . . . . 2.84 111.331 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.6 tp-100 -100.9 138.86 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.89 110.633 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -127.41 78.77 1.84 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.791 -0.448 . . . . 3.82 109.791 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.24 -158.91 16.13 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.97 -0.633 . . . . 3.23 111.892 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -94.56 -39.35 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.887 0.375 . . . . 4.27 110.238 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.72 155.74 21.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.985 -0.746 . . . . 3.32 108.985 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.462 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -96.87 -131.23 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.844 0.313 . . . . 2.39 111.844 -179.484 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' CE1' ' A' ' 131' ' ' PHE . 31.2 tp -114.77 135.95 53.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 2.06 112.253 -179.091 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -157.83 116.99 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.554 -0.748 . . . . 2.22 109.084 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 28.6 m-85 -105.89 138.81 19.75 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.78 111.003 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.55 -178.94 2.9 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.847 2.365 . . . . 2.15 112.876 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -66.49 126.7 29.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.532 -0.758 . . . . 2.6 111.583 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 48.77 66.26 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.005 -0.543 . . . . 1.65 112.924 179.364 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -166.49 154.73 10.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.094 -0.336 . . . . 2.31 110.094 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.26 4.98 35.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.56 -0.829 . . . . 1.33 112.925 179.192 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 43' ' ' GLN . 45.0 t -93.04 120.46 66.98 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.632 0.253 . . . . 1.06 110.506 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 121' ' ' LEU . 11.3 Cg_exo -71.97 178.75 5.53 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.069 2.512 . . . . 1.27 111.954 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.09 81.99 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 1.7 109.843 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.538 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 42.5 m-80 -83.3 75.18 9.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 1.23 110.946 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.93 3.62 6.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.395 0.617 . . . . 1.94 110.759 179.529 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -99.09 -8.5 25.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 1.96 110.667 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 1.4 p -134.61 165.33 25.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 1.42 112.056 -178.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -78.92 163.97 57.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 1.73 110.493 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 51.5 Cg_exo -57.11 -31.56 90.7 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.806 2.337 . . . . 1.42 112.566 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.54 -24.29 61.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 1.78 110.472 179.363 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.954 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 21.6 m-20 -84.59 -3.69 58.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.769 -0.651 . . . . 1.6 110.74 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 34.3 mm-40 -78.54 58.06 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 1.05 111.156 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.507 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -153.1 134.44 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.485 -0.561 . . . . 1.17 109.485 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.64 -141.93 4.57 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.322 -0.942 . . . . 0.6 112.663 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -155.1 164.02 39.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.141 0.496 . . . . 0.99 111.479 -178.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.623 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 46.1 m-85 -106.79 131.64 53.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.591 -0.731 . . . . 1.26 109.091 178.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -106.83 127.84 53.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 2.15 111.279 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 49' ' ' ARG . 29.4 ttt-85 -83.34 109.11 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.797 -0.638 . . . . 2.4 109.771 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.95 170.58 9.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.83 0.347 . . . . 2.21 111.316 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 165.67 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.605 . . . . 2.68 110.304 179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -141.32 104.08 4.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 3.59 110.587 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -126.26 107.44 10.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.141 -0.482 . . . . 3.43 111.404 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 62' ' ' LYS . 49.8 pt -70.9 163.7 3.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.449 -0.341 . . . . 4.26 110.679 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.673 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -130.17 94.92 3.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 5.17 111.906 -179.005 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.64 158.75 52.65 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.924 -0.655 . . . . 4.66 112.094 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.18 83.03 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.905 -0.665 . . . . 5.04 112.053 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 23.4 t0 -88.63 28.85 1.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.185 0.517 . . . . 5.51 110.943 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.87 38.03 88.78 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.945 -0.57 . . . . 4.73 112.309 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 58' ' ' ASP . 12.2 mptt -91.53 157.37 17.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.814 0.34 . . . . 5.52 111.15 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.9 ttm -158.74 139.14 12.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.28 -0.418 . . . . 4.48 110.501 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HG3' ' O4 ' ' C' ' 13' ' ' ' U' . 48.6 tttp -67.69 -48.05 67.68 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.304 0.377 . . . . 4.16 110.854 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 65.79 99.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.719 -0.673 . . . . 4.09 112.385 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.31 157.51 30.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 3.36 111.062 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -78.73 158.51 75.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.697 -0.683 . . . . 3.36 110.284 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.22 123.94 14.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.949 2.433 . . . . 2.69 111.871 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -122.22 122.56 39.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 3.03 111.053 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.623 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 45.8 m95 -98.72 129.95 45.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.774 -0.648 . . . . 1.84 111.184 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 47.9 m-85 -108.65 138.7 44.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.34 -0.615 . . . . 2.76 109.34 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.48 128.72 36.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 1.27 111.486 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.72 143.21 50.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 1.84 110.369 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -77.4 151.6 34.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.426 -0.352 . . . . 1.28 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -58.82 116.81 4.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 1.66 111.085 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 114.72 -3.37 23.06 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.555 -0.831 . . . . 1.66 113.735 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.41 114.18 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.994 0.397 . . . . 1.58 111.119 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.427 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 107.57 109.6 3.37 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.124 -0.791 . . . . 1.96 111.124 -179.117 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.427 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 14.2 Cg_endo -56.97 -39.61 90.15 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.098 2.532 . . . . 2.62 112.921 -179.013 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.71 31.17 6.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.377 . . . . 3.09 110.989 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.18 -42.94 59.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 1.79 111.137 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.39 51.65 41.49 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.971 -0.633 . . . . 1.65 111.546 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -120.41 97.33 48.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.614 0.245 . . . . 1.38 111.476 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.65 151.32 10.14 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.096 2.531 . . . . 1.62 110.914 178.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.71 ' HB2' HD11 ' A' ' 73' ' ' LEU . 68.9 t80 -62.77 111.32 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.368 . . . . 1.58 110.855 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.85 -27.09 5.23 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.456 -0.878 . . . . 1.44 112.201 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.53 122.37 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.683 0.277 . . . . 1.25 110.76 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -87.14 127.34 35.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.958 0.409 . . . . 1.86 111.524 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -139.97 157.89 44.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.728 -0.842 . . . . 1.68 108.728 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.54 115.87 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.229 0.455 . . . . 1.7 112.229 -179.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.55 30.36 62.29 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.27 112.756 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.51 95.19 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 1.01 110.476 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.44 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 27.2 pt -107.75 127.98 63.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.132 -0.486 . . . . 1.3 109.99 178.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.658 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 85.5 m95 -88.02 140.86 29.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.341 0.497 . . . . 1.08 112.341 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.73 146.78 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.446 -0.797 . . . . 1.04 109.781 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -140.9 173.6 11.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.013 0.435 . . . . 1.27 111.226 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.713 HG22 ' HB2' ' A' ' 98' ' ' ALA . 1.4 t -133.49 168.11 19.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.972 -0.558 . . . . 1.36 110.079 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.41 105.35 5.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 2.64 109.829 179.325 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.25 26.39 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.657 -0.782 . . . . 1.52 111.95 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.713 ' HB2' HG22 ' A' ' 95' ' ' THR . . . -78.74 149.47 32.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.754 -0.462 . . . . 1.59 109.754 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 45.3 mt -102.56 123.18 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.889 0.376 . . . . 2.15 110.721 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -76.63 72.3 3.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.584 0.707 . . . . 2.07 110.284 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.693 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 25.5 m -149.47 129.89 6.84 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.54 -0.911 . . . . 2.36 108.54 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.51 125.11 13.25 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.982 2.454 . . . . 2.08 112.418 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.954 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.3 69.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.344 0.593 . . . . 1.78 111.304 -179.488 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 1.2 p-10 -77.42 4.36 11.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.186 -0.461 . . . . 2.55 112.003 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.5 p80 -57.81 -23.15 51.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.949 0.404 . . . . 2.24 111.743 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.84 16.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 2.0 111.147 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.19 -15.98 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.742 -0.742 . . . . 2.33 111.704 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -82.51 123.55 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 2.99 111.157 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -167.63 147.06 4.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 2.83 109.419 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.9 113.19 62.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.071 0.463 . . . . 3.56 110.872 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HB2' " O4'" ' C' ' 9' ' ' ' U' . 48.0 Cg_endo -66.78 -35.45 27.63 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.116 2.544 . . . . 3.39 113.875 -178.465 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.415 ' HA ' ' N2 ' ' C' ' 8' ' ' ' G' . . . -81.36 18.13 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 4.05 111.888 -179.024 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -141.96 -39.08 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.195 -0.457 . . . . 4.48 110.707 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.271 -0.422 . . . . 3.39 110.911 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.691 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -92.87 146.9 23.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 3.21 110.585 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.511 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -81.17 165.36 21.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 2.85 110.957 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.6 mt -97.67 155.59 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.55 . . . . 2.42 110.077 -179.563 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.415 HG22 ' HA3' ' A' ' 135' ' ' GLY . 65.1 t -68.53 126.8 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.318 -0.253 . . . . 2.74 110.318 179.417 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -70.24 111.51 5.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.92 0.391 . . . . 2.11 110.407 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -128.38 153.57 46.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 2.49 109.952 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 33' ' ' PRO . 93.3 mt -108.18 148.65 37.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.22 -0.445 . . . . 1.91 110.482 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.01 157.03 63.73 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.191 1.927 . . . . 1.84 111.383 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -53.68 124.4 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 2.53 110.877 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.07 -18.24 16.43 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.207 -0.757 . . . . 2.2 111.207 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -94.87 100.19 12.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.031 0.443 . . . . 2.1 110.196 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.5 m -80.0 129.64 34.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 2.78 111.071 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 121' ' ' LEU . 12.7 mt -80.34 137.36 52.32 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 2.62 109.843 179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.7 141.85 97.69 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.546 2.164 . . . . 2.77 111.654 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -60.49 128.03 34.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.039 -0.528 . . . . 4.11 111.033 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.94 -18.95 39.17 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.204 -0.758 . . . . 3.18 111.204 -179.525 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.511 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -95.73 138.21 33.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.647 0.26 . . . . 2.91 110.493 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.561 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 27.2 p90 -136.19 155.24 50.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.453 -0.34 . . . . 3.54 110.397 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.33 123.77 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 2.93 110.072 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.13 128.59 35.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.165 -0.47 . . . . 3.64 110.339 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.415 ' HA3' HG22 ' A' ' 118' ' ' VAL . . . 112.16 -20.45 21.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.795 -0.717 . . . . 3.27 111.355 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.7 m -80.28 77.39 7.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.166 0.508 . . . . 3.59 110.333 179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 137' ' ' ARG . 4.4 ptp85 -144.1 39.14 1.32 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.599 -0.728 . . . . 5.55 109.86 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.76 47.45 4.8 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.858 -0.897 . . . . 5.22 110.858 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -99.87 69.54 0.52 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.047 -0.597 . . . . 5.91 112.969 -178.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.247 0.937 0 CA-C-O 119.071 -0.49 . . . . 7.27 111.727 179.569 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.404 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.491 -3.703 1 C4'-C3'-C2' 96.995 -5.705 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.478 2 N19-C1'-C2' 103.452 -6.217 . 0.231 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 024 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.85 3 O4'-C1'-N19 115.734 7.534 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 024 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.179 4 O4'-C1'-N19 116.635 8.435 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 024 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.081 2 C4'-C3'-C2' 97.584 -5.116 . 0.656 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 024 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.674 4 C4'-C3'-C2' 98.265 -4.435 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 024 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.499 5.429 3 P-O3'-C3' 127.098 6.165 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 024 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.691 " H1'" ' HA ' ' A' ' 115' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.368 3 O4'-C4'-C3' 114.917 6.726 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 024 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . 0.426 " O4'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.542 -5.127 2 O4'-C1'-N19 118.589 10.389 . 0.412 1a . 14.39 . . . . . . . . . . 3 2 . 1 . 024 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.474 3 O3'-P-O5' 116.371 6.511 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 024 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.108 1 C4'-C3'-C2' 98.286 -4.414 . 0.307 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 024 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.595 1 C4'-C3'-C2' 94.327 -8.373 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 024 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.528 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.588 5.837 1 O3'-P-O5' 111.776 4.093 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 024 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.966 2 C3'-C2'-C1' 105.647 4.608 . 0.341 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.902 -0.479 . . . . 9.05 111.902 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.95 96.09 8.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.93 0.395 . . . . 8.09 110.947 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.51 118.45 30.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.152 -0.476 . . . . 8.02 110.879 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.66 146.21 9.58 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.619 -0.801 . . . . 5.76 111.986 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.1 tp -113.95 107.36 52.38 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.763 0.316 . . . . 4.72 110.532 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -93.46 23.9 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.122 2.548 . . . . 4.45 113.213 -179.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -102.32 117.92 35.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.873 0.368 . . . . 4.41 110.838 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -76.15 105.06 6.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.885 -0.598 . . . . 3.92 110.734 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -129.95 118.88 22.33 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.977 -0.556 . . . . 2.53 110.222 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.88 129.2 27.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.891 -0.595 . . . . 2.48 110.169 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 p -69.78 145.87 51.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.574 -0.285 . . . . 2.13 110.6 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -75.14 -20.22 59.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.44 -0.346 . . . . 2.4 111.377 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 99.5 m-85 -108.16 166.27 10.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.02 112.098 -178.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.89 170.82 13.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.031 -0.986 . . . . 2.65 111.258 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -76.39 140.3 41.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.087 -0.506 . . . . 2.4 111.756 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.827 HD11 HD13 ' A' ' 119' ' ' LEU . 5.1 mp -107.61 115.75 30.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.294 -0.632 . . . . 2.27 109.294 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.437 HG23 ' HB2' ' A' ' 65' ' ' SER . 54.9 m -96.34 129.33 43.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.657 0.614 . . . . 2.84 112.657 -178.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -95.56 128.11 42.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.391 -0.822 . . . . 2.89 109.806 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.29 79.79 1.57 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.804 -0.443 . . . . 3.82 109.804 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.44 -167.54 39.13 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.652 -0.785 . . . . 3.23 111.991 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -81.58 -25.93 35.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.954 0.407 . . . . 4.27 111.681 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -81.35 173.1 12.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 3.32 109.771 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 -70.47 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.122 -0.696 . . . . 2.39 109.122 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD11 ' CE2' ' A' ' 26' ' ' PHE . 25.5 tp 178.61 127.91 0.06 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.603 -0.726 . . . . 2.06 111.133 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -159.59 107.43 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 2.22 110.24 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.405 ' CE2' HD11 ' A' ' 24' ' ' LEU . 27.3 m-85 -98.11 148.32 34.32 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.049 -0.523 . . . . 1.78 109.737 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.98 162.09 41.88 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.337 2.024 . . . . 2.15 111.251 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -62.22 135.88 57.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 2.6 110.297 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 21.75 58.85 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.549 -0.834 . . . . 1.65 111.748 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -156.81 172.18 19.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.067 -0.345 . . . . 2.31 110.067 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.56 56.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.784 -0.722 . . . . 1.33 112.345 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 43' ' ' GLN . 20.3 t -82.24 119.07 74.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 110.13 -0.322 . . . . 1.06 110.13 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.88 -179.14 5.16 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.299 . . . . 1.27 111.657 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -77.62 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 1.7 110.786 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.57 83.35 8.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.538 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.86 21.79 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.237 0.458 . . . . 1.94 112.237 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -124.44 -17.36 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.586 0.231 . . . . 1.96 111.457 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.523 ' HB3' HG21 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -118.6 168.6 10.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.84 0.352 . . . . 1.42 111.918 -178.382 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.626 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.8 m -86.86 166.3 27.56 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 1.73 110.687 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.4 Cg_endo -53.4 -39.84 80.34 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.268 2.645 . . . . 1.42 113.205 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.54 -13.93 61.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.077 0.465 . . . . 1.78 111.163 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -93.84 -1.63 54.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.614 . . . . 1.6 110.479 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.448 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 37.5 mm-40 -78.38 54.63 1.45 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.08 0.466 . . . . 1.05 111.108 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.754 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.8 tt -147.26 133.92 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.079 -0.51 . . . . 1.17 109.893 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.42 -144.4 4.99 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.432 -0.889 . . . . 0.6 112.477 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -156.15 164.43 38.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 0.99 110.935 -179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.49 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 34.7 m-85 -107.67 130.79 54.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.055 -0.721 . . . . 1.26 109.055 178.393 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HG3' HD11 ' A' ' 90' ' ' ILE . 22.3 ttt180 -110.09 135.39 50.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.089 0.243 . . . . 2.15 110.922 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -87.18 123.25 32.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.799 -0.445 . . . . 2.4 109.799 178.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.448 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -128.54 154.47 46.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.243 0.544 . . . . 2.21 111.399 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -154.26 111.4 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.483 -0.781 . . . . 2.68 109.828 179.241 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HB3' HD12 ' A' ' 64' ' ' LEU . 20.5 tpt180 -93.27 127.29 38.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.153 0.501 . . . . 3.59 110.917 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -128.59 141.13 51.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.478 -0.783 . . . . 3.43 109.922 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.755 HG12 ' H ' ' A' ' 62' ' ' LYS . 34.8 pt -92.83 175.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.203 -0.666 . . . . 4.26 109.203 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.4 92.57 3.75 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.256 -0.275 . . . . 5.17 110.256 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -140.11 113.11 0.86 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.924 -0.655 . . . . 4.66 111.682 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.02 5.91 78.9 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.966 -0.635 . . . . 5.04 112.485 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.79 -3.82 54.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.859 0.361 . . . . 5.51 110.452 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' HA3' ' OP2' ' C' ' 14' ' ' ' G' . . . -167.63 -134.79 1.76 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.81 -0.709 . . . . 4.73 112.277 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -108.29 143.85 36.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.83 0.347 . . . . 5.52 110.607 -179.404 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 mmt -77.71 151.26 34.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.46 -0.941 . . . . 4.48 108.46 178.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.755 ' H ' HG12 ' A' ' 54' ' ' ILE . 53.5 tttt -49.94 -43.57 49.98 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.189 0.306 . . . . 4.16 110.615 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 43.95 71.56 0.24 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.432 -0.804 . . . . 4.09 112.748 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.613 HD12 ' HB3' ' A' ' 52' ' ' ARG . 98.2 mt -67.04 145.35 55.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.002 -0.545 . . . . 3.36 110.363 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.437 ' HB2' HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -68.52 162.58 61.21 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.747 -0.464 . . . . 3.36 109.747 179.517 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.93 102.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.655 2.236 . . . . 2.69 111.858 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.418 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 3.1 mtp180 -108.74 122.69 47.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 3.03 110.893 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.49 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.0 m95 -98.27 145.17 26.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.84 110.042 179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.692 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 81.1 m-85 -128.01 137.98 52.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.762 -0.459 . . . . 2.76 109.762 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -88.49 128.98 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 1.27 111.444 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -128.13 150.57 49.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.806 -0.634 . . . . 1.84 109.686 178.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -84.53 156.78 21.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.941 0.401 . . . . 1.28 111.008 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.642 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.6 tt -64.0 115.01 4.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.408 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 113.46 1.17 24.76 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.731 -0.747 . . . . 1.66 113.769 179.033 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.8 p -58.47 110.18 0.93 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.192 0.496 . . . . 1.58 110.885 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 104.26 111.59 3.61 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.302 -0.719 . . . . 1.96 111.302 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.438 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 31.0 Cg_endo -63.21 -18.11 63.31 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.707 2.271 . . . . 2.62 112.134 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -119.54 24.15 10.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.456 -0.338 . . . . 3.09 111.45 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.95 -48.84 15.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 1.79 110.51 179.572 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.36 49.45 74.02 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.885 -0.598 . . . . 1.65 111.821 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.422 HD21 ' HD2' ' A' ' 87' ' ' LYS . 87.8 mt -119.72 100.06 49.17 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.866 0.365 . . . . 1.38 111.619 -179.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.22 153.28 14.16 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.464 2.11 . . . . 1.62 111.206 178.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.3 t80 -58.61 115.14 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 1.58 110.781 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.13 10.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.815 -0.707 . . . . 1.44 112.195 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.56 107.38 3.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 1.25 110.344 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.77 104.75 5.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.963 -0.562 . . . . 1.86 110.506 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.512 ' HB3' HG13 ' A' ' 90' ' ' ILE . 67.7 tttt -112.22 160.6 17.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.949 -0.569 . . . . 1.68 110.093 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.04 112.2 2.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.465 . . . . 1.7 111.298 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.33 32.17 65.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.923 -0.656 . . . . 1.27 112.327 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.512 HG13 ' HB3' ' A' ' 87' ' ' LYS . 36.6 mm -130.06 112.7 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.629 0.252 . . . . 1.01 110.601 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.434 HG13 ' HB2' ' A' ' 47' ' ' TYR . 7.0 pt -118.46 123.84 72.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.864 0.364 . . . . 1.3 110.428 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.637 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 89.7 m95 -82.61 137.95 34.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.069 -0.514 . . . . 1.08 111.769 -179.106 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.83 135.73 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 1.04 110.58 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.26 170.87 15.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 1.27 110.584 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -150.19 179.23 8.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.414 -0.587 . . . . 1.36 109.414 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -66.05 132.07 47.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.65 0.262 . . . . 2.64 110.382 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.66 32.88 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.854 -0.689 . . . . 1.52 111.53 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.754 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.18 134.3 36.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.117 -0.327 . . . . 1.59 110.117 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.92 149.05 26.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.387 -0.37 . . . . 2.15 110.634 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.73 74.03 5.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.521 0.677 . . . . 2.07 110.409 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -138.51 130.05 15.6 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.496 -0.774 . . . . 2.36 110.323 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.6 122.37 5.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.32 2.013 . . . . 2.08 111.466 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.745 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -146.07 106.29 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.103 -0.499 . . . . 1.78 111.402 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 5.0 p-10 -89.18 8.06 32.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.56 . . . . 2.55 112.164 -178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.745 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 6.4 p80 -56.73 -28.66 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.212 0.529 . . . . 2.24 111.594 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.523 HG21 ' HB3' ' A' ' 38' ' ' SER . 1.0 OUTLIER -99.13 5.42 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 2.0 110.913 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.95 -21.62 22.75 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.778 -0.725 . . . . 2.33 112.248 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.6 t -74.97 105.62 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.492 0.663 . . . . 2.99 111.261 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -149.75 125.49 10.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.668 -0.696 . . . . 2.83 109.742 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.7 m-80 -84.74 114.28 54.49 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.894 0.378 . . . . 3.56 110.341 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.511 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 28.4 Cg_endo -60.67 -34.6 91.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.181 2.588 . . . . 3.39 113.449 -178.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.608 ' HB1' " H2'" ' B' ' 7' ' ' ' C' . . . -91.35 15.68 11.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.151 0.426 . . . . 4.05 112.151 -179.174 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.48 -20.64 1.59 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.893 0.377 . . . . 4.48 111.664 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -131.78 137.4 48.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.694 0.283 . . . . 3.39 110.365 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.21 146.74 28.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.253 -0.431 . . . . 3.21 110.969 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.33 157.61 32.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.407 0.622 . . . . 2.85 111.904 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 62.4 mt -102.21 137.59 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.417 -0.81 . . . . 2.42 109.765 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.42 121.4 13.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.12 -0.696 . . . . 2.74 109.12 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 16' ' ' LEU . 3.9 tt -63.44 117.9 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 2.11 111.549 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -126.75 141.58 51.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.443 -0.799 . . . . 2.49 109.816 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 79.9 mt -105.62 145.04 30.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.258 -0.428 . . . . 1.91 110.344 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.56 150.84 79.49 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.702 2.268 . . . . 1.84 111.557 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.67 98.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 2.53 110.888 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 143.94 -30.74 1.9 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.96 -0.638 . . . . 2.2 111.574 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 24.1 m -84.44 115.04 22.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.69 0.281 . . . . 2.1 110.369 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 137.17 37.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.272 -0.422 . . . . 2.78 110.904 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.496 HD22 ' HD2' ' A' ' 131' ' ' PHE . 20.2 mt -74.97 149.02 85.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 2.62 110.875 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.35 161.75 19.32 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.817 2.345 . . . . 2.77 112.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.85 119.26 10.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.836 -0.62 . . . . 4.11 111.597 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.55 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.137 -0.554 . . . . 3.18 112.923 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.496 ' HD2' HD22 ' A' ' 127' ' ' LEU . 18.4 t80 -106.25 126.98 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.728 0.299 . . . . 2.91 110.464 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.78 164.02 34.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.033 -0.53 . . . . 3.54 110.635 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' LEU . . . -110.48 156.36 20.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.509 -0.314 . . . . 2.93 110.802 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.63 132.54 42.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.89 -0.595 . . . . 3.64 110.773 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.48 -45.15 1.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.097 -0.573 . . . . 3.27 112.936 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.97 132.52 45.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 3.59 110.588 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -110.3 -164.9 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.642 -0.253 . . . . 5.55 110.831 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.72 110.61 3.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.962 -0.637 . . . . 5.22 112.397 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.86 -67.91 3.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.126 -0.559 . . . . 5.91 112.61 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.76 -0.638 . . . . 7.27 111.281 -179.954 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.47 ' H5 ' HD23 ' A' ' 64' ' ' LEU . . . . . . . . 0 C2'--C1' 1.493 -3.503 1 C4'-C3'-C2' 97.092 -5.608 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.529 2 N19-C1'-C2' 103.502 -6.187 . 0.23 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 025 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.743 3 O4'-C1'-N19 115.73 7.53 . 0.526 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 025 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.217 4 O4'-C1'-N19 116.658 8.458 . 0.507 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 025 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.056 2 C4'-C3'-C2' 97.535 -5.165 . 0.652 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 025 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.604 4 C4'-C3'-C2' 98.271 -4.429 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 025 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.608 " H2'" ' HB1' ' A' ' 112' ' ' ALA . . . . . . . . 2 O3'--C3' 1.497 5.298 3 P-O3'-C3' 127.041 6.117 . 0.01 1a . 18.24 . . . . . . . . . . 3 2 . 1 . 025 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.692 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.581 5.289 3 O4'-C4'-C3' 114.931 6.736 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 025 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.122 2 O4'-C1'-N19 118.707 10.507 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 025 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.486 3 O3'-P-O5' 116.326 6.487 . 0.458 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 025 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.171 1 C4'-C3'-C2' 98.252 -4.448 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 025 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.57 1 C4'-C3'-C2' 94.388 -8.312 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 025 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.526 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.588 5.803 1 O3'-P-O5' 111.743 4.075 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 025 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . 0.536 ' OP2' ' HA3' ' A' ' 59' ' ' GLY . . . . . . . . 2 C2'--C1' 1.578 4.95 2 C3'-C2'-C1' 105.655 4.617 . 0.337 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.882 -0.487 . . . . 9.05 111.882 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.51 107.9 17.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.937 0.399 . . . . 8.09 110.35 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.2 tpt -84.45 111.29 19.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.852 -0.613 . . . . 8.02 111.158 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.69 107.7 3.44 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.262 -0.735 . . . . 5.76 111.262 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.6 tp -147.43 112.27 4.02 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.207 -0.294 . . . . 4.72 110.207 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.63 69.33 7.8 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.614 2.209 . . . . 4.45 112.179 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -155.1 154.63 32.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 4.41 110.897 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -122.11 -47.31 2.16 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.299 -0.41 . . . . 3.92 110.668 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.92 76.62 0.33 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.601 -0.727 . . . . 2.53 111.148 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.39 138.59 39.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.115 -0.493 . . . . 2.48 111.055 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -85.29 155.05 21.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.109 -0.496 . . . . 2.13 110.373 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.63 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 23.2 m95 -78.77 -28.29 44.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.442 . . . . 2.4 111.191 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.586 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 29.0 m-85 -99.33 173.81 6.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.737 -0.665 . . . . 2.02 110.957 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -78.8 -142.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.675 -0.693 . . . . 2.65 110.353 179.587 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' H ' ' HB ' ' A' ' 14' ' ' THR . . . -131.74 146.59 52.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.963 0.411 . . . . 2.4 111.566 -179.489 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.669 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.6 mt -96.99 120.02 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 2.27 109.112 178.722 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -92.97 122.99 35.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.433 -0.349 . . . . 2.84 111.249 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.3 tp-100 -101.22 145.02 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 2.89 110.067 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -140.58 89.47 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.384 -0.599 . . . . 3.82 109.384 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.38 -167.42 40.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.535 -0.84 . . . . 3.23 112.497 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -81.66 -36.47 28.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 4.27 110.605 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -75.59 154.68 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.47 -0.786 . . . . 3.32 110.671 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.02 -89.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.218 -0.446 . . . . 2.39 110.549 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.599 HD13 ' CE1' ' A' ' 131' ' ' PHE . 29.3 tp -168.71 134.61 1.76 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.985 0.421 . . . . 2.06 111.837 179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -163.42 120.18 1.8 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.765 -0.652 . . . . 2.22 110.221 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -106.09 137.17 19.3 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.026 -0.534 . . . . 1.78 110.156 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.7 163.53 30.05 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.547 2.165 . . . . 2.15 111.908 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -63.64 103.19 0.52 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.159 0.504 . . . . 2.6 110.967 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.09 -9.19 8.46 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.794 -0.639 . . . . 1.65 111.873 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -120.43 163.07 18.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.765 0.317 . . . . 2.31 110.368 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -6.7 28.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.902 -0.666 . . . . 1.33 112.421 179.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 t -88.72 117.39 68.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.762 0.315 . . . . 1.06 110.307 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.04 -169.04 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.902 2.401 . . . . 1.27 111.718 -179.75 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.437 ' O ' ' HZ ' ' A' ' 13' ' ' PHE . 18.1 mt -82.58 77.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.08 0.467 . . . . 1.7 109.817 179.319 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.524 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 78.6 m-20 -78.4 78.06 4.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.58 . . . . 1.23 110.823 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.94 -1.55 26.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.113 -0.494 . . . . 1.94 111.238 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.21 2.67 22.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.96 110.652 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.89 155.16 46.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 1.42 111.284 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 19.8 m -86.61 169.08 15.98 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.929 -0.578 . . . . 1.73 110.318 179.432 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 88.0 Cg_exo -47.62 -40.24 30.36 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.484 2.789 . . . . 1.42 114.252 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -17.44 44.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.732 0.301 . . . . 1.78 111.609 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.856 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -89.14 8.67 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 1.6 110.788 -179.628 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.524 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 85.1 mm-40 -80.76 0.57 34.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 1.05 112.104 -179.162 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.902 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.2 tt -89.51 126.62 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.975 0.417 . . . . 1.17 111.086 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.61 -152.2 6.28 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.345 -0.931 . . . . 0.6 112.919 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.444 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 44.0 p90 -163.19 170.9 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.917 0.389 . . . . 0.99 110.547 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.608 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 4.5 m-85 -111.46 138.22 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.213 -0.449 . . . . 1.26 110.422 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -117.94 127.44 53.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 2.15 110.819 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -79.01 126.92 31.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 2.4 109.95 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.01 151.82 42.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.005 0.431 . . . . 2.21 111.88 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 m -143.51 132.42 22.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 2.68 109.819 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HB3' HD12 ' A' ' 64' ' ' LEU . 2.2 tpt180 -106.91 138.04 43.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.093 -0.336 . . . . 3.59 110.093 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -147.43 128.03 14.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.83 0.348 . . . . 3.43 111.851 -178.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.63 HG12 ' HB2' ' A' ' 62' ' ' LYS . 41.3 pt -81.41 151.67 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.802 -0.814 . . . . 4.26 108.802 178.389 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -118.92 93.04 3.96 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.554 -0.458 . . . . 5.17 111.74 -179.412 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.91 148.7 26.02 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.506 -0.854 . . . . 4.66 111.519 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.64 -29.88 76.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.087 -0.578 . . . . 5.04 112.482 -179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.88 -0.86 36.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.28 0.562 . . . . 5.51 111.001 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.93 11.26 63.67 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.661 -0.78 . . . . 4.73 111.416 -179.6 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -70.14 129.16 38.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.59 -0.305 . . . . 5.52 110.499 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 mmt -124.25 127.18 47.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.066 -0.516 . . . . 4.48 110.909 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.63 ' HB2' HG12 ' A' ' 54' ' ' ILE . 75.9 tttt -66.84 -35.71 80.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.028 -0.73 . . . . 4.16 109.028 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 50.12 82.86 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.748 -1.114 . . . . 4.09 113.047 179.071 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 52' ' ' ARG . 9.0 mt -82.57 168.13 17.65 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.944 -0.571 . . . . 3.36 110.507 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -90.5 155.04 46.39 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.028 -0.533 . . . . 3.36 110.441 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.72 116.22 2.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.809 2.339 . . . . 2.69 111.757 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 29.3 mtt180 -115.79 119.03 34.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 3.03 111.265 -179.2 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.608 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 53.7 m95 -93.78 124.03 37.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 1.84 110.401 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -102.89 138.92 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.222 -0.444 . . . . 2.76 110.201 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -90.35 124.79 35.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.084 0.469 . . . . 1.27 111.344 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.0 167.75 12.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 1.84 109.894 179.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -108.02 151.58 25.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.688 -0.233 . . . . 1.28 110.43 -179.253 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.32 110.94 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.4 -0.364 . . . . 1.66 110.465 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.96 -15.55 6.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.763 -0.732 . . . . 1.66 112.357 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.71 HG22 ' HA3' ' A' ' 107' ' ' GLY . 9.5 p -59.13 125.77 24.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.571 0.224 . . . . 1.58 111.006 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.02 110.47 3.3 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.795 -0.717 . . . . 1.96 111.587 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.93 -37.0 97.8 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.006 2.47 . . . . 2.62 112.948 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -117.46 34.35 5.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 3.09 110.491 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.38 -52.23 29.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.79 110.379 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.34 46.47 93.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.977 -0.63 . . . . 1.65 111.693 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.1 mt -120.06 97.73 49.28 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.55 0.204 . . . . 1.38 111.55 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.22 147.43 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.896 2.398 . . . . 1.62 110.65 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 44.5 t80 -58.54 104.83 0.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 1.58 111.142 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.35 -16.69 5.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.852 -0.689 . . . . 1.44 111.878 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.48 20.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 1.25 110.753 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -80.93 119.34 23.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.007 -0.542 . . . . 1.86 110.75 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.531 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 9.1 ttmt -135.25 149.69 49.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.069 -0.514 . . . . 1.68 109.832 179.196 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.96 110.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.326 0.584 . . . . 1.7 112.123 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.68 64.76 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.697 -0.683 . . . . 1.27 112.964 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 38.1 mm -128.05 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 1.01 110.641 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 47' ' ' TYR . 13.2 pt -117.62 133.48 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.112 -0.494 . . . . 1.3 109.765 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.55 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 73.6 m95 -89.04 140.07 29.82 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.385 . . . . 1.08 112.038 -178.373 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 m -136.32 131.06 48.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.741 -0.663 . . . . 1.04 110.884 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.12 169.47 20.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.138 -0.483 . . . . 1.27 110.89 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -148.4 -169.99 3.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.535 -0.543 . . . . 1.36 109.535 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.91 136.84 57.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.875 0.369 . . . . 2.64 110.827 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.94 -25.15 27.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.148 -0.549 . . . . 1.52 112.404 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.902 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.45 136.24 45.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.813 0.339 . . . . 1.59 110.452 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.96 140.55 38.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.117 -0.492 . . . . 2.15 110.72 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -76.79 78.29 3.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.77 -0.455 . . . . 2.07 109.77 179.278 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.524 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 81.6 m -150.31 128.94 6.06 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.971 -0.752 . . . . 2.36 108.971 -179.394 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.71 124.54 12.49 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.602 2.201 . . . . 2.08 111.834 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.856 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.21 95.83 4.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 1.78 110.954 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.12 -5.91 58.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 2.55 112.427 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 14.8 p80 -61.44 -21.07 63.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.477 0.547 . . . . 2.24 112.477 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.666 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -102.02 12.26 7.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 2.0 111.363 -179.79 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.71 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -124.89 38.29 2.37 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.653 -0.784 . . . . 2.33 111.4 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -131.74 33.46 3.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.597 0.713 . . . . 2.99 110.658 -179.152 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HD3' ' HA ' ' A' ' 12' ' ' TRP . 54.0 ttp85 -72.99 137.63 45.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.895 -0.593 . . . . 2.83 111.258 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -98.43 107.68 43.48 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.17 -0.678 . . . . 3.56 109.17 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.47 ' CB ' " H1'" ' C' ' 8' ' ' ' G' . 57.4 Cg_endo -69.64 -14.24 36.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.876 2.384 . . . . 3.39 113.652 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.46 -25.03 27.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.663 0.268 . . . . 4.05 111.425 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -121.99 29.86 6.88 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.543 -0.299 . . . . 4.48 111.56 -179.484 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.433 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 9.7 t-20 -174.03 140.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 3.39 110.857 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.28 142.82 26.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.207 -0.451 . . . . 3.21 110.1 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.83 145.83 50.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.259 -0.428 . . . . 2.85 111.23 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.0 mt -78.53 139.54 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.118 -0.492 . . . . 2.42 109.889 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.98 122.14 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 2.74 110.183 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.586 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 1.2 tt -59.75 109.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 2.11 111.231 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.64 152.07 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.759 -0.655 . . . . 2.49 110.182 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 67.3 mt -108.65 153.09 42.42 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.128 -0.487 . . . . 1.91 110.228 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.32 172.21 8.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.13 . . . . 1.84 112.337 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.16 131.97 50.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 2.53 111.203 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.89 36.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.91 -0.662 . . . . 2.2 112.704 179.348 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 3.1 m -85.64 107.79 17.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.913 0.387 . . . . 2.1 110.134 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.52 143.25 26.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 2.78 111.825 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.8 143.61 50.59 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 2.62 109.943 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.16 146.69 95.95 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.57 2.18 . . . . 2.77 111.663 179.244 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -61.15 119.27 8.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 4.11 111.398 -179.331 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.89 -13.49 29.34 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.923 -0.656 . . . . 3.18 111.991 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.669 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -97.16 133.58 41.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.596 0.236 . . . . 2.91 110.742 179.647 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -144.65 144.55 31.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 3.54 110.269 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.55 150.56 26.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.83 0.348 . . . . 2.93 111.358 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.09 135.74 39.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.565 -0.531 . . . . 3.64 109.565 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.43 69.5 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 3.27 112.399 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t -69.1 115.62 8.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 3.59 110.141 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.441 ' HD3' ' OG ' ' A' ' 140' ' ' SER . 4.1 mmp_? -96.03 119.1 33.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.865 -0.607 . . . . 5.55 111.481 -179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.3 66.23 3.02 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.284 -0.726 . . . . 5.22 111.284 179.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.25 -71.63 0.39 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.728 -0.949 . . . . 5.91 110.728 -179.005 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.441 ' OG ' ' HD3' ' A' ' 137' ' ' ARG . 19.4 m . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.865 -0.588 . . . . 7.27 112.438 179.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.429 ' P ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 C2'--C1' 1.492 -3.607 1 C4'-C3'-C2' 97.038 -5.662 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.481 2 N19-C1'-C2' 103.578 -6.139 . 0.233 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 026 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.742 3 O4'-C1'-N19 115.83 7.63 . 0.53 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 026 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.233 4 O4'-C1'-N19 116.661 8.461 . 0.508 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 026 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.056 2 C4'-C3'-C2' 97.557 -5.143 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 026 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.732 5 C4'-C3'-C2' 98.246 -4.454 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 026 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 O3'--C3' 1.498 5.345 3 P-O3'-C3' 126.998 6.082 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 026 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.47 " H1'" ' CB ' ' A' ' 111' ' ' PRO . . . . . . . . 2 C2'--C1' 1.582 5.382 3 O4'-C4'-C3' 114.958 6.756 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 026 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.057 2 O4'-C1'-N19 118.652 10.452 . 0.415 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 026 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . 0.421 ' P ' HH21 ' A' ' 52' ' ' ARG . . . . . . . . 2 P--O5' 1.547 -4.578 3 O3'-P-O5' 116.301 6.474 . 0.459 1a . 13.77 . . . . . . . . . . 3 2 . 1 . 026 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.153 1 C4'-C3'-C2' 98.259 -4.441 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 026 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.534 1 C4'-C3'-C2' 94.366 -8.334 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 026 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.853 1 O3'-P-O5' 111.744 4.076 . 0.104 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 026 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . 0.504 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.578 4.967 2 C3'-C2'-C1' 105.749 4.721 . 0.335 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 111.743 -0.543 . . . . 9.05 111.743 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.81 143.14 57.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.977 0.418 . . . . 8.09 111.487 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.2 tpp -84.21 124.36 31.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.828 -0.624 . . . . 8.02 110.184 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.73 107.46 1.52 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.855 -0.688 . . . . 5.76 111.621 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 83.3 mt -100.77 117.76 62.0 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.804 0.335 . . . . 4.72 110.952 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 74.2 Cg_endo -93.62 65.82 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.207 2.605 . . . . 4.45 111.925 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -112.8 -78.41 0.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.456 -0.338 . . . . 4.41 111.332 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 t30 64.41 27.82 13.6 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.521 0.677 . . . . 3.92 110.665 -179.175 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.47 137.83 35.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.506 -0.77 . . . . 2.53 110.594 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.96 -178.59 5.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.103 -0.332 . . . . 2.48 110.103 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -109.18 130.24 55.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.639 -0.255 . . . . 2.13 110.492 179.586 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.59 -25.75 62.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 2.4 110.753 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 95.6 m-85 -118.34 168.37 10.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.777 -0.647 . . . . 2.02 110.874 -179.543 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 2.5 p -68.47 170.16 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 2.65 110.221 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 149.73 27.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.363 0.602 . . . . 2.4 112.008 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.817 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 12.1 mt -94.77 116.58 28.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 2.27 109.54 178.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.1 112.12 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.31 -0.405 . . . . 2.84 111.763 -179.355 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -91.82 135.13 34.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 2.89 111.01 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -137.48 83.23 1.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 3.82 109.472 178.378 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.35 -166.46 30.18 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.859 -0.686 . . . . 3.23 111.968 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.18 -19.43 28.44 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.352 . . . . 4.27 111.949 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -100.98 170.43 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.66 0.267 . . . . 3.32 110.671 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 t0 -92.43 -61.49 1.59 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.074 -0.343 . . . . 2.39 110.074 179.454 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD13 ' CE1' ' A' ' 131' ' ' PHE . 30.3 tp 169.76 137.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.742 0.651 . . . . 2.06 110.901 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -155.94 119.59 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 2.22 109.686 178.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 36.5 m-85 -101.34 144.67 29.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.297 -0.41 . . . . 1.78 111.127 -179.473 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 13.5 Cg_exo -71.34 177.67 6.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.274 2.649 . . . . 2.15 112.341 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -70.25 118.56 13.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 2.6 111.017 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.25 68.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.108 -0.568 . . . . 1.65 113.196 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.511 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -141.39 146.31 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.462 . . . . 2.31 109.754 179.92 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.68 -5.46 12.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.581 -0.818 . . . . 1.33 112.386 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.15 115.66 64.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.921 -0.399 . . . . 1.06 109.921 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HA ' HD23 ' A' ' 121' ' ' LEU . 58.2 Cg_endo -71.69 177.06 7.32 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.63 2.22 . . . . 1.27 112.383 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.2 mt -75.72 88.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 1.7 110.407 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.467 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 69.1 m-80 -80.47 82.85 6.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.23 110.263 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.46 26.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.659 -0.7 . . . . 1.94 112.182 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -137.13 -4.04 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.047 0.451 . . . . 1.96 110.328 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -126.47 148.37 49.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.022 -0.536 . . . . 1.42 111.363 -178.751 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.05 166.56 32.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.071 -0.513 . . . . 1.73 110.495 179.345 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.83 -35.25 78.71 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.861 2.374 . . . . 1.42 113.097 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 11.9 p-10 -85.68 -7.07 59.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.718 0.294 . . . . 1.78 111.281 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.39 10.2 40.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.519 . . . . 1.6 110.014 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -84.68 3.42 37.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 1.05 111.447 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.574 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.2 tt -85.5 124.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.068 0.461 . . . . 1.17 111.068 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 73' ' ' LEU . . . -159.77 -153.81 7.03 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.355 -0.926 . . . . 0.6 113.125 -179.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -161.84 173.09 15.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.805 0.336 . . . . 0.99 110.694 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.513 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 10.2 m-85 -116.96 140.88 48.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.949 -0.569 . . . . 1.26 110.281 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -121.63 139.1 53.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.605 -0.517 . . . . 2.15 109.605 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -84.67 133.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.121 0.486 . . . . 2.4 111.009 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.24 147.97 51.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.239 0.542 . . . . 2.21 111.016 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -138.04 128.13 25.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.609 -0.515 . . . . 2.68 109.609 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -113.47 123.67 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.961 -0.296 . . . . 3.59 110.962 -179.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -147.69 95.8 2.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.407 -0.36 . . . . 3.43 111.099 179.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.01 169.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.565 -0.532 . . . . 4.26 109.565 178.745 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -141.23 106.23 4.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.974 0.416 . . . . 5.17 111.366 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.506 ' HA3' ' P ' ' C' ' 13' ' ' ' U' . . . -73.6 -30.19 62.44 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.895 -0.669 . . . . 4.66 111.838 179.221 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.24 -67.16 0.48 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.439 -0.886 . . . . 5.04 113.151 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.02 57.71 2.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.161 0.505 . . . . 5.51 112.298 -178.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.38 14.58 49.17 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.906 -0.588 . . . . 4.73 113.751 179.246 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -86.06 120.33 27.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.755 -0.461 . . . . 5.52 109.755 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 59.2 mtt -139.29 132.09 29.15 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.133 -0.321 . . . . 4.48 110.133 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -60.09 -51.48 69.44 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.181 -0.303 . . . . 4.16 110.181 178.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.42 105.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.289 0.848 . . . . 4.09 113.289 178.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -108.53 140.5 41.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.997 -0.547 . . . . 3.36 110.635 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.82 159.88 9.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 3.36 110.897 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.1 108.9 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.037 2.492 . . . . 2.69 111.768 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -95.8 103.73 15.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.577 -0.738 . . . . 3.03 110.731 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.513 ' CE3' ' HB3' ' A' ' 47' ' ' TYR . 67.8 m95 -83.36 115.51 22.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 1.84 110.987 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -99.12 137.98 36.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.807 -0.633 . . . . 2.76 110.413 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -97.2 132.38 43.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 1.27 110.561 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.54 168.73 17.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 1.84 109.84 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -100.39 156.15 17.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 1.28 110.117 179.551 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 102' ' ' PRO . 14.5 tp -63.36 103.68 0.53 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.519 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 115.24 -2.38 22.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.282 -0.961 . . . . 1.66 113.787 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.567 HG22 ' HA3' ' A' ' 107' ' ' GLY . 5.8 p -59.04 114.0 2.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.118 0.459 . . . . 1.58 111.761 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 117.19 108.09 2.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.866 -0.683 . . . . 1.96 111.535 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 12.8 Cg_endo -57.34 -30.09 86.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.077 2.518 . . . . 2.62 112.789 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.77 42.74 2.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.145 0.498 . . . . 3.09 111.302 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.73 -55.08 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 1.79 110.568 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 42.89 79.11 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.937 -0.649 . . . . 1.65 112.373 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.9 mt -121.01 102.43 43.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.837 0.351 . . . . 1.38 111.701 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.711 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 1.3 Cg_endo -84.49 165.47 12.37 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.006 2.471 . . . . 1.62 110.635 178.639 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.73 112.96 2.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.933 0.397 . . . . 1.58 110.814 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.98 -12.88 14.45 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.979 -0.629 . . . . 1.44 112.608 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.711 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -56.23 116.53 3.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.049 0.452 . . . . 1.25 111.274 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -87.95 120.01 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 1.86 110.569 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 88' ' ' ASP . 29.5 mttt -134.63 -148.48 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.273 -0.421 . . . . 1.68 110.384 179.523 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 87' ' ' LYS . 16.3 t70 -108.05 103.29 12.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.004 0.431 . . . . 1.7 110.852 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.47 36.9 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.761 -0.733 . . . . 1.27 112.393 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mm -122.38 113.21 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.68 0.276 . . . . 1.01 110.319 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.0 122.58 67.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 1.3 110.176 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -88.01 145.83 25.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.133 -0.485 . . . . 1.08 111.87 -178.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.3 129.44 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 1.04 111.465 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.97 153.15 40.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.528 . . . . 1.27 110.403 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 t -132.13 -176.52 4.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.143 -0.48 . . . . 1.36 110.063 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.43 135.16 54.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.075 0.464 . . . . 2.64 110.67 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.95 58.58 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.906 -0.588 . . . . 1.52 112.165 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -78.86 144.36 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.847 0.356 . . . . 1.59 110.989 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -112.24 145.79 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.864 -0.607 . . . . 2.15 109.952 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -85.37 86.18 7.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.813 0.339 . . . . 2.07 110.826 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 m -157.24 137.29 8.77 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.67 -0.695 . . . . 2.36 109.215 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.7 Cg_endo -52.92 111.28 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.107 2.538 . . . . 2.08 112.439 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -101.83 47.04 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 1.78 109.802 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 3.9 p30 -70.25 -15.3 62.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.972 -0.558 . . . . 2.55 112.09 -179.016 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -57.44 -20.73 32.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.526 0.565 . . . . 2.24 112.526 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 pt -113.92 12.64 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.472 . . . . 2.0 110.85 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -86.98 -39.59 7.42 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.868 -0.682 . . . . 2.33 112.162 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 t -65.69 124.69 23.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.195 0.521 . . . . 2.99 111.237 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -158.33 132.6 8.04 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.411 -0.588 . . . . 2.83 109.411 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 38.3 t-20 -96.91 113.04 62.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.271 -0.27 . . . . 3.56 110.271 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 33.9 Cg_endo -64.61 -18.9 64.23 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.96 2.44 . . . . 3.39 112.711 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.45 0.97 57.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.035 0.445 . . . . 4.05 110.839 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -136.51 13.01 3.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 4.48 110.723 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -171.85 132.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 3.39 109.828 -179.142 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.98 153.53 20.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.777 0.322 . . . . 3.21 110.54 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.44 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -82.5 153.98 25.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.094 0.473 . . . . 2.85 111.122 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 17.9 mt -92.85 145.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.882 -0.599 . . . . 2.42 109.717 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.82 125.79 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.908 -0.404 . . . . 2.74 109.908 179.169 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.617 HD13 ' HG ' ' A' ' 16' ' ' LEU . 1.9 tt -58.46 113.87 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.264 0.554 . . . . 2.11 111.069 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -127.7 142.38 51.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.674 -0.693 . . . . 2.49 110.462 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' A' ' 127' ' ' LEU . 21.3 mt -103.63 148.37 35.67 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 1.91 110.013 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.98 155.94 57.55 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.535 2.157 . . . . 1.84 111.599 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -58.46 122.91 14.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 2.53 110.138 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.68 -11.28 42.12 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.212 -0.755 . . . . 2.2 111.212 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.437 HG22 HD13 ' A' ' 121' ' ' LEU . 4.7 m -104.18 105.89 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.638 -0.504 . . . . 2.1 109.638 179.432 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.35 159.36 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.886 -0.597 . . . . 2.78 111.823 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' A' ' 121' ' ' LEU . 15.8 mt -99.87 147.87 34.02 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 2.62 109.796 179.002 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.85 159.23 34.28 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.502 2.135 . . . . 2.77 111.666 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -73.36 134.78 44.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.917 0.389 . . . . 4.11 110.235 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.8 13.29 67.26 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.145 -0.782 . . . . 3.18 111.145 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.817 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -127.84 122.02 31.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.001 -0.37 . . . . 2.91 110.001 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -129.01 146.78 50.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 3.54 110.891 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -88.18 127.53 35.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 2.93 110.806 -179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 26.3 tt0 -58.88 129.88 44.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.971 -0.559 . . . . 3.64 110.521 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.13 -4.37 67.53 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.961 -0.638 . . . . 3.27 112.053 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m -108.97 159.02 17.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.275 -0.268 . . . . 3.59 110.275 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -126.38 -174.59 3.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.304 -0.407 . . . . 5.55 110.275 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -95.67 46.59 1.93 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.847 -0.692 . . . . 5.22 112.689 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 138.75 -47.88 0.9 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.726 -0.749 . . . . 5.91 112.336 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.981 -0.533 . . . . 7.27 111.243 -179.485 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.49 -3.75 1 C4'-C3'-C2' 96.968 -5.732 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.514 2 N19-C1'-C2' 103.517 -6.177 . 0.232 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 027 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.758 3 O4'-C1'-N19 115.703 7.503 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 027 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.144 4 O4'-C1'-N19 116.659 8.459 . 0.514 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 027 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.126 2 C4'-C3'-C2' 97.607 -5.093 . 0.651 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 027 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.759 4 C4'-C3'-C2' 98.289 -4.411 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 027 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.389 3 P-O3'-C3' 127.035 6.112 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 027 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.44 " H4'" ' HB3' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.404 3 O4'-C4'-C3' 114.937 6.741 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 027 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -4.973 2 O4'-C1'-N19 118.599 10.399 . 0.417 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 027 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.502 3 O3'-P-O5' 116.381 6.516 . 0.455 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 027 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.056 1 C4'-C3'-C2' 98.243 -4.457 . 0.307 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 027 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.545 1 C4'-C3'-C2' 94.321 -8.379 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 027 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . 0.506 ' P ' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.738 1 O3'-P-O5' 111.697 4.051 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 027 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.026 2 C3'-C2'-C1' 105.702 4.669 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 111.807 -0.517 . . . . 9.05 111.807 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.25 102.5 13.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.691 0.281 . . . . 8.09 110.578 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -87.81 101.06 13.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.328 -0.396 . . . . 8.02 110.915 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.15 131.91 1.85 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.944 -0.646 . . . . 5.76 111.982 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.3 mt -109.28 131.61 21.74 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.642 0.258 . . . . 4.72 110.742 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.11 44.49 1.56 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.919 2.413 . . . . 4.45 111.57 179.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -131.34 159.13 38.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.558 . . . . 4.41 109.868 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -85.01 -76.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.525 -0.307 . . . . 3.92 110.362 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 p 48.5 70.82 0.41 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.755 0.65 . . . . 2.53 112.755 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB2' ' HG3' ' A' ' 111' ' ' PRO . . . -84.71 143.77 28.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 2.48 110.396 179.576 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 p -78.53 151.28 32.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.303 -0.408 . . . . 2.13 111.1 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.583 ' HA ' HH11 ' A' ' 109' ' ' ARG . 92.9 m95 -81.02 -28.56 35.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 2.4 110.622 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 53.7 m-85 -103.54 159.21 15.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 2.02 111.403 -179.125 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.26 166.3 18.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.822 -0.627 . . . . 2.65 110.767 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.69 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -82.19 142.59 32.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.416 . . . . 2.4 111.443 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.522 HD13 ' HE2' ' A' ' 131' ' ' PHE . 28.7 mt -97.31 145.99 25.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.1 -0.704 . . . . 2.27 109.1 179.213 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.52 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -120.26 140.41 51.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 2.84 111.908 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -109.1 120.94 44.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 2.89 111.06 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.72 71.12 0.75 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.336 0.588 . . . . 3.82 109.645 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.43 -163.01 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.695 -0.764 . . . . 3.23 111.815 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -88.8 -39.66 13.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 4.27 111.0 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.31 171.12 15.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.746 -0.464 . . . . 3.32 109.746 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -98.75 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.817 -0.353 . . . . 2.39 111.727 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -151.4 140.5 21.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 2.06 111.648 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -171.42 100.13 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.324 -0.853 . . . . 2.22 109.046 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 59.9 m-85 -86.72 153.95 55.61 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.362 -0.381 . . . . 1.78 111.196 -179.597 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 3.0 Cg_exo -75.15 161.97 37.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.031 2.488 . . . . 2.15 111.717 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.22 131.72 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 2.6 110.543 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.5 74.68 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.218 -0.753 . . . . 1.65 111.218 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 11.5 tt0 -138.65 172.22 13.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.284 -0.636 . . . . 2.31 109.284 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' H ' ' HG2' ' A' ' 30' ' ' GLN . . . 101.99 -2.79 51.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.547 -0.835 . . . . 1.33 112.116 179.612 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.86 115.55 65.73 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.391 -0.596 . . . . 1.06 109.391 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.81 -173.39 1.8 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.0 2.467 . . . . 1.27 111.86 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.459 HG22 HG23 ' A' ' 36' ' ' THR . 63.4 mt -74.64 93.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.339 0.59 . . . . 1.7 110.154 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.439 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 51.9 m-20 -83.6 78.73 9.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.672 -0.694 . . . . 1.23 110.989 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -79.11 37.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.105 -0.498 . . . . 1.94 112.147 -179.389 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.73 -2.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.061 0.457 . . . . 1.96 111.443 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -122.14 150.17 42.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.338 -0.392 . . . . 1.42 111.336 -178.83 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.12 167.64 33.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 1.73 110.246 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -36.56 79.52 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.788 2.325 . . . . 1.42 113.011 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.731 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -78.56 -13.64 59.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.582 0.229 . . . . 1.78 111.396 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.903 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 25.5 m-20 -90.32 5.63 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 1.6 111.184 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -82.52 54.97 2.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.237 0.541 . . . . 1.05 111.232 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 94' ' ' ALA . 14.8 tt -151.29 132.83 5.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.632 -0.713 . . . . 1.17 110.236 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.9 -144.75 4.74 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.249 -0.976 . . . . 0.6 112.879 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -158.5 170.59 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.158 0.504 . . . . 0.99 110.735 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.735 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 29.8 m-85 -115.98 136.53 52.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.827 -0.624 . . . . 1.26 109.323 178.726 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -115.64 131.18 57.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 2.15 111.163 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -85.04 120.82 26.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.659 -0.701 . . . . 2.4 109.515 179.008 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.466 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -133.29 157.54 45.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.316 0.579 . . . . 2.21 111.932 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -146.98 114.37 6.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.758 -0.655 . . . . 2.68 110.759 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -78.52 119.23 21.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.996 0.427 . . . . 3.59 110.574 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -144.59 123.7 12.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 3.43 110.772 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.604 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -106.96 169.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 4.26 109.872 179.159 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.5 119.51 39.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.959 0.409 . . . . 5.17 110.687 179.759 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.19 155.24 19.53 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.961 -0.638 . . . . 4.66 111.884 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.0 -30.82 69.74 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.065 -0.588 . . . . 5.04 112.184 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -71.24 -55.89 7.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.429 0.633 . . . . 5.51 109.972 179.184 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.39 -40.76 1.2 Allowed Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 109.611 -1.396 . . . . 4.73 109.611 -178.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -86.2 116.37 24.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.415 -0.587 . . . . 5.52 109.415 178.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.19 179.05 4.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 4.48 110.966 -179.402 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.701 ' HA ' ' O6 ' ' C' ' 14' ' ' ' G' . 64.5 tttt -53.44 -55.9 21.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 4.16 110.497 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.42 99.32 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.277 0.843 . . . . 4.09 113.277 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 64' ' ' LEU . 11.1 mt -97.21 150.27 21.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 3.36 110.916 179.899 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.6 154.56 94.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.861 -0.609 . . . . 3.36 110.483 179.207 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.52 117.63 4.37 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.668 2.245 . . . . 2.69 111.017 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.69 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 48.0 mtt180 -119.35 140.01 51.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 3.03 111.402 -178.732 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.735 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 43.2 m95 -103.54 131.48 50.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 1.84 110.353 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.668 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 39.4 m-85 -111.09 139.21 46.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.719 -0.474 . . . . 2.76 109.719 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.19 130.55 35.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.688 0.28 . . . . 1.27 111.041 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.445 ' HD2' HG21 ' A' ' 75' ' ' THR . 41.5 m-85 -133.88 158.31 43.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.96 -0.564 . . . . 1.84 110.33 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -92.97 165.34 12.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.632 -0.258 . . . . 1.28 110.865 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.1 tt -57.78 118.99 5.88 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.309 0.381 . . . . 1.66 111.294 -179.513 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.44 53.98 8.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.062 -0.589 . . . . 1.66 112.966 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.445 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -86.55 48.11 1.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 1.58 111.11 -179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.44 137.02 4.23 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.093 -0.803 . . . . 1.96 111.093 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.39 -37.61 94.15 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.987 2.458 . . . . 2.62 112.482 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.09 35.95 4.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 3.09 110.574 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -49.78 49.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.79 110.823 -179.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.45 41.1 96.55 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.832 -0.622 . . . . 1.65 112.164 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.17 99.04 46.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.629 0.252 . . . . 1.38 111.426 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 89.2 Cg_endo -82.32 165.44 16.61 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 1.62 110.921 178.601 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.51 ' HB2' HD11 ' A' ' 73' ' ' LEU . 74.4 t80 -61.91 106.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 1.58 110.73 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.48 3.96 12.32 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.676 -0.773 . . . . 1.44 112.347 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.627 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -70.51 122.44 19.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 1.25 110.361 179.286 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -75.49 115.69 15.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.076 -0.511 . . . . 1.86 111.339 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 12.3 tttt -148.79 144.34 26.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 1.68 110.06 179.525 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.09 126.18 28.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.37 . . . . 1.7 111.055 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.58 77.25 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.032 -0.604 . . . . 1.27 112.219 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 29.5 mm -129.66 107.51 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.798 0.333 . . . . 1.01 110.216 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 91' ' ' ILE . 14.7 pt -112.89 128.48 69.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.432 . . . . 1.3 110.362 179.108 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -88.55 137.7 32.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.45 0.537 . . . . 1.08 112.45 -178.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -136.63 141.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.75 -0.659 . . . . 1.04 110.416 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -157.86 156.35 31.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 1.27 110.634 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 t -126.55 170.3 12.18 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.128 -0.487 . . . . 1.36 110.167 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.59 130.59 42.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.431 -0.35 . . . . 2.64 110.166 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.22 -10.44 28.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.836 -0.697 . . . . 1.52 111.784 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.731 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -94.2 146.39 24.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.43 -0.211 . . . . 1.59 110.43 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.3 mt -91.97 149.17 21.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 2.15 111.146 -179.228 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -87.73 76.66 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.2 0.524 . . . . 2.07 110.089 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 3.7 t -158.24 147.43 14.73 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.776 -0.647 . . . . 2.36 109.506 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 16.6 Cg_exo -69.82 140.12 41.7 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.494 2.129 . . . . 2.08 111.738 179.444 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.903 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -137.66 86.88 2.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.093 0.473 . . . . 1.78 110.708 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -5.8 53.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 2.55 112.319 -178.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.43 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 11.9 p80 -58.15 -25.94 62.09 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.132 0.419 . . . . 2.24 112.132 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.91 9.92 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.135 0.493 . . . . 2.0 110.799 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.33 -25.25 11.23 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.779 -0.646 . . . . 2.33 111.946 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -78.83 99.99 6.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 2.99 111.103 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.583 HH11 ' HA ' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -144.41 145.66 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 2.83 110.067 179.709 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 85.8 m-20 -100.89 130.73 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.301 -0.408 . . . . 3.56 110.153 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 110' ' ' ASN . 34.2 Cg_exo -61.91 -54.64 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.893 2.395 . . . . 3.39 112.905 -179.461 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.27 27.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 4.05 112.691 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.8 19.67 2.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.232 0.539 . . . . 4.48 110.364 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 109' ' ' ARG . 4.2 t-20 -170.59 163.47 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 3.39 109.641 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.66 173.86 6.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.818 0.342 . . . . 3.21 111.154 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 112.34 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.668 -0.493 . . . . 2.85 109.668 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 21.6 mt -77.18 129.74 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.245 -0.434 . . . . 2.42 110.252 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.03 120.94 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 2.74 110.372 179.303 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HB3' HD21 ' A' ' 16' ' ' LEU . 5.4 tt -68.39 105.4 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.916 -0.584 . . . . 2.11 109.996 -179.739 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -112.17 146.3 38.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.997 -0.547 . . . . 2.49 110.413 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.466 HD13 HG22 ' A' ' 125' ' ' THR . 51.1 mt -100.92 143.9 27.49 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.892 -0.594 . . . . 1.91 109.732 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.14 150.18 75.37 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.802 2.335 . . . . 1.84 111.91 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -51.05 119.91 4.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.684 -0.689 . . . . 2.53 111.58 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.7 -27.48 8.75 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.69 -0.964 . . . . 2.2 110.69 -179.344 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.466 HG22 HD13 ' A' ' 121' ' ' LEU . 9.9 m -102.13 116.58 32.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.723 -0.473 . . . . 2.1 109.723 179.666 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.49 163.08 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.419 -0.355 . . . . 2.78 110.763 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -85.41 144.88 41.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.343 -0.39 . . . . 2.62 110.137 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.46 151.75 66.51 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.816 2.344 . . . . 2.77 111.683 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.7 125.4 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.399 . . . . 4.11 111.121 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.42 -19.73 33.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.016 -0.612 . . . . 3.18 111.729 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.522 ' HE2' HD13 ' A' ' 16' ' ' LEU . 8.7 t80 -94.27 128.73 40.92 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.654 -0.498 . . . . 2.91 109.654 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.52 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 47.6 p90 -133.21 171.09 14.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.697 0.284 . . . . 3.54 111.058 -179.84 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.81 144.4 45.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.483 -0.326 . . . . 2.93 111.208 -179.476 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -74.45 143.05 44.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.245 -0.434 . . . . 3.64 110.08 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.34 82.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.414 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 m -70.6 122.31 19.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 3.59 110.603 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.421 ' HA ' ' HE ' ' A' ' 137' ' ' ARG . 1.4 mmp_? -110.61 131.95 54.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.149 -0.478 . . . . 5.55 110.006 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.14 59.28 3.88 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.923 -0.656 . . . . 5.22 112.425 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.63 -159.16 32.2 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.432 -0.667 . . . . 5.91 111.432 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.912 -0.566 . . . . 7.27 111.602 -179.871 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.599 ' H41' ' HG2' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.632 1 C4'-C3'-C2' 97.124 -5.576 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.513 2 N19-C1'-C2' 103.509 -6.182 . 0.227 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.766 3 O4'-C1'-N19 115.758 7.558 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.185 4 O4'-C1'-N19 116.662 8.462 . 0.51 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.373 -4.205 2 C4'-C3'-C2' 97.612 -5.088 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.659 4 C4'-C3'-C2' 98.248 -4.452 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 O3'--C3' 1.497 5.268 3 P-O3'-C3' 127.066 6.138 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.668 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.582 5.351 3 O4'-C4'-C3' 114.911 6.722 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 028 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.065 2 O4'-C1'-N19 118.656 10.456 . 0.414 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.549 -4.439 3 O4'-C1'-N19 114.758 6.558 . 0.466 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.105 1 C4'-C3'-C2' 98.248 -4.452 . 0.313 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.566 1 C4'-C3'-C2' 94.324 -8.376 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.861 1 O3'-P-O5' 111.743 4.075 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 028 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . 0.701 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.578 4.952 2 C3'-C2'-C1' 105.738 4.709 . 0.336 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.632 -0.587 . . . . 9.05 111.632 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.74 109.04 6.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 8.09 110.565 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.7 ptp -120.62 -5.55 9.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.259 -0.428 . . . . 8.02 111.231 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.2 116.15 0.67 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.904 -0.665 . . . . 5.76 112.084 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.57 137.83 22.87 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.91 -0.404 . . . . 4.72 109.91 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.83 31.43 0.38 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.884 2.389 . . . . 4.45 112.818 -179.542 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -98.7 159.01 15.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.507 -0.315 . . . . 4.41 110.621 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.43 -141.76 0.38 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.694 -0.484 . . . . 3.92 109.694 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.8 HG22 ' HA ' ' A' ' 108' ' ' THR . 76.1 p 53.81 81.28 0.1 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.029 0.752 . . . . 2.53 113.029 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . . . -74.94 146.71 41.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.386 -0.37 . . . . 2.48 110.018 179.568 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -62.25 143.6 56.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 2.13 110.642 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -68.92 -26.63 65.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 2.4 111.666 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.535 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 96.5 m-85 -111.08 167.73 10.04 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.14 0.422 . . . . 2.02 112.14 -179.233 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 p -69.08 170.32 10.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.647 -0.706 . . . . 2.65 111.332 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -90.14 133.27 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 2.4 111.291 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.565 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 mt -86.9 112.96 22.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.668 -0.493 . . . . 2.27 109.668 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 m -92.17 127.99 37.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.902 0.382 . . . . 2.84 111.203 -179.299 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.1 tp-100 -106.09 134.87 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 2.89 110.935 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.409 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 79.3 t60 -125.74 72.57 1.29 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.228 -0.656 . . . . 3.82 109.228 178.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.78 -169.23 26.99 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.964 -0.636 . . . . 3.23 112.067 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.68 -36.84 23.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.999 0.428 . . . . 4.27 110.844 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.09 172.2 13.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.796 -0.638 . . . . 3.32 110.712 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.477 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 1.2 t0 -103.84 -101.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.83 -0.433 . . . . 2.39 109.83 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.477 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 54.0 tp -156.74 133.6 10.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.798 0.332 . . . . 2.06 110.527 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.29 111.92 2.97 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.966 -0.561 . . . . 2.22 109.748 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.14 135.48 19.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.409 . . . . 1.78 110.563 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.423 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 39.3 Cg_endo -67.6 155.54 69.74 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.536 2.157 . . . . 2.15 111.963 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -57.88 125.85 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 2.6 110.769 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.53 -1.51 62.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.904 -0.665 . . . . 1.65 112.033 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 32.0 tt0 -137.09 155.15 49.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.204 -0.295 . . . . 2.31 110.204 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.05 -13.94 19.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.329 -0.938 . . . . 1.33 113.127 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.99 122.04 84.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.069 -0.345 . . . . 1.06 110.069 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.31 -179.13 5.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 1.27 111.661 -179.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.36 81.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.099 0.476 . . . . 1.7 110.821 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.86 97.87 4.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.382 -0.599 . . . . 1.23 109.382 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.33 -20.11 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.792 0.664 . . . . 1.94 112.792 -178.699 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -99.76 -29.54 12.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.422 0.527 . . . . 1.96 112.422 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.09 150.62 35.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.518 0.562 . . . . 1.42 112.518 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.58 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 2.0 m -74.42 166.92 40.77 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.681 -0.691 . . . . 1.73 110.895 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 17.5 Cg_endo -58.77 -39.75 79.0 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.814 2.343 . . . . 1.42 112.53 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -85.21 3.15 40.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 1.78 110.626 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.64 7.03 37.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.662 -0.699 . . . . 1.6 110.617 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -81.27 52.1 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 1.05 110.784 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.5 tt -144.87 134.91 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.92 -0.582 . . . . 1.17 110.17 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.14 -155.63 11.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.414 -0.898 . . . . 0.6 112.135 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -148.67 158.68 44.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.964 0.412 . . . . 0.99 111.151 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.755 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 13.2 m-85 -103.12 140.46 37.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.839 -0.8 . . . . 1.26 108.839 178.623 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -127.84 122.71 33.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.795 0.331 . . . . 2.15 110.965 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -77.81 128.37 33.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.858 -0.423 . . . . 2.4 109.858 179.373 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.04 156.21 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.108 0.48 . . . . 2.21 111.514 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.0 m -135.55 127.83 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.679 -0.691 . . . . 2.68 109.734 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.749 ' HB3' HD12 ' A' ' 64' ' ' LEU . 8.9 tpt180 -126.01 130.05 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.119 0.485 . . . . 3.59 111.702 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -143.87 -175.67 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.537 -0.756 . . . . 3.43 109.38 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.1 pt -126.72 161.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.544 -0.539 . . . . 4.26 109.544 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -106.03 69.15 0.8 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.334 0.588 . . . . 5.17 110.733 -179.912 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 60' ' ' LYS . . . -81.38 117.87 4.5 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.672 -0.775 . . . . 4.66 111.852 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.66 -25.3 63.24 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 121.374 -0.441 . . . . 5.04 112.531 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -82.74 -1.49 51.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.143 0.497 . . . . 5.51 110.511 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.91 26.6 12.42 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.062 -0.815 . . . . 4.73 111.062 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 75.2 mmtt -77.66 122.77 25.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.791 0.329 . . . . 5.52 111.005 -179.209 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt -127.12 113.58 16.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.053 -0.521 . . . . 4.48 111.127 -179.538 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -69.98 -42.98 72.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.078 -0.712 . . . . 4.16 109.078 178.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.72 82.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.939 -1.028 . . . . 4.09 113.451 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -74.6 160.55 30.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.872 0.368 . . . . 3.36 110.559 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 1.5 m -74.13 156.03 87.9 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.293 -0.412 . . . . 3.36 110.127 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.47 111.15 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.542 2.161 . . . . 2.69 111.357 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.609 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 10.1 mtp180 -116.7 131.63 56.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 3.03 111.579 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.755 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 35.8 m95 -105.67 124.32 49.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.684 -0.689 . . . . 1.84 109.99 179.053 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -102.81 151.22 22.67 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 2.76 109.71 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -102.98 126.45 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.913 0.387 . . . . 1.27 111.486 -179.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.46 150.21 48.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 1.84 110.067 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.87 165.39 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.506 -0.315 . . . . 1.28 111.463 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 44' ' ' ILE . 2.3 tt -54.48 113.48 1.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.445 0.905 . . . . 1.66 113.445 -178.21 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 63.4 47.9 83.39 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.508 -0.769 . . . . 1.66 114.065 178.331 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.455 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -72.98 86.36 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 1.58 111.444 179.58 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.63 131.0 2.53 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.019 -0.61 . . . . 1.96 111.68 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.23 -31.81 89.99 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.984 2.456 . . . . 2.62 112.558 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.93 30.69 4.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.849 0.357 . . . . 3.09 111.782 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.0 -70.57 0.41 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 1.79 110.582 179.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.97 34.38 55.84 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.829 -0.7 . . . . 1.65 111.546 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HD2' ' A' ' 87' ' ' LYS . 3.2 mt -123.4 95.17 45.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.727 0.298 . . . . 1.38 110.831 -179.649 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.77 158.13 43.26 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.591 2.194 . . . . 1.62 112.095 179.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -59.26 106.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 1.58 110.322 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.38 -17.8 5.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.819 -0.705 . . . . 1.44 112.408 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.3 138.3 51.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 1.25 110.492 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -100.04 144.86 28.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.458 -0.337 . . . . 1.86 111.026 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HD2' HD21 ' A' ' 81' ' ' LEU . 26.6 tttt -158.47 169.48 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 1.68 109.982 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.04 112.52 2.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.313 0.486 . . . . 1.7 112.313 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.3 39.62 91.94 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.841 -0.618 . . . . 1.27 112.389 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -128.88 113.71 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.073 0.464 . . . . 1.01 111.295 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.503 ' CG1' ' HB2' ' A' ' 47' ' ' TYR . 24.3 pt -122.54 139.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.369 -0.604 . . . . 1.3 109.369 178.423 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -96.44 137.88 34.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.877 0.37 . . . . 1.08 111.686 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -133.15 131.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.621 -0.718 . . . . 1.04 110.617 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -154.41 162.87 40.92 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.27 110.363 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -139.09 172.85 12.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 1.36 109.907 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.69 127.56 32.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.333 -0.394 . . . . 2.64 110.626 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.14 -20.5 26.01 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.908 -0.663 . . . . 1.52 111.618 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.771 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -82.68 135.27 35.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.894 0.378 . . . . 1.59 110.362 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.07 139.66 43.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 2.15 110.858 -179.806 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -72.6 107.02 4.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.489 . . . . 2.07 110.526 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.469 ' H ' HD13 ' A' ' 73' ' ' LEU . 1.9 t -174.57 150.22 1.41 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.959 -0.756 . . . . 2.36 108.959 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.452 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 10.5 Cg_endo -55.1 116.88 3.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.82 2.347 . . . . 2.08 112.231 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -114.76 34.29 4.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.852 -0.613 . . . . 1.78 110.383 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 8.7 p-10 -71.05 -3.68 20.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 2.55 112.175 -179.39 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -61.18 -21.16 63.55 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.437 0.532 . . . . 2.24 112.437 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.99 -16.54 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.265 0.555 . . . . 2.0 110.441 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.455 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -79.84 72.2 2.61 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.933 -0.576 . . . . 2.33 112.693 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.8 ' HA ' HG22 ' A' ' 9' ' ' THR . 14.9 t -160.65 36.07 0.16 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.787 0.803 . . . . 2.99 110.453 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -76.49 138.03 40.01 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.694 -0.684 . . . . 2.83 111.153 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -80.92 117.79 69.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 3.56 110.519 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.772 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 51.8 Cg_endo -70.88 -47.33 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.871 2.381 . . . . 3.39 114.219 -178.695 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.49 ' HA ' ' H21' ' C' ' 8' ' ' ' G' . . . -85.77 18.91 2.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.035 0.754 . . . . 4.05 113.035 -177.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -150.22 23.33 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.936 0.398 . . . . 4.48 111.589 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -174.51 136.02 0.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 3.39 109.986 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.2 154.66 19.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.662 0.268 . . . . 3.21 111.095 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.75 154.31 26.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.164 0.506 . . . . 2.85 111.234 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.2 mt -89.04 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.654 -0.703 . . . . 2.42 109.598 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.05 113.33 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.665 -0.495 . . . . 2.74 109.665 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 13' ' ' PHE . 7.5 tt -64.84 115.52 5.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 2.11 111.593 -178.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.0 148.71 50.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.652 -0.704 . . . . 2.49 109.399 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.12 157.37 34.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.343 -0.39 . . . . 1.91 110.695 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.32 148.49 92.83 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.538 2.158 . . . . 1.84 111.85 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -57.62 113.08 1.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.131 -0.486 . . . . 2.53 110.274 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 127.42 -24.15 5.32 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.194 -1.162 . . . . 2.2 110.194 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.7 m -91.94 109.75 21.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.127 0.489 . . . . 2.1 109.712 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 131.97 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 2.78 111.198 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.62 134.79 86.21 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.132 -0.485 . . . . 2.62 109.731 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.57 142.18 95.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.612 2.208 . . . . 2.77 111.468 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.83 124.25 21.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 4.11 110.621 -179.723 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.12 41.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.768 -0.73 . . . . 3.18 111.9 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -99.47 128.92 45.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.066 0.46 . . . . 2.91 111.416 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 33.1 p90 -145.98 139.13 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.627 -0.715 . . . . 3.54 109.738 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -107.45 148.15 29.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.631 0.253 . . . . 2.93 110.452 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.417 ' HB2' ' NH2' ' A' ' 67' ' ' ARG . 37.3 tt0 -67.77 125.9 27.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.384 -0.371 . . . . 3.64 110.232 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.2 -18.18 57.93 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.712 -0.756 . . . . 3.27 112.615 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 133' ' ' ALA . 14.7 m -75.13 95.26 3.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 3.59 110.806 179.621 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -93.13 123.84 36.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.074 -0.512 . . . . 5.55 110.141 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -94.84 100.35 2.56 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.831 -0.7 . . . . 5.22 111.892 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 99.31 -96.88 1.74 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.766 -0.731 . . . . 5.91 112.041 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.248 0.996 0 CA-C-O 119.108 -0.472 . . . . 7.27 111.331 -179.727 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.574 1 C4'-C3'-C2' 97.091 -5.609 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.473 4.607 2 N19-C1'-C2' 103.459 -6.213 . 0.233 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.726 3 O4'-C1'-N19 115.746 7.546 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.592 6.122 4 O4'-C1'-N19 116.641 8.441 . 0.514 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.141 2 C4'-C3'-C2' 97.567 -5.133 . 0.651 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.672 4 N19-C1'-C2' 106.341 -4.412 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.496 5.214 3 P-O3'-C3' 127.004 6.087 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . 0.49 ' H21' ' HA ' ' A' ' 112' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.315 3 O4'-C4'-C3' 114.958 6.756 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 029 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.935 2 O4'-C1'-N19 118.571 10.371 . 0.414 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.549 -4.443 3 O3'-P-O5' 116.298 6.473 . 0.458 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.191 1 C4'-C3'-C2' 98.267 -4.433 . 0.307 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.552 1 C4'-C3'-C2' 94.371 -8.329 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.731 1 O3'-P-O5' 111.75 4.079 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 029 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.934 2 C3'-C2'-C1' 105.7 4.666 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.491 -0.644 . . . . 9.05 111.491 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.42 133.98 45.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.768 0.318 . . . . 8.09 110.569 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.9 mtm -113.78 86.43 2.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.269 -0.423 . . . . 8.02 111.048 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.35 83.94 1.39 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.986 -0.626 . . . . 5.76 111.746 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.8 mt -77.99 139.52 61.49 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.535 0.207 . . . . 4.72 110.749 -179.438 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.28 -18.85 26.34 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.493 2.129 . . . . 4.45 111.72 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -82.21 125.53 31.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.834 -0.621 . . . . 4.41 110.478 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -99.75 -57.02 2.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.45 -0.341 . . . . 3.92 111.608 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.7 p 51.72 74.06 0.28 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.917 0.71 . . . . 2.53 112.917 -179.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.47 153.09 17.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.314 -0.403 . . . . 2.48 111.066 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.71 149.28 41.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.996 -0.547 . . . . 2.13 111.038 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 31.5 m95 -78.62 -30.63 46.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 2.4 111.254 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 76.7 m-85 -112.19 168.23 9.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.926 -0.579 . . . . 2.02 111.84 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 1.0 OUTLIER -70.1 175.02 4.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.817 -0.629 . . . . 2.65 111.362 179.644 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -91.87 148.33 22.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 2.4 111.058 -179.475 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD21 HD22 ' A' ' 119' ' ' LEU . 95.9 mt -84.22 119.21 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.847 -0.615 . . . . 2.27 109.653 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 107.28 14.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 2.84 110.523 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.829 ' HB3' ' HB2' ' A' ' 66' ' ' PRO . 5.8 tp-100 -85.9 133.93 33.92 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 2.89 111.286 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -129.96 10.05 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.951 -0.568 . . . . 3.82 110.428 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.4 -178.17 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.735 -0.745 . . . . 3.23 112.846 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -74.03 -38.08 64.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 4.27 111.468 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.94 166.78 23.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 3.32 111.412 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.78 -70.34 0.68 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.249 -0.648 . . . . 2.39 109.249 178.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.666 HD13 ' CE1' ' A' ' 131' ' ' PHE . 16.9 tp -177.58 134.28 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.747 -0.66 . . . . 2.06 110.614 178.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' H ' HD12 ' A' ' 24' ' ' LEU . 45.8 tptt -154.46 128.69 9.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 2.22 109.495 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 11.7 m-85 -123.56 144.78 45.16 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.466 . . . . 1.78 110.284 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 13.6 Cg_exo -69.58 161.77 44.59 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.814 2.343 . . . . 2.15 112.386 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.41 130.35 42.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.6 110.454 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.92 59.46 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.901 -0.666 . . . . 1.65 111.937 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -159.66 159.27 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.644 0.259 . . . . 2.31 110.328 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.67 -17.78 10.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.715 -0.755 . . . . 1.33 112.797 179.085 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.41 122.27 80.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.154 -0.313 . . . . 1.06 110.154 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 74.2 Cg_endo -76.71 -177.92 4.13 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.68 2.253 . . . . 1.27 112.047 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.21 98.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.594 -0.521 . . . . 1.7 109.594 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.446 ' HA ' ' HZ ' ' A' ' 13' ' ' PHE . 60.9 m-80 -89.48 83.41 6.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.087 0.47 . . . . 1.23 111.018 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.79 65.78 2.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.682 -0.69 . . . . 1.94 111.055 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -173.19 -28.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.258 -0.428 . . . . 1.96 111.255 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -105.59 167.16 9.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.31 -0.405 . . . . 1.42 111.827 -178.796 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.94 166.0 38.16 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 1.73 110.095 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.19 -37.47 94.24 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.894 2.396 . . . . 1.42 112.505 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.532 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.77 -20.36 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 1.78 110.75 179.804 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.946 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 27.1 m-20 -85.58 -0.72 55.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 1.6 110.777 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -78.62 55.47 1.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 1.05 111.637 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.614 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -149.72 130.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 1.17 109.82 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -144.45 4.33 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.311 -0.947 . . . . 0.6 112.631 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -157.2 161.89 39.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.853 0.359 . . . . 0.99 110.685 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.428 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 53.1 m-85 -103.27 131.82 50.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.054 -0.721 . . . . 1.26 109.054 178.367 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -110.75 125.35 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 2.15 110.965 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -72.15 130.85 41.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 2.4 109.775 178.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.14 155.14 51.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 2.21 110.753 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.69 160.08 42.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.046 -0.525 . . . . 2.68 110.538 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HB3' HD12 ' A' ' 64' ' ' LEU . 21.5 tpt180 -136.32 115.27 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 3.59 111.081 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -139.15 103.12 4.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.416 -0.356 . . . . 3.43 111.639 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 62' ' ' LYS . 22.2 pt -72.09 160.99 5.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.645 -0.502 . . . . 4.26 109.645 178.675 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -121.12 92.95 3.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 5.17 111.075 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.75 155.23 40.83 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 4.66 111.594 179.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.51 -38.56 96.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.249 -0.5 . . . . 5.04 112.288 -179.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.52 32.17 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.395 0.617 . . . . 5.51 110.834 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.76 21.71 71.34 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.935 -0.575 . . . . 4.73 112.267 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -76.62 145.75 38.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.675 0.274 . . . . 5.52 110.333 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt -141.88 139.24 32.55 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.204 -0.453 . . . . 4.48 110.286 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HB2' HG12 ' A' ' 54' ' ' ILE . 43.8 tptt -64.64 -57.88 7.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 4.16 109.586 179.356 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.64 83.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.507 -0.769 . . . . 4.09 112.354 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.42 HD21 ' HE3' ' A' ' 62' ' ' LYS . 37.2 mt -93.6 170.96 9.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.854 -0.612 . . . . 3.36 110.786 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -70.37 154.71 94.3 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 3.36 109.829 179.201 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.829 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 51.4 Cg_exo -55.28 123.62 14.26 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.559 2.173 . . . . 2.69 110.616 178.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 56.5 mtt-85 -120.27 144.16 47.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.563 0.579 . . . . 3.03 112.563 -178.052 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.428 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 53.4 m95 -128.11 124.71 37.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.68 -0.691 . . . . 1.84 109.699 178.717 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -103.6 145.95 29.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.047 -0.353 . . . . 2.76 110.047 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -96.48 129.43 43.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.812 0.339 . . . . 1.27 111.1 179.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -128.12 153.42 46.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 1.84 110.106 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -86.85 163.4 17.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.522 -0.308 . . . . 1.28 110.309 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.684 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 2.3 tt -62.69 121.93 14.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.297 -0.41 . . . . 1.66 110.513 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.82 29.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.918 -0.658 . . . . 1.66 113.762 178.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.21 90.11 4.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.338 0.569 . . . . 1.58 111.109 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.52 124.34 2.29 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.638 -0.791 . . . . 1.96 111.878 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.51 -21.61 39.83 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.701 2.267 . . . . 2.62 112.324 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -115.88 17.94 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.009 0.433 . . . . 3.09 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.65 -61.94 1.58 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 1.79 110.842 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.33 94.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.213 -0.518 . . . . 1.65 112.572 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.466 HD11 ' HE3' ' A' ' 87' ' ' LYS . 86.1 mt -118.13 104.76 47.95 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 120.676 0.274 . . . . 1.38 110.478 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.16 161.43 29.29 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.655 2.237 . . . . 1.62 111.344 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.515 ' HB2' HD11 ' A' ' 73' ' ' LEU . 92.2 t80 -54.21 119.34 4.99 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.488 -0.324 . . . . 1.58 110.464 179.598 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 111.38 -14.73 27.78 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.838 -0.696 . . . . 1.44 112.335 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.4 123.28 16.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.833 0.349 . . . . 1.25 110.845 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -90.74 131.45 36.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 1.86 111.278 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HE3' HD11 ' A' ' 81' ' ' LEU . 15.0 ttmm -150.93 154.99 38.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.992 -1.114 . . . . 1.68 107.992 179.075 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.5 115.41 3.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.04 0.448 . . . . 1.7 111.685 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.74 32.7 49.32 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.682 -0.69 . . . . 1.27 112.586 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.63 105.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.912 0.387 . . . . 1.01 110.995 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 91' ' ' ILE . 4.1 pt -117.31 130.23 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 1.3 109.72 178.66 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.684 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 86.3 m95 -86.23 145.42 26.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.714 0.635 . . . . 1.08 112.714 -178.508 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.47 133.84 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.218 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.6 166.53 24.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.365 -0.38 . . . . 1.27 111.102 -179.523 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -137.99 164.08 29.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.217 -0.66 . . . . 1.36 109.217 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.68 114.0 8.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.74 -0.467 . . . . 2.64 109.74 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.12 -18.15 6.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.538 -1.025 . . . . 1.52 110.538 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.25 142.45 34.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.516 -0.342 . . . . 1.59 110.084 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 97.0 mt -100.79 133.65 44.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.499 -0.319 . . . . 2.15 111.135 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -76.07 86.97 2.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.223 0.535 . . . . 2.07 109.873 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.554 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 6.3 t -161.98 144.34 8.73 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.609 -0.723 . . . . 2.36 109.125 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.93 126.94 17.48 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.159 1.906 . . . . 2.08 112.137 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.946 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -133.22 77.78 1.75 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.463 0.649 . . . . 1.78 111.22 179.584 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.15 -0.34 35.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.744 -0.662 . . . . 2.55 111.618 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.501 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.4 p80 -60.48 -19.85 58.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.075 0.464 . . . . 2.24 111.894 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.3 pt -114.12 14.21 8.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 2.0 110.296 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.74 69.28 0.29 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.71 -0.757 . . . . 2.33 112.067 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -165.04 27.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.33 0.586 . . . . 2.99 110.821 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 12' ' ' TRP . 59.5 ttp85 -65.33 128.05 34.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.057 -0.52 . . . . 2.83 110.291 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -75.87 117.58 64.85 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.311 -0.404 . . . . 3.56 110.213 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.56 ' HB2' " H5'" ' C' ' 9' ' ' ' U' . 73.4 Cg_endo -74.88 -21.55 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.691 2.261 . . . . 3.39 113.815 -178.367 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.14 -21.43 17.93 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.311 0.485 . . . . 4.05 112.311 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -113.7 19.32 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.032 0.382 . . . . 4.48 112.032 -178.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -163.68 139.52 6.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.421 -0.354 . . . . 3.39 110.412 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.96 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.051 -0.351 . . . . 3.21 110.051 179.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.14 161.19 31.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.209 0.528 . . . . 2.85 111.456 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.542 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 6.5 mt -100.04 155.15 4.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.099 -0.704 . . . . 2.42 109.099 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -74.69 127.36 36.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.182 -0.207 . . . . 2.74 110.445 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.673 HD22 HD21 ' A' ' 16' ' ' LEU . 4.6 tt -64.53 116.96 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 2.11 110.553 179.72 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -130.17 130.41 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.227 -0.442 . . . . 2.49 110.402 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.684 HD13 HG22 ' A' ' 125' ' ' THR . 72.9 mt -79.64 149.17 70.91 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.476 -0.329 . . . . 1.91 110.5 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 33' ' ' PRO . 54.4 Cg_endo -69.08 177.94 4.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.836 2.357 . . . . 1.84 112.974 -179.333 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -64.52 126.03 26.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.46 -0.791 . . . . 2.53 110.319 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.09 65.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.599 -0.81 . . . . 2.2 112.347 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.684 HG22 HD13 ' A' ' 121' ' ' LEU . 7.2 m -124.85 116.13 21.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.942 -0.392 . . . . 2.1 109.942 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.03 151.88 35.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 2.78 111.853 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.93 147.52 77.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 2.62 110.829 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.06 164.7 26.59 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.823 2.349 . . . . 2.77 112.359 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.39 120.5 12.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 4.11 111.728 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.41 55.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.975 -0.631 . . . . 3.18 112.913 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.666 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -114.2 130.95 56.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.761 0.315 . . . . 2.91 111.243 -179.294 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -142.17 152.63 43.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.439 . . . . 3.54 111.053 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.23 134.67 33.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.0 0.371 . . . . 2.93 112.0 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 25.7 tt0 -64.06 124.23 21.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.809 -0.632 . . . . 3.64 110.176 178.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.58 -9.46 64.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.995 -0.621 . . . . 3.27 112.651 -179.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.21 128.92 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.502 0.191 . . . . 3.59 110.548 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -126.27 110.79 13.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.266 -0.425 . . . . 5.55 110.618 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.29 126.67 13.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.811 -0.709 . . . . 5.22 112.182 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 134.69 -172.7 21.82 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.587 -0.605 . . . . 5.91 111.587 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 119.072 -0.49 . . . . 7.27 111.61 179.837 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.489 -3.853 1 C4'-C3'-C2' 97.018 -5.682 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.514 2 N19-C1'-C2' 103.471 -6.206 . 0.229 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 030 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.464 -5.581 2 O4'-C1'-N19 115.683 7.483 . 0.524 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.171 4 O4'-C1'-N19 116.685 8.485 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.062 2 C4'-C3'-C2' 97.652 -5.048 . 0.65 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.676 4 C4'-C3'-C2' 98.3 -4.4 . 0.946 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.267 3 P-O3'-C3' 127.067 6.139 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.448 3 O4'-C4'-C3' 114.916 6.726 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' C' C ' 9' ' ' ' U' . . . . . 0.56 " H5'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.543 -5.002 2 O4'-C1'-N19 118.619 10.419 . 0.419 1a . 14.39 . . . . . . . . . . 3 2 . 1 . 030 nuclear build full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.596 3 O3'-P-O5' 116.383 6.517 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.13 1 C4'-C3'-C2' 98.199 -4.501 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.638 1 C4'-C3'-C2' 94.325 -8.375 . 0.453 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.587 5.704 1 O3'-P-O5' 111.734 4.071 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 030 nuclear build full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.979 2 C3'-C2'-C1' 105.657 4.619 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.454 0 CA-C-O 120.832 0.349 . . . . 2.48 110.715 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -78.24 136.19 37.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 2.13 110.778 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -71.93 -15.5 62.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 2.4 111.634 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.69 172.27 8.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.952 -0.567 . . . . 2.02 109.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 p -75.55 -170.14 1.19 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.001 0.429 . . . . 2.65 110.709 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.58 -168.62 1.33 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.956 0.408 . . . . 2.4 110.885 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.731 HD21 HD22 ' A' ' 119' ' ' LEU . 77.3 mt -128.67 105.76 8.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.404 -0.591 . . . . 2.27 109.404 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.577 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -83.49 122.51 28.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.33 -0.396 . . . . 2.84 111.197 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.1 tp-100 -97.67 133.71 41.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.555 . . . . 2.89 111.182 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -128.22 76.32 1.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.237 -0.653 . . . . 3.82 109.237 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.41 -135.48 1.87 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.522 -0.847 . . . . 3.23 112.789 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -114.92 -38.88 3.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.092 0.472 . . . . 4.27 111.577 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -78.38 170.77 16.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.817 -0.629 . . . . 3.32 111.497 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.08 -92.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.17 -0.678 . . . . 2.39 109.17 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.499 HD13 ' CE1' ' A' ' 131' ' ' PHE . 39.8 tp -169.12 134.79 1.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.515 . . . . 2.06 109.975 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -153.37 113.4 3.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.199 -0.455 . . . . 2.22 110.166 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -100.86 145.68 30.79 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 1.78 110.066 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.65 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 51.1 Cg_endo -70.89 158.91 54.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.62 2.213 . . . . 2.15 111.608 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -62.77 113.98 3.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 2.6 110.923 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.12 -13.9 26.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.767 -0.73 . . . . 1.65 111.678 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.65 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 38.9 mt-30 -122.04 168.23 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 2.31 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.84 -10.19 29.79 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.335 -0.706 . . . . 1.33 111.335 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.403 HG11 ' HB3' ' A' ' 43' ' ' GLN . 22.2 t -94.58 115.01 64.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 1.06 109.629 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.12 -179.97 4.85 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.513 2.142 . . . . 1.27 112.159 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.25 83.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.197 -0.456 . . . . 1.7 110.364 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.425 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 63.0 m-80 -83.33 83.73 7.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.955 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -7.77 54.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.866 -0.607 . . . . 1.94 111.264 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -90.08 -22.49 21.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.344 -0.389 . . . . 1.96 111.742 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -110.97 168.68 9.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.145 0.498 . . . . 1.42 112.187 -178.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.05 167.15 22.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 1.73 110.089 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.4 -39.14 92.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 1.42 113.005 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -16.93 61.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.045 0.45 . . . . 1.78 110.815 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.773 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 41.8 m-20 -88.73 2.1 53.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 1.6 111.004 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.403 ' HB3' HG11 ' A' ' 32' ' ' VAL . 37.5 mm-40 -80.87 58.79 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.153 0.501 . . . . 1.05 111.674 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.9 tt -156.13 129.91 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.615 . . . . 1.17 109.991 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.91 -149.74 6.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.335 -0.936 . . . . 0.6 112.479 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.66 158.77 44.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.133 0.492 . . . . 0.99 111.019 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 14.8 m-85 -103.46 133.7 48.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.831 -0.622 . . . . 1.26 109.668 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.11 117.39 29.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 2.15 110.776 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -78.31 113.55 16.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.148 0.499 . . . . 2.4 110.978 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.74 159.55 24.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.082 -0.508 . . . . 2.21 110.793 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 148.93 45.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 2.68 110.137 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB3' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -121.86 93.41 3.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.075 0.464 . . . . 3.59 111.357 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.623 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 1.0 OUTLIER -121.43 104.03 9.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.223 -0.444 . . . . 3.43 110.662 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.33 125.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 4.26 110.791 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 5.17 110.076 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.4 mtt . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.515 0.198 . . . . 4.48 110.86 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -54.76 -44.78 73.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.785 -0.643 . . . . 4.16 110.358 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 36.1 t70 61.35 107.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.242 0.83 . . . . 4.09 113.242 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.597 HD12 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -123.89 143.32 50.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 3.36 110.3 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.577 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -61.04 143.66 91.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 3.36 111.391 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.27 126.27 19.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.955 2.437 . . . . 2.69 111.576 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -127.86 137.32 52.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.03 111.452 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.493 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 36.8 m95 -95.03 109.7 21.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.006 -0.543 . . . . 1.84 110.832 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -81.38 143.85 31.87 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.628 -0.508 . . . . 2.76 109.628 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -87.68 119.04 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.736 0.303 . . . . 1.27 111.032 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -120.61 139.35 53.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.735 -0.469 . . . . 1.84 109.735 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -79.69 159.06 26.82 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.312 -0.255 . . . . 1.28 110.312 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -61.15 123.24 17.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.666 0.27 . . . . 1.66 110.707 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 90.87 24.96 26.17 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.964 -0.636 . . . . 1.66 113.449 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.589 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -82.73 94.13 7.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.166 0.483 . . . . 1.58 110.811 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 137.22 122.02 2.08 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.954 -0.641 . . . . 1.96 111.696 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 18.9 Cg_endo -58.87 -29.38 89.99 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.248 2.632 . . . . 2.62 112.756 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.14 46.55 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 3.09 110.358 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 -48.9 16.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 1.79 110.345 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 36.93 86.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.744 -0.662 . . . . 1.65 112.599 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.92 97.99 47.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 1.38 111.635 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.688 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 3.9 Cg_exo -81.74 155.38 18.07 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.769 2.313 . . . . 1.62 110.19 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.622 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.0 t80 -53.81 115.25 1.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.839 0.352 . . . . 1.58 110.866 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.44 -17.17 16.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.726 -0.749 . . . . 1.44 112.575 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.688 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -58.06 127.54 32.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 1.25 111.273 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -91.71 114.51 27.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.025 -0.534 . . . . 1.86 111.026 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -137.29 153.8 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.476 -0.329 . . . . 1.68 110.547 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.64 121.27 12.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.982 -0.554 . . . . 1.7 111.028 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.9 76.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.584 -0.817 . . . . 1.27 112.205 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 26.1 mm -130.54 109.94 17.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.758 0.313 . . . . 1.01 110.839 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -121.34 137.84 53.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 1.3 109.3 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.538 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 85.7 m95 -93.44 143.81 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.22 0.533 . . . . 1.08 112.346 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.77 129.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.438 -0.801 . . . . 1.04 110.211 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.75 154.45 44.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.195 -0.457 . . . . 1.27 110.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.1 t -132.02 176.12 8.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.336 -0.393 . . . . 1.36 110.091 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.3 125.06 24.9 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.809 0.338 . . . . 2.64 111.127 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.31 -8.26 28.72 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.806 -0.634 . . . . 1.52 111.967 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.426 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -93.03 138.2 31.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.946 0.403 . . . . 1.59 111.186 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.63 155.93 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 2.15 110.747 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.5 96.76 8.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.032 0.444 . . . . 2.07 111.488 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 1.9 t -170.25 140.71 1.61 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.866 -0.606 . . . . 2.36 109.673 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 27.8 Cg_exo -64.36 136.98 53.57 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.728 2.285 . . . . 2.08 111.98 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.773 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -134.75 70.07 1.45 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.414 0.626 . . . . 1.78 110.842 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 7.5 p-10 -71.22 -1.3 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 2.55 112.397 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 9.8 p80 -61.92 -27.56 68.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 2.24 111.756 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.45 10.15 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 2.0 110.886 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -104.67 39.53 2.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 2.33 111.415 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -150.47 138.88 20.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.601 0.239 . . . . 2.99 110.658 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 109' ' ' ARG . 22.6 ttp180 179.59 147.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.688 -0.687 . . . . 2.83 109.25 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -82.02 109.74 16.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.24 -0.652 . . . . 3.56 109.24 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 -26.74 41.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.735 2.29 . . . . 3.39 113.004 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.89 23.0 6.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.971 0.415 . . . . 4.05 111.658 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -146.27 -36.22 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.457 . . . . 4.48 111.01 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -122.41 132.87 54.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.877 -0.786 . . . . 3.39 108.877 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.4 -175.06 5.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.464 -0.335 . . . . 3.21 111.551 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.83 155.63 29.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 2.85 110.602 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -90.84 147.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.86 -0.422 . . . . 2.42 109.86 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.84 121.98 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 2.74 110.25 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.731 HD22 HD21 ' A' ' 16' ' ' LEU . 4.6 tt -64.25 108.64 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.822 -0.626 . . . . 2.11 111.128 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -119.53 148.96 42.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.023 -0.535 . . . . 2.49 110.734 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.641 HD13 HG22 ' A' ' 125' ' ' THR . 16.0 mt -98.52 146.84 32.27 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.394 -0.367 . . . . 1.91 110.602 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.84 179.66 4.6 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.844 2.362 . . . . 1.84 112.581 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.67 138.96 58.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.739 -0.664 . . . . 2.53 111.002 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.02 80.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.956 -0.64 . . . . 2.2 112.108 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.641 HG22 HD13 ' A' ' 121' ' ' LEU . 1.3 m -135.26 121.51 20.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.843 0.354 . . . . 2.1 110.366 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -121.15 152.38 38.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.285 -0.416 . . . . 2.78 110.513 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.43 146.34 80.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.376 -0.374 . . . . 2.62 110.051 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.51 143.9 77.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.739 2.293 . . . . 2.77 111.795 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -61.65 111.8 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 4.11 110.834 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 136.46 -21.84 3.4 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.783 -1.327 . . . . 3.18 109.783 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 21.0 m-85 -104.31 153.5 20.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.19 -0.505 . . . . 2.91 110.341 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 32.3 p90 -135.54 162.06 33.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.191 -0.459 . . . . 3.54 110.304 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.11 126.78 33.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 2.93 111.211 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.08 103.86 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.013 -0.539 . . . . 3.64 110.464 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.67 12.2 51.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.677 -0.773 . . . . 3.27 112.482 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.323 -0.546 0 CA-C-O 120.924 0.392 . . . . 3.59 111.304 179.745 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.238 0 CA-C-O 121.034 0.445 . . . . 2.48 111.962 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.75 155.52 39.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.51 -0.768 . . . . 2.13 111.373 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -91.69 -32.46 15.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.394 0.516 . . . . 2.4 112.394 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.418 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 35.3 m-85 -109.38 -179.18 3.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 2.02 111.872 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.99 165.12 24.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.547 -0.751 . . . . 2.65 110.902 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -80.73 138.6 36.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.429 -0.35 . . . . 2.4 111.601 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 131' ' ' PHE . 75.9 mt -100.34 107.45 19.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 2.27 110.071 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -87.3 116.9 25.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.904 0.383 . . . . 2.84 111.692 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -91.36 140.33 29.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.469 . . . . 2.89 110.811 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -132.66 87.74 2.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 3.82 109.964 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.52 -166.01 34.55 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.696 -0.764 . . . . 3.23 111.732 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 46.2 mmtt -93.33 -16.93 24.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 4.27 111.551 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.44 177.03 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.091 -0.504 . . . . 3.32 110.565 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.487 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 2.0 t0 -98.73 -89.91 0.3 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.164 -0.68 . . . . 2.39 109.164 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 26.9 tp -172.0 135.63 0.82 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 2.06 110.694 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -155.95 143.05 19.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.571 -0.529 . . . . 2.22 109.571 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.64 147.94 51.9 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.369 -0.378 . . . . 1.78 110.305 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.66 163.26 18.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.357 2.705 . . . . 2.15 112.297 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.0 117.88 8.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.837 -0.619 . . . . 2.6 110.954 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.95 6.96 63.0 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.761 -0.733 . . . . 1.65 112.673 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -134.53 159.19 41.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.914 -0.402 . . . . 2.31 109.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.9 -10.01 7.52 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.043 -0.598 . . . . 1.33 111.613 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.18 117.78 67.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 110.085 -0.339 . . . . 1.06 110.085 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.99 -176.47 2.89 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.585 2.19 . . . . 1.27 111.791 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.55 87.91 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.128 0.49 . . . . 1.7 110.305 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.438 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 49.0 m-80 -80.33 80.07 6.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.23 110.747 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.84 57.12 2.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.079 -0.509 . . . . 1.94 110.736 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -161.66 -38.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 1.96 110.629 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.93 170.54 9.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.509 . . . . 1.42 111.306 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 5.1 m -86.61 162.1 46.06 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 1.73 110.135 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.52 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 12.4 Cg_endo -56.83 -32.7 92.68 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.93 2.42 . . . . 1.42 112.679 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 18.5 t70 -71.38 -22.03 61.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.464 0.649 . . . . 1.78 110.396 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.803 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 52.1 m-20 -93.11 9.83 34.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.507 -0.769 . . . . 1.6 111.429 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.52 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 39.0 mm-40 -83.82 54.02 2.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 1.05 110.948 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.48 HG12 HD12 ' A' ' 73' ' ' LEU . 18.7 tt -150.9 138.28 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.002 -0.544 . . . . 1.17 109.949 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.38 -136.49 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.387 -0.911 . . . . 0.6 112.433 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.427 ' CD2' HG23 ' A' ' 90' ' ' ILE . 50.4 p90 -160.13 174.2 14.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.052 0.453 . . . . 0.99 110.968 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 49.8 m-85 -114.93 139.31 49.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.242 -0.651 . . . . 1.26 109.242 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -112.41 127.69 56.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.247 -0.433 . . . . 2.15 111.072 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 49' ' ' ARG . 2.2 ttt-85 -88.5 112.27 22.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.014 -0.539 . . . . 2.4 110.09 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB3' ' HE2' ' A' ' 69' ' ' TYR . . . -125.26 156.5 38.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.037 0.446 . . . . 2.21 111.543 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.91 142.43 49.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.69 -0.687 . . . . 2.68 110.813 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.477 ' HB3' HD12 ' A' ' 64' ' ' LEU . 6.5 tpt180 -111.54 119.33 38.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.905 0.384 . . . . 3.59 111.264 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt180 -137.16 169.47 17.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 3.43 109.942 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 pt -143.76 153.12 15.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.2 -0.296 . . . . 4.26 110.2 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 5.17 109.957 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 29.2 mtt . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 110.247 -0.279 . . . . 4.48 110.247 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -64.63 -54.49 31.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.944 -0.391 . . . . 4.16 109.944 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.9 t70 52.92 74.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.744 . . . . 4.09 112.047 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 52' ' ' ARG . 89.0 mt -81.07 149.7 29.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.781 -0.645 . . . . 3.36 110.443 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.99 154.63 92.06 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.837 -0.62 . . . . 3.36 110.908 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.34 122.31 10.99 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.919 2.413 . . . . 2.69 111.486 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.603 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 97.7 mtt180 -119.84 135.57 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.005 -0.543 . . . . 3.03 110.738 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.522 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 73.8 m95 -97.57 135.43 39.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.751 -0.659 . . . . 1.84 110.463 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.742 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 73.0 m-85 -117.35 145.6 43.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 2.76 110.185 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -85.78 124.61 32.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.981 0.42 . . . . 1.27 111.449 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -126.19 138.97 53.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.71 -0.677 . . . . 1.84 110.117 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.88 161.33 29.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 1.28 111.679 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.9 tt -63.27 122.11 15.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 1.66 111.051 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.33 16.58 62.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.86 -0.686 . . . . 1.66 114.147 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.44 129.23 40.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.109 0.455 . . . . 1.58 110.416 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.5 110.29 3.32 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.928 -0.869 . . . . 1.96 110.928 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.14 -29.15 54.63 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.426 2.751 . . . . 2.62 113.62 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.91 25.73 9.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.987 0.366 . . . . 3.09 111.987 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.38 -53.78 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.515 -0.312 . . . . 1.79 111.156 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.0 44.07 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.843 -0.694 . . . . 1.65 111.629 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 78.2 mt -117.43 107.15 45.49 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.718 0.294 . . . . 1.38 111.441 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.6 159.4 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.971 2.447 . . . . 1.62 111.158 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.614 ' HB2' HD11 ' A' ' 73' ' ' LEU . 92.6 t80 -64.37 119.16 9.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 1.58 110.845 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.21 11.1 26.49 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.495 -0.86 . . . . 1.44 112.891 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.03 172.12 13.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.702 0.251 . . . . 1.25 110.407 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -124.62 111.28 15.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.784 0.326 . . . . 1.86 110.442 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -140.99 152.51 44.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.265 -0.425 . . . . 1.68 110.155 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.65 117.94 8.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.081 -0.509 . . . . 1.7 111.329 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.24 29.24 62.6 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.64 -0.709 . . . . 1.27 113.27 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.427 HG23 ' CD2' ' A' ' 46' ' ' TYR . 38.4 mm -131.77 108.5 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.734 0.267 . . . . 1.01 110.863 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.5 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 12.8 pt -113.77 125.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.77 -0.455 . . . . 1.3 109.77 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.421 ' HZ2' ' HB3' ' A' ' 81' ' ' LEU . 79.3 m95 -87.51 139.12 30.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.446 0.535 . . . . 1.08 112.446 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.76 150.2 31.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.82 -0.627 . . . . 1.04 110.862 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.61 177.22 10.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.33 -0.248 . . . . 1.27 110.33 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.42 163.01 40.64 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.699 -0.482 . . . . 1.36 109.699 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.51 125.95 25.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 2.64 111.246 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.94 25.97 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.806 -0.711 . . . . 1.52 112.261 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -100.29 123.86 45.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.204 -0.295 . . . . 1.59 110.204 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 99' ' ' LEU . 26.3 mt -88.62 150.23 23.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.033 0.444 . . . . 2.15 111.459 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -75.12 102.77 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.745 -0.661 . . . . 2.07 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -170.89 148.19 2.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.85 -0.796 . . . . 2.36 108.85 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.43 131.5 15.08 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.296 1.998 . . . . 2.08 112.498 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.64 66.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.513 0.673 . . . . 1.78 110.99 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -1.75 25.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.661 -0.7 . . . . 2.55 111.776 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.44 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 8.6 p80 -52.34 -28.7 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.348 0.499 . . . . 2.24 112.348 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -25.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.248 -0.433 . . . . 2.0 112.009 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.81 63.51 4.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.069 -0.586 . . . . 2.33 112.167 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.2 t -138.51 23.09 2.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.208 0.528 . . . . 2.99 110.481 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.52 125.17 25.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.93 -0.577 . . . . 2.83 111.005 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.41 118.68 72.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.149 -0.686 . . . . 3.56 109.149 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.07 -33.68 91.23 Favored 'Trans proline' 0 CA--C 1.527 0.137 0 C-N-CA 123.001 2.467 . . . . 3.39 114.25 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.62 4.62 48.04 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.618 0.599 . . . . 4.05 112.618 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -125.1 -6.37 7.22 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 4.48 111.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -155.69 137.83 14.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.024 -0.535 . . . . 3.39 109.63 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 153.79 22.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.529 -0.305 . . . . 3.21 110.726 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.67 159.26 28.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 2.85 111.103 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.7 mt -88.38 132.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.263 -0.426 . . . . 2.42 110.146 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.26 121.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.852 -0.425 . . . . 2.74 109.852 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.77 121.45 14.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 2.11 111.108 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.0 157.16 46.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.525 -0.762 . . . . 2.49 109.687 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.7 mt -112.81 146.4 35.0 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.499 -0.319 . . . . 1.91 110.413 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.88 156.85 64.29 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.452 2.101 . . . . 1.84 111.758 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -52.38 125.07 14.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.74 -0.664 . . . . 2.53 111.137 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.77 -16.29 47.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.985 -0.626 . . . . 2.2 111.881 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.23 116.84 32.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.933 0.397 . . . . 2.1 110.565 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.68 158.31 16.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.082 -0.508 . . . . 2.78 110.511 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 27.0 mt -81.49 150.71 67.52 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.519 -0.31 . . . . 2.62 110.464 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 127' ' ' LEU . 32.0 Cg_exo -61.02 142.11 96.39 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.675 2.25 . . . . 2.77 111.515 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.44 112.33 2.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.102 -0.499 . . . . 4.11 110.95 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.88 -9.19 40.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.967 -0.635 . . . . 3.18 111.68 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 16' ' ' LEU . 47.6 t80 -118.18 103.47 9.89 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.486 -0.561 . . . . 2.91 109.486 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -112.34 162.62 15.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.18 -0.464 . . . . 3.54 111.06 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 136' ' ' SER . . . -97.92 147.35 24.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.133 -0.485 . . . . 2.93 110.306 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.68 111.7 2.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 3.64 110.73 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.75 10.31 70.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.988 -0.625 . . . . 3.27 112.77 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.693 ' HB2' ' HB3' ' A' ' 133' ' ' ALA . 22.8 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.173 0.511 . . . . 3.59 111.019 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.298 0 N-CA-C 109.748 -0.464 . . . . 2.48 109.748 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -64.62 137.93 58.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.781 0.324 . . . . 2.13 111.431 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -73.36 -26.52 61.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 2.4 110.714 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.496 ' CZ ' ' HA ' ' A' ' 35' ' ' ASN . 74.3 m-85 -111.04 166.6 10.92 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.038 -0.528 . . . . 2.02 112.273 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -69.67 168.73 14.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.249 -0.887 . . . . 2.65 111.18 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -92.25 151.6 20.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.269 0.47 . . . . 2.4 112.269 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 133' ' ' ALA . 15.9 mt -99.88 125.17 45.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 2.27 109.031 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -95.87 121.92 38.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.195 0.521 . . . . 2.84 112.233 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -89.77 134.38 34.21 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.736 -0.666 . . . . 2.89 110.076 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -140.91 73.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 3.82 109.94 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -165.15 -140.83 2.97 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.781 -0.724 . . . . 3.23 112.438 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -110.81 -18.08 13.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.721 0.296 . . . . 4.27 111.342 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.12 -174.13 2.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.182 -0.463 . . . . 3.32 111.208 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -111.38 -77.46 0.59 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 2.39 110.208 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 31.6 tp 172.55 131.23 0.02 OUTLIER 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.863 0.727 . . . . 2.06 110.018 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -157.23 130.89 8.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 2.22 109.625 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -120.97 139.51 29.34 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.234 -0.439 . . . . 1.78 110.277 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.55 164.36 34.03 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.273 1.982 . . . . 2.15 110.696 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.91 131.79 51.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.602 0.239 . . . . 2.6 110.609 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.11 6.3 61.77 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 1.65 111.659 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -144.39 159.73 42.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.818 -0.438 . . . . 2.31 109.818 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 108.43 -11.48 36.23 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.906 -0.664 . . . . 1.33 111.481 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.76 114.58 61.84 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.809 -0.441 . . . . 1.06 109.809 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.28 -173.13 1.7 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.564 2.176 . . . . 1.27 111.102 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mt -79.97 91.92 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.751 -0.463 . . . . 1.7 109.751 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 13' ' ' PHE . 69.0 m-80 -87.44 77.38 8.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.97 -0.559 . . . . 1.23 110.694 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 39.65 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.016 -0.538 . . . . 1.94 111.68 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.49 -10.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.42 -0.355 . . . . 1.96 111.236 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.2 166.28 16.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.612 -0.267 . . . . 1.42 110.857 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 19.5 m -88.01 168.23 17.39 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.304 -0.407 . . . . 1.73 110.687 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 86.3 Cg_exo -49.79 -45.01 33.92 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.247 2.631 . . . . 1.42 113.855 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -72.18 -22.74 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 1.78 111.522 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.958 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 14.8 m-20 -87.05 11.61 13.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.974 -0.557 . . . . 1.6 111.43 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 39.3 mm-40 -83.25 -6.46 59.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.761 0.282 . . . . 1.05 111.761 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.593 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -82.93 126.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.117 0.484 . . . . 1.17 111.33 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.44 -161.08 11.67 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.683 -0.77 . . . . 0.6 112.229 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.495 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 48.6 p90 -146.42 163.12 36.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.088 0.47 . . . . 0.99 110.717 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.534 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 5.9 m-85 -108.52 133.99 51.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.805 -0.634 . . . . 1.26 109.585 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 48' ' ' ARG . 30.8 ttt180 -114.68 134.63 54.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.361 . . . . 2.15 111.234 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -85.38 123.73 31.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 2.4 110.245 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.605 0.24 . . . . 2.21 110.957 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -150.42 93.06 1.93 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.118 -0.492 . . . . 2.68 110.726 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.528 ' HB3' HD12 ' A' ' 64' ' ' LEU . 28.5 tpt180 -78.64 124.86 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.281 0.562 . . . . 3.59 111.826 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -141.71 117.65 10.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.901 -0.591 . . . . 3.43 109.991 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.3 pt -65.19 171.19 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.185 -0.461 . . . . 4.26 110.713 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.061 0.457 . . . . 5.17 112.149 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.781 -0.451 . . . . 4.48 109.781 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.423 ' HE2' HD21 ' A' ' 64' ' ' LEU . 79.0 tttt -57.13 -53.31 59.54 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.332 0.395 . . . . 4.16 110.906 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.9 t70 56.0 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.93 0.715 . . . . 4.09 112.93 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 52' ' ' ARG . 68.9 mt -84.85 152.74 23.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 3.36 110.691 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.3 m -75.21 162.83 71.51 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.646 . . . . 3.36 109.989 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 11.9 Cg_endo -55.95 111.06 0.66 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.64 2.227 . . . . 2.69 111.848 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -116.47 137.56 52.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.97 -0.559 . . . . 3.03 110.762 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.534 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 69.1 m95 -104.77 129.64 52.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.84 -0.618 . . . . 1.84 110.944 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -110.13 140.65 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 2.76 110.001 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -89.97 120.08 30.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 1.27 111.186 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.37 130.41 52.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 1.84 109.939 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -67.3 151.1 48.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.56 -0.291 . . . . 1.28 111.129 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.11 116.52 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 1.66 110.805 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.89 -4.29 24.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.474 -0.87 . . . . 1.66 112.901 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.532 HG22 ' HA3' ' A' ' 107' ' ' GLY . 1.2 p -63.74 123.54 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.64 0.257 . . . . 1.58 110.492 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.98 106.87 3.01 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.081 -0.807 . . . . 1.96 111.081 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -35.2 91.15 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.089 2.526 . . . . 2.62 113.062 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.72 21.98 13.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.473 -0.331 . . . . 3.09 111.619 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.33 -50.1 61.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 1.79 110.83 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.32 49.03 59.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.019 -0.61 . . . . 1.65 111.812 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 mt -118.44 91.68 41.85 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.692 0.282 . . . . 1.38 111.56 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.27 155.02 22.02 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.443 2.095 . . . . 1.62 110.301 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 76.7 t80 -60.54 110.46 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.772 0.32 . . . . 1.58 110.857 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.59 -14.49 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.869 -0.681 . . . . 1.44 112.393 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.62 147.21 49.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.809 0.338 . . . . 1.25 111.286 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -111.08 103.14 11.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.055 0.455 . . . . 1.86 111.424 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 90' ' ' ILE . 12.8 ttmt -125.77 149.43 48.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 1.68 109.712 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.75 118.62 5.91 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.455 0.472 . . . . 1.7 111.935 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.58 35.45 51.52 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.941 -0.572 . . . . 1.27 112.981 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.413 HG13 ' HB3' ' A' ' 87' ' ' LYS . 27.4 mm -134.87 113.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.544 0.212 . . . . 1.01 110.474 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.5 HG13 ' HB2' ' A' ' 47' ' ' TYR . 23.6 pt -119.9 134.67 62.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 110.444 -0.206 . . . . 1.3 110.444 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.495 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 70.2 m95 -95.34 140.98 29.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.403 -0.362 . . . . 1.08 111.907 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.49 HG11 ' HA3' ' A' ' 31' ' ' GLY . 9.2 m -134.22 125.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 1.04 110.394 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.9 158.7 40.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.013 0.435 . . . . 1.27 111.79 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 t -139.04 163.34 32.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.569 -0.9 . . . . 1.36 108.569 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.61 121.46 15.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 2.64 110.58 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.03 -17.91 12.61 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.992 -0.843 . . . . 1.52 110.992 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.674 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -81.97 121.08 26.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.857 0.36 . . . . 1.59 110.062 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -88.65 130.58 35.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.143 -0.481 . . . . 2.15 110.603 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -71.45 97.0 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.125 0.488 . . . . 2.07 110.9 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.579 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.6 t -168.41 143.44 2.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.863 -0.791 . . . . 2.36 108.863 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.89 128.7 25.05 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.605 2.204 . . . . 2.08 113.516 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.958 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -129.5 78.93 1.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.525 0.679 . . . . 1.78 110.244 178.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.6 -11.11 59.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 2.55 111.492 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -58.28 -22.86 54.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.73 0.641 . . . . 2.24 112.73 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.28 0.68 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.089 0.471 . . . . 2.0 110.97 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -86.94 -35.42 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.871 -0.681 . . . . 2.33 111.5 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 t -71.27 115.66 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.355 0.598 . . . . 2.99 110.623 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -154.22 138.66 16.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 2.83 110.159 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 97.4 m-20 -94.75 108.04 34.77 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.863 -0.421 . . . . 3.56 109.863 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 37.4 Cg_endo -63.79 -29.19 68.23 Favored 'Trans proline' 0 N--CA 1.47 0.124 0 C-N-CA 123.238 2.625 . . . . 3.39 113.451 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.99 12.71 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.113 0.412 . . . . 4.05 112.113 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -135.95 -43.0 0.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 4.48 110.777 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -103.33 134.58 46.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.555 -0.535 . . . . 3.39 109.555 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.92 150.67 25.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 3.21 111.24 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.05 158.93 19.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 2.85 111.258 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 15.7 mt -113.33 145.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 2.42 109.712 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.01 118.66 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.63 0.252 . . . . 2.74 110.749 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.45 117.72 8.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.782 -0.645 . . . . 2.11 111.175 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -130.33 150.45 51.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 2.49 110.747 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.599 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 26.1 mt -97.22 138.83 21.22 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.098 -0.501 . . . . 1.91 110.107 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.24 152.98 68.39 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.683 2.255 . . . . 1.84 111.775 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -50.5 124.12 10.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 2.53 111.277 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.91 -22.13 16.9 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.148 -0.781 . . . . 2.2 111.148 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -99.98 120.29 39.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.656 -0.498 . . . . 2.1 109.656 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.4 139.03 38.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.179 -0.464 . . . . 2.78 111.06 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.2 mt -72.61 146.39 88.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.81 149.23 26.2 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.646 2.23 . . . . 2.77 111.417 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.39 108.98 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.293 0.479 . . . . 4.11 112.293 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.12 6.03 54.13 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.735 -0.666 . . . . 3.18 112.998 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -94.02 141.87 28.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.958 0.379 . . . . 2.91 111.49 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -152.98 147.3 25.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.93 -0.577 . . . . 3.54 110.785 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.63 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -112.55 162.35 15.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.357 -0.383 . . . . 2.93 110.54 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.22 128.06 34.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.367 -0.378 . . . . 3.64 110.283 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.89 -12.35 62.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.725 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.326 -0.434 0 CA-C-O 120.839 0.352 . . . . 3.59 111.731 -179.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.268 0 N-CA-C 109.169 -0.678 . . . . 2.48 109.169 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 154.45 42.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.896 0.379 . . . . 2.13 111.332 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -31.45 53.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.464 0.65 . . . . 2.4 109.429 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.505 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 92.5 m-85 -114.9 176.57 5.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 2.02 109.878 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 134' ' ' GLU . 2.3 p -69.95 167.52 17.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 2.65 110.747 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.11 18.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.472 . . . . 2.4 111.409 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.564 HD21 HD22 ' A' ' 119' ' ' LEU . 90.7 mt -107.95 115.8 30.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.144 -0.688 . . . . 2.27 109.144 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 4.6 m -93.12 132.71 37.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.155 0.502 . . . . 2.84 111.769 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HA ' ' HD1' ' A' ' 131' ' ' PHE . 6.4 tp-100 -95.96 140.84 30.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.611 -0.722 . . . . 2.89 110.812 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -130.17 77.38 1.78 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.004 -0.544 . . . . 3.82 109.761 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -171.91 44.42 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.951 -0.642 . . . . 3.23 111.657 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -84.47 -23.69 29.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.027 0.441 . . . . 4.27 110.414 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.68 -179.9 6.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.626 -0.716 . . . . 3.32 110.802 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 1.4 t0 -117.96 -84.32 0.65 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.249 -0.432 . . . . 2.39 110.61 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 30.8 tp -175.72 129.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.06 111.072 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -152.27 88.95 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.218 -0.66 . . . . 2.22 109.218 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -72.68 142.06 83.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.277 -0.42 . . . . 1.78 111.877 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 56.2 Cg_endo -70.77 161.51 45.8 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.024 2.483 . . . . 2.15 112.426 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.59 119.58 8.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 2.6 111.784 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.63 -13.44 61.06 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.056 -0.593 . . . . 1.65 112.685 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.692 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 70.5 mt-30 -117.87 174.2 6.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.671 0.272 . . . . 2.31 110.753 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.78 -1.66 41.84 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.597 -0.811 . . . . 1.33 112.246 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 t -100.58 112.04 63.85 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.57 0.224 . . . . 1.06 110.482 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HA ' HD23 ' A' ' 121' ' ' LEU . 53.7 Cg_endo -70.2 174.86 9.26 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.676 2.251 . . . . 1.27 111.492 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.85 89.11 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.056 0.455 . . . . 1.7 110.642 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 13' ' ' PHE . 62.0 m-80 -85.88 84.8 7.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 1.23 109.63 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -66.66 -20.98 66.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.703 -0.68 . . . . 1.94 112.197 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -88.24 -11.86 45.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.319 0.488 . . . . 1.96 112.319 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.06 158.94 18.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.144 0.497 . . . . 1.42 111.993 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 0.7 OUTLIER -89.06 163.02 36.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.644 -0.707 . . . . 1.73 109.34 179.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.17 -45.16 26.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.321 2.681 . . . . 1.42 113.315 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.906 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.25 -18.78 61.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.024 0.44 . . . . 1.78 111.411 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.12 -2.45 58.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.956 -0.566 . . . . 1.6 110.824 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 39' ' ' SER . 73.2 mm-40 -80.39 60.92 3.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.228 0.537 . . . . 1.05 110.686 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.501 HG12 HD12 ' A' ' 73' ' ' LEU . 15.9 tt -149.37 135.35 11.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 1.17 110.167 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.82 -146.85 6.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.129 -1.034 . . . . 0.6 112.98 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -152.76 168.46 25.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.134 0.492 . . . . 0.99 110.772 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.714 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -112.51 134.78 53.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.976 -0.557 . . . . 1.26 109.632 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 48' ' ' ARG . 27.7 ttt180 -116.96 126.51 53.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.353 . . . . 2.15 111.113 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.69 132.45 34.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.085 -0.507 . . . . 2.4 110.774 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.591 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -139.3 147.87 42.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.606 0.241 . . . . 2.21 110.792 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 101.05 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 2.68 110.564 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HB3' HD12 ' A' ' 64' ' ' LEU . 6.4 tpt180 -77.53 129.24 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 3.59 111.315 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -144.58 93.35 2.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 3.43 110.884 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.77 HG12 ' HB2' ' A' ' 62' ' ' LYS . 8.5 pt -77.51 154.01 5.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.601 -0.272 . . . . 4.26 110.382 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 5.17 110.664 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 CA--C 1.521 -0.164 0 N-CA-C 110.022 -0.362 . . . . 4.48 110.022 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.77 ' HB2' HG12 ' A' ' 54' ' ' ILE . 70.4 tttt -63.5 -43.8 96.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 4.16 111.157 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 62.77 101.01 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.511 -0.768 . . . . 4.09 112.847 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 52' ' ' ARG . 22.4 mt -117.53 150.46 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 3.36 110.5 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.445 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 0.2 OUTLIER -68.93 147.61 97.83 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.215 -0.448 . . . . 3.36 110.449 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.32 120.42 8.33 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.869 2.379 . . . . 2.69 111.641 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -118.03 133.31 56.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.049 -0.523 . . . . 3.03 111.496 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.714 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 44.7 m95 -100.31 125.44 46.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.977 -0.556 . . . . 1.84 109.537 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 24.7 m-85 -102.2 135.46 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.337 -0.392 . . . . 2.76 110.113 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -85.97 120.43 27.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.762 0.315 . . . . 1.27 110.65 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -118.78 144.66 46.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.996 -0.547 . . . . 1.84 109.723 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.448 ' CD2' HD12 ' A' ' 106' ' ' ILE . 99.2 m-85 -79.45 164.49 23.92 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.136 -0.226 . . . . 1.28 110.7 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.501 HD12 HG12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -60.52 117.57 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 1.66 112.073 -179.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.15 38.89 17.34 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.749 -0.66 . . . . 1.66 113.043 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.496 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -78.31 70.08 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.58 111.234 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.64 121.56 0.58 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.531 -1.028 . . . . 1.96 110.531 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.03 -42.37 64.81 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.811 2.34 . . . . 2.62 112.801 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.64 29.19 8.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.428 -0.351 . . . . 3.09 111.339 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.72 -50.27 15.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 1.79 110.866 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.8 49.15 65.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.053 -0.594 . . . . 1.65 111.866 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.26 99.19 48.49 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.721 0.296 . . . . 1.38 111.638 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 94.6 Cg_endo -80.85 160.45 21.34 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.514 2.143 . . . . 1.62 110.595 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -59.06 112.46 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.016 0.436 . . . . 1.58 110.488 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.24 -3.89 23.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.902 -0.666 . . . . 1.44 112.34 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.569 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -64.52 116.66 6.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.808 0.337 . . . . 1.25 110.853 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.37 127.76 33.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.837 -0.62 . . . . 1.86 110.919 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.69 ' HD2' HG13 ' A' ' 90' ' ' ILE . 12.1 ttmm -154.38 159.18 41.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.935 -0.765 . . . . 1.68 108.935 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 118.45 10.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.06 0.457 . . . . 1.7 111.481 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.94 60.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.654 -0.703 . . . . 1.27 112.741 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.69 HG13 ' HD2' ' A' ' 87' ' ' LYS . 28.3 mm -133.72 116.06 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.201 0.524 . . . . 1.01 111.256 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -124.16 139.87 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.868 -0.79 . . . . 1.3 108.868 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -100.26 141.87 32.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.272 0.471 . . . . 1.08 112.272 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.7 145.86 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.774 -0.648 . . . . 1.04 110.311 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -159.58 140.94 12.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.626 -0.261 . . . . 1.27 110.999 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 t -99.58 175.68 5.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.677 -0.49 . . . . 1.36 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -73.97 133.74 43.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.813 0.339 . . . . 2.64 110.674 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.62 -9.5 57.16 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.659 -0.781 . . . . 1.52 112.156 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.906 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.04 148.17 27.71 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.639 0.257 . . . . 1.59 110.421 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.69 134.79 49.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.797 0.332 . . . . 2.15 110.942 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -78.28 93.51 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.07 110.565 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.1 t -158.92 138.71 8.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.829 -0.623 . . . . 2.36 109.823 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.37 130.43 19.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.622 2.215 . . . . 2.08 112.238 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.56 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 14.5 pttt -151.9 92.08 1.7 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.268 0.556 . . . . 1.78 111.144 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.31 -4.03 36.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 2.55 111.883 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.56 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 1.7 p80 -55.01 -29.1 56.63 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.513 0.561 . . . . 2.24 112.513 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -96.35 4.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.785 0.326 . . . . 2.0 111.437 -179.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.496 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -104.75 -21.74 8.93 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.368 -0.92 . . . . 2.33 113.301 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.1 t -80.24 111.58 16.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.309 0.576 . . . . 2.99 112.364 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 109' ' ' ARG . 12.4 ttp180 -167.02 136.65 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.794 -0.639 . . . . 2.83 110.573 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -90.69 117.97 68.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 3.56 110.0 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -32.67 44.18 Favored 'Trans proline' 0 N--CA 1.473 0.298 0 C-N-CA 122.749 2.299 . . . . 3.39 113.179 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -17.12 61.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.783 0.29 . . . . 4.05 111.783 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -112.39 0.43 15.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.477 -0.329 . . . . 4.48 111.217 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -155.48 117.92 4.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.569 0.223 . . . . 3.39 110.728 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.42 154.16 42.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 3.21 111.411 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.79 151.08 19.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.089 0.471 . . . . 2.85 111.597 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.505 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 13.2 mt -91.93 149.0 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.26 -0.644 . . . . 2.42 109.26 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.99 116.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.609 0.242 . . . . 2.74 110.582 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.564 HD22 HD21 ' A' ' 16' ' ' LEU . 6.0 tt -64.1 111.81 2.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 2.11 110.999 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -131.88 150.75 52.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 2.49 110.545 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 33' ' ' PRO . 60.3 mt -93.59 154.52 41.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.955 -0.566 . . . . 1.91 109.521 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.63 166.81 12.78 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.487 2.124 . . . . 1.84 112.542 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -64.65 119.53 10.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 2.53 110.497 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.19 -19.33 22.68 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.046 -0.822 . . . . 2.2 111.046 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -105.36 118.75 37.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 2.1 110.148 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.42 155.83 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.419 . . . . 2.78 110.933 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -84.67 151.44 58.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.94 150.37 78.55 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.347 2.032 . . . . 2.77 111.213 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -59.13 125.45 23.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 4.11 110.735 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.0 51.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.014 -0.612 . . . . 3.18 111.688 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -96.84 124.26 40.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.114 -0.328 . . . . 2.91 110.114 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.485 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 55.3 p90 -127.62 148.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.909 0.385 . . . . 3.54 111.156 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.506 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -91.55 137.04 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 2.93 111.062 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.49 ' HA ' ' OE1' ' A' ' 134' ' ' GLU . 39.6 mm-40 -69.61 137.25 52.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.918 0.389 . . . . 3.64 110.801 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.18 -31.35 6.74 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.994 -1.242 . . . . 3.27 109.994 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.46 -0.57 . . . . 3.59 109.46 179.097 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.297 0 CA-C-O 120.567 0.222 . . . . 2.48 110.756 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -64.46 149.61 48.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.603 . . . . 2.13 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -86.37 -18.42 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 2.4 111.257 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 96.8 m-85 -123.37 172.71 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.155 -0.475 . . . . 2.02 111.276 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 134' ' ' GLU . 17.7 p -70.44 170.37 12.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 2.65 109.996 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . . . -95.92 172.11 8.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.279 0.561 . . . . 2.4 111.211 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 131' ' ' PHE . 43.6 mt -106.04 102.07 11.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.901 -0.778 . . . . 2.27 108.901 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.738 HG23 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.42 119.24 22.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.967 -0.56 . . . . 2.84 110.952 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 5.3 tp60 -100.36 132.73 45.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.886 -0.597 . . . . 2.89 110.801 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -126.29 57.16 1.41 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.692 -0.685 . . . . 3.82 109.436 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.61 -166.41 11.86 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.39 -0.823 . . . . 3.23 111.546 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -91.78 -37.97 12.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.887 0.343 . . . . 4.27 111.595 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -83.14 156.19 23.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.505 -0.316 . . . . 3.32 110.944 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' OD2' ' HZ2' ' A' ' 68' ' ' TRP . 1.4 t0 -87.22 -154.37 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.278 -0.419 . . . . 2.39 110.556 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 tp -111.58 131.34 55.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.951 0.352 . . . . 2.06 111.951 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -154.65 105.44 2.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.782 -0.645 . . . . 2.22 109.371 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.54 150.59 51.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 1.78 110.952 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 72.8 Cg_endo -75.74 -172.85 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.942 2.428 . . . . 2.15 112.707 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 28' ' ' ARG . 7.2 tpt180 -69.6 130.04 41.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.625 -0.716 . . . . 2.6 111.447 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.98 87.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.24 -0.505 . . . . 1.65 112.575 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.525 HE22 HG23 ' A' ' 125' ' ' THR . 4.7 mm-40 -125.87 167.26 15.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.804 0.335 . . . . 2.31 111.018 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.508 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 110.0 -28.22 10.79 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.671 -0.695 . . . . 1.33 112.134 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 43' ' ' GLN . 45.4 t -80.01 115.23 52.79 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.839 0.352 . . . . 1.06 110.254 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 6.2 Cg_exo -78.38 -176.25 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.668 2.246 . . . . 1.27 111.095 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 36' ' ' THR . 32.9 mt -80.03 88.85 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.568 -0.53 . . . . 1.7 109.568 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -86.08 82.61 8.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.465 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.429 HG23 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -77.74 37.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 1.94 111.486 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.16 1.39 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.98 -0.555 . . . . 1.96 109.711 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.43 159.29 37.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.887 -0.597 . . . . 1.42 111.843 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.16 168.82 23.82 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.688 -0.687 . . . . 1.73 110.019 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.11 -37.96 93.77 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.648 2.232 . . . . 1.42 112.802 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 1.3 p30 -78.24 -15.76 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.631 0.234 . . . . 1.78 111.631 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.894 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 11.4 m-20 -88.75 -0.61 57.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 1.6 110.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.456 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.1 mm-40 -79.88 53.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.237 0.542 . . . . 1.05 111.074 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.868 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.4 tt -146.49 134.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.838 -0.619 . . . . 1.17 109.508 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.97 -146.67 5.41 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.412 -0.899 . . . . 0.6 112.498 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 51.2 p90 -156.41 165.78 35.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.611 0.243 . . . . 0.99 110.656 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.732 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 9.0 m-85 -106.15 141.91 36.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.483 -0.562 . . . . 1.26 109.483 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -121.77 127.75 50.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 2.15 110.912 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.4 ttt-85 -82.03 109.48 16.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 2.4 110.009 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.82 145.4 50.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.076 0.465 . . . . 2.21 112.114 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.9 m -140.44 119.58 12.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.68 109.765 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' A' ' 64' ' ' LEU . 25.0 tpt180 -84.58 125.35 32.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.075 0.464 . . . . 3.59 111.923 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -137.8 172.44 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 3.43 110.049 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.95 177.42 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.629 0.252 . . . . 4.26 110.857 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--N 1.323 -0.567 0 CA-C-N 116.408 -0.36 . . . . 5.17 110.086 178.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmt . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 110.048 -0.352 . . . . 4.48 110.048 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.54 -38.37 90.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.459 -0.571 . . . . 4.16 109.459 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 55.36 85.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.989 -1.005 . . . . 4.09 113.455 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 52' ' ' ARG . 81.3 mt -92.2 155.31 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 3.36 109.918 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -74.76 152.8 87.12 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.713 -0.222 . . . . 3.36 110.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.32 120.96 9.18 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 2.69 111.092 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.738 ' HG2' HG23 ' A' ' 17' ' ' THR . 63.2 mtt180 -112.77 126.89 55.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 3.03 111.222 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.732 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.04 104.36 16.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.122 -0.49 . . . . 1.84 109.88 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 89.0 m-85 -88.51 148.87 23.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.203 -0.453 . . . . 2.76 110.442 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.79 128.07 48.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.908 0.385 . . . . 1.27 111.294 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.67 157.82 31.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.157 -0.683 . . . . 1.84 109.157 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.69 159.0 16.6 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.633 -0.258 . . . . 1.28 110.999 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.1 120.45 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.183 -0.462 . . . . 1.66 112.111 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 88.67 36.08 8.12 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.939 -0.648 . . . . 1.66 112.728 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.44 104.46 15.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.966 0.412 . . . . 1.58 111.302 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.49 115.5 3.39 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.649 -0.786 . . . . 1.96 111.959 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.7 -24.03 55.49 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.642 2.228 . . . . 2.62 112.172 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 47.11 1.16 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.913 0.387 . . . . 3.09 110.531 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.69 -60.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.79 111.469 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.32 16.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.82 -0.705 . . . . 1.65 111.624 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HD2' ' A' ' 87' ' ' LYS . 32.0 mt -120.77 94.19 48.82 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 1.38 111.581 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 83.4 Cg_endo -83.11 164.43 15.19 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.541 2.161 . . . . 1.62 111.009 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.57 110.28 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.58 111.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.15 9.19 24.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.796 -0.716 . . . . 1.44 113.055 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.561 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -77.73 134.95 37.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.864 0.364 . . . . 1.25 111.243 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -81.22 127.15 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.401 -0.363 . . . . 1.86 110.918 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HD2' HD21 ' A' ' 81' ' ' LEU . 12.4 tttt -163.3 142.05 8.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 1.68 110.666 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.37 124.76 24.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 1.7 111.497 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.82 15.92 71.68 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.913 -0.585 . . . . 1.27 112.797 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.02 112.95 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.634 0.254 . . . . 1.01 110.709 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.457 HG13 ' HB2' ' A' ' 47' ' ' TYR . 17.5 pt -118.0 132.17 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.942 -0.392 . . . . 1.3 109.942 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 71.7 m95 -92.15 138.03 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.409 0.522 . . . . 1.08 112.409 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.508 HG11 ' HA3' ' A' ' 31' ' ' GLY . 17.4 m -132.75 146.4 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.407 -0.815 . . . . 1.04 109.706 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.19 174.71 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.831 0.348 . . . . 1.27 111.097 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -156.22 170.73 21.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 1.36 109.389 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.12 124.64 24.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 2.64 110.681 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' ASP . . . 112.84 -21.58 18.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.829 -0.908 . . . . 1.52 110.829 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.868 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.09 126.81 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.097 -0.335 . . . . 1.59 110.097 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.18 143.68 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.857 0.36 . . . . 2.15 111.158 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.06 93.38 4.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.317 0.579 . . . . 2.07 110.722 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.417 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 8.4 t -161.71 149.49 12.11 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.454 -0.943 . . . . 2.36 108.454 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 50.7 Cg_endo -69.99 129.73 17.85 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.259 1.973 . . . . 2.08 112.938 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.894 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -138.18 71.33 1.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.385 0.612 . . . . 1.78 111.203 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 1.2 p-10 -76.96 -4.38 43.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.505 . . . . 2.55 111.918 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.413 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.5 p80 -57.82 -22.21 46.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.973 0.416 . . . . 2.24 111.878 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.72 8.86 9.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 2.0 110.973 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.69 -26.73 10.35 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 120.999 -0.619 . . . . 2.33 111.612 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.7 t -79.77 118.17 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 2.99 110.539 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -161.5 140.44 9.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 2.83 109.999 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.65 103.3 23.31 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.5 -0.318 . . . . 3.56 110.579 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.39 -17.09 39.43 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.761 2.308 . . . . 3.39 112.702 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.49 -11.42 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.054 0.454 . . . . 4.05 110.982 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -116.83 -53.62 2.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.031 -0.532 . . . . 4.48 110.14 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.79 139.58 38.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.682 -0.69 . . . . 3.39 109.944 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 148.13 22.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.735 0.302 . . . . 3.21 111.106 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.76 153.13 31.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.394 -0.366 . . . . 2.85 110.816 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 9.1 mt -88.1 149.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 2.42 110.116 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 136' ' ' SER . 40.3 t -67.88 125.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.36 . . . . 2.74 110.471 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.07 105.47 3.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 2.11 110.979 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -121.31 150.53 41.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.143 -0.48 . . . . 2.49 110.688 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.633 HD13 HG22 ' A' ' 125' ' ' THR . 96.0 mt -100.18 153.87 37.52 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.093 -0.503 . . . . 1.91 110.835 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.71 167.92 25.9 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.731 2.287 . . . . 1.84 111.912 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.07 122.54 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.493 . . . . 2.53 111.214 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.57 12.13 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.69 -0.686 . . . . 2.2 111.766 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.633 HG22 HD13 ' A' ' 121' ' ' LEU . 6.4 m -96.24 122.26 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.927 -0.397 . . . . 2.1 109.927 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 p -118.67 149.06 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.655 0.264 . . . . 2.78 110.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.2 mt -77.71 144.01 68.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.812 -0.44 . . . . 2.62 109.812 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.439 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 12.4 Cg_endo -57.78 157.83 22.52 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.615 2.21 . . . . 2.77 111.701 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.7 118.34 7.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.136 -0.484 . . . . 4.11 110.733 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.21 -16.66 24.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 3.18 112.423 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.8 m-85 -99.63 124.92 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.71 0.291 . . . . 2.91 111.004 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -121.53 161.68 21.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 3.54 110.943 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 136' ' ' SER . . . -95.19 130.96 41.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.423 -0.353 . . . . 2.93 110.973 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 55.5 mt-10 -68.85 107.68 3.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 3.64 111.605 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.54 12.01 56.34 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.749 -0.66 . . . . 3.27 112.578 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' A' ' 133' ' ' ALA . 4.7 t . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 110.128 -0.323 . . . . 3.59 110.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.42 0 N-CA-C 109.72 -0.474 . . . . 2.48 109.72 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 m -56.57 144.22 32.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.252 0.464 . . . . 2.13 112.252 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.424 ' NE1' HG22 ' A' ' 106' ' ' ILE . 26.5 m95 -69.58 -30.48 68.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.586 -0.734 . . . . 2.4 112.761 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 93.4 m-85 -108.92 167.26 10.21 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.783 0.29 . . . . 2.02 111.783 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -73.19 165.99 23.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.024 -0.535 . . . . 2.65 111.339 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.59 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -78.82 140.71 38.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.275 0.843 . . . . 2.4 113.275 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 67' ' ' ARG . 40.6 mt -91.43 127.38 36.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.231 -1.026 . . . . 2.27 108.231 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -106.25 133.04 51.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.876 0.369 . . . . 2.84 111.692 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 20' ' ' GLY . 3.6 tp-100 -96.18 144.08 26.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.716 -0.674 . . . . 2.89 109.292 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -125.69 47.27 2.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 3.82 110.693 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.465 ' H ' ' HG3' ' A' ' 18' ' ' GLN . . . -162.8 -169.33 26.05 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.072 -0.585 . . . . 3.23 111.933 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -81.42 -28.96 34.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.753 0.311 . . . . 4.27 110.555 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -70.15 173.84 6.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.558 -0.746 . . . . 3.32 111.498 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.17 -156.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.375 -0.602 . . . . 2.39 109.375 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 35.8 tp -102.62 124.57 48.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.805 0.336 . . . . 2.06 111.408 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 40.8 tptt -151.5 116.88 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 2.22 110.064 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 47.7 m-85 -105.33 149.62 37.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 1.78 110.557 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 11.4 Cg_exo -72.45 173.31 13.4 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.066 2.51 . . . . 2.15 112.144 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -69.73 125.63 27.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.834 -0.621 . . . . 2.6 111.438 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 23.77 50.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.07 -0.586 . . . . 1.65 112.451 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.79 166.33 33.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.77 0.319 . . . . 2.31 110.188 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.36 2.86 50.83 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.895 -0.669 . . . . 1.33 113.156 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.16 121.04 63.2 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 110.203 -0.295 . . . . 1.06 110.203 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.03 178.88 5.41 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.707 2.271 . . . . 1.27 112.033 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.1 mt -76.06 86.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 1.7 110.607 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -88.94 79.91 7.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 1.23 110.523 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -17.06 56.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.94 110.82 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -74.79 -21.82 59.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 1.96 111.235 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.71 173.77 6.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.42 111.747 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.618 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 21.9 m -90.61 166.19 20.25 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 1.73 109.998 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.5 Cg_endo -51.92 -38.28 68.35 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.163 2.576 . . . . 1.42 113.763 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -72.71 -19.14 61.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.711 0.263 . . . . 1.78 111.711 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.86 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.0 m-20 -88.17 4.1 46.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 1.6 110.969 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -80.38 51.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.176 0.512 . . . . 1.05 111.246 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.763 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -148.36 132.9 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.065 -0.516 . . . . 1.17 110.033 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.95 -146.34 5.27 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.192 -1.004 . . . . 0.6 112.632 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -156.15 162.23 40.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.587 0.232 . . . . 0.99 110.468 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.452 ' HB2' HG13 ' A' ' 91' ' ' ILE . 61.8 m-85 -104.04 136.46 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.425 -0.583 . . . . 1.26 109.425 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -111.94 125.78 54.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 2.15 111.0 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -78.28 131.76 37.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.247 -0.433 . . . . 2.4 109.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.82 138.08 28.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 2.21 111.601 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.29 96.19 3.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.541 -0.754 . . . . 2.68 110.489 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HB3' HD12 ' A' ' 64' ' ' LEU . 22.6 tpt180 -68.5 120.92 15.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.212 0.529 . . . . 3.59 111.001 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.448 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 7.2 ttm180 -139.45 110.44 6.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.888 -0.596 . . . . 3.43 111.039 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.47 168.07 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 4.26 110.816 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 5.17 111.298 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.448 ' SD ' ' HD3' ' A' ' 53' ' ' ARG . 64.4 mtt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.989 -0.375 . . . . 4.48 109.989 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -59.12 -48.87 80.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.3 -0.63 . . . . 4.16 109.3 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.9 t70 55.41 97.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.333 1.234 . . . . 4.09 114.333 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' A' ' 52' ' ' ARG . 38.5 mt -88.61 153.65 20.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 3.36 110.221 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -73.54 159.71 83.99 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 3.36 110.892 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.08 110.17 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.858 2.372 . . . . 2.69 112.134 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 28.7 mtt-85 -120.44 148.63 43.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.728 -0.669 . . . . 3.03 111.494 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.426 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 56.4 m95 -121.53 137.46 54.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.072 -0.513 . . . . 1.84 110.49 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.8 m-85 -112.54 148.56 34.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.427 -0.583 . . . . 2.76 109.427 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.73 123.01 37.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.991 0.424 . . . . 1.27 111.642 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.446 ' HD2' HG21 ' A' ' 75' ' ' THR . 9.3 m-85 -119.13 162.78 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.759 -0.655 . . . . 1.84 109.791 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -102.21 155.77 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.596 -0.274 . . . . 1.28 110.644 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.4 tt -60.9 115.67 3.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.876 0.37 . . . . 1.66 111.322 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.26 38.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.841 -0.695 . . . . 1.66 114.53 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.446 HG21 ' HD2' ' A' ' 71' ' ' TYR . 5.6 p -56.48 119.9 6.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 117.599 0.699 . . . . 1.58 111.375 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 102.95 112.42 3.67 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.928 -0.654 . . . . 1.96 111.601 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 13.7 Cg_endo -58.06 -36.05 98.28 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 122.738 2.292 . . . . 2.62 112.389 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.02 28.44 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 3.09 111.281 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -55.64 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.153 -0.476 . . . . 1.79 110.43 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.73 48.5 49.11 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.973 -0.851 . . . . 1.65 110.973 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.532 HD21 ' HE3' ' A' ' 87' ' ' LYS . 32.7 mt -116.5 94.46 43.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 112.192 0.441 . . . . 1.38 112.192 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 87.4 Cg_endo -87.01 158.7 8.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.689 2.259 . . . . 1.62 110.389 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.599 ' HB2' HD11 ' A' ' 73' ' ' LEU . 48.4 t80 -58.86 115.17 2.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 1.58 111.112 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.76 -11.1 18.45 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.737 -0.744 . . . . 1.44 112.66 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.529 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -66.87 130.62 43.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 1.25 110.83 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -95.09 132.65 39.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.247 -0.433 . . . . 1.86 111.053 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.532 ' HE3' HD21 ' A' ' 81' ' ' LEU . 13.1 ttmm -158.38 152.94 24.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.152 -0.685 . . . . 1.68 109.152 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.74 112.53 3.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.873 0.368 . . . . 1.7 111.606 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.97 28.71 27.86 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.27 112.602 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 87' ' ' LYS . 29.6 mm -132.78 106.81 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 1.01 110.803 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 47' ' ' TYR . 3.7 pt -118.7 127.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.995 -0.372 . . . . 1.3 109.995 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.412 ' CZ3' ' HG ' ' A' ' 73' ' ' LEU . 92.1 m95 -85.53 139.52 31.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.966 0.728 . . . . 1.08 112.966 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 m -136.22 140.55 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.19 -0.914 . . . . 1.04 110.034 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.79 159.28 44.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.152 -0.476 . . . . 1.27 110.168 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 t -135.52 172.41 13.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 1.36 109.828 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.22 126.31 27.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.371 -0.377 . . . . 2.64 110.76 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.69 -10.5 38.32 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.649 . . . . 1.52 112.195 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.763 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.68 132.19 35.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.645 0.259 . . . . 1.59 111.342 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 59.0 mt -92.27 139.77 30.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.248 -0.433 . . . . 2.15 111.201 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -85.84 85.3 7.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 2.07 111.231 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.631 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 9.7 t -167.72 140.29 2.64 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.049 -0.723 . . . . 2.36 109.049 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.19 133.36 52.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.917 2.411 . . . . 2.08 113.038 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.33 67.53 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 1.78 110.968 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.3 6.97 7.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 2.55 112.48 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -59.78 -22.75 62.57 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.019 0.377 . . . . 2.24 112.019 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.424 HG22 ' NE1' ' A' ' 12' ' ' TRP . 3.5 mt -88.92 -18.27 7.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.258 0.552 . . . . 2.0 109.905 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.88 70.56 3.16 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.308 -0.717 . . . . 2.33 111.308 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.9 t -149.33 19.67 0.95 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.677 0.751 . . . . 2.99 109.411 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -77.88 135.76 37.95 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.65 -0.704 . . . . 2.83 111.404 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 113' ' ' ASN . 45.4 t-20 -111.95 118.81 45.7 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.239 -0.652 . . . . 3.56 109.239 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.15 -23.69 74.53 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.061 2.508 . . . . 3.39 113.206 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.46 -1.66 57.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 4.05 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 110' ' ' ASN . 40.6 m-20 -132.08 14.62 4.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.397 -0.365 . . . . 4.48 110.951 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -177.97 135.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.898 -0.592 . . . . 3.39 110.398 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.1 144.15 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.507 -0.553 . . . . 3.21 109.507 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.74 144.74 52.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 2.85 111.205 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 21.5 mt -86.21 140.81 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.779 -0.646 . . . . 2.42 109.475 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.05 128.12 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.879 -0.415 . . . . 2.74 109.879 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.457 HD13 ' HG ' ' A' ' 16' ' ' LEU . 2.0 tt -60.45 110.8 1.36 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 2.11 111.623 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -116.29 134.07 55.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.621 -0.718 . . . . 2.49 110.039 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.522 HD13 HG22 ' A' ' 125' ' ' THR . 29.7 mt -98.9 145.48 30.04 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.424 -0.353 . . . . 1.91 110.556 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.9 155.29 71.4 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.441 2.094 . . . . 1.84 111.942 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -61.62 111.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.0 -0.545 . . . . 2.53 110.693 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.98 -17.42 8.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.126 -1.19 . . . . 2.2 110.126 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.522 HG22 HD13 ' A' ' 121' ' ' LEU . 89.7 m -108.86 112.81 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.102 -0.703 . . . . 2.1 109.102 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.23 150.09 31.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 2.78 111.358 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.464 ' HG ' ' CD1' ' A' ' 121' ' ' LEU . 18.5 mt -78.14 147.08 72.44 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 2.62 110.28 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.53 153.69 69.62 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.757 2.305 . . . . 2.77 110.862 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -59.44 122.21 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 4.11 111.295 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.77 -9.85 40.85 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.014 -0.613 . . . . 3.18 112.255 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -102.84 134.65 45.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.766 0.317 . . . . 2.91 111.751 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -146.26 143.41 29.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 3.54 110.49 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.95 134.87 34.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.781 0.325 . . . . 2.93 110.662 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.67 123.74 19.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.05 -0.523 . . . . 3.64 110.529 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.81 -12.77 46.07 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.012 -0.613 . . . . 3.27 112.234 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.639 0.257 . . . . 3.59 111.194 -179.42 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.312 0 CA-C-O 120.96 0.41 . . . . 2.48 111.374 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -79.26 167.41 20.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.879 -0.6 . . . . 2.13 110.821 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.556 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 31.3 m95 -92.91 -45.57 7.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 2.4 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 29.9 m-85 -88.66 159.74 17.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.866 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 p -66.92 157.41 33.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 2.65 110.797 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -74.81 139.99 43.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.928 0.394 . . . . 2.4 111.321 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 95.6 mt -93.16 138.59 31.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.92 -0.582 . . . . 2.27 109.787 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -109.78 124.89 52.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.06 0.457 . . . . 2.84 111.897 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -97.39 124.3 41.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 2.89 110.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 35.5 t60 -116.82 92.61 3.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.115 -0.493 . . . . 3.82 110.104 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.77 -166.16 38.73 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.469 -0.872 . . . . 3.23 112.093 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 45.1 mmtt -87.98 -22.2 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 4.27 111.211 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -87.79 171.25 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.137 -0.483 . . . . 3.32 110.652 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.418 ' OD2' ' HZ2' ' A' ' 68' ' ' TRP . 13.3 t0 -102.63 -90.51 0.36 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 2.39 110.795 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 31.2 tp -169.27 129.64 1.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.766 0.317 . . . . 2.06 110.841 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -150.89 133.08 15.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 2.22 110.508 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -118.75 134.13 23.57 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.102 -0.499 . . . . 1.78 110.184 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.62 176.05 8.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.024 2.483 . . . . 2.15 112.56 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -58.92 126.87 29.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 2.6 112.102 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.17 20.63 75.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.182 -0.533 . . . . 1.65 113.339 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -141.52 153.32 44.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.065 -0.346 . . . . 2.31 110.065 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.5 -13.51 9.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.33 112.092 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.5 t -95.66 111.55 56.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.761 0.315 . . . . 1.06 110.37 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.25 -166.91 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.743 2.295 . . . . 1.27 111.648 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -79.66 88.4 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.166 0.508 . . . . 1.7 111.436 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.483 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . 31.3 t30 -98.55 91.89 5.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.214 0.531 . . . . 1.23 109.655 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.15 2.67 55.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.84 0.682 . . . . 1.94 112.84 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -100.87 21.32 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.186 0.517 . . . . 1.96 111.274 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.418 ' OG ' HG21 ' A' ' 106' ' ' ILE . 3.7 m -148.84 174.77 11.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.841 -0.618 . . . . 1.42 110.075 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.578 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 17.6 m -84.36 166.09 34.77 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.885 -0.413 . . . . 1.73 109.885 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 18.8 Cg_endo -59.03 -22.54 64.25 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.663 2.242 . . . . 1.42 113.321 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.712 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 1.5 p-10 -89.53 -10.68 45.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.312 . . . . 1.78 111.709 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.727 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 23.6 m-20 -85.87 -0.93 56.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.6 110.144 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.54 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.7 mm-40 -79.09 59.2 2.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.987 -0.551 . . . . 1.05 111.419 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.865 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.7 tt -151.89 133.5 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.17 110.092 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.97 -142.45 4.41 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.03 -1.081 . . . . 0.6 112.637 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -160.17 159.24 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.006 0.432 . . . . 0.99 110.527 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.692 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 5.1 m-85 -99.8 135.7 40.83 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.434 -0.58 . . . . 1.26 109.434 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -111.73 128.22 56.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.323 -0.399 . . . . 2.15 111.061 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -84.5 128.41 34.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.949 -0.569 . . . . 2.4 109.726 179.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.79 157.86 44.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.02 0.438 . . . . 2.21 111.498 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -148.47 125.75 11.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.214 -0.661 . . . . 2.68 109.214 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -112.25 134.84 53.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.381 . . . . 3.59 111.154 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 28.4 ttm180 -149.32 121.36 8.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.501 -0.318 . . . . 3.43 110.833 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 pt -92.7 136.27 25.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.789 -0.449 . . . . 4.26 109.789 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 116.26 -0.427 . . . . 5.17 110.699 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.402 ' SD ' ' HD3' ' A' ' 53' ' ' ARG . 17.1 mmt . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 109.19 -0.671 . . . . 4.48 109.19 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -54.62 -51.69 64.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.078 -0.341 . . . . 4.16 110.078 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.9 t70 63.9 115.22 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.767 1.025 . . . . 4.09 113.767 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.1 mt -109.84 -179.13 3.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.855 -0.612 . . . . 3.36 110.639 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -102.83 155.44 36.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.079 -0.51 . . . . 3.36 110.224 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.3 109.91 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.518 2.145 . . . . 2.69 111.526 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.597 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 59.4 mtt180 -113.0 145.95 39.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.105 0.479 . . . . 3.03 112.055 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.692 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.2 m95 -113.36 132.72 55.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.64 -0.709 . . . . 1.84 110.508 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -110.4 141.57 43.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 2.76 109.929 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.77 116.01 28.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 1.27 111.49 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -115.6 156.6 25.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.034 -0.53 . . . . 1.84 110.162 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -96.52 162.55 13.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.459 -0.337 . . . . 1.28 110.635 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.9 OUTLIER -64.13 117.27 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.428 -0.351 . . . . 1.66 110.803 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.97 7.81 37.7 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.806 -0.712 . . . . 1.66 113.679 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -70.11 120.83 16.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 1.58 111.496 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 111.44 122.82 4.27 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.14 -0.784 . . . . 1.96 111.14 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 9.7 Cg_endo -53.03 -56.64 2.6 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.07 2.514 . . . . 2.62 112.7 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.16 42.66 1.33 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 3.09 110.912 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.89 -54.1 14.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.014 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.62 38.51 96.53 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.649 -0.705 . . . . 1.65 112.223 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.48 101.93 48.36 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.751 0.31 . . . . 1.38 111.047 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.05 159.95 18.16 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.707 2.271 . . . . 1.62 111.258 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.623 ' HB2' HD11 ' A' ' 73' ' ' LEU . 51.2 t80 -56.74 113.46 1.65 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.421 -0.354 . . . . 1.58 110.688 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.67 -12.09 13.65 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.653 -0.784 . . . . 1.44 112.939 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.05 114.1 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 1.25 110.914 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -74.85 120.93 21.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.516 . . . . 1.86 111.396 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -143.84 151.71 40.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 1.68 110.041 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.37 115.52 4.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.89 0.376 . . . . 1.7 111.733 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.1 26.43 60.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.881 -0.676 . . . . 1.27 112.665 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -130.0 103.17 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.944 0.402 . . . . 1.01 110.6 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 47' ' ' TYR . 21.0 pt -111.52 119.91 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.283 -0.417 . . . . 1.3 110.675 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -79.44 137.53 37.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.08 111.55 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.62 143.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.957 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.2 165.6 32.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.487 . . . . 1.27 110.003 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -134.82 -177.47 4.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.258 -0.428 . . . . 1.36 109.985 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.58 120.1 14.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.167 0.508 . . . . 2.64 110.938 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.02 -9.15 39.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.05 -0.595 . . . . 1.52 111.795 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.865 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.17 121.84 20.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.747 0.308 . . . . 1.59 110.387 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.712 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 53.8 mt -89.39 146.38 24.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 2.15 109.982 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -79.73 69.03 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.536 . . . . 2.07 109.874 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 1.4 m -135.34 136.28 24.06 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 2.36 109.792 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 5.2 Cg_exo -81.2 119.21 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.926 2.417 . . . . 2.08 110.855 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.81 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -135.73 102.9 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.559 . . . . 1.78 111.143 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.13 4.1 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.968 -0.56 . . . . 2.55 111.924 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.81 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 12.3 p80 -57.75 -24.3 56.38 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.058 0.456 . . . . 2.24 112.102 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.418 HG21 ' OG ' ' A' ' 38' ' ' SER . 1.2 pt -105.36 5.33 10.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.178 -0.465 . . . . 2.0 111.129 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.61 46.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 2.33 111.64 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -146.56 28.62 1.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.315 0.579 . . . . 2.99 110.748 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 38.3 ttp85 -69.24 141.2 54.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 2.83 111.27 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -94.92 113.0 60.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.065 -0.516 . . . . 3.56 109.731 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.35 -12.99 23.06 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.045 2.497 . . . . 3.39 114.246 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.1 -15.22 44.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.102 0.477 . . . . 4.05 110.884 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -110.39 -9.32 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 4.48 111.546 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -153.01 138.67 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.718 0.294 . . . . 3.39 110.709 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.56 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 3.21 111.583 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.87 149.89 49.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 2.85 111.444 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.3 mt -91.02 138.62 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.807 -0.633 . . . . 2.42 110.258 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.23 119.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.377 -0.601 . . . . 2.74 109.377 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.436 HD22 HD21 ' A' ' 16' ' ' LEU . 1.4 tt -61.0 128.3 35.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 2.11 110.82 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -132.57 142.96 49.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.84 -0.618 . . . . 2.49 110.429 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 26.3 mt -105.62 145.69 31.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.075 -0.511 . . . . 1.91 110.19 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 36.9 Cg_exo -61.78 167.27 10.48 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.991 2.461 . . . . 1.84 112.48 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.73 121.64 14.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 2.53 110.845 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.48 -18.91 34.79 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.762 . . . . 2.2 111.934 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 1.9 m -94.25 99.16 11.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.099 0.476 . . . . 2.1 110.234 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.11 156.22 16.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.997 -0.547 . . . . 2.78 111.24 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.84 146.17 31.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 2.62 109.755 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.0 152.67 73.86 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.608 2.206 . . . . 2.77 111.889 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.97 120.49 11.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 4.11 110.684 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 19' ' ' HIS . . . 109.26 -8.15 32.86 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.724 -0.751 . . . . 3.18 111.55 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 2.7 t80 -94.15 132.08 39.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.189 -0.3 . . . . 2.91 110.189 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.472 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 41.3 p90 -134.65 146.84 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.865 0.365 . . . . 3.54 111.462 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.29 148.63 38.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.812 -0.631 . . . . 2.93 110.597 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.21 122.72 28.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 3.64 109.838 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.19 14.47 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.941 -0.647 . . . . 3.27 111.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 3.59 110.615 179.504 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.791 0.329 . . . . 2.48 111.403 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 m -71.33 152.76 42.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 2.13 110.653 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -86.58 -27.94 23.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.794 0.331 . . . . 2.4 111.199 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.92 164.04 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.327 -0.397 . . . . 2.02 111.945 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 p -63.22 166.01 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 2.65 111.779 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -89.0 150.4 22.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.226 -0.443 . . . . 2.4 111.408 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.561 HD21 HD22 ' A' ' 119' ' ' LEU . 96.9 mt -101.21 136.42 41.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 2.27 110.305 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.496 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 13.4 m -106.65 132.77 52.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.756 0.312 . . . . 2.84 111.397 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -99.79 133.42 44.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 2.89 110.761 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -127.68 82.74 2.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.702 -0.481 . . . . 3.82 109.702 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.82 -160.9 26.34 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.444 -0.663 . . . . 3.23 111.444 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -99.34 9.51 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.0 0.429 . . . . 4.27 111.122 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -112.99 -173.88 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.816 -0.629 . . . . 3.32 110.297 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -118.25 -73.69 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.367 -0.379 . . . . 2.39 109.981 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' CE1' ' A' ' 131' ' ' PHE . 32.0 tp 178.32 125.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.587 0.554 . . . . 2.06 110.382 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -146.58 121.58 10.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 2.22 110.792 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.447 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 26.2 m-85 -108.45 154.45 41.49 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.631 . . . . 1.78 109.896 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.796 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 58.4 Cg_endo -73.08 -163.16 0.15 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.761 2.307 . . . . 2.15 113.076 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -86.01 125.45 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 2.6 111.678 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 94' ' ' ALA . . . 70.3 18.96 75.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.87 -0.604 . . . . 1.65 113.19 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.796 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.3 tm0? -142.16 132.98 25.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.766 -0.457 . . . . 2.31 109.766 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.04 -9.12 2.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.413 -0.899 . . . . 1.33 112.334 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.06 124.24 65.45 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.215 -0.291 . . . . 1.06 110.215 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.48 179.43 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.482 2.122 . . . . 1.27 112.204 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mt -75.51 88.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 1.7 110.602 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.34 80.18 9.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.119 0.485 . . . . 1.23 110.545 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -21.18 66.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 1.94 111.872 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -89.05 3.7 50.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.418 -0.355 . . . . 1.96 111.679 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 m -128.45 162.27 27.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.734 0.302 . . . . 1.42 111.417 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -83.59 165.71 38.45 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 1.73 109.963 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 19.8 Cg_endo -59.44 -25.8 79.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.539 2.159 . . . . 1.42 111.958 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -89.16 -1.51 58.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 1.78 111.382 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -98.39 -1.38 41.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 1.6 110.243 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -77.49 60.5 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 1.05 111.552 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.71 121.11 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 1.17 109.953 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.1 -145.93 4.81 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.495 -0.86 . . . . 0.6 112.802 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -157.55 164.82 36.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.043 0.449 . . . . 0.99 111.106 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.702 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.9 m-85 -108.31 137.28 46.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.46 -0.791 . . . . 1.26 109.518 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -118.16 130.65 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.384 -0.371 . . . . 2.15 110.981 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -86.8 116.34 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.184 -0.462 . . . . 2.4 110.266 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.78 148.31 44.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.263 -0.426 . . . . 2.21 110.647 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -132.88 109.38 9.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.21 -0.45 . . . . 2.68 110.682 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.604 ' HB3' HD12 ' A' ' 64' ' ' LEU . 20.9 tpt180 -86.37 113.74 22.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 3.59 110.874 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -138.63 91.24 2.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 3.43 110.934 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 61' ' ' MET . 28.9 pt -70.46 146.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 4.26 111.01 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 5.17 110.492 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 76.5 mtm . . . . . 0 C--O 1.234 0.261 0 N-CA-C 110.251 -0.277 . . . . 4.48 110.251 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -67.8 -29.29 68.43 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.847 -0.797 . . . . 4.16 108.847 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t0 52.39 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.02 1.118 . . . . 4.09 114.02 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 52' ' ' ARG . 88.5 mt -106.07 140.25 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.015 -0.539 . . . . 3.36 110.064 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.46 ' O ' ' HD2' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -65.92 150.61 96.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.526 . . . . 3.36 110.896 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.59 120.04 7.66 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.57 2.18 . . . . 2.69 111.438 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -110.75 144.85 39.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.691 -0.686 . . . . 3.03 111.198 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.702 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 65.9 m95 -104.67 124.87 50.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.804 -0.634 . . . . 1.84 110.895 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.41 143.49 35.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.682 . . . . 2.76 109.871 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -95.23 127.28 41.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.816 0.341 . . . . 1.27 110.917 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.31 153.52 47.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.08 -0.509 . . . . 1.84 110.128 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.478 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 86.9 m-85 -84.46 163.14 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.9 tt -59.67 122.89 15.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.695 0.283 . . . . 1.66 111.759 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.6 20.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.003 -0.618 . . . . 1.66 112.634 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.66 70.85 7.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.914 0.388 . . . . 1.58 111.486 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 77' ' ' PRO . . . 150.41 148.36 4.76 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.015 -0.612 . . . . 1.96 111.744 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 76' ' ' GLY . 29.3 Cg_exo -62.0 -47.2 11.06 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.79 2.326 . . . . 2.62 111.867 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.8 45.61 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.58 . . . . 3.09 111.257 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.0 -56.13 4.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 1.79 110.463 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.67 52.98 47.18 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.646 -0.582 . . . . 1.65 111.646 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.565 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 57.9 mt -132.72 100.0 15.06 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 111.579 0.215 . . . . 1.38 111.579 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 74.0 Cg_endo -78.93 162.79 26.29 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.16 1.907 . . . . 1.62 110.257 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.99 104.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 1.58 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.43 10.22 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.591 -0.814 . . . . 1.44 112.233 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -59.13 114.64 2.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.74 0.305 . . . . 1.25 110.891 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -78.9 104.56 9.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 1.86 112.023 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HE3' HD21 ' A' ' 81' ' ' LEU . 26.4 ttmt -126.15 150.88 47.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.692 -0.855 . . . . 1.68 108.692 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -63.44 118.33 7.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.939 0.399 . . . . 1.7 111.975 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.38 57.67 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.703 -0.68 . . . . 1.27 112.502 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.8 118.14 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.723 0.297 . . . . 1.01 110.383 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 47' ' ' TYR . 10.4 pt -121.78 122.74 67.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.389 -0.369 . . . . 1.3 110.222 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.565 ' HZ2' ' HB3' ' A' ' 81' ' ' LEU . 87.7 m95 -86.55 138.24 31.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.014 0.376 . . . . 1.08 112.014 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.61 142.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 1.04 110.612 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' O ' ' HA2' ' A' ' 29' ' ' GLY . . . -152.27 -177.78 6.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 1.27 109.605 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 t -148.74 169.7 19.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.32 -0.252 . . . . 1.36 110.32 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.6 128.16 34.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.385 -0.371 . . . . 2.64 111.076 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.98 -24.3 23.55 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.785 -0.721 . . . . 1.52 111.823 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.827 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.11 133.02 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 1.59 110.487 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 94.2 mt -94.45 133.77 37.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.314 -0.403 . . . . 2.15 110.849 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -75.98 96.57 3.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.07 110.337 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.21 150.03 6.89 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.734 -0.666 . . . . 2.36 109.416 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.54 125.21 18.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.816 2.344 . . . . 2.08 112.534 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 72' ' ' TYR . 67.3 mmtt -113.21 34.64 4.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 1.78 109.744 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.6 -30.58 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.548 0.573 . . . . 2.55 112.548 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -64.28 -8.94 14.51 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.81 0.671 . . . . 2.24 112.81 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 103' ' ' LYS . 1.6 mt -109.11 0.58 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 2.0 109.822 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.05 -11.16 59.05 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.736 -0.745 . . . . 2.33 112.424 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 t -80.63 123.45 28.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.437 . . . . 2.99 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -164.37 146.15 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 2.83 109.806 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -107.42 106.93 59.62 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.84 0.352 . . . . 3.56 110.218 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.47 -21.4 26.13 Favored 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 122.862 2.375 . . . . 3.39 113.928 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.21 -14.04 59.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.104 0.409 . . . . 4.05 112.104 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -117.3 -18.51 9.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.201 -0.454 . . . . 4.48 111.408 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -140.72 131.2 25.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 3.39 111.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.26 163.99 20.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.193 -0.458 . . . . 3.21 110.332 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.74 165.65 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.037 0.446 . . . . 2.85 111.003 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -95.25 152.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.323 -0.621 . . . . 2.42 109.323 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.49 118.44 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.176 -0.305 . . . . 2.74 110.176 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.561 HD22 HD21 ' A' ' 16' ' ' LEU . 5.0 tt -63.13 114.31 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.278 0.561 . . . . 2.11 110.912 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.81 144.13 51.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.591 -0.731 . . . . 2.49 110.324 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 82.3 mt -95.02 148.17 34.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.088 -0.505 . . . . 1.91 110.216 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.23 159.74 45.59 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.576 2.184 . . . . 1.84 112.215 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -53.0 119.7 4.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 2.53 111.521 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.11 4.79 47.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.769 -0.729 . . . . 2.2 112.231 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.9 m -117.73 110.14 17.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.808 0.337 . . . . 2.1 110.227 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.34 137.7 40.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.159 -0.473 . . . . 2.78 111.42 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -70.61 140.92 87.22 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 116.199 -0.455 . . . . 2.62 109.825 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.74 148.97 62.49 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.963 2.442 . . . . 2.77 112.355 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.46 124.87 21.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 4.11 110.718 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.6 -12.55 39.11 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.315 -0.714 . . . . 3.18 111.315 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -105.42 152.09 23.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.816 0.341 . . . . 2.91 111.114 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.496 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 16.9 p90 -151.95 157.47 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 3.54 109.215 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.13 131.1 55.39 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.188 0.305 . . . . 2.93 111.158 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -66.97 125.49 26.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.443 -0.577 . . . . 3.64 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 108.8 -38.59 3.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.997 -0.841 . . . . 3.27 110.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.943 0.402 . . . . 3.59 110.596 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.847 0.356 . . . . 2.48 110.687 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.41 153.77 42.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.944 -0.571 . . . . 2.13 110.971 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.443 ' HD1' ' HE1' ' A' ' 72' ' ' TYR . 76.6 m95 -79.51 -18.82 51.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.053 0.454 . . . . 2.4 111.112 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 119' ' ' LEU . 80.2 m-85 -110.19 161.08 15.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.127 -0.488 . . . . 2.02 112.016 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 p -67.51 167.56 12.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.788 -0.642 . . . . 2.65 111.268 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -79.65 152.82 29.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.096 0.474 . . . . 2.4 111.408 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 76.8 mt -108.65 129.91 55.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 2.27 109.072 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.442 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -103.3 144.67 31.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.422 0.527 . . . . 2.84 112.422 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 5.0 tp-100 -112.21 134.72 53.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 2.89 110.158 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -125.85 69.36 1.19 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.057 -0.52 . . . . 3.82 109.826 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -172.76 -165.74 30.24 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.999 -0.62 . . . . 3.23 111.737 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 65.3 mmtt -88.21 -30.02 20.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.914 0.388 . . . . 4.27 111.544 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.58 166.46 22.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 3.32 110.202 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 4.6 t0 -99.77 -90.05 0.32 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.014 -0.365 . . . . 2.39 110.014 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.475 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 34.2 tp -159.26 134.97 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 2.06 111.018 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -151.51 134.58 15.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.733 -0.667 . . . . 2.22 109.457 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -130.73 134.54 26.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.447 -0.342 . . . . 1.78 110.405 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.46 156.53 55.92 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.985 2.457 . . . . 2.15 111.351 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.86 118.14 5.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.372 -0.377 . . . . 2.6 111.363 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.98 -9.07 57.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 1.65 111.982 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -120.71 152.25 38.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.752 0.31 . . . . 2.31 110.448 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.84 -6.07 22.26 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.698 -0.763 . . . . 1.33 112.77 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 43' ' ' GLN . 38.7 t -90.38 116.52 66.57 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.592 0.234 . . . . 1.06 110.372 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.547 ' HA ' HD23 ' A' ' 121' ' ' LEU . 57.1 Cg_endo -71.23 177.16 6.9 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.633 2.222 . . . . 1.27 112.145 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.62 79.57 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.296 -0.411 . . . . 1.7 110.441 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB2' HE22 ' A' ' 43' ' ' GLN . 46.9 m-80 -76.77 84.71 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 1.23 110.587 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -20.15 65.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 1.94 111.639 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -85.94 -11.92 51.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.199 -0.455 . . . . 1.96 111.553 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.48 ' HB2' HE22 ' A' ' 43' ' ' GLN . 0.7 OUTLIER -118.1 150.23 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.158 0.504 . . . . 1.42 112.03 -178.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.88 166.56 44.15 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.576 -0.738 . . . . 1.73 110.218 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.46 -40.06 79.89 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.947 2.431 . . . . 1.42 112.732 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.36 -24.84 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.977 0.418 . . . . 1.78 111.12 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.934 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 46.2 m-20 -84.82 1.53 46.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.802 -0.636 . . . . 1.6 111.829 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.48 HE22 ' HB2' ' A' ' 38' ' ' SER . 42.0 mm-40 -80.27 57.43 2.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.89 0.376 . . . . 1.05 111.222 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 tt -153.02 134.84 5.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 116.175 -0.466 . . . . 1.17 110.394 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.83 -147.24 6.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.386 -0.911 . . . . 0.6 112.718 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 52.5 p90 -151.58 163.44 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.023 0.44 . . . . 0.99 110.698 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.726 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 37.6 m-85 -105.94 137.15 44.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.451 -0.574 . . . . 1.26 109.451 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -116.35 125.77 52.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.503 -0.317 . . . . 2.15 110.929 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -80.85 123.93 28.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.08 -0.509 . . . . 2.4 109.905 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.2 150.67 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.948 0.404 . . . . 2.21 111.841 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -149.86 96.58 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.863 -0.608 . . . . 2.68 110.469 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HB3' HD12 ' A' ' 64' ' ' LEU . 32.1 ttt85 -71.45 119.46 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 3.59 110.439 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 15.9 ttt-85 -135.72 106.31 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.127 -0.488 . . . . 3.43 110.591 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 pt -86.73 159.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.849 -0.614 . . . . 4.26 110.744 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.216 -0.447 . . . . 5.17 110.428 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 109.619 -0.512 . . . . 4.48 109.619 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -66.26 -51.41 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.234 -0.654 . . . . 4.16 109.234 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 20.8 t70 63.93 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.525 0.935 . . . . 4.09 113.525 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' A' ' 52' ' ' ARG . 63.7 mt -114.9 156.99 23.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 3.36 110.562 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.25 153.53 92.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.842 -0.617 . . . . 3.36 110.962 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HA ' HG23 ' A' ' 51' ' ' THR . 19.7 Cg_endo -58.57 112.89 1.33 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.804 2.336 . . . . 2.69 111.625 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 93.8 mtt180 -114.47 125.38 53.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.249 0.547 . . . . 3.03 112.016 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.726 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 41.8 m95 -98.12 131.69 44.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.632 -0.713 . . . . 1.84 109.833 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -110.69 146.34 36.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.375 -0.375 . . . . 2.76 110.382 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.08 114.73 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.874 0.368 . . . . 1.27 110.927 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.41 ' HD2' HG21 ' A' ' 75' ' ' THR . 31.5 m-85 -113.63 143.65 44.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 1.84 110.085 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.443 ' HE1' ' HD1' ' A' ' 12' ' ' TRP . 76.6 m-85 -81.83 154.01 26.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.2 tt -58.53 118.84 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.556 -0.293 . . . . 1.66 110.448 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.71 27.57 5.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.013 -0.613 . . . . 1.66 112.732 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.41 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -92.49 106.29 18.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.47 -0.429 . . . . 1.58 110.726 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.67 119.86 3.01 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.211 -0.756 . . . . 1.96 111.211 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.46 -51.99 8.69 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.797 2.331 . . . . 2.62 112.206 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.1 30.5 4.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 3.09 111.336 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.96 72.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 1.79 110.27 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.89 39.08 95.04 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.784 -0.644 . . . . 1.65 112.394 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.523 HD21 ' HD2' ' A' ' 87' ' ' LYS . 83.2 mt -118.75 93.71 46.64 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.255 . . . . 1.38 111.149 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.699 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 7.5 Cg_exo -75.93 157.17 38.97 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.966 2.444 . . . . 1.62 110.377 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.671 ' HB2' HD11 ' A' ' 73' ' ' LEU . 80.8 t80 -57.32 112.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 1.58 110.708 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.7 -6.62 26.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.603 -0.808 . . . . 1.44 112.42 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.699 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -66.69 145.78 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.872 0.368 . . . . 1.25 110.682 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -98.14 129.21 44.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.327 -0.397 . . . . 1.86 110.63 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.523 ' HD2' HD21 ' A' ' 81' ' ' LEU . 1.9 ttmt -156.05 143.46 19.29 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.003 -0.74 . . . . 1.68 109.003 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.79 122.65 16.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.777 0.322 . . . . 1.7 111.589 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 21.76 70.84 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 1.27 112.575 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 31.7 mm -130.99 111.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.37 . . . . 1.01 110.87 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.5 pt -118.78 143.32 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.262 -0.644 . . . . 1.3 109.262 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.52 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 91.2 m95 -98.59 141.56 31.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.934 0.716 . . . . 1.08 112.934 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.81 138.5 38.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.329 -0.85 . . . . 1.04 110.387 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.61 168.94 20.72 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.378 -0.601 . . . . 1.27 109.378 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -140.74 157.93 44.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.23 -0.285 . . . . 1.36 110.23 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.06 118.69 8.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.394 . . . . 2.64 110.186 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.109 -0.567 . . . . 1.52 111.692 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.703 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -88.46 149.0 23.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.554 0.216 . . . . 1.59 110.54 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 48.9 mt -104.18 140.21 38.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 -0.285 . . . . 2.15 110.85 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -79.2 99.73 7.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 2.07 111.242 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.428 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 0.4 OUTLIER -173.33 147.37 1.43 Allowed Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.642 . . . . 2.36 109.268 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.12 114.32 3.72 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.191 1.927 . . . . 2.08 112.366 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.934 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -114.59 78.96 1.2 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.442 0.639 . . . . 1.78 110.451 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.91 -6.66 48.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.481 -0.781 . . . . 2.55 112.041 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.566 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 4.7 p80 -60.79 -15.99 35.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.378 0.51 . . . . 2.24 112.378 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.02 15.03 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.947 0.403 . . . . 2.0 111.124 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.36 15.91 53.4 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.873 -0.68 . . . . 2.33 111.957 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 t -108.28 103.03 12.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.025 0.441 . . . . 2.99 111.414 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -159.97 111.81 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.576 . . . . 2.83 110.666 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.64 122.14 76.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.783 -0.451 . . . . 3.56 109.783 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -65.65 -21.04 59.54 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.202 2.601 . . . . 3.39 114.236 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.49 10.88 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.785 0.326 . . . . 4.05 111.578 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -142.06 14.95 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.082 0.468 . . . . 4.48 110.858 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -172.92 135.74 0.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 3.39 110.177 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.47 134.68 39.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.479 -0.328 . . . . 3.21 110.36 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 157.25 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.138 0.494 . . . . 2.85 111.968 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 5.4 mt -94.26 145.57 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.716 -0.675 . . . . 2.42 109.614 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.4 t -61.61 117.17 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.685 0.279 . . . . 2.74 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.442 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . 2.8 tt -61.51 121.08 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.898 -0.592 . . . . 2.11 111.24 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -137.98 150.95 47.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 2.49 110.413 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 33' ' ' PRO . 33.0 mt -103.74 150.3 38.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.242 -0.435 . . . . 1.91 110.071 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.6 150.65 80.75 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.451 2.101 . . . . 1.84 111.288 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -51.67 130.86 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.51 . . . . 2.53 111.378 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.79 -17.47 38.77 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.691 -0.766 . . . . 2.2 111.488 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.03 102.38 12.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 2.1 110.301 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 148.82 29.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.342 -0.39 . . . . 2.78 111.366 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.454 HD23 HD12 ' A' ' 121' ' ' LEU . 70.7 mt -82.43 145.46 51.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.735 -0.469 . . . . 2.62 109.735 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.463 ' HG2' ' CB ' ' A' ' 131' ' ' PHE . 9.9 Cg_endo -54.59 146.32 54.32 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.83 2.353 . . . . 2.77 111.918 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -60.91 112.32 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.84 -0.618 . . . . 4.11 111.93 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.88 -6.99 41.13 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.143 -0.551 . . . . 3.18 112.177 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -101.16 146.31 27.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.486 -0.191 . . . . 2.91 110.486 -179.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.442 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 11.6 p90 -155.93 165.13 37.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 3.54 110.093 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.64 136.92 38.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.814 0.34 . . . . 2.93 111.116 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -65.15 126.02 26.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 3.64 110.376 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.93 21.64 65.34 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.106 -0.569 . . . . 3.27 112.415 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.777 0.322 . . . . 3.59 110.168 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.875 0.369 . . . . 2.48 110.747 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.84 38.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 2.13 110.599 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -87.43 -22.76 24.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.996 0.369 . . . . 2.4 111.996 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.71 161.54 19.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 2.02 111.662 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 p -67.14 158.15 31.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 2.65 111.259 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.406 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -87.13 145.49 26.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 2.4 110.496 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.57 HD11 HD13 ' A' ' 119' ' ' LEU . 2.8 mp -99.85 152.49 20.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.456 -0.572 . . . . 2.27 109.456 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.622 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 2.0 m -109.09 128.29 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.858 0.361 . . . . 2.84 111.148 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -97.06 135.73 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 2.89 109.954 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -132.98 103.35 6.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.842 0.353 . . . . 3.82 110.375 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.07 -151.31 22.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.774 -0.726 . . . . 3.23 111.629 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 25.7 mmtp -103.18 -19.25 14.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.91 0.386 . . . . 4.27 110.904 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -79.76 137.75 37.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.053 -0.721 . . . . 3.32 109.053 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 1.9 t0 -81.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.046 -0.724 . . . . 2.39 109.046 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 17.1 tp 173.07 122.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 2.06 110.98 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -144.39 123.19 12.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.104 -0.498 . . . . 2.22 109.768 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 29.4 m-85 -111.55 142.14 25.96 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 1.78 110.636 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 21.6 Cg_exo -66.75 164.93 27.4 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.238 2.625 . . . . 2.15 112.278 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -62.64 120.95 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 2.6 110.766 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 94' ' ' ALA . . . 75.63 21.95 76.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.987 -0.625 . . . . 1.65 112.542 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 1.7 tt0 -138.26 156.84 47.29 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.757 -0.261 . . . . 2.31 110.925 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.0 -3.92 48.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.817 -0.706 . . . . 1.33 112.719 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 120.94 79.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.602 0.239 . . . . 1.06 110.452 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.424 ' HD3' ' OH ' ' A' ' 47' ' ' TYR . 58.7 Cg_endo -71.79 174.93 10.36 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.646 2.231 . . . . 1.27 111.577 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mt -81.83 83.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.857 0.36 . . . . 1.7 110.376 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -79.08 91.76 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 1.23 109.908 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -17.76 60.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 1.94 112.092 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -89.51 -18.72 26.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.042 0.386 . . . . 1.96 112.042 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -99.44 160.3 14.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.69 0.281 . . . . 1.42 111.673 -179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.4 m -80.94 168.52 24.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.09 -0.505 . . . . 1.73 110.02 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.19 -39.02 93.59 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.462 2.108 . . . . 1.42 112.09 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.9 p-10 -85.05 -1.53 56.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 1.78 111.105 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 0.4 OUTLIER -98.3 0.12 44.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.805 -0.634 . . . . 1.6 110.212 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -79.43 57.52 2.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 1.05 110.814 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 tt -146.15 130.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 1.17 109.728 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.14 -148.03 5.88 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.297 -0.954 . . . . 0.6 112.404 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -153.84 152.96 31.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.802 0.334 . . . . 0.99 111.806 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.424 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 49.3 m-85 -100.16 117.64 34.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.525 -0.917 . . . . 1.26 108.525 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -96.9 131.09 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.991 0.424 . . . . 2.15 111.802 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -79.63 107.23 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 2.4 109.715 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.37 156.13 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.13 0.49 . . . . 2.21 111.67 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.97 140.6 32.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 2.68 109.94 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -124.97 123.48 39.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.976 0.417 . . . . 3.59 111.615 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -139.8 165.34 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 3.43 109.452 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.73 HG12 ' H ' ' A' ' 62' ' ' LYS . 43.1 pt -133.97 173.61 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.367 -0.235 . . . . 4.26 110.367 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.469 HH21 ' HB3' ' A' ' 61' ' ' MET . 3.7 mmp_? . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 116.525 -0.307 . . . . 5.17 110.766 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.469 ' HB3' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.929 0.395 . . . . 4.48 111.154 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.73 ' H ' HG12 ' A' ' 54' ' ' ILE . 66.6 tttt -72.67 -55.18 7.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.95 -0.759 . . . . 4.16 108.95 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.7 t70 56.78 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.162 -0.927 . . . . 4.09 113.042 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 157.07 16.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 3.36 110.304 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.24 158.24 82.42 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.491 . . . . 3.36 110.554 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 116.18 2.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.774 2.316 . . . . 2.69 111.898 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -117.14 125.97 52.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.746 -0.661 . . . . 3.03 110.692 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -99.77 126.18 45.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.976 -0.557 . . . . 1.84 111.128 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 42.5 m-85 -103.51 139.42 38.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 2.76 109.604 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.97 123.12 33.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.077 0.465 . . . . 1.27 111.564 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.448 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 57.5 m-85 -120.3 177.34 5.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.582 -0.735 . . . . 1.84 109.41 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.81 175.24 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.28 111.702 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.09 94.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.456 0.539 . . . . 1.66 112.456 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.69 45.62 3.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.95 -0.643 . . . . 1.66 114.04 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -78.85 84.65 4.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.173 0.487 . . . . 1.58 111.129 179.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.16 136.59 2.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.083 -0.579 . . . . 1.96 111.925 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.26 -35.3 74.78 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 2.62 112.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -129.08 40.36 3.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.3 0.571 . . . . 3.09 110.149 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.89 -60.78 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.727 -0.669 . . . . 1.79 110.069 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.13 51.91 16.07 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.886 -0.673 . . . . 1.65 111.487 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.3 mt -117.0 104.32 50.95 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.796 0.332 . . . . 1.38 111.537 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 91.5 Cg_endo -88.1 151.25 6.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.651 2.234 . . . . 1.62 110.737 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -59.05 111.36 1.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 1.58 110.896 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.83 -3.01 14.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.645 -0.788 . . . . 1.44 112.805 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.454 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -71.73 131.23 42.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 1.25 110.724 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -97.18 114.9 26.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.064 0.459 . . . . 1.86 110.857 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 90' ' ' ILE . 22.3 ttmm -142.0 152.7 43.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.012 -0.736 . . . . 1.68 109.012 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.07 119.6 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 1.7 111.98 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.56 71.17 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.769 -0.651 . . . . 1.27 112.873 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.544 HG13 ' HB3' ' A' ' 87' ' ' LYS . 33.2 mm -125.25 96.09 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.877 0.37 . . . . 1.01 111.572 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.75 137.28 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.492 -0.559 . . . . 1.3 109.492 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -96.58 147.84 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.76 0.652 . . . . 1.08 112.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.27 137.05 33.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.67 -0.696 . . . . 1.04 110.246 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' O ' ' HA2' ' A' ' 29' ' ' GLY . . . -148.36 166.44 28.05 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.655 -0.498 . . . . 1.27 109.655 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 t -139.76 168.4 19.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.745 -0.207 . . . . 1.36 110.689 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.2 124.39 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 2.64 111.254 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.9 -16.5 36.37 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.71 -0.677 . . . . 1.52 112.439 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.783 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -79.97 143.35 34.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.625 0.25 . . . . 1.59 110.656 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.76 148.62 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.417 -0.356 . . . . 2.15 110.526 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -84.54 64.43 8.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.465 0.65 . . . . 2.07 111.193 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.32 143.11 47.49 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.518 -0.765 . . . . 2.36 109.167 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.8 131.19 24.35 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.866 2.377 . . . . 2.08 112.988 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -119.93 44.26 2.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.944 -0.571 . . . . 1.78 110.302 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -13.04 62.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 2.55 112.155 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -21.63 65.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.283 0.475 . . . . 2.24 112.283 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.72 18.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.164 0.507 . . . . 2.0 110.963 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.33 12.19 69.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.862 -0.685 . . . . 2.33 111.659 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -114.44 128.16 56.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.859 0.362 . . . . 2.99 111.494 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -169.25 139.66 2.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.834 -0.621 . . . . 2.83 109.603 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -99.14 120.57 57.95 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.802 0.334 . . . . 3.56 110.648 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.91 -29.5 23.07 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.035 2.49 . . . . 3.39 114.975 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.02 -2.6 57.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.031 -0.418 . . . . 4.05 111.468 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -122.28 0.13 9.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.185 0.517 . . . . 4.48 111.223 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -160.21 142.66 13.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.137 -0.483 . . . . 3.39 109.77 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.33 145.93 24.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.75 0.31 . . . . 3.21 111.215 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.59 138.19 38.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.453 . . . . 2.85 109.778 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.79 141.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.27 -0.423 . . . . 2.42 110.337 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.92 122.37 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.858 -0.423 . . . . 2.74 109.858 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.57 HD13 HD11 ' A' ' 16' ' ' LEU . 2.3 tt -67.61 119.05 11.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.15 0.5 . . . . 2.11 111.436 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -131.01 143.62 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.574 -0.739 . . . . 2.49 110.452 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.3 mt -97.97 149.63 35.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.131 -0.486 . . . . 1.91 110.665 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.08 154.87 48.36 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.669 2.246 . . . . 1.84 111.875 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -58.76 119.2 6.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 2.53 110.515 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 117.81 -26.06 8.16 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.762 -0.732 . . . . 2.2 111.569 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 m -102.95 107.45 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 2.1 110.075 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 155.21 17.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.38 -0.373 . . . . 2.78 111.402 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.6 mt -74.57 142.51 77.71 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.505 -0.554 . . . . 2.62 109.505 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.1 150.01 59.41 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.649 2.233 . . . . 2.77 111.853 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -58.37 116.03 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 4.11 111.337 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 108.57 -20.19 30.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.076 -0.583 . . . . 3.18 111.762 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 16' ' ' LEU . 3.8 t80 -95.61 117.99 31.48 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.487 -0.56 . . . . 2.91 109.487 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.622 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 5.9 p90 -125.49 148.76 48.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.123 0.487 . . . . 3.54 111.535 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.49 142.17 28.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.854 -0.612 . . . . 2.93 110.018 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.85 140.14 33.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.958 0.408 . . . . 3.64 110.557 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.24 -19.57 52.33 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.287 -0.725 . . . . 3.27 111.287 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 120.734 0.302 . . . . 3.59 111.782 -179.648 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.919 0.39 . . . . 2.48 111.294 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.77 146.39 46.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 2.13 111.005 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.499 ' CE2' ' HD3' ' A' ' 109' ' ' ARG . 24.3 m95 -81.86 -34.93 29.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 2.4 111.234 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.07 164.97 11.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.834 -0.621 . . . . 2.02 111.355 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.903 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -62.8 164.65 7.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.068 -0.514 . . . . 2.65 111.663 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -80.11 149.54 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 2.4 112.144 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 119' ' ' LEU . 95.4 mt -105.41 119.15 38.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.325 -0.991 . . . . 2.27 108.325 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 m -100.32 129.42 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.64 0.607 . . . . 2.84 112.64 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -97.5 115.7 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 2.89 110.056 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -110.83 74.03 0.85 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.088 -0.506 . . . . 3.82 109.956 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.62 -162.24 22.61 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.861 -0.608 . . . . 3.23 111.649 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.56 -18.5 22.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.368 . . . . 4.27 110.82 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.18 170.08 12.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.039 -0.528 . . . . 3.32 111.103 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -101.59 -78.31 0.53 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.091 -0.707 . . . . 2.39 109.091 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -178.15 143.66 0.3 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.08 -0.509 . . . . 2.06 110.854 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -159.3 116.26 2.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.071 -0.513 . . . . 2.22 110.0 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.17 134.83 21.38 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 1.78 110.511 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 55.2 Cg_endo -69.66 150.92 69.47 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.599 2.199 . . . . 2.15 112.267 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.1 121.53 10.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.799 -0.637 . . . . 2.6 110.15 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.46 -25.75 13.1 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.215 -0.754 . . . . 1.65 111.215 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 50.5 mt-30 -113.78 -172.47 2.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.22 -0.289 . . . . 2.31 110.22 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.63 -26.08 21.78 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.882 -0.675 . . . . 1.33 112.163 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.25 119.27 75.96 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.576 0.227 . . . . 1.06 110.615 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.88 177.23 8.19 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.197 . . . . 1.27 111.183 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.453 HG22 HG23 ' A' ' 36' ' ' THR . 44.9 mt -77.16 91.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 1.7 110.201 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -84.42 82.88 8.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 1.23 110.287 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.453 HG23 HG22 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -78.07 41.38 0.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.791 -0.64 . . . . 1.94 112.198 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -150.29 -2.6 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 1.96 111.352 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -130.32 170.34 14.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.497 -0.32 . . . . 1.42 111.503 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.36 165.67 32.2 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.594 -0.276 . . . . 1.73 110.271 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 11.8 Cg_endo -56.43 -33.54 92.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.966 2.444 . . . . 1.42 112.225 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -71.74 -24.09 61.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 1.78 110.547 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.99 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 42.4 m-20 -83.53 -2.98 57.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.808 -0.633 . . . . 1.6 110.802 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 32.3 mm-40 -78.26 56.75 1.75 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.344 0.592 . . . . 1.05 111.354 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.418 HG13 ' HB2' ' A' ' 94' ' ' ALA . 14.4 tt -150.87 130.96 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.499 -0.773 . . . . 1.17 109.103 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.31 -146.45 5.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.113 -1.042 . . . . 0.6 112.979 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.453 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 34.2 p90 -155.41 161.35 41.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.003 0.43 . . . . 0.99 110.764 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.599 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 47.4 m-85 -104.56 134.66 47.36 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.187 -0.672 . . . . 1.26 109.187 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -114.65 122.47 46.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.027 -0.533 . . . . 2.15 110.834 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -87.6 123.42 32.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.33 . . . . 2.4 110.406 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.33 155.99 43.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.21 111.485 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.55 120.67 16.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.647 . . . . 2.68 109.95 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.61 ' HB3' HD12 ' A' ' 64' ' ' LEU . 25.9 tpt180 -96.56 122.18 39.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.101 0.477 . . . . 3.59 112.021 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -138.23 145.32 41.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.681 -0.69 . . . . 3.43 109.907 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.479 HG12 ' H ' ' A' ' 62' ' ' LYS . 33.4 pt -121.72 -178.3 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.207 -0.452 . . . . 4.26 109.986 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 5.17 110.528 179.907 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.88 0.372 . . . . 4.48 110.944 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.608 ' HE3' HD21 ' A' ' 64' ' ' LEU . 50.2 tttp -65.39 -54.37 29.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.556 . . . . 4.16 110.291 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.32 91.14 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.606 -0.724 . . . . 4.09 112.89 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 52' ' ' ARG . 63.6 mt -94.59 150.19 20.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 3.36 109.903 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.434 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m -64.83 161.54 45.26 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.224 -0.444 . . . . 3.36 110.39 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 12.2 Cg_endo -56.77 109.24 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.579 2.186 . . . . 2.69 111.244 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -103.51 123.38 46.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 3.03 111.422 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.599 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 79.9 m95 -96.2 120.64 36.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.976 -0.556 . . . . 1.84 110.056 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 53.9 m-85 -106.7 133.31 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.727 -0.472 . . . . 2.76 109.727 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -85.95 121.19 28.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.802 0.334 . . . . 1.27 111.163 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -118.76 146.27 44.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.024 -0.534 . . . . 1.84 109.808 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -82.67 149.3 27.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.463 -0.335 . . . . 1.28 110.504 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 tp -59.44 113.5 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.474 -0.33 . . . . 1.66 110.652 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 122.38 -13.92 8.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.141 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.471 HG22 ' HA3' ' A' ' 107' ' ' GLY . 9.8 p -59.72 123.66 17.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.711 0.291 . . . . 1.58 110.787 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.471 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 105.1 99.64 2.6 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.789 -0.72 . . . . 1.96 111.573 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 10.9 Cg_endo -54.9 -42.54 67.98 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 123.079 2.519 . . . . 2.62 112.334 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.47 28.13 8.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.034 0.445 . . . . 3.09 111.298 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.2 -43.22 53.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 1.79 110.484 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.33 51.82 56.35 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.923 -0.581 . . . . 1.65 111.973 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.22 95.66 35.8 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.735 0.302 . . . . 1.38 111.428 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 4.0 Cg_exo -76.04 159.61 37.42 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.836 2.357 . . . . 1.62 110.323 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -60.08 107.84 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 1.58 111.026 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.24 -13.91 8.35 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.706 -0.679 . . . . 1.44 112.19 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.626 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -60.02 116.64 4.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.054 0.454 . . . . 1.25 111.13 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -76.24 116.33 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 1.86 110.763 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -137.31 158.17 45.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.546 -0.539 . . . . 1.68 109.546 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.33 121.82 16.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.257 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 30.83 71.25 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.95 -0.568 . . . . 1.27 112.595 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.9 mm -131.74 113.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.621 0.248 . . . . 1.01 110.38 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 91' ' ' ILE . 11.8 pt -121.36 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 1.3 109.71 178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 76.4 m95 -91.72 139.61 30.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.347 0.499 . . . . 1.08 112.347 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.13 142.89 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.721 -0.672 . . . . 1.04 110.368 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -154.62 155.25 34.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.401 . . . . 1.27 110.588 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -121.83 170.11 10.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 1.36 109.73 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.73 114.33 11.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.934 0.397 . . . . 2.64 110.172 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.36 5.83 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.039 -0.824 . . . . 1.52 111.039 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.732 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.52 159.96 28.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 1.59 110.748 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.442 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 94.8 mt -118.49 140.56 49.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 2.15 111.263 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.67 80.58 7.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.399 0.619 . . . . 2.07 110.752 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.533 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.3 t -156.28 146.77 16.05 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.115 -0.698 . . . . 2.36 109.115 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.48 118.18 5.47 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.231 1.954 . . . . 2.08 112.401 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.99 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -118.31 67.42 0.77 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.728 . . . . 1.78 110.682 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.79 -4.24 36.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.897 . . . . 2.55 111.224 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -61.35 -14.19 25.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.005 -0.543 . . . . 2.24 112.392 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.42 HD13 ' HB3' ' A' ' 38' ' ' SER . 2.5 mt -104.7 -26.22 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.804 0.335 . . . . 2.0 110.724 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -61.31 -33.23 83.7 Favored Glycine 0 C--N 1.328 0.138 0 CA-C-N 115.901 -0.59 . . . . 2.33 113.482 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -67.23 113.21 4.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.845 0.355 . . . . 2.99 111.387 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HD3' ' CE2' ' A' ' 12' ' ' TRP . 10.7 ttp85 -162.95 128.83 3.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 2.83 111.1 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -91.59 116.92 67.39 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.722 -0.672 . . . . 3.56 109.882 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.81 -33.31 65.37 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.166 2.578 . . . . 3.39 113.044 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.21 14.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.976 0.417 . . . . 4.05 111.812 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -132.16 9.54 4.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.152 -0.476 . . . . 4.48 111.591 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.424 HD22 ' HA ' ' A' ' 114' ' ' ASN . 1.4 t-20 -168.61 129.75 1.26 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.664 0.269 . . . . 3.39 111.653 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.46 168.19 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 3.21 110.519 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 156.98 16.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 2.85 111.627 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 30.3 mt -101.1 142.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.362 -0.977 . . . . 2.42 108.362 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.06 121.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.793 0.33 . . . . 2.74 110.286 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 16' ' ' LEU . 4.2 tt -58.92 112.2 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.706 . . . . 2.11 110.872 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -111.92 144.1 41.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.807 -0.633 . . . . 2.49 110.211 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 65.7 mt -107.5 143.46 27.28 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.301 -0.409 . . . . 1.91 110.766 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.92 156.67 63.16 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.653 2.235 . . . . 1.84 111.635 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -55.66 121.36 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 2.53 110.432 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.57 -21.0 19.9 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.885 -0.674 . . . . 2.2 111.442 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 6.5 m -99.24 104.17 16.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 2.1 110.116 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.97 140.86 35.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.723 -0.671 . . . . 2.78 110.952 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.692 HD22 ' HD2' ' A' ' 131' ' ' PHE . 21.3 mt -73.99 137.97 76.1 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 2.62 110.058 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.74 155.31 38.25 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.665 2.243 . . . . 2.77 112.055 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -58.22 127.87 34.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.734 -0.666 . . . . 4.11 111.306 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -17.21 59.76 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.091 -0.576 . . . . 3.18 112.652 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.692 ' HD2' HD22 ' A' ' 127' ' ' LEU . 2.6 t80 -94.53 120.22 34.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.562 0.22 . . . . 2.91 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -124.35 155.42 38.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.65 -0.25 . . . . 3.54 111.287 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 136.4 41.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.93 111.754 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.903 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.0 tp10 -61.44 123.58 18.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.592 -0.731 . . . . 3.64 110.742 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.84 66.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.9 -0.667 . . . . 3.27 113.631 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.6 m . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 121.037 0.446 . . . . 3.59 111.7 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 N-CA-C 110.005 -0.368 . . . . 2.48 110.005 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -73.16 155.61 39.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.197 0.522 . . . . 2.13 111.543 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -90.42 -24.24 20.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.609 . . . . 2.4 110.985 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 89.2 m-85 -117.2 167.43 11.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 2.02 110.732 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -64.89 155.45 34.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.892 -0.595 . . . . 2.65 110.79 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 163.92 26.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.286 0.565 . . . . 2.4 111.261 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.849 ' HB3' ' HZ ' ' A' ' 131' ' ' PHE . 60.6 mt -111.3 111.55 22.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.675 -0.693 . . . . 2.27 109.854 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.2 OUTLIER -79.44 119.63 22.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 2.84 111.61 -179.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 23' ' ' ASP . 43.4 tp60 -90.49 124.99 35.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 2.89 110.673 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -132.24 91.29 2.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 3.82 110.424 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.13 38.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.298 -0.721 . . . . 3.23 111.298 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 52.6 mmtt -90.96 -7.76 51.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 4.27 111.176 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -114.73 -172.79 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.189 -0.671 . . . . 3.32 109.189 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.572 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -127.34 -149.99 0.43 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.178 -0.675 . . . . 2.39 109.178 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 5.3 mp -95.62 133.38 39.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.751 0.31 . . . . 2.06 110.648 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.18 92.28 1.33 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.174 -0.466 . . . . 2.22 109.858 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -91.67 136.3 26.69 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 1.78 110.995 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -74.16 158.96 44.84 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.658 2.239 . . . . 2.15 111.187 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.5 125.26 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.007 0.432 . . . . 2.6 111.665 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.81 -15.66 52.01 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.637 -0.792 . . . . 1.65 112.62 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -129.98 153.49 48.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.651 0.262 . . . . 2.31 110.379 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.74 1.55 11.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.575 -0.821 . . . . 1.33 112.688 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 43' ' ' GLN . 47.0 t -102.49 115.43 64.43 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.886 0.374 . . . . 1.06 110.852 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.45 178.64 5.93 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.761 2.308 . . . . 1.27 111.439 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.409 HG22 HG23 ' A' ' 36' ' ' THR . 28.8 mt -77.06 92.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.996 0.427 . . . . 1.7 110.456 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.467 ' HB2' HE22 ' A' ' 43' ' ' GLN . 56.0 m-80 -82.73 84.41 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 1.23 110.452 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.409 HG23 HG22 ' A' ' 34' ' ' ILE . 4.4 p -75.4 9.45 2.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.494 0.553 . . . . 1.94 112.494 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -118.08 -5.73 10.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.785 0.291 . . . . 1.96 111.785 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -124.52 168.11 13.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.89 0.376 . . . . 1.42 111.746 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.665 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.6 m -86.87 167.76 20.81 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 115.974 -0.557 . . . . 1.73 109.583 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.54 -36.86 72.39 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.344 2.696 . . . . 1.42 113.293 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.45 -14.76 59.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.057 0.391 . . . . 1.78 112.057 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -88.41 -0.04 56.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.624 0.25 . . . . 1.6 110.351 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.467 HE22 ' HB2' ' A' ' 35' ' ' ASN . 41.0 mm-40 -76.6 51.1 0.72 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.364 -0.38 . . . . 1.05 111.586 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.866 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.7 tt -146.39 130.46 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.17 -0.468 . . . . 1.17 110.233 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.63 -148.84 6.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.462 -0.875 . . . . 0.6 112.457 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -152.51 166.64 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 0.99 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.746 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.9 m-85 -111.72 134.53 53.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.944 -0.571 . . . . 1.26 109.955 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -112.94 133.98 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.195 -0.457 . . . . 2.15 111.211 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 49' ' ' ARG . 12.2 ttt-85 -87.25 121.77 30.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.1 -0.5 . . . . 2.4 109.876 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 156.85 47.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 2.21 111.531 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.409 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -145.21 154.5 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 2.68 110.288 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' HD12 ' A' ' 64' ' ' LEU . 12.8 tpt180 -130.14 118.65 21.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.973 -0.38 . . . . 3.59 109.973 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.88 107.52 5.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.634 -0.257 . . . . 3.43 110.409 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.933 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.8 pt -69.84 158.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 4.26 110.505 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 116.165 -0.47 . . . . 5.17 110.095 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.9 mmt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 110.106 -0.331 . . . . 4.48 110.106 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.933 ' HB2' HG12 ' A' ' 54' ' ' ILE . 43.7 tttt -71.07 -46.59 61.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.557 -0.534 . . . . 4.16 109.557 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 65.95 99.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.974 1.101 . . . . 4.09 113.974 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 52' ' ' ARG . 93.8 mt -126.73 151.1 48.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.484 -0.78 . . . . 3.36 110.024 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.46 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.4 OUTLIER -74.31 153.89 88.12 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.192 -0.458 . . . . 3.36 110.283 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HA ' HG23 ' A' ' 51' ' ' THR . 15.0 Cg_endo -58.14 127.4 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.76 2.307 . . . . 2.69 111.756 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -115.22 124.64 51.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.486 . . . . 3.03 110.613 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.746 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 37.1 m95 -94.26 121.33 35.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 1.84 110.134 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -96.95 146.76 24.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 2.76 110.673 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -94.19 126.92 39.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.899 0.38 . . . . 1.27 110.33 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -126.99 165.77 18.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.955 -0.566 . . . . 1.84 109.867 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -100.62 169.21 9.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.773 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.92 103.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.088 0.773 . . . . 1.66 113.088 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.64 44.74 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.923 -0.58 . . . . 1.66 114.065 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.527 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -74.46 82.93 1.96 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.116 0.484 . . . . 1.58 111.321 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 77' ' ' PRO . . . 159.71 131.18 1.21 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.596 -0.602 . . . . 1.96 111.596 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' ' 76' ' ' GLY . 31.9 Cg_exo -60.23 -37.87 79.98 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.007 2.472 . . . . 2.62 112.322 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.03 31.77 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 3.09 111.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 -53.22 8.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.819 0.342 . . . . 1.79 110.626 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.3 48.49 83.32 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.933 -0.576 . . . . 1.65 112.025 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.1 mt -125.04 103.76 30.11 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.87 0.367 . . . . 1.38 111.592 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.11 162.44 17.9 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.633 2.222 . . . . 1.62 110.933 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -60.88 117.86 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 1.58 111.102 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.08 10.48 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 1.44 112.539 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.83 108.05 2.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 1.25 110.751 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -84.02 137.2 33.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.335 -0.393 . . . . 1.86 110.902 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -147.21 168.43 21.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.459 -0.941 . . . . 1.68 108.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.17 112.23 1.3 Allowed 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.285 0.366 . . . . 1.7 111.783 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.52 39.03 91.09 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.705 -0.68 . . . . 1.27 112.586 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 mm -132.9 102.98 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.825 0.345 . . . . 1.01 110.696 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 47' ' ' TYR . 17.2 pt -113.73 133.86 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.812 -0.44 . . . . 1.3 109.812 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -90.38 140.03 30.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.035 0.445 . . . . 1.08 111.805 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.54 132.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.837 -0.62 . . . . 1.04 110.483 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -150.62 141.71 23.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 1.27 110.471 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 t -112.74 176.61 4.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.523 -0.547 . . . . 1.36 109.523 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -65.04 130.46 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 2.64 110.834 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.52 -15.36 49.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.003 -0.617 . . . . 1.52 112.148 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.866 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -74.56 130.26 39.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.59 110.742 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -103.14 139.51 38.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.136 -0.483 . . . . 2.15 110.873 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -74.15 88.84 1.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.215 0.531 . . . . 2.07 110.5 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.414 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -150.38 153.94 35.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 2.36 109.622 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.414 ' HD2' HG22 ' A' ' 101' ' ' THR . 17.6 Cg_endo -58.65 122.59 11.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.564 2.176 . . . . 2.08 111.468 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.8 mmtt -113.47 29.39 8.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.092 -0.503 . . . . 1.78 111.175 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -13.99 62.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 2.55 111.215 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -65.19 -17.65 64.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.08 -0.509 . . . . 2.24 112.105 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.55 -27.44 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 2.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.527 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -81.21 58.97 4.82 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.925 -0.579 . . . . 2.33 113.225 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 t -138.37 16.31 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 2.99 110.225 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -73.18 137.19 44.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.651 -0.704 . . . . 2.83 110.655 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -95.98 115.67 65.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.426 -0.352 . . . . 3.56 111.124 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.91 -27.97 11.71 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.721 2.281 . . . . 3.39 112.812 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.17 38.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.438 . . . . 4.05 110.847 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -170.1 -45.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 4.48 109.931 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -107.82 139.18 42.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.786 -0.643 . . . . 3.39 110.436 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.34 155.87 22.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.666 0.27 . . . . 3.21 110.876 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.04 162.11 14.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.22 0.533 . . . . 2.85 111.562 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 9.6 mt -98.48 150.55 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.082 -0.71 . . . . 2.42 109.082 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.1 t -69.43 126.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.301 -0.259 . . . . 2.74 110.301 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.476 HD22 HD21 ' A' ' 16' ' ' LEU . 4.4 tt -67.02 110.89 3.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.413 . . . . 2.11 109.911 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -118.11 146.13 44.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.004 -0.544 . . . . 2.49 110.978 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 64.9 mt -99.63 151.34 37.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.893 -0.594 . . . . 1.91 110.169 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.12 163.18 32.5 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.412 2.075 . . . . 1.84 112.48 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -60.69 115.33 3.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 2.53 110.783 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.49 -2.7 23.49 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.636 -0.792 . . . . 2.2 112.094 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 4.0 m -117.02 114.83 24.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 2.1 110.449 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.04 151.77 24.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.442 -0.345 . . . . 2.78 111.099 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.07 148.16 84.07 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.542 -0.54 . . . . 2.62 109.542 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.06 168.47 10.66 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.468 2.112 . . . . 2.77 112.059 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.38 130.93 45.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.076 -0.511 . . . . 4.11 111.891 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.32 65.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.103 -0.57 . . . . 3.18 112.347 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.849 ' HZ ' ' HB3' ' A' ' 16' ' ' LEU . 22.0 t80 -126.82 144.76 50.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.905 0.383 . . . . 2.91 111.384 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -146.65 157.87 43.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.932 -0.576 . . . . 3.54 109.801 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.07 134.12 45.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.012 -0.366 . . . . 2.93 110.012 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.51 150.25 47.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.846 0.355 . . . . 3.64 111.172 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.62 -91.7 0.49 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.873 -0.679 . . . . 3.27 111.779 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--N 1.322 -0.624 0 CA-C-O 120.64 0.257 . . . . 3.59 110.787 -179.703 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.24 0 N-CA-C 109.996 -0.372 . . . . 2.48 109.996 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.2 m -64.89 155.56 33.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.188 0.44 . . . . 2.13 112.188 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -84.53 -25.67 28.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.767 -0.652 . . . . 2.4 111.248 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 81.0 m-85 -114.31 164.95 13.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.969 -0.56 . . . . 2.02 110.751 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 10.4 p -70.99 158.42 36.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.101 -0.5 . . . . 2.65 110.256 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 177.09 9.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.489 . . . . 2.4 110.768 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.67 129.25 48.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.411 -0.589 . . . . 2.27 109.411 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -90.54 115.87 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 2.84 111.268 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -83.13 143.97 30.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 2.89 110.685 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -140.36 79.93 1.73 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 3.82 110.164 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -170.47 41.36 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.728 -0.748 . . . . 3.23 111.975 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 61.8 mmtt -88.09 -10.51 49.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 4.27 110.868 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.38 166.3 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 3.32 109.974 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -104.6 -82.28 0.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.77 -0.456 . . . . 2.39 109.77 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.3 tp -177.82 135.28 0.17 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.329 0.393 . . . . 2.06 110.803 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -162.84 124.09 2.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 2.22 109.576 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.3 138.9 23.9 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.578 -0.283 . . . . 1.78 110.709 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.23 175.25 6.96 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.074 2.516 . . . . 2.15 112.563 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.69 126.3 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 2.6 112.03 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.85 78.2 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.93 -0.652 . . . . 1.65 112.712 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.21 171.86 12.8 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.362 -0.236 . . . . 2.31 110.362 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.25 -8.14 69.49 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.661 -0.781 . . . . 1.33 112.783 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.15 114.73 63.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.673 0.273 . . . . 1.06 110.733 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.11 178.38 7.0 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.425 2.083 . . . . 1.27 111.472 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.449 HG22 HG23 ' A' ' 36' ' ' THR . 11.8 mt -77.38 81.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.868 0.366 . . . . 1.7 110.608 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 56.0 m-80 -81.73 81.55 7.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.23 109.942 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.449 HG23 HG22 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -76.07 3.98 9.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.1 -0.5 . . . . 1.94 112.156 -179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.9 -1.38 26.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 1.96 111.368 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.46 164.85 21.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.892 0.377 . . . . 1.42 111.59 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.432 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -80.88 168.08 27.73 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.013 -0.539 . . . . 1.73 110.275 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 10.3 Cg_endo -54.85 -39.27 90.89 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.932 2.421 . . . . 1.42 113.039 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 2.4 p-10 -73.16 -23.77 60.48 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.719 0.295 . . . . 1.78 110.772 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.977 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 34.4 m-20 -79.04 -2.12 38.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.6 111.256 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.462 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 39.9 mm-40 -81.86 55.71 2.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.245 0.545 . . . . 1.05 111.142 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.68 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.4 tt -152.14 131.96 3.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.17 109.961 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.79 -137.9 2.53 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.305 -0.95 . . . . 0.6 112.683 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -160.42 166.96 28.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.403 . . . . 0.99 110.645 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.631 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 3.0 m-85 -105.96 134.3 49.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.082 -0.71 . . . . 1.26 109.082 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -115.18 123.38 48.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.247 -0.433 . . . . 2.15 111.031 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -79.69 111.08 15.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 2.4 110.048 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.22 165.02 11.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 2.21 111.037 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -154.3 125.51 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 2.68 110.177 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HB3' HD12 ' A' ' 64' ' ' LEU . 17.4 tpt180 -115.37 120.62 40.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 3.59 110.656 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -132.03 162.88 29.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 3.43 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.58 HG12 ' HB2' ' A' ' 62' ' ' LYS . 38.1 pt -125.38 162.76 27.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 4.26 109.912 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.885 0.374 . . . . 5.17 110.631 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 mtm . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 120.743 0.306 . . . . 4.48 110.811 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.631 ' HE3' HD21 ' A' ' 64' ' ' LEU . 52.5 tttp -87.65 -40.19 14.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.19 -0.459 . . . . 4.16 110.451 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t70 40.96 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.247 1.202 . . . . 4.09 114.247 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.631 HD21 ' HE3' ' A' ' 62' ' ' LYS . 90.9 mt -95.78 157.32 15.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 3.36 110.365 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.507 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.7 OUTLIER -69.72 153.06 95.92 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.73 -0.47 . . . . 3.36 109.73 179.145 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 113.85 1.49 Allowed 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.741 2.294 . . . . 2.69 112.057 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.413 HH21 HD13 ' A' ' 64' ' ' LEU . 48.1 mtt-85 -105.72 122.41 46.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 3.03 110.686 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.631 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 67.3 m95 -99.44 115.48 29.39 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.223 -0.444 . . . . 1.84 110.435 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -97.27 142.98 28.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.118 -0.492 . . . . 2.76 109.719 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.89 130.24 35.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 1.27 111.016 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -125.58 154.69 41.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.082 -0.508 . . . . 1.84 109.706 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.02 151.85 20.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.335 -0.393 . . . . 1.28 109.952 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.4 tt -60.38 112.23 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.262 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.49 -5.46 11.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.465 -0.874 . . . . 1.66 113.115 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 p -61.3 108.76 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 1.58 111.646 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 119.86 3.84 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.697 -0.763 . . . . 1.96 112.108 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.2 -37.33 51.95 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.662 2.242 . . . . 2.62 111.954 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -123.33 47.37 2.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.017 0.437 . . . . 3.09 111.013 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.43 -41.86 46.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.449 -0.574 . . . . 1.79 109.449 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 33.58 83.27 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.617 -0.719 . . . . 1.65 112.693 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.583 HD11 ' HD2' ' A' ' 87' ' ' LYS . 82.1 mt -131.05 99.12 18.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.778 0.323 . . . . 1.38 111.467 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.64 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 87.3 Cg_endo -82.87 170.38 12.57 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.488 2.125 . . . . 1.62 110.203 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.695 ' HB2' HD11 ' A' ' 73' ' ' LEU . 69.0 t80 -57.82 111.09 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.783 0.325 . . . . 1.58 110.886 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.06 -17.31 10.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.807 -0.711 . . . . 1.44 112.386 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.04 108.22 1.76 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 1.25 110.954 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -77.61 129.02 35.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.55 . . . . 1.86 110.936 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.583 ' HD2' HD11 ' A' ' 81' ' ' LEU . 75.0 tttt -143.14 162.64 35.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.458 -0.941 . . . . 1.68 108.458 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.81 110.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.881 0.372 . . . . 1.7 111.487 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 28.25 53.8 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.879 -0.677 . . . . 1.27 112.477 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.472 HG13 ' HB3' ' A' ' 87' ' ' LYS . 35.7 mm -128.68 105.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.972 0.415 . . . . 1.01 110.339 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 47' ' ' TYR . 16.0 pt -117.7 127.0 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.198 -0.455 . . . . 1.3 110.135 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.527 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 80.3 m95 -87.25 138.25 31.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.141 0.423 . . . . 1.08 112.141 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.7 138.22 48.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.532 -0.758 . . . . 1.04 110.409 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.99 172.32 13.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.308 -0.406 . . . . 1.27 110.116 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 t -152.73 -176.37 5.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.403 -0.362 . . . . 1.36 110.791 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -65.71 134.82 54.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 2.64 111.118 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.4 -12.1 70.3 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.97 -0.633 . . . . 1.52 112.778 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.07 146.15 30.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.795 0.331 . . . . 1.59 110.727 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.55 149.14 43.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.165 -0.471 . . . . 2.15 110.704 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -82.15 82.75 7.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.259 0.552 . . . . 2.07 110.151 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.588 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 53.0 m -154.5 127.84 4.31 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.274 -0.876 . . . . 2.36 108.705 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.7 129.97 37.48 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.814 2.342 . . . . 2.08 112.783 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.977 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.12 67.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.707 0.765 . . . . 1.78 110.74 179.25 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.19 -7.94 51.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.291 -0.868 . . . . 2.55 111.7 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.405 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.0 p80 -60.14 -22.0 62.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.172 0.434 . . . . 2.24 112.172 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.2 mt -87.82 -35.64 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 2.0 110.563 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.83 66.42 3.75 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.931 -0.577 . . . . 2.33 112.436 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 t -148.35 16.68 1.04 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.533 0.682 . . . . 2.99 110.582 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -74.7 138.92 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.715 . . . . 2.83 110.855 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -85.68 123.16 72.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 3.56 110.605 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.62 -12.29 16.77 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.002 2.468 . . . . 3.39 114.293 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -111.3 9.67 21.65 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.995 -0.441 . . . . 4.05 111.544 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -136.85 12.16 3.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.215 -0.448 . . . . 4.48 111.226 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -169.38 142.12 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 3.39 111.033 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.37 141.73 28.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.388 -0.369 . . . . 3.21 110.624 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.49 146.89 38.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.323 -0.399 . . . . 2.85 110.755 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.419 ' H ' HG13 ' A' ' 117' ' ' ILE . 3.5 mt -77.17 147.58 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.645 -0.707 . . . . 2.42 109.988 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.75 120.19 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.055 -0.35 . . . . 2.74 110.055 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.31 121.67 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 2.11 111.536 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -132.11 142.56 49.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.702 -0.681 . . . . 2.49 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.561 HD13 HG22 ' A' ' 125' ' ' THR . 72.5 mt -94.16 148.39 35.06 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.184 -0.462 . . . . 1.91 110.296 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.21 167.25 16.78 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.894 2.396 . . . . 1.84 112.266 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -60.72 127.07 29.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 2.53 110.661 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.89 -19.66 46.15 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.548 -0.621 . . . . 2.2 111.548 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.561 HG22 HD13 ' A' ' 121' ' ' LEU . 6.4 m -102.42 109.21 20.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.748 0.308 . . . . 2.1 110.396 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 160.35 14.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.444 -0.344 . . . . 2.78 110.735 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -79.91 146.78 64.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.418 -0.355 . . . . 2.62 110.415 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 18.2 Cg_endo -62.87 160.49 33.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.33 2.02 . . . . 2.77 111.778 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.6 113.63 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.578 -0.737 . . . . 4.11 112.142 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.11 0.2 61.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.144 -0.55 . . . . 3.18 113.611 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.486 ' HB2' ' HG2' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -101.15 129.99 47.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.828 0.314 . . . . 2.91 110.895 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -135.52 146.48 48.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 3.54 110.518 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.13 144.93 25.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 2.93 111.691 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 5.9 tt0 -67.81 128.45 36.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.946 -0.57 . . . . 3.64 110.175 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.23 -1.98 74.19 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 3.27 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.7 m . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 120.936 0.398 . . . . 3.59 111.181 179.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.768 0.318 . . . . 2.48 110.719 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -55.64 139.42 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.671 -0.695 . . . . 2.13 112.195 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -73.26 -25.36 60.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 2.4 112.06 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.9 m-85 -109.92 172.97 6.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.496 0.554 . . . . 2.02 112.496 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 p -74.45 -172.94 1.6 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.244 -0.889 . . . . 2.65 111.032 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -95.65 136.81 35.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.838 0.681 . . . . 2.4 112.838 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.598 HD13 ' HE2' ' A' ' 131' ' ' PHE . 17.6 mt -96.55 102.86 14.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.095 -1.076 . . . . 2.27 108.095 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.603 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -85.75 129.27 34.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.362 0.504 . . . . 2.84 112.362 -178.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.468 ' HB2' ' HE1' ' A' ' 131' ' ' PHE . 6.1 tp-100 -97.2 127.83 43.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 2.89 109.706 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.782 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 1.1 t60 -114.74 1.64 14.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.656 0.243 . . . . 3.82 111.656 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.39 -168.65 32.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.901 -0.666 . . . . 3.23 111.869 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -85.71 -33.41 21.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.864 0.364 . . . . 4.27 110.828 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.12 172.39 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 3.32 110.115 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.422 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -101.05 -76.01 0.57 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.952 -0.299 . . . . 2.39 110.64 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 26' ' ' PHE . 23.6 tp -177.5 129.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.457 0.473 . . . . 2.06 111.16 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -156.34 119.23 4.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.291 -0.413 . . . . 2.22 110.212 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 62.2 m-85 -110.3 151.09 42.41 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.147 -0.478 . . . . 1.78 110.562 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.65 164.34 34.81 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.92 2.413 . . . . 2.15 111.538 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -70.44 124.02 23.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 2.6 110.616 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.69 -10.49 52.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.793 -0.718 . . . . 1.65 111.578 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -122.35 -176.82 3.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.62 -0.511 . . . . 2.31 109.62 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.55 -31.63 8.12 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 1.33 112.542 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.95 120.14 78.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 110.336 -0.246 . . . . 1.06 110.336 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.74 -175.43 2.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.787 2.325 . . . . 1.27 112.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.1 mt -78.51 87.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 1.7 110.109 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 63.7 m-80 -82.38 73.04 9.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.325 -0.398 . . . . 1.23 110.557 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.1 68.52 1.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.036 -0.529 . . . . 1.94 111.047 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -176.7 -27.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.913 -0.585 . . . . 1.96 110.906 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 157.99 16.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.149 0.426 . . . . 1.42 112.149 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.06 164.14 61.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.767 -0.652 . . . . 1.73 111.105 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.11 -40.38 77.46 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.555 . . . . 1.42 113.389 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.53 -16.61 61.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.781 -0.367 . . . . 1.78 111.404 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.86 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 16.1 m-20 -87.42 -0.77 57.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.857 -0.611 . . . . 1.6 110.75 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.531 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 54.0 mm-40 -79.29 58.17 2.5 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.242 0.544 . . . . 1.05 110.714 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.538 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.4 tt -149.19 133.24 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.546 -0.752 . . . . 1.17 109.598 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.3 -144.5 5.38 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.342 -0.932 . . . . 0.6 112.633 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.65 162.1 41.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.871 0.367 . . . . 0.99 110.581 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.561 ' HB2' HG13 ' A' ' 91' ' ' ILE . 27.9 m-85 -102.22 123.97 46.98 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.838 -0.801 . . . . 1.26 108.838 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -101.72 133.61 46.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.009 -0.541 . . . . 2.15 111.231 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -82.17 129.26 34.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 2.4 110.099 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 130.17 43.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.099 0.476 . . . . 2.21 111.501 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 111.82 12.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 2.68 109.773 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.637 ' HB3' HD12 ' A' ' 64' ' ' LEU . 12.1 tpt180 -91.68 111.02 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.293 0.568 . . . . 3.59 111.367 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -133.27 103.38 5.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 3.43 110.62 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.629 HG12 ' HB2' ' A' ' 62' ' ' LYS . 44.2 pt -84.8 146.87 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 4.26 110.357 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.799 0.333 . . . . 5.17 110.487 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 38.1 mtt . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 109.794 -0.447 . . . . 4.48 109.794 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.629 ' HB2' HG12 ' A' ' 54' ' ' ILE . 48.8 tttp -58.19 -52.15 66.76 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.729 -0.214 . . . . 4.16 111.134 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t0 56.84 89.28 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.811 0.695 . . . . 4.09 112.51 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.637 HD12 ' HB3' ' A' ' 52' ' ' ARG . 66.1 mt -101.08 170.15 8.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.112 0.482 . . . . 3.36 111.47 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.26 156.57 66.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 3.36 109.578 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.93 117.79 4.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 2.69 111.865 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 67' ' ' ARG . 15.0 mtt-85 -114.28 133.91 55.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.815 -0.63 . . . . 3.03 110.104 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.422 ' HZ2' ' HB3' ' A' ' 23' ' ' ASP . 80.7 m95 -109.49 136.44 48.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 1.84 111.149 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 55.6 m-85 -123.54 138.3 54.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.444 -0.576 . . . . 2.76 109.444 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -86.9 131.62 34.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.854 0.359 . . . . 1.27 111.611 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.23 144.9 51.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.942 -0.572 . . . . 1.84 110.115 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -77.69 151.81 34.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.247 -0.433 . . . . 1.28 110.083 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 6.1 tt -64.39 120.28 11.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.582 -0.281 . . . . 1.66 110.669 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 112.38 -1.36 26.54 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.697 -0.763 . . . . 1.66 112.495 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 p -65.9 117.15 7.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.777 0.322 . . . . 1.58 110.866 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.22 112.38 3.21 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.946 -0.645 . . . . 1.96 111.731 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.42 -41.42 78.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.993 2.462 . . . . 2.62 111.908 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -110.52 39.74 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 3.09 111.034 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.01 -56.15 4.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.398 . . . . 1.79 110.677 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.67 45.88 95.38 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.1 -0.571 . . . . 1.65 112.184 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.74 108.03 17.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.655 0.264 . . . . 1.38 111.514 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 96.1 Cg_endo -86.92 173.77 5.8 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.811 2.34 . . . . 1.62 111.042 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.422 ' HB2' HD11 ' A' ' 73' ' ' LEU . 54.9 t80 -64.17 113.42 3.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.998 0.427 . . . . 1.58 110.737 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.02 -0.37 25.57 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.773 -0.727 . . . . 1.44 112.51 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.01 113.33 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 1.25 110.981 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -77.1 103.25 6.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 1.86 111.329 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -132.22 165.6 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.219 -0.446 . . . . 1.68 110.542 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.36 111.19 2.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.652 0.612 . . . . 1.7 112.652 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.21 41.77 85.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.735 -0.666 . . . . 1.27 112.948 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -131.27 104.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 1.01 110.799 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.561 HG13 ' HB2' ' A' ' 47' ' ' TYR . 5.2 pt -110.12 123.59 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 1.3 109.875 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 80.5 m95 -89.76 135.88 33.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 1.08 112.082 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -137.24 145.63 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.032 -0.531 . . . . 1.04 110.612 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.29 149.69 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.491 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 169.29 8.63 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.07 -0.345 . . . . 1.36 110.07 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -70.11 111.34 5.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.799 -0.445 . . . . 2.64 109.799 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.49 -13.9 8.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 1.52 111.576 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.89 146.64 43.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.828 0.347 . . . . 1.59 110.547 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.1 mt -108.73 142.71 38.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.298 -0.41 . . . . 2.15 111.5 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -80.35 90.35 5.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 2.07 110.574 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.428 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 5.2 t -162.76 146.12 8.72 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.113 -0.699 . . . . 2.36 109.113 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.79 121.38 7.85 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.941 1.761 . . . . 2.08 111.246 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.83 76.9 1.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 1.78 112.343 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 2.7 p-10 -85.56 5.91 29.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.34 -0.391 . . . . 2.55 111.394 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.9 p80 -57.84 -23.11 51.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.773 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.17 9.2 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.003 -0.544 . . . . 2.0 110.256 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.53 -35.65 13.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.652 -0.785 . . . . 2.33 111.973 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 t -68.65 125.59 27.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 2.99 110.863 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -162.59 125.72 2.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 2.83 109.873 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -86.42 116.39 65.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 123.276 0.36 . . . . 3.56 110.673 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.73 -32.51 46.82 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.879 2.386 . . . . 3.39 112.958 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.35 0.26 49.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.84 0.311 . . . . 4.05 111.84 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -128.39 -4.76 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.963 0.411 . . . . 4.48 111.167 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -149.88 128.25 12.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.766 0.317 . . . . 3.39 110.944 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.29 155.42 30.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.019 -0.537 . . . . 3.21 110.756 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.3 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 2.85 111.435 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 18.6 mt -101.5 146.54 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.711 -0.677 . . . . 2.42 109.621 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.23 120.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.61 0.243 . . . . 2.74 110.407 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.57 114.43 3.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.008 -0.542 . . . . 2.11 111.082 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -136.84 152.96 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 2.49 110.61 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.51 HD13 HG22 ' A' ' 125' ' ' THR . 72.3 mt -100.94 147.7 34.05 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 1.91 110.114 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.56 160.86 30.27 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.756 2.304 . . . . 1.84 112.782 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.53 120.36 9.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.794 -0.639 . . . . 2.53 110.478 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.82 14.84 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.098 -1.201 . . . . 2.2 110.098 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.51 HG22 HD13 ' A' ' 121' ' ' LEU . 6.3 m -112.61 114.79 27.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 2.1 108.845 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 156.78 18.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.33 -0.396 . . . . 2.78 111.55 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.19 76.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 2.62 109.698 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 28.4 Cg_endo -65.64 156.99 60.96 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.44 2.094 . . . . 2.77 111.448 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.46 120.95 14.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 4.11 111.644 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.17 -2.1 47.32 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.419 -0.672 . . . . 3.18 111.419 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.598 ' HE2' HD13 ' A' ' 16' ' ' LEU . 1.6 t80 -110.3 129.38 55.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.29 . . . . 2.91 110.613 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.782 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 26.3 p90 -141.12 162.85 34.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 3.54 110.064 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -119.05 148.01 43.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.721 0.296 . . . . 2.93 111.029 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.0 131.05 43.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.591 -0.522 . . . . 3.64 109.591 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.78 -26.6 23.78 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 3.27 112.191 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--N 1.324 -0.521 0 O-C-N 122.593 -0.357 . . . . 3.59 110.701 179.847 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.647 0.261 . . . . 2.48 110.814 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.06 166.39 12.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.484 -0.326 . . . . 2.13 110.895 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.85 -38.64 7.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.313 0.577 . . . . 2.4 110.2 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.4 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 86.1 m-85 -108.58 165.67 11.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.649 -0.705 . . . . 2.02 110.402 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.939 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 8.3 p -58.86 151.76 20.84 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.397 0.436 . . . . 2.65 111.366 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HB3' ' HD3' ' A' ' 67' ' ' ARG . . . -75.98 137.31 40.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 2.4 112.015 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 55.4 mt -88.89 147.75 24.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.94 -0.763 . . . . 2.27 108.94 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.658 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -126.36 138.75 53.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.828 -0.349 . . . . 2.84 111.388 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -99.71 132.32 45.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 2.89 110.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.61 62.66 1.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.247 -0.649 . . . . 3.82 109.247 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.46 -159.68 9.58 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.686 -0.688 . . . . 3.23 111.907 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -91.05 -25.08 19.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.161 0.43 . . . . 4.27 112.161 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -90.6 176.02 6.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.671 0.272 . . . . 3.32 110.58 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.84 -71.38 0.68 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 2.39 109.961 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.9 tp 177.85 142.3 0.09 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.842 -0.617 . . . . 2.06 110.534 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -156.31 133.82 10.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.385 -0.37 . . . . 2.22 110.029 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 43.1 m-85 -127.61 134.32 26.05 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.956 -0.387 . . . . 1.78 109.956 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 22.3 Cg_exo -65.51 167.44 16.97 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.895 2.396 . . . . 2.15 112.411 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.54 127.06 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 2.6 110.518 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.09 6.88 78.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.826 -0.702 . . . . 1.65 112.466 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -138.75 147.27 42.45 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.232 -0.285 . . . . 2.31 110.232 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.63 -28.25 5.28 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.683 -0.77 . . . . 1.33 112.908 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.01 119.21 75.83 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.663 0.232 . . . . 1.06 110.725 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.478 ' HG2' HD21 ' A' ' 35' ' ' ASN . 41.8 Cg_endo -67.94 168.71 18.07 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.556 2.17 . . . . 1.27 111.851 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 mt -74.62 81.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 1.7 111.604 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.478 HD21 ' HG2' ' A' ' 33' ' ' PRO . 40.5 m-80 -83.97 86.61 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 1.23 110.118 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -21.66 65.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.94 111.597 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -75.85 -18.55 59.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 1.96 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -111.24 151.05 28.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.511 -0.313 . . . . 1.42 110.798 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.588 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 6.1 m -73.76 165.47 52.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 1.73 109.921 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.3 Cg_endo -52.77 -39.54 76.87 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.955 2.437 . . . . 1.42 113.342 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.682 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -76.51 -9.91 59.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.954 0.353 . . . . 1.78 111.954 -179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.65 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.6 m-20 -95.09 1.58 54.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.049 0.452 . . . . 1.6 109.946 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -83.9 61.64 6.52 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.058 -0.519 . . . . 1.05 111.108 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.761 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.2 tt -146.93 130.54 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.755 -0.657 . . . . 1.17 109.908 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.77 -141.32 3.51 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.237 -0.982 . . . . 0.6 113.111 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -163.69 170.18 17.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 0.99 110.345 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.466 ' HB2' HG13 ' A' ' 91' ' ' ILE . 42.9 m-85 -109.94 130.31 55.55 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.507 -0.553 . . . . 1.26 109.507 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -103.41 132.38 49.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.895 0.379 . . . . 2.15 111.657 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -85.54 119.53 25.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.744 . . . . 2.4 110.216 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -134.64 157.03 47.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 2.21 111.185 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 64' ' ' LEU . 93.9 m -154.06 104.6 2.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.793 -0.639 . . . . 2.68 109.764 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.482 ' HB3' HD12 ' A' ' 64' ' ' LEU . 10.1 tpt180 -83.32 113.15 20.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.912 0.387 . . . . 3.59 111.459 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 5.6 mtp180 -121.72 87.47 2.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 3.43 109.438 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 61' ' ' MET . 38.5 pt -79.38 148.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 4.26 111.134 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 5.17 110.084 179.892 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 35.6 mtt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 110.01 -0.367 . . . . 4.48 110.01 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -60.95 -36.6 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.422 -0.584 . . . . 4.16 109.422 178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 29.3 t0 50.28 77.93 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.766 -1.106 . . . . 4.09 112.824 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 52' ' ' ARG . 89.3 mt -80.37 146.03 31.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.397 -0.594 . . . . 3.36 109.397 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 45.1 m -69.12 158.15 87.34 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.278 -0.268 . . . . 3.36 110.278 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 9.7 Cg_endo -51.61 103.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.922 2.415 . . . . 2.69 112.644 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.501 HH22 ' CD ' ' A' ' 134' ' ' GLU . 3.4 mtt180 -101.42 138.8 37.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.836 -0.62 . . . . 3.03 110.296 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.8 124.55 49.75 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.728 -0.669 . . . . 1.84 110.72 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.535 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 32.6 m-85 -109.42 127.32 54.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.683 -0.689 . . . . 2.76 109.525 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -78.07 126.47 30.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.905 0.383 . . . . 1.27 111.26 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.54 149.32 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.895 -0.78 . . . . 1.84 108.895 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -81.72 157.49 24.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.326 -0.25 . . . . 1.28 110.326 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.6 tp -58.45 115.34 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.524 -0.307 . . . . 1.66 111.045 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.57 52.19 4.03 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.606 -0.807 . . . . 1.66 111.852 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.94 78.55 5.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.921 0.391 . . . . 1.58 111.419 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.46 139.32 2.75 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.846 -0.692 . . . . 1.96 112.178 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.84 -26.27 32.3 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.587 2.191 . . . . 2.62 112.162 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.2 35.92 4.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 3.09 110.645 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.18 -55.59 5.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.999 -0.546 . . . . 1.79 110.95 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.13 36.57 92.05 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 1.65 112.019 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.67 103.55 53.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.026 0.441 . . . . 1.38 111.658 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.755 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 85.8 Cg_endo -84.8 165.46 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.388 2.059 . . . . 1.62 110.546 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -64.47 105.99 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.861 0.362 . . . . 1.58 110.274 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.13 -11.87 7.67 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.8 -0.714 . . . . 1.44 112.376 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -54.78 117.12 3.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.806 0.336 . . . . 1.25 111.389 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -76.48 99.76 5.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.539 . . . . 1.86 111.405 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -129.65 148.72 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 1.68 110.128 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.62 119.34 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.193 0.442 . . . . 1.7 112.193 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.02 53.31 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.848 -0.614 . . . . 1.27 112.624 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -129.54 111.09 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.88 0.371 . . . . 1.01 110.875 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 47' ' ' TYR . 5.8 pt -115.91 118.71 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 1.3 110.08 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.72 136.95 35.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.634 0.605 . . . . 1.08 112.634 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 m -137.93 145.13 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.682 -0.69 . . . . 1.04 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.78 -177.58 6.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.274 -0.421 . . . . 1.27 109.972 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -153.64 172.8 16.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.629 -0.259 . . . . 1.36 110.581 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.62 115.91 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.275 0.559 . . . . 2.64 111.23 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.52 -19.63 16.47 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.82 -0.705 . . . . 1.52 112.001 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.761 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.85 126.98 31.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.382 -0.229 . . . . 1.59 110.382 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.682 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 66.9 mt -96.54 156.05 16.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.894 0.378 . . . . 2.15 111.295 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -84.4 83.82 7.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.145 0.498 . . . . 2.07 110.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.5 m -153.17 133.98 8.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.854 -0.612 . . . . 2.36 109.463 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.18 125.84 18.62 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.171 2.581 . . . . 2.08 112.086 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.65 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.3 mmtt -105.45 39.23 1.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.649 -0.705 . . . . 1.78 111.244 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -13.65 59.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.493 . . . . 2.55 111.551 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -70.38 -17.59 63.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.472 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.1 mt -96.02 -33.88 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.329 . . . . 2.0 110.768 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.58 57.22 4.17 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.914 -0.585 . . . . 2.33 112.389 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.7 t -134.1 20.23 3.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.421 0.629 . . . . 2.99 109.582 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 13.0 ttp180 -83.21 136.5 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.737 -0.665 . . . . 2.83 111.702 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.443 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 4.1 m-20 -96.84 114.6 64.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 3.56 110.095 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 26.6 Cg_endo -61.47 -28.3 83.42 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.912 2.408 . . . . 3.39 113.182 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 -10.84 59.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 4.05 111.364 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -116.31 -21.53 9.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.477 -0.328 . . . . 4.48 111.709 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.5 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 2.7 t-20 -137.14 120.0 16.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.689 0.28 . . . . 3.39 110.61 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 155.54 39.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.055 -0.52 . . . . 3.21 111.625 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.44 154.19 24.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 2.85 111.204 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 18.6 mt -102.74 150.34 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.777 -0.453 . . . . 2.42 109.777 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.7 120.19 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.586 0.231 . . . . 2.74 110.415 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.54 119.39 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 2.11 110.517 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -122.88 160.53 25.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.293 -0.412 . . . . 2.49 110.699 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.627 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 87.3 mt -110.08 150.4 41.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 1.91 111.297 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -65.05 170.88 9.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.986 2.457 . . . . 1.84 112.27 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.08 113.36 3.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 2.53 111.254 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.51 -14.0 30.2 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.993 -0.622 . . . . 2.2 112.723 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 4.7 m -88.47 140.95 28.94 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.707 -0.29 . . . . 2.1 110.393 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.39 144.82 50.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.818 0.342 . . . . 2.78 111.793 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.47 ' HG ' HD11 ' A' ' 121' ' ' LEU . 21.9 mt -87.28 144.38 35.91 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.08 -0.509 . . . . 2.62 109.738 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.34 156.18 26.89 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.913 2.408 . . . . 2.77 112.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -62.01 122.4 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.743 -0.662 . . . . 4.11 111.122 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.02 -8.53 61.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.917 -0.658 . . . . 3.18 111.873 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 3.7 t80 -97.1 144.16 27.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.916 -0.402 . . . . 2.91 109.916 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.658 ' CE1' ' HB ' ' A' ' 17' ' ' THR . 3.9 p90 -147.88 171.73 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 3.54 110.478 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -121.82 147.33 46.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 2.93 111.059 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.939 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.2 tp10 -68.47 122.5 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 3.64 110.67 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.86 66.65 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.013 -0.613 . . . . 3.27 112.98 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 3.59 111.779 -179.639 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.927 0.394 . . . . 2.48 111.906 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.52 164.91 26.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 2.13 111.016 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -90.65 -25.47 20.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 2.4 111.864 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 59.6 m-85 -115.75 171.61 7.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.27 0.47 . . . . 2.02 112.27 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 p -70.83 167.15 19.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 2.65 111.048 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -91.75 161.58 14.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.487 . . . . 2.4 111.058 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.98 127.24 56.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.505 -0.77 . . . . 2.27 109.758 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 65' ' ' SER . 80.7 m -90.93 126.86 36.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.301 -0.409 . . . . 2.84 111.058 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -97.08 134.01 40.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 2.89 110.199 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -130.82 90.26 2.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 3.82 109.308 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.36 -151.25 8.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.566 -0.826 . . . . 3.23 112.828 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 71.2 mmtt -108.6 -2.21 18.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.801 0.334 . . . . 4.27 111.789 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -120.07 176.76 5.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.257 -0.275 . . . . 3.32 110.257 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.49 -87.62 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.283 -0.417 . . . . 2.39 110.76 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 131' ' ' PHE . 55.4 tp -172.36 127.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.84 0.353 . . . . 2.06 110.869 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -148.93 105.11 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 2.22 109.949 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -89.24 146.97 37.26 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.074 -0.512 . . . . 1.78 110.541 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 57.6 Cg_endo -72.0 163.34 39.12 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.569 2.18 . . . . 2.15 111.857 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -58.11 122.54 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.884 -0.598 . . . . 2.6 111.016 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.11 -12.32 66.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.612 -0.804 . . . . 1.65 113.172 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.502 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 37.0 tt0 -118.06 157.73 26.29 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.632 -0.334 . . . . 2.31 110.969 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 126.16 -26.16 5.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.57 -0.612 . . . . 1.33 111.57 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.43 119.65 77.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.343 -0.243 . . . . 1.06 110.343 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.15 -170.44 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.488 2.125 . . . . 1.27 110.797 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.94 90.84 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.121 0.486 . . . . 1.7 110.816 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 70.2 m-20 -93.98 73.36 4.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.417 -0.586 . . . . 1.23 109.417 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -20.73 66.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.362 -0.835 . . . . 1.94 111.927 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -82.45 -3.48 55.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.33 -0.396 . . . . 1.96 111.84 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -126.69 159.58 33.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.921 0.391 . . . . 1.42 111.815 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.624 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 m -82.67 167.24 31.19 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.634 -0.712 . . . . 1.73 110.139 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.624 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 13.7 Cg_endo -55.88 -35.67 94.34 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.939 2.426 . . . . 1.42 112.878 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.667 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 p-10 -78.73 -11.22 59.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.267 -0.424 . . . . 1.78 111.605 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -97.46 -1.9 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 1.6 109.895 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 75.6 mm-40 -78.52 53.88 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 1.05 111.119 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.58 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 13.5 tt -144.09 125.57 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.794 -0.639 . . . . 1.17 109.856 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.44 -145.23 4.38 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.142 -1.028 . . . . 0.6 112.522 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.454 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 48.8 p90 -160.02 170.75 20.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.121 -0.326 . . . . 0.99 110.121 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.676 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 39.0 m-85 -112.51 136.95 51.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.503 -0.554 . . . . 1.26 109.503 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -115.27 132.07 56.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.569 0.224 . . . . 2.15 110.534 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -82.03 124.99 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.076 -0.511 . . . . 2.4 109.672 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -133.61 156.2 48.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 2.21 111.206 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 m -158.53 134.65 9.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 2.68 109.935 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 52' ' ' ARG . 4.1 tpt180 -107.07 122.17 45.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 3.59 110.461 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 4.3 ttt180 -138.96 82.38 1.9 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.716 0.293 . . . . 3.43 111.532 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.825 HG12 ' HB2' ' A' ' 62' ' ' LYS . 26.3 pt -72.13 154.73 7.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.448 -0.342 . . . . 4.26 110.539 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 5.17 110.091 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.873 -0.417 . . . . 4.48 109.873 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.825 ' HB2' HG12 ' A' ' 54' ' ' ILE . 39.6 tptt -55.44 -49.73 71.67 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.521 0.513 . . . . 4.16 110.421 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 15.0 t70 59.02 91.17 0.05 OUTLIER 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.561 -0.745 . . . . 4.09 112.691 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.78 148.63 36.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.735 -0.666 . . . . 3.36 110.161 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.562 ' HB2' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -70.32 146.44 94.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.16 -0.473 . . . . 3.36 110.557 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.5 118.45 5.33 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.858 2.372 . . . . 2.69 111.559 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -119.09 146.36 45.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 3.03 111.31 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.676 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.7 m95 -112.8 131.3 55.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.721 -0.672 . . . . 1.84 110.227 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 58.6 m-85 -109.66 145.29 36.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.101 -0.499 . . . . 2.76 109.685 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -94.63 127.64 40.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 1.27 111.257 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -130.4 162.49 29.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.977 -0.556 . . . . 1.84 109.673 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -93.52 168.39 11.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.582 -0.281 . . . . 1.28 110.418 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.58 126.94 29.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.524 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.67 47.1 92.49 Favored Glycine 0 CA--C 1.516 0.105 0 N-CA-C 115.274 0.869 . . . . 1.66 115.274 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -74.92 101.97 4.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.246 0.523 . . . . 1.58 110.023 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.82 136.97 5.1 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.828 -0.701 . . . . 1.96 111.431 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.79 -28.4 68.02 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.678 2.252 . . . . 2.62 112.496 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.9 53.01 1.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 3.09 110.743 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.08 -46.97 5.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.879 -0.6 . . . . 1.79 110.515 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.64 24.84 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.882 -0.887 . . . . 1.65 110.882 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.779 ' HB3' ' HH2' ' A' ' 92' ' ' TRP . 65.2 mt -125.93 94.93 40.73 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 1.38 111.968 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -91.33 135.93 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 1.62 110.812 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -52.57 115.16 1.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.251 -0.431 . . . . 1.58 111.568 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.38 8.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.658 . . . . 1.44 112.778 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.83 163.49 21.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.993 0.425 . . . . 1.25 111.026 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.64 131.21 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.442 -0.345 . . . . 1.86 110.936 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -148.53 155.83 41.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.52 . . . . 1.68 110.109 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.35 117.57 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.257 -0.429 . . . . 1.7 111.919 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.6 34.62 67.34 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.75 -0.659 . . . . 1.27 112.635 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.3 mm -134.44 114.95 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.748 0.308 . . . . 1.01 110.687 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 91' ' ' ILE . 8.5 pt -123.03 134.78 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.878 -0.416 . . . . 1.3 109.878 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.779 ' HH2' ' HB3' ' A' ' 81' ' ' LEU . 56.5 m95 -90.28 144.82 25.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.586 0.587 . . . . 1.08 112.586 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.466 HG11 ' HA3' ' A' ' 31' ' ' GLY . 11.0 m -142.07 134.6 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.521 -0.763 . . . . 1.04 109.993 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.62 147.46 26.78 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.818 0.342 . . . . 1.27 111.229 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 43' ' ' GLN . 2.8 t -106.42 166.83 10.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.984 -0.553 . . . . 1.36 109.892 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.05 117.87 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.048 0.452 . . . . 2.64 110.319 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.7 -4.71 22.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.901 -0.666 . . . . 1.52 111.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.667 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -80.27 144.98 32.41 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.439 -0.208 . . . . 1.59 110.439 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 62.0 mt -90.38 139.61 30.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.728 0.299 . . . . 2.15 110.867 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -84.06 79.21 9.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.247 0.546 . . . . 2.07 110.111 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.44 154.22 13.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.788 -0.642 . . . . 2.36 110.034 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.67 129.02 27.63 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.678 2.252 . . . . 2.08 112.292 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -116.53 45.63 1.77 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.797 -0.638 . . . . 1.78 110.508 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -13.74 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.691 -0.686 . . . . 2.55 112.282 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -61.62 -12.97 18.25 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.375 0.509 . . . . 2.24 112.375 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.8 mt -104.0 -32.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 2.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.57 -9.0 42.29 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.845 -0.616 . . . . 2.33 114.558 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.0 t -79.72 63.0 4.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.332 0.586 . . . . 2.99 111.215 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.402 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 47.0 ttp85 -118.33 139.71 50.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 2.83 110.926 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -99.98 115.26 65.7 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.981 -0.554 . . . . 3.56 110.317 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.02 -24.47 39.17 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.979 2.453 . . . . 3.39 113.332 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.09 1.48 56.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 4.05 111.366 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -119.04 -48.61 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 4.48 110.158 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 12.9 t-20 -106.93 137.13 45.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 3.39 110.52 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.44 139.5 45.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.103 -0.332 . . . . 3.21 110.103 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.8 158.1 28.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.057 0.456 . . . . 2.85 111.183 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 25.8 mt -104.99 141.92 19.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.974 -0.557 . . . . 2.42 109.796 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.62 127.08 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.883 -0.414 . . . . 2.74 109.883 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -66.7 116.73 7.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.485 . . . . 2.11 110.019 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.58 149.37 43.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.189 -0.46 . . . . 2.49 110.865 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.36 146.79 33.12 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.522 . . . . 1.91 109.957 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.64 157.18 62.18 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.603 2.202 . . . . 1.84 111.823 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.02 118.36 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 2.53 110.935 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.41 -15.18 17.85 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.744 -0.741 . . . . 2.2 111.349 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.2 m -104.99 119.42 38.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.965 0.412 . . . . 2.1 110.55 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.94 152.49 25.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.084 -0.507 . . . . 2.78 110.498 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.22 140.69 34.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.593 -0.276 . . . . 2.62 110.369 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.36 147.24 96.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.39 2.06 . . . . 2.77 110.902 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -51.3 123.15 9.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 4.11 112.042 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.24 4.74 56.31 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.059 -0.591 . . . . 3.18 112.586 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -123.1 130.95 53.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.792 0.329 . . . . 2.91 111.182 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -153.45 149.56 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.085 -0.507 . . . . 3.54 110.248 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.4 146.32 27.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 2.93 110.886 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -70.59 150.31 46.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 3.64 110.891 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.14 64.97 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.756 -0.735 . . . . 3.27 112.255 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 120.614 0.245 . . . . 3.59 110.769 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.336 0 N-CA-C 109.49 -0.559 . . . . 2.48 109.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -53.23 146.17 12.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.348 0.87 . . . . 2.13 113.348 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -73.12 -35.0 66.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.793 -0.64 . . . . 2.4 110.759 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -108.36 170.92 7.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.822 -0.626 . . . . 2.02 111.245 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.866 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 11.2 p -69.15 168.48 13.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.646 -0.706 . . . . 2.65 111.142 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -92.99 159.76 15.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 2.4 110.989 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 35.9 mt -100.17 112.7 25.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.258 -0.428 . . . . 2.27 110.267 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 m -82.82 113.33 20.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.237 -0.438 . . . . 2.84 111.632 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.37 146.58 26.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 2.89 111.331 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -141.18 89.26 2.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.927 -0.579 . . . . 3.82 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.63 -168.33 41.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.893 -0.67 . . . . 3.23 112.22 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 48.5 mmtt -81.93 -31.59 31.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.763 0.316 . . . . 4.27 111.267 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.61 -174.14 5.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.262 -0.426 . . . . 3.32 109.922 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.54 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -112.53 -88.12 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.608 -0.516 . . . . 2.39 109.608 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.405 HD13 ' CE1' ' A' ' 131' ' ' PHE . 52.5 tp -168.94 126.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 2.06 110.465 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -146.79 134.39 20.99 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.89 -0.411 . . . . 2.22 109.89 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.78 150.84 46.46 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 1.78 110.029 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.667 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 56.3 Cg_endo -73.06 -173.51 1.27 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.568 2.179 . . . . 2.15 112.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -79.97 126.39 30.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.234 -0.439 . . . . 2.6 110.891 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.9 -7.44 80.18 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 1.65 113.111 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.667 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 21.4 tt0 -122.55 154.28 38.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.184 -0.302 . . . . 2.31 110.184 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.3 -21.34 7.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.435 -0.888 . . . . 1.33 112.585 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 43' ' ' GLN . 43.1 t -80.06 119.53 76.89 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.661 0.267 . . . . 1.06 110.562 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.9 -176.59 2.68 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.947 2.431 . . . . 1.27 111.738 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.94 87.92 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.359 -0.382 . . . . 1.7 110.303 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.433 ' HB2' HE22 ' A' ' 43' ' ' GLN . 63.6 m-80 -85.83 83.14 7.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 1.23 110.197 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.68 1.21 3.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.567 -0.742 . . . . 1.94 112.879 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -107.57 -6.39 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.28 . . . . 1.96 111.212 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.31 150.35 47.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.09 -0.244 . . . . 1.42 110.957 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -71.95 162.49 73.11 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.814 -0.439 . . . . 1.73 109.814 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -34.9 78.19 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 1.42 112.24 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -18.86 61.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.903 -0.59 . . . . 1.78 111.432 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.14 0.99 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 1.6 111.092 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.61 ' HB3' HG11 ' A' ' 32' ' ' VAL . 69.0 mm-40 -79.15 59.98 2.89 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.09 0.471 . . . . 1.05 110.957 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.621 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -146.66 130.68 10.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.919 -0.582 . . . . 1.17 110.252 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.72 -141.36 3.62 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.522 -0.847 . . . . 0.6 112.807 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -160.56 159.47 30.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 0.99 110.374 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.564 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 49.0 m-85 -100.09 133.14 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.621 -0.881 . . . . 1.26 108.621 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -117.86 122.41 43.28 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.229 0.331 . . . . 2.15 111.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.52 129.93 35.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.281 -0.418 . . . . 2.4 110.035 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.27 140.0 27.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.727 0.299 . . . . 2.21 110.814 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 133.81 38.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 2.68 111.074 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.693 ' HB3' HD12 ' A' ' 64' ' ' LEU . 28.0 tpt180 -101.87 129.27 48.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.006 -0.738 . . . . 3.59 109.006 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttt180 -138.86 78.05 1.65 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.668 -0.242 . . . . 3.43 110.851 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 153.3 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.965 -0.294 . . . . 4.26 110.592 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 55' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 5.17 110.489 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.555 0.217 . . . . 4.48 110.836 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -62.16 -47.31 85.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 4.16 110.988 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.615 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 25.0 t70 61.24 90.3 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.895 -0.593 . . . . 4.09 112.291 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 52' ' ' ARG . 15.4 mt -87.13 157.94 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.317 -0.401 . . . . 3.36 110.384 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -77.83 149.42 77.29 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.08 -0.509 . . . . 3.36 109.919 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.41 110.5 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.917 2.412 . . . . 2.69 111.648 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.533 HH21 ' CD ' ' A' ' 134' ' ' GLU . 5.5 mtp180 -121.42 138.81 54.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 3.03 111.51 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.564 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 29.2 m95 -104.33 123.92 48.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.872 -0.604 . . . . 1.84 110.434 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.99 131.8 45.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.551 -0.537 . . . . 2.76 109.551 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -79.83 127.35 32.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.842 0.353 . . . . 1.27 111.099 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -124.84 148.25 48.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.988 -0.551 . . . . 1.84 109.587 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -84.87 159.27 20.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.939 -0.393 . . . . 1.28 109.939 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.685 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 1.9 tt -61.65 118.09 6.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.286 -0.265 . . . . 1.66 110.286 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.82 32.78 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 1.66 112.618 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.3 68.62 8.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 1.58 111.058 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.45 118.6 0.51 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.482 -1.047 . . . . 1.96 110.482 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.66 -43.68 44.54 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.101 2.534 . . . . 2.62 112.379 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.18 53.29 0.83 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.167 0.508 . . . . 3.09 111.153 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.19 -58.7 2.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.028 0.442 . . . . 1.79 109.808 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.72 65.02 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.65 112.706 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt -134.03 102.18 12.26 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.603 0.239 . . . . 1.38 110.509 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.05 176.61 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.933 2.422 . . . . 1.62 111.772 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.522 ' HB2' HD11 ' A' ' 73' ' ' LEU . 13.0 t80 -57.87 116.44 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 1.58 110.646 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.9 -17.51 9.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.685 -0.769 . . . . 1.44 111.987 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.16 110.35 3.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.408 . . . . 1.25 110.462 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -76.89 124.27 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 1.86 110.856 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB3' HG13 ' A' ' 90' ' ' ILE . 29.5 tttt -143.19 154.46 43.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.432 -0.581 . . . . 1.68 109.432 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.09 119.54 8.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.411 -0.358 . . . . 1.7 111.546 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.55 29.99 67.16 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.932 -0.577 . . . . 1.27 112.58 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.541 HG13 ' HB3' ' A' ' 87' ' ' LYS . 39.8 mm -127.77 111.82 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 1.01 110.933 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.525 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 26.7 pt -117.96 120.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.3 110.507 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.685 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 94.9 m95 -79.94 135.36 36.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.125 -0.488 . . . . 1.08 112.108 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.22 137.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.623 -0.717 . . . . 1.04 111.005 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.43 152.18 39.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.994 -0.548 . . . . 1.27 109.879 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.0 t -114.77 170.79 8.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.956 0.407 . . . . 1.36 110.694 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -67.27 113.23 5.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.081 -0.509 . . . . 2.64 110.67 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.39 -11.67 21.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.857 -0.687 . . . . 1.52 111.826 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -86.18 120.03 27.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.779 0.323 . . . . 1.59 110.512 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.77 142.72 27.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 2.15 111.397 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -71.5 96.66 1.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.894 -0.594 . . . . 2.07 110.237 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 72.7 m -156.19 138.62 10.35 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.561 -0.745 . . . . 2.36 109.176 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 21.8 Cg_exo -67.13 107.33 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.383 2.056 . . . . 2.08 111.244 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -95.66 75.42 3.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.314 -0.403 . . . . 1.78 110.149 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -15.89 61.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.548 -0.296 . . . . 2.55 111.321 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -60.19 -25.02 65.25 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.196 -0.456 . . . . 2.24 111.958 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.87 2.15 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.46 0.648 . . . . 2.0 110.246 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.33 51.63 1.84 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.004 -0.617 . . . . 2.33 111.579 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t -160.93 125.88 3.67 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.99 -0.374 . . . . 2.99 109.99 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 40.7 ttp85 -166.1 134.66 3.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.871 -0.418 . . . . 2.83 109.871 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -83.33 112.0 35.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 3.56 110.169 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.02 -30.61 90.03 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.065 2.51 . . . . 3.39 113.864 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.91 -5.15 57.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.78 0.324 . . . . 4.05 111.797 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -116.42 1.27 12.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.495 -0.32 . . . . 4.48 111.664 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 27.6 t-20 -154.39 133.64 12.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.673 0.273 . . . . 3.39 110.54 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.38 141.68 28.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.42 . . . . 3.21 110.209 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.59 140.77 49.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.992 0.425 . . . . 2.85 111.147 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 mt -92.21 150.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 2.42 109.885 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -62.54 120.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 2.74 110.683 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.52 124.27 22.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.736 -0.666 . . . . 2.11 110.333 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.66 151.83 48.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.17 -0.468 . . . . 2.49 110.704 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.496 HD13 HG22 ' A' ' 125' ' ' THR . 26.4 mt -98.58 137.48 20.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.049 -0.523 . . . . 1.91 109.921 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.72 152.53 41.34 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.123 2.549 . . . . 1.84 112.939 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -52.3 123.62 11.23 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.476 -0.784 . . . . 2.53 110.915 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 109.08 -14.65 33.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.809 -0.71 . . . . 2.2 111.45 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 HD13 ' A' ' 121' ' ' LEU . 15.1 m -111.81 123.64 50.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.915 -0.402 . . . . 2.1 109.915 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 150.03 32.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.883 0.373 . . . . 2.78 111.246 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.54 143.15 58.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.588 . . . . 2.62 109.858 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.58 138.78 87.78 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.675 2.25 . . . . 2.77 111.13 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -55.21 118.38 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 4.11 111.263 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.15 -20.11 12.97 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.54 -0.624 . . . . 3.18 111.54 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.749 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -89.28 147.53 24.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.638 0.256 . . . . 2.91 110.794 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.12 145.87 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.141 -0.482 . . . . 3.54 110.931 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.48 152.03 23.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.924 -0.58 . . . . 2.93 111.317 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.866 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.1 tp10 -73.3 128.11 34.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 3.64 110.446 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.82 80.02 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.027 -0.606 . . . . 3.27 112.323 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 3.59 111.489 -179.453 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.952 0.406 . . . . 2.48 111.342 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.6 m -73.5 151.25 41.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 2.13 110.491 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -87.0 -13.72 43.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.424 . . . . 2.4 112.061 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.491 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 85.8 m-85 -119.41 163.35 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.856 0.317 . . . . 2.02 111.856 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 118' ' ' VAL . 10.7 p -71.03 168.36 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 2.65 111.034 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.65 156.75 27.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.266 0.555 . . . . 2.4 112.129 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -112.39 122.32 47.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.55 -0.75 . . . . 2.27 109.23 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.43 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -92.95 128.62 38.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.883 0.373 . . . . 2.84 111.951 -178.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -105.26 128.89 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 2.89 110.25 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -119.7 89.36 3.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 3.82 110.504 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.53 -167.66 40.75 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.884 -0.886 . . . . 3.23 110.884 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -86.38 -34.87 20.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.146 0.473 . . . . 4.27 111.334 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -68.64 151.63 46.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.387 . . . . 3.32 110.105 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 -85.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.136 -0.32 . . . . 2.39 110.136 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 131' ' ' PHE . 34.4 tp -168.6 130.27 1.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.482 -0.326 . . . . 2.06 110.392 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -153.02 132.06 12.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 2.22 109.485 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.47 ' HD1' ' HD2' ' A' ' 27' ' ' PRO . 5.1 m-85 -125.55 138.2 31.39 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.581 -0.281 . . . . 1.78 110.69 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD2' ' HD1' ' A' ' 26' ' ' PHE . 38.1 Cg_endo -67.27 163.92 32.49 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.738 2.292 . . . . 2.15 112.235 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 28' ' ' ARG . 20.5 ttt180 -60.99 117.43 5.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.356 -0.838 . . . . 2.6 111.023 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.32 0.2 56.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.788 . . . . 1.65 112.618 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -127.88 162.37 26.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.78 0.324 . . . . 2.31 110.139 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.73 5.75 44.48 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.869 -0.682 . . . . 1.33 111.821 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 95' ' ' THR . 40.4 t -100.03 114.81 65.84 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.931 -0.396 . . . . 1.06 109.931 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.1 -175.58 2.73 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.043 2.495 . . . . 1.27 111.73 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -83.1 85.33 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.146 0.498 . . . . 1.7 110.66 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.491 ' HA ' ' HZ ' ' A' ' 13' ' ' PHE . 44.8 m-80 -80.74 93.81 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.861 -0.609 . . . . 1.23 110.916 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.3 p -85.57 3.69 39.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 1.94 111.473 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -107.9 -4.12 18.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 1.96 111.075 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.75 152.12 51.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.899 0.38 . . . . 1.42 111.874 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.4 m -78.75 168.69 25.11 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 1.73 110.111 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.512 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 77.3 Cg_exo -53.2 -37.49 80.27 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.835 2.357 . . . . 1.42 112.904 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -72.37 -8.76 56.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 1.78 111.469 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.795 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 12.2 m-20 -104.41 4.35 33.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 1.6 110.508 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 36.8 mm-40 -79.26 58.55 2.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.993 0.425 . . . . 1.05 111.822 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -152.03 128.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 1.17 110.263 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.83 -157.51 10.09 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.31 -0.948 . . . . 0.6 112.971 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -149.72 147.92 28.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.918 0.389 . . . . 0.99 111.296 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.689 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 11.0 m-85 -90.38 137.0 32.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 1.26 109.552 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 48' ' ' ARG . 33.2 ttt-85 -114.13 130.29 56.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.453 -0.34 . . . . 2.15 111.259 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -71.29 125.17 26.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.002 -0.74 . . . . 2.4 109.002 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.31 127.55 55.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.035 0.445 . . . . 2.21 112.066 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.11 140.34 51.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.905 -0.776 . . . . 2.68 108.905 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.645 ' HB3' HD12 ' A' ' 64' ' ' LEU . 14.9 tpt180 -150.19 111.1 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.618 0.599 . . . . 3.59 112.618 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.574 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 94.0 mtt180 -135.72 107.06 6.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.797 -0.638 . . . . 3.43 110.223 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.744 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.0 pt -68.4 171.04 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 4.26 110.842 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 55' ' ' ARG . 30.2 ttt180 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.839 0.352 . . . . 5.17 110.85 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 N--CA 1.456 -0.145 0 N-CA-C 109.996 -0.372 . . . . 4.48 109.996 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.744 ' HB2' HG12 ' A' ' 54' ' ' ILE . 68.9 tttt -75.7 -38.56 58.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 4.16 110.382 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 26.5 t70 52.4 81.45 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.547 -0.752 . . . . 4.09 112.429 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 52' ' ' ARG . 24.3 mt -81.7 151.51 27.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.222 -0.445 . . . . 3.36 110.439 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -67.85 148.14 98.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.902 -0.59 . . . . 3.36 110.011 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.39 108.12 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.849 2.366 . . . . 2.69 111.768 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.624 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 3.6 ptp180 -119.27 144.17 46.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 3.03 111.261 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.689 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 34.4 m95 -115.08 139.01 50.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.014 -0.539 . . . . 1.84 110.238 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -113.84 140.89 47.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 2.76 110.312 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.97 126.5 35.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 1.27 111.276 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -123.0 151.2 42.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 1.84 109.381 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.88 148.9 21.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.943 -0.392 . . . . 1.28 109.943 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.19 123.05 16.02 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.147 0.279 . . . . 1.66 110.563 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -9.16 19.01 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.631 -0.795 . . . . 1.66 112.22 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.413 HG22 ' HA3' ' A' ' 107' ' ' GLY . 1.2 p -65.24 131.7 47.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.607 0.242 . . . . 1.58 110.359 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 94.15 106.96 1.95 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.573 -0.822 . . . . 1.96 111.333 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 10.8 Cg_endo -55.85 -44.43 47.59 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.654 2.236 . . . . 2.62 112.282 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.71 28.85 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.148 -0.478 . . . . 3.09 111.636 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.2 -61.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.821 0.343 . . . . 1.79 110.695 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.05 48.83 10.49 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.042 -0.823 . . . . 1.65 111.042 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.8 91.22 48.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 1.38 111.659 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.34 162.74 13.05 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.467 2.111 . . . . 1.62 110.929 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.17 104.88 0.35 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.123 0.487 . . . . 1.58 111.246 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.39 -26.97 3.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.665 -0.698 . . . . 1.44 112.006 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.79 123.5 19.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 1.25 110.872 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -95.76 136.11 36.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.227 -0.442 . . . . 1.86 111.602 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -143.22 155.17 44.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.873 -0.788 . . . . 1.68 108.873 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.74 115.28 6.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.184 0.516 . . . . 1.7 111.694 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.16 22.01 46.84 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.825 -0.625 . . . . 1.27 112.533 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 48' ' ' ARG . 7.7 mm -136.7 133.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.163 -0.31 . . . . 1.01 110.163 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.4 pt -130.81 163.2 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.806 -0.442 . . . . 1.3 109.806 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -112.78 138.68 49.25 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.481 0.548 . . . . 1.08 112.481 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.62 133.29 32.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 1.04 110.233 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.74 132.97 14.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.354 -0.385 . . . . 1.27 110.214 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 32' ' ' VAL . 3.4 t -102.47 170.57 7.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.818 0.342 . . . . 1.36 110.89 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -69.48 126.53 30.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.082 -0.508 . . . . 2.64 110.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.46 -11.61 25.96 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.307 -0.717 . . . . 1.52 111.307 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -89.75 149.22 22.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.647 -0.277 . . . . 1.59 110.539 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.61 141.71 41.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.352 -0.385 . . . . 2.15 110.951 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -80.27 97.78 7.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 2.07 110.555 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.57 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 5.0 t -170.29 145.54 2.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.044 -0.724 . . . . 2.36 109.044 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.34 128.7 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.542 2.161 . . . . 2.08 112.783 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.02 73.68 1.49 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 1.78 111.075 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.24 1.15 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.328 -0.396 . . . . 2.55 111.895 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.456 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.0 p80 -60.11 -16.61 33.6 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.077 0.399 . . . . 2.24 112.077 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.4 pt -121.95 27.36 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.104 0.478 . . . . 2.0 109.975 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.413 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -102.92 -24.68 7.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.731 -0.747 . . . . 2.33 113.807 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -96.35 131.23 43.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.217 0.532 . . . . 2.99 111.504 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.3 ttp85 -159.53 133.48 7.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.258 -0.428 . . . . 2.83 110.28 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -77.26 113.27 29.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 110.072 -0.344 . . . . 3.56 110.072 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -85.17 -12.06 7.11 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 3.39 112.897 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.06 -9.71 47.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 4.05 110.694 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -133.15 18.64 4.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.73 -0.668 . . . . 4.48 110.641 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -169.35 132.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 3.39 111.128 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.58 159.09 15.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.214 -0.448 . . . . 3.21 110.419 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.09 150.57 23.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.799 0.333 . . . . 2.85 111.351 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 27.3 mt -78.11 143.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 2.42 109.735 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.4 ' HA ' ' OG1' ' A' ' 14' ' ' THR . 96.8 t -61.48 120.16 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.088 -0.245 . . . . 2.74 110.552 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.85 118.72 8.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.081 0.467 . . . . 2.11 110.603 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.12 148.76 52.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 2.49 110.489 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.657 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 66.1 mt -98.59 147.34 33.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.318 -0.401 . . . . 1.91 110.247 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.63 166.16 10.34 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.833 2.356 . . . . 1.84 112.435 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -61.85 118.47 7.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.057 -0.52 . . . . 2.53 110.815 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.13 -24.98 14.87 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.403 -0.679 . . . . 2.2 111.403 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 m -88.46 103.75 16.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.926 0.393 . . . . 2.1 110.093 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -90.68 144.46 25.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.313 -0.403 . . . . 2.78 111.217 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 15.7 mt -74.55 142.87 78.22 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 2.62 110.172 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 127' ' ' LEU . 42.2 Cg_exo -60.0 149.91 81.56 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 2.77 111.452 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -61.4 119.43 8.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 4.11 110.784 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.25 54.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.772 -0.728 . . . . 3.18 112.127 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -103.94 127.59 51.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 2.91 110.449 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 37.4 p90 -133.97 151.62 51.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.319 -0.401 . . . . 3.54 110.853 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.98 139.86 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 2.93 112.031 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.39 131.38 45.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.888 -0.596 . . . . 3.64 109.886 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.3 -37.07 3.14 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.328 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 120.64 0.257 . . . . 3.59 110.802 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.519 0.2 . . . . 2.48 110.851 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -55.08 143.47 26.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.052 -0.522 . . . . 2.13 112.019 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -67.89 -28.6 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 2.4 110.96 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 62.9 m-85 -107.87 168.61 9.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.111 -0.495 . . . . 2.02 112.28 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -70.95 160.78 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.168 -0.923 . . . . 2.65 111.289 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.72 134.75 33.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.4 110.533 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 133' ' ' ALA . 1.2 mt -87.37 132.62 33.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.148 -0.478 . . . . 2.27 110.163 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 m -96.34 112.82 24.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.294 -0.412 . . . . 2.84 110.067 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -83.9 140.28 32.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 2.89 111.016 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -141.84 80.13 1.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.692 -0.485 . . . . 3.82 109.692 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.6 -166.45 29.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.987 -0.625 . . . . 3.23 112.199 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -91.68 -9.87 42.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 4.27 111.019 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -105.18 162.07 13.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.085 -0.507 . . . . 3.32 109.884 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -90.0 -65.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.77 -0.826 . . . . 2.39 108.77 178.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 21.8 tp 175.31 133.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.395 -0.82 . . . . 2.06 110.533 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -150.64 117.57 5.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.068 -0.515 . . . . 2.22 110.304 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -108.12 139.63 20.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.55 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 49.8 Cg_endo -69.77 172.55 12.45 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.69 2.26 . . . . 2.15 112.421 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -69.45 127.62 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.878 -0.601 . . . . 2.6 110.848 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.68 25.06 63.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.942 -0.647 . . . . 1.65 112.622 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -151.38 158.78 44.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.547 -0.538 . . . . 2.31 109.547 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 21.63 9.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.744 -0.741 . . . . 1.33 111.418 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' A' ' 95' ' ' THR . 21.6 t -106.84 110.35 63.6 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.183 -0.303 . . . . 1.06 110.183 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' A' ' 121' ' ' LEU . 39.8 Cg_endo -68.65 175.15 7.5 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.723 2.282 . . . . 1.27 111.09 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.0 mt -72.93 87.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 1.7 110.686 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 71.3 m-20 -82.76 74.96 9.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.808 -0.633 . . . . 1.23 109.775 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -31.5 72.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.34 0.496 . . . . 1.94 112.34 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.58 -7.19 59.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.596 -0.274 . . . . 1.96 111.68 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.92 150.15 32.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.098 0.475 . . . . 1.42 112.095 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.712 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 13.7 m -90.29 170.2 10.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.51 -0.768 . . . . 1.73 109.471 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.712 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 3.0 Cg_endo -46.79 -44.92 21.38 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.324 2.683 . . . . 1.42 114.094 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -70.52 -25.98 63.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.888 0.329 . . . . 1.78 111.888 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.947 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.3 m-20 -86.77 2.79 47.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.267 -0.424 . . . . 1.6 110.844 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 83.4 mm-40 -80.48 46.08 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.107 0.48 . . . . 1.05 111.119 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.879 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.7 tt -143.12 132.47 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.022 -0.535 . . . . 1.17 110.191 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' ' N ' ' A' ' 73' ' ' LEU . . . -170.68 -145.55 4.8 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.414 -0.898 . . . . 0.6 112.158 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.479 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 45.7 p90 -155.6 159.91 40.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.122 0.487 . . . . 0.99 110.98 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.494 ' HB2' HG13 ' A' ' 91' ' ' ILE . 12.0 m-85 -99.91 117.86 35.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.471 -0.786 . . . . 1.26 109.475 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 48' ' ' ARG . 32.7 ttt180 -99.5 127.08 45.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.984 0.421 . . . . 2.15 111.321 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -85.24 135.25 34.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.839 -0.619 . . . . 2.4 110.432 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.7 42.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 2.21 111.37 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.7 m -152.98 127.32 9.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.062 -0.718 . . . . 2.68 109.062 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 3.8 tpt85 -103.63 126.67 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.492 0.553 . . . . 3.59 112.492 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 53' ' ' ARG . 17.5 mtt180 -142.92 107.56 4.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 3.43 109.472 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 169.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.63 0.252 . . . . 4.26 110.71 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.491 -0.322 . . . . 5.17 110.464 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.767 0.317 . . . . 4.48 110.906 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -97.89 -24.57 15.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 4.16 110.174 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 48.53 90.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.883 1.068 . . . . 4.09 113.883 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.53 147.75 33.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.257 -0.429 . . . . 3.36 110.178 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 24.4 m -78.4 162.12 67.43 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.492 -0.558 . . . . 3.36 109.492 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 9.2 Cg_endo -53.0 108.08 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.768 2.312 . . . . 2.69 112.166 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.454 HH22 ' HB2' ' A' ' 134' ' ' GLU . 19.4 mtp180 -99.91 134.03 43.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.78 -0.646 . . . . 3.03 109.629 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -106.61 115.75 30.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.07 -0.514 . . . . 1.84 112.0 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -102.36 121.29 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.868 -0.79 . . . . 2.76 108.868 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.98 135.57 43.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 1.27 111.686 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HD2' HG21 ' A' ' 75' ' ' THR . 14.3 m-85 -130.75 165.27 23.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 1.84 110.202 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -99.82 159.58 14.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.37 -0.377 . . . . 1.28 110.898 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.419 ' N ' ' HA2' ' A' ' 45' ' ' GLY . 54.8 tp -63.29 116.31 5.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.22 -0.445 . . . . 1.66 111.501 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.45 35.64 10.39 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.995 -0.621 . . . . 1.66 113.936 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.565 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.8 OUTLIER -73.3 90.47 1.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 1.58 111.135 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.39 139.78 5.51 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.032 -0.604 . . . . 1.96 112.2 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -33.34 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.603 2.202 . . . . 2.62 112.053 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -103.67 36.45 2.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.026 -0.534 . . . . 3.09 111.093 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.03 -56.6 10.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 1.79 110.096 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.12 32.5 80.69 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.915 -0.584 . . . . 1.65 112.971 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' ' HB3' ' A' ' 85' ' ' ALA . 3.0 tp -138.33 106.01 7.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.757 0.313 . . . . 1.38 110.688 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 92.2 Cg_endo -85.39 167.54 10.39 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.677 2.251 . . . . 1.62 111.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -60.95 106.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 1.58 110.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.54 -8.64 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.489 -0.862 . . . . 1.44 112.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.577 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . . . -69.24 137.99 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 1.25 110.967 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -88.44 128.18 35.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 1.86 111.839 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 6.5 ttmm -155.24 144.01 20.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.781 -0.645 . . . . 1.68 109.283 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.73 113.34 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.196 0.443 . . . . 1.7 112.196 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.27 20.57 58.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.891 -0.671 . . . . 1.27 112.752 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 35.0 mm -127.72 102.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 1.01 110.51 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 47' ' ' TYR . 24.8 pt -114.62 134.06 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.322 -0.399 . . . . 1.3 109.989 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.479 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 49.3 m95 -90.35 146.25 24.33 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.345 0.498 . . . . 1.08 112.345 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 m -140.47 144.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.518 -0.764 . . . . 1.04 110.311 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.95 169.59 23.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 1.27 110.869 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.445 ' HB ' HG21 ' A' ' 32' ' ' VAL . 13.4 t -146.17 179.04 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.969 -0.56 . . . . 1.36 109.5 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.7 123.37 19.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.399 . . . . 2.64 111.133 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 41' ' ' ASP . . . 107.35 -13.26 39.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.766 -0.73 . . . . 1.52 111.906 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.879 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.31 132.18 35.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.669 0.271 . . . . 1.59 110.785 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.9 mt -102.22 140.59 36.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.262 -0.426 . . . . 2.15 110.799 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -79.45 76.05 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.468 0.652 . . . . 2.07 110.09 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.632 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m -147.13 131.97 8.89 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.654 -0.869 . . . . 2.36 108.654 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.83 125.24 17.67 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.307 2.005 . . . . 2.08 112.251 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.947 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -126.85 75.87 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.585 0.707 . . . . 1.78 111.216 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.99 -4.53 44.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 2.55 112.058 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 4.1 p80 -59.18 -20.9 57.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.092 0.472 . . . . 2.24 111.864 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.3 pt -111.71 13.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.037 0.446 . . . . 2.0 110.616 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.22 -32.67 7.29 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.554 -0.831 . . . . 2.33 112.027 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.9 t -69.18 121.46 16.83 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.295 0.569 . . . . 2.99 110.978 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.0 ttp85 -164.57 131.18 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.781 . . . . 2.83 109.927 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 59.5 m-80 -94.99 117.84 66.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 3.56 110.663 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 18.3 Cg_endo -60.35 -34.97 92.94 Favored 'Trans proline' 0 N--CA 1.472 0.244 0 C-N-CA 123.123 2.549 . . . . 3.39 113.458 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.93 9.68 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.369 0.507 . . . . 4.05 112.369 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -139.52 9.1 2.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.871 0.367 . . . . 4.48 111.389 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -159.49 127.22 4.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 3.39 111.248 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.47 164.14 25.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 3.21 110.625 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.58 152.19 23.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.167 0.508 . . . . 2.85 111.466 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 3.4 mp -95.76 145.86 7.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.746 -0.661 . . . . 2.42 109.417 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.578 ' HA ' ' OG1' ' A' ' 14' ' ' THR . 70.0 t -68.25 115.31 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.251 -0.277 . . . . 2.74 110.251 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.75 121.24 12.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.066 -0.515 . . . . 2.11 110.604 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -139.83 173.64 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.858 -0.61 . . . . 2.49 110.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 33' ' ' PRO . 91.5 mt -123.14 152.48 63.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.558 -0.534 . . . . 1.91 109.558 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.42 154.65 34.39 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.003 2.469 . . . . 1.84 111.97 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -52.94 122.83 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 2.53 111.332 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.69 -11.34 49.88 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.632 -0.794 . . . . 2.2 112.321 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 HD13 ' A' ' 121' ' ' LEU . 5.3 m -109.11 113.89 27.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.486 -0.561 . . . . 2.1 109.486 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.2 159.63 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.358 -0.383 . . . . 2.78 110.892 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.416 HD22 ' HD2' ' A' ' 131' ' ' PHE . 28.4 mt -90.45 156.68 45.41 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.402 -0.363 . . . . 2.62 110.25 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.54 151.46 62.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.656 2.238 . . . . 2.77 111.912 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.36 119.2 8.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.185 0.517 . . . . 4.11 111.775 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.41 -8.88 44.8 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.723 -0.751 . . . . 3.18 112.346 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.416 ' HD2' HD22 ' A' ' 127' ' ' LEU . 2.1 t80 -101.51 112.91 25.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.788 -0.449 . . . . 2.91 109.788 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -133.1 149.88 52.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 3.54 111.663 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.422 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -103.45 147.35 27.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 2.93 110.073 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.454 ' HB2' HH22 ' A' ' 67' ' ' ARG . 25.5 tt0 -73.67 121.61 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 3.64 111.237 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.85 -0.47 45.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.688 -0.767 . . . . 3.27 112.265 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 120.875 0.369 . . . . 3.59 110.733 179.96 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.992 0.425 . . . . 2.48 111.588 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -87.36 155.6 19.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.906 -0.588 . . . . 2.13 110.032 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -86.09 -29.4 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 2.4 110.146 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.52 -179.72 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.409 -0.814 . . . . 2.02 110.532 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.71 -172.35 4.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.458 . . . . 2.65 110.679 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -105.66 173.25 6.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 2.4 112.602 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.607 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 16.0 mt -112.1 122.85 48.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.931 -1.031 . . . . 2.27 109.312 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.1 m -92.52 116.39 28.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.99 0.424 . . . . 2.84 111.261 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -86.38 142.43 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 2.89 110.842 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -134.44 44.86 2.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.977 -0.556 . . . . 3.82 109.862 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.9 -167.24 12.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.832 -0.699 . . . . 3.23 112.442 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -86.74 -28.14 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 4.27 110.645 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.89 163.55 23.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 3.32 111.007 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.2 -85.5 0.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.825 -0.435 . . . . 2.39 109.825 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.597 HD13 ' CE1' ' A' ' 131' ' ' PHE . 36.5 tp -168.97 140.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 2.06 110.462 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -163.01 120.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.716 -0.675 . . . . 2.22 110.021 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -110.54 142.5 26.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.269 -0.423 . . . . 1.78 110.234 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.57 164.94 16.78 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.114 2.543 . . . . 2.15 111.965 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -69.61 128.47 36.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 2.6 110.426 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.83 29.92 49.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.287 -0.725 . . . . 1.65 111.287 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -157.84 171.52 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.46 -0.57 . . . . 2.31 109.46 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.31 17.32 64.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 1.33 112.511 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.78 111.15 65.0 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 1.06 109.826 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.51 168.57 11.2 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.783 2.322 . . . . 1.27 112.051 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.9 mt -74.69 87.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.16 -0.473 . . . . 1.7 110.497 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -84.11 77.69 9.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.039 0.447 . . . . 1.23 109.913 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -26.31 68.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 1.94 111.628 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -80.78 -3.78 52.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.127 -0.488 . . . . 1.96 111.653 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.478 ' HB3' ' CB ' ' A' ' 42' ' ' ASP . 1.4 m -120.52 157.52 29.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.351 . . . . 1.42 111.672 -178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.672 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 23.4 m -83.04 168.84 20.19 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.96 -0.564 . . . . 1.73 109.922 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.8 Cg_endo -52.9 -35.71 71.77 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.947 2.432 . . . . 1.42 113.913 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.839 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.2 p-10 -80.81 -16.01 54.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.652 0.242 . . . . 1.78 111.652 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.827 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 29.5 m-20 -84.37 -3.39 58.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 1.6 111.106 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -78.55 56.37 1.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 1.05 110.827 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 94' ' ' ALA . 16.6 tt -149.97 127.38 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.673 . . . . 1.17 110.155 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.3 -139.83 3.0 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.515 -0.85 . . . . 0.6 112.214 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.483 ' CD2' HG23 ' A' ' 90' ' ' ILE . 53.7 p90 -162.09 158.65 25.12 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.08 0.467 . . . . 0.99 111.113 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.641 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -95.84 134.94 38.21 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.898 -0.778 . . . . 1.26 108.898 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -112.68 121.39 44.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.399 -0.364 . . . . 2.15 111.1 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -73.49 119.69 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.491 . . . . 2.4 109.787 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.31 148.29 43.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.173 0.511 . . . . 2.21 111.306 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.73 151.46 45.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.731 -0.84 . . . . 2.68 108.731 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.784 ' HB3' HD12 ' A' ' 64' ' ' LEU . 9.6 tpt180 -139.43 125.64 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.982 0.42 . . . . 3.59 111.604 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 25.7 mtt180 -140.73 98.58 3.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.905 -0.589 . . . . 3.43 110.789 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 61' ' ' MET . 33.8 pt -79.74 160.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.378 -0.601 . . . . 4.26 109.378 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 55' ' ' ARG . 3.8 ttt180 . . . . . 0 C--N 1.324 -0.533 0 C-N-CA 120.919 -0.312 . . . . 5.17 111.564 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 mtt . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.943 0.401 . . . . 4.48 111.852 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HE3' HD21 ' A' ' 64' ' ' LEU . 45.7 tttp -71.84 -33.72 68.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.517 -0.765 . . . . 4.16 110.288 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 26.1 t0 46.85 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.632 0.975 . . . . 4.09 113.632 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 52' ' ' ARG . 47.8 mt -89.22 137.3 32.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 3.36 110.46 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -64.04 144.73 98.17 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.099 -0.5 . . . . 3.36 110.271 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.81 119.32 5.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.915 2.41 . . . . 2.69 112.27 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.528 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 64.8 mtt85 -121.19 132.43 54.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 3.03 110.568 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.641 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.74 118.48 31.47 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.252 -0.431 . . . . 1.84 110.921 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.82 146.23 24.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.194 -0.669 . . . . 2.76 109.194 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.54 120.83 28.28 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.653 -0.419 . . . . 1.27 111.774 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -115.37 157.51 23.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.593 -0.521 . . . . 1.84 109.593 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -102.94 158.95 15.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.936 -0.394 . . . . 1.28 109.936 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -63.18 118.99 8.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.079 -0.341 . . . . 1.66 110.079 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.84 35.2 4.93 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.987 -0.625 . . . . 1.66 112.334 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.35 99.87 12.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.444 . . . . 1.58 110.796 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.85 123.94 3.38 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.181 -0.768 . . . . 1.96 111.181 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.3 -27.7 83.55 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.857 2.371 . . . . 2.62 113.181 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -127.59 35.35 4.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.737 0.303 . . . . 3.09 110.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.22 -50.65 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 1.79 111.023 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.62 51.27 26.38 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.308 -0.717 . . . . 1.65 111.308 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.7 mt -132.28 96.12 19.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.573 0.225 . . . . 1.38 111.596 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 92.9 Cg_endo -84.5 162.99 12.72 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.662 2.242 . . . . 1.62 110.661 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.538 ' HB2' HD11 ' A' ' 73' ' ' LEU . 34.7 t80 -58.8 113.26 1.97 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.013 0.435 . . . . 1.58 110.894 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.68 11.61 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.729 -0.748 . . . . 1.44 112.449 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -61.83 108.61 1.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.883 0.373 . . . . 1.25 110.486 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.0 107.45 8.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.153 -0.476 . . . . 1.86 110.543 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -125.62 149.83 48.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 1.68 109.968 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.15 110.49 1.62 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.236 -0.438 . . . . 1.7 111.683 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.17 21.48 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.794 -0.717 . . . . 1.27 112.284 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.483 HG23 ' CD2' ' A' ' 46' ' ' TYR . 48.1 mm -129.19 113.83 29.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.351 -0.24 . . . . 1.01 110.351 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 91' ' ' ILE . 7.8 pt -119.13 126.2 75.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.645 -0.502 . . . . 1.3 109.645 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.436 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 82.9 m95 -83.45 139.21 33.09 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.707 0.632 . . . . 1.08 112.707 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.45 139.44 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.538 -0.755 . . . . 1.04 110.411 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -155.5 172.33 18.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.082 -0.508 . . . . 1.27 109.745 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.2 t -142.9 170.84 14.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.748 0.309 . . . . 1.36 110.361 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.73 118.24 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.981 -0.554 . . . . 2.64 110.686 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.61 -15.22 8.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.967 -0.635 . . . . 1.52 111.647 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.839 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.25 159.26 22.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.671 0.272 . . . . 1.59 110.662 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.69 140.93 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 2.15 110.663 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -80.14 97.69 6.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.093 0.473 . . . . 2.07 111.179 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 t -171.2 148.93 2.51 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.968 -0.753 . . . . 2.36 108.968 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.54 111.75 3.39 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.045 1.83 . . . . 2.08 112.111 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.827 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -108.51 80.45 1.35 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.441 0.639 . . . . 1.78 110.264 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -72.64 -5.96 41.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.461 -0.79 . . . . 2.55 112.245 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -63.01 -15.61 56.99 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.519 0.562 . . . . 2.24 112.519 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.89 -24.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.463 . . . . 2.0 110.726 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.34 73.46 1.68 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.788 -0.72 . . . . 2.33 112.029 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.4 t -160.56 22.97 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.142 0.496 . . . . 2.99 110.979 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttp85 -84.29 136.85 33.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 2.83 110.824 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -83.85 119.64 73.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.42 -0.585 . . . . 3.56 109.42 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.52 -19.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.792 2.328 . . . . 3.39 113.769 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.43 -40.6 8.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.929 0.344 . . . . 4.05 111.929 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.88 7.72 26.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.41 -0.359 . . . . 4.48 111.394 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -160.23 139.92 11.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.333 . . . . 3.39 110.512 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.02 141.55 29.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.241 -0.436 . . . . 3.21 111.143 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.36 148.38 26.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 2.85 110.765 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.62 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 2.42 110.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.65 135.52 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.926 -0.398 . . . . 2.74 109.926 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.48 HD23 ' HG ' ' A' ' 16' ' ' LEU . 15.7 tp -63.3 119.66 10.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 2.11 110.691 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -124.33 135.24 53.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.49 110.915 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.0 mt -101.79 147.5 33.96 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 1.91 110.142 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.65 152.54 77.88 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.702 2.268 . . . . 1.84 111.807 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -54.86 129.49 37.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.858 -0.61 . . . . 2.53 111.258 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.64 14.17 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.419 -0.672 . . . . 2.2 111.419 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -99.81 98.26 9.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.718 0.294 . . . . 2.1 110.395 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.71 147.07 23.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 2.78 110.433 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.86 144.37 87.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.285 -0.416 . . . . 2.62 110.223 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.521 ' HG2' ' HD1' ' A' ' 131' ' ' PHE . 17.6 Cg_endo -60.34 155.64 45.34 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.399 2.066 . . . . 2.77 111.505 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -60.89 127.41 31.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 4.11 111.105 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.95 63.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.908 -0.663 . . . . 3.18 112.648 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.51 116.56 30.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.917 0.389 . . . . 2.91 111.828 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -124.09 137.78 54.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 3.54 110.64 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.473 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 2.93 111.372 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.0 121.49 15.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 3.64 111.114 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 23.26 34.05 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.941 -0.572 . . . . 3.27 112.849 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--N 1.325 -0.462 0 N-CA-C 112.207 0.447 . . . . 3.59 112.207 -179.769 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.27 0 CA-C-O 121.073 0.463 . . . . 2.48 112.236 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -73.1 139.21 46.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 2.13 110.306 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -98.06 -25.59 14.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.783 0.325 . . . . 2.4 111.788 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.66 176.98 5.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 2.02 110.571 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 p -69.89 175.62 4.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.983 0.421 . . . . 2.65 111.382 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -95.05 158.23 15.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.411 0.624 . . . . 2.4 111.527 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.743 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 88.7 mt -111.89 106.3 14.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.148 -0.933 . . . . 2.27 109.327 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.7 m -84.51 127.17 33.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 2.84 111.504 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.55 115.57 27.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.902 -0.59 . . . . 2.89 110.664 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -103.67 72.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.487 -0.56 . . . . 3.82 109.487 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.95 -161.85 26.86 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.842 -0.694 . . . . 3.23 112.156 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 70.3 mmtt -94.28 -42.52 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.684 0.278 . . . . 4.27 111.115 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.69 153.32 36.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 3.32 110.064 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.9 -76.0 0.31 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.915 -0.314 . . . . 2.39 110.574 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.1 tp 179.8 130.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.897 -0.592 . . . . 2.06 110.264 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -145.18 123.97 12.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 2.22 110.32 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.47 ' CD1' ' HA2' ' A' ' 31' ' ' GLY . 46.6 m-85 -107.0 140.21 21.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.356 -0.384 . . . . 1.78 110.866 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 13.4 Cg_exo -71.58 168.96 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.839 2.359 . . . . 2.15 111.901 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -61.0 124.93 21.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 2.6 111.279 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.96 9.97 84.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.885 -0.674 . . . . 1.65 112.737 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.584 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 16.6 tt0 -129.5 160.7 32.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.814 -0.439 . . . . 2.31 109.814 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 26' ' ' PHE . . . 118.36 -3.01 16.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.151 -0.547 . . . . 1.33 111.951 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.6 t -101.21 111.16 63.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.898 -0.408 . . . . 1.06 109.898 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 4.0 Cg_exo -76.88 -170.7 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.001 2.467 . . . . 1.27 111.327 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -74.2 100.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.191 0.52 . . . . 1.7 111.268 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.587 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 71.2 m-80 -103.37 86.03 2.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.0 -0.741 . . . . 1.23 109.0 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -51.67 53.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.579 0.955 . . . . 1.94 113.579 -178.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -80.71 11.33 3.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.836 0.68 . . . . 1.96 112.836 -178.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.587 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -115.02 137.73 51.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.713 0.292 . . . . 1.42 110.802 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.98 164.05 50.99 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 1.73 111.006 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.17 -37.94 93.89 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.177 2.585 . . . . 1.42 113.312 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.4 p-10 -82.33 -5.97 58.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.548 0.213 . . . . 1.78 111.453 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.07 5.24 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 1.6 110.279 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.483 ' HB3' HG11 ' A' ' 32' ' ' VAL . 63.3 mm-40 -83.7 53.31 2.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 1.05 111.062 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.448 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.7 tt -144.81 136.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.609 . . . . 1.17 110.142 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.19 -147.93 6.7 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.152 -1.023 . . . . 0.6 113.059 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.428 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 44.2 p90 -157.16 172.78 18.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.951 0.405 . . . . 0.99 110.699 -179.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -117.34 134.76 54.44 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.478 -0.564 . . . . 1.26 109.478 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -107.53 136.17 47.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 2.15 111.141 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -81.37 98.12 8.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.607 -0.724 . . . . 2.4 110.282 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.8 148.35 30.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 2.21 111.803 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -155.64 121.5 5.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.68 109.464 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.804 ' HB3' HD12 ' A' ' 64' ' ' LEU . 4.2 ttt85 -94.45 129.87 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.654 0.264 . . . . 3.59 111.038 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.17 94.95 2.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 3.43 110.457 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.529 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -83.17 141.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 4.26 111.359 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 5.17 112.237 -178.384 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.682 0.277 . . . . 4.48 110.969 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -62.35 -42.43 99.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 4.16 110.526 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 t70 58.85 77.53 0.3 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.353 -0.84 . . . . 4.09 112.069 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.804 HD12 ' HB3' ' A' ' 52' ' ' ARG . 40.0 mt -87.45 164.09 16.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.024 -0.534 . . . . 3.36 111.062 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.65 152.74 54.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.131 -0.486 . . . . 3.36 110.634 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 115.17 2.48 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.479 2.119 . . . . 2.69 111.283 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.663 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 4.3 ptp180 -113.15 119.57 38.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 3.03 110.82 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -84.43 126.34 33.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.836 -0.62 . . . . 1.84 110.648 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 51.1 m-85 -109.26 132.01 54.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.708 -0.479 . . . . 2.76 109.708 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.49 127.32 33.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.376 . . . . 1.27 111.179 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -130.24 157.66 41.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.51 -0.552 . . . . 1.84 109.51 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -86.28 156.31 20.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.984 0.421 . . . . 1.28 111.019 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 83' ' ' TYR . 4.2 tt -65.82 116.86 7.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.141 -0.481 . . . . 1.66 111.204 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.78 10.23 31.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.617 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -61.02 122.74 15.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.855 0.36 . . . . 1.58 110.976 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.419 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 97.63 123.87 4.76 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.87 -0.681 . . . . 1.96 112.005 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 9.9 Cg_endo -53.35 -63.89 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.219 2.613 . . . . 2.62 112.434 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -91.95 72.7 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.309 0.576 . . . . 3.09 111.12 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.99 -61.17 1.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 1.79 109.936 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 39.46 57.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.797 -0.638 . . . . 1.65 112.316 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.89 95.17 44.72 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.217 -0.29 . . . . 1.38 110.217 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 84.2 Cg_endo -89.67 179.46 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.865 2.377 . . . . 1.62 112.206 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.447 ' HB2' HD11 ' A' ' 73' ' ' LEU . 43.2 t80 -61.42 107.48 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.935 -0.575 . . . . 1.58 111.247 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.17 -15.55 8.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.513 -0.851 . . . . 1.44 113.061 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.634 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.72 105.24 1.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.156 0.503 . . . . 1.25 111.033 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -79.06 122.47 26.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.036 -0.529 . . . . 1.86 111.214 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -141.11 173.74 11.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 1.68 109.732 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -73.96 114.87 12.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 1.7 111.492 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 31.64 59.91 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.83 -0.623 . . . . 1.27 113.01 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.7 mm -128.58 107.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 110.333 -0.247 . . . . 1.01 110.333 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 pt -115.14 124.92 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.543 0.211 . . . . 1.3 110.446 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 76.3 m95 -88.41 138.79 31.12 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.045 0.387 . . . . 1.08 112.045 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.87 144.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 1.04 110.66 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.9 160.42 43.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.394 -0.366 . . . . 1.27 110.301 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -135.45 168.83 18.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.71 -0.478 . . . . 1.36 109.71 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.15 133.12 55.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 2.64 110.675 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.65 -16.97 55.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.969 -0.634 . . . . 1.52 112.349 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.41 143.05 29.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 1.59 110.577 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.6 mt -110.68 142.44 42.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.44 -0.345 . . . . 2.15 110.447 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.42 83.95 3.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.302 0.572 . . . . 2.07 110.902 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.1 t -151.65 139.09 12.47 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.459 -0.791 . . . . 2.36 109.416 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 126.55 22.39 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.013 2.476 . . . . 2.08 113.278 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -117.97 60.71 0.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.5 -0.773 . . . . 1.78 110.217 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.58 -0.87 21.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 2.55 112.101 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -74.76 -6.75 50.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 2.24 111.55 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.22 35.45 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 2.0 111.142 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 13.33 8.39 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.53 -0.843 . . . . 2.33 112.868 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -131.88 114.81 15.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.207 0.527 . . . . 2.99 110.898 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -151.05 160.57 43.83 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.604 -0.517 . . . . 2.83 109.604 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.14 105.83 50.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 3.56 110.715 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.47 -34.24 26.84 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.401 2.068 . . . . 3.39 113.087 -179.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.52 -8.07 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.972 0.36 . . . . 4.05 111.972 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -125.73 10.03 7.71 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.626 -0.261 . . . . 4.48 111.495 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -168.92 127.91 1.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 3.39 110.182 -179.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.33 164.5 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.703 0.287 . . . . 3.21 110.762 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.93 151.96 20.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.318 -0.401 . . . . 2.85 110.232 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.0 mt -83.97 143.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.589 -0.523 . . . . 2.42 109.589 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.546 HG11 ' HB2' ' A' ' 136' ' ' SER . 85.7 t -65.92 119.85 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.796 0.331 . . . . 2.74 110.474 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.612 HD22 HD21 ' A' ' 16' ' ' LEU . 7.8 tt -63.28 118.65 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 2.11 109.718 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -133.53 165.64 24.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.28 -0.418 . . . . 2.49 110.898 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.33 157.67 43.31 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.646 -0.706 . . . . 1.91 110.042 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.39 172.82 15.33 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.62 2.213 . . . . 1.84 112.075 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.2 120.87 13.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.006 -0.543 . . . . 2.53 110.336 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.42 -25.8 8.98 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.551 -0.833 . . . . 2.2 112.099 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 m -98.13 112.93 24.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.805 -0.442 . . . . 2.1 109.805 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.9 m -104.7 145.34 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.727 -0.669 . . . . 2.78 111.257 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -76.92 149.38 80.13 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.09 -0.707 . . . . 2.62 109.09 178.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 18.4 Cg_endo -60.42 146.23 97.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.529 2.153 . . . . 2.77 111.553 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.61 109.74 0.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 4.11 110.471 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.2 -12.42 9.73 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.371 -0.692 . . . . 3.18 111.371 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.743 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 1.4 t80 -103.24 134.34 46.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.125 -0.324 . . . . 2.91 110.125 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -128.78 164.95 21.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.349 -0.387 . . . . 3.54 110.53 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 136' ' ' SER . . . -103.34 139.54 38.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.511 -0.313 . . . . 2.93 110.479 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.82 123.11 28.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.921 0.391 . . . . 3.64 110.535 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.18 -1.39 82.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.297 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.546 ' HB2' HG11 ' A' ' 118' ' ' VAL . 4.7 t . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 3.59 110.566 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.286 0 CA-C-O 120.487 0.184 . . . . 2.48 111.012 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 m -57.86 153.02 14.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.082 -0.508 . . . . 2.13 112.35 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 109' ' ' ARG . 32.2 m95 -74.92 -54.44 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.609 -0.723 . . . . 2.4 110.52 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.82 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 24.8 m-85 -74.75 159.65 31.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 2.02 112.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -68.92 158.58 34.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.543 -0.753 . . . . 2.65 111.017 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -77.08 144.99 38.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.911 0.386 . . . . 2.4 111.207 -179.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.637 HD13 ' HE2' ' A' ' 131' ' ' PHE . 35.4 mt -89.53 119.9 30.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.988 -0.375 . . . . 2.27 109.988 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -90.97 126.44 36.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.279 0.561 . . . . 2.84 112.458 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.423 ' HB2' ' HE1' ' A' ' 131' ' ' PHE . 6.2 tp-100 -94.8 138.43 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.892 -0.594 . . . . 2.89 110.172 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 14.6 t60 -137.21 56.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.532 -0.544 . . . . 3.82 109.532 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -154.89 -169.34 19.39 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.58 -0.736 . . . . 3.23 111.685 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mmtt -92.84 -1.77 56.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.062 0.393 . . . . 4.27 112.062 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -104.53 171.92 7.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 3.32 110.308 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.74 -79.87 0.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.664 -0.243 . . . . 2.39 110.375 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.7 tp -179.57 132.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 2.06 110.421 179.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -154.07 117.31 4.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.333 -0.394 . . . . 2.22 110.628 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -109.74 141.29 23.37 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.191 -0.459 . . . . 1.78 110.155 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.72 165.01 29.12 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.564 2.176 . . . . 2.15 112.298 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -64.34 119.87 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.577 . . . . 2.6 111.085 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.36 0.52 56.88 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.798 -0.715 . . . . 1.65 112.567 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -130.0 165.76 21.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 2.31 110.62 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.38 -14.7 30.36 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.783 -0.722 . . . . 1.33 112.37 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.555 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.8 t -89.56 118.15 68.79 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.701 0.286 . . . . 1.06 110.999 -179.239 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.19 -176.36 2.87 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.608 2.206 . . . . 1.27 111.345 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 mt -84.63 79.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 1.7 110.781 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -83.85 86.85 7.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.323 -0.399 . . . . 1.23 110.31 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.07 64.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.994 0.426 . . . . 1.94 110.832 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -76.42 0.67 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.959 -0.564 . . . . 1.96 111.394 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.499 ' HB3' ' CB ' ' A' ' 42' ' ' ASP . 4.3 m -128.36 152.19 48.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.855 0.36 . . . . 1.42 111.033 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 168.49 27.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.099 -0.501 . . . . 1.73 109.88 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.28 -36.61 93.91 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.585 2.19 . . . . 1.42 111.961 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -77.79 -19.94 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 1.78 111.054 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.934 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 31.7 m-20 -81.97 -5.8 58.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 1.6 111.275 -179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.555 ' HB3' HG11 ' A' ' 32' ' ' VAL . 76.8 mm-40 -79.44 57.71 2.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.151 0.5 . . . . 1.05 111.379 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.493 HG13 ' HB2' ' A' ' 94' ' ' ALA . 10.9 tt -151.17 131.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.749 -0.659 . . . . 1.17 109.579 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.26 -146.15 6.07 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.368 -0.92 . . . . 0.6 112.661 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -153.03 165.01 36.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.914 0.387 . . . . 0.99 110.58 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -105.48 125.59 51.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 1.26 109.238 178.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -95.1 126.4 40.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.205 -0.452 . . . . 2.15 111.643 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -76.57 120.83 22.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.598 -0.728 . . . . 2.4 109.51 178.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.67 158.77 43.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 2.21 111.666 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.94 109.01 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.598 -0.728 . . . . 2.68 109.594 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.648 ' HB3' HD12 ' A' ' 64' ' ' LEU . 11.3 tpt85 -81.26 103.84 11.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 3.59 111.531 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -114.5 110.34 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 3.43 111.179 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.72 131.9 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.822 -0.626 . . . . 4.26 109.397 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 55' ' ' ARG . 1.4 ttp180 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 123.331 0.395 . . . . 5.17 110.232 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 120.545 0.212 . . . . 4.48 110.575 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -68.24 -42.65 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 4.16 109.542 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t0 47.48 75.23 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.18 -0.918 . . . . 4.09 112.676 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 52' ' ' ARG . 27.4 mt -94.46 158.92 15.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.912 -0.585 . . . . 3.36 111.195 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.11 149.51 89.58 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.777 -0.647 . . . . 3.36 111.289 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.66 116.25 3.12 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.844 2.363 . . . . 2.69 111.297 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 10.8 mtt-85 -119.91 147.6 44.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.051 -0.522 . . . . 3.03 111.594 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -114.93 129.14 56.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 1.84 110.946 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -103.65 133.65 48.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.365 -0.606 . . . . 2.76 109.365 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -81.6 121.36 26.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 1.27 111.481 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.44 ' HD2' HG21 ' A' ' 75' ' ' THR . 20.2 m-85 -122.74 133.52 54.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 1.84 109.743 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.63 159.74 33.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.539 -0.3 . . . . 1.28 110.899 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.38 122.0 12.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 1.66 111.825 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.39 24.34 26.65 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.906 -0.664 . . . . 1.66 113.678 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.44 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -77.2 102.16 6.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 1.58 111.204 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.403 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 127.25 114.23 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.13 -0.788 . . . . 1.96 111.13 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 18.0 Cg_endo -59.45 -26.51 82.22 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.91 2.407 . . . . 2.62 112.466 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.3 15.28 16.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.543 0.211 . . . . 3.09 111.526 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.66 -55.58 6.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.029 0.442 . . . . 1.79 110.223 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.64 36.35 89.29 Favored Glycine 0 C--N 1.329 0.157 0 CA-C-N 115.73 -0.668 . . . . 1.65 112.789 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 mt -107.85 105.9 57.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.565 0.221 . . . . 1.38 111.039 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.14 161.84 17.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.056 2.504 . . . . 1.62 111.511 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -57.91 111.07 1.04 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 1.58 110.51 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.76 -19.23 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.629 -0.796 . . . . 1.44 112.352 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.61 113.11 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 1.25 110.807 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -82.27 121.98 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.374 -0.376 . . . . 1.86 111.704 -179.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.94 171.46 14.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.295 -0.411 . . . . 1.68 110.269 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.35 110.29 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.878 -0.601 . . . . 1.7 111.195 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.37 97.06 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.95 -0.568 . . . . 1.27 112.823 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.5 mm -127.51 105.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.899 0.381 . . . . 1.01 110.611 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.8 pt -111.67 135.19 51.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.371 -0.603 . . . . 1.3 109.371 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -94.86 140.68 29.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.16 0.43 . . . . 1.08 112.16 -178.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.01 141.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.519 -0.764 . . . . 1.04 110.241 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -155.25 152.28 29.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.09 -0.337 . . . . 1.27 110.09 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -111.59 173.61 6.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.415 -0.357 . . . . 1.36 110.263 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.0 118.68 15.16 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.983 -0.377 . . . . 2.64 109.983 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.76 -3.8 24.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.84 -0.695 . . . . 1.52 111.881 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.21 131.4 34.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.46 -0.2 . . . . 1.59 110.46 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.14 148.52 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 2.15 111.188 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -87.1 72.27 10.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 2.07 110.557 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.504 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 8.5 m -148.68 125.93 5.58 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.466 -0.788 . . . . 2.36 109.498 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.18 133.75 53.69 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.983 2.455 . . . . 2.08 112.195 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.934 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.28 84.6 2.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.305 0.574 . . . . 1.78 111.346 -179.494 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -11.03 59.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.005 -0.543 . . . . 2.55 111.756 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.444 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.4 p80 -56.91 -22.24 35.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.797 0.665 . . . . 2.24 112.797 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.57 4.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.095 0.474 . . . . 2.0 110.753 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.27 -16.7 45.82 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.885 -0.674 . . . . 2.33 111.517 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -87.08 121.71 29.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.949 0.404 . . . . 2.99 110.519 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 12' ' ' TRP . 10.3 ttp85 -164.91 131.04 2.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 2.83 110.614 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 28.3 t-20 -95.12 122.64 59.45 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.553 -0.536 . . . . 3.56 109.553 178.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 11.7 Cg_endo -54.6 -37.23 90.83 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 123.449 2.766 . . . . 3.39 114.086 -178.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.67 -8.53 59.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.81 0.67 . . . . 4.05 112.81 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -115.5 7.18 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.463 0.542 . . . . 4.48 112.463 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.77 124.61 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.908 0.385 . . . . 3.39 110.998 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.31 158.59 28.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.26 -0.427 . . . . 3.21 110.871 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.24 151.98 41.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 2.85 111.487 -179.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 44.3 mt -107.96 132.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 2.42 109.044 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.29 119.34 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.434 -0.348 . . . . 2.74 111.009 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.82 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 3.9 tt -66.82 122.49 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.208 0.528 . . . . 2.11 110.733 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -133.15 145.49 50.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.515 -0.766 . . . . 2.49 110.582 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.553 HD13 HG22 ' A' ' 125' ' ' THR . 34.3 mt -106.83 143.74 27.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 1.91 109.767 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.71 159.08 50.16 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.557 2.171 . . . . 1.84 111.847 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.87 126.36 27.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.106 -0.497 . . . . 2.53 111.041 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 -11.8 45.5 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.967 -0.853 . . . . 2.2 110.967 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.553 HG22 HD13 ' A' ' 121' ' ' LEU . 10.4 m -108.52 109.01 20.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.269 -0.641 . . . . 2.1 109.269 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.08 147.85 28.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.412 -0.358 . . . . 2.78 111.296 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.494 HD22 ' HD2' ' A' ' 131' ' ' PHE . 27.8 mt -83.46 145.95 49.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.89 -0.596 . . . . 2.62 109.96 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.28 154.57 45.7 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.72 2.28 . . . . 2.77 112.095 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.2 120.87 15.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.01 -0.541 . . . . 4.11 110.462 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.95 4.56 48.14 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.845 -0.693 . . . . 3.18 111.705 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.637 ' HE2' HD13 ' A' ' 16' ' ' LEU . 2.3 t80 -115.57 121.81 43.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.341 -0.614 . . . . 2.91 109.341 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.408 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 29.8 p90 -126.41 140.87 52.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.989 0.423 . . . . 3.54 111.37 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.94 154.43 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.744 -0.662 . . . . 2.93 111.521 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.664 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.4 tt0 -83.59 131.57 34.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.405 -0.816 . . . . 3.64 109.224 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.51 -52.0 2.38 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.964 -0.854 . . . . 3.27 110.964 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 3.59 110.066 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.906 0.384 . . . . 2.48 111.258 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -81.02 162.36 23.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.046 -0.525 . . . . 2.13 110.54 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -98.79 -11.4 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.978 0.362 . . . . 2.4 111.978 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 92.6 m-85 -129.09 176.37 7.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.606 -0.27 . . . . 2.02 111.041 -179.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 134' ' ' GLU . 1.9 p -71.69 174.19 7.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.075 -0.511 . . . . 2.65 110.077 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -97.41 167.36 11.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.189 0.519 . . . . 2.4 111.269 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.79 107.05 15.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.552 -0.749 . . . . 2.27 109.28 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -82.43 115.74 21.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.218 -0.446 . . . . 2.84 110.607 -179.943 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -85.33 128.49 34.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 2.89 110.371 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.735 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 42.9 t60 -112.98 -7.67 13.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.752 0.311 . . . . 3.82 111.247 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.76 -159.15 26.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.958 -0.639 . . . . 3.23 111.674 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.37 -32.07 12.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.83 0.315 . . . . 4.27 111.325 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.33 174.78 8.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.893 -0.594 . . . . 3.32 110.179 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -96.78 -82.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 2.39 109.403 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 131' ' ' PHE . 31.6 tp -176.03 130.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 2.06 110.117 179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -153.15 99.14 2.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.187 -0.46 . . . . 2.22 110.647 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 24' ' ' LEU . 16.6 m-85 -89.22 137.05 29.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 1.78 110.511 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.93 158.14 55.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.649 2.232 . . . . 2.15 111.852 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -56.93 118.14 4.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 2.6 111.355 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.35 -13.96 43.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 1.65 112.33 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -115.64 163.9 15.12 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.969 -0.382 . . . . 2.31 109.969 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.448 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 116.0 -19.05 13.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.839 -0.696 . . . . 1.33 112.808 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 49.1 t -86.77 113.76 54.71 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.726 0.298 . . . . 1.06 110.568 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.536 ' HA ' HD23 ' A' ' 121' ' ' LEU . 2.9 Cg_exo -77.26 -174.89 2.39 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.265 2.643 . . . . 1.27 111.794 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.67 81.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 1.7 110.845 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.576 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 63.8 m-80 -81.79 84.18 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.424 . . . . 1.23 109.894 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -32.5 69.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.808 -0.633 . . . . 1.94 112.12 -178.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -76.95 -26.28 53.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 1.96 112.063 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.576 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -91.15 158.28 16.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.064 0.394 . . . . 1.42 112.064 -178.67 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.737 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 46.4 m -86.19 171.96 9.37 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.101 -0.499 . . . . 1.73 110.976 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.737 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.82 -43.53 55.46 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.037 2.491 . . . . 1.42 113.45 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.07 -16.05 60.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.78 111.53 179.966 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.834 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.0 m-20 -81.99 -3.62 54.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.6 111.237 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.478 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 41.0 mm-40 -77.2 51.8 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.3 0.572 . . . . 1.05 111.536 -179.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 94' ' ' ALA . 13.4 tt -150.98 128.03 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.654 -0.703 . . . . 1.17 109.468 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.28 -143.88 4.03 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.217 -0.992 . . . . 0.6 112.542 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -157.69 166.02 33.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.956 0.407 . . . . 0.99 111.001 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.782 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.5 m-85 -107.38 137.87 44.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 1.26 110.062 178.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.456 ' HA ' HD13 ' A' ' 90' ' ' ILE . 19.7 ttt180 -115.07 124.66 52.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.467 . . . . 2.15 110.82 -179.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -83.66 121.55 27.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.023 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.02 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 2.21 111.482 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -130.92 160.51 34.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.476 -0.784 . . . . 2.68 108.94 179.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 52' ' ' ARG . 5.0 tpt180 -134.77 123.56 23.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.983 0.42 . . . . 3.59 111.769 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 74.9 mtt180 -138.92 115.21 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 3.43 110.942 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.455 ' O ' ' HG2' ' A' ' 61' ' ' MET . 28.5 pt -90.09 149.42 4.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.185 -0.672 . . . . 4.26 109.185 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 120.843 0.354 . . . . 5.17 110.362 -179.787 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 20.8 mtt . . . . . 0 C--O 1.235 0.322 0 N-CA-C 110.337 -0.246 . . . . 4.48 110.337 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -54.37 -46.08 72.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 4.16 110.08 179.013 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 30.2 t70 52.07 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.961 -1.018 . . . . 4.09 113.539 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.67 138.03 31.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.873 -0.603 . . . . 3.36 109.937 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.481 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.7 OUTLIER -60.38 153.17 60.96 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 3.36 110.97 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 114.98 2.05 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.928 2.419 . . . . 2.69 111.89 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.465 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 56.7 mtp180 -110.03 113.18 25.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.776 -0.647 . . . . 3.03 110.046 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.782 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 47.3 m95 -84.91 120.3 26.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.241 -0.436 . . . . 1.84 111.117 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 79.5 m-85 -98.96 150.94 21.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 2.76 110.567 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.32 122.31 43.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.27 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.91 164.53 17.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.839 -0.618 . . . . 1.84 109.745 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.49 155.68 17.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.64 -0.255 . . . . 1.28 110.334 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -60.7 111.88 1.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.224 -179.859 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.63 -8.27 26.07 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.308 -0.949 . . . . 1.66 113.993 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 p -62.89 103.68 0.47 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.66 0.73 . . . . 1.58 111.595 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 127.23 111.95 1.72 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.723 -0.951 . . . . 1.96 110.723 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.423 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 26.2 Cg_endo -62.03 -26.07 78.12 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.762 2.308 . . . . 2.62 112.462 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -117.56 23.99 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 3.09 110.1 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.21 -53.98 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 1.79 111.122 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.2 49.29 80.14 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.877 -0.601 . . . . 1.65 112.146 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.6 mt -131.24 99.47 17.63 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.682 0.277 . . . . 1.38 111.548 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 7.7 Cg_exo -75.35 159.43 40.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.904 2.402 . . . . 1.62 110.974 178.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.768 ' HB2' HD11 ' A' ' 73' ' ' LEU . 79.5 t80 -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 1.58 111.021 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.12 -4.63 16.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.863 -0.684 . . . . 1.44 112.625 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -68.0 130.3 42.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 1.25 111.082 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -77.94 127.01 31.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.835 -0.62 . . . . 1.86 111.498 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.436 ' HG2' HG13 ' A' ' 90' ' ' ILE . 3.8 ttmt -152.12 143.17 23.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.2 -0.667 . . . . 1.68 109.2 178.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.02 118.83 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 1.7 112.1 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.13 33.83 56.33 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.617 -0.72 . . . . 1.27 112.52 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 48' ' ' ARG . 25.1 mm -136.3 112.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.157 -0.312 . . . . 1.01 110.157 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.494 HD13 ' HG ' ' A' ' 24' ' ' LEU . 19.6 pt -115.47 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.811 -0.44 . . . . 1.3 109.811 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -93.48 135.1 35.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 1.08 112.044 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.448 HG11 ' HA3' ' A' ' 31' ' ' GLY . 18.1 m -136.11 140.02 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.563 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.562 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -157.89 144.11 17.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 1.27 110.121 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -110.47 -176.22 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.044 0.45 . . . . 1.36 111.022 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.06 133.28 44.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.677 -0.692 . . . . 2.64 110.725 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.89 -9.1 63.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.719 -0.753 . . . . 1.52 112.444 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -82.89 142.34 31.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.186 -0.301 . . . . 1.59 110.186 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.45 144.0 31.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.714 -0.221 . . . . 2.15 110.584 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -80.47 74.63 7.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 2.07 109.806 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.445 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.8 t -144.8 141.41 17.48 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.558 -0.747 . . . . 2.36 109.019 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.39 130.64 21.5 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.596 2.197 . . . . 2.08 113.351 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.834 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.43 71.41 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.53 -0.759 . . . . 1.78 110.874 179.438 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -16.84 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.76 -0.654 . . . . 2.55 111.548 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -61.0 -7.36 2.41 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.577 0.954 . . . . 2.24 113.577 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.39 -23.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.612 -0.514 . . . . 2.0 109.612 178.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.32 81.53 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.859 -0.61 . . . . 2.33 113.433 -178.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 t -79.08 94.41 5.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.673 0.749 . . . . 2.99 110.644 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -150.81 130.73 13.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.377 -0.829 . . . . 2.83 109.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.21 115.75 64.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.836 -0.431 . . . . 3.56 109.836 179.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.49 0.92 8.98 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.808 2.338 . . . . 3.39 114.198 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.21 -31.7 9.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 4.05 111.126 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.44 -16.85 21.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 4.48 110.596 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -143.19 143.87 31.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 3.39 110.23 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.59 148.44 25.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.525 -0.307 . . . . 3.21 110.45 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.48 160.28 31.72 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.105 -0.498 . . . . 2.85 111.771 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 18.3 mt -86.4 158.77 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.631 -0.713 . . . . 2.42 109.448 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.78 117.8 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.587 0.232 . . . . 2.74 110.462 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.98 113.91 4.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 2.11 110.943 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -133.72 155.75 49.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 2.49 110.306 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 35.6 mt -105.79 146.35 32.68 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.194 -0.457 . . . . 1.91 110.59 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 25.7 Cg_exo -64.66 161.7 34.57 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.861 2.374 . . . . 1.84 112.429 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -53.92 127.09 24.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.98 -0.554 . . . . 2.53 111.181 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.22 -7.7 58.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.765 -0.731 . . . . 2.2 111.697 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -112.79 100.01 8.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 2.1 110.095 179.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.01 156.14 18.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.209 -0.45 . . . . 2.78 110.663 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.4 mt -85.21 146.9 46.15 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.71 -0.478 . . . . 2.62 109.71 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.97 143.57 91.41 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.417 2.078 . . . . 2.77 111.56 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -59.54 124.25 19.48 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.89 -0.595 . . . . 4.11 111.245 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.21 45.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.955 -0.641 . . . . 3.18 111.869 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.6 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -109.51 139.13 44.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.695 0.283 . . . . 2.91 110.474 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.735 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 2.5 p90 -135.24 139.82 44.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.416 -0.356 . . . . 3.54 110.582 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.02 128.69 38.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.947 -0.569 . . . . 2.93 110.758 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 49.1 mt-10 -64.14 132.18 49.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.11 -0.495 . . . . 3.64 110.719 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.55 -37.32 3.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.909 -0.662 . . . . 3.27 112.9 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 3.59 111.265 -179.341 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.053 -0.351 . . . . 2.48 110.053 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -69.84 153.66 43.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.462 -0.336 . . . . 2.13 110.758 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -88.12 -9.15 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 2.4 111.109 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.0 m-85 -128.07 162.68 26.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.376 -0.374 . . . . 2.02 111.454 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 p -68.38 162.14 26.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 2.65 111.086 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.05 146.87 31.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 2.4 111.708 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 57.3 mt -97.48 123.87 41.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 2.27 108.935 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.561 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 6.0 m -105.11 128.12 53.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.831 0.348 . . . . 2.84 111.331 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.6 tp-100 -100.9 138.86 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.89 110.633 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -127.41 78.77 1.84 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.791 -0.448 . . . . 3.82 109.791 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.24 -158.91 16.13 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.97 -0.633 . . . . 3.23 111.892 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -94.56 -39.35 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.887 0.375 . . . . 4.27 110.238 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.72 155.74 21.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.985 -0.746 . . . . 3.32 108.985 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.462 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -96.87 -131.23 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.844 0.313 . . . . 2.39 111.844 -179.484 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' CE1' ' A' ' 131' ' ' PHE . 31.2 tp -114.77 135.95 53.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 2.06 112.253 -179.091 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -157.83 116.99 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.554 -0.748 . . . . 2.22 109.084 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 28.6 m-85 -105.89 138.81 19.75 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.78 111.003 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.55 -178.94 2.9 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.847 2.365 . . . . 2.15 112.876 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -66.49 126.7 29.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.532 -0.758 . . . . 2.6 111.583 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 48.77 66.26 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.005 -0.543 . . . . 1.65 112.924 179.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -166.49 154.73 10.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.094 -0.336 . . . . 2.31 110.094 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.26 4.98 35.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.56 -0.829 . . . . 1.33 112.925 179.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 43' ' ' GLN . 45.0 t -93.04 120.46 66.98 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.632 0.253 . . . . 1.06 110.506 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 121' ' ' LEU . 11.3 Cg_exo -71.97 178.75 5.53 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.069 2.512 . . . . 1.27 111.954 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.09 81.99 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 1.7 109.843 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.538 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 42.5 m-80 -83.3 75.18 9.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 1.23 110.946 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.93 3.62 6.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.395 0.617 . . . . 1.94 110.759 179.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -99.09 -8.5 25.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 1.96 110.667 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 1.4 p -134.61 165.33 25.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 1.42 112.056 -178.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -78.92 163.97 57.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 1.73 110.493 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 51.5 Cg_exo -57.11 -31.56 90.7 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.806 2.337 . . . . 1.42 112.566 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.54 -24.29 61.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 1.78 110.472 179.363 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.954 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 21.6 m-20 -84.59 -3.69 58.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.769 -0.651 . . . . 1.6 110.74 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 34.3 mm-40 -78.54 58.06 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 1.05 111.156 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.507 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -153.1 134.44 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.485 -0.561 . . . . 1.17 109.485 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.64 -141.93 4.57 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.322 -0.942 . . . . 0.6 112.663 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -155.1 164.02 39.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.141 0.496 . . . . 0.99 111.479 -178.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.623 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 46.1 m-85 -106.79 131.64 53.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.591 -0.731 . . . . 1.26 109.091 178.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -106.83 127.84 53.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 2.15 111.279 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 49' ' ' ARG . 29.4 ttt-85 -83.34 109.11 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.797 -0.638 . . . . 2.4 109.771 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.95 170.58 9.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.83 0.347 . . . . 2.21 111.316 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 165.67 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.605 . . . . 2.68 110.304 179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -141.32 104.08 4.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 3.59 110.587 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -126.26 107.44 10.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.141 -0.482 . . . . 3.43 111.404 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 62' ' ' LYS . 49.8 pt -70.9 163.7 3.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.449 -0.341 . . . . 4.26 110.679 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.673 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 5.17 111.906 -179.005 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.9 ttm . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 110.501 -0.185 . . . . 4.48 110.501 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HB2' HG12 ' A' ' 54' ' ' ILE . 48.6 tttp -67.69 -48.05 67.68 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.304 0.377 . . . . 4.16 110.854 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 65.79 99.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.719 -0.673 . . . . 4.09 112.385 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.31 157.51 30.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 3.36 111.062 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -78.73 158.51 75.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.697 -0.683 . . . . 3.36 110.284 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.22 123.94 14.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.949 2.433 . . . . 2.69 111.871 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -122.22 122.56 39.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 3.03 111.053 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.623 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 45.8 m95 -98.72 129.95 45.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.774 -0.648 . . . . 1.84 111.184 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 47.9 m-85 -108.65 138.7 44.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.34 -0.615 . . . . 2.76 109.34 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.48 128.72 36.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 1.27 111.486 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.72 143.21 50.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 1.84 110.369 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -77.4 151.6 34.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.426 -0.352 . . . . 1.28 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -58.82 116.81 4.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 1.66 111.085 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 114.72 -3.37 23.06 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.555 -0.831 . . . . 1.66 113.735 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.41 114.18 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.994 0.397 . . . . 1.58 111.119 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.427 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 107.57 109.6 3.37 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.124 -0.791 . . . . 1.96 111.124 -179.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.427 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 14.2 Cg_endo -56.97 -39.61 90.15 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.098 2.532 . . . . 2.62 112.921 -179.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.71 31.17 6.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.377 . . . . 3.09 110.989 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.18 -42.94 59.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 1.79 111.137 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.39 51.65 41.49 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.971 -0.633 . . . . 1.65 111.546 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -120.41 97.33 48.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.614 0.245 . . . . 1.38 111.476 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.65 151.32 10.14 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.096 2.531 . . . . 1.62 110.914 178.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.71 ' HB2' HD11 ' A' ' 73' ' ' LEU . 68.9 t80 -62.77 111.32 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.368 . . . . 1.58 110.855 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.85 -27.09 5.23 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.456 -0.878 . . . . 1.44 112.201 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.53 122.37 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.683 0.277 . . . . 1.25 110.76 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -87.14 127.34 35.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.958 0.409 . . . . 1.86 111.524 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -139.97 157.89 44.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.728 -0.842 . . . . 1.68 108.728 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.54 115.87 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.229 0.455 . . . . 1.7 112.229 -179.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.55 30.36 62.29 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.27 112.756 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.51 95.19 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 1.01 110.476 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.44 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 27.2 pt -107.75 127.98 63.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.132 -0.486 . . . . 1.3 109.99 178.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.658 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 85.5 m95 -88.02 140.86 29.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.341 0.497 . . . . 1.08 112.341 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.73 146.78 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.446 -0.797 . . . . 1.04 109.781 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -140.9 173.6 11.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.013 0.435 . . . . 1.27 111.226 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.713 HG22 ' HB2' ' A' ' 98' ' ' ALA . 1.4 t -133.49 168.11 19.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.972 -0.558 . . . . 1.36 110.079 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.41 105.35 5.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 2.64 109.829 179.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.25 26.39 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.657 -0.782 . . . . 1.52 111.95 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.713 ' HB2' HG22 ' A' ' 95' ' ' THR . . . -78.74 149.47 32.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.754 -0.462 . . . . 1.59 109.754 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 45.3 mt -102.56 123.18 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.889 0.376 . . . . 2.15 110.721 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -76.63 72.3 3.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.584 0.707 . . . . 2.07 110.284 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.693 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 25.5 m -149.47 129.89 6.84 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.54 -0.911 . . . . 2.36 108.54 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.51 125.11 13.25 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.982 2.454 . . . . 2.08 112.418 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.954 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.3 69.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.344 0.593 . . . . 1.78 111.304 -179.488 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 1.2 p-10 -77.42 4.36 11.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.186 -0.461 . . . . 2.55 112.003 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.5 p80 -57.81 -23.15 51.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.949 0.404 . . . . 2.24 111.743 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.84 16.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 2.0 111.147 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.19 -15.98 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.742 -0.742 . . . . 2.33 111.704 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -82.51 123.55 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 2.99 111.157 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -167.63 147.06 4.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 2.83 109.419 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.9 113.19 62.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.071 0.463 . . . . 3.56 110.872 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.78 -35.45 27.63 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.116 2.544 . . . . 3.39 113.875 -178.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.36 18.13 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 4.05 111.888 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -141.96 -39.08 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.195 -0.457 . . . . 4.48 110.707 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.271 -0.422 . . . . 3.39 110.911 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.87 146.9 23.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 3.21 110.585 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.17 165.36 21.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 2.85 110.957 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.6 mt -97.67 155.59 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.55 . . . . 2.42 110.077 -179.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.415 HG22 ' HA3' ' A' ' 135' ' ' GLY . 65.1 t -68.53 126.8 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.318 -0.253 . . . . 2.74 110.318 179.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -70.24 111.51 5.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.92 0.391 . . . . 2.11 110.407 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -128.38 153.57 46.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 2.49 109.952 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 33' ' ' PRO . 93.3 mt -108.18 148.65 37.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.22 -0.445 . . . . 1.91 110.482 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.01 157.03 63.73 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.191 1.927 . . . . 1.84 111.383 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -53.68 124.4 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 2.53 110.877 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.07 -18.24 16.43 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.207 -0.757 . . . . 2.2 111.207 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -94.87 100.19 12.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.031 0.443 . . . . 2.1 110.196 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.5 m -80.0 129.64 34.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 2.78 111.071 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 121' ' ' LEU . 12.7 mt -80.34 137.36 52.32 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 2.62 109.843 179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.7 141.85 97.69 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.546 2.164 . . . . 2.77 111.654 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -60.49 128.03 34.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.039 -0.528 . . . . 4.11 111.033 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.94 -18.95 39.17 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.204 -0.758 . . . . 3.18 111.204 -179.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.511 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -95.73 138.21 33.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.647 0.26 . . . . 2.91 110.493 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.561 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 27.2 p90 -136.19 155.24 50.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.453 -0.34 . . . . 3.54 110.397 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.33 123.77 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 2.93 110.072 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.13 128.59 35.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.165 -0.47 . . . . 3.64 110.339 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.415 ' HA3' HG22 ' A' ' 118' ' ' VAL . . . 112.16 -20.45 21.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.795 -0.717 . . . . 3.27 111.355 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.166 0.508 . . . . 3.59 110.333 179.017 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 110.169 -0.308 . . . . 2.48 110.169 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 p -69.78 145.87 51.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.574 -0.285 . . . . 2.13 110.6 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -75.14 -20.22 59.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.44 -0.346 . . . . 2.4 111.377 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 99.5 m-85 -108.16 166.27 10.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.02 112.098 -178.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.89 170.82 13.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.031 -0.986 . . . . 2.65 111.258 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -76.39 140.3 41.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.087 -0.506 . . . . 2.4 111.756 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.827 HD11 HD13 ' A' ' 119' ' ' LEU . 5.1 mp -107.61 115.75 30.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.294 -0.632 . . . . 2.27 109.294 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.437 HG23 ' HB2' ' A' ' 65' ' ' SER . 54.9 m -96.34 129.33 43.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.657 0.614 . . . . 2.84 112.657 -178.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -95.56 128.11 42.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.391 -0.822 . . . . 2.89 109.806 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.29 79.79 1.57 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.804 -0.443 . . . . 3.82 109.804 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.44 -167.54 39.13 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.652 -0.785 . . . . 3.23 111.991 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -81.58 -25.93 35.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.954 0.407 . . . . 4.27 111.681 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -81.35 173.1 12.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 3.32 109.771 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 -70.47 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.122 -0.696 . . . . 2.39 109.122 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.405 HD11 ' CE2' ' A' ' 26' ' ' PHE . 25.5 tp 178.61 127.91 0.06 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.603 -0.726 . . . . 2.06 111.133 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -159.59 107.43 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 2.22 110.24 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.405 ' CE2' HD11 ' A' ' 24' ' ' LEU . 27.3 m-85 -98.11 148.32 34.32 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.049 -0.523 . . . . 1.78 109.737 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.98 162.09 41.88 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.337 2.024 . . . . 2.15 111.251 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -62.22 135.88 57.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 2.6 110.297 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 21.75 58.85 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.549 -0.834 . . . . 1.65 111.748 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -156.81 172.18 19.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.067 -0.345 . . . . 2.31 110.067 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.56 56.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.784 -0.722 . . . . 1.33 112.345 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 43' ' ' GLN . 20.3 t -82.24 119.07 74.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 110.13 -0.322 . . . . 1.06 110.13 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.88 -179.14 5.16 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.299 . . . . 1.27 111.657 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -77.62 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 1.7 110.786 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.57 83.35 8.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.538 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.86 21.79 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.237 0.458 . . . . 1.94 112.237 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -124.44 -17.36 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.586 0.231 . . . . 1.96 111.457 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.523 ' HB3' HG21 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -118.6 168.6 10.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.84 0.352 . . . . 1.42 111.918 -178.382 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.626 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.8 m -86.86 166.3 27.56 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 1.73 110.687 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.4 Cg_endo -53.4 -39.84 80.34 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.268 2.645 . . . . 1.42 113.205 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.54 -13.93 61.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.077 0.465 . . . . 1.78 111.163 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -93.84 -1.63 54.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.614 . . . . 1.6 110.479 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.448 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 37.5 mm-40 -78.38 54.63 1.45 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.08 0.466 . . . . 1.05 111.108 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.754 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.8 tt -147.26 133.92 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.079 -0.51 . . . . 1.17 109.893 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.42 -144.4 4.99 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.432 -0.889 . . . . 0.6 112.477 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -156.15 164.43 38.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 0.99 110.935 -179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.49 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 34.7 m-85 -107.67 130.79 54.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.055 -0.721 . . . . 1.26 109.055 178.393 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HG3' HD11 ' A' ' 90' ' ' ILE . 22.3 ttt180 -110.09 135.39 50.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.089 0.243 . . . . 2.15 110.922 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -87.18 123.25 32.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.799 -0.445 . . . . 2.4 109.799 178.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.448 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -128.54 154.47 46.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.243 0.544 . . . . 2.21 111.399 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -154.26 111.4 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.483 -0.781 . . . . 2.68 109.828 179.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HB3' HD12 ' A' ' 64' ' ' LEU . 20.5 tpt180 -93.27 127.29 38.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.153 0.501 . . . . 3.59 110.917 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -128.59 141.13 51.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.478 -0.783 . . . . 3.43 109.922 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.755 HG12 ' H ' ' A' ' 62' ' ' LYS . 34.8 pt -92.83 175.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.203 -0.666 . . . . 4.26 109.203 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.673 0 N-CA-C 110.256 -0.275 . . . . 5.17 110.256 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 mmt . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.46 -0.941 . . . . 4.48 108.46 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.755 ' H ' HG12 ' A' ' 54' ' ' ILE . 53.5 tttt -49.94 -43.57 49.98 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.189 0.306 . . . . 4.16 110.615 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 43.95 71.56 0.24 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.432 -0.804 . . . . 4.09 112.748 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.613 HD12 ' HB3' ' A' ' 52' ' ' ARG . 98.2 mt -67.04 145.35 55.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.002 -0.545 . . . . 3.36 110.363 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.437 ' HB2' HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -68.52 162.58 61.21 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.747 -0.464 . . . . 3.36 109.747 179.517 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.93 102.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.655 2.236 . . . . 2.69 111.858 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.418 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 3.1 mtp180 -108.74 122.69 47.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 3.03 110.893 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.49 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.0 m95 -98.27 145.17 26.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.84 110.042 179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 81.1 m-85 -128.01 137.98 52.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.762 -0.459 . . . . 2.76 109.762 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -88.49 128.98 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 1.27 111.444 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -128.13 150.57 49.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.806 -0.634 . . . . 1.84 109.686 178.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -84.53 156.78 21.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.941 0.401 . . . . 1.28 111.008 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.642 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.6 tt -64.0 115.01 4.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.408 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 113.46 1.17 24.76 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.731 -0.747 . . . . 1.66 113.769 179.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.8 p -58.47 110.18 0.93 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.192 0.496 . . . . 1.58 110.885 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 104.26 111.59 3.61 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.302 -0.719 . . . . 1.96 111.302 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.438 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 31.0 Cg_endo -63.21 -18.11 63.31 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.707 2.271 . . . . 2.62 112.134 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -119.54 24.15 10.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.456 -0.338 . . . . 3.09 111.45 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.95 -48.84 15.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 1.79 110.51 179.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.36 49.45 74.02 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.885 -0.598 . . . . 1.65 111.821 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.422 HD21 ' HD2' ' A' ' 87' ' ' LYS . 87.8 mt -119.72 100.06 49.17 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.866 0.365 . . . . 1.38 111.619 -179.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.22 153.28 14.16 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.464 2.11 . . . . 1.62 111.206 178.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.642 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.3 t80 -58.61 115.14 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 1.58 110.781 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.13 10.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.815 -0.707 . . . . 1.44 112.195 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.56 107.38 3.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 1.25 110.344 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.77 104.75 5.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.963 -0.562 . . . . 1.86 110.506 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.512 ' HB3' HG13 ' A' ' 90' ' ' ILE . 67.7 tttt -112.22 160.6 17.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.949 -0.569 . . . . 1.68 110.093 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.04 112.2 2.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.465 . . . . 1.7 111.298 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.33 32.17 65.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.923 -0.656 . . . . 1.27 112.327 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.512 HG13 ' HB3' ' A' ' 87' ' ' LYS . 36.6 mm -130.06 112.7 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.629 0.252 . . . . 1.01 110.601 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.434 HG13 ' HB2' ' A' ' 47' ' ' TYR . 7.0 pt -118.46 123.84 72.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.864 0.364 . . . . 1.3 110.428 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.637 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 89.7 m95 -82.61 137.95 34.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.069 -0.514 . . . . 1.08 111.769 -179.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.83 135.73 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 1.04 110.58 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.26 170.87 15.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 1.27 110.584 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -150.19 179.23 8.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.414 -0.587 . . . . 1.36 109.414 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -66.05 132.07 47.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.65 0.262 . . . . 2.64 110.382 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.66 32.88 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.854 -0.689 . . . . 1.52 111.53 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.754 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.18 134.3 36.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.117 -0.327 . . . . 1.59 110.117 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.92 149.05 26.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.387 -0.37 . . . . 2.15 110.634 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.73 74.03 5.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.521 0.677 . . . . 2.07 110.409 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -138.51 130.05 15.6 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.496 -0.774 . . . . 2.36 110.323 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.6 122.37 5.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.32 2.013 . . . . 2.08 111.466 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.745 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -146.07 106.29 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.103 -0.499 . . . . 1.78 111.402 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 5.0 p-10 -89.18 8.06 32.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.56 . . . . 2.55 112.164 -178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.745 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 6.4 p80 -56.73 -28.66 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.212 0.529 . . . . 2.24 111.594 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.523 HG21 ' HB3' ' A' ' 38' ' ' SER . 1.0 OUTLIER -99.13 5.42 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 2.0 110.913 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.95 -21.62 22.75 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.778 -0.725 . . . . 2.33 112.248 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.6 t -74.97 105.62 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.492 0.663 . . . . 2.99 111.261 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -149.75 125.49 10.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.668 -0.696 . . . . 2.83 109.742 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.7 m-80 -84.74 114.28 54.49 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.894 0.378 . . . . 3.56 110.341 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 28.4 Cg_endo -60.67 -34.6 91.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.181 2.588 . . . . 3.39 113.449 -178.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.35 15.68 11.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.151 0.426 . . . . 4.05 112.151 -179.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.48 -20.64 1.59 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.893 0.377 . . . . 4.48 111.664 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -131.78 137.4 48.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.694 0.283 . . . . 3.39 110.365 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.21 146.74 28.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.253 -0.431 . . . . 3.21 110.969 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.33 157.61 32.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.407 0.622 . . . . 2.85 111.904 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 62.4 mt -102.21 137.59 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.417 -0.81 . . . . 2.42 109.765 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.42 121.4 13.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.12 -0.696 . . . . 2.74 109.12 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 16' ' ' LEU . 3.9 tt -63.44 117.9 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 2.11 111.549 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -126.75 141.58 51.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.443 -0.799 . . . . 2.49 109.816 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 79.9 mt -105.62 145.04 30.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.258 -0.428 . . . . 1.91 110.344 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.56 150.84 79.49 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.702 2.268 . . . . 1.84 111.557 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.67 98.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 2.53 110.888 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 143.94 -30.74 1.9 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.96 -0.638 . . . . 2.2 111.574 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 24.1 m -84.44 115.04 22.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.69 0.281 . . . . 2.1 110.369 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 137.17 37.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.272 -0.422 . . . . 2.78 110.904 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.496 HD22 ' HD2' ' A' ' 131' ' ' PHE . 20.2 mt -74.97 149.02 85.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 2.62 110.875 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.35 161.75 19.32 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.817 2.345 . . . . 2.77 112.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.85 119.26 10.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.836 -0.62 . . . . 4.11 111.597 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.55 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.137 -0.554 . . . . 3.18 112.923 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.496 ' HD2' HD22 ' A' ' 127' ' ' LEU . 18.4 t80 -106.25 126.98 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.728 0.299 . . . . 2.91 110.464 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.78 164.02 34.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.033 -0.53 . . . . 3.54 110.635 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' LEU . . . -110.48 156.36 20.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.509 -0.314 . . . . 2.93 110.802 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.63 132.54 42.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.89 -0.595 . . . . 3.64 110.773 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.48 -45.15 1.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.097 -0.573 . . . . 3.27 112.936 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 3.59 110.588 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.891 0.377 . . . . 2.48 111.055 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -85.29 155.05 21.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.109 -0.496 . . . . 2.13 110.373 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.63 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 23.2 m95 -78.77 -28.29 44.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.442 . . . . 2.4 111.191 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.586 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 29.0 m-85 -99.33 173.81 6.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.737 -0.665 . . . . 2.02 110.957 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -78.8 -142.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.675 -0.693 . . . . 2.65 110.353 179.587 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' H ' ' HB ' ' A' ' 14' ' ' THR . . . -131.74 146.59 52.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.963 0.411 . . . . 2.4 111.566 -179.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.669 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.6 mt -96.99 120.02 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 2.27 109.112 178.722 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -92.97 122.99 35.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.433 -0.349 . . . . 2.84 111.249 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.3 tp-100 -101.22 145.02 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 2.89 110.067 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -140.58 89.47 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.384 -0.599 . . . . 3.82 109.384 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.38 -167.42 40.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.535 -0.84 . . . . 3.23 112.497 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -81.66 -36.47 28.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 4.27 110.605 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -75.59 154.68 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.47 -0.786 . . . . 3.32 110.671 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.02 -89.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.218 -0.446 . . . . 2.39 110.549 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.599 HD13 ' CE1' ' A' ' 131' ' ' PHE . 29.3 tp -168.71 134.61 1.76 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.985 0.421 . . . . 2.06 111.837 179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -163.42 120.18 1.8 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.765 -0.652 . . . . 2.22 110.221 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -106.09 137.17 19.3 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.026 -0.534 . . . . 1.78 110.156 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.7 163.53 30.05 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.547 2.165 . . . . 2.15 111.908 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -63.64 103.19 0.52 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.159 0.504 . . . . 2.6 110.967 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.09 -9.19 8.46 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.794 -0.639 . . . . 1.65 111.873 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -120.43 163.07 18.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.765 0.317 . . . . 2.31 110.368 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -6.7 28.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.902 -0.666 . . . . 1.33 112.421 179.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 t -88.72 117.39 68.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.762 0.315 . . . . 1.06 110.307 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.04 -169.04 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.902 2.401 . . . . 1.27 111.718 -179.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.437 ' O ' ' HZ ' ' A' ' 13' ' ' PHE . 18.1 mt -82.58 77.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.08 0.467 . . . . 1.7 109.817 179.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.524 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 78.6 m-20 -78.4 78.06 4.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.58 . . . . 1.23 110.823 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.94 -1.55 26.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.113 -0.494 . . . . 1.94 111.238 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.21 2.67 22.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.96 110.652 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.89 155.16 46.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 1.42 111.284 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 19.8 m -86.61 169.08 15.98 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.929 -0.578 . . . . 1.73 110.318 179.432 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 88.0 Cg_exo -47.62 -40.24 30.36 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.484 2.789 . . . . 1.42 114.252 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -17.44 44.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.732 0.301 . . . . 1.78 111.609 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.856 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -89.14 8.67 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 1.6 110.788 -179.628 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.524 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 85.1 mm-40 -80.76 0.57 34.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 1.05 112.104 -179.162 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.902 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.2 tt -89.51 126.62 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.975 0.417 . . . . 1.17 111.086 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.61 -152.2 6.28 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.345 -0.931 . . . . 0.6 112.919 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.444 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 44.0 p90 -163.19 170.9 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.917 0.389 . . . . 0.99 110.547 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.608 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 4.5 m-85 -111.46 138.22 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.213 -0.449 . . . . 1.26 110.422 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -117.94 127.44 53.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 2.15 110.819 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -79.01 126.92 31.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 2.4 109.95 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.01 151.82 42.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.005 0.431 . . . . 2.21 111.88 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 m -143.51 132.42 22.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 2.68 109.819 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HB3' HD12 ' A' ' 64' ' ' LEU . 2.2 tpt180 -106.91 138.04 43.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.093 -0.336 . . . . 3.59 110.093 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -147.43 128.03 14.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.83 0.348 . . . . 3.43 111.851 -178.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.63 HG12 ' HB2' ' A' ' 62' ' ' LYS . 41.3 pt -81.41 151.67 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.802 -0.814 . . . . 4.26 108.802 178.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 C--N 1.319 -0.734 0 C-N-CA 120.554 -0.458 . . . . 5.17 111.74 -179.412 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 mmt . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.615 0.245 . . . . 4.48 110.909 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.63 ' HB2' HG12 ' A' ' 54' ' ' ILE . 75.9 tttt -66.84 -35.71 80.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.028 -0.73 . . . . 4.16 109.028 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 50.12 82.86 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.748 -1.114 . . . . 4.09 113.047 179.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 52' ' ' ARG . 9.0 mt -82.57 168.13 17.65 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.944 -0.571 . . . . 3.36 110.507 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -90.5 155.04 46.39 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.028 -0.533 . . . . 3.36 110.441 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.72 116.22 2.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.809 2.339 . . . . 2.69 111.757 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 29.3 mtt180 -115.79 119.03 34.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 3.03 111.265 -179.2 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.608 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 53.7 m95 -93.78 124.03 37.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 1.84 110.401 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -102.89 138.92 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.222 -0.444 . . . . 2.76 110.201 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -90.35 124.79 35.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.084 0.469 . . . . 1.27 111.344 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.0 167.75 12.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 1.84 109.894 179.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -108.02 151.58 25.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.688 -0.233 . . . . 1.28 110.43 -179.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.32 110.94 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.4 -0.364 . . . . 1.66 110.465 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.96 -15.55 6.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.763 -0.732 . . . . 1.66 112.357 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.71 HG22 ' HA3' ' A' ' 107' ' ' GLY . 9.5 p -59.13 125.77 24.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.571 0.224 . . . . 1.58 111.006 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.02 110.47 3.3 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.795 -0.717 . . . . 1.96 111.587 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.93 -37.0 97.8 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.006 2.47 . . . . 2.62 112.948 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -117.46 34.35 5.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 3.09 110.491 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.38 -52.23 29.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.79 110.379 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.34 46.47 93.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.977 -0.63 . . . . 1.65 111.693 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.1 mt -120.06 97.73 49.28 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.55 0.204 . . . . 1.38 111.55 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.22 147.43 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.896 2.398 . . . . 1.62 110.65 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 44.5 t80 -58.54 104.83 0.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 1.58 111.142 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.35 -16.69 5.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.852 -0.689 . . . . 1.44 111.878 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.48 20.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 1.25 110.753 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -80.93 119.34 23.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.007 -0.542 . . . . 1.86 110.75 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.531 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 9.1 ttmt -135.25 149.69 49.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.069 -0.514 . . . . 1.68 109.832 179.196 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.96 110.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.326 0.584 . . . . 1.7 112.123 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.68 64.76 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.697 -0.683 . . . . 1.27 112.964 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 38.1 mm -128.05 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 1.01 110.641 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 47' ' ' TYR . 13.2 pt -117.62 133.48 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.112 -0.494 . . . . 1.3 109.765 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.55 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 73.6 m95 -89.04 140.07 29.82 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.385 . . . . 1.08 112.038 -178.373 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 m -136.32 131.06 48.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.741 -0.663 . . . . 1.04 110.884 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.12 169.47 20.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.138 -0.483 . . . . 1.27 110.89 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -148.4 -169.99 3.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.535 -0.543 . . . . 1.36 109.535 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.91 136.84 57.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.875 0.369 . . . . 2.64 110.827 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.94 -25.15 27.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.148 -0.549 . . . . 1.52 112.404 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.902 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.45 136.24 45.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.813 0.339 . . . . 1.59 110.452 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.96 140.55 38.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.117 -0.492 . . . . 2.15 110.72 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -76.79 78.29 3.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.77 -0.455 . . . . 2.07 109.77 179.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.524 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 81.6 m -150.31 128.94 6.06 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.971 -0.752 . . . . 2.36 108.971 -179.394 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.71 124.54 12.49 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.602 2.201 . . . . 2.08 111.834 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.856 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.21 95.83 4.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 1.78 110.954 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.12 -5.91 58.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 2.55 112.427 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 14.8 p80 -61.44 -21.07 63.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.477 0.547 . . . . 2.24 112.477 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.666 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -102.02 12.26 7.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 2.0 111.363 -179.79 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.71 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -124.89 38.29 2.37 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.653 -0.784 . . . . 2.33 111.4 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -131.74 33.46 3.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.597 0.713 . . . . 2.99 110.658 -179.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HD3' ' HA ' ' A' ' 12' ' ' TRP . 54.0 ttp85 -72.99 137.63 45.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.895 -0.593 . . . . 2.83 111.258 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -98.43 107.68 43.48 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.17 -0.678 . . . . 3.56 109.17 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.64 -14.24 36.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.876 2.384 . . . . 3.39 113.652 -178.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.46 -25.03 27.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.663 0.268 . . . . 4.05 111.425 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -121.99 29.86 6.88 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.543 -0.299 . . . . 4.48 111.56 -179.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.433 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 9.7 t-20 -174.03 140.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 3.39 110.857 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.28 142.82 26.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.207 -0.451 . . . . 3.21 110.1 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.83 145.83 50.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.259 -0.428 . . . . 2.85 111.23 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.0 mt -78.53 139.54 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.118 -0.492 . . . . 2.42 109.889 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.98 122.14 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 2.74 110.183 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.586 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 1.2 tt -59.75 109.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 2.11 111.231 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.64 152.07 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.759 -0.655 . . . . 2.49 110.182 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 67.3 mt -108.65 153.09 42.42 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.128 -0.487 . . . . 1.91 110.228 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.32 172.21 8.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.13 . . . . 1.84 112.337 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.16 131.97 50.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 2.53 111.203 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.89 36.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.91 -0.662 . . . . 2.2 112.704 179.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 3.1 m -85.64 107.79 17.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.913 0.387 . . . . 2.1 110.134 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.52 143.25 26.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 2.78 111.825 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.8 143.61 50.59 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 2.62 109.943 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.16 146.69 95.95 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.57 2.18 . . . . 2.77 111.663 179.244 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -61.15 119.27 8.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 4.11 111.398 -179.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.89 -13.49 29.34 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.923 -0.656 . . . . 3.18 111.991 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.669 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -97.16 133.58 41.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.596 0.236 . . . . 2.91 110.742 179.647 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -144.65 144.55 31.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 3.54 110.269 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.55 150.56 26.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.83 0.348 . . . . 2.93 111.358 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.09 135.74 39.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.565 -0.531 . . . . 3.64 109.565 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.43 69.5 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 3.27 112.399 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 3.59 110.141 -179.993 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.103 -0.332 . . . . 2.48 110.103 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -109.18 130.24 55.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.639 -0.255 . . . . 2.13 110.492 179.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.59 -25.75 62.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 2.4 110.753 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 95.6 m-85 -118.34 168.37 10.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.777 -0.647 . . . . 2.02 110.874 -179.543 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 2.5 p -68.47 170.16 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 2.65 110.221 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 149.73 27.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.363 0.602 . . . . 2.4 112.008 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.817 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 12.1 mt -94.77 116.58 28.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 2.27 109.54 178.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.1 112.12 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.31 -0.405 . . . . 2.84 111.763 -179.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -91.82 135.13 34.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 2.89 111.01 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -137.48 83.23 1.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 3.82 109.472 178.378 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.35 -166.46 30.18 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.859 -0.686 . . . . 3.23 111.968 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.18 -19.43 28.44 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.352 . . . . 4.27 111.949 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -100.98 170.43 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.66 0.267 . . . . 3.32 110.671 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 t0 -92.43 -61.49 1.59 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.074 -0.343 . . . . 2.39 110.074 179.454 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD13 ' CE1' ' A' ' 131' ' ' PHE . 30.3 tp 169.76 137.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.742 0.651 . . . . 2.06 110.901 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -155.94 119.59 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 2.22 109.686 178.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 36.5 m-85 -101.34 144.67 29.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.297 -0.41 . . . . 1.78 111.127 -179.473 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 13.5 Cg_exo -71.34 177.67 6.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.274 2.649 . . . . 2.15 112.341 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -70.25 118.56 13.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 2.6 111.017 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.25 68.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.108 -0.568 . . . . 1.65 113.196 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.511 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -141.39 146.31 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.462 . . . . 2.31 109.754 179.92 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.68 -5.46 12.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.581 -0.818 . . . . 1.33 112.386 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.15 115.66 64.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.921 -0.399 . . . . 1.06 109.921 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HA ' HD23 ' A' ' 121' ' ' LEU . 58.2 Cg_endo -71.69 177.06 7.32 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.63 2.22 . . . . 1.27 112.383 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.2 mt -75.72 88.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 1.7 110.407 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.467 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 69.1 m-80 -80.47 82.85 6.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.23 110.263 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.46 26.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.659 -0.7 . . . . 1.94 112.182 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -137.13 -4.04 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.047 0.451 . . . . 1.96 110.328 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -126.47 148.37 49.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.022 -0.536 . . . . 1.42 111.363 -178.751 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.05 166.56 32.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.071 -0.513 . . . . 1.73 110.495 179.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.83 -35.25 78.71 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.861 2.374 . . . . 1.42 113.097 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 11.9 p-10 -85.68 -7.07 59.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.718 0.294 . . . . 1.78 111.281 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.39 10.2 40.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.519 . . . . 1.6 110.014 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -84.68 3.42 37.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 1.05 111.447 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.574 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.2 tt -85.5 124.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.068 0.461 . . . . 1.17 111.068 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 73' ' ' LEU . . . -159.77 -153.81 7.03 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.355 -0.926 . . . . 0.6 113.125 -179.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -161.84 173.09 15.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.805 0.336 . . . . 0.99 110.694 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.513 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 10.2 m-85 -116.96 140.88 48.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.949 -0.569 . . . . 1.26 110.281 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -121.63 139.1 53.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.605 -0.517 . . . . 2.15 109.605 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -84.67 133.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.121 0.486 . . . . 2.4 111.009 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.24 147.97 51.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.239 0.542 . . . . 2.21 111.016 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -138.04 128.13 25.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.609 -0.515 . . . . 2.68 109.609 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -113.47 123.67 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.961 -0.296 . . . . 3.59 110.962 -179.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -147.69 95.8 2.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.407 -0.36 . . . . 3.43 111.099 179.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.01 169.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.565 -0.532 . . . . 4.26 109.565 178.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 120.974 0.416 . . . . 5.17 111.366 179.922 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 C--O 1.233 0.185 0 N-CA-C 110.133 -0.321 . . . . 4.48 110.133 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -60.09 -51.48 69.44 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.181 -0.303 . . . . 4.16 110.181 178.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.42 105.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.289 0.848 . . . . 4.09 113.289 178.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -108.53 140.5 41.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.997 -0.547 . . . . 3.36 110.635 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.82 159.88 9.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 3.36 110.897 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.1 108.9 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.037 2.492 . . . . 2.69 111.768 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -95.8 103.73 15.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.577 -0.738 . . . . 3.03 110.731 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.513 ' CE3' ' HB3' ' A' ' 47' ' ' TYR . 67.8 m95 -83.36 115.51 22.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 1.84 110.987 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -99.12 137.98 36.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.807 -0.633 . . . . 2.76 110.413 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -97.2 132.38 43.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 1.27 110.561 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.54 168.73 17.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 1.84 109.84 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -100.39 156.15 17.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 1.28 110.117 179.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 102' ' ' PRO . 14.5 tp -63.36 103.68 0.53 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.519 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 115.24 -2.38 22.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.282 -0.961 . . . . 1.66 113.787 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.567 HG22 ' HA3' ' A' ' 107' ' ' GLY . 5.8 p -59.04 114.0 2.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.118 0.459 . . . . 1.58 111.761 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 117.19 108.09 2.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.866 -0.683 . . . . 1.96 111.535 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 12.8 Cg_endo -57.34 -30.09 86.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.077 2.518 . . . . 2.62 112.789 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.77 42.74 2.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.145 0.498 . . . . 3.09 111.302 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.73 -55.08 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 1.79 110.568 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 42.89 79.11 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.937 -0.649 . . . . 1.65 112.373 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.9 mt -121.01 102.43 43.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.837 0.351 . . . . 1.38 111.701 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.711 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 1.3 Cg_endo -84.49 165.47 12.37 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.006 2.471 . . . . 1.62 110.635 178.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.73 112.96 2.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.933 0.397 . . . . 1.58 110.814 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.98 -12.88 14.45 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.979 -0.629 . . . . 1.44 112.608 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.711 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -56.23 116.53 3.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.049 0.452 . . . . 1.25 111.274 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -87.95 120.01 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 1.86 110.569 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 88' ' ' ASP . 29.5 mttt -134.63 -148.48 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.273 -0.421 . . . . 1.68 110.384 179.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 87' ' ' LYS . 16.3 t70 -108.05 103.29 12.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.004 0.431 . . . . 1.7 110.852 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.47 36.9 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.761 -0.733 . . . . 1.27 112.393 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mm -122.38 113.21 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.68 0.276 . . . . 1.01 110.319 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.0 122.58 67.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 1.3 110.176 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -88.01 145.83 25.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.133 -0.485 . . . . 1.08 111.87 -178.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.3 129.44 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 1.04 111.465 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.97 153.15 40.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.528 . . . . 1.27 110.403 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 t -132.13 -176.52 4.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.143 -0.48 . . . . 1.36 110.063 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.43 135.16 54.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.075 0.464 . . . . 2.64 110.67 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.95 58.58 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.906 -0.588 . . . . 1.52 112.165 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -78.86 144.36 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.847 0.356 . . . . 1.59 110.989 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -112.24 145.79 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.864 -0.607 . . . . 2.15 109.952 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -85.37 86.18 7.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.813 0.339 . . . . 2.07 110.826 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 m -157.24 137.29 8.77 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.67 -0.695 . . . . 2.36 109.215 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.7 Cg_endo -52.92 111.28 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.107 2.538 . . . . 2.08 112.439 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -101.83 47.04 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 1.78 109.802 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 3.9 p30 -70.25 -15.3 62.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.972 -0.558 . . . . 2.55 112.09 -179.016 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -57.44 -20.73 32.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.526 0.565 . . . . 2.24 112.526 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 pt -113.92 12.64 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.472 . . . . 2.0 110.85 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -86.98 -39.59 7.42 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.868 -0.682 . . . . 2.33 112.162 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 t -65.69 124.69 23.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.195 0.521 . . . . 2.99 111.237 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -158.33 132.6 8.04 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.411 -0.588 . . . . 2.83 109.411 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 38.3 t-20 -96.91 113.04 62.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.271 -0.27 . . . . 3.56 110.271 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 33.9 Cg_endo -64.61 -18.9 64.23 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.96 2.44 . . . . 3.39 112.711 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.45 0.97 57.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.035 0.445 . . . . 4.05 110.839 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -136.51 13.01 3.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 4.48 110.723 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -171.85 132.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 3.39 109.828 -179.142 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.98 153.53 20.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.777 0.322 . . . . 3.21 110.54 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.5 153.98 25.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.094 0.473 . . . . 2.85 111.122 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 17.9 mt -92.85 145.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.882 -0.599 . . . . 2.42 109.717 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.82 125.79 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.908 -0.404 . . . . 2.74 109.908 179.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.617 HD13 ' HG ' ' A' ' 16' ' ' LEU . 1.9 tt -58.46 113.87 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.264 0.554 . . . . 2.11 111.069 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -127.7 142.38 51.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.674 -0.693 . . . . 2.49 110.462 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' A' ' 127' ' ' LEU . 21.3 mt -103.63 148.37 35.67 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 1.91 110.013 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.98 155.94 57.55 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.535 2.157 . . . . 1.84 111.599 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -58.46 122.91 14.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 2.53 110.138 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.68 -11.28 42.12 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.212 -0.755 . . . . 2.2 111.212 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.437 HG22 HD13 ' A' ' 121' ' ' LEU . 4.7 m -104.18 105.89 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.638 -0.504 . . . . 2.1 109.638 179.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.35 159.36 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.886 -0.597 . . . . 2.78 111.823 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' A' ' 121' ' ' LEU . 15.8 mt -99.87 147.87 34.02 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 2.62 109.796 179.002 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.85 159.23 34.28 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.502 2.135 . . . . 2.77 111.666 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -73.36 134.78 44.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.917 0.389 . . . . 4.11 110.235 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.8 13.29 67.26 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.145 -0.782 . . . . 3.18 111.145 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.817 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -127.84 122.02 31.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.001 -0.37 . . . . 2.91 110.001 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -129.01 146.78 50.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 3.54 110.891 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -88.18 127.53 35.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 2.93 110.806 -179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 26.3 tt0 -58.88 129.88 44.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.971 -0.559 . . . . 3.64 110.521 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.13 -4.37 67.53 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.961 -0.638 . . . . 3.27 112.053 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.325 -0.498 0 N-CA-C 110.275 -0.268 . . . . 3.59 110.275 179.951 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB2' ' HG3' ' A' ' 111' ' ' PRO . . . . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.644 0.259 . . . . 2.48 110.396 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 p -78.53 151.28 32.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.303 -0.408 . . . . 2.13 111.1 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.583 ' HA ' HH11 ' A' ' 109' ' ' ARG . 92.9 m95 -81.02 -28.56 35.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 2.4 110.622 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 53.7 m-85 -103.54 159.21 15.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 2.02 111.403 -179.125 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.26 166.3 18.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.822 -0.627 . . . . 2.65 110.767 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.69 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -82.19 142.59 32.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.416 . . . . 2.4 111.443 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.522 HD13 ' HE2' ' A' ' 131' ' ' PHE . 28.7 mt -97.31 145.99 25.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.1 -0.704 . . . . 2.27 109.1 179.213 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.52 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -120.26 140.41 51.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 2.84 111.908 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -109.1 120.94 44.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 2.89 111.06 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.72 71.12 0.75 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.336 0.588 . . . . 3.82 109.645 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.43 -163.01 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.695 -0.764 . . . . 3.23 111.815 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -88.8 -39.66 13.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 4.27 111.0 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.31 171.12 15.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.746 -0.464 . . . . 3.32 109.746 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -98.75 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.817 -0.353 . . . . 2.39 111.727 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -151.4 140.5 21.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 2.06 111.648 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -171.42 100.13 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.324 -0.853 . . . . 2.22 109.046 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 59.9 m-85 -86.72 153.95 55.61 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.362 -0.381 . . . . 1.78 111.196 -179.597 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 3.0 Cg_exo -75.15 161.97 37.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.031 2.488 . . . . 2.15 111.717 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.22 131.72 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 2.6 110.543 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.5 74.68 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.218 -0.753 . . . . 1.65 111.218 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 11.5 tt0 -138.65 172.22 13.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.284 -0.636 . . . . 2.31 109.284 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.447 ' H ' ' HG2' ' A' ' 30' ' ' GLN . . . 101.99 -2.79 51.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.547 -0.835 . . . . 1.33 112.116 179.612 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.86 115.55 65.73 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.391 -0.596 . . . . 1.06 109.391 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.81 -173.39 1.8 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.0 2.467 . . . . 1.27 111.86 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.459 HG22 HG23 ' A' ' 36' ' ' THR . 63.4 mt -74.64 93.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.339 0.59 . . . . 1.7 110.154 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.439 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 51.9 m-20 -83.6 78.73 9.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.672 -0.694 . . . . 1.23 110.989 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -79.11 37.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.105 -0.498 . . . . 1.94 112.147 -179.389 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.73 -2.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.061 0.457 . . . . 1.96 111.443 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -122.14 150.17 42.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.338 -0.392 . . . . 1.42 111.336 -178.83 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.12 167.64 33.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 1.73 110.246 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -36.56 79.52 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.788 2.325 . . . . 1.42 113.011 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.731 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -78.56 -13.64 59.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.582 0.229 . . . . 1.78 111.396 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.903 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 25.5 m-20 -90.32 5.63 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 1.6 111.184 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -82.52 54.97 2.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.237 0.541 . . . . 1.05 111.232 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 94' ' ' ALA . 14.8 tt -151.29 132.83 5.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.632 -0.713 . . . . 1.17 110.236 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.9 -144.75 4.74 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.249 -0.976 . . . . 0.6 112.879 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -158.5 170.59 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.158 0.504 . . . . 0.99 110.735 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.735 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 29.8 m-85 -115.98 136.53 52.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.827 -0.624 . . . . 1.26 109.323 178.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -115.64 131.18 57.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 2.15 111.163 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -85.04 120.82 26.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.659 -0.701 . . . . 2.4 109.515 179.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.466 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -133.29 157.54 45.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.316 0.579 . . . . 2.21 111.932 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -146.98 114.37 6.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.758 -0.655 . . . . 2.68 110.759 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -78.52 119.23 21.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.996 0.427 . . . . 3.59 110.574 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -144.59 123.7 12.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 3.43 110.772 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.604 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -106.96 169.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 4.26 109.872 179.159 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 120.959 0.409 . . . . 5.17 110.687 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.503 0.192 . . . . 4.48 110.966 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -53.44 -55.9 21.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 4.16 110.497 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.42 99.32 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.277 0.843 . . . . 4.09 113.277 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 64' ' ' LEU . 11.1 mt -97.21 150.27 21.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 3.36 110.916 179.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.6 154.56 94.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.861 -0.609 . . . . 3.36 110.483 179.207 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.52 117.63 4.37 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.668 2.245 . . . . 2.69 111.017 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.69 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 48.0 mtt180 -119.35 140.01 51.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 3.03 111.402 -178.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.735 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 43.2 m95 -103.54 131.48 50.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 1.84 110.353 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 39.4 m-85 -111.09 139.21 46.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.719 -0.474 . . . . 2.76 109.719 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.19 130.55 35.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.688 0.28 . . . . 1.27 111.041 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.445 ' HD2' HG21 ' A' ' 75' ' ' THR . 41.5 m-85 -133.88 158.31 43.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.96 -0.564 . . . . 1.84 110.33 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -92.97 165.34 12.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.632 -0.258 . . . . 1.28 110.865 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.1 tt -57.78 118.99 5.88 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.309 0.381 . . . . 1.66 111.294 -179.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.44 53.98 8.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.062 -0.589 . . . . 1.66 112.966 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.445 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -86.55 48.11 1.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 1.58 111.11 -179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.44 137.02 4.23 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.093 -0.803 . . . . 1.96 111.093 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.39 -37.61 94.15 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.987 2.458 . . . . 2.62 112.482 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.09 35.95 4.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 3.09 110.574 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -49.78 49.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.79 110.823 -179.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.45 41.1 96.55 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.832 -0.622 . . . . 1.65 112.164 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.17 99.04 46.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.629 0.252 . . . . 1.38 111.426 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 89.2 Cg_endo -82.32 165.44 16.61 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 1.62 110.921 178.601 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.51 ' HB2' HD11 ' A' ' 73' ' ' LEU . 74.4 t80 -61.91 106.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 1.58 110.73 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.48 3.96 12.32 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.676 -0.773 . . . . 1.44 112.347 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.627 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -70.51 122.44 19.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 1.25 110.361 179.286 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -75.49 115.69 15.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.076 -0.511 . . . . 1.86 111.339 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 12.3 tttt -148.79 144.34 26.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 1.68 110.06 179.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.09 126.18 28.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.37 . . . . 1.7 111.055 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.58 77.25 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.032 -0.604 . . . . 1.27 112.219 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 29.5 mm -129.66 107.51 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.798 0.333 . . . . 1.01 110.216 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 91' ' ' ILE . 14.7 pt -112.89 128.48 69.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.432 . . . . 1.3 110.362 179.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -88.55 137.7 32.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.45 0.537 . . . . 1.08 112.45 -178.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -136.63 141.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.75 -0.659 . . . . 1.04 110.416 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -157.86 156.35 31.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 1.27 110.634 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 t -126.55 170.3 12.18 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.128 -0.487 . . . . 1.36 110.167 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.59 130.59 42.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.431 -0.35 . . . . 2.64 110.166 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.22 -10.44 28.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.836 -0.697 . . . . 1.52 111.784 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.731 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -94.2 146.39 24.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.43 -0.211 . . . . 1.59 110.43 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.3 mt -91.97 149.17 21.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 2.15 111.146 -179.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -87.73 76.66 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.2 0.524 . . . . 2.07 110.089 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 3.7 t -158.24 147.43 14.73 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.776 -0.647 . . . . 2.36 109.506 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 16.6 Cg_exo -69.82 140.12 41.7 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.494 2.129 . . . . 2.08 111.738 179.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.903 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -137.66 86.88 2.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.093 0.473 . . . . 1.78 110.708 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -5.8 53.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 2.55 112.319 -178.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.43 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 11.9 p80 -58.15 -25.94 62.09 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.132 0.419 . . . . 2.24 112.132 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.91 9.92 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.135 0.493 . . . . 2.0 110.799 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.33 -25.25 11.23 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.779 -0.646 . . . . 2.33 111.946 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -78.83 99.99 6.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 2.99 111.103 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.583 HH11 ' HA ' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -144.41 145.66 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 2.83 110.067 179.709 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 85.8 m-20 -100.89 130.73 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.301 -0.408 . . . . 3.56 110.153 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 110' ' ' ASN . 34.2 Cg_exo -61.91 -54.64 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.893 2.395 . . . . 3.39 112.905 -179.461 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.27 27.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 4.05 112.691 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.8 19.67 2.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.232 0.539 . . . . 4.48 110.364 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 109' ' ' ARG . 4.2 t-20 -170.59 163.47 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 3.39 109.641 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.66 173.86 6.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.818 0.342 . . . . 3.21 111.154 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 112.34 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.668 -0.493 . . . . 2.85 109.668 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 21.6 mt -77.18 129.74 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.245 -0.434 . . . . 2.42 110.252 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.03 120.94 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 2.74 110.372 179.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HB3' HD21 ' A' ' 16' ' ' LEU . 5.4 tt -68.39 105.4 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.916 -0.584 . . . . 2.11 109.996 -179.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -112.17 146.3 38.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.997 -0.547 . . . . 2.49 110.413 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.466 HD13 HG22 ' A' ' 125' ' ' THR . 51.1 mt -100.92 143.9 27.49 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.892 -0.594 . . . . 1.91 109.732 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.14 150.18 75.37 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.802 2.335 . . . . 1.84 111.91 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -51.05 119.91 4.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.684 -0.689 . . . . 2.53 111.58 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.7 -27.48 8.75 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.69 -0.964 . . . . 2.2 110.69 -179.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.466 HG22 HD13 ' A' ' 121' ' ' LEU . 9.9 m -102.13 116.58 32.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.723 -0.473 . . . . 2.1 109.723 179.666 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.49 163.08 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.419 -0.355 . . . . 2.78 110.763 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -85.41 144.88 41.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.343 -0.39 . . . . 2.62 110.137 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.46 151.75 66.51 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.816 2.344 . . . . 2.77 111.683 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.7 125.4 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.399 . . . . 4.11 111.121 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.42 -19.73 33.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.016 -0.612 . . . . 3.18 111.729 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.522 ' HE2' HD13 ' A' ' 16' ' ' LEU . 8.7 t80 -94.27 128.73 40.92 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.654 -0.498 . . . . 2.91 109.654 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.52 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 47.6 p90 -133.21 171.09 14.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.697 0.284 . . . . 3.54 111.058 -179.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.81 144.4 45.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.483 -0.326 . . . . 2.93 111.208 -179.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -74.45 143.05 44.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.245 -0.434 . . . . 3.64 110.08 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.34 82.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.414 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 3.59 110.603 179.671 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . . . . . . . . 0 C--O 1.232 0.17 0 N-CA-C 110.018 -0.364 . . . . 2.48 110.018 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -62.25 143.6 56.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 2.13 110.642 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -68.92 -26.63 65.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 2.4 111.666 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.535 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 96.5 m-85 -111.08 167.73 10.04 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.14 0.422 . . . . 2.02 112.14 -179.233 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 p -69.08 170.32 10.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.647 -0.706 . . . . 2.65 111.332 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -90.14 133.27 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 2.4 111.291 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.565 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 mt -86.9 112.96 22.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.668 -0.493 . . . . 2.27 109.668 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 m -92.17 127.99 37.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.902 0.382 . . . . 2.84 111.203 -179.299 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.1 tp-100 -106.09 134.87 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 2.89 110.935 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.409 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 79.3 t60 -125.74 72.57 1.29 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.228 -0.656 . . . . 3.82 109.228 178.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.78 -169.23 26.99 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.964 -0.636 . . . . 3.23 112.067 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.68 -36.84 23.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.999 0.428 . . . . 4.27 110.844 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.09 172.2 13.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.796 -0.638 . . . . 3.32 110.712 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.477 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 1.2 t0 -103.84 -101.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.83 -0.433 . . . . 2.39 109.83 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.477 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 54.0 tp -156.74 133.6 10.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.798 0.332 . . . . 2.06 110.527 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.29 111.92 2.97 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.966 -0.561 . . . . 2.22 109.748 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.14 135.48 19.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.409 . . . . 1.78 110.563 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.423 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 39.3 Cg_endo -67.6 155.54 69.74 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.536 2.157 . . . . 2.15 111.963 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -57.88 125.85 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 2.6 110.769 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.53 -1.51 62.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.904 -0.665 . . . . 1.65 112.033 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 32.0 tt0 -137.09 155.15 49.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.204 -0.295 . . . . 2.31 110.204 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.05 -13.94 19.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.329 -0.938 . . . . 1.33 113.127 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.99 122.04 84.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.069 -0.345 . . . . 1.06 110.069 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.31 -179.13 5.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 1.27 111.661 -179.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.36 81.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.099 0.476 . . . . 1.7 110.821 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.86 97.87 4.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.382 -0.599 . . . . 1.23 109.382 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.33 -20.11 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.792 0.664 . . . . 1.94 112.792 -178.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -99.76 -29.54 12.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.422 0.527 . . . . 1.96 112.422 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.09 150.62 35.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.518 0.562 . . . . 1.42 112.518 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.58 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 2.0 m -74.42 166.92 40.77 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.681 -0.691 . . . . 1.73 110.895 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 17.5 Cg_endo -58.77 -39.75 79.0 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.814 2.343 . . . . 1.42 112.53 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -85.21 3.15 40.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 1.78 110.626 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.64 7.03 37.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.662 -0.699 . . . . 1.6 110.617 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -81.27 52.1 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 1.05 110.784 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.5 tt -144.87 134.91 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.92 -0.582 . . . . 1.17 110.17 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.14 -155.63 11.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.414 -0.898 . . . . 0.6 112.135 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -148.67 158.68 44.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.964 0.412 . . . . 0.99 111.151 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.755 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 13.2 m-85 -103.12 140.46 37.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.839 -0.8 . . . . 1.26 108.839 178.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -127.84 122.71 33.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.795 0.331 . . . . 2.15 110.965 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -77.81 128.37 33.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.858 -0.423 . . . . 2.4 109.858 179.373 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.04 156.21 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.108 0.48 . . . . 2.21 111.514 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.0 m -135.55 127.83 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.679 -0.691 . . . . 2.68 109.734 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.749 ' HB3' HD12 ' A' ' 64' ' ' LEU . 8.9 tpt180 -126.01 130.05 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.119 0.485 . . . . 3.59 111.702 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -143.87 -175.67 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.537 -0.756 . . . . 3.43 109.38 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.1 pt -126.72 161.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.544 -0.539 . . . . 4.26 109.544 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.319 -0.754 0 CA-C-O 121.334 0.588 . . . . 5.17 110.733 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.498 0.189 . . . . 4.48 111.127 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -69.98 -42.98 72.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.078 -0.712 . . . . 4.16 109.078 178.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.72 82.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.939 -1.028 . . . . 4.09 113.451 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -74.6 160.55 30.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.872 0.368 . . . . 3.36 110.559 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 1.5 m -74.13 156.03 87.9 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.293 -0.412 . . . . 3.36 110.127 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.47 111.15 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.542 2.161 . . . . 2.69 111.357 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.609 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 10.1 mtp180 -116.7 131.63 56.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 3.03 111.579 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.755 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 35.8 m95 -105.67 124.32 49.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.684 -0.689 . . . . 1.84 109.99 179.053 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -102.81 151.22 22.67 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 2.76 109.71 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -102.98 126.45 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.913 0.387 . . . . 1.27 111.486 -179.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.46 150.21 48.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 1.84 110.067 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.87 165.39 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.506 -0.315 . . . . 1.28 111.463 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 44' ' ' ILE . 2.3 tt -54.48 113.48 1.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.445 0.905 . . . . 1.66 113.445 -178.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 63.4 47.9 83.39 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.508 -0.769 . . . . 1.66 114.065 178.331 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.455 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -72.98 86.36 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 1.58 111.444 179.58 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.63 131.0 2.53 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.019 -0.61 . . . . 1.96 111.68 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.23 -31.81 89.99 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.984 2.456 . . . . 2.62 112.558 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.93 30.69 4.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.849 0.357 . . . . 3.09 111.782 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.0 -70.57 0.41 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 1.79 110.582 179.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.97 34.38 55.84 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.829 -0.7 . . . . 1.65 111.546 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HD2' ' A' ' 87' ' ' LYS . 3.2 mt -123.4 95.17 45.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.727 0.298 . . . . 1.38 110.831 -179.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.77 158.13 43.26 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.591 2.194 . . . . 1.62 112.095 179.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -59.26 106.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 1.58 110.322 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.38 -17.8 5.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.819 -0.705 . . . . 1.44 112.408 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.3 138.3 51.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 1.25 110.492 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -100.04 144.86 28.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.458 -0.337 . . . . 1.86 111.026 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HD2' HD21 ' A' ' 81' ' ' LEU . 26.6 tttt -158.47 169.48 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 1.68 109.982 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.04 112.52 2.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.313 0.486 . . . . 1.7 112.313 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.3 39.62 91.94 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.841 -0.618 . . . . 1.27 112.389 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -128.88 113.71 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.073 0.464 . . . . 1.01 111.295 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.503 ' CG1' ' HB2' ' A' ' 47' ' ' TYR . 24.3 pt -122.54 139.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.369 -0.604 . . . . 1.3 109.369 178.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -96.44 137.88 34.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.877 0.37 . . . . 1.08 111.686 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -133.15 131.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.621 -0.718 . . . . 1.04 110.617 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -154.41 162.87 40.92 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.27 110.363 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -139.09 172.85 12.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 1.36 109.907 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.69 127.56 32.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.333 -0.394 . . . . 2.64 110.626 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.14 -20.5 26.01 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.908 -0.663 . . . . 1.52 111.618 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.771 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -82.68 135.27 35.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.894 0.378 . . . . 1.59 110.362 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.07 139.66 43.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 2.15 110.858 -179.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -72.6 107.02 4.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.489 . . . . 2.07 110.526 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.469 ' H ' HD13 ' A' ' 73' ' ' LEU . 1.9 t -174.57 150.22 1.41 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.959 -0.756 . . . . 2.36 108.959 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.452 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 10.5 Cg_endo -55.1 116.88 3.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.82 2.347 . . . . 2.08 112.231 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -114.76 34.29 4.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.852 -0.613 . . . . 1.78 110.383 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 8.7 p-10 -71.05 -3.68 20.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 2.55 112.175 -179.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -61.18 -21.16 63.55 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.437 0.532 . . . . 2.24 112.437 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.99 -16.54 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.265 0.555 . . . . 2.0 110.441 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.455 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -79.84 72.2 2.61 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.933 -0.576 . . . . 2.33 112.693 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.9 t -160.65 36.07 0.16 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.787 0.803 . . . . 2.99 110.453 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -76.49 138.03 40.01 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.694 -0.684 . . . . 2.83 111.153 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -80.92 117.79 69.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 3.56 110.519 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.772 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 51.8 Cg_endo -70.88 -47.33 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.871 2.381 . . . . 3.39 114.219 -178.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.77 18.91 2.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.035 0.754 . . . . 4.05 113.035 -177.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -150.22 23.33 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.936 0.398 . . . . 4.48 111.589 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -174.51 136.02 0.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 3.39 109.986 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.2 154.66 19.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.662 0.268 . . . . 3.21 111.095 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.75 154.31 26.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.164 0.506 . . . . 2.85 111.234 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.2 mt -89.04 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.654 -0.703 . . . . 2.42 109.598 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.05 113.33 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.665 -0.495 . . . . 2.74 109.665 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 13' ' ' PHE . 7.5 tt -64.84 115.52 5.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 2.11 111.593 -178.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.0 148.71 50.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.652 -0.704 . . . . 2.49 109.399 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.12 157.37 34.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.343 -0.39 . . . . 1.91 110.695 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.32 148.49 92.83 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.538 2.158 . . . . 1.84 111.85 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -57.62 113.08 1.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.131 -0.486 . . . . 2.53 110.274 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 127.42 -24.15 5.32 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.194 -1.162 . . . . 2.2 110.194 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.7 m -91.94 109.75 21.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.127 0.489 . . . . 2.1 109.712 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 131.97 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 2.78 111.198 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.62 134.79 86.21 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.132 -0.485 . . . . 2.62 109.731 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.57 142.18 95.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.612 2.208 . . . . 2.77 111.468 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.83 124.25 21.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 4.11 110.621 -179.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.12 41.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.768 -0.73 . . . . 3.18 111.9 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -99.47 128.92 45.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.066 0.46 . . . . 2.91 111.416 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.409 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 33.1 p90 -145.98 139.13 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.627 -0.715 . . . . 3.54 109.738 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -107.45 148.15 29.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.631 0.253 . . . . 2.93 110.452 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.417 ' HB2' ' NH2' ' A' ' 67' ' ' ARG . 37.3 tt0 -67.77 125.9 27.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.384 -0.371 . . . . 3.64 110.232 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.2 -18.18 57.93 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.712 -0.756 . . . . 3.27 112.615 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 133' ' ' ALA . 14.7 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 3.59 110.806 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.881 0.372 . . . . 2.48 111.066 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.71 149.28 41.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.996 -0.547 . . . . 2.13 111.038 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 31.5 m95 -78.62 -30.63 46.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 2.4 111.254 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 76.7 m-85 -112.19 168.23 9.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.926 -0.579 . . . . 2.02 111.84 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 1.0 OUTLIER -70.1 175.02 4.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.817 -0.629 . . . . 2.65 111.362 179.644 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -91.87 148.33 22.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 2.4 111.058 -179.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.673 HD21 HD22 ' A' ' 119' ' ' LEU . 95.9 mt -84.22 119.21 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.847 -0.615 . . . . 2.27 109.653 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 107.28 14.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 2.84 110.523 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.829 ' HB3' ' HB2' ' A' ' 66' ' ' PRO . 5.8 tp-100 -85.9 133.93 33.92 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 2.89 111.286 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -129.96 10.05 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.951 -0.568 . . . . 3.82 110.428 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.4 -178.17 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.735 -0.745 . . . . 3.23 112.846 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -74.03 -38.08 64.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 4.27 111.468 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.94 166.78 23.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 3.32 111.412 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.78 -70.34 0.68 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.249 -0.648 . . . . 2.39 109.249 178.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.666 HD13 ' CE1' ' A' ' 131' ' ' PHE . 16.9 tp -177.58 134.28 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.747 -0.66 . . . . 2.06 110.614 178.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' H ' HD12 ' A' ' 24' ' ' LEU . 45.8 tptt -154.46 128.69 9.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 2.22 109.495 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 11.7 m-85 -123.56 144.78 45.16 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.466 . . . . 1.78 110.284 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 13.6 Cg_exo -69.58 161.77 44.59 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.814 2.343 . . . . 2.15 112.386 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.41 130.35 42.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.6 110.454 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.92 59.46 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.901 -0.666 . . . . 1.65 111.937 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -159.66 159.27 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.644 0.259 . . . . 2.31 110.328 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.67 -17.78 10.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.715 -0.755 . . . . 1.33 112.797 179.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.41 122.27 80.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.154 -0.313 . . . . 1.06 110.154 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 74.2 Cg_endo -76.71 -177.92 4.13 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.68 2.253 . . . . 1.27 112.047 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.21 98.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.594 -0.521 . . . . 1.7 109.594 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.446 ' HA ' ' HZ ' ' A' ' 13' ' ' PHE . 60.9 m-80 -89.48 83.41 6.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.087 0.47 . . . . 1.23 111.018 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.79 65.78 2.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.682 -0.69 . . . . 1.94 111.055 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -173.19 -28.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.258 -0.428 . . . . 1.96 111.255 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -105.59 167.16 9.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.31 -0.405 . . . . 1.42 111.827 -178.796 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.94 166.0 38.16 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 1.73 110.095 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.19 -37.47 94.24 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.894 2.396 . . . . 1.42 112.505 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.532 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.77 -20.36 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 1.78 110.75 179.804 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.946 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 27.1 m-20 -85.58 -0.72 55.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 1.6 110.777 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -78.62 55.47 1.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 1.05 111.637 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.614 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -149.72 130.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 1.17 109.82 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -144.45 4.33 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.311 -0.947 . . . . 0.6 112.631 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -157.2 161.89 39.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.853 0.359 . . . . 0.99 110.685 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.428 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 53.1 m-85 -103.27 131.82 50.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.054 -0.721 . . . . 1.26 109.054 178.367 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -110.75 125.35 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 2.15 110.965 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -72.15 130.85 41.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 2.4 109.775 178.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.14 155.14 51.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 2.21 110.753 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.69 160.08 42.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.046 -0.525 . . . . 2.68 110.538 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HB3' HD12 ' A' ' 64' ' ' LEU . 21.5 tpt180 -136.32 115.27 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 3.59 111.081 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -139.15 103.12 4.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.416 -0.356 . . . . 3.43 111.639 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 62' ' ' LYS . 22.2 pt -72.09 160.99 5.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.645 -0.502 . . . . 4.26 109.645 178.675 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 . . . . . 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 5.17 111.075 -179.478 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.286 -0.264 . . . . 4.48 110.286 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HB2' HG12 ' A' ' 54' ' ' ILE . 43.8 tptt -64.64 -57.88 7.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 4.16 109.586 179.356 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.64 83.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.507 -0.769 . . . . 4.09 112.354 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.42 HD21 ' HE3' ' A' ' 62' ' ' LYS . 37.2 mt -93.6 170.96 9.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.854 -0.612 . . . . 3.36 110.786 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -70.37 154.71 94.3 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 3.36 109.829 179.201 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.829 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 51.4 Cg_exo -55.28 123.62 14.26 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.559 2.173 . . . . 2.69 110.616 178.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 56.5 mtt-85 -120.27 144.16 47.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.563 0.579 . . . . 3.03 112.563 -178.052 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.428 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 53.4 m95 -128.11 124.71 37.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.68 -0.691 . . . . 1.84 109.699 178.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -103.6 145.95 29.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.047 -0.353 . . . . 2.76 110.047 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -96.48 129.43 43.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.812 0.339 . . . . 1.27 111.1 179.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -128.12 153.42 46.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 1.84 110.106 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -86.85 163.4 17.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.522 -0.308 . . . . 1.28 110.309 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.684 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 2.3 tt -62.69 121.93 14.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.297 -0.41 . . . . 1.66 110.513 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.82 29.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.918 -0.658 . . . . 1.66 113.762 178.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.21 90.11 4.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.338 0.569 . . . . 1.58 111.109 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.52 124.34 2.29 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.638 -0.791 . . . . 1.96 111.878 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.51 -21.61 39.83 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.701 2.267 . . . . 2.62 112.324 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -115.88 17.94 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.009 0.433 . . . . 3.09 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.65 -61.94 1.58 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 1.79 110.842 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.33 94.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.213 -0.518 . . . . 1.65 112.572 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.466 HD11 ' HE3' ' A' ' 87' ' ' LYS . 86.1 mt -118.13 104.76 47.95 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 120.676 0.274 . . . . 1.38 110.478 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.16 161.43 29.29 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.655 2.237 . . . . 1.62 111.344 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.515 ' HB2' HD11 ' A' ' 73' ' ' LEU . 92.2 t80 -54.21 119.34 4.99 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.488 -0.324 . . . . 1.58 110.464 179.598 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 111.38 -14.73 27.78 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.838 -0.696 . . . . 1.44 112.335 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.4 123.28 16.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.833 0.349 . . . . 1.25 110.845 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -90.74 131.45 36.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 1.86 111.278 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HE3' HD11 ' A' ' 81' ' ' LEU . 15.0 ttmm -150.93 154.99 38.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.992 -1.114 . . . . 1.68 107.992 179.075 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.5 115.41 3.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.04 0.448 . . . . 1.7 111.685 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.74 32.7 49.32 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.682 -0.69 . . . . 1.27 112.586 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.63 105.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.912 0.387 . . . . 1.01 110.995 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 91' ' ' ILE . 4.1 pt -117.31 130.23 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 1.3 109.72 178.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.684 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 86.3 m95 -86.23 145.42 26.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.714 0.635 . . . . 1.08 112.714 -178.508 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.47 133.84 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.218 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.6 166.53 24.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.365 -0.38 . . . . 1.27 111.102 -179.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -137.99 164.08 29.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.217 -0.66 . . . . 1.36 109.217 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.68 114.0 8.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.74 -0.467 . . . . 2.64 109.74 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.12 -18.15 6.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.538 -1.025 . . . . 1.52 110.538 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.25 142.45 34.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.516 -0.342 . . . . 1.59 110.084 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.532 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 97.0 mt -100.79 133.65 44.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.499 -0.319 . . . . 2.15 111.135 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -76.07 86.97 2.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.223 0.535 . . . . 2.07 109.873 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.554 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 6.3 t -161.98 144.34 8.73 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.609 -0.723 . . . . 2.36 109.125 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.93 126.94 17.48 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.159 1.906 . . . . 2.08 112.137 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.946 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -133.22 77.78 1.75 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.463 0.649 . . . . 1.78 111.22 179.584 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.15 -0.34 35.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.744 -0.662 . . . . 2.55 111.618 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.501 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.4 p80 -60.48 -19.85 58.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.075 0.464 . . . . 2.24 111.894 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.3 pt -114.12 14.21 8.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 2.0 110.296 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.74 69.28 0.29 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.71 -0.757 . . . . 2.33 112.067 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -165.04 27.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.33 0.586 . . . . 2.99 110.821 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 12' ' ' TRP . 59.5 ttp85 -65.33 128.05 34.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.057 -0.52 . . . . 2.83 110.291 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -75.87 117.58 64.85 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.311 -0.404 . . . . 3.56 110.213 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.88 -21.55 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.691 2.261 . . . . 3.39 113.815 -178.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.14 -21.43 17.93 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.311 0.485 . . . . 4.05 112.311 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -113.7 19.32 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.032 0.382 . . . . 4.48 112.032 -178.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -163.68 139.52 6.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.421 -0.354 . . . . 3.39 110.412 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.96 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.051 -0.351 . . . . 3.21 110.051 179.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.14 161.19 31.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.209 0.528 . . . . 2.85 111.456 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.542 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 6.5 mt -100.04 155.15 4.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.099 -0.704 . . . . 2.42 109.099 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -74.69 127.36 36.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.182 -0.207 . . . . 2.74 110.445 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.673 HD22 HD21 ' A' ' 16' ' ' LEU . 4.6 tt -64.53 116.96 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 2.11 110.553 179.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -130.17 130.41 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.227 -0.442 . . . . 2.49 110.402 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.684 HD13 HG22 ' A' ' 125' ' ' THR . 72.9 mt -79.64 149.17 70.91 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.476 -0.329 . . . . 1.91 110.5 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 33' ' ' PRO . 54.4 Cg_endo -69.08 177.94 4.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.836 2.357 . . . . 1.84 112.974 -179.333 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -64.52 126.03 26.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.46 -0.791 . . . . 2.53 110.319 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.09 65.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.599 -0.81 . . . . 2.2 112.347 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.684 HG22 HD13 ' A' ' 121' ' ' LEU . 7.2 m -124.85 116.13 21.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.942 -0.392 . . . . 2.1 109.942 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.03 151.88 35.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 2.78 111.853 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.93 147.52 77.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 2.62 110.829 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.06 164.7 26.59 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.823 2.349 . . . . 2.77 112.359 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.39 120.5 12.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 4.11 111.728 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.41 55.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.975 -0.631 . . . . 3.18 112.913 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.666 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -114.2 130.95 56.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.761 0.315 . . . . 2.91 111.243 -179.294 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -142.17 152.63 43.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.439 . . . . 3.54 111.053 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.23 134.67 33.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.0 0.371 . . . . 2.93 112.0 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 25.7 tt0 -64.06 124.23 21.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.809 -0.632 . . . . 3.64 110.176 178.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.58 -9.46 64.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.995 -0.621 . . . . 3.27 112.651 -179.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.502 0.191 . . . . 3.59 110.548 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.493 -0.643 . . . . 9.05 111.493 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.03 143.53 26.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.962 0.411 . . . . 8.09 111.34 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.49 176.77 8.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.928 -0.578 . . . . 8.02 110.031 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.78 89.6 0.76 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.827 -0.701 . . . . 5.76 111.39 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 mp -99.79 113.67 65.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.585 0.231 . . . . 4.72 110.654 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.9 64.44 8.78 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.54 2.16 . . . . 4.45 111.816 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -101.72 124.14 46.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.047 -0.524 . . . . 4.41 111.215 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -92.77 -69.14 0.76 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.987 -0.551 . . . . 3.92 111.065 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p 48.83 83.81 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.082 0.771 . . . . 2.53 113.082 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.07 140.16 30.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 2.48 110.715 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.4 m -78.24 136.19 37.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.028 -0.533 . . . . 2.13 110.778 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -71.93 -15.5 62.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.187 -0.46 . . . . 2.4 111.634 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.69 172.27 8.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.952 -0.567 . . . . 2.02 109.7 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.0 p -75.55 -170.14 1.19 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.001 0.429 . . . . 2.65 110.709 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.58 -168.62 1.33 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.956 0.408 . . . . 2.4 110.885 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.731 HD21 HD22 ' A' ' 119' ' ' LEU . 77.3 mt -128.67 105.76 8.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.404 -0.591 . . . . 2.27 109.404 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.577 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -83.49 122.51 28.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.33 -0.396 . . . . 2.84 111.197 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.1 tp-100 -97.67 133.71 41.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.98 -0.555 . . . . 2.89 111.182 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -128.22 76.32 1.69 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.237 -0.653 . . . . 3.82 109.237 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.41 -135.48 1.87 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.522 -0.847 . . . . 3.23 112.789 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -114.92 -38.88 3.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.092 0.472 . . . . 4.27 111.577 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -78.38 170.77 16.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.817 -0.629 . . . . 3.32 111.497 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.08 -92.22 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.17 -0.678 . . . . 2.39 109.17 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.499 HD13 ' CE1' ' A' ' 131' ' ' PHE . 39.8 tp -169.12 134.79 1.62 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.068 -0.515 . . . . 2.06 109.975 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -153.37 113.4 3.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.199 -0.455 . . . . 2.22 110.166 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -100.86 145.68 30.79 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 1.78 110.066 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.65 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 51.1 Cg_endo -70.89 158.91 54.21 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.62 2.213 . . . . 2.15 111.608 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -62.77 113.98 3.35 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.893 -0.594 . . . . 2.6 110.923 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.12 -13.9 26.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.767 -0.73 . . . . 1.65 111.678 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.65 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 38.9 mt-30 -122.04 168.23 12.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 2.31 110.664 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.84 -10.19 29.79 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.335 -0.706 . . . . 1.33 111.335 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.403 HG11 ' HB3' ' A' ' 43' ' ' GLN . 22.2 t -94.58 115.01 64.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 1.06 109.629 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.12 -179.97 4.85 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.513 2.142 . . . . 1.27 112.159 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.1 mt -76.25 83.77 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.197 -0.456 . . . . 1.7 110.364 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.425 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 63.0 m-80 -83.33 83.73 7.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 1.23 110.955 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -7.77 54.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.866 -0.607 . . . . 1.94 111.264 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -90.08 -22.49 21.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.344 -0.389 . . . . 1.96 111.742 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -110.97 168.68 9.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.145 0.498 . . . . 1.42 112.187 -178.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.05 167.15 22.79 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.526 -0.761 . . . . 1.73 110.089 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.4 -39.14 92.67 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.875 2.383 . . . . 1.42 113.005 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.19 -16.93 61.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.045 0.45 . . . . 1.78 110.815 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.773 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 41.8 m-20 -88.73 2.1 53.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.952 -0.567 . . . . 1.6 111.004 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.403 ' HB3' HG11 ' A' ' 32' ' ' VAL . 37.5 mm-40 -80.87 58.79 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.153 0.501 . . . . 1.05 111.674 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.9 tt -156.13 129.91 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.848 -0.615 . . . . 1.17 109.991 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.91 -149.74 6.49 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.335 -0.936 . . . . 0.6 112.479 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -150.66 158.77 44.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.133 0.492 . . . . 0.99 111.019 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.493 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 14.8 m-85 -103.46 133.7 48.07 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.831 -0.622 . . . . 1.26 109.668 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.11 117.39 29.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.23 -0.441 . . . . 2.15 110.776 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -78.31 113.55 16.39 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.148 0.499 . . . . 2.4 110.978 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.74 159.55 24.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.082 -0.508 . . . . 2.21 110.793 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 148.93 45.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.898 -0.592 . . . . 2.68 110.137 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' HB3' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -121.86 93.41 3.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.075 0.464 . . . . 3.59 111.357 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.623 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 1.0 OUTLIER -121.43 104.03 9.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.223 -0.444 . . . . 3.43 110.662 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.33 125.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.078 -0.51 . . . . 4.26 110.791 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.43 98.48 11.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 5.17 110.076 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.66 167.56 32.38 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.771 -0.728 . . . . 4.66 112.7 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.12 -40.27 25.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.922 -0.656 . . . . 5.04 112.178 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.04 -31.41 61.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.04 0.448 . . . . 5.51 110.036 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.3 10.32 5.63 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.889 -0.672 . . . . 4.73 111.912 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -76.54 113.25 13.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.928 0.394 . . . . 5.52 110.624 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 27.4 mtt -118.02 126.47 52.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.218 -0.446 . . . . 4.48 110.86 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -54.76 -44.78 73.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.785 -0.643 . . . . 4.16 110.358 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 36.1 t70 61.35 107.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.242 0.83 . . . . 4.09 113.242 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.597 HD12 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -123.89 143.32 50.43 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.487 -0.779 . . . . 3.36 110.3 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.577 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -61.04 143.66 91.8 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.069 -0.514 . . . . 3.36 111.391 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.27 126.27 19.66 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.955 2.437 . . . . 2.69 111.576 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.0 OUTLIER -127.86 137.32 52.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.127 -0.488 . . . . 3.03 111.452 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.493 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 36.8 m95 -95.03 109.7 21.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.006 -0.543 . . . . 1.84 110.832 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -81.38 143.85 31.87 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.628 -0.508 . . . . 2.76 109.628 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -87.68 119.04 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.736 0.303 . . . . 1.27 111.032 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -120.61 139.35 53.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.735 -0.469 . . . . 1.84 109.735 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -79.69 159.06 26.82 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.312 -0.255 . . . . 1.28 110.312 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -61.15 123.24 17.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.666 0.27 . . . . 1.66 110.707 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 90.87 24.96 26.17 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.964 -0.636 . . . . 1.66 113.449 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.589 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.7 OUTLIER -82.73 94.13 7.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.166 0.483 . . . . 1.58 110.811 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 137.22 122.02 2.08 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.954 -0.641 . . . . 1.96 111.696 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 18.9 Cg_endo -58.87 -29.38 89.99 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.248 2.632 . . . . 2.62 112.756 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -134.14 46.55 2.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.039 0.447 . . . . 3.09 110.358 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.12 -48.9 16.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.866 -0.606 . . . . 1.79 110.345 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 36.93 86.91 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.744 -0.662 . . . . 1.65 112.599 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.92 97.99 47.87 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-O 120.642 0.258 . . . . 1.38 111.635 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.688 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 3.9 Cg_exo -81.74 155.38 18.07 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.769 2.313 . . . . 1.62 110.19 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.622 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.0 t80 -53.81 115.25 1.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.839 0.352 . . . . 1.58 110.866 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.44 -17.17 16.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.726 -0.749 . . . . 1.44 112.575 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.688 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -58.06 127.54 32.6 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.093 0.473 . . . . 1.25 111.273 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -91.71 114.51 27.06 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.025 -0.534 . . . . 1.86 111.026 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -137.29 153.8 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.476 -0.329 . . . . 1.68 110.547 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -62.64 121.27 12.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.982 -0.554 . . . . 1.7 111.028 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.12 23.9 76.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.584 -0.817 . . . . 1.27 112.205 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 26.1 mm -130.54 109.94 17.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.758 0.313 . . . . 1.01 110.839 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -121.34 137.84 53.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.3 -0.63 . . . . 1.3 109.3 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.538 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 85.7 m95 -93.44 143.81 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.22 0.533 . . . . 1.08 112.346 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 m -135.77 129.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.438 -0.801 . . . . 1.04 110.211 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.75 154.45 44.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.195 -0.457 . . . . 1.27 110.242 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.1 t -132.02 176.12 8.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.336 -0.393 . . . . 1.36 110.091 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -67.3 125.06 24.9 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.809 0.338 . . . . 2.64 111.127 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.31 -8.26 28.72 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.806 -0.634 . . . . 1.52 111.967 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.426 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -93.03 138.2 31.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.946 0.403 . . . . 1.59 111.186 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.63 155.93 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 2.15 110.747 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -82.5 96.76 8.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.032 0.444 . . . . 2.07 111.488 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 1.9 t -170.25 140.71 1.61 Allowed Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.866 -0.606 . . . . 2.36 109.673 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 27.8 Cg_exo -64.36 136.98 53.57 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.728 2.285 . . . . 2.08 111.98 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.773 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -134.75 70.07 1.45 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.414 0.626 . . . . 1.78 110.842 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 7.5 p-10 -71.22 -1.3 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 2.55 112.397 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.402 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 9.8 p80 -61.92 -27.56 68.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.841 0.353 . . . . 2.24 111.756 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.45 10.15 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.333 0.587 . . . . 2.0 110.886 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.589 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -104.67 39.53 2.8 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 2.33 111.415 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -150.47 138.88 20.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.601 0.239 . . . . 2.99 110.658 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 109' ' ' ARG . 22.6 ttp180 179.59 147.52 0.24 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.688 -0.687 . . . . 2.83 109.25 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -82.02 109.74 16.9 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.24 -0.652 . . . . 3.56 109.24 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 -26.74 41.28 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.735 2.29 . . . . 3.39 113.004 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -95.89 23.0 6.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.971 0.415 . . . . 4.05 111.658 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -146.27 -36.22 0.26 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.061 0.457 . . . . 4.48 111.01 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -122.41 132.87 54.57 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.877 -0.786 . . . . 3.39 108.877 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.4 -175.06 5.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.464 -0.335 . . . . 3.21 111.551 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.83 155.63 29.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.405 -0.361 . . . . 2.85 110.602 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -90.84 147.56 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.86 -0.422 . . . . 2.42 109.86 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.84 121.98 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 2.74 110.25 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.731 HD22 HD21 ' A' ' 16' ' ' LEU . 4.6 tt -64.25 108.64 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.822 -0.626 . . . . 2.11 111.128 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -119.53 148.96 42.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.023 -0.535 . . . . 2.49 110.734 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.641 HD13 HG22 ' A' ' 125' ' ' THR . 16.0 mt -98.52 146.84 32.27 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.394 -0.367 . . . . 1.91 110.602 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.84 179.66 4.6 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.844 2.362 . . . . 1.84 112.581 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -62.67 138.96 58.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.739 -0.664 . . . . 2.53 111.002 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.02 80.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.956 -0.64 . . . . 2.2 112.108 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.641 HG22 HD13 ' A' ' 121' ' ' LEU . 1.3 m -135.26 121.51 20.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.843 0.354 . . . . 2.1 110.366 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -121.15 152.38 38.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.285 -0.416 . . . . 2.78 110.513 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.5 mt -75.43 146.34 80.85 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.376 -0.374 . . . . 2.62 110.051 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.51 143.9 77.3 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.739 2.293 . . . . 2.77 111.795 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -61.65 111.8 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.546 . . . . 4.11 110.834 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 136.46 -21.84 3.4 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.783 -1.327 . . . . 3.18 109.783 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 21.0 m-85 -104.31 153.5 20.96 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.19 -0.505 . . . . 2.91 110.341 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 32.3 p90 -135.54 162.06 33.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.191 -0.459 . . . . 3.54 110.304 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -84.11 126.78 33.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.057 0.456 . . . . 2.93 111.211 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -78.08 103.86 8.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.013 -0.539 . . . . 3.64 110.464 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.67 12.2 51.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.677 -0.773 . . . . 3.27 112.482 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.1 m -148.24 131.22 16.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.924 0.392 . . . . 3.59 111.304 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.85 151.3 34.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.992 -0.549 . . . . 5.55 110.026 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.0 69.72 3.04 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.883 -0.675 . . . . 5.22 111.719 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 138.78 -46.97 0.94 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.425 -0.67 . . . . 5.91 111.425 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.973 -0.536 . . . . 7.27 111.772 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.493 -3.487 1 C4'-C3'-C2' 97.01 -5.69 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.506 2 N19-C1'-C2' 103.497 -6.19 . 0.231 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.716 3 O4'-C1'-N19 115.758 7.558 . 0.527 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.595 6.336 4 O4'-C1'-N19 116.707 8.507 . 0.509 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.15 2 C4'-C3'-C2' 97.58 -5.12 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.671 4 C1'-O4'-C4' 105.629 -4.412 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.321 3 P-O3'-C3' 127.096 6.163 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.581 5.337 3 O4'-C4'-C3' 114.977 6.769 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.054 2 O4'-C1'-N19 118.623 10.423 . 0.414 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.636 3 O3'-P-O5' 116.372 6.512 . 0.461 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.17 1 C4'-C3'-C2' 98.263 -4.437 . 0.311 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.435 1 C4'-C3'-C2' 94.318 -8.382 . 0.454 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.797 1 O3'-P-O5' 111.757 4.083 . 0.107 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.932 2 C3'-C2'-C1' 105.719 4.688 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 111.529 -0.628 . . . . 9.05 111.529 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.53 87.8 5.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.05 0.453 . . . . 8.09 110.688 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -133.61 174.17 10.72 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.962 -0.563 . . . . 8.02 110.495 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.57 -127.33 5.68 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 111.063 -0.815 . . . . 5.76 111.063 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.2 mt -132.1 82.01 60.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.589 0.233 . . . . 4.72 111.33 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -95.65 22.06 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.097 2.531 . . . . 4.45 111.477 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -104.61 134.5 47.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.802 -0.635 . . . . 4.41 110.315 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -107.59 -78.69 0.58 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.82 -0.173 . . . . 3.92 111.293 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.7 p 48.43 75.54 0.14 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.051 0.76 . . . . 2.53 113.051 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.72 162.9 20.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.034 0.445 . . . . 2.48 111.962 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.75 155.52 39.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.51 -0.768 . . . . 2.13 111.373 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -91.69 -32.46 15.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.394 0.516 . . . . 2.4 112.394 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.418 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 35.3 m-85 -109.38 -179.18 3.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.974 0.416 . . . . 2.02 111.872 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.99 165.12 24.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.547 -0.751 . . . . 2.65 110.902 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -80.73 138.6 36.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.429 -0.35 . . . . 2.4 111.601 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 131' ' ' PHE . 75.9 mt -100.34 107.45 19.23 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.071 -0.344 . . . . 2.27 110.071 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -87.3 116.9 25.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.904 0.383 . . . . 2.84 111.692 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -91.36 140.33 29.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.469 . . . . 2.89 110.811 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -132.66 87.74 2.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.955 -0.566 . . . . 3.82 109.964 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.52 -166.01 34.55 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.696 -0.764 . . . . 3.23 111.732 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 46.2 mmtt -93.33 -16.93 24.15 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.903 0.382 . . . . 4.27 111.551 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -92.44 177.03 6.25 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.091 -0.504 . . . . 3.32 110.565 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 2.0 t0 -98.73 -89.91 0.3 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.164 -0.68 . . . . 2.39 109.164 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 26.9 tp -172.0 135.63 0.82 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.325 -0.398 . . . . 2.06 110.694 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -155.95 143.05 19.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.571 -0.529 . . . . 2.22 109.571 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -122.64 147.94 51.9 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.369 -0.378 . . . . 1.78 110.305 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.66 163.26 18.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 123.357 2.705 . . . . 2.15 112.297 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.0 117.88 8.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.837 -0.619 . . . . 2.6 110.954 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.95 6.96 63.0 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.761 -0.733 . . . . 1.65 112.673 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -134.53 159.19 41.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.914 -0.402 . . . . 2.31 109.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.9 -10.01 7.52 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.043 -0.598 . . . . 1.33 111.613 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.18 117.78 67.12 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 110.085 -0.339 . . . . 1.06 110.085 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.99 -176.47 2.89 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.585 2.19 . . . . 1.27 111.791 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.55 87.91 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.128 0.49 . . . . 1.7 110.305 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.438 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 49.0 m-80 -80.33 80.07 6.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.23 110.747 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.84 57.12 2.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.079 -0.509 . . . . 1.94 110.736 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -161.66 -38.6 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.886 -0.597 . . . . 1.96 110.629 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.93 170.54 9.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.081 -0.509 . . . . 1.42 111.306 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 5.1 m -86.61 162.1 46.06 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 1.73 110.135 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.52 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 12.4 Cg_endo -56.83 -32.7 92.68 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.93 2.42 . . . . 1.42 112.679 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 18.5 t70 -71.38 -22.03 61.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.464 0.649 . . . . 1.78 110.396 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.803 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 52.1 m-20 -93.11 9.83 34.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.507 -0.769 . . . . 1.6 111.429 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.52 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 39.0 mm-40 -83.82 54.02 2.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 1.05 110.948 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.48 HG12 HD12 ' A' ' 73' ' ' LEU . 18.7 tt -150.9 138.28 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.002 -0.544 . . . . 1.17 109.949 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.38 -136.49 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.387 -0.911 . . . . 0.6 112.433 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.427 ' CD2' HG23 ' A' ' 90' ' ' ILE . 50.4 p90 -160.13 174.2 14.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.052 0.453 . . . . 0.99 110.968 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.522 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 49.8 m-85 -114.93 139.31 49.91 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.242 -0.651 . . . . 1.26 109.242 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -112.41 127.69 56.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.247 -0.433 . . . . 2.15 111.072 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 49' ' ' ARG . 2.2 ttt-85 -88.5 112.27 22.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.014 -0.539 . . . . 2.4 110.09 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB3' ' HE2' ' A' ' 69' ' ' TYR . . . -125.26 156.5 38.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.037 0.446 . . . . 2.21 111.543 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.91 142.43 49.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.69 -0.687 . . . . 2.68 110.813 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.477 ' HB3' HD12 ' A' ' 64' ' ' LEU . 6.5 tpt180 -111.54 119.33 38.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.905 0.384 . . . . 3.59 111.264 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 mtt180 -137.16 169.47 17.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 3.43 109.942 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 pt -143.76 153.12 15.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 110.2 -0.296 . . . . 4.26 110.2 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.03 85.87 7.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.002 0.43 . . . . 5.17 109.957 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.668 ' HA2' ' OP2' ' C' ' 13' ' ' ' U' . . . -64.8 133.55 37.59 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.632 -0.713 . . . . 4.66 113.277 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.5 -49.44 76.99 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.488 -0.387 . . . . 5.04 112.137 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -82.37 -23.24 35.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.387 0.613 . . . . 5.51 110.185 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.14 -16.56 6.77 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.838 -0.696 . . . . 4.73 111.597 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -73.12 122.7 22.25 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.495 -0.558 . . . . 5.52 109.495 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 29.2 mtt -130.0 159.29 37.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.316 -0.402 . . . . 4.48 110.247 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HE2' ' H62' ' B' ' 2' ' ' ' A' . 30.8 mttt -64.63 -54.49 31.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.944 -0.391 . . . . 4.16 109.944 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.9 t70 52.92 74.86 0.27 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.744 . . . . 4.09 112.047 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 52' ' ' ARG . 89.0 mt -81.07 149.7 29.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.781 -0.645 . . . . 3.36 110.443 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.99 154.63 92.06 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.837 -0.62 . . . . 3.36 110.908 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.34 122.31 10.99 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.919 2.413 . . . . 2.69 111.486 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.603 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 97.7 mtt180 -119.84 135.57 54.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.005 -0.543 . . . . 3.03 110.738 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.522 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 73.8 m95 -97.57 135.43 39.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.751 -0.659 . . . . 1.84 110.463 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.742 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 73.0 m-85 -117.35 145.6 43.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 2.76 110.185 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -85.78 124.61 32.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.981 0.42 . . . . 1.27 111.449 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -126.19 138.97 53.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.71 -0.677 . . . . 1.84 110.117 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.88 161.33 29.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.799 0.333 . . . . 1.28 111.679 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.9 tt -63.27 122.11 15.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.058 -0.519 . . . . 1.66 111.051 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.33 16.58 62.2 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.86 -0.686 . . . . 1.66 114.147 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.44 129.23 40.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.109 0.455 . . . . 1.58 110.416 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.5 110.29 3.32 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.928 -0.869 . . . . 1.96 110.928 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.14 -29.15 54.63 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.426 2.751 . . . . 2.62 113.62 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.91 25.73 9.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.987 0.366 . . . . 3.09 111.987 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.38 -53.78 7.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.515 -0.312 . . . . 1.79 111.156 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.0 44.07 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.843 -0.694 . . . . 1.65 111.629 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 78.2 mt -117.43 107.15 45.49 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.718 0.294 . . . . 1.38 111.441 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -88.6 159.4 6.44 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.971 2.447 . . . . 1.62 111.158 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.614 ' HB2' HD11 ' A' ' 73' ' ' LEU . 92.6 t80 -64.37 119.16 9.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 1.58 110.845 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.21 11.1 26.49 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.495 -0.86 . . . . 1.44 112.891 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.03 172.12 13.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.702 0.251 . . . . 1.25 110.407 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -124.62 111.28 15.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.784 0.326 . . . . 1.86 110.442 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -140.99 152.51 44.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.265 -0.425 . . . . 1.68 110.155 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.65 117.94 8.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.081 -0.509 . . . . 1.7 111.329 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.24 29.24 62.6 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.64 -0.709 . . . . 1.27 113.27 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.427 HG23 ' CD2' ' A' ' 46' ' ' TYR . 38.4 mm -131.77 108.5 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.734 0.267 . . . . 1.01 110.863 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.5 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 12.8 pt -113.77 125.85 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.77 -0.455 . . . . 1.3 109.77 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.421 ' HZ2' ' HB3' ' A' ' 81' ' ' LEU . 79.3 m95 -87.51 139.12 30.87 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.446 0.535 . . . . 1.08 112.446 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.76 150.2 31.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.82 -0.627 . . . . 1.04 110.862 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.61 177.22 10.56 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.33 -0.248 . . . . 1.27 110.33 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.42 163.01 40.64 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.699 -0.482 . . . . 1.36 109.699 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.51 125.95 25.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.827 0.346 . . . . 2.64 111.246 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.08 -14.94 25.97 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.806 -0.711 . . . . 1.52 112.261 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -100.29 123.86 45.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.204 -0.295 . . . . 1.59 110.204 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 99' ' ' LEU . 26.3 mt -88.62 150.23 23.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.033 0.444 . . . . 2.15 111.459 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -75.12 102.77 5.04 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.745 -0.661 . . . . 2.07 110.955 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -170.89 148.19 2.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.85 -0.796 . . . . 2.36 108.85 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.43 131.5 15.08 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.296 1.998 . . . . 2.08 112.498 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.64 66.63 1.32 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.513 0.673 . . . . 1.78 110.99 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -1.75 25.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.661 -0.7 . . . . 2.55 111.776 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.44 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 8.6 p80 -52.34 -28.7 20.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.348 0.499 . . . . 2.24 112.348 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -25.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.248 -0.433 . . . . 2.0 112.009 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.81 63.51 4.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.069 -0.586 . . . . 2.33 112.167 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.2 t -138.51 23.09 2.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.208 0.528 . . . . 2.99 110.481 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.52 125.17 25.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.93 -0.577 . . . . 2.83 111.005 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.41 118.68 72.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.149 -0.686 . . . . 3.56 109.149 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.07 -33.68 91.23 Favored 'Trans proline' 0 CA--C 1.527 0.137 0 C-N-CA 123.001 2.467 . . . . 3.39 114.25 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.407 ' HB1' " O2'" ' B' ' 7' ' ' ' C' . . . -98.62 4.62 48.04 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.618 0.599 . . . . 4.05 112.618 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -125.1 -6.37 7.22 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.617 -0.433 . . . . 4.48 111.596 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -155.69 137.83 14.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.024 -0.535 . . . . 3.39 109.63 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.75 153.79 22.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.529 -0.305 . . . . 3.21 110.726 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.67 159.26 28.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.888 0.375 . . . . 2.85 111.103 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.7 mt -88.38 132.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.263 -0.426 . . . . 2.42 110.146 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.26 121.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.852 -0.425 . . . . 2.74 109.852 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.77 121.45 14.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.27 0.557 . . . . 2.11 111.108 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.0 157.16 46.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.525 -0.762 . . . . 2.49 109.687 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.7 mt -112.81 146.4 35.0 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 116.499 -0.319 . . . . 1.91 110.413 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.88 156.85 64.29 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 122.452 2.101 . . . . 1.84 111.758 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -52.38 125.07 14.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.74 -0.664 . . . . 2.53 111.137 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.77 -16.29 47.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.985 -0.626 . . . . 2.2 111.881 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.23 116.84 32.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.933 0.397 . . . . 2.1 110.565 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.68 158.31 16.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.082 -0.508 . . . . 2.78 110.511 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 27.0 mt -81.49 150.71 67.52 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.519 -0.31 . . . . 2.62 110.464 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 127' ' ' LEU . 32.0 Cg_exo -61.02 142.11 96.39 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.675 2.25 . . . . 2.77 111.515 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -61.44 112.33 2.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.102 -0.499 . . . . 4.11 110.95 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.88 -9.19 40.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.967 -0.635 . . . . 3.18 111.68 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 16' ' ' LEU . 47.6 t80 -118.18 103.47 9.89 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.486 -0.561 . . . . 2.91 109.486 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -112.34 162.62 15.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.18 -0.464 . . . . 3.54 111.06 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.693 ' HB3' ' HB2' ' A' ' 136' ' ' SER . . . -97.92 147.35 24.55 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.133 -0.485 . . . . 2.93 110.306 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -63.68 111.7 2.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.237 -0.438 . . . . 3.64 110.73 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.75 10.31 70.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.988 -0.625 . . . . 3.27 112.77 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.693 ' HB2' ' HB3' ' A' ' 133' ' ' ALA . 22.8 t -78.62 96.3 5.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.173 0.511 . . . . 3.59 111.019 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -98.6 78.48 2.38 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.559 -0.534 . . . . 5.55 109.559 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.01 100.66 2.68 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.582 -0.736 . . . . 5.22 112.263 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.79 -90.47 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.512 -0.635 . . . . 5.91 111.512 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.999 -0.524 . . . . 7.27 110.834 179.75 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.604 1 C4'-C3'-C2' 97.053 -5.647 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.407 ' H62' ' HE2' ' A' ' 62' ' ' LYS . . . . . . . . 1 C2'--O2' 1.472 4.527 2 N19-C1'-C2' 103.559 -6.151 . 0.227 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.784 3 O4'-C1'-N19 115.757 7.557 . 0.526 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.228 4 O4'-C1'-N19 116.705 8.505 . 0.51 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.131 2 C4'-C3'-C2' 97.569 -5.131 . 0.647 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.564 5 C4'-C3'-C2' 98.302 -4.398 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.407 " O2'" ' HB1' ' A' ' 112' ' ' ALA . . . . . . . . 3 O3'--C3' 1.498 5.324 3 P-O3'-C3' 127.077 6.147 . 0.01 1a . 18.24 . . . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.449 3 O4'-C4'-C3' 114.938 6.741 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -4.977 2 O4'-C1'-N19 118.615 10.415 . 0.415 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.546 -4.667 3 O3'-P-O5' 116.391 6.521 . 0.461 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.079 1 C4'-C3'-C2' 98.318 -4.382 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.61 1 C4'-C3'-C2' 94.335 -8.365 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.668 ' OP2' ' HA2' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.588 5.864 1 O3'-P-O5' 111.749 4.078 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.035 2 C3'-C2'-C1' 105.638 4.598 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.627 -0.589 . . . . 9.05 111.627 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.42 133.11 55.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 8.09 111.265 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -81.23 123.34 28.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 8.02 110.648 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.08 67.29 3.63 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.793 -0.718 . . . . 5.76 111.42 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -99.45 111.28 61.03 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.626 0.25 . . . . 4.72 111.022 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -85.28 0.11 8.82 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.622 2.215 . . . . 4.45 112.28 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -91.89 147.07 23.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.94 0.4 . . . . 4.41 111.275 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.414 ' HB3' ' H ' ' A' ' 9' ' ' THR . 14.0 t-20 -101.03 -82.93 0.46 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.521 -0.548 . . . . 3.92 109.521 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 8' ' ' ASN . 40.4 m 65.65 117.66 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.338 0.866 . . . . 2.53 113.338 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' HB1' " O2'" ' C' ' 8' ' ' ' G' . . . -147.84 141.8 25.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.403 -0.817 . . . . 2.48 109.748 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.4 p -64.62 137.93 58.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.781 0.324 . . . . 2.13 111.431 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -73.36 -26.52 61.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 2.4 110.714 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.496 ' CZ ' ' HA ' ' A' ' 35' ' ' ASN . 74.3 m-85 -111.04 166.6 10.92 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.038 -0.528 . . . . 2.02 112.273 -178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.1 p -69.67 168.73 14.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.249 -0.887 . . . . 2.65 111.18 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -92.25 151.6 20.25 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.269 0.47 . . . . 2.4 112.269 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' A' ' 133' ' ' ALA . 15.9 mt -99.88 125.17 45.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.443 -0.799 . . . . 2.27 109.031 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -95.87 121.92 38.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.195 0.521 . . . . 2.84 112.233 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -89.77 134.38 34.21 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.736 -0.666 . . . . 2.89 110.076 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -140.91 73.91 1.44 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 3.82 109.94 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -165.15 -140.83 2.97 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.781 -0.724 . . . . 3.23 112.438 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -110.81 -18.08 13.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.721 0.296 . . . . 4.27 111.342 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.12 -174.13 2.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.182 -0.463 . . . . 3.32 111.208 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -111.38 -77.46 0.59 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.063 -0.517 . . . . 2.39 110.208 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 31.6 tp 172.55 131.23 0.02 OUTLIER 'General case' 0 C--O 1.234 0.268 0 O-C-N 123.863 0.727 . . . . 2.06 110.018 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -157.23 130.89 8.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 2.22 109.625 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -120.97 139.51 29.34 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.234 -0.439 . . . . 1.78 110.277 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.55 164.36 34.03 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.273 1.982 . . . . 2.15 110.696 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.91 131.79 51.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.602 0.239 . . . . 2.6 110.609 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.11 6.3 61.77 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.536 -0.84 . . . . 1.65 111.659 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -144.39 159.73 42.23 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.818 -0.438 . . . . 2.31 109.818 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 108.43 -11.48 36.23 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.906 -0.664 . . . . 1.33 111.481 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.7 t -90.76 114.58 61.84 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.809 -0.441 . . . . 1.06 109.809 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.28 -173.13 1.7 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.564 2.176 . . . . 1.27 111.102 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.5 mt -79.97 91.92 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.751 -0.463 . . . . 1.7 109.751 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 13' ' ' PHE . 69.0 m-80 -87.44 77.38 8.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.97 -0.559 . . . . 1.23 110.694 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.15 39.65 0.19 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.016 -0.538 . . . . 1.94 111.68 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.49 -10.81 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.42 -0.355 . . . . 1.96 111.236 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.2 166.28 16.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.612 -0.267 . . . . 1.42 110.857 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 19.5 m -88.01 168.23 17.39 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.304 -0.407 . . . . 1.73 110.687 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 86.3 Cg_exo -49.79 -45.01 33.92 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.247 2.631 . . . . 1.42 113.855 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.674 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.2 OUTLIER -72.18 -22.74 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 1.78 111.522 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.958 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 14.8 m-20 -87.05 11.61 13.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.974 -0.557 . . . . 1.6 111.43 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 39.3 mm-40 -83.25 -6.46 59.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.761 0.282 . . . . 1.05 111.761 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.593 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -82.93 126.56 40.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.117 0.484 . . . . 1.17 111.33 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.44 -161.08 11.67 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.683 -0.77 . . . . 0.6 112.229 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.495 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 48.6 p90 -146.42 163.12 36.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.088 0.47 . . . . 0.99 110.717 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.534 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 5.9 m-85 -108.52 133.99 51.9 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.805 -0.634 . . . . 1.26 109.585 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 48' ' ' ARG . 30.8 ttt180 -114.68 134.63 54.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.859 0.361 . . . . 2.15 111.234 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -85.38 123.73 31.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 2.4 110.245 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.98 154.26 47.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.605 0.24 . . . . 2.21 110.957 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.432 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -150.42 93.06 1.93 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.118 -0.492 . . . . 2.68 110.726 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.528 ' HB3' HD12 ' A' ' 64' ' ' LEU . 28.5 tpt180 -78.64 124.86 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.281 0.562 . . . . 3.59 111.826 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -141.71 117.65 10.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.901 -0.591 . . . . 3.43 109.991 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.3 pt -65.19 171.19 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.185 -0.461 . . . . 4.26 110.713 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.5 106.26 9.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.061 0.457 . . . . 5.17 112.149 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.62 169.12 22.07 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.083 -0.807 . . . . 4.66 111.083 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.51 -15.58 52.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.63 -0.795 . . . . 5.04 112.647 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -86.31 -38.17 17.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.907 0.384 . . . . 5.51 111.374 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.99 -10.13 6.66 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.755 -0.736 . . . . 4.73 111.805 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -90.83 122.88 33.92 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.619 -0.512 . . . . 5.52 109.619 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.19 155.2 50.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.781 -0.451 . . . . 4.48 109.781 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.423 ' HE2' HD21 ' A' ' 64' ' ' LEU . 79.0 tttt -57.13 -53.31 59.54 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.332 0.395 . . . . 4.16 110.906 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.9 t70 56.0 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.93 0.715 . . . . 4.09 112.93 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 52' ' ' ARG . 68.9 mt -84.85 152.74 23.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 3.36 110.691 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.3 m -75.21 162.83 71.51 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.646 . . . . 3.36 109.989 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 11.9 Cg_endo -55.95 111.06 0.66 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.64 2.227 . . . . 2.69 111.848 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -116.47 137.56 52.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.97 -0.559 . . . . 3.03 110.762 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.534 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 69.1 m95 -104.77 129.64 52.99 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.84 -0.618 . . . . 1.84 110.944 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.423 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 54.3 m-85 -110.13 140.65 44.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.788 -0.642 . . . . 2.76 110.001 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -89.97 120.08 30.88 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 1.27 111.186 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.37 130.41 52.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 1.84 109.939 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -67.3 151.1 48.09 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.56 -0.291 . . . . 1.28 111.129 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.11 116.52 4.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 1.66 110.805 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.89 -4.29 24.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.474 -0.87 . . . . 1.66 112.901 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.532 HG22 ' HA3' ' A' ' 107' ' ' GLY . 1.2 p -63.74 123.54 19.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.64 0.257 . . . . 1.58 110.492 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.98 106.87 3.01 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.081 -0.807 . . . . 1.96 111.081 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.35 -35.2 91.15 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.089 2.526 . . . . 2.62 113.062 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -114.72 21.98 13.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.473 -0.331 . . . . 3.09 111.619 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.33 -50.1 61.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 1.79 110.83 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.32 49.03 59.69 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.019 -0.61 . . . . 1.65 111.812 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.4 mt -118.44 91.68 41.85 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.692 0.282 . . . . 1.38 111.56 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.27 155.02 22.02 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.443 2.095 . . . . 1.62 110.301 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 76.7 t80 -60.54 110.46 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.772 0.32 . . . . 1.58 110.857 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.59 -14.49 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.869 -0.681 . . . . 1.44 112.393 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.62 147.21 49.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.809 0.338 . . . . 1.25 111.286 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -111.08 103.14 11.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.055 0.455 . . . . 1.86 111.424 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HB3' HG13 ' A' ' 90' ' ' ILE . 12.8 ttmt -125.77 149.43 48.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.739 -0.664 . . . . 1.68 109.712 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.75 118.62 5.91 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.455 0.472 . . . . 1.7 111.935 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.58 35.45 51.52 Favored Glycine 0 N--CA 1.452 -0.239 0 CA-C-N 115.941 -0.572 . . . . 1.27 112.981 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.413 HG13 ' HB3' ' A' ' 87' ' ' LYS . 27.4 mm -134.87 113.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.544 0.212 . . . . 1.01 110.474 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.5 HG13 ' HB2' ' A' ' 47' ' ' TYR . 23.6 pt -119.9 134.67 62.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 110.444 -0.206 . . . . 1.3 110.444 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.495 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 70.2 m95 -95.34 140.98 29.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.403 -0.362 . . . . 1.08 111.907 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.49 HG11 ' HA3' ' A' ' 31' ' ' GLY . 9.2 m -134.22 125.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 1.04 110.394 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.9 158.7 40.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.013 0.435 . . . . 1.27 111.79 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.5 t -139.04 163.34 32.65 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.569 -0.9 . . . . 1.36 108.569 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -67.61 121.46 15.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 2.64 110.58 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.03 -17.91 12.61 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.992 -0.843 . . . . 1.52 110.992 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.674 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -81.97 121.08 26.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.857 0.36 . . . . 1.59 110.062 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -88.65 130.58 35.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.143 -0.481 . . . . 2.15 110.603 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -71.45 97.0 1.56 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.125 0.488 . . . . 2.07 110.9 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.579 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.6 t -168.41 143.44 2.86 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.863 -0.791 . . . . 2.36 108.863 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.89 128.7 25.05 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.605 2.204 . . . . 2.08 113.516 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.958 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -129.5 78.93 1.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.525 0.679 . . . . 1.78 110.244 178.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -80.6 -11.11 59.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 2.55 111.492 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -58.28 -22.86 54.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.73 0.641 . . . . 2.24 112.73 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.28 0.68 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.089 0.471 . . . . 2.0 110.97 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -86.94 -35.42 9.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.871 -0.681 . . . . 2.33 111.5 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 t -71.27 115.66 10.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.355 0.598 . . . . 2.99 110.623 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.466 HH22 " H1'" ' C' ' 8' ' ' ' G' . 35.2 ttp85 -154.22 138.66 16.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.972 -0.558 . . . . 2.83 110.159 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 97.4 m-20 -94.75 108.04 34.77 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.863 -0.421 . . . . 3.56 109.863 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 37.4 Cg_endo -63.79 -29.19 68.23 Favored 'Trans proline' 0 N--CA 1.47 0.124 0 C-N-CA 123.238 2.625 . . . . 3.39 113.451 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.99 12.71 12.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.113 0.412 . . . . 4.05 112.113 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -135.95 -43.0 0.65 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 4.48 110.777 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -103.33 134.58 46.47 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.555 -0.535 . . . . 3.39 109.555 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.92 150.67 25.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.883 0.373 . . . . 3.21 111.24 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.05 158.93 19.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.026 -0.534 . . . . 2.85 111.258 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 15.7 mt -113.33 145.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.044 -0.526 . . . . 2.42 109.712 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.01 118.66 9.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.63 0.252 . . . . 2.74 110.749 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.45 117.72 8.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.782 -0.645 . . . . 2.11 111.175 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -130.33 150.45 51.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.985 -0.552 . . . . 2.49 110.747 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.599 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 26.1 mt -97.22 138.83 21.22 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.098 -0.501 . . . . 1.91 110.107 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.24 152.98 68.39 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.683 2.255 . . . . 1.84 111.775 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -50.5 124.12 10.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 2.53 111.277 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.91 -22.13 16.9 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.148 -0.781 . . . . 2.2 111.148 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -99.98 120.29 39.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.656 -0.498 . . . . 2.1 109.656 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.4 139.03 38.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.179 -0.464 . . . . 2.78 111.06 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.2 mt -72.61 146.39 88.45 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.81 149.23 26.2 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.646 2.23 . . . . 2.77 111.417 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -59.39 108.98 0.78 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.293 0.479 . . . . 4.11 112.293 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.12 6.03 54.13 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.735 -0.666 . . . . 3.18 112.998 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -94.02 141.87 28.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.958 0.379 . . . . 2.91 111.49 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.867 ' HE1' " H5'" ' B' ' 1' ' ' ' C' . 37.1 p90 -152.98 147.3 25.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.93 -0.577 . . . . 3.54 110.785 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.63 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -112.55 162.35 15.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.357 -0.383 . . . . 2.93 110.54 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.22 128.06 34.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.367 -0.378 . . . . 3.64 110.283 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 138' ' ' GLY . . . 98.89 -12.35 62.48 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.725 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.0 m -79.58 -18.56 51.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.839 0.352 . . . . 3.59 111.731 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -133.86 35.71 3.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.098 -0.501 . . . . 5.55 110.347 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.435 ' O ' ' HA2' ' A' ' 135' ' ' GLY . . . 110.68 -131.83 10.61 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.582 -0.818 . . . . 5.22 112.252 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.39 -131.46 10.77 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 5.91 112.098 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.563 -0.732 . . . . 7.27 110.992 -179.83 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.867 " H5'" ' HE1' ' A' ' 132' ' ' TYR . . . . . . . . 0 C2'--C1' 1.492 -3.6 1 C4'-C3'-C2' 97.067 -5.633 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.473 4.634 2 N19-C1'-C2' 103.444 -6.222 . 0.228 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.773 3 O4'-C1'-N19 115.719 7.519 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.223 4 O4'-C1'-N19 116.681 8.481 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.374 -4.141 2 C4'-C3'-C2' 97.579 -5.121 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.524 -6.897 4 N19-C1'-C2' 106.354 -4.404 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.289 3 P-O3'-C3' 127.079 6.149 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.557 " O2'" ' HB1' ' A' ' 10' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.374 3 O4'-C4'-C3' 115.046 6.818 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.049 2 O4'-C1'-N19 118.63 10.43 . 0.418 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.587 3 O4'-C1'-N19 114.681 6.481 . 0.462 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.218 1 C4'-C3'-C2' 98.31 -4.39 . 0.311 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.598 1 C4'-C3'-C2' 94.261 -8.439 . 0.449 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.589 5.877 1 O3'-P-O5' 111.725 4.066 . 0.103 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.576 4.846 2 C3'-C2'-C1' 105.739 4.71 . 0.335 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 111.66 -0.576 . . . . 9.05 111.66 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.62 147.92 23.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.745 0.307 . . . . 8.09 110.717 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -125.79 27.1 6.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.15 -0.477 . . . . 8.02 110.738 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.73 133.62 12.91 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.721 -0.752 . . . . 5.76 111.615 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.5 mt -129.49 134.51 26.32 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.553 0.216 . . . . 4.72 110.843 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.23 33.51 0.51 Allowed 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.915 2.41 . . . . 4.45 111.962 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.11 152.22 23.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 4.41 110.333 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.65 -77.28 0.55 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.197 -0.668 . . . . 3.92 109.197 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 108' ' ' THR . 6.8 p 45.37 78.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.019 1.118 . . . . 2.53 114.019 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.06 168.5 19.86 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.169 -0.678 . . . . 2.48 109.169 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 154.45 42.02 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.896 0.379 . . . . 2.13 111.332 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -31.45 53.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.464 0.65 . . . . 2.4 109.429 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.505 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 92.5 m-85 -114.9 176.57 5.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.121 -0.945 . . . . 2.02 109.878 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 134' ' ' GLU . 2.3 p -69.95 167.52 17.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.763 0.316 . . . . 2.65 110.747 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.89 160.11 18.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.09 0.472 . . . . 2.4 111.409 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.564 HD21 HD22 ' A' ' 119' ' ' LEU . 90.7 mt -107.95 115.8 30.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.144 -0.688 . . . . 2.27 109.144 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 4.6 m -93.12 132.71 37.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.155 0.502 . . . . 2.84 111.769 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HA ' ' HD1' ' A' ' 131' ' ' PHE . 6.4 tp-100 -95.96 140.84 30.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.611 -0.722 . . . . 2.89 110.812 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -130.17 77.38 1.78 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.004 -0.544 . . . . 3.82 109.761 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -171.91 44.42 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.951 -0.642 . . . . 3.23 111.657 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -84.47 -23.69 29.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.027 0.441 . . . . 4.27 110.414 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.68 -179.9 6.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.626 -0.716 . . . . 3.32 110.802 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 1.4 t0 -117.96 -84.32 0.65 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.249 -0.432 . . . . 2.39 110.61 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 30.8 tp -175.72 129.04 0.25 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 2.06 111.072 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -152.27 88.95 1.4 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.218 -0.66 . . . . 2.22 109.218 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -72.68 142.06 83.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.277 -0.42 . . . . 1.78 111.877 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.692 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 56.2 Cg_endo -70.77 161.51 45.8 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.024 2.483 . . . . 2.15 112.426 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -60.59 119.58 8.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 2.6 111.784 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.63 -13.44 61.06 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.056 -0.593 . . . . 1.65 112.685 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.692 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 70.5 mt-30 -117.87 174.2 6.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.671 0.272 . . . . 2.31 110.753 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.78 -1.66 41.84 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.597 -0.811 . . . . 1.33 112.246 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.4 t -100.58 112.04 63.85 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.57 0.224 . . . . 1.06 110.482 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HA ' HD23 ' A' ' 121' ' ' LEU . 53.7 Cg_endo -70.2 174.86 9.26 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.676 2.251 . . . . 1.27 111.492 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.4 mt -74.85 89.11 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.056 0.455 . . . . 1.7 110.642 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 13' ' ' PHE . 62.0 m-80 -85.88 84.8 7.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 1.23 109.63 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -66.66 -20.98 66.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.703 -0.68 . . . . 1.94 112.197 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -88.24 -11.86 45.38 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.319 0.488 . . . . 1.96 112.319 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.06 158.94 18.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.144 0.497 . . . . 1.42 111.993 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 0.7 OUTLIER -89.06 163.02 36.03 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.644 -0.707 . . . . 1.73 109.34 179.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.17 -45.16 26.61 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.321 2.681 . . . . 1.42 113.315 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.906 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.25 -18.78 61.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.024 0.44 . . . . 1.78 111.411 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.12 -2.45 58.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.956 -0.566 . . . . 1.6 110.824 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 39' ' ' SER . 73.2 mm-40 -80.39 60.92 3.97 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.228 0.537 . . . . 1.05 110.686 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.501 HG12 HD12 ' A' ' 73' ' ' LEU . 15.9 tt -149.37 135.35 11.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.83 -0.623 . . . . 1.17 110.167 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.82 -146.85 6.27 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.129 -1.034 . . . . 0.6 112.98 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -152.76 168.46 25.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.134 0.492 . . . . 0.99 110.772 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.714 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -112.51 134.78 53.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.976 -0.557 . . . . 1.26 109.632 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 48' ' ' ARG . 27.7 ttt180 -116.96 126.51 53.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.842 0.353 . . . . 2.15 111.113 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.69 132.45 34.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.085 -0.507 . . . . 2.4 110.774 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.591 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -139.3 147.87 42.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.606 0.241 . . . . 2.21 110.792 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 101.05 4.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.3 -0.409 . . . . 2.68 110.564 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.611 ' HB3' HD12 ' A' ' 64' ' ' LEU . 6.4 tpt180 -77.53 129.24 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 3.59 111.315 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -144.58 93.35 2.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.329 -0.396 . . . . 3.43 110.884 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.77 HG12 ' HB2' ' A' ' 62' ' ' LYS . 8.5 pt -77.51 154.01 5.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.601 -0.272 . . . . 4.26 110.382 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.09 119.34 39.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.189 -0.46 . . . . 5.17 110.664 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.22 162.14 40.04 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.783 -0.723 . . . . 4.66 111.758 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.6 -21.96 67.46 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.908 -0.477 . . . . 5.04 111.908 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -76.48 -12.8 60.1 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.311 0.576 . . . . 5.51 110.432 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.69 0.28 59.21 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.867 -0.682 . . . . 4.73 112.26 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -91.33 159.84 15.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.829 0.347 . . . . 5.52 110.588 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.8 mmt -108.82 150.5 27.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.228 -0.442 . . . . 4.48 110.022 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.77 ' HB2' HG12 ' A' ' 54' ' ' ILE . 70.4 tttt -63.5 -43.8 96.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.952 0.406 . . . . 4.16 111.157 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 62.77 101.01 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.511 -0.768 . . . . 4.09 112.847 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 52' ' ' ARG . 22.4 mt -117.53 150.46 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.856 -0.611 . . . . 3.36 110.5 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.445 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 0.2 OUTLIER -68.93 147.61 97.83 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.215 -0.448 . . . . 3.36 110.449 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.32 120.42 8.33 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.869 2.379 . . . . 2.69 111.641 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -118.03 133.31 56.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.049 -0.523 . . . . 3.03 111.496 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.714 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 44.7 m95 -100.31 125.44 46.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.977 -0.556 . . . . 1.84 109.537 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 24.7 m-85 -102.2 135.46 43.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.337 -0.392 . . . . 2.76 110.113 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -85.97 120.43 27.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.762 0.315 . . . . 1.27 110.65 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -118.78 144.66 46.15 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.996 -0.547 . . . . 1.84 109.723 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.448 ' CD2' HD12 ' A' ' 106' ' ' ILE . 99.2 m-85 -79.45 164.49 23.92 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.136 -0.226 . . . . 1.28 110.7 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.501 HD12 HG12 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -60.52 117.57 5.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.073 0.463 . . . . 1.66 112.073 -179.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.15 38.89 17.34 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.749 -0.66 . . . . 1.66 113.043 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.496 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -78.31 70.08 4.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.236 0.541 . . . . 1.58 111.234 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.64 121.56 0.58 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.531 -1.028 . . . . 1.96 110.531 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.03 -42.37 64.81 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.811 2.34 . . . . 2.62 112.801 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.64 29.19 8.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.428 -0.351 . . . . 3.09 111.339 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.72 -50.27 15.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.223 -0.444 . . . . 1.79 110.866 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.8 49.15 65.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.053 -0.594 . . . . 1.65 111.866 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.8 mt -120.26 99.19 48.49 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.721 0.296 . . . . 1.38 111.638 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 94.6 Cg_endo -80.85 160.45 21.34 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.514 2.143 . . . . 1.62 110.595 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -59.06 112.46 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.016 0.436 . . . . 1.58 110.488 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 114.24 -3.89 23.71 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.902 -0.666 . . . . 1.44 112.34 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.569 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -64.52 116.66 6.37 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.808 0.337 . . . . 1.25 110.853 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.37 127.76 33.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.837 -0.62 . . . . 1.86 110.919 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.69 ' HD2' HG13 ' A' ' 90' ' ' ILE . 12.1 ttmm -154.38 159.18 41.0 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.935 -0.765 . . . . 1.68 108.935 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 118.45 10.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.06 0.457 . . . . 1.7 111.481 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.34 34.94 60.4 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.654 -0.703 . . . . 1.27 112.741 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.69 HG13 ' HD2' ' A' ' 87' ' ' LYS . 28.3 mm -133.72 116.06 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.201 0.524 . . . . 1.01 111.256 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.7 pt -124.16 139.87 49.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.868 -0.79 . . . . 1.3 108.868 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -100.26 141.87 32.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.272 0.471 . . . . 1.08 112.272 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.2 m -138.7 145.86 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.774 -0.648 . . . . 1.04 110.311 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -159.58 140.94 12.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.626 -0.261 . . . . 1.27 110.999 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.3 t -99.58 175.68 5.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.677 -0.49 . . . . 1.36 109.677 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -73.97 133.74 43.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.813 0.339 . . . . 2.64 110.674 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.62 -9.5 57.16 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.659 -0.781 . . . . 1.52 112.156 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.906 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.04 148.17 27.71 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.639 0.257 . . . . 1.59 110.421 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.69 134.79 49.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.797 0.332 . . . . 2.15 110.942 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -78.28 93.51 4.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.023 -0.535 . . . . 2.07 110.565 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.1 t -158.92 138.71 8.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.829 -0.623 . . . . 2.36 109.823 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.37 130.43 19.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.622 2.215 . . . . 2.08 112.238 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.56 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 14.5 pttt -151.9 92.08 1.7 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.268 0.556 . . . . 1.78 111.144 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -75.31 -4.03 36.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 2.55 111.883 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.56 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 1.7 p80 -55.01 -29.1 56.63 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.513 0.561 . . . . 2.24 112.513 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.448 HD12 ' CD2' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -96.35 4.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.785 0.326 . . . . 2.0 111.437 -179.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.496 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -104.75 -21.74 8.93 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.368 -0.92 . . . . 2.33 113.301 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.558 ' HA ' HG22 ' A' ' 9' ' ' THR . 3.1 t -80.24 111.58 16.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.309 0.576 . . . . 2.99 112.364 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 109' ' ' ARG . 12.4 ttp180 -167.02 136.65 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.794 -0.639 . . . . 2.83 110.573 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -90.69 117.97 68.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 3.56 110.0 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -65.97 -32.67 44.18 Favored 'Trans proline' 0 N--CA 1.473 0.298 0 C-N-CA 122.749 2.299 . . . . 3.39 113.179 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.23 -17.12 61.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.783 0.29 . . . . 4.05 111.783 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -112.39 0.43 15.62 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.477 -0.329 . . . . 4.48 111.217 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -155.48 117.92 4.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.569 0.223 . . . . 3.39 110.728 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.42 154.16 42.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 3.21 111.411 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.79 151.08 19.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.089 0.471 . . . . 2.85 111.597 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.505 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 13.2 mt -91.93 149.0 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.26 -0.644 . . . . 2.42 109.26 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.99 116.09 7.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.609 0.242 . . . . 2.74 110.582 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.564 HD22 HD21 ' A' ' 16' ' ' LEU . 6.0 tt -64.1 111.81 2.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 2.11 110.999 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -131.88 150.75 52.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.122 -0.49 . . . . 2.49 110.545 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 33' ' ' PRO . 60.3 mt -93.59 154.52 41.12 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.955 -0.566 . . . . 1.91 109.521 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.63 166.81 12.78 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.487 2.124 . . . . 1.84 112.542 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -64.65 119.53 10.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.903 -0.59 . . . . 2.53 110.497 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.19 -19.33 22.68 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.046 -0.822 . . . . 2.2 111.046 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -105.36 118.75 37.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 2.1 110.148 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.42 155.83 22.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.277 -0.419 . . . . 2.78 110.933 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -84.67 151.44 58.42 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 109.49 -0.559 . . . . 2.62 109.49 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.94 150.37 78.55 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.347 2.032 . . . . 2.77 111.213 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -59.13 125.45 23.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 4.11 110.735 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.86 -16.0 51.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.014 -0.612 . . . . 3.18 111.688 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -96.84 124.26 40.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.114 -0.328 . . . . 2.91 110.114 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.485 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 55.3 p90 -127.62 148.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.909 0.385 . . . . 3.54 111.156 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.506 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -91.55 137.04 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.036 -0.529 . . . . 2.93 111.062 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.49 ' HA ' ' OE1' ' A' ' 134' ' ' GLU . 39.6 mm-40 -69.61 137.25 52.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.918 0.389 . . . . 3.64 110.801 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.18 -31.35 6.74 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 109.994 -1.242 . . . . 3.27 109.994 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.2 t -93.96 125.71 38.74 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.46 -0.57 . . . . 3.59 109.46 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -114.72 94.51 4.8 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.094 0.473 . . . . 5.55 110.158 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.18 160.18 18.57 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.734 -0.746 . . . . 5.22 112.233 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 69.01 -119.35 9.57 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.867 -0.683 . . . . 5.91 112.082 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 119.047 -0.501 . . . . 7.27 110.549 -179.543 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.63 1 C4'-C3'-C2' 97.141 -5.559 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.555 2 N19-C1'-C2' 103.499 -6.188 . 0.23 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.463 -5.676 3 O4'-C1'-N19 115.673 7.473 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.267 4 O4'-C1'-N19 116.583 8.383 . 0.51 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.044 2 C4'-C3'-C2' 97.626 -5.074 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.711 4 C4'-C3'-C2' 98.274 -4.426 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.498 5.358 3 P-O3'-C3' 127.08 6.15 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.422 3 O4'-C4'-C3' 114.961 6.758 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.028 2 O4'-C1'-N19 118.654 10.454 . 0.414 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.462 3 O3'-P-O5' 116.366 6.509 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.133 1 C4'-C3'-C2' 98.349 -4.351 . 0.308 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.611 1 C4'-C3'-C2' 94.38 -8.32 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.819 1 O3'-P-O5' 111.654 4.028 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . 0.599 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.579 5.148 2 C3'-C2'-C1' 105.681 4.645 . 0.338 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 111.729 -0.548 . . . . 9.05 111.729 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.15 128.03 34.48 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.935 0.398 . . . . 8.09 111.274 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 tpt -114.03 106.96 15.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.372 -0.377 . . . . 8.02 111.059 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 179.68 40.46 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.878 -0.677 . . . . 5.76 111.746 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 37.6 mt -137.78 109.49 8.55 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.694 0.283 . . . . 4.72 110.687 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.33 29.49 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.787 2.325 . . . . 4.45 111.816 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -66.19 116.48 7.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.152 -0.476 . . . . 4.41 110.893 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -163.91 -163.83 0.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.238 -0.437 . . . . 3.92 110.337 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 m 63.68 93.33 0.06 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.588 0.555 . . . . 2.53 111.155 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.45 139.68 51.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.072 -0.513 . . . . 2.48 110.756 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -64.46 149.61 48.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.872 -0.603 . . . . 2.13 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -86.37 -18.42 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 2.4 111.257 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 96.8 m-85 -123.37 172.71 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.155 -0.475 . . . . 2.02 111.276 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.914 HG22 " H5'" ' C' ' 8' ' ' ' G' . 17.7 p -70.44 170.37 12.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 2.65 109.996 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . . . -95.92 172.11 8.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.279 0.561 . . . . 2.4 111.211 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 131' ' ' PHE . 43.6 mt -106.04 102.07 11.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.901 -0.778 . . . . 2.27 108.901 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.738 HG23 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -79.42 119.24 22.15 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.967 -0.56 . . . . 2.84 110.952 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 5.3 tp60 -100.36 132.73 45.58 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.886 -0.597 . . . . 2.89 110.801 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -126.29 57.16 1.41 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.692 -0.685 . . . . 3.82 109.436 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.61 -166.41 11.86 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.39 -0.823 . . . . 3.23 111.546 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -91.78 -37.97 12.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.887 0.343 . . . . 4.27 111.595 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -83.14 156.19 23.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.505 -0.316 . . . . 3.32 110.944 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' OD2' ' HZ2' ' A' ' 68' ' ' TRP . 1.4 t0 -87.22 -154.37 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.278 -0.419 . . . . 2.39 110.556 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.3 tp -111.58 131.34 55.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.951 0.352 . . . . 2.06 111.951 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -154.65 105.44 2.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.782 -0.645 . . . . 2.22 109.371 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -86.54 150.59 51.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 1.78 110.952 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 72.8 Cg_endo -75.74 -172.85 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.942 2.428 . . . . 2.15 112.707 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 28' ' ' ARG . 7.2 tpt180 -69.6 130.04 41.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.625 -0.716 . . . . 2.6 111.447 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.35 8.98 87.36 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.24 -0.505 . . . . 1.65 112.575 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.525 HE22 HG23 ' A' ' 125' ' ' THR . 4.7 mm-40 -125.87 167.26 15.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.804 0.335 . . . . 2.31 111.018 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.508 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 110.0 -28.22 10.79 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.671 -0.695 . . . . 1.33 112.134 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 43' ' ' GLN . 45.4 t -80.01 115.23 52.79 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.839 0.352 . . . . 1.06 110.254 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 6.2 Cg_exo -78.38 -176.25 3.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.668 2.246 . . . . 1.27 111.095 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 36' ' ' THR . 32.9 mt -80.03 88.85 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.568 -0.53 . . . . 1.7 109.568 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -86.08 82.61 8.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.99 -0.55 . . . . 1.23 110.465 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.429 HG23 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -77.74 37.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.737 -0.665 . . . . 1.94 111.486 -179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.16 1.39 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.98 -0.555 . . . . 1.96 109.711 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.43 159.29 37.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.887 -0.597 . . . . 1.42 111.843 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.16 168.82 23.82 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.688 -0.687 . . . . 1.73 110.019 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.11 -37.96 93.77 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.648 2.232 . . . . 1.42 112.802 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 1.3 p30 -78.24 -15.76 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.631 0.234 . . . . 1.78 111.631 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.894 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 11.4 m-20 -88.75 -0.61 57.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 1.6 110.504 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.456 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.1 mm-40 -79.88 53.7 1.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.237 0.542 . . . . 1.05 111.074 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.868 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.4 tt -146.49 134.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.838 -0.619 . . . . 1.17 109.508 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.97 -146.67 5.41 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.412 -0.899 . . . . 0.6 112.498 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 51.2 p90 -156.41 165.78 35.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.611 0.243 . . . . 0.99 110.656 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.732 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 9.0 m-85 -106.15 141.91 36.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.483 -0.562 . . . . 1.26 109.483 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -121.77 127.75 50.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.194 -0.457 . . . . 2.15 110.912 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.4 ttt-85 -82.03 109.48 16.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.054 -0.521 . . . . 2.4 110.009 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.82 145.4 50.65 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.076 0.465 . . . . 2.21 112.114 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.9 m -140.44 119.58 12.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 2.68 109.765 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.685 ' HB3' HD12 ' A' ' 64' ' ' LEU . 25.0 tpt180 -84.58 125.35 32.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.075 0.464 . . . . 3.59 111.923 -178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -137.8 172.44 12.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 3.43 110.049 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.95 177.42 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.629 0.252 . . . . 4.26 110.857 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -112.7 113.18 25.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.408 -0.36 . . . . 5.17 110.086 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.63 144.67 15.51 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.97 -0.633 . . . . 4.66 111.573 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.95 -38.94 21.78 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.043 -0.599 . . . . 5.04 112.371 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -72.33 -45.76 58.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 5.51 110.949 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 129.21 3.0 5.39 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.329 -0.938 . . . . 4.73 113.305 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -79.22 118.86 21.55 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.912 -0.403 . . . . 5.52 109.912 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.4 mmt -131.15 152.4 50.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.264 -0.425 . . . . 4.48 110.048 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -64.54 -38.37 90.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.459 -0.571 . . . . 4.16 109.459 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 55.36 85.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.989 -1.005 . . . . 4.09 113.455 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.685 HD12 ' HB3' ' A' ' 52' ' ' ARG . 81.3 mt -92.2 155.31 18.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.974 -0.557 . . . . 3.36 109.918 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.8 m -74.76 152.8 87.12 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.713 -0.222 . . . . 3.36 110.789 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.32 120.96 9.18 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.645 2.23 . . . . 2.69 111.092 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.738 ' HG2' HG23 ' A' ' 17' ' ' THR . 63.2 mtt180 -112.77 126.89 55.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 3.03 111.222 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.732 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.04 104.36 16.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.122 -0.49 . . . . 1.84 109.88 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 15' ' ' ALA . 89.0 m-85 -88.51 148.87 23.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.203 -0.453 . . . . 2.76 110.442 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -101.79 128.07 48.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.908 0.385 . . . . 1.27 111.294 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.67 157.82 31.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.157 -0.683 . . . . 1.84 109.157 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.69 159.0 16.6 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.633 -0.258 . . . . 1.28 110.999 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 tp -62.1 120.45 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.183 -0.462 . . . . 1.66 112.111 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 88.67 36.08 8.12 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.939 -0.648 . . . . 1.66 112.728 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.44 104.46 15.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.966 0.412 . . . . 1.58 111.302 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.49 115.5 3.39 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.649 -0.786 . . . . 1.96 111.959 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.7 -24.03 55.49 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.642 2.228 . . . . 2.62 112.172 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 47.11 1.16 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.913 0.387 . . . . 3.09 110.531 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.69 -60.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 1.79 111.469 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.32 16.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.82 -0.705 . . . . 1.65 111.624 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HD2' ' A' ' 87' ' ' LYS . 32.0 mt -120.77 94.19 48.82 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 120.597 0.237 . . . . 1.38 111.581 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 83.4 Cg_endo -83.11 164.43 15.19 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.541 2.161 . . . . 1.62 111.009 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -59.57 110.28 1.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.58 111.356 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 110.15 9.19 24.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.796 -0.716 . . . . 1.44 113.055 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.561 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -77.73 134.95 37.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.864 0.364 . . . . 1.25 111.243 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -81.22 127.15 32.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.401 -0.363 . . . . 1.86 110.918 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HD2' HD21 ' A' ' 81' ' ' LEU . 12.4 tttt -163.3 142.05 8.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 1.68 110.666 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.37 124.76 24.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.047 -0.524 . . . . 1.7 111.497 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.82 15.92 71.68 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.913 -0.585 . . . . 1.27 112.797 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.02 112.95 26.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.634 0.254 . . . . 1.01 110.709 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.457 HG13 ' HB2' ' A' ' 47' ' ' TYR . 17.5 pt -118.0 132.17 68.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.942 -0.392 . . . . 1.3 109.942 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.422 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 71.7 m95 -92.15 138.03 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.409 0.522 . . . . 1.08 112.409 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.508 HG11 ' HA3' ' A' ' 31' ' ' GLY . 17.4 m -132.75 146.4 32.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.407 -0.815 . . . . 1.04 109.706 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.19 174.71 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.831 0.348 . . . . 1.27 111.097 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.5 t -156.22 170.73 21.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 1.36 109.389 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -69.12 124.64 24.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 2.64 110.681 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 41' ' ' ASP . . . 112.84 -21.58 18.16 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.829 -0.908 . . . . 1.52 110.829 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.868 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.09 126.81 31.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.097 -0.335 . . . . 1.59 110.097 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.6 mt -101.18 143.68 30.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.857 0.36 . . . . 2.15 111.158 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -78.06 93.38 4.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.317 0.579 . . . . 2.07 110.722 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.417 ' OG1' ' HD2' ' A' ' 102' ' ' PRO . 8.4 t -161.71 149.49 12.11 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.454 -0.943 . . . . 2.36 108.454 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.417 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 50.7 Cg_endo -69.99 129.73 17.85 Favored 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 122.259 1.973 . . . . 2.08 112.938 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.894 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -138.18 71.33 1.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.385 0.612 . . . . 1.78 111.203 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 1.2 p-10 -76.96 -4.38 43.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.088 -0.505 . . . . 2.55 111.918 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.413 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.5 p80 -57.82 -22.21 46.39 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.973 0.416 . . . . 2.24 111.878 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.72 8.86 9.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.241 0.543 . . . . 2.0 110.973 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.69 -26.73 10.35 Favored Glycine 0 C--O 1.236 0.242 0 C-N-CA 120.999 -0.619 . . . . 2.33 111.612 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.7 t -79.77 118.17 21.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.037 0.446 . . . . 2.99 110.539 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.4 ttp85 -161.5 140.44 9.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 2.83 109.999 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -100.65 103.3 23.31 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.5 -0.318 . . . . 3.56 110.579 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.39 -17.09 39.43 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.761 2.308 . . . . 3.39 112.702 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.49 -11.42 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.054 0.454 . . . . 4.05 110.982 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -116.83 -53.62 2.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.031 -0.532 . . . . 4.48 110.14 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.79 139.58 38.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.682 -0.69 . . . . 3.39 109.944 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 148.13 22.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.735 0.302 . . . . 3.21 111.106 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.542 ' H ' " H1'" ' C' ' 8' ' ' ' G' . . . -78.76 153.13 31.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.394 -0.366 . . . . 2.85 110.816 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 9.1 mt -88.1 149.81 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.941 -0.572 . . . . 2.42 110.116 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 136' ' ' SER . 40.3 t -67.88 125.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.36 . . . . 2.74 110.471 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.9 tt -72.07 105.47 3.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.141 -0.481 . . . . 2.11 110.979 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -121.31 150.53 41.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.143 -0.48 . . . . 2.49 110.688 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.633 HD13 HG22 ' A' ' 125' ' ' THR . 96.0 mt -100.18 153.87 37.52 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.093 -0.503 . . . . 1.91 110.835 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.71 167.92 25.9 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.731 2.287 . . . . 1.84 111.912 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.07 122.54 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.493 . . . . 2.53 111.214 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.57 12.13 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.69 -0.686 . . . . 2.2 111.766 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.633 HG22 HD13 ' A' ' 121' ' ' LEU . 6.4 m -96.24 122.26 38.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.927 -0.397 . . . . 2.1 109.927 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 p -118.67 149.06 42.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.655 0.264 . . . . 2.78 110.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.2 mt -77.71 144.01 68.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.812 -0.44 . . . . 2.62 109.812 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.439 ' HG2' ' CD1' ' A' ' 131' ' ' PHE . 12.4 Cg_endo -57.78 157.83 22.52 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.615 2.21 . . . . 2.77 111.701 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.7 118.34 7.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.136 -0.484 . . . . 4.11 110.733 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.21 -16.66 24.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.979 -0.629 . . . . 3.18 112.423 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.8 m-85 -99.63 124.92 45.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.71 0.291 . . . . 2.91 111.004 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -121.53 161.68 21.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 3.54 110.943 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 136' ' ' SER . . . -95.19 130.96 41.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.423 -0.353 . . . . 2.93 110.973 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 55.5 mt-10 -68.85 107.68 3.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 3.64 111.605 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.54 12.01 56.34 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.749 -0.66 . . . . 3.27 112.578 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' A' ' 133' ' ' ALA . 4.7 t -130.14 145.6 51.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.128 -0.323 . . . . 3.59 110.128 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -128.55 166.97 17.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.329 -0.396 . . . . 5.55 110.334 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.95 120.74 6.95 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.756 -0.735 . . . . 5.22 111.567 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 146.66 -122.67 1.65 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.664 -0.779 . . . . 5.91 111.963 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 119.02 -0.514 . . . . 7.27 111.163 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.649 1 C4'-C3'-C2' 97.108 -5.592 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.548 2 N19-C1'-C2' 103.556 -6.153 . 0.232 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.725 3 O4'-C1'-N19 115.758 7.558 . 0.526 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.265 4 O4'-C1'-N19 116.758 8.558 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.117 2 C4'-C3'-C2' 97.509 -5.191 . 0.655 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.711 4 C4'-C3'-C2' 98.261 -4.439 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.316 3 P-O3'-C3' 127.061 6.134 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.914 " H5'" HG22 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.581 5.308 3 O4'-C4'-C3' 114.89 6.707 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.106 2 O4'-C1'-N19 118.645 10.445 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.555 3 O3'-P-O5' 116.363 6.507 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.07 1 C4'-C3'-C2' 98.309 -4.391 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.536 1 C4'-C3'-C2' 94.402 -8.298 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.78 1 O3'-P-O5' 111.775 4.092 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.134 2 C3'-C2'-C1' 105.641 4.601 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 112.174 -0.37 . . . . 9.05 112.174 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.97 110.84 5.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.724 0.297 . . . . 8.09 110.306 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.9 mtm -94.05 84.47 4.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.153 0.502 . . . . 8.02 110.986 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.99 78.7 1.52 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.769 -0.651 . . . . 5.76 111.953 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.6 mt -77.36 138.94 63.74 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.764 0.316 . . . . 4.72 110.866 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.7 -12.25 20.18 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.656 2.237 . . . . 4.45 111.386 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -77.89 109.06 11.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.914 -0.585 . . . . 4.41 110.777 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -98.43 -61.03 1.43 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.358 -0.608 . . . . 3.92 109.358 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p 49.82 65.28 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.788 1.032 . . . . 2.53 113.788 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.99 134.78 41.4 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.72 -0.474 . . . . 2.48 109.72 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 m -56.57 144.22 32.61 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.252 0.464 . . . . 2.13 112.252 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.424 ' NE1' HG22 ' A' ' 106' ' ' ILE . 26.5 m95 -69.58 -30.48 68.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.586 -0.734 . . . . 2.4 112.761 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 93.4 m-85 -108.92 167.26 10.21 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 111.783 0.29 . . . . 2.02 111.783 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 p -73.19 165.99 23.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.024 -0.535 . . . . 2.65 111.339 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.59 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -78.82 140.71 38.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.275 0.843 . . . . 2.4 113.275 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 67' ' ' ARG . 40.6 mt -91.43 127.38 36.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.231 -1.026 . . . . 2.27 108.231 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 m -106.25 133.04 51.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.876 0.369 . . . . 2.84 111.692 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 20' ' ' GLY . 3.6 tp-100 -96.18 144.08 26.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.716 -0.674 . . . . 2.89 109.292 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -125.69 47.27 2.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 3.82 110.693 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.465 ' H ' ' HG3' ' A' ' 18' ' ' GLN . . . -162.8 -169.33 26.05 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.072 -0.585 . . . . 3.23 111.933 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -81.42 -28.96 34.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.753 0.311 . . . . 4.27 110.555 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -70.15 173.84 6.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.558 -0.746 . . . . 3.32 111.498 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.17 -156.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.375 -0.602 . . . . 2.39 109.375 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 35.8 tp -102.62 124.57 48.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.805 0.336 . . . . 2.06 111.408 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 40.8 tptt -151.5 116.88 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 2.22 110.064 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 47.7 m-85 -105.33 149.62 37.96 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 1.78 110.557 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 11.4 Cg_exo -72.45 173.31 13.4 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.066 2.51 . . . . 2.15 112.144 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -69.73 125.63 27.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.834 -0.621 . . . . 2.6 111.438 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 23.77 50.89 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.07 -0.586 . . . . 1.65 112.451 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.79 166.33 33.82 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.77 0.319 . . . . 2.31 110.188 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.36 2.86 50.83 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.895 -0.669 . . . . 1.33 113.156 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.1 t -95.16 121.04 63.2 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 110.203 -0.295 . . . . 1.06 110.203 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.03 178.88 5.41 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.707 2.271 . . . . 1.27 112.033 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.1 mt -76.06 86.78 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.293 0.568 . . . . 1.7 110.607 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -88.94 79.91 7.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.821 -0.627 . . . . 1.23 110.523 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -17.06 56.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.968 -0.56 . . . . 1.94 110.82 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -74.79 -21.82 59.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.9 -0.591 . . . . 1.96 111.235 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.71 173.77 6.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.42 111.747 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.618 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 21.9 m -90.61 166.19 20.25 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.066 -0.516 . . . . 1.73 109.998 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.5 Cg_endo -51.92 -38.28 68.35 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.163 2.576 . . . . 1.42 113.763 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -72.71 -19.14 61.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.711 0.263 . . . . 1.78 111.711 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.86 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.0 m-20 -88.17 4.1 46.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.439 -0.346 . . . . 1.6 110.969 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -80.38 51.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.176 0.512 . . . . 1.05 111.246 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.763 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -148.36 132.9 9.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.065 -0.516 . . . . 1.17 110.033 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.95 -146.34 5.27 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.192 -1.004 . . . . 0.6 112.632 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -156.15 162.23 40.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.587 0.232 . . . . 0.99 110.468 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.452 ' HB2' HG13 ' A' ' 91' ' ' ILE . 61.8 m-85 -104.04 136.46 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.425 -0.583 . . . . 1.26 109.425 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -111.94 125.78 54.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 2.15 111.0 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.5 ttt-85 -78.28 131.76 37.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.247 -0.433 . . . . 2.4 109.888 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.82 138.08 28.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.1 0.476 . . . . 2.21 111.601 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.29 96.19 3.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.541 -0.754 . . . . 2.68 110.489 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HB3' HD12 ' A' ' 64' ' ' LEU . 22.6 tpt180 -68.5 120.92 15.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.212 0.529 . . . . 3.59 111.001 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.448 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 7.2 ttm180 -139.45 110.44 6.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.888 -0.596 . . . . 3.43 111.039 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.47 168.07 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.035 -0.53 . . . . 4.26 110.816 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.57 118.42 32.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.666 0.27 . . . . 5.17 111.298 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.19 156.99 20.93 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.922 -0.656 . . . . 4.66 112.086 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.1 -31.8 72.43 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.399 -0.429 . . . . 5.04 112.608 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.32 -10.39 59.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.261 0.553 . . . . 5.51 110.248 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.61 -4.08 46.63 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.593 -1.003 . . . . 4.73 110.593 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -70.34 148.25 48.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.128 -0.536 . . . . 5.52 110.304 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.448 ' SD ' ' HD3' ' A' ' 53' ' ' ARG . 64.4 mtt -143.12 136.98 28.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.031 -0.531 . . . . 4.48 109.989 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -59.12 -48.87 80.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.3 -0.63 . . . . 4.16 109.3 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.9 t70 55.41 97.06 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 114.333 1.234 . . . . 4.09 114.333 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' A' ' 52' ' ' ARG . 38.5 mt -88.61 153.65 20.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.219 -0.446 . . . . 3.36 110.221 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -73.54 159.71 83.99 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.21 -0.45 . . . . 3.36 110.892 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.08 110.17 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.858 2.372 . . . . 2.69 112.134 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 28.7 mtt-85 -120.44 148.63 43.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.728 -0.669 . . . . 3.03 111.494 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.426 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 56.4 m95 -121.53 137.46 54.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.072 -0.513 . . . . 1.84 110.49 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.475 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.8 m-85 -112.54 148.56 34.24 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.427 -0.583 . . . . 2.76 109.427 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -94.73 123.01 37.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.991 0.424 . . . . 1.27 111.642 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.446 ' HD2' HG21 ' A' ' 75' ' ' THR . 9.3 m-85 -119.13 162.78 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.759 -0.655 . . . . 1.84 109.791 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -102.21 155.77 18.0 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.596 -0.274 . . . . 1.28 110.644 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.4 tt -60.9 115.67 3.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.876 0.37 . . . . 1.66 111.322 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.0 -3.26 38.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.841 -0.695 . . . . 1.66 114.53 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.446 HG21 ' HD2' ' A' ' 71' ' ' TYR . 5.6 p -56.48 119.9 6.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 117.599 0.699 . . . . 1.58 111.375 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 102.95 112.42 3.67 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.928 -0.654 . . . . 1.96 111.601 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 13.7 Cg_endo -58.06 -36.05 98.28 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 122.738 2.292 . . . . 2.62 112.389 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -110.02 28.44 8.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 3.09 111.281 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -55.64 4.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.153 -0.476 . . . . 1.79 110.43 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.73 48.5 49.11 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.973 -0.851 . . . . 1.65 110.973 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.532 HD21 ' HE3' ' A' ' 87' ' ' LYS . 32.7 mt -116.5 94.46 43.18 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 112.192 0.441 . . . . 1.38 112.192 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 87.4 Cg_endo -87.01 158.7 8.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.689 2.259 . . . . 1.62 110.389 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.599 ' HB2' HD11 ' A' ' 73' ' ' LEU . 48.4 t80 -58.86 115.17 2.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 1.58 111.112 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 115.76 -11.1 18.45 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.737 -0.744 . . . . 1.44 112.66 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.529 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -66.87 130.62 43.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 1.25 110.83 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -95.09 132.65 39.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.247 -0.433 . . . . 1.86 111.053 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.532 ' HE3' HD21 ' A' ' 81' ' ' LEU . 13.1 ttmm -158.38 152.94 24.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.152 -0.685 . . . . 1.68 109.152 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.74 112.53 3.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.873 0.368 . . . . 1.7 111.606 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.97 28.71 27.86 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.27 112.602 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 87' ' ' LYS . 29.6 mm -132.78 106.81 11.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.727 0.299 . . . . 1.01 110.803 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 47' ' ' TYR . 3.7 pt -118.7 127.02 75.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.995 -0.372 . . . . 1.3 109.995 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.412 ' CZ3' ' HG ' ' A' ' 73' ' ' LEU . 92.1 m95 -85.53 139.52 31.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.966 0.728 . . . . 1.08 112.966 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 m -136.22 140.55 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.19 -0.914 . . . . 1.04 110.034 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.79 159.28 44.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.152 -0.476 . . . . 1.27 110.168 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.3 t -135.52 172.41 13.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 1.36 109.828 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.22 126.31 27.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.371 -0.377 . . . . 2.64 110.76 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.69 -10.5 38.32 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.938 -0.649 . . . . 1.52 112.195 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.763 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.68 132.19 35.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.645 0.259 . . . . 1.59 111.342 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 59.0 mt -92.27 139.77 30.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.248 -0.433 . . . . 2.15 111.201 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -85.84 85.3 7.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.957 -0.565 . . . . 2.07 111.231 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.631 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 9.7 t -167.72 140.29 2.64 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.049 -0.723 . . . . 2.36 109.049 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.19 133.36 52.17 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.917 2.411 . . . . 2.08 113.038 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.33 67.53 1.32 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.844 -0.616 . . . . 1.78 110.968 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.3 6.97 7.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 2.55 112.48 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -59.78 -22.75 62.57 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.019 0.377 . . . . 2.24 112.019 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.424 HG22 ' NE1' ' A' ' 12' ' ' TRP . 3.5 mt -88.92 -18.27 7.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.258 0.552 . . . . 2.0 109.905 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.88 70.56 3.16 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.308 -0.717 . . . . 2.33 111.308 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.9 t -149.33 19.67 0.95 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.677 0.751 . . . . 2.99 109.411 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.1 ttp85 -77.88 135.76 37.95 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.65 -0.704 . . . . 2.83 111.404 -178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 113' ' ' ASN . 45.4 t-20 -111.95 118.81 45.7 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.239 -0.652 . . . . 3.56 109.239 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.15 -23.69 74.53 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.061 2.508 . . . . 3.39 113.206 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.46 -1.66 57.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 4.05 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 110' ' ' ASN . 40.6 m-20 -132.08 14.62 4.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.397 -0.365 . . . . 4.48 110.951 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -177.97 135.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.898 -0.592 . . . . 3.39 110.398 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.1 144.15 25.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.507 -0.553 . . . . 3.21 109.507 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.421 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -69.74 144.74 52.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.723 0.297 . . . . 2.85 111.205 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 21.5 mt -86.21 140.81 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.779 -0.646 . . . . 2.42 109.475 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -62.05 128.12 23.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.879 -0.415 . . . . 2.74 109.879 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.457 HD13 ' HG ' ' A' ' 16' ' ' LEU . 2.0 tt -60.45 110.8 1.36 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.248 0.547 . . . . 2.11 111.623 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -116.29 134.07 55.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.621 -0.718 . . . . 2.49 110.039 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.522 HD13 HG22 ' A' ' 125' ' ' THR . 29.7 mt -98.9 145.48 30.04 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.424 -0.353 . . . . 1.91 110.556 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.9 155.29 71.4 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.441 2.094 . . . . 1.84 111.942 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -61.62 111.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.0 -0.545 . . . . 2.53 110.693 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.98 -17.42 8.1 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.126 -1.19 . . . . 2.2 110.126 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.522 HG22 HD13 ' A' ' 121' ' ' LEU . 89.7 m -108.86 112.81 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.102 -0.703 . . . . 2.1 109.102 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.23 150.09 31.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.873 0.368 . . . . 2.78 111.358 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.464 ' HG ' ' CD1' ' A' ' 121' ' ' LEU . 18.5 mt -78.14 147.08 72.44 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 2.62 110.28 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.53 153.69 69.62 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.757 2.305 . . . . 2.77 110.862 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -59.44 122.21 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 4.11 111.295 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.77 -9.85 40.85 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.014 -0.613 . . . . 3.18 112.255 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -102.84 134.65 45.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.766 0.317 . . . . 2.91 111.751 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -146.26 143.41 29.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.861 -0.609 . . . . 3.54 110.49 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.95 134.87 34.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.781 0.325 . . . . 2.93 110.662 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.67 123.74 19.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.05 -0.523 . . . . 3.64 110.529 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.81 -12.77 46.07 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.012 -0.613 . . . . 3.27 112.234 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.3 m -85.62 111.17 19.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.639 0.257 . . . . 3.59 111.194 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -100.69 111.4 23.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.344 -0.389 . . . . 5.55 109.984 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.66 150.05 51.7 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.806 -0.634 . . . . 5.22 112.761 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.92 -122.81 7.73 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.873 -0.68 . . . . 5.91 111.771 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 119.04 -0.505 . . . . 7.27 111.24 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.401 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.491 -3.677 1 C4'-C3'-C2' 97.077 -5.623 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.401 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.539 2 N19-C1'-C2' 103.497 -6.189 . 0.23 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.777 3 O4'-C1'-N19 115.778 7.578 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.144 4 O4'-C1'-N19 116.713 8.513 . 0.508 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.376 -4.013 2 C4'-C3'-C2' 97.596 -5.104 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.799 4 C4'-C3'-C2' 98.255 -4.445 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.499 5.435 3 P-O3'-C3' 127.106 6.172 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.421 " H4'" ' HB3' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.345 3 O4'-C4'-C3' 114.957 6.755 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -4.995 2 O4'-C1'-N19 118.626 10.426 . 0.417 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.589 3 O3'-P-O5' 116.345 6.498 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.14 1 C4'-C3'-C2' 98.257 -4.443 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.556 1 C4'-C3'-C2' 94.305 -8.395 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.719 1 O3'-P-O5' 111.761 4.085 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.963 2 C3'-C2'-C1' 105.649 4.61 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 112.303 -0.319 . . . . 9.05 112.303 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.14 136.84 34.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.163 -0.31 . . . . 8.09 110.163 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.2 tpt -120.99 131.7 54.47 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.18 0.514 . . . . 8.02 111.226 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.82 145.4 13.71 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.841 -0.695 . . . . 5.76 111.764 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.91 105.78 46.82 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.048 -0.352 . . . . 4.72 110.048 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.91 36.66 0.62 Allowed 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.213 2.609 . . . . 4.45 111.983 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -86.86 135.63 33.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.914 -0.585 . . . . 4.41 110.464 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -111.57 -82.7 0.58 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.349 -0.387 . . . . 3.92 110.579 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p 51.39 76.46 0.16 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.241 0.543 . . . . 2.53 112.403 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.89 150.84 21.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.879 -0.6 . . . . 2.48 111.374 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -79.26 167.41 20.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.879 -0.6 . . . . 2.13 110.821 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.556 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 31.3 m95 -92.91 -45.57 7.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 2.4 111.15 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 29.9 m-85 -88.66 159.74 17.7 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.866 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 p -66.92 157.41 33.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.699 -0.682 . . . . 2.65 110.797 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -74.81 139.99 43.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.928 0.394 . . . . 2.4 111.321 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 95.6 mt -93.16 138.59 31.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.92 -0.582 . . . . 2.27 109.787 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -109.78 124.89 52.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.06 0.457 . . . . 2.84 111.897 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -97.39 124.3 41.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.623 -0.717 . . . . 2.89 110.095 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.472 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 35.5 t60 -116.82 92.61 3.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.115 -0.493 . . . . 3.82 110.104 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.77 -166.16 38.73 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.469 -0.872 . . . . 3.23 112.093 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 45.1 mmtt -87.98 -22.2 24.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 4.27 111.211 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -87.79 171.25 10.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.137 -0.483 . . . . 3.32 110.652 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' OD2' ' HZ2' ' A' ' 68' ' ' TRP . 13.3 t0 -102.63 -90.51 0.36 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.472 -0.331 . . . . 2.39 110.795 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 31.2 tp -169.27 129.64 1.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.766 0.317 . . . . 2.06 110.841 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -150.89 133.08 15.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.253 -0.43 . . . . 2.22 110.508 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -118.75 134.13 23.57 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.102 -0.499 . . . . 1.78 110.184 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.62 176.05 8.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.024 2.483 . . . . 2.15 112.56 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -58.92 126.87 29.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.747 -0.661 . . . . 2.6 112.102 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.17 20.63 75.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.182 -0.533 . . . . 1.65 113.339 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -141.52 153.32 44.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.065 -0.346 . . . . 2.31 110.065 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.5 -13.51 9.41 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.459 -0.877 . . . . 1.33 112.092 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.5 t -95.66 111.55 56.06 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.761 0.315 . . . . 1.06 110.37 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -73.25 -166.91 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.743 2.295 . . . . 1.27 111.648 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.5 mt -79.66 88.4 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.166 0.508 . . . . 1.7 111.436 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.483 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . 31.3 t30 -98.55 91.89 5.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.214 0.531 . . . . 1.23 109.655 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.15 2.67 55.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.84 0.682 . . . . 1.94 112.84 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -100.87 21.32 13.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.186 0.517 . . . . 1.96 111.274 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.418 ' OG ' HG21 ' A' ' 106' ' ' ILE . 3.7 m -148.84 174.77 11.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.841 -0.618 . . . . 1.42 110.075 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.578 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 17.6 m -84.36 166.09 34.77 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 109.885 -0.413 . . . . 1.73 109.885 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 18.8 Cg_endo -59.03 -22.54 64.25 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.663 2.242 . . . . 1.42 113.321 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.712 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 1.5 p-10 -89.53 -10.68 45.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.312 . . . . 1.78 111.709 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.727 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 23.6 m-20 -85.87 -0.93 56.66 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.6 110.144 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.54 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.7 mm-40 -79.09 59.2 2.65 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.987 -0.551 . . . . 1.05 111.419 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.865 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.7 tt -151.89 133.5 5.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 1.17 110.092 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.97 -142.45 4.41 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.03 -1.081 . . . . 0.6 112.637 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -160.17 159.24 31.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.006 0.432 . . . . 0.99 110.527 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.692 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 5.1 m-85 -99.8 135.7 40.83 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.434 -0.58 . . . . 1.26 109.434 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -111.73 128.22 56.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.323 -0.399 . . . . 2.15 111.061 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -84.5 128.41 34.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.949 -0.569 . . . . 2.4 109.726 179.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.79 157.86 44.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.02 0.438 . . . . 2.21 111.498 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -148.47 125.75 11.53 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.214 -0.661 . . . . 2.68 109.214 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -112.25 134.84 53.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.899 0.381 . . . . 3.59 111.154 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 28.4 ttm180 -149.32 121.36 8.26 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.501 -0.318 . . . . 3.43 110.833 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.8 pt -92.7 136.27 25.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.789 -0.449 . . . . 4.26 109.789 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.72 113.61 27.31 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.26 -0.427 . . . . 5.17 110.699 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.0 151.03 40.07 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.541 -0.838 . . . . 4.66 111.326 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.47 -28.34 69.38 Favored Glycine 0 N--CA 1.454 -0.126 0 C-N-CA 121.253 -0.498 . . . . 5.04 112.003 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.09 -31.55 69.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.159 0.505 . . . . 5.51 110.556 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.05 10.51 6.77 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.633 -0.794 . . . . 4.73 111.899 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -86.47 135.67 33.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.887 0.375 . . . . 5.52 110.834 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.402 ' SD ' ' HD3' ' A' ' 53' ' ' ARG . 17.1 mmt -114.76 115.31 26.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.19 -0.671 . . . . 4.48 109.19 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HG2' ' H41' ' B' ' 1' ' ' ' C' . 77.2 tttt -54.62 -51.69 64.58 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.078 -0.341 . . . . 4.16 110.078 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.9 t70 63.9 115.22 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.767 1.025 . . . . 4.09 113.767 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.497 HD23 ' H5 ' ' B' ' 1' ' ' ' C' . 27.1 mt -109.84 -179.13 3.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.855 -0.612 . . . . 3.36 110.639 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -102.83 155.44 36.56 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.079 -0.51 . . . . 3.36 110.224 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.3 109.91 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.518 2.145 . . . . 2.69 111.526 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.597 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 59.4 mtt180 -113.0 145.95 39.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.105 0.479 . . . . 3.03 112.055 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.692 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.2 m95 -113.36 132.72 55.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.64 -0.709 . . . . 1.84 110.508 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.623 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 44.8 m-85 -110.4 141.57 43.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.589 . . . . 2.76 109.929 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -91.77 116.01 28.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.864 0.364 . . . . 1.27 111.49 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -115.6 156.6 25.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.034 -0.53 . . . . 1.84 110.162 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -96.52 162.55 13.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.459 -0.337 . . . . 1.28 110.635 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.9 OUTLIER -64.13 117.27 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.428 -0.351 . . . . 1.66 110.803 -179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.97 7.81 37.7 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.806 -0.712 . . . . 1.66 113.679 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -70.11 120.83 16.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 1.58 111.496 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 111.44 122.82 4.27 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.14 -0.784 . . . . 1.96 111.14 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 9.7 Cg_endo -53.03 -56.64 2.6 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 123.07 2.514 . . . . 2.62 112.7 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -108.16 42.66 1.33 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 3.09 110.912 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.89 -54.1 14.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.091 -0.504 . . . . 1.79 110.014 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.62 38.51 96.53 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.649 -0.705 . . . . 1.65 112.223 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.48 101.93 48.36 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.751 0.31 . . . . 1.38 111.047 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.05 159.95 18.16 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.707 2.271 . . . . 1.62 111.258 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.623 ' HB2' HD11 ' A' ' 73' ' ' LEU . 51.2 t80 -56.74 113.46 1.65 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.421 -0.354 . . . . 1.58 110.688 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.67 -12.09 13.65 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.653 -0.784 . . . . 1.44 112.939 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.05 114.1 5.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.378 . . . . 1.25 110.914 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -74.85 120.93 21.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.064 -0.516 . . . . 1.86 111.396 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -143.84 151.71 40.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.892 -0.594 . . . . 1.68 110.041 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.37 115.52 4.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.89 0.376 . . . . 1.7 111.733 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.1 26.43 60.01 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.881 -0.676 . . . . 1.27 112.665 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -130.0 103.17 8.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.944 0.402 . . . . 1.01 110.6 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 47' ' ' TYR . 21.0 pt -111.52 119.91 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.283 -0.417 . . . . 1.3 110.675 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -79.44 137.53 37.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.08 -0.509 . . . . 1.08 111.55 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.62 143.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.957 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.2 165.6 32.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.13 -0.487 . . . . 1.27 110.003 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.2 t -134.82 -177.47 4.64 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.258 -0.428 . . . . 1.36 109.985 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -69.58 120.1 14.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.167 0.508 . . . . 2.64 110.938 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.02 -9.15 39.47 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.05 -0.595 . . . . 1.52 111.795 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.865 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.17 121.84 20.91 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.747 0.308 . . . . 1.59 110.387 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.712 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 53.8 mt -89.39 146.38 24.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 2.15 109.982 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -79.73 69.03 5.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.227 0.536 . . . . 2.07 109.874 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 1.4 m -135.34 136.28 24.06 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.589 -0.732 . . . . 2.36 109.792 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 5.2 Cg_exo -81.2 119.21 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.926 2.417 . . . . 2.08 110.855 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.81 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -135.73 102.9 5.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.559 . . . . 1.78 111.143 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.13 4.1 53.06 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.968 -0.56 . . . . 2.55 111.924 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.81 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 12.3 p80 -57.75 -24.3 56.38 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.058 0.456 . . . . 2.24 112.102 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.418 HG21 ' OG ' ' A' ' 38' ' ' SER . 1.2 pt -105.36 5.33 10.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.178 -0.465 . . . . 2.0 111.129 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.61 46.77 1.11 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.634 -0.793 . . . . 2.33 111.64 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -146.56 28.62 1.06 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.315 0.579 . . . . 2.99 110.748 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 38.3 ttp85 -69.24 141.2 54.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 2.83 111.27 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -94.92 113.0 60.27 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.065 -0.516 . . . . 3.56 109.731 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 73.6 Cg_endo -74.35 -12.99 23.06 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.045 2.497 . . . . 3.39 114.246 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.1 -15.22 44.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.102 0.477 . . . . 4.05 110.884 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -110.39 -9.32 14.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.847 -0.615 . . . . 4.48 111.546 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -153.01 138.67 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.718 0.294 . . . . 3.39 110.709 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.56 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.057 -0.519 . . . . 3.21 111.583 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.87 149.89 49.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.988 -0.551 . . . . 2.85 111.444 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.3 mt -91.02 138.62 19.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.807 -0.633 . . . . 2.42 110.258 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.23 119.07 12.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.377 -0.601 . . . . 2.74 109.377 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.436 HD22 HD21 ' A' ' 16' ' ' LEU . 1.4 tt -61.0 128.3 35.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.032 -0.531 . . . . 2.11 110.82 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -132.57 142.96 49.39 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.84 -0.618 . . . . 2.49 110.429 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.497 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 26.3 mt -105.62 145.69 31.35 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.075 -0.511 . . . . 1.91 110.19 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 36.9 Cg_exo -61.78 167.27 10.48 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.991 2.461 . . . . 1.84 112.48 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -63.73 121.64 14.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 2.53 110.845 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.48 -18.91 34.79 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.699 -0.762 . . . . 2.2 111.934 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 1.9 m -94.25 99.16 11.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.099 0.476 . . . . 2.1 110.234 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.11 156.22 16.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.997 -0.547 . . . . 2.78 111.24 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.5 mt -93.84 146.17 31.22 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.037 -0.529 . . . . 2.62 109.755 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.0 152.67 73.86 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.608 2.206 . . . . 2.77 111.889 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.97 120.49 11.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 4.11 110.684 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 19' ' ' HIS . . . 109.26 -8.15 32.86 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.724 -0.751 . . . . 3.18 111.55 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 2.7 t80 -94.15 132.08 39.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.189 -0.3 . . . . 2.91 110.189 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.472 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 41.3 p90 -134.65 146.84 49.9 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.865 0.365 . . . . 3.54 111.462 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -115.29 148.63 38.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.812 -0.631 . . . . 2.93 110.597 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.21 122.72 28.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.125 -0.489 . . . . 3.64 109.838 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.12 -20.19 14.47 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.941 -0.647 . . . . 3.27 111.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.3 m -75.22 89.26 2.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.86 0.362 . . . . 3.59 110.615 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -118.62 81.5 1.7 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 5.55 110.146 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.53 144.84 18.58 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.903 -0.665 . . . . 5.22 111.828 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.6 -80.07 1.83 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.855 -0.688 . . . . 5.91 112.306 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.969 -0.539 . . . . 7.27 111.295 -179.878 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.611 ' H41' ' HG2' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.605 1 C4'-C3'-C2' 97.044 -5.656 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.4 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.548 2 N19-C1'-C2' 103.537 -6.165 . 0.23 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.81 3 O4'-C1'-N19 115.647 7.447 . 0.527 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.268 4 O4'-C1'-N19 116.661 8.461 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.144 2 C4'-C3'-C2' 97.575 -5.125 . 0.652 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.699 4 N19-C1'-C2' 106.33 -4.419 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.314 3 P-O3'-C3' 127.063 6.136 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.623 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.582 5.353 3 O4'-C4'-C3' 114.962 6.759 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.541 -5.161 2 O4'-C1'-N19 118.644 10.444 . 0.418 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.523 3 O3'-P-O5' 116.341 6.495 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.237 1 C4'-C3'-C2' 98.248 -4.452 . 0.311 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.533 1 C4'-C3'-C2' 94.373 -8.327 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.466 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.587 5.77 1 O3'-P-O5' 111.738 4.073 . 0.104 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . 0.451 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.578 5.017 2 C3'-C2'-C1' 105.716 4.685 . 0.338 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.509 -0.636 . . . . 9.05 111.509 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.63 153.67 26.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.623 0.249 . . . . 8.09 110.832 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.4 ttm -148.47 129.96 14.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.14 -0.482 . . . . 8.02 110.208 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.85 160.89 27.64 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.619 -0.592 . . . . 5.76 111.619 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 64.5 mt -104.88 147.38 34.37 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.778 -0.453 . . . . 4.72 109.778 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 3.1 Cg_exo -78.64 31.28 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.285 2.657 . . . . 4.45 111.843 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -109.72 176.86 4.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.144 -0.48 . . . . 4.41 109.927 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -80.06 -80.74 0.13 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.713 -0.221 . . . . 3.92 110.936 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 21.4 p 48.66 79.76 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.712 0.634 . . . . 2.53 112.712 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.38 145.62 29.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 2.48 111.403 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 m -71.33 152.76 42.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 2.13 110.653 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -86.58 -27.94 23.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.794 0.331 . . . . 2.4 111.199 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -111.92 164.04 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.327 -0.397 . . . . 2.02 111.945 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.627 HG22 " H5'" ' C' ' 8' ' ' ' G' . 1.5 p -63.22 166.01 6.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.659 -0.7 . . . . 2.65 111.779 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -89.0 150.4 22.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.226 -0.443 . . . . 2.4 111.408 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.561 HD21 HD22 ' A' ' 119' ' ' LEU . 96.9 mt -101.21 136.42 41.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 2.27 110.305 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.496 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 13.4 m -106.65 132.77 52.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.756 0.312 . . . . 2.84 111.397 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -99.79 133.42 44.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.916 -0.584 . . . . 2.89 110.761 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -127.68 82.74 2.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.702 -0.481 . . . . 3.82 109.702 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.82 -160.9 26.34 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.444 -0.663 . . . . 3.23 111.444 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -99.34 9.51 43.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.0 0.429 . . . . 4.27 111.122 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -112.99 -173.88 2.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.816 -0.629 . . . . 3.32 110.297 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -118.25 -73.69 0.63 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.367 -0.379 . . . . 2.39 109.981 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' CE1' ' A' ' 131' ' ' PHE . 32.0 tp 178.32 125.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.587 0.554 . . . . 2.06 110.382 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -146.58 121.58 10.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.496 . . . . 2.22 110.792 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.447 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 26.2 m-85 -108.45 154.45 41.49 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.813 -0.631 . . . . 1.78 109.896 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.796 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 58.4 Cg_endo -73.08 -163.16 0.15 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.761 2.307 . . . . 2.15 113.076 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -86.01 125.45 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.213 -0.449 . . . . 2.6 111.678 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 94' ' ' ALA . . . 70.3 18.96 75.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.87 -0.604 . . . . 1.65 113.19 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.796 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.3 tm0? -142.16 132.98 25.66 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.766 -0.457 . . . . 2.31 109.766 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.04 -9.12 2.49 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.413 -0.899 . . . . 1.33 112.334 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -89.06 124.24 65.45 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.215 -0.291 . . . . 1.06 110.215 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.48 179.43 4.09 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.482 2.122 . . . . 1.27 112.204 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.5 mt -75.51 88.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 1.7 110.602 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -85.34 80.18 9.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.119 0.485 . . . . 1.23 110.545 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -21.18 66.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.732 -0.667 . . . . 1.94 111.872 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -89.05 3.7 50.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.418 -0.355 . . . . 1.96 111.679 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 m -128.45 162.27 27.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.734 0.302 . . . . 1.42 111.417 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.426 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -83.59 165.71 38.45 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 1.73 109.963 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 19.8 Cg_endo -59.44 -25.8 79.79 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.539 2.159 . . . . 1.42 111.958 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -89.16 -1.51 58.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 1.78 111.382 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -98.39 -1.38 41.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 1.6 110.243 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -77.49 60.5 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.937 -0.574 . . . . 1.05 111.552 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.71 121.11 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.896 -0.593 . . . . 1.17 109.953 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.1 -145.93 4.81 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.495 -0.86 . . . . 0.6 112.802 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -157.55 164.82 36.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.043 0.449 . . . . 0.99 111.106 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.702 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.9 m-85 -108.31 137.28 46.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.46 -0.791 . . . . 1.26 109.518 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -118.16 130.65 56.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.384 -0.371 . . . . 2.15 110.981 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -86.8 116.34 24.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.184 -0.462 . . . . 2.4 110.266 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.78 148.31 44.82 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.263 -0.426 . . . . 2.21 110.647 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -132.88 109.38 9.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.21 -0.45 . . . . 2.68 110.682 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.604 ' HB3' HD12 ' A' ' 64' ' ' LEU . 20.9 tpt180 -86.37 113.74 22.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.948 0.404 . . . . 3.59 110.874 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -138.63 91.24 2.52 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 3.43 110.934 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.448 ' O ' ' HG2' ' A' ' 61' ' ' MET . 28.9 pt -70.46 146.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.169 -0.469 . . . . 4.26 111.01 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -106.7 103.37 12.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 5.17 110.492 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.651 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -75.33 160.43 52.28 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.125 -0.56 . . . . 4.66 112.907 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.37 -23.19 71.67 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.58 -0.343 . . . . 5.04 113.489 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -92.77 14.29 17.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.177 0.513 . . . . 5.51 110.868 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.36 35.55 63.45 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.96 -0.638 . . . . 4.73 111.562 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -113.67 158.88 20.3 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.022 -0.362 . . . . 5.52 110.022 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 76.5 mtm -139.77 143.41 36.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.259 -0.428 . . . . 4.48 110.251 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -67.8 -29.29 68.43 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.847 -0.797 . . . . 4.16 108.847 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t0 52.39 88.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.02 1.118 . . . . 4.09 114.02 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.604 HD12 ' HB3' ' A' ' 52' ' ' ARG . 88.5 mt -106.07 140.25 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.015 -0.539 . . . . 3.36 110.064 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.46 ' O ' ' HD2' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -65.92 150.61 96.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.042 -0.526 . . . . 3.36 110.896 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.59 120.04 7.66 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.57 2.18 . . . . 2.69 111.438 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.491 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -110.75 144.85 39.08 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.691 -0.686 . . . . 3.03 111.198 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.702 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 65.9 m95 -104.67 124.87 50.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.804 -0.634 . . . . 1.84 110.895 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -107.41 143.49 35.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.701 -0.682 . . . . 2.76 109.871 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -95.23 127.28 41.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.816 0.341 . . . . 1.27 110.917 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -129.31 153.52 47.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.08 -0.509 . . . . 1.84 110.128 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.478 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 86.9 m-85 -84.46 163.14 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.9 tt -59.67 122.89 15.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.695 0.283 . . . . 1.66 111.759 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 45.6 20.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.003 -0.618 . . . . 1.66 112.634 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.66 70.85 7.49 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.914 0.388 . . . . 1.58 111.486 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 77' ' ' PRO . . . 150.41 148.36 4.76 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.015 -0.612 . . . . 1.96 111.744 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 76' ' ' GLY . 29.3 Cg_exo -62.0 -47.2 11.06 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.79 2.326 . . . . 2.62 111.867 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.8 45.61 0.95 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.319 0.58 . . . . 3.09 111.257 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.0 -56.13 4.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.061 -0.518 . . . . 1.79 110.463 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.67 52.98 47.18 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.646 -0.582 . . . . 1.65 111.646 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' HB3' ' HZ2' ' A' ' 92' ' ' TRP . 57.9 mt -132.72 100.0 15.06 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 111.579 0.215 . . . . 1.38 111.579 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 74.0 Cg_endo -78.93 162.79 26.29 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.16 1.907 . . . . 1.62 110.257 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -61.99 104.69 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 1.58 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.43 10.22 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.591 -0.814 . . . . 1.44 112.233 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.643 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -59.13 114.64 2.71 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 120.74 0.305 . . . . 1.25 110.891 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -78.9 104.56 9.62 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.269 -0.423 . . . . 1.86 112.023 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HE3' HD21 ' A' ' 81' ' ' LEU . 26.4 ttmt -126.15 150.88 47.96 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.692 -0.855 . . . . 1.68 108.692 178.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -63.44 118.33 7.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.939 0.399 . . . . 1.7 111.975 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.38 27.38 57.67 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.703 -0.68 . . . . 1.27 112.502 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.9 mm -130.8 118.14 40.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.723 0.297 . . . . 1.01 110.383 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.49 HG13 ' HB2' ' A' ' 47' ' ' TYR . 10.4 pt -121.78 122.74 67.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.389 -0.369 . . . . 1.3 110.222 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.565 ' HZ2' ' HB3' ' A' ' 81' ' ' LEU . 87.7 m95 -86.55 138.24 31.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.014 0.376 . . . . 1.08 112.014 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.61 142.54 26.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.728 -0.669 . . . . 1.04 110.612 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' O ' ' HA2' ' A' ' 29' ' ' GLY . . . -152.27 -177.78 6.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.037 -0.529 . . . . 1.27 109.605 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.6 t -148.74 169.7 19.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.32 -0.252 . . . . 1.36 110.32 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -63.6 128.16 34.59 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.385 -0.371 . . . . 2.64 111.076 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.98 -24.3 23.55 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.785 -0.721 . . . . 1.52 111.823 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.827 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.11 133.02 44.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 1.59 110.487 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 94.2 mt -94.45 133.77 37.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.314 -0.403 . . . . 2.15 110.849 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -75.98 96.57 3.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.173 0.511 . . . . 2.07 110.337 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.21 150.03 6.89 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.734 -0.666 . . . . 2.36 109.416 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.54 125.21 18.2 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.816 2.344 . . . . 2.08 112.534 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 72' ' ' TYR . 67.3 mmtt -113.21 34.64 4.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.587 -0.733 . . . . 1.78 109.744 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -57.6 -30.58 65.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.548 0.573 . . . . 2.55 112.548 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -64.28 -8.94 14.51 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.81 0.671 . . . . 2.24 112.81 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 103' ' ' LYS . 1.6 mt -109.11 0.58 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 2.0 109.822 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' THR . . . -93.05 -11.16 59.05 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.736 -0.745 . . . . 2.33 112.424 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.2 t -80.63 123.45 28.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.437 . . . . 2.99 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -164.37 146.15 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.98 -0.554 . . . . 2.83 109.806 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -107.42 106.93 59.62 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.84 0.352 . . . . 3.56 110.218 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.47 -21.4 26.13 Favored 'Trans proline' 0 CA--C 1.528 0.225 0 C-N-CA 122.862 2.375 . . . . 3.39 113.928 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.21 -14.04 59.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.104 0.409 . . . . 4.05 112.104 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -117.3 -18.51 9.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.201 -0.454 . . . . 4.48 111.408 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -140.72 131.2 25.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.835 0.35 . . . . 3.39 111.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.567 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -83.26 163.99 20.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.193 -0.458 . . . . 3.21 110.332 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.74 165.65 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.037 0.446 . . . . 2.85 111.003 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.6 mt -95.25 152.75 3.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.323 -0.621 . . . . 2.42 109.323 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.49 118.44 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 110.176 -0.305 . . . . 2.74 110.176 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.561 HD22 HD21 ' A' ' 16' ' ' LEU . 5.0 tt -63.13 114.31 3.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.278 0.561 . . . . 2.11 110.912 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -128.81 144.13 51.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.591 -0.731 . . . . 2.49 110.324 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 82.3 mt -95.02 148.17 34.25 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.088 -0.505 . . . . 1.91 110.216 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.23 159.74 45.59 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.576 2.184 . . . . 1.84 112.215 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -53.0 119.7 4.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.875 -0.602 . . . . 2.53 111.521 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.11 4.79 47.51 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.769 -0.729 . . . . 2.2 112.231 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.9 m -117.73 110.14 17.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.808 0.337 . . . . 2.1 110.227 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.34 137.7 40.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.159 -0.473 . . . . 2.78 111.42 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -70.61 140.92 87.22 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 116.199 -0.455 . . . . 2.62 109.825 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.74 148.97 62.49 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.963 2.442 . . . . 2.77 112.355 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.46 124.87 21.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 4.11 110.718 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.6 -12.55 39.11 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.315 -0.714 . . . . 3.18 111.315 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.52 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -105.42 152.09 23.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.816 0.341 . . . . 2.91 111.114 -179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.496 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 16.9 p90 -151.95 157.47 41.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.583 -0.735 . . . . 3.54 109.215 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -109.13 131.1 55.39 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.188 0.305 . . . . 2.93 111.158 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -66.97 125.49 26.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.443 -0.577 . . . . 3.64 109.443 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 108.8 -38.59 3.26 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.997 -0.841 . . . . 3.27 110.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.8 68.33 8.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.943 0.402 . . . . 3.59 110.596 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -106.75 -5.17 18.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.291 -0.413 . . . . 5.55 110.721 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 156.19 146.17 4.39 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.876 -0.678 . . . . 5.22 111.573 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.28 36.9 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.877 -0.678 . . . . 5.91 111.841 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.772 -0.632 . . . . 7.27 111.551 -179.736 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.491 -3.714 1 C4'-C3'-C2' 97.0 -5.7 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.473 4.608 2 N19-C1'-C2' 103.488 -6.195 . 0.235 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.809 3 O4'-C1'-N19 115.769 7.569 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.201 4 O4'-C1'-N19 116.692 8.492 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.156 2 C4'-C3'-C2' 97.542 -5.158 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.607 4 C1'-O4'-C4' 105.619 -4.424 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.499 5.396 3 P-O3'-C3' 127.073 6.144 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.627 " H5'" HG22 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.582 5.435 3 O4'-C4'-C3' 114.938 6.742 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.934 2 O4'-C1'-N19 118.65 10.45 . 0.415 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.576 3 O3'-P-O5' 116.388 6.52 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.125 1 C4'-C3'-C2' 98.29 -4.41 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.583 1 C4'-C3'-C2' 94.294 -8.406 . 0.451 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.651 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.588 5.809 1 O3'-P-O5' 111.76 4.084 . 0.106 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.926 2 C3'-C2'-C1' 105.772 4.747 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.976 0 N-CA-C 111.853 -0.499 . . . . 9.05 111.853 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.04 122.2 46.38 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.237 -0.283 . . . . 8.09 110.237 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 ttt -136.52 126.76 26.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.067 0.461 . . . . 8.02 111.715 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -122.18 158.08 16.88 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.233 -0.747 . . . . 5.76 111.233 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.5 OUTLIER -118.06 133.38 23.42 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.755 0.312 . . . . 4.72 110.711 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 2.7 Cg_exo -77.48 28.13 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.791 2.994 . . . . 4.45 113.641 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -108.11 133.96 51.66 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.52 -0.548 . . . . 4.41 109.52 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -79.87 -88.59 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.292 -0.413 . . . . 3.92 111.355 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m 65.15 75.13 0.37 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.969 0.414 . . . . 2.53 111.341 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.01 140.57 43.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.104 -0.498 . . . . 2.48 110.687 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.41 153.77 42.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.944 -0.571 . . . . 2.13 110.971 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.443 ' HD1' ' HE1' ' A' ' 72' ' ' TYR . 76.6 m95 -79.51 -18.82 51.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.053 0.454 . . . . 2.4 111.112 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 119' ' ' LEU . 80.2 m-85 -110.19 161.08 15.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.127 -0.488 . . . . 2.02 112.016 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 p -67.51 167.56 12.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.788 -0.642 . . . . 2.65 111.268 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -79.65 152.82 29.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.096 0.474 . . . . 2.4 111.408 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 76.8 mt -108.65 129.91 55.33 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.072 -0.714 . . . . 2.27 109.072 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.442 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.1 OUTLIER -103.3 144.67 31.04 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 112.422 0.527 . . . . 2.84 112.422 -178.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 5.0 tp-100 -112.21 134.72 53.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.681 -0.691 . . . . 2.89 110.158 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.0 t60 -125.85 69.36 1.19 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.057 -0.52 . . . . 3.82 109.826 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -172.76 -165.74 30.24 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.999 -0.62 . . . . 3.23 111.737 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 65.3 mmtt -88.21 -30.02 20.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.914 0.388 . . . . 4.27 111.544 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -78.58 166.46 22.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 3.32 110.202 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 4.6 t0 -99.77 -90.05 0.32 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.014 -0.365 . . . . 2.39 110.014 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.475 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 34.2 tp -159.26 134.97 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 2.06 111.018 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -151.51 134.58 15.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.733 -0.667 . . . . 2.22 109.457 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -130.73 134.54 26.13 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.447 -0.342 . . . . 1.78 110.405 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.46 156.53 55.92 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.985 2.457 . . . . 2.15 111.351 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.86 118.14 5.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.372 -0.377 . . . . 2.6 111.363 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.98 -9.07 57.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.865 -0.683 . . . . 1.65 111.982 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -120.71 152.25 38.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.752 0.31 . . . . 2.31 110.448 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.84 -6.07 22.26 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.698 -0.763 . . . . 1.33 112.77 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 43' ' ' GLN . 38.7 t -90.38 116.52 66.57 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 120.592 0.234 . . . . 1.06 110.372 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.547 ' HA ' HD23 ' A' ' 121' ' ' LEU . 57.1 Cg_endo -71.23 177.16 6.9 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.633 2.222 . . . . 1.27 112.145 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.62 79.57 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.296 -0.411 . . . . 1.7 110.441 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB2' HE22 ' A' ' 43' ' ' GLN . 46.9 m-80 -76.77 84.71 3.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.923 0.392 . . . . 1.23 110.587 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -20.15 65.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 1.94 111.639 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -85.94 -11.92 51.83 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.199 -0.455 . . . . 1.96 111.553 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.48 ' HB2' HE22 ' A' ' 43' ' ' GLN . 0.7 OUTLIER -118.1 150.23 39.68 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.158 0.504 . . . . 1.42 112.03 -178.563 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.88 166.56 44.15 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.576 -0.738 . . . . 1.73 110.218 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.46 -40.06 79.89 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.947 2.431 . . . . 1.42 112.732 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -68.36 -24.84 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.977 0.418 . . . . 1.78 111.12 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.934 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 46.2 m-20 -84.82 1.53 46.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.802 -0.636 . . . . 1.6 111.829 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.48 HE22 ' HB2' ' A' ' 38' ' ' SER . 42.0 mm-40 -80.27 57.43 2.76 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.89 0.376 . . . . 1.05 111.222 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 tt -153.02 134.84 5.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 116.175 -0.466 . . . . 1.17 110.394 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.83 -147.24 6.46 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.386 -0.911 . . . . 0.6 112.718 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.423 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 52.5 p90 -151.58 163.44 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.023 0.44 . . . . 0.99 110.698 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.726 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 37.6 m-85 -105.94 137.15 44.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.451 -0.574 . . . . 1.26 109.451 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -116.35 125.77 52.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.503 -0.317 . . . . 2.15 110.929 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 ttt-85 -80.85 123.93 28.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.08 -0.509 . . . . 2.4 109.905 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.2 150.67 51.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.948 0.404 . . . . 2.21 111.841 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -149.86 96.58 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.863 -0.608 . . . . 2.68 110.469 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HB3' HD12 ' A' ' 64' ' ' LEU . 32.1 ttt85 -71.45 119.46 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 3.59 110.439 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 15.9 ttt-85 -135.72 106.31 6.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.127 -0.488 . . . . 3.43 110.591 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 pt -86.73 159.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.849 -0.614 . . . . 4.26 110.744 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.37 114.14 21.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.216 -0.447 . . . . 5.17 110.428 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.65 158.3 41.01 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.668 -0.777 . . . . 4.66 112.146 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.63 -22.59 69.96 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.344 -0.455 . . . . 5.04 112.793 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.54 -4.5 59.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.255 0.55 . . . . 5.51 110.414 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.7 2.45 67.24 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.087 -0.805 . . . . 4.73 111.087 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -79.29 141.92 36.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.934 0.397 . . . . 5.52 110.513 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.3 mmt -118.98 132.31 56.06 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.619 -0.512 . . . . 4.48 109.619 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HE3' ' O4 ' ' C' ' 13' ' ' ' U' . 75.3 tttt -66.26 -51.41 57.79 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.234 -0.654 . . . . 4.16 109.234 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 20.8 t70 63.93 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.525 0.935 . . . . 4.09 113.525 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD12 ' HB3' ' A' ' 52' ' ' ARG . 63.7 mt -114.9 156.99 23.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 3.36 110.562 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.25 153.53 92.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.842 -0.617 . . . . 3.36 110.962 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.536 ' HA ' HG23 ' A' ' 51' ' ' THR . 19.7 Cg_endo -58.57 112.89 1.33 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.804 2.336 . . . . 2.69 111.625 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.639 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 93.8 mtt180 -114.47 125.38 53.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.249 0.547 . . . . 3.03 112.016 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.726 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 41.8 m95 -98.12 131.69 44.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.632 -0.713 . . . . 1.84 109.833 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -110.69 146.34 36.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.375 -0.375 . . . . 2.76 110.382 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -97.08 114.73 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.874 0.368 . . . . 1.27 110.927 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.41 ' HD2' HG21 ' A' ' 75' ' ' THR . 31.5 m-85 -113.63 143.65 44.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 1.84 110.085 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.443 ' HE1' ' HD1' ' A' ' 12' ' ' TRP . 76.6 m-85 -81.83 154.01 26.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.955 -0.387 . . . . 1.28 109.955 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.2 tt -58.53 118.84 6.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.556 -0.293 . . . . 1.66 110.448 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.71 27.57 5.98 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.013 -0.613 . . . . 1.66 112.732 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.41 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -92.49 106.29 18.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.47 -0.429 . . . . 1.58 110.726 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.67 119.86 3.01 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.211 -0.756 . . . . 1.96 111.211 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.46 -51.99 8.69 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.797 2.331 . . . . 2.62 112.206 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -103.1 30.5 4.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.036 0.446 . . . . 3.09 111.336 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.96 72.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 1.79 110.27 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.89 39.08 95.04 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.784 -0.644 . . . . 1.65 112.394 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.523 HD21 ' HD2' ' A' ' 87' ' ' LYS . 83.2 mt -118.75 93.71 46.64 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.255 . . . . 1.38 111.149 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.699 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 7.5 Cg_exo -75.93 157.17 38.97 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.966 2.444 . . . . 1.62 110.377 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.671 ' HB2' HD11 ' A' ' 73' ' ' LEU . 80.8 t80 -57.32 112.87 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.769 0.319 . . . . 1.58 110.708 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 112.7 -6.62 26.05 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.603 -0.808 . . . . 1.44 112.42 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.699 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -66.69 145.78 55.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.872 0.368 . . . . 1.25 110.682 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -98.14 129.21 44.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.327 -0.397 . . . . 1.86 110.63 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.523 ' HD2' HD21 ' A' ' 81' ' ' LEU . 1.9 ttmt -156.05 143.46 19.29 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.003 -0.74 . . . . 1.68 109.003 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.79 122.65 16.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.777 0.322 . . . . 1.7 111.589 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 21.76 70.84 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 1.27 112.575 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 31.7 mm -130.99 111.92 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.37 . . . . 1.01 110.87 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.5 pt -118.78 143.32 30.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.262 -0.644 . . . . 1.3 109.262 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.52 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 91.2 m95 -98.59 141.56 31.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.934 0.716 . . . . 1.08 112.934 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.81 138.5 38.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.329 -0.85 . . . . 1.04 110.387 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.61 168.94 20.72 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.378 -0.601 . . . . 1.27 109.378 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 t -140.74 157.93 44.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.23 -0.285 . . . . 1.36 110.23 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.06 118.69 8.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.332 -0.394 . . . . 2.64 110.186 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.02 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 121.109 -0.567 . . . . 1.52 111.692 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.703 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -88.46 149.0 23.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.554 0.216 . . . . 1.59 110.54 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 48.9 mt -104.18 140.21 38.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 -0.285 . . . . 2.15 110.85 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -79.2 99.73 7.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.854 0.359 . . . . 2.07 111.242 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.428 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 0.4 OUTLIER -173.33 147.37 1.43 Allowed Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.642 . . . . 2.36 109.268 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.12 114.32 3.72 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.191 1.927 . . . . 2.08 112.366 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.934 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -114.59 78.96 1.2 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.442 0.639 . . . . 1.78 110.451 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.91 -6.66 48.61 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.481 -0.781 . . . . 2.55 112.041 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.566 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 4.7 p80 -60.79 -15.99 35.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.378 0.51 . . . . 2.24 112.378 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.02 15.03 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.947 0.403 . . . . 2.0 111.124 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.36 15.91 53.4 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.873 -0.68 . . . . 2.33 111.957 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 t -108.28 103.03 12.11 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.025 0.441 . . . . 2.99 111.414 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.3 ttp85 -159.97 111.81 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.576 . . . . 2.83 110.666 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.64 122.14 76.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.783 -0.451 . . . . 3.56 109.783 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.464 ' HB2' " H4'" ' C' ' 9' ' ' ' U' . 41.1 Cg_endo -65.65 -21.04 59.54 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 123.202 2.601 . . . . 3.39 114.236 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -93.49 10.88 30.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.785 0.326 . . . . 4.05 111.578 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -142.06 14.95 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.082 0.468 . . . . 4.48 110.858 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -172.92 135.74 0.64 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.94 -0.573 . . . . 3.39 110.177 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -96.47 134.68 39.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.479 -0.328 . . . . 3.21 110.36 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 157.25 37.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.138 0.494 . . . . 2.85 111.968 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 5.4 mt -94.26 145.57 7.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.716 -0.675 . . . . 2.42 109.614 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.4 t -61.61 117.17 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.685 0.279 . . . . 2.74 110.751 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.442 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . 2.8 tt -61.51 121.08 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.898 -0.592 . . . . 2.11 111.24 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -137.98 150.95 47.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.822 -0.626 . . . . 2.49 110.413 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 33' ' ' PRO . 33.0 mt -103.74 150.3 38.01 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.242 -0.435 . . . . 1.91 110.071 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.6 150.65 80.75 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.451 2.101 . . . . 1.84 111.288 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -51.67 130.86 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.077 -0.51 . . . . 2.53 111.378 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.79 -17.47 38.77 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.691 -0.766 . . . . 2.2 111.488 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.03 102.38 12.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 2.1 110.301 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.0 148.82 29.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.342 -0.39 . . . . 2.78 111.366 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.454 HD23 HD12 ' A' ' 121' ' ' LEU . 70.7 mt -82.43 145.46 51.68 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.735 -0.469 . . . . 2.62 109.735 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.463 ' HG2' ' CB ' ' A' ' 131' ' ' PHE . 9.9 Cg_endo -54.59 146.32 54.32 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.83 2.353 . . . . 2.77 111.918 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -60.91 112.32 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.84 -0.618 . . . . 4.11 111.93 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.88 -6.99 41.13 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.143 -0.551 . . . . 3.18 112.177 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 18' ' ' GLN . 0.4 OUTLIER -101.16 146.31 27.66 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.486 -0.191 . . . . 2.91 110.486 -179.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.442 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 11.6 p90 -155.93 165.13 37.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.238 -0.437 . . . . 3.54 110.093 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.64 136.92 38.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.814 0.34 . . . . 2.93 111.116 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -65.15 126.02 26.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.985 -0.552 . . . . 3.64 110.376 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.93 21.64 65.34 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.106 -0.569 . . . . 3.27 112.415 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.96 135.35 47.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.777 0.322 . . . . 3.59 110.168 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -110.68 101.28 9.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.185 -0.461 . . . . 5.55 110.619 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -99.65 121.94 7.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.782 -0.723 . . . . 5.22 111.865 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.41 -61.23 4.22 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.431 -0.414 . . . . 5.91 112.719 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.856 -0.593 . . . . 7.27 110.795 -179.214 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.411 ' H41' ' HE2' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.625 1 C4'-C3'-C2' 97.036 -5.664 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.402 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.523 2 N19-C1'-C2' 103.499 -6.188 . 0.235 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.808 3 O4'-C1'-N19 115.681 7.481 . 0.533 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.17 4 O4'-C1'-N19 116.604 8.404 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.063 2 C4'-C3'-C2' 97.543 -5.157 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.753 4 N19-C1'-C2' 106.319 -4.426 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.322 3 P-O3'-C3' 126.978 6.065 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.411 3 O4'-C4'-C3' 114.895 6.71 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . 0.464 " H4'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.542 -5.125 2 O4'-C1'-N19 118.686 10.486 . 0.418 1a . 14.39 . . . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.547 4 O3'-P-O5' 116.285 6.466 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.139 1 C4'-C3'-C2' 98.236 -4.464 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.604 1 C4'-C3'-C2' 94.341 -8.359 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.528 ' O4 ' ' HE3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.588 5.848 1 O3'-P-O5' 111.83 4.121 . 0.105 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.079 2 C3'-C2'-C1' 105.728 4.697 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.907 -0.477 . . . . 9.05 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.36 121.09 33.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.78 0.324 . . . . 8.09 110.457 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.9 tpt -81.01 116.64 21.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.266 -0.425 . . . . 8.02 110.538 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.29 170.6 42.67 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.994 -0.622 . . . . 5.76 111.724 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 78' ' ' GLU . 80.7 mt -136.94 111.7 9.48 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 110.327 -0.249 . . . . 4.72 110.327 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.92 56.62 5.42 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.953 2.435 . . . . 4.45 111.638 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -128.14 164.04 23.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.988 -0.551 . . . . 4.41 109.751 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -77.27 -69.94 0.5 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.411 -0.359 . . . . 3.92 110.219 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m 58.74 82.59 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.819 -0.628 . . . . 2.53 112.083 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.25 145.54 41.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.554 -0.748 . . . . 2.48 110.747 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.84 38.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 2.13 110.599 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -87.43 -22.76 24.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.996 0.369 . . . . 2.4 111.996 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -117.71 161.54 19.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 2.02 111.662 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 p -67.14 158.15 31.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 2.65 111.259 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.406 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -87.13 145.49 26.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.993 0.425 . . . . 2.4 110.496 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.57 HD11 HD13 ' A' ' 119' ' ' LEU . 2.8 mp -99.85 152.49 20.08 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.456 -0.572 . . . . 2.27 109.456 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.622 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 2.0 m -109.09 128.29 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.858 0.361 . . . . 2.84 111.148 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -97.06 135.73 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.896 -0.593 . . . . 2.89 109.954 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -132.98 103.35 6.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.842 0.353 . . . . 3.82 110.375 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.07 -151.31 22.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.774 -0.726 . . . . 3.23 111.629 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 25.7 mmtp -103.18 -19.25 14.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.91 0.386 . . . . 4.27 110.904 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -79.76 137.75 37.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.053 -0.721 . . . . 3.32 109.053 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 1.9 t0 -81.07 -66.11 0.93 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.046 -0.724 . . . . 2.39 109.046 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 17.1 tp 173.07 122.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.591 -0.731 . . . . 2.06 110.98 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -144.39 123.19 12.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.104 -0.498 . . . . 2.22 109.768 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 29.4 m-85 -111.55 142.14 25.96 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.358 -0.383 . . . . 1.78 110.636 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 21.6 Cg_exo -66.75 164.93 27.4 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.238 2.625 . . . . 2.15 112.278 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -62.64 120.95 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 2.6 110.766 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 94' ' ' ALA . . . 75.63 21.95 76.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.987 -0.625 . . . . 1.65 112.542 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 1.7 tt0 -138.26 156.84 47.29 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.757 -0.261 . . . . 2.31 110.925 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.0 -3.92 48.76 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.817 -0.706 . . . . 1.33 112.719 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.2 t -81.65 120.94 79.12 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.602 0.239 . . . . 1.06 110.452 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.424 ' HD3' ' OH ' ' A' ' 47' ' ' TYR . 58.7 Cg_endo -71.79 174.93 10.36 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.646 2.231 . . . . 1.27 111.577 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.4 mt -81.83 83.29 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.857 0.36 . . . . 1.7 110.376 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -79.08 91.76 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 1.23 109.908 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -17.76 60.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.131 -0.486 . . . . 1.94 112.092 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -89.51 -18.72 26.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.042 0.386 . . . . 1.96 112.042 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 42' ' ' ASP . 0.8 OUTLIER -99.44 160.3 14.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.69 0.281 . . . . 1.42 111.673 -179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.4 m -80.94 168.52 24.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.09 -0.505 . . . . 1.73 110.02 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.19 -39.02 93.59 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.462 2.108 . . . . 1.42 112.09 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.9 p-10 -85.05 -1.53 56.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.064 -0.516 . . . . 1.78 111.105 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 38' ' ' SER . 0.4 OUTLIER -98.3 0.12 44.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.805 -0.634 . . . . 1.6 110.212 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -79.43 57.52 2.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 1.05 110.814 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.1 tt -146.15 130.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 1.17 109.728 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.14 -148.03 5.88 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.297 -0.954 . . . . 0.6 112.404 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -153.84 152.96 31.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.802 0.334 . . . . 0.99 111.806 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.424 ' OH ' ' HD3' ' A' ' 33' ' ' PRO . 49.3 m-85 -100.16 117.64 34.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.525 -0.917 . . . . 1.26 108.525 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.1 ttt-85 -96.9 131.09 44.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.991 0.424 . . . . 2.15 111.802 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -79.63 107.23 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.708 -0.678 . . . . 2.4 109.715 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -107.37 156.13 19.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.13 0.49 . . . . 2.21 111.67 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.97 140.6 32.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 2.68 109.94 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -124.97 123.48 39.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.976 0.417 . . . . 3.59 111.615 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.8 mtt180 -139.8 165.34 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 3.43 109.452 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.73 HG12 ' H ' ' A' ' 62' ' ' LYS . 43.1 pt -133.97 173.61 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.367 -0.235 . . . . 4.26 110.367 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.469 HH21 ' HB3' ' A' ' 61' ' ' MET . 3.7 mmp_? -128.91 100.91 5.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.525 -0.307 . . . . 5.17 110.766 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.96 168.39 35.55 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.909 -0.662 . . . . 4.66 111.813 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.79 -37.34 93.3 Favored Glycine 0 C--N 1.329 0.191 0 C-N-CA 121.022 -0.608 . . . . 5.04 112.272 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.73 -17.22 61.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.154 0.502 . . . . 5.51 110.325 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 101.95 9.01 43.79 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.958 -0.639 . . . . 4.73 111.574 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -86.32 169.32 13.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.747 0.308 . . . . 5.52 110.762 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.469 ' HB3' HH21 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -152.77 161.54 42.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.131 -0.486 . . . . 4.48 111.154 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.73 ' H ' HG12 ' A' ' 54' ' ' ILE . 66.6 tttt -72.67 -55.18 7.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.95 -0.759 . . . . 4.16 108.95 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.7 t70 56.78 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.162 -0.927 . . . . 4.09 113.042 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.43 157.07 16.4 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 3.36 110.304 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.24 158.24 82.42 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.491 . . . . 3.36 110.554 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.21 116.18 2.78 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.774 2.316 . . . . 2.69 111.898 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -117.14 125.97 52.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.746 -0.661 . . . . 3.03 110.692 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -99.77 126.18 45.81 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.976 -0.557 . . . . 1.84 111.128 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 42.5 m-85 -103.51 139.42 38.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.776 -0.647 . . . . 2.76 109.604 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -88.97 123.12 33.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.077 0.465 . . . . 1.27 111.564 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.448 ' HB3' ' OG1' ' A' ' 75' ' ' THR . 57.5 m-85 -120.3 177.34 5.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.582 -0.735 . . . . 1.84 109.41 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -109.81 175.24 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.716 0.293 . . . . 1.28 111.702 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.09 94.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.456 0.539 . . . . 1.66 112.456 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.69 45.62 3.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.95 -0.643 . . . . 1.66 114.04 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -78.85 84.65 4.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.173 0.487 . . . . 1.58 111.129 179.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.16 136.59 2.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.083 -0.579 . . . . 1.96 111.925 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.26 -35.3 74.78 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 2.62 112.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.469 ' HB2' HD21 ' A' ' 5' ' ' LEU . 36.5 mt-10 -129.08 40.36 3.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.3 0.571 . . . . 3.09 110.149 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.89 -60.78 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.727 -0.669 . . . . 1.79 110.069 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.13 51.91 16.07 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.886 -0.673 . . . . 1.65 111.487 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.3 mt -117.0 104.32 50.95 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.796 0.332 . . . . 1.38 111.537 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 91.5 Cg_endo -88.1 151.25 6.93 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.651 2.234 . . . . 1.62 110.737 178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -59.05 111.36 1.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.837 0.351 . . . . 1.58 110.896 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.83 -3.01 14.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.645 -0.788 . . . . 1.44 112.805 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.454 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -71.73 131.23 42.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 1.25 110.724 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.5 t-20 -97.18 114.9 26.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.064 0.459 . . . . 1.86 110.857 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 90' ' ' ILE . 22.3 ttmm -142.0 152.7 43.66 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.012 -0.736 . . . . 1.68 109.012 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.07 119.6 6.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 1.7 111.98 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.45 27.56 71.17 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.769 -0.651 . . . . 1.27 112.873 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.544 HG13 ' HB3' ' A' ' 87' ' ' LYS . 33.2 mm -125.25 96.09 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.877 0.37 . . . . 1.01 111.572 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.6 pt -109.75 137.28 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.492 -0.559 . . . . 1.3 109.492 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -96.58 147.84 23.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.76 0.652 . . . . 1.08 112.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.27 137.05 33.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.67 -0.696 . . . . 1.04 110.246 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' O ' ' HA2' ' A' ' 29' ' ' GLY . . . -148.36 166.44 28.05 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.655 -0.498 . . . . 1.27 109.655 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 t -139.76 168.4 19.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.745 -0.207 . . . . 1.36 110.689 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.2 124.39 21.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.042 0.449 . . . . 2.64 111.254 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 107.9 -16.5 36.37 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.71 -0.677 . . . . 1.52 112.439 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.783 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -79.97 143.35 34.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.625 0.25 . . . . 1.59 110.656 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.1 mt -104.76 148.62 26.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.417 -0.356 . . . . 2.15 110.526 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -84.54 64.43 8.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.465 0.65 . . . . 2.07 111.193 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.32 143.11 47.49 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.518 -0.765 . . . . 2.36 109.167 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.8 131.19 24.35 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.866 2.377 . . . . 2.08 112.988 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.2 mmtt -119.93 44.26 2.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.944 -0.571 . . . . 1.78 110.302 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.2 -13.04 62.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.907 -0.588 . . . . 2.55 112.155 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -21.63 65.5 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.283 0.475 . . . . 2.24 112.283 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.5 pt -111.72 18.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.164 0.507 . . . . 2.0 110.963 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.33 12.19 69.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.862 -0.685 . . . . 2.33 111.659 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 t -114.44 128.16 56.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.859 0.362 . . . . 2.99 111.494 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -169.25 139.66 2.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.834 -0.621 . . . . 2.83 109.603 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -99.14 120.57 57.95 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.802 0.334 . . . . 3.56 110.648 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.91 -29.5 23.07 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.035 2.49 . . . . 3.39 114.975 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -91.02 -2.6 57.65 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.031 -0.418 . . . . 4.05 111.468 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -122.28 0.13 9.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.185 0.517 . . . . 4.48 111.223 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -160.21 142.66 13.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.137 -0.483 . . . . 3.39 109.77 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.33 145.93 24.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.75 0.31 . . . . 3.21 111.215 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.597 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -78.59 138.19 38.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.778 -0.453 . . . . 2.85 109.778 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.79 141.53 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.27 -0.423 . . . . 2.42 110.337 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.92 122.37 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.858 -0.423 . . . . 2.74 109.858 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.57 HD13 HD11 ' A' ' 16' ' ' LEU . 2.3 tt -67.61 119.05 11.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.15 0.5 . . . . 2.11 111.436 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -131.01 143.62 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.574 -0.739 . . . . 2.49 110.452 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 51.3 mt -97.97 149.63 35.93 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.131 -0.486 . . . . 1.91 110.665 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.08 154.87 48.36 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.669 2.246 . . . . 1.84 111.875 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -58.76 119.2 6.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.208 -0.451 . . . . 2.53 110.515 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 117.81 -26.06 8.16 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.762 -0.732 . . . . 2.2 111.569 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 m -102.95 107.45 18.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.926 0.393 . . . . 2.1 110.075 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 155.21 17.07 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.38 -0.373 . . . . 2.78 111.402 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 54.6 mt -74.57 142.51 77.71 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.505 -0.554 . . . . 2.62 109.505 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.1 150.01 59.41 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 122.649 2.233 . . . . 2.77 111.853 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -58.37 116.03 3.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.157 -0.474 . . . . 4.11 111.337 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 108.57 -20.19 30.15 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.076 -0.583 . . . . 3.18 111.762 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.536 ' CZ ' ' HB2' ' A' ' 16' ' ' LEU . 3.8 t80 -95.61 117.99 31.48 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.487 -0.56 . . . . 2.91 109.487 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.622 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 5.9 p90 -125.49 148.76 48.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.123 0.487 . . . . 3.54 111.535 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.49 142.17 28.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.854 -0.612 . . . . 2.93 110.018 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -82.85 140.14 33.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.958 0.408 . . . . 3.64 110.557 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.24 -19.57 52.33 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.287 -0.725 . . . . 3.27 111.287 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.3 m -81.36 -9.26 59.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.734 0.302 . . . . 3.59 111.782 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -101.75 16.81 24.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.696 0.284 . . . . 5.55 111.33 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 120.51 39.85 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.358 -0.925 . . . . 5.22 113.134 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.48 61.36 3.2 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.782 -0.723 . . . . 5.91 111.816 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.993 -0.527 . . . . 7.27 110.999 -179.639 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.49 -3.759 1 C4'-C3'-C2' 97.054 -5.646 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.473 4.644 2 N19-C1'-C2' 103.458 -6.214 . 0.228 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.747 3 O4'-C1'-N19 115.69 7.49 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.182 3 O4'-C1'-N19 116.671 8.471 . 0.515 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.088 2 C4'-C3'-C2' 97.528 -5.172 . 0.656 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.688 5 N19-C1'-C2' 106.387 -4.383 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.367 3 P-O3'-C3' 127.021 6.101 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.597 " H4'" ' HB3' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.368 3 O4'-C4'-C3' 115.01 6.793 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.132 2 O4'-C1'-N19 118.612 10.412 . 0.415 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.55 3 O3'-P-O5' 116.369 6.51 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.119 1 C4'-C3'-C2' 98.274 -4.426 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.533 1 C4'-C3'-C2' 94.334 -8.366 . 0.458 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.795 1 O3'-P-O5' 111.683 4.044 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.063 2 C3'-C2'-C1' 105.653 4.614 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.583 -0.607 . . . . 9.05 111.583 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.02 128.54 51.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.745 0.307 . . . . 8.09 110.473 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.2 mtt -100.61 127.56 46.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.389 -0.369 . . . . 8.02 110.142 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.18 107.01 0.25 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.482 -0.866 . . . . 5.76 112.148 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.36 120.42 70.44 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-O 120.638 0.256 . . . . 4.72 110.435 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.06 -14.36 29.02 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.633 2.222 . . . . 4.45 111.63 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -71.53 150.23 44.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.473 -0.785 . . . . 4.41 110.343 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -81.2 -64.82 1.11 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.547 -0.297 . . . . 3.92 111.16 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 p 49.2 75.53 0.15 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.829 0.678 . . . . 2.53 112.829 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.491 ' HB1' " O2'" ' C' ' 8' ' ' ' G' . . . -77.51 142.04 39.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 2.48 111.294 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.77 146.39 46.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.66 -0.7 . . . . 2.13 111.005 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.499 ' CE2' ' HD3' ' A' ' 109' ' ' ARG . 24.3 m95 -81.86 -34.93 29.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.006 0.431 . . . . 2.4 111.234 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -109.07 164.97 11.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.834 -0.621 . . . . 2.02 111.355 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.903 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -62.8 164.65 7.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.068 -0.514 . . . . 2.65 111.663 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -80.11 149.54 30.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.181 0.515 . . . . 2.4 112.144 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 119' ' ' LEU . 95.4 mt -105.41 119.15 38.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.325 -0.991 . . . . 2.27 108.325 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 m -100.32 129.42 46.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.64 0.607 . . . . 2.84 112.64 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -97.5 115.7 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 2.89 110.056 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -110.83 74.03 0.85 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.088 -0.506 . . . . 3.82 109.956 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.62 -162.24 22.61 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.861 -0.608 . . . . 3.23 111.649 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -93.56 -18.5 22.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.368 . . . . 4.27 110.82 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.18 170.08 12.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.039 -0.528 . . . . 3.32 111.103 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -101.59 -78.31 0.53 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.091 -0.707 . . . . 2.39 109.091 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -178.15 143.66 0.3 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.08 -0.509 . . . . 2.06 110.854 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -159.3 116.26 2.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.071 -0.513 . . . . 2.22 110.0 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.17 134.83 21.38 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.494 -0.321 . . . . 1.78 110.511 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 30' ' ' GLN . 55.2 Cg_endo -69.66 150.92 69.47 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.599 2.199 . . . . 2.15 112.267 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.1 121.53 10.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.799 -0.637 . . . . 2.6 110.15 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.46 -25.75 13.1 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 111.215 -0.754 . . . . 1.65 111.215 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 50.5 mt-30 -113.78 -172.47 2.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.22 -0.289 . . . . 2.31 110.22 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.63 -26.08 21.78 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.882 -0.675 . . . . 1.33 112.163 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.25 119.27 75.96 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.576 0.227 . . . . 1.06 110.615 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.88 177.23 8.19 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.197 . . . . 1.27 111.183 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.453 HG22 HG23 ' A' ' 36' ' ' THR . 44.9 mt -77.16 91.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 1.7 110.201 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -84.42 82.88 8.2 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 1.23 110.287 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.453 HG23 HG22 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -78.07 41.38 0.36 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.791 -0.64 . . . . 1.94 112.198 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -150.29 -2.6 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.339 . . . . 1.96 111.352 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.546 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -130.32 170.34 14.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.497 -0.32 . . . . 1.42 111.503 -179.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.36 165.67 32.2 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.594 -0.276 . . . . 1.73 110.271 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 11.8 Cg_endo -56.43 -33.54 92.33 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.966 2.444 . . . . 1.42 112.225 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.5 OUTLIER -71.74 -24.09 61.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.09 -0.504 . . . . 1.78 110.547 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.99 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 42.4 m-20 -83.53 -2.98 57.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.808 -0.633 . . . . 1.6 110.802 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 32.3 mm-40 -78.26 56.75 1.75 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.344 0.592 . . . . 1.05 111.354 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.418 HG13 ' HB2' ' A' ' 94' ' ' ALA . 14.4 tt -150.87 130.96 3.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.499 -0.773 . . . . 1.17 109.103 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.31 -146.45 5.82 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.113 -1.042 . . . . 0.6 112.979 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.453 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 34.2 p90 -155.41 161.35 41.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.003 0.43 . . . . 0.99 110.764 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.599 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 47.4 m-85 -104.56 134.66 47.36 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.187 -0.672 . . . . 1.26 109.187 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.5 ttt-85 -114.65 122.47 46.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.027 -0.533 . . . . 2.15 110.834 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -87.6 123.42 32.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.33 . . . . 2.4 110.406 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.33 155.99 43.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.095 0.474 . . . . 2.21 111.485 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.55 120.67 16.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.778 -0.647 . . . . 2.68 109.95 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.61 ' HB3' HD12 ' A' ' 64' ' ' LEU . 25.9 tpt180 -96.56 122.18 39.19 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.101 0.477 . . . . 3.59 112.021 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -138.23 145.32 41.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.681 -0.69 . . . . 3.43 109.907 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.479 HG12 ' H ' ' A' ' 62' ' ' LYS . 33.4 pt -121.72 -178.3 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.207 -0.452 . . . . 4.26 109.986 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -145.98 96.01 2.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.84 0.352 . . . . 5.17 110.528 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.77 179.28 41.39 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.755 -0.736 . . . . 4.66 112.121 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.3 -47.51 89.15 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.919 -0.658 . . . . 5.04 112.012 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -63.69 -38.09 89.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 5.51 111.151 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.88 1.41 6.91 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.989 -0.624 . . . . 4.73 112.227 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.8 mmtm -71.81 160.27 32.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.734 0.302 . . . . 5.52 111.124 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.25 150.62 38.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 4.48 110.944 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.608 ' HE3' HD21 ' A' ' 64' ' ' LEU . 50.2 tttp -65.39 -54.37 29.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.978 -0.556 . . . . 4.16 110.291 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.32 91.14 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.606 -0.724 . . . . 4.09 112.89 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 52' ' ' ARG . 63.6 mt -94.59 150.19 20.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 3.36 109.903 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.434 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 1.5 m -64.83 161.54 45.26 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.224 -0.444 . . . . 3.36 110.39 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 12.2 Cg_endo -56.77 109.24 0.42 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.579 2.186 . . . . 2.69 111.244 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -103.51 123.38 46.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.917 -0.583 . . . . 3.03 111.422 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.599 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 79.9 m95 -96.2 120.64 36.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.976 -0.556 . . . . 1.84 110.056 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 53.9 m-85 -106.7 133.31 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.727 -0.472 . . . . 2.76 109.727 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -85.95 121.19 28.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.802 0.334 . . . . 1.27 111.163 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -118.76 146.27 44.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.024 -0.534 . . . . 1.84 109.808 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -82.67 149.3 27.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.463 -0.335 . . . . 1.28 110.504 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.7 tp -59.44 113.5 2.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.474 -0.33 . . . . 1.66 110.652 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 122.38 -13.92 8.83 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.141 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.471 HG22 ' HA3' ' A' ' 107' ' ' GLY . 9.8 p -59.72 123.66 17.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.711 0.291 . . . . 1.58 110.787 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.471 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 105.1 99.64 2.6 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.789 -0.72 . . . . 1.96 111.573 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 10.9 Cg_endo -54.9 -42.54 67.98 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 123.079 2.519 . . . . 2.62 112.334 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -109.47 28.13 8.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.034 0.445 . . . . 3.09 111.298 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.2 -43.22 53.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 1.79 110.484 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.33 51.82 56.35 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.923 -0.581 . . . . 1.65 111.973 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.22 95.66 35.8 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.735 0.302 . . . . 1.38 111.428 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 4.0 Cg_exo -76.04 159.61 37.42 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.836 2.357 . . . . 1.62 110.323 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -60.08 107.84 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 1.58 111.026 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.24 -13.91 8.35 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.706 -0.679 . . . . 1.44 112.19 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.626 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -60.02 116.64 4.31 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.054 0.454 . . . . 1.25 111.13 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -76.24 116.33 16.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.896 -0.593 . . . . 1.86 110.763 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -137.31 158.17 45.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.546 -0.539 . . . . 1.68 109.546 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -67.33 121.82 16.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 1.7 111.257 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.36 30.83 71.25 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.95 -0.568 . . . . 1.27 112.595 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.9 mm -131.74 113.99 23.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.621 0.248 . . . . 1.01 110.38 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 91' ' ' ILE . 11.8 pt -121.36 130.89 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.71 -0.478 . . . . 1.3 109.71 178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 76.4 m95 -91.72 139.61 30.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.347 0.499 . . . . 1.08 112.347 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.13 142.89 34.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.721 -0.672 . . . . 1.04 110.368 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -154.62 155.25 34.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.319 -0.401 . . . . 1.27 110.588 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -121.83 170.11 10.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.153 -0.476 . . . . 1.36 109.73 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.73 114.33 11.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.934 0.397 . . . . 2.64 110.172 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.36 5.83 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.039 -0.824 . . . . 1.52 111.039 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.732 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.52 159.96 28.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.96 0.41 . . . . 1.59 110.748 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.442 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 94.8 mt -118.49 140.56 49.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.12 -0.491 . . . . 2.15 111.263 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.67 80.58 7.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.399 0.619 . . . . 2.07 110.752 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.533 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.3 t -156.28 146.77 16.05 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 109.115 -0.698 . . . . 2.36 109.115 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.48 118.18 5.47 Favored 'Trans proline' 0 CA--C 1.529 0.23 0 C-N-CA 122.231 1.954 . . . . 2.08 112.401 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.99 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -118.31 67.42 0.77 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.728 . . . . 1.78 110.682 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -74.79 -4.24 36.5 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.228 -0.897 . . . . 2.55 111.224 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -61.35 -14.19 25.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.005 -0.543 . . . . 2.24 112.392 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.42 HD13 ' HB3' ' A' ' 38' ' ' SER . 2.5 mt -104.7 -26.22 3.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.804 0.335 . . . . 2.0 110.724 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.471 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -61.31 -33.23 83.7 Favored Glycine 0 C--N 1.328 0.138 0 CA-C-N 115.901 -0.59 . . . . 2.33 113.482 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -67.23 113.21 4.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.845 0.355 . . . . 2.99 111.387 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.499 ' HD3' ' CE2' ' A' ' 12' ' ' TRP . 10.7 ttp85 -162.95 128.83 3.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 2.83 111.1 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -91.59 116.92 67.39 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.722 -0.672 . . . . 3.56 109.882 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.422 ' HB3' " O2'" ' C' ' 8' ' ' ' G' . 34.7 Cg_endo -63.81 -33.31 65.37 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 123.166 2.578 . . . . 3.39 113.044 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.87 0.21 14.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.976 0.417 . . . . 4.05 111.812 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -132.16 9.54 4.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.152 -0.476 . . . . 4.48 111.591 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.424 HD22 ' HA ' ' A' ' 114' ' ' ASN . 1.4 t-20 -168.61 129.75 1.26 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.664 0.269 . . . . 3.39 111.653 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.46 168.19 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 3.21 110.519 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.56 156.98 16.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 2.85 111.627 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 30.3 mt -101.1 142.42 15.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.362 -0.977 . . . . 2.42 108.362 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.06 121.04 7.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.793 0.33 . . . . 2.74 110.286 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 16' ' ' LEU . 4.2 tt -58.92 112.2 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.647 -0.706 . . . . 2.11 110.872 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -111.92 144.1 41.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.807 -0.633 . . . . 2.49 110.211 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 65.7 mt -107.5 143.46 27.28 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.301 -0.409 . . . . 1.91 110.766 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.92 156.67 63.16 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.653 2.235 . . . . 1.84 111.635 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -55.66 121.36 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.006 -0.543 . . . . 2.53 110.432 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.57 -21.0 19.9 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.885 -0.674 . . . . 2.2 111.442 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 6.5 m -99.24 104.17 16.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 2.1 110.116 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.97 140.86 35.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.723 -0.671 . . . . 2.78 110.952 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.692 HD22 ' HD2' ' A' ' 131' ' ' PHE . 21.3 mt -73.99 137.97 76.1 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.254 -0.43 . . . . 2.62 110.058 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -58.74 155.31 38.25 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.665 2.243 . . . . 2.77 112.055 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -58.22 127.87 34.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.734 -0.666 . . . . 4.11 111.306 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -17.21 59.76 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.091 -0.576 . . . . 3.18 112.652 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.692 ' HD2' HD22 ' A' ' 127' ' ' LEU . 2.6 t80 -94.53 120.22 34.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.562 0.22 . . . . 2.91 110.629 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' OH ' " H5'" ' B' ' 1' ' ' ' C' . 36.7 p90 -124.35 155.42 38.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.65 -0.25 . . . . 3.54 111.287 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 136.4 41.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.93 111.754 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.903 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.0 tp10 -61.44 123.58 18.23 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.592 -0.731 . . . . 3.64 110.742 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.84 66.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.9 -0.667 . . . . 3.27 113.631 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 59.6 m -77.11 112.71 14.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.037 0.446 . . . . 3.59 111.7 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -160.24 155.47 24.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.834 -0.621 . . . . 5.55 110.563 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -119.39 80.66 0.32 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.861 -0.685 . . . . 5.22 112.226 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -105.79 111.0 3.54 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.884 -0.674 . . . . 5.91 111.52 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.861 -0.59 . . . . 7.27 111.206 -179.416 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.405 " H5'" ' OH ' ' A' ' 132' ' ' TYR . . . . . . . . 0 C2'--C1' 1.491 -3.663 1 C4'-C3'-C2' 97.058 -5.642 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.56 2 N19-C1'-C2' 103.521 -6.174 . 0.23 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.763 3 O4'-C1'-N19 115.743 7.543 . 0.53 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.167 4 O4'-C1'-N19 116.649 8.449 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O4'--C4' 1.403 -4.152 2 C4'-C3'-C2' 97.563 -5.137 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.733 4 N19-C1'-C2' 106.37 -4.394 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.496 5.223 3 P-O3'-C3' 127.002 6.085 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.491 " O2'" ' HB1' ' A' ' 10' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.325 3 O4'-C4'-C3' 114.961 6.758 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.107 2 O4'-C1'-N19 118.591 10.391 . 0.411 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.506 3 O3'-P-O5' 116.389 6.52 . 0.457 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.165 1 C4'-C3'-C2' 98.226 -4.474 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.432 1 C4'-C3'-C2' 94.336 -8.364 . 0.459 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.781 1 O3'-P-O5' 111.754 4.081 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.961 2 C3'-C2'-C1' 105.64 4.6 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.684 -0.566 . . . . 9.05 111.684 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.76 125.93 30.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.903 0.382 . . . . 8.09 110.791 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.9 mtt -119.52 107.94 13.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 8.02 110.088 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.57 150.57 22.6 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.838 -0.696 . . . . 5.76 112.65 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.69 136.82 21.06 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.947 -0.39 . . . . 4.72 109.947 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.92 48.06 2.37 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.001 2.468 . . . . 4.45 112.179 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -99.54 27.04 5.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.04 -0.527 . . . . 4.41 110.409 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -111.29 -160.33 0.71 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.798 -0.637 . . . . 3.92 109.526 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.585 HG22 ' HE2' ' A' ' 71' ' ' TYR . 28.7 m 68.45 83.35 0.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.429 0.633 . . . . 2.53 112.107 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.63 163.1 13.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.783 -0.644 . . . . 2.48 110.005 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -73.16 155.61 39.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.197 0.522 . . . . 2.13 111.543 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -90.42 -24.24 20.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.609 . . . . 2.4 110.985 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 89.2 m-85 -117.2 167.43 11.2 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 2.02 110.732 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 p -64.89 155.45 34.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.892 -0.595 . . . . 2.65 110.79 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 163.92 26.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.286 0.565 . . . . 2.4 111.261 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.849 ' HB3' ' HZ ' ' A' ' 131' ' ' PHE . 60.6 mt -111.3 111.55 22.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.675 -0.693 . . . . 2.27 109.854 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.2 OUTLIER -79.44 119.63 22.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 2.84 111.61 -179.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 23' ' ' ASP . 43.4 tp60 -90.49 124.99 35.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 2.89 110.673 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -132.24 91.29 2.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 3.82 110.424 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.14 -167.13 38.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.298 -0.721 . . . . 3.23 111.298 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 52.6 mmtt -90.96 -7.76 51.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 4.27 111.176 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -114.73 -172.79 2.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.189 -0.671 . . . . 3.32 109.189 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.572 ' HA ' ' HG2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER -127.34 -149.99 0.43 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.178 -0.675 . . . . 2.39 109.178 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 5.3 mp -95.62 133.38 39.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.751 0.31 . . . . 2.06 110.648 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.18 92.28 1.33 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.174 -0.466 . . . . 2.22 109.858 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -91.67 136.3 26.69 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 1.78 110.995 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -74.16 158.96 44.84 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.658 2.239 . . . . 2.15 111.187 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.5 125.26 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.007 0.432 . . . . 2.6 111.665 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.81 -15.66 52.01 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.637 -0.792 . . . . 1.65 112.62 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -129.98 153.49 48.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.651 0.262 . . . . 2.31 110.379 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.74 1.55 11.82 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.575 -0.821 . . . . 1.33 112.688 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 43' ' ' GLN . 47.0 t -102.49 115.43 64.43 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 120.886 0.374 . . . . 1.06 110.852 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.45 178.64 5.93 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.761 2.308 . . . . 1.27 111.439 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.409 HG22 HG23 ' A' ' 36' ' ' THR . 28.8 mt -77.06 92.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.996 0.427 . . . . 1.7 110.456 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.467 ' HB2' HE22 ' A' ' 43' ' ' GLN . 56.0 m-80 -82.73 84.41 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 1.23 110.452 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.409 HG23 HG22 ' A' ' 34' ' ' ILE . 4.4 p -75.4 9.45 2.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.494 0.553 . . . . 1.94 112.494 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -118.08 -5.73 10.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.785 0.291 . . . . 1.96 111.785 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -124.52 168.11 13.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.89 0.376 . . . . 1.42 111.746 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.665 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.6 m -86.87 167.76 20.81 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 115.974 -0.557 . . . . 1.73 109.583 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.54 -36.86 72.39 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.344 2.696 . . . . 1.42 113.293 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.45 -14.76 59.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.057 0.391 . . . . 1.78 112.057 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.546 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -88.41 -0.04 56.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.624 0.25 . . . . 1.6 110.351 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.467 HE22 ' HB2' ' A' ' 35' ' ' ASN . 41.0 mm-40 -76.6 51.1 0.72 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.364 -0.38 . . . . 1.05 111.586 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.866 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.7 tt -146.39 130.46 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.17 -0.468 . . . . 1.17 110.233 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.63 -148.84 6.14 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.462 -0.875 . . . . 0.6 112.457 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -152.51 166.64 31.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.853 0.358 . . . . 0.99 110.925 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.746 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.9 m-85 -111.72 134.53 53.23 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.944 -0.571 . . . . 1.26 109.955 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.8 ttt180 -112.94 133.98 54.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.195 -0.457 . . . . 2.15 111.211 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 49' ' ' ARG . 12.2 ttt-85 -87.25 121.77 30.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.1 -0.5 . . . . 2.4 109.876 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 156.85 47.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 2.21 111.531 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.409 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -145.21 154.5 42.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 2.68 110.288 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HB3' HD12 ' A' ' 64' ' ' LEU . 12.8 tpt180 -130.14 118.65 21.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.973 -0.38 . . . . 3.59 109.973 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.88 107.52 5.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.634 -0.257 . . . . 3.43 110.409 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.933 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.8 pt -69.84 158.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 4.26 110.505 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.15 98.98 4.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.165 -0.47 . . . . 5.17 110.095 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.2 157.55 51.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.842 -0.694 . . . . 4.66 111.81 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.33 -35.95 89.7 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.197 -0.525 . . . . 5.04 112.744 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -78.02 -0.36 27.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.061 0.458 . . . . 5.51 111.042 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.94 44.3 5.15 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.851 -0.69 . . . . 4.73 112.081 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -100.25 144.71 28.94 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.787 -0.449 . . . . 5.52 109.787 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.9 mmt -128.38 136.13 50.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.261 -0.427 . . . . 4.48 110.106 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.933 ' HB2' HG12 ' A' ' 54' ' ' ILE . 43.7 tttt -71.07 -46.59 61.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.557 -0.534 . . . . 4.16 109.557 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.5 t70 65.95 99.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.974 1.101 . . . . 4.09 113.974 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 52' ' ' ARG . 93.8 mt -126.73 151.1 48.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.484 -0.78 . . . . 3.36 110.024 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.46 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.4 OUTLIER -74.31 153.89 88.12 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.192 -0.458 . . . . 3.36 110.283 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HA ' HG23 ' A' ' 51' ' ' THR . 15.0 Cg_endo -58.14 127.4 24.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.76 2.307 . . . . 2.69 111.756 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -115.22 124.64 51.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.13 -0.486 . . . . 3.03 110.613 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.746 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 37.1 m95 -94.26 121.33 35.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 1.84 110.134 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -96.95 146.76 24.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.941 -0.572 . . . . 2.76 110.673 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -94.19 126.92 39.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.899 0.38 . . . . 1.27 110.33 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.585 ' HE2' HG22 ' A' ' 9' ' ' THR . 23.7 m-85 -126.99 165.77 18.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.955 -0.566 . . . . 1.84 109.867 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -100.62 169.21 9.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.454 -0.339 . . . . 1.28 110.773 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.92 103.28 0.09 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.088 0.773 . . . . 1.66 113.088 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.64 44.74 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.923 -0.58 . . . . 1.66 114.065 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.527 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -74.46 82.93 1.96 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.116 0.484 . . . . 1.58 111.321 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 77' ' ' PRO . . . 159.71 131.18 1.21 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.596 -0.602 . . . . 1.96 111.596 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' ' 76' ' ' GLY . 31.9 Cg_exo -60.23 -37.87 79.98 Favored 'Trans proline' 0 N--CA 1.471 0.195 0 C-N-CA 123.007 2.472 . . . . 2.62 112.322 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.03 31.77 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.289 -0.414 . . . . 3.09 111.413 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 -53.22 8.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.819 0.342 . . . . 1.79 110.626 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.3 48.49 83.32 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.933 -0.576 . . . . 1.65 112.025 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.1 mt -125.04 103.76 30.11 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.87 0.367 . . . . 1.38 111.592 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.11 162.44 17.9 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.633 2.222 . . . . 1.62 110.933 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -60.88 117.86 5.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.958 0.408 . . . . 1.58 111.102 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.08 10.48 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 1.44 112.539 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.83 108.05 2.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 1.25 110.751 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -84.02 137.2 33.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.335 -0.393 . . . . 1.86 110.902 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt -147.21 168.43 21.7 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.459 -0.941 . . . . 1.68 108.459 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -57.17 112.23 1.3 Allowed 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.285 0.366 . . . . 1.7 111.783 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.52 39.03 91.09 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.705 -0.68 . . . . 1.27 112.586 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 mm -132.9 102.98 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.825 0.345 . . . . 1.01 110.696 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 47' ' ' TYR . 17.2 pt -113.73 133.86 58.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.812 -0.44 . . . . 1.3 109.812 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -90.38 140.03 30.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.035 0.445 . . . . 1.08 111.805 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.54 132.81 54.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.837 -0.62 . . . . 1.04 110.483 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -150.62 141.71 23.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 1.27 110.471 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.5 t -112.74 176.61 4.94 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.523 -0.547 . . . . 1.36 109.523 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -65.04 130.46 43.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 2.64 110.834 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 104.52 -15.36 49.76 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 121.003 -0.617 . . . . 1.52 112.148 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.866 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -74.56 130.26 39.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.814 0.34 . . . . 1.59 110.742 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.6 mt -103.14 139.51 38.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.136 -0.483 . . . . 2.15 110.873 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -74.15 88.84 1.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.215 0.531 . . . . 2.07 110.5 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.414 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.0 OUTLIER -150.38 153.94 35.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.677 -0.692 . . . . 2.36 109.622 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.414 ' HD2' HG22 ' A' ' 101' ' ' THR . 17.6 Cg_endo -58.65 122.59 11.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.564 2.176 . . . . 2.08 111.468 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.8 mmtt -113.47 29.39 8.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.092 -0.503 . . . . 1.78 111.175 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -13.99 62.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.805 -0.634 . . . . 2.55 111.215 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -65.19 -17.65 64.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.08 -0.509 . . . . 2.24 112.105 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.55 -27.44 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.304 0.573 . . . . 2.0 110.549 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.527 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -81.21 58.97 4.82 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 115.925 -0.579 . . . . 2.33 113.225 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.4 t -138.37 16.31 2.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.335 0.588 . . . . 2.99 110.225 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.3 ttp85 -73.18 137.19 44.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.651 -0.704 . . . . 2.83 110.655 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -95.98 115.67 65.7 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.426 -0.352 . . . . 3.56 111.124 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.91 -27.97 11.71 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.721 2.281 . . . . 3.39 112.812 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.17 38.63 0.82 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.019 0.438 . . . . 4.05 110.847 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -170.1 -45.6 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 4.48 109.931 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -107.82 139.18 42.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.786 -0.643 . . . . 3.39 110.436 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.34 155.87 22.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.666 0.27 . . . . 3.21 110.876 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.04 162.11 14.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.22 0.533 . . . . 2.85 111.562 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 9.6 mt -98.48 150.55 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.082 -0.71 . . . . 2.42 109.082 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.1 t -69.43 126.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.301 -0.259 . . . . 2.74 110.301 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.476 HD22 HD21 ' A' ' 16' ' ' LEU . 4.4 tt -67.02 110.89 3.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.413 . . . . 2.11 109.911 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -118.11 146.13 44.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.004 -0.544 . . . . 2.49 110.978 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 64.9 mt -99.63 151.34 37.42 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.893 -0.594 . . . . 1.91 110.169 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.12 163.18 32.5 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.412 2.075 . . . . 1.84 112.48 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -60.69 115.33 3.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.742 -0.663 . . . . 2.53 110.783 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.49 -2.7 23.49 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.636 -0.792 . . . . 2.2 112.094 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 4.0 m -117.02 114.83 24.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 2.1 110.449 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.04 151.77 24.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.442 -0.345 . . . . 2.78 111.099 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.8 mt -75.07 148.16 84.07 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.542 -0.54 . . . . 2.62 109.542 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.06 168.47 10.66 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.468 2.112 . . . . 2.77 112.059 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.38 130.93 45.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.076 -0.511 . . . . 4.11 111.891 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.76 27.32 65.17 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.103 -0.57 . . . . 3.18 112.347 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.849 ' HZ ' ' HB3' ' A' ' 16' ' ' LEU . 22.0 t80 -126.82 144.76 50.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.905 0.383 . . . . 2.91 111.384 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -146.65 157.87 43.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.932 -0.576 . . . . 3.54 109.801 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.07 134.12 45.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.012 -0.366 . . . . 2.93 110.012 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.51 150.25 47.04 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.846 0.355 . . . . 3.64 111.172 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.62 -91.7 0.49 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.873 -0.679 . . . . 3.27 111.779 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 m -89.39 150.0 22.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.64 0.257 . . . . 3.59 110.787 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 137' ' ' ARG . 2.3 mmp_? -92.65 169.02 10.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.535 -0.302 . . . . 5.55 110.367 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -84.43 142.9 20.63 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.668 -0.777 . . . . 5.22 111.382 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.35 -108.74 3.24 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.774 -0.727 . . . . 5.91 111.68 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.4 m . . . . . 0 C--O 1.251 1.165 0 CA-C-O 119.228 -0.415 . . . . 7.27 111.439 179.841 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.492 -3.59 1 C4'-C3'-C2' 97.037 -5.663 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.467 2 N19-C1'-C2' 103.547 -6.158 . 0.235 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.709 3 O4'-C1'-N19 115.718 7.518 . 0.531 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.256 4 O4'-C1'-N19 116.633 8.433 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.092 2 C4'-C3'-C2' 97.556 -5.144 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.811 4 N19-C1'-C2' 106.361 -4.399 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.314 3 P-O3'-C3' 127.026 6.105 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.581 5.293 3 O4'-C4'-C3' 114.991 6.779 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.021 2 O4'-C1'-N19 118.705 10.505 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.603 3 O3'-P-O5' 116.374 6.513 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.113 1 C4'-C3'-C2' 98.302 -4.398 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.634 1 C4'-C3'-C2' 94.374 -8.326 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.738 1 O3'-P-O5' 111.72 4.063 . 0.107 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.01 2 C3'-C2'-C1' 105.723 4.692 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 111.606 -0.598 . . . . 9.05 111.606 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.47 163.72 25.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.918 -0.401 . . . . 8.09 109.918 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.0 tpt -93.41 103.7 15.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.454 -0.339 . . . . 8.02 110.203 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.49 79.43 0.34 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.619 -0.8 . . . . 5.76 112.616 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 22.9 mt -114.7 119.68 39.05 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 120.54 0.209 . . . . 4.72 110.644 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.32 63.94 7.13 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 123.218 2.612 . . . . 4.45 112.173 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -79.75 124.57 28.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 4.41 110.323 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -136.97 -102.58 0.2 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.337 -0.392 . . . . 3.92 110.437 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.3 m 59.66 84.99 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.826 0.676 . . . . 2.53 112.826 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.37 143.32 26.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.806 -0.634 . . . . 2.48 109.996 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 64.2 m -64.89 155.56 33.85 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.188 0.44 . . . . 2.13 112.188 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -84.53 -25.67 28.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.767 -0.652 . . . . 2.4 111.248 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 81.0 m-85 -114.31 164.95 13.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.969 -0.56 . . . . 2.02 110.751 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 10.4 p -70.99 158.42 36.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.101 -0.5 . . . . 2.65 110.256 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.41 177.09 9.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.489 . . . . 2.4 110.768 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.67 129.25 48.09 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.411 -0.589 . . . . 2.27 109.411 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -90.54 115.87 28.01 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.236 -0.438 . . . . 2.84 111.268 -179.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -83.13 143.97 30.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.835 0.35 . . . . 2.89 110.685 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -140.36 79.93 1.73 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.922 -0.581 . . . . 3.82 110.164 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -170.47 41.36 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.728 -0.748 . . . . 3.23 111.975 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 61.8 mmtt -88.09 -10.51 49.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.243 0.544 . . . . 4.27 110.868 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.38 166.3 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.554 -0.748 . . . . 3.32 109.974 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -104.6 -82.28 0.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.77 -0.456 . . . . 2.39 109.77 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.3 tp -177.82 135.28 0.17 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.329 0.393 . . . . 2.06 110.803 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -162.84 124.09 2.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.772 -0.649 . . . . 2.22 109.576 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.3 138.9 23.9 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.578 -0.283 . . . . 1.78 110.709 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.23 175.25 6.96 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.074 2.516 . . . . 2.15 112.563 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.69 126.3 27.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 2.6 112.03 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.85 78.2 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.93 -0.652 . . . . 1.65 112.712 178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -131.21 171.86 12.8 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.362 -0.236 . . . . 2.31 110.362 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.25 -8.14 69.49 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.661 -0.781 . . . . 1.33 112.783 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.15 114.73 63.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.673 0.273 . . . . 1.06 110.733 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.11 178.38 7.0 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.425 2.083 . . . . 1.27 111.472 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.449 HG22 HG23 ' A' ' 36' ' ' THR . 11.8 mt -77.38 81.77 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.868 0.366 . . . . 1.7 110.608 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 56.0 m-80 -81.73 81.55 7.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 1.23 109.942 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.449 HG23 HG22 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -76.07 3.98 9.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.1 -0.5 . . . . 1.94 112.156 -179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.9 -1.38 26.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.878 0.371 . . . . 1.96 111.368 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.46 164.85 21.85 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.892 0.377 . . . . 1.42 111.59 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.432 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -80.88 168.08 27.73 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 116.013 -0.539 . . . . 1.73 110.275 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 10.3 Cg_endo -54.85 -39.27 90.89 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.932 2.421 . . . . 1.42 113.039 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 2.4 p-10 -73.16 -23.77 60.48 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 120.719 0.295 . . . . 1.78 110.772 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.977 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 34.4 m-20 -79.04 -2.12 38.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.6 111.256 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.462 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 39.9 mm-40 -81.86 55.71 2.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.245 0.545 . . . . 1.05 111.142 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.68 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.4 tt -152.14 131.96 3.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.79 -0.641 . . . . 1.17 109.961 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.79 -137.9 2.53 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.305 -0.95 . . . . 0.6 112.683 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -160.42 166.96 28.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.945 0.403 . . . . 0.99 110.645 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.631 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 3.0 m-85 -105.96 134.3 49.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.082 -0.71 . . . . 1.26 109.082 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -115.18 123.38 48.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.247 -0.433 . . . . 2.15 111.031 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -79.69 111.08 15.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.991 -0.55 . . . . 2.4 110.048 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.22 165.02 11.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.892 0.377 . . . . 2.21 111.037 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.1 m -154.3 125.51 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 2.68 110.177 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HB3' HD12 ' A' ' 64' ' ' LEU . 17.4 tpt180 -115.37 120.62 40.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.915 0.388 . . . . 3.59 110.656 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -132.03 162.88 29.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 3.43 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.58 HG12 ' HB2' ' A' ' 62' ' ' LYS . 38.1 pt -125.38 162.76 27.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.175 -0.466 . . . . 4.26 109.912 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.71 99.29 6.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.885 0.374 . . . . 5.17 110.631 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.16 152.84 33.23 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.828 -0.701 . . . . 4.66 111.872 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.16 -37.57 94.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.032 -0.604 . . . . 5.04 112.382 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -85.0 11.18 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.174 0.511 . . . . 5.51 111.143 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.9 22.32 55.61 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.928 -0.653 . . . . 4.73 112.266 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 26.3 mmtt -79.54 156.56 27.7 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.246 -0.279 . . . . 5.52 110.246 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 48.3 mtm -140.1 158.89 43.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.743 0.306 . . . . 4.48 110.811 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.631 ' HE3' HD21 ' A' ' 64' ' ' LEU . 52.5 tttp -87.65 -40.19 14.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.19 -0.459 . . . . 4.16 110.451 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.7 t70 40.96 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.247 1.202 . . . . 4.09 114.247 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.631 HD21 ' HE3' ' A' ' 62' ' ' LYS . 90.9 mt -95.78 157.32 15.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.863 -0.608 . . . . 3.36 110.365 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.507 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.7 OUTLIER -69.72 153.06 95.92 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.73 -0.47 . . . . 3.36 109.73 179.145 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.46 113.85 1.49 Allowed 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.741 2.294 . . . . 2.69 112.057 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.413 HH21 HD13 ' A' ' 64' ' ' LEU . 48.1 mtt-85 -105.72 122.41 46.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 3.03 110.686 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.631 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 67.3 m95 -99.44 115.48 29.39 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.223 -0.444 . . . . 1.84 110.435 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -97.27 142.98 28.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.118 -0.492 . . . . 2.76 109.719 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.89 130.24 35.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 1.27 111.016 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -125.58 154.69 41.84 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.082 -0.508 . . . . 1.84 109.706 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -100.02 151.85 20.88 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.335 -0.393 . . . . 1.28 109.952 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.4 tt -60.38 112.23 1.87 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.262 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.49 -5.46 11.85 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.465 -0.874 . . . . 1.66 113.115 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 p -61.3 108.76 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 1.58 111.646 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.84 119.86 3.84 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.697 -0.763 . . . . 1.96 112.108 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.2 -37.33 51.95 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.662 2.242 . . . . 2.62 111.954 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -123.33 47.37 2.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.017 0.437 . . . . 3.09 111.013 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.43 -41.86 46.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.449 -0.574 . . . . 1.79 109.449 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 33.58 83.27 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.617 -0.719 . . . . 1.65 112.693 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.583 HD11 ' HD2' ' A' ' 87' ' ' LYS . 82.1 mt -131.05 99.12 18.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.778 0.323 . . . . 1.38 111.467 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.64 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 87.3 Cg_endo -82.87 170.38 12.57 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.488 2.125 . . . . 1.62 110.203 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.695 ' HB2' HD11 ' A' ' 73' ' ' LEU . 69.0 t80 -57.82 111.09 1.04 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.783 0.325 . . . . 1.58 110.886 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.06 -17.31 10.69 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.807 -0.711 . . . . 1.44 112.386 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.04 108.22 1.76 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.832 0.349 . . . . 1.25 110.954 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -77.61 129.02 35.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.55 . . . . 1.86 110.936 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.583 ' HD2' HD11 ' A' ' 81' ' ' LEU . 75.0 tttt -143.14 162.64 35.03 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.458 -0.941 . . . . 1.68 108.458 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -63.81 110.64 2.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.881 0.372 . . . . 1.7 111.487 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.21 28.25 53.8 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.879 -0.677 . . . . 1.27 112.477 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.472 HG13 ' HB3' ' A' ' 87' ' ' LYS . 35.7 mm -128.68 105.99 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.972 0.415 . . . . 1.01 110.339 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.489 HG13 ' HB2' ' A' ' 47' ' ' TYR . 16.0 pt -117.7 127.0 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.198 -0.455 . . . . 1.3 110.135 178.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.527 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 80.3 m95 -87.25 138.25 31.65 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.141 0.423 . . . . 1.08 112.141 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.7 138.22 48.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.532 -0.758 . . . . 1.04 110.409 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.99 172.32 13.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.308 -0.406 . . . . 1.27 110.116 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 t -152.73 -176.37 5.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.403 -0.362 . . . . 1.36 110.791 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -65.71 134.82 54.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 2.64 111.118 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.4 -12.1 70.3 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.97 -0.633 . . . . 1.52 112.778 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -81.07 146.15 30.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.795 0.331 . . . . 1.59 110.727 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.55 149.14 43.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.165 -0.471 . . . . 2.15 110.704 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -82.15 82.75 7.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.259 0.552 . . . . 2.07 110.151 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.588 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 53.0 m -154.5 127.84 4.31 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.274 -0.876 . . . . 2.36 108.705 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.7 129.97 37.48 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.814 2.342 . . . . 2.08 112.783 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.977 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.12 67.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.707 0.765 . . . . 1.78 110.74 179.25 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.19 -7.94 51.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.291 -0.868 . . . . 2.55 111.7 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.405 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.0 p80 -60.14 -22.0 62.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.172 0.434 . . . . 2.24 112.172 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.2 mt -87.82 -35.64 8.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.053 0.454 . . . . 2.0 110.563 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -80.83 66.42 3.75 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.931 -0.577 . . . . 2.33 112.436 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.5 t -148.35 16.68 1.04 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.533 0.682 . . . . 2.99 110.582 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -74.7 138.92 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.628 -0.715 . . . . 2.83 110.855 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -85.68 123.16 72.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.814 0.34 . . . . 3.56 110.605 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HB2' " H5'" ' C' ' 9' ' ' ' U' . 97.7 Cg_endo -77.62 -12.29 16.77 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.002 2.468 . . . . 3.39 114.293 -178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.487 ' HA ' ' H21' ' C' ' 8' ' ' ' G' . . . -111.3 9.67 21.65 Favored 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.995 -0.441 . . . . 4.05 111.544 -179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -136.85 12.16 3.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.215 -0.448 . . . . 4.48 111.226 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -169.38 142.12 2.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 3.39 111.033 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.447 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -92.37 141.73 28.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.388 -0.369 . . . . 3.21 110.624 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.49 146.89 38.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.323 -0.399 . . . . 2.85 110.755 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.419 ' H ' HG13 ' A' ' 117' ' ' ILE . 3.5 mt -77.17 147.58 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.645 -0.707 . . . . 2.42 109.988 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -67.75 120.19 14.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.055 -0.35 . . . . 2.74 110.055 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.31 121.67 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.08 -0.509 . . . . 2.11 111.536 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -132.11 142.56 49.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.702 -0.681 . . . . 2.49 110.482 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.561 HD13 HG22 ' A' ' 125' ' ' THR . 72.5 mt -94.16 148.39 35.06 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.184 -0.462 . . . . 1.91 110.296 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.21 167.25 16.78 Favored 'Trans proline' 0 C--O 1.237 0.448 0 C-N-CA 122.894 2.396 . . . . 1.84 112.266 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -60.72 127.07 29.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.924 -0.58 . . . . 2.53 110.661 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.89 -19.66 46.15 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.548 -0.621 . . . . 2.2 111.548 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.561 HG22 HD13 ' A' ' 121' ' ' LEU . 6.4 m -102.42 109.21 20.79 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.748 0.308 . . . . 2.1 110.396 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.6 160.35 14.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.444 -0.344 . . . . 2.78 110.735 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.3 mt -79.91 146.78 64.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.418 -0.355 . . . . 2.62 110.415 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 18.2 Cg_endo -62.87 160.49 33.14 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.33 2.02 . . . . 2.77 111.778 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -57.6 113.63 1.9 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.578 -0.737 . . . . 4.11 112.142 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.11 0.2 61.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.144 -0.55 . . . . 3.18 113.611 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.486 ' HB2' ' HG2' ' A' ' 128' ' ' PRO . 0.6 OUTLIER -101.15 129.99 47.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.828 0.314 . . . . 2.91 110.895 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -135.52 146.48 48.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.36 -0.382 . . . . 3.54 110.518 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.13 144.93 25.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.302 -0.408 . . . . 2.93 111.691 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 5.9 tt0 -67.81 128.45 36.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.946 -0.57 . . . . 3.64 110.175 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.23 -1.98 74.19 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 3.27 112.294 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 11.7 m -102.14 91.0 4.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.936 0.398 . . . . 3.59 111.181 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.476 ' NH2' H5'' ' B' ' 1' ' ' ' C' . 19.0 mmt180 -117.5 50.27 1.13 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.198 0.523 . . . . 5.55 109.918 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.76 153.97 35.31 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.743 -0.662 . . . . 5.22 112.768 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 138.32 -75.12 0.39 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.846 -0.902 . . . . 5.91 110.846 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 119.006 -0.521 . . . . 7.27 112.001 179.635 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.476 H5'' ' NH2' ' A' ' 137' ' ' ARG . . . . . . . . 0 C2'--C1' 1.491 -3.727 1 C4'-C3'-C2' 97.042 -5.658 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.507 2 N19-C1'-C2' 103.523 -6.173 . 0.235 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.699 3 O4'-C1'-N19 115.699 7.499 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.215 4 O4'-C1'-N19 116.718 8.518 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.115 2 C4'-C3'-C2' 97.565 -5.135 . 0.65 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.731 4 N19-C1'-C2' 106.338 -4.414 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.312 3 P-O3'-C3' 127.051 6.126 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.487 ' H21' ' HA ' ' A' ' 112' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.31 3 O4'-C4'-C3' 114.903 6.716 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . 0.444 " H5'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.543 -4.976 2 O4'-C1'-N19 118.697 10.497 . 0.415 1a . 14.39 . . . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.587 3 O3'-P-O5' 116.355 6.503 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.142 1 C4'-C3'-C2' 98.299 -4.401 . 0.308 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.606 1 C4'-C3'-C2' 94.356 -8.344 . 0.453 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.796 1 O3'-P-O5' 111.694 4.05 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.905 2 C3'-C2'-C1' 105.742 4.714 . 0.333 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.469 -0.652 . . . . 9.05 111.469 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.89 118.26 23.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.706 0.288 . . . . 8.09 110.225 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.7 mmt -75.21 -37.71 61.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.999 0.428 . . . . 8.02 111.314 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.95 34.55 55.62 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.958 -0.639 . . . . 5.76 111.558 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.2 mt -109.09 116.85 54.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.829 0.347 . . . . 4.72 111.188 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -78.57 51.41 3.76 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.974 2.449 . . . . 4.45 111.899 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -122.78 148.63 45.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.834 -0.621 . . . . 4.41 110.0 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -150.63 -61.53 0.19 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.471 -0.332 . . . . 3.92 110.94 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 p 53.01 78.17 0.15 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.362 0.875 . . . . 2.53 113.362 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.554 ' HB1' " O2'" ' C' ' 8' ' ' ' G' . . . -93.29 140.24 29.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.245 -0.434 . . . . 2.48 110.719 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -55.64 139.42 44.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.671 -0.695 . . . . 2.13 112.195 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -73.26 -25.36 60.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.887 -0.597 . . . . 2.4 112.06 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.9 m-85 -109.92 172.97 6.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.496 0.554 . . . . 2.02 112.496 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 p -74.45 -172.94 1.6 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.244 -0.889 . . . . 2.65 111.032 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -95.65 136.81 35.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.838 0.681 . . . . 2.4 112.838 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.598 HD13 ' HE2' ' A' ' 131' ' ' PHE . 17.6 mt -96.55 102.86 14.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.095 -1.076 . . . . 2.27 108.095 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.603 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -85.75 129.27 34.87 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 112.362 0.504 . . . . 2.84 112.362 -178.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.468 ' HB2' ' HE1' ' A' ' 131' ' ' PHE . 6.1 tp-100 -97.2 127.83 43.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.636 -0.711 . . . . 2.89 109.706 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.782 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 1.1 t60 -114.74 1.64 14.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.656 0.243 . . . . 3.82 111.656 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.39 -168.65 32.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.901 -0.666 . . . . 3.23 111.869 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -85.71 -33.41 21.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.864 0.364 . . . . 4.27 110.828 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -71.12 172.39 9.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 3.32 110.115 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.4 OUTLIER -101.05 -76.01 0.57 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.952 -0.299 . . . . 2.39 110.64 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 26' ' ' PHE . 23.6 tp -177.5 129.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.457 0.473 . . . . 2.06 111.16 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -156.34 119.23 4.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.291 -0.413 . . . . 2.22 110.212 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 62.2 m-85 -110.3 151.09 42.41 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.147 -0.478 . . . . 1.78 110.562 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.65 164.34 34.81 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.92 2.413 . . . . 2.15 111.538 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -70.44 124.02 23.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.553 -0.294 . . . . 2.6 110.616 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.69 -10.49 52.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.793 -0.718 . . . . 1.65 111.578 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -122.35 -176.82 3.46 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.62 -0.511 . . . . 2.31 109.62 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.55 -31.63 8.12 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.732 -0.747 . . . . 1.33 112.542 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.95 120.14 78.44 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 110.336 -0.246 . . . . 1.06 110.336 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.74 -175.43 2.69 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.787 2.325 . . . . 1.27 112.267 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.1 mt -78.51 87.17 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 1.7 110.109 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 63.7 m-80 -82.38 73.04 9.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.325 -0.398 . . . . 1.23 110.557 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.1 68.52 1.89 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.036 -0.529 . . . . 1.94 111.047 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -176.7 -27.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.913 -0.585 . . . . 1.96 110.906 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.76 157.99 16.82 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.149 0.426 . . . . 1.42 112.149 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.06 164.14 61.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.767 -0.652 . . . . 1.73 111.105 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.11 -40.38 77.46 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.132 2.555 . . . . 1.42 113.389 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.53 -16.61 61.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.781 -0.367 . . . . 1.78 111.404 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.86 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 16.1 m-20 -87.42 -0.77 57.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.857 -0.611 . . . . 1.6 110.75 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.531 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 54.0 mm-40 -79.29 58.17 2.5 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.242 0.544 . . . . 1.05 110.714 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.538 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.4 tt -149.19 133.24 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.546 -0.752 . . . . 1.17 109.598 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.3 -144.5 5.38 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.342 -0.932 . . . . 0.6 112.633 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.65 162.1 41.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.871 0.367 . . . . 0.99 110.581 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.561 ' HB2' HG13 ' A' ' 91' ' ' ILE . 27.9 m-85 -102.22 123.97 46.98 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.838 -0.801 . . . . 1.26 108.838 178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttt-85 -101.72 133.61 46.18 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.009 -0.541 . . . . 2.15 111.231 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -82.17 129.26 34.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.925 -0.58 . . . . 2.4 110.099 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.96 130.17 43.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.099 0.476 . . . . 2.21 111.501 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.46 111.82 12.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 2.68 109.773 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.637 ' HB3' HD12 ' A' ' 64' ' ' LEU . 12.1 tpt180 -91.68 111.02 22.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.293 0.568 . . . . 3.59 111.367 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -133.27 103.38 5.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 3.43 110.62 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.629 HG12 ' HB2' ' A' ' 62' ' ' LYS . 44.2 pt -84.8 146.87 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 4.26 110.357 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 -120.69 111.44 17.61 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.799 0.333 . . . . 5.17 110.487 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.13 160.5 32.14 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.801 -0.714 . . . . 4.66 112.268 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.48 -24.82 75.61 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.154 -0.546 . . . . 5.04 112.14 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.81 -34.4 71.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.089 0.471 . . . . 5.51 110.1 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.11 29.13 1.26 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.772 -0.728 . . . . 4.73 113.103 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -112.25 154.34 25.77 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.646 -0.326 . . . . 5.52 111.017 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.414 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 38.1 mtt -141.61 132.27 25.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.98 -0.554 . . . . 4.48 109.794 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.629 ' HB2' HG12 ' A' ' 54' ' ' ILE . 48.8 tttp -58.19 -52.15 66.76 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.729 -0.214 . . . . 4.16 111.134 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.4 t0 56.84 89.28 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.811 0.695 . . . . 4.09 112.51 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.637 HD12 ' HB3' ' A' ' 52' ' ' ARG . 66.1 mt -101.08 170.15 8.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.112 0.482 . . . . 3.36 111.47 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.26 156.57 66.24 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.61 -0.723 . . . . 3.36 109.578 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.93 117.79 4.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 2.69 111.865 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 67' ' ' ARG . 15.0 mtt-85 -114.28 133.91 55.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.815 -0.63 . . . . 3.03 110.104 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.422 ' HZ2' ' HB3' ' A' ' 23' ' ' ASP . 80.7 m95 -109.49 136.44 48.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.365 -0.38 . . . . 1.84 111.149 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.558 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 55.6 m-85 -123.54 138.3 54.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.444 -0.576 . . . . 2.76 109.444 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -86.9 131.62 34.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.854 0.359 . . . . 1.27 111.611 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -128.23 144.9 51.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.942 -0.572 . . . . 1.84 110.115 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -77.69 151.81 34.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.247 -0.433 . . . . 1.28 110.083 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 6.1 tt -64.39 120.28 11.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.582 -0.281 . . . . 1.66 110.669 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 112.38 -1.36 26.54 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.697 -0.763 . . . . 1.66 112.495 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 p -65.9 117.15 7.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.777 0.322 . . . . 1.58 110.866 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.22 112.38 3.21 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.946 -0.645 . . . . 1.96 111.731 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.42 -41.42 78.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.993 2.462 . . . . 2.62 111.908 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -110.52 39.74 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 3.09 111.034 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.01 -56.15 4.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.398 . . . . 1.79 110.677 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.67 45.88 95.38 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.1 -0.571 . . . . 1.65 112.184 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.74 108.03 17.03 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 120.655 0.264 . . . . 1.38 111.514 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 96.1 Cg_endo -86.92 173.77 5.8 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.811 2.34 . . . . 1.62 111.042 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.422 ' HB2' HD11 ' A' ' 73' ' ' LEU . 54.9 t80 -64.17 113.42 3.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.998 0.427 . . . . 1.58 110.737 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.02 -0.37 25.57 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.773 -0.727 . . . . 1.44 112.51 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.01 113.33 3.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 1.25 110.981 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -77.1 103.25 6.92 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 1.86 111.329 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 tttt -132.22 165.6 23.76 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.219 -0.446 . . . . 1.68 110.542 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -63.36 111.19 2.19 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.652 0.612 . . . . 1.7 112.652 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.21 41.77 85.44 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.735 -0.666 . . . . 1.27 112.948 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.9 mm -131.27 104.02 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 1.01 110.799 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.561 HG13 ' HB2' ' A' ' 47' ' ' TYR . 5.2 pt -110.12 123.59 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.068 -0.515 . . . . 1.3 109.875 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.444 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 80.5 m95 -89.76 135.88 33.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.129 -0.487 . . . . 1.08 112.082 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -137.24 145.63 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.032 -0.531 . . . . 1.04 110.612 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -149.29 149.69 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.144 -0.48 . . . . 1.27 110.491 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.4 t -106.84 169.29 8.63 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.07 -0.345 . . . . 1.36 110.07 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -70.11 111.34 5.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.799 -0.445 . . . . 2.64 109.799 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.49 -13.9 8.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.906 -0.664 . . . . 1.52 111.576 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.89 146.64 43.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.828 0.347 . . . . 1.59 110.547 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.1 mt -108.73 142.71 38.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.298 -0.41 . . . . 2.15 111.5 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -80.35 90.35 5.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.9 -0.591 . . . . 2.07 110.574 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.428 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 5.2 t -162.76 146.12 8.72 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.113 -0.699 . . . . 2.36 109.113 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.79 121.38 7.85 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 121.941 1.761 . . . . 2.08 111.246 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.86 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.83 76.9 1.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 1.78 112.343 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 2.7 p-10 -85.56 5.91 29.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.34 -0.391 . . . . 2.55 111.394 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.9 p80 -57.84 -23.11 51.27 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.773 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.17 9.2 8.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.003 -0.544 . . . . 2.0 110.256 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.53 -35.65 13.59 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.652 -0.785 . . . . 2.33 111.973 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 t -68.65 125.59 27.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.202 0.525 . . . . 2.99 110.863 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.8 ttp85 -162.59 125.72 2.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.9 -0.591 . . . . 2.83 109.873 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -86.42 116.39 65.7 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 123.276 0.36 . . . . 3.56 110.673 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.73 -32.51 46.82 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.879 2.386 . . . . 3.39 112.958 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.35 0.26 49.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.84 0.311 . . . . 4.05 111.84 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -128.39 -4.76 5.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.963 0.411 . . . . 4.48 111.167 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -149.88 128.25 12.17 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.766 0.317 . . . . 3.39 110.944 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.29 155.42 30.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.019 -0.537 . . . . 3.21 110.756 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.95 160.3 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.038 0.447 . . . . 2.85 111.435 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 18.6 mt -101.5 146.54 9.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.711 -0.677 . . . . 2.42 109.621 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.3 t -67.23 120.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.61 0.243 . . . . 2.74 110.407 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.2 tt -63.57 114.43 3.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.008 -0.542 . . . . 2.11 111.082 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -136.84 152.96 50.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.942 -0.572 . . . . 2.49 110.61 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.51 HD13 HG22 ' A' ' 125' ' ' THR . 72.3 mt -100.94 147.7 34.05 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.062 -0.517 . . . . 1.91 110.114 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.56 160.86 30.27 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.756 2.304 . . . . 1.84 112.782 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -60.53 120.36 9.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.794 -0.639 . . . . 2.53 110.478 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.1 -19.82 14.84 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.098 -1.201 . . . . 2.2 110.098 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.51 HG22 HD13 ' A' ' 121' ' ' LEU . 6.3 m -112.61 114.79 27.58 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.845 -0.798 . . . . 2.1 108.845 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 156.78 18.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.33 -0.396 . . . . 2.78 111.55 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.44 148.19 76.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.737 -0.665 . . . . 2.62 109.698 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 28.4 Cg_endo -65.64 156.99 60.96 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.44 2.094 . . . . 2.77 111.448 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.46 120.95 14.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 4.11 111.644 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 103.17 -2.1 47.32 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.419 -0.672 . . . . 3.18 111.419 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.598 ' HE2' HD13 ' A' ' 16' ' ' LEU . 1.6 t80 -110.3 129.38 55.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.619 -0.29 . . . . 2.91 110.613 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.782 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 26.3 p90 -141.12 162.85 34.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 3.54 110.064 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -119.05 148.01 43.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.721 0.296 . . . . 2.93 111.029 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -70.0 131.05 43.78 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.591 -0.522 . . . . 3.64 109.591 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.78 -26.6 23.78 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.836 -0.697 . . . . 3.27 112.191 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.3 m -77.39 141.87 39.57 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 122.593 -0.357 . . . . 3.59 110.701 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.458 ' NE ' ' HA ' ' A' ' 137' ' ' ARG . 3.5 mmp_? -133.85 87.0 2.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 5.55 110.424 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.67 105.43 1.24 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.81 -0.632 . . . . 5.22 112.408 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 126.72 -92.86 0.39 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.361 -0.696 . . . . 5.91 111.361 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.881 -0.58 . . . . 7.27 111.562 -179.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.4 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.492 -3.602 1 C4'-C3'-C2' 97.053 -5.647 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.4 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.504 2 N19-C1'-C2' 103.548 -6.158 . 0.229 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.697 3 O4'-C1'-N19 115.727 7.527 . 0.527 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.162 4 O4'-C1'-N19 116.668 8.468 . 0.509 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.374 -4.133 2 C4'-C3'-C2' 97.573 -5.127 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.653 4 N19-C1'-C2' 106.394 -4.379 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.497 5.319 3 P-O3'-C3' 127.006 6.088 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.558 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.583 5.518 3 O4'-C4'-C3' 114.971 6.765 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.029 2 O4'-C1'-N19 118.646 10.446 . 0.414 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.539 3 O3'-P-O5' 116.354 6.502 . 0.458 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.247 1 C4'-C3'-C2' 98.248 -4.452 . 0.308 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.645 1 C4'-C3'-C2' 94.303 -8.397 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.772 1 O3'-P-O5' 111.688 4.046 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.858 2 C3'-C2'-C1' 105.684 4.649 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 111.895 -0.482 . . . . 9.05 111.895 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.31 111.19 22.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.749 0.309 . . . . 8.09 110.376 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.442 ' HB3' ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER -91.86 -160.56 0.74 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.099 0.476 . . . . 8.02 111.192 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' H ' ' HB3' ' A' ' 3' ' ' MET . . . -134.52 -176.77 14.53 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.467 -0.653 . . . . 5.76 111.467 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.5 tp -113.75 103.19 55.35 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.744 0.307 . . . . 4.72 111.366 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -95.04 59.85 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.375 2.717 . . . . 4.45 111.539 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -95.53 104.85 16.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.958 -0.564 . . . . 4.41 111.34 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -133.77 -171.02 2.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.854 -0.612 . . . . 3.92 110.442 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 m 73.12 94.51 0.08 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.429 0.633 . . . . 2.53 112.345 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -115.21 -162.36 0.82 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.959 -0.564 . . . . 2.48 110.814 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.06 166.39 12.17 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.484 -0.326 . . . . 2.13 110.895 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.85 -38.64 7.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.313 0.577 . . . . 2.4 110.2 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.4 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 86.1 m-85 -108.58 165.67 11.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.649 -0.705 . . . . 2.02 110.402 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.939 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 8.3 p -58.86 151.76 20.84 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.397 0.436 . . . . 2.65 111.366 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HB3' ' HD3' ' A' ' 67' ' ' ARG . . . -75.98 137.31 40.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.124 0.488 . . . . 2.4 112.015 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 55.4 mt -88.89 147.75 24.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.94 -0.763 . . . . 2.27 108.94 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.658 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -126.36 138.75 53.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.828 -0.349 . . . . 2.84 111.388 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -99.71 132.32 45.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 2.89 110.98 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.61 62.66 1.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.247 -0.649 . . . . 3.82 109.247 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.46 -159.68 9.58 Favored Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.686 -0.688 . . . . 3.23 111.907 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -91.05 -25.08 19.84 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.161 0.43 . . . . 4.27 112.161 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -90.6 176.02 6.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.671 0.272 . . . . 3.32 110.58 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.84 -71.38 0.68 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.961 -0.385 . . . . 2.39 109.961 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.9 tp 177.85 142.3 0.09 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.842 -0.617 . . . . 2.06 110.534 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -156.31 133.82 10.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.385 -0.37 . . . . 2.22 110.029 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 43.1 m-85 -127.61 134.32 26.05 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.956 -0.387 . . . . 1.78 109.956 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 22.3 Cg_exo -65.51 167.44 16.97 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.895 2.396 . . . . 2.15 112.411 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -64.54 127.06 29.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.928 -0.578 . . . . 2.6 110.518 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.09 6.88 78.24 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.826 -0.702 . . . . 1.65 112.466 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -138.75 147.27 42.45 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.232 -0.285 . . . . 2.31 110.232 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.63 -28.25 5.28 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.683 -0.77 . . . . 1.33 112.908 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.01 119.21 75.83 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.663 0.232 . . . . 1.06 110.725 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.478 ' HG2' HD21 ' A' ' 35' ' ' ASN . 41.8 Cg_endo -67.94 168.71 18.07 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.556 2.17 . . . . 1.27 111.851 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.8 mt -74.62 81.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.133 0.492 . . . . 1.7 111.604 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.478 HD21 ' HG2' ' A' ' 33' ' ' PRO . 40.5 m-80 -83.97 86.61 7.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.943 -0.572 . . . . 1.23 110.118 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -21.66 65.48 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.186 -0.461 . . . . 1.94 111.597 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -75.85 -18.55 59.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.241 -0.436 . . . . 1.96 111.258 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -111.24 151.05 28.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.511 -0.313 . . . . 1.42 110.798 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.588 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 6.1 m -73.76 165.47 52.85 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 1.73 109.921 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.3 Cg_endo -52.77 -39.54 76.87 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.955 2.437 . . . . 1.42 113.342 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.682 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -76.51 -9.91 59.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.954 0.353 . . . . 1.78 111.954 -179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.65 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.6 m-20 -95.09 1.58 54.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.049 0.452 . . . . 1.6 109.946 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -83.9 61.64 6.52 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.058 -0.519 . . . . 1.05 111.108 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.761 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 15.2 tt -146.93 130.54 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.755 -0.657 . . . . 1.17 109.908 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.77 -141.32 3.51 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.237 -0.982 . . . . 0.6 113.111 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -163.69 170.18 17.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 0.99 110.345 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.466 ' HB2' HG13 ' A' ' 91' ' ' ILE . 42.9 m-85 -109.94 130.31 55.55 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.507 -0.553 . . . . 1.26 109.507 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -103.41 132.38 49.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.895 0.379 . . . . 2.15 111.657 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -85.54 119.53 25.99 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.744 . . . . 2.4 110.216 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -134.64 157.03 47.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.117 0.484 . . . . 2.21 111.185 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 64' ' ' LEU . 93.9 m -154.06 104.6 2.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.793 -0.639 . . . . 2.68 109.764 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' HB3' HD12 ' A' ' 64' ' ' LEU . 10.1 tpt180 -83.32 113.15 20.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.912 0.387 . . . . 3.59 111.459 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 5.6 mtp180 -121.72 87.47 2.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 3.43 109.438 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 61' ' ' MET . 38.5 pt -79.38 148.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 4.26 111.134 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -107.0 111.5 24.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 5.17 110.084 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.565 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -73.02 -167.03 10.74 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.933 -0.651 . . . . 4.66 113.606 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.56 -45.53 66.77 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.314 -0.47 . . . . 5.04 113.293 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' OD2' ' HE2' ' A' ' 60' ' ' LYS . 13.4 t70 -77.9 -10.86 59.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.342 0.591 . . . . 5.51 110.804 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.76 22.82 10.57 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.186 -0.765 . . . . 4.73 111.186 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.548 ' HE3' ' OP2' ' C' ' 14' ' ' ' G' . 72.0 mmtt -84.24 159.34 21.0 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.044 -0.354 . . . . 5.52 110.044 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 35.6 mtt -133.4 131.82 40.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.371 -0.377 . . . . 4.48 110.01 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.462 ' HA ' ' O4 ' ' C' ' 13' ' ' ' U' . 54.2 tttt -60.95 -36.6 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.422 -0.584 . . . . 4.16 109.422 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 29.3 t0 50.28 77.93 0.11 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 114.766 -1.106 . . . . 4.09 112.824 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 52' ' ' ARG . 89.3 mt -80.37 146.03 31.73 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.397 -0.594 . . . . 3.36 109.397 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 45.1 m -69.12 158.15 87.34 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.278 -0.268 . . . . 3.36 110.278 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 9.7 Cg_endo -51.61 103.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.922 2.415 . . . . 2.69 112.644 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.501 HH22 ' CD ' ' A' ' 134' ' ' GLU . 3.4 mtt180 -101.42 138.8 37.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.836 -0.62 . . . . 3.03 110.296 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -105.8 124.55 49.75 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.728 -0.669 . . . . 1.84 110.72 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.741 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 32.6 m-85 -109.42 127.32 54.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.683 -0.689 . . . . 2.76 109.525 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -78.07 126.47 30.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.905 0.383 . . . . 1.27 111.26 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -124.54 149.32 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.895 -0.78 . . . . 1.84 108.895 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -81.72 157.49 24.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.326 -0.25 . . . . 1.28 110.326 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.6 tp -58.45 115.34 2.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.524 -0.307 . . . . 1.66 111.045 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.57 52.19 4.03 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.606 -0.807 . . . . 1.66 111.852 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.94 78.55 5.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.921 0.391 . . . . 1.58 111.419 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.46 139.32 2.75 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.846 -0.692 . . . . 1.96 112.178 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.84 -26.27 32.3 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.587 2.191 . . . . 2.62 112.162 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -127.2 35.92 4.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.886 0.374 . . . . 3.09 110.645 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.18 -55.59 5.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.999 -0.546 . . . . 1.79 110.95 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.13 36.57 92.05 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.786 -0.721 . . . . 1.65 112.019 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.67 103.55 53.72 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.026 0.441 . . . . 1.38 111.658 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.755 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 85.8 Cg_endo -84.8 165.46 11.81 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.388 2.059 . . . . 1.62 110.546 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -64.47 105.99 1.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.861 0.362 . . . . 1.58 110.274 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.13 -11.87 7.67 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.8 -0.714 . . . . 1.44 112.376 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -54.78 117.12 3.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.806 0.336 . . . . 1.25 111.389 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -76.48 99.76 5.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.539 . . . . 1.86 111.405 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -129.65 148.72 51.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.832 -0.622 . . . . 1.68 110.128 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -67.62 119.34 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.193 0.442 . . . . 1.7 112.193 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.02 53.31 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.848 -0.614 . . . . 1.27 112.624 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -129.54 111.09 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.88 0.371 . . . . 1.01 110.875 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.466 HG13 ' HB2' ' A' ' 47' ' ' TYR . 5.8 pt -115.91 118.71 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 1.3 110.08 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -81.72 136.95 35.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.634 0.605 . . . . 1.08 112.634 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 m -137.93 145.13 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.682 -0.69 . . . . 1.04 110.832 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.78 -177.58 6.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.274 -0.421 . . . . 1.27 109.972 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 t -153.64 172.8 16.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.629 -0.259 . . . . 1.36 110.581 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -63.62 115.91 5.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.275 0.559 . . . . 2.64 111.23 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.52 -19.63 16.47 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.82 -0.705 . . . . 1.52 112.001 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.761 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.85 126.98 31.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.382 -0.229 . . . . 1.59 110.382 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.682 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 66.9 mt -96.54 156.05 16.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.894 0.378 . . . . 2.15 111.295 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -84.4 83.82 7.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.145 0.498 . . . . 2.07 110.176 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.5 m -153.17 133.98 8.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.854 -0.612 . . . . 2.36 109.463 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.18 125.84 18.62 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.171 2.581 . . . . 2.08 112.086 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.65 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 55.3 mmtt -105.45 39.23 1.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.649 -0.705 . . . . 1.78 111.244 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -13.65 59.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.114 -0.493 . . . . 2.55 111.551 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -70.38 -17.59 63.04 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.107 -0.497 . . . . 2.24 111.472 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 7.1 mt -96.02 -33.88 4.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.329 . . . . 2.0 110.768 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.58 57.22 4.17 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.914 -0.585 . . . . 2.33 112.389 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.7 t -134.1 20.23 3.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.421 0.629 . . . . 2.99 109.582 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.5 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 13.0 ttp180 -83.21 136.5 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.737 -0.665 . . . . 2.83 111.702 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.443 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 4.1 m-20 -96.84 114.6 64.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 3.56 110.095 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.53 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 26.6 Cg_endo -61.47 -28.3 83.42 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.912 2.408 . . . . 3.39 113.182 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.94 -10.84 59.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.806 0.336 . . . . 4.05 111.364 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -116.31 -21.53 9.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.477 -0.328 . . . . 4.48 111.709 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.5 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 2.7 t-20 -137.14 120.0 16.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.689 0.28 . . . . 3.39 110.61 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.95 155.54 39.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.055 -0.52 . . . . 3.21 111.625 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.44 154.19 24.09 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.157 -0.474 . . . . 2.85 111.204 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 18.6 mt -102.74 150.34 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.777 -0.453 . . . . 2.42 109.777 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.1 t -64.7 120.19 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.586 0.231 . . . . 2.74 110.415 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.54 119.39 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 2.11 110.517 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -122.88 160.53 25.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.293 -0.412 . . . . 2.49 110.699 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.627 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 87.3 mt -110.08 150.4 41.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.216 -0.447 . . . . 1.91 111.297 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -65.05 170.88 9.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.986 2.457 . . . . 1.84 112.27 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.08 113.36 3.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.81 -0.632 . . . . 2.53 111.254 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 110.51 -14.0 30.2 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.993 -0.622 . . . . 2.2 112.723 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 4.7 m -88.47 140.95 28.94 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.707 -0.29 . . . . 2.1 110.393 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.39 144.82 50.79 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.818 0.342 . . . . 2.78 111.793 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.47 ' HG ' HD11 ' A' ' 121' ' ' LEU . 21.9 mt -87.28 144.38 35.91 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.08 -0.509 . . . . 2.62 109.738 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -57.34 156.18 26.89 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.913 2.408 . . . . 2.77 112.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -62.01 122.4 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.743 -0.662 . . . . 4.11 111.122 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.02 -8.53 61.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.917 -0.658 . . . . 3.18 111.873 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 3.7 t80 -97.1 144.16 27.22 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.916 -0.402 . . . . 2.91 109.916 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.658 ' CE1' ' HB ' ' A' ' 17' ' ' THR . 3.9 p90 -147.88 171.73 15.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.172 -0.467 . . . . 3.54 110.478 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -121.82 147.33 46.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 2.93 111.059 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.939 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.2 tp10 -68.47 122.5 18.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 3.64 110.67 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.21 -13.86 66.65 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.013 -0.613 . . . . 3.27 112.98 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.7 m -76.54 106.28 8.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.929 0.395 . . . . 3.59 111.779 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -119.69 91.53 3.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.789 -0.819 . . . . 5.55 108.789 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.87 160.34 50.22 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.056 -0.592 . . . . 5.22 112.51 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.64 -94.83 0.77 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.923 -0.656 . . . . 5.91 112.087 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.415 -0.802 . . . . 7.27 111.662 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.572 1 C4'-C3'-C2' 97.023 -5.677 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.53 2 N19-C1'-C2' 103.505 -6.185 . 0.23 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.82 3 O4'-C1'-N19 115.743 7.543 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.188 4 O4'-C1'-N19 116.692 8.492 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.373 -4.159 2 C4'-C3'-C2' 97.541 -5.159 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.784 4 C1'-O4'-C4' 105.611 -4.432 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.252 3 P-O3'-C3' 127.053 6.128 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.741 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.581 5.31 3 O4'-C4'-C3' 114.96 6.757 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.101 2 O4'-C1'-N19 118.595 10.395 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.528 3 O3'-P-O5' 116.374 6.513 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.06 1 C4'-C3'-C2' 98.336 -4.364 . 0.313 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.533 1 C4'-C3'-C2' 94.393 -8.307 . 0.458 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.565 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.74 1 O3'-P-O5' 111.75 4.079 . 0.104 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . 0.548 ' OP2' ' HE3' ' A' ' 60' ' ' LYS . . . . . . . . 2 C2'--C1' 1.577 4.913 2 C3'-C2'-C1' 105.695 4.661 . 0.337 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.526 -0.63 . . . . 9.05 111.526 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.76 114.31 16.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.792 0.33 . . . . 8.09 110.176 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.75 110.62 12.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.275 -0.42 . . . . 8.02 111.339 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.76 141.66 7.66 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.365 -0.694 . . . . 5.76 111.365 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 mp -110.45 138.82 21.05 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.577 0.188 . . . . 4.72 110.738 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.93 -1.98 11.54 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.837 2.358 . . . . 4.45 112.46 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -73.12 142.74 47.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.209 -0.451 . . . . 4.41 110.521 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -92.79 -82.5 0.33 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.613 -0.267 . . . . 3.92 110.774 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 54.56 56.38 6.88 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.375 0.422 . . . . 2.53 111.564 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.53 160.49 29.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 2.48 111.906 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.52 164.91 26.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.964 -0.562 . . . . 2.13 111.016 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -90.65 -25.47 20.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.428 -0.351 . . . . 2.4 111.864 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 59.6 m-85 -115.75 171.61 7.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.27 0.47 . . . . 2.02 112.27 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.844 HG22 " H5'" ' C' ' 8' ' ' ' G' . 1.9 p -70.83 167.15 19.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 2.65 111.048 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -91.75 161.58 14.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.487 . . . . 2.4 111.058 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.98 127.24 56.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.505 -0.77 . . . . 2.27 109.758 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.562 HG23 ' HB2' ' A' ' 65' ' ' SER . 80.7 m -90.93 126.86 36.18 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.301 -0.409 . . . . 2.84 111.058 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -97.08 134.01 40.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 2.89 110.199 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -130.82 90.26 2.88 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.713 -0.676 . . . . 3.82 109.308 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.36 -151.25 8.72 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.566 -0.826 . . . . 3.23 112.828 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 71.2 mmtt -108.6 -2.21 18.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.801 0.334 . . . . 4.27 111.789 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -120.07 176.76 5.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.257 -0.275 . . . . 3.32 110.257 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.49 -87.62 0.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.283 -0.417 . . . . 2.39 110.76 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 131' ' ' PHE . 55.4 tp -172.36 127.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.84 0.353 . . . . 2.06 110.869 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -148.93 105.11 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.963 -0.562 . . . . 2.22 109.949 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -89.24 146.97 37.26 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.074 -0.512 . . . . 1.78 110.541 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 57.6 Cg_endo -72.0 163.34 39.12 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.569 2.18 . . . . 2.15 111.857 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -58.11 122.54 13.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.884 -0.598 . . . . 2.6 111.016 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.11 -12.32 66.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.612 -0.804 . . . . 1.65 113.172 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.502 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 37.0 tt0 -118.06 157.73 26.29 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.632 -0.334 . . . . 2.31 110.969 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 126.16 -26.16 5.34 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.57 -0.612 . . . . 1.33 111.57 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.1 t -79.43 119.65 77.69 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.343 -0.243 . . . . 1.06 110.343 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.15 -170.44 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.488 2.125 . . . . 1.27 110.797 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.94 90.84 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.121 0.486 . . . . 1.7 110.816 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 70.2 m-20 -93.98 73.36 4.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.417 -0.586 . . . . 1.23 109.417 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.45 -20.73 66.12 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.362 -0.835 . . . . 1.94 111.927 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -82.45 -3.48 55.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.33 -0.396 . . . . 1.96 111.84 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -126.69 159.58 33.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.921 0.391 . . . . 1.42 111.815 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.624 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 m -82.67 167.24 31.19 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.634 -0.712 . . . . 1.73 110.139 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.624 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 13.7 Cg_endo -55.88 -35.67 94.34 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.939 2.426 . . . . 1.42 112.878 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.667 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.4 p-10 -78.73 -11.22 59.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.267 -0.424 . . . . 1.78 111.605 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -97.46 -1.9 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 1.6 109.895 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.482 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 75.6 mm-40 -78.52 53.88 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 1.05 111.119 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.58 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 13.5 tt -144.09 125.57 10.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.794 -0.639 . . . . 1.17 109.856 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.44 -145.23 4.38 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.142 -1.028 . . . . 0.6 112.522 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.454 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 48.8 p90 -160.02 170.75 20.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.121 -0.326 . . . . 0.99 110.121 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.676 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 39.0 m-85 -112.51 136.95 51.41 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.503 -0.554 . . . . 1.26 109.503 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -115.27 132.07 56.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.569 0.224 . . . . 2.15 110.534 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -82.03 124.99 30.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.076 -0.511 . . . . 2.4 109.672 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -133.61 156.2 48.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.939 0.4 . . . . 2.21 111.206 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 m -158.53 134.65 9.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.978 -0.555 . . . . 2.68 109.935 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 52' ' ' ARG . 4.1 tpt180 -107.07 122.17 45.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 3.59 110.461 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 4.3 ttt180 -138.96 82.38 1.9 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.716 0.293 . . . . 3.43 111.532 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.825 HG12 ' HB2' ' A' ' 62' ' ' LYS . 26.3 pt -72.13 154.73 7.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.448 -0.342 . . . . 4.26 110.539 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -106.51 113.44 26.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.193 -0.458 . . . . 5.17 110.091 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.522 ' HA2' ' OP2' ' C' ' 13' ' ' ' U' . . . -72.51 161.52 54.39 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.161 -0.542 . . . . 4.66 112.449 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.94 -38.53 94.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.539 -0.362 . . . . 5.04 113.068 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -69.24 -35.98 76.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.161 0.505 . . . . 5.51 110.768 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 131.47 2.34 4.51 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.009 -0.836 . . . . 4.73 111.009 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -76.34 158.54 31.37 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.044 -0.354 . . . . 5.52 110.044 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.1 mmt -122.64 147.35 46.54 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.873 -0.417 . . . . 4.48 109.873 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.825 ' HB2' HG12 ' A' ' 54' ' ' ILE . 39.6 tptt -55.44 -49.73 71.67 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.521 0.513 . . . . 4.16 110.421 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.455 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 15.0 t70 59.02 91.17 0.05 OUTLIER 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.561 -0.745 . . . . 4.09 112.691 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.78 148.63 36.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.735 -0.666 . . . . 3.36 110.161 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.562 ' HB2' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -70.32 146.44 94.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.16 -0.473 . . . . 3.36 110.557 179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.5 118.45 5.33 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.858 2.372 . . . . 2.69 111.559 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -119.09 146.36 45.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.097 -0.502 . . . . 3.03 111.31 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.676 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.7 m95 -112.8 131.3 55.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.721 -0.672 . . . . 1.84 110.227 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 50' ' ' ALA . 58.6 m-85 -109.66 145.29 36.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.101 -0.499 . . . . 2.76 109.685 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -94.63 127.64 40.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 1.27 111.257 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -130.4 162.49 29.01 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.977 -0.556 . . . . 1.84 109.673 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -93.52 168.39 11.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.582 -0.281 . . . . 1.28 110.418 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.58 126.94 29.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.524 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.67 47.1 92.49 Favored Glycine 0 CA--C 1.516 0.105 0 N-CA-C 115.274 0.869 . . . . 1.66 115.274 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -74.92 101.97 4.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.246 0.523 . . . . 1.58 110.023 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 121.82 136.97 5.1 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.828 -0.701 . . . . 1.96 111.431 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.79 -28.4 68.02 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.678 2.252 . . . . 2.62 112.496 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.9 53.01 1.41 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 3.09 110.743 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.08 -46.97 5.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.879 -0.6 . . . . 1.79 110.515 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.26 55.64 24.84 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.882 -0.887 . . . . 1.65 110.882 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.779 ' HB3' ' HH2' ' A' ' 92' ' ' TRP . 65.2 mt -125.93 94.93 40.73 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 1.38 111.968 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -91.33 135.93 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 1.62 110.812 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -52.57 115.16 1.64 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.251 -0.431 . . . . 1.58 111.568 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.95 -21.38 8.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.919 -0.658 . . . . 1.44 112.778 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.83 163.49 21.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.993 0.425 . . . . 1.25 111.026 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.64 131.21 56.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.442 -0.345 . . . . 1.86 110.936 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -148.53 155.83 41.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.057 -0.52 . . . . 1.68 110.109 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.35 117.57 8.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.257 -0.429 . . . . 1.7 111.919 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.6 34.62 67.34 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.75 -0.659 . . . . 1.27 112.635 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.3 mm -134.44 114.95 19.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.748 0.308 . . . . 1.01 110.687 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 91' ' ' ILE . 8.5 pt -123.03 134.78 65.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.878 -0.416 . . . . 1.3 109.878 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.779 ' HH2' ' HB3' ' A' ' 81' ' ' LEU . 56.5 m95 -90.28 144.82 25.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.586 0.587 . . . . 1.08 112.586 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.466 HG11 ' HA3' ' A' ' 31' ' ' GLY . 11.0 m -142.07 134.6 27.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.521 -0.763 . . . . 1.04 109.993 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.62 147.46 26.78 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.818 0.342 . . . . 1.27 111.229 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 43' ' ' GLN . 2.8 t -106.42 166.83 10.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.984 -0.553 . . . . 1.36 109.892 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.05 117.87 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.048 0.452 . . . . 2.64 110.319 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.7 -4.71 22.84 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.901 -0.666 . . . . 1.52 111.974 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.667 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -80.27 144.98 32.41 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.439 -0.208 . . . . 1.59 110.439 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 62.0 mt -90.38 139.61 30.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.728 0.299 . . . . 2.15 110.867 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -84.06 79.21 9.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.247 0.546 . . . . 2.07 110.111 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.44 154.22 13.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.788 -0.642 . . . . 2.36 110.034 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.67 129.02 27.63 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.678 2.252 . . . . 2.08 112.292 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -116.53 45.63 1.77 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.797 -0.638 . . . . 1.78 110.508 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -13.74 58.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.691 -0.686 . . . . 2.55 112.282 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -61.62 -12.97 18.25 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.375 0.509 . . . . 2.24 112.375 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 47.8 mt -104.0 -32.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.976 0.417 . . . . 2.0 110.653 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -65.57 -9.0 42.29 Favored Glycine 0 CA--C 1.52 0.364 0 CA-C-N 115.845 -0.616 . . . . 2.33 114.558 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.0 t -79.72 63.0 4.16 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.332 0.586 . . . . 2.99 111.215 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.402 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 47.0 ttp85 -118.33 139.71 50.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 2.83 110.926 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -99.98 115.26 65.7 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.981 -0.554 . . . . 3.56 110.317 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -68.02 -24.47 39.17 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.979 2.453 . . . . 3.39 113.332 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.09 1.48 56.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.942 0.401 . . . . 4.05 111.366 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -119.04 -48.61 2.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 4.48 110.158 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.402 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 12.9 t-20 -106.93 137.13 45.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.695 -0.684 . . . . 3.39 110.52 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.44 139.5 45.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.103 -0.332 . . . . 3.21 110.103 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.8 158.1 28.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.057 0.456 . . . . 2.85 111.183 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 25.8 mt -104.99 141.92 19.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.974 -0.557 . . . . 2.42 109.796 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.62 127.08 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.883 -0.414 . . . . 2.74 109.883 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -66.7 116.73 7.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.132 -0.485 . . . . 2.11 110.019 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.58 149.37 43.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.189 -0.46 . . . . 2.49 110.865 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.1 mt -103.36 146.79 33.12 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.053 -0.522 . . . . 1.91 109.957 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.64 157.18 62.18 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.603 2.202 . . . . 1.84 111.823 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -59.02 118.36 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 2.53 110.935 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.41 -15.18 17.85 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.744 -0.741 . . . . 2.2 111.349 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.2 m -104.99 119.42 38.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.965 0.412 . . . . 2.1 110.55 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.94 152.49 25.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.084 -0.507 . . . . 2.78 110.498 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.2 mt -86.22 140.69 34.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.593 -0.276 . . . . 2.62 110.369 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.36 147.24 96.05 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.39 2.06 . . . . 2.77 110.902 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -51.3 123.15 9.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 4.11 112.042 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.24 4.74 56.31 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.059 -0.591 . . . . 3.18 112.586 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -123.1 130.95 53.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.792 0.329 . . . . 2.91 111.182 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -153.45 149.56 27.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.085 -0.507 . . . . 3.54 110.248 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.4 146.32 27.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 2.93 110.886 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -70.59 150.31 46.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 3.64 110.891 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.14 64.97 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.756 -0.735 . . . . 3.27 112.255 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 116.93 22.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.614 0.245 . . . . 3.59 110.769 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? -128.4 -178.88 4.74 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.507 -0.553 . . . . 5.55 109.507 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -78.54 70.65 2.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.661 -0.781 . . . . 5.22 111.862 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -110.69 93.72 0.74 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.905 -0.664 . . . . 5.91 112.245 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.879 -0.581 . . . . 7.27 111.195 179.78 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.407 ' H41' ' HE3' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.575 1 C4'-C3'-C2' 97.108 -5.592 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.473 4.594 2 N19-C1'-C2' 103.532 -6.167 . 0.229 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.463 -5.66 3 O4'-C1'-N19 115.798 7.598 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.592 6.112 4 O4'-C1'-N19 116.711 8.511 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.09 2 C4'-C3'-C2' 97.593 -5.107 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.734 4 N19-C1'-C2' 106.338 -4.413 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.381 3 P-O3'-C3' 127.03 6.109 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.844 " H5'" HG22 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.582 5.356 3 O4'-C4'-C3' 114.952 6.751 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.912 2 O4'-C1'-N19 118.616 10.416 . 0.415 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.483 3 O3'-P-O5' 116.334 6.492 . 0.461 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.211 1 C4'-C3'-C2' 98.274 -4.426 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.581 1 C4'-C3'-C2' 94.346 -8.354 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.522 ' OP2' ' HA2' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.723 1 O3'-P-O5' 111.747 4.077 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.958 2 C3'-C2'-C1' 105.749 4.721 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 111.827 -0.509 . . . . 9.05 111.827 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.71 109.56 20.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.856 0.36 . . . . 8.09 110.779 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -98.45 116.61 31.04 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.999 -0.546 . . . . 8.02 110.231 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.09 -149.66 6.01 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.558 -0.829 . . . . 5.76 112.125 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.0 mt -140.97 121.68 8.84 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 110.488 -0.19 . . . . 4.72 110.488 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.97 41.06 1.06 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.959 2.439 . . . . 4.45 111.261 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -134.23 -173.7 3.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.692 -0.686 . . . . 4.41 109.849 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -105.48 -68.91 0.84 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.459 -0.337 . . . . 3.92 110.276 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 57.69 75.21 0.39 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.412 0.893 . . . . 2.53 113.412 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.85 128.74 37.81 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.49 -0.559 . . . . 2.48 109.49 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.0 p -53.23 146.17 12.36 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.348 0.87 . . . . 2.13 113.348 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -73.12 -35.0 66.46 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.793 -0.64 . . . . 2.4 110.759 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -108.36 170.92 7.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.822 -0.626 . . . . 2.02 111.245 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.866 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 11.2 p -69.15 168.48 13.93 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.646 -0.706 . . . . 2.65 111.142 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -92.99 159.76 15.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.382 -0.372 . . . . 2.4 110.989 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.749 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 35.9 mt -100.17 112.7 25.02 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.258 -0.428 . . . . 2.27 110.267 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 m -82.82 113.33 20.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.237 -0.438 . . . . 2.84 111.632 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -85.37 146.58 26.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.889 -0.596 . . . . 2.89 111.331 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -141.18 89.26 2.22 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.927 -0.579 . . . . 3.82 109.642 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 170.63 -168.33 41.41 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.893 -0.67 . . . . 3.23 112.22 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 48.5 mmtt -81.93 -31.59 31.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.763 0.316 . . . . 4.27 111.267 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -82.61 -174.14 5.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.262 -0.426 . . . . 3.32 109.922 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.54 ' HB3' ' HZ2' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -112.53 -88.12 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.608 -0.516 . . . . 2.39 109.608 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD13 ' CE1' ' A' ' 131' ' ' PHE . 52.5 tp -168.94 126.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.858 0.361 . . . . 2.06 110.465 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -146.79 134.39 20.99 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.89 -0.411 . . . . 2.22 109.89 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -116.78 150.84 46.46 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.236 -0.438 . . . . 1.78 110.029 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.667 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 56.3 Cg_endo -73.06 -173.51 1.27 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.568 2.179 . . . . 2.15 112.488 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -79.97 126.39 30.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.234 -0.439 . . . . 2.6 110.891 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.9 -7.44 80.18 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 1.65 113.111 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.667 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 21.4 tt0 -122.55 154.28 38.11 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.184 -0.302 . . . . 2.31 110.184 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.3 -21.34 7.31 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.435 -0.888 . . . . 1.33 112.585 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.61 HG11 ' HB3' ' A' ' 43' ' ' GLN . 43.1 t -80.06 119.53 76.89 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.661 0.267 . . . . 1.06 110.562 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.9 -176.59 2.68 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.947 2.431 . . . . 1.27 111.738 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.2 mt -81.94 87.92 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.359 -0.382 . . . . 1.7 110.303 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' HB2' HE22 ' A' ' 43' ' ' GLN . 63.6 m-80 -85.83 83.14 7.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.03 0.443 . . . . 1.23 110.197 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.68 1.21 3.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.567 -0.742 . . . . 1.94 112.879 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -107.57 -6.39 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.687 0.28 . . . . 1.96 111.212 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.31 150.35 47.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.09 -0.244 . . . . 1.42 110.957 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -71.95 162.49 73.11 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.814 -0.439 . . . . 1.73 109.814 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.91 -34.9 78.19 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 1.42 112.24 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -18.86 61.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.903 -0.59 . . . . 1.78 111.432 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -95.14 0.99 54.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.29 -0.414 . . . . 1.6 111.092 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.61 ' HB3' HG11 ' A' ' 32' ' ' VAL . 69.0 mm-40 -79.15 59.98 2.89 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.09 0.471 . . . . 1.05 110.957 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.621 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -146.66 130.68 10.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.919 -0.582 . . . . 1.17 110.252 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.72 -141.36 3.62 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.522 -0.847 . . . . 0.6 112.807 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -160.56 159.47 30.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.951 0.405 . . . . 0.99 110.374 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.564 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 49.0 m-85 -100.09 133.14 44.92 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.621 -0.881 . . . . 1.26 108.621 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -117.86 122.41 43.28 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.229 0.331 . . . . 2.15 111.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.52 129.93 35.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.281 -0.418 . . . . 2.4 110.035 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.27 140.0 27.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.727 0.299 . . . . 2.21 110.814 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.46 133.81 38.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 2.68 111.074 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.693 ' HB3' HD12 ' A' ' 64' ' ' LEU . 28.0 tpt180 -101.87 129.27 48.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.006 -0.738 . . . . 3.59 109.006 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttt180 -138.86 78.05 1.65 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.668 -0.242 . . . . 3.43 110.851 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.7 pt -68.11 153.3 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.965 -0.294 . . . . 4.26 110.592 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -134.75 120.92 20.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.255 -0.43 . . . . 5.17 110.489 -178.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.77 179.86 40.41 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.869 -0.682 . . . . 4.66 112.306 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.65 -39.27 96.6 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.127 -0.559 . . . . 5.04 112.975 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.83 -35.5 78.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.852 0.358 . . . . 5.51 111.157 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.05 27.3 1.55 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.448 -0.882 . . . . 4.73 112.731 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 55' ' ' ARG . 21.8 mmtt -91.36 141.17 29.05 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.225 -0.657 . . . . 5.52 109.225 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 41.9 mtt -125.78 131.3 52.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.555 0.217 . . . . 4.48 110.836 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HG3' ' O4 ' ' C' ' 13' ' ' ' U' . 39.6 tttp -62.16 -47.31 85.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 4.16 110.988 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.615 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 25.0 t70 61.24 90.3 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.895 -0.593 . . . . 4.09 112.291 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 52' ' ' ARG . 15.4 mt -87.13 157.94 19.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.317 -0.401 . . . . 3.36 110.384 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -77.83 149.42 77.29 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.08 -0.509 . . . . 3.36 109.919 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.41 110.5 0.66 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.917 2.412 . . . . 2.69 111.648 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.533 HH21 ' CD ' ' A' ' 134' ' ' GLU . 5.5 mtp180 -121.42 138.81 54.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 3.03 111.51 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.564 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 29.2 m95 -104.33 123.92 48.26 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.872 -0.604 . . . . 1.84 110.434 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -99.99 131.8 45.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.551 -0.537 . . . . 2.76 109.551 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -79.83 127.35 32.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.842 0.353 . . . . 1.27 111.099 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -124.84 148.25 48.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.988 -0.551 . . . . 1.84 109.587 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -84.87 159.27 20.4 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.939 -0.393 . . . . 1.28 109.939 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.685 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 1.9 tt -61.65 118.09 6.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.286 -0.265 . . . . 1.66 110.286 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.82 32.78 7.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 1.66 112.618 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.3 68.62 8.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.187 0.518 . . . . 1.58 111.058 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.45 118.6 0.51 Allowed Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.482 -1.047 . . . . 1.96 110.482 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -50.66 -43.68 44.54 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.101 2.534 . . . . 2.62 112.379 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.18 53.29 0.83 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.167 0.508 . . . . 3.09 111.153 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.19 -58.7 2.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.028 0.442 . . . . 1.79 109.808 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 34.72 65.02 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.735 -0.666 . . . . 1.65 112.706 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt -134.03 102.18 12.26 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.603 0.239 . . . . 1.38 110.509 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -86.05 176.61 5.08 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.933 2.422 . . . . 1.62 111.772 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.522 ' HB2' HD11 ' A' ' 73' ' ' LEU . 13.0 t80 -57.87 116.44 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.071 -0.513 . . . . 1.58 110.646 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.9 -17.51 9.27 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.685 -0.769 . . . . 1.44 111.987 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.16 110.35 3.42 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.956 0.408 . . . . 1.25 110.462 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 -76.89 124.27 27.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.951 -0.568 . . . . 1.86 110.856 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.541 ' HB3' HG13 ' A' ' 90' ' ' ILE . 29.5 tttt -143.19 154.46 43.89 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.432 -0.581 . . . . 1.68 109.432 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.09 119.54 8.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.411 -0.358 . . . . 1.7 111.546 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.55 29.99 67.16 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.932 -0.577 . . . . 1.27 112.58 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.541 HG13 ' HB3' ' A' ' 87' ' ' LYS . 39.8 mm -127.77 111.82 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 1.01 110.933 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.525 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 26.7 pt -117.96 120.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.474 -0.33 . . . . 1.3 110.507 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.685 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 94.9 m95 -79.94 135.36 36.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.125 -0.488 . . . . 1.08 112.108 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.22 137.98 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.623 -0.717 . . . . 1.04 111.005 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.43 152.18 39.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.994 -0.548 . . . . 1.27 109.879 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.0 t -114.77 170.79 8.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.956 0.407 . . . . 1.36 110.694 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -67.27 113.23 5.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.081 -0.509 . . . . 2.64 110.67 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.39 -11.67 21.65 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.857 -0.687 . . . . 1.52 111.826 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -86.18 120.03 27.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.779 0.323 . . . . 1.59 110.512 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.9 mt -87.77 142.72 27.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.119 -0.491 . . . . 2.15 111.397 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -71.5 96.66 1.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.894 -0.594 . . . . 2.07 110.237 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 72.7 m -156.19 138.62 10.35 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.561 -0.745 . . . . 2.36 109.176 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 21.8 Cg_exo -67.13 107.33 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.383 2.056 . . . . 2.08 111.244 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -95.66 75.42 3.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.314 -0.403 . . . . 1.78 110.149 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -15.89 61.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.548 -0.296 . . . . 2.55 111.321 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -60.19 -25.02 65.25 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.196 -0.456 . . . . 2.24 111.958 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.87 2.15 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.46 0.648 . . . . 2.0 110.246 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.33 51.63 1.84 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.004 -0.617 . . . . 2.33 111.579 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t -160.93 125.88 3.67 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.99 -0.374 . . . . 2.99 109.99 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 40.7 ttp85 -166.1 134.66 3.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.871 -0.418 . . . . 2.83 109.871 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -83.33 112.0 35.58 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 3.56 110.169 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.02 -30.61 90.03 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.065 2.51 . . . . 3.39 113.864 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -89.91 -5.15 57.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.78 0.324 . . . . 4.05 111.797 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -116.42 1.27 12.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.495 -0.32 . . . . 4.48 111.664 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 27.6 t-20 -154.39 133.64 12.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.673 0.273 . . . . 3.39 110.54 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.38 141.68 28.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.275 -0.42 . . . . 3.21 110.209 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.59 140.77 49.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.992 0.425 . . . . 2.85 111.147 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.5 mt -92.21 150.72 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.955 -0.566 . . . . 2.42 109.885 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.1 t -62.54 120.01 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.89 0.376 . . . . 2.74 110.683 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.5 tt -66.52 124.27 22.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.736 -0.666 . . . . 2.11 110.333 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.66 151.83 48.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.17 -0.468 . . . . 2.49 110.704 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.496 HD13 HG22 ' A' ' 125' ' ' THR . 26.4 mt -98.58 137.48 20.65 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 116.049 -0.523 . . . . 1.91 109.921 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.72 152.53 41.34 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.123 2.549 . . . . 1.84 112.939 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -52.3 123.62 11.23 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.476 -0.784 . . . . 2.53 110.915 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 109.08 -14.65 33.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.809 -0.71 . . . . 2.2 111.45 -179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 HD13 ' A' ' 121' ' ' LEU . 15.1 m -111.81 123.64 50.67 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.915 -0.402 . . . . 2.1 109.915 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 150.03 32.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.883 0.373 . . . . 2.78 111.246 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mp -79.54 143.15 58.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.588 . . . . 2.62 109.858 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -57.58 138.78 87.78 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.675 2.25 . . . . 2.77 111.13 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -55.21 118.38 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 4.11 111.263 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.15 -20.11 12.97 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.54 -0.624 . . . . 3.18 111.54 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.749 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -89.28 147.53 24.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.638 0.256 . . . . 2.91 110.794 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -143.12 145.87 33.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.141 -0.482 . . . . 3.54 110.931 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.48 152.03 23.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.924 -0.58 . . . . 2.93 111.317 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.866 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.1 tp10 -73.3 128.11 34.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 3.64 110.446 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 74.61 18.82 80.02 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.027 -0.606 . . . . 3.27 112.323 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 t -101.4 134.44 44.48 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 3.59 111.489 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -167.81 176.61 6.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.381 -0.827 . . . . 5.55 108.829 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.43 133.72 33.09 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.429 -0.891 . . . . 5.22 111.254 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.33 -127.21 7.9 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.847 -0.692 . . . . 5.91 112.017 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.248 0.979 0 CA-C-O 119.021 -0.514 . . . . 7.27 111.971 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.61 1 C4'-C3'-C2' 97.045 -5.655 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.471 4.49 2 N19-C1'-C2' 103.557 -6.152 . 0.232 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.7 3 O4'-C1'-N19 115.773 7.573 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.272 4 O4'-C1'-N19 116.651 8.451 . 0.509 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.087 2 C4'-C3'-C2' 97.508 -5.192 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.778 4 N19-C1'-C2' 106.364 -4.398 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.33 3 P-O3'-C3' 126.972 6.06 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.581 5.324 3 O4'-C4'-C3' 114.855 6.682 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.946 2 O4'-C1'-N19 118.548 10.348 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.469 3 O3'-P-O5' 116.284 6.465 . 0.462 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.159 1 C4'-C3'-C2' 98.309 -4.391 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.521 1 C4'-C3'-C2' 94.401 -8.299 . 0.452 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.413 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.587 5.705 1 O3'-P-O5' 111.731 4.069 . 0.104 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.986 2 C3'-C2'-C1' 105.753 4.726 . 0.333 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 111.612 -0.595 . . . . 9.05 111.612 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.05 121.23 14.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.689 0.28 . . . . 8.09 110.611 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.0 ttt -105.86 140.39 38.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 8.02 110.724 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.9 143.1 11.5 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.957 -0.639 . . . . 5.76 111.646 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mp -119.8 134.01 23.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 O-C-N 122.603 -0.351 . . . . 4.72 111.204 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -90.48 26.14 0.51 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 123.143 2.562 . . . . 4.45 111.272 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -91.66 156.01 17.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.851 -0.613 . . . . 4.41 110.692 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.475 HD21 ' HD3' ' A' ' 111' ' ' PRO . 12.9 t-20 -71.1 -74.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.618 0.574 . . . . 3.92 110.781 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p 44.88 77.1 0.08 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.706 0.632 . . . . 2.53 112.706 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.29 135.62 50.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.952 0.406 . . . . 2.48 111.342 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.6 m -73.5 151.25 41.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.892 -0.595 . . . . 2.13 110.491 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -87.0 -13.72 43.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.424 . . . . 2.4 112.061 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.491 ' HZ ' ' HA ' ' A' ' 35' ' ' ASN . 85.8 m-85 -119.41 163.35 17.36 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 111.856 0.317 . . . . 2.02 111.856 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 118' ' ' VAL . 10.7 p -71.03 168.36 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 2.65 111.034 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.65 156.75 27.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.266 0.555 . . . . 2.4 112.129 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.713 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -112.39 122.32 47.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.55 -0.75 . . . . 2.27 109.23 178.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.43 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -92.95 128.62 38.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.883 0.373 . . . . 2.84 111.951 -178.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -105.26 128.89 53.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 2.89 110.25 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -119.7 89.36 3.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.91 0.386 . . . . 3.82 110.504 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.53 -167.66 40.75 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.884 -0.886 . . . . 3.23 110.884 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -86.38 -34.87 20.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.146 0.473 . . . . 4.27 111.334 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -68.64 151.63 46.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.35 -0.387 . . . . 3.32 110.105 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 -85.52 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.136 -0.32 . . . . 2.39 110.136 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 131' ' ' PHE . 34.4 tp -168.6 130.27 1.3 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.482 -0.326 . . . . 2.06 110.392 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -153.02 132.06 12.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 2.22 109.485 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.47 ' HD1' ' HD2' ' A' ' 27' ' ' PRO . 5.1 m-85 -125.55 138.2 31.39 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.581 -0.281 . . . . 1.78 110.69 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD2' ' HD1' ' A' ' 26' ' ' PHE . 38.1 Cg_endo -67.27 163.92 32.49 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.738 2.292 . . . . 2.15 112.235 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 28' ' ' ARG . 20.5 ttt180 -60.99 117.43 5.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.356 -0.838 . . . . 2.6 111.023 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.32 0.2 56.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.646 -0.788 . . . . 1.65 112.618 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -127.88 162.37 26.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.78 0.324 . . . . 2.31 110.139 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.73 5.75 44.48 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.869 -0.682 . . . . 1.33 111.821 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 95' ' ' THR . 40.4 t -100.03 114.81 65.84 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.931 -0.396 . . . . 1.06 109.931 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.1 -175.58 2.73 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.043 2.495 . . . . 1.27 111.73 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 mt -83.1 85.33 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.146 0.498 . . . . 1.7 110.66 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.491 ' HA ' ' HZ ' ' A' ' 13' ' ' PHE . 44.8 m-80 -80.74 93.81 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.861 -0.609 . . . . 1.23 110.916 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.3 p -85.57 3.69 39.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 1.94 111.473 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -107.9 -4.12 18.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.81 0.338 . . . . 1.96 111.075 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.75 152.12 51.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.899 0.38 . . . . 1.42 111.874 -178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.4 m -78.75 168.69 25.11 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.729 -0.669 . . . . 1.73 110.111 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.512 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 77.3 Cg_exo -53.2 -37.49 80.27 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.835 2.357 . . . . 1.42 112.904 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.638 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -72.37 -8.76 56.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 1.78 111.469 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.795 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 12.2 m-20 -104.41 4.35 33.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 1.6 110.508 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 36.8 mm-40 -79.26 58.55 2.58 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.993 0.425 . . . . 1.05 111.822 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.7 tt -152.03 128.09 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 1.17 110.263 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.83 -157.51 10.09 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.31 -0.948 . . . . 0.6 112.971 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -149.72 147.92 28.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.918 0.389 . . . . 0.99 111.296 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.689 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 11.0 m-85 -90.38 137.0 32.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.998 -0.546 . . . . 1.26 109.552 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 48' ' ' ARG . 33.2 ttt-85 -114.13 130.29 56.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.453 -0.34 . . . . 2.15 111.259 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -71.29 125.17 26.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.002 -0.74 . . . . 2.4 109.002 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -111.31 127.55 55.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.035 0.445 . . . . 2.21 112.066 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.11 140.34 51.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.905 -0.776 . . . . 2.68 108.905 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.645 ' HB3' HD12 ' A' ' 64' ' ' LEU . 14.9 tpt180 -150.19 111.1 4.32 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.618 0.599 . . . . 3.59 112.618 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.574 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 94.0 mtt180 -135.72 107.06 6.81 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.797 -0.638 . . . . 3.43 110.223 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.744 HG12 ' HB2' ' A' ' 62' ' ' LYS . 31.0 pt -68.4 171.04 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 4.26 110.842 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 55' ' ' ARG . 30.2 ttt180 -128.18 107.8 10.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.839 0.352 . . . . 5.17 110.85 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.43 164.59 36.5 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.648 -0.787 . . . . 4.66 111.408 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.32 -33.06 85.67 Favored Glycine 0 C--N 1.328 0.138 0 C-N-CA 120.931 -0.652 . . . . 5.04 112.137 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -79.27 -2.9 43.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.647 0.737 . . . . 5.51 110.421 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.37 29.38 22.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.595 -0.73 . . . . 4.73 111.399 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -90.08 164.21 14.58 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 110.342 -0.244 . . . . 5.52 110.342 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -139.37 148.13 42.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.047 -0.524 . . . . 4.48 109.996 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.744 ' HB2' HG12 ' A' ' 54' ' ' ILE . 68.9 tttt -75.7 -38.56 58.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 4.16 110.382 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 26.5 t70 52.4 81.45 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.547 -0.752 . . . . 4.09 112.429 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 52' ' ' ARG . 24.3 mt -81.7 151.51 27.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.222 -0.445 . . . . 3.36 110.439 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -67.85 148.14 98.48 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.902 -0.59 . . . . 3.36 110.011 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.39 108.12 0.29 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.849 2.366 . . . . 2.69 111.768 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.624 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 3.6 ptp180 -119.27 144.17 46.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.706 -0.679 . . . . 3.03 111.261 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.689 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 34.4 m95 -115.08 139.01 50.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.014 -0.539 . . . . 1.84 110.238 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.549 ' OH ' H5'' ' C' ' 8' ' ' ' G' . 6.1 m-85 -113.84 140.89 47.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.252 -0.431 . . . . 2.76 110.312 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.97 126.5 35.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.988 0.423 . . . . 1.27 111.276 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -123.0 151.2 42.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.789 -0.641 . . . . 1.84 109.381 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -91.88 148.9 21.87 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.943 -0.392 . . . . 1.28 109.943 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.19 123.05 16.02 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 123.147 0.279 . . . . 1.66 110.563 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -9.16 19.01 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.631 -0.795 . . . . 1.66 112.22 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.413 HG22 ' HA3' ' A' ' 107' ' ' GLY . 1.2 p -65.24 131.7 47.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.607 0.242 . . . . 1.58 110.359 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 94.15 106.96 1.95 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.573 -0.822 . . . . 1.96 111.333 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 10.8 Cg_endo -55.85 -44.43 47.59 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.654 2.236 . . . . 2.62 112.282 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.71 28.85 7.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.148 -0.478 . . . . 3.09 111.636 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.2 -61.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.821 0.343 . . . . 1.79 110.695 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.05 48.83 10.49 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.042 -0.823 . . . . 1.65 111.042 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.8 91.22 48.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 120.856 0.36 . . . . 1.38 111.659 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.34 162.74 13.05 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.467 2.111 . . . . 1.62 110.929 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.17 104.88 0.35 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.123 0.487 . . . . 1.58 111.246 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 132.39 -26.97 3.64 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.665 -0.698 . . . . 1.44 112.006 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.79 123.5 19.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 1.25 110.872 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -95.76 136.11 36.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.227 -0.442 . . . . 1.86 111.602 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -143.22 155.17 44.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.873 -0.788 . . . . 1.68 108.873 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -66.74 115.28 6.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.184 0.516 . . . . 1.7 111.694 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.16 22.01 46.84 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.825 -0.625 . . . . 1.27 112.533 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 48' ' ' ARG . 7.7 mm -136.7 133.62 48.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 110.163 -0.31 . . . . 1.01 110.163 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.4 pt -130.81 163.2 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.806 -0.442 . . . . 1.3 109.806 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -112.78 138.68 49.25 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.481 0.548 . . . . 1.08 112.481 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.62 133.29 32.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 1.04 110.233 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.74 132.97 14.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.354 -0.385 . . . . 1.27 110.214 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 32' ' ' VAL . 3.4 t -102.47 170.57 7.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.818 0.342 . . . . 1.36 110.89 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -69.48 126.53 30.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.082 -0.508 . . . . 2.64 110.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.46 -11.61 25.96 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.307 -0.717 . . . . 1.52 111.307 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -89.75 149.22 22.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.647 -0.277 . . . . 1.59 110.539 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.0 mt -109.61 141.71 41.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.352 -0.385 . . . . 2.15 110.951 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -80.27 97.78 7.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 2.07 110.555 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.57 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 5.0 t -170.29 145.54 2.29 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.044 -0.724 . . . . 2.36 109.044 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.34 128.7 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.542 2.161 . . . . 2.08 112.783 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.02 73.68 1.49 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.362 0.601 . . . . 1.78 111.075 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.24 1.15 19.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.328 -0.396 . . . . 2.55 111.895 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.456 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.0 p80 -60.11 -16.61 33.6 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.077 0.399 . . . . 2.24 112.077 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.4 pt -121.95 27.36 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.104 0.478 . . . . 2.0 109.975 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.413 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -102.92 -24.68 7.94 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.731 -0.747 . . . . 2.33 113.807 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -96.35 131.23 43.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.217 0.532 . . . . 2.99 111.504 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.3 ttp85 -159.53 133.48 7.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.258 -0.428 . . . . 2.83 110.28 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -77.26 113.27 29.63 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 110.072 -0.344 . . . . 3.56 110.072 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.475 ' HD3' HD21 ' A' ' 8' ' ' ASN . 94.0 Cg_endo -85.17 -12.06 7.11 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 3.39 112.897 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -90.06 -9.71 47.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.967 0.413 . . . . 4.05 110.694 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -133.15 18.64 4.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.73 -0.668 . . . . 4.48 110.641 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -169.35 132.13 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 3.39 111.128 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.647 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -94.58 159.09 15.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.214 -0.448 . . . . 3.21 110.419 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.09 150.57 23.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.799 0.333 . . . . 2.85 111.351 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 27.3 mt -78.11 143.67 12.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 2.42 109.735 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.4 ' HA ' ' OG1' ' A' ' 14' ' ' THR . 96.8 t -61.48 120.16 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.088 -0.245 . . . . 2.74 110.552 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.85 118.72 8.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.081 0.467 . . . . 2.11 110.603 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.12 148.76 52.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.931 -0.577 . . . . 2.49 110.489 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.657 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 66.1 mt -98.59 147.34 33.03 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.318 -0.401 . . . . 1.91 110.247 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.63 166.16 10.34 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.833 2.356 . . . . 1.84 112.435 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -61.85 118.47 7.25 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.057 -0.52 . . . . 2.53 110.815 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 111.13 -24.98 14.87 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.403 -0.679 . . . . 2.2 111.403 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.657 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 2.5 m -88.46 103.75 16.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.926 0.393 . . . . 2.1 110.093 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -90.68 144.46 25.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.313 -0.403 . . . . 2.78 111.217 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 15.7 mt -74.55 142.87 78.22 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.203 -0.453 . . . . 2.62 110.172 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 127' ' ' LEU . 42.2 Cg_exo -60.0 149.91 81.56 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.748 2.299 . . . . 2.77 111.452 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -61.4 119.43 8.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.373 -0.376 . . . . 4.11 110.784 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.07 -7.25 54.6 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.772 -0.728 . . . . 3.18 112.127 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -103.94 127.59 51.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 2.91 110.449 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.43 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 37.4 p90 -133.97 151.62 51.53 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.319 -0.401 . . . . 3.54 110.853 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -91.98 139.86 30.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 2.93 112.031 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.525 ' HG2' ' OP1' ' C' ' 8' ' ' ' G' . 10.6 tp10 -66.39 131.38 45.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.888 -0.596 . . . . 3.64 109.886 179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.3 -37.07 3.14 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.689 -0.767 . . . . 3.27 112.328 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.76 119.22 18.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.64 0.257 . . . . 3.59 110.802 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -118.3 113.96 22.25 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.576 -0.527 . . . . 5.55 109.576 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.09 134.54 12.63 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.847 -0.692 . . . . 5.22 112.648 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.32 -74.42 0.32 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.999 -0.619 . . . . 5.91 111.707 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 119.034 -0.508 . . . . 7.27 111.686 179.752 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.402 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.493 -3.533 1 C4'-C3'-C2' 97.068 -5.632 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.402 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.464 2 N19-C1'-C2' 103.569 -6.145 . 0.234 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.797 3 O4'-C1'-N19 115.687 7.487 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.268 4 O4'-C1'-N19 116.703 8.503 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.373 -4.206 2 C4'-C3'-C2' 97.525 -5.175 . 0.655 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.597 4 C4'-C3'-C2' 98.274 -4.426 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.496 5.228 3 P-O3'-C3' 126.991 6.076 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.647 " H1'" ' HA ' ' A' ' 115' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.357 3 O4'-C4'-C3' 114.909 6.721 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -5.019 2 O4'-C1'-N19 118.643 10.443 . 0.413 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.485 3 O3'-P-O5' 116.338 6.494 . 0.462 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.073 1 C4'-C3'-C2' 98.271 -4.429 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.658 1 C4'-C3'-C2' 94.298 -8.402 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.586 5.658 1 O3'-P-O5' 111.66 4.031 . 0.107 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.886 2 C3'-C2'-C1' 105.758 4.731 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.615 -0.594 . . . . 9.05 111.615 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 115.92 23.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.702 0.287 . . . . 8.09 110.734 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.6 tmm? -83.15 132.56 35.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.194 -0.457 . . . . 8.02 110.838 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.54 -172.27 40.25 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.512 -0.635 . . . . 5.76 111.512 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 28.7 tp -106.09 115.07 61.8 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.64 0.257 . . . . 4.72 110.461 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.59 40.68 0.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.107 2.538 . . . . 4.45 111.885 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -115.07 66.88 0.69 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.33 -0.396 . . . . 4.41 110.704 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -170.24 174.75 5.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 3.92 110.185 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 108' ' ' THR . 34.0 p 52.49 81.6 0.08 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.396 0.887 . . . . 2.53 113.396 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.24 138.33 31.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.25 -0.432 . . . . 2.48 110.851 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -55.08 143.47 26.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.052 -0.522 . . . . 2.13 112.019 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -67.89 -28.6 67.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.837 -0.619 . . . . 2.4 110.96 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 62.9 m-85 -107.87 168.61 9.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.111 -0.495 . . . . 2.02 112.28 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -70.95 160.78 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.168 -0.923 . . . . 2.65 111.289 -179.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.72 134.75 33.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.837 -0.62 . . . . 2.4 110.533 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 133' ' ' ALA . 1.2 mt -87.37 132.62 33.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.148 -0.478 . . . . 2.27 110.163 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 m -96.34 112.82 24.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.294 -0.412 . . . . 2.84 110.067 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -83.9 140.28 32.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 2.89 111.016 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -141.84 80.13 1.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.692 -0.485 . . . . 3.82 109.692 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.6 -166.45 29.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.987 -0.625 . . . . 3.23 112.199 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -91.68 -9.87 42.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.848 0.356 . . . . 4.27 111.019 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -105.18 162.07 13.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.085 -0.507 . . . . 3.32 109.884 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 0.3 OUTLIER -90.0 -65.57 1.0 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.77 -0.826 . . . . 2.39 108.77 178.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 21.8 tp 175.31 133.54 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.395 -0.82 . . . . 2.06 110.533 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -150.64 117.57 5.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.068 -0.515 . . . . 2.22 110.304 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -108.12 139.63 20.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.06 -0.518 . . . . 1.78 110.55 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.603 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 49.8 Cg_endo -69.77 172.55 12.45 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.69 2.26 . . . . 2.15 112.421 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -69.45 127.62 33.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.878 -0.601 . . . . 2.6 110.848 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.68 25.06 63.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.942 -0.647 . . . . 1.65 112.622 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.603 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -151.38 158.78 44.18 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.547 -0.538 . . . . 2.31 109.547 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 21.63 9.87 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.744 -0.741 . . . . 1.33 111.418 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' A' ' 95' ' ' THR . 21.6 t -106.84 110.35 63.6 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 110.183 -0.303 . . . . 1.06 110.183 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' A' ' 121' ' ' LEU . 39.8 Cg_endo -68.65 175.15 7.5 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.723 2.282 . . . . 1.27 111.09 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.0 mt -72.93 87.3 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.189 0.518 . . . . 1.7 110.686 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 71.3 m-20 -82.76 74.96 9.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.808 -0.633 . . . . 1.23 109.775 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -31.5 72.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.34 0.496 . . . . 1.94 112.34 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.58 -7.19 59.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.596 -0.274 . . . . 1.96 111.68 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.92 150.15 32.21 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.098 0.475 . . . . 1.42 112.095 -178.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.712 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 13.7 m -90.29 170.2 10.69 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.51 -0.768 . . . . 1.73 109.471 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.712 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 3.0 Cg_endo -46.79 -44.92 21.38 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.324 2.683 . . . . 1.42 114.094 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 0.2 OUTLIER -70.52 -25.98 63.37 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.888 0.329 . . . . 1.78 111.888 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.947 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.3 m-20 -86.77 2.79 47.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.267 -0.424 . . . . 1.6 110.844 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 83.4 mm-40 -80.48 46.08 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.107 0.48 . . . . 1.05 111.119 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.879 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.7 tt -143.12 132.47 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.022 -0.535 . . . . 1.17 110.191 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.419 ' HA2' ' N ' ' A' ' 73' ' ' LEU . . . -170.68 -145.55 4.8 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.414 -0.898 . . . . 0.6 112.158 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.479 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 45.7 p90 -155.6 159.91 40.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.122 0.487 . . . . 0.99 110.98 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.494 ' HB2' HG13 ' A' ' 91' ' ' ILE . 12.0 m-85 -99.91 117.86 35.11 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.471 -0.786 . . . . 1.26 109.475 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 48' ' ' ARG . 32.7 ttt180 -99.5 127.08 45.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.984 0.421 . . . . 2.15 111.321 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.3 ttt-85 -85.24 135.25 34.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.839 -0.619 . . . . 2.4 110.432 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.7 42.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.014 0.435 . . . . 2.21 111.37 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.7 m -152.98 127.32 9.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.062 -0.718 . . . . 2.68 109.062 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HA ' ' HD2' ' A' ' 52' ' ' ARG . 3.8 tpt85 -103.63 126.67 50.92 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.492 0.553 . . . . 3.59 112.492 -178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 53' ' ' ARG . 17.5 mtt180 -142.92 107.56 4.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 3.43 109.472 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.4 169.0 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.63 0.252 . . . . 4.26 110.71 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.4 110.6 22.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.491 -0.322 . . . . 5.17 110.464 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.426 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -81.07 168.53 50.82 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.529 -0.843 . . . . 4.66 112.714 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.35 -38.61 70.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.984 -0.627 . . . . 5.04 112.154 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -95.13 11.46 32.16 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.386 0.612 . . . . 5.51 110.351 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.09 18.93 54.91 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.812 -0.709 . . . . 4.73 111.76 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -76.45 155.4 33.93 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.175 -0.305 . . . . 5.52 110.175 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -133.32 174.3 10.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.317 . . . . 4.48 110.906 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -97.89 -24.57 15.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 4.16 110.174 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 48.53 90.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.883 1.068 . . . . 4.09 113.883 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.1 mt -110.53 147.75 33.53 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.257 -0.429 . . . . 3.36 110.178 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.468 ' HB3' ' HD2' ' A' ' 66' ' ' PRO . 24.4 m -78.4 162.12 67.43 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 109.492 -0.558 . . . . 3.36 109.492 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 65' ' ' SER . 9.2 Cg_endo -53.0 108.08 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.768 2.312 . . . . 2.69 112.166 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.454 HH22 ' HB2' ' A' ' 134' ' ' GLU . 19.4 mtp180 -99.91 134.03 43.41 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.78 -0.646 . . . . 3.03 109.629 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -106.61 115.75 30.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.07 -0.514 . . . . 1.84 112.0 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -102.36 121.29 42.01 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.868 -0.79 . . . . 2.76 108.868 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -73.98 135.57 43.16 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.911 0.386 . . . . 1.27 111.686 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.565 ' HD2' HG21 ' A' ' 75' ' ' THR . 14.3 m-85 -130.75 165.27 23.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 1.84 110.202 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -99.82 159.58 14.96 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.37 -0.377 . . . . 1.28 110.898 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.419 ' N ' ' HA2' ' A' ' 45' ' ' GLY . 54.8 tp -63.29 116.31 5.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.22 -0.445 . . . . 1.66 111.501 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.45 35.64 10.39 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.995 -0.621 . . . . 1.66 113.936 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.565 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.8 OUTLIER -73.3 90.47 1.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.96 0.41 . . . . 1.58 111.135 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 123.39 139.78 5.51 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.032 -0.604 . . . . 1.96 112.2 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 -33.34 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.603 2.202 . . . . 2.62 112.053 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -103.67 36.45 2.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.026 -0.534 . . . . 3.09 111.093 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.03 -56.6 10.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 1.79 110.096 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.12 32.5 80.69 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.915 -0.584 . . . . 1.65 112.971 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' ' HB3' ' A' ' 85' ' ' ALA . 3.0 tp -138.33 106.01 7.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 120.757 0.313 . . . . 1.38 110.688 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 92.2 Cg_endo -85.39 167.54 10.39 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.677 2.251 . . . . 1.62 111.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -60.95 106.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 1.58 110.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.54 -8.64 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.489 -0.862 . . . . 1.44 112.992 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.577 ' HB3' ' HG ' ' A' ' 81' ' ' LEU . . . -69.24 137.99 53.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.787 0.327 . . . . 1.25 110.967 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -88.44 128.18 35.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.909 0.385 . . . . 1.86 111.839 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 6.5 ttmm -155.24 144.01 20.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.781 -0.645 . . . . 1.68 109.283 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.73 113.34 3.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.196 0.443 . . . . 1.7 112.196 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.27 20.57 58.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.891 -0.671 . . . . 1.27 112.752 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 35.0 mm -127.72 102.02 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.93 0.395 . . . . 1.01 110.51 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 47' ' ' TYR . 24.8 pt -114.62 134.06 58.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.322 -0.399 . . . . 1.3 109.989 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.479 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 49.3 m95 -90.35 146.25 24.33 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.345 0.498 . . . . 1.08 112.345 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 m -140.47 144.65 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.518 -0.764 . . . . 1.04 110.311 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.95 169.59 23.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 1.27 110.869 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.445 ' HB ' HG21 ' A' ' 32' ' ' VAL . 13.4 t -146.17 179.04 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.969 -0.56 . . . . 1.36 109.5 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -66.7 123.37 19.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.937 0.399 . . . . 2.64 111.133 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 41' ' ' ASP . . . 107.35 -13.26 39.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.766 -0.73 . . . . 1.52 111.906 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.879 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.31 132.18 35.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.669 0.271 . . . . 1.59 110.785 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.9 mt -102.22 140.59 36.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.262 -0.426 . . . . 2.15 110.799 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -79.45 76.05 6.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.468 0.652 . . . . 2.07 110.09 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.632 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 3.9 m -147.13 131.97 8.89 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 108.654 -0.869 . . . . 2.36 108.654 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.83 125.24 17.67 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.307 2.005 . . . . 2.08 112.251 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.947 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -126.85 75.87 1.6 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.585 0.707 . . . . 1.78 111.216 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.99 -4.53 44.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.666 -0.697 . . . . 2.55 112.058 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 4.1 p80 -59.18 -20.9 57.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.092 0.472 . . . . 2.24 111.864 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.3 pt -111.71 13.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.037 0.446 . . . . 2.0 110.616 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -94.22 -32.67 7.29 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.554 -0.831 . . . . 2.33 112.027 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.467 ' HA ' HG22 ' A' ' 9' ' ' THR . 1.9 t -69.18 121.46 16.83 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.295 0.569 . . . . 2.99 110.978 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.0 ttp85 -164.57 131.18 3.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.483 -0.781 . . . . 2.83 109.927 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 59.5 m-80 -94.99 117.84 66.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 3.56 110.663 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 18.3 Cg_endo -60.35 -34.97 92.94 Favored 'Trans proline' 0 N--CA 1.472 0.244 0 C-N-CA 123.123 2.549 . . . . 3.39 113.458 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -87.93 9.68 21.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.369 0.507 . . . . 4.05 112.369 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -139.52 9.1 2.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.871 0.367 . . . . 4.48 111.389 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -159.49 127.22 4.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.821 0.343 . . . . 3.39 111.248 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.47 164.14 25.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 3.21 110.625 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.58 152.19 23.39 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.167 0.508 . . . . 2.85 111.466 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 3.4 mp -95.76 145.86 7.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.746 -0.661 . . . . 2.42 109.417 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.578 ' HA ' ' OG1' ' A' ' 14' ' ' THR . 70.0 t -68.25 115.31 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 110.251 -0.277 . . . . 2.74 110.251 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 tt -62.75 121.24 12.92 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.066 -0.515 . . . . 2.11 110.604 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -139.83 173.64 11.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.858 -0.61 . . . . 2.49 110.779 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 33' ' ' PRO . 91.5 mt -123.14 152.48 63.66 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.558 -0.534 . . . . 1.91 109.558 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.42 154.65 34.39 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.003 2.469 . . . . 1.84 111.97 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 140' ' ' SER . 24.2 tt0 -52.94 122.83 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.937 -0.574 . . . . 2.53 111.332 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.69 -11.34 49.88 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.632 -0.794 . . . . 2.2 112.321 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 HD13 ' A' ' 121' ' ' LEU . 5.3 m -109.11 113.89 27.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.486 -0.561 . . . . 2.1 109.486 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.2 159.63 16.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.358 -0.383 . . . . 2.78 110.892 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.416 HD22 ' HD2' ' A' ' 131' ' ' PHE . 28.4 mt -90.45 156.68 45.41 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.402 -0.363 . . . . 2.62 110.25 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.54 151.46 62.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.656 2.238 . . . . 2.77 111.912 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.36 119.2 8.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.185 0.517 . . . . 4.11 111.775 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.41 -8.88 44.8 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.723 -0.751 . . . . 3.18 112.346 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.416 ' HD2' HD22 ' A' ' 127' ' ' LEU . 2.1 t80 -101.51 112.91 25.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.788 -0.449 . . . . 2.91 109.788 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -133.1 149.88 52.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.37 . . . . 3.54 111.663 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.422 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -103.45 147.35 27.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 2.93 110.073 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.454 ' HB2' HH22 ' A' ' 67' ' ' ARG . 25.5 tt0 -73.67 121.61 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 3.64 111.237 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.85 -0.47 45.17 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.688 -0.767 . . . . 3.27 112.265 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -86.87 135.36 33.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.875 0.369 . . . . 3.59 110.733 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -121.58 4.32 10.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.191 0.519 . . . . 5.55 110.197 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.08 -138.71 6.61 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.656 -0.702 . . . . 5.22 111.402 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 109.57 -131.56 10.56 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.657 -0.782 . . . . 5.91 112.99 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 9.7 m . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.065 -0.969 . . . . 7.27 110.691 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.4 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.491 -3.722 1 C4'-C3'-C2' 97.005 -5.695 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.4 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.554 2 N19-C1'-C2' 103.574 -6.141 . 0.23 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.709 2 O4'-C1'-N19 115.723 7.523 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.21 4 O4'-C1'-N19 116.651 8.451 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.375 -4.063 2 C4'-C3'-C2' 97.576 -5.124 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.759 4 C4'-C3'-C2' 98.298 -4.402 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.275 3 P-O3'-C3' 127.008 6.09 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.58 5.249 3 O4'-C4'-C3' 114.875 6.696 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.541 -5.154 2 O4'-C1'-N19 118.641 10.441 . 0.417 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.589 3 O3'-P-O5' 116.394 6.523 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.556 -4.217 1 C4'-C3'-C2' 98.249 -4.451 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.482 1 C4'-C3'-C2' 94.401 -8.299 . 0.459 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.426 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.767 1 O3'-P-O5' 111.7 4.053 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.077 2 C3'-C2'-C1' 105.708 4.675 . 0.34 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.785 -0.526 . . . . 9.05 111.785 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.8 103.02 10.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.889 0.376 . . . . 8.09 111.207 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 46.4 mtt -127.17 84.07 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.901 0.381 . . . . 8.02 110.913 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.74 144.52 12.31 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.006 -0.616 . . . . 5.76 112.146 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.05 103.35 8.95 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.721 0.296 . . . . 4.72 110.483 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.59 35.2 0.55 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.008 2.472 . . . . 4.45 112.618 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -103.85 164.84 11.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.84 -0.43 . . . . 4.41 109.84 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -68.34 -74.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.141 -0.318 . . . . 3.92 110.141 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p 43.6 56.93 4.21 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 112.68 0.622 . . . . 2.53 112.68 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.91 154.5 26.99 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.211 -0.449 . . . . 2.48 111.588 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -87.36 155.6 19.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.906 -0.588 . . . . 2.13 110.032 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -86.09 -29.4 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 2.4 110.146 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -113.52 -179.72 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.409 -0.814 . . . . 2.02 110.532 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.71 -172.35 4.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.458 . . . . 2.65 110.679 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -105.66 173.25 6.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.379 0.609 . . . . 2.4 112.602 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.607 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 16.0 mt -112.1 122.85 48.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.931 -1.031 . . . . 2.27 109.312 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.1 m -92.52 116.39 28.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.99 0.424 . . . . 2.84 111.261 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -86.38 142.43 28.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.777 -0.647 . . . . 2.89 110.842 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -134.44 44.86 2.64 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.977 -0.556 . . . . 3.82 109.862 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.9 -167.24 12.46 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.832 -0.699 . . . . 3.23 112.442 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -86.74 -28.14 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 4.27 110.645 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.89 163.55 23.3 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.746 -0.661 . . . . 3.32 111.007 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.2 -85.5 0.29 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.825 -0.435 . . . . 2.39 109.825 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.597 HD13 ' CE1' ' A' ' 131' ' ' PHE . 36.5 tp -168.97 140.11 2.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 2.06 110.462 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -163.01 120.27 1.92 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.716 -0.675 . . . . 2.22 110.021 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -110.54 142.5 26.21 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.269 -0.423 . . . . 1.78 110.234 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.57 164.94 16.78 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.114 2.543 . . . . 2.15 111.965 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -69.61 128.47 36.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.396 -0.366 . . . . 2.6 110.426 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.83 29.92 49.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.287 -0.725 . . . . 1.65 111.287 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -157.84 171.52 20.14 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.46 -0.57 . . . . 2.31 109.46 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.31 17.32 64.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 1.33 112.511 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.78 111.15 65.0 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.826 -0.435 . . . . 1.06 109.826 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.51 168.57 11.2 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.783 2.322 . . . . 1.27 112.051 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.9 mt -74.69 87.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.16 -0.473 . . . . 1.7 110.497 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -84.11 77.69 9.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.039 0.447 . . . . 1.23 109.913 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -26.31 68.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 1.94 111.628 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -80.78 -3.78 52.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.127 -0.488 . . . . 1.96 111.653 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.478 ' HB3' ' CB ' ' A' ' 42' ' ' ASP . 1.4 m -120.52 157.52 29.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.351 . . . . 1.42 111.672 -178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.672 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 23.4 m -83.04 168.84 20.19 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.96 -0.564 . . . . 1.73 109.922 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.8 Cg_endo -52.9 -35.71 71.77 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.947 2.432 . . . . 1.42 113.913 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.839 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.2 p-10 -80.81 -16.01 54.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.652 0.242 . . . . 1.78 111.652 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.827 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 29.5 m-20 -84.37 -3.39 58.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 1.6 111.106 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -78.55 56.37 1.79 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.181 0.515 . . . . 1.05 110.827 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 94' ' ' ALA . 16.6 tt -149.97 127.38 2.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.718 -0.673 . . . . 1.17 110.155 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.3 -139.83 3.0 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.515 -0.85 . . . . 0.6 112.214 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.483 ' CD2' HG23 ' A' ' 90' ' ' ILE . 53.7 p90 -162.09 158.65 25.12 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.08 0.467 . . . . 0.99 111.113 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.641 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 10.3 m-85 -95.84 134.94 38.21 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.898 -0.778 . . . . 1.26 108.898 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -112.68 121.39 44.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.399 -0.364 . . . . 2.15 111.1 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.1 ttt-85 -73.49 119.69 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.119 -0.491 . . . . 2.4 109.787 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.31 148.29 43.92 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.173 0.511 . . . . 2.21 111.306 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.73 151.46 45.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.731 -0.84 . . . . 2.68 108.731 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.784 ' HB3' HD12 ' A' ' 64' ' ' LEU . 9.6 tpt180 -139.43 125.64 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.982 0.42 . . . . 3.59 111.604 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 25.7 mtt180 -140.73 98.58 3.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.905 -0.589 . . . . 3.43 110.789 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 61' ' ' MET . 33.8 pt -79.74 160.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.378 -0.601 . . . . 4.26 109.378 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 55' ' ' ARG . 3.8 ttt180 -131.23 120.27 23.0 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.919 -0.312 . . . . 5.17 111.564 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -83.64 -174.97 50.72 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.938 -0.648 . . . . 4.66 112.538 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.36 -51.52 54.0 Favored Glycine 0 CA--C 1.516 0.113 0 C-N-CA 121.416 -0.421 . . . . 5.04 113.249 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.3 -32.68 72.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.983 0.421 . . . . 5.51 110.054 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.5 36.16 0.75 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.908 -0.663 . . . . 4.73 112.125 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -86.99 154.74 20.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.15 -0.685 . . . . 5.52 109.15 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 mtt -137.77 138.04 38.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.943 0.401 . . . . 4.48 111.852 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HE3' HD21 ' A' ' 64' ' ' LEU . 45.7 tttp -71.84 -33.72 68.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.517 -0.765 . . . . 4.16 110.288 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 26.1 t0 46.85 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.632 0.975 . . . . 4.09 113.632 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 52' ' ' ARG . 47.8 mt -89.22 137.3 32.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 3.36 110.46 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -64.04 144.73 98.17 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.099 -0.5 . . . . 3.36 110.271 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.81 119.32 5.83 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.915 2.41 . . . . 2.69 112.27 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.528 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 64.8 mtt85 -121.19 132.43 54.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.989 -0.55 . . . . 3.03 110.568 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.641 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 48.0 m95 -93.74 118.48 31.47 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.252 -0.431 . . . . 1.84 110.921 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.82 146.23 24.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.194 -0.669 . . . . 2.76 109.194 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -86.54 120.83 28.28 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.653 -0.419 . . . . 1.27 111.774 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -115.37 157.51 23.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.593 -0.521 . . . . 1.84 109.593 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -102.94 158.95 15.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.936 -0.394 . . . . 1.28 109.936 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -63.18 118.99 8.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.079 -0.341 . . . . 1.66 110.079 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.84 35.2 4.93 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.987 -0.625 . . . . 1.66 112.334 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.35 99.87 12.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.033 0.444 . . . . 1.58 110.796 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.85 123.94 3.38 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.181 -0.768 . . . . 1.96 111.181 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.3 -27.7 83.55 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.857 2.371 . . . . 2.62 113.181 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -127.59 35.35 4.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.737 0.303 . . . . 3.09 110.597 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.22 -50.65 21.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 1.79 111.023 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.62 51.27 26.38 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.308 -0.717 . . . . 1.65 111.308 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 81.7 mt -132.28 96.12 19.99 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.573 0.225 . . . . 1.38 111.596 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 92.9 Cg_endo -84.5 162.99 12.72 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.662 2.242 . . . . 1.62 110.661 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.538 ' HB2' HD11 ' A' ' 73' ' ' LEU . 34.7 t80 -58.8 113.26 1.97 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.013 0.435 . . . . 1.58 110.894 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.67 -14.68 11.61 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.729 -0.748 . . . . 1.44 112.449 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -61.83 108.61 1.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.883 0.373 . . . . 1.25 110.486 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -76.0 107.45 8.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.153 -0.476 . . . . 1.86 110.543 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -125.62 149.83 48.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.959 -0.564 . . . . 1.68 109.968 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.15 110.49 1.62 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.236 -0.438 . . . . 1.7 111.683 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.17 21.48 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.794 -0.717 . . . . 1.27 112.284 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.483 HG23 ' CD2' ' A' ' 46' ' ' TYR . 48.1 mm -129.19 113.83 29.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.351 -0.24 . . . . 1.01 110.351 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 91' ' ' ILE . 7.8 pt -119.13 126.2 75.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.645 -0.502 . . . . 1.3 109.645 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.436 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 82.9 m95 -83.45 139.21 33.09 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.707 0.632 . . . . 1.08 112.707 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.45 139.44 38.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.538 -0.755 . . . . 1.04 110.411 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -155.5 172.33 18.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.082 -0.508 . . . . 1.27 109.745 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.2 t -142.9 170.84 14.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 120.748 0.309 . . . . 1.36 110.361 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.73 118.24 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.981 -0.554 . . . . 2.64 110.686 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.61 -15.22 8.56 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.967 -0.635 . . . . 1.52 111.647 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.839 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -83.25 159.26 22.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.671 0.272 . . . . 1.59 110.662 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.1 mt -118.69 140.93 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 2.15 110.663 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -80.14 97.69 6.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.093 0.473 . . . . 2.07 111.179 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.5 t -171.2 148.93 2.51 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.968 -0.753 . . . . 2.36 108.968 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -74.54 111.75 3.39 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.045 1.83 . . . . 2.08 112.111 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.827 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -108.51 80.45 1.35 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.441 0.639 . . . . 1.78 110.264 179.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -72.64 -5.96 41.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.461 -0.79 . . . . 2.55 112.245 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -63.01 -15.61 56.99 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.519 0.562 . . . . 2.24 112.519 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.89 -24.54 4.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.073 0.463 . . . . 2.0 110.726 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -91.34 73.46 1.68 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.788 -0.72 . . . . 2.33 112.029 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.4 t -160.56 22.97 0.15 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.142 0.496 . . . . 2.99 110.979 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttp85 -84.29 136.85 33.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 2.83 110.824 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -83.85 119.64 73.85 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.42 -0.585 . . . . 3.56 109.42 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.795 ' HB2' " H5'" ' C' ' 9' ' ' ' U' . 71.9 Cg_endo -75.52 -19.3 16.93 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.792 2.328 . . . . 3.39 113.769 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -97.43 -40.6 8.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.929 0.344 . . . . 4.05 111.929 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -86.88 7.72 26.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.41 -0.359 . . . . 4.48 111.394 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -160.23 139.92 11.18 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.798 0.333 . . . . 3.39 110.512 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.597 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -86.02 141.55 29.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.241 -0.436 . . . . 3.21 111.143 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.64 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -85.36 148.38 26.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.455 -0.339 . . . . 2.85 110.765 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.62 148.39 5.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 2.42 110.251 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -66.65 135.52 28.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.926 -0.398 . . . . 2.74 109.926 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.48 HD23 ' HG ' ' A' ' 16' ' ' LEU . 15.7 tp -63.3 119.66 10.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.22 -0.446 . . . . 2.11 110.691 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -124.33 135.24 53.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.959 -0.564 . . . . 2.49 110.915 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.0 mt -101.79 147.5 33.96 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.134 -0.485 . . . . 1.91 110.142 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.65 152.54 77.88 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.702 2.268 . . . . 1.84 111.807 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -54.86 129.49 37.57 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.858 -0.61 . . . . 2.53 111.258 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 107.88 -27.64 14.17 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.419 -0.672 . . . . 2.2 111.419 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -99.81 98.26 9.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.718 0.294 . . . . 2.1 110.395 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.71 147.07 23.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 2.78 110.433 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -71.86 144.37 87.95 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.285 -0.416 . . . . 2.62 110.223 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.521 ' HG2' ' HD1' ' A' ' 131' ' ' PHE . 17.6 Cg_endo -60.34 155.64 45.34 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.399 2.066 . . . . 2.77 111.505 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -60.89 127.41 31.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 4.11 111.105 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.36 2.95 63.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.908 -0.663 . . . . 3.18 112.648 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -112.51 116.56 30.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.917 0.389 . . . . 2.91 111.828 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -124.09 137.78 54.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 3.54 110.64 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.473 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -79.2 135.65 36.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.071 -0.513 . . . . 2.93 111.372 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.0 121.49 15.67 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.613 -0.721 . . . . 3.64 111.114 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 23.26 34.05 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.941 -0.572 . . . . 3.27 112.849 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 50.9 m -107.29 -23.37 12.26 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.207 0.447 . . . . 3.59 112.207 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -139.45 127.98 23.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.089 0.471 . . . . 5.55 111.783 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 134.6 -169.15 23.26 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.971 -0.851 . . . . 5.22 110.971 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -91.88 43.66 2.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.786 -0.721 . . . . 5.91 111.815 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 119.005 -0.522 . . . . 7.27 111.219 -179.868 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.491 -3.655 1 C4'-C3'-C2' 97.124 -5.576 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.503 2 N19-C1'-C2' 103.478 -6.201 . 0.232 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.863 3 O4'-C1'-N19 115.748 7.548 . 0.531 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.168 4 O4'-C1'-N19 116.661 8.461 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.119 2 C4'-C3'-C2' 97.573 -5.127 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.769 4 C1'-O4'-C4' 105.612 -4.431 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.496 5.235 3 P-O3'-C3' 127.041 6.117 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.64 " H4'" ' HB3' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.262 3 O4'-C4'-C3' 114.884 6.703 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . 0.795 " H5'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.543 -5.014 2 O4'-C1'-N19 118.634 10.434 . 0.416 1a . 14.39 . . . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.549 -4.404 3 O3'-P-O5' 116.382 6.517 . 0.457 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.148 1 C4'-C3'-C2' 98.237 -4.463 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.587 5.701 1 C4'-C3'-C2' 94.307 -8.393 . 0.461 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.529 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.587 5.693 1 O3'-P-O5' 111.706 4.056 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.042 2 C3'-C2'-C1' 105.754 4.727 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.755 -0.538 . . . . 9.05 111.755 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.69 93.97 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.018 0.437 . . . . 8.09 110.483 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -100.78 105.63 16.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.031 -0.532 . . . . 8.02 110.447 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.79 141.14 19.28 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.792 -0.718 . . . . 5.76 111.801 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.746 HD22 ' HB2' ' A' ' 7' ' ' ASN . 0.7 OUTLIER -110.37 112.8 56.75 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.557 0.218 . . . . 4.72 110.513 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HD2' HD23 ' A' ' 5' ' ' LEU . 79.9 Cg_endo -77.86 56.19 5.57 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.794 2.329 . . . . 4.45 111.249 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.746 ' HB2' HD22 ' A' ' 5' ' ' LEU . 17.5 t-20 -98.33 112.67 24.59 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.718 -0.674 . . . . 4.41 110.762 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -110.65 -58.02 2.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.56 -0.291 . . . . 3.92 110.918 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 m 69.54 104.73 0.06 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.606 0.566 . . . . 2.53 111.127 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.22 127.84 53.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.073 0.463 . . . . 2.48 112.236 -178.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -73.1 139.21 46.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.701 -0.681 . . . . 2.13 110.306 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -98.06 -25.59 14.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.783 0.325 . . . . 2.4 111.788 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.66 176.98 5.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 2.02 110.571 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.526 HG22 " H5'" ' C' ' 8' ' ' ' G' . 14.7 p -69.89 175.62 4.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.983 0.421 . . . . 2.65 111.382 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -95.05 158.23 15.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.411 0.624 . . . . 2.4 111.527 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.743 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 88.7 mt -111.89 106.3 14.98 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.148 -0.933 . . . . 2.27 109.327 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.7 m -84.51 127.17 33.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 2.84 111.504 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.55 115.57 27.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.902 -0.59 . . . . 2.89 110.664 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -103.67 72.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.487 -0.56 . . . . 3.82 109.487 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.95 -161.85 26.86 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.842 -0.694 . . . . 3.23 112.156 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 70.3 mmtt -94.28 -42.52 8.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.684 0.278 . . . . 4.27 111.115 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -63.69 153.32 36.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.107 -0.497 . . . . 3.32 110.064 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.9 -76.0 0.31 Allowed 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.915 -0.314 . . . . 2.39 110.574 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.1 tp 179.8 130.55 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.897 -0.592 . . . . 2.06 110.264 179.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -145.18 123.97 12.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 2.22 110.32 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.47 ' CD1' ' HA2' ' A' ' 31' ' ' GLY . 46.6 m-85 -107.0 140.21 21.17 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.356 -0.384 . . . . 1.78 110.866 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 13.4 Cg_exo -71.58 168.96 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.839 2.359 . . . . 2.15 111.901 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -61.0 124.93 21.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 2.6 111.279 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.96 9.97 84.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.885 -0.674 . . . . 1.65 112.737 179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.584 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 16.6 tt0 -129.5 160.7 32.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.814 -0.439 . . . . 2.31 109.814 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 26' ' ' PHE . . . 118.36 -3.01 16.05 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.151 -0.547 . . . . 1.33 111.951 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.6 t -101.21 111.16 63.15 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.898 -0.408 . . . . 1.06 109.898 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 4.0 Cg_exo -76.88 -170.7 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 123.001 2.467 . . . . 1.27 111.327 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.9 mt -74.2 100.75 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.191 0.52 . . . . 1.7 111.268 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.587 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 71.2 m-80 -103.37 86.03 2.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.0 -0.741 . . . . 1.23 109.0 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -51.67 53.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.579 0.955 . . . . 1.94 113.579 -178.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -80.71 11.33 3.92 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.836 0.68 . . . . 1.96 112.836 -178.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.587 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -115.02 137.73 51.68 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.713 0.292 . . . . 1.42 110.802 179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.98 164.05 50.99 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 1.73 111.006 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.17 -37.94 93.89 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.177 2.585 . . . . 1.42 113.312 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.4 p-10 -82.33 -5.97 58.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.548 0.213 . . . . 1.78 111.453 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.07 5.24 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 1.6 110.279 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.483 ' HB3' HG11 ' A' ' 32' ' ' VAL . 63.3 mm-40 -83.7 53.31 2.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 1.05 111.062 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.448 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.7 tt -144.81 136.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.859 -0.609 . . . . 1.17 110.142 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.19 -147.93 6.7 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.152 -1.023 . . . . 0.6 113.059 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.428 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 44.2 p90 -157.16 172.78 18.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.951 0.405 . . . . 0.99 110.699 -179.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -117.34 134.76 54.44 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.478 -0.564 . . . . 1.26 109.478 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -107.53 136.17 47.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 2.15 111.141 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -81.37 98.12 8.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.607 -0.724 . . . . 2.4 110.282 179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -108.8 148.35 30.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 2.21 111.803 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 m -155.64 121.5 5.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.68 109.464 179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.804 ' HB3' HD12 ' A' ' 64' ' ' LEU . 4.2 ttt85 -94.45 129.87 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.654 0.264 . . . . 3.59 111.038 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.17 94.95 2.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.33 -0.395 . . . . 3.43 110.457 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.529 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -83.17 141.89 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.778 0.323 . . . . 4.26 111.359 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -97.75 115.39 27.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 5.17 112.237 -178.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 157.97 52.02 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.845 -0.693 . . . . 4.66 111.47 178.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.15 -51.04 61.25 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.397 -0.43 . . . . 5.04 112.622 -179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -69.56 -25.27 63.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.187 0.517 . . . . 5.51 110.998 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.72 36.18 0.65 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.519 -0.848 . . . . 4.73 111.589 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -91.31 155.77 18.28 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.182 -0.303 . . . . 5.52 110.182 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 mmt -148.83 125.79 11.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.445 -0.343 . . . . 4.48 110.969 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.512 ' HG3' ' O4 ' ' C' ' 13' ' ' ' U' . 58.6 tttt -62.35 -42.43 99.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.078 -0.51 . . . . 4.16 110.526 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 t70 58.85 77.53 0.3 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.353 -0.84 . . . . 4.09 112.069 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.804 HD12 ' HB3' ' A' ' 52' ' ' ARG . 40.0 mt -87.45 164.09 16.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.024 -0.534 . . . . 3.36 111.062 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.65 152.74 54.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.131 -0.486 . . . . 3.36 110.634 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 115.17 2.48 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.479 2.119 . . . . 2.69 111.283 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.663 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 4.3 ptp180 -113.15 119.57 38.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 3.03 110.82 -179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -84.43 126.34 33.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.836 -0.62 . . . . 1.84 110.648 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 51.1 m-85 -109.26 132.01 54.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.708 -0.479 . . . . 2.76 109.708 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.49 127.32 33.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.374 -0.376 . . . . 1.27 111.179 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -130.24 157.66 41.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.51 -0.552 . . . . 1.84 109.51 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -86.28 156.31 20.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.984 0.421 . . . . 1.28 111.019 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 83' ' ' TYR . 4.2 tt -65.82 116.86 7.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.141 -0.481 . . . . 1.66 111.204 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.78 10.23 31.1 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.614 -0.803 . . . . 1.66 113.617 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -61.02 122.74 15.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.855 0.36 . . . . 1.58 110.976 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.419 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 97.63 123.87 4.76 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.87 -0.681 . . . . 1.96 112.005 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 9.9 Cg_endo -53.35 -63.89 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.219 2.613 . . . . 2.62 112.434 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.69 ' HB2' HD21 ' A' ' 5' ' ' LEU . 42.7 mt-10 -91.95 72.7 5.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.309 0.576 . . . . 3.09 111.12 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.99 -61.17 1.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.691 -0.686 . . . . 1.79 109.936 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.3 39.46 57.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.797 -0.638 . . . . 1.65 112.316 179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -123.89 95.17 44.72 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 110.217 -0.29 . . . . 1.38 110.217 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 84.2 Cg_endo -89.67 179.46 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.865 2.377 . . . . 1.62 112.206 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.447 ' HB2' HD11 ' A' ' 73' ' ' LEU . 43.2 t80 -61.42 107.48 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.935 -0.575 . . . . 1.58 111.247 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 123.17 -15.55 8.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.513 -0.851 . . . . 1.44 113.061 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.634 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -65.72 105.24 1.21 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.156 0.503 . . . . 1.25 111.033 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -79.06 122.47 26.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.036 -0.529 . . . . 1.86 111.214 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -141.11 173.74 11.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 1.68 109.732 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -73.96 114.87 12.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.012 0.434 . . . . 1.7 111.492 -179.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.86 31.64 59.91 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.83 -0.623 . . . . 1.27 113.01 179.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.7 mm -128.58 107.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 110.333 -0.247 . . . . 1.01 110.333 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 pt -115.14 124.92 72.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.543 0.211 . . . . 1.3 110.446 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 76.3 m95 -88.41 138.79 31.12 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.045 0.387 . . . . 1.08 112.045 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.87 144.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 1.04 110.66 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.9 160.42 43.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.394 -0.366 . . . . 1.27 110.301 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -135.45 168.83 18.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.71 -0.478 . . . . 1.36 109.71 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.15 133.12 55.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.854 0.359 . . . . 2.64 110.675 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.65 -16.97 55.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.969 -0.634 . . . . 1.52 112.349 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.41 143.05 29.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 1.59 110.577 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.6 mt -110.68 142.44 42.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.44 -0.345 . . . . 2.15 110.447 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -76.42 83.95 3.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.302 0.572 . . . . 2.07 110.902 179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.1 t -151.65 139.09 12.47 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.459 -0.791 . . . . 2.36 109.416 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.01 126.55 22.39 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 123.013 2.476 . . . . 2.08 113.278 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -117.97 60.71 0.77 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.5 -0.773 . . . . 1.78 110.217 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -75.58 -0.87 21.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.147 -0.479 . . . . 2.55 112.101 -179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -74.76 -6.75 50.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 2.24 111.55 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.22 35.45 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 2.0 111.142 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -123.27 13.33 8.39 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.53 -0.843 . . . . 2.33 112.868 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.7 t -131.88 114.81 15.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.207 0.527 . . . . 2.99 110.898 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.7 ttp85 -151.05 160.57 43.83 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.604 -0.517 . . . . 2.83 109.604 -179.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.14 105.83 50.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 3.56 110.715 179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.47 -34.24 26.84 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.401 2.068 . . . . 3.39 113.087 -179.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.592 ' HA ' ' N2 ' ' C' ' 8' ' ' ' G' . . . -74.52 -8.07 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.972 0.36 . . . . 4.05 111.972 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -125.73 10.03 7.71 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.626 -0.261 . . . . 4.48 111.495 -179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -168.92 127.91 1.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 3.39 110.182 -179.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.658 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -80.33 164.5 23.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.703 0.287 . . . . 3.21 110.762 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.521 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -99.93 151.96 20.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.318 -0.401 . . . . 2.85 110.232 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.0 mt -83.97 143.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.589 -0.523 . . . . 2.42 109.589 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.546 HG11 ' HB2' ' A' ' 136' ' ' SER . 85.7 t -65.92 119.85 11.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.796 0.331 . . . . 2.74 110.474 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.612 HD22 HD21 ' A' ' 16' ' ' LEU . 7.8 tt -63.28 118.65 8.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.814 -0.63 . . . . 2.11 109.718 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -133.53 165.64 24.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.28 -0.418 . . . . 2.49 110.898 -179.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.33 157.67 43.31 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.646 -0.706 . . . . 1.91 110.042 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -74.39 172.82 15.33 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.62 2.213 . . . . 1.84 112.075 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -66.2 120.87 13.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.006 -0.543 . . . . 2.53 110.336 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 116.42 -25.8 8.98 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.551 -0.833 . . . . 2.2 112.099 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 m -98.13 112.93 24.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.805 -0.442 . . . . 2.1 109.805 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.9 m -104.7 145.34 30.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.727 -0.669 . . . . 2.78 111.257 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.2 mt -76.92 149.38 80.13 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 109.09 -0.707 . . . . 2.62 109.09 178.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 131' ' ' PHE . 18.4 Cg_endo -60.42 146.23 97.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.529 2.153 . . . . 2.77 111.553 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -59.61 109.74 0.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 4.11 110.471 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.2 -12.42 9.73 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.371 -0.692 . . . . 3.18 111.371 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.743 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 1.4 t80 -103.24 134.34 46.81 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.125 -0.324 . . . . 2.91 110.125 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -128.78 164.95 21.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.349 -0.387 . . . . 3.54 110.53 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 136' ' ' SER . . . -103.34 139.54 38.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.511 -0.313 . . . . 2.93 110.479 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.82 123.11 28.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.921 0.391 . . . . 3.64 110.535 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.18 -1.39 82.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.297 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.546 ' HB2' HG11 ' A' ' 118' ' ' VAL . 4.7 t -118.19 110.69 17.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.036 0.446 . . . . 3.59 110.566 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.86 101.5 10.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.024 -0.535 . . . . 5.55 110.848 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 121.86 -134.04 9.7 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.266 -0.733 . . . . 5.22 111.266 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.43 79.29 0.51 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.914 -0.66 . . . . 5.91 112.786 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.253 1.262 0 CA-C-O 119.056 -0.497 . . . . 7.27 111.528 179.669 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.401 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.492 -3.615 1 C4'-C3'-C2' 97.04 -5.66 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.401 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.506 2 N19-C1'-C2' 103.494 -6.191 . 0.232 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.705 3 O4'-C1'-N19 115.722 7.522 . 0.531 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.195 4 O4'-C1'-N19 116.707 8.507 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 O5'--C5' 1.375 -4.086 2 C4'-C3'-C2' 97.608 -5.092 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.765 4 N19-C1'-C2' 106.385 -4.384 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.498 5.357 3 P-O3'-C3' 127.02 6.1 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 021 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.658 " H1'" ' HA ' ' A' ' 115' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.353 3 O4'-C4'-C3' 114.915 6.725 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 021 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.86 2 O4'-C1'-N19 118.668 10.468 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 021 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.532 3 O3'-P-O5' 116.424 6.539 . 0.463 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 021 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.142 1 C4'-C3'-C2' 98.325 -4.375 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 021 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.584 5.464 1 C4'-C3'-C2' 94.338 -8.362 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 021 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.512 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.588 5.856 1 O3'-P-O5' 111.688 4.046 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 021 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.579 5.065 2 C3'-C2'-C1' 105.657 4.619 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.597 -0.601 . . . . 9.05 111.597 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.53 119.96 18.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.817 0.341 . . . . 8.09 111.073 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.7 mmt -80.89 88.28 5.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.193 -0.458 . . . . 8.02 109.812 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.86 140.15 4.12 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.435 -0.802 . . . . 5.76 111.142 -179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -107.84 110.98 62.56 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.818 0.342 . . . . 4.72 110.51 -179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -93.47 18.82 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.064 2.51 . . . . 4.45 111.862 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -94.07 142.54 27.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.202 -0.454 . . . . 4.41 110.517 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -116.19 -77.33 0.57 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.506 -0.316 . . . . 3.92 110.29 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p 51.35 83.63 0.05 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.66 0.985 . . . . 2.53 113.66 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.45 135.05 40.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 2.48 111.012 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.1 m -57.86 153.02 14.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.082 -0.508 . . . . 2.13 112.35 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 109' ' ' ARG . 32.2 m95 -74.92 -54.44 7.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.609 -0.723 . . . . 2.4 110.52 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.82 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 24.8 m-85 -74.75 159.65 31.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.602 -0.726 . . . . 2.02 112.096 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 9.5 p -68.92 158.58 34.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.543 -0.753 . . . . 2.65 111.017 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -77.08 144.99 38.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.911 0.386 . . . . 2.4 111.207 -179.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.637 HD13 ' HE2' ' A' ' 131' ' ' PHE . 35.4 mt -89.53 119.9 30.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.988 -0.375 . . . . 2.27 109.988 179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 m -90.97 126.44 36.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.279 0.561 . . . . 2.84 112.458 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.423 ' HB2' ' HE1' ' A' ' 131' ' ' PHE . 6.2 tp-100 -94.8 138.43 32.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.892 -0.594 . . . . 2.89 110.172 179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.408 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 14.6 t60 -137.21 56.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.532 -0.544 . . . . 3.82 109.532 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -154.89 -169.34 19.39 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.58 -0.736 . . . . 3.23 111.685 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mmtt -92.84 -1.77 56.48 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.062 0.393 . . . . 4.27 112.062 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -104.53 171.92 7.07 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.566 -0.288 . . . . 3.32 110.308 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.74 -79.87 0.43 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.664 -0.243 . . . . 2.39 110.375 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.7 tp -179.57 132.23 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.067 -0.515 . . . . 2.06 110.421 179.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -154.07 117.31 4.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.333 -0.394 . . . . 2.22 110.628 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -109.74 141.29 23.37 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.191 -0.459 . . . . 1.78 110.155 179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.72 165.01 29.12 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.564 2.176 . . . . 2.15 112.298 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -64.34 119.87 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.932 -0.577 . . . . 2.6 111.085 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.36 0.52 56.88 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.798 -0.715 . . . . 1.65 112.567 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -130.0 165.76 21.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 2.31 110.62 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.38 -14.7 30.36 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.783 -0.722 . . . . 1.33 112.37 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.555 HG11 ' HB3' ' A' ' 43' ' ' GLN . 25.8 t -89.56 118.15 68.79 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.701 0.286 . . . . 1.06 110.999 -179.239 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.19 -176.36 2.87 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.608 2.206 . . . . 1.27 111.345 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 mt -84.63 79.16 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 1.7 110.781 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -83.85 86.85 7.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.323 -0.399 . . . . 1.23 110.31 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.07 64.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.994 0.426 . . . . 1.94 110.832 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -76.42 0.67 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.959 -0.564 . . . . 1.96 111.394 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.499 ' HB3' ' CB ' ' A' ' 42' ' ' ASP . 4.3 m -128.36 152.19 48.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.855 0.36 . . . . 1.42 111.033 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.55 168.49 27.26 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.099 -0.501 . . . . 1.73 109.88 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.28 -36.61 93.91 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.585 2.19 . . . . 1.42 111.961 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.1 OUTLIER -77.79 -19.94 54.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 1.78 111.054 179.765 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.934 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 31.7 m-20 -81.97 -5.8 58.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 1.6 111.275 -179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.555 ' HB3' HG11 ' A' ' 32' ' ' VAL . 76.8 mm-40 -79.44 57.71 2.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.151 0.5 . . . . 1.05 111.379 -179.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.493 HG13 ' HB2' ' A' ' 94' ' ' ALA . 10.9 tt -151.17 131.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.749 -0.659 . . . . 1.17 109.579 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.26 -146.15 6.07 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.368 -0.92 . . . . 0.6 112.661 -179.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -153.03 165.01 36.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.914 0.387 . . . . 0.99 110.58 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -105.48 125.59 51.16 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.238 -0.653 . . . . 1.26 109.238 178.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -95.1 126.4 40.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.205 -0.452 . . . . 2.15 111.643 -179.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.7 ttt-85 -76.57 120.83 22.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.598 -0.728 . . . . 2.4 109.51 178.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.67 158.77 43.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.998 0.428 . . . . 2.21 111.666 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.94 109.01 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.598 -0.728 . . . . 2.68 109.594 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.648 ' HB3' HD12 ' A' ' 64' ' ' LEU . 11.3 tpt85 -81.26 103.84 11.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.007 0.432 . . . . 3.59 111.531 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -114.5 110.34 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.129 0.49 . . . . 3.43 111.179 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.3 mt -96.72 131.9 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.822 -0.626 . . . . 4.26 109.397 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 55' ' ' ARG . 1.4 ttp180 -105.74 124.76 50.09 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.331 0.395 . . . . 5.17 110.232 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.44 165.8 28.96 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.862 -0.685 . . . . 4.66 111.697 179.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.8 -26.95 74.24 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.128 -0.558 . . . . 5.04 112.129 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -83.83 3.86 31.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.46 0.648 . . . . 5.51 110.602 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.06 10.62 68.73 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.805 -0.712 . . . . 4.73 111.57 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -73.47 144.35 46.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.712 0.291 . . . . 5.52 110.265 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt -121.9 141.36 51.36 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.104 -0.498 . . . . 4.48 110.575 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -68.24 -42.65 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 4.16 109.542 178.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t0 47.48 75.23 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.18 -0.918 . . . . 4.09 112.676 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 52' ' ' ARG . 27.4 mt -94.46 158.92 15.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.912 -0.585 . . . . 3.36 111.195 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.11 149.51 89.58 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.777 -0.647 . . . . 3.36 111.289 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.66 116.25 3.12 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.844 2.363 . . . . 2.69 111.297 178.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 10.8 mtt-85 -119.91 147.6 44.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.051 -0.522 . . . . 3.03 111.594 -179.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -114.93 129.14 56.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.017 -0.538 . . . . 1.84 110.946 -179.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -103.65 133.65 48.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.365 -0.606 . . . . 2.76 109.365 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -81.6 121.36 26.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.049 0.452 . . . . 1.27 111.481 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.44 ' HD2' HG21 ' A' ' 75' ' ' THR . 20.2 m-85 -122.74 133.52 54.48 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 1.84 109.743 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.63 159.74 33.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.539 -0.3 . . . . 1.28 110.899 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.38 122.0 12.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.334 -0.394 . . . . 1.66 111.825 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.39 24.34 26.65 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.906 -0.664 . . . . 1.66 113.678 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.44 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.6 OUTLIER -77.2 102.16 6.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.986 0.422 . . . . 1.58 111.204 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.403 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 127.25 114.23 1.85 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.13 -0.788 . . . . 1.96 111.13 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 18.0 Cg_endo -59.45 -26.51 82.22 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.91 2.407 . . . . 2.62 112.466 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -115.3 15.28 16.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.543 0.211 . . . . 3.09 111.526 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.66 -55.58 6.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.029 0.442 . . . . 1.79 110.223 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.64 36.35 89.29 Favored Glycine 0 C--N 1.329 0.157 0 CA-C-N 115.73 -0.668 . . . . 1.65 112.789 179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 63.0 mt -107.85 105.9 57.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.565 0.221 . . . . 1.38 111.039 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.14 161.84 17.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.056 2.504 . . . . 1.62 111.511 179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -57.91 111.07 1.04 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.486 . . . . 1.58 110.51 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.76 -19.23 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.629 -0.796 . . . . 1.44 112.352 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.61 113.11 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 1.25 110.807 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -82.27 121.98 27.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.374 -0.376 . . . . 1.86 111.704 -179.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -134.94 171.46 14.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.295 -0.411 . . . . 1.68 110.269 178.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.35 110.29 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.878 -0.601 . . . . 1.7 111.195 -179.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.13 41.37 97.06 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.95 -0.568 . . . . 1.27 112.823 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.5 mm -127.51 105.91 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.899 0.381 . . . . 1.01 110.611 179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.8 pt -111.67 135.19 51.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.371 -0.603 . . . . 1.3 109.371 178.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -94.86 140.68 29.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.16 0.43 . . . . 1.08 112.16 -178.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.01 141.54 36.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.519 -0.764 . . . . 1.04 110.241 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -155.25 152.28 29.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.09 -0.337 . . . . 1.27 110.09 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -111.59 173.61 6.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.415 -0.357 . . . . 1.36 110.263 179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.0 118.68 15.16 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.983 -0.377 . . . . 2.64 109.983 179.53 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.76 -3.8 24.46 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.84 -0.695 . . . . 1.52 111.881 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -84.21 131.4 34.75 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.46 -0.2 . . . . 1.59 110.46 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.14 148.52 23.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.235 -0.439 . . . . 2.15 111.188 -179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -87.1 72.27 10.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 2.07 110.557 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.504 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 8.5 m -148.68 125.93 5.58 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.466 -0.788 . . . . 2.36 109.498 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.18 133.75 53.69 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.983 2.455 . . . . 2.08 112.195 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.934 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.28 84.6 2.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.305 0.574 . . . . 1.78 111.346 -179.494 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -11.03 59.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.005 -0.543 . . . . 2.55 111.756 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.444 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.4 p80 -56.91 -22.24 35.98 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.797 0.665 . . . . 2.24 112.797 -179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.57 4.69 8.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.095 0.474 . . . . 2.0 110.753 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -93.27 -16.7 45.82 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.885 -0.674 . . . . 2.33 111.517 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -87.08 121.71 29.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.949 0.404 . . . . 2.99 110.519 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 12' ' ' TRP . 10.3 ttp85 -164.91 131.04 2.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.218 -0.446 . . . . 2.83 110.614 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 28.3 t-20 -95.12 122.64 59.45 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.553 -0.536 . . . . 3.56 109.553 178.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 11.7 Cg_endo -54.6 -37.23 90.83 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 123.449 2.766 . . . . 3.39 114.086 -178.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.67 -8.53 59.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.81 0.67 . . . . 4.05 112.81 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -115.5 7.18 14.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.463 0.542 . . . . 4.48 112.463 -179.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.77 124.61 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.908 0.385 . . . . 3.39 110.998 -179.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.31 158.59 28.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.26 -0.427 . . . . 3.21 110.871 -179.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.433 ' HB2' " O4'" ' C' ' 8' ' ' ' G' . . . -73.24 151.98 41.2 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.081 0.467 . . . . 2.85 111.487 -179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 44.3 mt -107.96 132.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.044 -0.725 . . . . 2.42 109.044 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.29 119.34 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.434 -0.348 . . . . 2.74 111.009 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.82 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 3.9 tt -66.82 122.49 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.208 0.528 . . . . 2.11 110.733 179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -133.15 145.49 50.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.515 -0.766 . . . . 2.49 110.582 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.553 HD13 HG22 ' A' ' 125' ' ' THR . 34.3 mt -106.83 143.74 27.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 1.91 109.767 178.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.71 159.08 50.16 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.557 2.171 . . . . 1.84 111.847 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -57.87 126.36 27.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.106 -0.497 . . . . 2.53 111.041 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.87 -11.8 45.5 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.967 -0.853 . . . . 2.2 110.967 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.553 HG22 HD13 ' A' ' 121' ' ' LEU . 10.4 m -108.52 109.01 20.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.269 -0.641 . . . . 2.1 109.269 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.08 147.85 28.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.412 -0.358 . . . . 2.78 111.296 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.494 HD22 ' HD2' ' A' ' 131' ' ' PHE . 27.8 mt -83.46 145.95 49.31 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.89 -0.596 . . . . 2.62 109.96 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.28 154.57 45.7 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.72 2.28 . . . . 2.77 112.095 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -68.2 120.87 15.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.01 -0.541 . . . . 4.11 110.462 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.95 4.56 48.14 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.845 -0.693 . . . . 3.18 111.705 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.637 ' HE2' HD13 ' A' ' 16' ' ' LEU . 2.3 t80 -115.57 121.81 43.74 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.341 -0.614 . . . . 2.91 109.341 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.408 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 29.8 p90 -126.41 140.87 52.15 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.989 0.423 . . . . 3.54 111.37 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.94 154.43 21.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.744 -0.662 . . . . 2.93 111.521 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.664 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 9.4 tt0 -83.59 131.57 34.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.405 -0.816 . . . . 3.64 109.224 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.51 -52.0 2.38 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.964 -0.854 . . . . 3.27 110.964 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.29 106.12 3.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 3.59 110.066 178.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -115.1 156.72 24.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.368 -0.378 . . . . 5.55 110.481 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.85 118.86 16.43 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.238 -0.506 . . . . 5.22 113.234 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 113.93 -92.02 0.59 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.109 -0.567 . . . . 5.91 111.763 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.248 0.996 0 CA-C-O 119.011 -0.519 . . . . 7.27 111.191 -179.979 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.566 1 C4'-C3'-C2' 97.065 -5.635 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.505 2 N19-C1'-C2' 103.543 -6.161 . 0.23 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.755 3 O4'-C1'-N19 115.717 7.517 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.231 4 O4'-C1'-N19 116.65 8.45 . 0.514 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.373 -4.171 2 C4'-C3'-C2' 97.583 -5.117 . 0.653 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.656 4 C4'-C3'-C2' 98.264 -4.436 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.498 5.344 3 P-O3'-C3' 127.002 6.085 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.433 " O4'" ' HB2' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.366 3 O4'-C4'-C3' 114.977 6.769 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 022 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.083 2 O4'-C1'-N19 118.609 10.409 . 0.417 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.49 3 O3'-P-O5' 116.308 6.478 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.136 1 C4'-C3'-C2' 98.305 -4.395 . 0.31 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.568 1 C4'-C3'-C2' 94.371 -8.329 . 0.455 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.844 1 O3'-P-O5' 111.696 4.051 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 022 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.964 2 C3'-C2'-C1' 105.718 4.686 . 0.339 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.974 0 N-CA-C 111.841 -0.504 . . . . 9.05 111.841 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.37 116.47 23.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.932 0.396 . . . . 8.09 110.624 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.5 mmm -120.69 131.14 54.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.019 -0.537 . . . . 8.02 110.672 -179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.58 126.41 7.39 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.631 -0.795 . . . . 5.76 111.966 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 85.8 mt -87.33 121.47 71.27 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.882 -0.414 . . . . 4.72 109.882 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 2.6 Cg_exo -76.84 63.99 7.56 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 123.201 2.601 . . . . 4.45 111.874 -179.542 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -106.25 115.82 30.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.02 -0.536 . . . . 4.41 110.604 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -89.37 -85.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.228 -0.442 . . . . 3.92 110.827 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m 61.92 90.89 0.07 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.187 0.518 . . . . 2.53 111.67 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.51 161.74 13.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 2.48 111.258 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 p -81.02 162.36 23.84 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.046 -0.525 . . . . 2.13 110.54 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -98.79 -11.4 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.978 0.362 . . . . 2.4 111.978 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 92.6 m-85 -129.09 176.37 7.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.606 -0.27 . . . . 2.02 111.041 -179.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.07 HG22 " H5'" ' C' ' 8' ' ' ' G' . 1.9 p -71.69 174.19 7.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.075 -0.511 . . . . 2.65 110.077 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -97.41 167.36 11.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.189 0.519 . . . . 2.4 111.269 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -111.79 107.05 15.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.552 -0.749 . . . . 2.27 109.28 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -82.43 115.74 21.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.218 -0.446 . . . . 2.84 110.607 -179.943 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -85.33 128.49 34.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 2.89 110.371 179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.735 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 42.9 t60 -112.98 -7.67 13.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.752 0.311 . . . . 3.82 111.247 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.76 -159.15 26.11 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.958 -0.639 . . . . 3.23 111.674 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -97.37 -32.07 12.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.83 0.315 . . . . 4.27 111.325 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.33 174.78 8.37 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.893 -0.594 . . . . 3.32 110.179 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -96.78 -82.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.403 -0.592 . . . . 2.39 109.403 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 131' ' ' PHE . 31.6 tp -176.03 130.14 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.403 -0.362 . . . . 2.06 110.117 179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -153.15 99.14 2.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.187 -0.46 . . . . 2.22 110.647 179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 24' ' ' LEU . 16.6 m-85 -89.22 137.05 29.5 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 1.78 110.511 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.93 158.14 55.59 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.649 2.232 . . . . 2.15 111.852 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -56.93 118.14 4.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.79 -0.641 . . . . 2.6 111.355 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.35 -13.96 43.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 1.65 112.33 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -115.64 163.9 15.12 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.969 -0.382 . . . . 2.31 109.969 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' HA3' HG11 ' A' ' 93' ' ' VAL . . . 116.0 -19.05 13.96 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.839 -0.696 . . . . 1.33 112.808 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 49.1 t -86.77 113.76 54.71 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.726 0.298 . . . . 1.06 110.568 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.536 ' HA ' HD23 ' A' ' 121' ' ' LEU . 2.9 Cg_exo -77.26 -174.89 2.39 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 123.265 2.643 . . . . 1.27 111.794 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.9 mt -73.67 81.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 1.7 110.845 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.576 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 63.8 m-80 -81.79 84.18 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.424 . . . . 1.23 109.894 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.64 -32.5 69.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.808 -0.633 . . . . 1.94 112.12 -178.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -76.95 -26.28 53.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 1.96 112.063 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.576 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -91.15 158.28 16.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.064 0.394 . . . . 1.42 112.064 -178.67 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.737 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 46.4 m -86.19 171.96 9.37 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.101 -0.499 . . . . 1.73 110.976 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.737 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.2 Cg_endo -52.82 -43.53 55.46 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.037 2.491 . . . . 1.42 113.45 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -75.07 -16.05 60.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.78 111.53 179.966 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.834 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.0 m-20 -81.99 -3.62 54.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.458 . . . . 1.6 111.237 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.478 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 41.0 mm-40 -77.2 51.8 0.86 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.3 0.572 . . . . 1.05 111.536 -179.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 94' ' ' ALA . 13.4 tt -150.98 128.03 2.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.654 -0.703 . . . . 1.17 109.468 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.28 -143.88 4.03 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.217 -0.992 . . . . 0.6 112.542 -179.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -157.69 166.02 33.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.956 0.407 . . . . 0.99 111.001 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.782 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 6.5 m-85 -107.38 137.87 44.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 1.26 110.062 178.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.456 ' HA ' HD13 ' A' ' 90' ' ' ILE . 19.7 ttt180 -115.07 124.66 52.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.467 . . . . 2.15 110.82 -179.278 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -83.66 121.55 27.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.023 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 147.02 52.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.078 0.466 . . . . 2.21 111.482 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -130.92 160.51 34.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.476 -0.784 . . . . 2.68 108.94 179.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 52' ' ' ARG . 5.0 tpt180 -134.77 123.56 23.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.983 0.42 . . . . 3.59 111.769 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' HD3' ' SD ' ' A' ' 61' ' ' MET . 74.9 mtt180 -138.92 115.21 10.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 3.43 110.942 179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.659 HD11 ' H5 ' ' C' ' 13' ' ' ' U' . 28.5 pt -90.09 149.42 4.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.185 -0.672 . . . . 4.26 109.185 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -90.57 97.12 10.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.843 0.354 . . . . 5.17 110.362 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.683 ' HA2' ' OP2' ' C' ' 13' ' ' ' U' . . . -73.78 134.71 19.31 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.936 -0.65 . . . . 4.66 111.882 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 -23.32 69.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.888 -0.672 . . . . 5.04 112.007 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.81 3.55 41.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.999 0.428 . . . . 5.51 110.994 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.91 13.53 66.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.849 -0.691 . . . . 4.73 111.719 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -99.55 166.78 10.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.558 -0.321 . . . . 5.52 110.478 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 20.8 mtt -146.6 132.31 18.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.264 -0.426 . . . . 4.48 110.337 179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.621 ' HG3' ' N4 ' ' B' ' 1' ' ' ' C' . 73.2 tttt -54.37 -46.08 72.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 4.16 110.08 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 30.2 t70 52.07 86.21 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.961 -1.018 . . . . 4.09 113.539 179.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.67 138.03 31.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.873 -0.603 . . . . 3.36 109.937 179.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.481 ' HB2' HG22 ' A' ' 17' ' ' THR . 0.7 OUTLIER -60.38 153.17 60.96 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.996 -0.547 . . . . 3.36 110.97 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 114.98 2.05 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.928 2.419 . . . . 2.69 111.89 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.465 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 56.7 mtp180 -110.03 113.18 25.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.776 -0.647 . . . . 3.03 110.046 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.782 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 47.3 m95 -84.91 120.3 26.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.241 -0.436 . . . . 1.84 111.117 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 79.5 m-85 -98.96 150.94 21.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 2.76 110.567 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -101.32 122.31 43.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.892 0.377 . . . . 1.27 110.542 179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -121.91 164.53 17.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.839 -0.618 . . . . 1.84 109.745 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -101.49 155.68 17.92 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.64 -0.255 . . . . 1.28 110.334 -179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 83' ' ' TYR . 0.7 OUTLIER -60.7 111.88 1.8 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.563 -0.289 . . . . 1.66 110.224 -179.859 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.63 -8.27 26.07 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.308 -0.949 . . . . 1.66 113.993 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 p -62.89 103.68 0.47 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.66 0.73 . . . . 1.58 111.595 -179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 127.23 111.95 1.72 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.723 -0.951 . . . . 1.96 110.723 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.423 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 26.2 Cg_endo -62.03 -26.07 78.12 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.762 2.308 . . . . 2.62 112.462 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -117.56 23.99 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.086 -0.506 . . . . 3.09 110.1 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.21 -53.98 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 1.79 111.122 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.2 49.29 80.14 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.877 -0.601 . . . . 1.65 112.146 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 64.6 mt -131.24 99.47 17.63 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.682 0.277 . . . . 1.38 111.548 -179.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 7.7 Cg_exo -75.35 159.43 40.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.904 2.402 . . . . 1.62 110.974 178.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.768 ' HB2' HD11 ' A' ' 73' ' ' LEU . 79.5 t80 -59.8 105.24 0.36 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 1.58 111.021 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 118.12 -4.63 16.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.863 -0.684 . . . . 1.44 112.625 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -68.0 130.3 42.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.033 0.444 . . . . 1.25 111.082 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -77.94 127.01 31.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.835 -0.62 . . . . 1.86 111.498 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.436 ' HG2' HG13 ' A' ' 90' ' ' ILE . 3.8 ttmt -152.12 143.17 23.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.2 -0.667 . . . . 1.68 109.2 178.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.02 118.83 8.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 1.7 112.1 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.13 33.83 56.33 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.617 -0.72 . . . . 1.27 112.52 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 48' ' ' ARG . 25.1 mm -136.3 112.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.157 -0.312 . . . . 1.01 110.157 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.494 HD13 ' HG ' ' A' ' 24' ' ' LEU . 19.6 pt -115.47 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.811 -0.44 . . . . 1.3 109.811 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -93.48 135.1 35.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.933 0.397 . . . . 1.08 112.044 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.448 HG11 ' HA3' ' A' ' 31' ' ' GLY . 18.1 m -136.11 140.02 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.563 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.562 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -157.89 144.11 17.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.08 -0.509 . . . . 1.27 110.121 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -110.47 -176.22 2.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.044 0.45 . . . . 1.36 111.022 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.06 133.28 44.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.677 -0.692 . . . . 2.64 110.725 -179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.89 -9.1 63.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.719 -0.753 . . . . 1.52 112.444 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -82.89 142.34 31.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.186 -0.301 . . . . 1.59 110.186 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.6 mt -103.45 144.0 31.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.714 -0.221 . . . . 2.15 110.584 -179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -80.47 74.63 7.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.155 0.502 . . . . 2.07 109.806 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.445 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 14.8 t -144.8 141.41 17.48 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.558 -0.747 . . . . 2.36 109.019 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.39 130.64 21.5 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.596 2.197 . . . . 2.08 113.351 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.834 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -130.43 71.41 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.53 -0.759 . . . . 1.78 110.874 179.438 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -16.84 61.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.76 -0.654 . . . . 2.55 111.548 -179.268 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -61.0 -7.36 2.41 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.577 0.954 . . . . 2.24 113.577 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 5.0 mt -98.39 -23.74 4.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.612 -0.514 . . . . 2.0 109.612 178.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.05 -11.32 81.53 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.859 -0.61 . . . . 2.33 113.433 -178.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.4 t -79.08 94.41 5.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.673 0.749 . . . . 2.99 110.644 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.0 ttp85 -150.81 130.73 13.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.377 -0.829 . . . . 2.83 109.857 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -88.21 115.75 64.15 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 109.836 -0.431 . . . . 3.56 109.836 179.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.49 0.92 8.98 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.808 2.338 . . . . 3.39 114.198 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.21 -31.7 9.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.053 0.454 . . . . 4.05 111.126 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -95.44 -16.85 21.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.905 -0.589 . . . . 4.48 110.596 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -143.19 143.87 31.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.153 -0.476 . . . . 3.39 110.23 -179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.59 148.44 25.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.525 -0.307 . . . . 3.21 110.45 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' H ' " H1'" ' C' ' 8' ' ' ' G' . . . -69.48 160.28 31.72 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.105 -0.498 . . . . 2.85 111.771 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 18.3 mt -86.4 158.77 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.631 -0.713 . . . . 2.42 109.448 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.78 117.8 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.587 0.232 . . . . 2.74 110.462 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.98 113.91 4.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 2.11 110.943 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -133.72 155.75 49.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.043 -0.526 . . . . 2.49 110.306 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 35.6 mt -105.79 146.35 32.68 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.194 -0.457 . . . . 1.91 110.59 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 25.7 Cg_exo -64.66 161.7 34.57 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.861 2.374 . . . . 1.84 112.429 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -53.92 127.09 24.82 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.98 -0.554 . . . . 2.53 111.181 179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.22 -7.7 58.62 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.765 -0.731 . . . . 2.2 111.697 -179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -112.79 100.01 8.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.829 0.347 . . . . 2.1 110.095 179.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.01 156.14 18.61 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.209 -0.45 . . . . 2.78 110.663 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.4 mt -85.21 146.9 46.15 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.71 -0.478 . . . . 2.62 109.71 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -62.97 143.57 91.41 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.417 2.078 . . . . 2.77 111.56 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -59.54 124.25 19.48 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.89 -0.595 . . . . 4.11 111.245 -179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.74 -7.21 45.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.955 -0.641 . . . . 3.18 111.869 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.6 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -109.51 139.13 44.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.695 0.283 . . . . 2.91 110.474 179.985 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.735 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 2.5 p90 -135.24 139.82 44.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.416 -0.356 . . . . 3.54 110.582 179.058 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -93.02 128.69 38.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.947 -0.569 . . . . 2.93 110.758 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 14' ' ' THR . 49.1 mt-10 -64.14 132.18 49.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.11 -0.495 . . . . 3.64 110.719 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.55 -37.32 3.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.909 -0.662 . . . . 3.27 112.9 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.1 m -75.2 142.98 43.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 3.59 111.265 -179.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -117.94 142.85 46.9 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.425 -0.583 . . . . 5.55 109.425 179.348 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.15 71.02 2.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.735 -0.745 . . . . 5.22 112.225 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.47 -114.67 5.0 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 111.424 -0.67 . . . . 5.91 111.424 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 119.167 -0.444 . . . . 7.27 111.504 -179.935 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.621 ' N4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.604 1 C4'-C3'-C2' 97.031 -5.669 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.405 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.474 4.69 2 N19-C1'-C2' 103.506 -6.184 . 0.233 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.757 3 O4'-C1'-N19 115.733 7.533 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.235 4 O4'-C1'-N19 116.694 8.494 . 0.511 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 3 O5'--C5' 1.374 -4.133 2 C4'-C3'-C2' 97.603 -5.097 . 0.648 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.659 4 C4'-C3'-C2' 98.267 -4.433 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.499 5.412 3 P-O3'-C3' 127.027 6.106 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 023 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 1.07 " H5'" HG22 ' A' ' 14' ' ' THR . . . . . . . . 2 C2'--C1' 1.582 5.446 3 O4'-C4'-C3' 114.861 6.686 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 023 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.541 -5.163 2 O4'-C1'-N19 118.618 10.418 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 023 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.473 3 O4'-C1'-N19 114.73 6.53 . 0.458 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 023 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.136 1 C4'-C3'-C2' 98.271 -4.429 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 023 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.606 1 C4'-C3'-C2' 94.39 -8.31 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 023 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.683 ' OP2' ' HA2' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.766 1 O3'-P-O5' 111.663 4.033 . 0.106 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 023 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . 0.452 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.578 5.002 2 C3'-C2'-C1' 105.679 4.643 . 0.338 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.622 -0.591 . . . . 9.05 111.622 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.28 86.49 5.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.097 0.475 . . . . 8.09 109.797 179.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -92.94 127.65 38.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.753 -0.658 . . . . 8.02 111.174 -179.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.18 174.86 34.03 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.459 -0.657 . . . . 5.76 111.459 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 96.9 mt -107.3 121.99 42.76 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 110.511 -0.181 . . . . 4.72 110.511 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 7.1 Cg_exo -75.3 51.28 2.84 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.293 2.662 . . . . 4.45 111.615 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -135.33 162.7 31.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.571 -0.9 . . . . 4.41 108.571 -179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -96.6 -60.1 1.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.824 0.345 . . . . 3.92 110.48 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.8 p 49.21 61.71 2.99 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 113.888 1.07 . . . . 2.53 113.888 179.468 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.01 147.39 45.17 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.053 -0.351 . . . . 2.48 110.053 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -69.84 153.66 43.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.462 -0.336 . . . . 2.13 110.758 -179.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -88.12 -9.15 54.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 2.4 111.109 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 97.0 m-85 -128.07 162.68 26.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.376 -0.374 . . . . 2.02 111.454 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.515 HG22 " H5'" ' C' ' 8' ' ' ' G' . 10.8 p -68.38 162.14 26.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.749 -0.66 . . . . 2.65 111.086 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.05 146.87 31.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.193 -0.458 . . . . 2.4 111.708 -179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.511 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 57.3 mt -97.48 123.87 41.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.935 -0.765 . . . . 2.27 108.935 178.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.561 ' HB ' ' CE2' ' A' ' 132' ' ' TYR . 6.0 m -105.11 128.12 53.21 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.831 0.348 . . . . 2.84 111.331 -179.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.6 tp-100 -100.9 138.86 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.89 110.633 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -127.41 78.77 1.84 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.791 -0.448 . . . . 3.82 109.791 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.24 -158.91 16.13 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.97 -0.633 . . . . 3.23 111.892 -179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -94.56 -39.35 10.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.887 0.375 . . . . 4.27 110.238 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.72 155.74 21.76 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.985 -0.746 . . . . 3.32 108.985 179.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.462 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -96.87 -131.23 0.19 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.844 0.313 . . . . 2.39 111.844 -179.484 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' CE1' ' A' ' 131' ' ' PHE . 31.2 tp -114.77 135.95 53.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 2.06 112.253 -179.091 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -157.83 116.99 3.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.554 -0.748 . . . . 2.22 109.084 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' A' ' 24' ' ' LEU . 28.6 m-85 -105.89 138.81 19.75 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.78 111.003 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.55 -178.94 2.9 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.847 2.365 . . . . 2.15 112.876 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -66.49 126.7 29.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.532 -0.758 . . . . 2.6 111.583 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 48.77 66.26 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 116.005 -0.543 . . . . 1.65 112.924 179.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -166.49 154.73 10.32 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.094 -0.336 . . . . 2.31 110.094 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.26 4.98 35.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.56 -0.829 . . . . 1.33 112.925 179.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 43' ' ' GLN . 45.0 t -93.04 120.46 66.98 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.632 0.253 . . . . 1.06 110.506 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 121' ' ' LEU . 11.3 Cg_exo -71.97 178.75 5.53 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.069 2.512 . . . . 1.27 111.954 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.3 mt -81.09 81.99 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.192 0.52 . . . . 1.7 109.843 179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.538 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 42.5 m-80 -83.3 75.18 9.98 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.888 -0.596 . . . . 1.23 110.946 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.93 3.62 6.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.395 0.617 . . . . 1.94 110.759 179.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -99.09 -8.5 25.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.341 -0.845 . . . . 1.96 110.667 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 1.4 p -134.61 165.33 25.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 1.42 112.056 -178.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.6 m -78.92 163.97 57.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.69 -0.686 . . . . 1.73 110.493 179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 51.5 Cg_exo -57.11 -31.56 90.7 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.806 2.337 . . . . 1.42 112.566 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.54 -24.29 61.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 1.78 110.472 179.363 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.954 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 21.6 m-20 -84.59 -3.69 58.6 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.769 -0.651 . . . . 1.6 110.74 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 34.3 mm-40 -78.54 58.06 2.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 1.05 111.156 -179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.507 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 18.5 tt -153.1 134.44 5.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.485 -0.561 . . . . 1.17 109.485 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.64 -141.93 4.57 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.322 -0.942 . . . . 0.6 112.663 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -155.1 164.02 39.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.141 0.496 . . . . 0.99 111.479 -178.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.623 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 46.1 m-85 -106.79 131.64 53.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.591 -0.731 . . . . 1.26 109.091 178.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -106.83 127.84 53.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 2.15 111.279 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 49' ' ' ARG . 29.4 ttt-85 -83.34 109.11 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.797 -0.638 . . . . 2.4 109.771 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.95 170.58 9.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.83 0.347 . . . . 2.21 111.316 -179.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.14 165.67 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.87 -0.605 . . . . 2.68 110.304 179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -141.32 104.08 4.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 3.59 110.587 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -126.26 107.44 10.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.141 -0.482 . . . . 3.43 111.404 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 62' ' ' LYS . 49.8 pt -70.9 163.7 3.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.449 -0.341 . . . . 4.26 110.679 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.673 ' HA ' ' HE ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -130.17 94.92 3.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 5.17 111.906 -179.005 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.64 158.75 52.65 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.924 -0.655 . . . . 4.66 112.094 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.18 83.03 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.905 -0.665 . . . . 5.04 112.053 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 23.4 t0 -88.63 28.85 1.07 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.185 0.517 . . . . 5.51 110.943 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.87 38.03 88.78 Favored Glycine 0 N--CA 1.451 -0.329 0 CA-C-N 115.945 -0.57 . . . . 4.73 112.309 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 58' ' ' ASP . 12.2 mptt -91.53 157.37 17.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.814 0.34 . . . . 5.52 111.15 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 45.9 ttm -158.74 139.14 12.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.28 -0.418 . . . . 4.48 110.501 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.528 ' HG3' ' O4 ' ' C' ' 13' ' ' ' U' . 48.6 tttp -67.69 -48.05 67.68 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.304 0.377 . . . . 4.16 110.854 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 65.79 99.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.719 -0.673 . . . . 4.09 112.385 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.6 mt -121.31 157.51 30.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 3.36 111.062 -179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -78.73 158.51 75.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.697 -0.683 . . . . 3.36 110.284 179.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -53.22 123.94 14.44 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.949 2.433 . . . . 2.69 111.871 179.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -122.22 122.56 39.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 3.03 111.053 -179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.623 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 45.8 m95 -98.72 129.95 45.19 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.774 -0.648 . . . . 1.84 111.184 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 47.9 m-85 -108.65 138.7 44.54 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.34 -0.615 . . . . 2.76 109.34 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -89.48 128.72 36.01 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.969 0.414 . . . . 1.27 111.486 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.72 143.21 50.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.029 -0.532 . . . . 1.84 110.369 179.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -77.4 151.6 34.72 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.426 -0.352 . . . . 1.28 110.632 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 83' ' ' TYR . 3.1 tt -58.82 116.81 4.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 1.66 111.085 -179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 114.72 -3.37 23.06 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.555 -0.831 . . . . 1.66 113.735 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.41 114.18 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.994 0.397 . . . . 1.58 111.119 -179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.427 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 107.57 109.6 3.37 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.124 -0.791 . . . . 1.96 111.124 -179.117 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.427 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 14.2 Cg_endo -56.97 -39.61 90.15 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.098 2.532 . . . . 2.62 112.921 -179.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -115.71 31.17 6.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.891 0.377 . . . . 3.09 110.989 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.18 -42.94 59.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.107 -0.497 . . . . 1.79 111.137 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.39 51.65 41.49 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.971 -0.633 . . . . 1.65 111.546 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.2 mt -120.41 97.33 48.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.614 0.245 . . . . 1.38 111.476 -179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.65 151.32 10.14 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.096 2.531 . . . . 1.62 110.914 178.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.71 ' HB2' HD11 ' A' ' 73' ' ' LEU . 68.9 t80 -62.77 111.32 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.874 0.368 . . . . 1.58 110.855 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 125.85 -27.09 5.23 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.456 -0.878 . . . . 1.44 112.201 179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.53 122.37 17.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.683 0.277 . . . . 1.25 110.76 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -87.14 127.34 35.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.958 0.409 . . . . 1.86 111.524 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -139.97 157.89 44.94 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.728 -0.842 . . . . 1.68 108.728 179.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.54 115.87 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.229 0.455 . . . . 1.7 112.229 -179.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.55 30.36 62.29 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.611 -0.722 . . . . 1.27 112.756 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.1 mm -132.51 95.19 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 1.01 110.476 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.44 HG12 ' CZ3' ' A' ' 68' ' ' TRP . 27.2 pt -107.75 127.98 63.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.132 -0.486 . . . . 1.3 109.99 178.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.658 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 85.5 m95 -88.02 140.86 29.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.341 0.497 . . . . 1.08 112.341 -178.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.73 146.78 29.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.446 -0.797 . . . . 1.04 109.781 179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -140.9 173.6 11.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.013 0.435 . . . . 1.27 111.226 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.713 HG22 ' HB2' ' A' ' 98' ' ' ALA . 1.4 t -133.49 168.11 19.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.972 -0.558 . . . . 1.36 110.079 179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.41 105.35 5.52 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 2.64 109.829 179.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.45 5.25 26.39 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.657 -0.782 . . . . 1.52 111.95 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.713 ' HB2' HG22 ' A' ' 95' ' ' THR . . . -78.74 149.47 32.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.754 -0.462 . . . . 1.59 109.754 179.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 45.3 mt -102.56 123.18 45.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.889 0.376 . . . . 2.15 110.721 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -76.63 72.3 3.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.584 0.707 . . . . 2.07 110.284 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.693 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 25.5 m -149.47 129.89 6.84 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 108.54 -0.911 . . . . 2.36 108.54 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.51 125.11 13.25 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.982 2.454 . . . . 2.08 112.418 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.954 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -135.3 69.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.344 0.593 . . . . 1.78 111.304 -179.488 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 1.2 p-10 -77.42 4.36 11.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.186 -0.461 . . . . 2.55 112.003 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 7.5 p80 -57.81 -23.15 51.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.949 0.404 . . . . 2.24 111.743 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.2 pt -107.84 16.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 2.0 111.147 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -96.19 -15.98 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.742 -0.742 . . . . 2.33 111.704 179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t -82.51 123.55 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 2.99 111.157 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -167.63 147.06 4.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 2.83 109.419 179.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -106.9 113.19 62.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 121.071 0.463 . . . . 3.56 110.872 179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HB2' " O4'" ' C' ' 9' ' ' ' U' . 48.0 Cg_endo -66.78 -35.45 27.63 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.116 2.544 . . . . 3.39 113.875 -178.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.415 ' HA ' ' N2 ' ' C' ' 8' ' ' ' G' . . . -81.36 18.13 1.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 4.05 111.888 -179.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -141.96 -39.08 0.37 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.195 -0.457 . . . . 4.48 110.707 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.271 -0.422 . . . . 3.39 110.911 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.691 ' HA ' " H1'" ' C' ' 8' ' ' ' G' . . . -92.87 146.9 23.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.383 -0.371 . . . . 3.21 110.585 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.511 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -81.17 165.36 21.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.057 -0.52 . . . . 2.85 110.957 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 4.6 mt -97.67 155.59 3.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.991 -0.55 . . . . 2.42 110.077 -179.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.415 HG22 ' HA3' ' A' ' 135' ' ' GLY . 65.1 t -68.53 126.8 29.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 110.318 -0.253 . . . . 2.74 110.318 179.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -70.24 111.51 5.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.92 0.391 . . . . 2.11 110.407 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -128.38 153.57 46.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.171 -0.468 . . . . 2.49 109.952 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 33' ' ' PRO . 93.3 mt -108.18 148.65 37.95 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.22 -0.445 . . . . 1.91 110.482 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.01 157.03 63.73 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.191 1.927 . . . . 1.84 111.383 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -53.68 124.4 15.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 2.53 110.877 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 115.07 -18.24 16.43 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 111.207 -0.757 . . . . 2.2 111.207 -179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -94.87 100.19 12.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.031 0.443 . . . . 2.1 110.196 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.5 m -80.0 129.64 34.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 2.78 111.071 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 121' ' ' LEU . 12.7 mt -80.34 137.36 52.32 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.524 . . . . 2.62 109.843 179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.7 141.85 97.69 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.546 2.164 . . . . 2.77 111.654 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.3 tttt -60.49 128.03 34.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.039 -0.528 . . . . 4.11 111.033 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.94 -18.95 39.17 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.204 -0.758 . . . . 3.18 111.204 -179.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.511 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -95.73 138.21 33.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.647 0.26 . . . . 2.91 110.493 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.561 ' CE2' ' HB ' ' A' ' 17' ' ' THR . 27.2 p90 -136.19 155.24 50.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.453 -0.34 . . . . 3.54 110.397 179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.33 123.77 43.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.121 -0.49 . . . . 2.93 110.072 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.13 128.59 35.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.165 -0.47 . . . . 3.64 110.339 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.415 ' HA3' HG22 ' A' ' 118' ' ' VAL . . . 112.16 -20.45 21.44 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.795 -0.717 . . . . 3.27 111.355 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.7 m -80.28 77.39 7.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.166 0.508 . . . . 3.59 110.333 179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 137' ' ' ARG . 4.4 ptp85 -144.1 39.14 1.32 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.599 -0.728 . . . . 5.55 109.86 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.76 47.45 4.8 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.858 -0.897 . . . . 5.22 110.858 -179.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -99.87 69.54 0.52 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.047 -0.597 . . . . 5.91 112.969 -178.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.247 0.937 0 CA-C-O 119.071 -0.49 . . . . 7.27 111.727 179.569 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.404 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.491 -3.703 1 C4'-C3'-C2' 96.995 -5.705 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.478 2 N19-C1'-C2' 103.452 -6.217 . 0.231 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 024 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.461 -5.85 3 O4'-C1'-N19 115.734 7.534 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 024 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.179 4 O4'-C1'-N19 116.635 8.435 . 0.512 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 024 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.081 2 C4'-C3'-C2' 97.584 -5.116 . 0.656 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 024 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.674 4 C4'-C3'-C2' 98.265 -4.435 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 024 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.499 5.429 3 P-O3'-C3' 127.098 6.165 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 024 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.691 " H1'" ' HA ' ' A' ' 115' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.368 3 O4'-C4'-C3' 114.917 6.726 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 024 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . 0.426 " O4'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.542 -5.127 2 O4'-C1'-N19 118.589 10.389 . 0.412 1a . 14.39 . . . . . . . . . . 3 2 . 1 . 024 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.474 3 O3'-P-O5' 116.371 6.511 . 0.46 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 024 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.108 1 C4'-C3'-C2' 98.286 -4.414 . 0.307 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 024 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.595 1 C4'-C3'-C2' 94.327 -8.373 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 024 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.528 ' O4 ' ' HG3' ' A' ' 62' ' ' LYS . . . . . . . . 3 C4'--C3' 1.588 5.837 1 O3'-P-O5' 111.776 4.093 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 024 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.966 2 C3'-C2'-C1' 105.647 4.608 . 0.341 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.902 -0.479 . . . . 9.05 111.902 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.95 96.09 8.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.93 0.395 . . . . 8.09 110.947 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.51 118.45 30.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.152 -0.476 . . . . 8.02 110.879 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.66 146.21 9.58 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.619 -0.801 . . . . 5.76 111.986 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.1 tp -113.95 107.36 52.38 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-O 120.763 0.316 . . . . 4.72 110.532 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -93.46 23.9 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.122 2.548 . . . . 4.45 113.213 -179.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -102.32 117.92 35.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.873 0.368 . . . . 4.41 110.838 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -76.15 105.06 6.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.885 -0.598 . . . . 3.92 110.734 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -129.95 118.88 22.33 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.977 -0.556 . . . . 2.53 110.222 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.88 129.2 27.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.891 -0.595 . . . . 2.48 110.169 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 p -69.78 145.87 51.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.574 -0.285 . . . . 2.13 110.6 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -75.14 -20.22 59.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.44 -0.346 . . . . 2.4 111.377 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 99.5 m-85 -108.16 166.27 10.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.02 0.438 . . . . 2.02 112.098 -178.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.89 170.82 13.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.031 -0.986 . . . . 2.65 111.258 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -76.39 140.3 41.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.087 -0.506 . . . . 2.4 111.756 -179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.827 HD11 HD13 ' A' ' 119' ' ' LEU . 5.1 mp -107.61 115.75 30.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.294 -0.632 . . . . 2.27 109.294 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.437 HG23 ' HB2' ' A' ' 65' ' ' SER . 54.9 m -96.34 129.33 43.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.657 0.614 . . . . 2.84 112.657 -178.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -95.56 128.11 42.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.391 -0.822 . . . . 2.89 109.806 179.01 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.29 79.79 1.57 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.804 -0.443 . . . . 3.82 109.804 179.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.44 -167.54 39.13 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.652 -0.785 . . . . 3.23 111.991 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -81.58 -25.93 35.37 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.954 0.407 . . . . 4.27 111.681 -179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -81.35 173.1 12.79 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.942 -0.572 . . . . 3.32 109.771 179.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 -70.47 0.8 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.122 -0.696 . . . . 2.39 109.122 178.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD11 ' CE2' ' A' ' 26' ' ' PHE . 25.5 tp 178.61 127.91 0.06 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.603 -0.726 . . . . 2.06 111.133 179.04 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -159.59 107.43 1.74 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 2.22 110.24 178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.405 ' CE2' HD11 ' A' ' 24' ' ' LEU . 27.3 m-85 -98.11 148.32 34.32 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.049 -0.523 . . . . 1.78 109.737 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.98 162.09 41.88 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.337 2.024 . . . . 2.15 111.251 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -62.22 135.88 57.69 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.271 -0.422 . . . . 2.6 110.297 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.91 21.75 58.85 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.549 -0.834 . . . . 1.65 111.748 -179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -156.81 172.18 19.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 110.067 -0.345 . . . . 2.31 110.067 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.51 -17.56 56.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.784 -0.722 . . . . 1.33 112.345 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 43' ' ' GLN . 20.3 t -82.24 119.07 74.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 110.13 -0.322 . . . . 1.06 110.13 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.88 -179.14 5.16 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.748 2.299 . . . . 1.27 111.657 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.5 mt -77.62 90.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.862 0.363 . . . . 1.7 110.786 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -84.57 83.35 8.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.538 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.86 21.79 0.2 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.237 0.458 . . . . 1.94 112.237 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -124.44 -17.36 6.07 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.586 0.231 . . . . 1.96 111.457 -179.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.523 ' HB3' HG21 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -118.6 168.6 10.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.84 0.352 . . . . 1.42 111.918 -178.382 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.626 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 14.8 m -86.86 166.3 27.56 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 1.73 110.687 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 9.4 Cg_endo -53.4 -39.84 80.34 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.268 2.645 . . . . 1.42 113.205 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.54 -13.93 61.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.077 0.465 . . . . 1.78 111.163 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -93.84 -1.63 54.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.848 -0.614 . . . . 1.6 110.479 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.448 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 37.5 mm-40 -78.38 54.63 1.45 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.08 0.466 . . . . 1.05 111.108 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.754 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.8 tt -147.26 133.92 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.079 -0.51 . . . . 1.17 109.893 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.42 -144.4 4.99 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.432 -0.889 . . . . 0.6 112.477 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -156.15 164.43 38.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.051 0.453 . . . . 0.99 110.935 -179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.49 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 34.7 m-85 -107.67 130.79 54.89 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.055 -0.721 . . . . 1.26 109.055 178.393 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HG3' HD11 ' A' ' 90' ' ' ILE . 22.3 ttt180 -110.09 135.39 50.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.089 0.243 . . . . 2.15 110.922 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -87.18 123.25 32.01 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.799 -0.445 . . . . 2.4 109.799 178.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.448 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -128.54 154.47 46.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.243 0.544 . . . . 2.21 111.399 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -154.26 111.4 3.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.483 -0.781 . . . . 2.68 109.828 179.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HB3' HD12 ' A' ' 64' ' ' LEU . 20.5 tpt180 -93.27 127.29 38.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.153 0.501 . . . . 3.59 110.917 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -128.59 141.13 51.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.478 -0.783 . . . . 3.43 109.922 179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.755 HG12 ' H ' ' A' ' 62' ' ' LYS . 34.8 pt -92.83 175.89 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.203 -0.666 . . . . 4.26 109.203 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.4 92.57 3.75 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.256 -0.275 . . . . 5.17 110.256 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' HA3' ' OP2' ' C' ' 13' ' ' ' U' . . . -140.11 113.11 0.86 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.924 -0.655 . . . . 4.66 111.682 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.02 5.91 78.9 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.966 -0.635 . . . . 5.04 112.485 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.79 -3.82 54.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.859 0.361 . . . . 5.51 110.452 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' HA3' ' OP2' ' C' ' 14' ' ' ' G' . . . -167.63 -134.79 1.76 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.81 -0.709 . . . . 4.73 112.277 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -108.29 143.85 36.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.83 0.347 . . . . 5.52 110.607 -179.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.6 mmt -77.71 151.26 34.26 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.46 -0.941 . . . . 4.48 108.46 178.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.755 ' H ' HG12 ' A' ' 54' ' ' ILE . 53.5 tttt -49.94 -43.57 49.98 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.189 0.306 . . . . 4.16 110.615 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 43.95 71.56 0.24 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.432 -0.804 . . . . 4.09 112.748 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.613 HD12 ' HB3' ' A' ' 52' ' ' ARG . 98.2 mt -67.04 145.35 55.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.002 -0.545 . . . . 3.36 110.363 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.437 ' HB2' HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -68.52 162.58 61.21 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 109.747 -0.464 . . . . 3.36 109.747 179.517 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -52.93 102.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.655 2.236 . . . . 2.69 111.858 179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.418 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 3.1 mtp180 -108.74 122.69 47.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 3.03 110.893 -179.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.49 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 51.0 m95 -98.27 145.17 26.92 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.84 110.042 179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.692 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 81.1 m-85 -128.01 137.98 52.41 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.762 -0.459 . . . . 2.76 109.762 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -88.49 128.98 35.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.912 0.387 . . . . 1.27 111.444 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -128.13 150.57 49.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.806 -0.634 . . . . 1.84 109.686 178.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -84.53 156.78 21.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.941 0.401 . . . . 1.28 111.008 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.642 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.6 tt -64.0 115.01 4.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.111 -0.495 . . . . 1.66 110.408 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 113.46 1.17 24.76 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.731 -0.747 . . . . 1.66 113.769 179.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.8 p -58.47 110.18 0.93 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 117.192 0.496 . . . . 1.58 110.885 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 104.26 111.59 3.61 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.302 -0.719 . . . . 1.96 111.302 -179.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.438 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 31.0 Cg_endo -63.21 -18.11 63.31 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 122.707 2.271 . . . . 2.62 112.134 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -119.54 24.15 10.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.456 -0.338 . . . . 3.09 111.45 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.95 -48.84 15.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 1.79 110.51 179.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.36 49.45 74.02 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.885 -0.598 . . . . 1.65 111.821 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.422 HD21 ' HD2' ' A' ' 87' ' ' LYS . 87.8 mt -119.72 100.06 49.17 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.866 0.365 . . . . 1.38 111.619 -179.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.22 153.28 14.16 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.464 2.11 . . . . 1.62 111.206 178.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.642 ' HB2' HD11 ' A' ' 73' ' ' LEU . 42.3 t80 -58.61 115.14 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 1.58 110.781 -179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.13 10.11 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.815 -0.707 . . . . 1.44 112.195 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.56 107.38 3.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.849 0.357 . . . . 1.25 110.344 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -74.77 104.75 5.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.963 -0.562 . . . . 1.86 110.506 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.512 ' HB3' HG13 ' A' ' 90' ' ' ILE . 67.7 tttt -112.22 160.6 17.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.949 -0.569 . . . . 1.68 110.093 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -62.04 112.2 2.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.176 -0.465 . . . . 1.7 111.298 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.33 32.17 65.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.923 -0.656 . . . . 1.27 112.327 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.512 HG13 ' HB3' ' A' ' 87' ' ' LYS . 36.6 mm -130.06 112.7 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.629 0.252 . . . . 1.01 110.601 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.434 HG13 ' HB2' ' A' ' 47' ' ' TYR . 7.0 pt -118.46 123.84 72.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.864 0.364 . . . . 1.3 110.428 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.637 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 89.7 m95 -82.61 137.95 34.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.069 -0.514 . . . . 1.08 111.769 -179.106 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.83 135.73 52.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.988 -0.551 . . . . 1.04 110.58 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.26 170.87 15.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.821 -0.627 . . . . 1.27 110.584 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -150.19 179.23 8.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.414 -0.587 . . . . 1.36 109.414 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -66.05 132.07 47.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.65 0.262 . . . . 2.64 110.382 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.06 -23.66 32.88 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.854 -0.689 . . . . 1.52 111.53 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.754 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.18 134.3 36.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.117 -0.327 . . . . 1.59 110.117 179.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.92 149.05 26.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.387 -0.37 . . . . 2.15 110.634 -179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.73 74.03 5.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.521 0.677 . . . . 2.07 110.409 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 m -138.51 130.05 15.6 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.496 -0.774 . . . . 2.36 110.323 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.6 122.37 5.95 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.32 2.013 . . . . 2.08 111.466 179.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.745 ' HB2' ' HD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -146.07 106.29 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.103 -0.499 . . . . 1.78 111.402 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 5.0 p-10 -89.18 8.06 32.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.969 -0.56 . . . . 2.55 112.164 -178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.745 ' HD2' ' HB2' ' A' ' 103' ' ' LYS . 6.4 p80 -56.73 -28.66 61.44 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.212 0.529 . . . . 2.24 111.594 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.523 HG21 ' HB3' ' A' ' 38' ' ' SER . 1.0 OUTLIER -99.13 5.42 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 2.0 110.913 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.95 -21.62 22.75 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.778 -0.725 . . . . 2.33 112.248 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.6 t -74.97 105.62 6.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.492 0.663 . . . . 2.99 111.261 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.8 ttp85 -149.75 125.49 10.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.668 -0.696 . . . . 2.83 109.742 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.7 m-80 -84.74 114.28 54.49 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.894 0.378 . . . . 3.56 110.341 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.511 ' HB2' ' N3 ' ' C' ' 8' ' ' ' G' . 28.4 Cg_endo -60.67 -34.6 91.89 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.181 2.588 . . . . 3.39 113.449 -178.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.608 ' HB1' " H2'" ' B' ' 7' ' ' ' C' . . . -91.35 15.68 11.64 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.151 0.426 . . . . 4.05 112.151 -179.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.48 -20.64 1.59 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.893 0.377 . . . . 4.48 111.664 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -131.78 137.4 48.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.694 0.283 . . . . 3.39 110.365 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.21 146.74 28.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.253 -0.431 . . . . 3.21 110.969 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.33 157.61 32.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.407 0.622 . . . . 2.85 111.904 -179.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 62.4 mt -102.21 137.59 29.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.417 -0.81 . . . . 2.42 109.765 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.42 121.4 13.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.12 -0.696 . . . . 2.74 109.12 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.827 HD13 HD11 ' A' ' 16' ' ' LEU . 3.9 tt -63.44 117.9 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.018 0.437 . . . . 2.11 111.549 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -126.75 141.58 51.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.443 -0.799 . . . . 2.49 109.816 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 79.9 mt -105.62 145.04 30.06 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.258 -0.428 . . . . 1.91 110.344 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.56 150.84 79.49 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.702 2.268 . . . . 1.84 111.557 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -57.67 98.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 2.53 110.888 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 143.94 -30.74 1.9 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.96 -0.638 . . . . 2.2 111.574 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 24.1 m -84.44 115.04 22.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.69 0.281 . . . . 2.1 110.369 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 137.17 37.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.272 -0.422 . . . . 2.78 110.904 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.496 HD22 ' HD2' ' A' ' 131' ' ' PHE . 20.2 mt -74.97 149.02 85.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 2.62 110.875 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.35 161.75 19.32 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.817 2.345 . . . . 2.77 112.274 179.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -64.85 119.26 10.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.836 -0.62 . . . . 4.11 111.597 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.55 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.137 -0.554 . . . . 3.18 112.923 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.496 ' HD2' HD22 ' A' ' 127' ' ' LEU . 18.4 t80 -106.25 126.98 52.89 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.728 0.299 . . . . 2.91 110.464 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -146.78 164.02 34.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.033 -0.53 . . . . 3.54 110.635 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 16' ' ' LEU . . . -110.48 156.36 20.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.509 -0.314 . . . . 2.93 110.802 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -73.63 132.54 42.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.89 -0.595 . . . . 3.64 110.773 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.48 -45.15 1.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.097 -0.573 . . . . 3.27 112.936 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.97 132.52 45.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 3.59 110.588 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -110.3 -164.9 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.642 -0.253 . . . . 5.55 110.831 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.72 110.61 3.09 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.962 -0.637 . . . . 5.22 112.397 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.86 -67.91 3.5 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.126 -0.559 . . . . 5.91 112.61 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.2 m . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.76 -0.638 . . . . 7.27 111.281 -179.954 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.47 ' H5 ' HD23 ' A' ' 64' ' ' LEU . . . . . . . . 0 C2'--C1' 1.493 -3.503 1 C4'-C3'-C2' 97.092 -5.608 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.529 2 N19-C1'-C2' 103.502 -6.187 . 0.23 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 025 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.743 3 O4'-C1'-N19 115.73 7.53 . 0.526 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 025 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.217 4 O4'-C1'-N19 116.658 8.458 . 0.507 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 025 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O4'--C4' 1.404 -4.056 2 C4'-C3'-C2' 97.535 -5.165 . 0.652 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 025 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.527 -6.604 4 C4'-C3'-C2' 98.271 -4.429 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 025 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.608 " H2'" ' HB1' ' A' ' 112' ' ' ALA . . . . . . . . 2 O3'--C3' 1.497 5.298 3 P-O3'-C3' 127.041 6.117 . 0.01 1a . 18.24 . . . . . . . . . . 3 2 . 1 . 025 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.692 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.581 5.289 3 O4'-C4'-C3' 114.931 6.736 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 025 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.122 2 O4'-C1'-N19 118.707 10.507 . 0.416 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 025 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.486 3 O3'-P-O5' 116.326 6.487 . 0.458 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 025 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.171 1 C4'-C3'-C2' 98.252 -4.448 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 025 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.57 1 C4'-C3'-C2' 94.388 -8.312 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 025 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.526 ' OP2' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.588 5.803 1 O3'-P-O5' 111.743 4.075 . 0.108 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 025 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . 0.536 ' OP2' ' HA3' ' A' ' 59' ' ' GLY . . . . . . . . 2 C2'--C1' 1.578 4.95 2 C3'-C2'-C1' 105.655 4.617 . 0.337 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.882 -0.487 . . . . 9.05 111.882 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.51 107.9 17.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.937 0.399 . . . . 8.09 110.35 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.2 tpt -84.45 111.29 19.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.852 -0.613 . . . . 8.02 111.158 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.69 107.7 3.44 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.262 -0.735 . . . . 5.76 111.262 179.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.6 tp -147.43 112.27 4.02 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.207 -0.294 . . . . 4.72 110.207 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.63 69.33 7.8 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.614 2.209 . . . . 4.45 112.179 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -155.1 154.63 32.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 4.41 110.897 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -122.11 -47.31 2.16 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.299 -0.41 . . . . 3.92 110.668 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 64.92 76.62 0.33 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.601 -0.727 . . . . 2.53 111.148 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.39 138.59 39.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.115 -0.493 . . . . 2.48 111.055 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -85.29 155.05 21.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.109 -0.496 . . . . 2.13 110.373 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.63 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 23.2 m95 -78.77 -28.29 44.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.027 0.442 . . . . 2.4 111.191 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.586 ' HD1' ' HA ' ' A' ' 119' ' ' LEU . 29.0 m-85 -99.33 173.81 6.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.737 -0.665 . . . . 2.02 110.957 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.456 ' HB ' ' H ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -78.8 -142.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.675 -0.693 . . . . 2.65 110.353 179.587 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' H ' ' HB ' ' A' ' 14' ' ' THR . . . -131.74 146.59 52.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.963 0.411 . . . . 2.4 111.566 -179.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.669 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.6 mt -96.99 120.02 36.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 2.27 109.112 178.722 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 m -92.97 122.99 35.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.433 -0.349 . . . . 2.84 111.249 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.3 tp-100 -101.22 145.02 29.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.074 -0.512 . . . . 2.89 110.067 179.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -140.58 89.47 2.27 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.384 -0.599 . . . . 3.82 109.384 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.38 -167.42 40.53 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.535 -0.84 . . . . 3.23 112.497 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -81.66 -36.47 28.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 4.27 110.605 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -75.59 154.68 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.47 -0.786 . . . . 3.32 110.671 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.02 -89.43 0.27 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.218 -0.446 . . . . 2.39 110.549 179.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.599 HD13 ' CE1' ' A' ' 131' ' ' PHE . 29.3 tp -168.71 134.61 1.76 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.985 0.421 . . . . 2.06 111.837 179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -163.42 120.18 1.8 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.765 -0.652 . . . . 2.22 110.221 178.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -106.09 137.17 19.3 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.026 -0.534 . . . . 1.78 110.156 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.7 163.53 30.05 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.547 2.165 . . . . 2.15 111.908 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -63.64 103.19 0.52 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.159 0.504 . . . . 2.6 110.967 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.09 -9.19 8.46 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.794 -0.639 . . . . 1.65 111.873 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -120.43 163.07 18.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.765 0.317 . . . . 2.31 110.368 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -6.7 28.89 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.902 -0.666 . . . . 1.33 112.421 179.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 t -88.72 117.39 68.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.762 0.315 . . . . 1.06 110.307 -179.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.04 -169.04 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.902 2.401 . . . . 1.27 111.718 -179.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.437 ' O ' ' HZ ' ' A' ' 13' ' ' PHE . 18.1 mt -82.58 77.5 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.08 0.467 . . . . 1.7 109.817 179.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.524 ' HB2' ' OE1' ' A' ' 43' ' ' GLN . 78.6 m-20 -78.4 78.06 4.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.923 -0.58 . . . . 1.23 110.823 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.94 -1.55 26.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.113 -0.494 . . . . 1.94 111.238 179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.21 2.67 22.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.96 110.652 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.89 155.16 46.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 1.42 111.284 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.493 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 19.8 m -86.61 169.08 15.98 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.929 -0.578 . . . . 1.73 110.318 179.432 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 88.0 Cg_exo -47.62 -40.24 30.36 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.484 2.789 . . . . 1.42 114.252 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.75 -17.44 44.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.732 0.301 . . . . 1.78 111.609 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.856 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.6 m-20 -89.14 8.67 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 1.6 110.788 -179.628 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.524 ' OE1' ' HB2' ' A' ' 35' ' ' ASN . 85.1 mm-40 -80.76 0.57 34.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 1.05 112.104 -179.162 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.902 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.2 tt -89.51 126.62 42.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.975 0.417 . . . . 1.17 111.086 -179.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.61 -152.2 6.28 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.345 -0.931 . . . . 0.6 112.919 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.444 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 44.0 p90 -163.19 170.9 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.917 0.389 . . . . 0.99 110.547 -179.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.608 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 4.5 m-85 -111.46 138.22 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.213 -0.449 . . . . 1.26 110.422 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt-85 -117.94 127.44 53.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 2.15 110.819 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.9 ttt-85 -79.01 126.92 31.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 2.4 109.95 179.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.01 151.82 42.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.005 0.431 . . . . 2.21 111.88 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.4 m -143.51 132.42 22.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.85 -0.614 . . . . 2.68 109.819 179.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' HB3' HD12 ' A' ' 64' ' ' LEU . 2.2 tpt180 -106.91 138.04 43.83 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.093 -0.336 . . . . 3.59 110.093 179.624 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -147.43 128.03 14.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.83 0.348 . . . . 3.43 111.851 -178.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.63 HG12 ' HB2' ' A' ' 62' ' ' LYS . 41.3 pt -81.41 151.67 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.802 -0.814 . . . . 4.26 108.802 178.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -118.92 93.04 3.96 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.554 -0.458 . . . . 5.17 111.74 -179.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.91 148.7 26.02 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.506 -0.854 . . . . 4.66 111.519 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.64 -29.88 76.13 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.087 -0.578 . . . . 5.04 112.482 -179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.88 -0.86 36.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.28 0.562 . . . . 5.51 111.001 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.93 11.26 63.67 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.661 -0.78 . . . . 4.73 111.416 -179.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -70.14 129.16 38.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.59 -0.305 . . . . 5.52 110.499 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.8 mmt -124.25 127.18 47.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.066 -0.516 . . . . 4.48 110.909 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.63 ' HB2' HG12 ' A' ' 54' ' ' ILE . 75.9 tttt -66.84 -35.71 80.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.028 -0.73 . . . . 4.16 109.028 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.9 t70 50.12 82.86 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.748 -1.114 . . . . 4.09 113.047 179.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 52' ' ' ARG . 9.0 mt -82.57 168.13 17.65 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.944 -0.571 . . . . 3.36 110.507 179.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -90.5 155.04 46.39 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.028 -0.533 . . . . 3.36 110.441 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.72 116.22 2.95 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.809 2.339 . . . . 2.69 111.757 179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 29.3 mtt180 -115.79 119.03 34.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.017 -0.538 . . . . 3.03 111.265 -179.2 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.608 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 53.7 m95 -93.78 124.03 37.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.933 -0.576 . . . . 1.84 110.401 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -102.89 138.92 39.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.222 -0.444 . . . . 2.76 110.201 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -90.35 124.79 35.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.084 0.469 . . . . 1.27 111.344 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -122.0 167.75 12.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.917 -0.583 . . . . 1.84 109.894 179.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -108.02 151.58 25.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.688 -0.233 . . . . 1.28 110.43 -179.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.32 110.94 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.4 -0.364 . . . . 1.66 110.465 179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.96 -15.55 6.2 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.763 -0.732 . . . . 1.66 112.357 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.71 HG22 ' HA3' ' A' ' 107' ' ' GLY . 9.5 p -59.13 125.77 24.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.571 0.224 . . . . 1.58 111.006 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.02 110.47 3.3 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.795 -0.717 . . . . 1.96 111.587 -179.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.93 -37.0 97.8 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.006 2.47 . . . . 2.62 112.948 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -117.46 34.35 5.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 3.09 110.491 -179.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.38 -52.23 29.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.064 -0.516 . . . . 1.79 110.379 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.34 46.47 93.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.977 -0.63 . . . . 1.65 111.693 -179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.1 mt -120.06 97.73 49.28 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 111.55 0.204 . . . . 1.38 111.55 -179.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -80.22 147.43 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.896 2.398 . . . . 1.62 110.65 178.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 44.5 t80 -58.54 104.83 0.24 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 1.58 111.142 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.35 -16.69 5.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.852 -0.689 . . . . 1.44 111.878 -179.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.48 20.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.939 0.4 . . . . 1.25 110.753 179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -80.93 119.34 23.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.007 -0.542 . . . . 1.86 110.75 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.531 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 9.1 ttmt -135.25 149.69 49.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.069 -0.514 . . . . 1.68 109.832 179.196 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.96 110.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.326 0.584 . . . . 1.7 112.123 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.26 22.68 64.76 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.697 -0.683 . . . . 1.27 112.964 179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 38.1 mm -128.05 107.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.742 0.306 . . . . 1.01 110.641 179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 47' ' ' TYR . 13.2 pt -117.62 133.48 64.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.112 -0.494 . . . . 1.3 109.765 178.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.55 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 73.6 m95 -89.04 140.07 29.82 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.038 0.385 . . . . 1.08 112.038 -178.373 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 m -136.32 131.06 48.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.741 -0.663 . . . . 1.04 110.884 179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.12 169.47 20.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.138 -0.483 . . . . 1.27 110.89 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -148.4 -169.99 3.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.535 -0.543 . . . . 1.36 109.535 179.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.91 136.84 57.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.875 0.369 . . . . 2.64 110.827 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.94 -25.15 27.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.148 -0.549 . . . . 1.52 112.404 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.902 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.45 136.24 45.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.813 0.339 . . . . 1.59 110.452 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.96 140.55 38.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.117 -0.492 . . . . 2.15 110.72 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -76.79 78.29 3.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.77 -0.455 . . . . 2.07 109.77 179.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.524 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 81.6 m -150.31 128.94 6.06 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 108.971 -0.752 . . . . 2.36 108.971 -179.394 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.71 124.54 12.49 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.602 2.201 . . . . 2.08 111.834 179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.856 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -128.21 95.83 4.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 1.78 110.954 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.12 -5.91 58.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.904 -0.589 . . . . 2.55 112.427 -179.398 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 14.8 p80 -61.44 -21.07 63.81 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.477 0.547 . . . . 2.24 112.477 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.666 HD11 ' HG3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -102.02 12.26 7.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 2.0 111.363 -179.79 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.71 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -124.89 38.29 2.37 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.653 -0.784 . . . . 2.33 111.4 179.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -131.74 33.46 3.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.597 0.713 . . . . 2.99 110.658 -179.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HD3' ' HA ' ' A' ' 12' ' ' TRP . 54.0 ttp85 -72.99 137.63 45.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.895 -0.593 . . . . 2.83 111.258 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -98.43 107.68 43.48 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.17 -0.678 . . . . 3.56 109.17 178.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.47 ' CB ' " H1'" ' C' ' 8' ' ' ' G' . 57.4 Cg_endo -69.64 -14.24 36.17 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.876 2.384 . . . . 3.39 113.652 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -85.46 -25.03 27.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.663 0.268 . . . . 4.05 111.425 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -121.99 29.86 6.88 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.543 -0.299 . . . . 4.48 111.56 -179.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.433 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 9.7 t-20 -174.03 140.41 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 3.39 110.857 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.28 142.82 26.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.207 -0.451 . . . . 3.21 110.1 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.83 145.83 50.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.259 -0.428 . . . . 2.85 111.23 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.0 mt -78.53 139.54 18.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.118 -0.492 . . . . 2.42 109.889 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.98 122.14 16.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.509 -0.314 . . . . 2.74 110.183 179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.586 ' HA ' ' HD1' ' A' ' 13' ' ' PHE . 1.2 tt -59.75 109.93 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.881 -0.6 . . . . 2.11 111.231 -179.768 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.64 152.07 51.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.759 -0.655 . . . . 2.49 110.182 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 67.3 mt -108.65 153.09 42.42 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.128 -0.487 . . . . 1.91 110.228 179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.32 172.21 8.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.496 2.13 . . . . 1.84 112.337 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -63.16 131.97 50.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 2.53 111.203 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.89 36.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.91 -0.662 . . . . 2.2 112.704 179.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 121' ' ' LEU . 3.1 m -85.64 107.79 17.7 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.913 0.387 . . . . 2.1 110.134 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.52 143.25 26.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.133 0.492 . . . . 2.78 111.825 -179.584 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.8 143.61 50.59 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.697 -0.683 . . . . 2.62 109.943 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.16 146.69 95.95 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.57 2.18 . . . . 2.77 111.663 179.244 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -61.15 119.27 8.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 4.11 111.398 -179.331 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.89 -13.49 29.34 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.923 -0.656 . . . . 3.18 111.991 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.669 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -97.16 133.58 41.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.596 0.236 . . . . 2.91 110.742 179.647 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -144.65 144.55 31.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 3.54 110.269 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.55 150.56 26.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.83 0.348 . . . . 2.93 111.358 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.09 135.74 39.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.565 -0.531 . . . . 3.64 109.565 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.43 69.5 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.427 -0.892 . . . . 3.27 112.399 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t -69.1 115.62 8.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 3.59 110.141 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.441 ' HD3' ' OG ' ' A' ' 140' ' ' SER . 4.1 mmp_? -96.03 119.1 33.91 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.865 -0.607 . . . . 5.55 111.481 -179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.3 66.23 3.02 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.284 -0.726 . . . . 5.22 111.284 179.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.25 -71.63 0.39 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.728 -0.949 . . . . 5.91 110.728 -179.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.441 ' OG ' ' HD3' ' A' ' 137' ' ' ARG . 19.4 m . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.865 -0.588 . . . . 7.27 112.438 179.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.429 ' P ' HH21 ' A' ' 67' ' ' ARG . . . . . . . . 0 C2'--C1' 1.492 -3.607 1 C4'-C3'-C2' 97.038 -5.662 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.404 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.471 4.481 2 N19-C1'-C2' 103.578 -6.139 . 0.233 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 026 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.742 3 O4'-C1'-N19 115.83 7.63 . 0.53 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 026 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.594 6.233 4 O4'-C1'-N19 116.661 8.461 . 0.508 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 026 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.056 2 C4'-C3'-C2' 97.557 -5.143 . 0.649 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 026 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.732 5 C4'-C3'-C2' 98.246 -4.454 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 026 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 O3'--C3' 1.498 5.345 3 P-O3'-C3' 126.998 6.082 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 026 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.47 " H1'" ' CB ' ' A' ' 111' ' ' PRO . . . . . . . . 2 C2'--C1' 1.582 5.382 3 O4'-C4'-C3' 114.958 6.756 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 026 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.057 2 O4'-C1'-N19 118.652 10.452 . 0.415 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 026 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . 0.421 ' P ' HH21 ' A' ' 52' ' ' ARG . . . . . . . . 2 P--O5' 1.547 -4.578 3 O3'-P-O5' 116.301 6.474 . 0.459 1a . 13.77 . . . . . . . . . . 3 2 . 1 . 026 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.153 1 C4'-C3'-C2' 98.259 -4.441 . 0.312 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 026 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.534 1 C4'-C3'-C2' 94.366 -8.334 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 026 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.853 1 O3'-P-O5' 111.744 4.076 . 0.104 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 026 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . 0.504 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.578 4.967 2 C3'-C2'-C1' 105.749 4.721 . 0.335 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 111.743 -0.543 . . . . 9.05 111.743 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.81 143.14 57.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.977 0.418 . . . . 8.09 111.487 -179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.2 tpp -84.21 124.36 31.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.828 -0.624 . . . . 8.02 110.184 179.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.73 107.46 1.52 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.855 -0.688 . . . . 5.76 111.621 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 83.3 mt -100.77 117.76 62.0 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.804 0.335 . . . . 4.72 110.952 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 5' ' ' LEU . 74.2 Cg_endo -93.62 65.82 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.207 2.605 . . . . 4.45 111.925 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -112.8 -78.41 0.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.456 -0.338 . . . . 4.41 111.332 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 t30 64.41 27.82 13.6 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.521 0.677 . . . . 3.92 110.665 -179.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.47 137.83 35.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.506 -0.77 . . . . 2.53 110.594 -179.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.96 -178.59 5.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.103 -0.332 . . . . 2.48 110.103 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 p -109.18 130.24 55.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.639 -0.255 . . . . 2.13 110.492 179.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -71.59 -25.75 62.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 2.4 110.753 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 95.6 m-85 -118.34 168.37 10.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.777 -0.647 . . . . 2.02 110.874 -179.543 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 2.5 p -68.47 170.16 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 2.65 110.221 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 149.73 27.38 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.363 0.602 . . . . 2.4 112.008 -179.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.817 ' HB3' ' HE2' ' A' ' 131' ' ' PHE . 12.1 mt -94.77 116.58 28.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.736 -0.665 . . . . 2.27 109.54 178.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.1 112.12 21.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.31 -0.405 . . . . 2.84 111.763 -179.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -91.82 135.13 34.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.871 -0.604 . . . . 2.89 111.01 179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -137.48 83.23 1.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.898 -0.592 . . . . 3.82 109.472 178.378 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.35 -166.46 30.18 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.859 -0.686 . . . . 3.23 111.968 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -87.18 -19.43 28.44 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.949 0.352 . . . . 4.27 111.949 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -100.98 170.43 8.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.66 0.267 . . . . 3.32 110.671 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.8 t0 -92.43 -61.49 1.59 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.074 -0.343 . . . . 2.39 110.074 179.454 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD13 ' CE1' ' A' ' 131' ' ' PHE . 30.3 tp 169.76 137.52 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.742 0.651 . . . . 2.06 110.901 178.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -155.94 119.59 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.975 -0.557 . . . . 2.22 109.686 178.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 36.5 m-85 -101.34 144.67 29.02 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.297 -0.41 . . . . 1.78 111.127 -179.473 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 13.5 Cg_exo -71.34 177.67 6.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.274 2.649 . . . . 2.15 112.341 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -70.25 118.56 13.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.086 -0.506 . . . . 2.6 111.017 -179.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.93 21.25 68.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.108 -0.568 . . . . 1.65 113.196 179.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.511 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -141.39 146.31 36.44 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.754 -0.462 . . . . 2.31 109.754 179.92 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.68 -5.46 12.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.581 -0.818 . . . . 1.33 112.386 179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.15 115.66 64.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.921 -0.399 . . . . 1.06 109.921 179.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HA ' HD23 ' A' ' 121' ' ' LEU . 58.2 Cg_endo -71.69 177.06 7.32 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.63 2.22 . . . . 1.27 112.383 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.2 mt -75.72 88.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.328 -0.396 . . . . 1.7 110.407 179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.467 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 69.1 m-80 -80.47 82.85 6.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.095 -0.502 . . . . 1.23 110.263 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.46 26.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.659 -0.7 . . . . 1.94 112.182 -179.384 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -137.13 -4.04 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.047 0.451 . . . . 1.96 110.328 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -126.47 148.37 49.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.022 -0.536 . . . . 1.42 111.363 -178.751 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.05 166.56 32.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.071 -0.513 . . . . 1.73 110.495 179.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.83 -35.25 78.71 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.861 2.374 . . . . 1.42 113.097 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 11.9 p-10 -85.68 -7.07 59.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.718 0.294 . . . . 1.78 111.281 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.39 10.2 40.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.519 . . . . 1.6 110.014 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -84.68 3.42 37.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.956 -0.566 . . . . 1.05 111.447 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.574 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.2 tt -85.5 124.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.068 0.461 . . . . 1.17 111.068 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 73' ' ' LEU . . . -159.77 -153.81 7.03 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.355 -0.926 . . . . 0.6 113.125 -179.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -161.84 173.09 15.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.805 0.336 . . . . 0.99 110.694 -179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.513 ' HB3' ' CE3' ' A' ' 68' ' ' TRP . 10.2 m-85 -116.96 140.88 48.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.949 -0.569 . . . . 1.26 110.281 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -121.63 139.1 53.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.605 -0.517 . . . . 2.15 109.605 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -84.67 133.24 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.121 0.486 . . . . 2.4 111.009 179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.24 147.97 51.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.239 0.542 . . . . 2.21 111.016 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.1 m -138.04 128.13 25.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.609 -0.515 . . . . 2.68 109.609 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -113.47 123.67 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.961 -0.296 . . . . 3.59 110.962 -179.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -147.69 95.8 2.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.407 -0.36 . . . . 3.43 111.099 179.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.5 pt -73.01 169.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.565 -0.532 . . . . 4.26 109.565 178.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 -141.23 106.23 4.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.974 0.416 . . . . 5.17 111.366 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.506 ' HA3' ' P ' ' C' ' 13' ' ' ' U' . . . -73.6 -30.19 62.44 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.895 -0.669 . . . . 4.66 111.838 179.221 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.24 -67.16 0.48 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.439 -0.886 . . . . 5.04 113.151 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.02 57.71 2.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.161 0.505 . . . . 5.51 112.298 -178.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.38 14.58 49.17 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.906 -0.588 . . . . 4.73 113.751 179.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -86.06 120.33 27.33 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.755 -0.461 . . . . 5.52 109.755 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 59.2 mtt -139.29 132.09 29.15 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.133 -0.321 . . . . 4.48 110.133 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -60.09 -51.48 69.44 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 110.181 -0.303 . . . . 4.16 110.181 178.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.4 t70 63.42 105.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.289 0.848 . . . . 4.09 113.289 178.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -108.53 140.5 41.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.997 -0.547 . . . . 3.36 110.635 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.82 159.88 9.26 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 3.36 110.897 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.1 108.9 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.037 2.492 . . . . 2.69 111.768 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -95.8 103.73 15.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.577 -0.738 . . . . 3.03 110.731 -179.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.513 ' CE3' ' HB3' ' A' ' 47' ' ' TYR . 67.8 m95 -83.36 115.51 22.05 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 1.84 110.987 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -99.12 137.98 36.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.807 -0.633 . . . . 2.76 110.413 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -97.2 132.38 43.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 1.27 110.561 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.54 168.73 17.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 1.84 109.84 179.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -100.39 156.15 17.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.296 -0.411 . . . . 1.28 110.117 179.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 102' ' ' PRO . 14.5 tp -63.36 103.68 0.53 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.385 -0.37 . . . . 1.66 111.519 -179.431 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 115.24 -2.38 22.36 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.282 -0.961 . . . . 1.66 113.787 178.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.567 HG22 ' HA3' ' A' ' 107' ' ' GLY . 5.8 p -59.04 114.0 2.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 117.118 0.459 . . . . 1.58 111.761 179.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 77' ' ' PRO . . . 117.19 108.09 2.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.866 -0.683 . . . . 1.96 111.535 -179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HD2' ' HA2' ' A' ' 76' ' ' GLY . 12.8 Cg_endo -57.34 -30.09 86.5 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.077 2.518 . . . . 2.62 112.789 -179.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.77 42.74 2.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.145 0.498 . . . . 3.09 111.302 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.73 -55.08 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.911 -0.586 . . . . 1.79 110.568 179.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 42.89 79.11 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.937 -0.649 . . . . 1.65 112.373 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.9 mt -121.01 102.43 43.89 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.837 0.351 . . . . 1.38 111.701 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.711 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 1.3 Cg_endo -84.49 165.47 12.37 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.006 2.471 . . . . 1.62 110.635 178.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -59.73 112.96 2.02 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.933 0.397 . . . . 1.58 110.814 179.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 116.98 -12.88 14.45 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.979 -0.629 . . . . 1.44 112.608 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.711 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -56.23 116.53 3.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.049 0.452 . . . . 1.25 111.274 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -87.95 120.01 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.702 -0.681 . . . . 1.86 110.569 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 88' ' ' ASP . 29.5 mttt -134.63 -148.48 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.273 -0.421 . . . . 1.68 110.384 179.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 87' ' ' LYS . 16.3 t70 -108.05 103.29 12.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.004 0.431 . . . . 1.7 110.852 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.47 36.9 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.761 -0.733 . . . . 1.27 112.393 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.1 mm -122.38 113.21 37.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.68 0.276 . . . . 1.01 110.319 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.0 122.58 67.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 1.3 110.176 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -88.01 145.83 25.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.133 -0.485 . . . . 1.08 111.87 -178.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.3 129.44 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 1.04 111.465 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.97 153.15 40.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.037 -0.528 . . . . 1.27 110.403 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.8 t -132.13 -176.52 4.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.143 -0.48 . . . . 1.36 110.063 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.43 135.16 54.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.075 0.464 . . . . 2.64 110.67 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 100.23 -15.95 58.58 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.906 -0.588 . . . . 1.52 112.165 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -78.86 144.36 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.847 0.356 . . . . 1.59 110.989 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.5 mt -112.24 145.79 39.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.864 -0.607 . . . . 2.15 109.952 179.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -85.37 86.18 7.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.813 0.339 . . . . 2.07 110.826 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.9 m -157.24 137.29 8.77 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.67 -0.695 . . . . 2.36 109.215 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.7 Cg_endo -52.92 111.28 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.107 2.538 . . . . 2.08 112.439 -179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -101.83 47.04 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.886 -0.597 . . . . 1.78 109.802 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 3.9 p30 -70.25 -15.3 62.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.972 -0.558 . . . . 2.55 112.09 -179.016 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -57.44 -20.73 32.27 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.526 0.565 . . . . 2.24 112.526 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.6 pt -113.92 12.64 8.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.472 . . . . 2.0 110.85 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -86.98 -39.59 7.42 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.868 -0.682 . . . . 2.33 112.162 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.1 t -65.69 124.69 23.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.195 0.521 . . . . 2.99 111.237 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 58.3 ttp85 -158.33 132.6 8.04 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.411 -0.588 . . . . 2.83 109.411 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 38.3 t-20 -96.91 113.04 62.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 110.271 -0.27 . . . . 3.56 110.271 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 110' ' ' ASN . 33.9 Cg_endo -64.61 -18.9 64.23 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.96 2.44 . . . . 3.39 112.711 -179.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -92.45 0.97 57.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.035 0.445 . . . . 4.05 110.839 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -136.51 13.01 3.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 4.48 110.723 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -171.85 132.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 3.39 109.828 -179.142 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.98 153.53 20.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.777 0.322 . . . . 3.21 110.54 -179.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.44 ' HB3' " H4'" ' C' ' 8' ' ' ' G' . . . -82.5 153.98 25.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.094 0.473 . . . . 2.85 111.122 -179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 17.9 mt -92.85 145.62 7.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.882 -0.599 . . . . 2.42 109.717 179.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.9 t -64.82 125.79 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.908 -0.404 . . . . 2.74 109.908 179.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.617 HD13 ' HG ' ' A' ' 16' ' ' LEU . 1.9 tt -58.46 113.87 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.264 0.554 . . . . 2.11 111.069 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -127.7 142.38 51.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.674 -0.693 . . . . 2.49 110.462 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' A' ' 127' ' ' LEU . 21.3 mt -103.63 148.37 35.67 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.0 -0.545 . . . . 1.91 110.013 179.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.98 155.94 57.55 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.535 2.157 . . . . 1.84 111.599 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -58.46 122.91 14.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 2.53 110.138 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.68 -11.28 42.12 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.212 -0.755 . . . . 2.2 111.212 -179.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.437 HG22 HD13 ' A' ' 121' ' ' LEU . 4.7 m -104.18 105.89 16.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.638 -0.504 . . . . 2.1 109.638 179.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.35 159.36 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.886 -0.597 . . . . 2.78 111.823 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' A' ' 121' ' ' LEU . 15.8 mt -99.87 147.87 34.02 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 2.62 109.796 179.002 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.85 159.23 34.28 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.502 2.135 . . . . 2.77 111.666 179.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -73.36 134.78 44.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.917 0.389 . . . . 4.11 110.235 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.8 13.29 67.26 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.145 -0.782 . . . . 3.18 111.145 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.817 ' HE2' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -127.84 122.02 31.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.001 -0.37 . . . . 2.91 110.001 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -129.01 146.78 50.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.21 -0.45 . . . . 3.54 110.891 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 16' ' ' LEU . . . -88.18 127.53 35.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 2.93 110.806 -179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 26.3 tt0 -58.88 129.88 44.29 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.971 -0.559 . . . . 3.64 110.521 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.13 -4.37 67.53 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.961 -0.638 . . . . 3.27 112.053 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m -108.97 159.02 17.15 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.275 -0.268 . . . . 3.59 110.275 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -126.38 -174.59 3.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.304 -0.407 . . . . 5.55 110.275 179.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -95.67 46.59 1.93 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.847 -0.692 . . . . 5.22 112.689 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 138.75 -47.88 0.9 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.726 -0.749 . . . . 5.91 112.336 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.981 -0.533 . . . . 7.27 111.243 -179.485 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.49 -3.75 1 C4'-C3'-C2' 96.968 -5.732 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.514 2 N19-C1'-C2' 103.517 -6.177 . 0.232 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 027 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.758 3 O4'-C1'-N19 115.703 7.503 . 0.525 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 027 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.144 4 O4'-C1'-N19 116.659 8.459 . 0.514 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 027 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.126 2 C4'-C3'-C2' 97.607 -5.093 . 0.651 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 027 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.525 -6.759 4 C4'-C3'-C2' 98.289 -4.411 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 027 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.498 5.389 3 P-O3'-C3' 127.035 6.112 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 027 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.44 " H4'" ' HB3' ' A' ' 116' ' ' ALA . . . . . . . . 2 C2'--C1' 1.582 5.404 3 O4'-C4'-C3' 114.937 6.741 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 027 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.543 -4.973 2 O4'-C1'-N19 118.599 10.399 . 0.417 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 027 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.548 -4.502 3 O3'-P-O5' 116.381 6.516 . 0.455 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 027 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.056 1 C4'-C3'-C2' 98.243 -4.457 . 0.307 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 027 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.545 1 C4'-C3'-C2' 94.321 -8.379 . 0.457 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 027 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . 0.506 ' P ' ' HA3' ' A' ' 56' ' ' GLY . . . . . . . . 3 C4'--C3' 1.587 5.738 1 O3'-P-O5' 111.697 4.051 . 0.107 1a . 14.81 . . . . . . . . . . 3 2 . 1 . 027 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 5.026 2 C3'-C2'-C1' 105.702 4.669 . 0.338 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 111.807 -0.517 . . . . 9.05 111.807 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.25 102.5 13.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.691 0.281 . . . . 8.09 110.578 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -87.81 101.06 13.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.328 -0.396 . . . . 8.02 110.915 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.15 131.91 1.85 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.944 -0.646 . . . . 5.76 111.982 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.3 mt -109.28 131.61 21.74 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.642 0.258 . . . . 4.72 110.742 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -84.11 44.49 1.56 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.919 2.413 . . . . 4.45 111.57 179.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -131.34 159.13 38.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.558 . . . . 4.41 109.868 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -85.01 -76.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.525 -0.307 . . . . 3.92 110.362 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 p 48.5 70.82 0.41 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.755 0.65 . . . . 2.53 112.755 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' HB2' ' HG3' ' A' ' 111' ' ' PRO . . . -84.71 143.77 28.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.911 -0.586 . . . . 2.48 110.396 179.576 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 p -78.53 151.28 32.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.303 -0.408 . . . . 2.13 111.1 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.583 ' HA ' HH11 ' A' ' 109' ' ' ARG . 92.9 m95 -81.02 -28.56 35.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.933 0.397 . . . . 2.4 110.622 179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 117' ' ' ILE . 53.7 m-85 -103.54 159.21 15.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.785 -0.643 . . . . 2.02 111.403 -179.125 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.26 166.3 18.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.822 -0.627 . . . . 2.65 110.767 179.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.69 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -82.19 142.59 32.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.286 -0.416 . . . . 2.4 111.443 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.522 HD13 ' HE2' ' A' ' 131' ' ' PHE . 28.7 mt -97.31 145.99 25.58 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.1 -0.704 . . . . 2.27 109.1 179.213 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.52 ' HB ' ' CZ ' ' A' ' 132' ' ' TYR . 0.8 OUTLIER -120.26 140.41 51.25 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.146 0.498 . . . . 2.84 111.908 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -109.1 120.94 44.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.06 -0.518 . . . . 2.89 111.06 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.72 71.12 0.75 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.336 0.588 . . . . 3.82 109.645 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -170.43 -163.01 23.74 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.695 -0.764 . . . . 3.23 111.815 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -88.8 -39.66 13.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.995 0.426 . . . . 4.27 111.0 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.31 171.12 15.61 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.746 -0.464 . . . . 3.32 109.746 179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.56 -98.75 0.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.817 -0.353 . . . . 2.39 111.727 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.4 tp -151.4 140.5 21.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.054 0.454 . . . . 2.06 111.648 -179.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -171.42 100.13 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.324 -0.853 . . . . 2.22 109.046 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 59.9 m-85 -86.72 153.95 55.61 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.362 -0.381 . . . . 1.78 111.196 -179.597 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 30' ' ' GLN . 3.0 Cg_exo -75.15 161.97 37.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.031 2.488 . . . . 2.15 111.717 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -63.22 131.72 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 2.6 110.543 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.06 4.5 74.68 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.218 -0.753 . . . . 1.65 111.218 -179.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HB3' ' HD2' ' A' ' 27' ' ' PRO . 11.5 tt0 -138.65 172.22 13.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.284 -0.636 . . . . 2.31 109.284 -179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' H ' ' HG2' ' A' ' 30' ' ' GLN . . . 101.99 -2.79 51.77 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.547 -0.835 . . . . 1.33 112.116 179.612 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.86 115.55 65.73 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.391 -0.596 . . . . 1.06 109.391 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.81 -173.39 1.8 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.0 2.467 . . . . 1.27 111.86 -179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.459 HG22 HG23 ' A' ' 36' ' ' THR . 63.4 mt -74.64 93.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.339 0.59 . . . . 1.7 110.154 179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.439 ' HB3' ' OG ' ' A' ' 38' ' ' SER . 51.9 m-20 -83.6 78.73 9.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.672 -0.694 . . . . 1.23 110.989 -179.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.459 HG23 HG22 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -79.11 37.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.105 -0.498 . . . . 1.94 112.147 -179.389 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -155.73 -2.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.061 0.457 . . . . 1.96 111.443 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -122.14 150.17 42.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.338 -0.392 . . . . 1.42 111.336 -178.83 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.12 167.64 33.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 1.73 110.246 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.39 -36.56 79.52 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.788 2.325 . . . . 1.42 113.011 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.731 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.8 OUTLIER -78.56 -13.64 59.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.582 0.229 . . . . 1.78 111.396 -179.822 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.903 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 25.5 m-20 -90.32 5.63 46.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.351 -0.386 . . . . 1.6 111.184 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -82.52 54.97 2.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.237 0.541 . . . . 1.05 111.232 -179.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 94' ' ' ALA . 14.8 tt -151.29 132.83 5.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 115.632 -0.713 . . . . 1.17 110.236 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.9 -144.75 4.74 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.249 -0.976 . . . . 0.6 112.879 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -158.5 170.59 21.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.158 0.504 . . . . 0.99 110.735 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.735 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 29.8 m-85 -115.98 136.53 52.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.827 -0.624 . . . . 1.26 109.323 178.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -115.64 131.18 57.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 2.15 111.163 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -85.04 120.82 26.98 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.659 -0.701 . . . . 2.4 109.515 179.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.466 ' HB3' ' CE2' ' A' ' 69' ' ' TYR . . . -133.29 157.54 45.19 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.316 0.579 . . . . 2.21 111.932 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.9 m -146.98 114.37 6.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.758 -0.655 . . . . 2.68 110.759 179.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -78.52 119.23 21.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.996 0.427 . . . . 3.59 110.574 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -144.59 123.7 12.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 3.43 110.772 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.604 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.3 OUTLIER -106.96 169.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 4.26 109.872 179.159 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.5 119.51 39.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.959 0.409 . . . . 5.17 110.687 179.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.19 155.24 19.53 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.961 -0.638 . . . . 4.66 111.884 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.0 -30.82 69.74 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.065 -0.588 . . . . 5.04 112.184 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -71.24 -55.89 7.17 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.429 0.633 . . . . 5.51 109.972 179.184 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.39 -40.76 1.2 Allowed Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 109.611 -1.396 . . . . 4.73 109.611 -178.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -86.2 116.37 24.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.415 -0.587 . . . . 5.52 109.415 178.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.19 179.05 4.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 4.48 110.966 -179.402 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.701 ' HA ' ' O6 ' ' C' ' 14' ' ' ' G' . 64.5 tttt -53.44 -55.9 21.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.87 -0.605 . . . . 4.16 110.497 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.42 99.32 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.277 0.843 . . . . 4.09 113.277 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 64' ' ' LEU . 11.1 mt -97.21 150.27 21.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.647 -0.706 . . . . 3.36 110.916 179.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.6 154.56 94.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.861 -0.609 . . . . 3.36 110.483 179.207 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -57.52 117.63 4.37 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.668 2.245 . . . . 2.69 111.017 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.69 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 48.0 mtt180 -119.35 140.01 51.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.023 -0.535 . . . . 3.03 111.402 -178.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.735 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 43.2 m95 -103.54 131.48 50.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 1.84 110.353 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.668 ' HE1' H5'' ' C' ' 8' ' ' ' G' . 39.4 m-85 -111.09 139.21 46.64 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.719 -0.474 . . . . 2.76 109.719 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -88.19 130.55 35.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.688 0.28 . . . . 1.27 111.041 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.445 ' HD2' HG21 ' A' ' 75' ' ' THR . 41.5 m-85 -133.88 158.31 43.76 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.96 -0.564 . . . . 1.84 110.33 179.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -92.97 165.34 12.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.632 -0.258 . . . . 1.28 110.865 179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 83' ' ' TYR . 1.1 tt -57.78 118.99 5.88 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.309 0.381 . . . . 1.66 111.294 -179.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.44 53.98 8.16 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.062 -0.589 . . . . 1.66 112.966 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.445 HG21 ' HD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -86.55 48.11 1.58 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.135 0.493 . . . . 1.58 111.11 -179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.44 137.02 4.23 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.093 -0.803 . . . . 1.96 111.093 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.39 -37.61 94.15 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.987 2.458 . . . . 2.62 112.482 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -127.09 35.95 4.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 3.09 110.574 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.8 -49.78 49.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 1.79 110.823 -179.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.45 41.1 96.55 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.832 -0.622 . . . . 1.65 112.164 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.6 mt -121.17 99.04 46.6 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.629 0.252 . . . . 1.38 111.426 -179.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 85' ' ' ALA . 89.2 Cg_endo -82.32 165.44 16.61 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.744 2.296 . . . . 1.62 110.921 178.601 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.51 ' HB2' HD11 ' A' ' 73' ' ' LEU . 74.4 t80 -61.91 106.42 0.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 1.58 110.73 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.48 3.96 12.32 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.676 -0.773 . . . . 1.44 112.347 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.627 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . . . -70.51 122.44 19.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.969 0.414 . . . . 1.25 110.361 179.286 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -75.49 115.69 15.42 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.076 -0.511 . . . . 1.86 111.339 -179.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HB3' ' HB ' ' A' ' 90' ' ' ILE . 12.3 tttt -148.79 144.34 26.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 1.68 110.06 179.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.09 126.18 28.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.37 . . . . 1.7 111.055 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.15 20.58 77.25 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.032 -0.604 . . . . 1.27 112.219 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 87' ' ' LYS . 29.5 mm -129.66 107.51 15.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.798 0.333 . . . . 1.01 110.216 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 91' ' ' ILE . 14.7 pt -112.89 128.48 69.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.251 -0.432 . . . . 1.3 110.362 179.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -88.55 137.7 32.09 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.45 0.537 . . . . 1.08 112.45 -178.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -136.63 141.47 40.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.75 -0.659 . . . . 1.04 110.416 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -157.86 156.35 31.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 1.27 110.634 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.9 t -126.55 170.3 12.18 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.128 -0.487 . . . . 1.36 110.167 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -69.59 130.59 42.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.431 -0.35 . . . . 2.64 110.166 179.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.22 -10.44 28.93 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.836 -0.697 . . . . 1.52 111.784 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.731 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -94.2 146.39 24.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.43 -0.211 . . . . 1.59 110.43 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.3 mt -91.97 149.17 21.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.365 -0.38 . . . . 2.15 111.146 -179.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -87.73 76.66 8.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.2 0.524 . . . . 2.07 110.089 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 3.7 t -158.24 147.43 14.73 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.776 -0.647 . . . . 2.36 109.506 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 101' ' ' THR . 16.6 Cg_exo -69.82 140.12 41.7 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.494 2.129 . . . . 2.08 111.738 179.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.903 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -137.66 86.88 2.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.093 0.473 . . . . 1.78 110.708 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.35 -5.8 53.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 2.55 112.319 -178.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.43 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 11.9 p80 -58.15 -25.94 62.09 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.132 0.419 . . . . 2.24 112.132 -179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -103.91 9.92 8.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.135 0.493 . . . . 2.0 110.799 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.33 -25.25 11.23 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.779 -0.646 . . . . 2.33 111.946 179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 t -78.83 99.99 6.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.322 0.582 . . . . 2.99 111.103 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.583 HH11 ' HA ' ' A' ' 12' ' ' TRP . 0.2 OUTLIER -144.41 145.66 32.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 2.83 110.067 179.709 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 85.8 m-20 -100.89 130.73 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.301 -0.408 . . . . 3.56 110.153 179.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 110' ' ' ASN . 34.2 Cg_exo -61.91 -54.64 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.893 2.395 . . . . 3.39 112.905 -179.461 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.27 27.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 4.05 112.691 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.8 19.67 2.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.232 0.539 . . . . 4.48 110.364 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 109' ' ' ARG . 4.2 t-20 -170.59 163.47 8.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 3.39 109.641 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.66 173.86 6.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.818 0.342 . . . . 3.21 111.154 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.15 112.34 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.668 -0.493 . . . . 2.85 109.668 179.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 21.6 mt -77.18 129.74 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.245 -0.434 . . . . 2.42 110.252 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.03 120.94 6.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 2.74 110.372 179.303 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HB3' HD21 ' A' ' 16' ' ' LEU . 5.4 tt -68.39 105.4 2.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.916 -0.584 . . . . 2.11 109.996 -179.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -112.17 146.3 38.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.997 -0.547 . . . . 2.49 110.413 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.466 HD13 HG22 ' A' ' 125' ' ' THR . 51.1 mt -100.92 143.9 27.49 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.892 -0.594 . . . . 1.91 109.732 179.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.14 150.18 75.37 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.802 2.335 . . . . 1.84 111.91 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -51.05 119.91 4.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.684 -0.689 . . . . 2.53 111.58 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 114.7 -27.48 8.75 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.69 -0.964 . . . . 2.2 110.69 -179.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.466 HG22 HD13 ' A' ' 121' ' ' LEU . 9.9 m -102.13 116.58 32.96 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.723 -0.473 . . . . 2.1 109.723 179.666 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.49 163.08 16.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.419 -0.355 . . . . 2.78 110.763 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.0 mt -85.41 144.88 41.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.343 -0.39 . . . . 2.62 110.137 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.46 151.75 66.51 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.816 2.344 . . . . 2.77 111.683 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -59.7 125.4 23.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.399 . . . . 4.11 111.121 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.42 -19.73 33.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.016 -0.612 . . . . 3.18 111.729 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.522 ' HE2' HD13 ' A' ' 16' ' ' LEU . 8.7 t80 -94.27 128.73 40.92 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.654 -0.498 . . . . 2.91 109.654 -179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.52 ' CZ ' ' HB ' ' A' ' 17' ' ' THR . 47.6 p90 -133.21 171.09 14.48 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.697 0.284 . . . . 3.54 111.058 -179.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -135.81 144.4 45.69 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.483 -0.326 . . . . 2.93 111.208 -179.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -74.45 143.05 44.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.245 -0.434 . . . . 3.64 110.08 179.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.57 -0.34 82.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 3.27 112.414 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 m -70.6 122.31 19.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.026 0.441 . . . . 3.59 110.603 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.421 ' HA ' ' HE ' ' A' ' 137' ' ' ARG . 1.4 mmp_? -110.61 131.95 54.61 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.149 -0.478 . . . . 5.55 110.006 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.14 59.28 3.88 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.923 -0.656 . . . . 5.22 112.425 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.63 -159.16 32.2 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.432 -0.667 . . . . 5.91 111.432 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.912 -0.566 . . . . 7.27 111.602 -179.871 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.599 ' H41' ' HG2' ' A' ' 62' ' ' LYS . . . . . . . . 0 C2'--C1' 1.492 -3.632 1 C4'-C3'-C2' 97.124 -5.576 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.472 4.513 2 N19-C1'-C2' 103.509 -6.182 . 0.227 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.766 3 O4'-C1'-N19 115.758 7.558 . 0.528 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.185 4 O4'-C1'-N19 116.662 8.462 . 0.51 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.373 -4.205 2 C4'-C3'-C2' 97.612 -5.088 . 0.654 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.659 4 C4'-C3'-C2' 98.248 -4.452 . 0.944 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 3 O3'--C3' 1.497 5.268 3 P-O3'-C3' 127.066 6.138 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.668 H5'' ' HE1' ' A' ' 69' ' ' TYR . . . . . . . . 2 C2'--C1' 1.582 5.351 3 O4'-C4'-C3' 114.911 6.722 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 028 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.542 -5.065 2 O4'-C1'-N19 118.656 10.456 . 0.414 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.549 -4.439 3 O4'-C1'-N19 114.758 6.558 . 0.466 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.558 -4.105 1 C4'-C3'-C2' 98.248 -4.452 . 0.313 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.566 1 C4'-C3'-C2' 94.324 -8.376 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.588 5.861 1 O3'-P-O5' 111.743 4.075 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 028 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . 0.701 ' O6 ' ' HA ' ' A' ' 62' ' ' LYS . . . . . . . . 2 C2'--C1' 1.578 4.952 2 C3'-C2'-C1' 105.738 4.709 . 0.336 1a . 15.71 . . . . . . . . . . 3 2 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.632 -0.587 . . . . 9.05 111.632 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.74 109.04 6.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.789 0.328 . . . . 8.09 110.565 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.7 ptp -120.62 -5.55 9.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.259 -0.428 . . . . 8.02 111.231 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.2 116.15 0.67 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.904 -0.665 . . . . 5.76 112.084 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.0 mt -114.57 137.83 22.87 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.91 -0.404 . . . . 4.72 109.91 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.83 31.43 0.38 Allowed 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.884 2.389 . . . . 4.45 112.818 -179.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -98.7 159.01 15.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.507 -0.315 . . . . 4.41 110.621 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -114.43 -141.76 0.38 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.694 -0.484 . . . . 3.92 109.694 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.8 HG22 ' HA ' ' A' ' 108' ' ' THR . 76.1 p 53.81 81.28 0.1 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.029 0.752 . . . . 2.53 113.029 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . . . -74.94 146.71 41.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.386 -0.37 . . . . 2.48 110.018 179.568 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -62.25 143.6 56.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.314 -0.403 . . . . 2.13 110.642 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -68.92 -26.63 65.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 2.4 111.666 -179.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.535 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 96.5 m-85 -111.08 167.73 10.04 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.14 0.422 . . . . 2.02 112.14 -179.233 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.3 p -69.08 170.32 10.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.647 -0.706 . . . . 2.65 111.332 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -90.14 133.27 34.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 2.4 111.291 -179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.565 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 mt -86.9 112.96 22.28 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.668 -0.493 . . . . 2.27 109.668 179.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 m -92.17 127.99 37.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.902 0.382 . . . . 2.84 111.203 -179.299 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 2.1 tp-100 -106.09 134.87 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 2.89 110.935 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.409 ' HB2' ' HE2' ' A' ' 132' ' ' TYR . 79.3 t60 -125.74 72.57 1.29 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.228 -0.656 . . . . 3.82 109.228 178.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.78 -169.23 26.99 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.964 -0.636 . . . . 3.23 112.067 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -83.68 -36.84 23.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.999 0.428 . . . . 4.27 110.844 -179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.09 172.2 13.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.796 -0.638 . . . . 3.32 110.712 179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.477 ' HB3' ' H ' ' A' ' 24' ' ' LEU . 1.2 t0 -103.84 -101.57 0.3 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.83 -0.433 . . . . 2.39 109.83 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.477 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 54.0 tp -156.74 133.6 10.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.798 0.332 . . . . 2.06 110.527 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -156.29 111.92 2.97 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.966 -0.561 . . . . 2.22 109.748 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -101.14 135.48 19.91 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.409 . . . . 1.78 110.563 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.423 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 39.3 Cg_endo -67.6 155.54 69.74 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.536 2.157 . . . . 2.15 111.963 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -57.88 125.85 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 2.6 110.769 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.53 -1.51 62.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.904 -0.665 . . . . 1.65 112.033 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.423 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 32.0 tt0 -137.09 155.15 49.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.204 -0.295 . . . . 2.31 110.204 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.05 -13.94 19.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.329 -0.938 . . . . 1.33 113.127 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.99 122.04 84.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 110.069 -0.345 . . . . 1.06 110.069 179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.31 -179.13 5.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.712 2.275 . . . . 1.27 111.661 -179.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 mt -76.36 81.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.099 0.476 . . . . 1.7 110.821 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -75.86 97.87 4.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.382 -0.599 . . . . 1.23 109.382 178.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.33 -20.11 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.792 0.664 . . . . 1.94 112.792 -178.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -99.76 -29.54 12.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.422 0.527 . . . . 1.96 112.422 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.09 150.62 35.65 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.518 0.562 . . . . 1.42 112.518 -178.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.58 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 2.0 m -74.42 166.92 40.77 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.681 -0.691 . . . . 1.73 110.895 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.58 ' HD2' ' HB3' ' A' ' 39' ' ' SER . 17.5 Cg_endo -58.77 -39.75 79.0 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.814 2.343 . . . . 1.42 112.53 179.752 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -85.21 3.15 40.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.028 0.442 . . . . 1.78 110.626 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.64 7.03 37.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.662 -0.699 . . . . 1.6 110.617 -179.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -81.27 52.1 1.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 1.05 110.784 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.771 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 16.5 tt -144.87 134.91 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.92 -0.582 . . . . 1.17 110.17 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.14 -155.63 11.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.414 -0.898 . . . . 0.6 112.135 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -148.67 158.68 44.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.964 0.412 . . . . 0.99 111.151 -179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.755 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 13.2 m-85 -103.12 140.46 37.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.839 -0.8 . . . . 1.26 108.839 178.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -127.84 122.71 33.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.795 0.331 . . . . 2.15 110.965 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -77.81 128.37 33.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.858 -0.423 . . . . 2.4 109.858 179.373 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -114.04 156.21 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.108 0.48 . . . . 2.21 111.514 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.0 m -135.55 127.83 30.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.679 -0.691 . . . . 2.68 109.734 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.749 ' HB3' HD12 ' A' ' 64' ' ' LEU . 8.9 tpt180 -126.01 130.05 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.119 0.485 . . . . 3.59 111.702 -179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -143.87 -175.67 4.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.537 -0.756 . . . . 3.43 109.38 179.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.1 pt -126.72 161.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.544 -0.539 . . . . 4.26 109.544 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -106.03 69.15 0.8 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.334 0.588 . . . . 5.17 110.733 -179.912 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 60' ' ' LYS . . . -81.38 117.87 4.5 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.672 -0.775 . . . . 4.66 111.852 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.66 -25.3 63.24 Favored Glycine 0 C--O 1.227 -0.313 0 C-N-CA 121.374 -0.441 . . . . 5.04 112.531 -179.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -82.74 -1.49 51.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.143 0.497 . . . . 5.51 110.511 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.91 26.6 12.42 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.062 -0.815 . . . . 4.73 111.062 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' HB2' ' HA3' ' A' ' 56' ' ' GLY . 75.2 mmtt -77.66 122.77 25.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.791 0.329 . . . . 5.52 111.005 -179.209 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 24.3 mmt -127.12 113.58 16.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.053 -0.521 . . . . 4.48 111.127 -179.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -69.98 -42.98 72.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.078 -0.712 . . . . 4.16 109.078 178.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 48.72 82.82 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 114.939 -1.028 . . . . 4.09 113.451 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' A' ' 52' ' ' ARG . 19.7 mt -74.6 160.55 30.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.872 0.368 . . . . 3.36 110.559 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 1.5 m -74.13 156.03 87.9 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.293 -0.412 . . . . 3.36 110.127 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.47 111.15 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.542 2.161 . . . . 2.69 111.357 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.609 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 10.1 mtp180 -116.7 131.63 56.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.94 0.4 . . . . 3.03 111.579 -179.136 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.755 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 35.8 m95 -105.67 124.32 49.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.684 -0.689 . . . . 1.84 109.99 179.053 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -102.81 151.22 22.67 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.71 -0.478 . . . . 2.76 109.71 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -102.98 126.45 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.913 0.387 . . . . 1.27 111.486 -179.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.46 150.21 48.83 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.878 -0.601 . . . . 1.84 110.067 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -78.87 165.39 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.506 -0.315 . . . . 1.28 111.463 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 44' ' ' ILE . 2.3 tt -54.48 113.48 1.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.445 0.905 . . . . 1.66 113.445 -178.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . 63.4 47.9 83.39 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.508 -0.769 . . . . 1.66 114.065 178.331 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.455 HG22 ' HA3' ' A' ' 107' ' ' GLY . 0.6 OUTLIER -72.98 86.36 1.31 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 1.58 111.444 179.58 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 142.63 131.0 2.53 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 121.019 -0.61 . . . . 1.96 111.68 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.23 -31.81 89.99 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.984 2.456 . . . . 2.62 112.558 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.93 30.69 4.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.849 0.357 . . . . 3.09 111.782 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.0 -70.57 0.41 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.79 0.329 . . . . 1.79 110.582 179.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.97 34.38 55.84 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.829 -0.7 . . . . 1.65 111.546 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HD2' ' A' ' 87' ' ' LYS . 3.2 mt -123.4 95.17 45.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 120.727 0.298 . . . . 1.38 110.831 -179.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.77 158.13 43.26 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.591 2.194 . . . . 1.62 112.095 179.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -59.26 106.39 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 1.58 110.322 179.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 128.38 -17.8 5.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.819 -0.705 . . . . 1.44 112.408 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.3 138.3 51.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 1.25 110.492 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -100.04 144.86 28.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.458 -0.337 . . . . 1.86 111.026 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HD2' HD21 ' A' ' 81' ' ' LEU . 26.6 tttt -158.47 169.48 24.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.931 -0.577 . . . . 1.68 109.982 179.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.04 112.52 2.38 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.313 0.486 . . . . 1.7 112.313 -179.554 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.3 39.62 91.94 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.841 -0.618 . . . . 1.27 112.389 179.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -128.88 113.71 30.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.073 0.464 . . . . 1.01 111.295 -179.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.503 ' CG1' ' HB2' ' A' ' 47' ' ' TYR . 24.3 pt -122.54 139.6 48.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.369 -0.604 . . . . 1.3 109.369 178.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -96.44 137.88 34.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.877 0.37 . . . . 1.08 111.686 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 m -133.15 131.84 58.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.621 -0.718 . . . . 1.04 110.617 -179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 44' ' ' ILE . . . -154.41 162.87 40.92 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.844 -0.616 . . . . 1.27 110.363 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -139.09 172.85 12.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.094 -0.503 . . . . 1.36 109.907 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.69 127.56 32.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.333 -0.394 . . . . 2.64 110.626 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.14 -20.5 26.01 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.908 -0.663 . . . . 1.52 111.618 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.771 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -82.68 135.27 35.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.894 0.378 . . . . 1.59 110.362 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.07 139.66 43.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 2.15 110.858 -179.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -72.6 107.02 4.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.123 -0.489 . . . . 2.07 110.526 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.469 ' H ' HD13 ' A' ' 73' ' ' LEU . 1.9 t -174.57 150.22 1.41 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.959 -0.756 . . . . 2.36 108.959 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.452 ' HD2' ' OG1' ' A' ' 101' ' ' THR . 10.5 Cg_endo -55.1 116.88 3.45 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.82 2.347 . . . . 2.08 112.231 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.2 mmtt -114.76 34.29 4.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.852 -0.613 . . . . 1.78 110.383 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 8.7 p-10 -71.05 -3.68 20.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 2.55 112.175 -179.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -61.18 -21.16 63.55 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.437 0.532 . . . . 2.24 112.437 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 16.9 mt -101.99 -16.54 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.265 0.555 . . . . 2.0 110.441 179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.455 ' HA3' HG22 ' A' ' 75' ' ' THR . . . -79.84 72.2 2.61 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.933 -0.576 . . . . 2.33 112.693 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.8 ' HA ' HG22 ' A' ' 9' ' ' THR . 14.9 t -160.65 36.07 0.16 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.787 0.803 . . . . 2.99 110.453 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -76.49 138.03 40.01 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.694 -0.684 . . . . 2.83 111.153 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -80.92 117.79 69.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 3.56 110.519 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.772 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 51.8 Cg_endo -70.88 -47.33 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.871 2.381 . . . . 3.39 114.219 -178.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.49 ' HA ' ' H21' ' C' ' 8' ' ' ' G' . . . -85.77 18.91 2.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.035 0.754 . . . . 4.05 113.035 -177.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -150.22 23.33 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.936 0.398 . . . . 4.48 111.589 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -174.51 136.02 0.44 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.071 -0.513 . . . . 3.39 109.986 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.2 154.66 19.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.662 0.268 . . . . 3.21 111.095 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -81.75 154.31 26.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.164 0.506 . . . . 2.85 111.234 -179.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.2 mt -89.04 140.36 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.654 -0.703 . . . . 2.42 109.598 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.05 113.33 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.665 -0.495 . . . . 2.74 109.665 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 13' ' ' PHE . 7.5 tt -64.84 115.52 5.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.721 -0.672 . . . . 2.11 111.593 -178.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.0 148.71 50.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.652 -0.704 . . . . 2.49 109.399 179.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.12 157.37 34.6 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.343 -0.39 . . . . 1.91 110.695 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.32 148.49 92.83 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.538 2.158 . . . . 1.84 111.85 179.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -57.62 113.08 1.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.131 -0.486 . . . . 2.53 110.274 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 127.42 -24.15 5.32 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.194 -1.162 . . . . 2.2 110.194 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.7 m -91.94 109.75 21.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.127 0.489 . . . . 2.1 109.712 179.139 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 131.97 35.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.702 -0.681 . . . . 2.78 111.198 -179.378 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.7 mt -70.62 134.79 86.21 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.132 -0.485 . . . . 2.62 109.731 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.57 142.18 95.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.612 2.208 . . . . 2.77 111.468 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.83 124.25 21.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 4.11 110.621 -179.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.22 -8.12 41.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.768 -0.73 . . . . 3.18 111.9 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -99.47 128.92 45.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.066 0.46 . . . . 2.91 111.416 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.409 ' HE2' ' HB2' ' A' ' 19' ' ' HIS . 33.1 p90 -145.98 139.13 25.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.627 -0.715 . . . . 3.54 109.738 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -107.45 148.15 29.52 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.631 0.253 . . . . 2.93 110.452 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.417 ' HB2' ' NH2' ' A' ' 67' ' ' ARG . 37.3 tt0 -67.77 125.9 27.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.384 -0.371 . . . . 3.64 110.232 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.2 -18.18 57.93 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.712 -0.756 . . . . 3.27 112.615 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 133' ' ' ALA . 14.7 m -75.13 95.26 3.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.865 0.364 . . . . 3.59 110.806 179.621 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -93.13 123.84 36.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.074 -0.512 . . . . 5.55 110.141 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -94.84 100.35 2.56 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.831 -0.7 . . . . 5.22 111.892 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 99.31 -96.88 1.74 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.766 -0.731 . . . . 5.91 112.041 179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 C--O 1.248 0.996 0 CA-C-O 119.108 -0.472 . . . . 7.27 111.331 -179.727 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.492 -3.574 1 C4'-C3'-C2' 97.091 -5.609 . 0.0 '__' . 12.01 . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 C2'--O2' 1.473 4.607 2 N19-C1'-C2' 103.459 -6.213 . 0.233 1a . 11.43 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.462 -5.726 3 O4'-C1'-N19 115.746 7.546 . 0.529 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.592 6.122 4 O4'-C1'-N19 116.641 8.441 . 0.514 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.374 -4.141 2 C4'-C3'-C2' 97.567 -5.133 . 0.651 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.672 4 N19-C1'-C2' 106.341 -4.412 . 0.945 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 1 O3'--C3' 1.496 5.214 3 P-O3'-C3' 127.004 6.087 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . 0.49 ' H21' ' HA ' ' A' ' 112' ' ' ALA . . . . . . . . 2 C2'--C1' 1.581 5.315 3 O4'-C4'-C3' 114.958 6.756 . 0.0 '__' . 15.26 . . . . . . . . . . 3 2 . 1 . 029 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.544 -4.935 2 O4'-C1'-N19 118.571 10.371 . 0.414 1a . 14.39 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.549 -4.443 3 O3'-P-O5' 116.298 6.473 . 0.458 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.191 1 C4'-C3'-C2' 98.267 -4.433 . 0.307 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.585 5.552 1 C4'-C3'-C2' 94.371 -8.329 . 0.456 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 3 C4'--C3' 1.587 5.731 1 O3'-P-O5' 111.75 4.079 . 0.106 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 029 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.577 4.934 2 C3'-C2'-C1' 105.7 4.666 . 0.336 1a . 15.71 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.491 -0.644 . . . . 9.05 111.491 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.42 133.98 45.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.768 0.318 . . . . 8.09 110.569 -179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.9 mtm -113.78 86.43 2.4 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.269 -0.423 . . . . 8.02 111.048 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.35 83.94 1.39 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.986 -0.626 . . . . 5.76 111.746 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.8 mt -77.99 139.52 61.49 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 120.535 0.207 . . . . 4.72 110.749 -179.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.28 -18.85 26.34 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.493 2.129 . . . . 4.45 111.72 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -82.21 125.53 31.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.834 -0.621 . . . . 4.41 110.478 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -99.75 -57.02 2.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.45 -0.341 . . . . 3.92 111.608 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.7 p 51.72 74.06 0.28 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.917 0.71 . . . . 2.53 112.917 -179.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.47 153.09 17.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.314 -0.403 . . . . 2.48 111.066 179.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.71 149.28 41.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.996 -0.547 . . . . 2.13 111.038 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 31.5 m95 -78.62 -30.63 46.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.99 0.424 . . . . 2.4 111.254 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CD1' ' HB ' ' A' ' 117' ' ' ILE . 76.7 m-85 -112.19 168.23 9.78 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.926 -0.579 . . . . 2.02 111.84 -178.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 1.0 OUTLIER -70.1 175.02 4.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.817 -0.629 . . . . 2.65 111.362 179.644 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -91.87 148.33 22.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 2.4 111.058 -179.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.673 HD21 HD22 ' A' ' 119' ' ' LEU . 95.9 mt -84.22 119.21 24.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.847 -0.615 . . . . 2.27 109.653 178.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.35 107.28 14.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 2.84 110.523 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.829 ' HB3' ' HB2' ' A' ' 66' ' ' PRO . 5.8 tp-100 -85.9 133.93 33.92 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 2.89 111.286 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -129.96 10.05 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.951 -0.568 . . . . 3.82 110.428 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.4 -178.17 23.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.735 -0.745 . . . . 3.23 112.846 -179.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -74.03 -38.08 64.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 4.27 111.468 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.94 166.78 23.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 3.32 111.412 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.78 -70.34 0.68 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.249 -0.648 . . . . 2.39 109.249 178.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.666 HD13 ' CE1' ' A' ' 131' ' ' PHE . 16.9 tp -177.58 134.28 0.17 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.747 -0.66 . . . . 2.06 110.614 178.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' H ' HD12 ' A' ' 24' ' ' LEU . 45.8 tptt -154.46 128.69 9.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 2.22 109.495 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 11.7 m-85 -123.56 144.78 45.16 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.466 . . . . 1.78 110.284 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 26' ' ' PHE . 13.6 Cg_exo -69.58 161.77 44.59 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.814 2.343 . . . . 2.15 112.386 -179.71 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -65.41 130.35 42.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.997 -0.547 . . . . 2.6 110.454 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.92 59.46 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.901 -0.666 . . . . 1.65 111.937 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -159.66 159.27 32.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.644 0.259 . . . . 2.31 110.328 -179.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.67 -17.78 10.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.715 -0.755 . . . . 1.33 112.797 179.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.41 122.27 80.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.154 -0.313 . . . . 1.06 110.154 -179.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 74.2 Cg_endo -76.71 -177.92 4.13 Favored 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.68 2.253 . . . . 1.27 112.047 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -77.21 98.69 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.594 -0.521 . . . . 1.7 109.594 179.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.446 ' HA ' ' HZ ' ' A' ' 13' ' ' PHE . 60.9 m-80 -89.48 83.41 6.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.087 0.47 . . . . 1.23 111.018 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.79 65.78 2.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.682 -0.69 . . . . 1.94 111.055 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -173.19 -28.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.258 -0.428 . . . . 1.96 111.255 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -105.59 167.16 9.94 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.31 -0.405 . . . . 1.42 111.827 -178.796 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.94 166.0 38.16 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.965 -0.561 . . . . 1.73 110.095 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.19 -37.47 94.24 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.894 2.396 . . . . 1.42 112.505 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.532 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.77 -20.36 61.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 1.78 110.75 179.804 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.946 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 27.1 m-20 -85.58 -0.72 55.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 1.6 110.777 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -78.62 55.47 1.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.032 0.444 . . . . 1.05 111.637 -179.594 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.614 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.4 tt -149.72 130.95 4.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.867 -0.606 . . . . 1.17 109.82 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -144.45 4.33 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.311 -0.947 . . . . 0.6 112.631 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -157.2 161.89 39.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.853 0.359 . . . . 0.99 110.685 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.428 ' HB3' ' HE3' ' A' ' 68' ' ' TRP . 53.1 m-85 -103.27 131.82 50.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.054 -0.721 . . . . 1.26 109.054 178.367 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -110.75 125.35 53.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.277 -0.419 . . . . 2.15 110.965 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -72.15 130.85 41.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.945 -0.571 . . . . 2.4 109.775 178.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.14 155.14 51.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.377 -0.374 . . . . 2.21 110.753 -179.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.69 160.08 42.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.046 -0.525 . . . . 2.68 110.538 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.41 ' HB3' HD12 ' A' ' 64' ' ' LEU . 21.5 tpt180 -136.32 115.27 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 3.59 111.081 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -139.15 103.12 4.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.416 -0.356 . . . . 3.43 111.639 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 62' ' ' LYS . 22.2 pt -72.09 160.99 5.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.645 -0.502 . . . . 4.26 109.645 178.675 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -121.12 92.95 3.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 5.17 111.075 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.75 155.23 40.83 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 4.66 111.594 179.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.51 -38.56 96.54 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.249 -0.5 . . . . 5.04 112.288 -179.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.52 32.17 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.395 0.617 . . . . 5.51 110.834 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.76 21.71 71.34 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.935 -0.575 . . . . 4.73 112.267 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -76.62 145.75 38.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.675 0.274 . . . . 5.52 110.333 -179.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.7 mtt -141.88 139.24 32.55 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.204 -0.453 . . . . 4.48 110.286 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HB2' HG12 ' A' ' 54' ' ' ILE . 43.8 tptt -64.64 -57.88 7.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.018 -0.537 . . . . 4.16 109.586 179.356 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.64 83.7 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.507 -0.769 . . . . 4.09 112.354 178.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.42 HD21 ' HE3' ' A' ' 62' ' ' LYS . 37.2 mt -93.6 170.96 9.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.854 -0.612 . . . . 3.36 110.786 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -70.37 154.71 94.3 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.761 -0.654 . . . . 3.36 109.829 179.201 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.829 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 51.4 Cg_exo -55.28 123.62 14.26 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.559 2.173 . . . . 2.69 110.616 178.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 56.5 mtt-85 -120.27 144.16 47.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.563 0.579 . . . . 3.03 112.563 -178.052 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.428 ' HE3' ' HB3' ' A' ' 47' ' ' TYR . 53.4 m95 -128.11 124.71 37.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.68 -0.691 . . . . 1.84 109.699 178.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -103.6 145.95 29.28 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.047 -0.353 . . . . 2.76 110.047 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -96.48 129.43 43.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.812 0.339 . . . . 1.27 111.1 179.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -128.12 153.42 46.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 1.84 110.106 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -86.85 163.4 17.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.522 -0.308 . . . . 1.28 110.309 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.684 ' HG ' ' HZ3' ' A' ' 92' ' ' TRP . 2.3 tt -62.69 121.93 14.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.297 -0.41 . . . . 1.66 110.513 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.21 26.82 29.82 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.918 -0.658 . . . . 1.66 113.762 178.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.21 90.11 4.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.338 0.569 . . . . 1.58 111.109 179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.52 124.34 2.29 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.638 -0.791 . . . . 1.96 111.878 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.51 -21.61 39.83 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.701 2.267 . . . . 2.62 112.324 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -115.88 17.94 15.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.009 0.433 . . . . 3.09 110.679 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.65 -61.94 1.58 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.959 -0.564 . . . . 1.79 110.842 -179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.33 94.51 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.213 -0.518 . . . . 1.65 112.572 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.466 HD11 ' HE3' ' A' ' 87' ' ' LYS . 86.1 mt -118.13 104.76 47.95 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 120.676 0.274 . . . . 1.38 110.478 -179.713 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.16 161.43 29.29 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.655 2.237 . . . . 1.62 111.344 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.515 ' HB2' HD11 ' A' ' 73' ' ' LEU . 92.2 t80 -54.21 119.34 4.99 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.488 -0.324 . . . . 1.58 110.464 179.598 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 111.38 -14.73 27.78 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.838 -0.696 . . . . 1.44 112.335 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.4 123.28 16.82 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.833 0.349 . . . . 1.25 110.845 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -90.74 131.45 36.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 1.86 111.278 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HE3' HD11 ' A' ' 81' ' ' LEU . 15.0 ttmm -150.93 154.99 38.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.992 -1.114 . . . . 1.68 107.992 179.075 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.5 115.41 3.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.04 0.448 . . . . 1.7 111.685 -179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.74 32.7 49.32 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.682 -0.69 . . . . 1.27 112.586 179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.4 mm -132.63 105.52 8.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.912 0.387 . . . . 1.01 110.995 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 91' ' ' ILE . 4.1 pt -117.31 130.23 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 1.3 109.72 178.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.684 ' HZ3' ' HG ' ' A' ' 73' ' ' LEU . 86.3 m95 -86.23 145.42 26.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.714 0.635 . . . . 1.08 112.714 -178.508 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.47 133.84 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.702 -0.681 . . . . 1.04 110.218 179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.6 166.53 24.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.365 -0.38 . . . . 1.27 111.102 -179.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -137.99 164.08 29.95 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.217 -0.66 . . . . 1.36 109.217 179.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.68 114.0 8.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.74 -0.467 . . . . 2.64 109.74 179.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.12 -18.15 6.6 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.538 -1.025 . . . . 1.52 110.538 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.614 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -80.25 142.45 34.6 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.516 -0.342 . . . . 1.59 110.084 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' HG ' ' HB2' ' A' ' 41' ' ' ASP . 97.0 mt -100.79 133.65 44.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.499 -0.319 . . . . 2.15 111.135 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -76.07 86.97 2.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.223 0.535 . . . . 2.07 109.873 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.554 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 6.3 t -161.98 144.34 8.73 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.609 -0.723 . . . . 2.36 109.125 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.93 126.94 17.48 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.159 1.906 . . . . 2.08 112.137 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.946 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -133.22 77.78 1.75 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.463 0.649 . . . . 1.78 111.22 179.584 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.15 -0.34 35.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.744 -0.662 . . . . 2.55 111.618 -179.585 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.501 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 10.4 p80 -60.48 -19.85 58.07 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.075 0.464 . . . . 2.24 111.894 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.3 pt -114.12 14.21 8.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.065 -0.516 . . . . 2.0 110.296 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.74 69.28 0.29 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.71 -0.757 . . . . 2.33 112.067 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -165.04 27.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.33 0.586 . . . . 2.99 110.821 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 12' ' ' TRP . 59.5 ttp85 -65.33 128.05 34.28 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.057 -0.52 . . . . 2.83 110.291 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -75.87 117.58 64.85 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.311 -0.404 . . . . 3.56 110.213 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.56 ' HB2' " H5'" ' C' ' 9' ' ' ' U' . 73.4 Cg_endo -74.88 -21.55 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.691 2.261 . . . . 3.39 113.815 -178.367 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -96.14 -21.43 17.93 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.311 0.485 . . . . 4.05 112.311 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -113.7 19.32 16.83 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.032 0.382 . . . . 4.48 112.032 -178.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -163.68 139.52 6.56 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.421 -0.354 . . . . 3.39 110.412 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.62 133.96 35.1 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.051 -0.351 . . . . 3.21 110.051 179.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.14 161.19 31.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.209 0.528 . . . . 2.85 111.456 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.542 ' HB ' ' CD1' ' A' ' 13' ' ' PHE . 6.5 mt -100.04 155.15 4.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.099 -0.704 . . . . 2.42 109.099 179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.6 t -74.69 127.36 36.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.182 -0.207 . . . . 2.74 110.445 179.74 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.673 HD22 HD21 ' A' ' 16' ' ' LEU . 4.6 tt -64.53 116.96 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.936 0.398 . . . . 2.11 110.553 179.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -130.17 130.41 44.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.227 -0.442 . . . . 2.49 110.402 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.684 HD13 HG22 ' A' ' 125' ' ' THR . 72.9 mt -79.64 149.17 70.91 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.476 -0.329 . . . . 1.91 110.5 179.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 33' ' ' PRO . 54.4 Cg_endo -69.08 177.94 4.63 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.836 2.357 . . . . 1.84 112.974 -179.333 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -64.52 126.03 26.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.46 -0.791 . . . . 2.53 110.319 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.79 4.09 65.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.599 -0.81 . . . . 2.2 112.347 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.684 HG22 HD13 ' A' ' 121' ' ' LEU . 7.2 m -124.85 116.13 21.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.942 -0.392 . . . . 2.1 109.942 179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.03 151.88 35.84 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.284 -0.416 . . . . 2.78 111.853 -179.436 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.93 147.52 77.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 2.62 110.829 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.06 164.7 26.59 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.823 2.349 . . . . 2.77 112.359 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.39 120.5 12.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 4.11 111.728 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.32 -0.41 55.84 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.975 -0.631 . . . . 3.18 112.913 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.666 ' CE1' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -114.2 130.95 56.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.761 0.315 . . . . 2.91 111.243 -179.294 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -142.17 152.63 43.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.439 . . . . 3.54 111.053 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.23 134.67 33.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.0 0.371 . . . . 2.93 112.0 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 25.7 tt0 -64.06 124.23 21.07 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.809 -0.632 . . . . 3.64 110.176 178.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.58 -9.46 64.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.995 -0.621 . . . . 3.27 112.651 -179.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.21 128.92 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.502 0.191 . . . . 3.59 110.548 -179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -126.27 110.79 13.81 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.266 -0.425 . . . . 5.55 110.618 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.29 126.67 13.38 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.811 -0.709 . . . . 5.22 112.182 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 134.69 -172.7 21.82 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.587 -0.605 . . . . 5.91 111.587 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 119.072 -0.49 . . . . 7.27 111.61 179.837 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.403 ' N4 ' ' N6 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 C2'--C1' 1.489 -3.853 1 C4'-C3'-C2' 97.018 -5.682 . 0.0 '__' . 12.01 . . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.403 ' N6 ' ' N4 ' ' B' ' 1' ' ' ' C' . . . . . . . . 1 C2'--O2' 1.472 4.514 2 N19-C1'-C2' 103.471 -6.206 . 0.229 1a . 11.43 . . . . . . . . . . 3 2 . 1 . 030 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.464 -5.581 2 O4'-C1'-N19 115.683 7.483 . 0.524 1a . 11.13 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C3'--C2' 1.593 6.171 4 O4'-C1'-N19 116.685 8.485 . 0.513 1a . 11.86 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' B' B ' 5' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 O5'--C5' 1.375 -4.062 2 C4'-C3'-C2' 97.652 -5.048 . 0.65 1a . 13.62 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.526 -6.676 4 C4'-C3'-C2' 98.3 -4.4 . 0.946 1a . 15.48 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 O3'--C3' 1.497 5.267 3 P-O3'-C3' 127.067 6.139 . 0.01 1a . 18.24 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' C' C ' 8' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.582 5.448 3 O4'-C4'-C3' 114.916 6.726 . 0.0 '__' . 15.26 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' C' C ' 9' ' ' ' U' . . . . . 0.56 " H5'" ' HB2' ' A' ' 111' ' ' PRO . . . . . . . . 2 P--O5' 1.543 -5.002 2 O4'-C1'-N19 118.619 10.419 . 0.419 1a . 14.39 . . . . . . . . . . 3 2 . 1 . 030 nuclear nobuild full ' C' C ' 10' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 2 P--O5' 1.547 -4.596 3 O3'-P-O5' 116.383 6.517 . 0.459 1a . 13.77 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' C' C ' 11' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 1 P--O3' 1.557 -4.13 1 C4'-C3'-C2' 98.199 -4.501 . 0.309 1a . 13.73 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' C' C ' 12' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 1 C4'--C3' 1.586 5.638 1 C4'-C3'-C2' 94.325 -8.375 . 0.453 1a . 14.32 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' C' C ' 13' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 2 C4'--C3' 1.587 5.704 1 O3'-P-O5' 111.734 4.071 . 0.105 1a . 14.81 . . . . . . . . . . 2 1 . 1 . 030 nuclear nobuild full ' C' C ' 14' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 2 C2'--C1' 1.578 4.979 2 C3'-C2'-C1' 105.657 4.619 . 0.337 1a . 15.71 . . . . . . . . . . 2 1 . 1 stop_ save_